{"meta":{"query_hash":"640f9589c59b","filters":{"topic":"Melanoma and MAPK Pathways"},"cohort_total":749,"direct_labels_cover":2,"predictions_cover":749,"exported":749,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/640f9589c59b","api":"https://metacan.xera.ac/api/v1/cohort?topic=Melanoma+and+MAPK+Pathways"},"results":[{"id":"W143619609","doi":"10.1023/a:1020705210855","title":"Genetic Selection for Modulators of the MAP Kinase and β-Catenin Growth-Control Pathways in Mammalian Cells","year":2002,"lang":"en","type":"article","venue":"Biochemical Genetics","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Aptose Biosciences (Canada)","funders":"","keywords":"Biology; Genetic screen; Kinase; Mitogen-activated protein kinase; Cell biology; Phenotype; Protein kinase A; Signal transduction; Genetics; Gene","score_opus":0.00985745415457887,"score_gpt":0.18748154573564443,"score_spread":0.17762409158106557,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W143619609","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99581784,0.0021895883,0.0012114694,0.000078623365,0.00015462903,0.00042511753,0.000066673376,0.00000608443,0.000049981463],"genre_scores_gemma":[0.9966918,0.00013545297,0.002697538,0.000112263486,0.00017111786,0.00004692752,0.000012983027,0.000025354402,0.00010653093],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99895483,0.00004351021,0.00028300067,0.00034458327,0.00010731496,0.00026678003],"domain_scores_gemma":[0.9994989,0.000015304851,0.000091936556,0.00023521118,0.00007262262,0.00008604188],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000081169754,0.00017023027,0.00016391545,0.000039314167,0.000042493655,0.000010180398,0.00018656556,0.00023655799,0.000008759289],"category_scores_gemma":[0.00004578342,0.00014285576,0.000099319535,0.00010515688,0.0001038292,0.0000014622112,0.000073619456,0.00007327062,0.000002140326],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000029155211,0.00007119589,0.012697782,0.000062982544,0.000013373985,4.4467214e-7,0.00003642186,0.00004403999,0.9846842,0.000039703387,0.0014488897,0.0008718033],"study_design_scores_gemma":[0.0009934102,0.000201906,0.008990722,0.000011513701,0.000021978633,0.000006421268,0.000013612523,0.0026381242,0.98490715,0.00023299885,0.001804236,0.00017793279],"about_ca_topic_score_codex":0.000012979315,"about_ca_topic_score_gemma":0.000009233614,"teacher_disagreement_score":0.0037070606,"about_ca_system_score_codex":0.000012378,"about_ca_system_score_gemma":0.00002035748,"threshold_uncertainty_score":0.5825489},"labels":[],"label_agreement":null},{"id":"W1490756663","doi":"10.1684/ejd.2014.2300","title":"Dramatic response to radiotherapy combined with vemurafenib. Is vemurafenib a radiosensitizer?","year":2014,"lang":"en","type":"article","venue":"European Journal of Dermatology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"","keywords":"Vemurafenib; Medicine; Radiosensitizer; Melanoma; Radiation therapy; Cancer research; Oncology; Internal medicine; Dermatology; Metastatic melanoma","score_opus":0.00578262844544919,"score_gpt":0.20826384239983944,"score_spread":0.20248121395439025,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1490756663","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9758203,0.00023712966,0.018048525,0.0043766545,0.00026578034,0.00013284657,0.0000034721672,0.000012509106,0.001102785],"genre_scores_gemma":[0.9900799,0.00003254608,0.0057994495,0.0035155006,0.0002585011,0.0000014111346,0.00000513799,0.000056932797,0.00025064053],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9973642,0.001418454,0.00050355744,0.00022977959,0.00017566058,0.00030835185],"domain_scores_gemma":[0.99874735,0.00007337701,0.0003227072,0.00041868308,0.00017191896,0.0002659806],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00064529735,0.00021982347,0.00042243148,0.00015628805,0.00007881903,0.000033031978,0.00036517112,0.000060220016,0.000024248206],"category_scores_gemma":[0.00017655206,0.0001713608,0.00012773057,0.000116594565,0.00009469093,0.0000066703237,0.00005383101,0.00016887252,0.000057858182],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008835619,0.000097175245,0.0011815276,0.000029869865,0.00023812625,0.0015077704,0.00087428774,0.00005117995,0.9602396,0.000117271644,0.023559945,0.0032676428],"study_design_scores_gemma":[0.010998797,0.012150604,0.012114278,0.0001517981,0.000109155895,0.040257633,0.00020072027,0.00015380935,0.4051847,0.000058933187,0.51788926,0.000730338],"about_ca_topic_score_codex":4.7008618e-7,"about_ca_topic_score_gemma":8.372213e-7,"teacher_disagreement_score":0.5550549,"about_ca_system_score_codex":0.0000142463205,"about_ca_system_score_gemma":0.00008557878,"threshold_uncertainty_score":0.6987891},"labels":[],"label_agreement":null},{"id":"W1502027962","doi":"10.1212/wnl.84.14_supplement.p4.232","title":"Guillain-Barre Syndrome after Treatment with Dabrafenib for Metastatic Recurrent Melaloma. (P4.232)","year":2015,"lang":"en","type":"article","venue":"Neurology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Guillain-Barre syndrome; Medicine; Dabrafenib; Internal medicine; Pediatrics; Metastatic melanoma; Cancer","score_opus":0.0253450538833018,"score_gpt":0.2518534204863586,"score_spread":0.22650836660305682,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1502027962","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956469,0.0012281935,0.00089715444,0.00056749734,0.00044016264,0.0005514134,0.00009129106,0.000023171371,0.00055422366],"genre_scores_gemma":[0.99701774,0.000043417043,0.00094045524,0.0008180484,0.00015653946,0.0004458311,0.00019024135,0.000041368694,0.00034636696],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9986942,0.00011080133,0.00019577664,0.0005137634,0.000104812745,0.0003806537],"domain_scores_gemma":[0.999143,0.000026158215,0.0000777175,0.00047327983,0.00008011497,0.00019971543],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000107050364,0.00024655944,0.00027553827,0.00005025445,0.000043208332,0.000013651824,0.00014168317,0.00012184467,0.000022982204],"category_scores_gemma":[0.000037938473,0.0001816977,0.000096795,0.000054124175,0.000081777565,0.000003160404,0.000059578244,0.000063968735,0.00003370346],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.11693637,0.0073880563,0.08335188,0.00082239934,0.005534969,0.010603508,0.00503892,0.0010863447,0.54706424,0.004059874,0.0623093,0.15580414],"study_design_scores_gemma":[0.011744685,0.10557429,0.0055944887,0.000014456277,0.00042006405,0.0033724015,0.0000619462,0.00029624905,0.04958835,0.0006097045,0.8217837,0.00093964336],"about_ca_topic_score_codex":0.000026749938,"about_ca_topic_score_gemma":0.00023254036,"teacher_disagreement_score":0.75947446,"about_ca_system_score_codex":0.000014449608,"about_ca_system_score_gemma":0.00013515887,"threshold_uncertainty_score":0.7409417},"labels":[],"label_agreement":null},{"id":"W1522194210","doi":"10.5772/20002","title":"The Role of Cellular Differentiation and Cell Fate in Malignant Melanoma","year":2011,"lang":"en","type":"book-chapter","venue":"InTech eBooks","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"National Cancer Institute; National Institutes of Health","keywords":"Cell fate determination; Biology; Embryonic stem cell; Cellular differentiation; Progenitor cell; Carcinogenesis; Cell biology; Cell; Cell type; Cancer cell; Stem cell; Cancer; Genetics; Transcription factor; Gene","score_opus":0.009364464319599301,"score_gpt":0.1829541375553763,"score_spread":0.17358967323577698,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1522194210","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.16713205,0.004963459,0.00058284425,0.0000055999553,0.00018792096,0.00041212735,0.000040145544,0.000010522709,0.82666534],"genre_scores_gemma":[0.8967166,0.00025441995,0.000026056248,0.000010280367,0.000058301393,0.0000144136275,0.00004157535,0.00002968757,0.102848664],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992168,0.000018803838,0.00026982982,0.00026064835,0.00008523229,0.00014871021],"domain_scores_gemma":[0.999382,0.000010362535,0.0001835467,0.00034022846,0.00004562167,0.000038197275],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010303341,0.00019686826,0.00018734728,0.000051348856,0.00003610999,0.00001106789,0.00017901498,0.0003315422,0.000015234058],"category_scores_gemma":[0.0000058185465,0.00014624394,0.000081889455,0.000003342163,0.00010137106,7.309451e-7,0.00015637821,0.00013914505,0.0000063086322],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000350891,0.0000070723295,0.00011790827,0.000022368382,0.000025797523,0.000004786216,0.000068433925,9.155977e-9,0.9832854,0.0077482103,0.000014815793,0.008670082],"study_design_scores_gemma":[0.00016058642,0.00016925752,0.000041943225,0.000052930918,0.000021418091,0.0000040287923,0.000018149198,0.0000015540809,0.9032832,0.015461654,0.08063584,0.00014946194],"about_ca_topic_score_codex":0.00003290018,"about_ca_topic_score_gemma":0.0000958577,"teacher_disagreement_score":0.7295846,"about_ca_system_score_codex":0.000007175997,"about_ca_system_score_gemma":0.000035415782,"threshold_uncertainty_score":0.59636545},"labels":[],"label_agreement":null},{"id":"W1530286875","doi":"10.1158/1538-7445.mel2014-a33","title":"Abstract A33: Loss of tumor suppressors KAI1 and p27 identifies a unique subgroup of primary melanoma patients with poor survival","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Melanoma; Cohort; Oncology; Internal medicine; Proportional hazards model; Hazard ratio; Survival analysis; Cancer; Primary tumor; Metastasis; Cancer research","score_opus":0.04099922852141936,"score_gpt":0.31047052523955737,"score_spread":0.269471296718138,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1530286875","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970061,0.0006748483,0.000011842058,0.000037007132,0.000085815795,0.00027374033,0.00017616915,0.000003791853,0.0017306651],"genre_scores_gemma":[0.9992844,0.00010671131,0.00005744882,0.000012907123,0.00006749253,0.000040391802,0.00010496507,0.000020192132,0.00030552477],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99866706,0.000115941286,0.00020479932,0.00028120435,0.00045458614,0.00027642548],"domain_scores_gemma":[0.9988364,0.000034773762,0.00009046275,0.00029460303,0.00059702335,0.00014672753],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00057195744,0.00011223417,0.00021925053,0.00008016371,0.000037997957,0.000015613125,0.00022236485,0.00008301196,0.000021007669],"category_scores_gemma":[0.00009727099,0.00009027763,0.00003288294,0.000117517266,0.0003570626,0.000009502643,0.00019817446,0.00013118178,0.0000015956954],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016039723,0.00020126696,0.32542947,0.00048202448,0.000110744,0.000019835761,0.00028058834,0.000009780827,0.66872114,0.00015141696,0.0023953542,0.0005944363],"study_design_scores_gemma":[0.0014483068,0.0007862215,0.23995656,0.0000745333,0.000010595981,0.0000028633874,0.00014841507,0.0000011367956,0.75526994,0.00009675389,0.0020689648,0.00013570112],"about_ca_topic_score_codex":0.00066043757,"about_ca_topic_score_gemma":0.0002916593,"teacher_disagreement_score":0.086548835,"about_ca_system_score_codex":0.0000278008,"about_ca_system_score_gemma":0.00036451055,"threshold_uncertainty_score":0.3681415},"labels":[],"label_agreement":null},{"id":"W1537901311","doi":"10.1186/ar479","title":"Overexpression of the autoantigen hnRNP-A2 (RA33), the tumour suppressor p53 and activated MAP-Kinase p38 in inflamed synovial tissue","year":2002,"lang":"en","type":"article","venue":"Arthritis Research","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"Gigtforeningen; Univerzita Karlova v Praze","keywords":"Computer science","score_opus":0.02823179607658402,"score_gpt":0.29140622406857036,"score_spread":0.2631744279919863,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1537901311","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938076,0.002466982,0.000003777336,0.0009227892,0.000085075575,0.0004784545,0.00004614543,0.0000063609045,0.0021828227],"genre_scores_gemma":[0.99741703,0.0010200517,0.00003228224,0.000044670498,0.00013905659,0.000053594275,0.000017558406,0.000018547153,0.0012571866],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99817127,0.00047074305,0.00023122848,0.00032394484,0.00038561042,0.00041720358],"domain_scores_gemma":[0.9991659,0.00008557029,0.000055601617,0.00050527765,0.00010693147,0.00008074955],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00052520883,0.0001258672,0.00015283207,0.00006688121,0.00020511777,0.000039369574,0.00038749533,0.0001586543,0.00018055832],"category_scores_gemma":[0.00037530446,0.000082263505,0.000046464807,0.0001973235,0.00035216095,0.000009873166,0.0004972499,0.0003284566,0.000019931871],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006721668,0.00007370252,0.0016049026,0.000024636112,0.0000098637975,0.000017320319,0.00023283978,0.0000038032047,0.98055583,0.00012449318,0.00767748,0.009607891],"study_design_scores_gemma":[0.00086688966,0.00024219739,0.014335132,0.0001473705,0.0000016001417,0.000021925665,0.00011936258,0.00007636859,0.9463187,0.000144717,0.03762157,0.00010415292],"about_ca_topic_score_codex":0.00022265175,"about_ca_topic_score_gemma":0.00024177671,"teacher_disagreement_score":0.03423714,"about_ca_system_score_codex":0.000011356222,"about_ca_system_score_gemma":0.00005365431,"threshold_uncertainty_score":0.33546084},"labels":[],"label_agreement":null},{"id":"W1557009112","doi":"","title":"Sustained activation of the extracellular signal-regulated kinase pathway protects cells from photofrin-mediated photodynamic therapy.","year":2002,"lang":"en","type":"article","venue":"PubMed","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":74,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"MAPK/ERK pathway; Kinase; Protein kinase A; Photodynamic therapy; Cell biology; Cancer research; Extracellular; Signal transduction; Photosensitizer; Biology; Mitogen-activated protein kinase; Chemistry","score_opus":0.010650561078665981,"score_gpt":0.17010030278792437,"score_spread":0.15944974170925838,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1557009112","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99609756,0.0006890412,0.00016785176,0.000081581406,0.00014457772,0.0018360625,0.00007419218,0.000027537495,0.00088157656],"genre_scores_gemma":[0.99721026,0.000064173124,0.000032848457,0.00009256732,0.00010818636,0.0007549519,0.00013737763,0.00003463333,0.0015649712],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986299,0.00014912806,0.00027831935,0.00036488855,0.00021756232,0.00036015647],"domain_scores_gemma":[0.9990189,0.000028691391,0.00022174542,0.0005388704,0.000096827,0.000094978706],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016586918,0.00021147096,0.00018141362,0.00004552935,0.00008149959,0.000019170448,0.00029824045,0.00022435743,0.00012022332],"category_scores_gemma":[0.00007736986,0.00015759173,0.00013815853,0.00019965645,0.00008326838,0.0000067186324,0.000101221754,0.0001236114,0.0000063742655],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000112994996,0.00015835982,0.00008507878,0.000013888863,0.00006125955,0.0000040095138,0.00007248214,0.000032554854,0.9800399,0.000010286638,0.00025173204,0.019157464],"study_design_scores_gemma":[0.0011301163,0.00007306857,0.005446142,0.000008704629,0.000009456766,0.0000011563301,0.000039008726,0.00049850985,0.9862134,0.00007041655,0.0063204337,0.00018959556],"about_ca_topic_score_codex":0.00009388941,"about_ca_topic_score_gemma":0.000012960642,"teacher_disagreement_score":0.018967869,"about_ca_system_score_codex":0.000026557143,"about_ca_system_score_gemma":0.00003619362,"threshold_uncertainty_score":0.6426404},"labels":[],"label_agreement":null},{"id":"W1602852817","doi":"10.1158/1538-7445.am2014-3895","title":"Abstract 3895: Tumor suppressor activity of the ERK/MAPK signaling: inhibition of cell reprogramming by degradation of specific proteins","year":2014,"lang":"en","type":"article","venue":"Cancer Research","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"MAPK/ERK pathway; Cell biology; Biology; PI3K/AKT/mTOR pathway; Senescence; Cancer cell; Cancer research; Cell cycle; Signal transduction; Cell; Cancer; Genetics","score_opus":0.04364875536596474,"score_gpt":0.31197097774244864,"score_spread":0.2683222223764839,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1602852817","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99807453,0.0003126387,0.00036059262,0.00004588996,0.000045341094,0.0004265001,0.00006996942,0.0000026788175,0.00066186173],"genre_scores_gemma":[0.99940866,0.000042042728,0.00014171636,0.0000035451346,0.000084915555,0.00006632615,0.000031813375,0.00001287926,0.00020808811],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988632,0.00015929135,0.00020797664,0.00024044809,0.0003340411,0.00019502421],"domain_scores_gemma":[0.99906874,0.00002955561,0.00018989788,0.0004052647,0.0002654069,0.000041133055],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007466494,0.000076285774,0.00013813883,0.000041083742,0.000056305435,0.000008029396,0.00018103216,0.00007924462,0.000034298315],"category_scores_gemma":[0.000108612985,0.00005972952,0.00007409302,0.00014260109,0.00018302273,0.000005523876,0.000097129065,0.00014987797,8.6811605e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010642197,0.00011549257,0.00035044993,0.00021005337,0.000008981979,2.3247364e-7,0.000045836598,0.00001162397,0.99547976,0.000035924855,0.0007196013,0.0029156224],"study_design_scores_gemma":[0.00030515663,0.00023092172,0.0017100828,0.000066480214,0.000003852468,4.1932392e-7,0.000046209967,0.000007267803,0.9940598,0.000039255345,0.0034732693,0.000057283894],"about_ca_topic_score_codex":0.0002872117,"about_ca_topic_score_gemma":0.000031024225,"teacher_disagreement_score":0.0028583384,"about_ca_system_score_codex":0.000019886553,"about_ca_system_score_gemma":0.00012309398,"threshold_uncertainty_score":0.24356991},"labels":[],"label_agreement":null},{"id":"W167223770","doi":"10.1096/fasebj.21.5.a138-b","title":"VEGFR2 regulates p38 but not ERK1/2 in response to shear stress","year":2007,"lang":"en","type":"article","venue":"The FASEB Journal","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"York University","funders":"Canadian Institutes of Health Research","keywords":"Phosphorylation; p38 mitogen-activated protein kinases; Shear stress; Kinase; Vascular endothelial growth factor; Chemistry; Internal medicine; Endocrinology; Cell biology; Biology; MAPK/ERK pathway; Medicine; VEGF receptors; Materials science","score_opus":0.01267770843528012,"score_gpt":0.24868531567213797,"score_spread":0.23600760723685785,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W167223770","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99741125,0.00022963787,0.00062511704,0.0006634436,0.00024695238,0.00010132837,0.000017416596,0.000005418143,0.0006994215],"genre_scores_gemma":[0.99661064,0.000031838947,0.000383371,0.00058491103,0.0004966798,0.0000022331394,0.000006870266,0.000015835021,0.001867639],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989324,0.0001517442,0.00024245722,0.00016353745,0.00016600343,0.00034382014],"domain_scores_gemma":[0.9993695,0.000049716364,0.000066613786,0.00029717715,0.000052033025,0.0001649646],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016364926,0.00011785333,0.00011074029,0.00008344193,0.00012264612,0.000039183466,0.000291795,0.000099690944,0.00004406078],"category_scores_gemma":[0.00018723431,0.000083637664,0.00007059518,0.000095698044,0.00004458138,0.0000034163916,0.000089306646,0.00021203858,0.000038707007],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018604327,0.0000313789,0.0014055071,0.0000027618348,0.000015130222,0.00010075986,0.00018299402,0.00010709428,0.99343896,0.000028542869,0.0009170191,0.001909441],"study_design_scores_gemma":[0.00048726937,0.0003357653,0.033594213,0.000027960028,0.000006752153,0.0002806043,0.0002977103,0.0000091426255,0.9568278,0.000051757015,0.007959628,0.00012139644],"about_ca_topic_score_codex":0.000019202807,"about_ca_topic_score_gemma":0.000064463406,"teacher_disagreement_score":0.03661114,"about_ca_system_score_codex":0.00002548932,"about_ca_system_score_gemma":0.0000821896,"threshold_uncertainty_score":0.3410645},"labels":[],"label_agreement":null},{"id":"W1743462958","doi":"10.1016/j.celrep.2015.07.011","title":"Functional Redundancy of ERK1 and ERK2 MAP Kinases during Development","year":2015,"lang":"en","type":"article","venue":"Cell Reports","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":104,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Institute for Research in Immunology and Cancer","funders":"Canadian Institutes of Health Research","keywords":"Biology; Kinase; Effector; MAPK/ERK pathway; Cell biology; Mitogen-activated protein kinase; Embryonic stem cell; MAPK7; Signal transduction; Embryo; Embryogenesis; Genetics; MAP kinase kinase kinase; Gene","score_opus":0.01734037690953149,"score_gpt":0.20556685864015506,"score_spread":0.18822648173062356,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1743462958","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99127734,0.0011848412,0.000117076335,0.000009426294,0.0002883396,0.00006193691,0.0000010812553,0.000006195057,0.00705376],"genre_scores_gemma":[0.99422413,0.000014652654,0.00073157426,0.0000130317085,0.0001008269,0.000007713231,0.00005910068,0.000008345438,0.0048406],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993895,0.000009735731,0.00019481011,0.0002024778,0.000100939,0.00010248947],"domain_scores_gemma":[0.9995639,0.0000020595874,0.00010604106,0.00017434961,0.00006526053,0.00008839837],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010892781,0.00007460498,0.00008218461,0.00002047129,0.000032505824,0.0000056951776,0.000024155452,0.00005839918,0.000015101807],"category_scores_gemma":[0.000032501273,0.00007017729,0.000022627386,0.00001904917,0.000030122035,0.0000019348013,0.00007181701,0.000025784295,0.0000027104854],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004044081,0.000056290537,0.03069154,0.00008320658,0.000017412327,0.00013850398,0.00007555016,0.000011491785,0.9636169,0.0000143962525,0.0046743383,0.0005798972],"study_design_scores_gemma":[0.0001871427,0.000059320515,0.029865423,0.0000106360785,0.0000058032165,0.0001961588,0.00003877636,4.9537294e-7,0.90657055,0.00005115187,0.06292652,0.00008799269],"about_ca_topic_score_codex":0.00000508212,"about_ca_topic_score_gemma":0.000003926721,"teacher_disagreement_score":0.058252186,"about_ca_system_score_codex":0.000007617707,"about_ca_system_score_gemma":0.00014572575,"threshold_uncertainty_score":0.28617468},"labels":[],"label_agreement":null},{"id":"W179471864","doi":"10.1096/fasebj.21.6.a1042-d","title":"p38 Stress Kinase Controls Late Apoptotic Events in L‐Glutamine‐deprived Sp2/0‐Ag14 Murine Hybridoma Cells","year":2007,"lang":"en","type":"article","venue":"The FASEB Journal","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Laurentian University","funders":"","keywords":"Apoptosis; p38 mitogen-activated protein kinases; Programmed cell death; Glutamine; Cell biology; Oxidative stress; Mitochondrion; Caspase 3; Kinase; Biology; Caspase; Molecular biology; Protein kinase A; Biochemistry; Amino acid","score_opus":0.008247807202436298,"score_gpt":0.22498434136190795,"score_spread":0.21673653415947167,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W179471864","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996118,0.0005715101,0.0016954523,0.000110355315,0.00048828457,0.00022974891,0.00003150872,0.000008418627,0.0007466837],"genre_scores_gemma":[0.9976428,0.00022685969,0.00017444465,0.0002554509,0.0006706555,0.000004440044,0.000032710785,0.000026644548,0.0009659491],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99844205,0.00015137692,0.00041892112,0.0002400855,0.00022514674,0.0005224454],"domain_scores_gemma":[0.9991341,0.00004558271,0.00019316278,0.00035877325,0.000068812136,0.0001995263],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000924818,0.00021370214,0.00022331584,0.00008669535,0.00013970264,0.000027681588,0.00039929224,0.00011112802,0.000062635074],"category_scores_gemma":[0.00007063412,0.00015554544,0.00014607453,0.0000903529,0.00006546129,0.000007256133,0.00011448342,0.00033212054,0.00004244788],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003255229,0.00012730948,0.008013309,0.000009629975,0.00005170707,0.00023514342,0.00005663272,0.00025847583,0.98892534,0.000017997536,0.00015838195,0.0018205333],"study_design_scores_gemma":[0.0025693877,0.00028481038,0.030447911,0.000048691367,0.000030365774,0.0002530273,0.000099434656,0.00009747594,0.9643056,0.00014358622,0.0015063785,0.00021335336],"about_ca_topic_score_codex":0.00002654968,"about_ca_topic_score_gemma":0.00008381041,"teacher_disagreement_score":0.024619779,"about_ca_system_score_codex":0.00003196221,"about_ca_system_score_gemma":0.00006491915,"threshold_uncertainty_score":0.6342959},"labels":[],"label_agreement":null},{"id":"W1807939285","doi":"10.1002/cncr.11644","title":"Use of tamoxifen in the treatment of malignant melanoma","year":2003,"lang":"en","type":"review","venue":"Cancer","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":65,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Ontario Institute for Cancer Research","funders":"","keywords":"Medicine; Tamoxifen; Oncology; Randomized controlled trial; Chemotherapy; Internal medicine; Regimen; Breast cancer; Cancer","score_opus":0.10515487838313409,"score_gpt":0.33695959819222127,"score_spread":0.23180471980908718,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1807939285","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004060181,0.99474955,0.000004511005,0.000003555438,0.0001407621,0.00042186375,0.00020554435,8.539182e-7,0.0004131828],"genre_scores_gemma":[0.00029141197,0.9984489,0.000044635708,0.000021960002,0.000089707435,0.00020085521,0.00011608507,0.000017215654,0.00076922146],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9991636,0.00012291966,0.0003084411,0.00020518327,0.000071111586,0.00012870351],"domain_scores_gemma":[0.999302,0.00002014948,0.00020842177,0.0004223324,0.00002571436,0.000021352007],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006368494,0.00018262661,0.00058977975,0.000035973055,0.00000896579,0.0000038342287,0.00014961249,0.0001862232,0.000029491388],"category_scores_gemma":[0.000008634796,0.00010266049,0.00025755184,0.000082973,0.000043547203,8.432343e-7,0.000013274096,0.000034620025,0.0000017790622],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000017726457,0.0002447072,0.0001898171,0.0030058713,0.00024453044,0.000016385886,0.0001326697,0.0000024183591,0.0013407809,0.00018766076,0.0021111332,0.9925063],"study_design_scores_gemma":[0.00012425975,0.00032303875,0.000020455556,0.0006438709,0.00017199566,0.000008625217,0.0000061556775,1.3039406e-7,0.002669498,0.0000035128623,0.9959255,0.00010298249],"about_ca_topic_score_codex":0.000092817165,"about_ca_topic_score_gemma":0.00007568768,"teacher_disagreement_score":0.99381435,"about_ca_system_score_codex":0.00002709939,"about_ca_system_score_gemma":0.00022054711,"threshold_uncertainty_score":0.4186373},"labels":[],"label_agreement":null},{"id":"W1829588377","doi":"10.3389/fbioe.2015.00128","title":"Gαi3-Dependent Inhibition of JNK Activity on Intracellular Membranes","year":2015,"lang":"en","type":"article","venue":"Frontiers in Bioengineering and Biotechnology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Heart and Stroke Foundation","funders":"Canadian Institutes of Health Research; Heart and Stroke Foundation of Canada","keywords":"Intracellular; Membrane; Chemistry; Cell biology; Biochemistry; Biology","score_opus":0.008850589721511273,"score_gpt":0.19570997048721087,"score_spread":0.18685938076569958,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1829588377","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97902364,0.0015648041,0.018498417,0.0002661767,0.00040940332,0.00009840272,0.0000102480235,0.000031541447,0.000097363976],"genre_scores_gemma":[0.9968326,0.0004757237,0.0025424948,0.000015614705,0.000048705664,0.000008171954,0.000015952084,0.000011425323,0.00004929157],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993752,0.000018540622,0.0001265425,0.00023914828,0.00006902829,0.0001715238],"domain_scores_gemma":[0.9996859,0.0000029951666,0.000042991232,0.00020131037,0.000017696806,0.000049121627],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000144386,0.00012229128,0.00017178369,0.0001846726,0.000013327924,0.0000043144787,0.000077636636,0.0003716857,6.6322644e-7],"category_scores_gemma":[0.000055960107,0.00011722008,0.00002568491,0.00009931278,0.0000904055,0.0000032496876,0.00006357151,0.00013379962,9.045311e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000091962145,0.000051139465,0.00087480183,0.000041496394,0.000017815159,0.000010706079,0.0000238812,0.00027591814,0.98958725,0.00025306715,0.00037432142,0.008397647],"study_design_scores_gemma":[0.00052299746,0.0004804328,0.00023078907,0.000019005789,0.0000058667997,0.000016210755,0.00009030736,0.0006891988,0.99243784,0.00011758907,0.00525946,0.00013029389],"about_ca_topic_score_codex":0.00001867686,"about_ca_topic_score_gemma":0.000005904842,"teacher_disagreement_score":0.017808978,"about_ca_system_score_codex":0.000016711887,"about_ca_system_score_gemma":0.000018840059,"threshold_uncertainty_score":0.4780096},"labels":[],"label_agreement":null},{"id":"W1854678029","doi":"10.1177/1066896915592016","title":"Malignant Melanoma With Osteoclast-Like Differentiation","year":2015,"lang":"en","type":"article","venue":"International Journal of Surgical Pathology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Giant cell; Pathology; Biology; CD68; Osteoclast; Multinucleate; CD163; Giant Cell Tumors; Melanoma; Cellular differentiation; Immunohistochemistry; Macrophage; Cancer research; Medicine","score_opus":0.015585009566943664,"score_gpt":0.24835265553167113,"score_spread":0.23276764596472746,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1854678029","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9923511,0.00026567484,0.0033121014,0.0005348005,0.0012083141,0.000041832434,0.000011389205,0.0000041467247,0.002270645],"genre_scores_gemma":[0.9978441,0.0000813046,0.0006842925,0.00014663387,0.0007560864,0.000002487838,0.000048805126,0.000011143392,0.00042515548],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990183,0.00009624795,0.00029628788,0.00014460649,0.0003117642,0.00013279032],"domain_scores_gemma":[0.99902594,0.000017920827,0.0002464454,0.0001056263,0.0004699315,0.00013414891],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026579967,0.00010485307,0.00016102685,0.000085295535,0.000015434554,0.000019474546,0.00026142038,0.00010868735,0.000035408102],"category_scores_gemma":[0.000040430645,0.00007311074,0.00008559758,0.00003296645,0.00006536313,0.000009181231,0.00007403405,0.00010589332,0.000013123956],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0138783045,0.001448915,0.20296048,0.000024983328,0.0013540458,0.029066859,0.00091680104,0.0009254665,0.6915484,0.008197455,0.021832531,0.027845765],"study_design_scores_gemma":[0.019451108,0.011304623,0.040880732,0.00012556501,0.00014887688,0.074948296,0.00055458484,0.00013757216,0.13788493,0.002032047,0.71166205,0.00086962816],"about_ca_topic_score_codex":0.0000024790552,"about_ca_topic_score_gemma":0.0000071476043,"teacher_disagreement_score":0.6898295,"about_ca_system_score_codex":0.00002312583,"about_ca_system_score_gemma":0.00011040112,"threshold_uncertainty_score":0.29813695},"labels":[],"label_agreement":null},{"id":"W1886526654","doi":"10.4081/rt.2015.5698","title":"Amelanotic Melanoma Presenting with Plasmacytoid Morphology and <i>BRAF V600</i> Mutation","year":2015,"lang":"en","type":"article","venue":"Rare Tumors","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Melanoma; Pathology; Amelanotic melanoma; Malignancy; Vimentin; Plasmacytoid dendritic cell; Immunohistochemistry; Eosinophilic; Differential diagnosis; Dabrafenib; HMB-45; Cancer research; Metastatic melanoma; Antigen; Immunology; Vemurafenib","score_opus":0.013337626051979284,"score_gpt":0.22050675759663585,"score_spread":0.20716913154465658,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1886526654","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955936,0.000301835,0.00039886136,0.00008381966,0.000100488454,0.00017220172,0.0000137481875,0.000029244358,0.0033061926],"genre_scores_gemma":[0.99788964,0.00000938854,0.000884061,0.00015567339,0.00016900762,0.000022238797,0.00017154301,0.000026486945,0.00067197444],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990771,0.00006147108,0.0001519292,0.00033575293,0.00012385599,0.0002498824],"domain_scores_gemma":[0.9994459,0.0000137607885,0.00008580621,0.0002271331,0.00006965867,0.00015771855],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011597055,0.00015691086,0.0001546701,0.000042505322,0.000060250735,0.000027050495,0.000107315536,0.000087725595,0.000010352599],"category_scores_gemma":[0.00007210362,0.0001322703,0.000026387503,0.0000666282,0.000090542555,0.0000075385465,0.00008824729,0.00007947961,0.000020478123],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010332228,0.0002533307,0.3743808,0.00020314731,0.00024537073,0.002575901,0.0017460902,0.0005150359,0.6018561,0.001184923,0.011520719,0.0044853496],"study_design_scores_gemma":[0.0073621613,0.0038881854,0.08204521,0.000078512945,0.00013937804,0.008377186,0.0016893903,0.0005293136,0.8756369,0.0007178015,0.018184027,0.0013519449],"about_ca_topic_score_codex":0.000027264225,"about_ca_topic_score_gemma":0.000031588832,"teacher_disagreement_score":0.2923356,"about_ca_system_score_codex":0.000009472152,"about_ca_system_score_gemma":0.000089962974,"threshold_uncertainty_score":0.53938264},"labels":[],"label_agreement":null},{"id":"W1887523814","doi":"10.1139/cjpp-2012-0258","title":"Involvement of mixed lineage kinase 3 in cancer","year":2012,"lang":"en","type":"review","venue":"Canadian Journal of Physiology and Pharmacology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"National Institute of General Medical Sciences; National Institutes of Health","keywords":"MAP kinase kinase kinase; ASK1; Cyclin-dependent kinase 9; Mitogen-activated protein kinase kinase; Cyclin-dependent kinase 4; MAP2K7; Cell biology; MAPK/ERK pathway; Biology; Cyclin-dependent kinase 2; Cancer research; Protein kinase A; Signal transduction; Kinase; c-Raf; Mitogen-activated protein kinase","score_opus":0.05018907658177918,"score_gpt":0.3286900407316889,"score_spread":0.2785009641499097,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1887523814","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.057714075,0.9404222,0.000002070915,0.000020247366,0.0015177005,0.0001697103,0.00011228651,4.9020645e-7,0.000041226067],"genre_scores_gemma":[0.056790043,0.9419456,0.00002754514,0.000141905,0.0009221686,0.00002170145,0.000068603,0.00001884559,0.00006354838],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99856764,0.00031932365,0.0005622108,0.00017894658,0.000034487228,0.00033738354],"domain_scores_gemma":[0.9989165,0.0000317577,0.00051657466,0.00011140345,0.00008067193,0.00034307234],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028825528,0.00022233736,0.00093626924,0.00025914478,0.0000329462,0.0000020891307,0.00023438652,0.0004287272,0.00034117678],"category_scores_gemma":[0.000013622338,0.00018635974,0.00019327825,0.00008721469,0.00016841384,0.00000380654,0.000040361185,0.00034426036,0.0000021240594],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017681104,0.00026005675,0.0010565828,0.020115646,0.0017008027,0.00025425208,0.0002698891,0.000020643944,0.54912364,0.00017704353,0.015340386,0.41150427],"study_design_scores_gemma":[0.00049304985,0.00033681278,0.00013537263,0.00038763028,0.0004527265,0.00006483526,0.000010706593,4.2781298e-7,0.024114214,0.00001807773,0.97380936,0.000176806],"about_ca_topic_score_codex":0.00053592824,"about_ca_topic_score_gemma":0.0035613864,"teacher_disagreement_score":0.958469,"about_ca_system_score_codex":0.00004006992,"about_ca_system_score_gemma":0.0015430681,"threshold_uncertainty_score":0.75995296},"labels":[],"label_agreement":null},{"id":"W1897773793","doi":"10.1002/cncr.28980","title":"Clinico‐morphological features of <scp>BRAF</scp> inhibition–induced proliferative skin lesions in cancer patients","year":2014,"lang":"en","type":"article","venue":"Cancer","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Augmentium Pharma Consulting (Canada)","funders":"","keywords":"Medicine; Keratoacanthoma; Dermatology; Biopsy; Dabrafenib; Cancer; Melanoma; Pathology; Skin biopsy; Hyperkeratosis; Skin cancer; Vemurafenib; Basal cell; Internal medicine; Metastatic melanoma","score_opus":0.023984977475985995,"score_gpt":0.2948491314484297,"score_spread":0.27086415397244373,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1897773793","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964909,0.00034986046,0.00003836343,0.00006524969,0.00028399055,0.00025464036,0.000097372285,0.0000072507687,0.0024123557],"genre_scores_gemma":[0.99807703,0.00018691993,0.00008081335,0.00054803037,0.00031213503,0.00020021858,0.00011096141,0.000014914317,0.0004689836],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989868,0.00010362369,0.00024369854,0.00032887803,0.00011389277,0.00022312911],"domain_scores_gemma":[0.99944985,0.000034246947,0.00012686235,0.00019205511,0.00012055778,0.000076419936],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011373688,0.00014382684,0.00020809482,0.00004225869,0.000043559725,0.00000767384,0.00010618851,0.00022402665,0.00003725003],"category_scores_gemma":[0.00023242932,0.00011717499,0.00007574492,0.00009433457,0.0000680321,0.0000042581787,0.00007716748,0.000137514,0.0000050122885],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007320306,0.00046683708,0.0779293,0.000053607808,0.000048094327,0.0000050448484,0.0003987979,0.00008698016,0.8833995,0.00045911656,0.018309524,0.018769994],"study_design_scores_gemma":[0.00122202,0.0005639333,0.2994297,0.00005997968,0.00001351988,0.0000016337458,0.00005037172,0.000010189591,0.6876451,0.000115840725,0.0107963765,0.00009133834],"about_ca_topic_score_codex":0.000108561115,"about_ca_topic_score_gemma":0.00044434846,"teacher_disagreement_score":0.22150041,"about_ca_system_score_codex":0.000024936586,"about_ca_system_score_gemma":0.00011241172,"threshold_uncertainty_score":0.47782576},"labels":[],"label_agreement":null},{"id":"W1907064528","doi":"10.18632/oncotarget.4854","title":"Loss of tumor suppressors KAI1 and p27 identifies a unique subgroup of primary melanoma patients with poor prognosis","year":2015,"lang":"en","type":"article","venue":"Oncotarget","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency; Vancouver Coastal Health Research Institute; University of British Columbia; Vancouver Coastal Health","funders":"Canadian Cancer Society Research Institute; Canadian Institutes of Health Research; Cancer Research Society; Canadian Dermatology Foundation","keywords":"Medicine; Melanoma; Subgroup analysis; Oncology; Survival analysis; Internal medicine; Cancer research; Meta-analysis","score_opus":0.008822382018303581,"score_gpt":0.20434775269320626,"score_spread":0.1955253706749027,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1907064528","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997767,0.0003125754,0.000057895257,0.000030630406,0.000074986885,0.0002565273,0.00012809983,0.000006867789,0.0013654593],"genre_scores_gemma":[0.99814934,0.000020229743,0.0012120919,0.000055255143,0.000037870905,0.000022844351,0.00027316416,0.000018992294,0.00021023107],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991233,0.00005628918,0.00022616386,0.00024206092,0.00018593468,0.00016628986],"domain_scores_gemma":[0.9992938,0.000010281754,0.00016976352,0.00020794607,0.00021172057,0.000106478285],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014430648,0.0001405749,0.00024950676,0.000042010353,0.000020773943,0.000008551655,0.00013555636,0.00008128203,0.000006993699],"category_scores_gemma":[0.000046867215,0.00011223457,0.000043361484,0.00006451323,0.00014731745,0.000008697563,0.00011987535,0.000047017926,0.0000013397515],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042594233,0.0002603397,0.8775864,0.0001580823,0.00007600872,0.000007581543,0.00018386105,0.0000028503143,0.11868111,0.00008943231,0.0024440205,0.000084359446],"study_design_scores_gemma":[0.0018758308,0.0018562601,0.263284,0.000053246167,0.000050075978,0.000010409939,0.000075660035,0.0000046083796,0.7267845,0.00012575091,0.0056582345,0.00022135566],"about_ca_topic_score_codex":0.00006423078,"about_ca_topic_score_gemma":0.000035744437,"teacher_disagreement_score":0.6143024,"about_ca_system_score_codex":0.000009372507,"about_ca_system_score_gemma":0.00010512391,"threshold_uncertainty_score":0.4576793},"labels":[],"label_agreement":null},{"id":"W1934017650","doi":"10.1111/pcmr.12423","title":"What's up <scp>NF</scp>1?","year":2015,"lang":"en","type":"letter","venue":"Pigment Cell & Melanoma Research","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Collège Lionel Groulx","funders":"","keywords":"Cell biology; Chemistry; Computational biology; Biology","score_opus":0.0715572374426514,"score_gpt":0.3262085447195253,"score_spread":0.2546513072768739,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1934017650","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.3150435,0.071902454,0.00022368264,0.17098896,0.033144556,0.007241178,0.0008043672,0.00031415655,0.40033713],"genre_scores_gemma":[0.014743917,0.007129031,0.00027101912,0.079385854,0.025210692,0.0008520011,0.01001531,0.0004904974,0.8619017],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99271727,0.000950973,0.0005878271,0.0016153465,0.002142216,0.001986357],"domain_scores_gemma":[0.99629724,0.0002212322,0.00021325138,0.0019844067,0.00081221136,0.00047164643],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0020911046,0.00071322377,0.00062653294,0.00042363952,0.0002915748,0.000593941,0.0016030376,0.0020366977,0.00020057017],"category_scores_gemma":[0.0003219478,0.0006709569,0.00033806777,0.0003128353,0.00032741038,0.00002309521,0.001230789,0.002757929,0.0021006388],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000023945599,0.00009334723,0.00009960495,0.00027570437,0.0001050757,0.00045103012,0.00016988434,0.0000015358306,0.06829635,0.000012182447,0.9296788,0.00079254044],"study_design_scores_gemma":[0.0008042006,0.0009379758,0.000020934862,0.00007386215,0.00003711556,0.00004122022,0.00042250764,0.000008541744,0.13702115,0.00018398935,0.8601764,0.00027212343],"about_ca_topic_score_codex":0.000085348154,"about_ca_topic_score_gemma":0.000021415935,"teacher_disagreement_score":0.46156454,"about_ca_system_score_codex":0.00018712979,"about_ca_system_score_gemma":0.00092141546,"threshold_uncertainty_score":0.9995742},"labels":[],"label_agreement":null},{"id":"W1937411730","doi":"10.1186/s12862-015-0450-x","title":"ERK1 and ERK2 present functional redundancy in tetrapods despite higher evolution rate of ERK1","year":2015,"lang":"en","type":"article","venue":"BMC Evolutionary Biology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Bamfield Marine Sciences Centre; University of Alberta","funders":"Natural Sciences and Engineering Research Council of Canada; Association pour la Recherche sur le Cancer","keywords":"Biology; Gene isoform; Gene knockdown; Lizard; MAPK/ERK pathway; Gene; Cell biology; Genetics; Signal transduction; Zoology","score_opus":0.03876393534504356,"score_gpt":0.25976582142312726,"score_spread":0.2210018860780837,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1937411730","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98501956,0.007423031,0.004411951,0.00022340605,0.0007170427,0.00024449258,0.00006993533,0.000017102517,0.0018734791],"genre_scores_gemma":[0.9961324,0.00006144985,0.0017343027,0.000058500067,0.0003957542,0.000044027096,0.00038231816,0.000013879851,0.0011774059],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986231,0.00026543395,0.00032351457,0.00043331704,0.00007807892,0.00027657123],"domain_scores_gemma":[0.9993239,0.000036244735,0.00011328558,0.0002718791,0.00013782375,0.00011687141],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003468236,0.00016757908,0.00020178338,0.00012351754,0.000045690624,0.000003955088,0.00011443598,0.00028799038,0.000036498735],"category_scores_gemma":[0.00012399162,0.0001574776,0.000063835316,0.00013784581,0.0002501028,0.000009690041,0.00014553407,0.00009815085,0.0000105156505],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00073810713,0.00020527406,0.48694304,0.000044450328,0.00004792004,0.0000036440133,0.000030392845,0.00028703368,0.48102242,0.020573461,0.009756935,0.0003473453],"study_design_scores_gemma":[0.001976673,0.0009901014,0.92059606,0.000018052267,0.000020002235,0.000060502116,0.00006297986,0.00033962206,0.00690714,0.009524182,0.059210002,0.00029469456],"about_ca_topic_score_codex":0.000115885945,"about_ca_topic_score_gemma":0.00008550524,"teacher_disagreement_score":0.47411528,"about_ca_system_score_codex":0.000054967637,"about_ca_system_score_gemma":0.00030122467,"threshold_uncertainty_score":0.642175},"labels":[],"label_agreement":null},{"id":"W1965097080","doi":"10.1158/1535-7163.mct-04-0297","title":"Raf kinase as a target for anticancer therapeutics","year":2005,"lang":"en","type":"review","venue":"Molecular Cancer Therapeutics","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":247,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"MAPK/ERK pathway; Receptor tyrosine kinase; Kinase; Tyrosine kinase; Cancer research; Signal transduction; Biology; Medicine; Cell biology","score_opus":0.055910670510332154,"score_gpt":0.36204434229330806,"score_spread":0.3061336717829759,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1965097080","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000076929144,0.9884716,0.007155266,0.00015733363,0.00079952896,0.0018425082,0.000568069,0.00005086054,0.0008778781],"genre_scores_gemma":[0.00014002879,0.9881042,0.0023508412,0.003487072,0.0014584902,0.0012973984,0.00088237686,0.00035413128,0.0019254441],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99683756,0.00019663367,0.00070670247,0.0010684488,0.00034830763,0.0008423753],"domain_scores_gemma":[0.99794006,0.00004011383,0.0004366282,0.0011885237,0.0002103047,0.00018437114],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00024385637,0.0009561764,0.0013557515,0.00013163885,0.00015773228,0.000089607274,0.00080624525,0.0009875401,0.00009547202],"category_scores_gemma":[0.000016096425,0.0008477849,0.001179758,0.000233423,0.00015269016,0.0000051411002,0.00016913695,0.00037431152,0.000048134083],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008206576,0.00012495687,0.0000020601337,0.0020141527,0.0016221008,0.0000197067,0.000032811746,0.000015649919,0.009118518,0.00044828435,0.00058537564,0.9859343],"study_design_scores_gemma":[0.000737434,0.0004952103,2.8128548e-7,0.0008215375,0.0019750998,0.000035737812,0.000008819394,0.000025612117,0.011273344,0.00017714557,0.98342925,0.0010205407],"about_ca_topic_score_codex":0.0000145297445,"about_ca_topic_score_gemma":0.000016664751,"teacher_disagreement_score":0.98491377,"about_ca_system_score_codex":0.00013341014,"about_ca_system_score_gemma":0.0012174333,"threshold_uncertainty_score":0.9993973},"labels":[],"label_agreement":null},{"id":"W1965301111","doi":"10.1517/14728222.2011.537656","title":"The promise and challenges of targeting RSK for the treatment of cancer","year":2010,"lang":"en","type":"article","venue":"Expert Opinion on Therapeutic Targets","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Canadian Institutes of Health Research","keywords":"Kinase; Serine; Threonine; Protein-Serine-Threonine Kinases; Biology; Phosphorylation; Cancer; Cancer research; Ribosomal s6 kinase; Cell biology; Genetics; Protein kinase A; Protein kinase B","score_opus":0.03705129146068916,"score_gpt":0.315687583912151,"score_spread":0.2786362924514619,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1965301111","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.12972213,0.8621108,0.00018564158,0.004925274,0.001749554,0.0010226453,0.000041611787,0.0000092381,0.00023307775],"genre_scores_gemma":[0.8026144,0.1963223,0.0001873563,0.00008647243,0.00040549802,0.00027983438,0.000010944937,0.000015114519,0.0000780709],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9994806,0.000027243472,0.00013818349,0.00015873632,0.00006550321,0.00012971488],"domain_scores_gemma":[0.99949473,0.00009472292,0.00009387356,0.00024089204,0.00004941738,0.000026353338],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000120900535,0.00010422043,0.000107571,0.000009385394,0.000119155084,0.0000053886874,0.000110334964,0.00007034424,0.0000072414664],"category_scores_gemma":[0.000017766006,0.00005193818,0.0000683768,0.000012948468,0.00009896483,0.000001314505,0.000013782518,0.000029586154,2.2442839e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025668807,0.00011981595,0.00012300117,0.000013692231,0.00012844772,4.8642203e-8,0.001055006,0.0000020949826,0.69970274,0.0026119747,0.00025616214,0.29573032],"study_design_scores_gemma":[0.00042908275,0.0007072011,0.00053090655,0.000004634447,0.000003211119,4.847493e-7,0.00023076656,0.00004848463,0.42119718,0.000102466285,0.5766961,0.00004947952],"about_ca_topic_score_codex":0.000021426522,"about_ca_topic_score_gemma":0.000036149362,"teacher_disagreement_score":0.6728923,"about_ca_system_score_codex":0.0000035143305,"about_ca_system_score_gemma":0.000030456973,"threshold_uncertainty_score":0.21179774},"labels":[],"label_agreement":null},{"id":"W1966894313","doi":"10.1038/sj.bjp.0706885","title":"Inhibitory effect of p38 mitogen‐activated protein kinase inhibitors on cytokine release from human macrophages","year":2006,"lang":"en","type":"article","venue":"British Journal of Pharmacology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":102,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Cytokine; p38 mitogen-activated protein kinases; Macrophage; Tumor necrosis factor alpha; MAPK/ERK pathway; Lipopolysaccharide; Immunology; Biology; Medicine; Pharmacology; Kinase; Cell biology; Biochemistry; In vitro","score_opus":0.004399314385054463,"score_gpt":0.23780940744026507,"score_spread":0.2334100930552106,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1966894313","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99559075,0.0027180878,0.000026042824,0.000049063547,0.00089932024,0.00030099813,0.000123977,0.000009051683,0.0002827145],"genre_scores_gemma":[0.9969155,0.0000637432,0.00009299011,0.00009683018,0.0024011205,0.000015644391,0.000096452895,0.000035781897,0.0002819417],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99818254,0.00043252585,0.00062974094,0.00026832247,0.0002128033,0.00027409729],"domain_scores_gemma":[0.99899393,0.00004403369,0.0005682762,0.00010577557,0.00017181596,0.00011616457],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000313415,0.00021049807,0.00041087408,0.00011000432,0.000093262395,0.000017391263,0.00022582061,0.00022334317,0.00013771412],"category_scores_gemma":[0.00007155175,0.00022088103,0.00023345945,0.0000887378,0.0001423605,0.000009720924,0.000057121695,0.00033400411,0.0000057123575],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009700714,0.00027823838,0.00040625737,0.000047197555,0.00012690503,0.001105555,0.000007995007,0.0000391382,0.96166337,0.000003693526,0.03187431,0.003477256],"study_design_scores_gemma":[0.004609515,0.0027955836,0.0012854016,0.00014293769,0.000101510275,0.0003215389,0.0000070301517,0.0000016397428,0.98344946,0.000031758904,0.0070656375,0.00018797461],"about_ca_topic_score_codex":0.00029357185,"about_ca_topic_score_gemma":0.000026717655,"teacher_disagreement_score":0.024808671,"about_ca_system_score_codex":0.00003349252,"about_ca_system_score_gemma":0.00008213675,"threshold_uncertainty_score":0.90072674},"labels":[],"label_agreement":null},{"id":"W1967035754","doi":"10.1038/ncomms1560","title":"P-Rex1 is required for efficient melanoblast migration and melanoma metastasis","year":2011,"lang":"en","type":"article","venue":"Nature Communications","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":180,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"Biotechnology and Biological Sciences Research Council; Cancer Research UK; National Cancer Institute; National Institute of Environmental Health Sciences; Beatson Institute for Cancer Research; Medical Research Council","keywords":"Melanoma; Metastasis; Cancer research; Guanine nucleotide exchange factor; Biology; Cell migration; Cancer; Medicine; Cell culture; Cell biology; GTPase; Genetics","score_opus":0.035386974122916866,"score_gpt":0.28086873522232764,"score_spread":0.24548176109941078,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1967035754","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96507907,0.015573322,0.004622924,0.0022160083,0.00026396208,0.0008803966,0.0004255695,0.00004895878,0.010889778],"genre_scores_gemma":[0.97949606,0.00047779578,0.018806534,0.0004160861,0.000049090806,0.00011190096,0.00038395418,0.000016444601,0.00024215829],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993492,0.00005887676,0.00016183498,0.0002233302,0.00006548444,0.00014130959],"domain_scores_gemma":[0.99863005,0.00003068079,0.00008108094,0.0010633327,0.00013217423,0.00006269333],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016207548,0.00011608041,0.000108624954,0.00004547725,0.000203614,0.000016125168,0.00039460082,0.00024607292,0.000011571892],"category_scores_gemma":[0.00009484723,0.000106983556,0.00007364186,0.000075676406,0.000090477144,0.0000037834948,0.00020036587,0.00013806096,0.000005689028],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026428152,0.00054679747,0.0064187394,0.00005725733,0.0003696054,0.0000010162119,0.0023140828,0.0000029693638,0.8928388,0.043870173,0.042360503,0.01095579],"study_design_scores_gemma":[0.00086069555,0.00047780716,0.008594434,0.000018119961,0.0001401756,0.000024479745,0.00027766582,0.0007068656,0.49515724,0.00048028902,0.49290082,0.0003614161],"about_ca_topic_score_codex":0.000024520341,"about_ca_topic_score_gemma":0.0006182398,"teacher_disagreement_score":0.4505403,"about_ca_system_score_codex":0.0000074551435,"about_ca_system_score_gemma":0.00003481596,"threshold_uncertainty_score":0.43626627},"labels":[],"label_agreement":null},{"id":"W1967124582","doi":"10.1074/jbc.m109.083808","title":"Differential Regulation of Mitogen- and Stress-activated Protein Kinase-1 and -2 (MSK1 and MSK2) by CK2 following UV Radiation","year":2009,"lang":"en","type":"article","venue":"Journal of Biological Chemistry","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre; Ontario Institute for Cancer Research; University of Toronto","funders":"Canadian Institutes of Health Research; Princess Margaret Hospital Foundation","keywords":"Kinase; Transactivation; p38 mitogen-activated protein kinases; Phosphorylation; Protein kinase A; Mitogen-activated protein kinase; Cell biology; Chemistry; MAPK/ERK pathway; Molecular biology; Biology; Biochemistry; Gene expression; Gene","score_opus":0.008920141025261714,"score_gpt":0.2205412476327776,"score_spread":0.2116211066075159,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1967124582","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973249,0.0022385549,0.00015581395,0.000085683554,0.000030535837,0.00006929816,0.000028139306,0.0000027996277,0.00006428614],"genre_scores_gemma":[0.99922204,0.000320271,0.00016165784,0.00001630121,0.00014162944,0.0000011176336,0.000080401755,0.0000038314097,0.000052720334],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99937564,0.000032453034,0.00025117703,0.00015561056,0.000081307655,0.00010378293],"domain_scores_gemma":[0.99955463,0.000013562086,0.00023300498,0.00007019285,0.000040727224,0.00008787529],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008701162,0.00011087139,0.00019147054,0.000013204373,0.000037629805,0.000015583442,0.000052128187,0.00021574192,0.000012258266],"category_scores_gemma":[0.000111656846,0.000082636325,0.000055150555,0.000027316008,0.000049235292,0.0000070739993,0.000029484558,0.000091341244,4.2394003e-8],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017603174,0.000043602082,0.006103197,0.000023482797,0.000029766285,0.0000026189593,0.000012887753,3.7955317e-7,0.9887368,0.0000043844248,0.00012733373,0.0047395118],"study_design_scores_gemma":[0.00069132855,0.00045643363,0.022579048,0.00003855332,0.00001805616,0.000030246012,0.00002560236,0.000010071419,0.97546726,0.00013422218,0.00045533123,0.000093836374],"about_ca_topic_score_codex":0.0000011527242,"about_ca_topic_score_gemma":9.9426096e-8,"teacher_disagreement_score":0.01647585,"about_ca_system_score_codex":0.0000060059588,"about_ca_system_score_gemma":0.000014899918,"threshold_uncertainty_score":0.33698115},"labels":[],"label_agreement":null},{"id":"W1967720595","doi":"10.1080/00498250110100720","title":"SB-242235, a selective inhibitor of p38 mitogenactivated protein kinase. I: Preclinical pharmacokinetics","year":2002,"lang":"en","type":"article","venue":"Xenobiotica","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Discovery Centre","funders":"","keywords":"Pharmacokinetics; Bioavailability; Pharmacology; Oral administration; Chemistry; Medicine","score_opus":0.023772721326301493,"score_gpt":0.2613691124793197,"score_spread":0.23759639115301823,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1967720595","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9886623,0.0005751629,0.0002351153,0.00021938069,0.00021193647,0.0005719798,0.00005767201,0.00003257443,0.009433873],"genre_scores_gemma":[0.9965508,0.0000719607,0.0011219727,0.00013175313,0.00046046733,0.000025512758,0.00004349482,0.00003578731,0.0015582431],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99853235,0.0001222319,0.00037869177,0.00044563232,0.00018004209,0.0003410643],"domain_scores_gemma":[0.99912494,0.000027884838,0.00014588915,0.00038493646,0.0001661549,0.00015020567],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001313276,0.00021813149,0.00025774015,0.00005197815,0.00005930877,0.000012692776,0.00021914073,0.00027750694,0.00022535487],"category_scores_gemma":[0.00022873841,0.00020395606,0.00014135573,0.00017452618,0.00014899873,0.0000040672744,0.00011812841,0.00020023272,0.000063647414],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014188228,0.00041344593,0.0005071235,0.00004854132,0.00009533462,0.000008292423,0.000058203463,0.000005396772,0.99028414,0.000095260635,0.006905029,0.0014373715],"study_design_scores_gemma":[0.0009876285,0.0009787936,0.0005224455,0.000035492678,0.00004205236,0.000012918617,0.000017144246,0.00015454511,0.965029,0.000038561997,0.0319445,0.00023694678],"about_ca_topic_score_codex":0.000010187336,"about_ca_topic_score_gemma":0.000005107788,"teacher_disagreement_score":0.025255146,"about_ca_system_score_codex":0.000016249978,"about_ca_system_score_gemma":0.0000513256,"threshold_uncertainty_score":0.83170867},"labels":[],"label_agreement":null},{"id":"W1968020384","doi":"10.1074/jbc.m300847200","title":"Defining the Involvement of p38α MAPK in the Production of Anti- and Proinflammatory Cytokines Using an SB 203580-resistant Form of the Kinase","year":2003,"lang":"en","type":"article","venue":"Journal of Biological Chemistry","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":72,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Proinflammatory cytokine; p38 mitogen-activated protein kinases; MAPK/ERK pathway; Cytokine; Tumor necrosis factor alpha; Biology; Cell biology; Kinase; Immunology; Inflammation","score_opus":0.0256076761310442,"score_gpt":0.24387958984122504,"score_spread":0.21827191371018084,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1968020384","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998241,0.0014029262,0.0000125001525,0.00006213187,0.000054540043,0.00010695406,0.0000065298973,6.411976e-7,0.00011276563],"genre_scores_gemma":[0.9995116,0.00014211093,0.0002369982,0.000023321209,0.000070600276,0.000002068321,0.0000026830708,0.0000038178305,0.0000067897586],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990719,0.00011289782,0.000446117,0.000117376876,0.00014133131,0.000110368965],"domain_scores_gemma":[0.99905723,0.000027653372,0.0005452364,0.00022797956,0.00011679841,0.000025122637],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008822977,0.00009742843,0.00018979766,0.000012578838,0.00004560011,0.0000052412647,0.00022328066,0.00010975853,0.0000040060077],"category_scores_gemma":[0.00037553287,0.00004266061,0.00009428411,0.00007886498,0.00021252809,0.0000054325096,0.000053512227,0.00013215683,1.850277e-8],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008501328,0.00011428537,0.020210318,0.000088441375,0.000019901376,0.0000022778115,0.00011674823,0.000022664915,0.9790988,0.00011910211,0.000019317826,0.00010314477],"study_design_scores_gemma":[0.00023390188,0.00023281609,0.015540209,0.000077113225,0.000020933268,0.000085553256,0.0009581277,0.000005651181,0.98222834,0.00022445704,0.00033874795,0.00005414046],"about_ca_topic_score_codex":0.0000050185567,"about_ca_topic_score_gemma":0.000003735953,"teacher_disagreement_score":0.004670109,"about_ca_system_score_codex":0.000009265517,"about_ca_system_score_gemma":0.00008568533,"threshold_uncertainty_score":0.1739649},"labels":[],"label_agreement":null},{"id":"W1968180930","doi":"10.1038/onc.2012.472","title":"RSK promotes G2 DNA damage checkpoint silencing and participates in melanoma chemoresistance","year":2012,"lang":"en","type":"article","venue":"Oncogene","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":58,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Institute for Research in Immunology and Cancer","funders":"Canadian Institutes of Health Research; Cancer Research Society; Dartmouth College","keywords":"Biology; DNA damage; Melanoma; MAPK/ERK pathway; CHEK1; Cancer research; Kinase; Protein kinase A; G2-M DNA damage checkpoint; Gene silencing; Ribosomal s6 kinase; Cell biology; Signal transduction; Cancer; DNA; Cell cycle checkpoint; Cell cycle; Genetics; PI3K/AKT/mTOR pathway; P70-S6 Kinase 1; Gene","score_opus":0.016287893807494763,"score_gpt":0.24759185748226198,"score_spread":0.23130396367476722,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1968180930","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945071,0.002703899,0.00006133607,0.000078777906,0.000095853546,0.0001412299,0.000011581874,0.000011820524,0.002388417],"genre_scores_gemma":[0.9981256,0.000098653574,0.00093727454,0.00008865275,0.00027900978,0.00004007359,0.000040960724,0.000020312553,0.0003694557],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99904066,0.000043376596,0.00019515108,0.00025326083,0.00008329166,0.00038426585],"domain_scores_gemma":[0.9995188,0.0000112771495,0.0000604457,0.00025042772,0.000022572523,0.00013648349],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002823476,0.00014949382,0.0001599116,0.00003065815,0.00004719192,0.000015155507,0.0000950832,0.00011160594,0.000030099969],"category_scores_gemma":[0.000082139915,0.00013833944,0.000038499256,0.0000666028,0.000052722993,0.000008180287,0.00010259965,0.00006170677,0.000014216614],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002849006,0.00007521555,0.037380785,0.000032910786,0.000012608633,0.0000067315423,0.00024029892,9.711431e-7,0.96074116,0.00007407439,0.00012777773,0.0012789802],"study_design_scores_gemma":[0.0004071785,0.00012391718,0.032705717,0.000022296923,0.000011963865,0.000014863178,0.00010833667,0.000029689014,0.96285945,0.000051782943,0.0034792083,0.0001855757],"about_ca_topic_score_codex":0.00002670588,"about_ca_topic_score_gemma":0.00010788961,"teacher_disagreement_score":0.004675068,"about_ca_system_score_codex":0.000015840915,"about_ca_system_score_gemma":0.000033514087,"threshold_uncertainty_score":0.5641319},"labels":[],"label_agreement":null},{"id":"W1968772238","doi":"10.1016/j.cyto.2009.07.149","title":"Regulation of innate immunity and inflammation by the mitotic kinase PLK1 through inhibition of IKKε activity","year":2009,"lang":"en","type":"article","venue":"Cytokine","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Innate immune system; Inflammation; Kinase; PLK1; Immunity; Mitosis; Cell biology; IκB kinase; Biology; Immunology; Cancer research; NF-κB; Immune system; Apoptosis; Genetics; Cell cycle","score_opus":0.00971759616034402,"score_gpt":0.2276273172319846,"score_spread":0.21790972107164058,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1968772238","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975459,0.00017675455,0.0011922357,0.00022559126,0.000024548995,0.000121388744,0.000021831573,0.0000039320494,0.00068780023],"genre_scores_gemma":[0.9995751,0.00006476619,0.000102139944,0.000028276374,0.000050917155,0.0000025437278,0.00012996228,0.0000036682475,0.000042659736],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9995837,0.0000577096,0.00013238259,0.00009373251,0.000067740475,0.000064701315],"domain_scores_gemma":[0.9996001,0.0000093482695,0.00013124393,0.00019247233,0.00005342637,0.00001336781],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012051691,0.000065178436,0.00008697122,0.000013729825,0.000039670776,0.0000041625913,0.000040868617,0.00007328337,0.0000038141511],"category_scores_gemma":[0.000048602287,0.000050866955,0.000026492722,0.000057135825,0.00006059276,0.000008583816,0.00002644773,0.00004359492,3.392469e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007628672,0.000033687942,0.0001521048,0.000019569516,0.0000071284426,1.5245118e-7,0.0000832678,0.000011184222,0.9914636,0.00036714398,0.00020606795,0.0075797793],"study_design_scores_gemma":[0.00033604985,0.00025359905,0.045684315,0.000015037961,0.000011361866,0.000003012057,0.00001641665,0.000056553807,0.95194525,0.0008478872,0.00078100443,0.000049489336],"about_ca_topic_score_codex":0.000027963488,"about_ca_topic_score_gemma":0.0000072691364,"teacher_disagreement_score":0.04553221,"about_ca_system_score_codex":0.0000047892677,"about_ca_system_score_gemma":0.000013247204,"threshold_uncertainty_score":0.20742942},"labels":[],"label_agreement":null},{"id":"W1971380103","doi":"10.1186/1471-2407-10-515","title":"Antitumour activity of a potent MEK inhibitor RDEA119/BAY 869766 combined with rapamycin in human orthotopic primary pancreatic cancer xenografts","year":2010,"lang":"en","type":"article","venue":"BMC Cancer","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; Ontario Institute for Cancer Research","funders":"National Cancer Institute","keywords":"Surgical oncology; Medicine; Pancreatic cancer; Cancer research; Discovery and development of mTOR inhibitors; Bay; Oncology; Pharmacology; Cancer; Internal medicine; Apoptosis; PI3K/AKT/mTOR pathway; Biology","score_opus":0.010368641812603016,"score_gpt":0.2491032595514882,"score_spread":0.23873461773888519,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1971380103","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975276,0.00050350477,0.00007097676,0.00006309057,0.00034488156,0.00044842323,0.000054107313,0.000012721357,0.0009747115],"genre_scores_gemma":[0.9981113,0.000121630874,0.00031923098,0.00011504064,0.00033301805,0.00023377044,0.00004262572,0.000028829936,0.0006945268],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988699,0.00005835904,0.0002275773,0.00037877512,0.00017511501,0.00029028012],"domain_scores_gemma":[0.9992741,0.000010918775,0.0001635841,0.0003802344,0.000081345635,0.00008985357],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013074063,0.00020721556,0.0003294515,0.000070654656,0.00005602029,0.000012490562,0.00015988342,0.0001582735,0.00007900077],"category_scores_gemma":[0.0000150240185,0.00017104456,0.00008104782,0.00013462325,0.00011017009,0.000008024871,0.00007559504,0.00018878395,0.0000012260804],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034843912,0.00013746035,0.2012034,0.00014436105,0.000034610715,0.0000061080946,0.00005296182,0.000026345911,0.79694045,0.000045318215,0.00025618944,0.0008043653],"study_design_scores_gemma":[0.002001553,0.00043508515,0.33932242,0.000100392645,0.000041326282,0.0000054555603,0.000017903569,0.000017204955,0.65457714,0.000012001649,0.0032230697,0.0002464303],"about_ca_topic_score_codex":0.0017848719,"about_ca_topic_score_gemma":0.030047728,"teacher_disagreement_score":0.14236328,"about_ca_system_score_codex":0.000033238284,"about_ca_system_score_gemma":0.00039579047,"threshold_uncertainty_score":0.98765135},"labels":[],"label_agreement":null},{"id":"W1972089204","doi":"10.1186/1755-8794-6-40","title":"Intratumoral genetic heterogeneity in metastatic melanoma is accompanied by variation in malignant behaviors","year":2013,"lang":"en","type":"article","venue":"BMC Medical Genomics","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Cancer Council Victoria; National Health and Medical Research Council; Natural Sciences and Engineering Research Council of Canada; Cure Cancer Australia Foundation; Cancer Australia; Melanoma Research Alliance","keywords":"Human genetics; Melanoma; Metastatic melanoma; Variation (astronomy); Biology; DNA microarray; Genetic variation; Cancer research; Oncology; Genetics; Internal medicine; Bioinformatics; Medicine; Gene; Gene expression","score_opus":0.014045152595532285,"score_gpt":0.2463499973945595,"score_spread":0.23230484479902722,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1972089204","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960005,0.00046856853,0.0027380201,0.000079338795,0.00017408449,0.00042018024,0.000024544737,0.000008106977,0.00008664741],"genre_scores_gemma":[0.99520105,0.00014356397,0.0036693749,0.0005409639,0.00009523991,0.00011589634,0.00014531643,0.000025515053,0.000063091946],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99822956,0.0001760119,0.00051363744,0.00044959423,0.00023758705,0.0003935787],"domain_scores_gemma":[0.9992785,0.000028020942,0.000097631106,0.000330496,0.000029638404,0.00023570658],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003223787,0.00020012354,0.00026694903,0.00007077744,0.000026903463,0.000030927724,0.00031229883,0.000217486,0.00026301117],"category_scores_gemma":[0.000110909226,0.00018909156,0.0000707665,0.00010799086,0.000059685688,0.000006471139,0.00013265834,0.00015425087,0.0000682659],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000063528765,0.00039468842,0.13141012,0.00005415912,0.000027808504,0.00004276384,0.000318258,0.00005572474,0.86192745,0.000053723787,0.0021604223,0.0034913546],"study_design_scores_gemma":[0.0043814452,0.0006390577,0.80029094,0.00006202387,0.00005614135,0.00013049356,0.00018135743,0.006971649,0.18252346,0.0006282461,0.0031941482,0.0009410622],"about_ca_topic_score_codex":0.00050194917,"about_ca_topic_score_gemma":0.0013651552,"teacher_disagreement_score":0.67940396,"about_ca_system_score_codex":0.00005297958,"about_ca_system_score_gemma":0.00031612915,"threshold_uncertainty_score":0.771093},"labels":[],"label_agreement":null},{"id":"W1973460380","doi":"10.1016/j.bbamcr.2006.11.001","title":"Atypical mitogen-activated protein kinases: Structure, regulation and functions","year":2006,"lang":"en","type":"review","venue":"Biochimica et Biophysica Acta (BBA) - Molecular Cell Research","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":299,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Institute for Research in Immunology and Cancer","funders":"National Cancer Institute; Canada Research Chairs","keywords":"MAPK7; MAPKAPK2; Mitogen-activated protein kinase; MAPK14; Kinase; MAP kinase kinase kinase; MAP2K7; c-Raf; Biology; Cell biology; ASK1; Protein-Serine-Threonine Kinases; p38 mitogen-activated protein kinases; Mitogen-activated protein kinase kinase; MAPK/ERK pathway; Protein kinase A; Cyclin-dependent kinase 2","score_opus":0.046034078759945224,"score_gpt":0.3393542111267232,"score_spread":0.293320132366778,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1973460380","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.33219633,0.6608082,0.0001751709,0.00010006997,0.0002701124,0.003449353,0.0008246823,0.00007589419,0.002100188],"genre_scores_gemma":[0.29557943,0.68081975,0.00068711466,0.000063796026,0.0011227457,0.00067613996,0.014192004,0.00044186573,0.00641717],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9944921,0.0013006405,0.0007134714,0.0016968816,0.00083503145,0.00096185046],"domain_scores_gemma":[0.99742794,0.00009462885,0.00034913415,0.001439179,0.0003383204,0.00035081143],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00043367676,0.00084956316,0.0010573564,0.00045549148,0.00036607438,0.00024030704,0.0006920732,0.0011966461,0.00003682729],"category_scores_gemma":[0.00015945268,0.00075887964,0.0005696317,0.0008121061,0.0004767276,0.000015123218,0.0007280382,0.0011147931,0.000054802393],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013035267,0.00017583769,1.1988692e-7,0.0024435534,0.0001820868,0.000022195187,0.000014079925,6.506087e-7,0.9714395,0.00012734365,0.0042275125,0.02123678],"study_design_scores_gemma":[0.00033332838,0.00041862758,0.000009759103,0.000541854,0.00015983458,0.000017667076,0.00001012657,0.0000043786963,0.56811064,0.000101721576,0.42973456,0.0005574662],"about_ca_topic_score_codex":0.00006572929,"about_ca_topic_score_gemma":0.000011931553,"teacher_disagreement_score":0.42550707,"about_ca_system_score_codex":0.00009619154,"about_ca_system_score_gemma":0.00078760413,"threshold_uncertainty_score":0.9994862},"labels":[],"label_agreement":null},{"id":"W1974404622","doi":"10.2741/3086","title":"The Mnks: MAP kinase-interacting kinases (MAP kinase signal-integrating kinases)","year":2008,"lang":"en","type":"review","venue":"Frontiers in bioscience","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":198,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Medical Research Council; Canadian Institutes of Health Research; European Commission","keywords":"Kinase; EIF4E; MAPK7; Mitogen-activated protein kinase; Cell biology; Translation (biology); Receptor tyrosine kinase; MAP2K7; Alternative splicing; Biology; Scaffold protein; MAPK14; Signal transduction; MAP kinase kinase kinase; Cyclin-dependent kinase 2; Biochemistry; Protein kinase A; Gene isoform; Gene; Messenger RNA","score_opus":0.02210076121847201,"score_gpt":0.2857966600787956,"score_spread":0.26369589886032363,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1974404622","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00030035776,0.99071026,0.002031351,0.000070903836,0.0050618225,0.00083068863,0.00009512259,0.00004118443,0.0008583027],"genre_scores_gemma":[0.0007014202,0.99263114,0.0036416254,0.00013002934,0.000726773,0.00020383569,0.00021873049,0.00008261627,0.0016638034],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99552995,0.00046147118,0.0010079877,0.0014148671,0.0004967262,0.0010889802],"domain_scores_gemma":[0.9975883,0.00020335712,0.0007267439,0.0011276809,0.0001161449,0.00023777457],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007007718,0.0008218605,0.001133973,0.00027796128,0.0007956919,0.00022871203,0.0018162893,0.00053293514,0.00001339292],"category_scores_gemma":[0.00079179107,0.00057936105,0.00063946703,0.0005962816,0.000694012,0.000026494243,0.0005358654,0.0007244545,0.00004476183],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000041126772,0.00015087757,0.0002930661,0.0018340116,0.000084450454,0.0003154792,0.000092931936,0.000005336612,0.0026225885,0.00012972276,0.07269377,0.92173666],"study_design_scores_gemma":[0.00018346719,0.00023639169,0.0000072160515,0.003654768,0.00006078266,0.000102817634,0.0003210122,0.000084194726,0.0025281096,0.00003722639,0.9920587,0.0007253202],"about_ca_topic_score_codex":0.00007827411,"about_ca_topic_score_gemma":0.0000779994,"teacher_disagreement_score":0.9210113,"about_ca_system_score_codex":0.00018581575,"about_ca_system_score_gemma":0.00077589153,"threshold_uncertainty_score":0.9996658},"labels":[],"label_agreement":null},{"id":"W1974646396","doi":"10.1038/sj.onc.1210408","title":"KSR and CNK: two scaffolds regulating RAS-mediated RAF activation","year":2007,"lang":"en","type":"review","venue":"Oncogene","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":140,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Montréal; Université de Montréal; Institute for Research in Immunology and Cancer","funders":"","keywords":"Scaffold protein; Biology; Cell biology; MAPK/ERK pathway; Kinase; Protein kinase A; Enhancer; Signal transduction; Suppressor; Intracellular; Biochemistry; Transcription factor","score_opus":0.050090262301154785,"score_gpt":0.3462977213887031,"score_spread":0.2962074590875483,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1974646396","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004968151,0.9891612,0.00032789537,0.000006835393,0.00020282339,0.00043261462,0.000044461663,0.00002625077,0.004829746],"genre_scores_gemma":[0.0010483153,0.99328715,0.0008238232,0.000078901816,0.0011116593,0.00003942941,0.0021741015,0.000075733915,0.0013609051],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984496,0.000100175304,0.00042905955,0.0005481477,0.00015578314,0.00031719758],"domain_scores_gemma":[0.99901855,0.000049371345,0.00031172024,0.00042210292,0.00006171969,0.00013650663],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00035799912,0.00036726374,0.0006638221,0.0001055775,0.00009378705,0.000029639748,0.00016567305,0.00054166786,0.000027384833],"category_scores_gemma":[0.00009454546,0.0003235821,0.0001986114,0.00016111505,0.00005292162,0.0000034400587,0.00015257535,0.00010640085,0.000028134365],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000013434394,0.000026566035,0.000011238076,0.0012696934,0.000109195506,0.000007448834,0.000008668979,4.2490188e-7,0.051249325,0.00004145424,0.000845119,0.94641745],"study_design_scores_gemma":[0.00039760256,0.00010909151,0.000005760091,0.000993989,0.0001444546,0.00006386137,0.0000054192806,0.000003761769,0.011912885,0.000010394925,0.98598987,0.00036288897],"about_ca_topic_score_codex":0.0000128121565,"about_ca_topic_score_gemma":0.0000108088825,"teacher_disagreement_score":0.9851448,"about_ca_system_score_codex":0.000036324844,"about_ca_system_score_gemma":0.00019471996,"threshold_uncertainty_score":0.9999216},"labels":[],"label_agreement":null},{"id":"W1976276721","doi":"10.1074/jbc.m203428200","title":"K252a and CEP1347 Are Neuroprotective Compounds That Inhibit Mixed-lineage Kinase-3 and Induce Activation of Akt and ERK","year":2002,"lang":"en","type":"article","venue":"Journal of Biological Chemistry","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":100,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Aegera Therapeutics (Canada); McGill University; Montreal Neurological Institute and Hospital","funders":"","keywords":"Trk receptor; Protein kinase B; Neuroprotection; MAPK/ERK pathway; Tropomyosin receptor kinase A; Neurotrophin; Kinase; Neurotrophic factors; PI3K/AKT/mTOR pathway; Neurite; Cell biology; Signal transduction; Biology; Pharmacology; Chemistry; Biochemistry; Receptor; In vitro","score_opus":0.03488339305626582,"score_gpt":0.22233951177399183,"score_spread":0.18745611871772602,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1976276721","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99806166,0.0013008021,0.000067098816,0.00013908229,0.000029410703,0.000060406208,0.000015492893,0.0000031772065,0.0003228901],"genre_scores_gemma":[0.99884754,0.0006339778,0.00020744563,0.00007360798,0.0001743951,0.0000018454829,0.000007333115,0.0000067612623,0.00004706726],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993019,0.00004590828,0.00023983058,0.0002008827,0.00008961862,0.00012184003],"domain_scores_gemma":[0.9993286,0.0000345891,0.00034149244,0.00010024196,0.00008692571,0.00010811486],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001440123,0.00013886766,0.00023968084,0.000019113957,0.000051159343,0.000017139484,0.000076650154,0.00024476458,0.000011873473],"category_scores_gemma":[0.00019653201,0.00010162524,0.000050303894,0.000041988216,0.00016367316,0.0000079734,0.00010492841,0.00021293438,1.664666e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000095707495,0.000076891345,0.011442913,0.000051619663,0.000026443588,0.000013019969,0.000025519894,6.1654174e-7,0.9868043,0.0000030829488,0.00017598928,0.001283866],"study_design_scores_gemma":[0.0005989192,0.00056457793,0.023043675,0.00005006743,0.000013535175,0.0002652699,0.00019435462,0.00001217297,0.97413677,0.000052838037,0.0009519413,0.00011587726],"about_ca_topic_score_codex":0.0000018588743,"about_ca_topic_score_gemma":3.45615e-7,"teacher_disagreement_score":0.012667559,"about_ca_system_score_codex":0.0000066104526,"about_ca_system_score_gemma":0.000009213815,"threshold_uncertainty_score":0.41441572},"labels":[],"label_agreement":null},{"id":"W1977852460","doi":"10.1073/pnas.0905139106","title":"Immune profile and mitotic index of metastatic melanoma lesions enhance clinical staging in predicting patient survival","year":2009,"lang":"en","type":"article","venue":"Proceedings of the National Academy of Sciences","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":381,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institute of Allergy and Infectious Diseases; York University; Emerald Foundation; National Cancer Institute; National Science Foundation; National Institutes of Health; Cancer Research Institute","keywords":"Melanoma; Immune system; Tumor-infiltrating lymphocytes; Gene expression profiling; Mitotic index; Oncology; Metastasis; Survival analysis; Medicine; Cancer research; Immunology; Internal medicine; Biology; Gene expression; Cancer; Immunotherapy; Gene; Mitosis","score_opus":0.0371327176768018,"score_gpt":0.3280444458010932,"score_spread":0.2909117281242914,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1977852460","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99802405,0.00032803376,0.0000046852633,0.0003156517,0.00001985558,0.00014233908,0.000012432166,0.0000017323044,0.0011512524],"genre_scores_gemma":[0.99872535,0.00004998749,0.001119856,0.000047176265,0.000028172923,0.0000035892397,4.4769016e-7,0.0000019575675,0.000023468741],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988639,0.00001633522,0.00043796116,0.00019534843,0.0003789106,0.000107589934],"domain_scores_gemma":[0.9994122,0.000055832395,0.0003804647,0.000010333096,0.00011701348,0.000024204774],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011247662,0.00006532917,0.00015511399,0.00006783702,0.00005719343,0.0000057062803,0.0002541763,0.000055692486,0.0000018224924],"category_scores_gemma":[0.000647512,0.00004633221,0.000047736004,0.0002133696,0.0003152286,0.000017736156,0.00009985689,0.00009654307,7.4751156e-8],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000031005307,0.00008554,0.12125707,0.00004354205,0.000011290245,1.1998757e-8,0.00011201839,0.000027441545,0.8731186,0.002376884,0.000031021693,0.002905595],"study_design_scores_gemma":[0.00016335254,0.00025291342,0.403527,0.000077652425,0.0000062355393,0.000002266066,0.00022593673,0.00051111524,0.5928643,0.0023041388,0.00001795101,0.000047146656],"about_ca_topic_score_codex":0.000006094186,"about_ca_topic_score_gemma":2.1021066e-7,"teacher_disagreement_score":0.28226992,"about_ca_system_score_codex":0.000004806716,"about_ca_system_score_gemma":0.000039528266,"threshold_uncertainty_score":0.18893726},"labels":[],"label_agreement":null},{"id":"W1979285069","doi":"10.1016/j.cellsig.2010.06.002","title":"Effect of pressure overload-induced hypertrophy on the expression and localization of p38 MAP kinase isoforms in the mouse heart","year":2010,"lang":"en","type":"article","venue":"Cellular Signalling","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":52,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Montreal Heart Institute; Université de Montréal","funders":"Canadian Institutes of Health Research","keywords":"Pressure overload; Gene isoform; Biology; Kinase; p38 mitogen-activated protein kinases; Protein kinase A; Muscle hypertrophy; Messenger RNA; Cell biology; Molecular biology; Endocrinology; Biochemistry; Gene; Cardiac hypertrophy","score_opus":0.007122410124129442,"score_gpt":0.21061510997966376,"score_spread":0.2034926998555343,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1979285069","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980288,0.00036970008,0.0011316219,0.000028267486,0.00006169087,0.0002758533,0.0000046919636,0.000002863813,0.00009646832],"genre_scores_gemma":[0.9997237,0.000013881385,0.000041120424,0.00006458175,0.0000715686,0.0000140175325,0.000027370459,0.000011028909,0.000032777098],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999302,0.00014649624,0.00015301992,0.00016277585,0.00012599332,0.000109670014],"domain_scores_gemma":[0.9995267,0.00007132338,0.00007724243,0.00027465678,0.000027014656,0.000023111717],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047349976,0.00010410722,0.00012412468,0.000025133108,0.000054261563,0.000010014149,0.00014028055,0.00012524478,0.00001131391],"category_scores_gemma":[0.00007103169,0.00005539544,0.000052755648,0.00004414843,0.00004554693,0.0000032534706,0.00003984874,0.00013332472,0.0000010052235],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000108630105,0.000037061043,0.00072977954,0.000083332874,0.000007637378,0.0000013713292,0.00012176816,0.00022262304,0.9983113,0.000093086295,0.000065513086,0.00021793845],"study_design_scores_gemma":[0.0003111587,0.00060668,0.000058202204,0.00003427081,0.000014385156,0.0000014173271,0.00003588802,0.00093853846,0.99650836,0.00002315411,0.0014037661,0.00006420294],"about_ca_topic_score_codex":0.00001757183,"about_ca_topic_score_gemma":0.0000038084231,"teacher_disagreement_score":0.0018029225,"about_ca_system_score_codex":0.0000011341416,"about_ca_system_score_gemma":0.000012253362,"threshold_uncertainty_score":0.22589606},"labels":[],"label_agreement":null},{"id":"W1980423706","doi":"10.1016/j.ddmec.2006.02.007","title":"New aspects of p38 mitogen activated protein kinase (MAPK) biology in lung inflammation","year":2006,"lang":"en","type":"review","venue":"Drug Discovery Today Disease Mechanisms","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Canadian Institutes of Health Research; Fondation pour la Recherche Médicale","keywords":"ARDS; Inflammation; COPD; Medicine; Lung; Cystic fibrosis; Asthma; p38 mitogen-activated protein kinases; Immunology; Protein kinase A; Mitogen-activated protein kinase; MAPK/ERK pathway; Kinase; Biology; Internal medicine; Cell biology","score_opus":0.010986314552388928,"score_gpt":0.2608264003285251,"score_spread":0.24984008577613617,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1980423706","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0073032533,0.9811463,0.005975954,0.000024469959,0.0006102105,0.002739561,0.0012048413,0.000036349644,0.00095908024],"genre_scores_gemma":[0.043600846,0.9152584,0.000921958,0.000050573322,0.0015211377,0.0011128718,0.028829083,0.00033535686,0.008369779],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9970964,0.00039500467,0.0008709086,0.00090872264,0.00023429684,0.00049465464],"domain_scores_gemma":[0.9981897,0.000028509003,0.00063201337,0.00083931733,0.000057030604,0.00025344396],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00022395913,0.0006669007,0.0011950225,0.0002933111,0.000052007574,0.000049355087,0.0004997576,0.00048424417,0.000052129893],"category_scores_gemma":[0.00012254457,0.000592727,0.0006105234,0.0003106722,0.000046914243,0.000024815434,0.0002691243,0.0002323985,0.000017179282],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005808113,0.00056042115,0.000022665816,0.026394913,0.0006483029,0.00025878163,0.00007404627,0.00005774306,0.5831505,0.087077536,0.0027674942,0.29840675],"study_design_scores_gemma":[0.0015898279,0.0002373464,0.00001613829,0.0066607846,0.0007918018,0.000009254741,0.000023457142,0.000018333852,0.36522326,0.010844504,0.6130059,0.0015794024],"about_ca_topic_score_codex":0.00022344451,"about_ca_topic_score_gemma":0.00011743958,"teacher_disagreement_score":0.6102384,"about_ca_system_score_codex":0.00009380306,"about_ca_system_score_gemma":0.0013501885,"threshold_uncertainty_score":0.9996524},"labels":[],"label_agreement":null},{"id":"W1980968474","doi":"10.2174/1381612023393107","title":"Rationale for Ras and Raf-kinase as a Target for Cancer Therapeutics","year":2002,"lang":"en","type":"review","venue":"Current Pharmaceutical Design","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre","funders":"","keywords":"MAPK/ERK pathway; Signal transduction; Anti-apoptotic Ras signalling cascade; Kinase; Protein kinase A; Cell biology; Biology; Cancer research; Signalling pathways; Computational biology","score_opus":0.2988579203544697,"score_gpt":0.45575172331042946,"score_spread":0.15689380295595978,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1980968474","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000005120232,0.92158705,0.07345382,0.000055309618,0.0007587566,0.003502182,0.00056874653,0.000014728373,0.000054274387],"genre_scores_gemma":[0.000014306532,0.99165356,0.0023127568,0.00020566775,0.0010976498,0.0031473476,0.00082286407,0.00007092586,0.00067491113],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99835443,0.00015193947,0.0003840603,0.00059506495,0.00011876693,0.00039575616],"domain_scores_gemma":[0.99910915,0.00021153847,0.00014656334,0.00022017863,0.00010994674,0.0002026288],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002669529,0.00041473625,0.00064042676,0.000051755134,0.0001246041,0.000045384128,0.00021047074,0.00029375727,0.000077295044],"category_scores_gemma":[0.00008747136,0.00034439965,0.00036637002,0.0000612788,0.0000870115,0.000003968183,0.000061936145,0.00017848104,0.000013513053],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010207814,0.00013138352,6.3459794e-7,0.0065131444,0.00022773785,0.0000010312928,0.00001119153,0.0000019205384,0.00081661297,0.00057424133,0.013252081,0.9783679],"study_design_scores_gemma":[0.0009871349,0.00034228244,7.411931e-8,0.0005783254,0.0009099442,0.000012848442,0.0000015877455,0.0005867038,0.0029363115,0.00027492578,0.99294627,0.00042361306],"about_ca_topic_score_codex":2.2169884e-7,"about_ca_topic_score_gemma":1.8097121e-7,"teacher_disagreement_score":0.9796942,"about_ca_system_score_codex":0.000027993374,"about_ca_system_score_gemma":0.00029887518,"threshold_uncertainty_score":0.9999008},"labels":[],"label_agreement":null},{"id":"W1981578404","doi":"10.1139/y10-088","title":"Regulation of stress-associated scaffold proteins JIP1 and JIP3 on the c-Jun NH<sub>2</sub>-terminal kinase in ischemia–reperfusion","year":2010,"lang":"en","type":"article","venue":"Canadian Journal of Physiology and Pharmacology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"University of Manitoba; St. Boniface Hospital; Agriculture and Agri-Food Canada","funders":"","keywords":"c-jun; Kinase; Ischemia; Chemistry; Scaffold protein; Terminal (telecommunication); Medicine; Cell biology; Internal medicine; Biology; Biochemistry; Signal transduction; Transcription factor; Gene; Computer science; Telecommunications","score_opus":0.007175286583832578,"score_gpt":0.2225109878749075,"score_spread":0.21533570129107493,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1981578404","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99879146,0.00021530254,0.0000018099755,0.00037868545,0.00033902613,0.00015351325,0.000031977383,0.0000010353897,0.00008717679],"genre_scores_gemma":[0.999261,0.00009928689,0.00001579493,0.0003367121,0.0002318033,0.0000070108285,0.000020978854,0.000008568622,0.000018799305],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991653,0.00016478736,0.00024558709,0.00016281263,0.000045375597,0.00021612295],"domain_scores_gemma":[0.9993451,0.00005234724,0.00023003099,0.00010210771,0.000095067706,0.00017533793],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029872637,0.0001205566,0.00019914818,0.000109396824,0.00010216355,0.0000050197086,0.00012630862,0.000250852,0.000089016656],"category_scores_gemma":[0.00007357901,0.000093142575,0.000045889596,0.00006277449,0.0002831571,0.000007053527,0.000027524326,0.00032731408,7.554482e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016007236,0.00004072382,0.004684112,0.000024198951,0.000035566063,0.000023920527,0.00010346274,0.000012481798,0.9932007,0.00012885356,0.0007323368,0.0008535603],"study_design_scores_gemma":[0.00077862135,0.0005587117,0.032904107,0.000024015762,0.000027050211,0.00008161188,0.000030414967,0.000043664462,0.9645829,0.00030133495,0.00057897944,0.000088540815],"about_ca_topic_score_codex":0.00013917517,"about_ca_topic_score_gemma":0.003299955,"teacher_disagreement_score":0.028617764,"about_ca_system_score_codex":0.000011648919,"about_ca_system_score_gemma":0.00029170295,"threshold_uncertainty_score":0.37982437},"labels":[],"label_agreement":null},{"id":"W1983590366","doi":"10.1371/journal.pgen.1004669","title":"Germline Mutations in MAP3K6 Are Associated with Familial Gastric Cancer","year":2014,"lang":"en","type":"article","venue":"PLoS Genetics","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":68,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Nova Scotia Health Authority; McGill University; Centre Hospitalier Universitaire Sainte-Justine; Université de Montréal; Queen Elizabeth II Health Sciences Centre; University of British Columbia; Princess Margaret Cancer Centre; Izaak Walton Killam Health Centre; Dalhousie University","funders":"Fundação para a Ciência e a Tecnologia; Health Canada; IWK Health Centre; Dalhousie University; Genome Atlantic; Nova Scotia Health Research Foundation; Genome Canada","keywords":"Biology; Germline mutation; Cancer; Genetics; Germline; CDH1; Cancer research; Gene; Point mutation; Mutation; DNA methylation; Somatic cell; Gene expression; Cell; Cadherin","score_opus":0.014706777808818714,"score_gpt":0.22640668497869218,"score_spread":0.21169990716987347,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1983590366","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99809223,0.00032062663,0.000494932,0.00007094465,0.000077982986,0.00014337144,0.00006577529,0.000013461535,0.0007206444],"genre_scores_gemma":[0.99844694,0.00008523616,0.00041875508,0.00018793119,0.00021591861,0.00005055379,0.0001968338,0.000025188248,0.00037263072],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99917924,0.000057864698,0.00015639211,0.0002446545,0.00012767073,0.00023417118],"domain_scores_gemma":[0.99953043,0.000014561227,0.00008616943,0.00021179985,0.000087716646,0.00006932721],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006680986,0.00012894139,0.00014040337,0.000049075883,0.000040830655,0.00001188379,0.00011626709,0.00011711029,0.000018086908],"category_scores_gemma":[0.00008772568,0.00011738382,0.000030292176,0.00013311859,0.00004132085,0.0000013120086,0.000039729195,0.000079492565,0.000007637669],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006017561,0.00031389596,0.34017634,0.000028969846,0.000100604,0.000011584367,0.00009521089,0.0024563572,0.65455425,0.000036568283,0.0007385879,0.0014274791],"study_design_scores_gemma":[0.0038370425,0.0013680396,0.3477795,0.0001621267,0.00017425191,0.000013847821,0.00014476628,0.012141035,0.62512,0.00021674913,0.008184015,0.00085864734],"about_ca_topic_score_codex":0.000011268624,"about_ca_topic_score_gemma":0.0010324132,"teacher_disagreement_score":0.029434277,"about_ca_system_score_codex":0.00001948282,"about_ca_system_score_gemma":0.0000676883,"threshold_uncertainty_score":0.47867733},"labels":[],"label_agreement":null},{"id":"W1983833034","doi":"10.1038/sj.onc.1210414","title":"The ERK1/2 mitogen-activated protein kinase pathway as a master regulator of the G1- to S-phase transition","year":2007,"lang":"en","type":"review","venue":"Oncogene","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1104,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Research in Immunology and Cancer","funders":"","keywords":"Biology; Cell biology; Cell cycle; MAPK/ERK pathway; Kinase; Protein kinase A; Cyclin-dependent kinase 2; Mitogen-activated protein kinase; Signal transduction; Cyclin; Cyclin-dependent kinase 4; Anti-apoptotic Ras signalling cascade; ASK1; Cell growth; Mitogen-Activated Protein Kinase 3; Mitogen-activated protein kinase kinase; Cell; Biochemistry","score_opus":0.04216164765805923,"score_gpt":0.32391421387175706,"score_spread":0.2817525662136978,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1983833034","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.02156582,0.9737856,0.00021593686,0.0000838852,0.0005037543,0.0025077744,0.0003312127,0.000013561906,0.000992499],"genre_scores_gemma":[0.0066684578,0.9770139,0.00036840347,0.00037331678,0.0014116365,0.00078118866,0.00077490177,0.00021376924,0.012394468],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9980183,0.00025863605,0.0005812211,0.0004993135,0.0002767077,0.00036582435],"domain_scores_gemma":[0.9982915,0.00002279769,0.00033779565,0.0010772113,0.000120864315,0.00014985689],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039601384,0.00040597908,0.0006052844,0.00005676885,0.0001623479,0.000026668826,0.0005325988,0.00048076306,0.000032658907],"category_scores_gemma":[0.00008506144,0.00022975211,0.0005852017,0.00027617204,0.00009403426,0.0000024497385,0.00014009258,0.00019285383,0.00003846404],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010045191,0.00007308775,5.8969935e-8,0.0006123864,0.00010275958,0.000008523986,0.000027762728,2.8952456e-7,0.46405897,0.000039841725,0.0004192705,0.53455657],"study_design_scores_gemma":[0.00028325306,0.00031904766,1.8563392e-7,0.0007911184,0.000090586815,0.00003103933,0.000008449757,2.1846063e-7,0.39131758,0.000007842008,0.6069753,0.00017538221],"about_ca_topic_score_codex":0.000016441514,"about_ca_topic_score_gemma":0.000029030212,"teacher_disagreement_score":0.606556,"about_ca_system_score_codex":0.00004058423,"about_ca_system_score_gemma":0.0004816537,"threshold_uncertainty_score":0.9369019},"labels":[],"label_agreement":null},{"id":"W1983899867","doi":"10.1186/2044-5040-2-5","title":"A novel whole-cell lysate kinase assay identifies substrates of the p38 MAPK in differentiating myoblasts","year":2012,"lang":"en","type":"article","venue":"Skeletal Muscle","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":52,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; Lunenfeld-Tanenbaum Research Institute; University of Toronto; Canada Research Chairs; Ottawa Hospital; University of Ottawa","funders":"Natural Sciences and Engineering Research Council of Canada; Multiple Sclerosis Society of Canada; Canadian Institutes of Health Research; Multiple Sclerosis Society; University of Ottawa","keywords":"Cell biology; Myogenesis; Kinase; Biology; p38 mitogen-activated protein kinases; Phosphorylation; Protein kinase A; Gene isoform; Myocyte; Biochemistry; Gene","score_opus":0.011473661751050239,"score_gpt":0.21856785002176285,"score_spread":0.2070941882707126,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1983899867","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99748385,0.0003024197,0.0001124166,0.000033880086,0.00034910894,0.00013425114,0.00003241123,0.0000068423183,0.0015448154],"genre_scores_gemma":[0.9989178,0.000008638438,0.00012440317,0.00003840618,0.0001504491,0.000014541511,0.000039233128,0.000018117928,0.00068840216],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990715,0.00006973358,0.00023114061,0.0001867502,0.0001277839,0.00031312386],"domain_scores_gemma":[0.9994529,0.000018807867,0.0001194574,0.00031785652,0.00003207692,0.000058883823],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023637191,0.00013899671,0.0001353388,0.00003288595,0.00005310315,0.000016372649,0.00020744435,0.00010674103,0.000020698091],"category_scores_gemma":[0.0000655154,0.00010600764,0.00012050672,0.00009951504,0.00006972915,0.000009379891,0.00017033046,0.000101771504,0.00001398373],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000049785267,0.00017236959,0.015956605,0.000053863714,0.000009870526,5.218589e-7,0.00013884314,0.000003282729,0.9827328,0.00007385029,0.00008301204,0.0007700179],"study_design_scores_gemma":[0.00036384116,0.000038389884,0.2863419,0.000025013816,0.000010006787,0.0000022040915,0.00013737731,0.000018459912,0.71182954,0.000029043043,0.0010913069,0.000112882844],"about_ca_topic_score_codex":0.00004784076,"about_ca_topic_score_gemma":0.0001497162,"teacher_disagreement_score":0.2709032,"about_ca_system_score_codex":0.000008046258,"about_ca_system_score_gemma":0.000026417676,"threshold_uncertainty_score":0.43228662},"labels":[],"label_agreement":null},{"id":"W1984912202","doi":"10.1021/jm900607f","title":"Development of Novel, Highly Potent Inhibitors of V-RAF Murine Sarcoma Viral Oncogene Homologue B1 (BRAF): Increasing Cellular Potency through Optimization of a Distal Heteroaromatic Group","year":2010,"lang":"en","type":"article","venue":"Journal of Medicinal Chemistry","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"Cancer Research UK; Wellcome Trust","keywords":"Chemistry; Viral Oncogene; Kinase; Potency; In vivo; Melanoma; Oncogene; In vitro; MAPK/ERK pathway; V600E; Mutant; Cancer research; Pharmacology; Biochemistry; Biology; Cell; Cell cycle","score_opus":0.008721649390379867,"score_gpt":0.22202580823373122,"score_spread":0.21330415884335135,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1984912202","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9828181,0.00050955504,0.015964782,0.000042106203,0.0002606038,0.000088451714,0.000019470343,0.000003098544,0.00029378856],"genre_scores_gemma":[0.93808186,0.000043360054,0.0613305,0.000015270463,0.00038988216,0.0000020380353,0.0000971672,0.00002003033,0.000019899471],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978486,0.00003770876,0.0012177557,0.00019237187,0.0004966787,0.00020693203],"domain_scores_gemma":[0.9979882,0.000026977597,0.0012835412,0.00026254682,0.00030311066,0.0001355704],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005637237,0.00021746554,0.00050369336,0.00005421588,0.000042952972,0.000004747193,0.0003001754,0.00024187,0.000025423107],"category_scores_gemma":[0.00023398192,0.0001818487,0.00019003045,0.00009408153,0.00021048526,0.000014993116,0.000120161014,0.00027242102,1.4016321e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035734868,0.000546888,0.0004695206,0.00048265533,0.00013037989,0.00004097564,0.00022545374,0.00018915317,0.99664056,0.0000086785185,0.000031877993,0.00087652233],"study_design_scores_gemma":[0.0019177744,0.00057109,0.00042836613,0.00032090678,0.00009601631,0.0006090991,0.00024790913,0.00013181052,0.9952436,0.000019591562,0.00025659445,0.00015723245],"about_ca_topic_score_codex":0.000031002415,"about_ca_topic_score_gemma":0.0000047592557,"teacher_disagreement_score":0.04536572,"about_ca_system_score_codex":0.000028681188,"about_ca_system_score_gemma":0.0002852754,"threshold_uncertainty_score":0.74155754},"labels":[],"label_agreement":null},{"id":"W1985309852","doi":"10.1038/nature08314","title":"A dimerization-dependent mechanism drives RAF catalytic activation","year":2009,"lang":"en","type":"article","venue":"Nature","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":498,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Institute for Research in Immunology and Cancer; Université de Montréal; Lunenfeld-Tanenbaum Research Institute","funders":"Canadian Institutes of Health Research","keywords":"MAPK/ERK pathway; Cell biology; Kinase; Receptor tyrosine kinase; Signal transduction; Tyrosine kinase; Chemistry; Phosphorylation; Biology","score_opus":0.0041429794295503005,"score_gpt":0.22573165602047665,"score_spread":0.22158867659092635,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1985309852","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9826142,0.00043025284,0.008133221,0.0010115709,0.00036805004,0.00023729075,0.000016328318,0.000039878,0.007149192],"genre_scores_gemma":[0.9962217,0.00003050626,0.0003482845,0.001414799,0.00025258542,0.0000047570734,0.0003314098,0.000008363446,0.0013875957],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99946976,0.000015629244,0.00007738436,0.00020727393,0.0001107295,0.000119240394],"domain_scores_gemma":[0.9996678,0.0000032478365,0.00004217059,0.00019942108,0.000044666536,0.000042690368],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000042338143,0.00009224045,0.00006644335,0.00002772981,0.000053774183,0.000015274485,0.00010603733,0.0006389422,0.000013535413],"category_scores_gemma":[0.00005421894,0.00008327388,0.000038711274,0.00005588747,0.000008153744,0.0000040521227,0.0000213358,0.0002474226,0.00000911203],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000019880634,0.000028300929,0.000045356224,0.0000032163425,0.000010518457,0.0000018060014,0.000029087665,0.0000064506453,0.9916519,0.004525813,0.0017489862,0.0019286686],"study_design_scores_gemma":[0.00027883932,0.00015045823,0.0024585435,0.000007128881,0.000008605952,0.000008138293,0.000021263413,0.000028863225,0.98432624,0.0017074783,0.010880671,0.00012377076],"about_ca_topic_score_codex":0.0000015600326,"about_ca_topic_score_gemma":0.000003146687,"teacher_disagreement_score":0.013607483,"about_ca_system_score_codex":0.0000081131275,"about_ca_system_score_gemma":0.000034629382,"threshold_uncertainty_score":0.49281073},"labels":[],"label_agreement":null},{"id":"W1985928174","doi":"10.1038/nature13121","title":"Reversible and adaptive resistance to BRAF(V600E) inhibition in melanoma","year":2014,"lang":"en","type":"article","venue":"Nature","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":910,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Institutes of Health Research","keywords":"Melanoma; Cancer research; Vemurafenib; V600E; MEK inhibitor; Epidermal growth factor receptor; MAPK/ERK pathway; EGFR inhibitors; Selumetinib; Biology; Medicine; Oncogene; Kinase; Cancer; Mutation; Internal medicine; Cell cycle; Cell biology","score_opus":0.004767629710370415,"score_gpt":0.21284127473919862,"score_spread":0.2080736450288282,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1985928174","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9853071,0.0008099783,0.0003770652,0.0005689037,0.000094956544,0.000121696845,0.000013536379,0.0000072065964,0.012699537],"genre_scores_gemma":[0.9954227,0.000024094772,0.0012650628,0.0013558214,0.00014343648,0.000007862604,0.000035569108,0.0000082255065,0.0017371773],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9994556,0.000036645823,0.000073357674,0.00024132809,0.00006627911,0.00012679303],"domain_scores_gemma":[0.9997286,0.0000078611065,0.000022806378,0.00015159347,0.00003215212,0.00005697077],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012180238,0.00007943068,0.000080623235,0.000040163064,0.000029680106,0.000008810853,0.000043294112,0.00050673925,0.000005683494],"category_scores_gemma":[0.00008042052,0.0000766923,0.00001893457,0.00007942917,0.00001585163,0.0000029809123,0.000051197458,0.00023938631,0.000006454883],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033774413,0.000035262496,0.0034614992,0.00003600648,0.000011548826,0.00001879191,0.0001567752,0.000008306651,0.932695,0.0064423713,0.054784704,0.002011989],"study_design_scores_gemma":[0.0009865216,0.00047634696,0.020013371,0.00008485762,0.0000073272627,0.000016400076,0.00008017864,0.00001655278,0.5632014,0.0013366302,0.41348368,0.00029670686],"about_ca_topic_score_codex":0.000005487367,"about_ca_topic_score_gemma":0.0004859781,"teacher_disagreement_score":0.36949357,"about_ca_system_score_codex":0.00000920425,"about_ca_system_score_gemma":0.000015826461,"threshold_uncertainty_score":0.39084372},"labels":[],"label_agreement":null},{"id":"W1986023178","doi":"10.1128/mcb.01701-13","title":"The Catalytic Activity of the Mitogen-Activated Protein Kinase Extracellular Signal-Regulated Kinase 3 Is Required To Sustain CD4<sup>+</sup> CD8<sup>+</sup> Thymocyte Survival","year":2014,"lang":"en","type":"article","venue":"Molecular and Cellular Biology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Research in Immunology and Cancer; Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Biology; Protein kinase A; Kinase; Cell biology; Extracellular; CD8; Thymocyte; Mitogen-activated protein kinase; Molecular biology; Signal transduction; Biochemistry; Antigen; Immunology","score_opus":0.008446801582782744,"score_gpt":0.21464563771381237,"score_spread":0.20619883613102963,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1986023178","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98567545,0.0020304085,0.009582695,0.0007712371,0.00015726114,0.0013335792,0.00009812669,0.000036136087,0.0003150903],"genre_scores_gemma":[0.99712,0.000035435318,0.00011848905,0.0002644195,0.00017703607,0.00012261083,0.00023073218,0.00008703106,0.0018442448],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9957107,0.0012700228,0.0006049191,0.0011247483,0.000327596,0.00096205744],"domain_scores_gemma":[0.9973749,0.00008445601,0.0002966951,0.0016476064,0.0002678555,0.00032848062],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010081272,0.00063432363,0.00061401917,0.00010641943,0.00049606035,0.000068729096,0.0008537019,0.000633894,0.00003053478],"category_scores_gemma":[0.00034572888,0.00044670602,0.00039882242,0.00040836298,0.0006151701,0.0000127284875,0.0006574866,0.00035526315,0.000016284048],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005708867,0.00012688222,0.00026071767,0.000073512165,0.00022386019,0.00002948421,0.00025341942,0.0003571173,0.9917762,0.0010468485,0.0002140155,0.005067036],"study_design_scores_gemma":[0.0012324057,0.00084041606,0.00007367476,0.0000376864,0.00009907325,0.000019552524,0.0001900079,0.0027127531,0.9586221,0.0004029201,0.0352285,0.0005409172],"about_ca_topic_score_codex":0.00028411535,"about_ca_topic_score_gemma":0.000021996926,"teacher_disagreement_score":0.035014484,"about_ca_system_score_codex":0.0000462769,"about_ca_system_score_gemma":0.000216785,"threshold_uncertainty_score":0.9997985},"labels":[],"label_agreement":null},{"id":"W1986193009","doi":"10.1016/j.ejmech.2013.10.052","title":"Structural determinants for ERK5 (MAPK7) and leucine rich repeat kinase 2 activities of benzo[e]pyrimido-[5,4-b]diazepine-6(11H)-ones","year":2013,"lang":"en","type":"article","venue":"European Journal of Medicinal Chemistry","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institute of General Medical Sciences; National Human Genome Research Institute; Wellcome Trust; Canadian Institutes of Health Research; Genome Canada; Novartis Foundation; Medical Research Council; Merck KGaA; National Cancer Institute; AbbVie; Life Technologies Corporation; GlaxoSmithKline; University of California; Pfizer","keywords":"Chemistry; Diazepine; Kinase; Stereochemistry; Biochemistry; Ring (chemistry); Organic chemistry","score_opus":0.011960522515839948,"score_gpt":0.23079304400279935,"score_spread":0.2188325214869594,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1986193009","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960742,0.002181316,0.00017313044,0.0001253614,0.00021726688,0.00011334043,0.000021874006,0.000004717961,0.0010887749],"genre_scores_gemma":[0.9972085,0.00021065408,0.00074225955,0.00008138269,0.0011615594,0.0000029949051,0.000022551978,0.000034830446,0.0005352973],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986276,0.000080593294,0.000580717,0.0002341118,0.00022564024,0.00025131865],"domain_scores_gemma":[0.99868804,0.00004481884,0.00054772437,0.00026079576,0.00024245046,0.00021619609],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004659522,0.00022584695,0.00037165463,0.000041786483,0.000070508264,0.000022838545,0.0002679709,0.00007332896,0.000060571845],"category_scores_gemma":[0.00027333194,0.00017660116,0.00012750692,0.00004332422,0.00018218615,0.000021480688,0.00010076583,0.00018004986,0.0000011859703],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021887061,0.000025486164,0.00164995,0.00029723742,0.00006438326,0.00007101879,0.00012096235,0.0000031083723,0.98561376,0.0000019344898,0.0018858046,0.010047491],"study_design_scores_gemma":[0.0018273818,0.0010756808,0.010851509,0.00020511194,0.00009061529,0.0010448515,0.00082226354,0.000031308773,0.9814727,0.000028560307,0.002340116,0.00020991059],"about_ca_topic_score_codex":0.0000056175427,"about_ca_topic_score_gemma":9.3297473e-7,"teacher_disagreement_score":0.00983758,"about_ca_system_score_codex":0.0000117382515,"about_ca_system_score_gemma":0.00007264728,"threshold_uncertainty_score":0.72015864},"labels":[],"label_agreement":null},{"id":"W1986408860","doi":"10.1309/5d7mm22davgdt1r8","title":"Loss of Raf-1 Kinase Inhibitor Protein Expression Is Associated With Tumor Progression and Metastasis in Colorectal Cancer","year":2007,"lang":"en","type":"article","venue":"American Journal of Clinical Pathology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":129,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Colorectal cancer; Cancer research; Metastasis; Protein kinase A; Regulator; Kinase; Medicine; Cancer; Biology; Oncology; Internal medicine; Gene; Cell biology; Genetics","score_opus":0.01717962287403015,"score_gpt":0.3443092566142189,"score_spread":0.3271296337401888,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1986408860","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99888945,0.0004029516,0.00025473247,0.00012109315,0.00010378025,0.00016369595,0.000019312016,0.0000022684394,0.000042695407],"genre_scores_gemma":[0.99717283,0.000087655324,0.0023683452,0.00017449254,0.00015868478,0.0000074840746,0.0000047897715,0.000014894406,0.000010805588],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980508,0.00038578262,0.0009118358,0.00024054205,0.00017686808,0.0002341524],"domain_scores_gemma":[0.998134,0.00012479113,0.0012708076,0.00011261147,0.00020147135,0.00015630804],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001717503,0.00013632482,0.00062649674,0.000085893524,0.000023699844,0.000003934572,0.00012391862,0.00012261014,0.000009513986],"category_scores_gemma":[0.0007097892,0.000093954586,0.000110910245,0.00014929702,0.0006414762,0.000006878549,0.00007246961,0.00028492324,2.6040527e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035144917,0.00037179413,0.23712505,0.000011870336,0.0000544265,0.0006528139,0.00010695687,0.000001898941,0.72125304,0.00000393293,0.000069158166,0.036834568],"study_design_scores_gemma":[0.0027399762,0.010477518,0.19511965,0.00027091426,0.000045097968,0.00024362285,0.00021727155,0.0000032319883,0.79027027,0.000028561974,0.00042370879,0.00016020077],"about_ca_topic_score_codex":0.000010910628,"about_ca_topic_score_gemma":0.0000572907,"teacher_disagreement_score":0.06901722,"about_ca_system_score_codex":0.00001111196,"about_ca_system_score_gemma":0.00017428267,"threshold_uncertainty_score":0.3831357},"labels":[],"label_agreement":null},{"id":"W1986449091","doi":"10.4161/cc.7.7.5610","title":"Mice lacking both mixed-lineage kinase genes Mlk1 and Mlk2 retain a wild type phenotype","year":2008,"lang":"en","type":"article","venue":"Cell Cycle","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"National Cancer Institute; Natural Sciences and Engineering Research Council of Canada; Terry Fox Foundation","keywords":"Biology; Kinase; MAP kinase kinase kinase; Mitogen-activated protein kinase kinase; Cell biology; ASK1; MAP2K7; Cyclin-dependent kinase 4; MAPK/ERK pathway; c-Raf; Protein kinase A; Mitogen-activated protein kinase; p38 mitogen-activated protein kinases; Cyclin-dependent kinase 2; Molecular biology","score_opus":0.012821056384172429,"score_gpt":0.21099434865069613,"score_spread":0.1981732922665237,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1986449091","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98721486,0.005113752,0.00020926676,0.00004351207,0.00017934944,0.00010268958,0.000010196853,0.000021132684,0.007105256],"genre_scores_gemma":[0.99496394,0.00080719346,0.0008949065,0.00033432926,0.0002814141,0.0000049066207,0.00007463102,0.000027726668,0.002610925],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991969,0.000042112228,0.00013460038,0.0003182687,0.00007684917,0.00023128281],"domain_scores_gemma":[0.9995199,0.000009325857,0.000053805164,0.00027459266,0.00004048389,0.00010189199],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008917691,0.00014363503,0.00012822036,0.000023963517,0.0001293113,0.000013984096,0.000115905525,0.00012820933,0.000027061771],"category_scores_gemma":[0.000028080509,0.00013999875,0.000043897817,0.00006407097,0.000062080355,0.000004117982,0.000102553015,0.00007353857,0.00003764762],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000058958285,0.000052581196,0.003860417,0.000033351156,0.000013193811,0.000044216722,0.00008534911,0.000023102732,0.98843557,0.000031794872,0.0058562434,0.0015052367],"study_design_scores_gemma":[0.0006024895,0.00027293255,0.0028251861,0.000010297741,0.00001744642,0.00004269298,0.00007822781,0.00021029385,0.86633354,0.000031654832,0.12929198,0.00028325067],"about_ca_topic_score_codex":0.00004686202,"about_ca_topic_score_gemma":0.000038291462,"teacher_disagreement_score":0.12343574,"about_ca_system_score_codex":0.000006097947,"about_ca_system_score_gemma":0.000049605736,"threshold_uncertainty_score":0.57089835},"labels":[],"label_agreement":null},{"id":"W1986755577","doi":"10.3892/or.2013.2645","title":"Expression and activation of P38 MAP kinase in invasive ductal breast cancers: Correlation with expression of the estrogen receptor, HER2 and downstream signaling phosphorylated proteins","year":2013,"lang":"en","type":"article","venue":"Oncology Reports","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre d'expertise et de recherche en infrastructures urbaines","funders":"Ligue Contre le Cancer","keywords":"Cancer research; MAPK/ERK pathway; Protein kinase B; Biology; Oncogene; Estrogen receptor; Carcinogenesis; Phosphorylation; Kinase; Breast cancer; Cell cycle; Cancer; Cell biology","score_opus":0.005277762863721409,"score_gpt":0.20642384940840297,"score_spread":0.20114608654468155,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1986755577","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99891365,0.00019284943,0.00006881371,0.000048760285,0.00006651255,0.0005567283,0.000004811418,0.0000033847707,0.00014451554],"genre_scores_gemma":[0.9989895,0.00003124168,0.0007631386,0.000011703817,0.000026801656,0.00007290379,0.000049168015,0.000008867843,0.000046633217],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99921143,0.00008545721,0.00027188793,0.00024146681,0.00008646541,0.00010330834],"domain_scores_gemma":[0.99920213,0.00002027379,0.00045865276,0.00018087386,0.00009731407,0.000040731706],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012399077,0.00010158654,0.00016822528,0.0000293681,0.000041014366,0.000004629476,0.000036894387,0.00018479128,0.000020054476],"category_scores_gemma":[0.00005648543,0.000068950016,0.000020443405,0.00005693064,0.0001195671,0.000014949507,0.000068532776,0.0000807111,1.5732114e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011373452,0.000051393054,0.12206952,0.00003408876,0.000009295976,0.000008112925,0.00021286578,0.00007268619,0.8762632,0.0000024976357,0.00009024788,0.0010723445],"study_design_scores_gemma":[0.0004454203,0.00039153153,0.023148157,0.00024393333,0.000009696283,0.00017362293,0.00030546382,0.000014229596,0.9750553,0.00004097373,0.000103594706,0.00006807413],"about_ca_topic_score_codex":0.00044503965,"about_ca_topic_score_gemma":0.000057774894,"teacher_disagreement_score":0.098921366,"about_ca_system_score_codex":0.00002974205,"about_ca_system_score_gemma":0.00020707292,"threshold_uncertainty_score":0.28117},"labels":[],"label_agreement":null},{"id":"W1987490886","doi":"10.1002/cyto.b.20092","title":"Pharmacodynamic monitoring of BAY 43‐9006 (Sorafenib) in phase I clinical trials involving solid tumor and AML/MDS patients, using flow cytometry to monitor activation of the ERK pathway in peripheral blood cells","year":2006,"lang":"en","type":"article","venue":"Cytometry Part B Clinical Cytometry","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":52,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Ontario Institute for Cancer Research","funders":"National Cancer Institute; Case Western Reserve University; Northwestern University","keywords":"Flow cytometry; MAPK/ERK pathway; Medicine; Pharmacology; Cancer research; Kinase; Chemistry; Immunology; Biochemistry","score_opus":0.06673508492901951,"score_gpt":0.4023568401769417,"score_spread":0.33562175524792215,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1987490886","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99494207,0.00059837924,0.0011191485,0.000019638646,0.0019366771,0.0010495903,0.00026442745,0.00002005576,0.00005001099],"genre_scores_gemma":[0.9952626,0.00017229888,0.0027094025,0.000116712516,0.001500886,0.000040672658,0.00007851792,0.00007774895,0.00004114955],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9912997,0.0019230831,0.0043183626,0.0010956342,0.00064573984,0.00071751827],"domain_scores_gemma":[0.9959335,0.0011291413,0.0014712802,0.00083838176,0.0003093324,0.00031840842],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0067426474,0.0005297426,0.001767596,0.0009138186,0.000111725465,0.000051852592,0.00063484925,0.0006606693,0.000025632764],"category_scores_gemma":[0.0053156447,0.0004562995,0.00063587364,0.0024792075,0.0003401753,0.000052106097,0.0005537673,0.00079992646,0.0000030388285],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000501328,0.0017134708,0.49942937,0.00010493331,0.00007737432,0.000007963476,0.000021490889,0.00023423416,0.4947996,0.0000024488688,0.000047802994,0.003059972],"study_design_scores_gemma":[0.008544955,0.0011863207,0.27193463,0.0003537402,0.00010628885,0.000004383612,0.0001221912,0.0011702814,0.7158435,0.000020712238,0.00022941652,0.00048356652],"about_ca_topic_score_codex":0.00007856051,"about_ca_topic_score_gemma":0.000017148426,"teacher_disagreement_score":0.22749475,"about_ca_system_score_codex":0.00009766503,"about_ca_system_score_gemma":0.00023862548,"threshold_uncertainty_score":0.9997889},"labels":[],"label_agreement":null},{"id":"W1989595797","doi":"10.1186/1479-5876-12-s1-p5","title":"Phase Ib/II, open-label, dose-escalation study of LGX818, an oral selective BRAF inhibitor, in combination with MEK162, an oral MEK1/2 inhibitor, in patients with BRAF V600-dependent advanced solid tumors: preliminary results","year":2014,"lang":"en","type":"article","venue":"Journal of Translational Medicine","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Maximum tolerated dose; Cancer research; Open label; Pharmacology; MEK inhibitor; Medicine; Oncology; Chemistry; Internal medicine; Adverse effect; MAPK/ERK pathway; Phosphorylation; Biochemistry","score_opus":0.018603095485809525,"score_gpt":0.30734829191077545,"score_spread":0.28874519642496593,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1989595797","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977881,0.000052897707,0.00072476594,0.0002518936,0.00012881779,0.00092066557,0.000024590428,0.00000486286,0.000103411025],"genre_scores_gemma":[0.9979624,0.000005333345,0.0013033819,0.00006141534,0.00018557072,0.000017061244,0.0004187231,0.00002916143,0.000016933956],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.997151,0.00038038538,0.0010618204,0.00038567279,0.00079825724,0.00022287578],"domain_scores_gemma":[0.9981705,0.000051621166,0.0007174842,0.00022699118,0.0006709567,0.00016245444],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011072673,0.0002560177,0.0005473416,0.00032130396,0.00008073609,0.000015941458,0.0002691313,0.00012817157,0.000006057946],"category_scores_gemma":[0.0001242466,0.00018966732,0.000023070936,0.00031780583,0.0000899897,0.00016897781,0.000034547258,0.000293374,1.8122786e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.23056224,0.08562728,0.20942879,0.00015746175,0.00044807955,0.00012496539,0.012962887,0.012238328,0.37667632,0.00019588582,0.00022345548,0.07135429],"study_design_scores_gemma":[0.21242943,0.33801225,0.41837198,0.0007325004,0.00014757845,0.000058827853,0.0009067313,0.0017724022,0.026727607,0.00030988443,0.000084840816,0.0004459849],"about_ca_topic_score_codex":0.000086218795,"about_ca_topic_score_gemma":0.0010080702,"teacher_disagreement_score":0.34994873,"about_ca_system_score_codex":0.00004970381,"about_ca_system_score_gemma":0.00024058395,"threshold_uncertainty_score":0.7734409},"labels":[],"label_agreement":null},{"id":"W1989836805","doi":"10.1016/j.cellsig.2003.07.003","title":"Calcium pyrophosphate dihydrate crystal associated induction of neutrophil activation and repression of TNF-α-induced apoptosis is mediated by the p38 MAP kinase","year":2003,"lang":"en","type":"article","venue":"Cellular Signalling","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Canadian Institutes of Health Research","keywords":"p38 mitogen-activated protein kinases; Psychological repression; Apoptosis; Chemistry; Cell biology; Tumor necrosis factor alpha; Kinase; Calcium; Protein kinase A; Biochemistry; Biology; Endocrinology; Gene expression; Gene","score_opus":0.017237330287706753,"score_gpt":0.2206108905607344,"score_spread":0.20337356027302766,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1989836805","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99583155,0.0007385222,0.0028769823,0.000057357334,0.00014438841,0.00020063754,0.000023553244,0.000008682264,0.00011834603],"genre_scores_gemma":[0.9993887,0.000088999666,0.000057595815,0.000046783636,0.000044283395,0.000010722264,0.00020498544,0.000022894263,0.00013504089],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99883085,0.00017256702,0.00032609963,0.00030693252,0.0001791928,0.00018436841],"domain_scores_gemma":[0.9991793,0.00003073178,0.0003500512,0.000238862,0.00013943258,0.00006163871],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003363725,0.00016015362,0.00019584504,0.00003775041,0.00010462849,0.000013547115,0.000102979175,0.0002328063,0.00002039381],"category_scores_gemma":[0.00012848538,0.00012915168,0.000075949836,0.00013075993,0.00006232087,0.000009776286,0.000042886644,0.00012343234,9.501789e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000056277124,0.00006925571,0.00024360437,0.000034212622,0.000059702146,5.103789e-7,0.0001364165,0.00005774923,0.99888784,0.000025800733,0.00020865089,0.00021995397],"study_design_scores_gemma":[0.000527682,0.00020347802,0.000097587756,0.00005026453,0.000040158087,6.219306e-7,0.000109797744,0.00023389647,0.9979154,0.000059784652,0.00062457484,0.00013679528],"about_ca_topic_score_codex":0.000055937522,"about_ca_topic_score_gemma":9.0632165e-7,"teacher_disagreement_score":0.003557164,"about_ca_system_score_codex":0.00001213249,"about_ca_system_score_gemma":0.000044613436,"threshold_uncertainty_score":0.5266653},"labels":[],"label_agreement":null},{"id":"W1989841664","doi":"10.1074/jbc.m709682200","title":"Determinants That Control the Distinct Subcellular Localization of p38α-PRAK and p38β-PRAK Complexes","year":2008,"lang":"en","type":"article","venue":"Journal of Biological Chemistry","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Project 211; Canadian Institutes of Health Research; National Natural Science Foundation of China","keywords":"Subcellular localization; Nuclear localization sequence; p38 mitogen-activated protein kinases; Biology; Protein kinase A; Cell biology; Kinase; Biochemistry; Nucleus; Cytoplasm","score_opus":0.027114566436126145,"score_gpt":0.23462396677771138,"score_spread":0.20750940034158524,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1989841664","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994849,0.002047979,0.002645315,0.000059074668,0.000057299167,0.000064866115,0.000023152605,0.0000030659419,0.00025023782],"genre_scores_gemma":[0.99890196,0.00059492706,0.0000858781,0.00008040405,0.00023667915,0.00000196405,0.000019214209,0.000007024191,0.00007193834],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991128,0.00006969443,0.0003598805,0.00015696835,0.00014024062,0.00016044079],"domain_scores_gemma":[0.99915886,0.000058363257,0.00039576128,0.00017607056,0.00011986082,0.00009106832],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025968454,0.00014155617,0.00028196562,0.000010423328,0.00009993438,0.000008792364,0.00022789817,0.00019736927,0.000031044427],"category_scores_gemma":[0.00022913677,0.00008021226,0.00013247266,0.000039907864,0.00038925014,0.00000423174,0.00007136444,0.00013076706,6.821978e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017640507,0.000056757763,0.17690843,0.000029060664,0.000031794825,0.0000369644,0.000017880344,0.00000980875,0.8220573,0.000004295201,0.00032416193,0.00034711687],"study_design_scores_gemma":[0.00087738485,0.00042633116,0.035969105,0.00002610539,0.000029939563,0.0009808189,0.00006598925,0.00010389938,0.95527124,0.00008371898,0.006035142,0.00013029846],"about_ca_topic_score_codex":0.0000031664295,"about_ca_topic_score_gemma":0.0000010888564,"teacher_disagreement_score":0.14093933,"about_ca_system_score_codex":0.00000697435,"about_ca_system_score_gemma":0.000043951015,"threshold_uncertainty_score":0.3270961},"labels":[],"label_agreement":null},{"id":"W1989876648","doi":"10.1038/sj.emboj.7600489","title":"Activation of MK5/PRAK by the atypical MAP kinase ERK3 defines a novel signal transduction pathway","year":2004,"lang":"en","type":"article","venue":"The EMBO Journal","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":138,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Institute for Research in Immunology and Cancer","funders":"Canadian Institutes of Health Research; Cancer Research UK; University of Dundee","keywords":"Biology; Signal transduction; Kinase; Cell biology; Genetics; Transduction (biophysics); Computational biology; Biochemistry","score_opus":0.013641739331838038,"score_gpt":0.22117470917641413,"score_spread":0.2075329698445761,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1989876648","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9701815,0.0004042942,0.026629107,0.0021898502,0.0002185324,0.000106770334,0.000023532664,0.0000045912775,0.00024178965],"genre_scores_gemma":[0.9987681,0.00004737106,0.00024836898,0.00021926686,0.0005395713,0.000006001493,0.000031310545,0.000010095851,0.00012993912],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99926376,0.00006579101,0.00021560257,0.00011976031,0.00017092803,0.00016412656],"domain_scores_gemma":[0.99953425,0.00001612235,0.000140076,0.00017910756,0.00007801448,0.000052430376],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032831822,0.00011021406,0.00009801194,0.00001926992,0.0001988574,0.000024674398,0.0002108723,0.000080125596,0.000053796954],"category_scores_gemma":[0.00003084325,0.00006130785,0.00011484944,0.00005757927,0.000094848096,0.000007080731,0.000024390654,0.00020481326,0.000005916325],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023388972,0.00010072762,0.000042657968,0.000006315621,0.00004015569,0.0000013203029,0.00015581284,0.00026694976,0.9944744,0.0006284305,0.0017491833,0.0023001635],"study_design_scores_gemma":[0.0009158754,0.00034760503,0.0006207955,0.000021136519,0.000026926124,0.0003498043,0.00018160093,0.000013112555,0.977737,0.0011524378,0.018535333,0.00009836283],"about_ca_topic_score_codex":0.000013556285,"about_ca_topic_score_gemma":0.000006121469,"teacher_disagreement_score":0.028586542,"about_ca_system_score_codex":0.000014921854,"about_ca_system_score_gemma":0.00010582639,"threshold_uncertainty_score":0.25000617},"labels":[],"label_agreement":null},{"id":"W1990899207","doi":"10.1016/j.bmc.2014.06.027","title":"Discovery of inhibitors of the mitotic kinase TTK based on N-(3-(3-sulfamoylphenyl)-1H-indazol-5-yl)-acetamides and carboxamides","year":2014,"lang":"en","type":"article","venue":"Bioorganic & Medicinal Chemistry","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":38,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Ontario Institute for Cancer Research; University Health Network","funders":"Argonne National Laboratory; Shionogi","keywords":"Chemistry; Kinase; Mitosis; Stereochemistry; Pharmacology; Biochemistry; Cell biology","score_opus":0.005042545180360394,"score_gpt":0.18944833312156176,"score_spread":0.18440578794120135,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1990899207","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99686193,0.00065588957,0.00015339244,0.00020640866,0.00023752394,0.00013559623,0.000032914035,0.000009564329,0.0017067979],"genre_scores_gemma":[0.9989405,0.000041837797,0.000070211274,0.00017494628,0.00042878394,0.0000069688826,0.00003647792,0.000029277318,0.00027096653],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998572,0.000064600164,0.00038412504,0.00039919355,0.00033205975,0.00024803355],"domain_scores_gemma":[0.9988178,0.000066382236,0.0002623924,0.00067117804,0.000078132085,0.000104141094],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029087154,0.00025796925,0.00033042335,0.000026326168,0.00006417147,0.000010747851,0.00031161745,0.00022763557,0.000019211382],"category_scores_gemma":[0.0005389146,0.00018389343,0.00013095382,0.00013449186,0.00045180361,0.00000495508,0.0001353662,0.00016157723,9.801006e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008936124,0.000084383035,0.0067297183,0.00034468423,0.000030311838,0.0000019798586,0.00003450448,0.000005955986,0.99176776,0.000032564152,0.00032041158,0.00055833336],"study_design_scores_gemma":[0.0008234351,0.00028753377,0.008235445,0.0002218224,0.00007319206,0.00001401984,0.00015511535,0.00009668372,0.98896676,0.000042574495,0.00089641946,0.00018696926],"about_ca_topic_score_codex":0.000038102407,"about_ca_topic_score_gemma":0.0000075107923,"teacher_disagreement_score":0.0028010022,"about_ca_system_score_codex":0.000019333886,"about_ca_system_score_gemma":0.00017254484,"threshold_uncertainty_score":0.74989563},"labels":[],"label_agreement":null},{"id":"W1991605733","doi":"10.1016/s0006-291x(02)02562-7","title":"Activation of p38 MAPK induces cell cycle arrest via inhibition of Raf/ERK pathway during muscle differentiation","year":2002,"lang":"en","type":"article","venue":"Biochemical and Biophysical Research Communications","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":84,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"University of Toronto","keywords":"Myogenesis; MAPK/ERK pathway; Cell biology; p38 mitogen-activated protein kinases; Cell cycle; Cellular differentiation; Cell cycle checkpoint; Cell growth; Chemistry; Myocyte; Biology; Cell; Signal transduction; Biochemistry","score_opus":0.04357955398602212,"score_gpt":0.28487098288375967,"score_spread":0.24129142889773755,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1991605733","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99832153,0.0003172691,0.0001186396,0.00024900478,0.000014846921,0.00018188021,0.00003673636,0.000008018662,0.0007520807],"genre_scores_gemma":[0.9987302,0.0005203379,0.00031603998,0.0000083639015,0.00008487169,0.00003601941,0.00022252327,0.000010605184,0.00007104503],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989124,0.00015474824,0.00025220285,0.0002297101,0.00025649264,0.00019445378],"domain_scores_gemma":[0.99885195,0.00008679912,0.000103417806,0.0006438263,0.00021899326,0.00009501823],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015126602,0.000102514234,0.0001414497,0.00007499986,0.00015348077,0.000013859577,0.0002763388,0.00014770133,0.000016114383],"category_scores_gemma":[0.00013567404,0.00009319173,0.00006935506,0.00023145272,0.000384013,0.000012298749,0.00035503984,0.0002023024,0.0000057598277],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002863898,0.0005800003,0.000075529286,0.00008655165,0.000010908151,1.2234372e-7,0.00007858689,4.8634604e-7,0.9972242,0.00029155737,0.00011633226,0.0015070518],"study_design_scores_gemma":[0.00034884838,0.00016644006,0.0070635076,0.000044598793,0.0000061799,4.3244884e-7,0.000062243,0.00033196283,0.99134576,0.00032898292,0.00020480916,0.000096229305],"about_ca_topic_score_codex":0.000048467842,"about_ca_topic_score_gemma":0.0000034042337,"teacher_disagreement_score":0.0069879787,"about_ca_system_score_codex":0.00001402568,"about_ca_system_score_gemma":0.000019710293,"threshold_uncertainty_score":0.38002485},"labels":[],"label_agreement":null},{"id":"W1993341051","doi":"10.1517/13543776.12.12.1795","title":"Developments in mitogen-induced extracellular kinase 1 inhibitors and their use in the treatment of disease","year":2002,"lang":"en","type":"article","venue":"Expert Opinion on Therapeutic Patents","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Joseph’s Healthcare Hamilton; McMaster University; St. Joseph's Hospital; University of Toronto","funders":"","keywords":"MAPK/ERK pathway; Kinase; Signal transduction; Cancer research; Extracellular; Protein kinase A; Mitogen-activated protein kinase; Immune system; ASK1; Biology; Cell biology; Medicine; Immunology; Mitogen-activated protein kinase kinase","score_opus":0.08536307861861339,"score_gpt":0.27448759424772895,"score_spread":0.18912451562911556,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1993341051","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98689353,0.012304347,0.00001037234,0.000079095465,0.0003103621,0.00034216937,0.00001049633,0.0000038062024,0.000045801484],"genre_scores_gemma":[0.9930244,0.006458093,0.000018554674,0.00021734014,0.000059591348,0.00008486629,0.000046835314,0.00001416909,0.00007616086],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99906605,0.00014043385,0.00021945777,0.00027671596,0.00010818216,0.0001891532],"domain_scores_gemma":[0.9995669,0.000021403297,0.000055818557,0.0002786004,0.000013880753,0.0000633853],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007261688,0.00018053518,0.00013839353,0.00006765675,0.000035987545,0.000013667496,0.000108687105,0.00008060806,0.0000069180487],"category_scores_gemma":[0.000008615671,0.00011494089,0.00005320706,0.00007732253,0.000030464704,0.000005820984,0.000017102084,0.000039098028,0.000003673096],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044857038,0.0021011364,0.0567137,0.000012569454,0.00006518504,0.000018067774,0.0065115304,0.000005407533,0.8114421,0.000074761985,0.00009949125,0.12250751],"study_design_scores_gemma":[0.005654291,0.0022799217,0.12832373,0.00014238946,0.0000046443142,0.0000067407127,0.0011432947,0.00021821025,0.7339102,0.00005324532,0.12773219,0.00053113885],"about_ca_topic_score_codex":0.000053487704,"about_ca_topic_score_gemma":0.000012510702,"teacher_disagreement_score":0.1276327,"about_ca_system_score_codex":0.000025353396,"about_ca_system_score_gemma":0.000015778021,"threshold_uncertainty_score":0.46871537},"labels":[],"label_agreement":null},{"id":"W1993628564","doi":"10.1074/jbc.m508356200","title":"Features of the Catalytic Domains and C Termini of the MAPK Signal-integrating Kinases Mnk1 and Mnk2 Determine Their Differing Activities and Regulatory Properties","year":2005,"lang":"en","type":"article","venue":"Journal of Biological Chemistry","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":68,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Kinase; MAPK/ERK pathway; Computational biology; Cell biology; Biology","score_opus":0.013640276647355879,"score_gpt":0.20152278505922486,"score_spread":0.187882508411869,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1993628564","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964017,0.003252836,0.0000043433524,0.000099928264,0.000022194925,0.00005596233,0.000012866366,0.00000155313,0.00014857796],"genre_scores_gemma":[0.9993871,0.00022646114,0.000081336584,0.000040471212,0.00014748935,0.0000017079261,0.000001068884,0.000005365188,0.000109022534],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99939513,0.000040892573,0.00025074254,0.00012464468,0.00008023133,0.000108351676],"domain_scores_gemma":[0.99942964,0.000042508636,0.00029691684,0.00014828566,0.00003858157,0.000044078803],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014018637,0.00013148041,0.00022507148,0.000008831644,0.00007001326,0.000012771655,0.00015937373,0.00012960633,0.0000023816738],"category_scores_gemma":[0.00010857486,0.00005632193,0.00008852679,0.000023119701,0.00046627608,0.0000060868124,0.000203491,0.00014376713,7.49676e-9],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006955444,0.00002559791,0.008365695,0.00009018037,0.000031050888,0.000001212914,0.0001103919,0.0000010769074,0.98730767,0.0000032415212,0.000021099611,0.003973257],"study_design_scores_gemma":[0.00023757364,0.00014391444,0.056525942,0.00013724077,0.000020020518,0.00033403613,0.00046738403,0.0000075955186,0.9418673,0.000029814119,0.0001572516,0.00007192709],"about_ca_topic_score_codex":0.0000022723739,"about_ca_topic_score_gemma":0.0000032482533,"teacher_disagreement_score":0.048160248,"about_ca_system_score_codex":0.0000067945302,"about_ca_system_score_gemma":0.00003340442,"threshold_uncertainty_score":0.22967416},"labels":[],"label_agreement":null},{"id":"W1995930415","doi":"10.1038/oncsis.2012.11","title":"Constitutive activation of breast tumor kinase accelerates cell migration and tumor growth in vivo","year":2012,"lang":"en","type":"article","venue":"Oncogenesis","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"Canadian Institutes of Health Research","keywords":"Cancer research; Tyrosine kinase; Kinase; Cell growth; Metastasis; Proto-oncogene tyrosine-protein kinase Src; Chemistry; Cancer; Biology; Signal transduction; Internal medicine; Medicine; Cell biology; Biochemistry","score_opus":0.009962973943617767,"score_gpt":0.21883716067176134,"score_spread":0.20887418672814356,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1995930415","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974831,0.00029601797,0.00013377688,0.000027244609,0.000055357894,0.00012383272,0.00004951655,0.000004147509,0.0018270196],"genre_scores_gemma":[0.99935544,0.000047815876,0.00029304155,0.0000688741,0.00010665905,0.000019779722,0.0000365423,0.0000086320315,0.0000632478],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99946797,0.000039817336,0.00013903165,0.00014880339,0.000059905124,0.0001444458],"domain_scores_gemma":[0.9996937,0.000012778723,0.000083117615,0.00009266416,0.00005919994,0.00005856107],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009894777,0.00009817192,0.00011187543,0.000048890895,0.000029855039,0.000006956522,0.000047016667,0.000050879768,0.000017523334],"category_scores_gemma":[0.000028276863,0.00009259796,0.000027822603,0.00007542626,0.000052083695,0.000012347138,0.000034652647,0.00002484335,0.0000021716082],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000060536662,0.000093057264,0.13113384,0.00003206026,0.000006206272,0.0000012981365,0.00006602808,0.0000015652942,0.8680552,0.00012448551,0.000112954454,0.00031275698],"study_design_scores_gemma":[0.000340466,0.000076065786,0.046902012,0.000013473897,0.000011039271,0.000019249113,0.00012298353,0.00001029638,0.9515537,0.00001059773,0.0008385101,0.00010163004],"about_ca_topic_score_codex":0.00019714326,"about_ca_topic_score_gemma":0.00005196058,"teacher_disagreement_score":0.08423182,"about_ca_system_score_codex":0.000011255313,"about_ca_system_score_gemma":0.00005286191,"threshold_uncertainty_score":0.37760353},"labels":[],"label_agreement":null},{"id":"W1997225815","doi":"10.1089/omi.2006.10.66","title":"Genetic Variation and the Mitogen-Activated Protein Kinase (MAPK) Signaling Pathway","year":2006,"lang":"en","type":"article","venue":"OMICS A Journal of Integrative Biology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; University of Toronto; Mount Sinai Hospital","funders":"Canadian Institutes of Health Research","keywords":"Biology; MAPK/ERK pathway; Protein kinase A; Epistasis; Genetics; dbSNP; Signal transduction; Gene; Phosphorylation; Single-nucleotide polymorphism; Allele; Kinase; Function (biology); Computational biology; Genotype","score_opus":0.006539377973044277,"score_gpt":0.21390299772629967,"score_spread":0.2073636197532554,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1997225815","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9788089,0.0018022857,0.018473594,0.00018475963,0.00023686721,0.00020531393,0.000020416119,0.000002650792,0.0002652223],"genre_scores_gemma":[0.99668473,0.00008045504,0.0024288634,0.000099246936,0.00048075235,0.000012323997,0.00002357105,0.000012397361,0.0001776441],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99890834,0.000312692,0.00039146133,0.0001685031,0.000060010138,0.00015897799],"domain_scores_gemma":[0.99906224,0.00005551772,0.00042939797,0.00012779435,0.0002813059,0.000043769178],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038789885,0.00016353613,0.00024951904,0.000059418468,0.0000856926,0.000025125622,0.00015948157,0.00016199474,0.000009161594],"category_scores_gemma":[0.00021487923,0.000089683024,0.000114948576,0.0000627814,0.0002097017,0.0000047901763,0.000046411795,0.00017791722,0.0000012086736],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00060507125,0.000029934967,0.00037512663,0.0000038352073,0.00007407912,0.000005676823,0.00017384169,0.00001602372,0.9894994,0.007964802,0.00007603545,0.0011762104],"study_design_scores_gemma":[0.0017977841,0.00068112556,0.0010316358,0.000021434069,0.000023585086,0.00011664345,0.00012960806,0.00006306267,0.98529786,0.0048664184,0.005846209,0.0001246199],"about_ca_topic_score_codex":0.000080649195,"about_ca_topic_score_gemma":0.000028014527,"teacher_disagreement_score":0.017875854,"about_ca_system_score_codex":0.000019374633,"about_ca_system_score_gemma":0.00012678566,"threshold_uncertainty_score":0.36571676},"labels":[],"label_agreement":null},{"id":"W1997245211","doi":"10.1038/jid.2014.26","title":"Loss of AMPKα1 Expression Is Associated with Poor Survival in Melanoma Patients","year":2014,"lang":"en","type":"letter","venue":"Journal of Investigative Dermatology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health; Quest University Canada; University of British Columbia","funders":"Canadian Institutes of Health Research","keywords":"Melanoma; Medicine; AMPK; Cancer research; Scopus; Oncology; Chemotherapy; Internal medicine; Protein kinase A; Kinase; MEDLINE; Biology","score_opus":0.01610958565522716,"score_gpt":0.22609428986185692,"score_spread":0.20998470420662976,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1997245211","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9704919,0.00016141863,0.000094662864,0.028308487,0.00030766884,0.00016373392,0.000085352425,0.0000028507707,0.00038394393],"genre_scores_gemma":[0.9121676,0.000035043162,0.00038854106,0.086308405,0.0004633185,0.000007712708,0.00045086493,0.000055569682,0.0001229648],"study_design_codex":"not_applicable","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99730426,0.00074160803,0.0009187068,0.00029957874,0.00038855482,0.0003472876],"domain_scores_gemma":[0.99684787,0.00012349343,0.0020022616,0.0002624644,0.00065818266,0.0001057329],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00024074363,0.00034940863,0.0010021519,0.00024310131,0.00003297004,0.000009639136,0.0004165095,0.0010715703,0.000018978613],"category_scores_gemma":[0.00053026207,0.0002654083,0.00018191362,0.00012702984,0.0004943815,0.000009381943,0.00009579619,0.000944967,0.0000031976385],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024948028,0.00016801048,0.084181234,0.00020734324,0.0004422658,0.0011005773,0.0003301166,0.00000626834,0.12521997,0.000018840517,0.7880413,0.000034626082],"study_design_scores_gemma":[0.0032305806,0.0015040158,0.011168135,0.0006712958,0.00009731197,0.0005311421,0.00004285353,0.000005635916,0.9009032,0.00043145064,0.0809679,0.00044643966],"about_ca_topic_score_codex":0.000011078995,"about_ca_topic_score_gemma":0.0000205948,"teacher_disagreement_score":0.7756833,"about_ca_system_score_codex":0.000036146495,"about_ca_system_score_gemma":0.0003057482,"threshold_uncertainty_score":0.9999798},"labels":[],"label_agreement":null},{"id":"W1997686190","doi":"10.1152/ajpgi.00453.2003","title":"Dual role of MEK/ERK signaling in senescence and transformation of intestinal epithelial cells","year":2004,"lang":"en","type":"article","venue":"American Journal of Physiology-Gastrointestinal and Liver Physiology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":76,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Institutes of Health Research; Université de Sherbrooke","funders":"","keywords":"Cell biology; MAPK/ERK pathway; Biology; Cell growth; Cell cycle; Kinase; Cell; Biochemistry","score_opus":0.004859156115739771,"score_gpt":0.1987681788471937,"score_spread":0.1939090227314539,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1997686190","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986788,0.0002258652,0.00092034123,0.000026194317,0.000035650504,0.0000726275,0.000016302427,0.0000021661986,0.000022067203],"genre_scores_gemma":[0.9936542,0.00014385949,0.006012144,0.000038520604,0.0001300259,0.0000017315616,0.000008984479,0.000009241442,0.0000013087266],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99882317,0.00013867153,0.00051632366,0.00021126482,0.00008463425,0.00022594204],"domain_scores_gemma":[0.9989907,0.00006729311,0.00058521674,0.00010320713,0.00016713064,0.000086460546],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018830076,0.00017577772,0.00048526947,0.000110615656,0.000029249513,0.0000026513833,0.00012668358,0.00004505656,0.0000051139687],"category_scores_gemma":[0.000054946227,0.00014782402,0.00009236786,0.000104042825,0.0007617737,0.000016298964,0.000063215266,0.00018643247,5.0363036e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00087439624,0.0001260372,0.001064031,0.000055927034,0.000024988654,0.000005834361,0.0003702506,0.00059556693,0.9943303,0.00035606354,0.0000015181316,0.0021950724],"study_design_scores_gemma":[0.0011531919,0.0083128605,0.07422027,0.00019158091,0.000034206812,0.001053801,0.0011299164,0.00008389377,0.9118218,0.0018299746,0.000018855457,0.00014964322],"about_ca_topic_score_codex":0.00015198103,"about_ca_topic_score_gemma":0.000010192571,"teacher_disagreement_score":0.082508504,"about_ca_system_score_codex":0.000009067624,"about_ca_system_score_gemma":0.00010850723,"threshold_uncertainty_score":0.6028089},"labels":[],"label_agreement":null},{"id":"W1998192314","doi":"10.4161/23723548.2014.964037","title":"Key regulators of apoptosis execution as biomarker candidates in melanoma","year":2014,"lang":"en","type":"review","venue":"Molecular & Cellular Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal College of Physicians and Surgeons of Canada","funders":"","keywords":"Apoptosis; Melanoma; Biomarker; Cancer research; Programmed cell death; Biology; Cancer; Disease; Bioinformatics; Medicine; Internal medicine; Genetics","score_opus":0.01703241044668241,"score_gpt":0.29647840818239896,"score_spread":0.27944599773571654,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1998192314","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.026566241,0.9636874,0.0010303524,0.000025899906,0.0005517658,0.0009438659,0.00005203136,0.000020455374,0.0071219937],"genre_scores_gemma":[0.03305557,0.9623655,0.00062528654,0.00011696208,0.00019212,0.00025478794,0.0025234418,0.00016799828,0.00069833075],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9958772,0.0010034404,0.0011971722,0.0010277255,0.00026950936,0.00062495156],"domain_scores_gemma":[0.99773395,0.00005626396,0.00078215235,0.0011278116,0.00010357923,0.00019623265],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00070891005,0.0006990977,0.0021610134,0.00044614624,0.000051402723,0.0000174095,0.0006499768,0.0017274212,0.00009241745],"category_scores_gemma":[0.00018567925,0.0006613808,0.0008162864,0.00038630603,0.00022812655,0.000004115536,0.00035632568,0.00033924458,0.00010142907],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015649047,0.00045866898,0.00006614645,0.007220124,0.00080169574,0.0002966896,0.00007766714,0.000005551868,0.46922445,0.0012970717,0.0029790585,0.5174164],"study_design_scores_gemma":[0.00054386473,0.00078690134,0.00000445341,0.0008025517,0.00041041258,0.000090465044,0.0000124002045,0.000008526889,0.15231416,0.000080569545,0.84440583,0.0005398937],"about_ca_topic_score_codex":0.00017158841,"about_ca_topic_score_gemma":0.00006506714,"teacher_disagreement_score":0.84142673,"about_ca_system_score_codex":0.0001543233,"about_ca_system_score_gemma":0.00076713494,"threshold_uncertainty_score":0.9995837},"labels":[],"label_agreement":null},{"id":"W1998796741","doi":"10.1038/sj.onc.1207226","title":"Expression of activated M-Ras in a murine mammary epithelial cell line induces epithelial–mesenchymal transition and tumorigenesis","year":2004,"lang":"en","type":"article","venue":"Oncogene","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":38,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Hospital and Health Sciences Centre; University of British Columbia","funders":"Cancer Research Institute","keywords":"Biology; Carcinogenesis; Epithelial–mesenchymal transition; Matrigel; Vimentin; Cell culture; Cancer research; Cell growth; Mammary tumor; Mesenchymal stem cell; Molecular biology; Cell biology; Downregulation and upregulation; Angiogenesis; Cancer; Immunology; Immunohistochemistry; Genetics; Gene","score_opus":0.009136337901732848,"score_gpt":0.22274327986932932,"score_spread":0.21360694196759647,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1998796741","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99773324,0.00057509955,0.00094349735,0.00010627809,0.00009228986,0.00016963095,0.00006328471,0.000009991428,0.00030667242],"genre_scores_gemma":[0.99720937,0.0005116779,0.0017978237,0.000057280544,0.00019452855,0.000017731545,0.000117833,0.000018434639,0.00007534592],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990862,0.00005524713,0.00024853917,0.00030876626,0.0001127737,0.00018845682],"domain_scores_gemma":[0.9995678,0.000007724528,0.00009038981,0.00021283625,0.00004274201,0.00007852478],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013015435,0.00015768013,0.00019915504,0.00008047898,0.000035685,0.0000070737115,0.00010954747,0.00017160385,0.00001082941],"category_scores_gemma":[0.000017132848,0.00014372614,0.00005639367,0.00010543336,0.000044059274,0.000008932216,0.000062659805,0.00007228146,0.0000022524239],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021060188,0.00021300926,0.000094261355,0.000049971142,0.000007685329,0.000026470228,0.00017069653,0.000117954565,0.9969169,0.0000124955295,0.0000068031954,0.0021731504],"study_design_scores_gemma":[0.0018177808,0.0005244185,0.001083272,0.000049982777,0.000011011619,0.000022070455,0.000056385084,0.0000056246704,0.99571115,0.00012741532,0.0004284568,0.00016243584],"about_ca_topic_score_codex":0.00010161964,"about_ca_topic_score_gemma":0.000034749464,"teacher_disagreement_score":0.0020107145,"about_ca_system_score_codex":0.000014507146,"about_ca_system_score_gemma":0.00010469139,"threshold_uncertainty_score":0.5860982},"labels":[],"label_agreement":null},{"id":"W1999513735","doi":"10.1080/00498250110100711","title":"SB-242235, a selective inhibitor of p38 mitogen-activated protein kinase. II: In vitro and in vivo metabolism studies and pharmacokinetic extrapolation to man","year":2002,"lang":"en","type":"article","venue":"Xenobiotica","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Discovery Centre","funders":"","keywords":"Pharmacokinetics; In vivo; Pharmacology; In vitro; Microsome; Metabolism; Kinase; Chemistry; Biology; Biochemistry","score_opus":0.016617292182223586,"score_gpt":0.2516120641375673,"score_spread":0.23499477195534374,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1999513735","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955263,0.0034253614,0.000012222139,0.00017793875,0.00006257693,0.0005612329,0.00002238673,0.0000067303868,0.00020526432],"genre_scores_gemma":[0.99886584,0.00018806211,0.0005377222,0.000069388705,0.00007333355,0.000039981227,0.0000061601568,0.000015079359,0.00020440211],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99904317,0.000094575655,0.0002305025,0.00033534042,0.00008106482,0.00021532126],"domain_scores_gemma":[0.9996741,0.000015344198,0.00005843926,0.0001225977,0.000058138718,0.000071397146],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011593833,0.00016110603,0.00024393697,0.00013660005,0.000047991165,0.000008107404,0.000055282773,0.00010601482,0.000010949266],"category_scores_gemma":[0.00009795199,0.0001534563,0.00002374973,0.00020165485,0.0000737354,0.0000071391414,0.00010366146,0.00010455042,9.284926e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025733415,0.00009863324,0.00027027435,0.000062781524,0.000036980357,0.000004381143,0.00090615964,0.0000035771693,0.99708194,0.000015385223,0.00013520676,0.0011273738],"study_design_scores_gemma":[0.0011005352,0.00029105108,0.0030755969,0.00005008081,0.000018712839,0.000005789342,0.00013279612,0.00007029834,0.9931371,0.00003481039,0.0019191937,0.00016402612],"about_ca_topic_score_codex":0.00002889068,"about_ca_topic_score_gemma":0.000045291104,"teacher_disagreement_score":0.0039448035,"about_ca_system_score_codex":0.000015149066,"about_ca_system_score_gemma":0.000013684245,"threshold_uncertainty_score":0.62577665},"labels":[],"label_agreement":null},{"id":"W2000123112","doi":"10.1023/b:drug.0000026258.02846.1c","title":"Phase II trial of flavopiridol, a cyclin dependent kinase inhibitor, in untreated metastatic malignant melanoma","year":2004,"lang":"en","type":"article","venue":"Investigational New Drugs","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":89,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Ottawa Regional Cancer Foundation; Hamilton Regional Laboratory Medicine Program; McGill University","funders":"National Cancer Institute; McGill University","keywords":"Nausea; Medicine; Gastroenterology; Internal medicine; Vomiting; Diarrhea; Melanoma; Progressive disease; Anorexia; Toxicity; Regimen; Phases of clinical research; Surgery; Chemotherapy; Cancer research","score_opus":0.021077545427093294,"score_gpt":0.2726131858557945,"score_spread":0.25153564042870125,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2000123112","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976671,0.00022878306,0.0002571511,0.00056462426,0.0002302335,0.00045548528,0.00008918453,0.000012147487,0.00049532304],"genre_scores_gemma":[0.995729,0.000020941936,0.002568599,0.00030345737,0.00032257393,0.000042535576,0.00053858705,0.000020501822,0.0004538001],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99848354,0.000083382736,0.000533783,0.0003672424,0.00029616253,0.00023588845],"domain_scores_gemma":[0.9992597,0.000023703695,0.00017951369,0.00026216038,0.00007018764,0.0002047053],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023943538,0.00020012238,0.00024988333,0.00011944024,0.00005688105,0.00001277003,0.00016969997,0.00011465022,0.000029303459],"category_scores_gemma":[0.00018719211,0.00018984359,0.000101910366,0.0001717239,0.000117347234,0.00001035861,0.00008966221,0.000094399846,0.00001529574],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003463191,0.0013602732,0.00013219789,0.000030600826,0.00007115663,0.000052860956,0.00040026905,0.00062931946,0.9872986,0.0039609927,0.00065396103,0.0019465942],"study_design_scores_gemma":[0.0747743,0.002993667,0.000103741964,0.00007408797,0.000036833448,0.000021531352,0.00006191953,0.000032512136,0.9106226,0.008556578,0.0024799393,0.00024226925],"about_ca_topic_score_codex":0.00046744116,"about_ca_topic_score_gemma":0.00018827379,"teacher_disagreement_score":0.07667597,"about_ca_system_score_codex":0.000039208528,"about_ca_system_score_gemma":0.00096676743,"threshold_uncertainty_score":0.77415967},"labels":[],"label_agreement":null},{"id":"W2001789499","doi":"10.1074/jbc.m205277200","title":"A Dominant-negative p38 MAPK Mutant and Novel Selective Inhibitors of p38 MAPK Reduce Insulin-stimulated Glucose Uptake in 3T3-L1 Adipocytes without Affecting GLUT4 Translocation","year":2002,"lang":"en","type":"article","venue":"Journal of Biological Chemistry","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":135,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"National Institute of Diabetes and Digestive and Kidney Diseases","keywords":"GLUT4; 3T3-L1; Glucose uptake; MAPK/ERK pathway; Chromosomal translocation; Glucose transporter; Insulin; Mutant; p38 mitogen-activated protein kinases; Chemistry; Internal medicine; Endocrinology; Cell biology; Adipocyte; Biology; Kinase; Biochemistry; Medicine; Adipose tissue; Gene","score_opus":0.022527578704434878,"score_gpt":0.2450945455803939,"score_spread":0.222566966875959,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2001789499","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99616265,0.0027636916,0.00036654403,0.000062009276,0.000078848425,0.00018600732,0.000028598888,0.0000067101064,0.00034494072],"genre_scores_gemma":[0.9978391,0.0007249747,0.0010781223,0.000031067433,0.00025580561,0.0000061683936,0.000016215705,0.000016322245,0.000032218017],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983305,0.00008043011,0.00076085306,0.0003645164,0.00016625288,0.00029745125],"domain_scores_gemma":[0.99877137,0.00008803271,0.00059941533,0.00015614496,0.00023416203,0.00015088712],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004267005,0.00027357042,0.0005085113,0.000059702903,0.000059332706,0.000016031026,0.00018590066,0.0004612535,0.000028590146],"category_scores_gemma":[0.0007126901,0.00020911808,0.00015807334,0.00021838478,0.00019413259,0.000013758006,0.000058768477,0.000397887,9.3846853e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006715741,0.0003418605,0.0023258044,0.0000653161,0.00008857739,0.000025540417,0.00030721416,0.000053855678,0.99321115,0.0000031496063,0.000026550653,0.0028793819],"study_design_scores_gemma":[0.0026663803,0.00083530665,0.0052049174,0.00021186477,0.000035139063,0.00036718324,0.0003391864,0.00030625536,0.9895835,0.000078451325,0.0001309663,0.00024088084],"about_ca_topic_score_codex":0.000010934656,"about_ca_topic_score_gemma":0.0000050366993,"teacher_disagreement_score":0.0036277066,"about_ca_system_score_codex":0.000051937175,"about_ca_system_score_gemma":0.000069019094,"threshold_uncertainty_score":0.8527588},"labels":[],"label_agreement":null},{"id":"W2002965548","doi":"10.1002/jcp.10432","title":"Down‐regulation of MEK/ERK signaling by E‐cadherin‐dependent PI3K/Akt pathway in differentiating intestinal epithelial cells","year":2003,"lang":"en","type":"article","venue":"Journal of Cellular Physiology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":99,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"Canada Research Chairs","keywords":"PI3K/AKT/mTOR pathway; Protein kinase B; Cell biology; MAPK/ERK pathway; Adherens junction; LY294002; Cadherin; Phosphorylation; Chemistry; MEK inhibitor; Biology; Signal transduction; Cell; Biochemistry","score_opus":0.007240307943950578,"score_gpt":0.2010914502718976,"score_spread":0.193851142327947,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2002965548","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99330854,0.00056135806,0.0054898346,0.000008266845,0.00031493156,0.0000959748,0.00000922706,0.0000017803619,0.00021005268],"genre_scores_gemma":[0.99893856,0.000036090925,0.00072243065,0.000024117522,0.00016894289,0.0000027490858,0.00002634691,0.000017341996,0.00006342443],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998287,0.00033368013,0.0007357126,0.00021714953,0.00016069236,0.00026573503],"domain_scores_gemma":[0.99903244,0.000046174955,0.00057659287,0.00016875443,0.00010831063,0.0000677366],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000494117,0.00017387613,0.00039065306,0.00011694925,0.000024751273,0.0000070460906,0.00018450357,0.00018155012,0.00006569341],"category_scores_gemma":[0.00011550479,0.00015469258,0.0001431461,0.00009443853,0.000054102133,0.000008891899,0.000044952198,0.00023431254,0.0000026143414],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015037306,0.00019236917,0.0011072214,0.000038348375,0.000025817457,0.000014085881,0.00008537538,0.00096108293,0.9968549,0.00014511262,0.000034520006,0.00039078112],"study_design_scores_gemma":[0.0011695658,0.00065897556,0.0019755317,0.00005075072,0.000010924343,0.00003133628,0.00008506559,0.0000814007,0.9945697,0.0007767803,0.0004448222,0.00014512999],"about_ca_topic_score_codex":0.000016021388,"about_ca_topic_score_gemma":0.000009418949,"teacher_disagreement_score":0.005629982,"about_ca_system_score_codex":0.000026579726,"about_ca_system_score_gemma":0.00010112021,"threshold_uncertainty_score":0.630818},"labels":[],"label_agreement":null},{"id":"W2003463518","doi":"10.1158/1538-7445.am2012-4166","title":"Abstract 4166: Tumor suppressor activity of the ERK/MAPK pathway by promoting selective protein degradation","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Notre-Dame; Université de Montréal","funders":"","keywords":"MAPK/ERK pathway; Protein kinase B; PI3K/AKT/mTOR pathway; Cancer research; Signal transduction; Cell biology; Kinase; Biology; Senescence","score_opus":0.04202752112323867,"score_gpt":0.3331159407019406,"score_spread":0.29108841957870196,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2003463518","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99704033,0.0006090157,0.00004194402,0.00013907878,0.00008950004,0.0007362089,0.000100794125,0.0000064843216,0.0012366447],"genre_scores_gemma":[0.9984235,0.000011201958,0.000026330043,0.000014189267,0.00025081012,0.0003254349,0.000021569918,0.00002048697,0.0009064852],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998514,0.00029834898,0.0001385481,0.0002446733,0.00034777776,0.00045666206],"domain_scores_gemma":[0.9992307,0.000024579296,0.00010210027,0.00032725016,0.0002143622,0.000101015576],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010536297,0.00010526231,0.000110009365,0.00003093151,0.00016456575,0.000017545077,0.00026354907,0.00009789881,0.00004371425],"category_scores_gemma":[0.00032952955,0.00007655541,0.00006139642,0.00017379045,0.000121876656,0.000013294734,0.0001613885,0.00030015153,0.000005594629],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000060329327,0.00011161436,0.0014214127,0.00007515136,0.000022765415,3.2692063e-7,0.00016434297,8.3701116e-7,0.9928483,0.00003748729,0.0022005711,0.0030568691],"study_design_scores_gemma":[0.00020231357,0.00010398033,0.010307368,0.00004039949,0.000003116149,0.0000018476895,0.000047307698,0.0000062714353,0.9837247,0.000021720578,0.005452619,0.00008834524],"about_ca_topic_score_codex":0.00027829158,"about_ca_topic_score_gemma":0.00005479329,"teacher_disagreement_score":0.009123581,"about_ca_system_score_codex":0.00005740686,"about_ca_system_score_gemma":0.00028679764,"threshold_uncertainty_score":0.3121839},"labels":[],"label_agreement":null},{"id":"W2003509083","doi":"10.1042/bj20040948","title":"p90 ribosomal S6 kinase 2 is associated with and dephosphorylated by protein phosphatase 2Cδ","year":2004,"lang":"en","type":"article","venue":"Biochemical Journal","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Biotechnology Research Institute","funders":"Medical Research Council; Sundhed og Sygdom, Det Frie Forskningsråd; Kræftens Bekæmpelse","keywords":"Mitogen-activated protein kinase kinase; Cyclin-dependent kinase 9; Protein kinase domain; Kinase; MAP kinase kinase kinase; Cyclin-dependent kinase 2; c-Raf; MAP2K7; P70-S6 Kinase 1; Phosphatase; Protein kinase A; Ribosomal s6 kinase; Phosphorylation; Biochemistry; Biology; Molecular biology; Chemistry; Cell biology; Mutant; Protein kinase B","score_opus":0.005100390114667312,"score_gpt":0.19925649189488318,"score_spread":0.19415610178021586,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2003509083","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99409854,0.0047343858,0.00034910828,0.0003196705,0.000055243916,0.00017384252,0.00013918143,0.00001697299,0.00011307211],"genre_scores_gemma":[0.99802655,0.00011235534,0.00064018316,0.00056194945,0.00013551755,0.000012394152,0.00027361413,0.000030602212,0.00020684353],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987743,0.00003225812,0.00024163711,0.00034608538,0.00022285983,0.00038287713],"domain_scores_gemma":[0.9991945,0.0000053336826,0.00014313863,0.00018781194,0.000108752574,0.00036048115],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013584271,0.0002348945,0.00018876103,0.000025681018,0.00014410779,0.00006713415,0.00017206252,0.00027739888,0.000042527972],"category_scores_gemma":[0.00011809416,0.00018839531,0.00007221869,0.00009697814,0.00013764757,0.000009949941,0.00007730096,0.0002704272,0.000007828884],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021857364,0.00016807306,0.00090905605,0.0000072561306,0.0001005796,0.00010752867,0.000019726565,8.4321874e-7,0.9887557,0.00003872402,0.009258902,0.0004150611],"study_design_scores_gemma":[0.0027647512,0.0006335773,0.0004176501,0.000080505,0.000035128112,0.0003950245,0.000021498894,0.000003134274,0.98891324,0.00012092478,0.006321311,0.00029325573],"about_ca_topic_score_codex":0.000011400628,"about_ca_topic_score_gemma":0.0000020666037,"teacher_disagreement_score":0.00462203,"about_ca_system_score_codex":0.00004362524,"about_ca_system_score_gemma":0.00014985053,"threshold_uncertainty_score":0.76825374},"labels":[],"label_agreement":null},{"id":"W2003701881","doi":"10.1158/0008-5472.can-04-2369","title":"Mitogen- and Stress-Activated Protein Kinase 1 Activity and Histone H3 Phosphorylation in Oncogene-Transformed Mouse Fibroblasts","year":2004,"lang":"en","type":"article","venue":"Cancer Research","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Histone H3; Protein kinase A; c-Raf; Mitogen-activated protein kinase; Mitogen-activated protein kinase kinase; MAPK/ERK pathway; Cell biology; Kinase; Signal transduction; MAP kinase kinase kinase; Mitogen-Activated Protein Kinase 3; Molecular biology; MAP2K7; ASK1; Biology; Chemistry; Chromatin; Cyclin-dependent kinase 2; Biochemistry","score_opus":0.031506656332913,"score_gpt":0.3431884818826738,"score_spread":0.3116818255497608,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2003701881","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972905,0.0016454975,0.00006384678,0.00018878689,0.00003138722,0.0005501806,0.000075613636,0.000007980326,0.00014621411],"genre_scores_gemma":[0.99829036,0.00062294933,0.000071656956,0.000011183848,0.00006708514,0.00019519833,0.000041710467,0.000019264344,0.00068056653],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99894273,0.00008258347,0.00010657498,0.00036948468,0.00018302916,0.0003156082],"domain_scores_gemma":[0.9995777,0.0000099228655,0.000026151321,0.00018058524,0.00007992051,0.00012570506],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021792029,0.00011553533,0.00011800065,0.000085589316,0.00009803614,0.000024531637,0.0000782189,0.00014584309,0.000016080183],"category_scores_gemma":[0.00005083853,0.00011330518,0.000019370387,0.00014225687,0.00015587523,0.0000111642585,0.00007037638,0.00019059442,0.0000016444973],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00053680333,0.000057433146,0.00068327616,0.00008707004,0.00001278091,0.000008422674,0.00018290823,0.000030146084,0.99181086,0.000036646303,0.000041746247,0.006511932],"study_design_scores_gemma":[0.0011660906,0.00029567102,0.0035677156,0.00006617748,0.000002110701,0.0000025575,0.000049058322,0.0000073531032,0.99305445,0.00006855855,0.0015923164,0.00012793847],"about_ca_topic_score_codex":0.0013617602,"about_ca_topic_score_gemma":0.002324188,"teacher_disagreement_score":0.0063839937,"about_ca_system_score_codex":0.00011696389,"about_ca_system_score_gemma":0.00026062803,"threshold_uncertainty_score":0.4620451},"labels":[],"label_agreement":null},{"id":"W2004474495","doi":"10.1038/nsmb.2924","title":"Crystal structure of a BRAF kinase domain monomer explains basis for allosteric regulation","year":2014,"lang":"en","type":"article","venue":"Nature Structural & Molecular Biology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":163,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Research in Immunology and Cancer; Université de Montréal; Lunenfeld-Tanenbaum Research Institute","funders":"Canadian Institutes of Health Research","keywords":"Allosteric regulation; Dimer; Protein kinase domain; Monomer; Helix (gastropod); Transferase; Chemistry; Kinase; Crystal structure; Active site; Stereochemistry; Crystallography; Enzyme; Biophysics; Biochemistry; Biology; Mutant; Gene","score_opus":0.003948953721555673,"score_gpt":0.25018331247628256,"score_spread":0.24623435875472688,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2004474495","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97704834,0.00064648344,0.020656673,0.00016638228,0.00050912454,0.0004130563,0.00038044612,0.000018011177,0.000161495],"genre_scores_gemma":[0.98673284,0.000004818948,0.010558389,0.00057299493,0.00040764362,0.000017964323,0.0016320376,0.000039752973,0.00003353167],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998377,0.00017156373,0.00034140085,0.00060037454,0.00012307666,0.0003865564],"domain_scores_gemma":[0.99891806,0.000039711853,0.0002257337,0.00052143284,0.00019048186,0.00010459268],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001108389,0.00031806304,0.00035895393,0.00010672065,0.000089048524,0.00001395114,0.00031330352,0.0010054645,0.000045961107],"category_scores_gemma":[0.0003300582,0.00027014248,0.00023822008,0.00012529228,0.00014356848,0.000006329985,0.00012478976,0.00024257897,7.53561e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019502806,0.000007926265,0.0006987434,0.00004123299,0.000075614575,0.0000013591192,0.000042615055,0.00003393424,0.98397905,0.012408002,0.00023751408,0.0022789568],"study_design_scores_gemma":[0.001218695,0.000768776,0.008114827,0.000013754454,0.00004619797,0.000054572232,0.00002970939,0.000116877476,0.95786065,0.013830607,0.017538909,0.0004064022],"about_ca_topic_score_codex":0.000015499154,"about_ca_topic_score_gemma":0.00005038349,"teacher_disagreement_score":0.026118401,"about_ca_system_score_codex":0.000018393073,"about_ca_system_score_gemma":0.00005092588,"threshold_uncertainty_score":0.9999751},"labels":[],"label_agreement":null},{"id":"W2006002450","doi":"10.1074/jbc.m004092200","title":"The Kinase Activation Loop Is the Key to Mixed Lineage Kinase-3 Activation via Both Autophosphorylation and Hematopoetic Progenitor Kinase 1 Phosphorylation","year":2001,"lang":"en","type":"article","venue":"Journal of Biological Chemistry","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":85,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Autophosphorylation; Phosphorylation; Cell biology; Chemistry; Biochemistry; Biology; Protein kinase A","score_opus":0.01679816095871574,"score_gpt":0.24141081760315425,"score_spread":0.2246126566444385,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2006002450","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99412984,0.00062101224,0.0032215659,0.0014100893,0.00013572288,0.00026923756,0.0000063428743,0.000011455259,0.00019474683],"genre_scores_gemma":[0.9977589,0.0003326947,0.00038684087,0.00037599783,0.0006258639,0.000024460307,0.000044097244,0.000015281643,0.0004358162],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986716,0.00008594409,0.0004767101,0.0002799904,0.00023414438,0.00025160934],"domain_scores_gemma":[0.99878156,0.000100071156,0.00043593228,0.00029173013,0.00023471187,0.00015597696],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005264438,0.00021745035,0.00019463376,0.000021252961,0.00030713176,0.00007817616,0.000254718,0.00029154518,0.000037374837],"category_scores_gemma":[0.0005158084,0.00012456336,0.00013665782,0.0001413499,0.000100791076,0.000017238232,0.00009409358,0.00025314916,0.000005052546],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045958802,0.00008398712,0.0014545106,0.000015931577,0.000038434093,0.000006609056,0.000071431794,0.000021697138,0.9885993,0.000012846902,0.0010780081,0.00815764],"study_design_scores_gemma":[0.00044113127,0.0003600836,0.00747073,0.000036497044,0.000021818127,0.00008239919,0.00018482086,0.00015508437,0.96487814,0.00013980831,0.02605969,0.0001697783],"about_ca_topic_score_codex":0.0000063008874,"about_ca_topic_score_gemma":0.0000013086861,"teacher_disagreement_score":0.024981681,"about_ca_system_score_codex":0.0000508131,"about_ca_system_score_gemma":0.00007177274,"threshold_uncertainty_score":0.50795466},"labels":[],"label_agreement":null},{"id":"W2007010482","doi":"10.1159/000330206","title":"Outcomes of Patients with Metastatic Melanoma Treated with Molecularly Targeted Agents in Phase I Clinical Trials","year":2011,"lang":"en","type":"article","venue":"Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"","keywords":"Medicine; Dacarbazine; Internal medicine; Clinical trial; Chemotherapy; Temozolomide; Phases of clinical research; Oncology; Melanoma; Cytokine; Gastroenterology; Surgery; Cancer research","score_opus":0.11932805219443275,"score_gpt":0.3919691157399389,"score_spread":0.27264106354550616,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2007010482","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966175,0.000056331697,0.0007679357,0.000013515704,0.00008327942,0.0005587683,0.000078794365,0.000007722888,0.0018161595],"genre_scores_gemma":[0.995566,0.000015300131,0.0036919974,0.00016447461,0.00001890543,0.000057366604,0.00033719762,0.000024192035,0.00012455837],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99762154,0.0008682701,0.000767172,0.00036267377,0.00012718211,0.00025314506],"domain_scores_gemma":[0.99889374,0.00008439422,0.00045036778,0.00033446867,0.00012268574,0.00011436179],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00085155,0.00019866493,0.0008439607,0.00008951762,0.000019299176,0.0000033509373,0.00017342616,0.00018368995,0.00011497577],"category_scores_gemma":[0.0003347211,0.00012821845,0.0001164025,0.00011592523,0.00014043953,0.0000050316867,0.00004701164,0.00010450712,0.0000068111235],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0050098994,0.004184876,0.9720202,0.000016396323,0.00062823907,0.00013842373,0.00011851857,0.000001611642,0.011518919,0.000067032175,0.00022248935,0.0060733664],"study_design_scores_gemma":[0.031768586,0.03495655,0.86029285,0.00001711382,0.00037044214,0.000009934666,0.00009265341,0.000016987193,0.06809851,0.000043397387,0.0039674584,0.0003655216],"about_ca_topic_score_codex":0.00008143147,"about_ca_topic_score_gemma":0.00016879421,"teacher_disagreement_score":0.11172738,"about_ca_system_score_codex":0.000016529999,"about_ca_system_score_gemma":0.00017243634,"threshold_uncertainty_score":0.5228597},"labels":[],"label_agreement":null},{"id":"W2008413774","doi":"10.1158/1078-0432.mechres-ia11","title":"Abstract IA11: Using Molecular Profiling Strategies in Clinical Trials to Understand Resistance Mechanisms in the Era of Personalized Cancer Medicine","year":2012,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Vemurafenib; Medicine; Acquired resistance; Druggability; Drug resistance; Clinical trial; Melanoma; Oncology; Precision medicine; Cancer; Cancer research; Ipilimumab; Internal medicine; Bioinformatics; Biology; Metastatic melanoma; Pathology; Immunotherapy; Gene; Genetics","score_opus":0.5070920791879917,"score_gpt":0.5937702580808246,"score_spread":0.08667817889283291,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2008413774","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9854543,0.00931169,0.0013107605,0.0016638659,0.00039004232,0.00091345824,0.000036099656,0.0000036192685,0.000916157],"genre_scores_gemma":[0.9956156,0.0021094999,0.00085033936,0.0004358315,0.0007848992,0.00010756563,0.000012845406,0.000023377646,0.000060034712],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99356055,0.0030719575,0.0015848362,0.0004952157,0.00065803283,0.00062943465],"domain_scores_gemma":[0.99760026,0.0012418964,0.00024782433,0.00047767235,0.00022205598,0.00021029012],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.034392457,0.00016786948,0.0006963759,0.00010053841,0.0000658019,0.00002456471,0.0004772038,0.00032635746,0.00012021012],"category_scores_gemma":[0.004317019,0.00011484188,0.0001907126,0.00042785463,0.0004911829,0.000013289258,0.00013147597,0.0009126522,0.0000022218774],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0051591354,0.00066244305,0.030166587,0.00035700612,0.00017535238,0.00005415645,0.0015055091,0.00020816152,0.9342448,0.019509548,0.0020794976,0.0058777765],"study_design_scores_gemma":[0.041740697,0.0073713395,0.30476975,0.0067857276,0.0004368842,0.00001976088,0.08620575,0.0004895865,0.46837294,0.041176535,0.039592464,0.003038554],"about_ca_topic_score_codex":0.00083063706,"about_ca_topic_score_gemma":0.0018834552,"teacher_disagreement_score":0.4658719,"about_ca_system_score_codex":0.000076123055,"about_ca_system_score_gemma":0.00092488417,"threshold_uncertainty_score":0.9942962},"labels":[],"label_agreement":null},{"id":"W2010317482","doi":"10.1016/j.mpdhp.2014.10.001","title":"Targeted therapy in melanoma: the era of personalized medicine","year":2014,"lang":"en","type":"article","venue":"Diagnostic histopathology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Medicine; Melanoma; Cancer; Incidence (geometry); Targeted therapy; Disease; Skin cancer; Oncology; Internal medicine; Cancer research","score_opus":0.008976732925360364,"score_gpt":0.23100024290482418,"score_spread":0.22202350997946382,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2010317482","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98875886,0.0049243085,0.0009662323,0.0010383462,0.00037865457,0.0002104552,0.00000829343,0.00000851741,0.0037063207],"genre_scores_gemma":[0.99762464,0.0006631187,0.00014894741,0.00096179696,0.00021924186,0.000059150258,0.00007779664,0.000016082591,0.00022920956],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9988296,0.00031124463,0.00027441917,0.00027235856,0.00009693023,0.00021543758],"domain_scores_gemma":[0.9990694,0.00033031165,0.000109877794,0.00039123045,0.000055650158,0.00004354671],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005098002,0.00013958913,0.00026640634,0.00004494054,0.00004575162,0.0000017148122,0.0002451643,0.00013965549,0.0001286146],"category_scores_gemma":[0.0017457088,0.000094026735,0.000060303177,0.00009285307,0.0004197108,0.0000014440179,0.00004441504,0.00013885308,0.000011812814],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022900802,0.00020627411,0.082745664,0.00002623201,0.000018477092,0.000062522005,0.0021090626,0.00002071792,0.87774086,0.00852837,0.009069095,0.01924373],"study_design_scores_gemma":[0.007420021,0.005236792,0.51753604,0.00008582395,0.000050687166,0.00026511226,0.0004444609,0.00009468313,0.07473501,0.0022131312,0.39134687,0.0005713659],"about_ca_topic_score_codex":0.00009203421,"about_ca_topic_score_gemma":0.000078988756,"teacher_disagreement_score":0.8030058,"about_ca_system_score_codex":0.000008326962,"about_ca_system_score_gemma":0.00004260508,"threshold_uncertainty_score":0.38342988},"labels":[],"label_agreement":null},{"id":"W2010789517","doi":"10.1074/jbc.m600497200","title":"Transgenic Drak2 Overexpression in Mice Leads to Increased T Cell Apoptosis and Compromised Memory T Cell Development","year":2006,"lang":"en","type":"article","venue":"Journal of Biological Chemistry","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital Notre-Dame; Centre Hospitalier de l’Université de Montréal","funders":"Canadian Institutes of Health Research; Heart And Stroke Foundation Of Quebec; Kidney Foundation of Canada; Heart and Stroke Foundation of Canada","keywords":"Biology; T cell; Apoptosis; CD8; IL-2 receptor; Cell biology; Programmed cell death; Molecular biology; Cancer research; Immune system; Immunology; Biochemistry","score_opus":0.01039291454899875,"score_gpt":0.21001622511550955,"score_spread":0.1996233105665108,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2010789517","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99670464,0.0004962891,0.00013854832,0.000037488357,0.000028323437,0.000094136194,0.000007817526,0.0000043822274,0.0024883943],"genre_scores_gemma":[0.9970012,0.000043258613,0.002341917,0.00011261664,0.00019151728,0.000005955835,0.000038038695,0.000009560668,0.00025599258],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988897,0.0000488665,0.00045595452,0.00025138754,0.00012333399,0.00023074588],"domain_scores_gemma":[0.9994659,0.000025381683,0.00017660813,0.00011151268,0.00005730728,0.00016332192],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002335019,0.00017972766,0.00025791838,0.000030031264,0.000042703872,0.000015264892,0.0001972071,0.0002751958,0.00004100976],"category_scores_gemma":[0.000029879298,0.00013611687,0.00009009075,0.00006295428,0.000044524208,0.000003750049,0.00007376494,0.00017689762,0.000002494671],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031232537,0.00021230796,0.0030308957,0.00006889595,0.0000053245626,0.000007558104,0.000022067547,0.000022186321,0.99561435,2.9278567e-7,0.0005245442,0.00017925828],"study_design_scores_gemma":[0.0014161308,0.00020770612,0.003971512,0.000057351073,0.0000066218035,0.000022123728,0.000044855005,0.0000025009874,0.9918916,0.000012934403,0.0021768343,0.00018982693],"about_ca_topic_score_codex":0.000008941289,"about_ca_topic_score_gemma":0.0000013242832,"teacher_disagreement_score":0.00372274,"about_ca_system_score_codex":0.000028029443,"about_ca_system_score_gemma":0.00008955963,"threshold_uncertainty_score":0.55506843},"labels":[],"label_agreement":null},{"id":"W2011089118","doi":"10.1016/s1359-6446(04)03251-9","title":"Targeting JNK3 for the treatment of neurodegenerative disorders","year":2004,"lang":"en","type":"review","venue":"Drug Discovery Today","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":126,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's Health Research Institute","funders":"","keywords":"Disease; Neuroscience; Neurotoxin; Neurodegeneration; Apoptosis; Kinase; Parkinson's disease; Biology; Medicine; Cell biology; Pathology; Endocrinology; Genetics","score_opus":0.019338972808985853,"score_gpt":0.2857150262731281,"score_spread":0.2663760534641423,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2011089118","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00021070933,0.9954865,0.0015594439,0.00003299916,0.00055612804,0.0012977088,0.00061828404,0.000005895945,0.00023232358],"genre_scores_gemma":[0.00046118043,0.9943067,0.000105877014,0.000019754174,0.0004709811,0.0004795418,0.0014117262,0.000056058565,0.0026881958],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987582,0.00008908191,0.00036774957,0.00044645483,0.000092753275,0.00024575036],"domain_scores_gemma":[0.9991139,0.000092910115,0.00027248356,0.00045519145,0.000027839033,0.000037666727],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000095332754,0.00037189992,0.0006547944,0.0000314442,0.00011510543,0.000030970852,0.0002640605,0.00014909645,0.0000056358867],"category_scores_gemma":[0.00003689117,0.00021335212,0.0007311506,0.00006575205,0.00008152083,0.0000043191053,0.00005185303,0.000057789865,0.000003707956],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008383545,0.00073520147,0.000011493613,0.007627655,0.0012118673,0.000003881295,0.00045505696,0.00067464006,0.0012888674,0.0016536638,0.0055559725,0.9806979],"study_design_scores_gemma":[0.00031131334,0.00040381108,6.89966e-7,0.0004002454,0.00038613635,0.0000020293644,0.00004377342,0.000004499425,0.0017618262,0.000043662058,0.9964066,0.00023541202],"about_ca_topic_score_codex":0.000032459233,"about_ca_topic_score_gemma":0.000041402385,"teacher_disagreement_score":0.9908506,"about_ca_system_score_codex":0.00003642064,"about_ca_system_score_gemma":0.00030744914,"threshold_uncertainty_score":0.8700247},"labels":[],"label_agreement":null},{"id":"W2011113518","doi":"10.1038/onc.2012.312","title":"RSK regulates activated BRAF signalling to mTORC1 and promotes melanoma growth","year":2012,"lang":"en","type":"article","venue":"Oncogene","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":66,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Institute for Research in Immunology and Cancer","funders":"National Cancer Institute","keywords":"Biology; MAPK/ERK pathway; mTORC1; PI3K/AKT/mTOR pathway; Ribosomal s6 kinase; Neuroblastoma RAS viral oncogene homolog; Cell biology; Protein kinase A; Kinase; Melanoma; Cancer research; HRAS; Cell growth; MAPK cascade; RNA interference; Signal transduction; P70-S6 Kinase 1; Genetics; RNA; Mutation; Gene; KRAS","score_opus":0.012035427890848702,"score_gpt":0.23018064391079834,"score_spread":0.21814521601994963,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2011113518","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99552155,0.00103147,0.00074434635,0.000108283224,0.00011814311,0.00018232288,0.0000133097765,0.000022650052,0.0022579345],"genre_scores_gemma":[0.9954819,0.000048326103,0.0026982047,0.00020055253,0.0005538583,0.000020512167,0.00006697095,0.000027916218,0.0009017275],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991418,0.0000401994,0.00013602698,0.0002620092,0.00009118467,0.00032876106],"domain_scores_gemma":[0.9994706,0.000012374379,0.00004625419,0.00018707801,0.00005293738,0.00023074735],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015730337,0.00015676413,0.00013915914,0.00003845574,0.000076856,0.000020744628,0.0001047827,0.00013588832,0.000030588788],"category_scores_gemma":[0.000052367108,0.00014115419,0.000042429434,0.000076914366,0.000027769645,0.000006991573,0.0001142043,0.0000487956,0.000034198743],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004450827,0.00005136316,0.0033451437,0.000016068989,0.000039203962,0.0000023530472,0.00010340626,0.000001877745,0.9922568,0.0001431144,0.0007202423,0.0032758738],"study_design_scores_gemma":[0.00024854534,0.0003062414,0.0013395693,0.000013472709,0.000016623673,0.000033966684,0.00002218275,0.0000049381188,0.9688656,0.00004629516,0.028903289,0.00019931597],"about_ca_topic_score_codex":0.00001729963,"about_ca_topic_score_gemma":0.0000072656076,"teacher_disagreement_score":0.028183047,"about_ca_system_score_codex":0.000010519052,"about_ca_system_score_gemma":0.000028340632,"threshold_uncertainty_score":0.5756101},"labels":[],"label_agreement":null},{"id":"W2011780255","doi":"10.1038/nchembio.1257","title":"Inhibitors that stabilize a closed RAF kinase domain conformation induce dimerization","year":2013,"lang":"en","type":"article","venue":"Nature Chemical Biology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":178,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Metropolitan University; University of Toronto; Mount Sinai Hospital; Lunenfeld-Tanenbaum Research Institute; Université de Montréal; Institute for Research in Immunology and Cancer","funders":"Canadian Institutes of Health Research","keywords":"Kinase; Protein kinase domain; Transactivation; Chemistry; Cell biology; Protein kinase A; Biochemistry; Förster resonance energy transfer; Allosteric regulation; Enzyme; Biology; Transcription factor; Gene; Mutant","score_opus":0.006135531041005006,"score_gpt":0.22668901362892158,"score_spread":0.22055348258791657,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2011780255","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99655026,0.0005953339,0.0003732479,0.0003981812,0.00040309734,0.00031234964,0.0000307264,0.00003348926,0.0013033035],"genre_scores_gemma":[0.9957508,0.000038477494,0.0009193628,0.00088238873,0.00038948318,0.000058093097,0.0019141785,0.00001619484,0.000031023894],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99898875,0.00006864709,0.00022281965,0.00034632228,0.00008625184,0.00028720664],"domain_scores_gemma":[0.9993588,0.000033777444,0.000110433204,0.0002802151,0.00010471707,0.00011207402],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010423339,0.00019002701,0.00017726501,0.00004278727,0.00004661958,0.000014626167,0.00018518798,0.0011379808,0.0001069136],"category_scores_gemma":[0.00023178862,0.00015648664,0.00008208455,0.000096668264,0.000120667486,0.000010150516,0.00010955328,0.00033802426,0.000055861103],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000042594285,0.000035301284,0.0012139656,0.000012204116,0.000015715881,4.4792355e-7,0.000046921734,2.0220732e-7,0.99128395,0.0007580586,0.0039822403,0.0026083705],"study_design_scores_gemma":[0.0006318978,0.00009063668,0.0006411016,0.000006483117,0.0000063762764,0.000008099478,0.00006699846,0.0000075075072,0.95532066,0.0012248233,0.04179446,0.00020093868],"about_ca_topic_score_codex":0.00001183783,"about_ca_topic_score_gemma":0.0000027213994,"teacher_disagreement_score":0.03781222,"about_ca_system_score_codex":0.000019851801,"about_ca_system_score_gemma":0.000044110253,"threshold_uncertainty_score":0.87771505},"labels":[],"label_agreement":null},{"id":"W2012074445","doi":"10.1074/jbc.m110.181529","title":"Activation Loop Phosphorylation of ERK3/ERK4 by Group I p21-activated Kinases (PAKs) Defines a Novel PAK-ERK3/4-MAPK-activated Protein Kinase 5 Signaling Pathway","year":2010,"lang":"en","type":"article","venue":"Journal of Biological Chemistry","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":81,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Institute for Research in Immunology and Cancer","funders":"National Cancer Institute; Canadian Institutes of Health Research; U.S. Public Health Service; National Institutes of Health; Leukemia and Lymphoma Society","keywords":"Kinase; PAK1; MAP2K7; Phosphorylation; MAP kinase kinase kinase; c-Raf; Mitogen-activated protein kinase kinase; ASK1; Cell biology; Cyclin-dependent kinase 2; MAPK14; Mitogen-activated protein kinase; Biology; Protein kinase A; Cyclin-dependent kinase 9; Chemistry; Biochemistry","score_opus":0.017491604067583152,"score_gpt":0.2283205964808308,"score_spread":0.21082899241324765,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2012074445","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99727845,0.00027764295,0.0016526924,0.00007383193,0.000114403956,0.00022006663,0.00008587392,0.000020444511,0.0002765821],"genre_scores_gemma":[0.99752706,0.00003228306,0.0014284009,0.00007845578,0.000399376,0.000019017125,0.00037912617,0.000028197723,0.000108063265],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981215,0.00006424086,0.0007967763,0.0003979925,0.00028311007,0.00033636924],"domain_scores_gemma":[0.9979014,0.000072996685,0.0010963016,0.0003019361,0.0004266768,0.0002007047],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00041469137,0.00034559917,0.00046018392,0.000046747584,0.00010035272,0.000032646014,0.00034699123,0.00070271525,0.00014975732],"category_scores_gemma":[0.00090024754,0.0002642922,0.00025638923,0.00020818184,0.00017691722,0.000027326256,0.000101237376,0.000545958,0.0000015177284],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008127101,0.0005714038,0.0009915874,0.000074848926,0.00009197622,0.000009538254,0.000015187603,0.000013323883,0.99566746,0.000023769053,0.00023624141,0.0014919449],"study_design_scores_gemma":[0.0012049528,0.0006857689,0.00074991793,0.0001031427,0.000021861988,0.000060321734,0.00007118195,0.000012940003,0.99197185,0.00007868807,0.0047186273,0.0003207742],"about_ca_topic_score_codex":0.000020326375,"about_ca_topic_score_gemma":0.0000011953458,"teacher_disagreement_score":0.0044823857,"about_ca_system_score_codex":0.00003308339,"about_ca_system_score_gemma":0.00013591572,"threshold_uncertainty_score":0.9999809},"labels":[],"label_agreement":null},{"id":"W2012440244","doi":"10.1074/jbc.c000917200","title":"Stress-induced Inhibition of ERK1 and ERK2 by Direct Interaction with p38 MAP Kinase","year":2001,"lang":"en","type":"article","venue":"Journal of Biological Chemistry","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":166,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Kinexus Bioinformatics Corporation (Canada); University of British Columbia","funders":"","keywords":"ASK1; Mitogen-activated protein kinase kinase; MAP2K7; MAP kinase kinase kinase; MAPK14; Kinase; Protein kinase A; c-Raf; Mitogen-activated protein kinase; Cyclin-dependent kinase 9; MAPK/ERK pathway; p38 mitogen-activated protein kinases; Phosphorylation; Activator (genetics); Cyclin-dependent kinase 2; Molecular biology; Cell biology; Biology; Chemistry; Biochemistry","score_opus":0.015280036115688662,"score_gpt":0.23800218362280454,"score_spread":0.2227221475071159,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2012440244","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99758595,0.00063572486,0.00010550653,0.00008642496,0.000047047215,0.000039074315,0.000023735724,0.0000035794656,0.0014729481],"genre_scores_gemma":[0.9990513,0.00035692996,0.00014091443,0.000042140335,0.00021717676,0.00000187624,0.00006208764,0.0000062155195,0.00012136071],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993258,0.000031040752,0.0002675112,0.00015838353,0.00009483453,0.0001224137],"domain_scores_gemma":[0.99937266,0.000018294915,0.00030125593,0.00010482098,0.000107306805,0.00009564234],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012581299,0.00011960217,0.00019555476,0.000014368988,0.000026802967,0.0000105629715,0.00007081262,0.00018664483,0.000047040852],"category_scores_gemma":[0.00007312746,0.000078905556,0.00006706178,0.000040523984,0.00006771593,0.0000065791933,0.00003843888,0.00014363776,5.771593e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044845,0.00012024112,0.0064246375,0.000031427255,0.000037816582,0.00003324212,0.000007927704,0.0000021466367,0.99107885,0.0000012342125,0.00065959664,0.0011544441],"study_design_scores_gemma":[0.00057494943,0.000912349,0.0012025695,0.00006807521,0.000017501708,0.00025772836,0.000103795355,0.0000028086693,0.99139583,0.000018661349,0.0053413385,0.00010440965],"about_ca_topic_score_codex":0.000003821306,"about_ca_topic_score_gemma":0.0000012432229,"teacher_disagreement_score":0.005222068,"about_ca_system_score_codex":0.000011411374,"about_ca_system_score_gemma":0.000026038868,"threshold_uncertainty_score":0.3217675},"labels":[],"label_agreement":null},{"id":"W2012445850","doi":"10.1097/00004872-200206000-00024","title":"Inhibition of mitogen-activated protein/extracellular signal-regulated kinase improves endothelial function and attenuates Ang II-induced contractility of mesenteric resistance arteries from spontaneously hypertensive rats","year":2002,"lang":"en","type":"article","venue":"Journal of Hypertension","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":63,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Clinical Research Institute; Université de Montréal","funders":"","keywords":"Contractility; Mesenteric arteries; Endocrinology; Medicine; Internal medicine; Vascular smooth muscle; Contraction (grammar); Angiotensin II; Spontaneously hypertensive rat; Kinase; Electrical impedance myography; Extracellular; Blood pressure; Vasodilation; Biology; Artery; Cell biology; Smooth muscle","score_opus":0.017230605372918272,"score_gpt":0.19153413741768474,"score_spread":0.17430353204476648,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2012445850","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963041,0.0029082603,0.00009015093,0.00014232923,0.00023663834,0.00025743723,0.000040602274,0.0000058530986,0.000014659875],"genre_scores_gemma":[0.99921507,0.00011917682,0.00027847057,0.00004631113,0.00016925261,0.0000031026975,0.000034342538,0.000020336387,0.0001139126],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985815,0.00014034065,0.00062008697,0.00025134496,0.00023934682,0.00016734672],"domain_scores_gemma":[0.9981923,0.00003732439,0.00078600383,0.00021272515,0.00068252406,0.00008912619],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014853073,0.00020213293,0.0004835588,0.00008506007,0.000089134286,0.000012762635,0.00006823801,0.00019174957,0.000023460627],"category_scores_gemma":[0.00015449863,0.00016473103,0.00014435172,0.000082249986,0.000101912985,0.000032926782,0.000043328655,0.00014081979,5.9683293e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029067753,0.00022158954,0.00009461831,0.000043026546,0.00013322815,0.00014340412,0.00011467702,0.0000019100075,0.99438673,0.0000030199556,0.00018045332,0.0017705812],"study_design_scores_gemma":[0.0017228435,0.0016487413,0.0026443005,0.00019252907,0.00012648746,0.00030388657,0.00022580932,0.00012303676,0.99231523,0.000093994044,0.0004503365,0.00015281563],"about_ca_topic_score_codex":0.00005597603,"about_ca_topic_score_gemma":0.000019610176,"teacher_disagreement_score":0.002911026,"about_ca_system_score_codex":0.000014118369,"about_ca_system_score_gemma":0.000032381697,"threshold_uncertainty_score":0.67175364},"labels":[],"label_agreement":null},{"id":"W2012871013","doi":"10.1186/1471-2407-8-337","title":"Activation of MEK1 or MEK2 isoform is sufficient to fully transform intestinal epithelial cells and induce the formation of metastatic tumors","year":2008,"lang":"en","type":"article","venue":"BMC Cancer","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":68,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; Université de Montréal; McGill University; Institute for Research in Immunology and Cancer","funders":"National Cancer Institute; Canada Research Chairs; Cancer Research Society","keywords":"Cancer research; Cell growth; Biology; Gene silencing; Cell biology; Carcinogenesis; Colorectal cancer; Cancer; Gene","score_opus":0.03504055605425711,"score_gpt":0.26620816107535067,"score_spread":0.23116760502109357,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2012871013","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9849611,0.000073410294,0.014264011,0.000082372644,0.000048962123,0.00027039408,0.000075777934,0.000002380767,0.00022157592],"genre_scores_gemma":[0.9988209,0.00006519213,0.00071403314,0.0001245373,0.000042580148,0.00003649575,0.000010881284,0.0000065063136,0.00017885759],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9994494,0.00001806587,0.000202905,0.00011081681,0.000115634364,0.00010321316],"domain_scores_gemma":[0.99964434,0.000017464637,0.00010199189,0.00011683502,0.000085201034,0.000034166787],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010323949,0.000079114914,0.00011050672,0.000031989173,0.00004840372,0.000003178444,0.00007702011,0.000029914225,0.000025993171],"category_scores_gemma":[0.000030478726,0.000050847728,0.00003819292,0.000087133274,0.000052143405,0.0000069551297,0.000022481834,0.000033184064,9.118293e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030452898,0.00003499681,0.00013007573,0.00008743578,0.000011229948,3.173416e-7,0.001938248,0.000111053894,0.99480957,0.000049055543,0.0005431671,0.0019803122],"study_design_scores_gemma":[0.00032621768,0.00042902274,0.0014517428,0.000028758706,0.000017190509,0.000015968306,0.00040223816,0.00020982881,0.9950034,0.000018309689,0.0020299049,0.00006741947],"about_ca_topic_score_codex":0.00015737212,"about_ca_topic_score_gemma":0.00018886873,"teacher_disagreement_score":0.013859801,"about_ca_system_score_codex":0.000013226351,"about_ca_system_score_gemma":0.00015036557,"threshold_uncertainty_score":0.20735103},"labels":[],"label_agreement":null},{"id":"W2014431943","doi":"10.1016/j.ahj.2015.02.012","title":"Rationale and design of the LosmApimod To Inhibit p38 MAP kinase as a TherapeUtic target and moDify outcomes after an acute coronary syndromE trial","year":2015,"lang":"en","type":"article","venue":"American Heart Journal","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":33,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"Agence Nationale de la Recherche","keywords":"Medicine; TIMI; Myocardial infarction; Clinical endpoint; Acute coronary syndrome; Placebo; Clinical trial; Internal medicine; Revascularization; Percutaneous coronary intervention; Randomized controlled trial; Cardiology; Pathology","score_opus":0.03182720917543021,"score_gpt":0.28484970855990366,"score_spread":0.25302249938447346,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2014431943","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967131,0.000440954,0.0011033263,0.0012167692,0.00013591384,0.00035513655,0.000021606189,0.0000028058805,0.000010415338],"genre_scores_gemma":[0.99518,0.000027073653,0.0028611452,0.0016633627,0.00008698398,0.000024454492,0.000004771735,0.000013386821,0.00013881507],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99911183,0.0002052222,0.00018497216,0.00017251901,0.00016590314,0.00015958157],"domain_scores_gemma":[0.999435,0.000019536767,0.000086117376,0.0001784974,0.00004953999,0.00023130733],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026277508,0.00011910679,0.00020704816,0.00003435576,0.00006888114,0.000029192688,0.000089539906,0.000043355423,0.000012846096],"category_scores_gemma":[0.000034203727,0.00008080935,0.000055328306,0.000050478957,0.00015558802,0.000010482424,0.000076670316,0.00009752913,0.0000029759194],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0363634,0.00072012783,0.21238902,0.000028883052,0.00080914894,0.00030907727,0.002160623,0.00035497514,0.7344908,0.00013754956,0.0066564335,0.0055799307],"study_design_scores_gemma":[0.052496504,0.069541626,0.6788775,0.00014380764,0.00059733633,0.020379588,0.0031087373,0.0005831614,0.12554272,0.0060993186,0.04055042,0.0020792992],"about_ca_topic_score_codex":0.000020519343,"about_ca_topic_score_gemma":0.0000034991422,"teacher_disagreement_score":0.6089481,"about_ca_system_score_codex":0.000009831778,"about_ca_system_score_gemma":0.00017231776,"threshold_uncertainty_score":0.32953095},"labels":[],"label_agreement":null},{"id":"W2018807996","doi":"10.1038/jid.2015.11","title":"The Role of eIF4E in Response and Acquired Resistance to Vemurafenib in Melanoma","year":2015,"lang":"en","type":"article","venue":"Journal of Investigative Dermatology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":30,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; McGill University","funders":"Canadian Institutes of Health Research; Plexxikon","keywords":"Vemurafenib; EIF4E; Melanoma; Cancer research; Cell culture; Cell growth; Biology; Translation (biology); Medicine; Messenger RNA; Genetics; Gene; Metastatic melanoma","score_opus":0.015278052005459864,"score_gpt":0.24610327934321893,"score_spread":0.23082522733775906,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2018807996","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99405676,0.00306992,0.0000127086105,0.0023367591,0.00006422236,0.000088487606,0.0000036500342,8.1688125e-7,0.00036665716],"genre_scores_gemma":[0.99884516,0.000052132193,0.00077281037,0.00023447188,0.000026122512,0.000005205078,0.000001142795,0.0000067369274,0.000056232162],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987079,0.00047850178,0.00043929485,0.00011156498,0.00010180261,0.00016092794],"domain_scores_gemma":[0.99919903,0.00011324321,0.000247683,0.00013951246,0.00016040543,0.0001401018],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00067692285,0.00008996836,0.00023612853,0.00011579682,0.00002140707,0.000006886047,0.00018149626,0.00009843339,5.461539e-7],"category_scores_gemma":[0.0012213645,0.0000662695,0.000030484724,0.00013235518,0.00027089592,0.000006935537,0.00007112663,0.00008757912,0.0000010255062],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002184923,0.000025226092,0.026177881,0.0000074664035,0.00001943827,0.000091948314,0.0013798643,0.000011921267,0.9678339,0.0009203224,0.0011436247,0.00020348564],"study_design_scores_gemma":[0.0010284475,0.0003890748,0.053566467,0.000045637982,0.000004663367,0.00030707597,0.0013500387,0.000009971604,0.9146036,0.0049412237,0.023670482,0.00008334389],"about_ca_topic_score_codex":0.000008985897,"about_ca_topic_score_gemma":0.00033305844,"teacher_disagreement_score":0.053230327,"about_ca_system_score_codex":0.000019854648,"about_ca_system_score_gemma":0.00025652282,"threshold_uncertainty_score":0.27023917},"labels":[],"label_agreement":null},{"id":"W2020620262","doi":"10.1016/j.ajpath.2014.11.021","title":"RSK1 Activation Promotes Invasion in Nodular Melanoma","year":2015,"lang":"en","type":"article","venue":"American Journal Of Pathology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":32,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; School of Medicine, New York University; National Institutes of Health; Melanoma Research Alliance; Chemotherapy Foundation; York University; American Skin Association","keywords":"Melanoma; Metastasis; Cancer research; Biology; Motility; Matrix metalloproteinase; Pathology; Tissue microarray; Nodular melanoma; Cancer; Immunohistochemistry; Medicine; Immunology; Cell biology","score_opus":0.017687117629509887,"score_gpt":0.251575593199775,"score_spread":0.23388847557026513,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2020620262","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966593,0.00013293148,0.0022156984,0.00026731344,0.00014411732,0.00005729332,0.0000015801488,0.0000025642548,0.00051921327],"genre_scores_gemma":[0.99661434,0.000033001543,0.0027715978,0.0002964487,0.00021967532,0.000002631624,0.0000111289855,0.000011761156,0.00003940994],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99910694,0.00019296347,0.00028279095,0.00014459525,0.00011015897,0.00016256145],"domain_scores_gemma":[0.99926907,0.000013399121,0.000319279,0.00015902038,0.00013657086,0.000102669685],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004622982,0.000094773124,0.00022022349,0.000116109855,0.000014453532,0.000005948537,0.00015053351,0.00007022926,0.0000048148427],"category_scores_gemma":[0.00026570176,0.00008050662,0.0000554202,0.00012042401,0.00011230389,0.000007239774,0.00004868069,0.00012452212,0.000006043894],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023920948,0.00009878083,0.034148376,0.0000036559877,0.000016061404,0.0002660787,0.00036845537,0.000033948574,0.945241,0.000074691765,0.00056517404,0.018944612],"study_design_scores_gemma":[0.003207392,0.015519755,0.055152692,0.000068589165,0.00003249844,0.0045776926,0.0022152578,0.00004590623,0.89749086,0.0013308437,0.019907167,0.000451342],"about_ca_topic_score_codex":0.000013326696,"about_ca_topic_score_gemma":0.00001294597,"teacher_disagreement_score":0.04775009,"about_ca_system_score_codex":0.000021590411,"about_ca_system_score_gemma":0.00014996745,"threshold_uncertainty_score":0.32829648},"labels":[],"label_agreement":null},{"id":"W2021563552","doi":"10.1007/s00018-010-0520-6","title":"Mechanistic principles of RAF kinase signaling","year":2010,"lang":"en","type":"review","venue":"Cellular and Molecular Life Sciences","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":72,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Lunenfeld-Tanenbaum Research Institute; Université de Montréal; Institute for Research in Immunology and Cancer","funders":"Canadian Institutes of Health Research","keywords":"Kinase; Cell biology; Receptor tyrosine kinase; Function (biology); Chemistry; Tyrosine kinase; Protein kinase domain; SH3 domain; Biology; Signal transduction; Biochemistry; Mutant; Gene","score_opus":0.04140567237559033,"score_gpt":0.28504004498691426,"score_spread":0.24363437261132392,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2021563552","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00400877,0.99005735,0.003560793,0.000006103867,0.00031227717,0.00036624403,0.000036168607,0.000010323276,0.001641963],"genre_scores_gemma":[0.0059826104,0.9913955,0.0019414661,0.00005772645,0.00019290566,0.000034534154,0.00013940295,0.00003807507,0.0002178128],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9980727,0.0001439671,0.0004805192,0.0006999728,0.00027571843,0.0003271264],"domain_scores_gemma":[0.9989227,0.000029748184,0.00033886515,0.00043141266,0.000061733735,0.00021553037],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00063296634,0.00036538846,0.00076105894,0.0001382028,0.00015891144,0.000040952233,0.0005159643,0.0004291091,0.000017885055],"category_scores_gemma":[0.00027026943,0.00029064086,0.00033657593,0.00019508715,0.0004512844,0.0000036869828,0.0002842465,0.00020762639,0.0000063283137],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000007484459,0.00007509886,0.0000048282413,0.0055260137,0.00011975348,0.00006223275,0.000027725973,0.0000068823333,0.8301598,0.010060232,0.000061465296,0.15388848],"study_design_scores_gemma":[0.000108000146,0.000234471,1.7338337e-7,0.0007365189,0.00025671144,0.000027956483,0.000019937608,0.0000142377885,0.13367137,0.000104043604,0.864464,0.0003625722],"about_ca_topic_score_codex":0.000007537077,"about_ca_topic_score_gemma":0.0000026013606,"teacher_disagreement_score":0.86440253,"about_ca_system_score_codex":0.000003908906,"about_ca_system_score_gemma":0.0005530855,"threshold_uncertainty_score":0.9999546},"labels":[],"label_agreement":null},{"id":"W2021643794","doi":"10.1158/0008-5472.can-07-2976","title":"3′-Deoxy-3′-[18F]Fluorothymidine Positron Emission Tomography Is a Sensitive Method for Imaging the Response of BRAF-Dependent Tumors to MEK Inhibition","year":2007,"lang":"en","type":"article","venue":"Cancer Research","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":64,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Institutes of Health; Golfers Against Cancer; National Cancer Institute; Samuel Waxman Cancer Research Foundation","keywords":"Cancer research; Cancer; Kinase; MEK inhibitor; Growth inhibition; Apoptosis; Positron emission tomography; Biology; MAPK/ERK pathway; Medicine; Internal medicine; Cell biology; Nuclear medicine; Biochemistry","score_opus":0.03009618755797126,"score_gpt":0.3947596411696007,"score_spread":0.36466345361162944,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2021643794","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96892697,0.000545126,0.027572274,0.0015634726,0.00008111024,0.000911517,0.00013681325,0.000009197423,0.00025353133],"genre_scores_gemma":[0.9959877,0.00004219981,0.002296875,0.00050133764,0.0002481941,0.00014665475,0.000033564076,0.000030528336,0.0007129208],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998054,0.0003843283,0.0002500359,0.0004284062,0.0003909463,0.0004922804],"domain_scores_gemma":[0.9986196,0.00022845312,0.00006841224,0.00037509724,0.00054151745,0.00016689807],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0043814806,0.00013581208,0.00015828048,0.00021684862,0.00020521667,0.000024783318,0.00018056722,0.000074985364,0.000018441819],"category_scores_gemma":[0.00030818323,0.000104741775,0.00012374196,0.00033999217,0.00010036742,0.000005660744,0.00018330208,0.00017320307,0.0000026473483],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004656869,0.000035434085,0.0003972663,0.000039489427,0.00003078194,0.0000149513735,0.00056101294,0.000007395497,0.9833148,0.000050566352,0.005008827,0.00588259],"study_design_scores_gemma":[0.0005254942,0.0005346448,0.0024176955,0.00008744982,0.000011195337,0.000022218434,0.00065658416,0.000036048074,0.98838776,0.00010019716,0.0070962193,0.00012449014],"about_ca_topic_score_codex":0.0002320594,"about_ca_topic_score_gemma":0.000055453995,"teacher_disagreement_score":0.027060766,"about_ca_system_score_codex":0.00006720302,"about_ca_system_score_gemma":0.00020476243,"threshold_uncertainty_score":0.42712456},"labels":[],"label_agreement":null},{"id":"W2022204925","doi":"10.1074/jbc.m115.648097","title":"The Crystal Structure of Cancer Osaka Thyroid Kinase Reveals an Unexpected Kinase Domain Fold","year":2015,"lang":"en","type":"article","venue":"Journal of Biological Chemistry","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Discovery Centre","funders":"Paul Scherrer Institut","keywords":"Kinase; Cyclin-dependent kinase 9; MAP2K7; Protein kinase domain; Mitogen-activated protein kinase kinase; MAP kinase kinase kinase; Protein kinase A; Biochemistry; Biology; ASK1; Cyclin-dependent kinase 2; Cell biology; Chemistry","score_opus":0.019906932317673185,"score_gpt":0.2682185433530814,"score_spread":0.2483116110354082,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2022204925","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945052,0.004644008,0.00005599092,0.000113529255,0.00017612774,0.00006378213,0.00011291963,0.0000053468007,0.00032308232],"genre_scores_gemma":[0.99808043,0.00023942835,0.00054750004,0.0000801748,0.00088268454,0.0000026050236,0.000054493685,0.0000115432285,0.00010114162],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99868125,0.00011537971,0.0005032554,0.00021718588,0.00022358728,0.0002593469],"domain_scores_gemma":[0.9985034,0.00003943714,0.00049977767,0.0003258574,0.00034341746,0.00028812466],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033635474,0.00019129134,0.0002974652,0.0000137579855,0.00006921904,0.000023248687,0.00046432466,0.0003377083,0.000044567914],"category_scores_gemma":[0.00043568708,0.00010746716,0.00017533569,0.000086662316,0.00019774189,0.0000061572437,0.00010888429,0.00024771786,4.1013107e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005162446,0.00007475525,0.0031809374,0.000014033589,0.000057658897,0.000030701663,0.000048502603,0.0000150673695,0.9939763,0.000028787863,0.0016531531,0.00040383975],"study_design_scores_gemma":[0.00091171934,0.00070051063,0.0015700606,0.000022782835,0.000022182576,0.00013029056,0.0004797753,0.0000022974195,0.9856373,0.0015967144,0.0087610185,0.00016532333],"about_ca_topic_score_codex":0.000012970936,"about_ca_topic_score_gemma":0.000013045996,"teacher_disagreement_score":0.008338993,"about_ca_system_score_codex":0.000030948824,"about_ca_system_score_gemma":0.00018119861,"threshold_uncertainty_score":0.43823835},"labels":[],"label_agreement":null},{"id":"W2022371765","doi":"10.2741/3003","title":"The RSK factors of activating the Ras/MAPK signaling cascade","year":2008,"lang":"en","type":"review","venue":"Frontiers in bioscience","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":222,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Research in Immunology and Cancer","funders":"National Cancer Institute; Terry Fox Foundation","keywords":"MAPK/ERK pathway; Gene isoform; Ribosomal s6 kinase; Kinase; Cell biology; Biology; Signal transduction; Effector; Protein kinase A; MAPK cascade; Gene; Biochemistry; PI3K/AKT/mTOR pathway; P70-S6 Kinase 1","score_opus":0.030618619885792297,"score_gpt":0.28175283828594966,"score_spread":0.25113421840015737,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2022371765","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0032655748,0.9936206,0.0010977015,0.000012931185,0.0012989679,0.00037566907,0.000026628273,0.0000053052354,0.0002966695],"genre_scores_gemma":[0.0029075765,0.99590826,0.0006959472,0.000020558702,0.00012990934,0.000026811747,0.000022969034,0.000019591844,0.00026838665],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99834794,0.00019037213,0.0004355541,0.00042131843,0.00024128992,0.00036351802],"domain_scores_gemma":[0.99887234,0.00011079638,0.00039485106,0.0005372979,0.00003387667,0.000050823837],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039343874,0.00026508485,0.0004922854,0.0000715381,0.00033087522,0.000029034036,0.0010904539,0.00024887748,0.0000011697706],"category_scores_gemma":[0.0004141788,0.0001347812,0.0002625259,0.0003856457,0.0005336956,0.0000046583004,0.00020140024,0.00026960918,9.517237e-7],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000014203958,0.000055476663,0.0009959175,0.0010740892,0.000115714116,0.000010164018,0.00044400772,0.000013502294,0.013770219,0.00010389652,0.013126399,0.9702764],"study_design_scores_gemma":[0.000055181794,0.00005644156,0.00003994926,0.00059285806,0.00001950501,0.00001669299,0.00023999943,0.000010856793,0.011490437,0.000016231845,0.98726225,0.0001995839],"about_ca_topic_score_codex":0.00002324257,"about_ca_topic_score_gemma":0.0000057944962,"teacher_disagreement_score":0.9741359,"about_ca_system_score_codex":0.000035684145,"about_ca_system_score_gemma":0.0003317805,"threshold_uncertainty_score":0.5496218},"labels":[],"label_agreement":null},{"id":"W2023276278","doi":"10.1007/s12032-015-0490-5","title":"ERK1/2 promoted proliferation and inhibited apoptosis of human cervical cancer cells and regulated the expression of c-Fos and c-Jun proteins","year":2015,"lang":"en","type":"article","venue":"Medical Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":56,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"HeLa; Apoptosis; Cell cycle; Cell growth; MAPK/ERK pathway; Flow cytometry; Cancer research; Cell; Kinase; Western blot; Biology; Cancer; Cancer cell; Molecular biology; Chemistry; Cell biology; Biochemistry; Gene; Genetics","score_opus":0.019487647846426464,"score_gpt":0.285930108448547,"score_spread":0.2664424606021205,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2023276278","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976014,0.00042744182,0.000096801465,0.0012333685,0.000050277777,0.00041335938,0.000009594139,0.0000048578704,0.00016293577],"genre_scores_gemma":[0.99931306,0.000089647874,0.00021463042,0.00013595179,0.00009157443,0.00005485481,0.000028557035,0.0000075006024,0.00006420334],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99908245,0.00017915225,0.00024691832,0.00020792948,0.00016583272,0.00011773703],"domain_scores_gemma":[0.99947095,0.000021546362,0.00012142558,0.00013050245,0.000097743454,0.00015780752],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037339446,0.00009037488,0.00021099346,0.000026238797,0.000042356514,0.000004008705,0.000068723064,0.000322616,0.000019261872],"category_scores_gemma":[0.00016199879,0.00005787081,0.000015578129,0.00005134794,0.0003416961,0.000003129187,0.00014540498,0.00010514721,1.3439643e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013747945,0.000095125375,0.0019952238,0.00006840564,0.000015836626,0.0000015524871,0.00033341872,4.139127e-7,0.9921355,0.000073087765,0.00067985326,0.0044640605],"study_design_scores_gemma":[0.00138034,0.0015802574,0.0021009871,0.000047419333,0.000024917903,0.00001529875,0.00008020708,0.00014118844,0.99097794,0.00010539824,0.0034760218,0.00007003397],"about_ca_topic_score_codex":0.000074265066,"about_ca_topic_score_gemma":0.000107109765,"teacher_disagreement_score":0.0043940265,"about_ca_system_score_codex":0.00000813519,"about_ca_system_score_gemma":0.00016187853,"threshold_uncertainty_score":0.24883099},"labels":[],"label_agreement":null},{"id":"W2023821657","doi":"10.1371/journal.pone.0017578","title":"Cytoplasmic Skp2 Expression Is Increased in Human Melanoma and Correlated with Patient Survival","year":2011,"lang":"en","type":"article","venue":"PLoS ONE","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Coastal Health; University of British Columbia; Vancouver Coastal Health Research Institute","funders":"CIHR Skin Research Training Centre; Canadian Institutes of Health Research; Michael Smith Health Research BC; Canadian Dermatology Foundation","keywords":"Melanoma; SKP2; Tissue microarray; Immunohistochemistry; Cancer research; Medicine; Cancer; Biomarker; Cell cycle; Pathology; Metastasis; Clinical significance; Oncology; Biology; Internal medicine; Ubiquitin; Gene; Ubiquitin ligase","score_opus":0.02843053325261224,"score_gpt":0.18975454579113782,"score_spread":0.16132401253852557,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2023821657","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99544114,0.00013559152,0.000018021785,0.000006499786,0.000016785994,0.00018030818,0.000015787808,0.000011839748,0.004174042],"genre_scores_gemma":[0.99901825,0.0000354528,0.0005948425,0.00007271827,0.000025069525,0.000023573077,0.00007774712,0.000017527356,0.00013480567],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992658,0.000050490817,0.00013973661,0.0002651242,0.00011405515,0.00016482187],"domain_scores_gemma":[0.9996019,0.000005368244,0.000057849906,0.00022055318,0.00003457244,0.000079737656],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000558799,0.00012170345,0.0001505319,0.000039853527,0.000048885937,0.000006854572,0.000070960894,0.00011726489,0.00006258071],"category_scores_gemma":[0.000013398782,0.0001016237,0.000016121134,0.000044450364,0.000044149798,0.0000035340026,0.00007156496,0.00007940815,0.0000066807884],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021565017,0.0004998607,0.11632438,0.000021871643,0.000040803727,0.000018233086,0.00031801075,1.1716073e-7,0.88239294,0.000020714633,0.000065431144,0.000082003964],"study_design_scores_gemma":[0.0009885586,0.0010321436,0.028013967,0.00009333044,0.000026058775,0.00000510029,0.00007319413,0.000019738167,0.96946424,0.000034200486,0.00008668487,0.00016277605],"about_ca_topic_score_codex":0.00013435997,"about_ca_topic_score_gemma":0.000086154796,"teacher_disagreement_score":0.08831041,"about_ca_system_score_codex":0.000006494613,"about_ca_system_score_gemma":0.00002123246,"threshold_uncertainty_score":0.4144094},"labels":[],"label_agreement":null},{"id":"W2025085818","doi":"10.1126/science.1158739","title":"Phosphorylation Networks Regulating JNK Activity in Diverse Genetic Backgrounds","year":2008,"lang":"en","type":"article","venue":"Science","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":123,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital","funders":"Howard Hughes Medical Institute","keywords":"Phosphoproteomics; RNA interference; Computational biology; Phosphorylation; Biology; Gene; Kinase; Signal transduction; Genetics; Computer science; RNA; Protein phosphorylation; Protein kinase A","score_opus":0.019924909245367644,"score_gpt":0.2414477783580355,"score_spread":0.22152286911266786,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2025085818","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940919,0.00013369731,0.0039801924,0.000014357443,0.00018269841,0.00007404131,8.140517e-7,0.000007239898,0.0015150317],"genre_scores_gemma":[0.9984975,0.000051850584,0.0010383709,0.000050403134,0.00010049132,0.0000045887205,0.0000034957543,0.0000045912366,0.00024871677],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9992091,0.000021531498,0.00008607315,0.0003017374,0.00014620177,0.00023535287],"domain_scores_gemma":[0.9996295,0.0000054084735,0.000043640484,0.00022452712,0.00003676023,0.000060141225],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021510865,0.00007122966,0.00006098163,0.000040926934,0.00019071964,0.000014488577,0.00017682336,0.000057081434,0.000009971071],"category_scores_gemma":[0.00004587474,0.00007042418,0.000023491542,0.00027327533,0.00024827707,0.000010775192,0.000113211776,0.000055759683,0.000006421309],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000022919636,0.000026912792,0.113412894,0.0000025447196,0.0000011145607,0.000008569284,0.00009731538,0.0027975116,0.8740204,0.00003532904,0.000093744624,0.009480768],"study_design_scores_gemma":[0.00025299544,0.000098765806,0.8217752,0.0000065424974,0.0000015922197,0.000024754689,0.00003307817,0.010170648,0.16655025,0.000035238238,0.0009080735,0.00014290123],"about_ca_topic_score_codex":0.00004099066,"about_ca_topic_score_gemma":0.000042114796,"teacher_disagreement_score":0.7083623,"about_ca_system_score_codex":0.000024137942,"about_ca_system_score_gemma":0.00010377345,"threshold_uncertainty_score":0.2871815},"labels":[],"label_agreement":null},{"id":"W2025194227","doi":"10.1006/bbrc.2000.3009","title":"Stress-Activated Protein Kinase-Dependent Induction of c-fos by Cd2+ Is Mediated by MKK7","year":2000,"lang":"en","type":"article","venue":"Biochemical and Biophysical Research Communications","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada Research Chairs; University of Toronto","funders":"","keywords":"MAPK/ERK pathway; Kinase; Chemistry; c-Fos; Protein kinase A; Mitogen-activated protein kinase; p38 mitogen-activated protein kinases; Cell biology; MAP kinase kinase kinase; Signal transduction; Mitogen-activated protein kinase kinase; Molecular biology; Biology; Gene expression; Biochemistry; Gene","score_opus":0.03948262302550619,"score_gpt":0.3209071248978224,"score_spread":0.2814245018723162,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2025194227","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99497736,0.0014095766,0.000010148421,0.00163048,0.0000073381952,0.00035334777,0.00062756863,0.00001662853,0.0009675746],"genre_scores_gemma":[0.995801,0.0012224206,0.00014386496,0.000053565054,0.000050443417,0.00011711304,0.0013629822,0.000016932578,0.0012317074],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984964,0.00023182096,0.00024410995,0.00035963356,0.0003584798,0.0003095147],"domain_scores_gemma":[0.9985389,0.00008484841,0.000052654043,0.00091475586,0.00020238648,0.00020643286],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002051549,0.00014634478,0.00016762747,0.000039389422,0.00018526432,0.000027424689,0.0005866452,0.00023607042,0.000111515255],"category_scores_gemma":[0.00021294112,0.00012746247,0.00006100021,0.0002665497,0.0006869103,0.000008931722,0.00029263573,0.00035553233,0.000025755442],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008311453,0.00059852505,0.000061430685,0.000025363439,0.000033614397,2.0035785e-7,0.000026607848,2.8882827e-8,0.97650385,0.000072162526,0.017392473,0.0052026478],"study_design_scores_gemma":[0.000358394,0.0003082487,0.00014565454,0.00003105606,0.000006741345,8.2173113e-7,0.00003664058,0.00003485437,0.95008796,0.00010956712,0.04874221,0.0001378538],"about_ca_topic_score_codex":0.00029758769,"about_ca_topic_score_gemma":0.0000063008238,"teacher_disagreement_score":0.031349737,"about_ca_system_score_codex":0.000018858347,"about_ca_system_score_gemma":0.000064078864,"threshold_uncertainty_score":0.5197768},"labels":[],"label_agreement":null},{"id":"W2025207475","doi":"10.1016/s0006-2952(01)00839-5","title":"Potentiation of cyclic AMP and cyclic GMP accumulation by p38 mitogen-activated protein kinase (p38MAPK) inhibitors in rat pinealocytes11Abbreviations: MAPK, mitogen-activated protein kinase; cAMP and cGMP, cyclic AMP and cyclic GMP, respectively; PKC, protein kinase C; IL-1β, interleukin-1β; IBMX, isobutylmethylxanthine; ISO, isoproterenol; PMA, 4β-phorbol 12-myristate 13-acetate; NE, norepinephrine; RIA, radioimmunoassay; DMEM, Dulbecco’s modified Eagle’s medium; PDE, phosphodiesterase; and CM, calmodulin.","year":2001,"lang":"en","type":"article","venue":"Biochemical Pharmacology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Medical Research Council Canada","keywords":"Protein kinase A; Pinealocyte; PDE10A; Phosphodiesterase; Phosphodiesterase 3; Rolipram; Cyclic nucleotide; Kinase; Phosphodiesterase inhibitor; Chemistry; Second messenger system; Endocrinology; Internal medicine; Biology; Biochemistry; Intracellular; Melatonin; Nucleotide; Enzyme; Pineal gland; Medicine","score_opus":0.01868846822094202,"score_gpt":0.27305437757822787,"score_spread":0.25436590935728587,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2025207475","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9828849,0.007697255,0.0007802657,0.0010091884,0.0004493469,0.006521373,0.0004980452,0.00013133936,0.000028287026],"genre_scores_gemma":[0.9923542,0.0015663804,0.0009078167,0.00028408624,0.0003583755,0.0018723698,0.0019354154,0.00018693827,0.00053438975],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9927626,0.0010192231,0.0020232755,0.0023465597,0.000548356,0.0012999434],"domain_scores_gemma":[0.996612,0.00015835282,0.0013069448,0.0008369098,0.0004180638,0.0006677184],"candidate_categories":["metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0007672836,0.001386153,0.0015188439,0.00063266006,0.00039443458,0.00017657453,0.0004893402,0.0011522121,0.0000944266],"category_scores_gemma":[0.000633712,0.0014022941,0.00022741106,0.0007909757,0.0009208162,0.00019550357,0.0006990307,0.0010023379,0.0000088028455],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005145588,0.00071051373,0.0019158097,0.00052940066,0.000383482,0.00007061906,0.00056711864,0.000020441923,0.986378,0.000020537687,0.0017127941,0.0025456557],"study_design_scores_gemma":[0.010806143,0.001001297,0.005194015,0.0003033526,0.00021108316,0.000121155324,0.0001249433,0.0004778629,0.9735302,0.00023089966,0.006626963,0.0013720928],"about_ca_topic_score_codex":0.001934144,"about_ca_topic_score_gemma":0.00022772333,"teacher_disagreement_score":0.012847847,"about_ca_system_score_codex":0.0002989745,"about_ca_system_score_gemma":0.0002594832,"threshold_uncertainty_score":0.9998889},"labels":[],"label_agreement":null},{"id":"W2026319826","doi":"10.1074/jbc.m103883200","title":"Inhibition of Anti-IgM-induced Translocation of Protein Kinase C βI Inhibits ERK2 Activation and Increases Apoptosis","year":2001,"lang":"en","type":"article","venue":"Journal of Biological Chemistry","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; University of Toronto","funders":"National Cancer Institute; University of Toronto; Cancer Research Society","keywords":"Chromosomal translocation; Apoptosis; ASK1; Cell biology; Protein kinase A; Chemistry; Kinase; Cancer research; Mitogen-activated protein kinase kinase; Molecular biology; Biology; Biochemistry; Gene","score_opus":0.021906699576330194,"score_gpt":0.23843381210151635,"score_spread":0.21652711252518614,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2026319826","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9989148,0.00026376636,0.0004206512,0.000067921756,0.000013953931,0.000097390024,0.000010916438,0.0000030001984,0.00020761607],"genre_scores_gemma":[0.99913716,0.00032936985,0.00030155212,0.000021004176,0.0001427679,0.0000040017844,0.000046539753,0.0000057276793,0.0000118455155],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991226,0.00004914411,0.0004575216,0.00014507167,0.00011946776,0.00010618663],"domain_scores_gemma":[0.9991089,0.000018396118,0.00048798858,0.00010601604,0.00020475472,0.00007390904],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023565542,0.000115718656,0.00024144031,0.000030514879,0.000025638325,0.000005456269,0.000072166746,0.0002487906,0.000019043286],"category_scores_gemma":[0.0002602191,0.00008831138,0.00009610784,0.00008899537,0.0000800138,0.000009790485,0.00002830911,0.000105072955,1.6219019e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029300386,0.00021330116,0.0021110366,0.00007658658,0.000026514585,0.0000020475213,0.000016761282,0.000002909297,0.9947975,0.000009661553,0.000012342895,0.0024382907],"study_design_scores_gemma":[0.0006931391,0.00056790054,0.003047911,0.00014271846,0.000014140023,0.00005410015,0.00009221866,0.0000040844266,0.9951067,0.000085253974,0.000097477314,0.00009437288],"about_ca_topic_score_codex":0.00000931208,"about_ca_topic_score_gemma":4.4418496e-7,"teacher_disagreement_score":0.0023439177,"about_ca_system_score_codex":0.000009549952,"about_ca_system_score_gemma":0.000054603566,"threshold_uncertainty_score":0.3601234},"labels":[],"label_agreement":null},{"id":"W2029014360","doi":"10.1016/j.ahj.2012.07.030","title":"The Study Of LoSmapimod treatment on inflammation and InfarCtSizE (SOLSTICE): Design and rationale","year":2012,"lang":"en","type":"article","venue":"American Heart Journal","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"","keywords":"Medicine; Solstice; Inflammation; Intensive care medicine; Internal medicine; Astronomy","score_opus":0.026097173621825946,"score_gpt":0.2767630739857006,"score_spread":0.25066590036387465,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2029014360","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9987884,0.00036554656,0.00035006003,0.00018698152,0.00004741228,0.00019630189,9.4055446e-7,0.0000013041603,0.00006306222],"genre_scores_gemma":[0.99867105,0.00033116277,0.0006681456,0.000048180354,0.00022463758,0.000011643087,0.0000013240578,0.000005014229,0.000038823408],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9994719,0.00014480985,0.0001242456,0.00006730949,0.00008152778,0.000110218716],"domain_scores_gemma":[0.9996329,0.00008215135,0.00008615426,0.00008836326,0.000033820295,0.000076624856],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024042766,0.00006446834,0.00008716573,0.000017891447,0.00014955073,0.000018875591,0.000027225457,0.0000148240915,0.0000023379391],"category_scores_gemma":[0.000057165358,0.000040672105,0.000017056924,0.000026426098,0.00007523939,0.000004775086,0.0000159371,0.000039297385,0.000001071238],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006672531,0.000521123,0.14074562,0.0000066504267,0.00024873836,0.000003041054,0.0025063716,0.00016450691,0.7307081,0.0002198843,0.0009855035,0.12322318],"study_design_scores_gemma":[0.0042251037,0.036947127,0.60217416,0.0000306591,0.00018997118,0.0008247396,0.009736802,0.0003227336,0.28035146,0.00028320318,0.06443191,0.00048213295],"about_ca_topic_score_codex":0.000016227214,"about_ca_topic_score_gemma":0.0000067550086,"teacher_disagreement_score":0.46142852,"about_ca_system_score_codex":0.000007576791,"about_ca_system_score_gemma":0.000031039013,"threshold_uncertainty_score":0.16585602},"labels":[],"label_agreement":null},{"id":"W2029575024","doi":"10.1038/nm.2166","title":"Rearrangements of the RAF kinase pathway in prostate cancer, gastric cancer and melanoma","year":2010,"lang":"en","type":"article","venue":"Nature Medicine","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":472,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Calgary Laboratory Services; University of Calgary","funders":"National Cancer Institute; National Institute on Drug Abuse; Canadian Institutes of Health Research; Weill Cornell Medical College; Howard Hughes Medical Institute","keywords":"Cancer research; Fusion gene; Prostate cancer; Chromoplexy; Cancer; Biology; Anaplastic lymphoma kinase; Oncogene; Oncogene Proteins; Melanoma; Viral Oncogene; Gene; Medicine; Lung cancer; Regulation of gene expression; Genetics; PCA3; Cell cycle; Internal medicine","score_opus":0.005012724505159081,"score_gpt":0.25060741129418523,"score_spread":0.24559468678902616,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2029575024","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9883709,0.008426319,0.0000015150334,0.0012510617,0.0008168074,0.00023981057,0.000041984964,0.0000031469488,0.0008484553],"genre_scores_gemma":[0.9976619,0.0007219921,0.000043630465,0.00043972133,0.0003529479,0.0000396533,0.000021286665,0.000010542439,0.0007083616],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993139,0.000026259244,0.00015031794,0.00020874273,0.0001455139,0.00015525651],"domain_scores_gemma":[0.99954295,0.0000084866015,0.00008523508,0.00024932172,0.000060106442,0.00005392302],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001775448,0.00010887102,0.00014479183,0.000043245564,0.00002921526,0.0000022227464,0.00014070106,0.00017396656,0.00004205384],"category_scores_gemma":[0.00011718664,0.00006455775,0.000022833698,0.00014314071,0.00012279619,0.0000019186218,0.00006941281,0.00035655728,2.6313808e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006629722,0.00001953903,0.08329366,0.000039543058,0.000013807699,0.0000052807004,0.00010682574,7.3995386e-7,0.90282667,0.00006957695,0.0017318414,0.011826207],"study_design_scores_gemma":[0.0026563434,0.00030155588,0.17962338,0.00016659174,0.000026748157,0.000019790645,0.00007560123,0.000011613725,0.70318735,0.00011515613,0.11366624,0.00014961857],"about_ca_topic_score_codex":0.00034987577,"about_ca_topic_score_gemma":0.0020164193,"teacher_disagreement_score":0.19963932,"about_ca_system_score_codex":0.0000067685223,"about_ca_system_score_gemma":0.0000800239,"threshold_uncertainty_score":0.26325887},"labels":[],"label_agreement":null},{"id":"W2032490154","doi":"10.2174/157488406778249325","title":"Sorafenib (BAY 43-9006): Review of Clinical Development","year":2006,"lang":"en","type":"review","venue":"Current Clinical Pharmacology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Sorafenib; Medicine; Hepatocellular carcinoma; Rash; Pharmacology; Tyrosine-kinase inhibitor; Renal cell carcinoma; Internal medicine; Platelet-derived growth factor receptor; Oncology; Toxicity; Cancer; Receptor","score_opus":0.2477982877687997,"score_gpt":0.5447069939674991,"score_spread":0.2969087061986994,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2032490154","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007632222,0.98368865,0.00013927919,0.000038445796,0.013047659,0.0014867487,0.00013999591,0.00002760991,0.0013552615],"genre_scores_gemma":[0.0000060138327,0.9892977,0.0004138733,0.00071906374,0.0057493146,0.00025438785,0.0027499332,0.00008311779,0.00072660757],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9894855,0.002144062,0.006082753,0.0013656212,0.00030693194,0.00061515736],"domain_scores_gemma":[0.9955636,0.00047952266,0.0025060487,0.00077367265,0.00027908324,0.00039804066],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0036624782,0.0007411413,0.0045034713,0.000099190154,0.00006988593,0.00000784056,0.0010638798,0.0012009107,0.00041342145],"category_scores_gemma":[0.00082078396,0.00060277124,0.0024254285,0.00021453448,0.00046026896,0.0000036077035,0.00071478705,0.0013172588,0.00034053577],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000026556123,0.00076292845,0.00009908684,0.05020495,0.00035718663,0.0000111341815,6.290866e-7,6.250466e-8,0.000005853587,0.000013570527,0.23614542,0.7123726],"study_design_scores_gemma":[0.0009649721,0.0003659879,0.000039464594,0.015703758,0.0015563865,0.000019752326,3.2661487e-7,6.3946686e-7,0.000046104426,0.000005907071,0.98071545,0.00058121805],"about_ca_topic_score_codex":9.2579864e-7,"about_ca_topic_score_gemma":0.0000029114535,"teacher_disagreement_score":0.7445701,"about_ca_system_score_codex":0.000030193723,"about_ca_system_score_gemma":0.0023405792,"threshold_uncertainty_score":0.9996424},"labels":[],"label_agreement":null},{"id":"W2033587656","doi":"10.2174/1381612023393053","title":"BAY 43-9006: Early Clinical Data in Patients with Advanced Solid Malignancies","year":2002,"lang":"en","type":"review","venue":"Current Pharmaceutical Design","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":102,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cancer Care Ontario; McMaster University Medical Centre","funders":"","keywords":"Medicine; Pharmacokinetics; Toxicity; Pharmacology; Bioavailability; Rash; Bay; Clinical trial; Diarrhea; Nausea; Refractory (planetary science); Gastrointestinal tract; Internal medicine; Oncology; Gastroenterology; Biology","score_opus":0.25302331392296024,"score_gpt":0.4456181802779548,"score_spread":0.19259486635499456,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2033587656","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0006134119,0.99333507,0.002678714,0.000005549229,0.0010654279,0.0017082017,0.00041512577,0.0000275429,0.00015096572],"genre_scores_gemma":[0.00074642396,0.9953825,0.0007546247,0.000052576223,0.00048407217,0.00013050417,0.0022544772,0.000092507675,0.000102348546],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99572134,0.00076389906,0.0010735112,0.0013645113,0.00037112416,0.00070562115],"domain_scores_gemma":[0.9976714,0.00014161188,0.0003227765,0.0013915714,0.000103871214,0.0003687245],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00067121757,0.0006616252,0.0013476994,0.000101778074,0.000060276594,0.000052796535,0.001214465,0.00046696514,0.00007955556],"category_scores_gemma":[0.0002639072,0.0004986485,0.0002552735,0.00022654362,0.00020292298,0.00001781325,0.00060911826,0.0007918863,0.00018689306],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014847633,0.00073718315,0.0010513497,0.002060014,0.00012731952,0.00001656445,0.000004234285,0.0000012068057,0.000009205954,0.000017074757,0.0032757604,0.9925516],"study_design_scores_gemma":[0.0017644101,0.00078860455,0.00034727764,0.0025553973,0.00044693923,0.0000052127502,7.4105003e-7,0.00004267645,0.000039081766,0.0000048246056,0.9933235,0.00068135204],"about_ca_topic_score_codex":3.7005537e-7,"about_ca_topic_score_gemma":6.861943e-7,"teacher_disagreement_score":0.9918703,"about_ca_system_score_codex":0.000034786804,"about_ca_system_score_gemma":0.0002761917,"threshold_uncertainty_score":0.9997465},"labels":[],"label_agreement":null},{"id":"W2034611095","doi":"10.1016/s0969-2126(03)00092-3","title":"Catalytically Active MAP KAP Kinase 2 Structures in Complex with Staurosporine and ADP Reveal Differences with the Autoinhibited Enzyme","year":2003,"lang":"en","type":"article","venue":"Structure","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":64,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's Health Research Institute","funders":"","keywords":"Staurosporine; Kinase; Enzyme; Phosphorylation; p38 mitogen-activated protein kinases; Substrate (aquarium); Chemistry; Protein kinase A; Biochemistry; Binding site; Active site; Mitogen-activated protein kinase; Stereochemistry; Cell biology; Biophysics; Biology","score_opus":0.00728327123550606,"score_gpt":0.20553663548692255,"score_spread":0.1982533642514165,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2034611095","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998559,0.00018788596,0.000094694835,0.00021030116,0.000035555637,0.0002616312,0.00012172408,0.000009695221,0.00051950186],"genre_scores_gemma":[0.99848104,0.0000067140877,0.00077175366,0.00023538909,0.000068626025,0.000008384661,0.00016725785,0.000018772265,0.00024204701],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9990068,0.000070639726,0.00011875756,0.00037872978,0.00016031224,0.0002647369],"domain_scores_gemma":[0.99947906,0.000014888245,0.000072304516,0.00029640528,0.00005319736,0.000084164625],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000047378686,0.00023235688,0.0001933872,0.000031262414,0.00013626296,0.000030674706,0.00014193234,0.00011754231,0.000049783255],"category_scores_gemma":[0.00002274539,0.00012274929,0.000020377509,0.00010147361,0.00023099117,0.000005085795,0.00008352235,0.00019073066,3.308145e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015573627,0.000060043403,0.06451874,0.00013532721,0.00020502017,0.00016089226,0.0013738724,0.00007541083,0.91545856,0.011446397,0.0026537129,0.00235465],"study_design_scores_gemma":[0.0030080648,0.0016160687,0.6553657,0.00003852842,0.00006984408,0.0003095024,0.0010184634,0.000020398073,0.32267353,0.0027910767,0.012396195,0.00069261837],"about_ca_topic_score_codex":0.000049083435,"about_ca_topic_score_gemma":0.00097356655,"teacher_disagreement_score":0.59278506,"about_ca_system_score_codex":0.000010207705,"about_ca_system_score_gemma":0.000077095894,"threshold_uncertainty_score":0.50055707},"labels":[],"label_agreement":null},{"id":"W2035166330","doi":"10.1371/journal.pone.0075405","title":"Decreased Expression of Nuclear p300 Is Associated with Disease Progression and Worse Prognosis of Melanoma Patients","year":2013,"lang":"en","type":"article","venue":"PLoS ONE","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Canadian Institutes of Health Research","keywords":"Melanoma; Tissue microarray; Cancer research; Cancer; Medicine; Metastasis; Oncology; Pathology; Nodular melanoma; Biology; Internal medicine","score_opus":0.012477188321729086,"score_gpt":0.19407130926080657,"score_spread":0.18159412093907748,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2035166330","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.999089,0.00013493739,0.0000023087114,0.000036993515,0.000005494075,0.0004677818,0.000049225622,0.000008353743,0.00020591539],"genre_scores_gemma":[0.99869823,0.00002969652,0.00095859193,0.000040362072,0.000014044672,0.0000517748,0.00013387234,0.000018493303,0.0000549083],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99925745,0.00004470339,0.00016209636,0.00020193898,0.00020665911,0.00012714056],"domain_scores_gemma":[0.9993027,0.000009045294,0.00017199329,0.00018960537,0.00018811699,0.00013855333],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00003935716,0.00010502313,0.0001715256,0.000028689545,0.000034661683,0.0000073200213,0.00007597801,0.00008141714,0.000060663355],"category_scores_gemma":[0.00010746394,0.000078183126,0.000030143374,0.000051613126,0.00007093808,0.0000065637414,0.000073948526,0.000034375094,0.0000024319756],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020904212,0.0018587101,0.3388447,0.000108708606,0.000075908676,8.080011e-7,0.000058706493,5.8329732e-8,0.6579976,0.0000030792603,0.00024483196,0.0005978827],"study_design_scores_gemma":[0.0009906713,0.000948264,0.26443282,0.00056549197,0.00008855953,1.09273316e-7,0.000015669475,0.000050559684,0.7327486,0.000017917606,0.000027556542,0.00011375374],"about_ca_topic_score_codex":0.000008274776,"about_ca_topic_score_gemma":0.0000011990938,"teacher_disagreement_score":0.07475104,"about_ca_system_score_codex":0.0000037090897,"about_ca_system_score_gemma":0.000024774525,"threshold_uncertainty_score":0.31882152},"labels":[],"label_agreement":null},{"id":"W2036442353","doi":"10.1016/j.ejmech.2014.07.018","title":"Towards the development of chromone-based MEK1/2 modulators","year":2014,"lang":"en","type":"article","venue":"European Journal of Medicinal Chemistry","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Institute for Research in Immunology and Cancer","funders":"Vetenskapsrådet; Knut och Alice Wallenbergs Stiftelse; Svenska Forskningsrådet Formas; Cancer Research Society","keywords":"Chromone; Chemistry; Allosteric regulation; Kinase; Structure–activity relationship; In vitro; Lead compound; Protein kinase A; IC50; MAPK/ERK pathway; Drug discovery; Biochemistry; Stereochemistry; Enzyme","score_opus":0.014596002274801767,"score_gpt":0.21871213868301803,"score_spread":0.20411613640821627,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2036442353","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9718763,0.00033693324,0.012423339,0.00019428476,0.00015462462,0.00003082185,0.0000016788496,0.0000030882188,0.014978884],"genre_scores_gemma":[0.9967205,0.00001029684,0.0022349753,0.00013446595,0.000725291,4.8541716e-7,0.000009187546,0.000018893244,0.00014590968],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99876326,0.00013008813,0.00050467096,0.00012442858,0.00033111154,0.0001464276],"domain_scores_gemma":[0.9990401,0.000015960497,0.00039745212,0.00026021618,0.00015620222,0.00013001362],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015411492,0.00013038905,0.00018315422,0.000018570205,0.00005522426,0.000006688359,0.0004257315,0.000038831375,0.00004240418],"category_scores_gemma":[0.00024308772,0.000083561325,0.00010861735,0.000050052877,0.00011205596,0.000002030213,0.00006247025,0.00016918645,0.000003391497],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009366528,0.000042646934,0.00022337757,0.000071262,0.000056471083,0.000018142842,0.00013640482,0.000067592366,0.98339117,0.0000049234895,0.0009659985,0.014928361],"study_design_scores_gemma":[0.0008598052,0.00028626557,0.0025899983,0.00009888092,0.00003177091,0.00010584103,0.00010662007,0.00004401691,0.95803386,0.000008755184,0.037733186,0.00010098697],"about_ca_topic_score_codex":3.7317574e-7,"about_ca_topic_score_gemma":2.8985588e-7,"teacher_disagreement_score":0.036767185,"about_ca_system_score_codex":0.000010954356,"about_ca_system_score_gemma":0.00022624973,"threshold_uncertainty_score":0.3407532},"labels":[],"label_agreement":null},{"id":"W2036553455","doi":"10.1006/geno.2002.7013","title":"The Protein Kinase ERK3 Is Encoded by a Single Functional Gene: Genomic Analysis of the ERK3 Gene Family","year":2002,"lang":"en","type":"article","venue":"Genomics","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Institute for Advanced Research; Université de Montréal; Montreal Clinical Research Institute","funders":"","keywords":"Pseudogene; Biology; Genetics; Gene; Gene family; Cyclin-dependent kinase 4; Gene duplication; Exon; c-Raf; Protein kinase A; MAP2K7; Subfamily; Kinase; Molecular biology; Cyclin-dependent kinase 2; Gene expression; Genome","score_opus":0.015178651131607991,"score_gpt":0.18267258542509543,"score_spread":0.16749393429348744,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2036553455","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99314666,0.0036248893,0.0013154083,0.00020059753,0.00017873506,0.0003003162,0.0003308402,0.000007409715,0.0008951683],"genre_scores_gemma":[0.9947746,0.0002777923,0.000498687,0.0005515152,0.00019341045,0.00004415821,0.0001538664,0.000027046497,0.0034789646],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99879676,0.00007705979,0.0003162918,0.00035947943,0.0001641201,0.00028628384],"domain_scores_gemma":[0.99888647,0.000013788928,0.00019121861,0.00075694744,0.00008115492,0.000070406684],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017333798,0.0001828209,0.00019329996,0.000043997472,0.00025213303,0.0000339492,0.00040570684,0.00015034685,0.00006002487],"category_scores_gemma":[0.00002755733,0.00012744019,0.00030745572,0.00023560657,0.0001322812,0.0000025802335,0.0001822669,0.00009489745,0.000020958983],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002962586,0.000071406444,0.00042808408,0.000003914408,0.00043205102,8.169552e-7,0.00008171581,0.00026343283,0.99032843,0.000030032137,0.0067515825,0.0015788903],"study_design_scores_gemma":[0.0003340247,0.000115537936,0.002821069,0.0000017269632,0.0002460165,0.0000047191743,0.0000513403,0.0009798458,0.885245,0.00004100068,0.109976985,0.00018273633],"about_ca_topic_score_codex":0.000033716122,"about_ca_topic_score_gemma":0.000046904184,"teacher_disagreement_score":0.10508345,"about_ca_system_score_codex":0.000048637616,"about_ca_system_score_gemma":0.000066128094,"threshold_uncertainty_score":0.519686},"labels":[],"label_agreement":null},{"id":"W2036813543","doi":"10.1016/j.coph.2014.07.015","title":"Recently targeted kinases and their inhibitors—the path to clinical trials","year":2014,"lang":"en","type":"review","venue":"Current Opinion in Pharmacology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":51,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institutes of Health; Ontario Ministry of Economic Development and Innovation; Wellcome Trust","keywords":"Kinase; Clinical trial; Medicine; Drug development; Pharmacology; Computational biology; Drug; Bioinformatics; Biology; Internal medicine; Biochemistry","score_opus":0.22630475708816697,"score_gpt":0.5048450191155313,"score_spread":0.27854026202736426,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2036813543","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00032840847,0.9680314,0.00011879398,0.00015221875,0.029441444,0.0017030057,0.00016964044,0.000014560573,0.000040500323],"genre_scores_gemma":[0.00017038014,0.9901137,0.000020085574,0.00019053805,0.008120011,0.0005183967,0.0007870532,0.000043656964,0.0000362105],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9928864,0.0041750497,0.0016269502,0.0008142335,0.00009318139,0.00040417613],"domain_scores_gemma":[0.9979969,0.0007047895,0.0006222991,0.0003812956,0.00006244816,0.00023225794],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0039347694,0.00047766019,0.0018726935,0.0001403274,0.000077348224,0.000025618872,0.00044300896,0.0005324736,0.00005395456],"category_scores_gemma":[0.0009747391,0.00029465673,0.00051301473,0.0001818284,0.00014267878,0.0000025496472,0.0004388778,0.0005839724,0.000043338765],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000052066433,0.00012536206,0.000038601193,0.00282291,0.00009582088,6.0556755e-7,0.000017761995,3.0276215e-7,0.00022477294,0.000026542995,0.18279198,0.81380326],"study_design_scores_gemma":[0.00073464337,0.00037358017,0.000011432713,0.0015037846,0.000119718046,0.00001707869,0.0000071587606,0.000004523696,0.00020304379,0.000019281444,0.9966785,0.0003272775],"about_ca_topic_score_codex":0.0000023217901,"about_ca_topic_score_gemma":0.0000014615455,"teacher_disagreement_score":0.81388646,"about_ca_system_score_codex":0.000024748677,"about_ca_system_score_gemma":0.00028165805,"threshold_uncertainty_score":0.9999505},"labels":[],"label_agreement":null},{"id":"W2037838528","doi":"10.1016/j.devcel.2007.03.009","title":"Mek1/2 MAPK Kinases Are Essential for Mammalian Development, Homeostasis, and Raf-Induced Hyperplasia","year":2007,"lang":"en","type":"article","venue":"Developmental Cell","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":144,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"National Institute of Arthritis and Musculoskeletal and Skin Diseases; Canadian Institutes of Health Research; National Institutes of Health; Office of Research and Development","keywords":"Biology; MAPK/ERK pathway; Cell biology; Kinase; Phenotype; Phosphorylation; Gene isoform; Protein kinase A; Genetics; Gene","score_opus":0.013692200700371183,"score_gpt":0.2335265452977893,"score_spread":0.2198343445974181,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2037838528","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943591,0.00050590036,0.00086850225,0.00003490332,0.00028365804,0.00036423886,0.00003407784,0.000023100709,0.0035265277],"genre_scores_gemma":[0.9807267,0.000046941917,0.01694494,0.00023046546,0.0001703108,0.00004079805,0.00047629297,0.000039200975,0.0013243257],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985914,0.000016480435,0.0003044006,0.0004798769,0.00014659401,0.00046120898],"domain_scores_gemma":[0.9994389,0.000018542538,0.00011052104,0.0001865047,0.000059310416,0.00018625087],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00025434096,0.00025639904,0.00018850648,0.00007560357,0.00022018311,0.000038869726,0.00020989335,0.00018505257,0.00003730108],"category_scores_gemma":[0.000037377125,0.00026013097,0.00005581657,0.000069250484,0.000043073804,0.0000068382947,0.00021525678,0.000067185894,0.000033619766],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022855046,0.0001039716,0.008862909,0.000110625995,0.00004670237,0.00003255271,0.00020807199,1.2040583e-7,0.97591674,0.00003845601,0.003314039,0.011137233],"study_design_scores_gemma":[0.0009999934,0.00009914687,0.01861434,0.000013533268,0.000011998973,0.000057167992,0.000531616,6.4223286e-7,0.8594958,0.000018556117,0.11981191,0.00034526942],"about_ca_topic_score_codex":0.000007786064,"about_ca_topic_score_gemma":0.00012590956,"teacher_disagreement_score":0.11649787,"about_ca_system_score_codex":0.000037033926,"about_ca_system_score_gemma":0.00015830641,"threshold_uncertainty_score":0.9999851},"labels":[],"label_agreement":null},{"id":"W2038264590","doi":"10.1158/2159-8290.cd-12-0386","title":"Inhibiting EGF Receptor or SRC Family Kinase Signaling Overcomes BRAF Inhibitor Resistance in Melanoma","year":2012,"lang":"en","type":"article","venue":"Cancer Discovery","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":373,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"Cancer Research UK; Wellcome Trust","keywords":"Vemurafenib; Dasatinib; Cancer research; Src family kinase; Melanoma; Tyrosine kinase; EGFR inhibitors; Metastasis; Epidermal growth factor receptor; Gefitinib; Medicine; Signal transduction; Kinase; Proto-oncogene tyrosine-protein kinase Src; Biology; Cancer; Oncogene; Internal medicine; Cell cycle; Cell biology","score_opus":0.020317167747091056,"score_gpt":0.2606265288370754,"score_spread":0.24030936108998432,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2038264590","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9847311,0.011049876,0.00024066292,0.00009265142,0.00089110207,0.00022430184,0.00013733967,0.000020187945,0.0026128278],"genre_scores_gemma":[0.9927188,0.00047589673,0.0004958298,0.0005826821,0.001759268,0.000108882174,0.000110402594,0.000047348716,0.0037008913],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983709,0.00008411908,0.00034718114,0.00042775486,0.00018602062,0.0005840473],"domain_scores_gemma":[0.9993317,0.00003689135,0.00013347661,0.00031284612,0.00004004668,0.00014500623],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002595705,0.00025737693,0.0002598318,0.00007003294,0.00008907971,0.00006155108,0.00017911519,0.00018737867,0.00006613028],"category_scores_gemma":[0.00010331299,0.00022545717,0.00010689135,0.00017879582,0.00006801676,0.000058763857,0.00014082452,0.0001563969,0.000018961431],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039802093,0.00008954854,0.032756343,0.00010391157,0.000029276942,0.00001275457,0.00022731606,0.00002028233,0.95870847,0.00026363024,0.006372783,0.0010176612],"study_design_scores_gemma":[0.0011403204,0.0001350782,0.008789263,0.00034064142,0.000020519505,0.000004339799,0.0005304193,0.0000030868825,0.9029054,0.000049646456,0.085537575,0.00054370536],"about_ca_topic_score_codex":0.0000917827,"about_ca_topic_score_gemma":0.0004222788,"teacher_disagreement_score":0.07916479,"about_ca_system_score_codex":0.00010329691,"about_ca_system_score_gemma":0.00023216066,"threshold_uncertainty_score":0.91938764},"labels":[],"label_agreement":null},{"id":"W2038472314","doi":"10.1016/s0140-6736(14)60417-7","title":"Losmapimod, a novel p38 mitogen-activated protein kinase inhibitor, in non-ST-segment elevation myocardial infarction: a randomised phase 2 trial","year":2014,"lang":"en","type":"article","venue":"The Lancet","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":155,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"Agency for Healthcare Research and Quality; National Institutes of Health; Duke Clinical Research Institute; King's College London; NIHR Biomedical Research Centre, Royal Marsden NHS Foundation Trust/Institute of Cancer Research; Guy's and St Thomas' NHS Foundation Trust; Abbott Vascular; GlaxoSmithKline; AstraZeneca","keywords":"Medicine; Myocardial infarction; Placebo; Internal medicine; Adverse effect; Cardiology; Gastroenterology; ST segment; Heart failure; Natriuretic peptide; Pathology","score_opus":0.019417503229661348,"score_gpt":0.26140549362228505,"score_spread":0.2419879903926237,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2038472314","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9919528,0.000039817904,0.0047133714,0.0005255646,0.0005482022,0.0015524941,0.000043629345,0.00001910731,0.0006050471],"genre_scores_gemma":[0.9946067,0.000011971192,0.00028370012,0.00037298977,0.0037999696,0.0004815288,0.0002338394,0.000020019885,0.00018932161],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988013,0.00016683659,0.0002843995,0.00030033904,0.00016456853,0.00028258344],"domain_scores_gemma":[0.9992492,0.000021234453,0.00013246895,0.00048709326,0.000051702547,0.00005825443],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000640383,0.00017567373,0.00031630282,0.000042202002,0.000077644225,0.000033242708,0.00019908482,0.00014305676,0.000017042983],"category_scores_gemma":[0.00017325244,0.00013261853,0.000102823295,0.00011762654,0.000046533252,0.000006575188,0.000065161505,0.000146444,0.0000123146165],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06545448,0.00019151134,0.00007448263,0.0000152110815,0.000039552575,8.682729e-7,0.00012389498,0.000023037534,0.930409,0.00004319728,0.0015950559,0.0020297123],"study_design_scores_gemma":[0.30123508,0.00096868974,0.00034488572,0.000030508845,0.0000204966,0.0000040366654,0.000024541943,0.00027800704,0.6463267,0.00007340766,0.050478768,0.00021485634],"about_ca_topic_score_codex":0.000052375213,"about_ca_topic_score_gemma":0.000030295962,"teacher_disagreement_score":0.28408226,"about_ca_system_score_codex":0.000032048145,"about_ca_system_score_gemma":0.000101191654,"threshold_uncertainty_score":0.54080266},"labels":[],"label_agreement":null},{"id":"W2038496625","doi":"10.1139/o04-114","title":"Wiring diagrams of MAPK regulation by MEKK1, 2, and 3","year":2004,"lang":"en","type":"review","venue":"Biochemistry and Cell Biology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":101,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"National Institute of General Medical Sciences","keywords":"MAPK/ERK pathway; Signal transduction; Cell biology; Kinase; Biology; MAP kinase kinase kinase; Phenotype; Protein kinase A; Neuroscience; Mitogen-activated protein kinase; Computational biology; Genetics; Gene","score_opus":0.01161571582897742,"score_gpt":0.24610419855307025,"score_spread":0.23448848272409284,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2038496625","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.013084659,0.9850451,0.00006925285,0.0000045676816,0.00008296795,0.00018953864,0.0001838547,0.000008506775,0.0013315916],"genre_scores_gemma":[0.017626334,0.9788173,0.00013416304,0.00001172633,0.0001683427,0.000028474069,0.0022114476,0.000025833191,0.00097638543],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99871963,0.00005511542,0.00037359784,0.00057834125,0.000045114888,0.00022818665],"domain_scores_gemma":[0.99923503,0.00002101057,0.00028445295,0.0003254979,0.000029582228,0.000104413484],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000118277254,0.00033792385,0.00065693446,0.000027647686,0.000050143033,0.000010277504,0.00014710908,0.00090227247,0.000013284622],"category_scores_gemma":[0.000026759864,0.000291286,0.00014078799,0.000053194446,0.00022661162,0.0000016216438,0.0001684198,0.00013102365,0.0000020090897],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000016282953,0.00005575672,0.00003322223,0.013070067,0.00008977928,0.0000018018163,0.00000843968,9.313474e-8,0.6699016,0.000081860584,0.00050703477,0.31623405],"study_design_scores_gemma":[0.00023701876,0.00014742448,0.0000017724782,0.00060181064,0.00012514365,0.000035866728,0.0000072300845,3.172735e-7,0.28778857,0.00005282121,0.7107233,0.00027871734],"about_ca_topic_score_codex":0.0000090039575,"about_ca_topic_score_gemma":7.016262e-7,"teacher_disagreement_score":0.7102163,"about_ca_system_score_codex":0.00001212631,"about_ca_system_score_gemma":0.000113305825,"threshold_uncertainty_score":0.9999539},"labels":[],"label_agreement":null},{"id":"W2039322311","doi":"10.1371/journal.pone.0086681","title":"The Non-Classical MAP Kinase ERK3 Controls T Cell Activation","year":2014,"lang":"en","type":"article","venue":"PLoS ONE","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Research in Immunology and Cancer; Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"Canadian Institutes of Health Research","keywords":"MAPK/ERK pathway; T cell; Cell biology; Kinase; T-cell receptor; CD8; Mitogen-activated protein kinase; Cytotoxic T cell; Protein kinase A; Biology; Molecular biology; Chemistry; Immune system; Immunology; In vitro; Biochemistry","score_opus":0.013894357291389702,"score_gpt":0.19432496822272616,"score_spread":0.18043061093133644,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2039322311","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9858524,0.00007643739,0.001781795,0.0009507149,0.0000643479,0.00019749251,0.0000051329407,0.000011944019,0.011059708],"genre_scores_gemma":[0.9944757,0.000023582334,0.000344418,0.0003338343,0.00052108464,0.00004123316,0.000050148217,0.000013159998,0.0041968212],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99937236,0.00004932288,0.000105653075,0.00017466991,0.00012463346,0.00017332996],"domain_scores_gemma":[0.99949765,0.000037703132,0.000052423402,0.0002989676,0.000051522205,0.000061748164],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013208305,0.00008634394,0.000096453296,0.00000937737,0.00011874807,0.000025987725,0.00013182538,0.00009308075,0.0000116937845],"category_scores_gemma":[0.00009631487,0.00006254055,0.000042373267,0.00002106343,0.000043114138,0.0000018910038,0.00004761127,0.00007337564,0.00008425216],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000057066525,0.00023100273,0.00029101243,0.000017055501,0.000031309137,3.844774e-7,0.000008620396,8.3967734e-7,0.99589896,0.00026958855,0.0024350458,0.00075909594],"study_design_scores_gemma":[0.0005241589,0.0002845202,0.0007486637,0.00001243413,0.000022735441,2.5866152e-7,0.000008318168,0.0003704193,0.95389754,0.00013869,0.04390006,0.000092198854],"about_ca_topic_score_codex":0.0000032284286,"about_ca_topic_score_gemma":0.000005617398,"teacher_disagreement_score":0.04200144,"about_ca_system_score_codex":0.0000060686434,"about_ca_system_score_gemma":0.000022868071,"threshold_uncertainty_score":0.25503296},"labels":[],"label_agreement":null},{"id":"W2040110061","doi":"10.1517/14728220802607363","title":"Melanoma: targeting signaling pathways and RaLP","year":2008,"lang":"en","type":"article","venue":"Expert Opinion on Therapeutic Targets","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"University of Waterloo","keywords":"Melanoma; Metastatic melanoma; Medicine; Cancer research; Signal transduction; Disease; Cancer; Biology; Internal medicine; Genetics","score_opus":0.03357481669340083,"score_gpt":0.26063119984644734,"score_spread":0.2270563831530465,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2040110061","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.77718437,0.20504777,0.0065040975,0.00081890513,0.0027728158,0.00075859815,0.00004158705,0.0001984797,0.0066734077],"genre_scores_gemma":[0.9914881,0.0048229704,0.0011383742,0.0013839775,0.0007902797,0.000038111757,0.00014700978,0.000042833242,0.00014836325],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986917,0.00009464957,0.00023257654,0.00046476422,0.00017280455,0.00034355294],"domain_scores_gemma":[0.99944055,0.000026963977,0.00008303772,0.00027842043,0.000038631875,0.00013240112],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015440234,0.00024668287,0.0001957669,0.000050234743,0.0002862418,0.000017209104,0.00015216749,0.0001690802,0.000054583303],"category_scores_gemma":[0.000030672814,0.00021679273,0.00008844699,0.00005285101,0.000089323614,0.0000065958675,0.00006985958,0.000112212285,0.000020896758],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000134637,0.00009340664,0.0008833402,0.0000072758075,0.000057205914,0.000013729557,0.0009196383,0.000010375047,0.9825877,0.00063449884,0.005985662,0.008672548],"study_design_scores_gemma":[0.0009218335,0.0007188458,0.0007365386,0.000016453141,0.0000018293571,0.00007065556,0.00024924244,0.000070027374,0.52543783,0.00017682103,0.4712193,0.00038065342],"about_ca_topic_score_codex":0.000007531785,"about_ca_topic_score_gemma":4.967098e-7,"teacher_disagreement_score":0.46523362,"about_ca_system_score_codex":0.000012248662,"about_ca_system_score_gemma":0.000049187893,"threshold_uncertainty_score":0.8840551},"labels":[],"label_agreement":null},{"id":"W2041648860","doi":"10.1016/s0014-4886(03)00101-8","title":"Inhibition of p38 mitogen-activated protein kinase interferes with cell shape changes and gene expression associated with Schwann cell myelination","year":2003,"lang":"en","type":"article","venue":"Experimental Neurology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":56,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Canadian Institutes of Health Research; Multiple Sclerosis Society; Multiple Sclerosis Society of Canada; ALS Association","keywords":"Protein kinase A; Schwann cell; Mitogen-activated protein kinase; Cell biology; Neuroscience; Gene expression; Gene; Cell; p38 mitogen-activated protein kinases; Kinase; Biology; Genetics","score_opus":0.00882924632211903,"score_gpt":0.2068816712628207,"score_spread":0.19805242494070166,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2041648860","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99820584,0.00063928595,0.00008467489,0.000025474721,0.000056736237,0.0003562185,0.000016399852,0.000014621212,0.0006007651],"genre_scores_gemma":[0.99919087,0.000013966645,0.00029252638,0.00010980137,0.00002989712,0.000075257,0.00014295852,0.000027400327,0.00011735022],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990695,0.00016395006,0.00012925678,0.00035578175,0.00009693869,0.00018457307],"domain_scores_gemma":[0.99957347,0.000007967683,0.00015008342,0.00015242184,0.00005554662,0.000060499744],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00005655831,0.0001744159,0.00015220106,0.000053659573,0.000059960304,0.000008838136,0.00005000527,0.00015607555,0.000029937919],"category_scores_gemma":[0.000015184942,0.0001416788,0.000019491757,0.000060604645,0.00010492296,0.000007587149,0.00005161267,0.000086863954,0.000001066643],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007986855,0.00026864486,0.00051843683,0.0000147715355,0.000010772275,0.000017789442,0.00017708982,0.000003655499,0.99808353,0.000012660227,0.000038057806,0.000055899738],"study_design_scores_gemma":[0.0017533468,0.0056304014,0.00022587013,0.000019416826,0.0000057297207,0.000017354218,0.0001262511,0.000016639768,0.9917258,0.000003976779,0.00032084118,0.00015434515],"about_ca_topic_score_codex":0.0000070094115,"about_ca_topic_score_gemma":0.000009440287,"teacher_disagreement_score":0.00635771,"about_ca_system_score_codex":0.0000070258316,"about_ca_system_score_gemma":0.000027301698,"threshold_uncertainty_score":0.5777494},"labels":[],"label_agreement":null},{"id":"W2044257846","doi":"10.1615/critrevoncog.2014011899","title":"Raf Kinase Inhibitory Protein (RKIP): Functional Pleiotropy in the Mammalian Brain","year":2014,"lang":"en","type":"review","venue":"Critical Reviews™ in Oncogenesis","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Canadian Institutes of Health Research","keywords":"Neuroscience; Protein kinase A; Context (archaeology); Biology; Kinase; Cell biology","score_opus":0.06036767630130355,"score_gpt":0.3526379026840249,"score_spread":0.2922702263827214,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2044257846","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002995995,0.99519295,0.00030715982,0.0004311887,0.00039848057,0.002063226,0.000055627203,0.000010719459,0.0012410502],"genre_scores_gemma":[0.00046041602,0.99285984,0.00034158776,0.0011969119,0.0016965845,0.0022567227,0.00047519171,0.00008599337,0.00062675116],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9941627,0.0023859313,0.0014268579,0.0009936313,0.0003547869,0.0006760874],"domain_scores_gemma":[0.9980648,0.00039067125,0.00020673865,0.0010706687,0.00007103734,0.00019604969],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0025243927,0.0006839142,0.0018544595,0.00018552368,0.00010279214,0.000058427504,0.00071693823,0.00078250695,0.00012098582],"category_scores_gemma":[0.0036769703,0.00047085286,0.0008559797,0.0004095649,0.0002561354,0.0000067120604,0.0002088011,0.00056105544,0.00031248466],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000031203825,0.00029415544,0.000018706498,0.022616038,0.000027004098,0.00013559344,0.000015353991,2.464003e-7,0.0019453398,0.003383533,0.01648191,0.95505095],"study_design_scores_gemma":[0.0002711395,0.0002512188,0.000018457577,0.007079958,0.00014440039,0.000077622375,0.000009979744,8.995744e-7,0.00022132792,0.00010554305,0.99128664,0.00053283316],"about_ca_topic_score_codex":0.00001929545,"about_ca_topic_score_gemma":0.00009050067,"teacher_disagreement_score":0.9748047,"about_ca_system_score_codex":0.00010270366,"about_ca_system_score_gemma":0.0004116284,"threshold_uncertainty_score":0.99977434},"labels":[],"label_agreement":null},{"id":"W2045506400","doi":"10.1038/ncb2130","title":"AKAP-Lbc enhances cyclic AMP control of the ERK1/2 cascade","year":2010,"lang":"en","type":"article","venue":"Nature Cell Biology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":125,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital","funders":"National Heart, Lung, and Blood Institute; National Institutes of Health; Howard Hughes Medical Institute","keywords":"MAPK/ERK pathway; Protein kinase A; Cell biology; Scaffold protein; Kinase; MAPK cascade; Phosphorylation; IQGAP1; Signal transduction; Second messenger system; Mitogen-activated protein kinase kinase; Chemistry; c-Raf; Biology","score_opus":0.003011618706480639,"score_gpt":0.22528188726650886,"score_spread":0.2222702685600282,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2045506400","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9872817,0.0027341484,0.00015856886,0.00023299234,0.0016221205,0.00018057738,0.00006711683,0.000008676417,0.0077141207],"genre_scores_gemma":[0.99714994,0.00011223839,0.00019728644,0.00084186764,0.0005016682,0.000013660785,0.00006679883,0.000012173894,0.0011043471],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991264,0.000088365494,0.00017835494,0.00030410284,0.000060997885,0.0002418115],"domain_scores_gemma":[0.9991979,0.00003658067,0.00013704374,0.00050687214,0.000069144946,0.000052480566],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015272306,0.00014819535,0.00018299262,0.000024746263,0.000062248975,0.000004705296,0.0004183761,0.00096785347,0.00006879913],"category_scores_gemma":[0.00014327728,0.000093199546,0.00013742539,0.00006679146,0.00020984664,0.0000013380513,0.0000912371,0.0005654145,0.000017668272],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000038231272,0.000033573608,0.0028139034,0.000010634898,0.00002211807,5.2887833e-7,0.000013362684,8.9117486e-7,0.9940262,0.00056937186,0.001355628,0.0011155432],"study_design_scores_gemma":[0.0003226449,0.00008603245,0.0014512279,0.000001783997,0.000012350943,0.000008088144,0.0000039228767,0.000002330895,0.6791172,0.00014657588,0.31876555,0.00008227717],"about_ca_topic_score_codex":0.000016619704,"about_ca_topic_score_gemma":0.000220226,"teacher_disagreement_score":0.31740993,"about_ca_system_score_codex":0.0000024841363,"about_ca_system_score_gemma":0.000064500964,"threshold_uncertainty_score":0.7464972},"labels":[],"label_agreement":null},{"id":"W2046576482","doi":"10.1503/cmaj.130989","title":"New treatments for metastatic melanoma","year":2014,"lang":"en","type":"review","venue":"Canadian Medical Association Journal","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Dacarbazine; Medicine; Metastatic melanoma; Melanoma; Randomized controlled trial; Chemotherapy; Overall survival; Standard of care; Surgery; Oncology; Internal medicine; Cancer research","score_opus":0.019768470485664918,"score_gpt":0.29344630586354686,"score_spread":0.27367783537788193,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2046576482","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000010762956,0.9941552,0.0020685527,0.00042498886,0.0012899713,0.00039796327,0.00018675897,0.0000050333206,0.0014607694],"genre_scores_gemma":[0.0000042650527,0.98473775,0.00085201574,0.0010435006,0.004772309,0.00004632664,0.00060541107,0.000050304232,0.007888095],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99799764,0.00022477627,0.0005608356,0.0002583115,0.00047070606,0.00048774833],"domain_scores_gemma":[0.9973611,0.000087918415,0.00046898227,0.00017037147,0.00014117981,0.0017704183],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008732019,0.00026686804,0.00078779383,0.00012875505,0.00015931028,0.000070545946,0.00033662148,0.00074747246,0.0006260813],"category_scores_gemma":[0.0011629699,0.00021613803,0.0005621355,0.000077049735,0.000010954857,0.0000027574642,0.000018311746,0.0003658607,0.00013750006],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000014322878,0.0000064744904,0.000013159777,0.00019632616,0.0005829437,0.00002878158,0.0000044788317,4.6602068e-8,5.6493184e-7,0.00005630938,0.23624593,0.7628636],"study_design_scores_gemma":[0.0005594971,0.00018932045,0.000004173771,0.00051344436,0.0006114739,0.00038829126,0.0000050312715,0.0000019276647,0.000002518713,0.00005581899,0.9974575,0.00021100377],"about_ca_topic_score_codex":0.00033002975,"about_ca_topic_score_gemma":0.0052782567,"teacher_disagreement_score":0.7626526,"about_ca_system_score_codex":0.00038178888,"about_ca_system_score_gemma":0.008349916,"threshold_uncertainty_score":0.99727184},"labels":[],"label_agreement":null},{"id":"W2049211399","doi":"10.1161/01.cir.0000147773.86866.cd","title":"Inhibition of Vascular Smooth Muscle Cell Proliferation and Neointimal Formation in Injured Arteries by a Novel, Oral Mitogen-Activated Protein Kinase/Extracellular Signal–Regulated Kinase Inhibitor","year":2004,"lang":"en","type":"article","venue":"Circulation","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":80,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"Canadian Institutes of Health Research","keywords":"MAPK/ERK pathway; Medicine; Vascular smooth muscle; Kinase; Neointima; Cell growth; Protein kinase A; Mitogen-activated protein kinase; Endocrinology; Cell biology; Internal medicine; Biology; Biochemistry; Restenosis; Smooth muscle","score_opus":0.00825379092483082,"score_gpt":0.19667467730987961,"score_spread":0.18842088638504878,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2049211399","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9728839,0.00033425205,0.02573549,0.000036049878,0.00004738322,0.00088565395,0.00003241926,0.000021755382,0.000023096236],"genre_scores_gemma":[0.99759835,0.000008173977,0.0006862685,0.000016964064,0.000056770597,0.000076354154,0.001522191,0.000024228657,0.000010682644],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988168,0.000071778915,0.0004120698,0.00032410445,0.00018226689,0.00019300211],"domain_scores_gemma":[0.99940866,0.0000031095353,0.0002127922,0.00018565457,0.0001293269,0.000060449664],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017899367,0.000187597,0.00017822122,0.00012330936,0.000074970725,0.00003662497,0.000042393294,0.00024224509,0.000007584323],"category_scores_gemma":[0.000028556668,0.00020547796,0.00005863578,0.00019893459,0.00005903331,0.00006754907,0.000028680191,0.00008379467,0.0000016917203],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012374525,0.00018894453,0.00040302682,0.00011827042,0.000008331634,0.0000022481497,0.00037607757,0.00071481976,0.99606246,0.000060516664,0.000015601494,0.0019259638],"study_design_scores_gemma":[0.0024632267,0.00025240442,0.010233694,0.000079421334,0.000017170109,0.0000031215345,0.00008171104,0.0011116215,0.9849984,0.00016408335,0.00037325168,0.00022186963],"about_ca_topic_score_codex":0.00006164941,"about_ca_topic_score_gemma":0.00003152408,"teacher_disagreement_score":0.02504922,"about_ca_system_score_codex":0.000052082483,"about_ca_system_score_gemma":0.000058237747,"threshold_uncertainty_score":0.8379148},"labels":[],"label_agreement":null},{"id":"W2049723387","doi":"10.1021/bi0487692","title":"Identification of Key Residues in the A-Raf Kinase Important for Phosphoinositide Lipid Binding Specificity","year":2005,"lang":"en","type":"article","venue":"Biochemistry","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Saskatchewan Cancer Agency; University of Saskatchewan","funders":"","keywords":"Kinase; Phosphatidylinositol; Biochemistry; c-Raf; Cell biology; C2 domain; Phosphatidic acid; Signal transduction; Protein kinase domain; Mutant; Chemistry; Biology; Protein kinase A; Mitogen-activated protein kinase kinase; Membrane; Phospholipid","score_opus":0.01182483567150565,"score_gpt":0.24724713045454272,"score_spread":0.23542229478303706,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2049723387","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99780566,0.0009089152,0.00025042135,0.00020673458,0.000071154274,0.0002108693,0.00011613283,0.0000069585262,0.0004231687],"genre_scores_gemma":[0.99804056,0.00013566003,0.0005177616,0.00007126793,0.00050115417,0.00005013932,0.00026802227,0.0000127481135,0.00040267265],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989797,0.000021896505,0.0003964864,0.00029121342,0.00012054855,0.00019016227],"domain_scores_gemma":[0.9992648,0.000023230876,0.00018721257,0.00043033806,0.000057786863,0.00003663161],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004323428,0.0001240615,0.00011847256,0.000023580815,0.00005374949,0.000018661147,0.00026943363,0.00013843212,0.000009701286],"category_scores_gemma":[0.00014758842,0.0001043758,0.00009601892,0.00007860736,0.000057455534,0.0000036001925,0.000039523453,0.000062837804,0.0000032510202],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007280275,0.00008350407,0.003220775,0.000056540513,0.0000098713435,0.0000015050525,0.00005799338,0.0000038880767,0.9929273,0.0001239065,0.0028949196,0.0005469857],"study_design_scores_gemma":[0.00032789062,0.00005123043,0.0019021978,0.000017848832,0.000011169804,0.000008605476,0.00019682804,0.000035344314,0.99014187,0.000035601697,0.0071468125,0.000124589],"about_ca_topic_score_codex":0.000012120587,"about_ca_topic_score_gemma":0.00002369069,"teacher_disagreement_score":0.004251893,"about_ca_system_score_codex":0.000019573694,"about_ca_system_score_gemma":0.00006305679,"threshold_uncertainty_score":0.42563218},"labels":[],"label_agreement":null},{"id":"W2051269487","doi":"10.1186/1471-2407-14-2","title":"Mitogen activated protein kinase kinase kinase 3 (MAP3K3/MEKK3) overexpression is an early event in esophageal tumorigenesis and is a predictor of poor disease prognosis","year":2014,"lang":"en","type":"article","venue":"BMC Cancer","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mount Sinai Hospital","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Surgical oncology; Hazard ratio; Internal medicine; Proportional hazards model; Survival analysis; Oncology; Esophageal cancer; Gastroenterology; Cancer; Confidence interval","score_opus":0.012966461517297384,"score_gpt":0.25176702367209697,"score_spread":0.23880056215479958,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2051269487","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969536,0.0012246912,0.000109600966,0.00009229194,0.000116871386,0.0008946652,0.00056094467,0.000018601495,0.00002874128],"genre_scores_gemma":[0.9977519,0.00006902351,0.00027961764,0.00018392027,0.00029321163,0.00059808715,0.00009867821,0.000044979573,0.0006806117],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982008,0.00016585285,0.00034067864,0.00067641353,0.00025628525,0.00036000603],"domain_scores_gemma":[0.9988668,0.000012032267,0.00018636827,0.0004760354,0.0000994202,0.00035937387],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00014725106,0.00028818418,0.00028344453,0.00008866652,0.000070154274,0.000026731714,0.00020271212,0.00017420281,0.000099550525],"category_scores_gemma":[0.00008463978,0.00026085964,0.000113542075,0.00013407573,0.00008357442,0.00002071276,0.00014867113,0.00009082488,0.0000026846694],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010767063,0.00027920236,0.11857916,0.00027562038,0.000026439056,0.0000091806005,0.000231237,0.000007905419,0.8766602,0.000015291369,0.0006182681,0.0022207382],"study_design_scores_gemma":[0.0015350507,0.00049174624,0.14718258,0.00025521484,0.000039147428,8.35481e-7,0.000023482426,0.0002565665,0.8478641,0.00004602249,0.0020352858,0.00026994862],"about_ca_topic_score_codex":0.00083487015,"about_ca_topic_score_gemma":0.0001502443,"teacher_disagreement_score":0.028796146,"about_ca_system_score_codex":0.00004482222,"about_ca_system_score_gemma":0.00023797146,"threshold_uncertainty_score":0.9999844},"labels":[],"label_agreement":null},{"id":"W2051557275","doi":"10.1074/jbc.m111.235275","title":"Distinct Functions of the Mitogen-activated Protein Kinase-activated Protein (MAPKAP) Kinases MK2 and MK3","year":2011,"lang":"en","type":"article","venue":"Journal of Biological Chemistry","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":71,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Deutsche Forschungsgemeinschaft","keywords":"Kinase; Cell biology; STAT3; MAPK/ERK pathway; Gene expression; Signal transduction; Phosphorylation; Protein kinase A; Chemistry; Regulation of gene expression; Interferon; Biology; Molecular biology; Gene; Immunology; Biochemistry","score_opus":0.03176602623745515,"score_gpt":0.2213487305174324,"score_spread":0.18958270427997725,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2051557275","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977812,0.000460271,0.000075240976,0.000053654443,0.000096327334,0.00021274718,0.000041893105,0.000008095025,0.0012705438],"genre_scores_gemma":[0.9988638,0.000018702456,0.0002410226,0.000022126449,0.00020032401,0.000017890146,0.000019531522,0.000012267645,0.00060433336],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988809,0.00009106942,0.0004356985,0.00023681897,0.000141502,0.00021399991],"domain_scores_gemma":[0.9988668,0.00001624484,0.00051503157,0.00027634474,0.00019482602,0.00013076178],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018493755,0.00020323697,0.00027608228,0.000017497523,0.00009446332,0.000010164291,0.0002902565,0.0002991073,0.00013504726],"category_scores_gemma":[0.00045677848,0.00011838456,0.00019284096,0.00011491098,0.0003384823,0.00000708261,0.00016039853,0.00026597688,0.0000010827406],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048593132,0.00018615295,0.0032669837,0.000051294057,0.00007797045,0.000011009548,0.000028178149,2.243312e-7,0.9951855,0.000009730256,0.00016203326,0.00053498865],"study_design_scores_gemma":[0.00053426984,0.00057876075,0.010508041,0.00008180789,0.000023318775,0.00009894776,0.00010647897,6.82396e-7,0.98353803,0.00011311881,0.004261934,0.00015462452],"about_ca_topic_score_codex":0.000012862645,"about_ca_topic_score_gemma":0.0000013601671,"teacher_disagreement_score":0.011647488,"about_ca_system_score_codex":0.000015648693,"about_ca_system_score_gemma":0.0000956278,"threshold_uncertainty_score":0.48275822},"labels":[],"label_agreement":null},{"id":"W2051858387","doi":"10.1016/j.jmb.2010.03.064","title":"The Crystal Structure of the Active Form of the C-Terminal Kinase Domain of Mitogen- and Stress-Activated Protein Kinase 1","year":2010,"lang":"en","type":"article","venue":"Journal of Molecular Biology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Zymeworks (Canada)","funders":"National Center for Research Resources; National Institute of Environmental Health Sciences; Hormel Foundation; National Cancer Institute; Basic Energy Sciences; Foundation for the National Institutes of Health","keywords":"Protein kinase A; Protein kinase R; Terminal (telecommunication); Chemistry; Mitogen-activated protein kinase kinase; Mitogen-activated protein kinase; Kinase; ASK1; Cell biology; Biochemistry; Biology; Computer science","score_opus":0.0037508788368404316,"score_gpt":0.22478102683772314,"score_spread":0.2210301480008827,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2051858387","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986304,0.00031292,0.00012179865,0.00016957706,0.0003082882,0.00022923962,0.00019161795,6.921145e-7,0.000035474503],"genre_scores_gemma":[0.9994573,0.000019006955,0.00037261748,0.000028783486,0.00008898058,0.000002208097,0.000006841068,0.000011239752,0.000013016395],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989134,0.00022906478,0.0004034157,0.00013678639,0.00014526122,0.0001720353],"domain_scores_gemma":[0.99833286,0.000036497422,0.0009262738,0.000405011,0.00024857625,0.000050770097],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020019237,0.00014612626,0.00025343313,0.000034359007,0.00008029828,0.000005697653,0.00047666568,0.00019763193,0.000005420651],"category_scores_gemma":[0.00028478337,0.0000696132,0.00021461403,0.00009303991,0.00068872934,0.0000041611725,0.00021301587,0.00031149262,3.108895e-8],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046211077,0.000043381842,0.0018434967,0.000024486337,0.00011714273,0.0000056935273,0.00012918221,0.000001739793,0.99497783,0.0007742298,0.000016999697,0.0016037255],"study_design_scores_gemma":[0.0006468853,0.0005659354,0.0073948307,0.000034415294,0.000038456597,0.00017339186,0.00018788192,0.0000011285874,0.9876762,0.0021131972,0.001094345,0.00007334533],"about_ca_topic_score_codex":0.00001761971,"about_ca_topic_score_gemma":0.00011335934,"teacher_disagreement_score":0.0073016244,"about_ca_system_score_codex":0.00000589987,"about_ca_system_score_gemma":0.00016409198,"threshold_uncertainty_score":0.28387436},"labels":[],"label_agreement":null},{"id":"W2052341771","doi":"10.1002/eji.200636620","title":"Pathologic expression of MHC class II is driven by mitogen‐activated protein kinases","year":2007,"lang":"en","type":"article","venue":"European Journal of Immunology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"Institut National de la Santé et de la Recherche Médicale; Canadian Institutes of Health Research; Cancer Research Society; Association pour la Recherche sur le Cancer","keywords":"CIITA; MAPK/ERK pathway; Biology; Enhancer; Kinase; Transcription factor; Cancer research; Microphthalmia-associated transcription factor; Cell biology; Protein kinase A; MHC class I; MHC class II; Transactivation; Mitogen-activated protein kinase; Molecular biology; Major histocompatibility complex; Genetics; Gene","score_opus":0.009438724971073143,"score_gpt":0.2166225842017941,"score_spread":0.20718385923072094,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2052341771","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9935858,0.0028309186,0.0013791093,0.0000850451,0.00031335338,0.00009710906,0.000018052384,0.000008619997,0.001681949],"genre_scores_gemma":[0.9981596,0.00016787047,0.00073551876,0.00011897505,0.00015587872,7.042743e-7,0.000020815589,0.00003213599,0.0006085396],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99852836,0.0003701029,0.000553144,0.00018254746,0.00011597034,0.00024988057],"domain_scores_gemma":[0.9988199,0.000014687884,0.00062707334,0.000275328,0.00019657414,0.000066425724],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005760742,0.00015661426,0.0002454916,0.00009055645,0.000076465796,0.000005568344,0.00036288056,0.000109057866,0.000038268554],"category_scores_gemma":[0.0001534459,0.00012458315,0.00014223947,0.000071446935,0.0001446488,0.0000067190986,0.00019592528,0.00022164754,0.000009949175],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005253416,0.00012631174,0.00029687458,0.000007850523,0.000059755082,0.00017808146,0.00019882385,0.0000014166471,0.989034,0.00000899481,0.0052813874,0.0042811395],"study_design_scores_gemma":[0.0009981162,0.0028805083,0.0020666246,0.000054417902,0.000013206864,0.0002808791,0.00014301138,2.53689e-7,0.9446854,0.00001280483,0.04874501,0.00011975593],"about_ca_topic_score_codex":0.0000015057637,"about_ca_topic_score_gemma":3.8704917e-7,"teacher_disagreement_score":0.044348612,"about_ca_system_score_codex":0.000010786154,"about_ca_system_score_gemma":0.0000426751,"threshold_uncertainty_score":0.5080353},"labels":[],"label_agreement":null},{"id":"W2053089175","doi":"10.1007/s00403-012-1294-5","title":"Role of translocator protein in melanoma growth and progression","year":2012,"lang":"en","type":"article","venue":"Archives of Dermatological Research","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"Canadian Institutes of Health Research; Health Canada; National Institutes of Health","keywords":"Translocator protein; Immunohistochemistry; Melanoma; Carcinogenesis; Biology; Cytoplasm; Mitochondrion; Cancer research; Pathology; Tumor progression; Cell growth; Cancer; Medicine; Cell biology; Immunology; Inflammation; Biochemistry","score_opus":0.02712453352296963,"score_gpt":0.3214395937405405,"score_spread":0.29431506021757087,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2053089175","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9914275,0.0026278344,0.000043521693,0.000098422766,0.0000054834345,0.0003050782,0.000007148029,0.0000028631862,0.005482174],"genre_scores_gemma":[0.9981147,0.00014292332,0.0016311462,0.0000054102998,0.000019720112,0.0000509567,0.000013074349,0.0000061812966,0.000015855174],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99883795,0.00028292777,0.00020172978,0.0001640919,0.00018168835,0.00033161673],"domain_scores_gemma":[0.9995891,0.00008581906,0.00003736149,0.00014825721,0.000023324703,0.000116141804],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027456856,0.00007556358,0.00016375163,0.000100781355,0.000029766854,0.0000032697192,0.00016548934,0.000094714334,0.0000055439064],"category_scores_gemma":[0.00023303066,0.000055385397,0.000039081442,0.000091139824,0.00037228642,0.000004661187,0.00015987607,0.00013293765,0.0000010994202],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017788418,0.0001802033,0.15853944,0.00010477512,0.0000066879975,0.00000222634,0.00018277936,4.5701757e-8,0.82907444,0.0050695697,0.0000061793094,0.006655757],"study_design_scores_gemma":[0.00033391098,0.00032717458,0.106728196,0.00004662417,0.0000013613073,0.00001728886,0.00012695603,0.000016276172,0.88997734,0.001983788,0.00038225116,0.000058810834],"about_ca_topic_score_codex":0.000010928483,"about_ca_topic_score_gemma":0.0000043198534,"teacher_disagreement_score":0.060902912,"about_ca_system_score_codex":0.0000011080757,"about_ca_system_score_gemma":0.00003521503,"threshold_uncertainty_score":0.2258551},"labels":[],"label_agreement":null},{"id":"W2053283364","doi":"10.1016/j.cellsig.2010.05.019","title":"Characterization of a novel MK3 splice variant from murine ventricular myocardium","year":2010,"lang":"en","type":"article","venue":"Cellular Signalling","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Université de Montréal; Montreal Heart Institute","funders":"Canadian Institutes of Health Research; Heart and Stroke Foundation of Canada","keywords":"Messenger RNA; p38 mitogen-activated protein kinases; Biology; Cytoplasm; Molecular biology; Phosphorylation; Chemistry; Protein kinase A; Cell biology; Biochemistry; Gene","score_opus":0.008698175824077156,"score_gpt":0.19309891340231303,"score_spread":0.18440073757823588,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2053283364","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.844345,0.0001548438,0.15467769,0.000016876382,0.00038378785,0.00012854191,0.000055163357,0.000011083583,0.00022703207],"genre_scores_gemma":[0.9954306,0.00002868607,0.002559583,0.000056177054,0.00072457903,0.000010345273,0.0010631647,0.000025395839,0.000101483245],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991178,0.000021969205,0.00023892353,0.0003085186,0.00013409495,0.0001787076],"domain_scores_gemma":[0.9993581,0.000009247243,0.00014068258,0.00032717458,0.000086717206,0.00007808586],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015831484,0.00014017652,0.00016804213,0.000037160637,0.000048080386,0.00001238951,0.0001834505,0.00017821742,0.00007065439],"category_scores_gemma":[0.000031361396,0.00013987989,0.000110977075,0.00007501211,0.000030265439,0.000004283163,0.00007602368,0.0001240245,0.000011075972],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000025337491,0.00010052048,0.00023037543,0.000016390908,0.000052201667,0.00002607743,0.000036173435,0.000035397596,0.9990745,0.00016689148,0.0000097661705,0.00022632293],"study_design_scores_gemma":[0.0004908241,0.00006642654,0.000662218,0.00001536046,0.0000397229,0.000012462711,0.000010135137,0.0010944095,0.9872746,0.00002206084,0.010150127,0.00016164171],"about_ca_topic_score_codex":0.000032617158,"about_ca_topic_score_gemma":0.0000039779634,"teacher_disagreement_score":0.1521181,"about_ca_system_score_codex":0.0000034021684,"about_ca_system_score_gemma":0.000044009867,"threshold_uncertainty_score":0.57041365},"labels":[],"label_agreement":null},{"id":"W2054151334","doi":"10.2310/7750.2013.13120","title":"Cutaneous Adverse Events during Vemurafenib Therapy","year":2014,"lang":"en","type":"review","venue":"Journal of Cutaneous Medicine and Surgery","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Women's College Hospital; Sunnybrook Health Science Centre","funders":"","keywords":"Vemurafenib; Medicine; Adverse effect; Keratoacanthoma; Discontinuation; Dermatology; Melanoma; Basal cell; Internal medicine; Metastatic melanoma; Cancer research","score_opus":0.03353372408600606,"score_gpt":0.29355354859090155,"score_spread":0.26001982450489547,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2054151334","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.029964177,0.968332,0.0000212311,0.00005956114,0.0011161715,0.0001775606,0.0000074563745,0.0000064835795,0.00031536235],"genre_scores_gemma":[0.0034150437,0.99240565,0.00002589032,0.00019079434,0.003065533,0.0000041653534,0.000048400336,0.00006345943,0.00078106456],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9975794,0.00024150821,0.0012253366,0.0002641101,0.00035904272,0.00033057728],"domain_scores_gemma":[0.9977265,0.00028889714,0.0012080199,0.00034116508,0.00014832111,0.00028710745],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004951682,0.00045170562,0.0021749209,0.0002961919,0.00008527549,0.000006170359,0.00022930234,0.0004018443,0.00005968357],"category_scores_gemma":[0.00036335425,0.00029513444,0.0007087738,0.00010288132,0.00009963868,0.000004237629,0.000053212283,0.00038135584,0.0000076009583],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044083956,0.000116024494,0.0002451748,0.0078002578,0.001140362,0.0057213283,0.00012172233,0.0000026383204,0.0018570655,0.000006572143,0.016579738,0.96596825],"study_design_scores_gemma":[0.00029189378,0.00054583495,0.0000033873625,0.0053520873,0.00030482333,0.074562535,0.000029767925,3.6252348e-7,0.000065849636,0.000015065466,0.9185524,0.00027599512],"about_ca_topic_score_codex":0.000004182148,"about_ca_topic_score_gemma":0.0000016561883,"teacher_disagreement_score":0.9656923,"about_ca_system_score_codex":0.000024218774,"about_ca_system_score_gemma":0.0003117341,"threshold_uncertainty_score":0.99995005},"labels":[],"label_agreement":null},{"id":"W2054312364","doi":"10.1158/0008-5472.can-13-1310","title":"MAPK Kinase 3 Is a Tumor Suppressor with Reduced Copy Number in Breast Cancer","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Beatrice Hunter Cancer Research Institute; Dalhousie University","funders":"Canadian Institutes of Health Research","keywords":"Suppressor; Breast cancer; Cancer research; Cancer; Cell cycle; Kinase; Cyclin-dependent kinase 4; MAPK/ERK pathway; Biology; Cell growth; Protein kinase A; Cyclin-dependent kinase 2; Cell biology; Genetics","score_opus":0.02897470359871875,"score_gpt":0.34534608945878104,"score_spread":0.3163713858600623,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2054312364","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99429876,0.00039594018,0.000004367956,0.0016989291,0.000076365985,0.0006589973,0.00016461416,0.00000876192,0.0026932594],"genre_scores_gemma":[0.99300015,0.00017691546,0.00007101015,0.00042778606,0.00034590618,0.0021720987,0.00002929855,0.000037817987,0.0037390217],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99831873,0.00011004028,0.00014950689,0.00048584706,0.00031996873,0.0006159051],"domain_scores_gemma":[0.99900883,0.0000132759915,0.00003336132,0.0004320879,0.00032156406,0.00019086293],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00019694936,0.00015061803,0.00015870147,0.0000661388,0.00008230683,0.000056904984,0.0002952416,0.00010174439,0.0040868428],"category_scores_gemma":[0.000016045515,0.00012038921,0.00003805327,0.00025017327,0.00016398197,0.000009604466,0.00014826945,0.00026533852,0.00017730394],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028160488,0.00006302731,0.02566784,0.000055166496,0.000026490341,0.0000270862,0.00011008804,0.000004017746,0.8813705,0.00003094624,0.09147652,0.0008867223],"study_design_scores_gemma":[0.0011136477,0.00013171897,0.025117327,0.00012276588,0.0000044668805,0.000036492802,0.00013647923,0.0000149352445,0.9425308,0.00006679143,0.030492062,0.00023250235],"about_ca_topic_score_codex":0.006081692,"about_ca_topic_score_gemma":0.00073852355,"teacher_disagreement_score":0.061160322,"about_ca_system_score_codex":0.000080057,"about_ca_system_score_gemma":0.0004708179,"threshold_uncertainty_score":0.99682355},"labels":[],"label_agreement":null},{"id":"W2054828913","doi":"10.1007/s40265-013-0014-6","title":"Mitogen-Activated Protein Kinases as Therapeutic Targets for Rheumatoid Arthritis","year":2013,"lang":"en","type":"review","venue":"Drugs","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":61,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"","keywords":"Medicine; Rheumatoid arthritis; Druggability; Context (archaeology); Kinase; Immunology; Inflammation; Proinflammatory cytokine; Arthritis; MAPK/ERK pathway; Methotrexate; p38 mitogen-activated protein kinases; Pharmacology","score_opus":0.026024606140518408,"score_gpt":0.2893558393361413,"score_spread":0.2633312331956229,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2054828913","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005565632,0.99511546,0.000103677696,0.000013975226,0.0004293555,0.0026383975,0.00022735307,0.000035592955,0.0008796311],"genre_scores_gemma":[0.0004127096,0.98998886,0.00022461648,0.00007308706,0.00034664053,0.0025077362,0.0025447113,0.00011484627,0.0037868135],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99832684,0.00011383041,0.00042108403,0.0005972523,0.0001276354,0.00041335885],"domain_scores_gemma":[0.9989238,0.000027693788,0.0002814526,0.00054615684,0.00009783779,0.00012305635],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00011447282,0.0004782909,0.00087306777,0.00006528796,0.00010611567,0.000052645693,0.0003252603,0.000523592,0.0001353108],"category_scores_gemma":[0.00007055702,0.00039540435,0.0005305773,0.00007891367,0.000056616835,0.00000387444,0.000094838135,0.00014458939,0.0002292999],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000015801388,0.0000465626,1.7175714e-7,0.0021400712,0.0002307817,0.0000028,0.000030048373,3.069748e-8,0.024116203,0.00020851308,0.0061015994,0.9671074],"study_design_scores_gemma":[0.00033765944,0.00024783815,9.318298e-8,0.0017275187,0.000041951076,0.00003217528,0.00001898076,3.5668765e-7,0.057495512,0.00011829586,0.9395239,0.00045572175],"about_ca_topic_score_codex":0.00003434322,"about_ca_topic_score_gemma":0.000003992626,"teacher_disagreement_score":0.9666517,"about_ca_system_score_codex":0.000019856305,"about_ca_system_score_gemma":0.00030967558,"threshold_uncertainty_score":0.9998498},"labels":[],"label_agreement":null},{"id":"W2054913636","doi":"10.1158/1078-0432.ccr-14-0341","title":"Phase I Expansion and Pharmacodynamic Study of the Oral MEK Inhibitor RO4987655 (CH4987655) in Selected Patients with Advanced Cancer with <i>RAS–RAF</i> Mutations","year":2014,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":70,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"","keywords":"KRAS; Medicine; MEK inhibitor; Colorectal cancer; Neuroblastoma RAS viral oncogene homolog; Melanoma; Cancer; Oncology; Internal medicine; Pharmacodynamics; Lung cancer; Adverse effect; Progressive disease; Cancer research; MAPK/ERK pathway; Pharmacokinetics; Kinase; Disease; Biology","score_opus":0.04652522395130103,"score_gpt":0.44238819226232884,"score_spread":0.3958629683110278,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2054913636","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99844176,0.00017903435,0.000028431747,0.00010749294,0.000109609195,0.0010150797,0.000052217103,0.000006428971,0.000059937465],"genre_scores_gemma":[0.9991706,0.00013034994,0.000052533287,0.00007102023,0.00010394671,0.0003122791,0.000040660852,0.000025969852,0.000092662776],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99781317,0.00058393,0.0003632452,0.0004888155,0.00042788585,0.0003229719],"domain_scores_gemma":[0.99876106,0.000121665566,0.00011665437,0.00033922723,0.00053454796,0.0001268515],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006231678,0.00014289687,0.0002524717,0.00006045171,0.00012577287,0.000014804115,0.00021672965,0.0000904453,0.00001672107],"category_scores_gemma":[0.00021602793,0.00008801669,0.000029612163,0.0004795151,0.00030457834,0.000009795397,0.00015573628,0.0003802305,6.49386e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006039283,0.003996776,0.8031542,0.000071518,0.00011624811,0.0000038297017,0.00041438814,0.00037705075,0.12973946,0.000005904662,0.00045655473,0.055624805],"study_design_scores_gemma":[0.06600013,0.02764849,0.8186474,0.0003380747,0.00013008833,0.0000021603032,0.0007927629,0.0013512551,0.079675935,0.000030961226,0.0047881133,0.00059466425],"about_ca_topic_score_codex":0.000566184,"about_ca_topic_score_gemma":0.008907567,"teacher_disagreement_score":0.059960842,"about_ca_system_score_codex":0.000033188335,"about_ca_system_score_gemma":0.00036469518,"threshold_uncertainty_score":0.49706313},"labels":[],"label_agreement":null},{"id":"W2054946171","doi":"10.1038/nrm3979","title":"Regulation of RAF protein kinases in ERK signalling","year":2015,"lang":"en","type":"review","venue":"Nature Reviews Molecular Cell Biology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":702,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Montréal; Université de Montréal; Institute for Research in Immunology and Cancer","funders":"","keywords":"Kinase; Allosteric regulation; MAPK/ERK pathway; Signalling; Cell biology; Function (biology); Suppressor; Phosphorylation; Chemistry; Biology; Biochemistry; Enzyme; Cancer; Genetics","score_opus":0.028283402185940106,"score_gpt":0.317174288496513,"score_spread":0.2888908863105729,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2054946171","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00021369437,0.99374336,0.000327297,0.000006064539,0.0002116143,0.002365679,0.00006223233,0.0000098027895,0.0030602776],"genre_scores_gemma":[0.0009561759,0.9942365,0.0014078979,0.000057520174,0.00021851827,0.00028916475,0.0024994258,0.00007125144,0.0002634893],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99612164,0.0012170043,0.0012284887,0.00087563216,0.00014982597,0.0004074149],"domain_scores_gemma":[0.9978906,0.000025199433,0.0010057194,0.00081585103,0.00014689344,0.00011576408],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0010983603,0.00062584225,0.0023411596,0.00024933068,0.000023233808,0.00000914787,0.0005600764,0.002498543,0.000022331433],"category_scores_gemma":[0.00033322847,0.0004897008,0.0007593574,0.00039223625,0.00009632801,0.000003031423,0.00020784243,0.00078946585,0.00003364235],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000024174535,0.000102681974,0.0000031283025,0.014617166,0.00006693138,0.000020955773,0.000006726089,0.0000032190842,0.25118813,0.00044065007,0.0007114283,0.7328148],"study_design_scores_gemma":[0.00026255276,0.0002896339,3.909991e-7,0.0039375275,0.00019149295,0.000011113712,0.0000014884101,0.0000013320549,0.018476443,0.0001416935,0.97624004,0.00044627648],"about_ca_topic_score_codex":0.000008360352,"about_ca_topic_score_gemma":0.000009614839,"teacher_disagreement_score":0.9755286,"about_ca_system_score_codex":0.000050783598,"about_ca_system_score_gemma":0.00041920991,"threshold_uncertainty_score":0.99975544},"labels":[],"label_agreement":null},{"id":"W2056148985","doi":"10.1074/jbc.m705895200","title":"Glycogen Synthase Kinase-3β Induces Neuronal Cell Death via Direct Phosphorylation of Mixed Lineage Kinase 3","year":2007,"lang":"en","type":"article","venue":"Journal of Biological Chemistry","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":78,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; Lunenfeld-Tanenbaum Research Institute","funders":"National Institute of General Medical Sciences; Canadian Institutes of Health Research","keywords":"GSK-3; Phosphorylation; Cell biology; Glycogen synthase; GSK3B; Kinase; Lineage (genetic); Protein kinase A; Biology; Chemistry; Biochemistry; Gene","score_opus":0.019935758585784908,"score_gpt":0.24206113815783603,"score_spread":0.2221253795720511,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2056148985","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951548,0.001217887,0.0010174729,0.000021849935,0.00018188714,0.00006722871,0.00003653756,0.000007284075,0.0022950594],"genre_scores_gemma":[0.997896,0.00017614759,0.0010306479,0.00005272114,0.00061998673,0.0000016189599,0.00007517517,0.0000137030775,0.00013399741],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985564,0.000054172524,0.0006443307,0.00026011004,0.00020543845,0.000279562],"domain_scores_gemma":[0.99871397,0.00007140569,0.0005784213,0.00022042751,0.00020056851,0.00021523044],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00060854276,0.00021403303,0.00033326575,0.00003231667,0.000051185743,0.000010806177,0.00029407814,0.00039612438,0.00008022828],"category_scores_gemma":[0.00030846414,0.00016066342,0.0002744923,0.00009141436,0.00008833282,0.000006087811,0.00009612563,0.00025242227,0.0000027758688],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00052133994,0.00029228293,0.0047407853,0.000042267446,0.000037849084,0.00009552643,0.000007155204,0.000012157393,0.99243575,0.0000021129,0.00020065188,0.0016121425],"study_design_scores_gemma":[0.0006340855,0.00070309313,0.007871442,0.000023174343,0.00003334415,0.00009172144,0.00003898679,0.000007754789,0.98742354,0.00002227448,0.0029693253,0.00018124847],"about_ca_topic_score_codex":0.0000045890874,"about_ca_topic_score_gemma":7.389352e-7,"teacher_disagreement_score":0.0050121793,"about_ca_system_score_codex":0.000022693283,"about_ca_system_score_gemma":0.00008516921,"threshold_uncertainty_score":0.6551664},"labels":[],"label_agreement":null},{"id":"W2056469580","doi":"10.1016/j.cellsig.2004.11.006","title":"A-Raf associates with and regulates platelet-derived growth factor receptor signalling","year":2004,"lang":"en","type":"article","venue":"Cellular Signalling","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Saskatchewan Cancer Agency; University of Saskatchewan","funders":"National Cancer Institute; Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research; Terry Fox Foundation; Saskatchewan Cancer Agency","keywords":"Autophosphorylation; Platelet-derived growth factor receptor; GRB2; Cell biology; Receptor tyrosine kinase; Growth factor receptor; Tyrosine kinase; Chemistry; Tyrosine phosphorylation; Tropomyosin receptor kinase C; MAPK/ERK pathway; Cancer research; Signal transduction; Biology; Phosphorylation; Growth factor; Biochemistry; Receptor; Protein kinase A","score_opus":0.00993843304290545,"score_gpt":0.1904841164186484,"score_spread":0.18054568337574295,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2056469580","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9808081,0.0019780423,0.016551383,0.000082828155,0.0000921056,0.00021558942,0.000017478953,0.000049045797,0.00020544651],"genre_scores_gemma":[0.99486506,0.00024318373,0.0040458743,0.0000952674,0.00030715307,0.000014982184,0.0001808671,0.000059064314,0.00018854455],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985729,0.00004664886,0.00024716486,0.0005286303,0.00019092426,0.0004137347],"domain_scores_gemma":[0.9993682,0.000025313871,0.00014130273,0.00017843972,0.00011675199,0.00016997986],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00016029608,0.00029345354,0.00025796698,0.000053356474,0.00020189515,0.00007873761,0.0001725313,0.00024137895,0.00003898791],"category_scores_gemma":[0.00004591928,0.00025624284,0.00008301849,0.000090836045,0.00009112177,0.000011548678,0.00007288481,0.00016021045,0.000017269696],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008131819,0.000037786176,0.0008486871,0.000038890637,0.00011130444,0.00001960449,0.00020373228,0.00033484702,0.99786013,0.00016662142,0.00002358925,0.00027345735],"study_design_scores_gemma":[0.0010522502,0.0004104099,0.00017833055,0.00008041058,0.000025559195,0.000013029039,0.000104096434,0.000051521267,0.9965024,0.0003975167,0.000794478,0.0003899846],"about_ca_topic_score_codex":0.000026361959,"about_ca_topic_score_gemma":0.00001104799,"teacher_disagreement_score":0.0140569825,"about_ca_system_score_codex":0.00002753704,"about_ca_system_score_gemma":0.00008405646,"threshold_uncertainty_score":0.999989},"labels":[],"label_agreement":null},{"id":"W2057255923","doi":"10.1016/s0960-9822(02)00831-x","title":"MAP Kinase Module: The Ksr Connection","year":2002,"lang":"en","type":"article","venue":"Current Biology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":30,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Clinical Research Institute","funders":"","keywords":"Biology; Kinase; Cell biology; Mitogen-activated protein kinase; Computational biology; Connection (principal bundle); MAP kinase kinase kinase; MAPK/ERK pathway","score_opus":0.0330297781244277,"score_gpt":0.2636431814857027,"score_spread":0.230613403361275,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2057255923","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9738855,0.014315481,0.0033528004,0.0009906798,0.0039309077,0.00027686282,0.000048331975,0.00003810267,0.0031613754],"genre_scores_gemma":[0.99752486,0.00060065836,0.000037755468,0.00020958012,0.0007717255,0.000035448018,0.00017240168,0.000009536111,0.000638038],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99927205,0.00008772305,0.00012507178,0.0002644281,0.000034903012,0.00021584616],"domain_scores_gemma":[0.99953884,0.000012023859,0.000050895796,0.00031359115,0.000035823567,0.000048852504],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000091241425,0.0001139836,0.00008947597,0.000021320859,0.00010216665,0.000009246673,0.00017166455,0.00011591845,0.00023609406],"category_scores_gemma":[0.000044770422,0.00007715849,0.00006856199,0.00003778856,0.000104069244,0.0000013816706,0.00007991679,0.00009798726,0.00027062692],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003897418,0.00021112336,0.0072260187,0.000031672535,0.000054831493,0.000002781216,0.000077037694,0.0000076016177,0.6997713,0.0067264764,0.116264366,0.16958785],"study_design_scores_gemma":[0.00032444866,0.00025237477,0.00085373945,0.0000041034923,0.000010956602,0.000016088554,0.000016231003,0.0002852552,0.03626188,0.0005379231,0.9612948,0.00014225634],"about_ca_topic_score_codex":0.0000053775207,"about_ca_topic_score_gemma":0.000008889122,"teacher_disagreement_score":0.84503037,"about_ca_system_score_codex":0.0000064448577,"about_ca_system_score_gemma":0.000008857204,"threshold_uncertainty_score":0.34784517},"labels":[],"label_agreement":null},{"id":"W2057923468","doi":"10.1074/jbc.m606225200","title":"Regulation of MAPK-activated Protein Kinase 5 Activity and Subcellular Localization by the Atypical MAPK ERK4/MAPK4","year":2006,"lang":"en","type":"article","venue":"Journal of Biological Chemistry","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":87,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Research in Immunology and Cancer","funders":"","keywords":"Protein kinase A; MAPK/ERK pathway; Kinase; HeLa; Phosphorylation; Cell biology; p38 mitogen-activated protein kinases; Cytoplasm; Chemistry; Biology; Biochemistry; Cell","score_opus":0.00992572397851768,"score_gpt":0.20629523351490142,"score_spread":0.19636950953638374,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2057923468","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946931,0.00075903576,0.0040025427,0.000122040736,0.000024692788,0.00010692761,0.000016085025,0.0000045205643,0.00027104147],"genre_scores_gemma":[0.99920875,0.000041225005,0.00015497788,0.00002293154,0.00022660631,0.0000036152508,0.0000765026,0.000007561988,0.00025784154],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991417,0.00008195188,0.00032199133,0.00017355429,0.00013898015,0.00014185072],"domain_scores_gemma":[0.999269,0.000020586362,0.0003669254,0.00015808697,0.00012358415,0.000061780775],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024548575,0.00013418934,0.00019695311,0.0000110518695,0.000059043752,0.00001394693,0.00013756554,0.00029471304,0.000033203367],"category_scores_gemma":[0.00011710472,0.00008331088,0.00009489926,0.00006945145,0.00016985691,0.0000063109924,0.000058859823,0.00015490327,4.451936e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045460675,0.00012453493,0.0018646618,0.000034636392,0.00002082349,0.0000042399115,0.0000036458434,0.000020216301,0.9960982,0.000025134299,0.00081312074,0.000536185],"study_design_scores_gemma":[0.0004453163,0.0002645485,0.009953342,0.000022973007,0.000013596537,0.000055997134,0.000010821597,0.000063449224,0.98354363,0.00026918828,0.005255086,0.00010202366],"about_ca_topic_score_codex":0.000011995062,"about_ca_topic_score_gemma":7.8983214e-7,"teacher_disagreement_score":0.0125545375,"about_ca_system_score_codex":0.000016185666,"about_ca_system_score_gemma":0.00003499193,"threshold_uncertainty_score":0.3397319},"labels":[],"label_agreement":null},{"id":"W2059719338","doi":"10.1001/jamadermatol.2013.4200","title":"Vemurafenib and Radiosensitization","year":2013,"lang":"en","type":"article","venue":"JAMA Dermatology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":90,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôtel-Dieu de Québec","funders":"","keywords":"Medicine; Vemurafenib; Dermatology; Medical physics; Cancer research; Melanoma; Metastatic melanoma","score_opus":0.004179907464712682,"score_gpt":0.1903157000028476,"score_spread":0.1861357925381349,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2059719338","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9933928,0.00037423873,0.0008789255,0.0012915346,0.000114482966,0.000116328156,0.000002243336,0.000014841653,0.0038145948],"genre_scores_gemma":[0.99778306,0.000079342615,0.000532677,0.0011416274,0.00010709353,0.000018081711,0.00007081462,0.000009524635,0.00025774882],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9995061,0.000044590255,0.00010213378,0.0001681124,0.000033379183,0.00014568208],"domain_scores_gemma":[0.99970603,0.000009195872,0.000032141368,0.0001478947,0.00004488045,0.000059861675],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000023624481,0.00007595457,0.00009159497,0.000025904916,0.00004306802,0.00002444653,0.00005044306,0.00015139996,0.00003368577],"category_scores_gemma":[0.000044196146,0.00007095741,0.00001996977,0.000027148308,0.000053622512,0.000004817184,0.00004943396,0.000042645846,0.00008018314],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000012580251,0.000016609629,0.010775956,0.000019617191,0.000022176364,0.000019901663,0.00005281423,0.0000014799305,0.94369376,0.0021694228,0.03278489,0.010430767],"study_design_scores_gemma":[0.001167566,0.00015040327,0.051720686,0.000007907684,0.000017700175,0.003465959,0.00012269976,0.00066433934,0.77408,0.0013569064,0.16688934,0.00035649043],"about_ca_topic_score_codex":0.000015163058,"about_ca_topic_score_gemma":0.000005171047,"teacher_disagreement_score":0.16961378,"about_ca_system_score_codex":0.0000021116973,"about_ca_system_score_gemma":0.000014594171,"threshold_uncertainty_score":0.28935593},"labels":[],"label_agreement":null},{"id":"W2060163314","doi":"10.1074/jbc.m000312200","title":"Stress-induced Activation of Protein Kinase CK2 by Direct Interaction with p38 Mitogen-activated Protein Kinase","year":2000,"lang":"en","type":"article","venue":"Journal of Biological Chemistry","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":144,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Mitogen-activated protein kinase kinase; ASK1; Protein kinase A; Protein kinase R; MAP kinase kinase kinase; MAP2K7; Cyclin-dependent kinase 9; Cyclin-dependent kinase 2; c-Raf; p38 mitogen-activated protein kinases; Cell biology; Chemistry; Mitogen-activated protein kinase; Kinase; Biology","score_opus":0.015578738641299661,"score_gpt":0.23696449889511084,"score_spread":0.22138576025381118,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2060163314","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980517,0.00018491397,0.00005568125,0.00007158995,0.000032116764,0.00022464956,0.000039842285,0.000009868124,0.0013296253],"genre_scores_gemma":[0.99868965,0.000043816333,0.00022721915,0.000025157316,0.00025315754,0.000021632843,0.00012554442,0.000015373906,0.0005984597],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987981,0.00008436011,0.00044554807,0.00026947097,0.00019042088,0.00021215684],"domain_scores_gemma":[0.99893767,0.000015782569,0.0005046502,0.00021678925,0.00019150456,0.0001335996],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015579557,0.00022007948,0.0003041465,0.000022912041,0.00004892085,0.000017706025,0.00020455982,0.00032051717,0.00029587944],"category_scores_gemma":[0.00015607556,0.00014988269,0.00013497825,0.00010976264,0.000076307035,0.000015830303,0.00003084569,0.00027510678,0.0000020277294],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001959599,0.0003186431,0.00034736953,0.000056560722,0.00008525968,0.000015927495,0.000016190636,0.0000109648345,0.9915126,6.9125934e-7,0.00024306466,0.005433137],"study_design_scores_gemma":[0.0009044541,0.0013765334,0.00026316376,0.00018624001,0.000015021142,0.000043753316,0.000069703296,0.000004046912,0.9912989,0.000010009451,0.005635511,0.00019264076],"about_ca_topic_score_codex":0.00001231757,"about_ca_topic_score_gemma":6.912202e-7,"teacher_disagreement_score":0.0053924466,"about_ca_system_score_codex":0.000036004072,"about_ca_system_score_gemma":0.000087302134,"threshold_uncertainty_score":0.61120385},"labels":[],"label_agreement":null},{"id":"W2061091085","doi":"10.1371/journal.pone.0057185","title":"GADD45α Induction by Nickel Negatively Regulates JNKs/p38 Activation via Promoting PP2Cα Expression","year":2013,"lang":"en","type":"article","venue":"PLoS ONE","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institute of Environmental Health Sciences; National Cancer Institute; National Institutes of Health; Queen's University; National Natural Science Foundation of China","keywords":"Gadd45; p38 mitogen-activated protein kinases; Cell biology; Ectopic expression; Downregulation and upregulation; DNA damage; MAPK/ERK pathway; Phosphorylation; Biology; Chemistry; Cell culture; Cell; Gene; Biochemistry; Cell cycle; Genetics; Cell cycle checkpoint; DNA","score_opus":0.02141665828696358,"score_gpt":0.20177932232774276,"score_spread":0.1803626640407792,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2061091085","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975184,0.00009371927,0.0007687094,0.00023875546,0.00004011028,0.00040489915,0.0000062132062,0.00003376353,0.0008954318],"genre_scores_gemma":[0.9953878,0.000027275852,0.0022016189,0.000088489265,0.00022567192,0.00011138352,0.000297613,0.000025821631,0.0016343417],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990457,0.00006157809,0.00018329006,0.00032608854,0.00017455872,0.00020875949],"domain_scores_gemma":[0.9994059,0.000009897937,0.0001371254,0.00024381667,0.00012532281,0.00007788778],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000083585925,0.00014291715,0.00013065219,0.000031524225,0.00011791122,0.000032861335,0.00010742654,0.00018825228,0.000100342244],"category_scores_gemma":[0.000105325795,0.00013170647,0.000035966703,0.00006755164,0.000037074322,0.000023852865,0.00007387306,0.00010786908,0.00006668962],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000018176295,0.0003349501,0.00041310122,0.00003858083,0.000041825966,1.7330377e-7,0.00010262973,5.875333e-7,0.9932884,0.000005375195,0.0028670186,0.0028891726],"study_design_scores_gemma":[0.00028126774,0.0002319615,0.00225792,0.00009453309,0.000015071512,0.0000015705901,0.000049376806,0.00014956544,0.99608827,0.00023837137,0.0004253756,0.00016670213],"about_ca_topic_score_codex":0.00003605539,"about_ca_topic_score_gemma":0.0000012332074,"teacher_disagreement_score":0.0027998756,"about_ca_system_score_codex":0.000016536376,"about_ca_system_score_gemma":0.000020439924,"threshold_uncertainty_score":0.53708345},"labels":[],"label_agreement":null},{"id":"W2061339803","doi":"10.1007/s10555-013-9433-9","title":"Targeting MAPK pathway in melanoma therapy","year":2013,"lang":"en","type":"review","venue":"Cancer and Metastasis Reviews","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":96,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Coastal Health Research Institute; University of British Columbia; Vancouver Coastal Health","funders":"Canadian Institutes of Health Research","keywords":"Vemurafenib; Melanoma; MAPK/ERK pathway; Medicine; Dabrafenib; Targeted therapy; Cancer research; Trametinib; Pharmacology; Drug resistance; Metastatic melanoma; Kinase; Cancer; Internal medicine; Biology","score_opus":0.0835042255553753,"score_gpt":0.34484216514126104,"score_spread":0.26133793958588575,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2061339803","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000098182434,0.9969055,0.000028898348,0.000010877435,0.00035229468,0.0018142001,0.00012707109,0.000008579919,0.0006543942],"genre_scores_gemma":[0.0000070744245,0.99542886,0.00046172398,0.00016840815,0.0005175107,0.0019444618,0.0004475621,0.0000702931,0.00095413043],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9974028,0.00039971154,0.00091089215,0.00076137984,0.0001065913,0.0004186583],"domain_scores_gemma":[0.9988362,0.000020610109,0.00043330365,0.0005160616,0.000038450806,0.00015534769],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00063139794,0.0006043468,0.0020835847,0.00008979727,0.000058989073,0.000047594218,0.00030796416,0.00033450598,0.000251957],"category_scores_gemma":[0.00007151652,0.00040886807,0.0004988005,0.00019131042,0.000054177486,0.0000066252296,0.00014190275,0.00025828675,0.00007116477],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000034286757,0.000022104503,0.000007259642,0.004411196,0.000087693166,0.0000044276853,0.000013644116,7.9053905e-8,0.00051654794,0.00003604796,0.0064673885,0.9884302],"study_design_scores_gemma":[0.0002437115,0.00008835904,0.000002420595,0.002319994,0.000105601786,0.000013721887,0.0000056235813,3.1745301e-7,0.00040739842,0.000007901323,0.9963443,0.00046064024],"about_ca_topic_score_codex":0.000043076387,"about_ca_topic_score_gemma":0.000017650857,"teacher_disagreement_score":0.9898769,"about_ca_system_score_codex":0.000032636548,"about_ca_system_score_gemma":0.00022347562,"threshold_uncertainty_score":0.9998363},"labels":[],"label_agreement":null},{"id":"W2064854415","doi":"10.1042/bj20110289","title":"Regulation and function of the RSK family of protein kinases","year":2011,"lang":"en","type":"review","venue":"Biochemical Journal","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":376,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Institute for Research in Immunology and Cancer","funders":"","keywords":"Biology; Gene isoform; Kinase; Effector; Cell biology; Ribosomal s6 kinase; Caenorhabditis elegans; Function (biology); Signal transduction; MAPK/ERK pathway; SH3 domain; Genetics; Receptor tyrosine kinase; Gene; PI3K/AKT/mTOR pathway; P70-S6 Kinase 1","score_opus":0.033976305682259504,"score_gpt":0.25459849156119935,"score_spread":0.22062218587893984,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2064854415","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.02897961,0.97022676,0.0001029644,0.0000032046933,0.00014047115,0.0002291566,0.000025174366,0.0000015506006,0.0002910847],"genre_scores_gemma":[0.015477793,0.9837239,0.00017959446,0.000008366004,0.00033797897,0.000009949388,0.00004194307,0.000018687804,0.00020181849],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99913204,0.00009224188,0.00040738864,0.00015784221,0.00010905683,0.00010140853],"domain_scores_gemma":[0.9990866,0.000007000717,0.0005344052,0.00022995692,0.00008893035,0.000053070882],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015199053,0.00015457736,0.0003762385,0.00003550195,0.0000332092,0.0000062649224,0.00017511353,0.00031031627,0.000010674781],"category_scores_gemma":[0.00007699337,0.00009410482,0.00027354615,0.00006319056,0.000112533584,0.0000017932726,0.00010442925,0.00016041675,7.1710605e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000043255102,0.000044320397,0.000012518504,0.0020500286,0.00010222553,4.2709956e-7,0.000005178823,2.5291914e-8,0.6870347,0.00014193717,0.0014489064,0.30911642],"study_design_scores_gemma":[0.00019129604,0.0002649447,0.00018453247,0.002968905,0.00030454574,0.000118610966,0.0000065818126,2.0357083e-7,0.17662238,0.0002024881,0.81897813,0.00015736661],"about_ca_topic_score_codex":0.0000028196355,"about_ca_topic_score_gemma":2.3994278e-7,"teacher_disagreement_score":0.81752926,"about_ca_system_score_codex":0.0000074564,"about_ca_system_score_gemma":0.00014776339,"threshold_uncertainty_score":0.38374832},"labels":[],"label_agreement":null},{"id":"W2065973638","doi":"10.1038/modpathol.3800206","title":"Ets-1 transcription factor is widely expressed in benign and malignant melanocytes and its expression has no significant association with prognosis","year":2004,"lang":"en","type":"article","venue":"Modern Pathology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan; Royal University Hospital","funders":"","keywords":"Immunohistochemistry; Melanoma; Medicine; Pathology; Breslow Thickness; Correlation; Exact test; Mann–Whitney U test; Spearman's rank correlation coefficient; Oncology; Internal medicine; Cancer; Cancer research","score_opus":0.02021665198394415,"score_gpt":0.21697667410773983,"score_spread":0.19676002212379567,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2065973638","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949652,0.00081481604,0.0032938868,0.0003493608,0.000054013577,0.00033545034,0.000089801586,0.000016520531,0.00008094189],"genre_scores_gemma":[0.9983127,0.00030525995,0.0008631726,0.00018009963,0.000046527428,0.00008861461,0.000065085595,0.000022156652,0.000116392766],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987872,0.00009307908,0.00020001469,0.00052330864,0.00012357977,0.00027277973],"domain_scores_gemma":[0.99958885,0.000012791783,0.00010365385,0.00014897244,0.000071500624,0.00007421396],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014657054,0.00018542688,0.00021284587,0.00005743724,0.000077263336,0.000031004587,0.00007014703,0.0002987073,0.0000071684785],"category_scores_gemma":[0.00004099215,0.00015332233,0.000029134178,0.000037752357,0.00004529921,0.0000140250895,0.00003935322,0.000102695914,0.0000032204723],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001747615,0.00007679059,0.013502046,0.000034258872,0.000013534263,0.00003563706,0.0012358627,0.000028100796,0.98433214,0.000032403274,0.000034658548,0.000499819],"study_design_scores_gemma":[0.0016885909,0.00071036594,0.016502855,0.00005081664,0.000018885476,0.000028495364,0.000052679938,0.00015735437,0.9796868,0.00031135345,0.0005677595,0.00022404919],"about_ca_topic_score_codex":0.000020771746,"about_ca_topic_score_gemma":0.00004988843,"teacher_disagreement_score":0.0046453336,"about_ca_system_score_codex":0.000028318345,"about_ca_system_score_gemma":0.00005253729,"threshold_uncertainty_score":0.62523025},"labels":[],"label_agreement":null},{"id":"W2066436694","doi":"10.1016/s1056-8719(00)00118-0","title":"Simultaneous measurement of ERK, p38, and JNK MAP kinase cascades in vascular smooth muscle cells","year":2000,"lang":"en","type":"article","venue":"Journal of Pharmacological and Toxicological Methods","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Heart Institute; Université de Montréal","funders":"Canadian Institutes of Health Research","keywords":"Kinase; Mitogen-activated protein kinase; Mitogen-activated protein kinase kinase; MAP2K7; MAPK14; p38 mitogen-activated protein kinases; Chemistry; Protein kinase C; MAP kinase kinase kinase; Protein kinase A; Cyclin-dependent kinase 9; Molecular biology; MAPK/ERK pathway; cGMP-dependent protein kinase; Cyclin-dependent kinase 2; Mitogen-Activated Protein Kinase 3; Phosphorylation; Cell biology; Biochemistry; Biology","score_opus":0.03474266798551937,"score_gpt":0.3323664458268894,"score_spread":0.29762377784137,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2066436694","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9922222,0.005392797,0.0015087702,0.00016834695,0.00015381984,0.00019553429,0.0000063157227,0.000004418112,0.00034778917],"genre_scores_gemma":[0.9709233,0.0029466425,0.025502207,0.0003889051,0.00017929278,0.0000072127373,9.015622e-7,0.000007746003,0.000043765547],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978243,0.0008197376,0.0005670778,0.0002796664,0.00023448674,0.00027470622],"domain_scores_gemma":[0.99912405,0.00023114026,0.00019516925,0.00008868633,0.00011681011,0.00024415273],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019661463,0.00019676484,0.00047533185,0.00005860104,0.000050550636,0.0000157827,0.0001747483,0.00028264907,0.0004026444],"category_scores_gemma":[0.00033301665,0.00012742745,0.00015320201,0.00009103137,0.00020167763,0.000007733708,0.00009433727,0.0003045514,0.0000012261677],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036590794,0.00043099615,0.00017109282,0.000028599221,0.00006225126,0.00017199432,0.000027534787,0.0002230251,0.8725597,0.000019188305,0.000117325115,0.12582234],"study_design_scores_gemma":[0.0037326482,0.006557072,0.018336391,0.00005052558,0.00024717604,0.00006972976,0.0000879059,0.0005665208,0.87630135,0.0011248593,0.09252465,0.0004011492],"about_ca_topic_score_codex":0.0000036201182,"about_ca_topic_score_gemma":0.000002295784,"teacher_disagreement_score":0.1254212,"about_ca_system_score_codex":0.000021651258,"about_ca_system_score_gemma":0.00004062986,"threshold_uncertainty_score":0.51963407},"labels":[],"label_agreement":null},{"id":"W2068645642","doi":"10.1016/s0960-894x(01)00238-4","title":"MEK (MAPKK) inhibitors. Part 2: structure–activity relationships of 4-anilino-3-cyano-6,7-dialkoxyquinolines","year":2001,"lang":"en","type":"article","venue":"Bioorganic & Medicinal Chemistry Letters","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's Health Research Institute","funders":"","keywords":"Chemistry; Linker; Kinase; Structure–activity relationship; Stereochemistry; Methylene; Aniline; Enzyme inhibitor; Protein kinase A; Enzyme; Biochemistry; In vitro; Medicinal chemistry; Organic chemistry","score_opus":0.016883754146990112,"score_gpt":0.2186558177986337,"score_spread":0.20177206365164357,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2068645642","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962573,0.00055472244,0.00038059754,0.0013246703,0.000465491,0.00016375596,0.000063558124,0.000037778133,0.0007521107],"genre_scores_gemma":[0.9964866,0.00011570487,0.00014743184,0.00040732053,0.0022883269,0.000009074263,0.00025953972,0.00004213688,0.00024388901],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99809194,0.00008664793,0.0004641937,0.00056199345,0.00037865783,0.00041658923],"domain_scores_gemma":[0.9987143,0.000042909942,0.0002890909,0.0006228766,0.00011036976,0.00022040255],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00026143907,0.00033591024,0.0003505658,0.00004248726,0.00013294455,0.000014197878,0.0003316057,0.00034416848,0.00030403538],"category_scores_gemma":[0.00035510157,0.00031549012,0.00014522413,0.00022363041,0.0002660379,0.00001065635,0.000110332236,0.0003438132,0.000011264039],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012804993,0.000060132767,0.009891746,0.000087936016,0.000069913105,0.000027013544,0.00005784758,0.00000603875,0.9825131,0.0000067821125,0.006601883,0.00054954865],"study_design_scores_gemma":[0.00077483495,0.00007853473,0.004404388,0.000054214128,0.00007276494,0.00018394888,0.00008333909,0.000010698454,0.9722164,0.0000251005,0.021780165,0.00031559405],"about_ca_topic_score_codex":0.000033462384,"about_ca_topic_score_gemma":0.000018729483,"teacher_disagreement_score":0.015178282,"about_ca_system_score_codex":0.000042812804,"about_ca_system_score_gemma":0.0001524451,"threshold_uncertainty_score":0.9999297},"labels":[],"label_agreement":null},{"id":"W2070028004","doi":"10.1016/j.jval.2014.03.485","title":"Cost Effectiveness of Trametinib as First-Line (1l) Treatment for Braf V600 Positive Advanced or Metastatic Melanoma — A Canadian Societal Perspective","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"GlaxoSmithKline (Canada)","funders":"","keywords":"Trametinib; Dacarbazine; Vemurafenib; Medicine; Internal medicine; Oncology; Melanoma; Metastatic melanoma; Chemotherapy; Cancer research; Biology","score_opus":0.0471651896086674,"score_gpt":0.34261534361423285,"score_spread":0.29545015400556546,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2070028004","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99304396,0.00064485916,0.002322613,0.00045501455,0.00016245455,0.0023128802,0.0005046987,0.0000077896575,0.00054571475],"genre_scores_gemma":[0.99656427,0.00016047664,0.0023482589,0.00017636461,0.00007155928,0.00032406923,0.00022261332,0.000028754997,0.00010365435],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99841756,0.0003682311,0.0002917186,0.0004169065,0.00008919149,0.0004163854],"domain_scores_gemma":[0.99895996,0.00031404672,0.00013701279,0.00023383033,0.00011780703,0.00023731733],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005976671,0.00020119837,0.00041229266,0.00008249712,0.0001060073,0.000007478056,0.00010665675,0.00009422216,0.000009730421],"category_scores_gemma":[0.0003466972,0.00016774511,0.00013777126,0.00011587237,0.000060441806,0.0000043663013,0.00001595613,0.000060787188,0.0000032528342],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.042015847,0.010133645,0.013061912,0.010305859,0.0043002516,0.00025513236,0.032406937,0.07226029,0.29268682,0.12039375,0.0008062577,0.4013733],"study_design_scores_gemma":[0.048321962,0.14315161,0.030188741,0.001660128,0.00033842644,0.00030229034,0.0068779318,0.010196001,0.7002456,0.01042271,0.046086658,0.0022079009],"about_ca_topic_score_codex":0.104307584,"about_ca_topic_score_gemma":0.05927528,"teacher_disagreement_score":0.40755883,"about_ca_system_score_codex":0.00041802425,"about_ca_system_score_gemma":0.001139958,"threshold_uncertainty_score":0.9578905},"labels":[],"label_agreement":null},{"id":"W2074141001","doi":"10.1016/s0090-8258(02)00144-0","title":"Phase II study of CGP 69846A (ISIS 5132) in recurrent epithelial ovarian cancer: an NCIC clinical trials group study (NCIC IND.116)☆","year":2003,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":75,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; Hamilton Regional Laboratory Medicine Program; Ottawa Regional Cancer Foundation; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Ovarian cancer; Toxicity; Internal medicine; Cancer; Phases of clinical research; Oncology; Gastroenterology; Ovary","score_opus":0.14226297164992605,"score_gpt":0.46476003455572107,"score_spread":0.32249706290579505,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2074141001","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.992545,0.00044141692,0.00006132667,0.00007375734,0.002757684,0.0029385923,0.00008717308,0.000027545615,0.0010674794],"genre_scores_gemma":[0.9977227,0.00028801974,0.00031103592,0.00026155447,0.00047318407,0.00071115355,0.00008400307,0.000032889126,0.00011549464],"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9873453,0.008283091,0.0022348699,0.0011972211,0.0002633047,0.00067623064],"domain_scores_gemma":[0.99704796,0.0007277425,0.0009113695,0.00087352697,0.00016155576,0.0002778376],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.010042926,0.00042761312,0.0017181807,0.00020720108,0.00018763104,0.000015444699,0.00058737205,0.00080535916,0.00046412548],"category_scores_gemma":[0.0052855313,0.00036077475,0.00026708408,0.000329828,0.00018135166,0.000012148512,0.00030159496,0.0005136599,0.000013764506],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0070199673,0.21362042,0.28724322,0.00005535824,0.0010924246,0.0005036649,0.0043967725,0.00008145636,0.09355678,0.0005696456,0.0022132962,0.38964698],"study_design_scores_gemma":[0.10219235,0.64521605,0.14502421,0.000027059988,0.00094014016,0.0000530792,0.018761134,0.00007505985,0.009066974,0.0008235805,0.0763303,0.0014900782],"about_ca_topic_score_codex":0.0003128722,"about_ca_topic_score_gemma":0.010540318,"teacher_disagreement_score":0.4315956,"about_ca_system_score_codex":0.00015659088,"about_ca_system_score_gemma":0.0007462316,"threshold_uncertainty_score":0.9998844},"labels":[],"label_agreement":null},{"id":"W2075525534","doi":"10.1016/s0960-894x(00)00580-1","title":"Synthesis and Structure–Activity Relationships of 3-Cyano-4-(phenoxyanilino)quinolines as MEK (MAPKK) Inhibitors","year":2000,"lang":"en","type":"article","venue":"Bioorganic & Medicinal Chemistry Letters","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":49,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's Health Research Institute","funders":"","keywords":"Chemistry; Kinase; Enzyme inhibitor; Alkoxy group; Mitogen-activated protein kinase; Structure–activity relationship; IC50; Inhibitory postsynaptic potential; Stereochemistry; Mitogen-activated protein kinase kinase; Enzyme; Protein kinase A; Biochemistry; In vitro; Organic chemistry; Endocrinology; Biology","score_opus":0.008896503226833899,"score_gpt":0.20487395553096968,"score_spread":0.19597745230413577,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2075525534","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99723417,0.00059508276,0.00005888413,0.001008319,0.0000980748,0.00012484053,0.00005267918,0.000024322457,0.0008036211],"genre_scores_gemma":[0.99844885,0.0001411659,0.0001682847,0.00029128144,0.0006157053,0.000008227047,0.00006345626,0.000033116976,0.00022990868],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99854213,0.00007645722,0.00032596494,0.0004894659,0.0002709679,0.0002950377],"domain_scores_gemma":[0.99912393,0.00006522524,0.00014919243,0.00042443708,0.000050140152,0.00018705205],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00018998225,0.0002791602,0.0002962045,0.000031021886,0.00012345864,0.000013419484,0.00020984754,0.0002720181,0.0006205191],"category_scores_gemma":[0.00031608023,0.00025834722,0.000082609076,0.00012887338,0.00028667337,0.000008802138,0.00005981235,0.00024012449,0.000009768674],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013178634,0.000034478096,0.0030451328,0.00011277633,0.00006438562,0.000011811637,0.00008458692,0.000002429325,0.99197966,0.0000049347423,0.0009168353,0.0036111786],"study_design_scores_gemma":[0.00042676966,0.000062883555,0.0053610136,0.00005726032,0.000085052394,0.00015916048,0.000093054354,0.0000087733915,0.99025315,0.00003113021,0.0032045215,0.00025721118],"about_ca_topic_score_codex":0.00005265301,"about_ca_topic_score_gemma":0.0000064169517,"teacher_disagreement_score":0.0033539673,"about_ca_system_score_codex":0.000025213441,"about_ca_system_score_gemma":0.00009968766,"threshold_uncertainty_score":0.9999869},"labels":[],"label_agreement":null},{"id":"W2075925391","doi":"10.1016/j.cell.2014.11.053","title":"Pathological Axonal Death through a MAPK Cascade that Triggers a Local Energy Deficit","year":2015,"lang":"en","type":"article","venue":"Cell","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":306,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; University of Ottawa","funders":"National Institute of Neurological Disorders and Stroke","keywords":"MAPK/ERK pathway; Biology; Cell biology; Neuroscience; Axon; Protein kinase A; Signal transduction; Programmed cell death; Autophagy; Kinase; Apoptosis; Genetics","score_opus":0.04483218265073828,"score_gpt":0.24115619216840908,"score_spread":0.19632400951767082,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2075925391","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9083699,0.002160656,0.039203465,0.000051801486,0.00028268434,0.0000837031,0.000024919815,0.000029370343,0.049793478],"genre_scores_gemma":[0.99518865,0.00009965941,0.0010929827,0.00067926827,0.00025141856,0.00002361064,0.00015287385,0.000020316815,0.0024912162],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989093,0.00007333454,0.0001432402,0.00038225626,0.00016291467,0.00032898644],"domain_scores_gemma":[0.999426,0.000010513862,0.000053809752,0.00029052843,0.000043111475,0.00017601751],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011984198,0.00018170709,0.00016791828,0.00001828073,0.000047659865,0.00001807361,0.00019476097,0.0002743475,0.00003840259],"category_scores_gemma":[0.00002147003,0.0001481768,0.000115623916,0.00004640012,0.00008288371,0.000003585565,0.00012413268,0.0000918429,0.00006199744],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006030869,0.00046319683,0.0028352742,0.00004724181,0.00006610823,0.0005814665,0.00042806688,0.00019199635,0.9309074,0.004873037,0.054687146,0.0043159267],"study_design_scores_gemma":[0.0009129616,0.0004747213,0.00015946546,0.0000035537767,0.000018166662,0.00013069267,0.00024796225,0.000058218386,0.71833545,0.0006071871,0.2788083,0.00024333515],"about_ca_topic_score_codex":0.00007308415,"about_ca_topic_score_gemma":0.000015950458,"teacher_disagreement_score":0.22412115,"about_ca_system_score_codex":0.000021647793,"about_ca_system_score_gemma":0.00011386394,"threshold_uncertainty_score":0.6042474},"labels":[],"label_agreement":null},{"id":"W2076242481","doi":"10.1073/pnas.0709705105","title":"CNK and HYP form a discrete dimer by their SAM domains to mediate RAF kinase signaling","year":2008,"lang":"en","type":"article","venue":"Proceedings of the National Academy of Sciences","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Research in Immunology and Cancer; Université de Montréal; Lunenfeld-Tanenbaum Research Institute; University of Toronto","funders":"Argonne National Laboratory; National Cancer Institute; University of Toronto; Cancer Research Society","keywords":"Kinase; MAPK/ERK pathway; Cell biology; Protein kinase A; Protein kinase domain; Signal transduction; Chemistry; Dimer; Biology; Biochemistry; Gene","score_opus":0.02543315918479728,"score_gpt":0.2641857467895435,"score_spread":0.2387525876047462,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2076242481","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99688005,0.0003696269,0.0000074541417,0.0009651939,0.00001324192,0.00012333054,0.00004654039,0.000003262235,0.001591304],"genre_scores_gemma":[0.9983794,0.000107643464,0.0008251764,0.00043448847,0.00008427073,0.000010097782,0.0000010319663,0.0000038005905,0.00015409633],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991001,0.0000037954112,0.000168654,0.00021577526,0.0003753301,0.00013634269],"domain_scores_gemma":[0.9996746,0.000024263813,0.00014009024,0.00000856971,0.00009429635,0.000058142203],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045807284,0.00008450259,0.00009993002,0.000047942493,0.00018653394,0.000009382353,0.000348284,0.00007028218,0.0000031394316],"category_scores_gemma":[0.00020645434,0.00005258594,0.000046521105,0.00017906088,0.00042877303,0.000018845678,0.00016192712,0.000059768605,3.879426e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000017126224,0.000012105101,0.0021387206,0.000012573,0.000009821305,6.2005614e-9,0.00017535119,0.000004739452,0.9947464,0.0011128735,0.001610291,0.0001599999],"study_design_scores_gemma":[0.00016105425,0.0001043627,0.00510889,0.000020130012,0.0000056977606,0.000011469047,0.000098420074,0.00004571057,0.9879941,0.003479236,0.0028912774,0.00007969303],"about_ca_topic_score_codex":0.0000030882836,"about_ca_topic_score_gemma":8.543504e-8,"teacher_disagreement_score":0.006752333,"about_ca_system_score_codex":0.0000050548742,"about_ca_system_score_gemma":0.000022389693,"threshold_uncertainty_score":0.21443924},"labels":[],"label_agreement":null},{"id":"W2076869933","doi":"10.1007/s40273-014-0241-z","title":"Cost Effectiveness of Dabrafenib as a First-Line Treatment in Patients with BRAF V600 Mutation-Positive Unresectable or Metastatic Melanoma in Canada","year":2014,"lang":"en","type":"article","venue":"PharmacoEconomics","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"GlaxoSmithKline (Canada)","funders":"GlaxoSmithKline; Eli Lilly and Company","keywords":"Dabrafenib; Dacarbazine; Vemurafenib; Medicine; Oncology; Progression-free survival; Internal medicine; Hazard ratio; Metastatic melanoma; Melanoma; Cancer research; Overall survival; Confidence interval","score_opus":0.013149909881605824,"score_gpt":0.26533107913349996,"score_spread":0.25218116925189416,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2076869933","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983977,0.000042784257,0.00019804917,0.000016728303,0.00009024542,0.00074476673,0.0001715477,0.0000022210318,0.0003359725],"genre_scores_gemma":[0.9991285,0.000030330992,0.00010601298,0.00008779281,0.00002196094,0.00013498022,0.00043126763,0.000020693455,0.000038431204],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990448,0.00014486517,0.00025342725,0.00028319366,0.00005729895,0.00021644999],"domain_scores_gemma":[0.99946016,0.00014685391,0.00011620841,0.0001559353,0.000043757344,0.00007708512],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015052472,0.00017191957,0.00028513774,0.00006078335,0.000024981937,0.000007749091,0.00010433903,0.000030801777,0.000038792354],"category_scores_gemma":[0.000030331457,0.00014140473,0.000028501992,0.00007033153,0.000023226137,0.000009845975,0.000030727482,0.000047880196,0.000003410025],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010847455,0.0012585095,0.9268394,0.0003097542,0.0004907878,0.00007300181,0.00028797376,0.031865355,0.015161846,0.00014378567,0.000057513516,0.0126646],"study_design_scores_gemma":[0.023856942,0.0031506517,0.2757384,0.00008657194,0.00008742387,0.000010112439,0.00007840418,0.002462333,0.69260895,0.000053214,0.0013961581,0.00047082288],"about_ca_topic_score_codex":0.20100187,"about_ca_topic_score_gemma":0.6659194,"teacher_disagreement_score":0.67744714,"about_ca_system_score_codex":0.00031022375,"about_ca_system_score_gemma":0.0006677825,"threshold_uncertainty_score":0.8043187},"labels":[],"label_agreement":null},{"id":"W2077996667","doi":"10.1177/1087057113497401","title":"Perspective on the Discovery and Scientific Impact of p38 MAP Kinase","year":2013,"lang":"en","type":"review","venue":"SLAS DISCOVERY","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":34,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Resverlogix (Canada)","funders":"","keywords":"Drug discovery; Computational biology; Perspective (graphical); p38 mitogen-activated protein kinases; Mitogen-activated protein kinase; Data science; Field (mathematics); Biology; Computer science; Kinase; Bioinformatics; Protein kinase A; Cell biology; Artificial intelligence","score_opus":0.030433995127690034,"score_gpt":0.3169229605518093,"score_spread":0.2864889654241193,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2077996667","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.02585263,0.9703882,0.000031735246,0.000020427111,0.00046123445,0.0007425342,0.0006370277,0.0000052753653,0.001860953],"genre_scores_gemma":[0.015021655,0.9706657,0.000013161632,0.000020442929,0.00037361874,0.000107438784,0.000393795,0.000059073,0.013345151],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9983629,0.00016827938,0.00031050647,0.00066124473,0.00019647084,0.00030058992],"domain_scores_gemma":[0.9986135,0.00007530796,0.0002886223,0.0008743606,0.000073116724,0.000075129436],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022710099,0.0004240177,0.00068910024,0.000099131845,0.00012793527,0.00029893185,0.00036574175,0.00025381436,0.00003481784],"category_scores_gemma":[0.00012262061,0.00022898352,0.000721146,0.00012802378,0.00040739143,0.000021404156,0.00027840852,0.00021385675,0.000049495262],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00056263746,0.002287568,0.00044999033,0.028990442,0.008537302,0.00013011444,0.0011917505,0.000022741837,0.048918597,0.22661592,0.29867715,0.38361576],"study_design_scores_gemma":[0.0003178253,0.0011485555,0.000099469624,0.003140652,0.000495536,0.000039277973,0.0002968596,0.000002061778,0.002210135,0.0009996892,0.99046105,0.0007888777],"about_ca_topic_score_codex":0.00010649193,"about_ca_topic_score_gemma":0.000015909849,"teacher_disagreement_score":0.6917839,"about_ca_system_score_codex":0.00008122862,"about_ca_system_score_gemma":0.0005268068,"threshold_uncertainty_score":0.93376774},"labels":[],"label_agreement":null},{"id":"W2078902726","doi":"10.1038/nchembio.1629","title":"A unique inhibitor binding site in ERK1/2 is associated with slow binding kinetics","year":2014,"lang":"en","type":"article","venue":"Nature Chemical Biology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":248,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Institutes of Health Research; Cancer Research UK; Wellcome Trust","keywords":"Binding site; Receptor–ligand kinetics; Kinase; Kinetics; Chemistry; Plasma protein binding; Biophysics; MAPK/ERK pathway; Pyrimidine; Biochemistry; Stereochemistry; Biology; Receptor","score_opus":0.005112793602613707,"score_gpt":0.2249571127614532,"score_spread":0.21984431915883948,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2078902726","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973823,0.00026370416,0.00012644235,0.00025755147,0.00017404412,0.00014726877,0.00009066055,0.000028035132,0.0015299842],"genre_scores_gemma":[0.9965953,0.000029607425,0.0006051656,0.0009071662,0.00031163756,0.000018070512,0.0012469522,0.000029652487,0.00025643394],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99859244,0.000098598655,0.00023436427,0.00054019195,0.00009021656,0.00044417786],"domain_scores_gemma":[0.999345,0.00007025028,0.00011409602,0.00028351994,0.00007645882,0.000110652574],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0002157856,0.00024297385,0.0002929147,0.00009470011,0.000034358614,0.0000138511505,0.00022091564,0.0014365884,0.00002051032],"category_scores_gemma":[0.0005192907,0.00019677983,0.000071702896,0.00023674435,0.00011619924,0.0000030590588,0.00013124206,0.0006124372,0.000020196716],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000078048244,0.00006638663,0.011394652,0.000010151132,0.00003088932,0.0000060349853,0.000026226977,5.389735e-7,0.98513734,0.00015544631,0.0026220777,0.00047219556],"study_design_scores_gemma":[0.0009849912,0.00042578072,0.00049017364,0.000050757262,0.000014097752,0.000018654793,0.000007286272,0.000029961562,0.9606875,0.000089646666,0.036906797,0.00029432558],"about_ca_topic_score_codex":0.000005482575,"about_ca_topic_score_gemma":0.000026595168,"teacher_disagreement_score":0.03428472,"about_ca_system_score_codex":0.000045310437,"about_ca_system_score_gemma":0.00003860605,"threshold_uncertainty_score":0.99985975},"labels":[],"label_agreement":null},{"id":"W2079421845","doi":"10.1371/journal.pone.0029336","title":"Intra- and Inter-Tumor Heterogeneity of BRAFV600EMutations in Primary and Metastatic Melanoma","year":2012,"lang":"en","type":"article","venue":"PLoS ONE","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":286,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; National Institute of Arthritis and Musculoskeletal and Skin Diseases; York University; U.S. Department of Veterans Affairs","keywords":"Tumor heterogeneity; Metastatic melanoma; Melanoma; Primary (astronomy); Primary tumor; Medicine; Cancer research; Oncology; Metastasis; Biology; Pathology; Internal medicine; Cancer","score_opus":0.029787512688763756,"score_gpt":0.23192001735446996,"score_spread":0.2021325046657062,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2079421845","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977828,0.001376788,0.00015957403,0.00003385431,0.000015383235,0.00013241965,0.000024079118,0.000003434306,0.00047167047],"genre_scores_gemma":[0.9970169,0.00008323684,0.002663048,0.00010374771,0.0000350679,0.000017051205,0.00004014112,0.000008356621,0.000032424392],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99949896,0.00004367841,0.00014509089,0.00012350729,0.000057272817,0.00013149038],"domain_scores_gemma":[0.9997333,0.000015299454,0.000047762616,0.00011808638,0.000019812787,0.00006573637],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011721146,0.0000743036,0.00014792288,0.000038427293,0.000016955288,0.0000052037653,0.000040391908,0.000030077237,0.000006256132],"category_scores_gemma":[0.000048159396,0.0000706585,0.000015611224,0.000034524393,0.00006006102,0.000006470275,0.00007124167,0.000040412517,0.0000015323202],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000028847693,0.0004166025,0.13917342,0.00016106345,0.00008479602,0.0000016074246,0.00012806253,1.5046555e-7,0.859197,0.0000854702,0.000016310732,0.00070665404],"study_design_scores_gemma":[0.00055285305,0.00027580178,0.15687512,0.000044404173,0.00007098123,0.000018154431,0.00005857071,0.000024619123,0.8417921,0.00007166915,0.0000929853,0.00012272283],"about_ca_topic_score_codex":0.000008684834,"about_ca_topic_score_gemma":0.00002563352,"teacher_disagreement_score":0.017701708,"about_ca_system_score_codex":0.0000047193903,"about_ca_system_score_gemma":0.0000150452925,"threshold_uncertainty_score":0.288137},"labels":[],"label_agreement":null},{"id":"W2080087856","doi":"10.1016/j.bbrc.2008.05.135","title":"Major contribution of MEK1 to the activation of ERK1/ERK2 and to the growth of LS174T colon carcinoma cells","year":2008,"lang":"en","type":"article","venue":"Biochemical and Biophysical Research Communications","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute of Cancer Research; Institut National Du Cancer; Canceropôle PACA; Centre National de la Recherche Scientifique","keywords":"Cell growth; Activator (genetics); MAPK/ERK pathway; In vivo; Small hairpin RNA; Gene isoform; Cell biology; Cancer research; Biology; Kinase; Chemistry; Cell culture; Gene knockdown; Biochemistry; Gene; Genetics","score_opus":0.04567662822636049,"score_gpt":0.31434466776609543,"score_spread":0.26866803953973495,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2080087856","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939574,0.0003243623,0.00016440751,0.0049324664,0.0000080473865,0.00039347666,0.00008103973,0.0000019485663,0.00013687136],"genre_scores_gemma":[0.99902314,0.0003193405,0.00038495535,0.00006429909,0.000049914164,0.000050493527,0.00005921209,0.0000049682367,0.000043648357],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990864,0.0001839317,0.00019391748,0.00016030979,0.00022238123,0.00015308365],"domain_scores_gemma":[0.99848217,0.00023360888,0.00005795011,0.0006535551,0.00047890306,0.00009379462],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035380974,0.00007292408,0.0001371966,0.00003850485,0.00018479483,0.0000055909727,0.00048439557,0.00007851942,0.0000012041647],"category_scores_gemma":[0.00042849142,0.000044903845,0.00004566766,0.00028226606,0.00061770144,0.0000034963218,0.0005544126,0.00013280705,0.000001785504],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012497357,0.0002474423,0.00028926917,0.000019870206,0.000015520045,6.686317e-8,0.00014418513,1.5555472e-7,0.99420494,0.0024207176,0.0022371549,0.0002957227],"study_design_scores_gemma":[0.0003064427,0.00043348715,0.007964466,0.00001846475,0.00000899744,0.0000015101674,0.0000691872,0.000041259864,0.98738086,0.00013079893,0.0035941708,0.000050359184],"about_ca_topic_score_codex":0.00019677245,"about_ca_topic_score_gemma":0.000017136575,"teacher_disagreement_score":0.007675196,"about_ca_system_score_codex":0.000008488707,"about_ca_system_score_gemma":0.00006382581,"threshold_uncertainty_score":0.22759467},"labels":[],"label_agreement":null},{"id":"W2081113836","doi":"10.1038/sj.onc.1207422","title":"p38 MAP kinase signaling is necessary for rat chondrosarcoma cell proliferation","year":2004,"lang":"en","type":"article","venue":"Oncogene","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":53,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Shriners Hospitals for Children - Canada; Canadian Institutes of Health Research; Western University","funders":"","keywords":"Biology; Cell cycle; Cancer research; Cyclin-dependent kinase; Cell growth; Cell biology; Cyclin; Cyclin E; Mitogen-activated protein kinase; Cyclin A; Kinase; Cyclin-dependent kinase 2; Protein kinase A; Cell; Biochemistry","score_opus":0.012647482756312597,"score_gpt":0.2419429090879394,"score_spread":0.2292954263316268,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2081113836","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9766836,0.0012620722,0.019296532,0.00046452213,0.00035440797,0.00046492694,0.0000706586,0.000020816417,0.001382448],"genre_scores_gemma":[0.9892241,0.000037963586,0.006258328,0.00091914803,0.0007237257,0.00009284349,0.00045691637,0.000030343665,0.002256636],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991567,0.000018259303,0.00017205015,0.00032442503,0.00009557191,0.00023298476],"domain_scores_gemma":[0.9995157,0.0000049112477,0.00006266551,0.00025475785,0.000073178155,0.00008877133],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010019534,0.00014728626,0.00012009137,0.000029216018,0.00011452269,0.000029399747,0.00012815982,0.00014749431,0.000030246048],"category_scores_gemma":[0.0000139221565,0.00014331096,0.00010189685,0.000046245837,0.000026037362,0.0000049852943,0.000043198223,0.00004613658,0.00003633892],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007937152,0.00009177796,0.00020911379,0.00005210332,0.000012191081,0.0000063626194,0.0000533293,0.00010303628,0.99394953,0.00010456717,0.004427619,0.0009110179],"study_design_scores_gemma":[0.0013253769,0.00040397135,0.000011482368,0.000011108147,0.000018050669,0.000009096556,0.00003902792,0.000026970545,0.9313575,0.00038253306,0.066236384,0.00017852164],"about_ca_topic_score_codex":0.000009587118,"about_ca_topic_score_gemma":0.000014237696,"teacher_disagreement_score":0.06259204,"about_ca_system_score_codex":0.000016111515,"about_ca_system_score_gemma":0.00013107921,"threshold_uncertainty_score":0.5844051},"labels":[],"label_agreement":null},{"id":"W2082339380","doi":"10.1038/480329a","title":"A drug-resistant duo","year":2011,"lang":"en","type":"letter","venue":"Nature","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Institute for Research in Immunology and Cancer","funders":"","keywords":"Vemurafenib; Acquired resistance; Drug resistance; Cancer research; Melanoma; Drug; Medicine; Kinase; Mutant; Pharmacology; Metastatic melanoma; Biology; Genetics; Gene","score_opus":0.006980386219293363,"score_gpt":0.2142752218983333,"score_spread":0.20729483567903995,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2082339380","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.030505951,0.045077667,0.0001450927,0.5882227,0.010108712,0.0014821439,0.001680269,0.00021941827,0.32255805],"genre_scores_gemma":[0.016087744,0.00018072381,0.0004036899,0.88949484,0.012055787,0.00004200522,0.0034676827,0.000108165994,0.07815936],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99874514,0.000071760674,0.00015035206,0.0005102077,0.0001921969,0.00033033607],"domain_scores_gemma":[0.9990947,0.0000068813197,0.00010217559,0.00066398986,0.000081600214,0.00005063034],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.00009537572,0.00029333285,0.00021909887,0.00005097782,0.000050807943,0.000019713694,0.00041622587,0.0072105858,0.00014682476],"category_scores_gemma":[0.000040598934,0.0002502639,0.00019535373,0.000046655372,0.000044024382,9.534566e-7,0.00012516667,0.0037617534,0.000077518634],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000021090354,0.000009922372,0.000016316366,0.000067541645,0.00005722845,0.00020649393,0.0000137703355,2.0261803e-8,0.033523332,0.000043019412,0.9657815,0.00025974918],"study_design_scores_gemma":[0.0001673983,0.000078391866,0.000055977875,0.000026006634,0.00003406237,0.000025921472,0.0000031683162,1.3193318e-7,0.037081957,0.00013382288,0.96208346,0.00030968527],"about_ca_topic_score_codex":0.000012372842,"about_ca_topic_score_gemma":0.000030788247,"teacher_disagreement_score":0.30127212,"about_ca_system_score_codex":0.000010869699,"about_ca_system_score_gemma":0.000104753475,"threshold_uncertainty_score":0.99999493},"labels":[],"label_agreement":null},{"id":"W2082700617","doi":"10.1016/j.clinbiochem.2008.03.011","title":"Prognostic significance of BP1 mRNA expression level in patients with non-small cell lung cancer","year":2008,"lang":"en","type":"article","venue":"Clinical Biochemistry","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Genomics; University of Ottawa","funders":"University of Ottawa","keywords":"Lung cancer; Messenger RNA; Medicine; Cancer; Oncology; Expression (computer science); Internal medicine; Clinical significance; Biology; Cancer research; Genetics; Gene; Computer science","score_opus":0.0259217992379839,"score_gpt":0.2769537409259857,"score_spread":0.2510319416880018,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2082700617","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998169,0.0003811603,0.00024360574,0.000012169388,0.00010968916,0.00032232833,0.00008613302,0.0000070061656,0.00066890457],"genre_scores_gemma":[0.99757606,0.0001323576,0.0012291959,0.00007024504,0.00017479091,0.000063024636,0.00015418052,0.000022851107,0.00057728926],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985234,0.000040687202,0.00048812825,0.0005323082,0.00015571188,0.00025974997],"domain_scores_gemma":[0.9989977,0.000052044536,0.00023026776,0.00044738254,0.00013442,0.00013817668],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013993056,0.00019146205,0.00027656482,0.000017678973,0.000039010858,0.0000039396155,0.00025733048,0.00030955527,0.000021517902],"category_scores_gemma":[0.00016672486,0.00015937057,0.000097102486,0.000088497225,0.00018743913,0.0000028592895,0.00011069759,0.00019317042,0.000002461248],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001992666,0.0003508841,0.6018124,0.00010983051,0.000010967421,0.0000063484313,0.000011603907,0.000008079985,0.39625853,1.06508246e-7,0.0010588701,0.00017310755],"study_design_scores_gemma":[0.0016830043,0.0002508575,0.27315515,0.00011202218,0.000014918023,8.664424e-7,0.000009859704,0.000010759272,0.7244196,0.0000011415152,0.00016194176,0.00017985256],"about_ca_topic_score_codex":0.000017299895,"about_ca_topic_score_gemma":0.0000052065357,"teacher_disagreement_score":0.32865724,"about_ca_system_score_codex":0.000014084203,"about_ca_system_score_gemma":0.00029200624,"threshold_uncertainty_score":0.64989436},"labels":[],"label_agreement":null},{"id":"W2083246985","doi":"10.1111/j.1471-4159.2009.06300.x","title":"Serine 209 resides within a putative p38(MAPK) consensus motif and regulates monoamine oxidase‐A activity","year":2009,"lang":"en","type":"article","venue":"Journal of Neurochemistry","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; University of Saskatchewan","funders":"Canadian Institutes of Health Research; Saskatchewan Health Research Foundation","keywords":"Monoamine oxidase; MAPK/ERK pathway; Phosphorylation; Biology; p38 mitogen-activated protein kinases; Protein kinase A; Cell biology; Biochemistry; Enzyme","score_opus":0.00892688236097565,"score_gpt":0.23556422702461746,"score_spread":0.22663734466364183,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2083246985","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99806833,0.0005637627,0.000066126624,0.00058350567,0.00008439049,0.00006129847,0.000017514634,0.000007880219,0.0005472083],"genre_scores_gemma":[0.99787873,0.00012647046,0.00084966444,0.00019081043,0.00031492478,9.2482026e-7,0.00000910398,0.000015079018,0.00061426783],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998973,0.000057454876,0.00034691652,0.0002552524,0.00016746648,0.00019991348],"domain_scores_gemma":[0.99894404,0.000035080473,0.00042048164,0.00022546694,0.00018704848,0.00018787105],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001873289,0.00020671303,0.0002731772,0.00003897808,0.00006452856,0.000032410728,0.00015390552,0.00014592141,0.000006207471],"category_scores_gemma":[0.00033912776,0.00018257748,0.0000994323,0.0000674371,0.00009663826,0.000007854506,0.00005595246,0.00024387662,7.5620994e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040682364,0.00009889596,0.00030573478,0.000033921042,0.00004351294,0.00019445234,0.000048102604,0.00004421384,0.99643046,0.000006888777,0.0012223676,0.0011646127],"study_design_scores_gemma":[0.0007919992,0.00083301496,0.029077476,0.000037242622,0.000033188306,0.001661747,0.00007002888,0.000059730864,0.96643806,0.0002620631,0.0005656242,0.00016984569],"about_ca_topic_score_codex":0.0000023306507,"about_ca_topic_score_gemma":0.0000012991544,"teacher_disagreement_score":0.029992433,"about_ca_system_score_codex":0.000011707649,"about_ca_system_score_gemma":0.00009701462,"threshold_uncertainty_score":0.74452937},"labels":[],"label_agreement":null},{"id":"W2085079049","doi":"10.3892/ijo.24.1.65","title":"Involvement of the mitogen-activated protein kinase kinase 2 in the induction of cell dissociation in pancreatic cancer","year":2004,"lang":"en","type":"article","venue":"International Journal of Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Public Health Agency of Canada","keywords":"Pancreatic cancer; Cancer research; Protein kinase A; Kinase; Oncogene; Biology; Cancer cell; Cell; Internal medicine; Cell biology; Cell cycle; Cancer; Endocrinology; Medicine; Biochemistry","score_opus":0.017386830262002453,"score_gpt":0.2875466202597049,"score_spread":0.27015978999770246,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2085079049","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978652,0.00017708962,0.000059461967,0.0010899208,0.0004607881,0.0001631019,0.000009991205,3.7028428e-7,0.00017408255],"genre_scores_gemma":[0.9994984,0.00008593008,0.00011132546,0.000104708706,0.00014498013,0.000016169002,0.000007441318,0.000003835048,0.000027167693],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99914926,0.00014024125,0.00037199171,0.000068687536,0.00019871636,0.000071072725],"domain_scores_gemma":[0.9991674,0.000016814338,0.0005254759,0.000078134624,0.00019872839,0.000013434502],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003257019,0.000057358684,0.00012080455,0.000076007396,0.000010671207,0.0000032603398,0.00026203654,0.000084000756,0.000008054874],"category_scores_gemma":[0.00010218501,0.000036739548,0.00006617057,0.00008830939,0.00004389526,0.0000072497864,0.000037027254,0.00012213591,1.861292e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022681378,0.000336446,0.012368124,0.000009643991,0.000036726404,0.00000999527,0.00070571824,0.00046650358,0.98440653,0.00016189639,0.00003343454,0.0012381758],"study_design_scores_gemma":[0.0017445391,0.0004745021,0.053141672,0.000077026234,0.000011785372,0.000013430388,0.00041866535,0.0000036830938,0.94236815,0.00049617613,0.0012129039,0.000037452806],"about_ca_topic_score_codex":0.00039623826,"about_ca_topic_score_gemma":0.0006805834,"teacher_disagreement_score":0.04203836,"about_ca_system_score_codex":0.00018249823,"about_ca_system_score_gemma":0.0003180662,"threshold_uncertainty_score":0.14981954},"labels":[],"label_agreement":null},{"id":"W2085362455","doi":"10.1002/jcp.21560","title":"Activation loop phosphorylation of the atypical MAP kinases ERK3 and ERK4 is required for binding, activation and cytoplasmic relocalization of MK5","year":2008,"lang":"en","type":"article","venue":"Journal of Cellular Physiology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":77,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Institute for Research in Immunology and Cancer","funders":"","keywords":"Kinase; Phosphorylation; Mitogen-activated protein kinase; MAPK14; p38 mitogen-activated protein kinases; Cell biology; Protein-Serine-Threonine Kinases; MAP2K7; Biology; Chemistry; MAP kinase kinase kinase; Protein kinase A; Biochemistry; Cyclin-dependent kinase 2","score_opus":0.015389080973899297,"score_gpt":0.22366006093259788,"score_spread":0.2082709799586986,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2085362455","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9921757,0.00021347035,0.0072604623,0.0001004291,0.000092339105,0.00013633679,0.000007014966,0.0000011091425,0.000013120086],"genre_scores_gemma":[0.999257,0.00018863265,0.00027765238,0.000046358036,0.00011022847,0.0000016527712,0.00003352012,0.0000084730555,0.00007644007],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993548,0.000063489184,0.00030154316,0.000115397,0.0000851201,0.000079654026],"domain_scores_gemma":[0.9991042,0.000036421097,0.00054577796,0.00010977672,0.00017800197,0.000025797912],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011501853,0.00008045552,0.00018013825,0.000047286707,0.000063414955,0.000002290367,0.000065718166,0.00013867812,0.0000041712046],"category_scores_gemma":[0.000108644526,0.000060350034,0.00007004061,0.000053060845,0.00012154751,0.00001336405,0.000033435757,0.0000547735,1.2293279e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00056641677,0.000042904987,0.0020517283,0.000059779544,0.000035997884,1.9569377e-7,0.00009919927,0.00005342104,0.99618375,0.00013430545,0.00047383903,0.00029847538],"study_design_scores_gemma":[0.0007014535,0.00057690573,0.019439679,0.000039239858,0.00002480807,0.000016504426,0.00003709788,0.00032268057,0.97727334,0.00045317042,0.0010582078,0.0000568947],"about_ca_topic_score_codex":0.0000029114806,"about_ca_topic_score_gemma":4.4761833e-7,"teacher_disagreement_score":0.018910378,"about_ca_system_score_codex":0.00000914131,"about_ca_system_score_gemma":0.000058633483,"threshold_uncertainty_score":0.24610029},"labels":[],"label_agreement":null},{"id":"W2085971293","doi":"10.1002/cbic.201402512","title":"Identification and Characterization of a Small‐Molecule Inhibitor of Death‐Associated Protein Kinase 1","year":2014,"lang":"en","type":"article","venue":"ChemBioChem","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Ministero dello Sviluppo Economico; Strategic Research Council; Novo Nordisk; Ontario Ministry of Economic Development and Innovation; Genome Canada; Wellcome Trust; GlaxoSmithKline; Pfizer; Eli Lilly and Company","keywords":"Identification (biology); Small molecule; Chemistry; Kinase; Protein kinase A; Computational biology; Molecule; Biochemistry; Cell biology; Biology","score_opus":0.00832888224529081,"score_gpt":0.2011807604510626,"score_spread":0.1928518782057718,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2085971293","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981074,0.000053760792,0.0012652446,0.0000249501,0.000033644086,0.00018558704,0.00002212068,0.00000724045,0.000300059],"genre_scores_gemma":[0.99900514,0.0000102631775,0.000106917556,0.000018232175,0.00005730413,0.000023351498,0.00035213883,0.000012711326,0.00041394425],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99937713,0.000032600845,0.00022399802,0.00019899273,0.00006949654,0.00009780344],"domain_scores_gemma":[0.9994131,0.0000037965847,0.00021147872,0.00021124542,0.000119243814,0.000041145388],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016048156,0.000090225105,0.00012961257,0.000028231767,0.000021587493,0.0000068654845,0.000076295975,0.00012768863,0.0000034530854],"category_scores_gemma":[0.00015489539,0.000093901566,0.000040362265,0.00005983458,0.000045849283,0.000002676462,0.000051736137,0.000029977386,0.0000011651578],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000024767634,0.000073699346,0.0007947507,0.000082274375,0.000015680933,1.5411548e-7,0.00003646257,6.991594e-8,0.9981671,0.0002053941,0.000014722193,0.00058492465],"study_design_scores_gemma":[0.0003736065,0.00015025173,0.007258958,0.000036259138,0.000013556303,0.000001038355,0.000008955947,0.00004999408,0.99175733,0.00003615749,0.00022195363,0.00009193808],"about_ca_topic_score_codex":0.0000050376434,"about_ca_topic_score_gemma":0.0000020653624,"teacher_disagreement_score":0.0064642075,"about_ca_system_score_codex":0.0000050489293,"about_ca_system_score_gemma":0.000024116338,"threshold_uncertainty_score":0.38291946},"labels":[],"label_agreement":null},{"id":"W2086921761","doi":"10.1158/1535-7163.targ-11-a229","title":"Abstract A229: BRAF inhibitors upregulate EGFR ligands: A molecular link to RAF inhibitor-induced cutaneous squamous cell carcinomas.","year":2011,"lang":"en","type":"article","venue":"Molecular Cancer Therapeutics","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Workplace Health, Safety and Compensation Commission","funders":"","keywords":"Vemurafenib; Cancer research; HRAS; Melanoma; Cancer; Downregulation and upregulation; Neuroblastoma RAS viral oncogene homolog; EGFR inhibitors; MAPK/ERK pathway; Skin cancer; Kinase; Cell growth; Medicine; Biology; KRAS; Epidermal growth factor receptor; Internal medicine; Colorectal cancer; Cell biology","score_opus":0.022563827664879663,"score_gpt":0.2431232919268744,"score_spread":0.22055946426199474,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2086921761","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98827964,0.0040890216,0.001212588,0.00032806597,0.0011176076,0.00082730595,0.00006076605,0.00010106094,0.0039839153],"genre_scores_gemma":[0.9941236,0.00014144262,0.00076545286,0.0035524939,0.0006002013,0.00015497011,0.000076019314,0.00021794051,0.00036790082],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99672085,0.00008865357,0.0006328991,0.0011028461,0.00048820372,0.00096657337],"domain_scores_gemma":[0.99778175,0.000014368309,0.0002401902,0.001240522,0.00024391124,0.00047923482],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00018285752,0.0007107483,0.000481238,0.00016798246,0.00016256764,0.00007830474,0.00067215814,0.00062304095,0.0000898922],"category_scores_gemma":[0.000020988675,0.0007312769,0.00039716056,0.00031925194,0.00009822765,0.000012230796,0.0002885122,0.00038554487,0.00007796019],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030835922,0.00018689568,0.0004599111,0.00007448352,0.00015330075,0.00052051165,0.00065948657,0.00015253409,0.9817195,0.000059352617,0.00028623422,0.015419422],"study_design_scores_gemma":[0.0012033675,0.0009484197,0.0009920975,0.000046164296,0.00016206331,0.00007356506,0.00007787283,0.000036748446,0.9779076,0.00012413076,0.017497353,0.00093060586],"about_ca_topic_score_codex":0.00031443,"about_ca_topic_score_gemma":0.00009012011,"teacher_disagreement_score":0.017211119,"about_ca_system_score_codex":0.00010775036,"about_ca_system_score_gemma":0.0003394953,"threshold_uncertainty_score":0.9995138},"labels":[],"label_agreement":null},{"id":"W2087731919","doi":"10.1002/1521-4141(200111)31:11<3218::aid-immu3218>3.0.co;2-9","title":"The p38 mitogen-activated protein kinases can have opposing roles in the antigen-dependent or endotoxin-stimulated production of IL-12 and IFN-γ","year":2001,"lang":"en","type":"article","venue":"European Journal of Immunology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Canadian Arthritis Network; Canadian Institutes of Health Research; Arthritis Society","keywords":"p38 mitogen-activated protein kinases; Biology; Mitogen-activated protein kinase; Kinase; Cell biology; Antigen; Protein kinase A; Immunology","score_opus":0.018310708027950876,"score_gpt":0.22976537209561998,"score_spread":0.2114546640676691,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2087731919","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99651885,0.00217178,0.000053433512,0.0004792567,0.00026046642,0.00022944405,0.000004057973,0.0000031189475,0.00027956764],"genre_scores_gemma":[0.9983032,0.0010394051,0.000068651156,0.000037114907,0.00016046189,0.0000023832745,0.0000059647177,0.000018226547,0.00036461963],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982274,0.0008710303,0.0004296999,0.000158722,0.000108473585,0.0002046425],"domain_scores_gemma":[0.99918777,0.00002919227,0.0003802327,0.00025084577,0.00012333848,0.000028604054],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007941253,0.00013289048,0.00017028365,0.00007095628,0.0001270421,0.000025230638,0.00029291908,0.000047705893,0.000004671417],"category_scores_gemma":[0.00031155505,0.00007412368,0.00005419716,0.00007201674,0.00017300561,0.0000074869104,0.000079035846,0.00021112923,8.40995e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010977515,0.00006181336,0.0011336366,0.000005048435,0.00009607036,0.00017888208,0.00047337648,0.000030412702,0.9850337,0.000009668047,0.0000711585,0.011808486],"study_design_scores_gemma":[0.0010433577,0.0014926741,0.019866083,0.00006581827,0.000017175436,0.002076221,0.0010918775,0.000004096431,0.9627029,0.000011811723,0.0115257185,0.00010228729],"about_ca_topic_score_codex":0.000021033604,"about_ca_topic_score_gemma":0.00009001702,"teacher_disagreement_score":0.022330815,"about_ca_system_score_codex":0.000010940672,"about_ca_system_score_gemma":0.00007298822,"threshold_uncertainty_score":0.30226758},"labels":[],"label_agreement":null},{"id":"W2089686819","doi":"10.1016/j.celrep.2014.02.045","title":"Intrinsic Resistance to MEK Inhibition in KRAS Mutant Lung and Colon Cancer through Transcriptional Induction of ERBB3","year":2014,"lang":"en","type":"article","venue":"Cell Reports","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":316,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"Associazione Italiana per la Ricerca sul Cancro; Ministero dell’Istruzione, dell’Università e della Ricerca; Nederlandse Organisatie voor Wetenschappelijk Onderzoek","keywords":"KRAS; ERBB3; Kinome; Downregulation and upregulation; Cancer research; Receptor tyrosine kinase; Mutant; Cetuximab; ErbB; MEK inhibitor; Kinase; Colorectal cancer; Biology; Cancer; MAPK/ERK pathway; Signal transduction; Medicine; Cell biology; Internal medicine; Gene; Biochemistry","score_opus":0.008725670807022873,"score_gpt":0.2299171364603361,"score_spread":0.2211914656533132,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2089686819","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959851,0.00067003816,0.0008932212,0.00011653401,0.00022775646,0.00017075034,0.0000059411705,0.0000043104915,0.0019263614],"genre_scores_gemma":[0.9989551,0.00013332388,0.00031751965,0.00009744613,0.0001103934,0.000032913587,0.000041400977,0.000008417957,0.0003035049],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99928,0.00003058646,0.00023916116,0.0002536892,0.00008944662,0.00010715517],"domain_scores_gemma":[0.9996529,0.0000042331885,0.000104837534,0.00014367039,0.000055944038,0.000038396185],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015693229,0.000077672106,0.00011075777,0.000031241456,0.000025168556,0.000005303644,0.000016746875,0.00009079756,0.000010233781],"category_scores_gemma":[0.00003410044,0.00007826483,0.000024328809,0.00006943805,0.00003184407,0.0000053703,0.000017457378,0.000047720838,3.6414582e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000061605,0.000031250325,0.002645911,0.00006795828,0.0000043384225,0.000021706897,0.00016944333,0.00003424849,0.99580294,0.00017418913,0.00056011707,0.0004263218],"study_design_scores_gemma":[0.00024013621,0.00009434978,0.011775845,0.0000498618,0.000009516182,0.000034277928,0.000026958545,0.00000434431,0.9600799,0.000417798,0.027170425,0.0000966038],"about_ca_topic_score_codex":0.00006830391,"about_ca_topic_score_gemma":0.000423163,"teacher_disagreement_score":0.035723027,"about_ca_system_score_codex":0.000018437813,"about_ca_system_score_gemma":0.000048032016,"threshold_uncertainty_score":0.3191547},"labels":[],"label_agreement":null},{"id":"W2091567174","doi":"10.1586/14737140.2015.1014343","title":"Dabrafenib in the treatment of metastatic or unresectable melanoma","year":2015,"lang":"en","type":"review","venue":"Expert Review of Anticancer Therapy","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Dabrafenib; Medicine; Trametinib; Melanoma; Metastatic melanoma; Oncology; Vemurafenib; Internal medicine; Clinical trial; Immunotherapy; Progression-free survival; Overall survival; Cancer research; Cancer; MAPK/ERK pathway; Kinase","score_opus":0.11361302437224512,"score_gpt":0.4255522667774826,"score_spread":0.31193924240523746,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2091567174","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00003983042,0.99697006,0.000015203329,0.00004754094,0.0001570121,0.0016231012,0.000070943504,0.0000028647912,0.0010734617],"genre_scores_gemma":[0.000017977349,0.9981578,0.0003552857,0.00026820242,0.00022107267,0.00048318537,0.00021922826,0.00003842803,0.0002388497],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99776435,0.00053432543,0.0008229971,0.00036405958,0.00027472593,0.00023955927],"domain_scores_gemma":[0.9983995,0.00007888726,0.00046874143,0.00091030146,0.00009089591,0.000051651576],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005387164,0.00039774866,0.0020638376,0.00006254272,0.00001900777,0.000007026594,0.00053013564,0.00011876396,0.00017959533],"category_scores_gemma":[0.00004281489,0.00018300241,0.00055782736,0.0002887609,0.000101668236,0.0000032884864,0.000026190539,0.000068303176,0.0000057627126],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007066696,0.00046759463,0.0000028401962,0.0148625905,0.00032207413,0.000013499702,0.00015330176,3.4423348e-8,0.0001761841,0.000046913778,0.0066622566,0.977222],"study_design_scores_gemma":[0.00057590037,0.0019928096,6.9785546e-7,0.013158998,0.0001468645,0.000033368844,0.00003921276,2.1478752e-7,0.0007841543,0.0000072099688,0.9830636,0.00019698926],"about_ca_topic_score_codex":0.00009327947,"about_ca_topic_score_gemma":0.000024035036,"teacher_disagreement_score":0.97702503,"about_ca_system_score_codex":0.000030938758,"about_ca_system_score_gemma":0.0007991566,"threshold_uncertainty_score":0.7462622},"labels":[],"label_agreement":null},{"id":"W2091983242","doi":"10.3129/i09-109","title":"p38 mitogen-activated protein kinase protects human retinal pigment epithelial cells exposed to oxidative stress","year":2009,"lang":"en","type":"article","venue":"Canadian Journal of Ophthalmology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"MAPK/ERK pathway; p38 mitogen-activated protein kinases; Protein kinase A; Cell biology; Viability assay; Kinase; Oxidative stress; Molecular biology; Programmed cell death; Chemistry; Transfection; Cell culture; Biology; Cell; Biochemistry; Apoptosis","score_opus":0.019591576888704606,"score_gpt":0.25132677276944765,"score_spread":0.23173519588074304,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2091983242","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963965,0.00012612913,0.00015151875,0.000262476,0.00037521502,0.00054673903,0.00008352511,0.000002624847,0.002055286],"genre_scores_gemma":[0.9977914,7.0316423e-7,0.00068332674,0.00009756578,0.0004479051,0.000016957512,0.000031637835,0.000018466739,0.000912034],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99845535,0.00019712457,0.00040319748,0.00029832093,0.00013590514,0.00051012775],"domain_scores_gemma":[0.9983719,0.0000064573032,0.00026611218,0.00027541252,0.00025739445,0.00082272984],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023257552,0.0002301055,0.00029306713,0.00021213347,0.00015986213,0.000031410375,0.0003812995,0.0002228372,0.00024507192],"category_scores_gemma":[0.000115956944,0.0002194658,0.00012167768,0.00012300348,0.00008252556,0.000007817044,0.000024350193,0.00023763179,0.000014170419],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022389628,0.000055659824,0.00020245473,0.000010234849,0.000044170934,0.00496423,0.00019528242,0.000024880384,0.9932662,0.00010593969,0.0005540972,0.00035290493],"study_design_scores_gemma":[0.0007348429,0.0055671674,0.0016172765,0.000054334523,0.000012174655,0.0047222753,0.00009863098,5.452609e-7,0.9840207,0.00016390184,0.0027698353,0.00023830228],"about_ca_topic_score_codex":0.0004173811,"about_ca_topic_score_gemma":0.00014779183,"teacher_disagreement_score":0.009245535,"about_ca_system_score_codex":0.000085973246,"about_ca_system_score_gemma":0.00076041935,"threshold_uncertainty_score":0.8949556},"labels":[],"label_agreement":null},{"id":"W2092096790","doi":"10.1038/jid.2013.378","title":"Is a Single BRAF Wild-Type Test Sufficient to Exclude Melanoma Patients from Vemurafenib Therapy?","year":2013,"lang":"en","type":"letter","venue":"Journal of Investigative Dermatology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":39,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"Institut National Du Cancer","keywords":"Vemurafenib; Medicine; Melanoma; Dermatology; Test (biology); Oncology; Internal medicine; Cancer research; Metastatic melanoma; Biology","score_opus":0.03078801824767424,"score_gpt":0.23806569278434192,"score_spread":0.20727767453666768,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2092096790","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.89436346,0.0010450664,0.000063841486,0.102448985,0.0011126174,0.0003833327,0.00021219386,0.000009410555,0.00036108072],"genre_scores_gemma":[0.37516102,0.00013852566,0.0018989092,0.6182281,0.0029357856,0.000025233909,0.0008481797,0.00012412589,0.000640145],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9970806,0.00034244292,0.0010024282,0.0005581154,0.0004533019,0.000563103],"domain_scores_gemma":[0.99669176,0.00017620042,0.0011875595,0.00055434904,0.0010658934,0.0003242068],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00010299946,0.00056604116,0.00090323616,0.00027274757,0.00009800846,0.00006816026,0.0007706356,0.0011445386,0.00016284257],"category_scores_gemma":[0.0006403962,0.00046688278,0.00031298195,0.00019779881,0.00035101426,0.000015410953,0.0002109252,0.0010429329,0.00017969095],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005028717,0.00016338928,0.0039068516,0.000020679005,0.00024802546,0.00023977466,0.00042228517,0.0000017537736,0.26142156,0.0000021927654,0.73336464,0.00015853973],"study_design_scores_gemma":[0.00084564113,0.0019453651,0.0026764774,0.00008057698,0.000050238126,0.00026082032,0.00003814548,0.0000029021326,0.4531212,0.00019437331,0.5404147,0.0003695913],"about_ca_topic_score_codex":0.000047686466,"about_ca_topic_score_gemma":0.000009855515,"teacher_disagreement_score":0.5192024,"about_ca_system_score_codex":0.00006687654,"about_ca_system_score_gemma":0.00037686533,"threshold_uncertainty_score":0.9997783},"labels":[],"label_agreement":null},{"id":"W2092363432","doi":"10.1074/jbc.m211598200","title":"Negative Regulation of Mixed Lineage Kinase 3 by Protein Kinase B/AKT Leads to Cell Survival","year":2003,"lang":"en","type":"article","venue":"Journal of Biological Chemistry","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":139,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"National Institute of General Medical Sciences; National Institutes of Health","keywords":"AKT1; MAP kinase kinase kinase; MAP2K7; ASK1; Cyclin-dependent kinase 9; Protein kinase B; Mitogen-activated protein kinase kinase; Cyclin-dependent kinase 2; Cyclin-dependent kinase 4; c-Raf; Cell biology; Biology; Protein kinase A; Kinase; Signal transduction","score_opus":0.01605063107311191,"score_gpt":0.2330801445419591,"score_spread":0.2170295134688472,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2092363432","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99614763,0.00038283013,0.0010144039,0.000055705365,0.00009495766,0.00012911817,0.00004280326,0.000004184388,0.0021283776],"genre_scores_gemma":[0.9966854,0.000026119931,0.0019969943,0.000044786797,0.00021126764,0.0000060030234,0.000044620578,0.000011196784,0.00097364915],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99874455,0.00012853574,0.00050590304,0.00023401734,0.00017240348,0.00021458116],"domain_scores_gemma":[0.9989116,0.00002911593,0.00041294767,0.00021285146,0.0002358304,0.00019763937],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042906194,0.00018178791,0.00031373365,0.000019795887,0.000037144997,0.000010518116,0.00021102715,0.00030771832,0.000094510906],"category_scores_gemma":[0.0006962305,0.00013683162,0.0001785207,0.00010192076,0.000076435266,0.000004425604,0.000053517262,0.00017981046,0.0000035960454],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027520515,0.0001997458,0.001233477,0.00004125658,0.000018690025,0.000010938069,0.000010518068,0.00001603863,0.9963147,0.000014180747,0.0016979873,0.00016723847],"study_design_scores_gemma":[0.0007282557,0.0008105326,0.00070236746,0.000027846007,0.000012008561,0.000020667767,0.00007019028,0.0000015552093,0.99004126,0.000069623165,0.007349297,0.00016641623],"about_ca_topic_score_codex":0.0000022390234,"about_ca_topic_score_gemma":5.9241376e-7,"teacher_disagreement_score":0.0062734843,"about_ca_system_score_codex":0.00002050883,"about_ca_system_score_gemma":0.0000831197,"threshold_uncertainty_score":0.55798316},"labels":[],"label_agreement":null},{"id":"W2096376623","doi":"10.1093/carcin/bgu016","title":"Targeted deletion of RasGRP1 impairs skin tumorigenesis","year":2014,"lang":"en","type":"article","venue":"Carcinogenesis","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"National Cancer Institute","keywords":"Carcinogenesis; Cancer research; Keratinocyte; Activator (genetics); Biology; Cell culture; Cancer; Genetics; Receptor","score_opus":0.006008155161474483,"score_gpt":0.2019179562737574,"score_spread":0.1959098011122829,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2096376623","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99245775,0.0007733341,0.00472412,0.000022521945,0.00019137391,0.00012600361,0.000024030258,0.000017948982,0.0016629163],"genre_scores_gemma":[0.9983852,0.00007911701,0.0006240502,0.00009683901,0.00032295674,0.0000250264,0.00014398816,0.000029372768,0.00029345154],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989529,0.00010340693,0.00024599215,0.00031793184,0.00013954124,0.00024018277],"domain_scores_gemma":[0.9992004,0.000014184298,0.000106692314,0.00045010296,0.00012645875,0.00010213156],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022987385,0.00016145162,0.00020872637,0.00006532142,0.000058541653,0.0000066190582,0.00018896088,0.00014010568,0.000046715522],"category_scores_gemma":[0.00008965531,0.0001546808,0.00016571007,0.00011663176,0.000057498142,0.0000024144522,0.00006800195,0.000030634812,0.000019438548],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000045867637,0.000034334782,0.024432987,0.000037563877,0.000029061026,0.0000011496046,0.000028101365,0.000028386768,0.96750337,0.00020801999,0.0012624639,0.006388692],"study_design_scores_gemma":[0.00033756843,0.00034333704,0.06371794,0.0000060845355,0.000032894917,0.000009459271,0.00003378741,0.00007460999,0.92459714,0.00005685822,0.0106135905,0.00017673952],"about_ca_topic_score_codex":0.00006122222,"about_ca_topic_score_gemma":0.000021116914,"teacher_disagreement_score":0.04290624,"about_ca_system_score_codex":0.000010666424,"about_ca_system_score_gemma":0.00005352588,"threshold_uncertainty_score":0.63077},"labels":[],"label_agreement":null},{"id":"W2096440522","doi":"10.1042/bj3460169","title":"Cloning and characterization of mouse extracellular-signal-regulated protein kinase 3 as a unique gene product of 100 kDa","year":2000,"lang":"en","type":"article","venue":"Biochemical Journal","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôtel-Dieu de Montréal","funders":"Medical Research Council; Medical Research Council Canada; Heart and Stroke Foundation of Canada","keywords":"Biology; Molecular biology; Complementary DNA; Gene product; Kinase; Protein kinase A; Gene; c-Raf; Gene expression; Signal transduction; Mitogen-activated protein kinase kinase; Genetics","score_opus":0.006976926530902134,"score_gpt":0.2075050572245967,"score_spread":0.20052813069369457,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2096440522","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99841475,0.0008771482,0.00031790114,0.000058719754,0.00002025028,0.00019847287,0.000020766647,0.0000056282643,0.000086358195],"genre_scores_gemma":[0.9970864,0.00020673314,0.0010604347,0.000020303423,0.0001893349,0.0000062989825,0.0001281322,0.000018485749,0.0012838683],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990306,0.000069381786,0.00036279732,0.00022241201,0.00014105467,0.00017377245],"domain_scores_gemma":[0.9993627,0.0000032537387,0.00019851832,0.00018448292,0.00012693668,0.00012409939],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018992729,0.00013768923,0.00018345627,0.000042927015,0.000043054297,0.00001480324,0.00012134357,0.00014882792,0.00013266172],"category_scores_gemma":[0.000037772796,0.00012387495,0.000070841736,0.00008006104,0.00009619753,0.0000066512903,0.000036976846,0.00012282206,0.0000018934919],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027272382,0.00010742098,0.00016246641,0.000041712785,0.00003669995,0.0000096745325,0.000033898803,0.0000020751095,0.9961053,0.000021431271,0.000046952067,0.0031596152],"study_design_scores_gemma":[0.00049016124,0.00030669433,0.00037602708,0.00005924377,0.000017802291,0.0002191449,0.000005992518,0.000026637876,0.9969798,0.000033506858,0.0013514888,0.00013354649],"about_ca_topic_score_codex":0.000007692368,"about_ca_topic_score_gemma":2.1619758e-7,"teacher_disagreement_score":0.0030260687,"about_ca_system_score_codex":0.000008047785,"about_ca_system_score_gemma":0.0000978835,"threshold_uncertainty_score":0.5051474},"labels":[],"label_agreement":null},{"id":"W2098106638","doi":"10.1016/j.molonc.2011.03.005","title":"Melanoma — The pieces of the puzzle finally start coming together!","year":2011,"lang":"en","type":"article","venue":"Molecular Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Melanoma; Biology; Medicine; Computer science; Computational biology; Cancer research","score_opus":0.02541976603476033,"score_gpt":0.24011855738211163,"score_spread":0.21469879134735131,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2098106638","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9641647,0.00074737397,0.0015211874,0.0007353452,0.0003894621,0.00026565618,0.00001389995,0.000007894527,0.032154493],"genre_scores_gemma":[0.9970882,0.000029992676,0.0008351858,0.0012923594,0.00008510011,0.00003261083,0.000012109637,0.000019418292,0.00060502224],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99888736,0.0002634824,0.0002334555,0.000245469,0.00012415419,0.00024609335],"domain_scores_gemma":[0.9990413,0.000019723966,0.00015748519,0.00063973083,0.00009623093,0.000045532168],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030757042,0.00014070033,0.0001770687,0.000020604468,0.0001196401,0.0000057421184,0.0005956268,0.00018597288,0.0000830541],"category_scores_gemma":[0.00010979478,0.000084918676,0.00016013713,0.0000832084,0.00020849971,0.0000020280893,0.0002805063,0.00013007068,0.000016248558],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011738724,0.00013375805,0.0040387674,0.000013477202,0.00011121947,0.000028655531,0.00055466057,0.000013004665,0.98566115,0.0023419678,0.003138382,0.003847572],"study_design_scores_gemma":[0.00039810984,0.0006981412,0.0051840907,0.0000070519736,0.0000448461,0.00005796473,0.00019944725,0.000013661395,0.75506115,0.00039808545,0.23781109,0.00012635482],"about_ca_topic_score_codex":0.00008522269,"about_ca_topic_score_gemma":0.00034205854,"teacher_disagreement_score":0.23467271,"about_ca_system_score_codex":0.000013500473,"about_ca_system_score_gemma":0.00014477408,"threshold_uncertainty_score":0.3462883},"labels":[],"label_agreement":null},{"id":"W2099259685","doi":"10.1093/annonc/mdi310","title":"Phase I study to determine the safety and pharmacokinetics of the novel Raf kinase and VEGFR inhibitor BAY 43-9006, administered for 28 days on/7 days off in patients with advanced, refractory solid tumors","year":2005,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":301,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Bayer (Canada); Juravinski Cancer Centre","funders":"","keywords":"Medicine; Pharmacokinetics; Dosing; Toxicity; Adverse effect; Kinase; Internal medicine; Bay; Pharmacology; Refractory (planetary science); Tyrosine-kinase inhibitor; Cancer; Gastroenterology; Oncology","score_opus":0.03243005053116366,"score_gpt":0.3398462573339467,"score_spread":0.30741620680278303,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2099259685","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99760365,0.00018175533,0.00003998737,0.0005757836,0.000090042835,0.0010773616,0.00021752619,0.0000023404139,0.00021156723],"genre_scores_gemma":[0.99838024,0.00008721308,0.00029101103,0.0010078553,0.0001003409,0.000036415964,0.000027391992,0.000017865785,0.000051651765],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988721,0.00009139609,0.00039434424,0.00030322804,0.00011581203,0.00022310209],"domain_scores_gemma":[0.99910855,0.00009369328,0.0002445798,0.000322197,0.00014645586,0.00008452741],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029123967,0.00017087274,0.00031710937,0.000048147976,0.000059225422,0.000004622375,0.00018538891,0.000075771284,0.0000031386896],"category_scores_gemma":[0.00014346807,0.00010741306,0.00004265171,0.0000705299,0.00014736726,0.00000685259,0.00016063021,0.00009227706,2.5139613e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.025258213,0.0144018065,0.017148338,0.0001390934,0.00021001232,0.000010953485,0.002436272,0.00024426277,0.6419104,0.0000510268,0.0013819481,0.2968077],"study_design_scores_gemma":[0.036748946,0.097478256,0.08194674,0.0001263192,0.00011454284,0.000013826391,0.0008243746,0.00014636866,0.6124875,0.00001223736,0.16963176,0.0004691409],"about_ca_topic_score_codex":0.0000034871189,"about_ca_topic_score_gemma":0.00012136799,"teacher_disagreement_score":0.2963386,"about_ca_system_score_codex":0.000010197402,"about_ca_system_score_gemma":0.00009299443,"threshold_uncertainty_score":0.43801776},"labels":[],"label_agreement":null},{"id":"W2099267053","doi":"10.1101/gad.962902","title":"KSR is a scaffold required for activation of the ERK/MAPK module","year":2002,"lang":"en","type":"article","venue":"Genes & Development","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":220,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Clinical Research Institute","funders":"National Cancer Institute","keywords":"MAPK/ERK pathway; Cell biology; Scaffold protein; Biology; Caenorhabditis elegans; Kinase; Phosphorylation; Scaffold; Suppressor; MEK inhibitor; Signal transduction; Genetics; Cancer; Computer science; Gene","score_opus":0.026683812078635235,"score_gpt":0.2261812319709946,"score_spread":0.19949741989235936,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2099267053","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99483126,0.00049227144,0.0027623367,0.0002215307,0.00017116,0.00032545076,0.000012305362,0.0000071883587,0.0011764643],"genre_scores_gemma":[0.99075365,0.00007363257,0.005483085,0.0003537844,0.00010428205,0.00008953288,0.00003721193,0.0000141870305,0.0030906098],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993293,0.000014469019,0.00018320182,0.0002032502,0.00011055406,0.00015917413],"domain_scores_gemma":[0.9995502,0.000004146132,0.00008713809,0.00025665184,0.00007065124,0.000031195006],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008349195,0.000099413905,0.00009040872,0.000019125597,0.00008992713,0.000006981827,0.00016062452,0.0000829016,0.00003514455],"category_scores_gemma":[0.000018931594,0.00007569392,0.000065935805,0.00005699885,0.000022124159,0.0000024733667,0.000083600295,0.00001693246,0.000008387282],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000015120777,0.00004180487,0.0004827459,0.000027367341,0.00004220386,9.98354e-8,0.0002462656,0.00000979886,0.9595992,0.00009203381,0.008355424,0.031087957],"study_design_scores_gemma":[0.00025621557,0.000042357795,0.0023973433,0.000011466647,0.0000057612515,0.0000014857504,0.000022058875,0.00005690223,0.814069,0.00005753539,0.18299057,0.000089340494],"about_ca_topic_score_codex":0.0000026738423,"about_ca_topic_score_gemma":0.000003928999,"teacher_disagreement_score":0.17463514,"about_ca_system_score_codex":0.00001449624,"about_ca_system_score_gemma":0.000053846426,"threshold_uncertainty_score":0.30867085},"labels":[],"label_agreement":null},{"id":"W2100743480","doi":"10.1158/0008-5472.can-13-2775","title":"A Meta-analysis of Lung Cancer Gene Expression Identifies <i>PTK7</i> as a Survival Gene in Lung Adenocarcinoma","year":2014,"lang":"en","type":"review","venue":"Cancer Research","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":158,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"National Cancer Institute","keywords":"Adenocarcinoma; Lung cancer; Cancer research; Gene signature; Biology; Cancer; Gene; Gene expression; Pathology; Medicine; Genetics","score_opus":0.19682232174945372,"score_gpt":0.4574054528975547,"score_spread":0.26058313114810094,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2100743480","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.008673159,0.98895305,0.0000889407,0.000025024603,0.00025873774,0.00098244,0.0007001041,0.000007800625,0.00031072946],"genre_scores_gemma":[0.0056611337,0.98718,0.00004539872,0.000025817279,0.00046558568,0.0022940564,0.00074286736,0.000089983536,0.0034951873],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99456656,0.0014844427,0.0009786754,0.0012432727,0.0009469456,0.00078009284],"domain_scores_gemma":[0.9973825,0.00015313835,0.00041925634,0.0013857362,0.0004416069,0.0002177551],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0021272977,0.0005131213,0.0034135517,0.0009221706,0.000116780146,0.00006371749,0.0010424996,0.0006346261,0.00071567995],"category_scores_gemma":[0.00014336617,0.00039958098,0.0020629144,0.0014312654,0.00019616194,0.000007705058,0.0007177402,0.00061016425,0.000010452855],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000520169,0.000495219,0.003162677,0.07107078,0.37548575,0.00027856146,0.0006518537,0.00047624073,0.4859235,0.00013338492,0.02419024,0.03761164],"study_design_scores_gemma":[0.0007112174,0.00020230042,0.00012191202,0.0018986104,0.17195933,0.000012758806,0.00004473048,0.00006155342,0.17458817,0.000019329906,0.64910424,0.0012758423],"about_ca_topic_score_codex":0.0024983818,"about_ca_topic_score_gemma":0.0017418443,"teacher_disagreement_score":0.624914,"about_ca_system_score_codex":0.00018370252,"about_ca_system_score_gemma":0.0013342131,"threshold_uncertainty_score":0.9998456},"labels":[],"label_agreement":null},{"id":"W2101417059","doi":"10.1074/jbc.m008096200","title":"Kinase Suppressor of Ras Signals through Thr269 of c-Raf-1","year":2001,"lang":"en","type":"retraction","venue":"Journal of Biological Chemistry","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":71,"is_retracted":true,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; Medical Research Council; National Institutes of Health; Medical Research Council Canada","keywords":"Autophosphorylation; Phosphorylation; Kinase; Serine; Tyrosine phosphorylation; Cell biology; Substrate-level phosphorylation; Biochemistry; Chemistry; Tyrosine kinase; Signal transduction; Protein kinase A; Biology","score_opus":0.03792983156927502,"score_gpt":0.2859136230190474,"score_spread":0.24798379144977237,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2101417059","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9561363,0.02259165,0.00044394418,0.00007887498,0.00079753506,0.0001701322,0.00045289975,0.000007006912,0.019321643],"genre_scores_gemma":[0.96826,0.024360238,0.00079205795,0.000065669126,0.00291439,0.0000054291463,0.0005740942,0.000038377548,0.0029897543],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9977922,0.00009887946,0.0011512482,0.00032382202,0.0003516353,0.0002822403],"domain_scores_gemma":[0.9968602,0.000089487155,0.002048303,0.0003823788,0.0004930077,0.00012664334],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00041377766,0.00035093323,0.0009778797,0.000037580972,0.00003034833,0.000009233814,0.0005327199,0.0016452732,0.0005902066],"category_scores_gemma":[0.00055379723,0.00025105377,0.00073588075,0.0001042124,0.00024758783,0.00000646115,0.00013789082,0.00062248536,0.0000024141857],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041154772,0.00028952645,0.00027367167,0.00045125134,0.00024854494,0.00005598009,0.000011175103,0.000010378685,0.97687465,0.000003375137,0.02060243,0.0007674954],"study_design_scores_gemma":[0.00057082187,0.0008233335,0.00010572336,0.00024860835,0.00010305665,0.0002983738,0.000047766345,8.343008e-7,0.85659266,0.00012941638,0.1408583,0.00022109861],"about_ca_topic_score_codex":0.000007935554,"about_ca_topic_score_gemma":4.1021354e-7,"teacher_disagreement_score":0.12028195,"about_ca_system_score_codex":0.000028743607,"about_ca_system_score_gemma":0.00025635556,"threshold_uncertainty_score":0.99999416},"labels":[],"label_agreement":null},{"id":"W2101666731","doi":"10.1136/jclinpath-2013-201471","title":"Molecular biology of normal melanocytes and melanoma cells","year":2013,"lang":"en","type":"review","venue":"Journal of Clinical Pathology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":136,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Melanoma; Melanocyte; Cancer research; Malignant transformation; Skin cancer; Biology; Population; Cell; Cancer; Cell growth; Medicine; Immunology; Internal medicine; Genetics","score_opus":0.0628149022130208,"score_gpt":0.400415545993399,"score_spread":0.33760064378037824,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2101666731","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.03443592,0.96282566,0.00063082145,0.00001933463,0.0011948241,0.0002496417,0.00005405754,0.0000028321335,0.00058691675],"genre_scores_gemma":[0.0022547226,0.993874,0.0027299987,0.000094954834,0.0008246691,0.000008750597,0.000046530407,0.000043913096,0.00012247321],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.995249,0.0011003694,0.0027917016,0.0004152595,0.00012732892,0.0003163389],"domain_scores_gemma":[0.9958404,0.00034804505,0.002838827,0.00046162392,0.00027031128,0.00024080087],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0014997682,0.00038611164,0.0030033875,0.0001743758,0.00002474074,0.000010020924,0.00052580866,0.0014732184,0.000045229455],"category_scores_gemma":[0.000762341,0.00027353322,0.0011341404,0.000077393044,0.00045516904,0.0000052422392,0.00031299365,0.00068267365,0.000018303137],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008933757,0.00022220351,0.00036184306,0.002197794,0.00067115604,0.0003751897,0.000011862087,8.1081663e-7,0.018486353,0.00046754495,0.0013847542,0.97573113],"study_design_scores_gemma":[0.0007930776,0.003884407,0.000044112337,0.0005881048,0.0007152215,0.0017576475,0.000007726282,7.7530876e-7,0.004492478,0.00026609737,0.98713803,0.00031230252],"about_ca_topic_score_codex":0.000002325906,"about_ca_topic_score_gemma":0.0000012209181,"teacher_disagreement_score":0.9857533,"about_ca_system_score_codex":0.000006192494,"about_ca_system_score_gemma":0.00040536385,"threshold_uncertainty_score":0.9999717},"labels":[],"label_agreement":null},{"id":"W2102646127","doi":"10.1016/j.molcel.2005.10.022","title":"Wild-Type and Mutant B-RAF Activate C-RAF through Distinct Mechanisms Involving Heterodimerization","year":2005,"lang":"en","type":"article","venue":"Molecular Cell","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":421,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute of Cancer Research; Cancer Research UK; Cancer Research Institute","keywords":"Biology; Mutant; Genetics; Wild type; Cell biology; Mutation; Gene","score_opus":0.007918534931107038,"score_gpt":0.20997684267740618,"score_spread":0.20205830774629915,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2102646127","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9443386,0.0010501567,0.051142436,0.000108089596,0.00015840109,0.00019032125,0.00000968872,0.000029447343,0.0029728257],"genre_scores_gemma":[0.99313194,0.0001467771,0.005347722,0.0006314732,0.00012175821,0.000010446023,0.00020109392,0.000042990087,0.0003657991],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988774,0.00006823238,0.00018677715,0.00044653434,0.0001397262,0.00028135127],"domain_scores_gemma":[0.999403,0.0000057696793,0.00008725241,0.00035093285,0.00006297413,0.00009010057],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008976748,0.00021443736,0.00015341006,0.000027632432,0.00010454364,0.000041476847,0.00013491591,0.0001622705,0.000026750235],"category_scores_gemma":[0.000041313273,0.00020952019,0.000057324232,0.00010330649,0.000043154556,0.000010640839,0.00014271456,0.000092994705,0.00002416731],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000036814086,0.000048119397,0.00013131351,0.00002269743,0.000022051021,0.00001757989,0.00008239333,0.000061226114,0.9978448,0.0004152485,0.00012416716,0.0011935731],"study_design_scores_gemma":[0.0004615802,0.00023690773,0.00014923183,0.000011182003,0.000026970616,0.000015965235,0.000028171016,0.00026700337,0.96779716,0.0003103862,0.030433271,0.0002621781],"about_ca_topic_score_codex":0.00001691593,"about_ca_topic_score_gemma":0.000013721799,"teacher_disagreement_score":0.048793305,"about_ca_system_score_codex":0.000013696125,"about_ca_system_score_gemma":0.00004124302,"threshold_uncertainty_score":0.85439855},"labels":[],"label_agreement":null},{"id":"W2103845135","doi":"10.1200/jco.2012.30.15_suppl.8502","title":"Updated overall survival (OS) results for BRIM-3, a phase III randomized, open-label, multicenter trial comparing BRAF inhibitor vemurafenib (vem) with dacarbazine (DTIC) in previously untreated patients with <i>BRAF<sup>V600E</sup></i>-mutated melanoma.","year":2012,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":140,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Vemurafenib; Dacarbazine; Hazard ratio; Internal medicine; Interim analysis; Temozolomide; Metastatic melanoma; Gastroenterology; Oncology; Surgery; Randomized controlled trial; Confidence interval; Chemotherapy; Cancer","score_opus":0.07959961057608907,"score_gpt":0.3936601599823536,"score_spread":0.31406054940626454,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2103845135","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936966,0.0002200617,0.0004225175,0.00032082995,0.0009605181,0.0034373133,0.00008958283,0.000013063314,0.00083951314],"genre_scores_gemma":[0.99403834,0.00011713891,0.002605995,0.00057632127,0.0014569894,0.00008943947,0.0008610373,0.000064257896,0.0001904604],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99263436,0.0016972501,0.0038405673,0.0005898764,0.0004241267,0.0008138216],"domain_scores_gemma":[0.99396014,0.0012658086,0.0029206462,0.00043882985,0.0007790429,0.0006355163],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.005730469,0.00048015485,0.003068575,0.00014640151,0.00009661718,0.00006822674,0.0006197964,0.00065342983,0.000020498359],"category_scores_gemma":[0.0026007628,0.00031507388,0.00032032898,0.0001911736,0.00030840086,0.00008963889,0.00026017608,0.0007347792,0.0000056789045],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.96728814,0.010855598,0.013597354,0.000027317552,0.001113146,0.00009604257,0.00019699242,0.00016071646,0.0011417705,0.000027210936,0.0030960115,0.0023997081],"study_design_scores_gemma":[0.94078845,0.034773353,0.0016607754,0.00015309906,0.00064396486,0.000049742313,0.00005275258,0.0009996195,0.0012094303,0.000010395903,0.019231915,0.00042648558],"about_ca_topic_score_codex":0.00009847146,"about_ca_topic_score_gemma":0.00028142857,"teacher_disagreement_score":0.026499664,"about_ca_system_score_codex":0.00010226967,"about_ca_system_score_gemma":0.0008952728,"threshold_uncertainty_score":0.99993014},"labels":[],"label_agreement":null},{"id":"W2104902103","doi":"10.1186/1471-2407-14-398","title":"A combination of p300 and Braf expression in the diagnosis and prognosis of melanoma","year":2014,"lang":"en","type":"article","venue":"BMC Cancer","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health; University of British Columbia","funders":"Canadian Institutes of Health Research; Canadian Dermatology Foundation","keywords":"Melanoma; Vemurafenib; Medicine; Surgical oncology; Oncology; Proportional hazards model; Nodular melanoma; Internal medicine; Cancer research; Metastatic melanoma","score_opus":0.017481146146583547,"score_gpt":0.25760253572705977,"score_spread":0.2401213895804762,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2104902103","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99803936,0.0013137182,0.000111439556,0.000065424676,0.000023462297,0.0001319679,0.000008074406,9.426064e-7,0.00030562928],"genre_scores_gemma":[0.99923635,0.00040897806,0.00016447487,0.00003980987,0.000025993475,0.00009643427,0.000006589363,0.0000034206823,0.0000179375],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9996537,0.00005339086,0.00009106781,0.000099425626,0.00005126414,0.000051134164],"domain_scores_gemma":[0.9997958,0.000027053875,0.0000557047,0.00008825602,0.000020569,0.0000126142395],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001267767,0.0000435437,0.00007455761,0.000018364755,0.000012666756,0.0000033727972,0.000046471803,0.00004552341,0.000004752644],"category_scores_gemma":[0.000039175156,0.000030324567,0.000014370025,0.000031147123,0.000040110954,0.0000018920009,0.000031561358,0.000018319908,6.479926e-8],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000033419372,0.000057058707,0.6657541,0.000107606116,0.000004419566,1.0014408e-7,0.00021560738,0.0000020426708,0.3242888,0.00024187232,0.00039513147,0.008899885],"study_design_scores_gemma":[0.00050691894,0.00023436506,0.41139245,0.000056650362,0.00000887292,0.000001246988,0.000056034496,0.00004851551,0.5848933,0.00010976339,0.0026448756,0.000047056164],"about_ca_topic_score_codex":0.000078987585,"about_ca_topic_score_gemma":0.00023394077,"teacher_disagreement_score":0.2606045,"about_ca_system_score_codex":0.0000016422666,"about_ca_system_score_gemma":0.0000132712585,"threshold_uncertainty_score":0.12366},"labels":[],"label_agreement":null},{"id":"W2105061758","doi":"10.1016/j.jcjo.2013.12.012","title":"Regression of orbital and choroidal metastases from melanoma after treatment with vemurafenib","year":2014,"lang":"en","type":"letter","venue":"Canadian Journal of Ophthalmology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Vemurafenib; Choroidal melanoma; Melanoma; Medicine; Regression; Oncology; Dermatology; Internal medicine; Cancer research; Metastatic melanoma; Mathematics; Statistics","score_opus":0.015344114267266298,"score_gpt":0.22849415541181825,"score_spread":0.21315004114455194,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2105061758","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98649234,0.0062118378,0.000016353293,0.0050933873,0.00035905917,0.00011507599,0.0004908502,7.941467e-7,0.0012202916],"genre_scores_gemma":[0.99353904,0.000028112241,0.0005483303,0.0028555351,0.0016770874,0.000009362723,0.00042145673,0.00004600838,0.000875081],"study_design_codex":"case_report","study_design_gemma":"not_applicable","domain_scores_codex":[0.9986648,0.00018429277,0.00039866116,0.00030160326,0.00011797029,0.00033269348],"domain_scores_gemma":[0.9986998,0.000043344455,0.00047956317,0.00032811056,0.00014481672,0.00030437857],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000095096126,0.0003344753,0.0006625075,0.00018911043,0.000043262447,0.000018757311,0.00019445633,0.0006157024,0.0003122935],"category_scores_gemma":[0.000031218235,0.00022315232,0.00015920782,0.000036057565,0.00025003662,0.0000049342098,0.000021928689,0.00032746643,0.0000027268063],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023916813,0.00012787458,0.11561141,0.00029220895,0.003943227,0.4597711,0.00041029043,0.00001086034,0.030992968,0.000017858094,0.3837495,0.0026810085],"study_design_scores_gemma":[0.0028246809,0.017056078,0.007936048,0.0003579235,0.0007278646,0.28976858,0.000060917453,0.0000016939016,0.028690804,0.00013842713,0.65162295,0.0008140476],"about_ca_topic_score_codex":0.0026886694,"about_ca_topic_score_gemma":0.0004236781,"teacher_disagreement_score":0.26787344,"about_ca_system_score_codex":0.000038518265,"about_ca_system_score_gemma":0.00078549294,"threshold_uncertainty_score":0.90998876},"labels":[],"label_agreement":null},{"id":"W2105195683","doi":"10.1002/cyto.1067","title":"Measurement of MAP kinase activation by flow cytometry using phospho‐specific antibodies to MEK and ERK: Potential for pharmacodynamic monitoring of signal transduction inhibitors","year":2001,"lang":"en","type":"article","venue":"Cytometry","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":178,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"MAPK/ERK pathway; Signal transduction; Flow cytometry; Kinase; Mitogen-activated protein kinase; MEK inhibitor; Mitogen-activated protein kinase kinase; Protein kinase A; Biology; Cell biology; Cancer research; Protein kinase C; Chemistry; Pharmacology; Molecular biology","score_opus":0.02178551514584201,"score_gpt":0.26953978126859096,"score_spread":0.24775426612274895,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2105195683","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.86324173,0.0016554935,0.13432403,0.000018028917,0.0004090969,0.0002731182,0.00005931559,0.000007937294,0.000011256592],"genre_scores_gemma":[0.9950355,0.00022499604,0.0042691566,0.000007645639,0.00035534595,0.000012544045,0.000052559255,0.00002412665,0.00001808529],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99889237,0.000030144092,0.00029976814,0.00030241662,0.00026665063,0.00020863902],"domain_scores_gemma":[0.9994249,0.000007956423,0.00013143584,0.00013948262,0.00021380145,0.00008243772],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027036224,0.00016203993,0.00020943319,0.00023041554,0.000075637334,0.000012854734,0.000084361585,0.00011587137,0.000010509017],"category_scores_gemma":[0.000024289684,0.00017116724,0.00009348382,0.00027198947,0.000048883983,0.000014396962,0.000034144818,0.00005715882,3.8774698e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042747962,0.00010081458,0.004752528,0.00014657152,0.00007300676,0.0000010619381,0.00005193659,0.00028003086,0.9842367,0.0000012006964,0.00021269394,0.009715966],"study_design_scores_gemma":[0.00082408794,0.0003059126,0.0022260854,0.000081428756,0.000044186512,0.0000069022008,0.00020762123,0.00040619358,0.9948731,0.0000064524525,0.00085008907,0.0001679328],"about_ca_topic_score_codex":0.000014040807,"about_ca_topic_score_gemma":4.9349615e-7,"teacher_disagreement_score":0.13179381,"about_ca_system_score_codex":0.000045588575,"about_ca_system_score_gemma":0.00003367996,"threshold_uncertainty_score":0.6979998},"labels":[],"label_agreement":null},{"id":"W2106773063","doi":"10.1093/jnci/93.19.1473","title":"In Vitro Evidence for Homologous Recombinational Repair in Resistance to Melphalan","year":2001,"lang":"en","type":"article","venue":"JNCI Journal of the National Cancer Institute","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":65,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Melphalan; XRCC3; RAD51; Ku80; DNA repair; Ku70; Homologous recombination; Nitrogen mustard; DNA damage; Biology; Non-homologous end joining; RAD52; ERCC1; DNA; Molecular biology; Cancer research; Genetics; Nucleotide excision repair; DNA-binding protein; Gene; Transcription factor; Chemotherapy","score_opus":0.07110099166967875,"score_gpt":0.359029660498361,"score_spread":0.28792866882868223,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2106773063","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9868873,0.0013954332,0.0004269331,0.008445263,0.0018529705,0.00028490342,0.0000685553,0.000002606228,0.0006360683],"genre_scores_gemma":[0.9932738,0.00019996257,0.0020785264,0.0019270115,0.00074843055,0.000052160143,0.000005360276,0.0000067462274,0.0017080101],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99906725,0.000043880656,0.00032945513,0.0001408401,0.000287089,0.0001315091],"domain_scores_gemma":[0.99928856,0.000044541473,0.00016919355,0.000084497595,0.00036993,0.000043282238],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00061927974,0.00007732785,0.00011878339,0.0001145986,0.000047519603,0.000007392964,0.00027375997,0.000065288645,0.00000848253],"category_scores_gemma":[0.00097022724,0.00006113884,0.00010977336,0.00020334327,0.00003310336,0.000026438966,0.000041965894,0.00010656527,9.687176e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0048431824,0.00024437343,0.012202488,0.000059334514,0.00008599279,0.000054014792,0.00018551985,0.007863227,0.8632054,0.0028498792,0.1068097,0.0015969056],"study_design_scores_gemma":[0.0030553539,0.0003005721,0.06625772,0.00040181752,0.000022217017,0.00025901225,0.000020136338,0.00012076034,0.25007507,0.007492457,0.67167974,0.0003151386],"about_ca_topic_score_codex":0.000026466743,"about_ca_topic_score_gemma":0.0011470846,"teacher_disagreement_score":0.61313033,"about_ca_system_score_codex":0.00022684422,"about_ca_system_score_gemma":0.0005393214,"threshold_uncertainty_score":0.24931695},"labels":[],"label_agreement":null},{"id":"W2106971217","doi":"10.1371/journal.pone.0008044","title":"Structural Diversity of the Active N-Terminal Kinase Domain of p90 Ribosomal S6 Kinase 2","year":2009,"lang":"en","type":"article","venue":"PLoS ONE","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Light Source (Canada)","funders":"National Cancer Institute; National Institutes of Health; National Institute of Environmental Health Sciences; Hormel Foundation","keywords":"Protein kinase domain; Kinase; Biology; Biochemistry; Molecular biology; Protein kinase A; Cell biology; Chemistry; Biophysics; Mutant; Gene","score_opus":0.02097129361313658,"score_gpt":0.20939129152658667,"score_spread":0.1884199979134501,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2106971217","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99874616,0.0000693676,0.000009332243,0.000077203586,0.000035487144,0.00013184585,0.000121109704,0.0000038112723,0.0008056783],"genre_scores_gemma":[0.999241,0.000007927659,0.00046169906,0.00007506709,0.000092962,0.0000012855353,0.00003097594,0.000004454689,0.00008464268],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99933845,0.000050393817,0.0001265455,0.0001643382,0.00018146797,0.00013880375],"domain_scores_gemma":[0.999462,0.000008047542,0.000113514136,0.00029477026,0.000074513264,0.000047166694],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00004542586,0.00009807678,0.00015711474,0.000018798748,0.000089394845,0.0000027540812,0.0002353722,0.00008580219,0.000025055768],"category_scores_gemma":[0.00004562778,0.0000753421,0.00009130947,0.000053611486,0.00010309631,0.000004478254,0.00021695753,0.00006882216,0.0000012680488],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021847832,0.00026740413,0.0069329836,0.000027881066,0.00005986675,0.000009400341,0.00015636615,0.0000010317686,0.99135876,0.00030285335,0.000037497663,0.00062749797],"study_design_scores_gemma":[0.00046231682,0.00035749824,0.09809525,0.000030070616,0.000056145025,0.0000051818906,0.00006236063,0.000006142764,0.90036315,0.00045137914,0.000026673619,0.000083837534],"about_ca_topic_score_codex":0.000015996324,"about_ca_topic_score_gemma":0.000012310091,"teacher_disagreement_score":0.091162264,"about_ca_system_score_codex":0.0000085876645,"about_ca_system_score_gemma":0.000032579002,"threshold_uncertainty_score":0.30723616},"labels":[],"label_agreement":null},{"id":"W2107233903","doi":"10.1093/annonc/mdp254","title":"Small molecules and targeted therapies in distant metastatic disease","year":2009,"lang":"en","type":"review","venue":"Annals of Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":85,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Sunitinib; Everolimus; Targeted therapy; Sorafenib; Cancer research; Imatinib; Temsirolimus; Axitinib; Melanoma; Trametinib; Pazopanib; Pharmacology; Tyrosine kinase; Oncology; PI3K/AKT/mTOR pathway; Internal medicine; Cancer; Kinase; MAPK/ERK pathway; Signal transduction; Biology; Receptor; Discovery and development of mTOR inhibitors","score_opus":0.12445407943585476,"score_gpt":0.377092111462753,"score_spread":0.2526380320268983,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2107233903","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0016993227,0.9969258,0.00005344387,0.00014556659,0.000070320006,0.0003777002,0.000116849646,0.000004845038,0.0006061918],"genre_scores_gemma":[0.0010246746,0.99756986,0.00048419306,0.000263023,0.0000588098,0.000056523066,0.00041255166,0.00002460501,0.00010574585],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984685,0.00032909663,0.00048308208,0.0003899097,0.00006515527,0.00026422867],"domain_scores_gemma":[0.99917126,0.000051130028,0.00028591562,0.0003112277,0.00005324451,0.00012721067],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025538792,0.00028602476,0.0010706177,0.00012011021,0.000020325702,0.0000074528753,0.00019777322,0.00018771853,0.00000965694],"category_scores_gemma":[0.00011776816,0.00022769983,0.0002360994,0.000090351416,0.00012075729,0.0000017310538,0.00008734947,0.00012610151,0.0000027139693],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007226168,0.00021503554,0.000011950567,0.0022482672,0.00017194859,0.00014138463,0.000031288386,8.0117724e-7,0.0003327153,0.0005562801,0.0006443577,0.9955737],"study_design_scores_gemma":[0.00024588354,0.0010708332,0.00007484752,0.000567554,0.00015095746,0.000018437288,0.000015876074,0.0000017598193,0.0001264664,0.00063164317,0.99686706,0.0002286661],"about_ca_topic_score_codex":0.000013212782,"about_ca_topic_score_gemma":0.000060490907,"teacher_disagreement_score":0.99622273,"about_ca_system_score_codex":0.000007551289,"about_ca_system_score_gemma":0.00036295145,"threshold_uncertainty_score":0.92853296},"labels":[],"label_agreement":null},{"id":"W2107400826","doi":"10.1158/0008-5472.can-11-2126","title":"Sef Downregulation by Ras Causes MEK1/2 to Become Aberrantly Nuclear Localized Leading to Polyploidy and Neoplastic Transformation","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":55,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Institute for Research in Immunology and Cancer; Jewish General Hospital","funders":"Canadian Institutes of Health Research","keywords":"Downregulation and upregulation; Neoplastic transformation; Carcinogenesis; MAPK/ERK pathway; Nuclear localization sequence; Cell biology; Biology; Phosphorylation; Cancer research; Nuclear export signal; Signal transduction; Kinase; Subcellular localization; Malignant transformation; Cancer; Cell growth; Cell nucleus; Nucleus; Genetics; Cytoplasm; Gene","score_opus":0.04321457610070474,"score_gpt":0.3559262528742646,"score_spread":0.3127116767735599,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2107400826","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955139,0.00082615664,0.001740135,0.00069816347,0.00011875811,0.0004069183,0.000047688438,0.000014306406,0.00063393917],"genre_scores_gemma":[0.9983667,0.00014073883,0.00011553493,0.00027307743,0.0002443329,0.000084082974,0.00005198921,0.000025850695,0.00069768366],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998811,0.00009047776,0.0001485323,0.00023060922,0.00025071783,0.00046864856],"domain_scores_gemma":[0.9993659,0.00002371331,0.000018175448,0.00017416294,0.000093168215,0.00032486403],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041473904,0.00010922069,0.00012401817,0.000107860156,0.00016523658,0.000048884172,0.00011375424,0.00010270773,0.00010016916],"category_scores_gemma":[0.0000702307,0.0001036012,0.000025575024,0.00018390376,0.000049153452,0.000018244778,0.000069193935,0.00010463872,0.00008773727],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019254898,0.000020598638,0.00057622994,0.000041235297,0.000018139268,3.8196316e-7,0.0009645827,0.00003954432,0.98343796,0.00018488127,0.010538672,0.003985224],"study_design_scores_gemma":[0.00078486453,0.0004925583,0.0045895698,0.000055289354,0.00001520728,0.000010545596,0.0003879279,0.00006288113,0.6531685,0.000025053007,0.34012303,0.00028456855],"about_ca_topic_score_codex":0.00021808491,"about_ca_topic_score_gemma":0.00012498832,"teacher_disagreement_score":0.33026946,"about_ca_system_score_codex":0.000055179982,"about_ca_system_score_gemma":0.000048928407,"threshold_uncertainty_score":0.42247343},"labels":[],"label_agreement":null},{"id":"W2107495112","doi":"10.1128/mmbr.00031-10","title":"Activation and Function of the MAPKs and Their Substrates, the MAPK-Activated Protein Kinases","year":2011,"lang":"en","type":"review","venue":"Microbiology and Molecular Biology Reviews","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3257,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Institute for Research in Immunology and Cancer","funders":"","keywords":"Kinase; Biology; Cell biology; MAPK/ERK pathway; p38 mitogen-activated protein kinases; Ribosomal s6 kinase; Mitogen-activated protein kinase; Protein kinase A; Mitogen-activated protein kinase kinase; MAP2K7; MAP kinase kinase kinase; ASK1; Signal transduction; Cyclin-dependent kinase 2; P70-S6 Kinase 1; Protein kinase B","score_opus":0.029848210072261107,"score_gpt":0.2585359077245694,"score_spread":0.2286876976523083,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2107495112","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.026204178,0.97152483,0.00018994292,0.000036548907,0.000120620476,0.0017092098,0.00011954446,0.0000066311222,0.000088517845],"genre_scores_gemma":[0.009080611,0.989669,0.000057902827,0.00019519543,0.000059149097,0.0002279507,0.00058379455,0.000029296345,0.00009706588],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9973797,0.001189359,0.0005397662,0.0006164965,0.000013861169,0.00026076796],"domain_scores_gemma":[0.9987201,0.000037804668,0.0005924171,0.00055551063,0.00004674799,0.000047425354],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004889088,0.00048777796,0.0010227623,0.00004442847,0.00016638501,0.000011091929,0.00026716563,0.0008221394,0.000008943827],"category_scores_gemma":[0.0001003435,0.00023196137,0.00024566843,0.000110659195,0.0007417451,0.0000039038714,0.00033148171,0.00032184256,0.000001848737],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000024923429,0.000018534925,0.000019151428,0.001265451,0.00015909215,3.2400902e-7,0.000016194972,4.265234e-9,0.76629,0.0008747806,0.00012798142,0.23120359],"study_design_scores_gemma":[0.00014687447,0.00027402063,0.000027957132,0.0009008679,0.0002057911,0.00012896708,0.0000074651243,4.0217035e-8,0.14833319,0.00016618975,0.849584,0.00022467057],"about_ca_topic_score_codex":0.000016471495,"about_ca_topic_score_gemma":0.000014210341,"teacher_disagreement_score":0.849456,"about_ca_system_score_codex":0.000006225433,"about_ca_system_score_gemma":0.00008341836,"threshold_uncertainty_score":0.945911},"labels":[],"label_agreement":null},{"id":"W2110962636","doi":"10.1186/1476-4598-9-271","title":"The serine protease inhibitor serpinE2 is a novel target of ERK signaling involved in human colorectal tumorigenesis","year":2010,"lang":"en","type":"article","venue":"Molecular Cancer","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":92,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Université de Sherbrooke","funders":"Canadian Institutes of Health Research; Canadian Association of Gastroenterology; Crohn's and Colitis Foundation of Canada","keywords":"Biology; KRAS; Carcinogenesis; Cancer research; MAPK/ERK pathway; Kinase; MEK inhibitor; Colorectal cancer; Molecular biology; Cancer; Cell biology; Genetics","score_opus":0.007997924231554338,"score_gpt":0.2428362163992162,"score_spread":0.23483829216766186,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2110962636","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99798554,0.00054644875,0.0004023754,0.00016663005,0.00024920987,0.0004210798,0.00006117223,0.000008697,0.00015882117],"genre_scores_gemma":[0.9983138,0.000021522852,0.00076084153,0.00020634703,0.00022050017,0.0002485096,0.000043540764,0.00003304385,0.00015191064],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99891615,0.00003572372,0.0002801837,0.0003262567,0.00016196484,0.0002797271],"domain_scores_gemma":[0.99933785,0.0000063136285,0.00012248276,0.00034179035,0.0001100161,0.000081533144],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020726399,0.00017691973,0.00017652234,0.00004096809,0.0000937103,0.000019179339,0.00024089024,0.00014242646,0.000047493606],"category_scores_gemma":[0.000052192634,0.00014493277,0.000107856686,0.00013646936,0.000100291676,0.000003955559,0.00011612571,0.00016587213,0.0000015690649],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000093208764,0.00007118644,0.007342766,0.000033441655,0.000036982077,0.000009543815,0.00006498722,0.000060206836,0.9917982,0.00012723735,0.00019810704,0.00016408335],"study_design_scores_gemma":[0.0006689635,0.00016261372,0.0021093276,0.000021510037,0.000011821558,0.0000030838305,0.000033260105,0.000087482826,0.9860406,0.00007253989,0.010604855,0.00018394607],"about_ca_topic_score_codex":0.0002921949,"about_ca_topic_score_gemma":0.00071364426,"teacher_disagreement_score":0.010406747,"about_ca_system_score_codex":0.000017158654,"about_ca_system_score_gemma":0.00019246413,"threshold_uncertainty_score":0.5910187},"labels":[],"label_agreement":null},{"id":"W2111404068","doi":"10.1016/s1470-2045(14)70012-9","title":"Safety and efficacy of vemurafenib in BRAFV600E and BRAFV600K mutation-positive melanoma (BRIM-3): extended follow-up of a phase 3, randomised, open-label study","year":2014,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":978,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"National Medical Research Council; National Health and Medical Research Council; National Cancer Institute; National Institutes of Health; National Institute for Health and Care Research; NIHR Biomedical Research Centre, Royal Marsden NHS Foundation Trust/Institute of Cancer Research; Genentech; F. Hoffmann-La Roche","keywords":"Vemurafenib; Dacarbazine; Medicine; Internal medicine; Melanoma; Population; Oncology; Progression-free survival; Metastatic melanoma; Chemotherapy; Cancer research; Cancer","score_opus":0.0286159142605539,"score_gpt":0.3339014764236995,"score_spread":0.3052855621631456,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2111404068","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99506813,0.00031286658,0.0003243542,0.00025117994,0.00010798077,0.0011329814,0.000041513744,0.000004699333,0.0027562866],"genre_scores_gemma":[0.9989465,0.00012769057,0.00037134535,0.0001959751,0.000107638305,0.000047935137,0.000051433864,0.000013991938,0.00013752749],"study_design_codex":"bench_or_experimental","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9982852,0.00067222095,0.00041700812,0.0003223228,0.00008594214,0.00021730294],"domain_scores_gemma":[0.9989133,0.0003558692,0.0002529949,0.0003504614,0.00006953995,0.00005783344],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011778183,0.00015636784,0.00067078695,0.000048021153,0.000062176274,0.00001137866,0.00030448026,0.00012444291,0.0000081633925],"category_scores_gemma":[0.0002849355,0.000115953546,0.000031851654,0.00008858667,0.0002112981,0.000007345978,0.00027289,0.00011055446,9.1193925e-7],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.11723933,0.005918985,0.0074286326,0.00013672051,0.00066282664,0.000055513443,0.006525965,0.000016317386,0.71319085,0.003644714,0.0005567797,0.14462338],"study_design_scores_gemma":[0.7619356,0.023933085,0.091748916,0.00008302523,0.00034691312,0.00018076375,0.0014294119,0.0005928241,0.11127973,0.0009786859,0.006951217,0.00053980714],"about_ca_topic_score_codex":0.00012726754,"about_ca_topic_score_gemma":0.00042344426,"teacher_disagreement_score":0.6446963,"about_ca_system_score_codex":0.000012129177,"about_ca_system_score_gemma":0.00008710973,"threshold_uncertainty_score":0.4728448},"labels":[],"label_agreement":null},{"id":"W2111650683","doi":"10.1007/s12012-009-9056-0","title":"Mechanisms of Myocyte Cytotoxicity Induced by the Multikinase Inhibitor Sorafenib","year":2009,"lang":"en","type":"article","venue":"Cardiovascular Toxicology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":48,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Apotex (Canada); University of Manitoba","funders":"Canadian Institutes of Health Research","keywords":"Cytotoxicity; Sorafenib; Chemistry; Pharmacology; Myocyte; Cancer research; Internal medicine; Medicine; Biochemistry; In vitro; Hepatocellular carcinoma","score_opus":0.012619230312792003,"score_gpt":0.22452430043128604,"score_spread":0.21190507011849405,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2111650683","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9817996,0.0023800945,0.013548722,0.0001804952,0.0004269577,0.00047521127,0.000036894813,0.0000245375,0.0011275151],"genre_scores_gemma":[0.9982857,0.000078970756,0.0003745757,0.0007617398,0.00021677291,0.000040756004,0.000073119256,0.000021632644,0.00014669537],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99830663,0.0003077209,0.00030469205,0.00046906274,0.00023860183,0.00037326937],"domain_scores_gemma":[0.9986816,0.000021416776,0.00010781569,0.0009702272,0.00011077679,0.000108152446],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00058706093,0.00023586229,0.0004382098,0.000044177574,0.000116185096,0.000012238635,0.00038228807,0.00040215327,0.000016657277],"category_scores_gemma":[0.00017484471,0.0001847585,0.00068223197,0.00012763309,0.00010989755,0.0000045258466,0.00011652509,0.00017851833,0.0000127851445],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007151238,0.00010455244,0.000011864121,0.000008722219,0.0003252552,0.00001278555,0.00003037437,0.000037850194,0.991602,0.00068957615,0.0016026051,0.0055028815],"study_design_scores_gemma":[0.0011214811,0.00082844443,0.0010447716,0.0000056964714,0.00010747938,0.000068585476,0.000050789153,0.00002046108,0.9789924,0.0004183894,0.01712275,0.00021872565],"about_ca_topic_score_codex":0.000013233357,"about_ca_topic_score_gemma":0.0000059010094,"teacher_disagreement_score":0.016486164,"about_ca_system_score_codex":0.000022162587,"about_ca_system_score_gemma":0.00008617673,"threshold_uncertainty_score":0.7534233},"labels":[],"label_agreement":null},{"id":"W2112967018","doi":"10.1158/1078-0432.ccr-11-1344","title":"Skin Tumors Induced by Sorafenib; Paradoxic RAS–RAF Pathway Activation and Oncogenic Mutations of <i>HRAS</i> , <i>TP53</i> , and <i>TGFBR1</i>","year":2011,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":120,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"HRAS; Sorafenib; Neuroblastoma RAS viral oncogene homolog; Cancer research; Keratinocyte; MAPK/ERK pathway; In vivo; Kinase; Malignant transformation; Medicine; Pathology; Biology; Cancer; KRAS; In vitro; Internal medicine; Hepatocellular carcinoma","score_opus":0.15463426291045915,"score_gpt":0.41440380203132415,"score_spread":0.259769539120865,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2112967018","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99678016,0.0010510205,0.00011792571,0.00016804019,0.00009809429,0.00039016453,0.00008445348,0.000010123383,0.0013000177],"genre_scores_gemma":[0.99768335,0.0012170003,0.0001602995,0.00022799545,0.00019237427,0.00011725771,0.00007532632,0.000028884779,0.0002975392],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99783736,0.00040194305,0.00052015315,0.0005668263,0.00029902387,0.00037469255],"domain_scores_gemma":[0.9987794,0.00020622561,0.00014985469,0.0003742089,0.00023659047,0.0002536828],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013253068,0.00016005515,0.00029034083,0.00006810459,0.00013971106,0.000020984016,0.0002184168,0.00024220656,0.00005030596],"category_scores_gemma":[0.00041775967,0.00014693981,0.00007628073,0.00020610695,0.000495228,0.000013903411,0.00022403487,0.00039441304,0.000006401178],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004928328,0.00024938828,0.006985602,0.000057204896,0.00005250755,0.0000031611912,0.00016760398,3.228012e-7,0.97368413,0.00016202834,0.0030469603,0.015098269],"study_design_scores_gemma":[0.0015563564,0.0018225125,0.013613399,0.00004898849,0.000017601304,0.0000055362048,0.00016624613,0.000011016254,0.9727517,0.00061012607,0.009183065,0.00021347929],"about_ca_topic_score_codex":0.00044690972,"about_ca_topic_score_gemma":0.00012727798,"teacher_disagreement_score":0.0148847895,"about_ca_system_score_codex":0.000016786242,"about_ca_system_score_gemma":0.00036076867,"threshold_uncertainty_score":0.59920317},"labels":[],"label_agreement":null},{"id":"W2114067189","doi":"10.1158/0008-5472.can-13-2381","title":"ERKs in Cancer: Friends or Foes?","year":2014,"lang":"en","type":"review","venue":"Cancer Research","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":211,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Institute for Research in Immunology and Cancer","funders":"Canadian Institutes of Health Research","keywords":"Cancer; Medicine; Internal medicine","score_opus":0.207352210794642,"score_gpt":0.5086070552722703,"score_spread":0.30125484447762835,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2114067189","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00042972775,0.9947413,0.000013699549,0.000044493256,0.0004297271,0.00065876154,0.00015859463,0.000009068554,0.0035145923],"genre_scores_gemma":[0.00021439345,0.98511213,0.000021448512,0.000046306523,0.0015316344,0.0020101871,0.00021505603,0.00008135809,0.010767461],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9971898,0.000469806,0.00040863606,0.00078531855,0.00037379854,0.00077262626],"domain_scores_gemma":[0.99872965,0.00006953529,0.000108864406,0.000750292,0.00015190155,0.00018977823],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00091888185,0.00031538328,0.0008970902,0.0002634352,0.000093369476,0.000045921835,0.0007455641,0.0006335603,0.00052534783],"category_scores_gemma":[0.00014176904,0.00023003641,0.00022111105,0.0004853336,0.00014906243,0.0000022959582,0.00039453473,0.00077219796,0.00007946293],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005402098,0.000035778437,0.000026707088,0.007714448,0.0000970388,0.000035311525,0.000020355183,0.00000122105,0.0005462838,0.00009430394,0.022513228,0.9688613],"study_design_scores_gemma":[0.00024210243,0.00021506526,0.0000035005182,0.0034315567,0.000040449948,0.000009949733,0.0000088496645,0.0000011971504,0.0005796151,0.00001457639,0.99516666,0.00028649552],"about_ca_topic_score_codex":0.0006878316,"about_ca_topic_score_gemma":0.0022901522,"teacher_disagreement_score":0.9726534,"about_ca_system_score_codex":0.00019963049,"about_ca_system_score_gemma":0.0022077824,"threshold_uncertainty_score":0.9380613},"labels":[],"label_agreement":null},{"id":"W2115142313","doi":"10.1074/jbc.m306002200","title":"Identification of a Novel Human Kinase Supporter of Ras (hKSR-2) That Functions as a Negative Regulator of Cot (Tpl2) Signaling","year":2003,"lang":"en","type":"article","venue":"Journal of Biological Chemistry","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's Health Research Institute","funders":"","keywords":"MAP kinase kinase kinase; Cell biology; c-Raf; MAPK/ERK pathway; Kinase; MAP2K7; Mitogen-activated protein kinase kinase; Protein kinase A; ASK1; Signal transduction; Biology; Chemistry; Cyclin-dependent kinase 2","score_opus":0.03380380386447431,"score_gpt":0.2681899655970171,"score_spread":0.23438616173254276,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2115142313","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99738973,0.00022918916,0.001343309,0.000017539449,0.00006559809,0.000073989824,0.00005330375,0.000002199901,0.00082516135],"genre_scores_gemma":[0.9991037,0.000027701615,0.00040792074,0.000016770384,0.00009204449,0.00000302743,0.00003395858,0.00000793812,0.00030692632],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987082,0.000052052004,0.00074828253,0.00017975151,0.00017468876,0.00013701782],"domain_scores_gemma":[0.9981296,0.000039974584,0.001154034,0.0002244839,0.00036193267,0.00008997649],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004317857,0.00013629129,0.00034093027,0.00003166605,0.000036143418,0.0000053975964,0.00018127437,0.00025260876,0.0001582196],"category_scores_gemma":[0.00043642675,0.0001036958,0.00026234635,0.000085047635,0.00021475236,0.0000062320523,0.000037581376,0.00013183404,5.924038e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014570105,0.0003466173,0.0035447727,0.000078485966,0.00010077805,0.0000036864726,0.000036182075,0.000017961956,0.99543583,0.00007631409,0.00015475448,0.00005893993],"study_design_scores_gemma":[0.00083144946,0.00052045163,0.0018221114,0.00005216742,0.000049250175,0.000087583685,0.00037991913,0.000002823276,0.9955007,0.00021906357,0.00043146906,0.00010303198],"about_ca_topic_score_codex":0.0000035439182,"about_ca_topic_score_gemma":4.0360027e-7,"teacher_disagreement_score":0.0017226614,"about_ca_system_score_codex":0.00001326066,"about_ca_system_score_gemma":0.00011162726,"threshold_uncertainty_score":0.4228592},"labels":[],"label_agreement":null},{"id":"W2116155140","doi":"10.1017/s146239941100202x","title":"Towards new therapeutic approaches for malignant melanoma","year":2011,"lang":"en","type":"review","venue":"Expert Reviews in Molecular Medicine","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"Canadian Institutes of Health Research; Melanoma Research Alliance","keywords":"Melanoma; Cancer research; Cancer; Disease; Medicine; Computational biology; Biology; Pathology; Internal medicine","score_opus":0.1497417081651183,"score_gpt":0.3551992918440242,"score_spread":0.2054575836789059,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2116155140","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[9.997244e-7,0.9699941,0.022024365,0.000087828805,0.0006103973,0.0033296838,0.000012334043,0.000016396103,0.003923883],"genre_scores_gemma":[0.00000375373,0.9893872,0.0046487856,0.00084441784,0.001311014,0.001537024,0.00082737976,0.00015498605,0.0012854461],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9961581,0.00059533934,0.0013494012,0.0011023977,0.00020017508,0.0005945454],"domain_scores_gemma":[0.9977943,0.000032598786,0.00051966123,0.001347246,0.000040374987,0.00026587365],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011826083,0.0009030863,0.0029147689,0.00020291115,0.000052882308,0.0000127140665,0.0008576789,0.0007071341,0.000117528354],"category_scores_gemma":[0.00038313714,0.000592901,0.0009084449,0.00025324282,0.00013930068,0.000003559978,0.00017442052,0.00033320222,0.000037804315],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00001586538,0.000053642227,4.6179974e-7,0.004513315,0.00014192879,0.000021845359,0.00012745363,4.924522e-8,0.0010094651,0.0019244491,0.008062577,0.98412895],"study_design_scores_gemma":[0.0006018078,0.0006774126,5.178097e-7,0.009650496,0.0003418215,0.00010572644,0.0000200202,0.0000014225673,0.00054363796,0.00029731347,0.9871336,0.0006262275],"about_ca_topic_score_codex":0.00007382047,"about_ca_topic_score_gemma":0.000017202005,"teacher_disagreement_score":0.98350275,"about_ca_system_score_codex":0.0000514621,"about_ca_system_score_gemma":0.00040375115,"threshold_uncertainty_score":0.99965227},"labels":[],"label_agreement":null},{"id":"W2116254970","doi":"10.1038/ncb1098","title":"MKK7 couples stress signalling to G2/M cell-cycle progression and cellular senescence","year":2004,"lang":"en","type":"article","venue":"Nature Cell Biology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":146,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Cell biology; Cyclin-dependent kinase 1; Cell cycle; Senescence; Cell cycle checkpoint; Biology; Embryonic stem cell; Cell growth; Kinase; Cell; Genetics; Gene","score_opus":0.0041888761731188025,"score_gpt":0.23464169549599076,"score_spread":0.23045281932287195,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2116254970","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9855543,0.008793365,0.0033819736,0.00015315504,0.00034058472,0.00028721863,0.000041630734,0.000026195054,0.0014215707],"genre_scores_gemma":[0.9958469,0.00031473202,0.0026027053,0.0004361618,0.0003283871,0.000019657793,0.00025065636,0.000023235845,0.00017752714],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987406,0.00005013815,0.00017590831,0.0005814431,0.00008431746,0.00036758563],"domain_scores_gemma":[0.99939305,0.000015758531,0.000077351535,0.0002698204,0.00007230646,0.00017171979],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012618038,0.00022266702,0.00018313789,0.00005226962,0.00011301988,0.00001988687,0.000219746,0.00072721415,0.000012257227],"category_scores_gemma":[0.000029791505,0.00018713431,0.000056281762,0.0000872892,0.00008230622,0.0000031255165,0.00017781171,0.00028313458,0.000020629097],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006107541,0.0000770796,0.0015183078,0.00004790735,0.000008003568,0.000017478495,0.00005581857,0.0001309654,0.9963501,0.0001459049,0.00013632697,0.0014510023],"study_design_scores_gemma":[0.000541992,0.0005259321,0.00016691617,0.000029275392,0.000012216243,0.0000071624627,0.000039496146,0.000020525064,0.9761122,0.0001579923,0.022139052,0.00024722423],"about_ca_topic_score_codex":0.000010870389,"about_ca_topic_score_gemma":0.000021033306,"teacher_disagreement_score":0.022002725,"about_ca_system_score_codex":0.000012842694,"about_ca_system_score_gemma":0.00006784353,"threshold_uncertainty_score":0.7631116},"labels":[],"label_agreement":null},{"id":"W2116344367","doi":"10.1517/14728222.2010.531014","title":"Paving the way for targeting RSK in cancer","year":2010,"lang":"en","type":"article","venue":"Expert Opinion on Therapeutic Targets","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":67,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Institute for Research in Immunology and Cancer","funders":"","keywords":"Kinase; Ribosomal s6 kinase; MAPK/ERK pathway; Biology; Cell biology; Motility; Cancer cell; Cancer; Signal transduction; Phosphorylation; Cell growth; Protein kinase A; p38 mitogen-activated protein kinases; Cancer research; PI3K/AKT/mTOR pathway; Biochemistry; Genetics; P70-S6 Kinase 1","score_opus":0.02663451962857396,"score_gpt":0.31911428966363176,"score_spread":0.2924797700350578,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2116344367","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7903795,0.1475563,0.010778699,0.017059185,0.025246257,0.003969853,0.0001523076,0.00017086716,0.0046870303],"genre_scores_gemma":[0.99356616,0.0012660199,0.000587161,0.0024965764,0.0013791336,0.0003649911,0.00008269601,0.00003515526,0.00022211368],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990655,0.000047862726,0.00017951673,0.00030779807,0.00009907208,0.0003002588],"domain_scores_gemma":[0.99951065,0.000045470246,0.00006432106,0.00029246125,0.00003894694,0.00004813944],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026972764,0.00015683864,0.000116907526,0.000030113313,0.00014109797,0.000021201666,0.0002340099,0.0001439459,0.000078597994],"category_scores_gemma":[0.00005306832,0.00010788847,0.00008504595,0.000047668746,0.00004452095,0.0000035896499,0.00004032567,0.00015733554,0.0000067273863],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009646661,0.00006637235,0.0006323371,0.0000054107636,0.00002350761,4.0875702e-7,0.00044147242,0.000016688642,0.95139897,0.0012879703,0.0048597953,0.041170575],"study_design_scores_gemma":[0.00048946775,0.00016218012,0.0010388354,0.000010065623,9.0665515e-7,0.0000017175038,0.00013588546,0.00021669087,0.24839783,0.00022465039,0.74916214,0.00015960685],"about_ca_topic_score_codex":0.000043221367,"about_ca_topic_score_gemma":0.00006764598,"teacher_disagreement_score":0.7443024,"about_ca_system_score_codex":0.0000107937585,"about_ca_system_score_gemma":0.000045817666,"threshold_uncertainty_score":0.43995643},"labels":[],"label_agreement":null},{"id":"W2117514750","doi":"10.1158/1535-7163.mct-07-2376","title":"Transient exposure of carcinoma cells to RAS/MEK inhibitors and UCN-01 causes cell death<i>in vitro</i>and<i>in vivo</i>","year":2008,"lang":"en","type":"article","venue":"Molecular Cancer Therapeutics","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; National Cancer Institute","keywords":"In vivo; In vitro; Programmed cell death; Cancer research; Chemistry; Transient (computer programming); Cell culture; Cell biology; Biology; Apoptosis; Pharmacology; Biochemistry; Genetics","score_opus":0.014835812172876427,"score_gpt":0.22654438564568544,"score_spread":0.211708573472809,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2117514750","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98936194,0.00949884,0.00028663987,0.00009836577,0.00013291699,0.00033110465,0.00006761809,0.0000060714383,0.00021649318],"genre_scores_gemma":[0.9962505,0.002028603,0.00045251203,0.0010259917,0.0000472871,0.00004750503,0.000009545479,0.000038883318,0.00009917729],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987058,0.000077637764,0.00030363855,0.0004228493,0.00016273397,0.00032733273],"domain_scores_gemma":[0.9994811,0.000010607338,0.00006417245,0.00028640253,0.00004115001,0.00011657568],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009443455,0.00023906145,0.00027946942,0.00009902658,0.000038153576,0.000008455974,0.00012273813,0.0001660073,0.000004015971],"category_scores_gemma":[0.0000026698383,0.00024108724,0.000069846785,0.00014082446,0.00008141535,0.000004210534,0.00006092913,0.00010858627,5.556765e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023244566,0.00017374541,0.008730759,0.000059226248,0.000022412756,0.00007387796,0.00065212254,0.0000992269,0.9893718,0.0000072891207,0.000039637835,0.00053750386],"study_design_scores_gemma":[0.0020487965,0.00029133412,0.0035115303,0.000025756615,0.0000288972,0.00001571629,0.00007320155,0.000025494237,0.98668903,0.000011017564,0.007016531,0.0002627171],"about_ca_topic_score_codex":0.00021635811,"about_ca_topic_score_gemma":0.00017988,"teacher_disagreement_score":0.0074702366,"about_ca_system_score_codex":0.000024295408,"about_ca_system_score_gemma":0.00010495378,"threshold_uncertainty_score":0.9831252},"labels":[],"label_agreement":null},{"id":"W2119081353","doi":"10.1158/1078-0432.ccr-11-1122","title":"RAF265 Inhibits the Growth of Advanced Human Melanoma Tumors","year":2012,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":62,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"National Center for Advancing Translational Sciences; National Institute of General Medical Sciences; National Cancer Institute; National Heart, Lung, and Blood Institute; U.S. Public Health Service; U.S. Food and Drug Administration; Vanderbilt University Medical Center; Vanderbilt University; U.S. Department of Veterans Affairs","keywords":"Cancer research; Melanoma; MAPK/ERK pathway; Cell growth; V600E; Kinase; Cancer; Medicine; Apoptosis; Signal transduction; Mutation; Biology; Internal medicine; Gene; Cell biology","score_opus":0.15127478355897447,"score_gpt":0.4782351862684745,"score_spread":0.3269604027095,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2119081353","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99108624,0.002315514,0.000014224671,0.00037041583,0.00025551792,0.00027564378,0.000019920823,0.000006411467,0.0056560845],"genre_scores_gemma":[0.99685127,0.0003693871,0.000055484463,0.0001686729,0.0011598747,0.00009357476,0.000023959221,0.000021072807,0.0012567331],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979773,0.00046577296,0.00041646732,0.00028145785,0.0003516707,0.00050732505],"domain_scores_gemma":[0.9987613,0.00016447876,0.00009393398,0.00048997294,0.00029284332,0.00019745727],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026508349,0.00010524512,0.00020355127,0.00003852595,0.00016100118,0.000010599705,0.00043527293,0.00015681626,0.000119457465],"category_scores_gemma":[0.0007127712,0.00007115146,0.00013781017,0.00017562705,0.00050286355,0.0000056956906,0.00034095565,0.0003910168,0.000030552255],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039434328,0.0003524546,0.20543516,0.00008463874,0.00008382843,0.00000310957,0.00015098245,0.0000021706849,0.7595587,0.004382703,0.01925763,0.01029431],"study_design_scores_gemma":[0.0011964827,0.0012239857,0.13512221,0.000055979133,0.000014633422,0.000005429416,0.00018284639,0.000002386213,0.79723173,0.0004952299,0.06426342,0.00020569045],"about_ca_topic_score_codex":0.00011017624,"about_ca_topic_score_gemma":0.000075839045,"teacher_disagreement_score":0.070312954,"about_ca_system_score_codex":0.000015113444,"about_ca_system_score_gemma":0.00016832244,"threshold_uncertainty_score":0.29014724},"labels":[],"label_agreement":null},{"id":"W2120136426","doi":"10.1139/o04-121","title":"The Ras-MAPK signal transduction pathway, cancer and chromatin remodeling","year":2005,"lang":"en","type":"review","venue":"Biochemistry and Cell Biology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":217,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"National Cancer Institute; Canadian Institutes of Health Research; Canada Research Chairs; CancerCare Manitoba Foundation","keywords":"Chromatin remodeling; MAPK/ERK pathway; Cell biology; Histone H3; Chromatin; Biology; Signal transduction; Histone; Kinase; Mitogen-activated protein kinase; Phosphorylation; Protein kinase A; Chromatin immunoprecipitation; Cancer research; Gene expression; Gene; Genetics; Promoter","score_opus":0.020777105371813827,"score_gpt":0.2729986952507849,"score_spread":0.2522215898789711,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2120136426","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.006864643,0.99132013,0.00006195472,0.0000403631,0.00021634625,0.00026728248,0.00015584871,0.000015992902,0.0010574514],"genre_scores_gemma":[0.0046121897,0.9914133,0.00011157337,0.000040110303,0.0013267975,0.00011882383,0.00058515667,0.000035331563,0.0017567466],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9983195,0.00010501339,0.00043071285,0.00071572786,0.000060311315,0.00036875365],"domain_scores_gemma":[0.9991949,0.000050006325,0.00023775986,0.00034861744,0.00004025395,0.00012843238],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00024068065,0.00043725138,0.00057056284,0.00002304329,0.00027684707,0.0000398715,0.00022763183,0.00089188834,0.000031875214],"category_scores_gemma":[0.000019871997,0.0003034496,0.00018979615,0.000055502132,0.0002613894,0.0000024861693,0.00012426736,0.00027087354,0.0000037595803],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00001557044,0.00001578605,0.0000018138948,0.0013576465,0.00005572605,0.0000011819519,0.0000089866635,3.7590576e-7,0.19900349,0.00001609861,0.00031138616,0.7992119],"study_design_scores_gemma":[0.00020028118,0.000092885384,3.214788e-7,0.00033466422,0.00013967694,0.0000806285,0.000023496354,0.0000112632215,0.083329275,0.00001638285,0.9154218,0.000349339],"about_ca_topic_score_codex":0.000013145829,"about_ca_topic_score_gemma":0.000008387839,"teacher_disagreement_score":0.9151104,"about_ca_system_score_codex":0.000020393181,"about_ca_system_score_gemma":0.00024702874,"threshold_uncertainty_score":0.99994177},"labels":[],"label_agreement":null},{"id":"W2120707752","doi":"10.1158/1055-9965.epi-11-0472","title":"Prognostic Significance of Cytoplasmic p27 Expression in Human Melanoma","year":2011,"lang":"en","type":"article","venue":"Cancer Epidemiology Biomarkers & Prevention","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; Vancouver Coastal Health Research Institute; University of British Columbia","funders":"Canadian Institutes of Health Research","keywords":"Melanoma; Tissue microarray; Medicine; Cancer research; Biomarker; Pathology; Oncology; Proportional hazards model; Cytoplasm; Cancer; Internal medicine; Immunohistochemistry; Biology","score_opus":0.06269212030114905,"score_gpt":0.324242944876315,"score_spread":0.26155082457516593,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2120707752","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99003154,0.003631596,0.0042006397,0.00004784243,0.0003398343,0.0005147128,0.00001674106,0.00001564261,0.0012014415],"genre_scores_gemma":[0.99547905,0.0002894697,0.0033024799,0.00006942838,0.000092388385,0.00028146242,0.00014821398,0.000020088612,0.00031741604],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978499,0.0005989128,0.0006246613,0.0005166535,0.000061224884,0.00034869392],"domain_scores_gemma":[0.99904627,0.0000619825,0.00039255767,0.00036506055,0.000054012617,0.00008012245],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00096361997,0.00019276133,0.00035820852,0.00010528871,0.000050675513,0.000001551774,0.00023592597,0.00031427862,0.0001250839],"category_scores_gemma":[0.0002438612,0.00018253886,0.0001470406,0.00010640385,0.00019432651,0.0000087820845,0.000091651025,0.00010226847,0.0000054666225],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017905919,0.000087283326,0.4380376,0.00004867795,0.00005279387,0.000002655749,0.000047723614,0.0000054927696,0.5586342,0.00015536761,0.00092634594,0.0018227714],"study_design_scores_gemma":[0.000803359,0.00060976425,0.45182782,0.00020932624,0.000041325307,0.0000063310454,0.000056706886,0.000025358615,0.5409155,0.004144925,0.0011173903,0.00024219995],"about_ca_topic_score_codex":0.00018567883,"about_ca_topic_score_gemma":0.0003045777,"teacher_disagreement_score":0.017718723,"about_ca_system_score_codex":0.00003237032,"about_ca_system_score_gemma":0.00009265441,"threshold_uncertainty_score":0.7443719},"labels":[],"label_agreement":null},{"id":"W2125048552","doi":"10.1084/jem.194.6.757","title":"The Stress Kinase Mitogen-Activated Protein Kinase Kinase (Mkk)7 Is a Negative Regulator of Antigen Receptor and Growth Factor Receptor–Induced Proliferation in Hematopoietic Cells","year":2001,"lang":"en","type":"article","venue":"The Journal of Experimental Medicine","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":63,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Amgen (Canada); University of Toronto; Ontario Institute for Cancer Research","funders":"","keywords":"Cell biology; Interleukin 33; Mitogen-activated protein kinase kinase; MAP kinase kinase kinase; ASK1; Cancer research; MAPK/ERK pathway; Biology; Mitogen-activated protein kinase; Kinase; Protein kinase A; Chemistry; Cytokine; Immunology; Interleukin","score_opus":0.015903587272496612,"score_gpt":0.26223208883878774,"score_spread":0.24632850156629113,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2125048552","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951732,0.0030702932,0.000021760774,0.00076755986,0.0002896349,0.0006025441,0.000015965716,0.000003192607,0.000055846624],"genre_scores_gemma":[0.99874717,0.0005670115,0.0000948639,0.000096440795,0.00031979248,0.000018014365,0.0000095398855,0.000021480448,0.00012568138],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984546,0.00027519773,0.0005616524,0.00017777158,0.00030959464,0.0002212247],"domain_scores_gemma":[0.9988919,0.000054800515,0.0004907976,0.00025616423,0.00017260942,0.00013372645],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039536424,0.0002143504,0.00030808192,0.00006970497,0.0001225968,0.000012846968,0.00023510169,0.00010995226,0.00006716617],"category_scores_gemma":[0.00016020695,0.00011999467,0.000060972336,0.00015397096,0.00023939756,0.000018294504,0.000070715105,0.00018043935,0.0000013391614],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015565298,0.00016174305,0.00071771466,0.000022118575,0.000058553996,0.000008943361,0.0035782484,5.316886e-7,0.99298507,0.00002734871,0.000525022,0.0003581855],"study_design_scores_gemma":[0.0021278793,0.0023468882,0.00071601145,0.0002721636,0.000015861471,0.000041247884,0.0035884944,0.0000079271485,0.99026644,0.000035130197,0.00045591802,0.00012602149],"about_ca_topic_score_codex":0.00008529973,"about_ca_topic_score_gemma":0.00001036673,"teacher_disagreement_score":0.003573973,"about_ca_system_score_codex":0.000044000895,"about_ca_system_score_gemma":0.00007968554,"threshold_uncertainty_score":0.48932406},"labels":[],"label_agreement":null},{"id":"W2126281471","doi":"10.1128/mcb.01265-06","title":"Differential Regulation of B-Raf Isoforms by Phosphorylation and AutoinhibitoryMechanisms","year":2006,"lang":"en","type":"article","venue":"Molecular and Cellular Biology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Nautical Research Society","funders":"Institut National de la Santé et de la Recherche Médicale; Institut National Du Cancer; Centre National de la Recherche Scientifique; Association pour la Recherche sur le Cancer","keywords":"Gene isoform; Phosphorylation; Biology; Exon; Alternative splicing; RNA splicing; Kinase; Protein kinase domain; Mutation; Molecular biology; Cell biology; Biochemistry; Gene; Mutant","score_opus":0.002355465144577604,"score_gpt":0.17373805012107998,"score_spread":0.17138258497650238,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2126281471","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9254825,0.0026971267,0.07110401,0.000026650547,0.00009350338,0.00012704328,0.000025221432,0.000009361954,0.00043455593],"genre_scores_gemma":[0.9983665,0.000060599865,0.00033769375,0.000034179615,0.000068277,0.000008575183,0.00082490034,0.000014848421,0.00028442845],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992203,0.00005029501,0.00020088618,0.00030285915,0.000057718305,0.00016793328],"domain_scores_gemma":[0.9996652,0.0000042840556,0.00009137854,0.00016329624,0.000033050088,0.000042818527],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006851944,0.00014155204,0.00015476254,0.000035508303,0.000056503635,0.0000097542,0.00005260245,0.0002276804,0.000019720814],"category_scores_gemma":[0.000007753049,0.00012849149,0.000050915918,0.000034843455,0.000109998095,0.0000029146208,0.00006789687,0.000044653993,0.0000010757589],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000035759902,0.000032080916,0.0009243518,0.000015607555,0.000016138285,0.000001006102,0.0000076088677,0.0000020166449,0.9907916,0.0061104894,0.00019035557,0.0018729873],"study_design_scores_gemma":[0.0005301429,0.00033479734,0.0010043057,0.0000044600556,0.00002072349,0.00000829218,0.00000811301,0.00013137842,0.9904618,0.0030626815,0.0042841053,0.00014918497],"about_ca_topic_score_codex":0.000053146356,"about_ca_topic_score_gemma":0.0000051753896,"teacher_disagreement_score":0.07288398,"about_ca_system_score_codex":0.000003694685,"about_ca_system_score_gemma":0.000013223676,"threshold_uncertainty_score":0.5239731},"labels":[],"label_agreement":null},{"id":"W2128035403","doi":"10.1056/nejmoa1412082","title":"Nivolumab in Previously Untreated Melanoma without <i>BRAF</i> Mutation","year":2014,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5352,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Victoria Hospital; BC Cancer Agency","funders":"","keywords":"Nivolumab; Melanoma; Mutation; Medicine; Cancer research; Biology; Genetics; Internal medicine; Cancer; Immunotherapy; Gene","score_opus":0.007510965650476341,"score_gpt":0.2337536327064622,"score_spread":0.22624266705598586,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2128035403","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9921202,0.00097575365,0.002882851,0.0007961017,0.00032989672,0.000083584906,7.3717945e-7,0.000004047619,0.0028068367],"genre_scores_gemma":[0.9960175,0.0001661948,0.00037923176,0.0003310781,0.0025303925,9.744093e-7,0.000023837709,0.0000129872815,0.0005377925],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99901986,0.00013437415,0.0003776746,0.0001260449,0.00018040252,0.00016161778],"domain_scores_gemma":[0.9993515,0.000030537743,0.00022482043,0.00014488769,0.000093468865,0.00015480381],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000690329,0.00011633958,0.00026515053,0.00009567281,0.00002078341,0.00000601595,0.00012785802,0.000084928484,0.00003687906],"category_scores_gemma":[0.0003523449,0.000081414095,0.00004070977,0.000080254766,0.000041945666,0.000005419823,0.000016023425,0.00013215024,0.0000035738933],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018815384,0.00012691731,0.09006483,0.0000633016,0.00012437534,0.00024262772,0.0013198566,0.00022106558,0.44668332,0.00025237154,0.016001275,0.44301853],"study_design_scores_gemma":[0.21670093,0.036222406,0.051284343,0.0010182405,0.00032487398,0.0072732,0.0003703437,0.0005501881,0.12665252,0.0025603808,0.5562831,0.00075946585],"about_ca_topic_score_codex":0.00007931194,"about_ca_topic_score_gemma":0.00022551874,"teacher_disagreement_score":0.54028183,"about_ca_system_score_codex":0.000013016411,"about_ca_system_score_gemma":0.000091316564,"threshold_uncertainty_score":0.33199704},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"nonrandomized_trial","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":[],"domain":null,"study_design":"design_other","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"}],"label_agreement":"split"},{"id":"W2128463141","doi":"10.1074/jbc.m011780200","title":"Impaired Synergistic Activation of Stress-activated Protein Kinase SAPK/JNK in Mouse Embryonic Stem Cells Lacking SEK1/MKK4","year":2001,"lang":"en","type":"article","venue":"Journal of Biological Chemistry","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":65,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Amgen (Canada); University of Toronto; Ontario Institute for Cancer Research","funders":"","keywords":"Phosphorylation; Kinase; MAPK/ERK pathway; Cell biology; p38 mitogen-activated protein kinases; Protein kinase A; Chemistry; Mitogen-activated protein kinase; Molecular biology; Biology","score_opus":0.02437249285869776,"score_gpt":0.24042394110580628,"score_spread":0.21605144824710854,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2128463141","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99886495,0.00018917164,0.00024798416,0.000050916133,0.00004485211,0.00013458822,0.000022138736,0.000008183697,0.00043722935],"genre_scores_gemma":[0.9989898,0.00014375857,0.00015646323,0.000025983396,0.0002204308,0.0000071069503,0.00003679712,0.0000147204355,0.0004049325],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986226,0.000096335025,0.00057726144,0.0002520817,0.00017349148,0.00027826373],"domain_scores_gemma":[0.9988586,0.00003706675,0.0005844111,0.000231752,0.00016182639,0.00012636246],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028876038,0.00020900337,0.00036233765,0.000044733257,0.00003356219,0.0000147997425,0.00027242734,0.00038376165,0.000053250034],"category_scores_gemma":[0.00016783075,0.00016076588,0.00016679456,0.0001487193,0.00008556091,0.000010294443,0.00008395552,0.00028590442,0.0000012736932],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00055652164,0.00027040413,0.003917148,0.00008683973,0.00004217995,0.000064925174,0.000018300529,0.0001369188,0.9939884,0.000006228608,0.00004524464,0.00086687226],"study_design_scores_gemma":[0.0008572088,0.0004430421,0.0010018061,0.00014229807,0.000009149411,0.000036506302,0.00010627972,0.000025822046,0.9966008,0.000047684316,0.0005479765,0.00018140771],"about_ca_topic_score_codex":0.000007589261,"about_ca_topic_score_gemma":0.000001545247,"teacher_disagreement_score":0.0029153419,"about_ca_system_score_codex":0.00005745498,"about_ca_system_score_gemma":0.0001128886,"threshold_uncertainty_score":0.6555843},"labels":[],"label_agreement":null},{"id":"W2128542677","doi":"10.1056/nejmoa1103782","title":"Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation","year":2011,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":7688,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"National Center for Advancing Translational Sciences; National Cancer Institute","keywords":"Vemurafenib; Medicine; Dacarbazine; Interim analysis; Internal medicine; Adverse effect; Melanoma; Oncology; Rash; Dabrafenib; Progression-free survival; Nausea; Clinical trial; Cancer research; Metastatic melanoma; Chemotherapy; Cancer","score_opus":0.015999499600173304,"score_gpt":0.22066546399615003,"score_spread":0.20466596439597673,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2128542677","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9930816,0.0003796256,0.0027670257,0.00029597976,0.00021296972,0.00008507541,0.0000011786314,0.0000029750229,0.003173555],"genre_scores_gemma":[0.9969872,0.00006286081,0.0013618158,0.00010945823,0.0011955977,0.0000012782508,0.0000131082315,0.000014781335,0.00025388645],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992082,0.000062058345,0.0002691626,0.00012743667,0.00017884192,0.00015426666],"domain_scores_gemma":[0.9993707,0.000018887105,0.00021312655,0.00013325064,0.00011722695,0.000146794],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039280043,0.00012480268,0.00023362126,0.0000854891,0.00001877638,0.000003868903,0.000117944364,0.00006452744,0.000048165737],"category_scores_gemma":[0.00005677231,0.00007046247,0.000023168686,0.00008589045,0.000064758,0.000007591206,0.000011776164,0.00014584823,7.827972e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018453537,0.00031546748,0.118224256,0.00008120484,0.00043320676,0.0023348595,0.005860635,0.00005098737,0.7096181,0.00041834166,0.0013952467,0.14281419],"study_design_scores_gemma":[0.26566592,0.08820555,0.22840725,0.0009640936,0.00046949746,0.013542044,0.0027377598,0.00012646355,0.34529045,0.00072698155,0.052777175,0.001086796],"about_ca_topic_score_codex":0.00017930621,"about_ca_topic_score_gemma":0.0007822742,"teacher_disagreement_score":0.3643276,"about_ca_system_score_codex":0.0000091181055,"about_ca_system_score_gemma":0.00015126735,"threshold_uncertainty_score":0.28733763},"labels":[],"label_agreement":null},{"id":"W2130044807","doi":"10.1038/sj.embor.embor939","title":"An essential function of the mitogen‐activated protein kinase Erk2 in mouse trophoblast development","year":2003,"lang":"en","type":"article","venue":"EMBO Reports","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":359,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Clinical Research Institute","funders":"Canadian Institutes of Health Research; Centre National de la Recherche Scientifique; Cancer Research Society","keywords":"Trophoblast; Cell biology; Biology; MAPK/ERK pathway; Protein kinase A; Kinase; Embryonic stem cell; Embryogenesis; Embryo; Cell growth; Placenta; Fetus; Genetics; Gene","score_opus":0.006149139100158751,"score_gpt":0.20613872026186705,"score_spread":0.1999895811617083,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2130044807","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9982888,0.000055463268,0.00031195785,0.000005373116,0.00030737664,0.00029397977,0.0000016443108,0.000006907866,0.00072848715],"genre_scores_gemma":[0.99844205,0.0000014318854,0.0002581024,0.000019699159,0.000043646007,0.000041997762,0.0000361842,0.000013752533,0.0011431477],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999081,0.00008441637,0.00029499034,0.00026291463,0.00012824258,0.00014844746],"domain_scores_gemma":[0.99933463,0.0000013440177,0.00016796762,0.00039816284,0.000051746687,0.000046164536],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001761861,0.00010547257,0.00010250975,0.000029568695,0.000047861377,0.000007817669,0.000060581726,0.00010105709,0.000029332768],"category_scores_gemma":[0.00006402569,0.000081861646,0.0000466635,0.00008565835,0.000028647835,0.0000037763596,0.000027273994,0.000060988285,0.0000012070242],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000050277285,0.00012186474,0.003997123,0.000012862814,0.000015112223,0.000030649655,0.000054389067,0.000030069508,0.99518144,0.000029553355,0.000095501506,0.00038117977],"study_design_scores_gemma":[0.00022279339,0.0001003784,0.006578143,0.000011514135,0.000004588596,0.000033548084,0.0000365211,0.000001467295,0.98221713,0.00003170066,0.010661086,0.00010110243],"about_ca_topic_score_codex":0.000024806359,"about_ca_topic_score_gemma":0.00008206915,"teacher_disagreement_score":0.012964261,"about_ca_system_score_codex":0.000015270116,"about_ca_system_score_gemma":0.0001979337,"threshold_uncertainty_score":0.3338221},"labels":[],"label_agreement":null},{"id":"W2131375222","doi":"10.1128/mcb.24.10.4255-4266.2004","title":"Characterization of Mouse <i>Rsk4</i> as an Inhibitor of Fibroblast Growth Factor-RAS-Extracellular Signal-Regulated Kinase Signaling","year":2004,"lang":"en","type":"article","venue":"Molecular and Cellular Biology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":59,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Lunenfeld-Tanenbaum Research Institute","funders":"Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Institute of General Medical Sciences","keywords":"Biology; Ribosomal s6 kinase; Cell biology; MAPK/ERK pathway; Signal transduction; Kinase; Receptor tyrosine kinase; Extracellular; Fibroblast growth factor; Receptor; Genetics; Protein kinase B","score_opus":0.005645776628842951,"score_gpt":0.1981594532899964,"score_spread":0.19251367666115346,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2131375222","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.971736,0.0006350818,0.027043397,0.000028095634,0.00006518326,0.00028084428,0.00012418066,0.000018843202,0.00006838959],"genre_scores_gemma":[0.99749166,0.000051003633,0.00052968727,0.00007447532,0.00008345133,0.000011475879,0.0016288947,0.00004469931,0.000084665204],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983491,0.00016475761,0.0004891119,0.00054216007,0.00013202024,0.00032287915],"domain_scores_gemma":[0.99898714,0.000006358724,0.00027448274,0.00038423037,0.0001837472,0.00016407188],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00015166154,0.0002991165,0.00038722024,0.00011383428,0.0000653777,0.000013598233,0.00020587421,0.0004158913,0.00003550033],"category_scores_gemma":[0.00003217829,0.00029293017,0.00014881241,0.00013564766,0.00022711215,0.000011876988,0.00011234522,0.0001102877,0.000003950493],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012799415,0.00019032079,0.0003918994,0.00009000606,0.00007489869,0.000021303274,0.00009836349,0.00004520209,0.9963794,0.0022711086,0.0000012872732,0.00030821838],"study_design_scores_gemma":[0.0010566299,0.0016669942,0.000109043045,0.00003739392,0.000036319227,0.000017777447,0.000038678805,0.000018719204,0.99599344,0.00045876965,0.000261695,0.00030454953],"about_ca_topic_score_codex":0.0000811664,"about_ca_topic_score_gemma":0.000005049196,"teacher_disagreement_score":0.026513709,"about_ca_system_score_codex":0.000010162033,"about_ca_system_score_gemma":0.000097833625,"threshold_uncertainty_score":0.99995226},"labels":[],"label_agreement":null},{"id":"W2132230514","doi":"10.1523/jneurosci.4216-06.2006","title":"JNK Gives Axons a Second Chance: Figure 1.","year":2006,"lang":"en","type":"review","venue":"Journal of Neuroscience","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Michael Smith Health Research BC","keywords":"Neuroscience; Neurite; Axon; Polarity (international relations); Cell polarity; Biology; In vitro; Cell","score_opus":0.04241066476734407,"score_gpt":0.3122661441583711,"score_spread":0.26985547939102705,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2132230514","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0006477428,0.9961203,0.00018059566,0.000021535427,0.0013120597,0.00014088597,0.000051607905,0.0000032954476,0.0015220129],"genre_scores_gemma":[0.0004180242,0.9937699,0.00012306198,0.00016612918,0.00095335086,0.0000052578334,0.000008159332,0.000023820548,0.004532299],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99852824,0.00010030888,0.00053680904,0.0003162576,0.00025424597,0.0002641602],"domain_scores_gemma":[0.9986571,0.000018854314,0.0008124361,0.00029496136,0.00008783106,0.0001288232],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023276705,0.0002535715,0.00065209303,0.00012841442,0.00008393783,0.000055831893,0.00068170164,0.00020551705,0.0000192553],"category_scores_gemma":[0.00014528075,0.00018467814,0.00046940433,0.00019307154,0.0001237466,0.0000081004355,0.00011427979,0.00032896054,0.000007902197],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000033539185,0.0003889927,0.00002845153,0.0077753323,0.00006833874,0.0009671789,0.00004354116,0.000019468682,0.16298056,0.00011805536,0.12106264,0.7065139],"study_design_scores_gemma":[0.000093313996,0.0004208011,0.000037512204,0.0006926008,0.00006410436,0.0011526188,0.0000019771383,0.0000013460402,0.00051771133,0.000008683049,0.9968304,0.00017893144],"about_ca_topic_score_codex":4.6276946e-7,"about_ca_topic_score_gemma":0.0000025240322,"teacher_disagreement_score":0.87576777,"about_ca_system_score_codex":0.000013382478,"about_ca_system_score_gemma":0.00046566868,"threshold_uncertainty_score":0.75309557},"labels":[],"label_agreement":null},{"id":"W2134846340","doi":"10.1111/ijd.12724","title":"Bench to bedside: mechanistic principles of targeting the RAF kinase in melanoma","year":2014,"lang":"en","type":"review","venue":"International Journal of Dermatology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Vemurafenib; Medicine; Melanoma; Kinase; Cancer research; Metastatic melanoma; Bench to bedside; Disease; Bioinformatics; Internal medicine; Biology; Genetics","score_opus":0.026478632058435154,"score_gpt":0.3195187637903334,"score_spread":0.29304013173189825,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2134846340","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0049387007,0.98890996,0.0027061652,0.00068378716,0.0017368714,0.00029092637,0.000037458,0.0000025724835,0.0006935411],"genre_scores_gemma":[0.10128554,0.8962654,0.0012284141,0.00019011392,0.0007396581,0.000024852483,0.000114514216,0.000039364975,0.000112168156],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99796563,0.00028026514,0.0011432235,0.00018418653,0.0002489609,0.00017772769],"domain_scores_gemma":[0.99826777,0.00014228042,0.001016656,0.00020062452,0.00030331974,0.000069361806],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027744062,0.0002076222,0.0008266345,0.00025763933,0.000021116828,0.000015499892,0.0009558441,0.0002446092,0.00002055385],"category_scores_gemma":[0.0006542887,0.00014080464,0.00033192363,0.00007666324,0.000048791084,0.0000035512905,0.00024661937,0.00025258222,0.000009438063],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006785406,0.00094922935,0.002160303,0.010031042,0.0048423773,0.008477938,0.0007484295,0.00027106103,0.03444664,0.06798806,0.014680779,0.8547256],"study_design_scores_gemma":[0.00027134904,0.00012569061,0.000011797517,0.0010809802,0.000095139265,0.0069312253,0.000019507497,0.000010112438,0.0034008888,0.00016365344,0.98774827,0.00014137066],"about_ca_topic_score_codex":0.000006620789,"about_ca_topic_score_gemma":0.000026563672,"teacher_disagreement_score":0.9730675,"about_ca_system_score_codex":0.000033063996,"about_ca_system_score_gemma":0.0002925065,"threshold_uncertainty_score":0.57418466},"labels":[],"label_agreement":null},{"id":"W2135344663","doi":"10.1080/00498250110065621","title":"Preclinical pharmacokinetics of SB-203580, a potent inhibitor of p38 mitogen-activated protein kinase","year":2001,"lang":"en","type":"article","venue":"Xenobiotica","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Discovery Centre","funders":"","keywords":"In vivo; Pharmacokinetics; Bioavailability; Pharmacology; In vitro; Mitogen-activated protein kinase; Chemistry; p38 mitogen-activated protein kinases; Protein kinase A; Kinase; Biology; Biochemistry; Biotechnology","score_opus":0.0216553931093105,"score_gpt":0.27896684578753567,"score_spread":0.2573114526782252,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2135344663","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964821,0.0003970376,0.0003141925,0.00015354918,0.0002535815,0.0004415953,0.00006022049,0.000015311016,0.0018824171],"genre_scores_gemma":[0.99760914,0.00011337838,0.0010225843,0.000068929825,0.00027873483,0.000013159833,0.000070015645,0.00002815918,0.00079588435],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998636,0.00009160427,0.0004819225,0.00033687428,0.00018540477,0.00026820094],"domain_scores_gemma":[0.9990444,0.000019125384,0.00019846598,0.0004309456,0.00017330378,0.00013374351],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016629169,0.00018335535,0.0002727745,0.000049169717,0.000030514011,0.000006070657,0.00021795515,0.00023061351,0.00008545762],"category_scores_gemma":[0.00018265519,0.0001676445,0.00015378273,0.00013174661,0.0001589986,0.0000030652586,0.00013896954,0.0001273612,0.000011505781],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00049813406,0.00039919943,0.000872896,0.00008406208,0.0000796316,0.00001151095,0.00003840359,0.000009432534,0.9950439,0.00009185815,0.0008030858,0.0020679014],"study_design_scores_gemma":[0.0011498887,0.00095948554,0.00088678463,0.00005672114,0.00004478337,0.000014741745,0.000023313294,0.000033744178,0.97159344,0.000033231987,0.025028871,0.00017496417],"about_ca_topic_score_codex":0.000017063783,"about_ca_topic_score_gemma":0.0000039288975,"teacher_disagreement_score":0.024225786,"about_ca_system_score_codex":0.0000089142795,"about_ca_system_score_gemma":0.00010845772,"threshold_uncertainty_score":0.6836344},"labels":[],"label_agreement":null},{"id":"W2136128469","doi":"10.1016/j.bmcl.2006.05.019","title":"Discovery of 3-hydroxy-4-carboxyalkylamidino-5-arylamino-isothiazoles as potent MEK1 inhibitors","year":2006,"lang":"en","type":"article","venue":"Bioorganic & Medicinal Chemistry Letters","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":35,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Valeant Pharmaceuticals International","keywords":"Chemistry; Stereochemistry; Combinatorial chemistry","score_opus":0.0036186011745197714,"score_gpt":0.18667245101142793,"score_spread":0.18305384983690817,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2136128469","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99238914,0.0013878172,0.000495628,0.0013045561,0.00034269164,0.00016645991,0.000037437225,0.00003517246,0.0038410767],"genre_scores_gemma":[0.99643576,0.00008832894,0.000092301016,0.00067684904,0.0013648286,0.000014098853,0.00036086128,0.000053727657,0.00091324124],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978098,0.000039156355,0.00056724646,0.0006137666,0.00048743485,0.0004825412],"domain_scores_gemma":[0.99889547,0.000021416845,0.0002777947,0.00061427464,0.000065886125,0.00012513522],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00020525455,0.00039105729,0.00037013198,0.000046146157,0.00008045275,0.000026080776,0.00041490173,0.0002780708,0.000060357634],"category_scores_gemma":[0.00008426093,0.0003565355,0.00021635705,0.00016205356,0.00032155603,0.000012514941,0.00016928707,0.00020495612,0.00001747621],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000100743106,0.0001094619,0.0018309125,0.00014321042,0.0000668138,0.00005276725,0.00002795098,0.00000802523,0.98919433,0.000043725642,0.008243545,0.00017849865],"study_design_scores_gemma":[0.0008130431,0.00011199625,0.002539325,0.00007906529,0.00007523212,0.00013764836,0.00013115758,0.0000066989132,0.990511,0.000047821108,0.0051692035,0.00037781885],"about_ca_topic_score_codex":0.00022206495,"about_ca_topic_score_gemma":0.000007959411,"teacher_disagreement_score":0.0040466026,"about_ca_system_score_codex":0.000053516007,"about_ca_system_score_gemma":0.00015734218,"threshold_uncertainty_score":0.99988866},"labels":[],"label_agreement":null},{"id":"W2136718845","doi":"10.1074/jbc.m213182200","title":"Different Properties of SEK1 and MKK7 in Dual Phosphorylation of Stress-induced Activated Protein Kinase SAPK/JNK in Embryonic Stem Cells","year":2003,"lang":"en","type":"article","venue":"Journal of Biological Chemistry","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":72,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto","funders":"Japan Society for the Promotion of Science; Mitsubishi Foundation; Ministry of Education, Culture, Sports, Science and Technology","keywords":"Embryonic stem cell; Cell biology; Phosphorylation; Protein kinase A; Dual (grammatical number); Kinase; Chemistry; Biology; Biochemistry","score_opus":0.02484527172999496,"score_gpt":0.21715186338599832,"score_spread":0.19230659165600336,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2136718845","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9988407,0.0008382237,0.000005671933,0.000015573984,0.000027211847,0.00013437028,0.000008207686,0.0000014785273,0.00012858462],"genre_scores_gemma":[0.9997114,0.00014569817,0.000043846154,0.0000052094933,0.000029756771,0.0000053122703,0.0000050288704,0.0000061656883,0.000047586105],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989878,0.00009544866,0.00048239544,0.00016882052,0.00011034824,0.00015516934],"domain_scores_gemma":[0.99936044,0.000013448059,0.00036373528,0.000118365635,0.00008077229,0.00006326624],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021432152,0.00014265408,0.00032645592,0.000031722517,0.000011551254,0.000005135351,0.000081665276,0.0002669413,0.000012816108],"category_scores_gemma":[0.00009334829,0.00009577731,0.000072097835,0.00007245588,0.00006906024,0.0000050790973,0.000043501,0.00018866346,1.0392929e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039248206,0.0002591561,0.00937957,0.00014353209,0.00002021352,0.000015855217,0.000044482073,0.000010099648,0.9893628,0.000007515426,0.0000027553504,0.0003615321],"study_design_scores_gemma":[0.000937417,0.0005288848,0.00576552,0.0001869055,0.0000060426696,0.000020856956,0.00018618433,0.0000050750627,0.9921906,0.000032489494,0.000032794764,0.00010724355],"about_ca_topic_score_codex":0.0000045443244,"about_ca_topic_score_gemma":0.0000024213255,"teacher_disagreement_score":0.0036140503,"about_ca_system_score_codex":0.000023247672,"about_ca_system_score_gemma":0.000072969095,"threshold_uncertainty_score":0.39056852},"labels":[],"label_agreement":null},{"id":"W2136742446","doi":"10.1016/j.cellsig.2010.02.009","title":"Characterization of the expression and regulation of MK5 in the murine ventricular myocardium","year":2010,"lang":"en","type":"article","venue":"Cellular Signalling","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Université de Montréal; Montreal Heart Institute","funders":"Canadian Institutes of Health Research","keywords":"Exon; Messenger RNA; Protein kinase A; Biology; Kinase; Cell biology; Genetics; Gene","score_opus":0.005594686090634668,"score_gpt":0.1824374679987618,"score_spread":0.17684278190812713,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2136742446","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966274,0.00012782468,0.0028912004,0.000026468631,0.00009512449,0.00013912609,0.0000029729908,0.00000125451,0.000088626526],"genre_scores_gemma":[0.99968237,0.000016357035,0.0001011159,0.00001614809,0.00009101233,0.000004666946,0.000053197367,0.0000051898483,0.000029966468],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9995455,0.000057019664,0.0001411612,0.0001027719,0.00009124715,0.000062308085],"domain_scores_gemma":[0.99965763,0.00000774821,0.00010349898,0.00018858467,0.00003148983,0.000011051315],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023269582,0.00005318398,0.00006832485,0.00001865391,0.0000304025,0.000004841131,0.000108080654,0.00007273378,0.0000055971423],"category_scores_gemma":[0.00002347761,0.00003305671,0.000039119903,0.000059462887,0.000035569454,0.0000026685125,0.000041519375,0.00006450739,1.9348872e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000009802811,0.00001845886,0.002770557,0.00002082021,0.0000032712603,6.89732e-7,0.00007917348,0.000028644476,0.9967764,0.00012099232,0.0000033399522,0.00016785417],"study_design_scores_gemma":[0.00015611004,0.000026796444,0.014475248,0.000021358448,0.000007705071,0.0000033716308,0.00001929596,0.00018188429,0.98402846,0.000052737694,0.0009893741,0.000037663085],"about_ca_topic_score_codex":0.0000033375968,"about_ca_topic_score_gemma":0.0000018641989,"teacher_disagreement_score":0.01274794,"about_ca_system_score_codex":9.2193164e-7,"about_ca_system_score_gemma":0.000013612672,"threshold_uncertainty_score":0.13480136},"labels":[],"label_agreement":null},{"id":"W2137723371","doi":"10.1200/jco.2007.12.7837","title":"Meta-Analysis of Phase II Cooperative Group Trials in Metastatic Stage IV Melanoma to Determine Progression-Free and Overall Survival Benchmarks for Future Phase II Trials","year":2008,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":700,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Center for Advancing Translational Sciences","keywords":"Medicine; Internal medicine; Clinical trial; Oncology; Multivariate analysis; Progression-free survival; Clinical endpoint; Cancer; Randomized controlled trial; Overall survival","score_opus":0.3381739698257792,"score_gpt":0.5079362980495256,"score_spread":0.16976232822374637,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2137723371","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99150485,0.0023990097,0.0024029613,0.0013818789,0.00062637357,0.00093625375,0.0006548919,0.0000018659733,0.00009194635],"genre_scores_gemma":[0.9800194,0.0008993881,0.01675012,0.00067934033,0.0010802968,0.00007867885,0.00018965836,0.000019847712,0.0002832868],"study_design_codex":"bench_or_experimental","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.98882425,0.0043808664,0.0057352744,0.00042697813,0.00033993126,0.00029267522],"domain_scores_gemma":[0.99006414,0.004545237,0.0041067633,0.0003907689,0.00050135795,0.00039175726],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.025434284,0.00028986717,0.0073251184,0.00031569682,0.000116140465,0.00001025304,0.00037180955,0.00044019485,0.0002765723],"category_scores_gemma":[0.023055086,0.00017914841,0.0027207572,0.00024233265,0.00017080388,0.000020131685,0.00023082894,0.00033280117,1.8701097e-7],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.14311723,0.037729345,0.0022051495,0.00017598817,0.30331725,0.0013850279,0.0018854546,0.00036035123,0.36831465,0.0010487166,0.020337716,0.1201231],"study_design_scores_gemma":[0.16624027,0.40032333,0.0025983555,0.000038251557,0.1869288,0.00019297458,0.00060673984,0.00072073116,0.03701869,0.00047236445,0.20389876,0.0009607392],"about_ca_topic_score_codex":0.000011263765,"about_ca_topic_score_gemma":0.00026949597,"teacher_disagreement_score":0.362594,"about_ca_system_score_codex":0.000021261907,"about_ca_system_score_gemma":0.0006620433,"threshold_uncertainty_score":0.9851741},"labels":[],"label_agreement":null},{"id":"W2137990944","doi":"10.1186/1756-8722-3-8","title":"From basic research to clinical development of MEK1/2 inhibitors for cancer therapy","year":2010,"lang":"en","type":"review","venue":"Journal of Hematology & Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":244,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Institute for Research in Immunology and Cancer","funders":"National Cancer Institute; Canadian Institutes of Health Research; Cancer Research Society","keywords":"Cancer research; Regulator; Cancer; Kinase; Receptor tyrosine kinase; MAPK/ERK pathway; Hematology; Tyrosine kinase; Signal transduction; Function (biology); Hyperactivation; Medicine; Biology; Internal medicine; Cell biology; Gene; Biochemistry","score_opus":0.23335411210150298,"score_gpt":0.5308665528212848,"score_spread":0.29751244071978183,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2137990944","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.02971811,0.96507275,0.00028255503,0.00029555013,0.0035676046,0.00083926413,0.00007166103,0.0000028217835,0.00014969878],"genre_scores_gemma":[0.00023491666,0.9828714,0.013211017,0.00015919586,0.0030196249,0.000205882,0.00007640992,0.000060489267,0.0001610545],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99549204,0.0008636026,0.0024367473,0.00047909145,0.00025679026,0.0004717121],"domain_scores_gemma":[0.9958784,0.00094725087,0.0016268126,0.00043382216,0.0008407733,0.00027295627],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0033726399,0.0003296162,0.0029281015,0.00033987444,0.00009118459,0.000007916285,0.00079816795,0.0019725435,0.000069397865],"category_scores_gemma":[0.0008034293,0.00024091764,0.00080231234,0.00015571382,0.0002611871,0.0000033685978,0.00023772172,0.0011237832,0.00001461433],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037981314,0.0003502489,0.00010904505,0.0006378561,0.00072194834,0.000041662926,0.00013657798,1.1941992e-7,0.0029991467,0.00007270773,0.02677259,0.96777827],"study_design_scores_gemma":[0.000922996,0.0024154065,0.000011972155,0.00096346816,0.00016722476,0.00029467413,0.00004894797,8.8597574e-8,0.009611187,0.00009695093,0.9852634,0.0002036797],"about_ca_topic_score_codex":0.000010767703,"about_ca_topic_score_gemma":0.00018749184,"teacher_disagreement_score":0.9675746,"about_ca_system_score_codex":0.00008373987,"about_ca_system_score_gemma":0.0058380477,"threshold_uncertainty_score":0.99979794},"labels":[],"label_agreement":null},{"id":"W2138718238","doi":"10.1523/jneurosci.5227-03.2004","title":"Mitogen- and Stress-Activated Protein Kinase 1 Mediates cAMP Response Element-Binding Protein Phosphorylation and Activation by Neurotrophins","year":2004,"lang":"en","type":"article","venue":"Journal of Neuroscience","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":222,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pediatric Oncology Group","funders":"National Institute of Mental Health; Medical Research Council; Merck KGaA; GlaxoSmithKline; National Institutes of Health; Pfizer","keywords":"CREB; Protein kinase A; Ribosomal s6 kinase; Cell biology; Mitogen-activated protein kinase kinase; Phosphorylation; Neurotrophin; Kinase; MAP kinase kinase kinase; Biology; Molecular biology; Transcription factor; Biochemistry; Protein kinase B; P70-S6 Kinase 1; Receptor; Gene","score_opus":0.012715642609635452,"score_gpt":0.23927841705704953,"score_spread":0.22656277444741407,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2138718238","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99857485,0.00010332187,0.000576053,0.00035319658,0.00010764973,0.0002559152,0.000019521225,0.000004214707,0.000005292444],"genre_scores_gemma":[0.9994364,0.0000564202,0.00026939,0.000070752714,0.000054675304,0.000007881218,0.0000049107166,0.0000101218875,0.00008946358],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990974,0.00009141954,0.00022194204,0.00021955642,0.0002103072,0.0001593734],"domain_scores_gemma":[0.99941695,0.000011111697,0.00028261813,0.00010018663,0.00007229553,0.00011683261],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026248134,0.000111816014,0.00010073401,0.00007094864,0.0001254472,0.00005872736,0.00010870412,0.000056073324,0.0000010330413],"category_scores_gemma":[0.00050940114,0.000095874,0.00002441209,0.00011517838,0.00009579174,0.00003928633,0.00005374999,0.000117948926,2.5450544e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004075785,0.000043506523,0.00043637637,0.000010090582,0.0000022841066,0.000010629931,0.000052400468,0.000020440026,0.99859726,0.000014347432,0.000019927204,0.00038513402],"study_design_scores_gemma":[0.0007276388,0.0010306664,0.0055822977,0.000046811914,0.0000042127413,0.000049784518,0.000039039653,0.000013824862,0.9912523,0.000042437536,0.0011162854,0.000094701405],"about_ca_topic_score_codex":0.000004949688,"about_ca_topic_score_gemma":0.0000010243516,"teacher_disagreement_score":0.0073449854,"about_ca_system_score_codex":0.00001868576,"about_ca_system_score_gemma":0.000100938916,"threshold_uncertainty_score":0.39096284},"labels":[],"label_agreement":null},{"id":"W2140777372","doi":"10.1158/1541-7786.mcr-07-2001","title":"BRAF Silencing by Short Hairpin RNA or Chemical Blockade by PLX4032 Leads to Different Responses in Melanoma and Thyroid Carcinoma Cells","year":2008,"lang":"en","type":"article","venue":"Molecular Cancer Research","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":187,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Concordia University; McGill University","funders":"Plexxikon","keywords":"Cancer research; Gene silencing; Thyroid cancer; Small hairpin RNA; Melanoma; Thyroid carcinoma; Cancer; Biology; Anaplastic thyroid cancer; Gene knockdown; Cell growth; RNA interference; Cell culture; Medicine; Thyroid; Internal medicine; Endocrinology; RNA","score_opus":0.03724670571200836,"score_gpt":0.31836257568427995,"score_spread":0.28111586997227156,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2140777372","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99267423,0.0056511997,0.000190758,0.00043560148,0.0000624953,0.0005333826,0.00011186473,0.000014475207,0.00032597338],"genre_scores_gemma":[0.9963213,0.00076579576,0.00010844492,0.0002661659,0.00011108418,0.00027471478,0.00007715304,0.000059330876,0.002015973],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.997078,0.00032121426,0.0003071533,0.0008652134,0.0005831079,0.0008453153],"domain_scores_gemma":[0.9988989,0.00005232419,0.000028608709,0.0005300154,0.00010487326,0.00038526786],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003644081,0.0002928797,0.00033171024,0.00016998229,0.00015108226,0.00004263215,0.0004196916,0.00026649085,0.00002961896],"category_scores_gemma":[0.00014822203,0.00025809128,0.000075402844,0.00028178628,0.00022163634,0.0000062886693,0.00044914987,0.00040735822,0.000008699611],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00087981694,0.00019445636,0.0077356477,0.00003662585,0.000023747625,0.00028006732,0.00018597743,0.0000037742373,0.9717004,0.0000036877536,0.01821259,0.0007432513],"study_design_scores_gemma":[0.0013048036,0.0008222366,0.0011650565,0.000035540525,0.000006805458,0.00004860023,0.000067275294,0.00004638678,0.9916832,0.0000048306956,0.004487512,0.00032775098],"about_ca_topic_score_codex":0.0006583085,"about_ca_topic_score_gemma":0.0002337229,"teacher_disagreement_score":0.019982845,"about_ca_system_score_codex":0.00012987947,"about_ca_system_score_gemma":0.00028592648,"threshold_uncertainty_score":0.9999871},"labels":[],"label_agreement":null},{"id":"W2142308379","doi":"10.1158/1078-0432.ccr-07-4496","title":"Inverse Association between Raf Kinase Inhibitory Protein and Signal Transducers and Activators of Transcription 3 Expression in Gastric Adenocarcinoma Patients: Implications for Clinical Outcome","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":85,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"National Center for Research Resources","keywords":"STAT3; Tissue microarray; Cancer research; Immunohistochemistry; STAT protein; Adenocarcinoma; Medicine; Cancer; Metastasis; Transcription factor; Pathology; Signal transduction; Biology; Internal medicine; Gene","score_opus":0.23121385549468268,"score_gpt":0.45240654009255904,"score_spread":0.22119268459787636,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2142308379","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980435,0.00035161103,0.00021065382,0.0002783372,0.000061789324,0.0008933849,0.00013790483,0.0000043819655,0.000018476478],"genre_scores_gemma":[0.99824405,0.0007858083,0.00025707384,0.00003521589,0.00028033828,0.00022786965,0.00008088944,0.000015065223,0.00007366868],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997882,0.00050996325,0.00070550933,0.00043595495,0.00020258415,0.00026397803],"domain_scores_gemma":[0.9989413,0.000323588,0.00015362097,0.0001732628,0.00023428623,0.00017394319],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018021682,0.000101797355,0.00028061232,0.000098044344,0.000108390755,0.0000074487966,0.00010909604,0.00034588345,0.0000058861388],"category_scores_gemma":[0.00073668244,0.000095245894,0.00010526214,0.00013990508,0.0002589026,0.000014528909,0.000052504332,0.00035119176,4.5012183e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041844,0.00015616076,0.8738471,0.00006179669,0.000019794994,3.6530577e-7,0.000055246965,4.5164435e-7,0.11956336,0.0000045516963,0.00063024065,0.0052424707],"study_design_scores_gemma":[0.0029627576,0.0013216586,0.96033746,0.00004142877,0.000015486748,2.8691633e-7,0.00003807244,0.000005883901,0.034081776,0.000067996625,0.0010286568,0.00009855578],"about_ca_topic_score_codex":0.000048460788,"about_ca_topic_score_gemma":0.00004557065,"teacher_disagreement_score":0.08649032,"about_ca_system_score_codex":0.000057302168,"about_ca_system_score_gemma":0.00021113093,"threshold_uncertainty_score":0.38840148},"labels":[],"label_agreement":null},{"id":"W2142663890","doi":"10.1128/mcb.06633-11","title":"The Extracellular Signal-Regulated Kinase 3 (Mitogen-Activated Protein Kinase 6 [MAPK6])–MAPK-Activated Protein Kinase 5 Signaling Complex Regulates Septin Function and Dendrite Morphology","year":2012,"lang":"en","type":"article","venue":"Molecular and Cellular Biology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":71,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Institute for Research in Immunology and Cancer","funders":"Canadian Institutes of Health Research; National Institutes of Health","keywords":"Cell biology; ASK1; Protein kinase A; MAP kinase kinase kinase; Kinase; MAPK/ERK pathway; Biology; Mitogen-activated protein kinase kinase; Signal transduction; c-Raf; Cyclin-dependent kinase 9","score_opus":0.013267015536219458,"score_gpt":0.2182804152633671,"score_spread":0.20501339972714766,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2142663890","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97404253,0.015941022,0.007873169,0.00019179097,0.00027070683,0.0014400431,0.000049193877,0.000088624336,0.00010294098],"genre_scores_gemma":[0.9965381,0.000056681758,0.0006376872,0.00016610956,0.0002909069,0.00025479868,0.0011546005,0.00011267351,0.00078842684],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9958398,0.0009796746,0.0006709817,0.0010738805,0.00021221269,0.0012234703],"domain_scores_gemma":[0.9981461,0.000048599046,0.00036578276,0.0007924781,0.00019224353,0.0004547624],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00076520944,0.00072642963,0.00056175183,0.00012319168,0.00068492524,0.00010202199,0.0003251385,0.0008247982,0.00010509179],"category_scores_gemma":[0.00012147425,0.0006017758,0.0002124017,0.0002850124,0.0006685461,0.000027825115,0.0003721992,0.00042395532,0.000020384428],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007631108,0.00017453326,0.0005046842,0.00006896232,0.00027498876,0.00007254659,0.00008193854,0.000014152013,0.99197924,0.0015739248,0.00008681113,0.0044051334],"study_design_scores_gemma":[0.0016677123,0.0010210939,0.00041722925,0.000044621444,0.0001143018,0.00009137362,0.00012770713,0.00013276326,0.9668196,0.000525745,0.028305847,0.00073201436],"about_ca_topic_score_codex":0.000112282665,"about_ca_topic_score_gemma":0.000011453952,"teacher_disagreement_score":0.028219037,"about_ca_system_score_codex":0.0000360912,"about_ca_system_score_gemma":0.00006982217,"threshold_uncertainty_score":0.9996434},"labels":[],"label_agreement":null},{"id":"W2142850270","doi":"10.1186/jbiol45","title":"Dimerization in protein kinase signaling.","year":2006,"lang":"en","type":"article","venue":"Journal of Biology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Kinase; Cell biology; Phosphorylation; Protein kinase A; Mitogen-activated protein kinase; Biology; Protein phosphorylation; Chemistry; Biochemistry","score_opus":0.006039574453730711,"score_gpt":0.22297198972135182,"score_spread":0.2169324152676211,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2142850270","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99581456,0.00059047685,0.0026977612,0.00010487889,0.00012842736,0.000058987483,0.0000027356687,0.0000014635953,0.00060072937],"genre_scores_gemma":[0.998443,0.00001589691,0.0008940661,0.00006095769,0.0004127678,0.0000023110517,0.000026266225,0.0000057101356,0.0001390007],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99944127,0.0000687114,0.0002601293,0.00008320791,0.00003548321,0.000111201145],"domain_scores_gemma":[0.9996749,0.000005021247,0.00016884116,0.00007058576,0.00005620668,0.000024439136],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018110001,0.000060749815,0.00011162746,0.00006693751,0.00001374615,0.0000041731337,0.00008350377,0.00011211819,0.000014225891],"category_scores_gemma":[0.000048033373,0.000049292932,0.000049766753,0.000052990083,0.000029688495,0.0000020559762,0.00001869417,0.000067849156,0.0000025668546],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000064985456,0.00004887656,0.009656829,0.0000037792277,0.0000060387238,0.000013408842,0.0000044076805,0.000045191297,0.98838866,0.0004679939,0.00022418823,0.0010756411],"study_design_scores_gemma":[0.0006819111,0.00078861124,0.0065694083,0.000015683774,0.0000051962566,0.00005623854,0.000014132941,0.000011644056,0.9650384,0.0012997728,0.025429172,0.00008980364],"about_ca_topic_score_codex":0.000020236832,"about_ca_topic_score_gemma":0.00001941653,"teacher_disagreement_score":0.025204984,"about_ca_system_score_codex":0.000007216785,"about_ca_system_score_gemma":0.000050543953,"threshold_uncertainty_score":0.20101073},"labels":[],"label_agreement":null},{"id":"W2143918464","doi":"10.1158/1078-0432.ccr-09-1180","title":"c-Jun-NH2-kinase-1 Inhibition Leads to Antitumor Activity in Ovarian Cancer","year":2009,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":71,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"National Center for Research Resources; National Cancer Institute","keywords":"Ovarian cancer; Cancer research; Debulking; Ovarian carcinoma; In vivo; Cancer; Medicine; Kinase; Apoptosis; Docetaxel; Cell growth; Internal medicine; Biology","score_opus":0.15785474597755314,"score_gpt":0.4952506165954008,"score_spread":0.3373958706178477,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2143918464","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9919183,0.0004942141,0.000121835634,0.0043455497,0.00029800175,0.000422325,0.000045502802,0.00001058897,0.0023436584],"genre_scores_gemma":[0.9954912,0.00084068405,0.00009464797,0.0011004587,0.0011215924,0.00014242096,0.00002255398,0.000016875003,0.0011695365],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.997728,0.00038275568,0.00032716492,0.00064429146,0.0003439352,0.00057385507],"domain_scores_gemma":[0.99898773,0.000060233004,0.000046584835,0.00043865814,0.00019091478,0.00027587143],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016848255,0.00013595949,0.00024489555,0.00012257638,0.000101090875,0.000036593294,0.00023553094,0.00025092697,0.0001519902],"category_scores_gemma":[0.00044856413,0.00012881708,0.000098945646,0.0003965824,0.00012918827,0.0000082237775,0.00015559809,0.00053888216,0.000058640708],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008752185,0.00030214945,0.03105179,0.000022216693,0.000010178407,0.000048842365,0.000028522625,0.000029470675,0.9072999,0.00017808535,0.014881752,0.04527188],"study_design_scores_gemma":[0.0015402576,0.0016883073,0.36170045,0.00011789943,0.0000061916085,0.0000026663479,0.000018655113,0.000028138147,0.58614826,0.0003123003,0.04814412,0.00029272426],"about_ca_topic_score_codex":0.0007874909,"about_ca_topic_score_gemma":0.0024058938,"teacher_disagreement_score":0.33064866,"about_ca_system_score_codex":0.00008629308,"about_ca_system_score_gemma":0.0004974687,"threshold_uncertainty_score":0.5253008},"labels":[],"label_agreement":null},{"id":"W2144547786","doi":"10.1158/1078-0432.ccr-11-2436","title":"Phase I Study of the Combination of Sorafenib and Temsirolimus in Patients with Metastatic Melanoma","year":2012,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":52,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"National Cancer Institute","keywords":"Temsirolimus; Sorafenib; Medicine; Internal medicine; Oncology; Response Evaluation Criteria in Solid Tumors; Neuroblastoma RAS viral oncogene homolog; Cancer; Gastroenterology; Phases of clinical research; Toxicity; Surgery; Hepatocellular carcinoma; KRAS; Biology","score_opus":0.1270920474656933,"score_gpt":0.4640427284017923,"score_spread":0.336950680936099,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2144547786","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9989916,0.0002719877,0.0000033689562,0.000027222526,0.00006516679,0.0005142744,0.000017801844,7.138027e-7,0.00010786559],"genre_scores_gemma":[0.9998192,0.000030780397,0.000013513054,0.000011442973,0.00003249104,0.000035612476,0.00000788566,0.0000068804293,0.000042146454],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987044,0.00044006485,0.00028149123,0.00014372401,0.00026416482,0.00016615464],"domain_scores_gemma":[0.9993608,0.000085025,0.000088792614,0.00024147239,0.00016601448,0.000057901834],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011671105,0.00005338012,0.00015956417,0.00003766339,0.00002935644,0.0000031070144,0.00013038647,0.000043616044,0.00000815158],"category_scores_gemma":[0.00021891961,0.000032758664,0.000023457476,0.00013879775,0.0001815307,0.0000040286745,0.00012807033,0.00013890186,3.825145e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00075946026,0.0043811486,0.98698705,0.00002775666,0.000039653027,2.762014e-7,0.00018290537,0.0000011164435,0.0029283715,0.000041843632,0.000079583544,0.004570846],"study_design_scores_gemma":[0.009968422,0.0066310135,0.9729035,0.000020258924,0.000018128674,1.9448896e-7,0.00024331725,0.000007601298,0.009858298,0.000029724653,0.00026643454,0.000053095293],"about_ca_topic_score_codex":0.00014513666,"about_ca_topic_score_gemma":0.00016415397,"teacher_disagreement_score":0.014083529,"about_ca_system_score_codex":0.000007667406,"about_ca_system_score_gemma":0.00007285788,"threshold_uncertainty_score":0.13358596},"labels":[],"label_agreement":null},{"id":"W2144669213","doi":"10.1017/s0317167100012191","title":"ERK5: A Novel IKKα-Kinase in Rat Hippocampal Neurons","year":2011,"lang":"en","type":"article","venue":"Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"U.S. Department of Veterans Affairs","keywords":"Hippocampal formation; Wortmannin; Phosphorylation; Endocrinology; Pathogenesis; Neurodegeneration; Internal medicine; Insulin receptor; Insulin; Insulin resistance; IκB kinase; Biology; Neuroscience; Cell biology; Medicine; Phosphatidylinositol; Signal transduction; NF-κB; Disease","score_opus":0.04512972583174145,"score_gpt":0.24745740982582876,"score_spread":0.2023276839940873,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2144669213","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99210244,0.0007878594,0.000080149955,0.0006455039,0.0011249423,0.00012889989,0.000011537532,0.0000070091955,0.005111628],"genre_scores_gemma":[0.9948202,0.0002030474,0.0021142394,0.0025120866,0.00029067099,0.0000032526723,6.44249e-7,0.000013070605,0.000042836873],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9963125,0.0005872243,0.0007710692,0.00057994266,0.00044114602,0.0013081476],"domain_scores_gemma":[0.99736595,0.0001043695,0.0004981387,0.00019070023,0.00028055868,0.001560275],"candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.002771226,0.00032184078,0.00038148725,0.00071659795,0.0011021321,0.00024843845,0.0019620128,0.00023624102,0.00013737274],"category_scores_gemma":[0.0016922096,0.00023327467,0.00020290536,0.0009128437,0.003892474,0.00010814073,0.000103590624,0.00085401896,0.0000038847297],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024447014,0.00011944301,0.97835505,0.000007093387,0.000014095951,0.00736899,0.00052830845,0.0007581061,0.0070467466,0.0013451973,0.0011883778,0.0030241096],"study_design_scores_gemma":[0.0023733904,0.2588184,0.5843006,0.00010680911,0.000088071974,0.08422849,0.0010194425,0.0009555375,0.014132593,0.019183094,0.033062845,0.0017307713],"about_ca_topic_score_codex":0.0013226323,"about_ca_topic_score_gemma":0.09540721,"teacher_disagreement_score":0.3940545,"about_ca_system_score_codex":0.00007277836,"about_ca_system_score_gemma":0.0030753822,"threshold_uncertainty_score":0.99881834},"labels":[],"label_agreement":null},{"id":"W2144708319","doi":"10.1016/j.ccr.2011.04.002","title":"c-Raf, but Not B-Raf, Is Essential for Development of K-Ras Oncogene-Driven Non-Small Cell Lung Carcinoma","year":2011,"lang":"en","type":"article","venue":"Cancer Cell","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":297,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Hôtel-Dieu de Québec","funders":"","keywords":"Oncogene; MAPK/ERK pathway; Cancer research; Kinase; Biology; Concomitant; Anti-apoptotic Ras signalling cascade; Lung; Carcinoma; clone (Java method); Cell; Medicine; Cell biology; Internal medicine; Cell cycle; Gene; Genetics","score_opus":0.025568695649902887,"score_gpt":0.2407732591841122,"score_spread":0.2152045635342093,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2144708319","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98405856,0.0012795363,0.0062236963,0.000008383688,0.00050895324,0.0004318629,0.0001479153,0.000008404032,0.007332688],"genre_scores_gemma":[0.98643214,0.000107024855,0.00899291,0.00019596408,0.00033599907,0.00016630358,0.00010499326,0.000043017844,0.0036216446],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99875116,0.000017232247,0.00032414863,0.0004472661,0.00010774616,0.0003524632],"domain_scores_gemma":[0.9991908,0.0000069193247,0.00017628416,0.0003619895,0.00013553379,0.00012845319],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007939234,0.00022371212,0.00023384095,0.000029441664,0.000095246054,0.00000996838,0.00030008933,0.00019759538,0.00017634392],"category_scores_gemma":[0.0000034314862,0.00022314902,0.00015382287,0.000039710205,0.000055057983,0.0000037465354,0.00013417122,0.00005619324,0.0000121605235],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016595074,0.0001054103,0.0035256513,0.0002877735,0.00004659699,0.0000032656426,0.0017005373,0.0000053463095,0.9904621,0.0000072089756,0.00281373,0.0008763963],"study_design_scores_gemma":[0.0011067886,0.00016568473,0.0012424837,0.000016140293,0.00006529082,0.0000012813766,0.00014882204,0.00008512684,0.96555054,0.0000035416067,0.03133211,0.00028218984],"about_ca_topic_score_codex":0.00023198687,"about_ca_topic_score_gemma":0.00026795204,"teacher_disagreement_score":0.02851838,"about_ca_system_score_codex":0.00004384689,"about_ca_system_score_gemma":0.000606117,"threshold_uncertainty_score":0.90997535},"labels":[],"label_agreement":null},{"id":"W2144906866","doi":"10.1093/annonc/mdu049","title":"Whole-genome sequencing reveals complex mechanisms of intrinsic resistance to BRAF inhibition","year":2014,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":65,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"University College London; Cancer Research UK; Wellcome Trust; Harry J. Lloyd Charitable Trust","keywords":"Vemurafenib; Dabrafenib; Sanger sequencing; Cancer research; PTEN; Medicine; GNAQ; Melanoma; MEK inhibitor; Mutation; Biology; MAPK/ERK pathway; Genetics; PI3K/AKT/mTOR pathway; Kinase; Signal transduction; Gene","score_opus":0.06010748525716944,"score_gpt":0.3109945371453774,"score_spread":0.2508870518882079,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2144906866","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97036296,0.000110871035,0.0137494225,0.0016816511,0.00011268796,0.00022368549,0.00007476131,0.000009528468,0.013674433],"genre_scores_gemma":[0.9929081,0.000030672407,0.0043837824,0.0018969243,0.0001320604,0.00001370549,0.00014272387,0.000013650345,0.00047833167],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988876,0.00015171108,0.0003721194,0.00025971053,0.00010449513,0.00022437838],"domain_scores_gemma":[0.99909025,0.000031572323,0.0002309613,0.00031746484,0.00023795135,0.00009179074],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004621555,0.00011350642,0.00031637526,0.000075966214,0.000034610377,0.0000032475298,0.00014693243,0.00016976435,0.000020536436],"category_scores_gemma":[0.00020028761,0.00011621542,0.00008121408,0.00010096418,0.00006846265,0.0000034852076,0.00010859526,0.000055559667,0.000013512092],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000119950535,0.00004569432,0.000032294818,0.000055574146,0.000021055836,0.0000040437926,0.00007056839,0.000018987053,0.9842906,0.009704838,0.0032101523,0.0024262378],"study_design_scores_gemma":[0.00039089515,0.0025580323,0.0017369628,0.00003101492,0.000009168163,0.000012797472,0.00005051889,0.0000032106393,0.84398454,0.0071857534,0.14390421,0.00013289966],"about_ca_topic_score_codex":0.000012067758,"about_ca_topic_score_gemma":0.00009503208,"teacher_disagreement_score":0.14069407,"about_ca_system_score_codex":0.000014244374,"about_ca_system_score_gemma":0.0000908764,"threshold_uncertainty_score":0.47391275},"labels":[],"label_agreement":null},{"id":"W2146021917","doi":"10.1074/jbc.m310335200","title":"Stress Induces Mitochondria-mediated Apoptosis Independent of SAPK/JNK Activation in Embryonic Stem Cells","year":2004,"lang":"en","type":"article","venue":"Journal of Biological Chemistry","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto","funders":"","keywords":"Cell biology; Apoptosis; Embryonic stem cell; p38 mitogen-activated protein kinases; MAPK/ERK pathway; Kinase; Protein kinase A; Biology; Mitogen-activated protein kinase; Chemistry; Gene; Biochemistry","score_opus":0.01836099353921242,"score_gpt":0.23232319991421696,"score_spread":0.21396220637500454,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2146021917","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9989688,0.000186131,0.00015117199,0.000087006054,0.00013185735,0.00007901189,0.00001839162,0.0000037619982,0.00037391006],"genre_scores_gemma":[0.99914366,0.0002669243,0.00020330327,0.000043284075,0.00024291252,0.000004076089,0.000035917034,0.000008583496,0.00005132187],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988172,0.000047466783,0.00052122225,0.00021275035,0.00019346274,0.00020789528],"domain_scores_gemma":[0.99905246,0.000033662218,0.00050323043,0.00017057716,0.00013091853,0.000109155946],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020200122,0.00016459936,0.00030619654,0.00004282453,0.000021628308,0.000010773717,0.00028965663,0.00044929833,0.000028049015],"category_scores_gemma":[0.00009524908,0.00012301317,0.00015272266,0.00011785328,0.00007092825,0.000007954052,0.000080351005,0.00028740524,0.0000018416907],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021845632,0.00024464153,0.0020968362,0.000045139368,0.000040994735,0.0000067421397,0.000032733802,0.000111159265,0.9967244,0.000005861046,0.00004420622,0.00042879712],"study_design_scores_gemma":[0.0011689872,0.00044815004,0.0021737956,0.000093866365,0.000009391944,0.000017706156,0.0002221848,8.039087e-7,0.99539447,0.00008868841,0.0002458584,0.00013609782],"about_ca_topic_score_codex":0.000006159153,"about_ca_topic_score_gemma":0.0000016486855,"teacher_disagreement_score":0.0013299627,"about_ca_system_score_codex":0.00005207558,"about_ca_system_score_gemma":0.00015263847,"threshold_uncertainty_score":0.50163317},"labels":[],"label_agreement":null},{"id":"W2146211196","doi":"10.3747/co.v15i2.173","title":"Biochemotherapy for the Treatment of Metastatic Malignant Melanoma: A Clinical Practice Guideline","year":2008,"lang":"en","type":"article","venue":"Current Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Cancer Care Ontario","funders":"","keywords":"Medicine; Guideline; Melanoma; Quality of life (healthcare); Oncology; Disease; Cancer; Internal medicine; Intensive care medicine; Radiation therapy; Regimen; Adverse effect; Pathology; Nursing","score_opus":0.17885961851759366,"score_gpt":0.4605014070652123,"score_spread":0.2816417885476187,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2146211196","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8592668,0.058136493,0.07069164,0.003776747,0.0042362874,0.002350952,0.00021567155,0.000025999789,0.0012994007],"genre_scores_gemma":[0.8024258,0.10407151,0.08306382,0.002390571,0.0045709354,0.0010860612,0.0009531556,0.000112812806,0.0013253362],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99859583,0.00020085051,0.00059084914,0.0003058186,0.00009046191,0.00021620061],"domain_scores_gemma":[0.9986467,0.00035369134,0.0002968521,0.0003942712,0.00023855068,0.00006997092],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005090895,0.00015537937,0.00032461536,0.000025603236,0.00009067165,0.0000028996265,0.00017561908,0.000104330196,0.000020415839],"category_scores_gemma":[0.00031465472,0.000096018935,0.0002569021,0.00005333878,0.00019786981,0.0000024535357,0.000027305552,0.0000488596,0.000007043866],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034930683,0.011654908,0.0054669892,0.00007711095,0.0015649115,0.000051197454,0.0008581276,0.000027641263,0.10801068,0.0016758714,0.18728639,0.6798331],"study_design_scores_gemma":[0.0026253709,0.0070289904,0.00026216742,0.000003396617,0.0001550236,0.00012471566,0.000108535154,0.0001387015,0.02902872,0.000044253637,0.96037585,0.00010429938],"about_ca_topic_score_codex":0.000011587244,"about_ca_topic_score_gemma":0.000012648852,"teacher_disagreement_score":0.7730894,"about_ca_system_score_codex":0.000025601776,"about_ca_system_score_gemma":0.0002851613,"threshold_uncertainty_score":0.39155385},"labels":[],"label_agreement":null},{"id":"W2148291345","doi":"10.1111/pcmr.12424","title":"Extrinsic factors can mediate resistance to <scp>BRAF</scp> inhibition in central nervous system melanoma metastases","year":2015,"lang":"en","type":"article","venue":"Pigment Cell & Melanoma Research","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute of Cancer Research; Cancer Research UK; National Institute for Health and Care Research; Novartis; NIHR Biomedical Research Centre, Royal Marsden NHS Foundation Trust/Institute of Cancer Research; Pfizer; Royal Marsden NHS Foundation Trust; Francis Crick Institute","keywords":"Vemurafenib; Dabrafenib; Melanoma; Medicine; Cancer research; Central nervous system; Cerebrospinal fluid; MAPK/ERK pathway; MEK inhibitor; Pathology; Kinase; Internal medicine; Biology; Metastatic melanoma","score_opus":0.04991186967412619,"score_gpt":0.28753509411835854,"score_spread":0.23762322444423234,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2148291345","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9858027,0.0015479029,0.00014554358,0.00015358694,0.00044384968,0.0010443362,0.00020838156,0.000046001107,0.0106076915],"genre_scores_gemma":[0.99452883,0.00009310784,0.00031428345,0.000055928595,0.0004233151,0.00022538986,0.00060473976,0.00006793493,0.0036864448],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9950625,0.0008273151,0.00057373615,0.000959038,0.0011134411,0.0014639765],"domain_scores_gemma":[0.9976768,0.0001423621,0.0001263873,0.000788741,0.00030717737,0.0009585246],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0016072788,0.0003971883,0.00043477645,0.00044936608,0.0001788389,0.0001227403,0.0004308722,0.0002629986,0.000015501244],"category_scores_gemma":[0.00040751393,0.00036758682,0.00012980061,0.00061243953,0.00011545766,0.000017530367,0.00044991716,0.00038352216,0.00012217117],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042099366,0.0007154061,0.03920412,0.00057925045,0.0001135404,0.0011526647,0.0029815969,0.00034788143,0.9069393,0.0012367249,0.04531929,0.0009892083],"study_design_scores_gemma":[0.0020140505,0.0012595677,0.018039415,0.00012143211,0.000026615886,0.00002435252,0.0055774604,0.00003411174,0.9146602,0.00007466788,0.057863213,0.00030488585],"about_ca_topic_score_codex":0.000539082,"about_ca_topic_score_gemma":0.0020596718,"teacher_disagreement_score":0.021164706,"about_ca_system_score_codex":0.00043650062,"about_ca_system_score_gemma":0.00048633324,"threshold_uncertainty_score":0.99987763},"labels":[],"label_agreement":null},{"id":"W2150153870","doi":"10.1093/annonc/mdu154","title":"Patient perception of the benefit of a BRAF inhibitor in metastatic melanoma: quality-of-life analyses of the BREAK-3 study comparing dabrafenib with dacarbazine","year":2014,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":54,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Dabrafenib; Medicine; Dacarbazine; Nausea; Vomiting; Quality of life (healthcare); Internal medicine; Oncology; Chemotherapy; Vemurafenib; Cancer; Metastatic melanoma","score_opus":0.10730208951411321,"score_gpt":0.37843127100091906,"score_spread":0.27112918148680587,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2150153870","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986744,0.00013427128,0.00005229986,0.00010208157,0.00005903446,0.00032409403,0.000029667468,0.0000011320767,0.000623051],"genre_scores_gemma":[0.9996963,0.000017108176,0.00015252242,0.000071010574,0.0000202937,0.000011435579,0.000013099981,0.0000082045735,0.0000099992585],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99821776,0.00049207115,0.0007655774,0.00018477943,0.00020955077,0.0001302391],"domain_scores_gemma":[0.9982783,0.000092212314,0.0008843943,0.0004639522,0.00025053596,0.000030581068],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00057406764,0.000118900665,0.0006106033,0.00006500389,0.000020448146,0.000001159485,0.00025377533,0.00007682264,0.000007420762],"category_scores_gemma":[0.00020987999,0.00006962415,0.00014293083,0.00018810651,0.00022030661,0.0000042636975,0.00018702478,0.00007426243,1.4752526e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047511663,0.0012085871,0.28151715,0.00013967103,0.00021736816,2.906483e-7,0.0011085131,0.0006043026,0.71284807,0.00021786608,0.000056774516,0.001606287],"study_design_scores_gemma":[0.001757848,0.0055880714,0.5501263,0.000063873944,0.00009835919,0.0000027371414,0.0016957632,0.00007269649,0.44023398,0.00008536363,0.00018358194,0.000091396425],"about_ca_topic_score_codex":0.0010738454,"about_ca_topic_score_gemma":0.0019128309,"teacher_disagreement_score":0.2726141,"about_ca_system_score_codex":0.0000057960733,"about_ca_system_score_gemma":0.00013825402,"threshold_uncertainty_score":0.28391904},"labels":[],"label_agreement":null},{"id":"W2151507583","doi":"10.1634/theoncologist.12-4-426","title":"Safety, Pharmacokinetics, and Preliminary Antitumor Activity of Sorafenib: A Review of Four Phase I Trials in Patients with Advanced Refractory Solid Tumors","year":2007,"lang":"en","type":"review","venue":"The Oncologist","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":418,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Cancer Centre; Princess Margaret Cancer Centre","funders":"","keywords":"Sorafenib; Medicine; Clinical trial; Pharmacokinetics; Refractory (planetary science); Pharmacology; Oncology; Drug; Toxicity; Safety profile; Phases of clinical research; Internal medicine; Medical physics; Adverse effect; Hepatocellular carcinoma","score_opus":0.07306418962376841,"score_gpt":0.4061245175451803,"score_spread":0.3330603279214119,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2151507583","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.014436416,0.982094,0.0000513755,0.00001695019,0.0001241218,0.002377074,0.0003499078,0.0000057302723,0.00054446433],"genre_scores_gemma":[0.015294903,0.983953,0.00019136883,0.00005513,0.0000918709,0.00006934455,0.00025046172,0.000036086407,0.000057831487],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9969282,0.0009414047,0.00125477,0.00040847712,0.00020998644,0.00025713418],"domain_scores_gemma":[0.99687874,0.00032638406,0.002046304,0.0005431658,0.00013657582,0.00006879766],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025282253,0.00037882884,0.002687295,0.00008980659,0.000036303332,0.000004059964,0.00035722248,0.00022201035,0.000016729466],"category_scores_gemma":[0.0008430054,0.0002237392,0.0002925249,0.00017363047,0.00034855542,0.0000054032184,0.00021224089,0.00027691794,0.0000010331061],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021084812,0.0008143817,0.000032171363,0.03626572,0.00015990651,0.000019974004,0.000009222145,6.8726536e-7,0.0010416255,0.0000051288353,0.0003713441,0.95917135],"study_design_scores_gemma":[0.0063548284,0.010962876,0.0004801076,0.048626393,0.0015156688,0.000035595185,0.000011166451,0.0000012565481,0.004239493,0.000004528715,0.9271909,0.0005771985],"about_ca_topic_score_codex":0.000010229779,"about_ca_topic_score_gemma":0.000007816653,"teacher_disagreement_score":0.95859414,"about_ca_system_score_codex":0.000043598717,"about_ca_system_score_gemma":0.00039328472,"threshold_uncertainty_score":0.912382},"labels":[],"label_agreement":null},{"id":"W2155321348","doi":"10.1158/1535-7163.mct-05-0099","title":"Combined inhibition of the phosphatidylinositol 3-kinase/Akt and Ras/mitogen-activated protein kinase pathways results in synergistic effects in glioblastoma cells","year":2006,"lang":"en","type":"article","venue":"Molecular Cancer Therapeutics","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":53,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Protein kinase B; Kinase; Integrin-linked kinase; MAPK/ERK pathway; Cancer research; Wortmannin; PI3K/AKT/mTOR pathway; Protein kinase A; Phosphatidylinositol; Chemistry; Biology; Cell biology; Molecular biology; Signal transduction; Cyclin-dependent kinase 2","score_opus":0.0073327816817469645,"score_gpt":0.21447004087722632,"score_spread":0.20713725919547935,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2155321348","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99634194,0.0019153453,0.00033907435,0.00010680193,0.00020238965,0.00089699804,0.000069462956,0.000011786999,0.000116208066],"genre_scores_gemma":[0.99930197,0.00005992671,0.00007508632,0.00022264375,0.00004806989,0.00014555635,0.000040879786,0.000038295948,0.00006759502],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984524,0.00022032241,0.0004057995,0.00041138715,0.00019910591,0.00031098054],"domain_scores_gemma":[0.9992571,0.00002261941,0.00019889434,0.0004107497,0.000069138194,0.00004150959],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001478532,0.0002577038,0.00025334998,0.00008134502,0.00004997713,0.00001892873,0.00015461602,0.00022555375,0.0000015735963],"category_scores_gemma":[0.00001990139,0.00022211634,0.00008032654,0.00030573146,0.00012210866,0.00000592829,0.00009760582,0.000164034,6.9067346e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007510766,0.00022386594,0.001028923,0.00011375178,0.000030472753,0.000052007184,0.000089151785,0.00039312628,0.9958637,0.00030142523,0.00002348758,0.0011290454],"study_design_scores_gemma":[0.0033982224,0.0005497787,0.0034563458,0.00023093923,0.00003241712,0.0000014061654,0.000017695502,0.00022426131,0.9908762,0.00034890155,0.0006133664,0.00025044326],"about_ca_topic_score_codex":0.00040742496,"about_ca_topic_score_gemma":0.00041571204,"teacher_disagreement_score":0.004987444,"about_ca_system_score_codex":0.00005500508,"about_ca_system_score_gemma":0.000116781164,"threshold_uncertainty_score":0.90576416},"labels":[],"label_agreement":null},{"id":"W2155461614","doi":"10.1056/nejmoa1105358","title":"<i>RAS</i> Mutations in Cutaneous Squamous-Cell Carcinomas in Patients Treated with BRAF Inhibitors","year":2012,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1028,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"University of California, San Francisco; Plexxikon; European Organisation for Research and Treatment of Cancer; Jonsson Cancer Center Foundation; National Cancer Institute; University of California, Los Angeles; Cancer Research UK; Wellcome Trust; California Institute of Technology","keywords":"HRAS; Vemurafenib; Neuroblastoma RAS viral oncogene homolog; KRAS; Cancer research; MAPK/ERK pathway; Carcinogenesis; V600E; Cell growth; Mutation; Biology; Medicine; Kinase; Melanoma; Cancer; Internal medicine; Gene; Genetics","score_opus":0.006657930907524172,"score_gpt":0.2093037642751884,"score_spread":0.20264583336766423,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2155461614","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972275,0.00077503576,0.00003400996,0.00016406737,0.00020480996,0.00010094215,0.0000026727762,0.0000020345112,0.0014889656],"genre_scores_gemma":[0.99833995,0.000037745387,0.00009300914,0.00012806579,0.0011710275,0.0000012172106,0.00004024537,0.000013921744,0.00017479862],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99907357,0.00007285052,0.00035054496,0.00009766142,0.00018765092,0.00021772113],"domain_scores_gemma":[0.9994264,0.00003387804,0.00016906144,0.000105131534,0.00007374243,0.00019176723],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022652428,0.00012335076,0.00021819073,0.00014394934,0.00001722492,0.0000032914422,0.000081730665,0.0000773773,0.00001885762],"category_scores_gemma":[0.00009950801,0.00008182491,0.000027183782,0.00013068988,0.00004196037,0.000008650726,0.000013826516,0.00016427555,0.000001552962],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005912785,0.00023189945,0.95012534,0.000013935434,0.000009829279,0.000110081164,0.00064206426,0.00006279113,0.04191819,0.000004693761,0.0014432864,0.0048466073],"study_design_scores_gemma":[0.16310272,0.01801462,0.62368,0.000365689,0.00019613076,0.002012728,0.00073650683,0.00002093713,0.142799,0.000051738705,0.04838484,0.0006351144],"about_ca_topic_score_codex":0.00015634934,"about_ca_topic_score_gemma":0.00021298049,"teacher_disagreement_score":0.32644537,"about_ca_system_score_codex":0.000024477813,"about_ca_system_score_gemma":0.00008009286,"threshold_uncertainty_score":0.33367229},"labels":[],"label_agreement":null},{"id":"W2157745333","doi":"10.1101/gad.1390406","title":"A KSR/CNK complex mediated by HYP, a novel SAM domain-containing protein, regulates RAS-dependent RAF activation in <i>Drosophila</i>","year":2006,"lang":"en","type":"article","venue":"Genes & Development","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":56,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Institute for Research in Immunology and Cancer","funders":"National Cancer Institute; Canadian Institutes of Health Research","keywords":"Scaffold protein; Biology; Cell biology; MAPK/ERK pathway; Protein kinase A; Kinase; Effector; Small GTPase; Activator (genetics); Signal transduction; Biochemistry; Receptor","score_opus":0.012085240826816092,"score_gpt":0.21021876128880218,"score_spread":0.1981335204619861,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2157745333","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99458194,0.0005670936,0.0028154158,0.00020623782,0.00007606512,0.0006552841,0.000022469143,0.000035591496,0.0010399172],"genre_scores_gemma":[0.9886916,0.00002717135,0.008279539,0.00027718832,0.00016207996,0.0002762357,0.0017578559,0.000038762337,0.00048953836],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981894,0.000051238727,0.0004956508,0.00054029614,0.00027184247,0.00045156345],"domain_scores_gemma":[0.9993935,0.000014186818,0.00017100941,0.0002572151,0.00007880692,0.00008528481],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00030603277,0.000290785,0.00025276418,0.00008475182,0.00012862789,0.00003743186,0.00020887151,0.0002033623,0.00002304373],"category_scores_gemma":[0.000025142897,0.00028731578,0.0000531354,0.0001421089,0.00004127668,0.000008740128,0.00014238888,0.00009149274,0.000016564698],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001504626,0.00016113433,0.0016546077,0.000022566514,0.000035245368,0.0000049301048,0.00012761644,0.000035413606,0.99419665,0.000125074,0.0010351029,0.0024512147],"study_design_scores_gemma":[0.0019262534,0.000104754225,0.0128219,0.00003747812,0.0000048584347,0.000010910603,0.00009251716,0.000018435547,0.89473736,0.00020114533,0.08965781,0.0003865669],"about_ca_topic_score_codex":0.000098860844,"about_ca_topic_score_gemma":0.00018288015,"teacher_disagreement_score":0.09945927,"about_ca_system_score_codex":0.00009819243,"about_ca_system_score_gemma":0.00022203705,"threshold_uncertainty_score":0.9999579},"labels":[],"label_agreement":null},{"id":"W2158791991","doi":"10.1016/j.bmcl.2009.10.049","title":"Non-hinge-binding pyrazolo[1,5-a]pyrimidines as potent B-Raf kinase inhibitors","year":2009,"lang":"en","type":"article","venue":"Bioorganic & Medicinal Chemistry Letters","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":36,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's Health Research Institute","funders":"","keywords":"Chemistry; Trifluoromethyl; Stereochemistry; Kinase; Hydrogen bond; Amine gas treating; Aryl; Protein kinase A; Chemical synthesis; Structure–activity relationship; In vitro; Combinatorial chemistry; Biochemistry; Molecule; Organic chemistry","score_opus":0.006420254641340049,"score_gpt":0.2185084930702599,"score_spread":0.21208823842891986,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2158791991","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99099165,0.0007485088,0.0001568306,0.005169357,0.00047338346,0.00019147253,0.000012440863,0.00006657022,0.0021897668],"genre_scores_gemma":[0.99200314,0.00009018105,0.00014333417,0.0043161563,0.0024408998,0.000011274667,0.00025899583,0.00004590731,0.00069010205],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9976764,0.00002147802,0.00043046425,0.00074743514,0.00042037625,0.0007038997],"domain_scores_gemma":[0.9987331,0.000012485091,0.00018738736,0.0006042965,0.00006720825,0.0003955371],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00026553427,0.00044583937,0.00033371875,0.000052766758,0.00018192684,0.000042739208,0.0004614998,0.00031481948,0.00014187253],"category_scores_gemma":[0.00016779141,0.00041591455,0.0001862782,0.00018775623,0.000157296,0.000009969962,0.000114866474,0.00030729355,0.00009012354],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008935717,0.00007791595,0.00044136835,0.000054777887,0.000045401706,0.00017124615,0.000084882464,0.000002419763,0.973281,0.000004042003,0.024375584,0.0013719621],"study_design_scores_gemma":[0.0009481128,0.00021301651,0.0009472635,0.00009171788,0.00006408462,0.00026193776,0.00020048853,0.0000075038315,0.981859,0.000016100292,0.014917283,0.00047348865],"about_ca_topic_score_codex":0.000023509754,"about_ca_topic_score_gemma":0.000001420647,"teacher_disagreement_score":0.009458301,"about_ca_system_score_codex":0.000085454776,"about_ca_system_score_gemma":0.0001498133,"threshold_uncertainty_score":0.9998293},"labels":[],"label_agreement":null},{"id":"W2159246510","doi":"10.1158/1541-7786.mcr-13-0294","title":"Hematopoietic Expression of Oncogenic <i>BRAF</i> Promotes Aberrant Growth of Monocyte-Lineage Cells Resistant to PLX4720","year":2013,"lang":"en","type":"article","venue":"Molecular Cancer Research","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"National Cancer Institute; National Heart, Lung, and Blood Institute; Home Office; Cancer Research UK","keywords":"Cancer research; Biology; Haematopoiesis; Monocyte; Myeloid; Cytokine; Bone marrow; PI3K/AKT/mTOR pathway; Macrophage; Immunology; Cell biology; Stem cell; Signal transduction; In vitro","score_opus":0.030141430433383107,"score_gpt":0.31480745100598573,"score_spread":0.2846660205726026,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2159246510","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946878,0.0020392234,0.0008770415,0.00022867524,0.00007480758,0.00095847243,0.00005549463,0.000009261087,0.0010692248],"genre_scores_gemma":[0.997053,0.00019002707,0.0015879606,0.00010451345,0.000072100614,0.0003347221,0.000027183607,0.000048853854,0.00058163836],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99761546,0.00023833493,0.0004371167,0.0005291108,0.0006530973,0.0005268771],"domain_scores_gemma":[0.9982584,0.000027538494,0.00011426936,0.0007439522,0.00061828154,0.00023751946],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00050761463,0.00019873508,0.00032303308,0.00016190339,0.0000689273,0.00002320129,0.0005341722,0.0001775708,0.00012927782],"category_scores_gemma":[0.00012134388,0.00017400025,0.00015832442,0.00035042755,0.00015247254,0.00000672063,0.00042087826,0.00019193967,0.000030751606],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002065915,0.00013776628,0.00013333806,0.00029791569,0.000038665912,0.000015655578,0.00017013571,0.000024466373,0.99413,0.00010513251,0.0044485596,0.0002917287],"study_design_scores_gemma":[0.00050818495,0.0008042927,0.00014503612,0.0001606372,0.000011304673,0.0000029951755,0.000086339656,0.000020288786,0.9960534,0.00013111727,0.0018929113,0.00018351898],"about_ca_topic_score_codex":0.00077781413,"about_ca_topic_score_gemma":0.00003901094,"teacher_disagreement_score":0.0025556483,"about_ca_system_score_codex":0.000034458553,"about_ca_system_score_gemma":0.0002715068,"threshold_uncertainty_score":0.7095524},"labels":[],"label_agreement":null},{"id":"W2159381901","doi":"10.1161/hypertensionaha.110.159889","title":"Mitogen-Activated Protein Kinase–Activated Protein Kinase 2 in Angiotensin II–Induced Inflammation and Hypertension","year":2010,"lang":"en","type":"article","venue":"Hypertension","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":61,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"National Heart, Lung, and Blood Institute; Canadian Institutes of Health Research; Institut de Cardiologie de Montréal","keywords":"Angiotensin II; Nicotinamide adenine dinucleotide phosphate; Protein kinase A; Chemistry; Internal medicine; Endocrinology; Kinase; Biology; Oxidase test; Biochemistry; Medicine; Receptor; Enzyme","score_opus":0.015745438883132932,"score_gpt":0.21187925238870184,"score_spread":0.1961338135055689,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2159381901","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975685,0.00016752964,0.000020641482,0.0005395682,0.00031216952,0.0011807426,0.000008349621,0.000062138846,0.00014038423],"genre_scores_gemma":[0.99790627,0.00001523376,0.0009597224,0.0001584218,0.00028919382,0.00008557553,0.0002432198,0.000058949583,0.00028340772],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99810344,0.00012838088,0.000380702,0.00071904657,0.00023136126,0.00043708447],"domain_scores_gemma":[0.9987988,0.000012806957,0.00015633104,0.0005833233,0.00026365332,0.00018512338],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00025486256,0.0003608117,0.00035084947,0.0001783813,0.00022539038,0.00003817138,0.00013714952,0.00058042654,0.00001648557],"category_scores_gemma":[0.0003895205,0.00031911136,0.00008317845,0.0002457001,0.00007671378,0.00002783194,0.00021069465,0.00038616205,0.000015228686],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036279793,0.00012632147,0.0001601379,0.00002751236,0.000018884686,0.00008626339,0.00005831926,0.0000021196238,0.9910441,0.000051596577,0.00029738914,0.0077645644],"study_design_scores_gemma":[0.0017356448,0.00051930733,0.004309771,0.00012650808,0.000017862742,0.00012758178,0.00003621673,0.00035329812,0.9829248,0.000067648136,0.009357119,0.0004242351],"about_ca_topic_score_codex":0.00027024964,"about_ca_topic_score_gemma":0.00019358232,"teacher_disagreement_score":0.00905973,"about_ca_system_score_codex":0.000019185823,"about_ca_system_score_gemma":0.00009761877,"threshold_uncertainty_score":0.9999261},"labels":[],"label_agreement":null},{"id":"W2159631216","doi":"10.5430/jst.v2n5p13","title":"Combinatorial treatment with carboxyamidotriazole- orotate and temozolomide in sc-implanted human LOX IMVI melanoma xenografts","year":2012,"lang":"en","type":"article","venue":"Journal of Solid Tumors","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Temozolomide; Medicine; Pharmacology; Melanoma; Cancer research; Glioma","score_opus":0.011171134092234549,"score_gpt":0.2529653365666711,"score_spread":0.24179420247443653,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2159631216","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980042,0.0008160015,0.000014891767,0.000034085504,0.0004215847,0.00015333701,0.000016138196,0.0000041176086,0.0005356274],"genre_scores_gemma":[0.99879783,0.00013107424,0.000102510836,0.000033777505,0.0008274704,0.00000643429,0.000017688593,0.000022336624,0.000060889502],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99885714,0.000080191494,0.00041083942,0.0001458658,0.00015482631,0.00035116053],"domain_scores_gemma":[0.99923325,0.000014304177,0.00030750575,0.00015457135,0.00006899793,0.00022139148],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027602853,0.00020142412,0.00036695987,0.00012112612,0.00006450836,0.000017953022,0.00011175091,0.00009631451,0.000006762421],"category_scores_gemma":[0.000017552435,0.00014350712,0.00007452524,0.0000774243,0.000069224,0.000015091263,0.00003881273,0.00012830483,0.0000020391255],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001557705,0.00062326284,0.23410872,0.000035129815,0.00030047787,0.00047147958,0.00070311496,0.000021789549,0.7603142,0.00037778323,0.00040163027,0.0010847094],"study_design_scores_gemma":[0.017260907,0.013328964,0.16079701,0.0002259852,0.00021377075,0.0053453464,0.0005983068,0.000018312869,0.7898691,0.0002890762,0.011300158,0.0007530266],"about_ca_topic_score_codex":0.000053236523,"about_ca_topic_score_gemma":0.00004933154,"teacher_disagreement_score":0.0733117,"about_ca_system_score_codex":0.000047903337,"about_ca_system_score_gemma":0.000092555085,"threshold_uncertainty_score":0.585205},"labels":[],"label_agreement":null},{"id":"W2159793198","doi":"10.1021/jm4000837","title":"X-ray Crystal Structure of ERK5 (MAPK7) in Complex with a Specific Inhibitor","year":2013,"lang":"en","type":"article","venue":"Journal of Medicinal Chemistry","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Institutes of Health Research; Wellcome Trust","keywords":"Chemistry; Kinase; MAPK7; Protein kinase domain; Binding site; Angiogenesis; Structure–activity relationship; Computational biology; Protein kinase A; Biochemistry; Cancer research; Cyclin-dependent kinase 2; Biology; Gene","score_opus":0.007936707667701498,"score_gpt":0.20800692326045764,"score_spread":0.20007021559275615,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2159793198","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977893,0.00067593076,0.00016010489,0.00014135997,0.000074486314,0.0000737011,0.000010253987,0.0000016326301,0.0010732366],"genre_scores_gemma":[0.99775356,0.000051962932,0.001137701,0.000059932445,0.0008441582,0.0000011659198,0.000026107064,0.00001385696,0.00011153246],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988688,0.000023229355,0.00045163,0.0001476014,0.00032347202,0.00018525688],"domain_scores_gemma":[0.9990751,0.000013326271,0.00036100228,0.00019036072,0.00021579435,0.0001443949],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012335509,0.0001502639,0.00029992516,0.000040131632,0.000017358527,0.00001076236,0.00021140934,0.00014595762,0.000428962],"category_scores_gemma":[0.000048487662,0.000106082814,0.00007417533,0.00008475683,0.00012686652,0.0000089499445,0.000037617487,0.00026397768,0.0000010819314],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021861529,0.00006111254,0.003278716,0.00010278874,0.000036085494,0.000047432295,0.000068017674,0.00002257022,0.99078226,0.000002628749,0.0049753967,0.00040438556],"study_design_scores_gemma":[0.002107209,0.0007165939,0.013500537,0.0001724846,0.000021035636,0.00077291887,0.0007314511,0.000008312301,0.97282493,0.000054390446,0.008935367,0.0001547713],"about_ca_topic_score_codex":0.000010631938,"about_ca_topic_score_gemma":0.0000045005754,"teacher_disagreement_score":0.017957322,"about_ca_system_score_codex":0.00002100971,"about_ca_system_score_gemma":0.00013944281,"threshold_uncertainty_score":0.46968332},"labels":[],"label_agreement":null},{"id":"W2161028192","doi":"10.1038/msb.2013.25","title":"Phosphoproteome dynamics reveal novel ERK1/2 MAP kinase substrates with broad spectrum of functions","year":2013,"lang":"en","type":"article","venue":"Molecular Systems Biology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":156,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Institute for Research in Immunology and Cancer","funders":"Canada Research Chairs; Canadian Institutes of Health Research; Fondation de France; Cancer Research Society","keywords":"Biology; Phosphoproteomics; Kinase; Cell biology; Phosphorylation; Alternative splicing; Chromatin; Computational biology; Protein phosphorylation; Genetics; Protein kinase A; Gene; Gene isoform","score_opus":0.005699035251137267,"score_gpt":0.1940205345149684,"score_spread":0.18832149926383113,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2161028192","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9491472,0.0014770174,0.04583116,0.00021601903,0.00047033615,0.00077613094,0.0001656215,0.000029016324,0.0018874925],"genre_scores_gemma":[0.9964553,0.000012073759,0.0009406651,0.000068867834,0.00013552577,0.00019870502,0.0006545235,0.000040799892,0.0014935365],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984554,0.00009149024,0.000392212,0.0005250449,0.00010963876,0.0004261997],"domain_scores_gemma":[0.99863994,0.000009826921,0.00022276834,0.0008359533,0.0001617515,0.0001297601],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013885315,0.00028233268,0.00036081445,0.00008218719,0.00006739223,0.000026311216,0.0003419226,0.00033671278,0.000037931117],"category_scores_gemma":[0.000034289624,0.00023001476,0.00011538225,0.00013966777,0.0001849762,0.000005559919,0.00012661585,0.0001316815,0.00006776676],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000058186237,0.00009402374,0.0049982346,0.000089336645,0.00014878003,0.000011616301,0.000011587907,0.00009645246,0.99020165,0.0034497674,0.00066730374,0.00017306789],"study_design_scores_gemma":[0.0018301967,0.002977395,0.0039361217,0.00009453787,0.000086633605,0.00032212085,0.00033722716,0.00081369677,0.9793166,0.00027707126,0.009223745,0.0007846502],"about_ca_topic_score_codex":0.001138665,"about_ca_topic_score_gemma":0.00014747829,"teacher_disagreement_score":0.047308095,"about_ca_system_score_codex":0.000028660626,"about_ca_system_score_gemma":0.00010034433,"threshold_uncertainty_score":0.93797296},"labels":[],"label_agreement":null},{"id":"W2162808671","doi":"10.1158/0008-5472.can-09-3669","title":"The Mitogen-Activated Protein Kinase Kinase 4 Has a Pro-Oncogenic Role in Skin Cancer","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Centre National de la Recherche Scientifique; Institute of Genetics; Wellcome Trust","keywords":"Carcinogenesis; Protein kinase A; MAPK/ERK pathway; Kinase; Cancer; Cancer research; Biology; Cell biology; Mitogen-activated protein kinase; Signal transduction; Cancer cell; Genetics","score_opus":0.043867190907508596,"score_gpt":0.35013322029543975,"score_spread":0.3062660293879311,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2162808671","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9934621,0.0035769397,0.0000043540645,0.00086595205,0.0003392658,0.0010429245,0.000047981233,0.000012282149,0.00064819696],"genre_scores_gemma":[0.99231595,0.00030548318,0.00003404824,0.00005021487,0.0006815143,0.002710493,0.00002734935,0.00004031748,0.0038346243],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99795794,0.00022074029,0.0002094345,0.000506947,0.00036886404,0.000736061],"domain_scores_gemma":[0.99883157,0.0000306583,0.000052043004,0.000647559,0.00026089948,0.0001772778],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007846203,0.00016924823,0.00014034174,0.00008663845,0.00036753775,0.00010627968,0.00053444196,0.00022604998,0.00016666365],"category_scores_gemma":[0.0002398289,0.00012585818,0.00007416009,0.00035539622,0.00036087644,0.000006658768,0.00024899805,0.0007060727,0.00002763507],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003699279,0.000057621055,0.0010898283,0.000024685838,0.000027002829,0.000015001009,0.0001650336,0.0000039260817,0.9754074,0.000106765474,0.0026775517,0.020055223],"study_design_scores_gemma":[0.0005408225,0.00011902327,0.00070972566,0.000024300896,0.0000023980056,0.0000023963273,0.000093104165,0.000015753141,0.7414635,0.00011582134,0.2567839,0.00012924336],"about_ca_topic_score_codex":0.003231585,"about_ca_topic_score_gemma":0.017508723,"teacher_disagreement_score":0.25410634,"about_ca_system_score_codex":0.000086608285,"about_ca_system_score_gemma":0.0011813275,"threshold_uncertainty_score":0.9770279},"labels":[],"label_agreement":null},{"id":"W2162845412","doi":"10.1517/14728222.11.10.1339","title":"c-Jun N-terminal kinases as potential therapeutic targets","year":2007,"lang":"en","type":"review","venue":"Expert Opinion on Therapeutic Targets","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"University of Otago","keywords":"Kinase; Disease; Signal transduction; Inflammation; Pathogenesis; p38 mitogen-activated protein kinases; Diabetes mellitus; c-jun; Cancer; Bioinformatics; Medicine; Immunology; Biology; Cancer research; Neuroscience; Cell biology; Gene; Protein kinase A; Genetics; Transcription factor; Pathology; Endocrinology","score_opus":0.0574021792479626,"score_gpt":0.36577426696190085,"score_spread":0.30837208771393826,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2162845412","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000006074574,0.99073976,0.0011578118,0.00006328338,0.004374149,0.0010670911,0.000086584194,0.00009302363,0.0024122477],"genre_scores_gemma":[0.000548132,0.9892957,0.00019530734,0.0021269314,0.0035682956,0.00025075665,0.0022430941,0.00025021608,0.0015215403],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99559474,0.0004339833,0.0009285364,0.0014074807,0.00059914147,0.001036136],"domain_scores_gemma":[0.997691,0.00007521564,0.00051771314,0.0012619055,0.000115208044,0.00033896993],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00039867565,0.0012283843,0.0014676712,0.00030741774,0.0003029041,0.000095912284,0.000924034,0.0012195931,0.0006136578],"category_scores_gemma":[0.000035699322,0.001000169,0.0011414398,0.00020458309,0.00019024368,0.000010730682,0.00021123064,0.0005616918,0.000582794],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018032285,0.0003427924,7.061707e-7,0.0005748568,0.0005191989,0.00011106668,0.00009493269,0.0000010837599,0.0014902246,0.00047874142,0.0048900135,0.9913161],"study_design_scores_gemma":[0.0005954304,0.0013953669,0.000003745911,0.0008912888,0.00008013123,0.00048139726,0.00005074612,0.0000038872513,0.0027409268,0.0001369341,0.99248224,0.001137902],"about_ca_topic_score_codex":0.000016767659,"about_ca_topic_score_gemma":0.0000025435675,"teacher_disagreement_score":0.99017817,"about_ca_system_score_codex":0.000091983406,"about_ca_system_score_gemma":0.00045605205,"threshold_uncertainty_score":0.99924487},"labels":[],"label_agreement":null},{"id":"W2163563579","doi":"10.1016/s1470-2045(14)70051-8","title":"Vemurafenib in patients with BRAFV600 mutated metastatic melanoma: an open-label, multicentre, safety study","year":2014,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":292,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Medicine; Vemurafenib; Rash; Adverse effect; Internal medicine; Nausea; Clinical endpoint; Population; Dacarbazine; Expanded access; Interim analysis; Dermatology; Surgery; Oncology; Gastroenterology; Clinical trial; Metastatic melanoma; Chemotherapy; Cancer","score_opus":0.03517410555670822,"score_gpt":0.3139019102081614,"score_spread":0.2787278046514532,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2163563579","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949029,0.000030557167,0.00009614218,0.0002278753,0.00015999397,0.0011552665,0.000027816493,0.00001745484,0.0033819783],"genre_scores_gemma":[0.997593,0.000009733186,0.0008644376,0.0008209051,0.00015771808,0.00008422242,0.00026051953,0.000028358041,0.00018112652],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99773294,0.0009934418,0.00029090204,0.00043200437,0.00013350631,0.0004171795],"domain_scores_gemma":[0.9989026,0.00007119676,0.00015272923,0.0007030849,0.00007953819,0.000090846166],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00085654244,0.00020279638,0.00046584656,0.00003626823,0.000111620786,0.000032051605,0.00076218473,0.00008911734,0.000031361134],"category_scores_gemma":[0.00008864375,0.00012882835,0.0000143917205,0.00012836406,0.000090722475,0.000011594971,0.00028744095,0.00017429165,0.000026549375],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.031731594,0.024646433,0.8312964,0.00009524908,0.0009929746,0.00015395838,0.0053033107,0.00051210116,0.03734244,0.0017391319,0.003532278,0.062654175],"study_design_scores_gemma":[0.0794867,0.03651858,0.7938864,0.000023809176,0.00021058676,0.000023482557,0.00093287823,0.0006405738,0.0027680646,0.00019153845,0.08456129,0.0007560689],"about_ca_topic_score_codex":0.0001597276,"about_ca_topic_score_gemma":0.0027679089,"teacher_disagreement_score":0.08102901,"about_ca_system_score_codex":0.000038051265,"about_ca_system_score_gemma":0.00009390497,"threshold_uncertainty_score":0.52534676},"labels":[],"label_agreement":null},{"id":"W2164670208","doi":"10.1002/9783527683031.ch1","title":"Global Approaches to Understanding Protein Kinase Functions","year":2015,"lang":"en","type":"other","venue":"","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital","funders":"","keywords":"Kinase; Function (biology); Gene knockdown; Computational biology; Protein kinase A; Biology; Cell biology; ASK1; RNA interference; Disease; Mitogen-activated protein kinase kinase; Genetics; Medicine; Cell culture; Gene; Pathology","score_opus":0.14767627515741125,"score_gpt":0.2495025798191389,"score_spread":0.10182630466172765,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2164670208","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00016452154,0.00034700698,0.038448043,0.00012828174,0.00024052967,0.00050832576,0.00024559238,0.00006781846,0.9598499],"genre_scores_gemma":[0.011852008,0.0000035036633,0.0018128572,0.0001146561,0.00070869795,0.00007646109,0.0006329999,0.00014272663,0.9846561],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9991676,0.000026770538,0.00009568817,0.00038255146,0.00011760158,0.0002097607],"domain_scores_gemma":[0.99939126,6.8587235e-7,0.000043757755,0.00036980907,0.000009670104,0.00018483303],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007295206,0.00020296266,0.0001459343,0.000049806014,0.00003080353,0.00002149786,0.00013688431,0.0003189205,0.00041452772],"category_scores_gemma":[0.00001983979,0.00017873097,0.000056440895,0.00009967477,0.000028808956,5.6491695e-7,0.000117018186,0.00004335044,0.00021277301],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000018878405,0.000030443962,0.000028132428,0.000024618095,0.000053579006,0.0000034968214,0.0000040310015,0.0000028220416,0.0018704828,0.006514229,0.9912614,0.00018786803],"study_design_scores_gemma":[0.00020016318,0.00019730693,0.000002742879,0.000027319516,0.00001661053,0.0000061748947,0.000120007186,0.000002112023,0.0007963892,0.00031674054,0.9980591,0.00025532598],"about_ca_topic_score_codex":0.00008323774,"about_ca_topic_score_gemma":0.0011883663,"teacher_disagreement_score":0.036635187,"about_ca_system_score_codex":0.000059810227,"about_ca_system_score_gemma":0.00014203457,"threshold_uncertainty_score":0.72884375},"labels":[],"label_agreement":null},{"id":"W2165575701","doi":"10.1016/j.cell.2012.02.053","title":"Dynamic Reprogramming of the Kinome in Response to Targeted MEK Inhibition in Triple-Negative Breast Cancer","year":2012,"lang":"en","type":"article","venue":"Cell","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":744,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institute of General Medical Sciences; National Institute of Diabetes and Digestive and Kidney Diseases; National Cancer Institute; National Institute of Environmental Health Sciences; Canadian Institutes of Health Research","keywords":"Kinome; Triple-negative breast cancer; MEK inhibitor; Biology; Cancer research; MAPK/ERK pathway; Reprogramming; Receptor tyrosine kinase; Kinase; Trametinib; Gene knockdown; Cancer; Cell biology; Breast cancer; Apoptosis; Biochemistry; Cell; Genetics","score_opus":0.007236532849522338,"score_gpt":0.23873211960605845,"score_spread":0.23149558675653611,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2165575701","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9988793,0.00029567254,0.00004083091,0.0001305164,0.00013723114,0.00024552754,0.00003785046,0.000002557165,0.00023047732],"genre_scores_gemma":[0.99924314,0.000012973722,0.00019389733,0.00008007341,0.000028648972,0.00004636607,0.0000135667,0.000008673926,0.00037263858],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993369,0.00012355472,0.00015008736,0.0001476764,0.000056753004,0.00018501254],"domain_scores_gemma":[0.9996731,0.0000122252995,0.00005676361,0.00019124674,0.000024506986,0.00004210007],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000297684,0.000071446426,0.000086845765,0.000049755698,0.000015218695,0.0000029731161,0.00005910307,0.00007258557,0.000014328667],"category_scores_gemma":[0.000057938247,0.00005733639,0.00003616082,0.00017346942,0.00002603098,0.0000033480114,0.000063239604,0.000061292,0.0000032457083],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004034046,0.0000688546,0.011639177,0.000012600245,0.000002401853,0.0000013812221,0.00049137115,0.00003440939,0.9867434,0.0000039435595,0.00005091489,0.0005481601],"study_design_scores_gemma":[0.0005455526,0.00005507107,0.26992825,0.000026378577,0.0000030171836,0.000003852719,0.00017292991,0.00002137676,0.7283266,0.000013752153,0.0008255906,0.0000776088],"about_ca_topic_score_codex":0.00020218048,"about_ca_topic_score_gemma":0.0004274807,"teacher_disagreement_score":0.25841677,"about_ca_system_score_codex":0.0000362841,"about_ca_system_score_gemma":0.000053535063,"threshold_uncertainty_score":0.233811},"labels":[],"label_agreement":null},{"id":"W2166039202","doi":"10.1007/s12031-007-9011-0","title":"p38 Mitogen-Activated Protein Kinase Regulates Myelination","year":2007,"lang":"en","type":"review","venue":"Journal of Molecular Neuroscience","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":52,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Multiple Sclerosis Society","keywords":"Protein kinase A; Neurochemistry; Mitogen-activated protein kinase; p38 mitogen-activated protein kinases; Cell biology; Kinase; Chemistry; Neurology; Biology; Neuroscience","score_opus":0.04326119599476313,"score_gpt":0.32450406353456246,"score_spread":0.2812428675397993,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2166039202","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.01180322,0.9833681,0.003013954,0.000020909729,0.0011108826,0.00048276148,0.000013213164,0.000008559469,0.0001784153],"genre_scores_gemma":[0.0052788616,0.99252987,0.00075853436,0.00016882,0.00044432204,0.000012136723,0.00002952038,0.00007419509,0.00070373894],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9975184,0.00024508737,0.0008469509,0.00047149966,0.00055279135,0.00036527467],"domain_scores_gemma":[0.9978205,0.000016151174,0.0011836571,0.00047057652,0.00029196107,0.00021718141],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006845765,0.00038008482,0.0007185844,0.00031099658,0.00009082276,0.000070504415,0.00075779815,0.00036278457,0.0000050311087],"category_scores_gemma":[0.000633587,0.00030587442,0.0005871994,0.00045910338,0.00014251156,0.000013021073,0.00016163848,0.0004084563,0.000005794279],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000019077654,0.000054141048,4.2178394e-7,0.00054011756,0.00001670951,0.0002812112,0.000004312145,0.0000054841976,0.7789502,0.000029727413,0.00017934052,0.21991922],"study_design_scores_gemma":[0.0001554934,0.00045761434,0.0000031810637,0.0009810365,0.00008068552,0.0005896428,0.0000019322206,0.000002030149,0.32167324,0.000015609618,0.6758177,0.00022177692],"about_ca_topic_score_codex":0.0000012333378,"about_ca_topic_score_gemma":4.0917058e-7,"teacher_disagreement_score":0.67563844,"about_ca_system_score_codex":0.00004000505,"about_ca_system_score_gemma":0.00053968304,"threshold_uncertainty_score":0.9999393},"labels":[],"label_agreement":null},{"id":"W2166262263","doi":"10.1016/s0140-6736(12)60868-x","title":"Dabrafenib in BRAF-mutated metastatic melanoma: a multicentre, open-label, phase 3 randomised controlled trial","year":2012,"lang":"en","type":"article","venue":"The Lancet","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2960,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"GlaxoSmithKline","keywords":"Dabrafenib; Dacarbazine; Medicine; Internal medicine; Melanoma; Hazard ratio; Clinical endpoint; Adverse effect; Oncology; Phases of clinical research; Progression-free survival; Clinical trial; Randomized controlled trial; Gastroenterology; Surgery; Metastatic melanoma; Chemotherapy; Cancer; Vemurafenib; Confidence interval; Cancer research","score_opus":0.057439172744314745,"score_gpt":0.33927841828956995,"score_spread":0.2818392455452552,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2166262263","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9887992,0.0011637022,0.00019774013,0.000401394,0.0004911134,0.0038059088,0.000046777055,0.000017262248,0.0050768624],"genre_scores_gemma":[0.9961952,0.00007801665,0.00043865372,0.0007019794,0.00094067556,0.00055652537,0.0001734339,0.000024522109,0.0008909822],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99817795,0.0005254332,0.0003939501,0.0002437205,0.00012722198,0.0005317463],"domain_scores_gemma":[0.99897844,0.00013698536,0.00017098234,0.00056460965,0.00003468851,0.000114288894],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012340214,0.0002062793,0.0007175959,0.00003404228,0.000080948186,0.000059287584,0.0005963035,0.00008007403,0.00009657974],"category_scores_gemma":[0.0004614054,0.00012981838,0.00007746924,0.00010679467,0.0000565674,0.000013657376,0.00017520555,0.000136237,0.000051351577],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.761595,0.001889063,0.0001764193,0.000019269486,0.00028991903,0.000017382828,0.0004449646,0.000006265577,0.22544882,0.00019878703,0.008666135,0.0012479556],"study_design_scores_gemma":[0.95575714,0.0005414794,0.00005798559,0.000010148998,0.00010936767,0.0000138889545,0.000066629094,0.00027279806,0.029266737,0.000056959652,0.01365161,0.00019527841],"about_ca_topic_score_codex":0.00004019395,"about_ca_topic_score_gemma":0.00005429997,"teacher_disagreement_score":0.19618207,"about_ca_system_score_codex":0.000016715014,"about_ca_system_score_gemma":0.000100074656,"threshold_uncertainty_score":0.52938396},"labels":[],"label_agreement":null},{"id":"W2167229341","doi":"10.1161/01.atv.0000053182.58636.be","title":"Role of p44/p42 MAP Kinase in the Age-Dependent Increase in Vascular Smooth Muscle Cell Proliferation and Neointimal Formation","year":2003,"lang":"en","type":"article","venue":"Arteriosclerosis Thrombosis and Vascular Biology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":54,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Clinical Research Institute","funders":"Canadian Institutes of Health Research","keywords":"MAPK/ERK pathway; Vascular smooth muscle; Cell growth; Mitogen-activated protein kinase; Neointima; Medicine; Cell biology; Endocrinology; Internal medicine; Kinase; Cancer research; Biology; Restenosis; Smooth muscle; Stent; Biochemistry","score_opus":0.013210116697113148,"score_gpt":0.2244197281662989,"score_spread":0.21120961146918577,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2167229341","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983555,0.0005546556,0.0003513514,0.000050180686,0.000040542956,0.00041238294,0.000012635206,0.000004944232,0.00021782007],"genre_scores_gemma":[0.9974668,0.0017014699,0.00038720205,0.00021910641,0.000029553346,0.000082004284,0.00009887503,0.000013623753,0.0000013712515],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9984891,0.0004581834,0.00034210912,0.00035903824,0.00009526327,0.0002563435],"domain_scores_gemma":[0.99947536,0.000019415807,0.000096738855,0.00032774996,0.000032453347,0.000048297956],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00070793985,0.00018577492,0.00026752922,0.00009691267,0.000075689524,0.000032470954,0.00011841914,0.00019771533,0.000010338585],"category_scores_gemma":[0.000039588675,0.00014744747,0.00008652513,0.00009880496,0.000106179985,0.000019089006,0.00006873084,0.00009903609,0.0000020877208],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000005568975,0.00018394676,0.050974205,0.000048458463,0.000018709157,1.9228355e-7,0.00060506543,0.0000073325623,0.9470576,0.0004933533,0.000022827173,0.00058272603],"study_design_scores_gemma":[0.0016698972,0.00054416637,0.959011,0.000031827953,0.000040336883,8.5591216e-7,0.0007558439,0.00013938459,0.032664653,0.00030303776,0.004601708,0.00023728273],"about_ca_topic_score_codex":0.00019597165,"about_ca_topic_score_gemma":0.00052075606,"teacher_disagreement_score":0.91439295,"about_ca_system_score_codex":0.000010389092,"about_ca_system_score_gemma":0.00002470572,"threshold_uncertainty_score":0.6012733},"labels":[],"label_agreement":null},{"id":"W2167689405","doi":"10.1158/1078-0432.ccr-07-1380","title":"Node-Negative Colorectal Cancer at High Risk of Distant Metastasis Identified by Combined Analysis of Lymph Node Status, Vascular Invasion, and Raf-1 Kinase Inhibitor Protein Expression","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":72,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Colorectal cancer; Medicine; Univariate analysis; Oncology; Internal medicine; Stage (stratigraphy); Metastasis; Cancer; Immunohistochemistry; Multivariate analysis; Lymph node; Tissue microarray; Pathology; Cancer research; Biology","score_opus":0.056547800871899354,"score_gpt":0.3718547099314861,"score_spread":0.31530690905958675,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2167689405","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99398404,0.003188492,0.00010330324,0.00004820438,0.00010216587,0.0005896448,0.0019467814,0.000006363823,0.000031026808],"genre_scores_gemma":[0.9895938,0.009157224,0.00025441914,0.000020673511,0.00007982292,0.00029550437,0.00031917405,0.000026203788,0.00025317786],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99618644,0.0010902111,0.00080501585,0.00075317983,0.0007211362,0.00044399756],"domain_scores_gemma":[0.99781954,0.00029710558,0.00036778123,0.00054569193,0.0006622358,0.00030766355],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001527739,0.00020369932,0.0007160625,0.00016292704,0.00022803963,0.000013150114,0.00026555307,0.0002654812,0.00017396829],"category_scores_gemma":[0.001247495,0.00016462129,0.00032396615,0.00061947625,0.00096489326,0.000010620686,0.0005543754,0.00027769245,0.000001969412],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002719632,0.0003388179,0.16201594,0.0000998963,0.0011741044,0.000008646609,0.00016096908,0.000044195855,0.83036876,0.000008553437,0.0024847735,0.0005757155],"study_design_scores_gemma":[0.0027036169,0.0004903156,0.089701265,0.00007712787,0.00033873104,3.2039117e-7,0.000106107436,0.0001029142,0.905297,0.000037278543,0.00096426037,0.00018107882],"about_ca_topic_score_codex":0.0059437007,"about_ca_topic_score_gemma":0.0010456704,"teacher_disagreement_score":0.07492824,"about_ca_system_score_codex":0.00008758189,"about_ca_system_score_gemma":0.00043326552,"threshold_uncertainty_score":0.8985137},"labels":[],"label_agreement":null},{"id":"W2169278779","doi":"10.1093/annonc/mdv188","title":"Titration of signalling output: insights into clinical combinations of MEK and AKT inhibitors","year":2015,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"Institute of Cancer Research; Cancer Research UK; National Institute for Health and Care Research; NIHR Biomedical Research Centre, Royal Marsden NHS Foundation Trust/Institute of Cancer Research","keywords":"Protein kinase B; PI3K/AKT/mTOR pathway; MAPK/ERK pathway; MEK inhibitor; Medicine; Growth inhibition; Cell growth; Cancer research; Pharmacology; Cell biology; Biology; Signal transduction; Biochemistry","score_opus":0.13088846515186378,"score_gpt":0.3920301638741505,"score_spread":0.26114169872228676,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2169278779","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99453765,0.00092267856,0.0005755261,0.00026094588,0.00015804754,0.0000852075,0.000004153198,0.0000021344604,0.0034536598],"genre_scores_gemma":[0.9987284,0.00033302064,0.0006541242,0.000108497305,0.00007800263,0.0000032989892,0.00003677896,0.000004966685,0.000052928648],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991855,0.00011912568,0.00041577255,0.00013026038,0.00007738201,0.0000719474],"domain_scores_gemma":[0.9991586,0.000051002826,0.00025266252,0.00011351642,0.00035685053,0.00006734325],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040710653,0.00006041824,0.00022558116,0.00004936803,0.000014063373,0.0000013702663,0.00007111689,0.00018557011,0.0000017226887],"category_scores_gemma":[0.00025631502,0.000055736396,0.000057455647,0.000047967063,0.00017344412,0.0000043802834,0.000055176177,0.000047162088,8.825076e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037102707,0.0015418235,0.0120031,0.00010750347,0.00019020907,0.000005023762,0.0016249502,0.00005857922,0.9217725,0.009758394,0.010269145,0.042297736],"study_design_scores_gemma":[0.0015988573,0.0078080497,0.0026743507,0.00002079937,0.000028163131,0.000003809598,0.00030002894,0.00008759546,0.9351786,0.0044457344,0.04775152,0.00010250158],"about_ca_topic_score_codex":0.00003658511,"about_ca_topic_score_gemma":0.0000630397,"teacher_disagreement_score":0.042195234,"about_ca_system_score_codex":0.000002461899,"about_ca_system_score_gemma":0.00018147213,"threshold_uncertainty_score":0.22728643},"labels":[],"label_agreement":null},{"id":"W2170022976","doi":"10.1016/j.ajhg.2014.11.009","title":"Fine-Scale Mapping of the 5q11.2 Breast Cancer Locus Reveals at Least Three Independent Risk Variants Regulating MAP3K1","year":2014,"lang":"en","type":"article","venue":"The American Journal of Human Genetics","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":90,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University and Génome Québec Innovation Centre; Public Health Ontario; Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital; McGill University Health Centre; McGill University; University of Toronto; Centre hospitalier universitaire de Québec; Royal Victoria Hospital; Université de Montréal; Royal Victoria Regional Health Centre; Université Laval","funders":"Medical Research Council; Canadian Institutes of Health Research; National Institute for Health and Care Research; National Cancer Institute; Cancer Research UK; National Institutes of Health; Francis Crick Institute; World Health Organization","keywords":"Locus (genetics); Breast cancer; Genetics; Biology; Scale (ratio); Cancer; Geography; Gene; Cartography","score_opus":0.010677906471367026,"score_gpt":0.23363551846775227,"score_spread":0.22295761199638525,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2170022976","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99715686,0.0005334611,0.0014642656,0.00023676355,0.00016959087,0.00010845584,0.000044880235,0.000002678715,0.0002830358],"genre_scores_gemma":[0.99834985,0.00010503115,0.00047348582,0.00012202046,0.00069200876,0.0000027065576,0.000001923783,0.000028762151,0.0002241921],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99839383,0.00029370518,0.0005355896,0.00018421633,0.0003294581,0.0002631973],"domain_scores_gemma":[0.99761325,0.000030038424,0.0015267894,0.0005373708,0.00020147167,0.00009108934],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006888958,0.00017767867,0.00033315588,0.0000419033,0.00025423238,0.000020765725,0.0006809031,0.000053624815,0.000034983244],"category_scores_gemma":[0.000039136667,0.000108394794,0.00020298829,0.00012333892,0.00036023845,0.000003094334,0.0003195292,0.00022226783,0.000002105202],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001008665,0.000036105648,0.15858689,0.000015080794,0.00013408314,0.0000013042533,0.00026119524,0.0012387176,0.8210949,0.000026310701,0.0005756726,0.017928882],"study_design_scores_gemma":[0.00083074335,0.0008418369,0.91232246,0.00014869329,0.00017561488,0.00042157894,0.00031617942,0.00020899881,0.082527325,0.0007903027,0.0011450272,0.00027124412],"about_ca_topic_score_codex":0.00007935538,"about_ca_topic_score_gemma":0.0003641672,"teacher_disagreement_score":0.75373554,"about_ca_system_score_codex":0.00003221968,"about_ca_system_score_gemma":0.00007179867,"threshold_uncertainty_score":0.44202116},"labels":[],"label_agreement":null},{"id":"W2171367970","doi":"10.1200/jco.2012.44.7888","title":"Pharmacodynamic Effects and Mechanisms of Resistance to Vemurafenib in Patients With Metastatic Melanoma","year":2013,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":363,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Jonsson Comprehensive Cancer Center; University of Texas MD Anderson Cancer Center; University of California, Los Angeles; Peter MacCallum Cancer Centre; Plexxikon; Vanderbilt University; Moffitt Cancer Center; Genentech; University of Pittsburgh; F. Hoffmann-La Roche; Vanderbilt-Ingram Cancer Center; York University; University of Pennsylvania; Massachusetts General Hospital; GlaxoSmithKline","keywords":"Vemurafenib; Medicine; Neuroblastoma RAS viral oncogene homolog; MAPK/ERK pathway; Cancer research; Melanoma; Kinase; Phosphorylation; Internal medicine; Cancer; Metastatic melanoma; KRAS; Biology; Colorectal cancer; Cell biology","score_opus":0.019358797503458477,"score_gpt":0.34063784778405976,"score_spread":0.3212790502806013,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2171367970","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997168,0.00012016012,0.0015799872,0.00026113805,0.0002641339,0.00026115196,0.0000035459652,0.0000010002342,0.00034087015],"genre_scores_gemma":[0.99127984,0.000036774138,0.007975697,0.0005242741,0.00006681668,0.000007728568,0.000003103973,0.000010087004,0.000095654286],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9983845,0.0002828089,0.00088178826,0.00015468501,0.00014641356,0.00014982477],"domain_scores_gemma":[0.9985882,0.0002571171,0.000637396,0.000118790274,0.00021441461,0.00018407872],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007347963,0.000100219644,0.0005939146,0.000068560934,0.000011791734,0.0000040507225,0.0001404532,0.00011900918,0.000013273589],"category_scores_gemma":[0.0005284789,0.000069375834,0.00008124469,0.000066899695,0.00006388313,0.000008220682,0.000054121443,0.00018039695,0.0000034777997],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017111143,0.004916823,0.4016236,0.00050686,0.0012459223,0.00030721634,0.00024906517,0.00009365167,0.4269823,0.0017570001,0.0046780687,0.14052834],"study_design_scores_gemma":[0.012986026,0.027684538,0.9277217,0.00011484357,0.0001396783,0.000019495037,0.000046786678,0.000024008345,0.024548126,0.0016353779,0.004867116,0.00021234476],"about_ca_topic_score_codex":0.000007110828,"about_ca_topic_score_gemma":0.000056425597,"teacher_disagreement_score":0.5260981,"about_ca_system_score_codex":0.000014056975,"about_ca_system_score_gemma":0.00018153028,"threshold_uncertainty_score":0.28290644},"labels":[],"label_agreement":null},{"id":"W2172224626","doi":"","title":"Activated mitogen-activated protein kinase expression during human breast tumorigenesis and breast cancer progression.","year":2002,"lang":"en","type":"article","venue":"PubMed","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":196,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Breast cancer; Tamoxifen; Medicine; MAPK/ERK pathway; Immunohistochemistry; Carcinogenesis; Kinase; Cancer research; Cancer; Lymph node; Internal medicine; Metastasis; Oncology; Mammary gland; Pathology; Biology","score_opus":0.014394704781926521,"score_gpt":0.22121279831514729,"score_spread":0.20681809353322075,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2172224626","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99760336,0.00071190984,0.0000034068664,0.00017166158,0.00013017458,0.00092598994,0.00010127181,0.000058855327,0.00029335628],"genre_scores_gemma":[0.9950093,0.0000693779,0.000038599068,0.000026248455,0.00038217663,0.002463905,0.00005127555,0.000045992318,0.0019131488],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998498,0.0000788332,0.00021094063,0.0005387875,0.00017571647,0.0004976702],"domain_scores_gemma":[0.9991933,0.0000032669693,0.00013127721,0.00033451652,0.000075570075,0.00026206087],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008002188,0.0002549286,0.00018871744,0.00006490787,0.000267272,0.000047803736,0.00015644555,0.00017807394,0.00009929544],"category_scores_gemma":[0.000017505934,0.00021551987,0.000061136794,0.00012492214,0.00007532513,0.00001557098,0.00015851857,0.00010973361,0.0000032871221],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017179686,0.00012307511,0.005492353,0.00006217016,0.00003707846,0.000017043769,0.000036064073,9.067897e-7,0.9686503,0.0000028009047,0.00037425026,0.025032157],"study_design_scores_gemma":[0.00078143226,0.000024669887,0.2252439,0.00004562717,0.000011389471,0.000089768895,0.0000158792,0.0000023231169,0.7725271,0.000003002995,0.0010198815,0.00023502656],"about_ca_topic_score_codex":0.000049061873,"about_ca_topic_score_gemma":0.000009827786,"teacher_disagreement_score":0.21975155,"about_ca_system_score_codex":0.00003241867,"about_ca_system_score_gemma":0.000013993585,"threshold_uncertainty_score":0.8788645},"labels":[],"label_agreement":null},{"id":"W2172450144","doi":"10.1016/s0960-894x(03)00640-1","title":"Synthesis and evaluation of 4-Anilino-6,7-dialkoxy-3-quinolinecarbonitriles as inhibitors of kinases of the Ras-MAPK signaling cascade","year":2003,"lang":"en","type":"article","venue":"Bioorganic & Medicinal Chemistry Letters","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":28,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's Health Research Institute","funders":"","keywords":"Chemistry; Aniline; Kinase; MAPK/ERK pathway; Phosphorylation; Mitogen-activated protein kinase; Structure–activity relationship; Stereochemistry; Biochemistry; In vitro; Organic chemistry","score_opus":0.013331390779175218,"score_gpt":0.2330483175607817,"score_spread":0.21971692678160648,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2172450144","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99724483,0.001836731,0.000020141153,0.0001793527,0.00013311139,0.00017822598,0.000020477057,0.000004202661,0.00038290262],"genre_scores_gemma":[0.99953926,0.00006185477,0.00006736389,0.000091568036,0.00018808013,0.000010711067,0.0000128951315,0.000018009596,0.000010265279],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984751,0.00014240324,0.00044458333,0.00027898996,0.00048241444,0.00017652808],"domain_scores_gemma":[0.9989472,0.00008294955,0.00036220386,0.0003641387,0.0001721969,0.0000712959],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006580611,0.00018114889,0.0002878211,0.000028850458,0.000040277053,0.0000033107854,0.00019052681,0.00016281445,0.000062764266],"category_scores_gemma":[0.0013625363,0.0001413387,0.00011464444,0.00013941943,0.00031925988,0.0000035901608,0.000057222493,0.000095955664,3.565157e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003743515,0.00004066268,0.0023731296,0.00020560788,0.00007089543,0.0000013654233,0.00007699319,0.000010777942,0.9966561,0.00001005993,0.00017349598,0.00034346982],"study_design_scores_gemma":[0.0005716319,0.00005300295,0.00093220803,0.00017929882,0.000267651,0.000041564497,0.00033583108,0.000009531804,0.99729234,0.000026063803,0.00016272934,0.00012816109],"about_ca_topic_score_codex":0.00004297668,"about_ca_topic_score_gemma":0.0000023849163,"teacher_disagreement_score":0.0022943965,"about_ca_system_score_codex":0.000022050363,"about_ca_system_score_gemma":0.00025252136,"threshold_uncertainty_score":0.5763625},"labels":[],"label_agreement":null},{"id":"W2192572578","doi":"10.1158/1078-0432.ccr-15-1681","title":"A Phase I Study of the Safety, Pharmacokinetics, and Pharmacodynamics of Combination Therapy with Refametinib plus Sorafenib in Patients with Advanced Cancer","year":2015,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"National Cancer Institute; Bayer HealthCare","keywords":"Sorafenib; Pharmacokinetics; Medicine; Tolerability; Pharmacodynamics; Dosing; Pharmacology; Internal medicine; Hepatocellular carcinoma; Adverse effect; Cancer; Oncology; Gastroenterology","score_opus":0.11807690024990147,"score_gpt":0.47949471591080817,"score_spread":0.3614178156609067,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2192572578","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977988,0.0006334331,0.000012341171,0.00012467321,0.00010874432,0.0011541073,0.000058824382,0.0000023360044,0.000106725056],"genre_scores_gemma":[0.9984121,0.0012362902,0.000035347577,0.00004506826,0.000048316233,0.00011244222,0.00001759796,0.000018686513,0.000074207215],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981512,0.00045436012,0.00038237325,0.00032363553,0.00048197055,0.0002064496],"domain_scores_gemma":[0.9986737,0.000069695714,0.00017090216,0.0002947808,0.0006870539,0.00010390717],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010026739,0.00011051637,0.00025284514,0.00005194868,0.000039045037,0.000006256302,0.00024833335,0.00006779839,0.000009132166],"category_scores_gemma":[0.000103421604,0.00006718213,0.00002626142,0.00027187457,0.00034284292,0.0000063590287,0.00014877829,0.0002712519,1.3898322e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.041270595,0.0071370043,0.87090266,0.00006753285,0.00020249649,0.000003004715,0.00073139754,0.00055183255,0.0153435925,0.000023131637,0.0002568461,0.063509904],"study_design_scores_gemma":[0.27458775,0.067548454,0.57053244,0.0002896227,0.0001035194,0.0000010709231,0.0014956939,0.0011928807,0.076256335,0.000077970915,0.007362084,0.0005521655],"about_ca_topic_score_codex":0.00030129086,"about_ca_topic_score_gemma":0.0005692803,"teacher_disagreement_score":0.30037022,"about_ca_system_score_codex":0.000040774426,"about_ca_system_score_gemma":0.0004622253,"threshold_uncertainty_score":0.2739608},"labels":[],"label_agreement":null},{"id":"W2209218670","doi":"10.1007/s10198-015-0757-y","title":"Economic burden of toxicities associated with treating metastatic melanoma in eight countries","year":2015,"lang":"en","type":"article","venue":"The European Journal of Health Economics","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Amgen","keywords":"Medicine; Diarrhea; Adverse effect; Internal medicine","score_opus":0.0288019819752227,"score_gpt":0.24471893674072437,"score_spread":0.21591695476550166,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2209218670","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947097,0.0013498991,0.000115175746,0.0004925707,0.00013647073,0.00009063246,0.000030944666,0.0000016910177,0.0030729463],"genre_scores_gemma":[0.99883455,0.00039660727,0.00030165564,0.00014576607,0.00018062361,7.110439e-7,0.000013721056,0.000022823737,0.00010353906],"study_design_codex":"simulation_or_modeling","study_design_gemma":"not_applicable","domain_scores_codex":[0.99839455,0.0005862634,0.0006956333,0.00009743261,0.000045957626,0.00018019226],"domain_scores_gemma":[0.9986847,0.000050648807,0.00095652125,0.00016374588,0.000059880815,0.0000845069],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028690381,0.00011039162,0.00032151624,0.000061579834,0.00004241135,0.000017440147,0.00023105161,0.000016546071,0.00000505459],"category_scores_gemma":[0.00006906638,0.00007631929,0.000052052288,0.000022418964,0.000083501116,0.000010366756,0.00004135065,0.000094384115,0.0000049512078],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013090077,0.0016618605,0.24424087,0.0014215377,0.008157491,0.0009139861,0.10734491,0.41626003,0.018166052,0.017610395,0.042323783,0.12880902],"study_design_scores_gemma":[0.09059423,0.09492983,0.18579482,0.004232978,0.0011587815,0.0060415473,0.098654024,0.009056328,0.12752023,0.007023433,0.36918736,0.005806426],"about_ca_topic_score_codex":0.000052846633,"about_ca_topic_score_gemma":0.00017504624,"teacher_disagreement_score":0.4072037,"about_ca_system_score_codex":0.00008979546,"about_ca_system_score_gemma":0.00054691976,"threshold_uncertainty_score":0.311221},"labels":[],"label_agreement":null},{"id":"W2214943066","doi":"10.14740/jocmr2424w","title":"Novel Drugs and Combination Therapies for the Treatment of Metastatic Melanoma","year":2015,"lang":"en","type":"review","venue":"Journal of Clinical Medicine Research","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":59,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Dabrafenib; Vemurafenib; Medicine; Ipilimumab; Trametinib; Nivolumab; Pembrolizumab; Targeted therapy; Melanoma; Metastatic melanoma; MAPK/ERK pathway; Adverse effect; Combination therapy; Oncology; Immune checkpoint; Cancer research; Immunotherapy; Cancer; Pharmacology; Internal medicine; Kinase","score_opus":0.4573143908375632,"score_gpt":0.5752513556841012,"score_spread":0.11793696484653804,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2214943066","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0007036517,0.99695736,0.0003992205,0.0006444565,0.00039226736,0.0007226306,0.000024019711,6.66531e-7,0.00015574622],"genre_scores_gemma":[0.0005405079,0.9971113,0.0004067767,0.00001554326,0.0014213916,0.00003590902,0.000027213577,0.000020140009,0.0004211728],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9970842,0.0006184974,0.0013918262,0.00017966621,0.0005460539,0.00017975821],"domain_scores_gemma":[0.99441373,0.003301886,0.00086078676,0.0002865826,0.0009711545,0.00016585959],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008607851,0.0001654671,0.0015295539,0.00013850108,0.000053480457,0.0000091549955,0.0002963193,0.00018926145,0.000007781447],"category_scores_gemma":[0.0023526903,0.00007187459,0.000412489,0.00011413492,0.00048015267,0.0000026900984,0.00004426648,0.00028664264,7.031212e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001738423,0.0003493252,0.000012405635,0.0011774168,0.0008014704,0.0000032410999,0.00011834777,6.317222e-8,0.0000617538,0.00016938733,0.0030721119,0.99406064],"study_design_scores_gemma":[0.0025408382,0.016428968,0.000020438589,0.0011867612,0.00066020107,0.00007243925,0.0002459087,0.0000059266463,0.00003811642,0.00027140515,0.97846794,0.000061050596],"about_ca_topic_score_codex":0.000010991259,"about_ca_topic_score_gemma":0.000003269857,"teacher_disagreement_score":0.9939996,"about_ca_system_score_codex":0.000022094518,"about_ca_system_score_gemma":0.0007147044,"threshold_uncertainty_score":0.29833266},"labels":[],"label_agreement":null},{"id":"W222191070","doi":"10.1023/a:1020694425356","title":"A Randomized Phase II Study of Two Schedules of Bryostatin-1 (NSC339555) in Patients with Advanced Malignant Melanoma – A National Cancer Institute of Canada Clinical Trials Group Study","year":2002,"lang":"en","type":"article","venue":"Investigational New Drugs","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Nova Scotia Cancer Centre; Université de Montréal; Cancer Care Ontario; Hôpital Notre-Dame; Centre Hospitalier de l’Université de Montréal; McGill University","funders":"National Cancer Institute","keywords":"Medicine; Nausea; myalgia; Adverse effect; Toxicity; Internal medicine; Lethargy; Phases of clinical research; Chemotherapy; Surgery; Clinical endpoint; Randomized controlled trial; Bryostatin 1; Gastroenterology","score_opus":0.05453415470042501,"score_gpt":0.34755567791445957,"score_spread":0.2930215232140346,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W222191070","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974664,0.00016125229,0.000041012554,0.00007370211,0.00023483181,0.0016590055,0.00025475575,0.0000027389985,0.000106336156],"genre_scores_gemma":[0.9980703,0.000011303565,0.0013562846,0.00008239824,0.000089088026,0.00012238944,0.00015498926,0.000013316616,0.000099902114],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99666566,0.0006585095,0.0014976399,0.00034216422,0.00068252924,0.00015347285],"domain_scores_gemma":[0.9980702,0.00024922803,0.0009423253,0.00019853012,0.0004078767,0.00013183197],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015466381,0.00018534152,0.0008593593,0.00009413882,0.000045439163,0.00000391827,0.00018091266,0.000058325804,0.00004047514],"category_scores_gemma":[0.0014237047,0.00014455535,0.000095098636,0.00018928076,0.00020413035,0.000015601767,0.00006954959,0.00008685182,1.8356974e-7],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.123186044,0.035638556,0.75629985,0.00021889682,0.0036487395,0.00002360427,0.0061537134,0.008140611,0.045729127,0.0059955595,0.003361975,0.011603339],"study_design_scores_gemma":[0.9170735,0.010294221,0.05209151,0.00022340422,0.00028540983,0.0000012994757,0.000957241,0.0005721626,0.016706385,0.0008726034,0.0004169192,0.0005053542],"about_ca_topic_score_codex":0.024041045,"about_ca_topic_score_gemma":0.066276036,"teacher_disagreement_score":0.79388744,"about_ca_system_score_codex":0.000030916195,"about_ca_system_score_gemma":0.0012272185,"threshold_uncertainty_score":0.98245794},"labels":[],"label_agreement":null},{"id":"W2223807461","doi":"10.1016/j.coi.2015.12.006","title":"Melanoma: the intersection of molecular targeted therapy and immune checkpoint inhibition","year":2016,"lang":"en","type":"review","venue":"Current Opinion in Immunology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Bristol-Myers Squibb Canada","keywords":"Melanoma; Immune checkpoint; Targeted therapy; Blockade; Immune system; Medicine; Cancer research; Immunotherapy; Immunology; Cancer; Internal medicine; Receptor","score_opus":0.04236795058960134,"score_gpt":0.3149179662027996,"score_spread":0.27255001561319825,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2223807461","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0056479033,0.9899429,0.00030868157,0.000026954513,0.0033247748,0.0006056375,0.000042495118,0.00000842907,0.000092196795],"genre_scores_gemma":[0.0051646433,0.9938474,0.000017341185,0.0000033593399,0.00020885178,0.00018589458,0.0005245415,0.000031544594,0.000016397438],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9982183,0.00039065006,0.0006800629,0.00040469857,0.00007585386,0.00023041757],"domain_scores_gemma":[0.9989611,0.000033385037,0.0004548519,0.00047022675,0.000057072524,0.000023396371],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028819632,0.00031092684,0.0006663884,0.00013585917,0.000040907573,0.0000091120555,0.00021177145,0.00040455261,0.000021492899],"category_scores_gemma":[0.000063558706,0.00019567758,0.00027530149,0.00012840529,0.0002298527,0.0000043545597,0.00021518511,0.00028068677,0.000009621341],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000586619,0.00008113712,0.000008021411,0.0014156925,0.00015038047,5.9696094e-7,0.000047694495,8.095432e-8,0.044538725,0.0012167546,0.00010348417,0.95237875],"study_design_scores_gemma":[0.00078132836,0.00045939992,0.0001303703,0.004198509,0.00002538893,0.00007760072,0.000024911269,5.886761e-7,0.013544588,0.00027115227,0.98021764,0.0002685029],"about_ca_topic_score_codex":0.00001158196,"about_ca_topic_score_gemma":0.0000012001071,"teacher_disagreement_score":0.98011416,"about_ca_system_score_codex":0.000038208553,"about_ca_system_score_gemma":0.0001396512,"threshold_uncertainty_score":0.79795},"labels":[],"label_agreement":null},{"id":"W2224326414","doi":"10.1016/j.ejca.2015.09.025","title":"Small data sets to develop and validate prognostic models are problematic","year":2015,"lang":"en","type":"letter","venue":"European Journal of Cancer","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Population Health Research Institute","funders":"","keywords":"Ipilimumab; Medicine; Nomogram; Prognostic model; Internal medicine; Oncology; Metastatic melanoma; Melanoma; Overall survival; Cancer; Immunotherapy; Cancer research","score_opus":0.13992624113722474,"score_gpt":0.2838337292900866,"score_spread":0.14390748815286186,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2224326414","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.2635926,0.04586967,0.022874484,0.6401447,0.0051918183,0.0029001907,0.002943838,0.000060214996,0.016422465],"genre_scores_gemma":[0.104082964,0.005237595,0.05207559,0.7867849,0.0328155,0.000058218928,0.0031541663,0.0010164932,0.014774571],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99819565,0.00035410083,0.0005036739,0.00036915153,0.0002825593,0.00029485545],"domain_scores_gemma":[0.99794286,0.000013472859,0.0005996342,0.0005719579,0.0006711304,0.00020093526],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010092738,0.00026778816,0.00035955835,0.0000823822,0.00003579894,0.00007547734,0.00082176743,0.00011858069,0.000011327627],"category_scores_gemma":[0.0002978478,0.00021293297,0.000041599316,0.000082359395,0.00003458984,0.000009654571,0.0005726507,0.0004886838,0.000014779372],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000035689518,0.0000101071455,0.00013370464,0.00023899198,0.00015802225,0.0007407228,0.00009234697,0.000107632026,0.002244311,6.6744525e-7,0.9925068,0.0037309735],"study_design_scores_gemma":[0.00048719285,0.00034518962,0.0002721751,0.0007116503,0.00016831033,0.00034172676,0.00001580807,0.000043409596,0.0004810678,0.000080151,0.99671495,0.0003383481],"about_ca_topic_score_codex":0.0000027948638,"about_ca_topic_score_gemma":0.000014337646,"teacher_disagreement_score":0.15950964,"about_ca_system_score_codex":0.000021284342,"about_ca_system_score_gemma":0.0004983724,"threshold_uncertainty_score":0.8683154},"labels":[],"label_agreement":null},{"id":"W2242926713","doi":"10.1200/jco.2004.22.90140.7529","title":"A meta-analysis of biochemotherapy (BCT) for the treatment of metastatic malignant melanoma (MM)","year":2004,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Internal medicine; Chemotherapy; Randomized controlled trial; Meta-analysis; Oncology; Cochrane Library; Clinical trial; Immunotherapy; Relative risk; Surgery; Cancer; Confidence interval","score_opus":0.2551563295747263,"score_gpt":0.4505082426026526,"score_spread":0.19535191302792632,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2242926713","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9758529,0.008879948,0.012410151,0.0019300658,0.0003447448,0.0003401289,0.000089338304,0.0000013265524,0.00015136128],"genre_scores_gemma":[0.98584706,0.0029703155,0.010278654,0.0004399293,0.00024121172,0.00001959363,0.000012900487,0.000012689939,0.00017765138],"study_design_codex":"meta_analysis","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9973443,0.00024861275,0.001897148,0.0001793205,0.00017454829,0.00015603976],"domain_scores_gemma":[0.9962477,0.0008720462,0.0020808047,0.00034239108,0.00035268973,0.000104369145],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001734198,0.00014697062,0.0020658574,0.00010477868,0.00002709389,0.000003488196,0.00026659213,0.0001883663,0.000058993446],"category_scores_gemma":[0.000353508,0.00007334088,0.0036857822,0.00015679469,0.00018944065,0.000003067675,0.000018269833,0.000076574404,6.9945776e-7],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0063503645,0.00855509,0.0020470233,0.000051993255,0.7595048,0.00006823068,0.00046749864,0.0027993743,0.17432266,0.0016138233,0.000793922,0.04342521],"study_design_scores_gemma":[0.012464724,0.08583178,0.0057287547,0.000006989453,0.36904573,0.00008189609,0.00029572612,0.000114223556,0.38739884,0.0015705496,0.13720722,0.0002535551],"about_ca_topic_score_codex":0.000034350553,"about_ca_topic_score_gemma":0.00011074899,"teacher_disagreement_score":0.39045906,"about_ca_system_score_codex":0.00002302979,"about_ca_system_score_gemma":0.0006074283,"threshold_uncertainty_score":0.371721},"labels":[],"label_agreement":null},{"id":"W2256206968","doi":"10.1021/jm100095x","title":"Discovery and Evaluation of 7-Alkyl-1,5-bis-aryl-pyrazolopyridinones as Highly Potent, Selective, and Orally Efficacious Inhibitors of p38α Mitogen-Activated Protein Kinase<sup>⊥</sup>⊥ Atomic coordinates and structure factors for crystal structure of compound<b>3d</b>with p38α can be accessed using PDB code 3LHJ.","year":2010,"lang":"en","type":"article","venue":"Journal of Medicinal Chemistry","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Discovery Centre","funders":"","keywords":"Chemistry; Proinflammatory cytokine; Protein kinase A; Kinase; Arthritis; Tumor necrosis factor alpha; p38 mitogen-activated protein kinases; Signal transduction; Mitogen-activated protein kinase; Biochemistry; Pharmacology; Immunology; Inflammation; Biology","score_opus":0.011735952853591716,"score_gpt":0.2564363059530085,"score_spread":0.24470035309941676,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2256206968","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981772,0.0007707661,0.000055070956,0.000069516915,0.00007941049,0.00042779357,0.00041096777,0.0000031786776,0.0000061236187],"genre_scores_gemma":[0.9990863,0.000034837885,0.0005213496,0.00000981081,0.00020197513,0.0000025807838,0.00010402061,0.000029767389,0.000009331622],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983415,0.000052141062,0.0005746624,0.0003175713,0.00049556186,0.00021853403],"domain_scores_gemma":[0.99736387,0.00006960404,0.0013872281,0.00018200735,0.0008395726,0.00015775026],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003005786,0.0003116775,0.0006048942,0.00007770141,0.00008530963,0.000025290861,0.00016835229,0.0003461991,0.0000068460613],"category_scores_gemma":[0.0004201979,0.00022707776,0.00007644964,0.000115382856,0.00041760993,0.000035625755,0.000072704126,0.00034483257,2.000288e-9],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015829997,0.000058802547,0.011718017,0.00068426976,0.00027550728,0.00000608214,0.0003660277,0.00014830007,0.9849278,0.0000035574863,0.000030235911,0.00019840695],"study_design_scores_gemma":[0.0038737357,0.0009842014,0.004065948,0.00026904358,0.0003922046,0.00046998393,0.0009112435,0.00041067865,0.9882735,0.00009687585,0.00003255115,0.00022006001],"about_ca_topic_score_codex":0.00009179428,"about_ca_topic_score_gemma":0.000046782076,"teacher_disagreement_score":0.007652069,"about_ca_system_score_codex":0.000034705245,"about_ca_system_score_gemma":0.0006554239,"threshold_uncertainty_score":0.92599624},"labels":[],"label_agreement":null},{"id":"W2258535515","doi":"10.1158/2159-8290.cd-15-1336","title":"Application of Sequencing, Liquid Biopsies, and Patient-Derived Xenografts for Personalized Medicine in Melanoma","year":2015,"lang":"en","type":"article","venue":"Cancer Discovery","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":230,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"National Institute for Health and Care Research; Cancer Research UK; Wellcome Trust; Wellcome","keywords":"Melanoma; Precision medicine; Medicine; Personalized medicine; Liquid biopsy; Targeted therapy; Exome sequencing; Biopsy; Oncology; Cancer research; Exome; Internal medicine; Mutation; Bioinformatics; Pathology; Cancer; Biology; Gene","score_opus":0.024170638168393165,"score_gpt":0.27138030036339983,"score_spread":0.24720966219500667,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2258535515","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99012184,0.005998166,0.002987881,0.00014258033,0.00013171621,0.00029399156,0.0000764054,0.0000038023693,0.00024359621],"genre_scores_gemma":[0.9988398,0.0002691273,0.00015536048,0.00016695274,0.00014806041,0.00017539017,0.00013821923,0.000011264271,0.00009584367],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9994183,0.000018971296,0.00016140858,0.00020938656,0.00007164486,0.00012029868],"domain_scores_gemma":[0.9996396,0.000008242212,0.000089646186,0.00014298578,0.00006213395,0.000057444653],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000080820646,0.00009050785,0.00015033048,0.000034283807,0.00001489069,0.0000044444464,0.00006116495,0.0000705493,0.000002355235],"category_scores_gemma":[0.000044588593,0.000076677024,0.000026986365,0.000051967338,0.00011096035,0.000007494504,0.00003572911,0.000024390089,1.9947701e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005064385,0.000014913688,0.0033330463,0.000053386295,0.000019499494,6.171129e-7,0.00058664655,0.000019929734,0.9925637,0.00029036257,0.0009526859,0.00165874],"study_design_scores_gemma":[0.0028829554,0.0018882891,0.0012342085,0.000079513884,0.000032770877,0.0000072008474,0.0015599958,0.00012191753,0.9415138,0.0001972529,0.05026153,0.00022059985],"about_ca_topic_score_codex":0.00033854978,"about_ca_topic_score_gemma":0.00015825253,"teacher_disagreement_score":0.05104997,"about_ca_system_score_codex":0.000031891133,"about_ca_system_score_gemma":0.00014287616,"threshold_uncertainty_score":0.31267983},"labels":[],"label_agreement":null},{"id":"W2258872553","doi":"10.1016/j.ejca.2015.12.002","title":"p53 Reactivation by PRIMA-1Met (APR-246) sensitises V600E/KBRAF melanoma to vemurafenib","year":2016,"lang":"en","type":"article","venue":"European Journal of Cancer","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":56,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"Amis de l'Institut Bordet","keywords":"Vemurafenib; Melanoma; Cancer research; PI3K/AKT/mTOR pathway; Medicine; MAPK/ERK pathway; Protein kinase B; V600E; MEK inhibitor; Pharmacology; Apoptosis; Biology; Signal transduction; Mutation; Metastatic melanoma","score_opus":0.0087270120395586,"score_gpt":0.23768664893815036,"score_spread":0.22895963689859175,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2258872553","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98355734,0.0011801539,0.00507837,0.0018650319,0.0005901097,0.00009129756,0.000053828866,0.0000084599615,0.00757541],"genre_scores_gemma":[0.9926917,0.00043771695,0.0005679264,0.0008385139,0.0012486478,0.0000019286128,0.000009133573,0.00004136449,0.004163048],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99885035,0.0001946753,0.00033788773,0.000200619,0.00020813386,0.00020835403],"domain_scores_gemma":[0.99906594,0.000017420316,0.00028101917,0.00021751391,0.00023417873,0.00018393746],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039363324,0.0001466774,0.00016948668,0.00005881097,0.00004814598,0.00002439247,0.00020213235,0.000037717076,0.00007454101],"category_scores_gemma":[0.00014147496,0.00010086599,0.00009944805,0.00006355256,0.00003461929,0.000014014229,0.00006501051,0.000079613164,0.000047596342],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017732137,0.000021189499,0.00071553874,0.000004539134,0.000054868113,0.00004843691,0.00004652768,0.0000044104613,0.8443281,0.000015968124,0.08895835,0.06562475],"study_design_scores_gemma":[0.0006028228,0.00047872934,0.006216835,0.00006055093,0.000017079105,0.00006626401,0.0000141956,2.9013452e-7,0.5047459,0.000006815024,0.4876682,0.00012232517],"about_ca_topic_score_codex":0.0000059670097,"about_ca_topic_score_gemma":0.0000055152204,"teacher_disagreement_score":0.39870983,"about_ca_system_score_codex":0.00003722267,"about_ca_system_score_gemma":0.0000903679,"threshold_uncertainty_score":0.41131958},"labels":[],"label_agreement":null},{"id":"W2265121903","doi":"10.1007/s10637-016-0324-0","title":"A phase II study of cediranib, an oral VEGF inhibitor, in previously untreated patients with metastatic or recurrent malignant melanoma","year":2016,"lang":"en","type":"article","venue":"Investigational New Drugs","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Health Sciences Centre; Ontario Clinical Oncology Group; Juravinski Cancer Centre; Princess Margaret Cancer Centre; Hamilton Health Sciences","funders":"National Cancer Institute; U.S. Public Health Service","keywords":"Medicine; Nausea; Internal medicine; Progressive disease; Melanoma; Adverse effect; Gastroenterology; Phases of clinical research; Response Evaluation Criteria in Solid Tumors; Oncology; Toxicity; Chemotherapy; Surgery; Cancer research","score_opus":0.024027290171344008,"score_gpt":0.27115774109121094,"score_spread":0.24713045091986693,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2265121903","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99892527,0.000049124763,0.00004371686,0.00008919318,0.000079114325,0.00066861464,0.00008864832,0.000011024395,0.00004530417],"genre_scores_gemma":[0.99827933,0.000005588699,0.0008656528,0.00007953108,0.0000747721,0.00005105305,0.0003071605,0.000022278879,0.00031462996],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985287,0.0001474545,0.00039579967,0.0003990553,0.0003053622,0.00022362336],"domain_scores_gemma":[0.9991715,0.000023450159,0.00017765553,0.00027438867,0.00014109953,0.00021193117],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015431405,0.0002025806,0.00023643216,0.000088040826,0.000050497107,0.000009888512,0.00016125837,0.000057301662,0.00004107812],"category_scores_gemma":[0.000094447016,0.00012049398,0.000031535124,0.00016930338,0.00008918297,0.000019551862,0.00006872157,0.000047925543,0.0000044505473],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011114899,0.029803053,0.27798653,0.00019175532,0.00069239654,0.000118338874,0.011179834,0.00006735307,0.5877476,0.0009891817,0.0050928704,0.07501623],"study_design_scores_gemma":[0.16357972,0.20292503,0.09460555,0.0012720298,0.00048277993,0.000048180354,0.0016240997,0.00016696875,0.52152056,0.0021840045,0.009402692,0.0021884257],"about_ca_topic_score_codex":0.00016257375,"about_ca_topic_score_gemma":0.00060674385,"teacher_disagreement_score":0.18338098,"about_ca_system_score_codex":0.000026345417,"about_ca_system_score_gemma":0.00045537754,"threshold_uncertainty_score":0.49136022},"labels":[],"label_agreement":null},{"id":"W2266830739","doi":"10.1684/ejd.2015.2628","title":"Phototoxicity of B-RAF inhibitors: Exclusively due to UVA radiation and rapidly regressive","year":2015,"lang":"en","type":"article","venue":"European Journal of Dermatology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"","keywords":"Phototoxicity; Medicine; Dermatology; Photosensitivity; Sunscreening Agents; Internal medicine; Cancer; Skin cancer; Genetics; Optics; In vitro","score_opus":0.0147695089208061,"score_gpt":0.23579492478913247,"score_spread":0.22102541586832636,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2266830739","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99383855,0.0013595354,0.0020145779,0.00049597013,0.00030741506,0.0000854691,0.000006913643,0.0000028725485,0.0018886946],"genre_scores_gemma":[0.99823755,0.000072997944,0.0010641325,0.0002947598,0.0002727823,6.324996e-7,0.000005871147,0.00001578545,0.000035465953],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99878734,0.00041106166,0.00041633516,0.00013379972,0.00011313692,0.00013832956],"domain_scores_gemma":[0.9989803,0.000016544449,0.00041493645,0.00014259256,0.00023645374,0.00020918161],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032004426,0.00010848077,0.00024705796,0.000103079634,0.000027167302,0.000009059683,0.00015987712,0.00005236491,0.000004211734],"category_scores_gemma":[0.00033602086,0.000093593284,0.00006119543,0.00006117393,0.000069836075,0.000007893014,0.000113973445,0.00009569957,0.00000846061],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047006938,0.00007395099,0.0041008885,0.000030775584,0.00008612911,0.0012627346,0.00093874306,0.000025662966,0.9613619,0.00008477227,0.025986724,0.0055776755],"study_design_scores_gemma":[0.0020505206,0.0010928183,0.006890338,0.000050852606,0.00002834397,0.008959025,0.00026189827,0.000010752072,0.932648,0.00006504654,0.047776293,0.00016611315],"about_ca_topic_score_codex":0.0000016883901,"about_ca_topic_score_gemma":0.0000015183596,"teacher_disagreement_score":0.028713876,"about_ca_system_score_codex":0.000007664106,"about_ca_system_score_gemma":0.000090600835,"threshold_uncertainty_score":0.38166234},"labels":[],"label_agreement":null},{"id":"W2277864649","doi":"10.1091/mbc.e15-07-0527","title":"Regulatory roles of conserved phosphorylation sites in the activation T-loop of the MAP kinase ERK1","year":2016,"lang":"en","type":"article","venue":"Molecular Biology of the Cell","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Kinexus Bioinformatics Corporation (Canada); University of British Columbia","funders":"University of British Columbia; Johns Hopkins University","keywords":"Autophosphorylation; Biology; MAP2K7; MAPK14; Cyclin-dependent kinase 2; Kinase; Mitogen-activated protein kinase kinase; MAP kinase kinase kinase; Phosphorylation; c-Raf; Protein kinase A; Cyclin-dependent kinase 9; Cell biology; ASK1; Biochemistry","score_opus":0.007934838574307714,"score_gpt":0.21206488047174882,"score_spread":0.2041300418974411,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2277864649","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976101,0.000684989,0.000395124,0.00060326996,0.000081313796,0.00023919306,0.00002181061,0.0000018042832,0.00036240567],"genre_scores_gemma":[0.9995192,0.000021180611,0.000075328,0.00015722863,0.000016351605,0.000009450116,0.000016770702,0.000008063595,0.00017639357],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99902713,0.00034611078,0.00024884962,0.00016999197,0.00008874462,0.00011919672],"domain_scores_gemma":[0.99895585,0.00004548508,0.00029099183,0.0006259971,0.00006951837,0.000012144612],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003156195,0.000103264916,0.0001381513,0.000025198866,0.00003206632,0.0000014493885,0.00043690554,0.00016427969,0.000007874697],"category_scores_gemma":[0.000109400695,0.000047546175,0.00014145965,0.000082571554,0.00032498402,0.0000021063408,0.00013410496,0.00005442512,9.0174706e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006209439,0.000057176836,0.015708981,0.000024882218,0.00001809306,2.0831443e-7,0.00005715258,0.000014134257,0.9828274,0.00070303347,0.00017904639,0.0003477983],"study_design_scores_gemma":[0.0004359576,0.0001174211,0.017045887,0.000032779702,0.000016908285,0.0000011327318,0.00004993748,0.00000576394,0.9805174,0.0009729713,0.0007427467,0.00006107851],"about_ca_topic_score_codex":0.000024015295,"about_ca_topic_score_gemma":0.000027816384,"teacher_disagreement_score":0.002309983,"about_ca_system_score_codex":0.0000067907486,"about_ca_system_score_gemma":0.000056531742,"threshold_uncertainty_score":0.19388768},"labels":[],"label_agreement":null},{"id":"W2278622931","doi":"10.69645/wzqs6265","title":"RAS and RAF signaling in melanoma: biology and therapies","year":2010,"lang":"en","type":"article","venue":"˜The œbiomedical & life sciences collection.","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"","keywords":"Melanoma; Cancer research; Biology; Computational biology; Cell biology","score_opus":0.011145501380478644,"score_gpt":0.26192180965292516,"score_spread":0.2507763082724465,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2278622931","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99558485,0.0013166796,0.0004849645,0.0011699898,0.0005049994,0.00013160054,0.000004345589,0.000010024875,0.00079252955],"genre_scores_gemma":[0.9981952,0.00016089815,0.00054782454,0.00046428302,0.00029814497,0.00002204581,0.0000065553077,0.000004798636,0.0003002914],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990787,0.00008501529,0.00016568207,0.00033087214,0.00011470062,0.00022505532],"domain_scores_gemma":[0.9996108,0.00007894967,0.000046293142,0.00011708062,0.000022843677,0.00012403486],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007218637,0.0001011012,0.00011705112,0.00009516084,0.00036800373,0.0000366761,0.00017779642,0.00015669619,0.00004033451],"category_scores_gemma":[0.00014104928,0.00006492869,0.000023821322,0.00034448056,0.0012837215,0.0000054980405,0.00010789117,0.00015429324,0.000002415788],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000036201804,0.000046492256,0.029174257,0.0000070326228,0.000017894308,0.0000019956244,0.00027437153,0.000001117163,0.96373606,0.00090685155,0.0020571242,0.0037406327],"study_design_scores_gemma":[0.0059892978,0.0051036268,0.11938384,0.000050466213,0.000064355125,0.0006133375,0.0034264142,0.0036463675,0.07237508,0.018169312,0.76976204,0.0014158516],"about_ca_topic_score_codex":0.00010793657,"about_ca_topic_score_gemma":0.00046253117,"teacher_disagreement_score":0.89136094,"about_ca_system_score_codex":0.000003475527,"about_ca_system_score_gemma":0.00015800368,"threshold_uncertainty_score":0.47299257},"labels":[],"label_agreement":null},{"id":"W2293149121","doi":"10.7554/elife.09976","title":"Registered report: RAF inhibitors prime wild-type RAF to activate the MAPK pathway and enhance growth","year":2016,"lang":"en","type":"article","venue":"eLife","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Kinexus Bioinformatics Corporation (Canada)","funders":"Laura and John Arnold Foundation","keywords":"MAPK/ERK pathway; Kinase; Cancer research; p38 mitogen-activated protein kinases; Chemistry; Biology; Cell biology","score_opus":0.011194078382118252,"score_gpt":0.240807449064828,"score_spread":0.22961337068270976,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2293149121","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940983,0.00036863392,0.00087283785,0.0017302783,0.000456994,0.00026086334,0.000011435766,0.000023992634,0.0021766762],"genre_scores_gemma":[0.98983943,0.00015598492,0.00025281508,0.00079885905,0.0006121344,0.000024692468,0.000016998823,0.000025003794,0.008274098],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988094,0.00006273159,0.00024256257,0.0004577643,0.00016790134,0.00025966112],"domain_scores_gemma":[0.9989539,0.000024035575,0.00013335522,0.0006380908,0.000109124216,0.00014149661],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003059141,0.0001675239,0.00014710412,0.000025188569,0.00009855912,0.000025578724,0.00018294409,0.00012370372,0.0000133084095],"category_scores_gemma":[0.0004753514,0.00009701792,0.000054030927,0.00007744709,0.00007407467,0.0000063221764,0.00019415245,0.00006325713,0.000046226734],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000105961306,0.000016630054,0.0018259882,0.000007662141,0.000020250338,0.000028250055,0.000066930384,9.116265e-8,0.98251593,0.00009295148,0.011116242,0.004203107],"study_design_scores_gemma":[0.0002214086,0.00017086367,0.0029993376,0.000029132532,0.000005545526,0.000056406472,0.000013188072,2.4576988e-7,0.7751979,0.000038208313,0.22112642,0.00014133548],"about_ca_topic_score_codex":0.000016698968,"about_ca_topic_score_gemma":0.000017842003,"teacher_disagreement_score":0.21001017,"about_ca_system_score_codex":0.000011755897,"about_ca_system_score_gemma":0.000081411745,"threshold_uncertainty_score":0.3956276},"labels":[],"label_agreement":null},{"id":"W2293555343","doi":"10.1016/j.str.2015.12.015","title":"Family-wide Structural Analysis of Human Numb-Associated Protein Kinases","year":2016,"lang":"en","type":"article","venue":"Structure","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":149,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canada Foundation for Innovation; Novartis Foundation; Ontario Ministry of Economic Development and Innovation; Wellcome Trust; Genome Canada; AbbVie; Janssen Biotech; Canadian Institutes of Health Research; Wellcome; GlaxoSmithKline; Bayer; Pfizer; Diamond Light Source; Boehringer Ingelheim","keywords":"NUMB; Kinase; Protein-Serine-Threonine Kinases; Cell biology; SH3 domain; Computational biology; Biology; Chemistry; Protein kinase A; Proto-oncogene tyrosine-protein kinase Src","score_opus":0.007312482021153567,"score_gpt":0.2382263931156565,"score_spread":0.23091391109450293,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2293555343","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99844986,0.00010347589,0.00006865469,0.00003412419,0.00008103217,0.000141625,0.0005606314,0.000014887308,0.00054568745],"genre_scores_gemma":[0.9985771,0.0000038797966,0.00010271615,0.00006168524,0.00008710648,0.0000040906507,0.00040597437,0.000015339887,0.0007420919],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990474,0.000058879905,0.0002226831,0.00030073125,0.00014992838,0.00022039776],"domain_scores_gemma":[0.9992836,0.000009775206,0.00016293893,0.00037646358,0.000104019025,0.00006320507],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000050169383,0.00016467048,0.0002650182,0.00009152238,0.00006897833,0.000009208363,0.00020476678,0.00019612948,0.00017411374],"category_scores_gemma":[0.000116115574,0.00010770109,0.0001786149,0.00023218017,0.000087168475,0.0000035349665,0.00007209853,0.000052089297,0.000001308937],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000022127755,0.000006409897,0.03574242,0.000007855593,0.00046069035,0.000002369009,0.000021804744,0.0000037434488,0.96225905,0.00035748963,0.0004463989,0.00066960824],"study_design_scores_gemma":[0.00043033657,0.00018484726,0.24073914,0.000015183545,0.00018681043,0.0000010092234,0.000024220359,0.0000033875199,0.7567227,0.0008336799,0.00068130734,0.00017740877],"about_ca_topic_score_codex":0.00007452497,"about_ca_topic_score_gemma":0.0003100043,"teacher_disagreement_score":0.20553641,"about_ca_system_score_codex":0.000014674078,"about_ca_system_score_gemma":0.00003700414,"threshold_uncertainty_score":0.4391923},"labels":[],"label_agreement":null},{"id":"W2294989188","doi":"10.1093/annonc/mdw100","title":"Ocular toxicities of MEK inhibitors and other targeted therapies","year":2016,"lang":"en","type":"review","venue":"Annals of Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":106,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Toxicity; Retinopathy; Targeted therapy; Pharmacology; Bioinformatics; Cancer; Internal medicine","score_opus":0.07494947418798979,"score_gpt":0.367025249348498,"score_spread":0.2920757751605082,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2294989188","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0024209525,0.9935603,0.000017875635,0.000060872673,0.0001787288,0.00023286269,0.0002424711,0.000004689306,0.003281258],"genre_scores_gemma":[0.0010503993,0.99792606,0.000118010474,0.00017491373,0.00024515286,0.000030028596,0.000045961566,0.000033876575,0.00037561788],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987114,0.00022348088,0.0004990476,0.00027689,0.000083301944,0.00020586769],"domain_scores_gemma":[0.99899006,0.00006366696,0.0004902302,0.0002969082,0.000102889855,0.00005627406],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027979235,0.00024575496,0.001091048,0.000098199,0.00002099462,0.000002989509,0.0001827753,0.0005569005,0.00005305225],"category_scores_gemma":[0.000072937684,0.00016666821,0.00030521097,0.000049270442,0.00029940275,0.0000020558662,0.00011581901,0.00007462732,0.0000039903694],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000032924898,0.00007338881,0.000019082101,0.0021997956,0.0005134415,0.000004983554,0.00007536992,3.0665863e-8,0.011203966,0.0006437425,0.0053742314,0.97985905],"study_design_scores_gemma":[0.00018113693,0.0013125701,0.0000029568282,0.00085841893,0.000056458382,0.00002028985,0.00003054297,3.0442248e-8,0.019575784,0.00015978854,0.97763187,0.00017017883],"about_ca_topic_score_codex":0.00001339516,"about_ca_topic_score_gemma":0.000007852608,"teacher_disagreement_score":0.9796889,"about_ca_system_score_codex":0.000004312875,"about_ca_system_score_gemma":0.00023349513,"threshold_uncertainty_score":0.6796532},"labels":[],"label_agreement":null},{"id":"W2308664614","doi":"10.1021/acschembio.6b00043","title":"Structure of the Human Protein Kinase ZAK in Complex with Vemurafenib","year":2016,"lang":"en","type":"article","venue":"ACS Chemical Biology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Structural Genomics Consortium; John Fell Fund, University of Oxford; Boehringer Ingelheim; Wellcome; National Institute of General Medical Sciences; Wellcome Trust","keywords":"Vemurafenib; Kinase; Cancer research; Protein kinase A; Computational biology; Medicine; Biology; Cell biology; Metastatic melanoma; Melanoma","score_opus":0.010833529963615156,"score_gpt":0.2312153847882892,"score_spread":0.22038185482467404,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2308664614","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9990579,0.000039738847,0.000024194283,0.00027207445,0.00002159794,0.0001856999,0.00005580741,0.0000046880186,0.00033830802],"genre_scores_gemma":[0.99944997,0.0000019358856,0.00016753252,0.000118445125,0.0000773694,0.000011290496,0.00007149209,0.000009427952,0.00009256499],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99929863,0.000052439813,0.00016104737,0.00024744147,0.000045394805,0.00019506457],"domain_scores_gemma":[0.999502,0.000010522332,0.000077609475,0.00034054086,0.000033934175,0.000035378875],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000036735437,0.00011471687,0.00014898115,0.000015663263,0.00002126285,0.0000017657732,0.0002730013,0.00019372831,0.000040341492],"category_scores_gemma":[0.00005668482,0.00005450785,0.000038251146,0.000059326067,0.00028065874,0.0000012745153,0.000141107,0.00007152182,0.0000017014773],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000060544437,0.00002618369,0.011740794,0.000008775599,0.000011983102,9.956839e-7,0.000008054391,8.738763e-8,0.98606014,0.0010979566,0.00015318047,0.0008313106],"study_design_scores_gemma":[0.0007740241,0.00018089412,0.0046176193,0.000017438031,0.000003838316,0.000008246769,0.000004990824,1.3020703e-7,0.9891236,0.0009476309,0.0042227157,0.000098913384],"about_ca_topic_score_codex":0.000017382345,"about_ca_topic_score_gemma":0.00004811705,"teacher_disagreement_score":0.0071231755,"about_ca_system_score_codex":0.000009005696,"about_ca_system_score_gemma":0.000030139483,"threshold_uncertainty_score":0.22227657},"labels":[],"label_agreement":null},{"id":"W2308813726","doi":"10.1096/fasebj.24.1_supplement.521.1","title":"ERK3‐MK5 regulates interstitial fibrosis during pressure‐overload hypertrophy","year":2010,"lang":"en","type":"article","venue":"The FASEB Journal","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"","keywords":"Pressure overload; Internal medicine; Muscle hypertrophy; Fibrosis; Endocrinology; Medicine; Myocardial fibrosis; Cardiology; Cardiac hypertrophy","score_opus":0.005406856677841136,"score_gpt":0.1998973593376913,"score_spread":0.19449050265985016,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2308813726","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99693453,0.00039831127,0.0001606948,0.00020401969,0.00091478304,0.000068557994,0.000018763247,0.000010722162,0.0012896067],"genre_scores_gemma":[0.99595594,0.00006366653,0.00033794774,0.0001161627,0.001934051,0.0000038052337,0.000011138166,0.000018929923,0.001558368],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992041,0.000054347543,0.00017376244,0.00016673862,0.00014068684,0.00026039415],"domain_scores_gemma":[0.99938446,0.000010490738,0.000099797886,0.0003299172,0.00005730282,0.00011802103],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016832676,0.00013758097,0.00011069898,0.000030606177,0.0002990569,0.00008344227,0.0003433987,0.0001149207,0.00017017702],"category_scores_gemma":[0.000059113638,0.00009188012,0.00014143581,0.000035677356,0.000100105346,0.0000072196353,0.00012380387,0.0003562486,0.000025463964],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017528766,0.000021006756,0.0006600282,0.0000072693924,0.0000718691,0.00001318547,0.000060971055,0.000024378009,0.99670625,0.00006071486,0.001560627,0.0006384437],"study_design_scores_gemma":[0.00051335467,0.0001979318,0.0036780601,0.000013049324,0.000044000015,0.0007961437,0.00004067223,0.0000322911,0.9756134,0.0001072542,0.01882712,0.00013671033],"about_ca_topic_score_codex":0.000010530236,"about_ca_topic_score_gemma":0.000016336491,"teacher_disagreement_score":0.021092806,"about_ca_system_score_codex":0.0000047804515,"about_ca_system_score_gemma":0.000046403464,"threshold_uncertainty_score":0.37467626},"labels":[],"label_agreement":null},{"id":"W2313564723","doi":"10.1158/1538-7445.am10-2521","title":"Abstract 2521: The pan-RAF inhibitor PLX4032 inhibits ERK signaling and tumor cell proliferation in a V600E BRAF mutant-selective manner","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Workplace Health, Safety and Compensation Commission","funders":"","keywords":"MAPK/ERK pathway; MEK inhibitor; Cancer research; Kinase; V600E; Mutant; Phosphorylation; Cell growth; Signal transduction; Protein kinase A; Biology; Chemistry; Cell biology; Biochemistry; Gene","score_opus":0.02505307162938562,"score_gpt":0.31663698929806644,"score_spread":0.2915839176686808,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2313564723","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971799,0.00062318926,0.000011447074,0.0003214402,0.00015728273,0.00060242694,0.000025100391,0.000008486977,0.0010706777],"genre_scores_gemma":[0.9982147,0.00007741609,0.000045097906,0.00012288717,0.0007724364,0.00028844734,0.00002299515,0.000026910313,0.00042909116],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985086,0.00011995469,0.00019900425,0.00043840747,0.0002888279,0.00044524748],"domain_scores_gemma":[0.9993275,0.000047991027,0.000051200463,0.0002631791,0.0002090016,0.00010115081],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008543306,0.00014172542,0.00012319052,0.0000989046,0.00020795014,0.0000899675,0.00018914962,0.00015884977,0.00004655406],"category_scores_gemma":[0.00015479462,0.00010614401,0.00003525267,0.00021588283,0.0001705471,0.0000113626675,0.0001358642,0.00069723447,0.000013298692],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013795808,0.00005328114,0.0028998973,0.000051845873,0.000008243986,0.000014330132,0.0003517018,0.000008388701,0.9941742,0.00006335834,0.00076558796,0.0014711984],"study_design_scores_gemma":[0.00064056215,0.00016999186,0.0063620135,0.00002778836,0.0000035004648,0.000011827536,0.00019067373,0.000042263848,0.98862517,0.00014287046,0.003641051,0.00014230458],"about_ca_topic_score_codex":0.00026785253,"about_ca_topic_score_gemma":0.001808548,"teacher_disagreement_score":0.005549056,"about_ca_system_score_codex":0.00003232824,"about_ca_system_score_gemma":0.0003792113,"threshold_uncertainty_score":0.43284273},"labels":[],"label_agreement":null},{"id":"W2315879546","doi":"10.1038/sj.onc.1205643","title":"Dominant negative MEKK1 inhibits survival of pancreatic cancer cells","year":2002,"lang":"en","type":"article","venue":"Oncogene","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":62,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Public Health Agency of Canada","keywords":"Pancreatic cancer; Biology; Cancer research; MAPK/ERK pathway; Transfection; Kinase; Cancer cell; Cancer; Cell culture; Molecular biology; Cell biology; Genetics","score_opus":0.019804603529525937,"score_gpt":0.2428662086793078,"score_spread":0.22306160514978188,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2315879546","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9881262,0.001822151,0.00018124079,0.000049570677,0.00028503317,0.00013525457,0.00007858561,0.0000048969127,0.009317061],"genre_scores_gemma":[0.9948651,0.0010163644,0.00039374133,0.000068458176,0.00024215506,0.000024531137,0.000017778551,0.00001760472,0.0033542423],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992283,0.000051121642,0.00018525553,0.00022923581,0.00011577003,0.00019033287],"domain_scores_gemma":[0.9994997,0.000014985223,0.0000988508,0.00024326512,0.000071013375,0.00007219119],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008416046,0.00012662695,0.00019791033,0.000023690407,0.000035141857,0.000004782034,0.00011306666,0.000098457705,0.00026319036],"category_scores_gemma":[0.000029514578,0.000109739696,0.00008035071,0.00007395592,0.00005814851,0.0000019239733,0.000061091305,0.000041718995,0.000031697702],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003148192,0.00006814942,0.000476453,0.000022209535,0.000050047158,0.000004441346,0.00009664806,0.000014801465,0.994422,0.000036926318,0.0019903951,0.0027864552],"study_design_scores_gemma":[0.00056852197,0.00022525158,0.00018546895,0.000020566828,0.00003313941,0.0000038085668,0.00004283202,0.000046423345,0.98571426,0.000020734478,0.01300322,0.00013577408],"about_ca_topic_score_codex":0.000100658166,"about_ca_topic_score_gemma":0.000113113194,"teacher_disagreement_score":0.011012825,"about_ca_system_score_codex":0.000011865086,"about_ca_system_score_gemma":0.000034272656,"threshold_uncertainty_score":0.4475055},"labels":[],"label_agreement":null},{"id":"W2319234722","doi":"10.1158/0008-5472.fbcr09-b59","title":"Abstract B59: Role of Nf1 signaling in regulating pigmentation in the mouse","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Neurofibromin 1; Microphthalmia-associated transcription factor; Melanocyte; Dermis; Biology; Melanocortin 1 receptor; Knockout mouse; Gene knockin; Allele; Neurofibromatosis; Cancer research; Genetics; Cell biology; Gene; Anatomy; Melanoma; Transcription factor","score_opus":0.05199039787244116,"score_gpt":0.37962530007676654,"score_spread":0.3276349022043254,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2319234722","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971757,0.00067409594,0.0000061139067,0.00014718156,0.000009235805,0.00015459722,0.000003799036,0.0000013698856,0.001827889],"genre_scores_gemma":[0.99961233,0.00008715516,0.00004969543,0.000045056626,0.00008102939,0.00002732022,0.000020397916,0.0000044019735,0.0000726409],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992729,0.00009003309,0.00013935428,0.00013768085,0.00017630302,0.00018376812],"domain_scores_gemma":[0.9997336,0.000022244209,0.000028634167,0.00015118539,0.0000457234,0.000018565976],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007531216,0.000043758235,0.000059176622,0.00006630068,0.000030294656,0.000011388296,0.00014593355,0.000052334493,0.000018702682],"category_scores_gemma":[0.000053138298,0.00003510628,0.000019491685,0.00014830168,0.000028971566,0.0000033070773,0.000020028028,0.00012839268,0.000001342662],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000049630813,0.000032326978,0.0027900438,0.000010707706,0.0000018042326,0.000001783078,0.00040765657,0.00033410566,0.9880476,0.00010929542,0.00012402887,0.008091001],"study_design_scores_gemma":[0.0002701925,0.00010594877,0.028599136,0.000026433061,5.979743e-7,5.6568354e-7,0.0009135678,0.00003352933,0.9691215,0.00039414858,0.0004917103,0.000042674146],"about_ca_topic_score_codex":0.00031691758,"about_ca_topic_score_gemma":0.00019403851,"teacher_disagreement_score":0.025809092,"about_ca_system_score_codex":0.000023500063,"about_ca_system_score_gemma":0.00008407952,"threshold_uncertainty_score":0.14315926},"labels":[],"label_agreement":null},{"id":"W2319418820","doi":"10.1016/s1470-2045(16)00117-0","title":"Targeted therapy in BRAF-mutated lung adenocarcinoma","year":2016,"lang":"en","type":"letter","venue":"The Lancet Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Adenocarcinoma; Targeted therapy; Cancer research; Lung; Oncology; Medicine; Adenocarcinoma of the lung; Internal medicine; Cancer","score_opus":0.031531213826955166,"score_gpt":0.2888015405649193,"score_spread":0.25727032673796413,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2319418820","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.15270494,0.010921586,0.000112379916,0.81708837,0.0018685957,0.0010303363,0.00024740043,0.00007075442,0.01595561],"genre_scores_gemma":[0.13101515,0.0027956697,0.00013792711,0.8321052,0.024909707,0.00027112602,0.0014963149,0.00012807717,0.007140826],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9974941,0.0006776527,0.0003377899,0.00056926924,0.00014374004,0.000777453],"domain_scores_gemma":[0.9986754,0.000099501995,0.00021776425,0.0009037691,0.000061122315,0.00004242963],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00048055852,0.00035499423,0.00065286236,0.00008265548,0.000066103064,0.000016736574,0.0008498153,0.001410364,0.00019366656],"category_scores_gemma":[0.00005391529,0.00021623983,0.0001400289,0.000098014614,0.00018638281,0.0000024306528,0.00018117845,0.0009493719,0.000100001904],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002689546,0.000019927647,0.0019803063,0.000029307574,0.00011023301,0.00038418785,0.00007383219,8.341801e-7,0.056343332,0.000022963884,0.9364287,0.0043374104],"study_design_scores_gemma":[0.0021929112,0.00066412805,0.0026435968,0.000024436153,0.00001804817,0.00012102446,0.0000082946435,0.000006726152,0.009699738,0.00019748358,0.984104,0.00031964504],"about_ca_topic_score_codex":0.00005247441,"about_ca_topic_score_gemma":0.00007240902,"teacher_disagreement_score":0.04767526,"about_ca_system_score_codex":0.00008254322,"about_ca_system_score_gemma":0.0003086884,"threshold_uncertainty_score":0.99988604},"labels":[],"label_agreement":null},{"id":"W2320148628","doi":"10.1097/cmr.0000000000000034","title":"Vemurafenib in the French temporary authorization for use metastatic melanoma cohort","year":2013,"lang":"en","type":"article","venue":"Melanoma Research","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"","keywords":"Vemurafenib; Medicine; Discontinuation; Internal medicine; Melanoma; Confidence interval; Adverse effect; Oncology; Brain metastasis; Cohort; Surgery; Metastasis; Metastatic melanoma; Cancer; Cancer research","score_opus":0.0817002284918776,"score_gpt":0.3392314328487025,"score_spread":0.2575312043568249,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2320148628","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99193466,0.00036295239,0.002384174,0.0005698963,0.00013711632,0.0021620889,0.00004682718,0.000013297662,0.0023890182],"genre_scores_gemma":[0.9930918,0.0000459629,0.0013459291,0.0001249671,0.00026932854,0.0014122927,0.0006183214,0.000033938402,0.0030574217],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99745315,0.00067271653,0.00032630115,0.0004982474,0.00046390228,0.0005856882],"domain_scores_gemma":[0.9986535,0.00028686697,0.000059499846,0.0006054929,0.00028761834,0.0001070284],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018201609,0.00017841037,0.00019416348,0.00018421857,0.0002159256,0.00018495343,0.0005340092,0.00015020992,0.00008525379],"category_scores_gemma":[0.00045354172,0.00012883462,0.00009198812,0.00035770782,0.00012234657,0.00002780731,0.00013636978,0.00024763469,0.000104184575],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019629546,0.0005806213,0.36032933,0.00021118589,0.00017049335,0.000091801776,0.0007357498,0.000017892984,0.4500345,0.0055498723,0.17047504,0.011607217],"study_design_scores_gemma":[0.0030860205,0.0033198548,0.6257203,0.00006690209,0.00005146072,0.00014287869,0.001304046,0.0032142818,0.124077685,0.003699559,0.2344278,0.0008892039],"about_ca_topic_score_codex":0.0009513565,"about_ca_topic_score_gemma":0.00029619227,"teacher_disagreement_score":0.32595682,"about_ca_system_score_codex":0.00003130376,"about_ca_system_score_gemma":0.00014556956,"threshold_uncertainty_score":0.5253723},"labels":[],"label_agreement":null},{"id":"W2321350289","doi":"10.1158/1538-7445.am10-2680","title":"Abstract 2680: Nonautoinhibitory properties of the C-terminal helix of the mitogen- and stress-activated protein kinase 1","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Light Source (Canada)","funders":"","keywords":"Autophosphorylation; Mitogen-activated protein kinase kinase; MAP2K7; Cyclin-dependent kinase 9; c-Raf; MAP kinase kinase kinase; Protein kinase A; Cyclin-dependent kinase 2; MAPK14; Protein kinase domain; Protein kinase R; Chemistry; Kinase; Cell biology; Biochemistry; Molecular biology; Biology; Mutant; Gene","score_opus":0.0380924380102597,"score_gpt":0.30561936430842024,"score_spread":0.26752692629816055,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2321350289","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980301,0.0007911616,3.969962e-7,0.00017194514,0.00020255365,0.00043735196,0.00007002476,0.0000020871207,0.00029435498],"genre_scores_gemma":[0.99864006,0.000034211036,0.000007922896,0.000010342114,0.00017187132,0.00006699877,0.0000026160185,0.000011803164,0.0010541953],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999123,0.000089328394,0.0001382633,0.00018768552,0.00026714688,0.00019460314],"domain_scores_gemma":[0.99923784,0.000008355651,0.000069531685,0.00042985953,0.00020979902,0.00004463032],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026390655,0.00008054788,0.000090654314,0.000023456012,0.00011489918,0.000011461202,0.0003132587,0.000105906525,0.000031826057],"category_scores_gemma":[0.00012916136,0.00004363383,0.000053037013,0.00008987035,0.0005585711,0.0000035056692,0.00026385506,0.00029510685,7.6233357e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000111257126,0.00003680581,0.00210257,0.00017176133,0.000014891213,0.00000106615,0.000100428544,0.0000010805343,0.995846,0.000027315846,0.00023241978,0.0013544328],"study_design_scores_gemma":[0.00021706581,0.00006883633,0.011958498,0.00013891468,0.0000031503557,0.0000035135524,0.000073897056,0.0000019329436,0.9836957,0.0000141227865,0.0037697048,0.000054650296],"about_ca_topic_score_codex":0.00028080287,"about_ca_topic_score_gemma":0.00027915233,"teacher_disagreement_score":0.012150258,"about_ca_system_score_codex":0.0000078729045,"about_ca_system_score_gemma":0.000361739,"threshold_uncertainty_score":0.20580785},"labels":[],"label_agreement":null},{"id":"W2324097249","doi":"10.1007/s10555-016-9623-3","title":"Understanding the cellular roles of Fyn-related kinase (FRK): implications in cancer biology","year":2016,"lang":"en","type":"review","venue":"Cancer and Metastasis Reviews","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":59,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"","keywords":"FYN; Biology; Kinase; Tyrosine kinase; Context (archaeology); Proto-oncogene tyrosine-protein kinase Src; Cell biology; Receptor tyrosine kinase; Cancer research; Ectopic expression; Signal transduction; Genetics; Cell culture","score_opus":0.18372154927041917,"score_gpt":0.38480153723194815,"score_spread":0.20107998796152898,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2324097249","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007541107,0.99688154,0.00054945966,0.00011725255,0.00022073682,0.0010499812,0.00059822924,0.0000042570928,0.0005031375],"genre_scores_gemma":[0.00049645355,0.9978158,0.00003471453,0.00006290268,0.00014676957,0.00094538083,0.0001826128,0.000034453467,0.00028092455],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99790066,0.00039947985,0.0008408031,0.000516934,0.000054403085,0.00028772064],"domain_scores_gemma":[0.99866194,0.000051357445,0.00057831954,0.00058896333,0.00003734796,0.00008205768],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005738635,0.00036804454,0.001385925,0.000086885666,0.000076773744,0.000011280987,0.00032896112,0.0002801502,0.000116995114],"category_scores_gemma":[0.00006611035,0.00019680947,0.00042389194,0.0002478087,0.00018982671,0.000003790411,0.00013939652,0.00016637245,0.000006210262],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000035929409,0.000017873199,0.000034629993,0.0027470898,0.00017833938,5.9493743e-7,0.000022803759,2.3149302e-7,0.0029200045,0.002863052,0.0009782764,0.99023354],"study_design_scores_gemma":[0.00019624254,0.00004315455,0.000005972092,0.0038249667,0.00054335024,0.0000041183034,0.000010452029,2.2505317e-7,0.00045672568,0.00026128424,0.9944173,0.00023618079],"about_ca_topic_score_codex":0.00004195856,"about_ca_topic_score_gemma":0.00020072125,"teacher_disagreement_score":0.9934391,"about_ca_system_score_codex":0.00008006458,"about_ca_system_score_gemma":0.00028401735,"threshold_uncertainty_score":0.8025657},"labels":[],"label_agreement":null},{"id":"W2326270405","doi":"10.1158/1538-7445.am2012-lb-517","title":"Abstract LB-517: EIF5A2, A downstream target of PI3K/Akt pathway, Is an adverse prognostic marker of melanoma patient survival by increasing cell invasion","year":2012,"lang":"en","type":"article","venue":"Cancer Research","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Coastal Health Research Institute; Vancouver Coastal Health","funders":"","keywords":"Melanoma; Protein kinase B; Cancer research; Medicine; Tissue microarray; Metastasis; PTEN; PI3K/AKT/mTOR pathway; Immunohistochemistry; Cancer; Pathology; Oncology; Internal medicine; Biology; Signal transduction; Cell biology","score_opus":0.03944835908933938,"score_gpt":0.3089208844004857,"score_spread":0.26947252531114635,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2326270405","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9923684,0.002347251,0.000018649507,0.000024449413,0.0001759509,0.00045551677,0.0004951821,0.000007481416,0.004107146],"genre_scores_gemma":[0.99869615,0.00025162665,0.00025955486,0.000028544468,0.00018584046,0.00007735417,0.00030237596,0.000037141923,0.00016140664],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9976654,0.0003482001,0.00038556923,0.0003925522,0.00057413656,0.00063414336],"domain_scores_gemma":[0.9985373,0.00008333252,0.00017310196,0.0005370012,0.00036079736,0.00030843873],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011139056,0.00019480246,0.00026702855,0.00010373291,0.000093010814,0.0000115583525,0.00029621794,0.00022000053,0.00037089575],"category_scores_gemma":[0.00018475954,0.00017413207,0.0001029761,0.0001889303,0.0002119933,0.000021959266,0.00024308989,0.00022790574,0.000013142008],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004459892,0.00048097863,0.10834043,0.00020931261,0.000035881378,0.0000040737286,0.00034776615,0.0000030889257,0.8847197,0.000011573469,0.0022222234,0.0031789502],"study_design_scores_gemma":[0.0005863582,0.000838851,0.026177634,0.00007835791,0.000011757946,0.0000040423797,0.0004939701,0.0000071244335,0.9604671,0.00001626789,0.011128813,0.00018971006],"about_ca_topic_score_codex":0.0013255663,"about_ca_topic_score_gemma":0.000056517783,"teacher_disagreement_score":0.0821628,"about_ca_system_score_codex":0.000048529717,"about_ca_system_score_gemma":0.00036837673,"threshold_uncertainty_score":0.71009},"labels":[],"label_agreement":null},{"id":"W2326404665","doi":"10.1167/iovs.12-10553","title":"ERK5 Regulates Glucose-Induced Increased Fibronectin Production in the Endothelial Cells and in the Retina in Diabetes","year":2012,"lang":"en","type":"article","venue":"Investigative Ophthalmology & Visual Science","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Downregulation and upregulation; Fibronectin; MAPK/ERK pathway; Internal medicine; Protein kinase A; Signal transduction; Endocrinology; Retinal; Vascular endothelial growth factor A; Diabetic retinopathy; Cell biology; Kinase; Biology; Vascular endothelial growth factor; Chemistry; Diabetes mellitus; Medicine; Extracellular matrix; Biochemistry","score_opus":0.025906083825517835,"score_gpt":0.28592608524656554,"score_spread":0.2600200014210477,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2326404665","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984036,0.00015708593,1.0692483e-7,0.0003732877,0.0001712037,0.0004246318,0.000004036423,0.000003591614,0.00046243702],"genre_scores_gemma":[0.9994108,0.000007245427,0.000097488504,0.00021999721,0.00014968867,0.000084141866,0.000007712691,0.000007101655,0.000015827733],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979031,0.0007345675,0.00022165451,0.0004427211,0.0001953871,0.0005025423],"domain_scores_gemma":[0.9994386,0.00012824002,0.000093690614,0.00023221775,0.000033846696,0.000073442694],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027452083,0.00016172207,0.00014948647,0.00011713688,0.00013912239,0.000030333033,0.00037276125,0.00011930829,0.000004445698],"category_scores_gemma":[0.0009040618,0.000104267114,0.0000220269,0.0005953736,0.0012456925,0.000034125107,0.00012360538,0.00022138814,0.00000423492],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000022709686,0.0000892908,0.17286262,0.000006297965,0.0000015223015,0.000009053408,0.0013506982,0.0000026071182,0.8255301,0.000028023578,0.00001864144,0.00007841179],"study_design_scores_gemma":[0.00015736531,0.0002505785,0.3756669,0.000014547827,0.000002144275,0.00007277556,0.0005299788,0.000019104002,0.6227951,0.00038079428,0.000025248719,0.000085457374],"about_ca_topic_score_codex":0.00021706193,"about_ca_topic_score_gemma":0.00005060526,"teacher_disagreement_score":0.20280425,"about_ca_system_score_codex":0.000027301941,"about_ca_system_score_gemma":0.000116881885,"threshold_uncertainty_score":0.4589806},"labels":[],"label_agreement":null},{"id":"W2332505255","doi":"10.1503/jpn.140062","title":"Increased levels of cerebrospinal fluid JNK3 associated with amyloid pathology: links to cognitive decline","year":2015,"lang":"en","type":"article","venue":"Journal of Psychiatry and Neuroscience","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":97,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"Institut Servier; Institut National de la Santé et de la Recherche Médicale; Servier; Sanofi","keywords":"Senile plaques; Cerebrospinal fluid; Cognitive decline; Alzheimer's disease; Pathology; Neurodegeneration; Disease; Kinase; Tauopathy; Medicine; Degenerative disease; Internal medicine; Endocrinology; Biology; Dementia; Biochemistry","score_opus":0.02616125229602223,"score_gpt":0.27448501376034357,"score_spread":0.24832376146432134,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2332505255","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958242,0.00024173668,0.002748871,0.00038370423,0.0005150444,0.000080562175,0.00005293448,0.000002548351,0.00015037373],"genre_scores_gemma":[0.99737996,0.0000268755,0.0010485029,0.0013239007,0.00016428073,0.0000011781025,0.0000026446064,0.000007846254,0.00004479694],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9990088,0.000099824865,0.00029382488,0.00020335069,0.00022631706,0.00016790978],"domain_scores_gemma":[0.99900645,0.000018033008,0.00031601862,0.00010586804,0.00029563427,0.0002579872],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00054671377,0.00011288469,0.00020033255,0.000069305,0.000057504953,0.000016502756,0.0001859231,0.00011351263,0.0000023428925],"category_scores_gemma":[0.00056893606,0.00008460292,0.00004841784,0.00017217755,0.00015738183,0.000011849789,0.00007695769,0.00016809984,5.36898e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00091178535,0.00032441143,0.075069174,0.000010318213,0.000013079337,0.000030967967,0.000063102634,0.000018250455,0.92270684,0.00006573082,0.00033702893,0.00044933055],"study_design_scores_gemma":[0.007047693,0.032511313,0.65704936,0.0002539963,0.00011386039,0.0013822311,0.00031237275,0.000069535636,0.2991481,0.00042862762,0.0013048011,0.00037813495],"about_ca_topic_score_codex":0.0000022594759,"about_ca_topic_score_gemma":0.000017039052,"teacher_disagreement_score":0.6235587,"about_ca_system_score_codex":0.0000044449903,"about_ca_system_score_gemma":0.00035191467,"threshold_uncertainty_score":0.34500068},"labels":[],"label_agreement":null},{"id":"W2332850103","doi":"10.7554/elife.11414","title":"Registered report: COT drives resistance to RAF inhibition through MAP kinase pathway reactivation","year":2016,"lang":"en","type":"article","venue":"eLife","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Applied Biological Materials (Canada)","funders":"Laura and John Arnold Foundation","keywords":"MAPK/ERK pathway; MEK inhibitor; Kinase; Medicine; Cancer research; Biology; Cell biology","score_opus":0.019402117826239577,"score_gpt":0.2528786237664669,"score_spread":0.23347650594022734,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2332850103","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9713338,0.0002331307,0.01525457,0.0032299438,0.00041309372,0.0003079274,0.00005145966,0.00004572461,0.009130335],"genre_scores_gemma":[0.9797308,0.00006333892,0.0020624946,0.000793764,0.00055140053,0.000055479366,0.00017460732,0.000024022049,0.016544135],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99882174,0.000053478732,0.00027788398,0.00045201692,0.00018626188,0.00020864882],"domain_scores_gemma":[0.9989831,0.0000143795405,0.00016655994,0.00061653304,0.00012938849,0.00009007623],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019104399,0.00013989503,0.00012536709,0.000027113589,0.000075950076,0.000017634526,0.000088058434,0.00012748702,0.000021200394],"category_scores_gemma":[0.00036872737,0.00010804016,0.000062309664,0.00006208494,0.000042480176,0.00001206126,0.000069923466,0.000040119416,0.00007845283],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001396711,0.000030416064,0.00032748232,0.0000145190825,0.0000104313995,0.00006177267,0.000070409755,3.5117222e-7,0.95081794,0.0008811138,0.046823047,0.00082286075],"study_design_scores_gemma":[0.00029246416,0.00008030056,0.0010854966,0.000059453872,0.000002754128,0.000012890236,0.000017121742,9.7942504e-8,0.59429675,0.00017250584,0.4038655,0.00011464233],"about_ca_topic_score_codex":0.000009716833,"about_ca_topic_score_gemma":0.00007285959,"teacher_disagreement_score":0.35704246,"about_ca_system_score_codex":0.00002790428,"about_ca_system_score_gemma":0.00006819946,"threshold_uncertainty_score":0.440575},"labels":[],"label_agreement":null},{"id":"W2333651255","doi":"10.1158/1538-7445.am2011-4398","title":"Abstract 4398: MEK inhibitors prevent rebound reactivation of ERK signaling by the RAF inhibitor PLX4032 and enhance its antitumor activity","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Workplace Health, Safety and Compensation Commission","funders":"","keywords":"MAPK/ERK pathway; Melanoma; MEK inhibitor; Cancer research; Kinase; Phosphorylation; Therapeutic index; Medicine; V600E; Signal transduction; Mutant; Pharmacology; Chemistry; Biology; Drug; Cell biology; Biochemistry","score_opus":0.06595565880279666,"score_gpt":0.3472648796411768,"score_spread":0.28130922083838017,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2333651255","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967115,0.0017574886,0.000026107036,0.00008765576,0.00009357779,0.00036048086,0.000029723582,0.0000035167525,0.00092994905],"genre_scores_gemma":[0.9988281,0.00052775996,0.000026638176,0.000012455553,0.00016569691,0.00009108575,0.000009689345,0.000014394897,0.00032417418],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988661,0.00013176733,0.0001765967,0.00030995684,0.0002488959,0.00026673067],"domain_scores_gemma":[0.9994379,0.000047531383,0.00008880242,0.0002294646,0.00013543971,0.00006081353],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000856465,0.0000987749,0.000121231344,0.00005443465,0.00009418487,0.000016729737,0.00015308613,0.00010166499,0.00003374737],"category_scores_gemma":[0.00013433004,0.00007721208,0.00003256527,0.00013979289,0.00015005587,0.000014107318,0.00010655448,0.00023478849,0.0000017989723],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022105638,0.00008894409,0.0009886642,0.00007662112,0.000015899175,0.0000024143737,0.0002497359,0.0000011376826,0.9936797,0.000028178847,0.0009160816,0.003731557],"study_design_scores_gemma":[0.00022136078,0.00015387182,0.0068313223,0.00008554788,0.000003053204,0.0000014905271,0.00010532026,0.0000029717098,0.9905939,0.00006424596,0.0018511986,0.000085680724],"about_ca_topic_score_codex":0.000500542,"about_ca_topic_score_gemma":0.00015725681,"teacher_disagreement_score":0.005842658,"about_ca_system_score_codex":0.00003617763,"about_ca_system_score_gemma":0.00017247525,"threshold_uncertainty_score":0.3148617},"labels":[],"label_agreement":null},{"id":"W2336162936","doi":"10.1200/jco.2013.31.15_suppl.9013","title":"An update on BREAK-3, a phase III, randomized trial: Dabrafenib (DAB) versus dacarbazine (DTIC) in patients with BRAF V600E-positive mutation metastatic melanoma (MM).","year":2013,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":111,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Dabrafenib; Medicine; Trametinib; Internal medicine; Dacarbazine; Hazard ratio; Progression-free survival; Oncology; Vemurafenib; Melanoma; Clinical endpoint; Adverse effect; Phases of clinical research; Gastroenterology; Chemotherapy; Randomized controlled trial; Confidence interval; Cancer; Cancer research; Metastatic melanoma; Kinase","score_opus":0.03970374677695072,"score_gpt":0.3917280835614726,"score_spread":0.3520243367845219,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2336162936","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995331,0.00007406998,0.0008337799,0.0005992551,0.0010966866,0.0012162032,0.000019587176,0.0000056173453,0.0008238344],"genre_scores_gemma":[0.996008,0.00008332621,0.0020299258,0.0009813447,0.0005660587,0.000047455498,0.00021018994,0.000028567387,0.00004516681],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99494255,0.0017910551,0.002246648,0.00036722605,0.00034358085,0.00030896955],"domain_scores_gemma":[0.9957676,0.0011580365,0.0019172457,0.00030792257,0.0004999573,0.00034925272],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00265814,0.00025598018,0.0016852785,0.00015252747,0.000044319884,0.000030560128,0.0002881155,0.00033622794,0.00011822826],"category_scores_gemma":[0.0021077623,0.00017091485,0.00036660634,0.00012192697,0.00022819216,0.00004263883,0.000043689655,0.00049289817,0.00002300716],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.956968,0.0051388843,0.00044886844,0.0000063084253,0.00062762684,0.00014841021,0.0000703799,0.00007125195,0.0010710389,0.00011767962,0.000704245,0.0346273],"study_design_scores_gemma":[0.9184589,0.07360778,0.0041041262,0.000031186442,0.00036422347,0.000025299087,0.00005674515,0.0002354481,0.0013683906,0.000247665,0.0012833718,0.00021691351],"about_ca_topic_score_codex":0.00004434656,"about_ca_topic_score_gemma":0.00007887163,"teacher_disagreement_score":0.0684689,"about_ca_system_score_codex":0.000051278734,"about_ca_system_score_gemma":0.0005879678,"threshold_uncertainty_score":0.6969705},"labels":[],"label_agreement":null},{"id":"W2343203314","doi":"10.1016/j.jval.2015.03.1234","title":"Metastatic Melanoma Patient Characteristics as A Determening Factor for Braf Gene Mutation Testing and Treatment In Canada – A Retrospective Cohort Study","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Merck Canada Inc. (Canada)","funders":"","keywords":"Medicine; Ipilimumab; Metastatic melanoma; Melanoma; Internal medicine; Oncology; Cohort; Retrospective cohort study; Mutation; Cancer; Disease; Stage (stratigraphy); Gene; Cancer research; Immunotherapy; Genetics","score_opus":0.047629491895566256,"score_gpt":0.2770613135548097,"score_spread":0.22943182165924342,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2343203314","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99803585,0.00012875632,0.000068339265,0.000023965875,0.0001126956,0.0014918025,0.000119951466,0.0000035750927,0.0000150657],"genre_scores_gemma":[0.9978919,0.000013086608,0.0017025158,0.000065664426,0.00003438491,0.00021123276,0.00006031323,0.000013928334,0.0000069854195],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989005,0.0001423561,0.00032166837,0.00029201142,0.00011567059,0.00022784773],"domain_scores_gemma":[0.9994939,0.0000559908,0.00014787563,0.00012247097,0.00005813302,0.00012163554],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023811015,0.00012357725,0.00024282446,0.00004517727,0.0000400207,0.000011225359,0.000035289293,0.000024634079,6.8805775e-7],"category_scores_gemma":[0.0003515812,0.000115296105,0.000012718794,0.0000676369,0.000007967208,0.0000032832795,0.00002320224,0.000039687664,2.3712309e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007848792,0.00011642628,0.98632026,0.000026695936,0.000026313544,0.00005273454,0.0014652538,0.00017018261,0.0020556434,0.0000033914575,0.000004897307,0.009679737],"study_design_scores_gemma":[0.0018929747,0.006710029,0.9815287,0.000032915905,0.000013779592,0.00004283416,0.0012950673,0.0044533326,0.0037231015,0.00006402326,0.000068399466,0.00017482488],"about_ca_topic_score_codex":0.68241996,"about_ca_topic_score_gemma":0.42414144,"teacher_disagreement_score":0.25827852,"about_ca_system_score_codex":0.00069890305,"about_ca_system_score_gemma":0.0015268831,"threshold_uncertainty_score":0.5863665},"labels":[],"label_agreement":null},{"id":"W2344830850","doi":"10.1002/cam4.717","title":"Real‐world treatment practice in patients with advanced melanoma in the era before ipilimumab: results from the <scp>IMAGE</scp> study","year":2016,"lang":"en","type":"article","venue":"Cancer Medicine","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier universitaire de Québec","funders":"Flatiron Health; Helsinn; Cardinal Health; Celgene; Pfizer; Bristol-Myers Squibb","keywords":"Ipilimumab; Melanoma; Medicine; Internal medicine; Oncology; Clinical Practice; Dermatology; Cancer research; Family medicine; Cancer; Immunotherapy","score_opus":0.009487964172250214,"score_gpt":0.2719503305099874,"score_spread":0.2624623663377372,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2344830850","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99170965,0.0005772194,0.000007470622,0.0027076872,0.00018569172,0.0009523446,0.00011863765,0.0000074358027,0.0037338384],"genre_scores_gemma":[0.99731076,0.00056060054,0.00006408637,0.00064536993,0.00043862822,0.0002540491,0.00013340959,0.000020134667,0.0005729513],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985048,0.00023084578,0.00030188568,0.00043809923,0.00025870756,0.0002656617],"domain_scores_gemma":[0.99862474,0.00038628402,0.00017088556,0.00067093555,0.000090607624,0.000056566907],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033508224,0.00020802849,0.00022673943,0.000039534938,0.000059304428,0.000008115847,0.00027450093,0.000053309977,0.000010679016],"category_scores_gemma":[0.0005300045,0.00007940371,0.00002454533,0.00018919543,0.00011834647,0.0000124129965,0.000044622255,0.00010747564,0.0000043434793],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032360954,0.0015431995,0.8117087,0.000011703307,0.00033637087,0.0001487615,0.025980856,0.00001560955,0.018417817,0.000058417754,0.010122808,0.12841968],"study_design_scores_gemma":[0.017905647,0.00559508,0.9085552,0.00015248534,0.00008423407,0.000001278929,0.0039213663,0.0000012508405,0.002172925,0.000028290273,0.06151311,0.00006914792],"about_ca_topic_score_codex":0.0028279822,"about_ca_topic_score_gemma":0.020772727,"teacher_disagreement_score":0.12835053,"about_ca_system_score_codex":0.00009027082,"about_ca_system_score_gemma":0.00011360593,"threshold_uncertainty_score":0.99709564},"labels":[],"label_agreement":null},{"id":"W2353777016","doi":"","title":"Expression of MEK-1 in regulation of αV integrin and E-cadherin of MCF-7 breast cancer cells","year":2003,"lang":"en","type":"article","venue":"Zhongguo aizheng zazhi","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Northeast Cancer Centre","funders":"","keywords":"MEK inhibitor; Integrin; MAPK/ERK pathway; Cadherin; MCF-7; Phosphorylation; Cell biology; Transfection; Chemistry; Cancer research; Molecular biology; Cancer cell; Biology; Cell; Cancer; Gene; Biochemistry; Human breast; Genetics","score_opus":0.0075772778683541086,"score_gpt":0.22189310087476866,"score_spread":0.21431582300641455,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2353777016","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977402,0.0004898328,0.00019521534,0.000011688283,0.000094262075,0.00011276999,0.000060613325,0.0000021141575,0.0012932953],"genre_scores_gemma":[0.9987755,0.0001435795,0.0007486005,0.000008101502,0.00002676496,0.0000072759244,0.00001617016,0.000011347244,0.00026268236],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991669,0.00008527235,0.00033178207,0.00019601495,0.00010521511,0.000114797935],"domain_scores_gemma":[0.9994308,0.000013088026,0.0001951902,0.00023571422,0.00008910632,0.000036112437],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021007791,0.00010236501,0.00021450708,0.000055028242,0.000011076893,0.0000021358483,0.00007948151,0.00013011153,0.00007098527],"category_scores_gemma":[0.000037927817,0.000090283575,0.000044737833,0.00009128416,0.00006638257,0.000004653543,0.000043207652,0.000056990306,5.5017733e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000062197825,0.000055860844,0.01950907,0.00009321751,0.000009239083,4.4240548e-7,0.00014531668,0.00006181732,0.9782913,0.00022089129,0.0001460903,0.0014045702],"study_design_scores_gemma":[0.00048618435,0.00008753325,0.050531324,0.00009554841,0.000007944441,0.000004144299,0.00010740395,0.000020523381,0.94772184,0.000078028985,0.0007775369,0.00008196292],"about_ca_topic_score_codex":0.00011667499,"about_ca_topic_score_gemma":0.0000590782,"teacher_disagreement_score":0.031022253,"about_ca_system_score_codex":0.000006829284,"about_ca_system_score_gemma":0.000051402218,"threshold_uncertainty_score":0.36816573},"labels":[],"label_agreement":null},{"id":"W2409346424","doi":"10.1200/jco.2014.32.15_suppl.3000","title":"Randomized comparison of two doses of the anti-PD-1 monoclonal antibody MK-3475 for ipilimumab-refractory (IPI-R) and IPI-naive (IPI-N) melanoma (MEL).","year":2014,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Internal medicine; Ipilimumab; Refractory (planetary science); Clinical endpoint; Mallinckrodt; Clinical trial; Cancer; Immunotherapy; Family medicine","score_opus":0.07231325230553105,"score_gpt":0.4469057133558252,"score_spread":0.37459246105029415,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2409346424","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99207014,0.0015600916,0.0025661692,0.00051581004,0.0016012851,0.0004244138,0.000030143081,0.0000029944094,0.0012289749],"genre_scores_gemma":[0.99480313,0.0006702136,0.0028669524,0.00034242557,0.0011658818,0.000007513432,0.000014364959,0.00002178143,0.00010773152],"study_design_codex":"bench_or_experimental","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9950808,0.0012995447,0.002767138,0.00029716533,0.00028277107,0.00027254145],"domain_scores_gemma":[0.9925041,0.0028511737,0.0035375638,0.00035812773,0.00054957904,0.00019945615],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0046069836,0.00023177224,0.0023892424,0.00007544985,0.000075175616,0.000009521377,0.00047474392,0.0005100248,0.000022120948],"category_scores_gemma":[0.0041064145,0.00014535624,0.0009974991,0.000067193694,0.00079518964,0.000013118941,0.00019193174,0.00045303168,0.0000012324082],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.14205323,0.003590742,0.28353712,0.0002927309,0.002306146,0.000013835658,0.00044576603,0.00017293569,0.5163107,0.003068912,0.0057776743,0.042430237],"study_design_scores_gemma":[0.46801773,0.031412307,0.122126594,0.00034385544,0.0020662548,0.00023274135,0.00046610518,0.0022709032,0.2394758,0.0045552626,0.12825543,0.00077701244],"about_ca_topic_score_codex":0.000019279598,"about_ca_topic_score_gemma":0.00002674763,"teacher_disagreement_score":0.3259645,"about_ca_system_score_codex":0.000015232827,"about_ca_system_score_gemma":0.00062628504,"threshold_uncertainty_score":0.59274554},"labels":[],"label_agreement":null},{"id":"W2416476141","doi":"10.1002/dvdy.24421","title":"Raf kinase inhibitor protein1 is a myogenic inhibitor with conserved function in avians and mammals","year":2016,"lang":"en","type":"article","venue":"Developmental Dynamics","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"","keywords":"Myogenesis; Biology; C2C12; MAPK/ERK pathway; Cell biology; Kinase; Phosphorylation; MEK inhibitor; Myocyte; Signal transduction; Activator (genetics); Molecular biology; Receptor; Genetics","score_opus":0.005689135811775824,"score_gpt":0.1827615306132875,"score_spread":0.17707239480151168,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2416476141","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99713176,0.00009009641,0.0015843764,0.00020084849,0.000099591016,0.00040060462,0.00007399325,0.000016301747,0.00040242416],"genre_scores_gemma":[0.9966254,0.000042852498,0.0014691853,0.00025554126,0.00006227949,0.000090894595,0.00011747631,0.000026956091,0.0013093961],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99901,0.000032551685,0.00021055204,0.00038119976,0.00011378236,0.00025189182],"domain_scores_gemma":[0.99965966,0.000007791276,0.00006175304,0.00013866393,0.00003901531,0.000093136536],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001076642,0.00018770738,0.00013949665,0.00006143688,0.000058673282,0.00001991629,0.00007202937,0.00014785277,0.000023704779],"category_scores_gemma":[0.000015429065,0.00013655412,0.00002836211,0.00008626899,0.00007424691,0.000009990865,0.000099330755,0.00005711878,0.00001813878],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00050603267,0.00006916229,0.08238079,0.000037291855,0.000041810683,0.000031806787,0.00008954602,3.6582705e-7,0.90557295,0.00014540693,0.0002614873,0.010863331],"study_design_scores_gemma":[0.004853246,0.0009629341,0.08856587,0.00023620525,0.000023475051,0.00017997065,0.0003310349,0.000082030456,0.89501536,0.00012109571,0.0088737905,0.0007549813],"about_ca_topic_score_codex":0.000028726407,"about_ca_topic_score_gemma":0.0012361922,"teacher_disagreement_score":0.010557605,"about_ca_system_score_codex":0.00007757846,"about_ca_system_score_gemma":0.00015226437,"threshold_uncertainty_score":0.5568515},"labels":[],"label_agreement":null},{"id":"W2462587944","doi":"10.1038/bjc.2016.195","title":"Molecular characterisation of cutaneous melanoma: creating a framework for targeted and immune therapies","year":2016,"lang":"en","type":"review","venue":"British Journal of Cancer","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":54,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"University of Texas MD Anderson Cancer Center; Curtin University of Technology; Melanoma Research Alliance","keywords":"Melanoma; Immune checkpoint; Immune system; Disease; Computational biology; Medicine; Precision medicine; Biology; Bioinformatics; Cancer research; Immunotherapy; Immunology; Genetics; Internal medicine","score_opus":0.013800042175460794,"score_gpt":0.29672233756004146,"score_spread":0.2829222953845807,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2462587944","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.012365038,0.98455495,0.0022186546,0.000012740978,0.0002708513,0.00027224942,0.00026352928,0.000002024224,0.000039955812],"genre_scores_gemma":[0.0048214262,0.992796,0.0015869145,0.000020243415,0.00058584474,0.000040195868,0.000043598684,0.000043158165,0.00006259383],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99884564,0.00008035526,0.0006298859,0.00017093193,0.0001182693,0.00015493085],"domain_scores_gemma":[0.9984277,0.000054314976,0.0011218047,0.00012188074,0.00021834027,0.000055989585],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017741452,0.00018126568,0.00082687143,0.000050910927,0.000045023822,0.00003114437,0.00015661448,0.00030128672,0.000027888675],"category_scores_gemma":[0.00018351548,0.00015589184,0.00036810816,0.000037936486,0.000053935106,0.0000051962706,0.00003594268,0.00014058547,2.2819408e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000044403576,0.000017016759,0.0000066467355,0.0018652758,0.00044033764,0.00004613837,0.000024081968,1.8414295e-7,0.01954036,0.00006697199,0.000038753773,0.9779098],"study_design_scores_gemma":[0.0005057181,0.00055299874,0.00005393122,0.025202274,0.00047644653,0.0029933292,0.000018354785,4.5172837e-7,0.010709616,0.00041942307,0.9587587,0.00030875823],"about_ca_topic_score_codex":0.000016355594,"about_ca_topic_score_gemma":0.000005811189,"teacher_disagreement_score":0.97760105,"about_ca_system_score_codex":0.000019548648,"about_ca_system_score_gemma":0.0002277143,"threshold_uncertainty_score":0.6357085},"labels":[],"label_agreement":null},{"id":"W2466439203","doi":"10.3389/fcell.2016.00067","title":"Redundancy in the World of MAP Kinases: All for One","year":2016,"lang":"en","type":"review","venue":"Frontiers in Cell and Developmental Biology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":60,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Institute for Research in Immunology and Cancer","funders":"Canadian Cancer Society Research Institute; Canadian Institutes of Health Research","keywords":"Kinase; Mitogen-activated protein kinase; Biology; Cell biology; Effector; Gene isoform; Embryonic stem cell; p38 mitogen-activated protein kinases; Signal transduction; Redundancy (engineering); MAPK/ERK pathway; Genetics; Computer science; Gene","score_opus":0.029380579268283805,"score_gpt":0.28239533029225455,"score_spread":0.25301475102397075,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2466439203","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0003659431,0.9949771,0.00033605553,0.000027620928,0.0005391101,0.000738959,0.00014734945,0.00000234383,0.0028655268],"genre_scores_gemma":[0.00028752146,0.98952514,0.0074189873,0.0001094423,0.000102709564,0.00024314658,0.0007537521,0.000019653531,0.0015396355],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9986615,0.00013566978,0.0004682941,0.00040807368,0.000041400286,0.00028507196],"domain_scores_gemma":[0.99955344,0.000060365204,0.0001687846,0.00017012011,0.000013147277,0.00003415302],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003050142,0.000244944,0.0007021813,0.00017533735,0.00002512987,0.000005502843,0.0002953208,0.00032025186,0.000010054752],"category_scores_gemma":[0.000024821518,0.00015433836,0.00012069934,0.00008984767,0.00013754572,0.0000018793753,0.000122037185,0.00010399635,0.0000038772464],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012014312,0.00019466411,0.0011707891,0.005996482,0.00015341277,0.0000082146225,0.00013965534,1.968084e-8,0.0024824152,0.0002836479,0.047450677,0.94199985],"study_design_scores_gemma":[0.0004671129,0.00015310258,0.000018330387,0.00081333605,0.000029517621,0.000007581854,0.000067431,9.8760324e-8,0.0012364654,0.00039086933,0.9965962,0.00021994906],"about_ca_topic_score_codex":0.000007050102,"about_ca_topic_score_gemma":0.000060405684,"teacher_disagreement_score":0.94914556,"about_ca_system_score_codex":0.00003114869,"about_ca_system_score_gemma":0.0001704154,"threshold_uncertainty_score":0.62937355},"labels":[],"label_agreement":null},{"id":"W2468294668","doi":"10.1097/cji.0000000000000131","title":"An Association Between Glatiramer Acetate and Malignant Melanoma","year":2016,"lang":"en","type":"article","venue":"Journal of Immunotherapy","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Glatiramer acetate; Medicine; Melanoma; Dermatology; Association (psychology); Oncology; Internal medicine; Cancer research; Psychology; Disease","score_opus":0.008823298688931851,"score_gpt":0.24556153186318544,"score_spread":0.23673823317425358,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2468294668","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953621,0.0012505937,0.0027020986,0.00037389586,0.0001326499,0.00004230353,0.000010333216,0.0000025835907,0.00012342543],"genre_scores_gemma":[0.9965366,0.0016350147,0.0007190241,0.00014824234,0.00041793892,9.4080326e-7,0.00000329114,0.000014539016,0.00052442163],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99932945,0.00008116529,0.00024606124,0.000094481984,0.000120100296,0.00012874472],"domain_scores_gemma":[0.9993583,0.000022439768,0.00032347612,0.00013664557,0.00010136245,0.00005777892],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040350508,0.00008496487,0.00015218774,0.000037256803,0.000034996356,0.000021121434,0.00011236794,0.000098665485,0.000027045731],"category_scores_gemma":[0.000029794444,0.00005156242,0.000067447276,0.000023038316,0.000020156745,0.00001229231,0.000011117764,0.00004752147,0.0000035425012],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009231204,0.00001708834,0.087374255,0.0000014764793,0.00014045289,0.0000024936166,0.00004814511,1.9742104e-7,0.86126935,0.000018120796,0.00032241057,0.050713696],"study_design_scores_gemma":[0.0027550608,0.002276031,0.2031902,0.000051188912,0.00003416501,0.00006685761,0.000032214666,0.0000012859206,0.7100498,0.00039447538,0.080959216,0.00018950478],"about_ca_topic_score_codex":0.0000030787262,"about_ca_topic_score_gemma":0.0000016159128,"teacher_disagreement_score":0.15121953,"about_ca_system_score_codex":0.000020387384,"about_ca_system_score_gemma":0.000039563798,"threshold_uncertainty_score":0.21026546},"labels":[],"label_agreement":null},{"id":"W2472992307","doi":"10.1039/c6md00241b","title":"Novel p38α MAP kinase inhibitors identified from yoctoReactor DNA-encoded small molecule library","year":2016,"lang":"en","type":"article","venue":"MedChemComm","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":84,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Structural Genomics Consortium","funders":"Engineering and Physical Sciences Research Council","keywords":"Small molecule; Computational biology; DNA; Kinase; Biology; Combinatorial chemistry; Chemistry; Genetics","score_opus":0.015329803184348043,"score_gpt":0.20439455643016935,"score_spread":0.1890647532458213,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2472992307","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9920548,0.0005808411,0.0022855552,0.00080924813,0.00087611703,0.00021038082,0.00033091975,0.000086240914,0.0027658953],"genre_scores_gemma":[0.98852277,0.000055460474,0.0016804397,0.0006194797,0.0010791738,0.000053510714,0.0005483061,0.00007909154,0.0073617464],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99838954,0.00006332998,0.0003332525,0.00061646453,0.00018587755,0.00041153704],"domain_scores_gemma":[0.9987075,0.00004626475,0.00013258659,0.00081435725,0.00004368832,0.00025560474],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011056185,0.0003057381,0.0002464914,0.000058231577,0.00007605166,0.000056458655,0.00048090235,0.00030042644,0.0003562798],"category_scores_gemma":[0.00010642538,0.00022934032,0.00018648762,0.00007936278,0.00009950266,0.000017599355,0.00037490987,0.00010896209,0.00020405678],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008204121,0.00013532145,0.0019876554,0.0000141324645,0.00005795681,0.000019259558,0.000050971797,1.3170165e-7,0.9722897,0.00008954375,0.023415143,0.0018581741],"study_design_scores_gemma":[0.0011222786,0.00010202065,0.0015505699,0.000050388364,0.000023144194,0.0000055287624,0.000032767028,0.000004081549,0.90606236,0.00014505969,0.09056287,0.00033892872],"about_ca_topic_score_codex":0.00007902366,"about_ca_topic_score_gemma":0.000048639195,"teacher_disagreement_score":0.06714773,"about_ca_system_score_codex":0.000018469,"about_ca_system_score_gemma":0.00010117658,"threshold_uncertainty_score":0.9352227},"labels":[],"label_agreement":null},{"id":"W2483841276","doi":"10.1007/978-1-59259-994-3","title":"From Melanocytes to Melanoma","year":2006,"lang":"en","type":"book","venue":"Humana Press eBooks","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":30,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"University of California, San Francisco; St. George's, University of London; Feinberg School of Medicine; Universität Regensburg; Deutsches Krebsforschungszentrum; University of Queensland; University of Oklahoma; University of Cincinnati; University of Pittsburgh; National Cancer Institute; College of Medicine, University of Cincinnati; University of Toronto; Cleveland Clinic; Melanoma Research Alliance; Cleveland Clinic Foundation; Lawrence Berkeley National Laboratory; Northwestern University; National Institutes of Health; College of Medicine, University of Oklahoma; Ohio State University; Comprehensive Cancer Center, University of Alabama at Birmingham; Yale University; University of Pennsylvania","keywords":"Melanoma; Biology; Cancer research","score_opus":0.026907465919635047,"score_gpt":0.24221531395537463,"score_spread":0.21530784803573957,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2483841276","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0023375251,0.005534111,0.0002583204,0.0000074411305,0.00052227976,0.00053971267,0.0006174416,0.000065097636,0.9901181],"genre_scores_gemma":[0.0022211962,0.00005039359,0.00044528075,0.00033469804,0.00402192,0.00011891945,0.0028850175,0.00014098555,0.9897816],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99800295,0.000051439863,0.00038215885,0.0008812999,0.00026761007,0.00041451666],"domain_scores_gemma":[0.99845374,0.000018783714,0.00017478506,0.0010827626,0.00008174014,0.00018819104],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000077098775,0.0005171709,0.00045388527,0.00008189065,0.000101616904,0.00007603457,0.000621055,0.0006800357,0.0000694942],"category_scores_gemma":[0.000014740232,0.00052583247,0.00023837805,0.000005412995,0.0000772956,0.0000014431507,0.00043429283,0.00022690174,0.00012163828],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008055907,0.000023676037,0.000002531978,0.000059417584,0.0002421238,0.00006978995,0.00010694618,0.0000072056796,0.016016364,0.0049830046,0.96609557,0.012312819],"study_design_scores_gemma":[0.00033970433,0.0002410153,0.00002599347,0.00007331475,0.00009951508,0.0000052414393,0.0000027047677,0.000001622486,0.05197811,0.0014501498,0.94518477,0.0005978413],"about_ca_topic_score_codex":0.00055793946,"about_ca_topic_score_gemma":0.00040018125,"teacher_disagreement_score":0.035961747,"about_ca_system_score_codex":0.00004073977,"about_ca_system_score_gemma":0.00015958156,"threshold_uncertainty_score":0.9997193},"labels":[],"label_agreement":null},{"id":"W2495037279","doi":"10.1016/b978-0-12-803582-5.00010-3","title":"Diversity and implication of MAPK signal transduction involved in the regulation of chemotherapy-induced DNA damage response","year":2016,"lang":"en","type":"book-chapter","venue":"Elsevier eBooks","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"Canadian Institutes of Health Research; Canadian Cancer Society","keywords":"DNA damage; MAPK/ERK pathway; DNA repair; Biology; Cancer research; Signal transduction; Cell biology; DNA; Genetics","score_opus":0.017236534091971692,"score_gpt":0.22307285273864189,"score_spread":0.20583631864667018,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2495037279","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9259263,0.00012969226,0.000024063536,0.00007079459,0.00003492785,0.00041050473,0.000031441763,0.0000032742635,0.073368974],"genre_scores_gemma":[0.9512051,0.000057583606,0.000030075107,0.000036314006,0.00007855899,0.000007861921,0.000032105003,0.000015831054,0.048536588],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992144,0.00008656114,0.0002449028,0.00023704987,0.00013155573,0.00008551926],"domain_scores_gemma":[0.99931973,0.000024814386,0.00022820887,0.00033625748,0.00006783859,0.000023135675],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044125904,0.00014746684,0.00019410641,0.00007006299,0.00008898448,0.0000025810366,0.00014503069,0.0002665891,0.000019285913],"category_scores_gemma":[0.00000854667,0.00011070346,0.0000847167,0.0000091797165,0.00009811918,0.0000029561443,0.0001025276,0.00007660741,5.582845e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00052759645,0.000008676638,0.00007554305,0.00004236695,0.000026906693,4.05526e-7,0.0006140603,6.321665e-8,0.88791203,0.0005820798,0.000007479188,0.1102028],"study_design_scores_gemma":[0.0011655237,0.0005738389,0.022377122,0.0001830023,0.00007005237,0.000006993239,0.000047104328,0.0000017822628,0.921637,0.0045413156,0.04912936,0.00026692476],"about_ca_topic_score_codex":0.000001329162,"about_ca_topic_score_gemma":0.000016599815,"teacher_disagreement_score":0.10993587,"about_ca_system_score_codex":0.000012897678,"about_ca_system_score_gemma":0.00004366785,"threshold_uncertainty_score":0.45143563},"labels":[],"label_agreement":null},{"id":"W2507950939","doi":"10.1158/1078-0432.ccr-16-1192","title":"MAPK Pathway Inhibitors Sensitize BRAF-Mutant Melanoma to an Antibody-Drug Conjugate Targeting GPNMB","year":2016,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"National Cancer Institute; Deutsches Krebsforschungszentrum; McGill University","keywords":"Microphthalmia-associated transcription factor; Melanoma; MEK inhibitor; MAPK/ERK pathway; Cancer research; Gene knockdown; Medicine; Antibody-drug conjugate; Trametinib; Dabrafenib; Antibody; Monoclonal antibody; Cell culture; Immunology; Biology; Vemurafenib; Signal transduction; Tyrosinase; Metastatic melanoma; Cell biology","score_opus":0.08395417958845613,"score_gpt":0.44757959507761497,"score_spread":0.36362541548915883,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2507950939","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994172,0.00048531962,0.0002683996,0.0022753642,0.00085524097,0.00050403865,0.0001783441,0.000040799772,0.0012205387],"genre_scores_gemma":[0.9926019,0.00063215056,0.00030742615,0.0007728611,0.003023595,0.000076899865,0.00008159002,0.00006674383,0.0024368728],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9956633,0.0009328768,0.0007272266,0.0011139212,0.0005788241,0.0009838432],"domain_scores_gemma":[0.99749863,0.0002354632,0.00010667052,0.000825792,0.0005381221,0.0007952965],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0039133094,0.00025333776,0.00038871562,0.00010710405,0.0002463467,0.00007220617,0.0005274666,0.0003140925,0.00021766679],"category_scores_gemma":[0.00133399,0.00017930342,0.00019298436,0.0002405368,0.00037244655,0.000015145066,0.0005964339,0.0004150106,0.0003262884],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042082422,0.000115674135,0.008971483,0.000024174156,0.00004283716,0.00011434133,0.000053450578,0.0000019414038,0.9553922,0.0001486505,0.012971876,0.021742545],"study_design_scores_gemma":[0.0012468337,0.0013640573,0.0046880483,0.00011973979,0.0000077659,0.000013248355,0.000115210234,0.000013045069,0.7892384,0.00018296609,0.2026294,0.00038128506],"about_ca_topic_score_codex":0.00023950677,"about_ca_topic_score_gemma":0.00031473697,"teacher_disagreement_score":0.18965752,"about_ca_system_score_codex":0.0000591692,"about_ca_system_score_gemma":0.00057578465,"threshold_uncertainty_score":0.7311781},"labels":[],"label_agreement":null},{"id":"W2518848423","doi":"10.1177/1203475416670368","title":"Prospective Case Series of Cutaneous Adverse Effects Associated With Dabrafenib and Trametinib","year":2016,"lang":"en","type":"article","venue":"Journal of Cutaneous Medicine and Surgery","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Canadian Dermatology Foundation; McGill University Health Centre; Dermatology Foundation","keywords":"Trametinib; Dabrafenib; Medicine; Vemurafenib; Adverse effect; MEK inhibitor; Dermatology; Melanoma; Keratoacanthoma; Oncology; Rash; Internal medicine; Cancer research; MAPK/ERK pathway; Basal cell; Metastatic melanoma","score_opus":0.008931934955345442,"score_gpt":0.21620470601691855,"score_spread":0.2072727710615731,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2518848423","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99784905,0.0011923326,0.00008544212,0.00032570903,0.000152043,0.00010984659,0.000010069826,0.0000041836456,0.00027135146],"genre_scores_gemma":[0.99817175,0.0010809574,0.000079427875,0.00010066088,0.00020743282,0.0000017005267,0.0000029605455,0.00001594615,0.00033915025],"study_design_codex":"bench_or_experimental","study_design_gemma":"case_report","domain_scores_codex":[0.9990055,0.00009400839,0.00038359195,0.00016062125,0.00018302872,0.0001732786],"domain_scores_gemma":[0.99858207,0.0005168991,0.0004074509,0.00011689637,0.00021867907,0.00015801161],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030638007,0.00015848936,0.0004956693,0.000096288975,0.00004771327,0.000004014166,0.000041937357,0.000110799185,0.000012957215],"category_scores_gemma":[0.0010681382,0.000084785665,0.00006847188,0.000066735265,0.00029578665,0.000009677543,0.000020300262,0.00008640737,1.8812975e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0041243643,0.00024124204,0.10969203,0.00029658942,0.0009456026,0.08164239,0.0009871932,0.000002506682,0.77606577,0.000083306644,0.0045952755,0.021323752],"study_design_scores_gemma":[0.0038783588,0.012617914,0.0041211625,0.0019762386,0.00055560336,0.8089231,0.0011898221,0.0000041416424,0.16015634,0.00036765967,0.005716982,0.00049267063],"about_ca_topic_score_codex":0.000008066669,"about_ca_topic_score_gemma":0.000031831223,"teacher_disagreement_score":0.72728074,"about_ca_system_score_codex":0.000010583794,"about_ca_system_score_gemma":0.000105090236,"threshold_uncertainty_score":0.3457459},"labels":[],"label_agreement":null},{"id":"W2520271306","doi":"10.5489/cuaj.3652","title":"Initial response of renal cell carcinoma to vemurafenib in a patient treated for metastatic melanoma","year":2016,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Queen's University; University of Ottawa; Dalhousie University","funders":"","keywords":"Vemurafenib; Renal cell carcinoma; Medicine; Melanoma; Metastatic melanoma; Cancer research; Internal medicine; Oncology; V600E; Mutation; Biology","score_opus":0.012923369004801035,"score_gpt":0.22252219637139706,"score_spread":0.20959882736659602,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2520271306","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99707484,0.000052238094,0.0003405705,0.001765953,0.000105236475,0.00021445926,0.00023995206,0.000002146062,0.00020460699],"genre_scores_gemma":[0.99866647,0.0000036754464,0.00028418357,0.0006481389,0.000105615436,0.000027766897,0.000020118314,0.000009253402,0.00023476199],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987119,0.0003062129,0.000332793,0.00017614884,0.00012273822,0.0003502048],"domain_scores_gemma":[0.99906623,0.00013088647,0.000186633,0.00009552588,0.00017279538,0.00034789834],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00058017706,0.00010473884,0.00017506476,0.00015377217,0.000059934235,0.000013286266,0.00011845249,0.00014343715,0.000057943776],"category_scores_gemma":[0.00091223064,0.000074454794,0.00009982251,0.000094099276,0.00001574648,0.0000045258043,0.000016870335,0.00007399684,0.0000070892615],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028351622,0.00010111506,0.1330376,0.0000055145874,0.00005372092,0.00011750739,0.00021042649,0.000041345585,0.8512035,0.00005284847,0.0073467167,0.004994561],"study_design_scores_gemma":[0.00576473,0.010348327,0.42611817,0.000023206505,0.00006359909,0.0001257859,0.00011136741,0.00002594901,0.4427481,0.0004158089,0.113788754,0.00046621027],"about_ca_topic_score_codex":0.00020701555,"about_ca_topic_score_gemma":0.00091442856,"teacher_disagreement_score":0.4084554,"about_ca_system_score_codex":0.00021204825,"about_ca_system_score_gemma":0.00037861642,"threshold_uncertainty_score":0.30361784},"labels":[],"label_agreement":null},{"id":"W2526572293","doi":"10.1007/s40487-016-0030-2","title":"Network Meta-analysis of Progression-Free Survival and Overall Survival in First-Line Treatment of BRAF Mutation-Positive Metastatic Melanoma","year":2016,"lang":"en","type":"article","venue":"Oncology and Therapy","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Dabrafenib; Trametinib; Vemurafenib; Ipilimumab; Medicine; Dacarbazine; Internal medicine; Oncology; Hazard ratio; Progression-free survival; Melanoma; Confidence interval; Metastatic melanoma; Cancer research; Chemotherapy; Cancer; Biology; Immunotherapy; MAPK/ERK pathway","score_opus":0.05188755218340509,"score_gpt":0.320069913384466,"score_spread":0.2681823612010609,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2526572293","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98957324,0.008581823,0.000539874,0.00047942623,0.0000626553,0.0002484467,0.00012741111,0.0000027318208,0.00038436253],"genre_scores_gemma":[0.9954143,0.003603513,0.0006299228,0.000044111417,0.000037955135,0.00004792492,0.00006750094,0.000008196519,0.00014658703],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99896705,0.00026844576,0.0002818507,0.00025437525,0.00008095677,0.00014734016],"domain_scores_gemma":[0.99922425,0.00027203307,0.00018289634,0.00021790525,0.00005660464,0.000046314868],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029819814,0.0001442833,0.0007274847,0.00007142033,0.000034545963,0.0000029472767,0.00007119347,0.000108376415,0.0000564119],"category_scores_gemma":[0.000025728237,0.000083452294,0.00018107524,0.00010665441,0.00013843477,0.0000046590085,0.000033245793,0.000021809909,2.3049148e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01020266,0.00468784,0.25006488,0.00008548587,0.24272929,0.00023777461,0.0021871212,0.00046807635,0.2292728,0.018166462,0.00021771657,0.2416799],"study_design_scores_gemma":[0.04930663,0.067469425,0.49043503,0.000056796594,0.072838515,0.000095339405,0.00047626052,0.00039548043,0.27541396,0.021809725,0.0200819,0.0016209253],"about_ca_topic_score_codex":0.000081861355,"about_ca_topic_score_gemma":0.0009295553,"teacher_disagreement_score":0.24037015,"about_ca_system_score_codex":0.000009770393,"about_ca_system_score_gemma":0.000049185142,"threshold_uncertainty_score":0.34030858},"labels":[],"label_agreement":null},{"id":"W2529261316","doi":"10.1111/cyt.12366","title":"<scp>CSF</scp> cytology diagnosis of <scp>NRAS</scp>‐mutated primary leptomeningeal melanomatosis with neurocutaneous melanosis","year":2016,"lang":"en","type":"article","venue":"Cytopathology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Medicine; Immunocytochemistry; Neuroblastoma RAS viral oncogene homolog; Pathology; Cytology; Melanoma; Cytopathology; Cancer; Cancer research; Internal medicine","score_opus":0.007383496912232193,"score_gpt":0.20439080346001698,"score_spread":0.19700730654778478,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2529261316","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98883873,0.00092812895,0.0014603421,0.00017244891,0.00042091863,0.00044393627,0.0002308238,0.000109301865,0.0073953485],"genre_scores_gemma":[0.99476063,0.0008258382,0.001149141,0.00062480464,0.00026925342,0.00027350476,0.0002134308,0.000121027,0.0017623889],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99635345,0.00043071064,0.00071186177,0.0011641833,0.00029872422,0.0010410527],"domain_scores_gemma":[0.9972963,0.00061404984,0.0005089651,0.0009901498,0.00028643,0.00030410846],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00030869796,0.0005953213,0.0009253278,0.00026907987,0.00014923401,0.000023614579,0.00068200263,0.00070809707,0.00003203556],"category_scores_gemma":[0.0008428489,0.00044169227,0.00023864963,0.0002963459,0.00066175667,0.000019893761,0.00040994384,0.00023636302,0.0000989005],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000066697314,0.00023969205,0.23963183,0.00007963739,0.00014941696,0.00079497375,0.00023121905,0.000007689396,0.7499189,0.00021948337,0.006468684,0.0021917964],"study_design_scores_gemma":[0.002279198,0.004301332,0.057282258,0.00007033109,0.0002102212,0.004158264,0.0001659305,0.0000044059425,0.88274586,0.0001890544,0.048391856,0.00020128989],"about_ca_topic_score_codex":0.000019556393,"about_ca_topic_score_gemma":0.00004137226,"teacher_disagreement_score":0.18234956,"about_ca_system_score_codex":0.000048502367,"about_ca_system_score_gemma":0.00022649133,"threshold_uncertainty_score":0.9998035},"labels":[],"label_agreement":null},{"id":"W2529971012","doi":"10.1200/jco.2012.30.15_suppl.8517","title":"An open-label, multicenter safety study of vemurafenib (PLX4032, RO5185426) in patients with metastatic melanoma.","year":2012,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Vemurafenib; Medicine; Internal medicine; Clinical endpoint; Rash; Ipilimumab; Adverse effect; Melanoma; Oncology; Metastatic melanoma; Gastroenterology; Dermatology; Surgery; Cancer; Clinical trial; Cancer research; Immunotherapy","score_opus":0.09662255233445871,"score_gpt":0.43254964147480046,"score_spread":0.33592708914034175,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2529971012","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99800956,0.00011723728,0.00014370026,0.000059408612,0.0006198646,0.0004674045,0.000010636321,0.0000014410145,0.00057075266],"genre_scores_gemma":[0.9952546,0.00003528187,0.0040583424,0.00028575165,0.0002852418,0.000006275287,0.000017836346,0.000019614063,0.00003706475],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9963114,0.0010334299,0.0018925478,0.00021365561,0.00026007555,0.0002888748],"domain_scores_gemma":[0.9973038,0.00022684633,0.0014960384,0.00034127402,0.0003225707,0.00030950856],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002838675,0.00016116395,0.0009902153,0.00007765586,0.000029956196,0.00000985274,0.0005443974,0.00019809717,0.000037428363],"category_scores_gemma":[0.0006274854,0.00010934517,0.00007219243,0.00009065487,0.000092662674,0.000041129628,0.00017469151,0.00036210605,0.000004109299],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01146754,0.03257665,0.9363882,0.000012451722,0.00036352093,0.00003181745,0.00025078622,0.000020466205,0.0022353437,0.000024483024,0.00022858562,0.016400171],"study_design_scores_gemma":[0.03512168,0.075841345,0.87876713,0.000023935403,0.00018852517,0.000012703389,0.00042187967,0.000013968735,0.0005565075,0.000010799542,0.008881923,0.00015962093],"about_ca_topic_score_codex":0.00003322653,"about_ca_topic_score_gemma":0.0002318181,"teacher_disagreement_score":0.057621066,"about_ca_system_score_codex":0.000030500769,"about_ca_system_score_gemma":0.00033370566,"threshold_uncertainty_score":0.44589666},"labels":[],"label_agreement":null},{"id":"W2540613192","doi":"10.1001/jamaoncol.2016.4877","title":"Systemic Therapy for Previously Untreated Advanced <i>BRAF</i>-Mutated Melanoma","year":2016,"lang":"en","type":"review","venue":"JAMA Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":63,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Joseph’s Healthcare Hamilton; McMaster University","funders":"","keywords":"Medicine; Hazard ratio; Oncology; Internal medicine; Melanoma; Randomized controlled trial; Meta-analysis; Odds ratio; Confidence interval; Adverse effect; MEK inhibitor; Progression-free survival; Overall survival; Cancer research; MAPK/ERK pathway","score_opus":0.028164773284773216,"score_gpt":0.3337088176855344,"score_spread":0.30554404440076116,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2540613192","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0007530202,0.9909684,0.00045217815,0.00007403677,0.0009962165,0.0034859183,0.00047481267,0.000076553006,0.0027188715],"genre_scores_gemma":[0.00023328826,0.98971057,0.0004505884,0.00030353453,0.0012252844,0.0021124186,0.0024054989,0.0001673709,0.003391421],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99661624,0.00053572597,0.000913229,0.0010510294,0.00012540157,0.00075836724],"domain_scores_gemma":[0.9976537,0.00024094836,0.0007962295,0.00087017304,0.00023214107,0.00020678276],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00043784516,0.0007244161,0.0020652332,0.00013875026,0.00011177474,0.000034302426,0.00065974455,0.0018404031,0.00006110517],"category_scores_gemma":[0.000213983,0.00049164065,0.0007975041,0.00014768816,0.00010870433,0.0000063590705,0.00014956143,0.00023733685,0.00015529025],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031355736,0.00010214195,0.0000036043382,0.0027655554,0.0004911676,0.00004459466,0.000019172816,2.8906393e-7,0.004647917,0.00011447895,0.009938022,0.9815595],"study_design_scores_gemma":[0.0033322342,0.0034469413,0.0000011759797,0.00270763,0.00025891722,0.0007181592,0.000009556439,7.0186127e-7,0.0011208737,0.000036297344,0.98776436,0.0006031745],"about_ca_topic_score_codex":0.0000066016814,"about_ca_topic_score_gemma":0.000015627398,"teacher_disagreement_score":0.9809563,"about_ca_system_score_codex":0.000190478,"about_ca_system_score_gemma":0.0012295922,"threshold_uncertainty_score":0.99975353},"labels":[],"label_agreement":null},{"id":"W2553199263","doi":"10.1002/ijc.30508","title":"<scp>G</scp>enetic variants of JNK and p38α pathways and risk of non‐small cell lung cancer in an <scp>E</scp>astern <scp>C</scp>hinese population","year":2016,"lang":"en","type":"article","venue":"International Journal of Cancer","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Ministry of Health, British Columbia; Fudan University","keywords":"Single-nucleotide polymorphism; Lung cancer; Genotype; Biology; Carcinogenesis; Cancer; Genetics; Oncology; Cart; Gene; Bioinformatics; Internal medicine; Cancer research; Medicine","score_opus":0.008559517738421405,"score_gpt":0.2594573567613309,"score_spread":0.2508978390229095,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2553199263","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99081856,0.0062665627,0.0012316729,0.000030090574,0.0007073983,0.00016229886,0.00034973878,0.0000034815403,0.00043018305],"genre_scores_gemma":[0.9917221,0.006643896,0.00039646297,0.000057285866,0.0005939477,0.000011218735,0.000019177976,0.00003262786,0.00052325864],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99820507,0.00011126706,0.00070587307,0.0003186646,0.0004008662,0.00025825243],"domain_scores_gemma":[0.9978668,0.00021253942,0.00097312964,0.00019108778,0.0005854355,0.0001709743],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036613183,0.0002398864,0.00036534484,0.00019261432,0.000031671418,0.000035091303,0.0003504762,0.00020059857,0.0000122572565],"category_scores_gemma":[0.00038630678,0.00018579904,0.000110229645,0.00008324423,0.00008454269,0.00005220405,0.00013594923,0.00016039447,6.9471383e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003060193,0.000090550435,0.504525,0.00005526222,0.00018743543,0.000017549848,0.0005830502,0.00041047545,0.48972806,0.000022769447,0.0003436517,0.0040055965],"study_design_scores_gemma":[0.003675869,0.00057785993,0.78570807,0.0004984308,0.00016394205,0.000063329215,0.00033532837,0.0010877681,0.20525181,0.00042359415,0.0021413933,0.00007260495],"about_ca_topic_score_codex":0.0005649309,"about_ca_topic_score_gemma":0.0010482797,"teacher_disagreement_score":0.28447625,"about_ca_system_score_codex":0.00006506291,"about_ca_system_score_gemma":0.00020666892,"threshold_uncertainty_score":0.7576665},"labels":[],"label_agreement":null},{"id":"W2560245514","doi":"10.1016/j.bmc.2016.11.034","title":"Studies of TAK1-centered polypharmacology with novel covalent TAK1 inhibitors","year":2016,"lang":"en","type":"article","venue":"Bioorganic & Medicinal Chemistry","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institute of General Medical Sciences; National Heart, Lung, and Blood Institute; National Cancer Institute; National Institutes of Health; Public Health Agency of Canada; Pediatric Low Grade Astrocytoma Foundation; Cancer Prevention and Research Institute of Texas","keywords":"Chemistry; Biotinylation; Kinase; Computational biology; Biochemistry; Biology","score_opus":0.02979926222147639,"score_gpt":0.27576516126940603,"score_spread":0.24596589904792965,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2560245514","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995288,0.0025833952,0.000524801,0.000611322,0.00030877264,0.00014697517,0.00008166575,0.000019234507,0.00043580064],"genre_scores_gemma":[0.9967452,0.00045612358,0.00015938656,0.00020634674,0.0007876003,0.000018298806,0.000039934937,0.000032976404,0.0015541179],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985821,0.000023485549,0.00035083143,0.0004520509,0.0002526061,0.0003389168],"domain_scores_gemma":[0.9990278,0.000027907405,0.00022249491,0.0003762982,0.00017761222,0.00016792046],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018080276,0.00025982183,0.0003250663,0.000025329213,0.000051587478,0.0000031495829,0.0002603003,0.00018620181,0.00015017032],"category_scores_gemma":[0.0001648448,0.00016366868,0.00007818403,0.00009365104,0.00043343895,0.000003208703,0.00015816085,0.000090127534,0.0000065959925],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003190173,0.0001379654,0.0025662798,0.00015386248,0.00024512268,0.000016891567,0.000054715547,1.2234197e-7,0.9904526,0.0000076253546,0.0054084947,0.000637304],"study_design_scores_gemma":[0.0026483187,0.0005342782,0.00069745694,0.00017259282,0.000089732646,0.00017234795,0.00034892117,4.2350302e-7,0.9820196,0.0000043432847,0.013094821,0.00021714706],"about_ca_topic_score_codex":0.0000064867027,"about_ca_topic_score_gemma":0.000004741882,"teacher_disagreement_score":0.0084329825,"about_ca_system_score_codex":0.000040231305,"about_ca_system_score_gemma":0.00020840559,"threshold_uncertainty_score":0.6674215},"labels":[],"label_agreement":null},{"id":"W2586486297","doi":"10.1016/j.critrevonc.2017.02.003","title":"Enzastaurin: A lesson in drug development","year":2017,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":54,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Canadian Cancer Society","keywords":"Medicine; Drug development; Drug; Clinical trial; Pharmacology; MAPK/ERK pathway; Oncology; Kinase; Internal medicine; Biology","score_opus":0.17130075587845123,"score_gpt":0.466556597083607,"score_spread":0.2952558412051558,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2586486297","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000051587045,0.98687357,0.000100084806,0.0001670166,0.0009176754,0.0014729727,0.000015134807,0.00001379138,0.010388176],"genre_scores_gemma":[0.00010266044,0.99426913,0.002460832,0.00027257783,0.00026004564,0.0016260745,0.00023824781,0.000073932526,0.00069650245],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9936832,0.0015069207,0.0022895883,0.001321094,0.00015148227,0.0010477229],"domain_scores_gemma":[0.9973873,0.0004438938,0.0005506818,0.0012930813,0.000069247144,0.00025581688],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0021620772,0.0007951297,0.0049118837,0.0003277453,0.00012165692,0.000031266838,0.0012142195,0.0017022493,0.00009362741],"category_scores_gemma":[0.0044786185,0.00067338615,0.0005437759,0.00016205951,0.00046943888,0.000007856973,0.00074801105,0.0010371865,0.00051390583],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000018327572,0.0003500547,0.00005137097,0.013031782,0.00003385931,0.00065498316,0.00006258023,2.0143446e-8,0.000008729504,0.008380668,0.004577222,0.9728304],"study_design_scores_gemma":[0.0004260929,0.00014770342,0.0000065342256,0.014408067,0.000093784314,0.0007824697,0.000014129262,4.025366e-7,0.000074947806,0.00020686234,0.9832155,0.00062351226],"about_ca_topic_score_codex":0.000013187131,"about_ca_topic_score_gemma":0.0007780526,"teacher_disagreement_score":0.9786383,"about_ca_system_score_codex":0.00026770946,"about_ca_system_score_gemma":0.0016533884,"threshold_uncertainty_score":0.99959373},"labels":[],"label_agreement":null},{"id":"W2586724626","doi":"10.1074/mcp.m116.065128","title":"Time-resolved Phosphoproteome Analysis of Paradoxical RAF Activation Reveals Novel Targets of ERK","year":2017,"lang":"en","type":"article","venue":"Molecular & Cellular Proteomics","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Université du Québec à Montréal; Institute for Research in Immunology and Cancer","funders":"Canadian Institutes of Health Research; Canada Research Chairs; Genome Canada","keywords":"Vemurafenib; Phosphoproteomics; MAPK/ERK pathway; Phosphorylation; Kinase; Actin cytoskeleton; Cell biology; Cancer research; V600E; Chemistry; Signal transduction; GTPase; Biology; Melanoma; Protein kinase A; Cell; Protein phosphorylation; Mutant; Cytoskeleton; Biochemistry","score_opus":0.011099547197506577,"score_gpt":0.23583559430668702,"score_spread":0.22473604710918044,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2586724626","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.87770265,0.00018422963,0.120779954,0.00007997814,0.00005486937,0.0006477988,0.00008464829,0.00000910235,0.0004567749],"genre_scores_gemma":[0.9873651,0.000017384818,0.01167563,0.000054061795,0.00007444213,0.000058549278,0.00035512273,0.000040662777,0.00035901828],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982126,0.00007601874,0.00055255636,0.00052384404,0.00031765306,0.00031736286],"domain_scores_gemma":[0.9974155,0.000010751757,0.0007517614,0.0014853306,0.00021755623,0.00011914496],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00044841316,0.00027977984,0.00060124934,0.00014842075,0.00014175718,0.00003250244,0.0006282663,0.00034352497,0.00004260164],"category_scores_gemma":[0.00033404483,0.0002757109,0.0004925196,0.00017472288,0.00024051977,0.00001100096,0.00027143382,0.0001364321,0.0000068016457],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020635551,0.00018830191,0.00073493976,0.000054385517,0.00079477765,0.000007643588,0.000040711144,0.0004668855,0.99698234,0.00026827055,0.00005669858,0.0001987165],"study_design_scores_gemma":[0.0007944171,0.00024683416,0.0019465322,0.000027975831,0.00037651364,0.0000018223857,0.000010796912,0.0016894068,0.9939447,0.00010946257,0.0005730763,0.0002784612],"about_ca_topic_score_codex":0.000064418244,"about_ca_topic_score_gemma":0.000003276484,"teacher_disagreement_score":0.10966248,"about_ca_system_score_codex":0.000018540779,"about_ca_system_score_gemma":0.000095347285,"threshold_uncertainty_score":0.9999695},"labels":[],"label_agreement":null},{"id":"W2588722468","doi":"10.1093/annonc/mdw379.17","title":"Impact of ipilimumab on metastatic melanoma: Evaluation using patient registry in Canada","year":2016,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta; Princess Margaret Cancer Centre; Sunnybrook Health Science Centre; Western University","funders":"","keywords":"Medicine; Ipilimumab; Internal medicine; Cohort; Metastatic melanoma; Disease registry; Melanoma; Clinical trial; Overall survival; Oncology; Cancer; Disease; Immunotherapy","score_opus":0.09076096803751592,"score_gpt":0.3757494754393978,"score_spread":0.28498850740188186,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588722468","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99775934,0.00021200196,0.000039058796,0.000113933216,0.000102123835,0.00015664879,0.00006930259,8.202296e-7,0.0015467956],"genre_scores_gemma":[0.9996756,0.000052741845,0.000113517075,0.0000836918,0.000024128723,0.000008827417,0.000020815492,0.0000074260906,0.000013273292],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99899125,0.00018633848,0.00031152053,0.0001757811,0.00015570782,0.00017938625],"domain_scores_gemma":[0.9992084,0.000051785555,0.0002631725,0.00024939654,0.0001781009,0.000049131748],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027852834,0.000094565694,0.00022935428,0.0000536538,0.000010613497,8.155115e-7,0.00009428737,0.00006740131,0.000050630802],"category_scores_gemma":[0.00023407587,0.00006574865,0.00007431544,0.000056680736,0.000041813768,0.0000027260598,0.00003431298,0.000033001026,8.5597924e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006276603,0.00027678764,0.022407658,0.000022584392,0.0001369757,0.000019127052,0.000055861365,0.0007112312,0.8613644,0.00006041072,0.00237545,0.11194183],"study_design_scores_gemma":[0.003530432,0.01333229,0.09391975,0.00011042952,0.00005733051,0.000043617332,0.00017172299,0.00035504138,0.884211,0.0004111439,0.0035635044,0.00029371947],"about_ca_topic_score_codex":0.12949482,"about_ca_topic_score_gemma":0.16186218,"teacher_disagreement_score":0.111648105,"about_ca_system_score_codex":0.00014097572,"about_ca_system_score_gemma":0.002524064,"threshold_uncertainty_score":0.87630194},"labels":[],"label_agreement":null},{"id":"W2589428111","doi":"10.1200/jco.2005.23.16_suppl.5566","title":"A phase II study of BAY 43–9006 in patients with recurrent and/or metastatic head and neck squamous cell carcinoma (HNSCC) and nasopharyngeal cancer (NPC)","year":2005,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Bayer (Canada)","funders":"","keywords":"Medicine; Head and neck squamous-cell carcinoma; Internal medicine; Oncology; Progressive disease; Cancer; KRAS; Head and neck cancer; Chemotherapy; Cancer research","score_opus":0.054887103285731785,"score_gpt":0.3927872439765381,"score_spread":0.3379001406908063,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2589428111","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974009,0.0018512543,0.0000058688597,0.0001738031,0.0001745002,0.0002902294,0.000017226683,9.548207e-7,0.00008531178],"genre_scores_gemma":[0.998506,0.00031133695,0.00069205865,0.00021733613,0.00020863194,0.0000074947043,0.0000042449105,0.000011049526,0.000041866744],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99807465,0.00028376654,0.0010735902,0.0002406266,0.00015166965,0.00017572544],"domain_scores_gemma":[0.9986043,0.00017350953,0.000739102,0.000117034935,0.00014923936,0.00021678886],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00065515854,0.0001452809,0.0007494103,0.0000680229,0.000036101734,0.0000056372774,0.00009045064,0.00013817931,0.000013487379],"category_scores_gemma":[0.00021667109,0.00009516155,0.00005612388,0.000053542066,0.000120131765,0.000011787722,0.000105181134,0.00028040833,1.6605911e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019814402,0.020388346,0.82613397,0.00008715585,0.0001561518,0.0001118426,0.0006429134,0.000014067348,0.0016426147,0.0000044135454,0.0004908031,0.1305133],"study_design_scores_gemma":[0.07044181,0.25501317,0.66619897,0.000035344434,0.00029433417,0.000044887234,0.0002541544,0.00006766581,0.00061376556,0.000010163767,0.0068431995,0.00018255567],"about_ca_topic_score_codex":0.000050560775,"about_ca_topic_score_gemma":0.0015095156,"teacher_disagreement_score":0.23462482,"about_ca_system_score_codex":0.000020994117,"about_ca_system_score_gemma":0.0003476191,"threshold_uncertainty_score":0.38805753},"labels":[],"label_agreement":null},{"id":"W2589762716","doi":"10.71781/29309","title":"Nouveaux modes de régulation des voies MAP kinase eucaryotes par phosphorylation","year":2008,"lang":"fr","type":"dissertation","venue":"Papyrus : Institutional Repository (Université de Montréal)","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; Canadian Institutes of Health Research","keywords":"Phosphorylation; Kinase; Cell biology; Biology","score_opus":0.005589219598864192,"score_gpt":0.17145392808000817,"score_spread":0.16586470848114399,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2589762716","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93604904,0.04866059,0.0020379848,0.000092356866,0.00086802576,0.00038971938,0.00012907262,0.000060385904,0.011712817],"genre_scores_gemma":[0.9566777,0.0033429533,0.0025968347,0.000065456996,0.00045692667,0.00003994277,0.0035169995,0.000054778895,0.033248443],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9975312,0.00018001396,0.00045782208,0.00078530714,0.00044055498,0.00060515053],"domain_scores_gemma":[0.99828964,0.000047614296,0.0004207568,0.00045596433,0.00043358773,0.00035240516],"candidate_categories":["metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.00015451349,0.0005872138,0.00039879853,0.00019832453,0.0064383782,0.000059772574,0.00034607013,0.00094589195,0.00003587352],"category_scores_gemma":[0.00008937811,0.0007184622,0.0004094495,0.00018617278,0.00052527763,0.00006900251,0.00014457843,0.00031431275,0.000044010285],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015455943,0.00037181698,0.0729046,0.00048574986,0.00051823776,0.0010964075,0.032947462,0.015808314,0.86339045,0.00480317,0.0010465294,0.0050816964],"study_design_scores_gemma":[0.0013695251,0.00042991276,0.14685342,0.0003697706,0.00044631035,0.000894939,0.0137145715,0.005515262,0.78043437,0.00059962686,0.048248492,0.0011237906],"about_ca_topic_score_codex":0.01667048,"about_ca_topic_score_gemma":0.0075059664,"teacher_disagreement_score":0.08295603,"about_ca_system_score_codex":0.0030611968,"about_ca_system_score_gemma":0.003116962,"threshold_uncertainty_score":0.9995266},"labels":[],"label_agreement":null},{"id":"W2592587564","doi":"10.3390/ijms18030585","title":"Strategies for Overcoming Resistance in Tumours Harboring BRAF Mutations","year":2017,"lang":"en","type":"review","venue":"International Journal of Molecular Sciences","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Nova Scotia Health Authority; Dalhousie University","funders":"","keywords":"Kinase; Acquired resistance; Targeted therapy; Cancer research; Melanoma; MAPK/ERK pathway; Effector; Cancer; Colorectal cancer; Medicine; Mutation; Drug resistance; Bioinformatics; Biology; Gene; Immunology; Internal medicine; Genetics","score_opus":0.07573742879583725,"score_gpt":0.3929465407020033,"score_spread":0.3172091119061661,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2592587564","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0018319279,0.9901847,0.0043879803,0.000074902186,0.0010188944,0.00016934666,0.00003552452,0.0000018889738,0.0022948377],"genre_scores_gemma":[0.024129683,0.9683471,0.0066884416,0.000043473774,0.0005492018,0.00002628997,0.00003322589,0.000022035167,0.00016056353],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99864805,0.00006370913,0.0005211508,0.00023920597,0.00036016217,0.0001677299],"domain_scores_gemma":[0.9986639,0.000046886213,0.0008519345,0.00015277647,0.00023607683,0.00004841951],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00068365695,0.00016609847,0.00040230723,0.00026842093,0.000091391994,0.00026405536,0.0012472629,0.00011355185,0.0000027541525],"category_scores_gemma":[0.00023501513,0.00013986544,0.00035031288,0.00006077217,0.00014709063,0.000030826184,0.00008946355,0.0001362547,9.617288e-7],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019412342,0.00034559346,0.00023650107,0.0031486298,0.0011573919,0.0015852016,0.0004655951,0.0008033856,0.018853879,0.05821348,0.0016973934,0.91329885],"study_design_scores_gemma":[0.00034041403,0.00014663902,0.000023153814,0.0034746027,0.00007622795,0.00015431363,0.00010423806,0.0000075635753,0.0008127725,0.001958671,0.9926735,0.00022791224],"about_ca_topic_score_codex":0.0000057682005,"about_ca_topic_score_gemma":0.00005640431,"teacher_disagreement_score":0.9909761,"about_ca_system_score_codex":0.000040487797,"about_ca_system_score_gemma":0.0011061218,"threshold_uncertainty_score":0.57035476},"labels":[],"label_agreement":null},{"id":"W2592846677","doi":"10.71781/32289","title":"Rôle physiologique de la MAP kinase atypique ERK3 : analyse génétique et étude de l'expression génique chez la souris","year":2007,"lang":"fr","type":"dissertation","venue":"Papyrus : Institutional Repository (Université de Montréal)","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; Medical Research Council; Canadian Institutes of Health Research; Medical Research Council Canada; Heart and Stroke Foundation of Canada","keywords":"Molecular biology; Philosophy; Biology","score_opus":0.003582079347832778,"score_gpt":0.20593475539936817,"score_spread":0.2023526760515354,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2592846677","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95924157,0.010060378,0.00961745,0.00016049539,0.00039691245,0.00042826423,0.00012903225,0.000080532795,0.019885385],"genre_scores_gemma":[0.9759523,0.0024622665,0.0050483905,0.00031617106,0.00044902516,0.00006918101,0.0021603631,0.00007303835,0.013469256],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9958513,0.0015101839,0.0005096155,0.0009884423,0.00036146998,0.0007789893],"domain_scores_gemma":[0.9977403,0.00023314978,0.00053341023,0.0006174133,0.00030029874,0.0005754201],"candidate_categories":["metaepi_narrow","sts","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0011400804,0.0007144077,0.0005495684,0.00027375662,0.0023067333,0.00007895576,0.00060502,0.0024714174,0.00004432956],"category_scores_gemma":[0.00020932335,0.0008148847,0.00060954265,0.00021729678,0.00045284745,0.000045337794,0.00030979316,0.0010882658,0.000020079557],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015237841,0.00048098288,0.01678711,0.00032655365,0.00038131545,0.0033451288,0.008096128,0.003591995,0.95639956,0.0071118535,0.0011584763,0.0007971337],"study_design_scores_gemma":[0.0011163921,0.00031451197,0.04301189,0.0004499982,0.00030633042,0.0010355944,0.0083427075,0.000609398,0.89925313,0.0004728922,0.044192296,0.0008948729],"about_ca_topic_score_codex":0.014031268,"about_ca_topic_score_gemma":0.006609801,"teacher_disagreement_score":0.057146423,"about_ca_system_score_codex":0.0021857475,"about_ca_system_score_gemma":0.0038723776,"threshold_uncertainty_score":0.9994302},"labels":[],"label_agreement":null},{"id":"W2594529508","doi":"10.1016/s1470-2045(17)30180-8","title":"Binimetinib versus dacarbazine in patients with advanced NRAS-mutant melanoma (NEMO): a multicentre, open-label, randomised, phase 3 trial","year":2017,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":491,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Dacarbazine; Medicine; Neuroblastoma RAS viral oncogene homolog; Hazard ratio; Melanoma; Internal medicine; Clinical endpoint; Population; Adverse effect; Oncology; Progression-free survival; Randomized controlled trial; Vemurafenib; Cancer; Confidence interval; Chemotherapy; Metastatic melanoma; Cancer research; Colorectal cancer","score_opus":0.05756250214883237,"score_gpt":0.3665577832550817,"score_spread":0.30899528110624935,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2594529508","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9826784,0.00012876837,0.000021809992,0.00052769243,0.0009830422,0.0021465197,0.00007460718,0.000012372542,0.013426766],"genre_scores_gemma":[0.9974016,0.00014673085,0.000793519,0.0003195207,0.00063837506,0.00026416662,0.00019610162,0.000030318266,0.00020968956],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9981857,0.00033407993,0.00034605662,0.000476838,0.00015035163,0.00050699146],"domain_scores_gemma":[0.9981112,0.00012487055,0.00041527534,0.0011605998,0.000085068365,0.000103014376],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00069734885,0.00024678957,0.00063579436,0.000033616565,0.00026037375,0.0000720822,0.0012516886,0.00020074655,0.000046228626],"category_scores_gemma":[0.00057658675,0.00016084609,0.00004649681,0.000052565007,0.00020600152,0.000016208982,0.0004937221,0.0002162379,0.000025963973],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9413875,0.0017882733,0.0025046552,0.000012705067,0.00016538399,0.000037572514,0.00010189913,0.0000060338884,0.03283108,0.0001461193,0.0011645388,0.01985425],"study_design_scores_gemma":[0.89130294,0.013356244,0.0029745344,0.00001950546,0.000071828734,0.000003948862,0.000038682945,0.000037227255,0.007827321,0.000021356254,0.084079355,0.00026705253],"about_ca_topic_score_codex":0.000045433368,"about_ca_topic_score_gemma":0.00043202387,"teacher_disagreement_score":0.082914814,"about_ca_system_score_codex":0.000046626126,"about_ca_system_score_gemma":0.00020772261,"threshold_uncertainty_score":0.6559113},"labels":[],"label_agreement":null},{"id":"W2595795225","doi":"10.7150/thno.18238","title":"Design and Development of Fluorescent Vemurafenib Analogs for <i>In Vivo</i> Imaging","year":2017,"lang":"en","type":"article","venue":"Theranostics","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institute of Biomedical Imaging and Bioengineering; National Cancer Institute; National Heart, Lung, and Blood Institute; National Institute of General Medical Sciences; Natural Sciences and Engineering Research Council of Canada; Austrian Science Fund","keywords":"Vemurafenib; In vivo; Fluorescence; Chemistry; Nanotechnology; Biomedical engineering; Biophysics; Medicine; Materials science; Biology; Internal medicine; Biotechnology; Physics; Cancer; Optics","score_opus":0.024428557461649934,"score_gpt":0.2605637515785838,"score_spread":0.23613519411693387,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2595795225","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.82167435,0.0006187733,0.17696045,0.000063662024,0.00013916728,0.00035690574,0.000011883508,0.000010662655,0.00016416666],"genre_scores_gemma":[0.9688921,0.0000752344,0.030854885,0.000056057852,0.00004583338,0.0000139267395,0.000008506167,0.000021866663,0.000031591408],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9995268,0.000015639049,0.00013860411,0.00014028868,0.000045356635,0.00013329058],"domain_scores_gemma":[0.9996085,0.000019301271,0.0000777446,0.0002253238,0.000037414513,0.00003170372],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017224907,0.00008023219,0.0001016761,0.000017523302,0.00006533889,0.000015204924,0.0001306632,0.00004166607,0.0000011899276],"category_scores_gemma":[0.000060464186,0.00007372269,0.000017188222,0.0000066480507,0.0000558611,0.0000019687543,0.00005283559,0.000022299902,2.6633506e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010706007,0.000028180164,0.0038931912,0.000027079821,0.000013971847,0.0000016689488,0.00016713017,0.000013859869,0.98558855,0.000103995815,0.00021156047,0.009843745],"study_design_scores_gemma":[0.0008486846,0.000073793315,0.0038153187,0.000022822916,0.000007222399,0.0000024253386,0.000025566686,0.00026653416,0.9830858,0.00013282771,0.011612408,0.000106576255],"about_ca_topic_score_codex":0.000004939223,"about_ca_topic_score_gemma":0.000011547568,"teacher_disagreement_score":0.14721778,"about_ca_system_score_codex":0.0000047410795,"about_ca_system_score_gemma":0.000060902097,"threshold_uncertainty_score":0.3006324},"labels":[],"label_agreement":null},{"id":"W2597369162","doi":"10.1200/jco.2013.31.15_suppl.9046","title":"Open-label, multicenter safety study of vemurafenib in patients with <i>BRAF<sup>V600</sup></i> mutation–positive metastatic melanoma.","year":2013,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Medicine; Vemurafenib; Rash; Internal medicine; Adverse effect; Metastatic melanoma; Population; Melanoma; Oncology; Surgery; Gastroenterology; Cancer; Cancer research","score_opus":0.05019999233793844,"score_gpt":0.37571206789341166,"score_spread":0.32551207555547323,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2597369162","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973546,0.0000651768,0.00011134613,0.00023895761,0.00022888469,0.0009764396,0.000017718628,0.0000016796272,0.0010051938],"genre_scores_gemma":[0.9958709,0.000029922605,0.0031509215,0.00062779296,0.0001383563,0.000020969588,0.000032194264,0.000020576372,0.00010837651],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9960971,0.0009445378,0.002126321,0.00029769534,0.000289995,0.00024436467],"domain_scores_gemma":[0.99671817,0.00047836278,0.0015989229,0.00026951692,0.0007266013,0.000208434],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013697554,0.00018857158,0.0010380911,0.00008968043,0.000039692393,0.00002104863,0.00051471405,0.0002029685,0.00006728877],"category_scores_gemma":[0.000774519,0.00013089398,0.000105664134,0.00012028784,0.000131337,0.000041166146,0.00023444681,0.00039832256,0.000013994663],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018599605,0.042057462,0.8698488,0.000044867767,0.0019194977,0.00034322715,0.0015322323,0.0007141401,0.0020808019,0.000060959235,0.0020168999,0.060781535],"study_design_scores_gemma":[0.060257792,0.080819175,0.8525517,0.00007066781,0.00028616533,0.000033799763,0.0011909152,0.00015641536,0.0007510906,0.000061792314,0.00355413,0.00026637514],"about_ca_topic_score_codex":0.0001013796,"about_ca_topic_score_gemma":0.00017292847,"teacher_disagreement_score":0.060515158,"about_ca_system_score_codex":0.00003785978,"about_ca_system_score_gemma":0.00045085658,"threshold_uncertainty_score":0.5337702},"labels":[],"label_agreement":null},{"id":"W2598875489","doi":"10.1200/jco.2009.27.15_suppl.9054","title":"Long-term survival of patients with metastatic melanoma (MM) treated with dacarbazine (DTIC) or temozolomide (TMZ)","year":2009,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Dacarbazine; Medicine; Temozolomide; Internal medicine; Chemotherapy; Melanoma; Oncology; Cancer; Surgery; Gastroenterology; Cancer research","score_opus":0.06095066757354006,"score_gpt":0.3711432739701306,"score_spread":0.3101926063965905,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2598875489","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99741846,0.00015774414,0.0005618559,0.00023172484,0.00022627779,0.00020332902,0.000020116706,0.0000042220568,0.0011762821],"genre_scores_gemma":[0.99610156,0.00014464303,0.0026652117,0.00037791277,0.0003348356,0.0000020549908,0.00005051841,0.000019831565,0.00030343528],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99713445,0.00042438,0.0015738736,0.0002654092,0.00032589037,0.00027598222],"domain_scores_gemma":[0.9967755,0.00032490943,0.0017488308,0.00030227358,0.00056628475,0.00028218774],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009727804,0.0002236046,0.0012348798,0.00007811335,0.00003233045,0.000008216295,0.0002989614,0.00027148364,0.00006370084],"category_scores_gemma":[0.0007031809,0.00012210768,0.00023283307,0.0001293998,0.0002064309,0.000012556053,0.000040302246,0.0003335893,0.00000347409],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.033668056,0.003581771,0.9122835,0.00003974505,0.0011267761,0.00075630995,0.000027175267,0.000030911313,0.0073133814,0.00005543023,0.0006906823,0.040426277],"study_design_scores_gemma":[0.012397885,0.08290789,0.8944136,0.000058783222,0.00049314287,0.00016047293,0.000022496119,0.0000044052294,0.0056850603,0.000025232648,0.0036251706,0.00020586916],"about_ca_topic_score_codex":0.0000044808853,"about_ca_topic_score_gemma":0.00009896835,"teacher_disagreement_score":0.07932612,"about_ca_system_score_codex":0.000024262145,"about_ca_system_score_gemma":0.00077600946,"threshold_uncertainty_score":0.4979407},"labels":[],"label_agreement":null},{"id":"W2602599927","doi":"10.1200/jco.2013.31.15_suppl.e20045","title":"Outcome and prognostic factors in BRAF mutation positive metastatic melanoma treated with a BRAF inhibitor: A population-based study in British Columbia.","year":2013,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"SKiN Health; University of British Columbia; BC Cancer Agency","funders":"","keywords":"Vemurafenib; Medicine; Internal medicine; Melanoma; Oncology; Metastatic melanoma; Asymptomatic; Population; V600E; Clinical trial; Mutation; Gastroenterology; Cancer; Cancer research","score_opus":0.04258170396466641,"score_gpt":0.35631837989130954,"score_spread":0.3137366759266431,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2602599927","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9989522,0.00006279376,0.000040114894,0.000103216684,0.00010574021,0.00068591814,0.000008849307,0.0000031529282,0.00003801839],"genre_scores_gemma":[0.9990265,0.000006001453,0.0005808455,0.00018947992,0.00008002373,0.000025236672,0.000035716803,0.000015032032,0.000041162126],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997287,0.0006708163,0.0014447568,0.0002464047,0.00016458688,0.00018646542],"domain_scores_gemma":[0.99825555,0.0005953613,0.00070898276,0.00009622574,0.00019023207,0.00015364689],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008688092,0.00011321587,0.0007304592,0.000088916015,0.000029463848,0.000056371246,0.00009116936,0.0001970764,0.000024266132],"category_scores_gemma":[0.0014343379,0.00011296226,0.00009253554,0.00012960583,0.000059692535,0.000020929827,0.000027910848,0.00031033187,0.0000012683915],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021979207,0.0014101936,0.9920686,0.000011128343,0.0000794371,0.0005213223,0.00005148997,0.000039884988,0.00038750266,5.819799e-7,0.000036302434,0.0051737837],"study_design_scores_gemma":[0.00647915,0.016106887,0.976417,0.00004824185,0.00007820079,0.000120346725,0.0004169938,0.0000874418,0.00006347957,0.000034973265,0.000022722192,0.00012457278],"about_ca_topic_score_codex":0.007867989,"about_ca_topic_score_gemma":0.13363339,"teacher_disagreement_score":0.1257654,"about_ca_system_score_codex":0.000049149523,"about_ca_system_score_gemma":0.0003418556,"threshold_uncertainty_score":0.9987387},"labels":[],"label_agreement":null},{"id":"W2602918057","doi":"10.1200/jco.2013.31.15_suppl.9029","title":"Preliminary results from a phase Ib/II, open-label, dose-escalation study of the oral BRAF inhibitor LGX818 in combination with the oral MEK1/2 inhibitor MEK162 in <i>BRAF</i> V600-dependent advanced solid tumors.","year":2013,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Medicine; MEK inhibitor; Internal medicine; Nausea; Adverse effect; Melanoma; Oncology; Cancer; Gastroenterology; Colorectal cancer; Pharmacology; Cancer research; MAPK/ERK pathway; Kinase","score_opus":0.06499674081682533,"score_gpt":0.39974818246612964,"score_spread":0.3347514416493043,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2602918057","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99479073,0.0001108936,0.00003727478,0.0026770309,0.0007273452,0.0013396593,0.00002546452,0.0000033793483,0.0002882372],"genre_scores_gemma":[0.9982183,0.000044683315,0.000546595,0.0005821531,0.00036501364,0.000052308907,0.00002945968,0.00002258144,0.0001388996],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99490947,0.0014363647,0.0025314612,0.00040783774,0.00043618534,0.00027871496],"domain_scores_gemma":[0.9961171,0.0005471774,0.0023359358,0.00046031206,0.00039798857,0.00014145041],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029694855,0.00022833103,0.000979416,0.000084254796,0.00009491513,0.000033473712,0.00076765823,0.0003774472,0.00001734058],"category_scores_gemma":[0.0014704579,0.00012963997,0.00011592057,0.00022700733,0.00019896269,0.00006721203,0.00054159935,0.00080803887,0.0000029815396],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.12911075,0.10262068,0.056710735,0.00004735726,0.0007520793,0.0005155971,0.004339742,0.00159691,0.46740773,0.000094100775,0.015271024,0.22153327],"study_design_scores_gemma":[0.2772828,0.29427427,0.34751052,0.0004931377,0.00036068208,0.00017273873,0.004520745,0.0013152399,0.062757865,0.00095945573,0.009577157,0.00077536487],"about_ca_topic_score_codex":0.00031058388,"about_ca_topic_score_gemma":0.0023126039,"teacher_disagreement_score":0.40464988,"about_ca_system_score_codex":0.00007156323,"about_ca_system_score_gemma":0.0006965295,"threshold_uncertainty_score":0.5286564},"labels":[],"label_agreement":null},{"id":"W2610260729","doi":"10.1016/j.semcancer.2017.04.016","title":"Defining the role of the RSK isoforms in cancer","year":2017,"lang":"en","type":"review","venue":"Seminars in Cancer Biology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":126,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Institute for Research in Immunology and Cancer","funders":"Canadian Cancer Society Research Institute; Canadian Institutes of Health Research; Cancer Research Society","keywords":"Ribosomal s6 kinase; Kinase; Gene isoform; Biology; MAPK/ERK pathway; Carcinogenesis; Cancer research; Function (biology); Protein kinase A; Cell biology; Cancer; Prostate cancer; Signal transduction; Biochemistry; Genetics; Protein kinase B; Gene; P70-S6 Kinase 1","score_opus":0.03400841041748916,"score_gpt":0.36499854027678286,"score_spread":0.3309901298592937,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2610260729","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.001924543,0.9933273,8.881087e-7,0.000056717745,0.000846449,0.00046028942,0.00026568616,0.0000025706308,0.003115509],"genre_scores_gemma":[0.004233617,0.9940097,0.000018291388,0.00007935272,0.00024973467,0.00055145065,0.00008845713,0.000031104482,0.0007383032],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9983911,0.00020214186,0.000488719,0.00045637606,0.00006932273,0.00039233928],"domain_scores_gemma":[0.99844205,0.000054341588,0.00054509065,0.0008988572,0.00003056655,0.00002911608],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039009776,0.0003067749,0.00082697225,0.00006903982,0.000087490596,0.000008843884,0.0011328517,0.0006522752,0.000040484887],"category_scores_gemma":[0.00011252797,0.00016165333,0.00028200605,0.00012944578,0.00031816476,0.000002084756,0.00047356187,0.00040624768,0.0000046840205],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000012868543,0.000020886722,0.0059582386,0.0005515472,0.00005833117,0.0000014020411,0.000064908745,0.0000033167898,0.0005872247,0.0004171649,0.0006242005,0.99169993],"study_design_scores_gemma":[0.0001441016,0.00008215438,0.00017449551,0.0034362045,0.00006395549,0.000012064972,0.000036925605,0.0000018549953,0.001414208,0.00022605371,0.99420244,0.00020553144],"about_ca_topic_score_codex":0.0014500666,"about_ca_topic_score_gemma":0.0047813877,"teacher_disagreement_score":0.99357826,"about_ca_system_score_codex":0.000082387836,"about_ca_system_score_gemma":0.0007401643,"threshold_uncertainty_score":0.6592031},"labels":[],"label_agreement":null},{"id":"W2610788188","doi":"10.7554/elife.26947","title":"Size uniformity of animal cells is actively maintained by a p38 MAPK-dependent regulation of G1-length","year":2018,"lang":"en","type":"article","venue":"eLife","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":80,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"National Institute of General Medical Sciences; Canadian Institutes of Health Research","keywords":"Cell biology; Cell cycle; Cell size; Cell cycle progression; Cell; Small molecule; Biology; MAPK/ERK pathway; p38 mitogen-activated protein kinases; Biophysics; Chemistry; Signal transduction; Genetics","score_opus":0.007206563809472791,"score_gpt":0.22904273750929793,"score_spread":0.22183617369982514,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2610788188","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957273,0.00006153521,0.00070880156,0.00005436246,0.00008665378,0.00013572787,0.00015749034,0.0000067394726,0.003061392],"genre_scores_gemma":[0.99777055,0.00003173373,0.00075996306,0.00013294654,0.00016458113,0.000003928892,0.000036250618,0.000013036378,0.0010870106],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991757,0.000039684386,0.00022754731,0.00021750142,0.00018136085,0.0001581673],"domain_scores_gemma":[0.9993136,0.000013467187,0.00017453183,0.00027278575,0.00016519052,0.000060406735],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017113176,0.00011019149,0.00015322123,0.000020528658,0.00003367034,0.00000414327,0.00013300864,0.00013681366,0.00014709569],"category_scores_gemma":[0.00005374168,0.00010376681,0.000069604896,0.000048837002,0.000093955576,0.0000042055326,0.00008278485,0.00004275263,0.000013705402],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031967094,0.00007186853,0.000723993,0.000021220936,0.000036818597,4.1860434e-7,0.00008992283,4.7228932e-7,0.9906264,0.00015695416,0.00763059,0.00032167014],"study_design_scores_gemma":[0.00049603876,0.00096794864,0.011361074,0.000008622264,0.000014598111,0.0000023801617,0.00007421186,0.00003580286,0.9771184,0.000046113797,0.009769934,0.00010492464],"about_ca_topic_score_codex":0.00004178498,"about_ca_topic_score_gemma":0.0000123636855,"teacher_disagreement_score":0.013508049,"about_ca_system_score_codex":0.000011751593,"about_ca_system_score_gemma":0.0000666003,"threshold_uncertainty_score":0.42314878},"labels":[],"label_agreement":null},{"id":"W2612095536","doi":"10.1016/j.ejca.2017.04.007","title":"Open-label, multicentre safety study of vemurafenib in 3219 patients with BRAF V600 mutation-positive metastatic melanoma: 2-year follow-up data and long-term responders' analysis","year":2017,"lang":"en","type":"article","venue":"European Journal of Cancer","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":36,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Vemurafenib; Medicine; Adverse effect; Internal medicine; Melanoma; Population; Metastatic melanoma; Clinical trial; Oncology; Dermatology; Surgery; Gastroenterology; Cancer; Cancer research","score_opus":0.03186342165667164,"score_gpt":0.3152514821229644,"score_spread":0.2833880604662927,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2612095536","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99838495,0.00045618555,0.00021191304,0.000044266057,0.000113161135,0.00031118593,0.00017230856,9.62709e-7,0.00030504094],"genre_scores_gemma":[0.99910945,0.00011517111,0.00035823983,0.000028654491,0.000050002745,0.0000014996253,0.000101045516,0.000021681171,0.0002142693],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99844015,0.0004197918,0.00045125905,0.00029847433,0.00024142361,0.00014892894],"domain_scores_gemma":[0.99816024,0.000026592486,0.0007957916,0.00063656515,0.00028245646,0.00009834249],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00061542314,0.00014972397,0.00034934233,0.00011433764,0.0001168594,0.00009296769,0.00085677055,0.000019098687,0.000023227149],"category_scores_gemma":[0.00013027871,0.00011529119,0.000034196004,0.000097947915,0.00006840123,0.000054604014,0.00046882403,0.00011207045,0.0000010272836],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0049735247,0.0007747278,0.9769205,0.000025344867,0.0022360454,0.0003649953,0.0015623516,0.000065085784,0.0035692102,0.0000025816921,0.00008872915,0.009416889],"study_design_scores_gemma":[0.01773556,0.001905572,0.97769856,0.00008292719,0.00089188607,0.000006674157,0.00049055764,0.000023904526,0.00089501723,6.986343e-7,0.000118795564,0.00014983193],"about_ca_topic_score_codex":0.000057873203,"about_ca_topic_score_gemma":0.001769566,"teacher_disagreement_score":0.012762035,"about_ca_system_score_codex":0.00001839758,"about_ca_system_score_gemma":0.00009886176,"threshold_uncertainty_score":0.47014382},"labels":[],"label_agreement":null},{"id":"W2620067227","doi":"10.18632/oncotarget.18264","title":"The p38 pathway, a major pleiotropic cascade that transduces stress and metastatic signals in endothelial cells","year":2017,"lang":"en","type":"review","venue":"Oncotarget","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":197,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier de l'Université Laval","funders":"","keywords":"Cell biology; Angiogenesis; Biology; p38 mitogen-activated protein kinases; Signal transduction; Inflammation; Endothelial stem cell; MAPK/ERK pathway; Protein kinase A; Homeostasis; Kinase; Cancer research; Immunology; Genetics","score_opus":0.05936227944713657,"score_gpt":0.32146177999053877,"score_spread":0.2620995005434022,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2620067227","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0044558635,0.99226207,0.000027234528,0.000031406842,0.00044444125,0.0008030658,0.0012105176,0.000008543091,0.0007568805],"genre_scores_gemma":[0.0022376792,0.9945219,0.00014649586,0.000033431294,0.0003859476,0.00019086464,0.0002973223,0.000063325795,0.0021230383],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979036,0.00034734127,0.00046574418,0.0006055077,0.00019729036,0.00048054592],"domain_scores_gemma":[0.99864644,0.000111343834,0.00037614047,0.0007103856,0.000023848314,0.00013183703],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003638738,0.000491315,0.0010524775,0.00006786226,0.00023360799,0.00014784066,0.0006396199,0.00031758615,0.000024693618],"category_scores_gemma":[0.000054361044,0.00031486034,0.00034935153,0.00004193391,0.0001689777,0.000006280403,0.00014404168,0.00030401352,0.000021400827],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000117669195,0.00029822416,0.00021122703,0.015622085,0.0011007555,0.0005137366,0.000343738,0.00000332546,0.019191856,0.00025148477,0.0032386254,0.9591073],"study_design_scores_gemma":[0.0004357461,0.00016860306,0.000015439562,0.0011720512,0.00020696227,0.000039536742,0.000030642143,0.0000016549278,0.009229593,0.000052164614,0.98827803,0.0003695462],"about_ca_topic_score_codex":0.00009668254,"about_ca_topic_score_gemma":0.0005771,"teacher_disagreement_score":0.9850394,"about_ca_system_score_codex":0.000021683125,"about_ca_system_score_gemma":0.00035283843,"threshold_uncertainty_score":0.9999303},"labels":[],"label_agreement":null},{"id":"W2620651944","doi":"10.1016/s1470-2045(17)30429-1","title":"Dabrafenib plus trametinib in patients with BRAFV600-mutant melanoma brain metastases (COMBI-MB): a multicentre, multicohort, open-label, phase 2 trial","year":2017,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":775,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute; Bristol-Myers Squibb","keywords":"Dabrafenib; Trametinib; Medicine; Melanoma; Asymptomatic; Clinical endpoint; Oncology; MEK inhibitor; Internal medicine; Brain metastasis; Phases of clinical research; Clinical trial; Metastatic melanoma; Cancer; Metastasis; Vemurafenib; Cancer research; Biology; MAPK/ERK pathway","score_opus":0.06803476530507808,"score_gpt":0.3693754023310494,"score_spread":0.3013406370259713,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2620651944","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9921213,0.0000980471,0.000097396594,0.0016723595,0.0005507236,0.0022552793,0.00025161938,0.000019135885,0.0029341732],"genre_scores_gemma":[0.99562854,0.000043542317,0.0014559528,0.0012678724,0.000546632,0.0002453519,0.00034632007,0.00004430251,0.00042149078],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9973586,0.0006460969,0.00046082947,0.0006459358,0.00020790496,0.00068059727],"domain_scores_gemma":[0.9976071,0.00017089462,0.00049035205,0.0014924972,0.0000873243,0.00015180388],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010757813,0.0003349062,0.00081946276,0.000051713367,0.0003483401,0.00015614748,0.0016811994,0.0002517022,0.000065115615],"category_scores_gemma":[0.0007101872,0.00022113953,0.000065203385,0.00006675661,0.00033418866,0.000025304776,0.0006534105,0.0002996603,0.000024967418],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.690795,0.023356315,0.035740267,0.00015633204,0.0016391957,0.0007052405,0.0018158405,0.00008625597,0.12515377,0.0020004131,0.03676676,0.081784606],"study_design_scores_gemma":[0.7498624,0.017876778,0.017721744,0.000054586762,0.00022056648,0.000033651646,0.00015916154,0.0003824114,0.017977215,0.00016198092,0.19475456,0.0007949995],"about_ca_topic_score_codex":0.00028960968,"about_ca_topic_score_gemma":0.0016609972,"teacher_disagreement_score":0.1579878,"about_ca_system_score_codex":0.000071233015,"about_ca_system_score_gemma":0.00033073843,"threshold_uncertainty_score":0.90178084},"labels":[],"label_agreement":null},{"id":"W263438489","doi":"10.1016/j.bbcan.2015.05.001","title":"Tracing the footprints of the breast cancer oncogene BRK — Past till present","year":2015,"lang":"en","type":"review","venue":"Biochimica et Biophysica Acta (BBA) - Reviews on Cancer","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":38,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"","keywords":"Kinase; Carcinogenesis; Biology; Receptor tyrosine kinase; Cancer research; Tyrosine kinase; Breast cancer; Cancer; Metastasis; Oncogene; Signal transduction; Cell biology; Genetics; Cell cycle","score_opus":0.07008028108793904,"score_gpt":0.35974380642426834,"score_spread":0.28966352533632933,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W263438489","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0049235327,0.9873911,0.0000025055026,0.0010154606,0.0011127228,0.0026904931,0.0017471957,0.000016513772,0.0011004509],"genre_scores_gemma":[0.0035766184,0.9907038,0.000020877005,0.00055239286,0.0025696715,0.0012506946,0.00016705954,0.00013574763,0.0010231322],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9957616,0.00089923164,0.0011566344,0.0010706354,0.000542657,0.0005692729],"domain_scores_gemma":[0.99567086,0.000063765765,0.0016416098,0.0021691094,0.00025108713,0.00020354317],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00066321087,0.00095152424,0.0020543465,0.0000662092,0.00016622989,0.000055568526,0.001713578,0.00048002513,0.00006404058],"category_scores_gemma":[0.000068130415,0.0004853253,0.0014587209,0.00053781347,0.0002921906,0.000007944588,0.0006139467,0.00058943895,0.00004494345],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008794716,0.00031959033,0.000002329714,0.009059707,0.0008237567,0.0000018468716,0.00010710383,0.000004137081,0.048292667,0.000046841436,0.06261736,0.8786367],"study_design_scores_gemma":[0.00020033552,0.00012493216,0.00005139435,0.010951126,0.00091548014,0.000025403207,0.000006250824,0.0000012666665,0.031812377,0.0000060908965,0.9553406,0.00056473084],"about_ca_topic_score_codex":0.00013362218,"about_ca_topic_score_gemma":0.00007539177,"teacher_disagreement_score":0.89272326,"about_ca_system_score_codex":0.00016559882,"about_ca_system_score_gemma":0.0011533451,"threshold_uncertainty_score":0.99975985},"labels":[],"label_agreement":null},{"id":"W2725132187","doi":"10.1161/res.109.suppl_1.ap188","title":"Abstract P188: Suppression of MK2 Signaling Protects Against Pressure Overload-Induced Cardiac Dysfunction","year":2011,"lang":"en","type":"article","venue":"Circulation Research","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Heart Institute","funders":"","keywords":"Pressure overload; Internal medicine; Medicine; p38 mitogen-activated protein kinases; Endocrinology; Diastole; Ventricular remodeling; Blood pressure; Heart failure; Chemistry; Kinase; Cardiology; MAPK/ERK pathway; Biochemistry","score_opus":0.09826054560905076,"score_gpt":0.31573047476317734,"score_spread":0.21746992915412658,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2725132187","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9892726,0.0002459848,0.00030845567,0.000010509755,0.00019530025,0.0005968122,0.000016043672,0.00001600018,0.009338308],"genre_scores_gemma":[0.99926937,0.000024015151,0.000097469616,0.000008193495,0.00021756154,0.00006516289,0.00012174466,0.000022060809,0.00017440873],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984849,0.00019731901,0.00023997796,0.00035425668,0.00043634107,0.00028720152],"domain_scores_gemma":[0.998968,0.000024777059,0.000098943216,0.00042294126,0.00038819938,0.000097142714],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00080186984,0.00011449733,0.00014296928,0.000119223594,0.00013693658,0.000019129722,0.00015821443,0.00025145258,0.000099464494],"category_scores_gemma":[0.00020517825,0.00010935385,0.000096733085,0.00016102394,0.00005450521,0.000012955112,0.000089674286,0.00021434543,0.00002100039],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012170024,0.000066413304,0.0062881843,0.00011250932,0.000047103695,0.000002238684,0.00016840037,0.00024569573,0.98948413,0.00007760823,0.0003606345,0.0030253876],"study_design_scores_gemma":[0.0002972309,0.00015835755,0.10396075,0.00004803511,0.000007453928,7.825766e-7,0.00009584765,0.00020868007,0.8936171,0.00011201522,0.0013766101,0.00011712588],"about_ca_topic_score_codex":0.000121960846,"about_ca_topic_score_gemma":0.0000032687572,"teacher_disagreement_score":0.09767257,"about_ca_system_score_codex":0.00001434286,"about_ca_system_score_gemma":0.0001254028,"threshold_uncertainty_score":0.44593206},"labels":[],"label_agreement":null},{"id":"W2727112076","doi":"10.1200/jco.2017.35.15_suppl.e21060","title":"Non-classical BRAF melanoma: A retrospective review of disease characteristics and prognostic implications.","year":2017,"lang":"en","type":"review","venue":"Journal of Clinical Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; V600E; Melanoma; Retrospective cohort study; Internal medicine; Oncology; Cohort; Cancer; Disease; Mutation; Vemurafenib; Cancer research; Metastatic melanoma; Gene; Genetics; Biology","score_opus":0.14645723722527285,"score_gpt":0.4762306594476197,"score_spread":0.32977342222234685,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2727112076","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005741425,0.9963941,0.00006176167,0.0005537165,0.00075650495,0.00058928295,0.00014780858,0.0000020214507,0.0009206661],"genre_scores_gemma":[0.0013660627,0.9957562,0.00035531516,0.0002967907,0.0018459877,0.000031550506,0.00010514131,0.000031662763,0.00021127702],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9954617,0.0004866084,0.003252178,0.000389906,0.0001987819,0.00021082004],"domain_scores_gemma":[0.9906515,0.00048982084,0.007113685,0.00065044867,0.0006032386,0.00049131346],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0023077712,0.0003029666,0.004257192,0.00007050137,0.000059677233,0.000014564027,0.0005690072,0.0007569549,0.000017977627],"category_scores_gemma":[0.011848491,0.00021188267,0.0012418098,0.00005516187,0.00041158986,0.000007255808,0.00026336763,0.0007946471,0.000007125048],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015676937,0.0005307595,0.0033437526,0.02130088,0.0005033155,0.000102146914,0.0000020969017,2.9373552e-9,0.000008687998,0.00013265689,0.0074817785,0.96643716],"study_design_scores_gemma":[0.00058099104,0.0037882242,0.02679977,0.019243866,0.002239633,0.0002555138,6.7973326e-7,3.787091e-7,0.0000010538515,0.00008073831,0.94681776,0.00019136627],"about_ca_topic_score_codex":8.410105e-7,"about_ca_topic_score_gemma":0.0000018852584,"teacher_disagreement_score":0.9662458,"about_ca_system_score_codex":0.000041779414,"about_ca_system_score_gemma":0.0036440492,"threshold_uncertainty_score":0.9964751},"labels":[],"label_agreement":null},{"id":"W2731399710","doi":"10.1038/s41598-017-05482-y","title":"GLYAT regulates JNK-mediated cell death in Drosophila","year":2017,"lang":"en","type":"article","venue":"Scientific Reports","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute of Genetics; National Natural Science Foundation of China; Natural Science Foundation of Shanghai","keywords":"Cell biology; Programmed cell death; Kinase; Ectopic expression; Biology; Signal transduction; Cell; Gene; Cell growth; Function (biology); Apoptosis; Genetics","score_opus":0.01411910575121484,"score_gpt":0.2391566058814915,"score_spread":0.22503750013027668,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2731399710","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98108226,0.0002117851,0.000011795245,0.000085541295,0.003198711,0.00016154618,0.000004327411,0.000013332042,0.015230694],"genre_scores_gemma":[0.9885858,0.0000127310705,0.0001976113,0.000026404732,0.00013912692,0.0000133374015,0.00020629546,0.000014476912,0.01080417],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998486,0.00002411145,0.00029108106,0.0006939676,0.00020498922,0.00029989769],"domain_scores_gemma":[0.9978867,0.0000045596794,0.00026698192,0.0016588854,0.00007248719,0.00011035234],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006816108,0.00013147657,0.00013628695,0.000064965185,0.00035662585,0.0002490624,0.0002670731,0.00013610987,0.000032889584],"category_scores_gemma":[0.00024057126,0.00011974095,0.000073886804,0.00005421087,0.00018336061,0.000009500208,0.00019900643,0.00006727298,0.000034456734],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000009302139,0.00005030253,0.05273923,0.000011692266,0.0000040558084,0.0003543232,0.000033682758,0.0000071802015,0.9401634,0.000025528716,0.00640211,0.00019924577],"study_design_scores_gemma":[0.00025901286,0.000055366658,0.046420813,0.000018375402,0.0000060614248,0.00010420688,0.000013061844,0.000042273175,0.86342067,0.0022842162,0.0871639,0.0002120381],"about_ca_topic_score_codex":0.00004370506,"about_ca_topic_score_gemma":0.000089793,"teacher_disagreement_score":0.0807618,"about_ca_system_score_codex":0.000011448669,"about_ca_system_score_gemma":0.00012206201,"threshold_uncertainty_score":0.48828945},"labels":[],"label_agreement":null},{"id":"W2737779999","doi":"10.1016/j.bbadis.2017.07.015","title":"Protecting the heart through MK2 modulation, toward a role in diabetic cardiomyopathy and lipid metabolism","year":2017,"lang":"en","type":"review","venue":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":31,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Heart Institute","funders":"Canadian Institutes of Health Research; Heart and Stroke Foundation of Canada","keywords":"Lipid metabolism; Diabetic cardiomyopathy; Diabetes mellitus; Medicine; Bioinformatics; Inflammation; Signal transduction; Cardiomyopathy; Biology; Heart failure; Endocrinology; Internal medicine; Cell biology","score_opus":0.03282656073238309,"score_gpt":0.3021240001889688,"score_spread":0.2692974394565857,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2737779999","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.26346967,0.7334074,0.00007752579,0.0003781809,0.00017162182,0.0019149741,0.00039436558,0.000022830318,0.00016344988],"genre_scores_gemma":[0.5491347,0.44902065,0.00024859983,0.00014284368,0.00033403453,0.00046652835,0.0005209086,0.000112037866,0.000019737752],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9962438,0.0009818956,0.0007553971,0.0011156545,0.0003869245,0.00051635],"domain_scores_gemma":[0.9970341,0.000060782506,0.0007208651,0.0018220936,0.000118254735,0.00024392385],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005283355,0.0007628645,0.0015388159,0.0001444898,0.00024523845,0.00013654669,0.00083536585,0.00038065066,0.000003006674],"category_scores_gemma":[0.0005189574,0.00059411826,0.0010637634,0.00022536638,0.00031780667,0.00002385541,0.0006389735,0.00048851426,0.000005715313],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035325068,0.0008819097,0.000024142013,0.0150993625,0.0018512732,0.000049812603,0.00070479815,0.000017648457,0.8466451,0.00054780714,0.0003404889,0.13348436],"study_design_scores_gemma":[0.0021859275,0.0006060255,0.003326,0.0072298697,0.0051418534,0.000040973842,0.00017694633,0.0000877053,0.35265955,0.001052832,0.6241108,0.0033814674],"about_ca_topic_score_codex":0.00006461442,"about_ca_topic_score_gemma":0.0000034018053,"teacher_disagreement_score":0.62377036,"about_ca_system_score_codex":0.000024700446,"about_ca_system_score_gemma":0.00053042953,"threshold_uncertainty_score":0.999651},"labels":[],"label_agreement":null},{"id":"W2740393355","doi":"10.1093/annonc/mdx339","title":"Vemurafenib in patients with BRAFV600 mutation-positive metastatic melanoma: final overall survival results of the randomized BRIM-3 study","year":2017,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":258,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"National Cancer Institute; F. Hoffmann-La Roche; Roche","keywords":"Vemurafenib; Dacarbazine; Medicine; Confidence interval; Hazard ratio; Internal medicine; Metastatic melanoma; Progression-free survival; Melanoma; Gastroenterology; Oncology; Chemotherapy; Cancer; Cancer research","score_opus":0.04370504422132651,"score_gpt":0.32638251676067626,"score_spread":0.2826774725393497,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2740393355","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946056,0.000043745174,0.000020363355,0.000338125,0.00016607127,0.00082203886,0.00010472526,0.0000017021599,0.0038976346],"genre_scores_gemma":[0.99941975,0.000012459609,0.000113669135,0.00009608618,0.000031050302,0.000029667975,0.000068912836,0.000010151663,0.00021823467],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99832344,0.0005846559,0.00046517648,0.00025551356,0.00018707156,0.0001841595],"domain_scores_gemma":[0.9983073,0.00015712605,0.0006972569,0.0005126448,0.0002876611,0.000038022652],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008253628,0.00013830833,0.0005504427,0.000043317603,0.000082820574,0.000009352439,0.00035131385,0.000080312406,0.0000051608345],"category_scores_gemma":[0.00065403624,0.0000898216,0.00011962717,0.0000376459,0.00028125313,0.000008944715,0.0001441733,0.00008718829,0.0000011527916],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5510487,0.011583482,0.39156237,0.00013179635,0.002845347,0.00015487634,0.00488879,0.00039116232,0.016783243,0.0015484795,0.0023219415,0.016739836],"study_design_scores_gemma":[0.18556072,0.0075840624,0.7776275,0.000033187265,0.00010856729,0.0000039591578,0.00014905767,0.000015275278,0.028011115,0.00022411458,0.00051201036,0.00017037947],"about_ca_topic_score_codex":0.00048029947,"about_ca_topic_score_gemma":0.00090273377,"teacher_disagreement_score":0.38606519,"about_ca_system_score_codex":0.0000072606417,"about_ca_system_score_gemma":0.00018214984,"threshold_uncertainty_score":0.36628187},"labels":[],"label_agreement":null},{"id":"W2745512715","doi":"10.18632/oncotarget.20534","title":"Combined targeting of Raf and Mek synergistically inhibits tumorigenesis in triple negative breast cancer model systems","year":2017,"lang":"en","type":"article","venue":"Oncotarget","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Queen's University","funders":"Canadian Cancer Society Research Institute; Canadian Institutes of Health Research; Terry Fox Foundation","keywords":"Triple-negative breast cancer; MAPK/ERK pathway; Cancer research; Erlotinib; Lapatinib; MEK inhibitor; Epidermal growth factor receptor; Breast cancer; Medicine; Cancer; Receptor tyrosine kinase; Carcinogenesis; EGFR inhibitors; Kinase; Biology; Internal medicine; Receptor; Cell biology","score_opus":0.012358972104898003,"score_gpt":0.2579569937641509,"score_spread":0.24559802165925287,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2745512715","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968161,0.0005364413,0.000482894,0.00013034159,0.00022973554,0.0002186194,0.00024596244,0.0000063439816,0.0013335374],"genre_scores_gemma":[0.9982599,0.0002560143,0.0006640971,0.000030479596,0.00013007114,0.000045897646,0.00004377462,0.000020542224,0.0005492207],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998978,0.000051928524,0.00029391513,0.00031671388,0.000120753524,0.00023864064],"domain_scores_gemma":[0.9992338,0.000016000477,0.00021991397,0.00031422856,0.000117546486,0.000098499426],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023712145,0.00015924507,0.00029810227,0.00003646726,0.00012329745,0.000034094726,0.00019465141,0.00012332773,0.000008656055],"category_scores_gemma":[0.00016450846,0.00014492888,0.00004688,0.000031945194,0.000116985924,0.000009104928,0.00014634382,0.000072655275,0.000001407978],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033403386,0.000099336,0.03979801,0.00013187843,0.00004792548,0.000011714999,0.00012963291,0.0011480482,0.95568794,0.0009770119,0.0014535269,0.0001809658],"study_design_scores_gemma":[0.007727142,0.0006650368,0.1447674,0.0004400512,0.00010410203,0.000029038812,0.0003915195,0.065190025,0.77708834,0.0009479231,0.0015260833,0.0011233201],"about_ca_topic_score_codex":0.0008624786,"about_ca_topic_score_gemma":0.000165442,"teacher_disagreement_score":0.17859957,"about_ca_system_score_codex":0.000019203519,"about_ca_system_score_gemma":0.00014109939,"threshold_uncertainty_score":0.5910029},"labels":[],"label_agreement":null},{"id":"W2745595414","doi":"10.1016/j.jid.2017.07.832","title":"Associations of MC1R Genotype and Patient Phenotypes with BRAF and NRAS Mutations in Melanoma","year":2017,"lang":"en","type":"article","venue":"Journal of Investigative Dermatology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Institute of Environmental Health Sciences; National Institute of General Medical Sciences; National Cancer Institute","keywords":"Neuroblastoma RAS viral oncogene homolog; Melanoma; Medicine; Phenotype; V600E; Genotype; Population; Dermatology; Oncology; Cancer research; Internal medicine; Cancer; Mutation; Gene; Genetics; Biology","score_opus":0.018180276651612533,"score_gpt":0.25044554508459094,"score_spread":0.2322652684329784,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2745595414","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979948,0.00058042206,0.00007478217,0.0008430175,0.000046036992,0.00006524455,0.000016407612,8.2901266e-7,0.0003784956],"genre_scores_gemma":[0.99765944,0.00005424651,0.0021133786,0.00012949384,0.000019899244,0.0000020487537,0.0000074839577,0.0000060501447,0.0000079556385],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99940073,0.00007595063,0.00026527126,0.00009453842,0.000068430054,0.00009508852],"domain_scores_gemma":[0.9990347,0.000034661025,0.00057425495,0.00011265472,0.00017376571,0.000069940754],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007630547,0.000078995276,0.00021702262,0.00006491552,0.00009218864,0.000014122433,0.000084898966,0.0000835381,0.000002030911],"category_scores_gemma":[0.00035283575,0.000062826715,0.000021398735,0.000025218376,0.00042462762,0.000013775834,0.000049970768,0.000090137124,3.2214717e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000106481835,0.00009060869,0.4318014,0.000037245063,0.00021737088,0.0001055655,0.002220991,0.000024992794,0.55925477,0.004235379,0.00048467008,0.0014205067],"study_design_scores_gemma":[0.0009024339,0.0005971686,0.5796035,0.000034075063,0.000035620164,0.0005177273,0.00030741617,0.000019775987,0.41474,0.0026955605,0.0004515617,0.00009514119],"about_ca_topic_score_codex":0.00003423579,"about_ca_topic_score_gemma":0.00025496763,"teacher_disagreement_score":0.14780211,"about_ca_system_score_codex":0.0000064862224,"about_ca_system_score_gemma":0.0001167764,"threshold_uncertainty_score":0.2561999},"labels":[],"label_agreement":null},{"id":"W2745671375","doi":"10.1200/jco.2017.35.15_suppl.3063","title":"Atezolizumab (A) + cobimetinib (C) + vemurafenib (V) in BRAF<sup>V600</sup>-mutant metastatic melanoma (mel): Updated safety and clinical activity.","year":2017,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":51,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada)","funders":"","keywords":"Medicine; Vemurafenib; Maculopapular rash; Rash; Nausea; Internal medicine; Melanoma; Atezolizumab; CD8; Adverse effect; Oncology; Gastroenterology; Metastatic melanoma; Pharmacology; Nivolumab; Cancer; Cancer research; Immune system; Immunotherapy; Immunology","score_opus":0.08158401592202198,"score_gpt":0.42470405659330257,"score_spread":0.3431200406712806,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2745671375","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99198484,0.0003596644,0.0002518784,0.0022778446,0.001128272,0.000277074,0.00003550624,0.000006815277,0.0036780715],"genre_scores_gemma":[0.9935062,0.0024918471,0.0017126936,0.0007027674,0.0011606839,0.000003689039,0.000020430554,0.000035738016,0.00036594528],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99387693,0.0015816728,0.0031620744,0.00057845877,0.00030760828,0.0004932649],"domain_scores_gemma":[0.9942828,0.0009931212,0.0030951572,0.00077874743,0.0002836918,0.00056651497],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.006670812,0.00031950188,0.0019778097,0.00011531809,0.00019082587,0.00006350892,0.0008040081,0.0008466874,0.00008756107],"category_scores_gemma":[0.006217684,0.00025378566,0.0006180151,0.00006851315,0.00071805733,0.00004190162,0.00046690705,0.0012444983,0.000024300458],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.032446824,0.00524861,0.26319042,0.000073708776,0.0022668152,0.0039842315,0.00017623896,0.00009223404,0.022316048,0.00061512686,0.004862514,0.6647272],"study_design_scores_gemma":[0.024582727,0.020362083,0.56355625,0.00009318643,0.00048397723,0.0012209053,0.00013194302,0.0007728189,0.0038528547,0.00043485183,0.3839253,0.0005831188],"about_ca_topic_score_codex":0.000058573667,"about_ca_topic_score_gemma":0.00029284816,"teacher_disagreement_score":0.6641441,"about_ca_system_score_codex":0.000051761763,"about_ca_system_score_gemma":0.001282478,"threshold_uncertainty_score":0.9999914},"labels":[],"label_agreement":null},{"id":"W2751872432","doi":"10.1016/j.jid.2017.07.807","title":"610 A case of metastatic malignant melanoma of the scalp responding to ipilimumab","year":2017,"lang":"en","type":"article","venue":"Journal of Investigative Dermatology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Regina Qu'Appelle Health Region; University of Saskatchewan","funders":"","keywords":"Ipilimumab; Medicine; Melanoma; Dabrafenib; Oncology; Dermatology; Scalp; Immunotherapy; Vemurafenib; Internal medicine; Surgery; Metastatic melanoma; Cancer; Cancer research","score_opus":0.03018014890233582,"score_gpt":0.29407970882405676,"score_spread":0.2638995599217209,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2751872432","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972154,0.0002418894,0.00034974507,0.0013166001,0.00024240598,0.0001337423,0.000029791627,9.391345e-7,0.00046947348],"genre_scores_gemma":[0.9966079,0.000012788445,0.0029883098,0.00023231217,0.000048201982,0.00000334889,0.0000012723792,0.000011437969,0.000094446325],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99864113,0.00030071326,0.00060548424,0.00013924263,0.00013604859,0.00017737383],"domain_scores_gemma":[0.99769413,0.00005970288,0.0012695558,0.00050065515,0.00033798473,0.00013798718],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037716798,0.00013318418,0.00041900383,0.00016850956,0.00014317443,0.000012120817,0.0005149171,0.000076723714,0.000008768653],"category_scores_gemma":[0.0015047457,0.000087693385,0.00018414418,0.000100807425,0.00058500003,0.000010707262,0.00022886622,0.00013333648,0.0000017308256],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015846387,0.000039569255,0.0030833916,0.000055455654,0.00015802219,0.00080279657,0.00043001593,0.000013484271,0.9914541,0.0025437938,0.0010434855,0.00021738587],"study_design_scores_gemma":[0.00068204536,0.00043154348,0.003949929,0.00010056717,0.000073390525,0.015950942,0.00037549296,0.00001482517,0.97581655,0.0012545136,0.0012629388,0.00008724487],"about_ca_topic_score_codex":0.000021734551,"about_ca_topic_score_gemma":0.00004740891,"teacher_disagreement_score":0.01563757,"about_ca_system_score_codex":0.000010747344,"about_ca_system_score_gemma":0.0002523575,"threshold_uncertainty_score":0.35760325},"labels":[],"label_agreement":null},{"id":"W2754563145","doi":"10.1101/189761","title":"Evolution and Engineering of Allosteric Regulation in Protein Kinases","year":2017,"lang":"en","type":"preprint","venue":"bioRxiv (Cold Spring Harbor Laboratory)","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hillsborough Hospital","funders":"National Institutes of Health; Gordon and Betty Moore Foundation","keywords":"Allosteric regulation; Phosphorylation; Kinase; Allosteric enzyme; Function (biology); Protein engineering; Protein kinase A","score_opus":0.009453179132250113,"score_gpt":0.198546507973863,"score_spread":0.1890933288416129,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2754563145","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965564,0.0014517539,0.0011927008,0.000018811457,0.00024261397,0.0004601974,0.00004781989,0.000022403028,0.0000072794714],"genre_scores_gemma":[0.99791443,0.00007030011,0.0016738825,0.0000052481228,0.00019310384,0.00009750019,0.0000012606394,0.000038885428,0.0000053617728],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988874,0.000040784325,0.00027339702,0.0004811947,0.00011482996,0.00020239904],"domain_scores_gemma":[0.99878544,0.000004737122,0.0002768043,0.00074219843,0.00012109408,0.00006975961],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002457475,0.00023306692,0.00025717166,0.00012745585,0.000039343024,0.000040059436,0.00017588402,0.0003821807,0.000002370521],"category_scores_gemma":[0.00019411235,0.00026586567,0.00005203615,0.000056513876,0.000053506657,0.000008278232,0.0003236585,0.00016070671,0.0000011177663],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000022412263,0.000030095012,0.007557473,0.0003526261,0.000021183012,0.0000080264945,0.0000019415447,0.00008283947,0.99172413,0.00018061903,0.000017049035,0.0000015900226],"study_design_scores_gemma":[0.00020939733,0.00006742439,0.2709665,0.00032686087,0.000015099181,2.4207994e-8,4.803357e-7,0.00026718897,0.72733265,0.0000030489948,0.0005657636,0.0002455943],"about_ca_topic_score_codex":0.000072620554,"about_ca_topic_score_gemma":0.000006468904,"teacher_disagreement_score":0.2643915,"about_ca_system_score_codex":0.00004162425,"about_ca_system_score_gemma":0.0001657365,"threshold_uncertainty_score":0.9999794},"labels":[],"label_agreement":null},{"id":"W2755929010","doi":"10.1038/s41467-017-00452-4","title":"Tumor-associated B-cells induce tumor heterogeneity and therapy resistance","year":2017,"lang":"en","type":"article","venue":"Nature Communications","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":141,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"National Cancer Institute; National Institutes of Health; Melanoma Institute Australia; Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; Universität Wien; Medical Research Council; Vienna Science and Technology Fund; Cancer Institute NSW; National Health and Medical Research Council; Medizinische Universität Wien","keywords":"Melanoma; Cancer research; Tumor microenvironment; Drug resistance; CD20; Tumor progression; Medicine; Mechanism (biology); Cancer; Biology; Immunology; Antibody; Tumor cells; Internal medicine","score_opus":0.02567919250786586,"score_gpt":0.29789614995040314,"score_spread":0.27221695744253727,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2755929010","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9798779,0.012941112,0.0000073387005,0.0010644671,0.00013097559,0.00016496255,0.00006778478,0.000017188135,0.005728288],"genre_scores_gemma":[0.99596083,0.0019352937,0.00095316366,0.0005708153,0.000054194006,0.00002757024,0.00009762109,0.000014936639,0.0003855476],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993535,0.000098679186,0.00011837981,0.00021115948,0.00007459703,0.00014363977],"domain_scores_gemma":[0.99725837,0.000024415816,0.00016727956,0.0023839977,0.000102791586,0.0000631343],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001564826,0.00011245059,0.000110460256,0.000017507937,0.00070543843,0.00007498919,0.0010313417,0.00018222918,0.0000022177464],"category_scores_gemma":[0.00021144054,0.000106364096,0.000049231727,0.000027800841,0.00018118162,0.0000064161286,0.00041517575,0.00032862602,0.0000044744847],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000041410578,0.0001806459,0.015134684,0.000006130694,0.000072351846,0.000003898516,0.000039440794,1.6485492e-7,0.97384286,0.0014635226,0.00819122,0.0010236913],"study_design_scores_gemma":[0.00087041897,0.000088494795,0.13035002,0.00002471802,0.000014682898,0.000010953188,0.0000209989,0.000012999631,0.45764795,0.00022136915,0.41046408,0.0002732977],"about_ca_topic_score_codex":0.000015976135,"about_ca_topic_score_gemma":0.001442943,"teacher_disagreement_score":0.5161949,"about_ca_system_score_codex":0.000008947146,"about_ca_system_score_gemma":0.000049748705,"threshold_uncertainty_score":0.54257333},"labels":[],"label_agreement":null},{"id":"W2756647112","doi":"10.1158/1535-7163.mct-17-0456","title":"Targeting the MAPK Signaling Pathway in Cancer: Promising Preclinical Activity with the Novel Selective ERK1/2 Inhibitor BVD-523 (Ulixertinib)","year":2017,"lang":"en","type":"article","venue":"Molecular Cancer Therapeutics","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":234,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Phenomenome Discoveries (Canada)","funders":"","keywords":"MAPK/ERK pathway; Medicine; In vivo; Melanoma; Cancer research; Cancer; Pharmacology; Phosphorylation; Potency; MEK inhibitor; Targeted therapy; In vitro; Internal medicine; Biology; Cell biology; Biochemistry","score_opus":0.039443511507001754,"score_gpt":0.3106321426094479,"score_spread":0.2711886311024461,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2756647112","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98812985,0.0022350908,0.005285225,0.0028570355,0.00030020435,0.0007680457,0.000046000496,0.000019128403,0.000359434],"genre_scores_gemma":[0.9971607,0.00018989271,0.00030621633,0.0012695558,0.0005307146,0.00031415035,0.000011766615,0.0000701098,0.00014693967],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980711,0.00019577086,0.00027589378,0.0006116888,0.0003113881,0.00053418975],"domain_scores_gemma":[0.9984624,0.000054297652,0.00039301798,0.0008553367,0.00016185438,0.00007310725],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00059831736,0.00033509458,0.00028048214,0.000026672724,0.00069137017,0.00017490533,0.0007290062,0.00022909621,0.000010047267],"category_scores_gemma":[0.00006628419,0.00020388006,0.00013124982,0.00011091185,0.0002948581,0.000015943586,0.00022424165,0.00051675824,0.0000016833824],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004083852,0.000107620035,0.0044497196,0.000022449734,0.00023055832,0.000011116064,0.00044131998,0.0010566002,0.982826,0.000040025363,0.00005906405,0.010347147],"study_design_scores_gemma":[0.0012239804,0.00028895235,0.0037834318,0.00009224686,0.000078509154,0.0000071546324,0.00012630998,0.00066508487,0.97420955,0.000038359358,0.019118905,0.00036750254],"about_ca_topic_score_codex":0.0004249576,"about_ca_topic_score_gemma":0.000813902,"teacher_disagreement_score":0.019059842,"about_ca_system_score_codex":0.00007914755,"about_ca_system_score_gemma":0.00048568728,"threshold_uncertainty_score":0.8313987},"labels":[],"label_agreement":null},{"id":"W2758153481","doi":"10.18632/oncotarget.21352","title":"Eyes absent gene (EYA1) is a pathogenic driver and a therapeutic target for melanoma","year":2017,"lang":"en","type":"article","venue":"Oncotarget","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Welichem Biotech (Canada); University of British Columbia","funders":"","keywords":"Medicine; Melanoma; Cancer research; Gene; Bioinformatics; Oncology; Genetics; Biology","score_opus":0.017114928993907517,"score_gpt":0.266597748511279,"score_spread":0.24948281951737147,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2758153481","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9934674,0.001913259,0.0015027055,0.00050016516,0.0002814752,0.00033572025,0.00019610152,0.00001232963,0.0017908273],"genre_scores_gemma":[0.98924285,0.0002906019,0.005015842,0.0007135271,0.00045944593,0.000081182785,0.0001273192,0.000033680222,0.004035535],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990003,0.000023348308,0.00015637261,0.00042686553,0.000094003255,0.0002991128],"domain_scores_gemma":[0.99904495,0.000010082057,0.00012174562,0.00064871367,0.000059367627,0.000115164316],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015984556,0.00018797247,0.00019161668,0.000022842632,0.00033229735,0.0000727179,0.0002704125,0.00016069988,0.000083084335],"category_scores_gemma":[0.000038581435,0.00016377741,0.00012818362,0.000011846592,0.00009472763,0.0000052984133,0.00014645001,0.000053466294,0.00003108229],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011789482,0.000059765927,0.0311781,0.000029377326,0.00011770324,0.000008841832,0.00014957227,9.5036773e-7,0.95760804,0.00030916696,0.007673639,0.0027469576],"study_design_scores_gemma":[0.0015037734,0.0006669391,0.046081312,0.000010079223,0.000054114887,0.000031538115,0.000029000701,0.00016398683,0.37477946,0.0017279906,0.5745722,0.00037963514],"about_ca_topic_score_codex":0.00002099501,"about_ca_topic_score_gemma":0.000020193685,"teacher_disagreement_score":0.5828286,"about_ca_system_score_codex":0.000009282599,"about_ca_system_score_gemma":0.00006755252,"threshold_uncertainty_score":0.66786486},"labels":[],"label_agreement":null},{"id":"W2761934863","doi":"10.1093/hmg/ddx368","title":"Rare germline variants in known melanoma susceptibility genes in familial melanoma","year":2017,"lang":"en","type":"article","venue":"Human Molecular Genetics","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; National Institutes of Health; Division of Cancer Epidemiology and Genetics, National Cancer Institute; McMaster University","keywords":"Biology; Genetics; Nonsynonymous substitution; Missense mutation; Germline; Germline mutation; Exome sequencing; Population; Exome; Gene; Melanoma; Mutation; Genome; Medicine","score_opus":0.0205141760911975,"score_gpt":0.27635765070968354,"score_spread":0.25584347461848606,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2761934863","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9927096,0.0021626882,0.00034840137,0.000058600563,0.0002904867,0.00045570495,0.000048914884,0.000015888829,0.0039097136],"genre_scores_gemma":[0.99763393,0.00023835959,0.0009874696,0.00012924771,0.00030590198,0.000044874134,0.00022139604,0.000062729145,0.00037611744],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9974825,0.0001921501,0.0005670151,0.00088895386,0.00025317413,0.0006162323],"domain_scores_gemma":[0.9976537,0.000008708197,0.0002105823,0.0018683396,0.000092620496,0.00016602114],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003953442,0.00038447487,0.00039841727,0.00013856748,0.00023231939,0.000106143096,0.0008964615,0.00041515366,0.00006850341],"category_scores_gemma":[0.00012756175,0.0004188539,0.0001625853,0.00007561995,0.00020963921,0.000008942025,0.0005376868,0.00022761404,0.00002918208],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000065794,0.0001825887,0.17112161,0.00003284013,0.000024118202,0.00031997642,0.00006681733,0.00009590104,0.82456434,0.00029540618,0.000096132615,0.0031344895],"study_design_scores_gemma":[0.0023396602,0.000580125,0.7680913,0.000038386286,0.000022540638,0.000030035253,0.000039416445,0.00015180018,0.22391044,0.00077840185,0.0034292599,0.00058863533],"about_ca_topic_score_codex":0.00023202281,"about_ca_topic_score_gemma":0.0039870567,"teacher_disagreement_score":0.6006539,"about_ca_system_score_codex":0.000043918742,"about_ca_system_score_gemma":0.00013834982,"threshold_uncertainty_score":0.9998263},"labels":[],"label_agreement":null},{"id":"W2762161610","doi":"10.1093/annonc/mdx377.003","title":"KEYNOTE-022 update: phase 1 study of first-line pembrolizumab (pembro) plus dabrafenib (D) and trametinib (T) for BRAF-mutant advanced melanoma","year":2017,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":36,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Dabrafenib; Medicine; Trametinib; Pembrolizumab; Neutropenia; Discontinuation; Regimen; Melanoma; Internal medicine; Oncology; Metastatic melanoma; Vemurafenib; Gastroenterology; Cancer research; Cancer; Chemotherapy; Immunotherapy; MAPK/ERK pathway","score_opus":0.06839828692160825,"score_gpt":0.39015154680752706,"score_spread":0.3217532598859188,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2762161610","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99553525,0.00060109945,0.0005307285,0.00068503123,0.00024717476,0.000902975,0.00023184101,0.000008891912,0.001257028],"genre_scores_gemma":[0.9980697,0.00056528684,0.00063231133,0.00018603052,0.00015192018,0.0001028677,0.000116716794,0.00003043906,0.00014472198],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99835956,0.00009393177,0.00056064595,0.00050153024,0.00012763104,0.00035669957],"domain_scores_gemma":[0.9980262,0.00007381182,0.00066289614,0.00083159003,0.00027145696,0.0001340432],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041634619,0.00023982314,0.00066191744,0.00007167052,0.00021277589,0.000016092923,0.00047497888,0.00026314607,0.000023386485],"category_scores_gemma":[0.00045425733,0.00022151228,0.00014155828,0.00003561384,0.00023736861,0.000013870507,0.0002537345,0.00009783836,0.0000014131657],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018415283,0.0063797175,0.0024840252,0.0003670295,0.00071043073,0.00008450218,0.0010040348,0.00012526252,0.7450622,0.000705812,0.0035982882,0.22106345],"study_design_scores_gemma":[0.05662424,0.07669604,0.004702145,0.00004564601,0.00020756588,0.00010313072,0.0007721548,0.00041293737,0.6921769,0.00088211376,0.16675499,0.00062217226],"about_ca_topic_score_codex":0.00006249415,"about_ca_topic_score_gemma":0.00039739077,"teacher_disagreement_score":0.22044128,"about_ca_system_score_codex":0.000009264716,"about_ca_system_score_gemma":0.00016837049,"threshold_uncertainty_score":0.9033009},"labels":[],"label_agreement":null},{"id":"W2762653748","doi":"10.1200/jco.2017.35.15_suppl.9074","title":"Efficacy of vemurafenib in patients (pts) with non-small cell lung cancer (NSCLC) with <i>BRAF</i><sup>V600</sup> mutation.","year":2017,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada)","funders":"","keywords":"Medicine; Vemurafenib; Internal medicine; Oncology; Cohort; Clinical endpoint; Rash; Lung cancer; Adverse effect; Expanded access; Progression-free survival; non-small cell lung cancer (NSCLC); Nausea; Cancer; Clinical trial; Metastatic melanoma; Overall survival","score_opus":0.029809604321270836,"score_gpt":0.3542964915474961,"score_spread":0.32448688722622526,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2762653748","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99571085,0.00018888393,0.00021075548,0.00027927972,0.0003035207,0.00025762746,0.000010577369,0.0000017124629,0.0030367994],"genre_scores_gemma":[0.9968931,0.00019220212,0.0018242038,0.0003171192,0.0005357334,0.0000083631385,0.000010763764,0.00002323162,0.0001952979],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978385,0.00018462642,0.0012217975,0.00026817742,0.00023136342,0.00025554156],"domain_scores_gemma":[0.9965046,0.00020945043,0.002222386,0.00040137552,0.00045525868,0.00020694801],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00082739897,0.0001776008,0.0007948073,0.00006489409,0.0000699447,0.000016818054,0.00047455574,0.00036352346,0.000021700658],"category_scores_gemma":[0.00047582228,0.00011980253,0.00019095758,0.000048078917,0.00023969717,0.00001645052,0.00009712587,0.00044337654,0.0000023904586],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009581666,0.0024570753,0.9542441,0.00007146942,0.0003099805,0.00022636214,0.0002581198,0.0014699867,0.002577239,0.000012783085,0.0012782816,0.027512984],"study_design_scores_gemma":[0.03228326,0.019909447,0.92710197,0.00021527546,0.00023957703,0.00003723959,0.00007390939,0.00014414042,0.008163633,0.000011810849,0.011554855,0.00026490298],"about_ca_topic_score_codex":0.00006925771,"about_ca_topic_score_gemma":0.00022300587,"teacher_disagreement_score":0.02724808,"about_ca_system_score_codex":0.000035767705,"about_ca_system_score_gemma":0.0012917443,"threshold_uncertainty_score":0.48854053},"labels":[],"label_agreement":null},{"id":"W2767191415","doi":"10.1038/s41467-017-01274-0","title":"RAF inhibitors promote RAS-RAF interaction by allosterically disrupting RAF autoinhibition","year":2017,"lang":"en","type":"article","venue":"Nature Communications","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":105,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Institute for Research in Immunology and Cancer","funders":"Canadian Institutes of Health Research","keywords":"Kinase; Chemistry; Allosteric regulation; Enzyme; Effector; MAPK/ERK pathway; Cell biology; Enzyme activator; Biochemistry; Biology; Cancer research","score_opus":0.016481119543406312,"score_gpt":0.3123844973971795,"score_spread":0.2959033778537732,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767191415","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9588534,0.0037510558,0.0011202254,0.011408323,0.0010339054,0.00071479677,0.00013749774,0.00011472209,0.02286605],"genre_scores_gemma":[0.9938323,0.00036659124,0.003078224,0.00037074232,0.00024500972,0.00006222869,0.0011636121,0.000028917857,0.00085235614],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99891835,0.00012394342,0.00027057686,0.00031495365,0.00013623667,0.00023591828],"domain_scores_gemma":[0.9970443,0.00003365976,0.0003158117,0.0023634112,0.00015107148,0.000091706286],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027028046,0.00017716292,0.00014565454,0.000038529666,0.0009520089,0.00015942805,0.0010075639,0.0004295494,0.000013861941],"category_scores_gemma":[0.00048487142,0.00017322015,0.000114049995,0.000046794838,0.000148055,0.00002968347,0.0008429704,0.0006248459,0.000030187104],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000038670045,0.00014871277,0.0010060312,0.0000125586885,0.000038918686,0.0000012593628,0.00009848926,0.0000015031736,0.96205115,0.00043304064,0.029201876,0.0069677914],"study_design_scores_gemma":[0.0007923849,0.00019765853,0.0041260305,0.000093386916,0.000044040327,0.000036384426,0.00010100984,0.0003697234,0.28842688,0.0001240745,0.70529044,0.00039797954],"about_ca_topic_score_codex":0.00002807274,"about_ca_topic_score_gemma":0.00021697105,"teacher_disagreement_score":0.6760886,"about_ca_system_score_codex":0.000036728616,"about_ca_system_score_gemma":0.00006118858,"threshold_uncertainty_score":0.7322179},"labels":[],"label_agreement":null},{"id":"W2774483419","doi":"10.1158/2159-8290.cd-17-1119","title":"First-in-Class ERK1/2 Inhibitor Ulixertinib (BVD-523) in Patients with MAPK Mutant Advanced Solid Tumors: Results of a Phase I Dose-Escalation and Expansion Study","year":2017,"lang":"en","type":"article","venue":"Cancer Discovery","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":418,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Phenomenome Discoveries (Canada)","funders":"","keywords":"Medicine; Adverse effect; Nausea; Neuroblastoma RAS viral oncogene homolog; Cohort; Response Evaluation Criteria in Solid Tumors; Tolerability; Internal medicine; Cancer; Pharmacokinetics; MEK inhibitor; Oncology; Gastroenterology; MAPK/ERK pathway; Pharmacology; Clinical trial; Phases of clinical research; Kinase; Colorectal cancer; KRAS","score_opus":0.010347313231420165,"score_gpt":0.27351285796243774,"score_spread":0.26316554473101755,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2774483419","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99867934,0.00013529645,0.000024267298,0.000040884028,0.00015756284,0.0006388788,0.00017834816,0.0000036716358,0.00014175456],"genre_scores_gemma":[0.99954,0.00006314118,0.000028635306,0.000021060896,0.000082217026,0.00008258001,0.00009075343,0.000018049452,0.000073602365],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988205,0.00003368854,0.00034838042,0.0004353083,0.0001553776,0.00020674772],"domain_scores_gemma":[0.9991203,0.0000099655335,0.0002842321,0.0004768349,0.000053697946,0.00005497839],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011555033,0.00016801008,0.00025476827,0.000053046824,0.00007669353,0.000039576735,0.00013801217,0.00007598925,0.0000022433312],"category_scores_gemma":[0.00008071801,0.00013745611,0.000028879866,0.000049271817,0.00007591431,0.000047928712,0.000112810405,0.000077716526,4.521464e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012453327,0.0020488086,0.62630785,0.00013454772,0.00005113744,0.00003422829,0.0010139872,0.00036310276,0.3484898,0.00000810243,0.00011003114,0.008985083],"study_design_scores_gemma":[0.021266308,0.0028076922,0.8086477,0.00039995543,0.00001998333,7.107826e-7,0.000317183,0.00013030057,0.16584931,0.000015279351,0.00027793608,0.00026765917],"about_ca_topic_score_codex":0.00020377053,"about_ca_topic_score_gemma":0.0019685465,"teacher_disagreement_score":0.1826405,"about_ca_system_score_codex":0.0000336349,"about_ca_system_score_gemma":0.00009725372,"threshold_uncertainty_score":0.5605297},"labels":[],"label_agreement":null},{"id":"W2774981435","doi":"10.1007/s00280-017-3486-3","title":"Model based analysis of the heterogeneity in the tumour size dynamics differentiates vemurafenib, dabrafenib and trametinib in metastatic melanoma","year":2017,"lang":"en","type":"article","venue":"Cancer Chemotherapy and Pharmacology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CBC (Canada)","funders":"","keywords":"Dabrafenib; Vemurafenib; Trametinib; Tumour heterogeneity; Melanoma; Medicine; Oncology; Cancer research; Metastatic melanoma; Pathology; Internal medicine; Biology; Cancer; MAPK/ERK pathway; Kinase","score_opus":0.024330399213969414,"score_gpt":0.3176762638160448,"score_spread":0.2933458646020754,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2774981435","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997424,0.00081060844,0.00019137093,0.0010829343,0.00008135064,0.00023893348,0.000111332425,0.000001746163,0.00005769637],"genre_scores_gemma":[0.9978599,0.0007149503,0.00008603614,0.00119228,0.000028086406,0.000065252534,0.00001699697,0.000009796679,0.00002672941],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9991329,0.00016101713,0.00019742514,0.00026378382,0.00006715075,0.00017777311],"domain_scores_gemma":[0.999443,0.00006952063,0.00016069553,0.00027325717,0.000020339661,0.00003319935],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024037265,0.00014389394,0.00027980664,0.00004761457,0.00010165604,0.00002057301,0.00033050103,0.0000795186,0.000017933786],"category_scores_gemma":[0.000018744053,0.000092214,0.00009351421,0.00009236362,0.00021950874,0.000005191933,0.000054632023,0.00011157783,7.0603626e-8],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040987876,0.00018769415,0.20604567,0.00006500826,0.00051171565,0.0000046427335,0.00037820035,0.0013660036,0.78788984,0.00007380283,0.00006804131,0.0029995048],"study_design_scores_gemma":[0.003663389,0.00011938244,0.4662765,0.000011800971,0.00047635316,0.0000037047712,0.00007163753,0.13615291,0.39267036,0.00020722866,0.00015002942,0.00019671641],"about_ca_topic_score_codex":0.00018014209,"about_ca_topic_score_gemma":0.0027823055,"teacher_disagreement_score":0.39521948,"about_ca_system_score_codex":0.000012756772,"about_ca_system_score_gemma":0.00005568286,"threshold_uncertainty_score":0.3760378},"labels":[],"label_agreement":null},{"id":"W2775591256","doi":"10.1097/dad.0000000000001066","title":"Granulomatous Tumoral Melanosis Associated With Pembrolizumab Therapy: A Mimicker of Disease Progression in Metastatic Melanoma","year":2017,"lang":"en","type":"article","venue":"American Journal of Dermatopathology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Calgary Laboratory Services; University of Calgary","funders":"","keywords":"Pembrolizumab; Medicine; Melanoma; Sarcoidosis; Immunotherapy; Adverse effect; Concomitant; Metastatic melanoma; Disease; Dermatology; Nivolumab; Oncology; Internal medicine; Pathology; Cancer; Cancer research","score_opus":0.012401068507559062,"score_gpt":0.27244376360585154,"score_spread":0.2600426950982925,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2775591256","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998295,0.00079363614,0.00018046741,0.00032982047,0.000087870896,0.00014612218,0.000022516037,0.0000039908987,0.00014056353],"genre_scores_gemma":[0.99882793,0.000245824,0.0006458649,0.00016704807,0.000041234016,0.000013184176,0.000018041907,0.000026818045,0.000014055815],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99845433,0.00034049276,0.0004923299,0.00021173638,0.00021033082,0.0002907736],"domain_scores_gemma":[0.9977888,0.000028221759,0.0014209315,0.0004316074,0.00017157945,0.00015887638],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003026504,0.00019955615,0.0005811318,0.00013869336,0.00008739437,0.000022308906,0.00042464654,0.000051050396,0.0000066956104],"category_scores_gemma":[0.00017616693,0.00014436916,0.00014652226,0.00007039862,0.000545957,0.00001669305,0.00007679281,0.00015459799,0.0000011271509],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029026116,0.0005070907,0.9024986,0.000024577801,0.00015355177,0.0017452175,0.00031105257,0.000013687714,0.08012936,0.000056548964,0.00012451915,0.011533168],"study_design_scores_gemma":[0.006227822,0.0065245056,0.9132221,0.00028194624,0.00015040772,0.0045860466,0.00027457756,0.000043469252,0.067517705,0.00023131353,0.0005277377,0.0004123942],"about_ca_topic_score_codex":0.000015848742,"about_ca_topic_score_gemma":0.00002499644,"teacher_disagreement_score":0.012611654,"about_ca_system_score_codex":0.000015692522,"about_ca_system_score_gemma":0.00022935441,"threshold_uncertainty_score":0.5887203},"labels":[],"label_agreement":null},{"id":"W2780350829","doi":"10.1200/jco.2016.34.15_suppl.2578","title":"Phase I pharmacokinetic study of single agent trametinib in advanced cancer patients with hepatic dysfunction: An NCI Organ Dysfunction Working Group (ODWG) study.","year":2016,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Cancer Centre; BC Cancer Agency; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Rash; Pharmacokinetics; Internal medicine; Cancer; Melanoma; Gastroenterology; Refractory (planetary science); Cmax; Toxicity; Cohort; Oncology; Urology","score_opus":0.0724240469470236,"score_gpt":0.40042437631507255,"score_spread":0.32800032936804896,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2780350829","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971658,0.00010113681,0.0004672271,0.000086011765,0.0015020022,0.0005848095,0.0000042606043,0.000004647063,0.00008409787],"genre_scores_gemma":[0.9988322,0.000091165086,0.00024067123,0.00013604853,0.0006018873,0.00002669964,0.0000056752197,0.000024776733,0.000040825038],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9964902,0.00081839587,0.0017665245,0.00035510125,0.0003353995,0.00023440392],"domain_scores_gemma":[0.99740297,0.00022746356,0.001572292,0.0002450492,0.00034502652,0.0002072054],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001372113,0.00018924638,0.0007902072,0.000112739544,0.000038490303,0.000007027395,0.00021614766,0.00018620759,0.0000743284],"category_scores_gemma":[0.000495952,0.00011722032,0.00012351735,0.00016751059,0.00008425301,0.000022828171,0.000057551868,0.00026541934,0.0000014438128],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011598952,0.045362037,0.56769115,0.000010822543,0.0002810044,0.00006511822,0.0002387033,0.00007347926,0.08126716,9.3000125e-7,0.00006254632,0.2933481],"study_design_scores_gemma":[0.09378475,0.33254248,0.5609606,0.00012825863,0.00045516485,0.000015503065,0.0010271989,0.000018571925,0.005229225,0.000018077735,0.005527946,0.00029221748],"about_ca_topic_score_codex":0.000026746713,"about_ca_topic_score_gemma":0.000876562,"teacher_disagreement_score":0.2930559,"about_ca_system_score_codex":0.000086354514,"about_ca_system_score_gemma":0.00025982558,"threshold_uncertainty_score":0.4780106},"labels":[],"label_agreement":null},{"id":"W2784831101","doi":"10.1172/jci94840","title":"COP1/DET1/ETS axis regulates ERK transcriptome and sensitivity to MAPK inhibitors","year":2018,"lang":"en","type":"article","venue":"Journal of Clinical Investigation","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":57,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"York University; U.S. Department of Defense; University of Minnesota; Geoffrey Beene Cancer Research Center; Gerstner Family Foundation; Memorial Sloan-Kettering Cancer Center; National Cancer Institute; Office of Defense Programs; Cancer Research UK; GIST Cancer Research Fund; Prostate Cancer Foundation","keywords":"Transcriptome; MAPK/ERK pathway; Sensitivity (control systems); Cell biology; Biology; Genetics; Signal transduction; Gene; Gene expression; Engineering","score_opus":0.04126453199566905,"score_gpt":0.3278556770233905,"score_spread":0.2865911450277215,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2784831101","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966433,0.00010457071,0.00081153616,0.0013509183,0.0007993194,0.00009130708,0.0000058512624,0.000004939129,0.00018824574],"genre_scores_gemma":[0.9931099,0.00004922253,0.0031527348,0.0013413172,0.0021810576,9.167484e-7,0.000008052372,0.0000113200085,0.0001454743],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99854845,0.00022780916,0.0007210456,0.00019584953,0.00017023197,0.00013662364],"domain_scores_gemma":[0.99882436,0.00007364814,0.00031922458,0.00015149912,0.0002980025,0.00033327684],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015478027,0.00010867112,0.0002605251,0.000053821543,0.000059624206,0.000026405605,0.00005831558,0.00020542565,0.000008353116],"category_scores_gemma":[0.0010810682,0.0000909958,0.000119721684,0.000080585145,0.00025596283,0.000013502954,0.000035887395,0.00015484211,0.000010335731],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020781082,0.000038362057,0.017297078,0.000013980987,0.000042993015,0.0000129092805,0.00013307897,0.0000036577173,0.9678768,0.000076659475,0.008948056,0.0053486447],"study_design_scores_gemma":[0.0008906491,0.002760699,0.16097738,0.000093909424,0.00004751014,0.00014699015,0.000043112796,0.0000793077,0.80487114,0.0012710866,0.028639544,0.00017869275],"about_ca_topic_score_codex":0.0000069231,"about_ca_topic_score_gemma":0.000029139055,"teacher_disagreement_score":0.16300565,"about_ca_system_score_codex":0.0000065020076,"about_ca_system_score_gemma":0.00010736333,"threshold_uncertainty_score":0.37107012},"labels":[],"label_agreement":null},{"id":"W2784833105","doi":"10.2174/1381612824666180125093357","title":"The Emerging Therapeutic Landscape of Advanced Melanoma","year":2018,"lang":"en","type":"review","venue":"Current Pharmaceutical Design","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Oncolytics Biotech; Amgen","keywords":"Medicine; Therapeutic modalities; Melanoma; Modalities; Intensive care medicine; Cancer; Immunotherapy; Treatment modality; Skin cancer; Metastatic melanoma; Internal medicine; Cancer research","score_opus":0.12135652071522658,"score_gpt":0.406393798695927,"score_spread":0.28503727798070044,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2784833105","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00001529998,0.99272406,0.0043903617,0.000012212224,0.001451364,0.0008084971,0.00003567196,0.000017510956,0.0005450186],"genre_scores_gemma":[0.0002658369,0.99832135,0.00014903993,0.000021392347,0.0007070952,0.00014939634,0.00012739144,0.00005877791,0.00019970872],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9976757,0.00050947216,0.00060946133,0.0005103091,0.00022747653,0.00046759195],"domain_scores_gemma":[0.99864084,0.00019251654,0.00030507913,0.0006006453,0.00010174542,0.00015917442],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005961122,0.000428332,0.00070060056,0.000055645996,0.00015655182,0.00003100089,0.000679624,0.00023596507,0.00005047265],"category_scores_gemma":[0.0001027137,0.00026646655,0.00047639658,0.0001694368,0.00021641683,0.0000032056641,0.00019293264,0.00031682578,0.00007574542],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000057619705,0.000059598544,0.0000019817182,0.0019959142,0.00019768688,0.0000015688075,0.000007752579,7.5152457e-7,0.000535337,0.0002632512,0.0038314178,0.9930471],"study_design_scores_gemma":[0.0002984115,0.00028006182,9.570331e-7,0.00096261624,0.00048097104,0.00001841487,0.0000057114844,0.00004903637,0.0023023628,0.000060188984,0.9952298,0.00031146937],"about_ca_topic_score_codex":1.11495694e-7,"about_ca_topic_score_gemma":1.8806406e-7,"teacher_disagreement_score":0.9927356,"about_ca_system_score_codex":0.0000144836695,"about_ca_system_score_gemma":0.0002640973,"threshold_uncertainty_score":0.9999788},"labels":[],"label_agreement":null},{"id":"W2785160602","doi":"10.14740/jocmr3248w","title":"Validation of the Graded Prognostic Assessment for Melanoma Using Molecular Markers (Melanoma-molGPA)","year":2018,"lang":"en","type":"article","venue":"Journal of Clinical Medicine Research","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Melanoma; Confidence interval; Log-rank test; Oncology; Internal medicine; Survival analysis; Overall survival; Retrospective cohort study; Nodular melanoma; Cancer research","score_opus":0.18404346310155423,"score_gpt":0.5125204512913224,"score_spread":0.32847698818976817,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2785160602","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99099886,0.00027123344,0.0051410072,0.0013854782,0.0007980888,0.00047103106,0.0000045719753,0.0000014697888,0.00092827657],"genre_scores_gemma":[0.9943898,0.00007023402,0.0032030158,0.00010043402,0.002101364,0.00000730701,0.0000067985175,0.000018612162,0.00010249067],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9966393,0.000875221,0.0011448977,0.00021711104,0.0008301346,0.0002933411],"domain_scores_gemma":[0.9966527,0.000659322,0.00063075824,0.00038109525,0.0014951704,0.00018092073],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008013793,0.000112534944,0.00040699576,0.00011660639,0.00011010816,0.000011034777,0.00048369713,0.00019149942,0.00003236535],"category_scores_gemma":[0.007577749,0.00006685902,0.00026553692,0.00022362384,0.000687148,0.000006387248,0.00014616542,0.00039661274,8.876565e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00093368196,0.00025748587,0.07512962,0.00011733386,0.00028317375,0.0000170864,0.00004449387,0.000011683038,0.91130716,0.0004227856,0.0051016314,0.006373887],"study_design_scores_gemma":[0.006980672,0.027400423,0.08139264,0.0008462508,0.00031053816,0.00021099344,0.00043426378,0.0008481721,0.86129326,0.0037440462,0.016288653,0.00025010316],"about_ca_topic_score_codex":0.00001073899,"about_ca_topic_score_gemma":0.0000024375943,"teacher_disagreement_score":0.050013892,"about_ca_system_score_codex":0.000023721112,"about_ca_system_score_gemma":0.0006992892,"threshold_uncertainty_score":0.90718204},"labels":[],"label_agreement":null},{"id":"W2787439801","doi":"10.1101/cshperspect.a031492","title":"Targeting the MAPK Pathway in RAS Mutant Cancers","year":2018,"lang":"en","type":"review","venue":"Cold Spring Harbor Perspectives in Medicine","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":75,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Discovery Centre","funders":"","keywords":"KRAS; MAPK/ERK pathway; Cancer research; Protein kinase A; Mutant; Kinase; Carcinogenesis; c-Raf; Mitogen-activated protein kinase; Mitogen-activated protein kinase kinase; Biology; Cell biology; Mutation; Cancer; Biochemistry; Genetics","score_opus":0.028950949646896738,"score_gpt":0.3038557426473558,"score_spread":0.27490479300045906,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2787439801","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0018046942,0.9952842,0.00008039076,0.00008045291,0.00069414283,0.0008418115,0.0000150768565,0.000016654161,0.0011825528],"genre_scores_gemma":[0.013344957,0.9839169,0.00010052975,0.00007902828,0.002108416,0.0002141177,0.000011639071,0.000073257026,0.00015119324],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99756914,0.00026500164,0.0006133229,0.00082457997,0.0002332753,0.00049467885],"domain_scores_gemma":[0.9987755,0.0000840963,0.0002764419,0.00069497654,0.00007666394,0.0000923325],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010444549,0.0004543277,0.0010215124,0.00020997097,0.00008701612,0.000015511898,0.0006120656,0.0003374552,0.000051495776],"category_scores_gemma":[0.00072894426,0.00030340682,0.0001723343,0.00037288785,0.00040245615,0.0000037900015,0.00021676766,0.00056761474,0.0000141413575],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011409916,0.002075788,0.002739103,0.07075815,0.004817872,0.0048752357,0.033198565,0.00023293243,0.43568063,0.13471268,0.031638175,0.27812985],"study_design_scores_gemma":[0.00052676816,0.00024008736,0.00006193528,0.0060587334,0.00006369707,0.0000047723374,0.0008185676,0.000013413074,0.00069930207,0.000009617014,0.9911269,0.00037623342],"about_ca_topic_score_codex":0.00030674302,"about_ca_topic_score_gemma":0.00018779407,"teacher_disagreement_score":0.9594887,"about_ca_system_score_codex":0.00039828982,"about_ca_system_score_gemma":0.00052386266,"threshold_uncertainty_score":0.9999418},"labels":[],"label_agreement":null},{"id":"W2787519262","doi":"10.1038/nature25478","title":"MEK drives BRAF activation through allosteric control of KSR proteins","year":2018,"lang":"en","type":"article","venue":"Nature","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":156,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sinai Health System; Lunenfeld-Tanenbaum Research Institute; Université de Montréal; Institute for Research in Immunology and Cancer","funders":"National Center for Research Resources; National Institute of General Medical Sciences; Canadian Institutes of Health Research","keywords":"Kinase; Allosteric regulation; Cell biology; Protein kinase domain; Chemistry; Protein kinase A; MAPK/ERK pathway; Scaffold protein; c-Raf; Mitogen-activated protein kinase kinase; Biochemistry; Biology; Enzyme; Signal transduction; Mutant; Gene","score_opus":0.006254970096759588,"score_gpt":0.24424895081812326,"score_spread":0.23799398072136366,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2787519262","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.985611,0.0003969335,0.006564535,0.00034233413,0.00020962302,0.0002813544,0.00002626787,0.000011603877,0.0065563004],"genre_scores_gemma":[0.99679214,0.00001514741,0.0012779624,0.0009007238,0.00048032403,0.000013137746,0.000060131486,0.000010795521,0.00044961265],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99948275,0.000029227254,0.00009924501,0.00017822681,0.000095021926,0.00011554218],"domain_scores_gemma":[0.99956167,0.0000058940286,0.00007807413,0.00021229612,0.000118450516,0.00002362495],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00004870965,0.00008683716,0.000098272365,0.000014716831,0.000036819754,0.000006149257,0.00011514133,0.00061372685,0.000030405132],"category_scores_gemma":[0.000072981944,0.00007187116,0.00004881621,0.000054211847,0.00006422722,0.0000047628773,0.000032471806,0.00018282796,0.0000057963807],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009977013,0.00003165314,0.00040240577,0.000015571773,0.00003204486,6.1856207e-7,0.000089902656,5.386836e-7,0.9949773,0.0005827898,0.0028215852,0.00094581634],"study_design_scores_gemma":[0.0005267153,0.00046548754,0.002363991,0.000013490014,0.000008715295,0.0000038694966,0.000023287463,0.000009057259,0.9109151,0.00024354324,0.08534401,0.000082762126],"about_ca_topic_score_codex":0.0000054318625,"about_ca_topic_score_gemma":0.0000116681795,"teacher_disagreement_score":0.084062226,"about_ca_system_score_codex":0.0000041346234,"about_ca_system_score_gemma":0.000037687627,"threshold_uncertainty_score":0.47336236},"labels":[],"label_agreement":null},{"id":"W2788163753","doi":"10.1016/j.ejmech.2018.01.053","title":"Effects of rigidity on the selectivity of protein kinase inhibitors","year":2018,"lang":"en","type":"article","venue":"European Journal of Medicinal Chemistry","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital","funders":"Division of Chemistry; National Institute of Dental and Craniofacial Research; National Center for Research Resources; National Institute of General Medical Sciences; Canadian Cancer Society Research Institute; Canadian Institutes of Health Research; TD Bank; National Institutes of Health; National Science Foundation","keywords":"Kinase; Chemistry; Selectivity; Isoquinoline; Biochemistry; Structure–activity relationship; Stereochemistry; Combinatorial chemistry; Catalysis; In vitro","score_opus":0.006772026038693152,"score_gpt":0.20595523823113157,"score_spread":0.19918321219243842,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2788163753","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99181867,0.00035549785,0.00022764102,0.00011078196,0.00013101769,0.00008438624,0.0000031428963,0.000002014503,0.0072668516],"genre_scores_gemma":[0.9983222,0.000018866223,0.00008798378,0.000055248707,0.0013412808,7.7346726e-7,0.0000016239167,0.000014355295,0.00015765792],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99888116,0.00023472823,0.00034957958,0.00012425006,0.0002818593,0.0001284236],"domain_scores_gemma":[0.99889565,0.000047189656,0.00050234585,0.00021742866,0.00024432907,0.00009304077],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010228276,0.00012120755,0.00019206326,0.000019013309,0.00004025121,0.0000033029041,0.00027971482,0.0000437904,0.000026948936],"category_scores_gemma":[0.00079300895,0.00007683706,0.00011646495,0.00007313012,0.00027514715,0.000002531231,0.000058601687,0.00021637378,0.0000026134965],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002912142,0.000114609276,0.0001747735,0.00016029186,0.00004676967,0.000051355317,0.00006267047,6.095903e-7,0.9950499,0.000008731586,0.002318799,0.0017203004],"study_design_scores_gemma":[0.0006470582,0.001863781,0.0014737543,0.00031472516,0.000031079195,0.000071137234,0.000038587084,0.0000013298154,0.9906781,0.000017958713,0.0047938786,0.000068645255],"about_ca_topic_score_codex":0.0000017939523,"about_ca_topic_score_gemma":2.8313605e-7,"teacher_disagreement_score":0.0071091936,"about_ca_system_score_codex":0.000009294159,"about_ca_system_score_gemma":0.00009704843,"threshold_uncertainty_score":0.3133324},"labels":[],"label_agreement":null},{"id":"W2789665281","doi":"10.1038/s41388-018-0171-x","title":"Classifying BRAF alterations in cancer: new rational therapeutic strategies for actionable mutations","year":2018,"lang":"en","type":"review","venue":"Oncogene","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":559,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; McGill University; McGill University Health Centre","funders":"","keywords":"Biology; Druggability; Melanoma; V600E; Cancer research; Mutation; Mutant; MAPK/ERK pathway; Cancer; Kinase; Colorectal cancer; Targeted therapy; Genetics; Gene","score_opus":0.1142483572554173,"score_gpt":0.39143045460058423,"score_spread":0.27718209734516697,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2789665281","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007583779,0.98590803,0.010981148,0.000060196824,0.00048342595,0.0007312409,0.0002690786,0.000012119918,0.0014789265],"genre_scores_gemma":[0.00019868863,0.9862614,0.0018251381,0.000100333884,0.0019784027,0.0008465594,0.003312061,0.000048212074,0.0054291864],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99890614,0.000058059744,0.00034699624,0.00038196487,0.00008898215,0.00021786953],"domain_scores_gemma":[0.9994141,0.00003917731,0.00016909311,0.00022807681,0.000083532526,0.00006604896],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010177532,0.00023132157,0.0003780094,0.00009268635,0.00013957478,0.000073498566,0.0001585601,0.0002794656,0.0000914313],"category_scores_gemma":[0.000021257967,0.00021323026,0.00021389451,0.00012748536,0.000036645106,0.000009834243,0.00003025027,0.00009061343,0.00001872216],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000036393114,0.00015571769,0.000008371786,0.0026425186,0.00044849058,0.000003135455,0.000103894,0.00019708797,0.012701438,0.0050772903,0.019278714,0.95934695],"study_design_scores_gemma":[0.00026997397,0.00012800527,0.0000018535584,0.00041414768,0.00014435186,0.000014537236,0.00003157944,0.00003113346,0.00064258405,0.00060080976,0.99749064,0.00023040253],"about_ca_topic_score_codex":0.000066371125,"about_ca_topic_score_gemma":0.0009506592,"teacher_disagreement_score":0.9782119,"about_ca_system_score_codex":0.0000721765,"about_ca_system_score_gemma":0.002863835,"threshold_uncertainty_score":0.86952776},"labels":[],"label_agreement":null},{"id":"W2802693169","doi":"10.1016/j.jid.2018.04.025","title":"Inherited Genetic Variants Associated with Melanoma BRAF/NRAS Subtypes","year":2018,"lang":"en","type":"article","venue":"Journal of Investigative Dermatology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Institute of Environmental Health Sciences; National Institute of General Medical Sciences; National Cancer Institute","keywords":"Neuroblastoma RAS viral oncogene homolog; Melanoma; Penetrance; Single-nucleotide polymorphism; Genotype; Odds ratio; V600E; Genetics; Cancer research; Biology; Medicine; Oncology; Phenotype; Mutation; Gene; Internal medicine","score_opus":0.015656443054754294,"score_gpt":0.2306325358010614,"score_spread":0.2149760927463071,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2802693169","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969139,0.0003334223,0.00087844266,0.0005199293,0.0002220435,0.00009235156,0.000012309805,0.000008178431,0.0010194414],"genre_scores_gemma":[0.99562275,0.000024302972,0.0028671995,0.0010227297,0.00029452602,0.000003469102,0.000021591743,0.000025680209,0.00011776686],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99859345,0.00030262707,0.0004355995,0.00021015316,0.00016954991,0.00028859358],"domain_scores_gemma":[0.99834603,0.000042987296,0.0005712336,0.00021140881,0.0006316264,0.00019672136],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016215988,0.00019567237,0.0003514988,0.00011007159,0.00009703971,0.000020485248,0.00027174962,0.00023165814,0.000044040324],"category_scores_gemma":[0.00058180396,0.00015081515,0.00007721373,0.00018184444,0.0007384835,0.000010888888,0.000060956085,0.0001828353,0.00001917201],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022276207,0.00010502417,0.036989268,0.000012990588,0.00047976425,0.0004532643,0.00040858515,0.0000060566745,0.9514563,0.0003182459,0.009332022,0.00021573075],"study_design_scores_gemma":[0.0014184678,0.0021265522,0.1567048,0.00006128156,0.000074726304,0.0037319004,0.000086238615,0.00004108053,0.8298064,0.0012917336,0.0044224733,0.00023435346],"about_ca_topic_score_codex":0.000008619046,"about_ca_topic_score_gemma":0.00009678443,"teacher_disagreement_score":0.1216499,"about_ca_system_score_codex":0.000018447863,"about_ca_system_score_gemma":0.0003218801,"threshold_uncertainty_score":0.61500627},"labels":[],"label_agreement":null},{"id":"W2806753114","doi":"10.1084/jem.20171960","title":"Loss of USP28-mediated BRAF degradation drives resistance to RAF cancer therapies","year":2018,"lang":"en","type":"article","venue":"The Journal of Experimental Medicine","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":58,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Terry Fox Foundation; Ministry of Education - Singapore; National Research Foundation Singapore","keywords":"Deubiquitinating enzyme; Cancer research; Melanoma; MAPK/ERK pathway; Kinase; In vivo; Cancer; V600E; Mutant; Biology; Medicine; Ubiquitin; Gene; Cell biology; Genetics","score_opus":0.016076339825746626,"score_gpt":0.29935870867977943,"score_spread":0.2832823688540328,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2806753114","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98804665,0.009022272,0.00037068248,0.0013020845,0.00039178255,0.00009260885,0.000005362156,0.0000019215931,0.000766626],"genre_scores_gemma":[0.9972321,0.0005996936,0.00023772733,0.0004961742,0.0008786283,0.0000029666658,0.0000051641555,0.000009721489,0.0005378599],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99927175,0.000071623974,0.00027938207,0.00007515627,0.00019575351,0.00010631695],"domain_scores_gemma":[0.99935526,0.000026509999,0.00023389651,0.00016064559,0.00015394569,0.0000697384],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027873582,0.000090519396,0.00016336922,0.000041503015,0.00004981567,0.0000023783161,0.00020456334,0.00003885493,0.00010171398],"category_scores_gemma":[0.000073372146,0.00005149179,0.0000345284,0.00007971527,0.00025404932,0.000004984759,0.000035887006,0.00005088798,0.0000023835137],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00068077294,0.000036981546,0.00054253015,0.000004697882,0.000057704503,0.0000019563317,0.0018923393,0.0000011696068,0.98963106,0.000042293577,0.006799001,0.00030950012],"study_design_scores_gemma":[0.00072012394,0.0017704458,0.0017171387,0.000110470086,0.000020695361,0.00002307408,0.0015539301,0.0000018605496,0.97894424,0.000022579059,0.015057107,0.00005835707],"about_ca_topic_score_codex":0.000031345524,"about_ca_topic_score_gemma":0.00004945503,"teacher_disagreement_score":0.010686836,"about_ca_system_score_codex":0.000015021972,"about_ca_system_score_gemma":0.000043748958,"threshold_uncertainty_score":0.20997742},"labels":[],"label_agreement":null},{"id":"W2808608845","doi":"10.1158/1078-0432.ccr-17-3384","title":"Dual MAPK Inhibition Is an Effective Therapeutic Strategy for a Subset of Class II BRAF Mutant Melanomas","year":2018,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":76,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; Nickel Institute; Montreal General Hospital; McGill University; McGill University Health Centre","funders":"Melanoma Research Alliance; Canadian Institutes of Health Research; V Foundation for Cancer Research; U.S. Department of Defense","keywords":"Mutant; Melanoma; Cancer research; Class (philosophy); MAPK/ERK pathway; Medicine; Biology; Genetics; Computer science; Gene; Kinase","score_opus":0.21338425190616878,"score_gpt":0.49637302213594536,"score_spread":0.2829887702297766,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2808608845","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968555,0.00044756156,0.00027282248,0.00027147876,0.00022368695,0.00081601646,0.0002628429,0.000008744427,0.0008413271],"genre_scores_gemma":[0.99719393,0.00018001799,0.00006592979,0.00028087717,0.0014382001,0.00027268467,0.00012671121,0.000027717713,0.0004139264],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978791,0.00044338766,0.00040154462,0.00056027423,0.00028726525,0.0004284351],"domain_scores_gemma":[0.9986128,0.0001455074,0.00009679329,0.00044945427,0.0005234463,0.0001719874],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018644028,0.0001341086,0.00025676354,0.0000592762,0.00019260602,0.000020971684,0.00019059327,0.00032478257,0.00012609627],"category_scores_gemma":[0.00020721338,0.000113166025,0.00015073453,0.00014925172,0.0006324961,0.0000075915495,0.00015444325,0.00025421425,0.00001273775],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021217435,0.00042343873,0.0023104083,0.00007446863,0.00014313769,0.0000055535247,0.00019276918,0.000001264941,0.9452845,0.0008569443,0.0042061103,0.044379696],"study_design_scores_gemma":[0.0020869668,0.018451124,0.012645702,0.00003903359,0.000026368953,0.000005688834,0.00014371703,0.00017691696,0.9316084,0.0020937375,0.032530848,0.00019150574],"about_ca_topic_score_codex":0.000119629745,"about_ca_topic_score_gemma":0.00048162916,"teacher_disagreement_score":0.04418819,"about_ca_system_score_codex":0.000027296917,"about_ca_system_score_gemma":0.00034519672,"threshold_uncertainty_score":0.46147767},"labels":[],"label_agreement":null},{"id":"W2808796425","doi":"10.1158/0008-5472.can-18-0027","title":"CD271+ Cells Are Diagnostic and Prognostic and Exhibit Elevated MAPK Activity in SHH Medulloblastoma","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Hospital for Sick Children; University of Toronto; Calgary Laboratory Services; University of Manitoba; Ottawa Hospital; Children's Hospital Research Institute of Manitoba","funders":"Canadian Institutes of Health Research; Canada Research Chairs; Government of Canada","keywords":"Medulloblastoma; Vismodegib; Selumetinib; Sonic hedgehog; Cancer research; Smoothened; Progenitor cell; Biology; MEK inhibitor; Population; MAPK/ERK pathway; Medicine; Stem cell; Hedgehog signaling pathway; Signal transduction; Cell biology","score_opus":0.034729770139126225,"score_gpt":0.33415707932083216,"score_spread":0.29942730918170596,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2808796425","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99761474,0.0012947603,0.0000215664,0.00020898654,0.00009112352,0.00040011495,0.000033240456,0.000008404017,0.0003270789],"genre_scores_gemma":[0.99813074,0.00087714795,0.000031873322,0.00005086992,0.00027535675,0.00015535842,0.000008032287,0.00002009642,0.00045053734],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986373,0.00016076415,0.0001077684,0.0004613616,0.00019429845,0.0004384718],"domain_scores_gemma":[0.999287,0.00013191545,0.00003233293,0.00023660636,0.00015378337,0.00015833159],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040894336,0.00012304215,0.00014023716,0.00009543172,0.00011160878,0.000041111267,0.00012408677,0.00014249381,0.000048441347],"category_scores_gemma":[0.00046027455,0.000113815455,0.000016543745,0.0001849916,0.00036265855,0.0000060693123,0.00024231174,0.00020162223,0.000016104654],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014181946,0.000047433907,0.043128,0.00007810266,0.000013149201,0.000027525788,0.000098460805,5.5062696e-7,0.95092344,0.000018876206,0.0015615039,0.003961134],"study_design_scores_gemma":[0.00056238944,0.00055919547,0.112317406,0.000101048456,0.0000052046666,0.000008468266,0.00008476053,0.00003683486,0.8798975,0.000080178455,0.006198305,0.00014874719],"about_ca_topic_score_codex":0.0002278971,"about_ca_topic_score_gemma":0.0013348527,"teacher_disagreement_score":0.07102598,"about_ca_system_score_codex":0.000029162034,"about_ca_system_score_gemma":0.00013336087,"threshold_uncertainty_score":0.46412596},"labels":[],"label_agreement":null},{"id":"W2809197883","doi":"10.2217/mmt-2017-0026","title":"Combination Therapy for Metastatic Melanoma: A Pharmacist’s Role, Drug Interactions &amp; Complementary Alternative Therapies","year":2018,"lang":"en","type":"review","venue":"Melanoma Management","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Royal Victoria Hospital","funders":"","keywords":"Medicine; Pharmacist; Vemurafenib; Metastatic melanoma; Drug; Intensive care medicine; Dabrafenib; Oncology; Trametinib; Melanoma; Internal medicine; Pharmacology; Cancer; Pharmacy; Cancer research; Nursing","score_opus":0.08007154233816013,"score_gpt":0.3657265639335599,"score_spread":0.2856550215953998,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2809197883","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00073536247,0.9822586,0.004353518,0.00009408994,0.0018018715,0.0048275767,0.0007622973,0.00005716107,0.0051094964],"genre_scores_gemma":[0.00064181985,0.9691885,0.003734983,0.00023683698,0.00079494494,0.002891,0.008545329,0.00013760415,0.013828948],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9971583,0.00035063602,0.00077263144,0.00094752025,0.0002833605,0.00048755293],"domain_scores_gemma":[0.99829113,0.00007656794,0.0005924086,0.0007891332,0.00013886254,0.00011187521],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004897567,0.0007140934,0.0009713233,0.00029734452,0.00026762218,0.00011343693,0.0007350964,0.00007691084,0.00022076542],"category_scores_gemma":[0.000011691076,0.00060574303,0.0006910216,0.0001620138,0.00009711129,0.000016658985,0.00032722572,0.0001657485,0.00018342082],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021341241,0.0007764222,0.000015081199,0.0043514436,0.0063716276,0.000019780076,0.00038861306,0.0000012882947,0.00011484194,0.0027296543,0.056746155,0.92827165],"study_design_scores_gemma":[0.0018246694,0.00035988117,0.000005844604,0.0005406166,0.0008277942,0.000030247462,0.00013964495,0.00001869557,0.00028940223,0.0005145637,0.9948371,0.0006115522],"about_ca_topic_score_codex":0.00004083592,"about_ca_topic_score_gemma":0.00010079235,"teacher_disagreement_score":0.9380909,"about_ca_system_score_codex":0.00010809629,"about_ca_system_score_gemma":0.00006321339,"threshold_uncertainty_score":0.9996394},"labels":[],"label_agreement":null},{"id":"W2877242924","doi":"10.1186/s13046-018-0812-5","title":"(Arg)9-SH2 superbinder: a novel promising anticancer therapy to melanoma by blocking phosphotyrosine signaling","year":2018,"lang":"en","type":"article","venue":"Journal of Experimental & Clinical Cancer Research","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"Fundamental Research Funds for the Central Universities; Natural Science Foundation of Hubei Province; National Natural Science Foundation of China","keywords":"Blocking (statistics); Cancer research; Melanoma; Chemistry; Medicine; Pharmacology; Computer science","score_opus":0.16310925027198273,"score_gpt":0.49484477852532266,"score_spread":0.33173552825333996,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2877242924","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98601526,0.011594913,0.0003564238,0.00058652594,0.00071048166,0.00033465397,0.00002286696,0.0000058898268,0.00037296547],"genre_scores_gemma":[0.99329793,0.00096525205,0.001358559,0.0008930006,0.0031172817,0.00003127265,0.000006134795,0.000049528127,0.00028104393],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9969896,0.00023100495,0.00087464054,0.0004812257,0.00081348687,0.00061002973],"domain_scores_gemma":[0.99819046,0.00010841661,0.00022127817,0.000331207,0.0006932303,0.00045537954],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023112122,0.00021210728,0.0004132532,0.00010754869,0.00025253877,0.000103735416,0.0005552063,0.00021307547,0.0003902886],"category_scores_gemma":[0.0002682942,0.00017230598,0.00024375781,0.00025848244,0.00037036676,0.00001862809,0.00024595315,0.0005214173,0.000015462621],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021731872,0.00058500195,0.0052419687,0.000005544998,0.00013391401,0.000012610321,0.00024796007,0.000002624348,0.9758162,0.000016958695,0.011023511,0.0047405497],"study_design_scores_gemma":[0.0024929198,0.006226264,0.00063183066,0.00011299611,0.000007861666,0.000033168242,0.00031616716,0.000016969061,0.9223979,0.000011444987,0.06755432,0.00019815011],"about_ca_topic_score_codex":0.00013655444,"about_ca_topic_score_gemma":0.000018258323,"teacher_disagreement_score":0.056530807,"about_ca_system_score_codex":0.00011835633,"about_ca_system_score_gemma":0.000503006,"threshold_uncertainty_score":0.7026434},"labels":[],"label_agreement":null},{"id":"W2884253050","doi":"10.3747/co.25.3936","title":"Overcoming Resistance in a BRAF V600e–Mutant Adenocarcinoma of the Lung","year":2018,"lang":"en","type":"article","venue":"Current Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Dabrafenib; Trametinib; Vemurafenib; Medicine; Adenocarcinoma; V600E; Mutation; Cancer research; Melanoma; Mutant; Oncology; Internal medicine; Cancer; Metastatic melanoma; Biology; MAPK/ERK pathway; Gene; Genetics; Kinase","score_opus":0.04052335778572433,"score_gpt":0.3319546082158654,"score_spread":0.29143125043014106,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2884253050","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98780775,0.005409359,0.00017193916,0.00016445243,0.0011123072,0.00017379675,0.000013289429,0.0000042047554,0.005142918],"genre_scores_gemma":[0.9990889,0.0000977381,0.00015259474,0.00008014373,0.00036484122,0.000016596496,0.0000085444635,0.000009554957,0.00018109662],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990847,0.00012243606,0.00023846078,0.00024781274,0.000086951935,0.00021959834],"domain_scores_gemma":[0.99939126,0.000022292117,0.00012293505,0.00035753162,0.000067780114,0.000038219587],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001957539,0.000100914636,0.00016937089,0.00003440998,0.00004824451,0.0000035765938,0.0002707293,0.00012440678,0.000025821815],"category_scores_gemma":[0.0001312612,0.00007771095,0.00007006878,0.00011285481,0.00019699204,0.0000021233072,0.0001856915,0.00011413459,0.0000053448716],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034112902,0.0003226355,0.33444527,0.00014271581,0.000031620388,0.000009833027,0.00074508705,0.0000012940156,0.64091766,0.003521768,0.014535877,0.0049850945],"study_design_scores_gemma":[0.00195888,0.0006530997,0.21968077,0.00017630334,0.000034614466,0.00003002968,0.00012803322,0.00009676025,0.29371464,0.0007748187,0.48246703,0.00028502644],"about_ca_topic_score_codex":0.000008531782,"about_ca_topic_score_gemma":0.0005250394,"teacher_disagreement_score":0.46793115,"about_ca_system_score_codex":0.000044104985,"about_ca_system_score_gemma":0.00017321613,"threshold_uncertainty_score":0.31689605},"labels":[],"label_agreement":null},{"id":"W2884269426","doi":"10.1017/cjn.2018.294","title":"15 CD271/p75NTR is a novel diagnostic marker, prognostic indicator and therapeutic target for SHH medulloblastoma","year":2018,"lang":"en","type":"article","venue":"Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Selumetinib; Low-affinity nerve growth factor receptor; Cancer research; Progenitor cell; MAPK/ERK pathway; Downregulation and upregulation; Biology; Population; MEK inhibitor; Stem cell; Neurotrophin; Cell biology; Medicine; Signal transduction; Receptor; Genetics","score_opus":0.02237524677293073,"score_gpt":0.25329413615216695,"score_spread":0.23091888937923621,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2884269426","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9935846,0.0021235296,0.00038190334,0.0023565965,0.00077188585,0.00027820232,0.00004725779,0.00000770269,0.00044834125],"genre_scores_gemma":[0.99071884,0.00020881313,0.0031700765,0.005151034,0.000691904,0.000010043235,8.882011e-7,0.000015201254,0.000033168555],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968995,0.00032942352,0.00059713796,0.00060945534,0.00041211664,0.0011523718],"domain_scores_gemma":[0.9969138,0.0005147626,0.000532838,0.00015099962,0.00039299426,0.0014946355],"candidate_categories":["sts"],"consensus_categories":["sts"],"category_scores_codex":[0.0024564085,0.00031333635,0.0003605704,0.00042309344,0.0019511437,0.00040904083,0.0013174122,0.0002387565,0.00010262734],"category_scores_gemma":[0.0035716307,0.0002166122,0.00017528803,0.00044214132,0.006228414,0.00006199563,0.00008511871,0.00042807974,0.0000025425181],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002479055,0.000064461434,0.98590446,0.000017167164,0.00005135109,0.0004864452,0.0004108209,0.00006438287,0.00376726,0.00091899384,0.0034805955,0.0045861797],"study_design_scores_gemma":[0.0017952895,0.35674113,0.45895672,0.00009955156,0.00018064599,0.036207467,0.00045889264,0.0023887514,0.007508561,0.022808796,0.11161614,0.0012380788],"about_ca_topic_score_codex":0.00015367474,"about_ca_topic_score_gemma":0.011265753,"teacher_disagreement_score":0.52694774,"about_ca_system_score_codex":0.000043941756,"about_ca_system_score_gemma":0.0022508232,"threshold_uncertainty_score":0.99934816},"labels":[],"label_agreement":null},{"id":"W2886364267","doi":"10.1158/1538-7445.am2018-2515","title":"Abstract 2515: Aberrant expression of CSF1R in melanoma is driven through an endogenous viral promoter and it contributes to malignant growth and BRAF-inhibitor resistance","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Workplace Health, Safety and Compensation Commission","funders":"","keywords":"Melanoma; Cancer research; Biology; Autocrine signalling; Small hairpin RNA; Cancer; Gene knockdown; Carcinogenesis; Metastasis; Cell culture; Molecular biology; Genetics","score_opus":0.053638940093703444,"score_gpt":0.3392327324144388,"score_spread":0.28559379232073534,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2886364267","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99561036,0.0020567107,0.000039405975,0.0005668364,0.00006275495,0.00047529713,0.00012244625,0.000004216514,0.0010619559],"genre_scores_gemma":[0.9982777,0.00067810394,0.0003218123,0.00015721281,0.00022324588,0.00009238826,0.00001779404,0.000019658532,0.00021204454],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985441,0.00010851685,0.00022661967,0.0004992798,0.0002165757,0.00040492558],"domain_scores_gemma":[0.9992977,0.000025230187,0.000047531285,0.00030360324,0.00020210941,0.00012382271],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035592707,0.00013304058,0.00020070066,0.00007606696,0.00011184172,0.00003373051,0.00018162208,0.0001451523,0.00003599189],"category_scores_gemma":[0.000074777265,0.00011193743,0.00002441065,0.00011093378,0.000268835,0.000017347942,0.00019666392,0.00012718441,0.00000328163],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005245561,0.000059357644,0.003611184,0.00011526878,0.000013238459,0.000019294279,0.0010734657,1.4486076e-7,0.9921249,0.00010787922,0.0019132112,0.00043747283],"study_design_scores_gemma":[0.00078919186,0.0006771826,0.007149469,0.0002147066,0.0000037713814,0.0000052500823,0.00013147466,0.000001593182,0.982665,0.000331899,0.007899416,0.00013105274],"about_ca_topic_score_codex":0.00036574676,"about_ca_topic_score_gemma":0.00090979383,"teacher_disagreement_score":0.009459934,"about_ca_system_score_codex":0.00002452588,"about_ca_system_score_gemma":0.00013148876,"threshold_uncertainty_score":0.4564676},"labels":[],"label_agreement":null},{"id":"W2887121914","doi":"10.1158/1538-7445.am2018-1206","title":"Abstract 1206: Patterns of BRAF testing and treatment in patients with metastatic melanoma presumed BRAF positive","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Medicine; Melanoma; Metastatic melanoma; Internal medicine; Mutation; Oncology; Cancer research; Biology","score_opus":0.05028103803597944,"score_gpt":0.3394714339502016,"score_spread":0.28919039591422213,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2887121914","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986071,0.00015839022,0.000010760685,0.000024642977,0.000023139362,0.0004158133,0.00013509506,0.0000026888883,0.0006223976],"genre_scores_gemma":[0.9994222,0.000035735964,0.0001673064,0.000013883767,0.000073982184,0.000078971105,0.000045185905,0.0000152047105,0.00014755435],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99902844,0.000079124206,0.00013740324,0.00028435525,0.00019452772,0.00027613566],"domain_scores_gemma":[0.9993702,0.00006326017,0.000048125625,0.00019575436,0.00024413722,0.00007849933],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017998411,0.00010204927,0.00013640124,0.000074082265,0.00005414024,0.000014662425,0.000093061186,0.000044334745,0.000031270167],"category_scores_gemma":[0.00007816078,0.000076431905,0.00001584116,0.00010398042,0.000133517,0.000005260274,0.000069279995,0.00007137265,0.000002320365],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005413723,0.0001981333,0.8075425,0.00005560249,0.00008443388,0.000012676375,0.00027436405,0.0000028520408,0.17143837,0.000009899769,0.000051752682,0.019788062],"study_design_scores_gemma":[0.001427755,0.0024154251,0.7510838,0.000077434765,0.000007707705,0.0000012500798,0.00004451269,0.0000052198898,0.2447018,0.000012862031,0.0001422389,0.00007998739],"about_ca_topic_score_codex":0.0018870039,"about_ca_topic_score_gemma":0.0014685502,"teacher_disagreement_score":0.07326344,"about_ca_system_score_codex":0.000041711843,"about_ca_system_score_gemma":0.00015812046,"threshold_uncertainty_score":0.3116803},"labels":[],"label_agreement":null},{"id":"W2887451076","doi":"10.1158/1535-7163.targ-17-b056","title":"Abstract B056: Non-V600 BRAF mutations in melanoma: actionable targets for rational drug combinations","year":2018,"lang":"en","type":"article","venue":"Molecular Cancer Therapeutics","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Concordia University; McGill University; University of Toronto","funders":"","keywords":"Trametinib; Dabrafenib; Vemurafenib; Melanoma; Cancer research; MAPK/ERK pathway; MEK inhibitor; Medicine; Kinase; Targeted therapy; Mutant; V600E; In vivo; Cell culture; Cell growth; Metastatic melanoma; Cancer; Biology; Internal medicine; Cell biology; Biochemistry; Genetics","score_opus":0.017198359884491442,"score_gpt":0.28795492942818246,"score_spread":0.27075656954369104,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2887451076","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9501817,0.0014404705,0.040091533,0.0018413552,0.0008038828,0.0008618148,0.00024218553,0.00002805042,0.004508991],"genre_scores_gemma":[0.9950894,0.0000643331,0.0016292946,0.0011474288,0.00028700457,0.0003394537,0.0005062874,0.000037949805,0.0008988357],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99897665,0.000028560427,0.00023356278,0.00033118422,0.00014754185,0.00028248478],"domain_scores_gemma":[0.99933785,0.00001809527,0.00008996253,0.0002569456,0.00023735529,0.000059808233],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013454996,0.00016864766,0.00013309982,0.00008014123,0.00017386061,0.000034083503,0.00017114368,0.00012887982,0.00007719608],"category_scores_gemma":[0.000016337735,0.00018084387,0.00009724597,0.00013431584,0.00009666762,0.00001051262,0.000033210756,0.00008800197,0.000015586584],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000089699024,0.00025270166,0.0010964659,0.000026562151,0.00013940095,0.000004429519,0.00025371675,0.0004053801,0.990908,0.002149245,0.0017825066,0.0028918912],"study_design_scores_gemma":[0.0023838547,0.0002608385,0.00968022,0.000020807549,0.000055498025,0.0000063966727,0.00012192717,0.0010996995,0.85187846,0.00341306,0.13068937,0.00038987005],"about_ca_topic_score_codex":0.00007044473,"about_ca_topic_score_gemma":0.00050367485,"teacher_disagreement_score":0.13902955,"about_ca_system_score_codex":0.00005541177,"about_ca_system_score_gemma":0.00029239213,"threshold_uncertainty_score":0.7374599},"labels":[],"label_agreement":null},{"id":"W2888332715","doi":"10.1172/jci.insight.121144","title":"The TAB1-p38α complex aggravates myocardial injury and can be targeted by small molecules","year":2018,"lang":"en","type":"article","venue":"JCI Insight","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"Menzies Centre for Australian Studies, King's College London, University of London; Biotechnology and Biological Sciences Research Council; Medical Research Council; National Institutes of Health; King's College London; National Institute for Health and Care Research; King's College Hospital NHS Foundation Trust; Francis Crick Institute; British Heart Foundation; Wellcome Trust","keywords":"Medicine; Internal medicine; Chemistry","score_opus":0.013898057202651082,"score_gpt":0.22419419619844433,"score_spread":0.21029613899579325,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2888332715","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98976856,0.0021155607,0.0001763168,0.00081665016,0.0003192437,0.00018399203,0.00016159887,0.000023245664,0.006434813],"genre_scores_gemma":[0.9964927,0.00041465202,0.00030192174,0.0010879847,0.0005450043,0.000021766304,0.000327446,0.000025078452,0.00078344275],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99908483,0.00007013898,0.00016010729,0.0003072842,0.00009689959,0.00028071727],"domain_scores_gemma":[0.9993931,0.000016247703,0.000065668704,0.0003285705,0.000087876,0.00010853004],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009434611,0.0001722802,0.0001351594,0.000020241261,0.0002909285,0.00005925949,0.00018847789,0.00013855784,0.000018114406],"category_scores_gemma":[0.000058793445,0.00012330052,0.000057522644,0.00006086986,0.00030434705,0.0000020613816,0.00015377419,0.0000767999,0.000009240971],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000611146,0.000019506286,0.00034114893,0.000004281512,0.00005333348,0.0000023634798,0.0001233329,1.1864733e-7,0.9305226,0.00042786216,0.066209294,0.0022350468],"study_design_scores_gemma":[0.00021161516,0.00036135645,0.0011708036,0.000002779346,0.000011415921,0.0000059435206,0.000042295553,0.000024329238,0.41762632,0.000097375996,0.5803056,0.00014021255],"about_ca_topic_score_codex":0.00009523619,"about_ca_topic_score_gemma":0.0002532976,"teacher_disagreement_score":0.51409626,"about_ca_system_score_codex":0.000006908925,"about_ca_system_score_gemma":0.000048006375,"threshold_uncertainty_score":0.5028049},"labels":[],"label_agreement":null},{"id":"W2890051143","doi":"10.1016/j.jbior.2018.09.010","title":"Mitogen and stress- activated protein kinase regulated gene expression in cancer cells","year":2018,"lang":"en","type":"review","venue":"Advances in Biological Regulation","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"CancerCare Manitoba Foundation","keywords":"ASK1; Protein kinase A; Mitogen-activated protein kinase; Kinase; Cell biology; c-Raf; Biology; MAP kinase kinase kinase; Cyclin-dependent kinase 2; Mitogen-activated protein kinase kinase; MAP2K7; p38 mitogen-activated protein kinases; Transcription factor; Cancer research; Gene; Genetics","score_opus":0.03389226257274681,"score_gpt":0.3238834349372045,"score_spread":0.2899911723644577,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2890051143","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0881304,0.9104557,0.000071118055,0.000004230857,0.00019363164,0.0009519205,0.00011349901,0.000014511404,0.00006498299],"genre_scores_gemma":[0.012757471,0.9844929,0.000756719,0.000008949908,0.00025931324,0.00032384318,0.0011933938,0.000025442307,0.00018196563],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9980083,0.0003123964,0.0005025656,0.0007756296,0.000101465346,0.00029961774],"domain_scores_gemma":[0.9992227,0.000031832344,0.00031268413,0.0003187695,0.000044570785,0.00006942086],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00018405977,0.00035522765,0.0006335392,0.00011298761,0.00004365356,0.000014361748,0.00018745367,0.00079625135,0.000028062968],"category_scores_gemma":[0.00009811078,0.00025047184,0.000094119205,0.00022479224,0.0001466954,0.000014045564,0.00016206165,0.00017235716,0.0000034508266],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010445273,0.000059401762,0.00023723638,0.00085991726,0.000011789034,0.0000061907504,0.000010604002,0.000019606647,0.6232175,0.000015834774,0.00002917286,0.3754283],"study_design_scores_gemma":[0.0003675583,0.00024810826,0.00032976666,0.0037281716,0.000016182143,0.0000035523944,0.000004405192,0.000008493434,0.44350824,0.00020888301,0.5511933,0.00038337518],"about_ca_topic_score_codex":0.000010418522,"about_ca_topic_score_gemma":0.00005876215,"teacher_disagreement_score":0.5511641,"about_ca_system_score_codex":0.00005638671,"about_ca_system_score_gemma":0.00006191064,"threshold_uncertainty_score":0.99999475},"labels":[],"label_agreement":null},{"id":"W2891803344","doi":"10.1016/j.pupt.2018.09.004","title":"Differential regulation of cytokine and chemokine expression by MK2 and MK3 in airway smooth muscle cells","year":2018,"lang":"en","type":"article","venue":"Pulmonary Pharmacology & Therapeutics","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"National Heart, Lung, and Blood Institute; Canadian Institutes of Health Research; National Institutes of Health; Canada Research Chairs; GlaxoSmithKline","keywords":"Chemokine; Cytokine; Cell biology; Airway; Immunology; Chemistry; Neuroscience; Medicine; Biology; Inflammation; Anesthesia","score_opus":0.010494352039516283,"score_gpt":0.2507076953803528,"score_spread":0.24021334334083652,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2891803344","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997843,0.0010268547,0.00023919388,0.0001628638,0.00022693284,0.00018833128,0.000039102815,0.000007985889,0.00026571416],"genre_scores_gemma":[0.9978444,0.0010682556,0.00014587042,0.0004320735,0.00023495175,0.000013541646,0.00008043087,0.000019240482,0.00016122224],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991437,0.00008412561,0.00020471381,0.00029735384,0.00007269601,0.00019740032],"domain_scores_gemma":[0.9996517,0.000017370689,0.00009464128,0.00013642735,0.000042114807,0.000057800396],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000083391235,0.00015160945,0.00016663295,0.000047930072,0.00005376951,0.000004897719,0.000092986294,0.00017740575,0.000093455965],"category_scores_gemma":[0.0000011194153,0.00014056901,0.000025583326,0.00005526306,0.00028678484,0.0000065466697,0.0001191314,0.00008609596,0.0000012028377],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029850108,0.0001582005,0.001598105,0.000022631317,0.000019217736,0.0000021287606,0.00009057222,0.0000010723104,0.981356,0.0000029357175,0.00046806873,0.015982512],"study_design_scores_gemma":[0.0008842077,0.0003599959,0.015366652,0.000008741363,0.000051870655,0.0000058096903,0.000027786882,0.00048771233,0.9337182,0.000048738246,0.048906848,0.00013345454],"about_ca_topic_score_codex":0.0000073428473,"about_ca_topic_score_gemma":0.0000040411837,"teacher_disagreement_score":0.048438776,"about_ca_system_score_codex":0.0000069593225,"about_ca_system_score_gemma":0.000016940357,"threshold_uncertainty_score":0.5732238},"labels":[],"label_agreement":null},{"id":"W2892144284","doi":"10.1200/jco.2016.34.15_suppl.e21054","title":"Second-line drug regimens in metastatic melanoma patients based on BRAF mutation status: A Canadian real-world retrospective study.","year":2016,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Canada; Merck Canada Inc. (Canada)","funders":"","keywords":"Medicine; Metastatic melanoma; Oncology; Melanoma; Internal medicine; Retrospective cohort study; Targeted therapy; Metastasis; Mutation; Immunotherapy; Cancer; Cancer research; Gene","score_opus":0.042917849054351455,"score_gpt":0.374787704850302,"score_spread":0.3318698557959505,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2892144284","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9929556,0.000022443846,0.000052821462,0.0009640118,0.0007592545,0.00031270814,0.00005702253,0.0000028661718,0.004873259],"genre_scores_gemma":[0.99720263,0.000048939764,0.00051634747,0.0011026196,0.00033916897,0.000009530134,0.000017548522,0.000020039797,0.0007431935],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99667764,0.0009122342,0.0014882397,0.00031640832,0.00025488247,0.00035060433],"domain_scores_gemma":[0.9973829,0.0004512939,0.0010664404,0.00026388717,0.00038308927,0.0004524221],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022310424,0.0001670639,0.00072656636,0.00029275945,0.000039692204,0.000008701528,0.00019551806,0.00016501403,0.00015998993],"category_scores_gemma":[0.0023790332,0.000111736816,0.00020674178,0.00014662772,0.00008460228,0.000012263623,0.00003140434,0.0003413225,0.000015622625],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026291653,0.002531265,0.9688539,0.000009125864,0.00022335185,0.0006789541,0.00015129389,0.000039622457,0.001132022,0.000106759595,0.0047447383,0.018899824],"study_design_scores_gemma":[0.010488318,0.021782303,0.9485196,0.000044738714,0.00006541816,0.000008058931,0.00010868128,0.000027806733,0.0006464988,0.00023463275,0.017911445,0.00016249563],"about_ca_topic_score_codex":0.0023490118,"about_ca_topic_score_gemma":0.3174242,"teacher_disagreement_score":0.3150752,"about_ca_system_score_codex":0.0003268171,"about_ca_system_score_gemma":0.002163551,"threshold_uncertainty_score":0.695031},"labels":[],"label_agreement":null},{"id":"W2898547742","doi":"10.1093/annonc/mdy289","title":"KEYNOTE-022 Part 3: Phase II randomized study of 1L dabrafenib (D) and trametinib (T) plus pembrolizumab (Pembro) or placebo (PBO) for BRAF-mutant advanced melanoma","year":2018,"lang":"fr","type":"article","venue":"Annals of Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Centre hospitalier universitaire de Québec","funders":"","keywords":"Dabrafenib; Medicine; Tolerability; Discontinuation; Pembrolizumab; Internal medicine; Placebo; Clinical endpoint; Gastroenterology; Nuclear medicine; Clinical trial; Adverse effect; Metastatic melanoma; Immunotherapy; Cancer; Pathology; Vemurafenib","score_opus":0.0654847845609551,"score_gpt":0.3826286166165271,"score_spread":0.31714383205557195,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2898547742","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9817339,0.0069789723,0.000916814,0.0014262466,0.0015729051,0.0039332574,0.00056923245,0.000017530554,0.0028511258],"genre_scores_gemma":[0.9905027,0.0025453067,0.0015147598,0.00056597294,0.000819858,0.00044614298,0.00016023518,0.00007150314,0.0033734858],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99524015,0.0010731721,0.0016068309,0.00097082264,0.00025401806,0.00085500244],"domain_scores_gemma":[0.99623585,0.00074990717,0.0011609603,0.00077190023,0.0007632609,0.0003181311],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0018821002,0.0005728352,0.002303292,0.00017014991,0.00025606772,0.00001665011,0.000466018,0.0007602309,0.00034115236],"category_scores_gemma":[0.0015720741,0.0004940633,0.0004420355,0.00019753283,0.0013695621,0.000024395476,0.00037854945,0.00022002163,0.000005930903],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6198724,0.00822306,0.000025108673,0.0004917526,0.0015923829,0.000075051605,0.003672162,0.000023855457,0.21232876,0.0011127124,0.0071151997,0.14546753],"study_design_scores_gemma":[0.39805177,0.11456429,0.000017625649,0.00009320642,0.0005174318,0.00014866542,0.0013260513,0.0004172758,0.23190337,0.00029470888,0.2521972,0.0004683986],"about_ca_topic_score_codex":0.000114025584,"about_ca_topic_score_gemma":0.0005539124,"teacher_disagreement_score":0.24508199,"about_ca_system_score_codex":0.00003275315,"about_ca_system_score_gemma":0.00094983616,"threshold_uncertainty_score":0.9997511},"labels":[],"label_agreement":null},{"id":"W2899103245","doi":"10.4049/jimmunol.1800284","title":"TAOK3 Regulates Canonical TCR Signaling by Preventing Early SHP-1–Mediated Inactivation of LCK","year":2018,"lang":"en","type":"article","venue":"The Journal of Immunology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Canadian Institutes of Health Research; McGill University","keywords":"T-cell receptor; Cell biology; Regulator; Signal transduction; Jurkat cells; Src family kinase; T cell; Superantigen; Phosphorylation; Biology; Phosphatase; Proto-oncogene tyrosine-protein kinase Src; Immunology; Immune system; Biochemistry","score_opus":0.007967681467150555,"score_gpt":0.22424725135693654,"score_spread":0.216279569889786,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2899103245","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99780154,0.0013546225,0.0002996535,0.00012585752,0.00015805004,0.0000557299,0.000002599653,0.0000016145294,0.00020034867],"genre_scores_gemma":[0.9994285,0.000117699055,0.0001486234,0.000036134057,0.00014712964,7.9148896e-7,0.000007100014,0.000008646033,0.00010537442],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991028,0.00019744756,0.00039201186,0.00007275727,0.00007860516,0.00015641432],"domain_scores_gemma":[0.99919575,0.000062148836,0.0004127471,0.00015148932,0.00015836545,0.000019515439],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00057749846,0.0000762381,0.00016735481,0.000052425796,0.00003928752,0.000003964696,0.00022591367,0.0001298941,0.000021854088],"category_scores_gemma":[0.00021067244,0.000054075157,0.00005196748,0.00008180565,0.00015890309,0.000006465443,0.00006194238,0.00015130827,0.0000023211678],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032924805,0.00004117879,0.0013435484,0.000004049459,0.00007297219,0.000001386924,0.0001938179,0.0000062979498,0.9968981,0.000025112824,0.00024467014,0.0008396251],"study_design_scores_gemma":[0.000575776,0.0012055793,0.0087795835,0.00003637276,0.000018555173,0.00007107917,0.00014138744,0.000010994293,0.98774105,0.00013400576,0.00122812,0.000057483667],"about_ca_topic_score_codex":0.00006570149,"about_ca_topic_score_gemma":0.000017761018,"teacher_disagreement_score":0.009157029,"about_ca_system_score_codex":0.000014629127,"about_ca_system_score_gemma":0.00008988548,"threshold_uncertainty_score":0.22051209},"labels":[],"label_agreement":null},{"id":"W2899366572","doi":"10.1097/md.0000000000012751","title":"Cardiac tamponade induced by dabrafenib and trametinib combination therapy for melanoma","year":2018,"lang":"en","type":"article","venue":"Medicine","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Saskatoon Medical Imaging","funders":"","keywords":"Medicine; Dabrafenib; Trametinib; Pericardiocentesis; Pericardial effusion; Cardiac tamponade; Discontinuation; Peripheral edema; Melanoma; Adverse effect; Edema; Surgery; Internal medicine; Cancer research; Vemurafenib; MAPK/ERK pathway","score_opus":0.017701767454888523,"score_gpt":0.2710314692834071,"score_spread":0.25332970182851855,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2899366572","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99420625,0.0011693268,0.0008289215,0.0014292558,0.0003851379,0.00034447704,0.000026118256,0.000011327162,0.001599189],"genre_scores_gemma":[0.9971798,0.00019804954,0.00015625778,0.0006584644,0.00076871645,0.000048483085,0.00034885725,0.00001613726,0.0006252401],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99936765,0.000037068377,0.00012699985,0.00023529414,0.000084249456,0.00014874351],"domain_scores_gemma":[0.9996099,0.000023299423,0.00004809344,0.00017576202,0.00007100313,0.000071975046],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023867626,0.00010748948,0.00015185087,0.00002681516,0.000069727444,0.000005793101,0.00007534756,0.00011214022,0.000029601084],"category_scores_gemma":[0.00008140288,0.00008275458,0.000028534474,0.000036217778,0.00011518343,0.0000020473774,0.000017918821,0.000037222027,0.0000029223943],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000100149846,0.000028309823,0.00057932,0.000007398249,0.00002750669,1.9598103e-7,0.00012532674,4.5371507e-9,0.9564328,0.00030374748,0.024100559,0.018294686],"study_design_scores_gemma":[0.002412178,0.0036687392,0.0043864907,0.000009212938,0.000014845754,0.000003035048,0.000069416936,0.000011798971,0.573724,0.0002372161,0.4153433,0.000119757286],"about_ca_topic_score_codex":0.000025632075,"about_ca_topic_score_gemma":0.000005102188,"teacher_disagreement_score":0.39124274,"about_ca_system_score_codex":0.0000042260876,"about_ca_system_score_gemma":0.00002026815,"threshold_uncertainty_score":0.33746338},"labels":[],"label_agreement":null},{"id":"W2899797865","doi":"10.1101/467605","title":"Reevaluation of the Role of ERK3 in Perinatal Survival and Post-Natal Growth Using New Genetically-Engineered Mouse Models","year":2018,"lang":"en","type":"preprint","venue":"bioRxiv (Cold Spring Harbor Laboratory)","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Institute for Research in Immunology and Cancer","funders":"","keywords":"Phenotype; Biology; Mutant; Gene; Allele; Genetics; Locus (genetics)","score_opus":0.014501900717828134,"score_gpt":0.21227047300809737,"score_spread":0.19776857229026923,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2899797865","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99626136,0.0012464169,0.0015368199,0.0000201336,0.00025066792,0.0003981737,0.00026263797,0.000012219726,0.000011600775],"genre_scores_gemma":[0.995288,0.00011206712,0.0043112673,0.000012462051,0.00020562057,0.000012757056,0.00000154983,0.00005303289,0.000003217248],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984243,0.00012875519,0.0004185732,0.0005207004,0.00026259213,0.0002450619],"domain_scores_gemma":[0.998441,0.000012863831,0.00025560305,0.0007310081,0.0004519809,0.00010754362],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00039407166,0.0002818536,0.00033706776,0.00010135089,0.00003802713,0.000022674049,0.00037247292,0.00043197055,0.0000057105703],"category_scores_gemma":[0.00022592809,0.00026388906,0.00010130771,0.00013851386,0.00014485227,0.00000940019,0.0006753564,0.00021594316,5.1957e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000062267885,0.00004055186,0.0042399145,0.0001528693,0.000053867418,0.0000012131626,0.000012716328,0.00038195483,0.9944436,0.00060325075,0.0000047987273,0.0000029980024],"study_design_scores_gemma":[0.00046397242,0.00010954054,0.037970208,0.00010641618,0.0000501097,5.2140006e-8,0.000005896328,0.005605083,0.9553496,0.000019338844,0.00004918939,0.00027057758],"about_ca_topic_score_codex":0.00022317223,"about_ca_topic_score_gemma":0.0000125544375,"teacher_disagreement_score":0.039093982,"about_ca_system_score_codex":0.00003498612,"about_ca_system_score_gemma":0.0006179698,"threshold_uncertainty_score":0.99998134},"labels":[],"label_agreement":null},{"id":"W2905822848","doi":"10.1016/j.ejca.2018.11.018","title":"An open-label, multicentre safety study of vemurafenib in patients with BRAFV600-mutant metastatic melanoma: final analysis and a validated prognostic scoring system","year":2018,"lang":"en","type":"article","venue":"European Journal of Cancer","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"Merck Sharp and Dohme; EUSA Pharma; Eisai; Genentech; Les Laboratories Pierre Fabre; Regeneron Pharmaceuticals; Chugai Pharmaceutical; Amgen; Pfizer; Bristol-Myers Squibb; F. Hoffmann-La Roche","keywords":"Vemurafenib; Medicine; Internal medicine; Tolerability; Melanoma; Metastatic melanoma; Dacarbazine; Oncology; Clinical trial; Population; Surgery; Adverse effect; Chemotherapy; Cancer research; Cancer","score_opus":0.022977513247716175,"score_gpt":0.2802544449555863,"score_spread":0.25727693170787014,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2905822848","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99885106,0.00019641804,0.0003624159,0.0000063852144,0.000081058315,0.0003530101,0.000026281157,0.0000025212507,0.000120845565],"genre_scores_gemma":[0.99914,0.000014429264,0.000702117,0.000012750086,0.000078423385,0.000002709538,0.000012270876,0.000022069853,0.000015210104],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983495,0.0005083318,0.0005206722,0.00023384989,0.00022055389,0.00016707936],"domain_scores_gemma":[0.9987763,0.000012257199,0.00049968384,0.00022656095,0.00037190685,0.00011326762],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00056890096,0.00014666207,0.0003541755,0.00013977902,0.0000560208,0.0000422916,0.00029862087,0.0000151845725,0.000009827004],"category_scores_gemma":[0.000036545523,0.000105735846,0.000024092098,0.0002829396,0.00004971294,0.00002166043,0.00010344169,0.000086317974,7.1487375e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003844666,0.0015286873,0.93505967,0.00007274269,0.0015395039,0.00019245595,0.0013535923,0.00026917376,0.05059719,0.0000043772648,0.000010685201,0.0055272332],"study_design_scores_gemma":[0.0143433735,0.0138411755,0.95963484,0.0002479593,0.0012125291,0.000018295079,0.0009834666,0.00025189127,0.009084357,3.1874094e-7,0.00016212884,0.00021964737],"about_ca_topic_score_codex":0.00005492609,"about_ca_topic_score_gemma":0.00037695072,"teacher_disagreement_score":0.041512832,"about_ca_system_score_codex":0.00002512767,"about_ca_system_score_gemma":0.00007670813,"threshold_uncertainty_score":0.43117827},"labels":[],"label_agreement":null},{"id":"W2906348647","doi":"10.1002/cpdd.643","title":"Effect of Rifampicin on the Pharmacokinetics of a Single Dose of Vemurafenib in Patients With <i>BRAF</i> <sup>V600</sup> Mutation–Positive Metastatic Malignancy","year":2018,"lang":"en","type":"article","venue":"Clinical Pharmacology in Drug Development","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada)","funders":"F. Hoffmann-La Roche","keywords":"Vemurafenib; Medicine; Pharmacokinetics; Pharmacology; Area under the curve; Dosing; Rifampicin; Confidence interval; Internal medicine; Gastroenterology; Urology; Metastatic melanoma; Cancer; Pathology; Tuberculosis","score_opus":0.01646367025858358,"score_gpt":0.3114050173212828,"score_spread":0.2949413470626992,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2906348647","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983308,0.00006398036,0.000026012602,0.00008332675,0.00022347028,0.0008792715,0.000027400472,0.0000032301857,0.00036253888],"genre_scores_gemma":[0.9987236,0.000020755564,0.0005456829,0.00046046686,0.000059941656,0.00006793179,0.000062334235,0.000017468898,0.000041786785],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99745584,0.00079082977,0.00097018736,0.00034197065,0.00019682506,0.00024434752],"domain_scores_gemma":[0.9984826,0.0006641058,0.00040798564,0.00019230659,0.00019172094,0.00006127318],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011066049,0.0002066295,0.00047304214,0.00010006025,0.000028101722,0.0000020971972,0.000263735,0.000096123724,0.000046087025],"category_scores_gemma":[0.00018127738,0.0001404581,0.00007618639,0.00021843266,0.00045596279,0.0000047568005,0.00011851796,0.00017555618,0.0000057662774],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.026339425,0.012972215,0.4845274,0.00080348004,0.0018597698,0.00010728098,0.007681996,0.0017673398,0.42482823,0.000099961166,0.0056356587,0.03337723],"study_design_scores_gemma":[0.008269846,0.004814955,0.0717115,0.00013212016,0.00009129764,0.0000013368858,0.00004542625,0.000054845175,0.91413283,0.000012396082,0.00057452027,0.00015894082],"about_ca_topic_score_codex":0.000008773456,"about_ca_topic_score_gemma":0.000014800773,"teacher_disagreement_score":0.48930457,"about_ca_system_score_codex":0.000025359479,"about_ca_system_score_gemma":0.00016793009,"threshold_uncertainty_score":0.5727715},"labels":[],"label_agreement":null},{"id":"W2908482697","doi":"10.4196/kjpp.2019.23.1.29","title":"Decursin induces apoptosis in glioblastoma cells, but not in glial cells <i>via</i> a mitochondria-related caspase pathway","year":2019,"lang":"en","type":"article","venue":"Korean Journal of Physiology and Pharmacology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Child, Adolescent and Family Mental Health","funders":"","keywords":"Apoptosis; U87; Glioma; Cancer research; Cell culture; Cyclin D1; Glioblastoma; Cytotoxic T cell; Cell biology; Chemistry; Cell cycle; Pharmacology; Medicine; Biology; In vitro; Biochemistry","score_opus":0.006112934864680502,"score_gpt":0.22724757757235925,"score_spread":0.22113464270767874,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2908482697","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99679655,0.00043012152,0.000010072628,0.00013122357,0.0022264328,0.00024027427,0.000028420656,0.000004232109,0.0001326672],"genre_scores_gemma":[0.99844384,0.00033404728,0.000092689705,0.0005792829,0.00039045827,0.000008916384,0.000013052128,0.000021701926,0.00011599071],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980325,0.00044408225,0.0006172191,0.00037789234,0.000093779585,0.0004345023],"domain_scores_gemma":[0.999165,0.00008542927,0.000358246,0.0001525745,0.00007830287,0.00016046298],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034096726,0.000259881,0.0005244165,0.00024112019,0.000039505376,0.000006989039,0.00026857867,0.00042411935,0.00017048352],"category_scores_gemma":[0.000014207343,0.00023339283,0.00013087346,0.00015461828,0.00017945051,0.000016657867,0.000108285974,0.0005312548,0.000021394837],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020604003,0.00028177496,0.0004975682,0.00004372823,0.00008545106,0.000092412745,0.0002329295,0.00020520868,0.9947915,0.000022186014,0.0009852982,0.0007015266],"study_design_scores_gemma":[0.0042517595,0.002103402,0.0009727626,0.000026573454,0.000035002176,0.00016243609,0.00008884786,0.000060654613,0.9905811,0.00019146645,0.0012897217,0.00023630599],"about_ca_topic_score_codex":0.000031462874,"about_ca_topic_score_gemma":0.000033556356,"teacher_disagreement_score":0.004210448,"about_ca_system_score_codex":0.000025143281,"about_ca_system_score_gemma":0.00015525652,"threshold_uncertainty_score":0.9517484},"labels":[],"label_agreement":null},{"id":"W2911354154","doi":"10.1016/j.jid.2019.01.027","title":"Dynamic Evolution of Clonal Composition and Neoantigen Landscape in Recurrent Metastatic Melanoma with a Rare Combination of Driver Mutations","year":2019,"lang":"en","type":"article","venue":"Journal of Investigative Dermatology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute of Genetics; Ligue Contre le Cancer; Agence Nationale de la Recherche; Institute of Cancer Research; Institut National Du Cancer; Centre National de la Recherche Scientifique; Association pour la Recherche sur le Cancer","keywords":"Neuroblastoma RAS viral oncogene homolog; Somatic evolution in cancer; Biology; Melanoma; Missense mutation; Exome sequencing; Cancer research; Exome; Genome instability; Mutation; Phenotype; Chromosome instability; V600E; Genetics; Cancer; Gene; KRAS; Chromosome; DNA; DNA damage","score_opus":0.006976649683310307,"score_gpt":0.2265958688252995,"score_spread":0.2196192191419892,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2911354154","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99784386,0.0005530526,0.001143679,0.0001703922,0.00005123476,0.00014041546,0.000017942171,9.0256066e-7,0.00007851129],"genre_scores_gemma":[0.9976646,0.00003258081,0.0022000696,0.000019387184,0.0000044270096,0.0000025659622,0.00006617986,0.0000054488496,0.000004799064],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991864,0.00016640587,0.0003637646,0.000095789685,0.00010568274,0.00008193395],"domain_scores_gemma":[0.9990932,0.00003561903,0.00051243,0.00006869411,0.00024839747,0.00004167555],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010607546,0.00008278709,0.00026094032,0.00016661572,0.000015141209,0.0000027635263,0.00006227713,0.00005777144,0.000006860017],"category_scores_gemma":[0.000035324305,0.00006806887,0.000038141225,0.00010253753,0.0001844044,0.000014825002,0.000020745387,0.000087346154,7.3514275e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023658856,0.00012519013,0.120585494,0.00012636658,0.0001089539,0.000019547602,0.00047653826,0.00019302315,0.87592864,0.002046176,0.00004567774,0.00010780554],"study_design_scores_gemma":[0.0035918225,0.0020181995,0.4120105,0.00023492782,0.00008984482,0.00141305,0.00086013286,0.0021673602,0.57464266,0.00278178,0.000040498697,0.00014926009],"about_ca_topic_score_codex":0.0000050724934,"about_ca_topic_score_gemma":0.000024472365,"teacher_disagreement_score":0.301286,"about_ca_system_score_codex":0.000016079435,"about_ca_system_score_gemma":0.0001422645,"threshold_uncertainty_score":0.2775768},"labels":[],"label_agreement":null},{"id":"W2913370005","doi":"10.1186/s12885-018-5186-8","title":"Estrogen receptor signaling regulates the expression of the breast tumor kinase in breast cancer cells","year":2019,"lang":"en","type":"article","venue":"BMC Cancer","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Saskatchewan Cancer Agency; University of Saskatchewan","funders":"Canadian Institutes of Health Research; Cure Brain Cancer Foundation; Saskatchewan Cancer Agency","keywords":"Fulvestrant; Breast cancer; Estrogen receptor; Tamoxifen; Medicine; Cancer research; Cancer; Immunohistochemistry; Surgical oncology; Estrogen; Estrogen receptor alpha; Internal medicine; Oncology","score_opus":0.006887831661311291,"score_gpt":0.21859619018600723,"score_spread":0.21170835852469594,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2913370005","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997195,0.0015174646,0.0000070648816,0.00016899974,0.00041084905,0.00027204072,0.00024074217,0.0000040344853,0.00018378164],"genre_scores_gemma":[0.9985507,0.00008646958,0.0000641616,0.00015296228,0.00027255146,0.00007245352,0.000009932959,0.000018247365,0.00077252166],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991939,0.000076120145,0.00017109026,0.00024108113,0.00012592238,0.0001918645],"domain_scores_gemma":[0.9993835,0.000013769627,0.00012549383,0.00038998947,0.000052005624,0.000035211353],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011581219,0.000121939695,0.00012593358,0.00001530544,0.00004296704,0.000011064363,0.00026572833,0.000070976304,0.00035065511],"category_scores_gemma":[0.000004859832,0.00006993087,0.00009406296,0.00008900399,0.00005628499,0.000004034795,0.00012665962,0.00007865345,0.000007233655],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000120015604,0.000021345735,0.07468233,0.000037776877,0.000007906422,2.6212638e-7,0.000054557386,0.00071063684,0.9226407,0.00002192704,0.0013562253,0.0003463396],"study_design_scores_gemma":[0.00036649054,0.00001791648,0.019182516,0.00015821995,0.000009851188,0.0000090552785,0.00008941801,0.000036603713,0.9758535,0.00001082102,0.004159538,0.00010606413],"about_ca_topic_score_codex":0.00062919204,"about_ca_topic_score_gemma":0.00019426923,"teacher_disagreement_score":0.055499814,"about_ca_system_score_codex":0.000026195237,"about_ca_system_score_gemma":0.00019288449,"threshold_uncertainty_score":0.38394275},"labels":[],"label_agreement":null},{"id":"W2913586357","doi":"10.1038/s41419-019-1350-6","title":"MKK3 modulates JNK-dependent cell migration and invasion","year":2019,"lang":"en","type":"article","venue":"Cell Death and Disease","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute of Genetics; National Natural Science Foundation of China","keywords":"Cell biology; Cell migration; Cell; Chemistry; Biology; Biochemistry","score_opus":0.006426854840862928,"score_gpt":0.19003002857505338,"score_spread":0.18360317373419047,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2913586357","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.993639,0.0032781612,0.00009519133,0.000043043925,0.00007980525,0.00016479215,0.000022680286,0.000007928648,0.0026694045],"genre_scores_gemma":[0.99593306,0.00064296054,0.00008047983,0.00021243864,0.000067336165,0.0000074104123,0.0001707105,0.000009792402,0.0028758117],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9994351,0.000019161187,0.000079786274,0.00027725482,0.00006221515,0.00012643384],"domain_scores_gemma":[0.9994776,0.0000048848174,0.000028800709,0.00018501145,0.000018809698,0.00028489463],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000041123887,0.00010316141,0.000071266186,0.000019288664,0.000045958353,0.000028069602,0.00004200993,0.0000620308,0.000024797737],"category_scores_gemma":[0.0000114550385,0.00009008924,0.000029385588,0.00001405763,0.000014712237,0.000004794371,0.00006453615,0.00002986011,0.00002590841],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012337482,0.00007289683,0.1503723,0.00012787423,0.000004059505,0.000009063581,0.000034084664,0.00001534882,0.8478728,0.00007321959,0.00061799056,0.00067702064],"study_design_scores_gemma":[0.0029231217,0.00066879136,0.14530076,0.000031954158,0.0001023799,0.00000915371,0.00014470107,0.0016838278,0.82501614,0.0012089688,0.02225999,0.0006502166],"about_ca_topic_score_codex":0.000018445888,"about_ca_topic_score_gemma":0.0000069369084,"teacher_disagreement_score":0.022856643,"about_ca_system_score_codex":0.0000026447283,"about_ca_system_score_gemma":0.00003860435,"threshold_uncertainty_score":0.36737326},"labels":[],"label_agreement":null},{"id":"W2914108875","doi":"10.1016/j.ctrv.2019.02.001","title":"Network meta-analysis of therapies for previously untreated advanced BRAF-mutated melanoma","year":2019,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":29,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Cancer Centre; McMaster University; Impact","funders":"","keywords":"Medicine; Dabrafenib; Vemurafenib; Trametinib; Dacarbazine; Oncology; Internal medicine; Ipilimumab; Melanoma; Hazard ratio; Nivolumab; Randomized controlled trial; Population; Progression-free survival; Metastatic melanoma; Cancer; Immunotherapy; Chemotherapy; Cancer research; Overall survival; Confidence interval","score_opus":0.20660714001164493,"score_gpt":0.3974582458880378,"score_spread":0.19085110587639287,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2914108875","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000018585393,0.9921441,0.00013408848,0.000015522472,0.00020957783,0.0059858686,0.0011708286,0.00001659037,0.0003048424],"genre_scores_gemma":[0.000012531369,0.98070973,0.0009432868,0.000082174396,0.00020576119,0.0070266933,0.006518159,0.000092985756,0.0044086557],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9965823,0.00045481056,0.0013341988,0.001010527,0.0001224114,0.0004957506],"domain_scores_gemma":[0.99677575,0.00009370467,0.0015271296,0.0013659223,0.00012481723,0.000112674716],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00031223128,0.00096108404,0.008394031,0.00012284378,0.000065941276,0.000022152104,0.0003921131,0.00040354792,0.0003386459],"category_scores_gemma":[0.000024685294,0.00056219305,0.0073051434,0.0006500993,0.000053114916,0.000004962422,0.000060079918,0.00007443108,0.000024045146],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004055373,0.00009193529,0.000011132702,0.005827496,0.21951368,0.0000017482682,0.000023979197,0.00005743715,0.00004057485,0.00003444337,0.0015965019,0.7727605],"study_design_scores_gemma":[0.00031937167,0.00056780316,9.801831e-7,0.00040944316,0.3666663,0.0000020293633,0.0000012584072,0.0000020140708,0.000081799735,0.000003726936,0.631636,0.0003092526],"about_ca_topic_score_codex":0.000048229504,"about_ca_topic_score_gemma":0.00017426092,"teacher_disagreement_score":0.7724513,"about_ca_system_score_codex":0.00012479014,"about_ca_system_score_gemma":0.00037311338,"threshold_uncertainty_score":0.99968296},"labels":[],"label_agreement":null},{"id":"W2915353133","doi":"10.3389/fimmu.2019.00326","title":"Editorial: TRAF Proteins in Health and Disease","year":2019,"lang":"en","type":"editorial","venue":"Frontiers in Immunology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; York University","funders":"National Institute of Environmental Health Sciences; National Institute of Allergy and Infectious Diseases","keywords":"Innate immune system; Immunity; Disease; Immunology; Medicine; Biology; Computational biology; Immune system; Internal medicine","score_opus":0.0038752051202077978,"score_gpt":0.22246115829687532,"score_spread":0.2185859531766675,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2915353133","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0021940195,0.022783753,0.00023932851,0.00015273898,0.97361094,0.0007223645,0.00016352981,0.000011903164,0.00012141651],"genre_scores_gemma":[0.0004905235,0.0071999333,0.00071143033,0.00007953284,0.987689,0.00017763411,0.0019039513,0.000066477885,0.0016814931],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99779695,0.0002807227,0.00046417664,0.00072964834,0.0001992705,0.0005292051],"domain_scores_gemma":[0.9989783,0.000033674758,0.00021069232,0.0005624063,0.00005262295,0.00016227503],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0003807896,0.0003273767,0.00061393407,0.00024400321,0.000036878588,0.000019536556,0.0003479399,0.0013859349,0.0000038148146],"category_scores_gemma":[0.0010841344,0.00034698503,0.00007613077,0.0000935335,0.00014985153,0.0000046039427,0.00019976293,0.0007727067,0.0000064566916],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00069228106,0.000072981464,0.0011297567,0.00021957161,0.00004863717,0.000009657702,0.00007432875,0.000002609207,0.00091799465,0.000018694645,0.99554235,0.0012711444],"study_design_scores_gemma":[0.0016544965,0.00065439334,0.00015240196,0.00012851392,0.0000065537342,8.854891e-7,0.00007681578,0.000004948729,0.00007281856,0.0002844724,0.9966474,0.00031626382],"about_ca_topic_score_codex":0.00019102862,"about_ca_topic_score_gemma":0.00009630785,"teacher_disagreement_score":0.01558382,"about_ca_system_score_codex":0.00011734211,"about_ca_system_score_gemma":0.0019459781,"threshold_uncertainty_score":0.9999105},"labels":[],"label_agreement":null},{"id":"W2915924826","doi":"","title":"The Mechanisms of ERK1/2 Involvement in Neuron Death after Ischemic Injury and Axotomy","year":2018,"lang":"en","type":"article","venue":"Investigative Ophthalmology & Visual Science","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Rehabilitation Institute; University of Toronto","funders":"","keywords":"Axotomy; Ischemic injury; Medicine; Neuroscience; Ischemia; Cardiology; Internal medicine; Biology; Central nervous system","score_opus":0.02246056207473737,"score_gpt":0.3003845064423126,"score_spread":0.2779239443675753,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2915924826","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9982684,0.00012921686,0.00001635987,0.00009135191,0.00015717177,0.00020827909,0.000006134125,0.0000035944101,0.001119463],"genre_scores_gemma":[0.99893796,0.000011991783,0.0005783756,0.00024471272,0.000053844233,0.00005605591,0.0000028592733,0.000007959811,0.000106242085],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987138,0.00010255495,0.00021667461,0.00046012716,0.00017268832,0.0003341917],"domain_scores_gemma":[0.9993793,0.00002761071,0.00010419272,0.0002466567,0.00012162437,0.00012061866],"candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.00062274816,0.00014132439,0.00012949773,0.000064779284,0.0001641252,0.000019540319,0.00032632367,0.00009188929,0.000014491893],"category_scores_gemma":[0.00022322421,0.00010387337,0.000024396533,0.00024958418,0.003401996,0.00001303026,0.0003939943,0.00009686415,0.000005673287],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000058809896,0.000027221453,0.02774313,0.000005121185,0.0000049430064,0.0000107633505,0.00014552817,1.536977e-7,0.97131765,0.000515022,0.000028356493,0.00014329323],"study_design_scores_gemma":[0.00014955434,0.0013879342,0.10010558,0.000014651658,0.000003870974,0.00003642405,0.000086051055,0.00003616055,0.8937357,0.0040563056,0.00028208597,0.000105685824],"about_ca_topic_score_codex":0.00005709207,"about_ca_topic_score_gemma":0.000018110126,"teacher_disagreement_score":0.077581964,"about_ca_system_score_codex":0.000016471256,"about_ca_system_score_gemma":0.00020194952,"threshold_uncertainty_score":0.9993102},"labels":[],"label_agreement":null},{"id":"W2916721669","doi":"10.1038/s41391-019-0134-5","title":"MEK-ERK signaling is a therapeutic target in metastatic castration resistant prostate cancer","year":2019,"lang":"en","type":"article","venue":"Prostate Cancer and Prostatic Diseases","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":96,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"U.S. National Library of Medicine; National Cancer Institute; Stand Up To Cancer; Prostate Cancer Foundation","keywords":"Medicine; Prostate cancer; Castration; Oncology; MAPK/ERK pathway; Prostate; Cancer research; Cancer; Internal medicine; Orchiectomy; Signal transduction; Hormone","score_opus":0.012716193190937043,"score_gpt":0.26943046605789966,"score_spread":0.25671427286696263,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2916721669","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96986836,0.026335035,0.000032688095,0.00044923433,0.00020703665,0.0015222165,0.0013679432,0.000022376154,0.00019510863],"genre_scores_gemma":[0.9930026,0.0028592888,0.00030832933,0.0009122004,0.000069993395,0.00082187686,0.00031251257,0.000050685845,0.0016625051],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998107,0.00010428975,0.00040669105,0.00065058714,0.0002446982,0.00048670746],"domain_scores_gemma":[0.9992206,0.000032805656,0.00016967731,0.0002782989,0.00011538406,0.00018322624],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000175918,0.0003206531,0.00033631487,0.00008692937,0.00009583803,0.000105238134,0.00011951227,0.000060687053,0.00021526031],"category_scores_gemma":[0.000025024394,0.00027687117,0.00007601542,0.00018817233,0.00009169253,0.000032090476,0.000061341525,0.000109655135,0.000009799439],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029132306,0.00027478155,0.286315,0.0018657477,0.00032386245,0.000050760103,0.00450983,0.0008089017,0.68073505,0.00027647475,0.0009844413,0.02094194],"study_design_scores_gemma":[0.020822862,0.005293767,0.21976964,0.0022958699,0.0011709761,0.000047275953,0.0076509197,0.0041873483,0.6435088,0.018309563,0.07222483,0.0047181523],"about_ca_topic_score_codex":0.00033257346,"about_ca_topic_score_gemma":0.00017079404,"teacher_disagreement_score":0.071240395,"about_ca_system_score_codex":0.00004445941,"about_ca_system_score_gemma":0.0004612416,"threshold_uncertainty_score":0.99996835},"labels":[],"label_agreement":null},{"id":"W2917321490","doi":"10.1016/j.ejca.2019.01.017","title":"Neurotoxicity induced by targeted therapies in patients treated for metastatic melanoma","year":2019,"lang":"en","type":"letter","venue":"European Journal of Cancer","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Vemurafenib; Dabrafenib; Trametinib; Medicine; Melanoma; Internal medicine; Oncology; Rash; Dermatology; Cancer research; Metastatic melanoma; MAPK/ERK pathway; Chemistry","score_opus":0.017833210656384584,"score_gpt":0.24688768634669964,"score_spread":0.22905447569031506,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2917321490","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9808972,0.0027688395,0.00011980458,0.013325398,0.0010868221,0.00072239264,0.0004943171,0.00000553338,0.0005796836],"genre_scores_gemma":[0.8237546,0.0004738415,0.00024706905,0.1668702,0.0036010107,0.000038339436,0.0010745617,0.00028661604,0.0036537254],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981248,0.00051080034,0.00056048646,0.00027693718,0.00023493597,0.00029206384],"domain_scores_gemma":[0.99874187,0.000028420687,0.0006915774,0.00023419868,0.00025608632,0.000047878635],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031910746,0.00029538467,0.00043724978,0.00011760373,0.000027885555,0.00003055511,0.0003773248,0.00013265287,0.000040454885],"category_scores_gemma":[0.00008106976,0.00023651555,0.00022480956,0.00006560113,0.000026271573,0.0000067408964,0.000044310582,0.00053665997,0.0000065994855],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003568044,0.00006678362,0.0035356276,0.00007987017,0.0003134276,0.00007049187,0.000057671747,0.000004554051,0.1381047,3.4585102e-7,0.85396934,0.0034403482],"study_design_scores_gemma":[0.003240539,0.002430406,0.007291114,0.00008937566,0.00008851626,0.000005910248,0.0000055711334,0.0000023599493,0.035162974,0.0000032502771,0.95136505,0.00031492423],"about_ca_topic_score_codex":0.000010094503,"about_ca_topic_score_gemma":0.0000048308943,"teacher_disagreement_score":0.15714258,"about_ca_system_score_codex":0.00003425582,"about_ca_system_score_gemma":0.00011334769,"threshold_uncertainty_score":0.9644824},"labels":[],"label_agreement":null},{"id":"W2939988319","doi":"10.1200/jco.2015.33.15_suppl.e20094","title":"Evolution of BRAF gene mutation testing and treatment options in BRAF mutation carriers in Canada.","year":2015,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Dabrafenib; Vemurafenib; Trametinib; Medicine; Ipilimumab; Oncology; Internal medicine; Melanoma; Mutation; Cancer; Metastatic melanoma; Immunotherapy; Cancer research; Gene; MAPK/ERK pathway; Genetics","score_opus":0.09995703269657306,"score_gpt":0.37960054990944736,"score_spread":0.2796435172128743,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2939988319","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984683,0.00045167972,0.0002424448,0.0002058978,0.00030738124,0.00008064595,0.000005807638,6.1868127e-7,0.00023725424],"genre_scores_gemma":[0.9962554,0.00008572845,0.0033975,0.000055008837,0.00017955362,0.0000026851505,0.000007690542,0.000004340017,0.000012111807],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985318,0.0002526622,0.00090706535,0.000108049986,0.000099770725,0.00010062397],"domain_scores_gemma":[0.9987985,0.00023418132,0.0005817701,0.000063736414,0.00019252548,0.00012931267],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009450303,0.00006228113,0.00032503117,0.000068625974,0.000010419867,0.000002094128,0.00004848536,0.00014742515,0.0000013102039],"category_scores_gemma":[0.0023698343,0.000053400297,0.000042329397,0.000085749285,0.000045048662,0.0000072573903,0.000016462336,0.00011347961,1.883528e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012164142,0.0006151538,0.76365286,0.000016568274,0.00010120306,0.0005836108,0.00030893556,0.012326359,0.05256103,0.0000924832,0.00037365584,0.16815175],"study_design_scores_gemma":[0.0082699675,0.010787523,0.96833414,0.000035743975,0.00006126948,0.00047035192,0.0012650875,0.0022393744,0.0060929614,0.00068403303,0.0016278515,0.00013170844],"about_ca_topic_score_codex":0.100697465,"about_ca_topic_score_gemma":0.5643015,"teacher_disagreement_score":0.463604,"about_ca_system_score_codex":0.00036922615,"about_ca_system_score_gemma":0.0051724934,"threshold_uncertainty_score":0.91757816},"labels":[],"label_agreement":null},{"id":"W2942062551","doi":"10.1358/dot.2019.55.4.2958476","title":"Encorafenib and binimetinib for the treatment of BRAFV600E/K-mutated melanoma","year":2019,"lang":"en","type":"review","venue":"Drugs of today","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Melanoma; MAPK/ERK pathway; Metastatic melanoma; V600E; Cancer research; Oncology; Kinase; Pharmacology; Mutation; Internal medicine; Biology; Genetics","score_opus":0.04074034639323368,"score_gpt":0.3182639523817377,"score_spread":0.277523605988504,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2942062551","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0019007359,0.9953208,0.000038713428,0.000017199924,0.0002678185,0.0012794676,0.00052166596,0.0000044087574,0.0006492175],"genre_scores_gemma":[0.0010995872,0.9959205,0.00021324882,0.000010560188,0.00015873747,0.00013982867,0.0005437486,0.00003913536,0.0018746924],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9988687,0.00007058049,0.00044640797,0.00034315826,0.0000905817,0.00018058409],"domain_scores_gemma":[0.9987227,0.0001963721,0.00042109424,0.00054410216,0.00006951325,0.000046272427],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016406257,0.00029406146,0.00097099994,0.000055100132,0.00003428814,0.000007779531,0.00024130118,0.0002784668,0.000013912882],"category_scores_gemma":[0.000037732087,0.00017174995,0.0004958543,0.00006324753,0.000093045805,0.0000013554367,0.000057587302,0.000042252443,0.0000054117777],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005805655,0.0001342631,0.000012699645,0.0044779163,0.0007244644,6.406922e-7,0.00011235979,5.5920776e-7,0.0014279878,0.0001280815,0.0010288897,0.99189407],"study_design_scores_gemma":[0.0005617005,0.0012866043,0.0000050250815,0.00043509755,0.00087691663,0.000008492454,0.000026314692,0.0000030865629,0.009883668,0.0000117636455,0.9867259,0.00017543045],"about_ca_topic_score_codex":0.000026299525,"about_ca_topic_score_gemma":0.0000041515436,"teacher_disagreement_score":0.99171865,"about_ca_system_score_codex":0.000010563691,"about_ca_system_score_gemma":0.00016920581,"threshold_uncertainty_score":0.70037603},"labels":[],"label_agreement":null},{"id":"W2945161193","doi":"10.1177/2050313x19847358","title":"Cobimetinib- and vemurafenib-induced granulomatous dermatitis and erythema induratum: A case report","year":2019,"lang":"en","type":"article","venue":"SAGE Open Medical Case Reports","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Juravinski Hospital; Juravinski Cancer Centre","funders":"","keywords":"Medicine; Vemurafenib; Dermatology; Internal medicine; Metastatic melanoma; Cancer","score_opus":0.01063546363307694,"score_gpt":0.26792881881206115,"score_spread":0.2572933551789842,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2945161193","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99199647,0.00081368745,0.00006638208,0.0002632385,0.000358399,0.00073863164,0.000013607805,0.000018002298,0.005731614],"genre_scores_gemma":[0.99778724,0.0001012101,0.0003405115,0.00053817744,0.00013500068,0.00005221793,0.00009707918,0.00003242806,0.00091614755],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9979031,0.000115293326,0.0006194563,0.00072398427,0.00031761374,0.00032053632],"domain_scores_gemma":[0.9983459,0.000042496315,0.00028791992,0.000708128,0.000067181834,0.0005483776],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010622944,0.00024163774,0.00038179546,0.000043443513,0.0001571453,0.00011842982,0.0000914232,0.0003619486,0.0002732367],"category_scores_gemma":[0.00061542954,0.00020871038,0.00005814053,0.00008405701,0.0001119307,0.000017544686,0.0005998777,0.00022099326,0.000008409116],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000018102366,0.000047587615,0.0036114436,0.000069077374,0.00004831751,0.96780443,0.00009317214,3.4938292e-8,0.015846424,0.000017527995,0.0014069101,0.011036978],"study_design_scores_gemma":[0.0006928187,0.00023079992,0.00057966035,0.00008168407,0.000036613143,0.96839446,0.00022299917,0.000016304937,0.014902761,0.00009701942,0.014468357,0.00027650845],"about_ca_topic_score_codex":0.00063028705,"about_ca_topic_score_gemma":0.0003625434,"teacher_disagreement_score":0.013061447,"about_ca_system_score_codex":0.000009154548,"about_ca_system_score_gemma":0.0002665893,"threshold_uncertainty_score":0.8510963},"labels":[],"label_agreement":null},{"id":"W2945717805","doi":"10.1097/cmr.0000000000000608","title":"Effectiveness of dabrafenib in the treatment of patients with BRAF V600–mutated metastatic melanoma in a Named Patient Program","year":2019,"lang":"en","type":"article","venue":"Melanoma Research","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia Hospital","funders":"","keywords":"Dabrafenib; Metastatic melanoma; Melanoma; Medicine; Cancer research; Oncology; Internal medicine; Vemurafenib","score_opus":0.019890890050654916,"score_gpt":0.310129275355793,"score_spread":0.29023838530513807,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2945717805","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99588,0.00028093212,0.0000049786254,0.000014149675,0.00004060019,0.003055388,0.00004969421,0.0000043170535,0.00066996174],"genre_scores_gemma":[0.9989359,0.000030111416,0.00015615646,0.00000379275,0.000009117836,0.0005281648,0.0002747392,0.00002240239,0.000039642702],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970276,0.0012417175,0.0003539756,0.00040383666,0.00053778297,0.00043509278],"domain_scores_gemma":[0.99881613,0.00024292075,0.00010364918,0.00056522764,0.00021665652,0.000055415494],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00085709227,0.00018659391,0.0003728873,0.0002388461,0.000028178665,0.0000139940885,0.0002925034,0.000093319235,0.000020638217],"category_scores_gemma":[0.00006763587,0.00011360355,0.00007523788,0.00054475386,0.00014975565,0.000006950858,0.000064943735,0.00013128038,0.000008806898],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0046150335,0.0071402024,0.8798667,0.000514466,0.00017818676,0.00006592373,0.0016464993,0.00008543333,0.081740156,0.00015431143,0.0000145297645,0.023978569],"study_design_scores_gemma":[0.0068802745,0.025807396,0.73218274,0.00013366292,0.000015967647,0.000005135618,0.0005335496,0.00006722947,0.23296337,0.00005897599,0.0011688466,0.0001828403],"about_ca_topic_score_codex":0.00038272908,"about_ca_topic_score_gemma":0.0002479329,"teacher_disagreement_score":0.15122321,"about_ca_system_score_codex":0.00006255645,"about_ca_system_score_gemma":0.00016218175,"threshold_uncertainty_score":0.4632618},"labels":[],"label_agreement":null},{"id":"W2945906071","doi":"10.1016/j.bmcl.2019.05.032","title":"Tool inhibitors and assays to interrogate the biology of the TRAF2 and NCK interacting kinase","year":2019,"lang":"en","type":"article","venue":"Bioorganic & Medicinal Chemistry Letters","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"TC Scientific (Canada)","funders":"National Institutes of Health; Ministry of Education, India; National Institute of Neurological Disorders and Stroke; National Institute of Mental Health; Ministry of Earth Sciences","keywords":"TRAF2; Kinase; Context (archaeology); Small molecule; In silico; Chemistry; Cell biology; Computational biology; Cancer research; Biology; Biochemistry; Gene; Receptor","score_opus":0.005079186828949344,"score_gpt":0.20980534846051058,"score_spread":0.20472616163156124,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2945906071","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99427235,0.00032021356,0.00003069863,0.004623212,0.00030559232,0.0001863809,0.000010412699,0.0000063875327,0.00024478082],"genre_scores_gemma":[0.99793637,0.000019008912,0.00003696348,0.001585838,0.000288469,0.0000067897763,0.000009479397,0.000014821006,0.00010226024],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999105,0.000047714406,0.00022512388,0.00031671952,0.000100734906,0.00020472959],"domain_scores_gemma":[0.99938923,0.00004575651,0.00011571564,0.0003490596,0.000027628788,0.00007260847],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023834729,0.0001634126,0.00016497674,0.000013425525,0.00005862609,0.000012049011,0.00024131064,0.00010491932,0.000041521667],"category_scores_gemma":[0.00019704166,0.000098788165,0.0000520937,0.000074870506,0.00018481196,0.0000027838885,0.00027033046,0.00017274206,0.0000039311917],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003946428,0.000009512358,0.0070034317,0.000059289898,0.000031171345,0.0000017705595,0.00023170759,5.498067e-7,0.99053276,0.000007263166,0.000983789,0.0010992953],"study_design_scores_gemma":[0.0004079737,0.00009085412,0.0026416774,0.00008504043,0.000027806804,0.00008583924,0.0005178184,0.000009977949,0.9877542,0.0000052927967,0.0082429005,0.00013060057],"about_ca_topic_score_codex":0.000022115797,"about_ca_topic_score_gemma":0.00000467601,"teacher_disagreement_score":0.0072591114,"about_ca_system_score_codex":0.000013316881,"about_ca_system_score_gemma":0.000033897963,"threshold_uncertainty_score":0.40284646},"labels":[],"label_agreement":null},{"id":"W2948740360","doi":"10.1038/s41591-019-0448-9","title":"Dabrafenib, trametinib and pembrolizumab or placebo in BRAF-mutant melanoma","year":2019,"lang":"en","type":"article","venue":"Nature Medicine","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":323,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Centre hospitalier universitaire de Québec","funders":"Merck Sharp and Dohme","keywords":"Dabrafenib; Trametinib; Pembrolizumab; Melanoma; Medicine; Mutant; Cancer research; Oncology; Internal medicine; Vemurafenib; Biology; Immunotherapy; Metastatic melanoma; Genetics; MAPK/ERK pathway; Cancer; Phosphorylation; Gene","score_opus":0.005862682673053842,"score_gpt":0.2530370359029938,"score_spread":0.24717435322993997,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2948740360","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98438805,0.0031738987,0.000028944827,0.0008858199,0.0004626727,0.00035803806,0.000010486472,0.000014005017,0.010678101],"genre_scores_gemma":[0.99530596,0.00024284345,0.00013652554,0.0011305704,0.00041354678,0.000012418797,0.000092829185,0.000022701608,0.0026426294],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99885756,0.000058203244,0.00022248382,0.00042041801,0.00017776286,0.0002635841],"domain_scores_gemma":[0.99941593,0.000038933595,0.00006286393,0.00033602674,0.00003568506,0.000110528534],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002692339,0.00019150968,0.00028784233,0.0000899418,0.000024194418,0.0000070875417,0.00016016532,0.00045857453,0.0002521366],"category_scores_gemma":[0.00023793931,0.00012686558,0.00003166889,0.00013037938,0.00007875059,0.000003542676,0.00006908543,0.00038078064,0.000017097365],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014898888,0.00006627198,0.009792275,0.00010444834,0.000037669557,0.00010534122,0.00023370406,0.0000022596037,0.97781825,0.0005505081,0.0049469564,0.004852421],"study_design_scores_gemma":[0.033858813,0.0066053728,0.061111968,0.0004405701,0.000089618785,0.001218236,0.000819965,0.00021964748,0.41121662,0.0003472147,0.4830629,0.0010090775],"about_ca_topic_score_codex":0.000022076598,"about_ca_topic_score_gemma":0.00013071092,"teacher_disagreement_score":0.56660163,"about_ca_system_score_codex":0.000012086321,"about_ca_system_score_gemma":0.000071911905,"threshold_uncertainty_score":0.5173428},"labels":[],"label_agreement":null},{"id":"W2948866156","doi":"10.1371/journal.pcbi.1007034","title":"Phenotypic heterogeneity and evolution of melanoma cells associated with targeted therapy resistance","year":2019,"lang":"en","type":"article","venue":"PLoS Computational Biology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":58,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; Banting Research Foundation; Jean Perkins Foundation; V Foundation for Cancer Research","keywords":"Biology; Epigenetics; Phenotype; Population; Reprogramming; Transcriptome; Phenotypic plasticity; Computational biology; Systems biology; Somatic evolution in cancer; Genetics; Cell; Cancer; Gene expression; Gene","score_opus":0.009154825070728376,"score_gpt":0.20808523803071896,"score_spread":0.1989304129599906,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2948866156","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967592,0.00096437475,0.0016118214,0.000027293554,0.000055085042,0.00018099968,0.00007713473,0.000009854807,0.00031427978],"genre_scores_gemma":[0.99819344,0.000020517531,0.0011926861,0.00006540451,0.000029825751,0.0000080686605,0.00039788254,0.000009597757,0.00008259546],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999312,0.00009723848,0.00014340176,0.0002523285,0.00006771518,0.00012732825],"domain_scores_gemma":[0.9995634,0.000044915923,0.00011910751,0.00011434924,0.00012593887,0.000032313896],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007362072,0.00010219507,0.00015445355,0.000033322787,0.000032313215,0.0000036066872,0.000074885116,0.00011380422,0.000012288744],"category_scores_gemma":[0.00001944838,0.00008425786,0.000028559467,0.00005914657,0.00008372875,0.00000265076,0.000030075653,0.000041395106,0.000005357754],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025172578,0.000085036794,0.12533972,0.000012246931,0.00014431553,4.6211522e-7,0.000019699908,0.00033895505,0.87212396,0.0015425702,0.000053500087,0.00008782909],"study_design_scores_gemma":[0.0023921637,0.0017956474,0.483768,0.00003019565,0.000021219554,0.0000048021748,0.000023843657,0.001048811,0.506826,0.0029812825,0.0007948386,0.00031322578],"about_ca_topic_score_codex":0.000005233318,"about_ca_topic_score_gemma":0.000030011102,"teacher_disagreement_score":0.36529794,"about_ca_system_score_codex":0.000013165907,"about_ca_system_score_gemma":0.00006453046,"threshold_uncertainty_score":0.34359357},"labels":[],"label_agreement":null},{"id":"W2948884915","doi":"10.1038/s41591-019-0476-5","title":"Combined BRAF and MEK inhibition with PD-1 blockade immunotherapy in BRAF-mutant melanoma","year":2019,"lang":"en","type":"article","venue":"Nature Medicine","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":326,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"National Cancer Institute; National Institutes of Health; Nature","keywords":"Medicine; Dabrafenib; Melanoma; Trametinib; Pembrolizumab; MEK inhibitor; Immunotherapy; Discontinuation; Blockade; Internal medicine; Oncology; Adverse effect; Combination therapy; Targeted therapy; MAPK/ERK pathway; Vemurafenib; Immunology; Pharmacology; Cancer research; Cancer; Kinase; Metastatic melanoma; Biology; Receptor","score_opus":0.0024313152308695026,"score_gpt":0.20831390238842046,"score_spread":0.20588258715755095,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2948884915","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99224085,0.0033221852,0.000047285284,0.0012479158,0.00020096185,0.0003193176,0.0000071671147,0.000013400579,0.0026009316],"genre_scores_gemma":[0.99729043,0.00027912328,0.00012575138,0.0013443475,0.00021730553,0.000011154404,0.00016921607,0.000022773935,0.0005398668],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999082,0.00004224757,0.00017657103,0.00032775768,0.00016983307,0.00020154055],"domain_scores_gemma":[0.9995309,0.000015386377,0.00006917084,0.00027185885,0.000047141755,0.00006551688],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018554289,0.00017477864,0.00024009275,0.00008048589,0.000027438762,0.0000067579763,0.00008104361,0.0003232635,0.00007144124],"category_scores_gemma":[0.00003015291,0.000119987235,0.000022084292,0.00012474075,0.0000832571,0.0000043230702,0.00003228992,0.0003051044,0.000006008216],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047702854,0.000042518237,0.011610361,0.000032381813,0.000030947056,0.000038025773,0.00013558927,0.0000012999593,0.9855612,0.00034272939,0.00046550436,0.0012624434],"study_design_scores_gemma":[0.014146759,0.005704735,0.07601328,0.00030890337,0.00002966909,0.00025444213,0.00025257363,0.00004681145,0.8693783,0.00030631814,0.03312759,0.00043058183],"about_ca_topic_score_codex":0.000032828833,"about_ca_topic_score_gemma":0.00007699897,"teacher_disagreement_score":0.11618284,"about_ca_system_score_codex":0.000012167331,"about_ca_system_score_gemma":0.000040904848,"threshold_uncertainty_score":0.48929372},"labels":[],"label_agreement":null},{"id":"W2950933169","doi":"10.1002/chin.201544271","title":"ChemInform Abstract: Recent Progress on MAP Kinase Pathway Inhibitors","year":2015,"lang":"en","type":"article","venue":"ChemInform","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Chemistry; Nanotechnology; Computational biology","score_opus":0.021048559248135597,"score_gpt":0.24485972743238557,"score_spread":0.22381116818424998,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2950933169","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.10478752,0.00058093213,2.388852e-7,0.0002759236,0.00073855405,0.00033788782,0.00003874574,0.00006408235,0.89317614],"genre_scores_gemma":[0.9476796,0.000106218606,0.00008557473,0.00072459463,0.0013273769,0.00014495263,0.0011213779,0.000059571386,0.048750743],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99856097,1.5050743e-7,0.00034447436,0.00033392402,0.0003161847,0.00044428548],"domain_scores_gemma":[0.99871314,0.0000069978796,0.00015702909,0.0005548133,0.00017575722,0.00039227068],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00024079492,0.0002900925,0.00019043956,0.000047539652,0.000059808008,0.000046098496,0.00028219455,0.0002967365,0.00015207332],"category_scores_gemma":[0.00011789971,0.0002543707,0.00010765164,0.00009153775,0.00010207434,0.000012822019,0.00015343467,0.00016444863,0.00036195078],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021721257,0.00015096486,0.000096886186,0.00007581713,0.000033062104,0.000029762177,0.00022217292,3.3240474e-7,0.028904123,0.00016293247,0.32407936,0.6460274],"study_design_scores_gemma":[0.00046258932,0.00020534225,0.000057589677,0.000019592624,0.000003921585,0.000011446002,0.00010659194,5.453577e-7,0.51094466,0.000024387953,0.48797542,0.00018788685],"about_ca_topic_score_codex":0.000004116755,"about_ca_topic_score_gemma":0.000004172963,"teacher_disagreement_score":0.8444254,"about_ca_system_score_codex":0.00007209166,"about_ca_system_score_gemma":0.00024912824,"threshold_uncertainty_score":0.9999909},"labels":[],"label_agreement":null},{"id":"W2953511998","doi":"10.1200/po.18.00266","title":"Efficacy of Vemurafenib in Patients With Non–Small-Cell Lung Cancer With <i>BRAF</i> V600 Mutation: An Open-Label, Single-Arm Cohort of the Histology-Independent VE-BASKET Study","year":2019,"lang":"en","type":"article","venue":"JCO Precision Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":66,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada)","funders":"National Cancer Institute","keywords":"Medicine; Vemurafenib; Internal medicine; Cohort; Lung cancer; Clinical endpoint; Oncology; Adverse effect; Progression-free survival; Cancer; Surgery; Clinical trial; Overall survival; Metastatic melanoma","score_opus":0.01430066329293688,"score_gpt":0.27751511090114606,"score_spread":0.26321444760820917,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2953511998","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947349,0.00007666886,0.000050691135,0.000033312,0.00035096655,0.0028987199,0.00002453969,0.00000501645,0.001825207],"genre_scores_gemma":[0.9986949,0.000008892235,0.000488482,0.00012815365,0.0000313456,0.00013587376,0.000068543115,0.000030659226,0.00041313228],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998101,0.0003216501,0.0004487523,0.00058727467,0.00028800103,0.0002533239],"domain_scores_gemma":[0.99831766,0.00007940884,0.00049477245,0.0007668611,0.0002663815,0.00007489816],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036383915,0.00022038905,0.00049944385,0.00007473258,0.00005001831,0.000011349789,0.00070642267,0.00023919516,0.000056354475],"category_scores_gemma":[0.000029085144,0.00014497114,0.000028219192,0.00018466811,0.00010470934,0.000011670348,0.00035654442,0.00018035552,0.0000026481453],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00502763,0.010353246,0.8721364,0.00004017642,0.00011509656,0.000011740014,0.00059698254,0.000366317,0.105190285,0.000006275466,0.00013544789,0.0060204114],"study_design_scores_gemma":[0.031439237,0.041885294,0.85407937,0.000099453195,0.00018019171,0.0000117715335,0.0002491673,0.000059688085,0.07049302,0.0000049309806,0.0011643101,0.00033358939],"about_ca_topic_score_codex":0.00015801466,"about_ca_topic_score_gemma":0.0019232255,"teacher_disagreement_score":0.03469726,"about_ca_system_score_codex":0.00010311559,"about_ca_system_score_gemma":0.00048070098,"threshold_uncertainty_score":0.59117514},"labels":[],"label_agreement":null},{"id":"W295353521","doi":"","title":"Role of mitogen-activated protein kinase in cardiac hypertrophy and heart failure.","year":2003,"lang":"en","type":"article","venue":"PubMed","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":128,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; St. Boniface Hospital","funders":"","keywords":"p38 mitogen-activated protein kinases; Kinase; Mitogen-activated protein kinase; Cell biology; Signal transduction; MAPK/ERK pathway; Protein kinase A; Biology","score_opus":0.00654977939369372,"score_gpt":0.17670737311966978,"score_spread":0.17015759372597605,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W295353521","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970255,0.0012232084,0.0000046045516,0.00003494032,0.00005310188,0.000483577,0.000011030028,0.000004541186,0.0011595272],"genre_scores_gemma":[0.9990192,0.00001461244,0.00025411425,0.000027106486,0.000035771725,0.00046102874,0.000013544973,0.0000110946385,0.00016349448],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999349,0.00007840937,0.00011675075,0.00019493263,0.00005910998,0.00020179151],"domain_scores_gemma":[0.99969697,0.000003952497,0.000031317184,0.00017247946,0.000023731101,0.00007153733],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012846169,0.00008737166,0.00014197628,0.000035753674,0.000016194197,0.0000062032454,0.00004309122,0.00008995235,0.000002866476],"category_scores_gemma":[0.00008778424,0.00008267599,0.000043148884,0.00006960942,0.000034996527,0.0000024437438,0.00002569098,0.00004508103,9.3462876e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000031553922,0.000029972603,0.009272609,0.000012573301,0.000014537596,7.6908844e-7,0.000014541398,6.503641e-7,0.9878195,0.00013610633,0.00013862929,0.0025285883],"study_design_scores_gemma":[0.00031913663,0.000042736065,0.053222656,0.000002771458,0.0000038624867,0.0000024182136,0.000037632413,4.0206558e-7,0.88025165,0.000060467246,0.065970734,0.00008552061],"about_ca_topic_score_codex":0.000031572457,"about_ca_topic_score_gemma":0.0000133353815,"teacher_disagreement_score":0.1075678,"about_ca_system_score_codex":0.000005629727,"about_ca_system_score_gemma":0.00002247024,"threshold_uncertainty_score":0.3371429},"labels":[],"label_agreement":null},{"id":"W2955525741","doi":"10.1038/s41591-019-0535-y","title":"Publisher Correction: Combined BRAF and MEK inhibition with PD-1 blockade immunotherapy in BRAF-mutant melanoma","year":2019,"lang":"en","type":"erratum","venue":"Nature Medicine","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Blockade; Melanoma; Immunotherapy; Mutant; Cancer research; Medicine; Biology; Immunology; Internal medicine; Immune system; Receptor; Biochemistry","score_opus":0.0035787299736039827,"score_gpt":0.2152071796316137,"score_spread":0.21162844965800973,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2955525741","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.49247047,0.10726883,0.0003094424,0.011320617,0.17037953,0.0036864753,0.0001151529,0.00018636952,0.2142631],"genre_scores_gemma":[0.61277,0.005681086,0.00014270515,0.0055960007,0.008463659,0.00012469201,0.010722597,0.0002695725,0.35622966],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9978892,0.00010716437,0.00040253947,0.00079283665,0.00042625316,0.0003820084],"domain_scores_gemma":[0.9987902,0.000027116257,0.00027255982,0.0006019208,0.00018437543,0.00012380423],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00033205017,0.00051378337,0.0006866183,0.00026384598,0.000067197296,0.00004081107,0.00021010362,0.0020885689,0.000115140494],"category_scores_gemma":[0.00013469036,0.0003718937,0.00006815508,0.000286129,0.00018989253,0.000012086298,0.00008146357,0.0018842471,0.0000059498434],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00067415973,0.00008282133,0.0007995851,0.00014921182,0.00013946708,0.00010911434,0.00013191722,9.3095537e-7,0.0747585,0.000048303566,0.9212092,0.0018967909],"study_design_scores_gemma":[0.007262974,0.0043356554,0.0057712025,0.0010071368,0.00008954006,0.00053473364,0.0001618044,0.000025306017,0.009923289,0.000110193156,0.9700944,0.00068379875],"about_ca_topic_score_codex":0.00010885559,"about_ca_topic_score_gemma":0.00049526186,"teacher_disagreement_score":0.16191587,"about_ca_system_score_codex":0.000052741885,"about_ca_system_score_gemma":0.00028329183,"threshold_uncertainty_score":0.9998733},"labels":[],"label_agreement":null},{"id":"W2969359604","doi":"10.1002/cmdc.201900428","title":"Targeting an EGFR Water Network with 4‐Anilinoquin(az)oline Inhibitors for Chordoma","year":2019,"lang":"en","type":"article","venue":"ChemMedChem","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill; China Scholarship Council; Novartis Pharma; University of North Carolina at Chapel Hill; Ministero dello Sviluppo Economico; Genome Canada; Fundação de Amparo à Pesquisa do Estado de São Paulo; European Federation of Pharmaceutical Industries and Associations; Merck KGaA; Ontario Ministry of Economic Development and Innovation; Engineering and Physical Sciences Research Council; Pfizer","keywords":"EGFR inhibitors; Epidermal growth factor receptor; Quinazoline; Chemistry; IC50; Cancer research; Amine gas treating; Chordoma; Stereochemistry; Biology; Biochemistry; Receptor; In vitro; Medicine","score_opus":0.006594312264942149,"score_gpt":0.21167948003727927,"score_spread":0.20508516777233712,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2969359604","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99599326,0.00023272824,0.00097078405,0.000123694,0.0003765135,0.000485271,0.000011761069,0.000037427617,0.0017685499],"genre_scores_gemma":[0.9904866,0.000014055788,0.0036413383,0.0004041577,0.0022701027,0.000077823504,0.0011125818,0.000065051965,0.0019282411],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998549,0.000020215666,0.00022902965,0.00051977026,0.00012189519,0.0005600873],"domain_scores_gemma":[0.9992293,0.000011430884,0.00006895462,0.00042924518,0.00010797261,0.00015308123],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002482929,0.00024091845,0.00022432984,0.000019247256,0.0000871644,0.000027503744,0.00020837908,0.00022002308,0.00006883431],"category_scores_gemma":[0.000020710539,0.00017122539,0.00008906897,0.00005206545,0.000048175978,0.0000087246435,0.00009483918,0.00010149122,0.000045847304],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025180375,0.000056004646,0.0040276125,0.00006028428,0.00004302839,0.0000026031878,0.000079168036,0.00020172523,0.98844546,0.00006361848,0.006224786,0.0005438995],"study_design_scores_gemma":[0.0011156519,0.00065808074,0.00010391732,0.000018002902,0.000019363173,0.000011560172,0.00008397774,0.0002309138,0.9124828,0.000072382194,0.084900856,0.00030247073],"about_ca_topic_score_codex":0.0000055354863,"about_ca_topic_score_gemma":0.000009047129,"teacher_disagreement_score":0.07867607,"about_ca_system_score_codex":0.00001557756,"about_ca_system_score_gemma":0.000047763566,"threshold_uncertainty_score":0.6982369},"labels":[],"label_agreement":null},{"id":"W2970448152","doi":"10.3747/co.26.4779","title":"Reconsidering the Turnaround Times for BRAF V600 Mutation Analysis in Non-Small-Cell Lung Cancer: A Molecular Diagnosis in One Day Is Achievable for Rapid Treatment Choices","year":2019,"lang":"en","type":"letter","venue":"Current Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Lung cancer; Mutation; Oncology; Lung; Internal medicine; Cancer research; Bioinformatics; Pathology; Genetics; Gene; Biology","score_opus":0.09037548139081107,"score_gpt":0.33502748723717585,"score_spread":0.24465200584636476,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2970448152","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9003069,0.0354232,0.0040510288,0.049557857,0.0022501983,0.006893476,0.0010967028,0.000017518269,0.00040311285],"genre_scores_gemma":[0.61812365,0.061240263,0.005481308,0.17344245,0.015502415,0.08023432,0.0368718,0.0007512089,0.008352562],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9977585,0.00022678236,0.0005263528,0.000832671,0.00010494256,0.0005507184],"domain_scores_gemma":[0.9984756,0.00048346742,0.00041000402,0.00049376587,0.000096556476,0.00004060536],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003476787,0.000405898,0.0007944076,0.00031923834,0.00007403702,0.00004355806,0.0003185854,0.00074730243,0.000054520493],"category_scores_gemma":[0.00006960636,0.00033984994,0.00045728273,0.00021852374,0.000048947677,0.000007088035,0.00008034425,0.00035527998,0.000003136887],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009160401,0.0034497827,0.13220891,0.0060259313,0.009105349,0.00019676975,0.0048781014,0.0056470684,0.06461408,0.000018159511,0.58779037,0.18514945],"study_design_scores_gemma":[0.004188411,0.0015617884,0.00074442406,0.00015801686,0.0021041492,0.000004235795,0.00006770814,0.0027596746,0.049079973,0.00006077682,0.9386419,0.00062895095],"about_ca_topic_score_codex":0.00017258273,"about_ca_topic_score_gemma":0.0015197186,"teacher_disagreement_score":0.35085154,"about_ca_system_score_codex":0.00033378246,"about_ca_system_score_gemma":0.00040343878,"threshold_uncertainty_score":0.99990535},"labels":[],"label_agreement":null},{"id":"W2972559932","doi":"10.1158/1078-0432.ccr-17-3572","title":"A Phase I and Pharmacokinetic Study of Oral Dabrafenib in Children and Adolescent Patients with Recurrent or Refractory <i>BRAF</i> V600 Mutation–Positive Solid Tumors","year":2019,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":96,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"National Institutes of Health; Brain Tumour Charity; National Cancer Institute; KWF Kankerbestrijding; National Institute for Health and Care Research","keywords":"Refractory (planetary science); Pharmacokinetics; Medicine; Dabrafenib; Solid tumor; Mutation; Oncology; Internal medicine; Cancer; Genetics; Biology; Gene","score_opus":0.05948289162910631,"score_gpt":0.45527820933167135,"score_spread":0.39579531770256504,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2972559932","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979689,0.00046644796,0.0000025318577,0.00002757999,0.000059206566,0.0013441823,0.00009042474,0.0000028950994,0.0000378103],"genre_scores_gemma":[0.9992425,0.0003762229,0.0000185286,0.00006743438,0.00006685867,0.00006231016,0.00008145723,0.000017011902,0.000067692345],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981774,0.00039077693,0.00037575074,0.00049757736,0.00030184857,0.00025664328],"domain_scores_gemma":[0.9992659,0.000068553236,0.0000990268,0.00021558005,0.0002020081,0.0001489057],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005859234,0.00012381433,0.00026999266,0.00007494165,0.000039212304,0.000015176541,0.00012980743,0.00007649022,0.00003458556],"category_scores_gemma":[0.00009709056,0.00008958468,0.000023397808,0.00014281682,0.00019239151,0.00000778066,0.00018534734,0.00033093765,0.0000019748459],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007560905,0.0059123253,0.9205705,0.00006815961,0.000097895514,0.000013255484,0.00024447576,0.0000047258536,0.0064646853,0.0000014057048,0.00032895576,0.058732737],"study_design_scores_gemma":[0.022109486,0.020864498,0.951618,0.00014157096,0.000025873958,0.0000034923476,0.00017980186,0.00002721546,0.004646792,0.0000042418583,0.00021530088,0.00016369295],"about_ca_topic_score_codex":0.000091130125,"about_ca_topic_score_gemma":0.0001379416,"teacher_disagreement_score":0.058569044,"about_ca_system_score_codex":0.000019257517,"about_ca_system_score_gemma":0.00017731267,"threshold_uncertainty_score":0.36531574},"labels":[],"label_agreement":null},{"id":"W2983389082","doi":"10.7554/elife.33718.022","title":"Author response: Hyperactivation of ERK by multiple mechanisms is toxic to RTK-RAS mutation-driven lung adenocarcinoma cells","year":2018,"lang":"en","type":"peer-review","venue":"","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Hyperactivation; MAPK/ERK pathway; Cancer research; Adenocarcinoma; Mutation; Cell biology; Lung cancer; Biology; Lung; Genetics; Medicine; Cancer; Signal transduction; Internal medicine; Gene","score_opus":0.021771971340108488,"score_gpt":0.297361096386786,"score_spread":0.2755891250466775,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2983389082","genre_codex":"empirical","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6085765,0.051301252,0.20022577,0.07969486,0.015505751,0.014224552,0.020715423,0.00029391111,0.009462022],"genre_scores_gemma":[0.18204106,0.0005426282,0.018450832,0.008524753,0.0009888367,0.0003946572,0.009307149,0.0002174528,0.7795326],"study_design_codex":"not_applicable","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9975098,0.00024390664,0.00062925095,0.00083884347,0.00042550833,0.00035271412],"domain_scores_gemma":[0.9979205,0.00009204864,0.0004055362,0.00086651737,0.00051443937,0.00020093414],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00048121889,0.0004399689,0.0005781314,0.00013349371,0.00009145796,0.000024773673,0.00044555252,0.00063425425,0.00087811955],"category_scores_gemma":[0.00048698048,0.00041485272,0.00024665723,0.00018409973,0.000045075263,0.000006326553,0.0002130188,0.00017518144,0.00014310614],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001305606,0.000036635993,0.000011584236,0.00032260333,0.00006045284,0.0000023491716,0.000036662816,0.0000017504908,0.47489405,0.000009002796,0.52426636,0.00022796716],"study_design_scores_gemma":[0.00024002844,0.0005305653,0.00007515602,0.00027000357,0.00008675735,0.000008808155,0.000021733571,0.000055043693,0.54939276,0.000013868261,0.44899622,0.00030905663],"about_ca_topic_score_codex":0.000108060485,"about_ca_topic_score_gemma":0.00005565773,"teacher_disagreement_score":0.7700706,"about_ca_system_score_codex":0.0000541476,"about_ca_system_score_gemma":0.0003242874,"threshold_uncertainty_score":0.9998303},"labels":[],"label_agreement":null},{"id":"W2985852902","doi":"10.1021/acs.jmedchem.9b01227","title":"Fast Iterative Synthetic Approach toward Identification of Novel Highly Selective p38 MAP Kinase Inhibitors","year":2019,"lang":"en","type":"article","venue":"Journal of Medicinal Chemistry","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Eshelman Institute for Innovation, University of North Carolina at Chapel Hill; Merck Sharp and Dohme; Ontario Ministry of Research, Innovation and Science; Fundação de Amparo à Pesquisa do Estado de São Paulo; Deutsche Forschungsgemeinschaft; Deutschen Konsortium für Translationale Krebsforschung; Novartis; Ontario Genomics Institute; Canada Foundation for Innovation; Wellcome Trust; AbbVie; Takeda Pharmaceutical Company; Janssen Pharmaceuticals; Merck KGaA; Innovative Medicines Initiative; Wellcome; Bayer; Pfizer; Boehringer Ingelheim","keywords":"Chemistry; p38 mitogen-activated protein kinases; Kinase; Mitogen-activated protein kinase; Drug discovery; Potency; Small molecule; Gene isoform; Selectivity; Protein kinase A; Biochemistry; Combinatorial chemistry; Computational biology; In vitro; Pharmacology; Biology; Gene","score_opus":0.009223267021268149,"score_gpt":0.230152640214313,"score_spread":0.22092937319304484,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2985852902","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9920364,0.00087859744,0.0038802347,0.00013977957,0.00033857638,0.00011396921,0.000020796142,0.0000032205844,0.002588413],"genre_scores_gemma":[0.99778366,0.00003830426,0.00055639306,0.000038444734,0.00064593274,0.0000037697168,0.000038680053,0.000015993279,0.00087881304],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986123,0.000032070955,0.0005906562,0.00022708702,0.00037032555,0.00016759367],"domain_scores_gemma":[0.9985438,0.000021114662,0.0006929083,0.00022414324,0.00039509102,0.0001229309],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043151775,0.00016463398,0.00030199628,0.000046772057,0.000025533665,0.000011990524,0.00023774403,0.00017755118,0.00002044205],"category_scores_gemma":[0.00014733565,0.000135197,0.00015447885,0.000091669936,0.000091886526,0.000010176171,0.000047534828,0.00024698878,0.0000034403606],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021529633,0.00021819484,0.00078269036,0.0003218587,0.00009511599,0.0000066740326,0.0002630595,0.000061942665,0.99668676,0.000015117501,0.00095756,0.00037576215],"study_design_scores_gemma":[0.0011292993,0.00039866313,0.00052720855,0.00013815962,0.00006473578,0.0002693316,0.0009016547,0.00010960297,0.9948418,0.000011980938,0.0014741163,0.00013343718],"about_ca_topic_score_codex":0.0000029798816,"about_ca_topic_score_gemma":1.1994898e-7,"teacher_disagreement_score":0.0057472563,"about_ca_system_score_codex":0.00003982675,"about_ca_system_score_gemma":0.00019131745,"threshold_uncertainty_score":0.55131733},"labels":[],"label_agreement":null},{"id":"W2999136960","doi":"10.1016/j.annonc.2019.10.022","title":"Vemurafenib in non-small-cell lung cancer patients with BRAFV600 and BRAFnonV600 mutations","year":2020,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":189,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"PharmaMar; Direction Générale de l’offre de Soins; Institut National Du Cancer; Chugai Pharmaceutical; Roche; Fondation ARC pour la Recherche sur le Cancer; Agence Nationale de la Recherche; Novartis; Amgen; Pfizer; CNIB; AbbVie; Merck","keywords":"Vemurafenib; Medicine; Internal medicine; Oncology; Cohort; Lung cancer; Trametinib; Dabrafenib; Cancer; Metastatic melanoma","score_opus":0.02275642131417564,"score_gpt":0.29257216364256583,"score_spread":0.2698157423283902,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2999136960","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963554,0.00036379087,0.00007915616,0.0010965536,0.000047336634,0.00022356222,0.00004771837,0.000003663249,0.0017827764],"genre_scores_gemma":[0.99757993,0.00018829468,0.00030191327,0.0016573671,0.00006949099,0.00003193138,0.00009365885,0.0000126830955,0.0000647427],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993225,0.000041242663,0.00017398168,0.00023323129,0.000055175205,0.0001738798],"domain_scores_gemma":[0.9995946,0.000017753102,0.0000993842,0.00009700872,0.00009866053,0.00009258796],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000053647545,0.00010099965,0.00018515589,0.00003272113,0.000023990868,0.0000041976923,0.00009192018,0.00012044567,0.000021990245],"category_scores_gemma":[0.000022512784,0.00009003501,0.000025823314,0.000084090185,0.00006339547,0.000003908327,0.00006288952,0.00007181498,0.0000018130283],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00097290915,0.0008282957,0.7130746,0.00031069308,0.00017073497,0.00003893602,0.0020761578,0.00037648727,0.2487766,0.00013078726,0.007997088,0.025246697],"study_design_scores_gemma":[0.007793393,0.010249777,0.6170927,0.000058402296,0.00007721585,0.0000050074377,0.0002600707,0.00034882405,0.32570824,0.000059892845,0.037789624,0.00055683154],"about_ca_topic_score_codex":0.000107539956,"about_ca_topic_score_gemma":0.00026584882,"teacher_disagreement_score":0.0959819,"about_ca_system_score_codex":0.000004499764,"about_ca_system_score_gemma":0.00013545842,"threshold_uncertainty_score":0.36715212},"labels":[],"label_agreement":null},{"id":"W2999167819","doi":"10.3390/molecules25020325","title":"In Depth Analysis of Kinase Cross Screening Data to Identify CAMKK2 Inhibitory Scaffolds","year":2020,"lang":"en","type":"article","venue":"Molecules","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Center for Advancing Translational Sciences; National Health and Medical Research Council; Novartis Pharma; National Institutes of Health; Medical Research Council; Ministero dello Sviluppo Economico; Genome Canada; Fundação de Amparo à Pesquisa do Estado de São Paulo; National Cancer Institute; European Federation of Pharmaceutical Industries and Associations; Merck KGaA; Conselho Nacional de Desenvolvimento Científico e Tecnológico; Ontario Ministry of Economic Development and Innovation; Pfizer","keywords":"AMPK; Kinase; Protein kinase A; Enzyme; Biochemistry; Chemistry; Biology; Cell biology","score_opus":0.05823401505428979,"score_gpt":0.34140516456448783,"score_spread":0.28317114951019806,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2999167819","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98975325,0.00043254122,0.008912522,0.0002033454,0.000051965988,0.000109251596,0.00018161254,0.000008234901,0.00034729368],"genre_scores_gemma":[0.99643433,0.000015498903,0.0020012518,0.0007769402,0.00009793828,0.000007533405,0.0005978709,0.000016268772,0.00005234781],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99882877,0.000057596426,0.0002699709,0.0004916414,0.0001523447,0.0001997022],"domain_scores_gemma":[0.9991247,0.000008385744,0.00007045735,0.00060883793,0.000048401205,0.00013918642],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015738617,0.0001285603,0.00022830804,0.0001284025,0.000029051555,0.000026321417,0.00047816642,0.0000999255,0.000021735774],"category_scores_gemma":[0.00013894434,0.00013506941,0.00009209292,0.00050228974,0.00004335814,0.00000783378,0.0005658445,0.00004293053,0.000009082063],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007073852,0.000030904874,0.024428258,0.00002621331,0.00016700504,0.00003966014,0.00010588286,0.0010050244,0.97134477,0.000025305775,0.002128594,0.00062763016],"study_design_scores_gemma":[0.00046082452,0.00017206366,0.09870598,0.0000182866,0.00016846116,0.000001627402,0.00010375602,0.0018285402,0.89047813,0.0000044765106,0.007802799,0.0002550477],"about_ca_topic_score_codex":0.00013630603,"about_ca_topic_score_gemma":0.0003438942,"teacher_disagreement_score":0.08086664,"about_ca_system_score_codex":0.0000049440096,"about_ca_system_score_gemma":0.00003878864,"threshold_uncertainty_score":0.5507971},"labels":[],"label_agreement":null},{"id":"W2999417880","doi":"10.1007/s11538-019-00691-0","title":"Overcoming Drug Resistance to BRAF Inhibitor","year":2020,"lang":"en","type":"article","venue":"Bulletin of Mathematical Biology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia, Okanagan Campus; University of British Columbia","funders":"","keywords":"Drug resistance; Cancer research; Drug; Melanoma; MEK inhibitor; Chemokine; Medicine; Cancer; Pharmacology; Immunology; Biology; Inflammation; Internal medicine; MAPK/ERK pathway; Signal transduction; Genetics","score_opus":0.013392137442881353,"score_gpt":0.2355541636642941,"score_spread":0.22216202622141276,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2999417880","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93598396,0.00043704762,0.011716707,0.021608224,0.00013266547,0.00041228914,0.000049283153,0.000037897644,0.029621959],"genre_scores_gemma":[0.97486407,0.0000133278545,0.019670637,0.0032290455,0.00031075862,0.000022393753,0.000025359443,0.0000204105,0.0018439727],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99903744,0.00006803872,0.0002990177,0.0003118612,0.00007065634,0.00021295308],"domain_scores_gemma":[0.99942136,0.0000625232,0.0000719218,0.00023483424,0.000046107358,0.00016326336],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016469634,0.0001301099,0.00025432187,0.000017279588,0.000028268396,0.0000052644855,0.00022163066,0.000120636236,0.00042280936],"category_scores_gemma":[0.00070221286,0.000112385125,0.00008627782,0.00004798209,0.00008112286,4.1898548e-7,0.0001953493,0.00006799004,0.00034011094],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019079196,0.00006589411,0.00013964402,0.00015272431,0.000026060987,0.0000040268765,0.00014537452,0.0000011671178,0.84274155,0.01712358,0.13902293,0.00038626915],"study_design_scores_gemma":[0.0002989209,0.00023089035,0.00003122295,0.000028384817,0.000008194492,0.0000037888244,0.00003460467,0.0000034304774,0.34095073,0.0013146205,0.65695256,0.00014264419],"about_ca_topic_score_codex":0.0000018330046,"about_ca_topic_score_gemma":0.0000019004118,"teacher_disagreement_score":0.5179296,"about_ca_system_score_codex":0.0000038649673,"about_ca_system_score_gemma":0.000021960679,"threshold_uncertainty_score":0.4629466},"labels":[],"label_agreement":null},{"id":"W3000205532","doi":"10.1158/1078-0432.ccr-19-1606","title":"A Combinatorial Strategy for Targeting <i>BRAF</i> V600E-Mutant Cancers with BRAFV600E Inhibitor (PLX4720) and Tyrosine Kinase Inhibitor (Ponatinib)","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Aging","funders":"Intramural Research Program; National Institutes of Health","keywords":"Ponatinib; Tyrosine-kinase inhibitor; Cancer research; Tyrosine kinase; MEK inhibitor; Medicine; Mutant; Kinase; Dasatinib; Cancer; Pharmacology; Biology; Imatinib; Internal medicine; Myeloid leukemia; Genetics; Receptor; MAPK/ERK pathway","score_opus":0.11930498942149106,"score_gpt":0.41560940435192795,"score_spread":0.2963044149304369,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3000205532","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99281806,0.002178681,0.00016495038,0.0022711297,0.0006705192,0.001067554,0.00029890478,0.000030351144,0.0004998357],"genre_scores_gemma":[0.99232614,0.00060773647,0.00032144706,0.00080117513,0.00528206,0.00033985707,0.00013588111,0.00006652954,0.0001191749],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99693406,0.00030575297,0.00058506185,0.00097216526,0.00049267296,0.00071031065],"domain_scores_gemma":[0.99814254,0.00027526816,0.00013879903,0.00029356114,0.00053233624,0.0006174936],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013549816,0.00025888675,0.00042286137,0.000046029636,0.00027486158,0.00010454681,0.0003097968,0.00032323564,0.000044684995],"category_scores_gemma":[0.001087576,0.00021403328,0.00012364205,0.0002792828,0.00051324733,0.000013819796,0.00029203529,0.0006044165,0.0000064676774],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012944015,0.00037215758,0.009904033,0.00060250645,0.00025879566,0.000095575,0.00026521063,0.00012070355,0.8814103,0.0018557266,0.07273737,0.019433608],"study_design_scores_gemma":[0.016443886,0.019086575,0.0008656999,0.00022659794,0.00007832597,0.00001148182,0.0006537411,0.00085359754,0.55280894,0.00057569257,0.40739465,0.0010008013],"about_ca_topic_score_codex":0.00018546605,"about_ca_topic_score_gemma":0.00017425751,"teacher_disagreement_score":0.33465728,"about_ca_system_score_codex":0.0000612054,"about_ca_system_score_gemma":0.0012584229,"threshold_uncertainty_score":0.8728024},"labels":[],"label_agreement":null},{"id":"W3004870356","doi":"10.1200/jco.2020.38.5_suppl.60","title":"Immune adverse events (irAEs) with adjuvant ipilimumab in melanoma, use of hormone replacement and immunosuppressants, and association with outcome: E1609 study analysis.","year":2020,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"National Institutes of Health","keywords":"Medicine; Ipilimumab; Internal medicine; Rash; Adverse effect; Adjuvant; Melanoma; Cancer; Gastroenterology; Oncology; Immunotherapy","score_opus":0.06398664518698148,"score_gpt":0.36053636204142514,"score_spread":0.29654971685444365,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3004870356","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984293,0.0006516134,0.0001470842,0.0004222507,0.0000657602,0.00023966737,0.000010305378,0.0000021468095,0.00003189569],"genre_scores_gemma":[0.99796504,0.0006000708,0.0010822464,0.00021258957,0.0000751247,0.0000039100914,0.00000877833,0.000012025912,0.00004020338],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99722147,0.000498285,0.0015930779,0.0002593314,0.00026904422,0.00015880124],"domain_scores_gemma":[0.99738115,0.00025671595,0.0018249049,0.00018134333,0.00020018421,0.00015572998],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017595722,0.00014288192,0.0011681955,0.00008197317,0.000024367278,0.000005106434,0.0001165524,0.00021634657,0.0000037854618],"category_scores_gemma":[0.00086834613,0.00009569848,0.00013730064,0.00015759285,0.00006615689,0.000018634348,0.000115043535,0.0003315413,3.8818558e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009867485,0.0008957979,0.98167664,0.0000092836035,0.0017104645,0.00008552758,0.00018028372,0.00010683446,0.0044773156,0.0000025130057,0.00011194558,0.00087591104],"study_design_scores_gemma":[0.011884448,0.034322903,0.9504189,0.000011050912,0.0009266659,0.000017851798,0.00048398884,0.00006303255,0.00050466176,0.0000029553594,0.0012521481,0.00011139777],"about_ca_topic_score_codex":0.00006709688,"about_ca_topic_score_gemma":0.00026366158,"teacher_disagreement_score":0.033427108,"about_ca_system_score_codex":0.0000314289,"about_ca_system_score_gemma":0.00020351246,"threshold_uncertainty_score":0.39024708},"labels":[],"label_agreement":null},{"id":"W3005155748","doi":"10.1158/2159-8290.cd-19-1265","title":"Pan-Cancer Efficacy of Vemurafenib in <i>BRAF</i> V600-Mutant Non-Melanoma Cancers","year":2020,"lang":"en","type":"article","venue":"Cancer Discovery","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":125,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada)","funders":"National Cancer Institute; National Institutes of Health; Roche","keywords":"Vemurafenib; Melanoma; Cancer research; Cancer; Mutant; Medicine; Mutation; Metastatic melanoma; Oncology; Biology; Internal medicine; Genetics; Gene","score_opus":0.014753547116940652,"score_gpt":0.25478500527250764,"score_spread":0.24003145815556698,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3005155748","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99269783,0.0040376503,0.00019626273,0.00047304394,0.00047267237,0.00029534713,0.00029972693,0.00001028165,0.0015171891],"genre_scores_gemma":[0.99550104,0.0019991875,0.000035915153,0.0012898933,0.0006684062,0.00012245696,0.00006699333,0.00003749204,0.0002786076],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986008,0.000035191726,0.0003402106,0.0005097875,0.00016582753,0.000348187],"domain_scores_gemma":[0.99935156,0.000016585793,0.00015279438,0.00031208014,0.00004180132,0.00012519387],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000059967813,0.00023075998,0.00033556347,0.000036698493,0.000031917472,0.00002198323,0.00029724865,0.00014350636,0.000067943016],"category_scores_gemma":[0.00003217567,0.00021626169,0.0001457241,0.00021409588,0.00010097268,0.0000165797,0.00013002494,0.00013537054,0.000007748384],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00054338446,0.00006365126,0.031946193,0.0001356133,0.00008975561,0.00001871457,0.0003638146,0.0009917192,0.95624685,0.00005078816,0.0025964412,0.006953099],"study_design_scores_gemma":[0.002869148,0.00043978274,0.03419765,0.00016391338,0.000050421364,0.0000028105405,0.00017155008,0.00012613073,0.92244804,0.000015911086,0.039058257,0.00045635644],"about_ca_topic_score_codex":0.0007678505,"about_ca_topic_score_gemma":0.0005523668,"teacher_disagreement_score":0.036461815,"about_ca_system_score_codex":0.000079763115,"about_ca_system_score_gemma":0.00060734845,"threshold_uncertainty_score":0.8818896},"labels":[],"label_agreement":null},{"id":"W3006140059","doi":"10.1007/s00280-020-04038-8","title":"Phase I dose-escalation trial of the oral AKT inhibitor uprosertib in combination with the oral MEK1/MEK2 inhibitor trametinib in patients with solid tumors","year":2020,"lang":"en","type":"article","venue":"Cancer Chemotherapy and Pharmacology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":58,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Nexen (Canada)","funders":"Novartis Pharmaceuticals Corporation","keywords":"Tolerability; Trametinib; Dosing; Medicine; Rash; Adverse effect; Internal medicine; Mucositis; Oncology; Pharmacology; Toxicity; MAPK/ERK pathway","score_opus":0.014149507990633454,"score_gpt":0.2872376165837309,"score_spread":0.27308810859309746,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3006140059","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965128,0.00010821868,0.000038106773,0.0020449194,0.00019651781,0.0010372169,0.000023384373,0.000005137809,0.00003372861],"genre_scores_gemma":[0.9977234,0.000045950717,0.000029035931,0.0018083809,0.00020201891,0.00011750051,0.000034990313,0.00001871661,0.000019998528],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99903274,0.0001587118,0.0002366347,0.00026920284,0.0001195957,0.00018313996],"domain_scores_gemma":[0.9996101,0.000017448936,0.00016273519,0.00010000509,0.00005783509,0.00005186294],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014254582,0.00015680554,0.00022864414,0.00002709196,0.000048946746,0.00000937748,0.00012860523,0.00010567478,0.000033275857],"category_scores_gemma":[0.000008493539,0.00009154955,0.00003480144,0.00019619931,0.00016363949,0.000010832927,0.000027987347,0.00016059855,2.2596844e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.111816056,0.0016477786,0.038073838,0.00007640244,0.0001106344,0.0000027078775,0.0017708379,0.0001495272,0.82730174,0.000022541157,0.0014390035,0.017588934],"study_design_scores_gemma":[0.15340045,0.0063198623,0.0144190565,0.00002631186,0.00003701599,8.584262e-7,0.00007982578,0.00026495373,0.8214734,0.000014393797,0.0037730557,0.00019082963],"about_ca_topic_score_codex":0.000027151696,"about_ca_topic_score_gemma":0.00009152128,"teacher_disagreement_score":0.041584387,"about_ca_system_score_codex":0.00002077759,"about_ca_system_score_gemma":0.000120734614,"threshold_uncertainty_score":0.3733282},"labels":[],"label_agreement":null},{"id":"W3008560653","doi":"10.1016/j.jid.2020.01.027","title":"TERT, BRAF, and NRAS Mutational Heterogeneity between Paired Primary and Metastatic Melanoma Tumors","year":2020,"lang":"en","type":"article","venue":"Journal of Investigative Dermatology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; U.S. Food and Drug Administration; National Institute of Arthritis and Musculoskeletal and Skin Diseases; York University","keywords":"Neuroblastoma RAS viral oncogene homolog; Sanger sequencing; Melanoma; Tumor heterogeneity; Cancer research; Genetic heterogeneity; Tumour heterogeneity; Primary tumor; Biology; Mutation; Digital polymerase chain reaction; V600E; Gene; Medicine; Oncology; Cancer; Metastasis; Genetics; Polymerase chain reaction; Phenotype; KRAS","score_opus":0.03592270650365747,"score_gpt":0.2475793456700025,"score_spread":0.21165663916634503,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3008560653","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99447817,0.0011071062,0.0010471703,0.00311656,0.000034888217,0.00009183827,0.000036978072,0.000004329233,0.00008294959],"genre_scores_gemma":[0.9934237,0.000037859463,0.0038137184,0.0025258819,0.00013346449,0.000002991852,0.00004207454,0.000013008645,0.0000073031874],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99884874,0.00024703392,0.00042424785,0.00019898635,0.0001224866,0.0001585006],"domain_scores_gemma":[0.9990929,0.00007134194,0.00034339292,0.00007196757,0.00011279656,0.0003076454],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013236103,0.00015733035,0.00038317736,0.000052718355,0.00006365086,0.00001800703,0.000109973706,0.00008311457,0.000005142854],"category_scores_gemma":[0.0002690942,0.00013391941,0.00006484969,0.000056747944,0.00041287858,0.000015286714,0.000095475116,0.00014908888,0.0000019112938],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011924349,0.000031253363,0.11302225,0.00019439276,0.00044373906,0.0005021141,0.0006745814,0.000006519607,0.88141364,0.00040984535,0.002178382,0.0010040093],"study_design_scores_gemma":[0.0013386769,0.00079571875,0.17495772,0.000025760592,0.00009569025,0.0043615266,0.00016064894,0.00005473339,0.8143053,0.0013046531,0.002391841,0.00020771797],"about_ca_topic_score_codex":0.000002220168,"about_ca_topic_score_gemma":0.0000031233674,"teacher_disagreement_score":0.067108355,"about_ca_system_score_codex":0.000007110324,"about_ca_system_score_gemma":0.0001580927,"threshold_uncertainty_score":0.54610753},"labels":[],"label_agreement":null},{"id":"W3008901859","doi":"10.1002/cpdd.773","title":"Absolute Bioavailability of Vemurafenib in Patients With <i>BRAF</i><sup>V600</sup> Mutation–Positive Malignancies","year":2020,"lang":"en","type":"article","venue":"Clinical Pharmacology in Drug Development","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada)","funders":"","keywords":"Vemurafenib; Medicine; Bioavailability; Mutation; Internal medicine; Cancer research; Oncology; Pharmacology; Cancer; Genetics; Metastatic melanoma; Gene","score_opus":0.018109760222120016,"score_gpt":0.28101741849757805,"score_spread":0.26290765827545803,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3008901859","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980971,0.00009401143,0.00003940207,0.0005349955,0.00019729619,0.0007175207,0.000030169913,0.000010531474,0.00027895105],"genre_scores_gemma":[0.9959898,0.00003209421,0.0013614268,0.0021574646,0.00009973479,0.0000919201,0.00018556174,0.000016720565,0.00006525374],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99779963,0.00027594424,0.0009003503,0.0005605985,0.00015423496,0.00030924912],"domain_scores_gemma":[0.9992395,0.00011867688,0.0001990395,0.00014688588,0.0001432259,0.00015264457],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00049871526,0.00020314787,0.00038965145,0.000053135936,0.00003496135,0.00000475635,0.0002480272,0.00017257436,0.00006266226],"category_scores_gemma":[0.00014056459,0.00018160677,0.000064468324,0.00019618525,0.00026655826,0.000008324729,0.00019610705,0.00023503482,0.000025916863],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026772157,0.0018194986,0.96822196,0.00012681438,0.00024407262,0.00008104715,0.0033489373,0.00074229727,0.011637321,0.000016153304,0.0061494787,0.0049351812],"study_design_scores_gemma":[0.0069458997,0.00073129055,0.89012986,0.000037386813,0.00002769224,0.000001331065,0.00013737108,0.0000842524,0.089853436,0.000013442212,0.011701673,0.0003363613],"about_ca_topic_score_codex":0.0000101929545,"about_ca_topic_score_gemma":0.000034247612,"teacher_disagreement_score":0.07821611,"about_ca_system_score_codex":0.000038199756,"about_ca_system_score_gemma":0.00035895713,"threshold_uncertainty_score":0.7405709},"labels":[],"label_agreement":null},{"id":"W3010215117","doi":"10.1016/j.ajpath.2020.01.012","title":"Oxidative Phosphorylation Promotes Primary Melanoma Invasion","year":2020,"lang":"en","type":"article","venue":"American Journal Of Pathology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":34,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institutes of Health; York University; National Cancer Institute; NYU Langone Medical Center","keywords":"Melanoma; Biology; Cancer research; Tumor progression; Cancer; Genetics","score_opus":0.01244661518154512,"score_gpt":0.22810321966214384,"score_spread":0.2156566044805987,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3010215117","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99135184,0.0003410655,0.00647307,0.0007151738,0.000100689336,0.00007032401,0.00000925247,0.0000051776437,0.00093337824],"genre_scores_gemma":[0.99285084,0.000109708475,0.0051125246,0.0014939876,0.00035322536,0.0000021112826,0.0000330098,0.000014769154,0.000029795368],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991148,0.00015986204,0.00028923937,0.00017725334,0.000110442095,0.00014840653],"domain_scores_gemma":[0.9991576,0.000018923016,0.00044340437,0.00011872553,0.00013209615,0.00012925825],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018467208,0.000111642934,0.00025850802,0.000038115923,0.000033800796,0.000007104003,0.00017139729,0.000060401806,0.000025611356],"category_scores_gemma":[0.0001740887,0.00009445209,0.000095753094,0.00010527769,0.0001607407,0.0000063493108,0.000067730405,0.00013323415,0.000017120416],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026755378,0.000036224254,0.0051107653,0.000006604779,0.000033073786,0.00015442628,0.00035450797,0.000006694314,0.9707163,0.00003696094,0.0009865663,0.022290321],"study_design_scores_gemma":[0.0011886916,0.015149823,0.02553415,0.000020903872,0.00006174338,0.0014723865,0.000690357,0.000023834335,0.93362826,0.00019714431,0.021727026,0.00030569447],"about_ca_topic_score_codex":0.000001977734,"about_ca_topic_score_gemma":8.587931e-7,"teacher_disagreement_score":0.037088055,"about_ca_system_score_codex":0.0000108386075,"about_ca_system_score_gemma":0.0001135688,"threshold_uncertainty_score":0.38516444},"labels":[],"label_agreement":null},{"id":"W3010422213","doi":"10.1038/s41388-020-1240-5","title":"MNK1 signaling induces an ANGPTL4-mediated gene signature to drive melanoma progression","year":2020,"lang":"en","type":"article","venue":"Oncogene","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; McGill University; Jewish General Hospital","funders":"Canadian Cancer Society Research Institute; Canadian Institutes of Health Research; Government of Canada","keywords":"Biology; MAPK/ERK pathway; Cancer research; Kinase; Signal transduction; Translation (biology); Protein kinase A; Gene; Cell biology; Messenger RNA; Genetics","score_opus":0.018842612516687108,"score_gpt":0.2675009502663078,"score_spread":0.2486583377496207,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3010422213","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996156,0.0008759063,0.0010106813,0.00074993994,0.0001624525,0.00032488612,0.000097848395,0.00004843836,0.00057387876],"genre_scores_gemma":[0.99064755,0.000033681295,0.0043652547,0.002766038,0.0011541527,0.00004103943,0.0008386694,0.00004070105,0.00011291691],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985865,0.00008807694,0.0002131739,0.0005773321,0.00021108982,0.00032384953],"domain_scores_gemma":[0.9990405,0.000009960107,0.00008661546,0.00029345966,0.00010007275,0.00046942147],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000114870956,0.00022863243,0.00020125663,0.000039050472,0.000099724886,0.000035095145,0.0003008515,0.0002942381,0.0000723133],"category_scores_gemma":[0.0001084622,0.00020334267,0.000077814875,0.00018280078,0.000028216582,0.000007244524,0.0001569291,0.00013645731,0.00009462128],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001381039,0.00006565684,0.0003210152,0.000012469705,0.00003663302,0.00006233918,0.0003181038,0.000094188625,0.9921906,0.0000091758175,0.0019088438,0.0048428825],"study_design_scores_gemma":[0.00045418562,0.0016009477,0.00024614375,0.0000139087,0.000020043602,0.000014284948,0.00010105768,0.000092177885,0.9630053,0.0000089244695,0.034153275,0.00028976818],"about_ca_topic_score_codex":0.000005933059,"about_ca_topic_score_gemma":0.000008001106,"teacher_disagreement_score":0.03224443,"about_ca_system_score_codex":0.0000126464065,"about_ca_system_score_gemma":0.00010765275,"threshold_uncertainty_score":0.82920736},"labels":[],"label_agreement":null},{"id":"W3011435761","doi":"10.1016/j.ejca.2020.02.021","title":"Survival of patients with advanced metastatic melanoma: The impact of MAP kinase pathway inhibition and immune checkpoint inhibition - Update 2019","year":2020,"lang":"en","type":"article","venue":"European Journal of Cancer","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":110,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Sandoz; Merck Sharp and Dohme; Bristol-Myers Squibb Canada; InflaRx; Les Laboratories Pierre Fabre; Helsinn; OncoSec Medical; Roche; CureVac; Regeneron Pharmaceuticals; Novartis; Alcedis; Bristol-Myers Squibb; Sanofi; Merck; Boehringer Ingelheim; Amgen; Array BioPharma","keywords":"Medicine; Oncology; Melanoma; Blockade; Clinical trial; Internal medicine; Survival analysis; Progression-free survival; MEK inhibitor; Kinase; Cancer research; Overall survival; MAPK/ERK pathway; Biology; Receptor","score_opus":0.009071601066493962,"score_gpt":0.22957760785355402,"score_spread":0.22050600678706006,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3011435761","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99639285,0.0023190002,0.00057493045,0.00018722625,0.00007360502,0.00011938189,0.00014914128,0.0000015423232,0.00018234506],"genre_scores_gemma":[0.99930584,0.00024827867,0.00021591083,0.000045224715,0.00009846846,9.925225e-7,0.000051300714,0.00002025678,0.00001371172],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989778,0.00021737875,0.00041419687,0.00011356733,0.00017112805,0.000105949825],"domain_scores_gemma":[0.9988885,0.00000816044,0.0006422117,0.000118778386,0.00026361455,0.000078728146],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000311972,0.00012231585,0.00021986863,0.000027234735,0.000026860125,0.00000862775,0.000076605065,0.000014801528,0.000028271415],"category_scores_gemma":[0.00003939615,0.00007223303,0.00011471548,0.000064026426,0.0000784177,0.000014840615,0.000053921212,0.000098170116,0.0000012840464],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015855076,0.00009230882,0.0039384533,0.00006729345,0.0002072439,0.000027678134,0.00026392503,0.00041665707,0.98685116,0.000018139044,0.00041667503,0.0061149504],"study_design_scores_gemma":[0.0048927623,0.0054148734,0.14714539,0.00017533083,0.00010719028,0.000013553356,0.00013117245,0.000015741425,0.8402896,0.00002918727,0.0015963563,0.00018884502],"about_ca_topic_score_codex":0.000007660631,"about_ca_topic_score_gemma":0.0000026429868,"teacher_disagreement_score":0.14656158,"about_ca_system_score_codex":0.000010328619,"about_ca_system_score_gemma":0.000082218576,"threshold_uncertainty_score":0.29455775},"labels":[],"label_agreement":null},{"id":"W3013420908","doi":"10.1158/2326-6074.tumimm19-a53","title":"Abstract A53: Phosphorylation of eIF4E promotes phenotype switching and MDSC-mediated immunosuppression in melanoma","year":2020,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; McGill University","funders":"","keywords":"Melanoma; Cancer research; Immunotherapy; EIF4E; Cytokine; Immune system; Microphthalmia-associated transcription factor; Immunology; Biology; Medicine; Transcription factor; Gene","score_opus":0.04469111608526693,"score_gpt":0.3249136380126815,"score_spread":0.2802225219274146,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3013420908","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9824807,0.0157598,0.000022333788,0.0005558143,0.000086814835,0.00026956503,0.00001861076,0.000008865684,0.00079747254],"genre_scores_gemma":[0.99786675,0.0017441154,0.00007655863,0.00004357934,0.000088432986,0.000051319515,0.00007560135,0.00001846426,0.000035199326],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987796,0.00014253033,0.0002576183,0.00034983738,0.00014898326,0.00032143318],"domain_scores_gemma":[0.9994501,0.00006380286,0.000076110446,0.0002212902,0.00012737152,0.000061345476],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039117038,0.000117049305,0.00019640084,0.00008807613,0.00007574839,0.0000126857785,0.00022050455,0.00023695253,0.00007444617],"category_scores_gemma":[0.0003402243,0.000108465916,0.00003052715,0.00020258345,0.00016030355,0.0000081522185,0.0002363793,0.00036525377,0.000010674361],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000535958,0.00004195996,0.017545199,0.00006542065,0.00004486636,0.000006462379,0.00050533,0.0000054000425,0.97122246,0.000058308782,0.00018695921,0.009781701],"study_design_scores_gemma":[0.0010987503,0.0006772849,0.1504667,0.000073122574,0.0000051014435,0.000003284747,0.00029000035,0.000119349344,0.8439674,0.00012539137,0.0030279423,0.0001457244],"about_ca_topic_score_codex":0.0002934793,"about_ca_topic_score_gemma":0.00005303855,"teacher_disagreement_score":0.1329215,"about_ca_system_score_codex":0.000020956688,"about_ca_system_score_gemma":0.00018501485,"threshold_uncertainty_score":0.44231117},"labels":[],"label_agreement":null},{"id":"W3015889104","doi":"10.1186/s12885-020-06798-1","title":"Real-world comparative effectiveness of second-line ipilimumab for metastatic melanoma: a population-based cohort study in Ontario, Canada","year":2020,"lang":"en","type":"article","venue":"BMC Cancer","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Sunnybrook Health Science Centre; University of Toronto; St. Michael's Hospital; Health Sciences Centre; Canadian Centre for Applied Research in Cancer Control; Institute for Clinical Evaluative Sciences; Queen's University; Cancer Care Ontario","funders":"Canadian Institutes of Health Research; Canadian Cancer Society; Government of Ontario; Canadian Centre for Applied Research in Cancer Control; Ontario Ministry of Health and Long-Term Care; Ontario Institute for Cancer Research; Cancer Care Ontario","keywords":"Ipilimumab; Medicine; Internal medicine; Cohort; Population; Oncology; Propensity score matching; Clinical trial; Surgical oncology; Proportional hazards model; Cancer registry; Cancer; Immunotherapy","score_opus":0.04038648890419611,"score_gpt":0.30261044230070044,"score_spread":0.26222395339650434,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3015889104","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974234,0.00007373697,0.00039924993,0.000011581009,0.00011916369,0.0014644406,0.00019774462,0.000003865174,0.00030683356],"genre_scores_gemma":[0.9984847,8.285253e-7,0.00027244567,0.000071472154,0.000042608313,0.00053414167,0.0003812539,0.000013112647,0.00019946159],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99901605,0.00013965173,0.00025997817,0.00031736086,0.000117075266,0.00014987671],"domain_scores_gemma":[0.9994865,0.00009534594,0.000112328635,0.00016102115,0.00007913232,0.000065688386],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001749737,0.00013964792,0.0003755082,0.00003024025,0.000027583244,0.000004792618,0.00009729304,0.000028031236,0.00010384638],"category_scores_gemma":[0.00002721856,0.00013331248,0.00005603157,0.000103612896,0.000013406009,0.0000025905902,0.00002353556,0.00005882528,3.1555314e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010205026,0.00010297595,0.97750515,0.00016692556,0.00010048535,0.000002452439,0.00009798345,0.0037642026,0.01690261,0.000022794477,0.0002983651,0.00001552532],"study_design_scores_gemma":[0.002602735,0.00053333916,0.9525709,0.000023320645,0.00005995486,1.8445604e-7,0.0000698606,0.0005277621,0.042697515,0.000008800702,0.00075331196,0.00015229186],"about_ca_topic_score_codex":0.9186207,"about_ca_topic_score_gemma":0.9995615,"teacher_disagreement_score":0.08094075,"about_ca_system_score_codex":0.00019855938,"about_ca_system_score_gemma":0.0016937065,"threshold_uncertainty_score":0.5436325},"labels":[],"label_agreement":null},{"id":"W3017244061","doi":"10.1002/cpdd.788","title":"Effect of Vemurafenib on the Pharmacokinetics of a Single Dose of Tizanidine (a CYP1A2 Substrate) in Patients With <i>BRAF</i><sup>V600</sup> Mutation–Positive Malignancies","year":2020,"lang":"en","type":"article","venue":"Clinical Pharmacology in Drug Development","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada)","funders":"F. Hoffmann-La Roche","keywords":"Medicine; Pharmacokinetics; Vemurafenib; Pharmacology; Mutation; Oncology; Internal medicine; Cancer research; Genetics; Cancer; Gene","score_opus":0.018069228122625944,"score_gpt":0.2851740033891128,"score_spread":0.26710477526648685,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3017244061","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99847895,0.00008480599,0.000014858955,0.00028248507,0.00013127585,0.00076170085,0.000031735857,0.0000044803455,0.00020970443],"genre_scores_gemma":[0.99883145,0.000038370592,0.00018479743,0.00071158155,0.000058142294,0.00005031235,0.000092522925,0.000017214757,0.000015629867],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978158,0.00051345665,0.0009122474,0.0003434926,0.0001909699,0.00022404571],"domain_scores_gemma":[0.9988157,0.00047208095,0.00035329242,0.0001311786,0.00014488846,0.000082864804],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006724622,0.00020783668,0.0004619129,0.000057166348,0.000022296945,0.00000248577,0.00026395233,0.00012338854,0.00003564781],"category_scores_gemma":[0.00018572948,0.0001459862,0.000076898694,0.00022376048,0.0002731512,0.000004918107,0.00011910568,0.00020598268,0.0000038836115],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014186704,0.0037019416,0.34696016,0.00048817776,0.00060529786,0.0000766475,0.0039460286,0.0042649517,0.61774886,0.00004424074,0.002848211,0.00512881],"study_design_scores_gemma":[0.006470987,0.0030750243,0.08383639,0.00007340326,0.000051453317,7.804169e-7,0.00006454289,0.00007540613,0.9057941,0.000003845179,0.0004057312,0.00014832396],"about_ca_topic_score_codex":0.0000051961456,"about_ca_topic_score_gemma":0.0000060010047,"teacher_disagreement_score":0.28804526,"about_ca_system_score_codex":0.000019821679,"about_ca_system_score_gemma":0.00016804006,"threshold_uncertainty_score":0.59531444},"labels":[],"label_agreement":null},{"id":"W3020083376","doi":"10.1096/fasebj.2020.34.s1.09579","title":"Transcriptional, Post‐transcriptional, and Post‐translational Regulation of MK5 in Cardiac Cells","year":2020,"lang":"en","type":"article","venue":"The FASEB Journal","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Montreal Heart Institute","funders":"","keywords":"Myocyte; Messenger RNA; Kinase; Protein kinase A; Internal medicine; Endocrinology; Biology; Cell biology; Molecular biology; Chemistry; Medicine; Biochemistry; Gene","score_opus":0.014439529142087003,"score_gpt":0.21092862851244956,"score_spread":0.19648909937036255,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3020083376","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9930767,0.0018746819,0.001567263,0.0027736097,0.00015770062,0.00012129187,0.00015497115,0.0000033463577,0.00027042706],"genre_scores_gemma":[0.99825466,0.00028985296,0.0004243403,0.0005032083,0.0003313893,0.0000026659109,0.00011620693,0.000011024758,0.000066627734],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991269,0.00012109024,0.00026950845,0.00014737285,0.0002020108,0.00013307936],"domain_scores_gemma":[0.9995984,0.0000181681,0.000080498634,0.00008876019,0.00012232928,0.00009185558],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027553109,0.00010531597,0.00013642415,0.00004000193,0.00008403773,0.000019473455,0.000119152275,0.00008143591,0.00008828218],"category_scores_gemma":[0.000019293326,0.00008281726,0.00012215367,0.000068967725,0.00008259012,0.000011992784,0.000011975373,0.0001514534,0.0000037214559],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002397721,0.000024058838,0.001787433,0.000018250888,0.000039574792,0.0000017994064,0.0004631011,0.00030230518,0.99543506,0.0010155472,0.0002293143,0.00044380865],"study_design_scores_gemma":[0.0011918094,0.00048708913,0.1748738,0.000028108518,0.000054366727,0.00008047066,0.00034811298,0.0002691564,0.8159051,0.0005624895,0.0060054944,0.00019399947],"about_ca_topic_score_codex":0.000009337309,"about_ca_topic_score_gemma":0.0000069549556,"teacher_disagreement_score":0.17952994,"about_ca_system_score_codex":0.0000052601445,"about_ca_system_score_gemma":0.00010539414,"threshold_uncertainty_score":0.337719},"labels":[],"label_agreement":null},{"id":"W3022006578","doi":"10.1038/s41598-020-64305-9","title":"Anti-inflammatory effects of α-MSH through p-CREB expression in sarcoidosis like granuloma model","year":2020,"lang":"en","type":"article","venue":"Scientific Reports","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Health Resources and Services Administration; Mallinckrodt Pharmaceuticals; Edward Mallinckrodt, Jr. Foundation; U.S. Department of Health and Human Services","keywords":"Sarcoidosis; Granuloma; CREB; Expression (computer science); Medicine; Immunology; Internal medicine; Computer science; Biology; Transcription factor; Genetics; Gene","score_opus":0.01042503504471102,"score_gpt":0.22244372782020397,"score_spread":0.21201869277549296,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3022006578","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946553,0.00065958325,0.0020717469,0.000045947516,0.0012867105,0.00028328152,0.0000034134478,0.000017595776,0.0009763973],"genre_scores_gemma":[0.998043,0.00003164098,0.0013140826,0.00009518819,0.00007303149,0.000019178056,0.0000738786,0.000017356797,0.0003326152],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983173,0.00005047446,0.00042054738,0.00069137773,0.00027615915,0.00024414924],"domain_scores_gemma":[0.998987,0.000008522508,0.00021834127,0.00061167986,0.00006920296,0.00010523746],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002920962,0.00014804176,0.00022291901,0.000046379166,0.00007568638,0.000030224835,0.00015418848,0.00013243368,0.0000076237748],"category_scores_gemma":[0.00014095925,0.00013478313,0.000114596216,0.00018396816,0.00013801988,0.000012122542,0.00016413681,0.000076401826,0.0000049865935],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000017981421,0.000049905688,0.005234886,0.0001528402,0.0000067138003,0.00017093898,0.0003859715,0.0003181707,0.9854728,0.000018355195,0.007960064,0.00021136504],"study_design_scores_gemma":[0.00024280943,0.000068961024,0.00097120396,0.000059813738,0.000008612004,0.000021117425,0.000027747226,0.00052335527,0.9886806,0.0004889033,0.00875537,0.00015148902],"about_ca_topic_score_codex":0.000006285887,"about_ca_topic_score_gemma":0.000005764075,"teacher_disagreement_score":0.0042636823,"about_ca_system_score_codex":0.0000069530192,"about_ca_system_score_gemma":0.00013031576,"threshold_uncertainty_score":0.5496296},"labels":[],"label_agreement":null},{"id":"W3025475588","doi":"10.1136/lba2019.16","title":"P863 KEYNOTE-022 parts 4 and 5: pembrolizumab plus trametinib for patients with solid tumors or BRAF wild-type melanoma","year":2020,"lang":"en","type":"article","venue":"Poster presentations","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital; McMaster University; Juravinski Cancer Centre","funders":"Pfizer","keywords":"Trametinib; Pembrolizumab; Dabrafenib; Medicine; Tolerability; Melanoma; Internal medicine; Oncology; Adverse effect; Vemurafenib; Cancer research; Immunotherapy; MAPK/ERK pathway; Biology; Cancer; Metastatic melanoma; Kinase","score_opus":0.023898150230606634,"score_gpt":0.2698003080044721,"score_spread":0.24590215777386545,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3025475588","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960538,0.00006975441,0.0014109453,0.000641753,0.00009727129,0.00077878335,0.0002020946,0.000022430271,0.00072316604],"genre_scores_gemma":[0.99664116,0.000012281499,0.0008825949,0.0007698284,0.00017437883,0.00009915612,0.00086340535,0.000032872835,0.0005243223],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990282,0.000045197987,0.00020193277,0.00036777777,0.0001206683,0.00023623614],"domain_scores_gemma":[0.99938166,0.000040641626,0.00008267045,0.00019666502,0.00012333084,0.00017500702],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000032806245,0.00016413156,0.00017392806,0.00002781462,0.0001253885,0.000050927567,0.00012307156,0.000073131174,0.00004024192],"category_scores_gemma":[0.00011944234,0.00012974297,0.000047230904,0.00008185431,0.0000617312,0.0000128524625,0.0000823825,0.000057543657,0.000008097019],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04882392,0.002116761,0.606193,0.001520544,0.0020798328,0.00015506198,0.019458065,0.0009953418,0.18430601,0.0012391985,0.11250628,0.02060597],"study_design_scores_gemma":[0.055207115,0.039660983,0.4087159,0.00015127443,0.0009881875,0.00022258701,0.0023866077,0.002884048,0.27969843,0.00044312936,0.20613906,0.0035026972],"about_ca_topic_score_codex":0.000012336388,"about_ca_topic_score_gemma":0.000041235322,"teacher_disagreement_score":0.19747712,"about_ca_system_score_codex":0.0000051985503,"about_ca_system_score_gemma":0.000103438586,"threshold_uncertainty_score":0.52907646},"labels":[],"label_agreement":null},{"id":"W3028009597","doi":"10.1038/s43018-020-0064-0","title":"Activation of p38α stress-activated protein kinase drives the formation of the pre-metastatic niche in the lungs","year":2020,"lang":"en","type":"article","venue":"Nature Cancer","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":81,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"National Cancer Institute; U.S. Department of Health and Human Services","keywords":"p38 mitogen-activated protein kinases; Niche; Cell biology; Protein kinase A; Stress (linguistics); Kinase; Medicine; Chemistry; Biology; Biochemistry","score_opus":0.010624996229818832,"score_gpt":0.2596324474144047,"score_spread":0.2490074511845859,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3028009597","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99544823,0.00069258356,0.00014548369,0.0028734226,0.00004354337,0.00056203833,0.000049275735,0.0000022690895,0.0001831558],"genre_scores_gemma":[0.9991063,0.00003149614,0.000031597778,0.0006181976,0.00006839491,0.00007646814,0.00003238526,0.00000572799,0.000029452072],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99942386,0.000117727184,0.00013764092,0.000103429695,0.00013960538,0.00007771775],"domain_scores_gemma":[0.999543,0.00001646086,0.00016407864,0.00019941546,0.00006498814,0.000012047203],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009636819,0.00007309389,0.00007732266,0.000010278281,0.00003306795,0.0000058695946,0.00023690973,0.00009882719,0.000007888198],"category_scores_gemma":[0.00015888936,0.00003469956,0.00004767708,0.00017151392,0.000056275585,0.000007389536,0.00004085003,0.0002151895,1.4376407e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009892389,0.000022058697,0.00052662386,0.000087416774,0.000015565423,1.4645813e-7,0.0012088552,0.00013497945,0.99617016,0.00020209978,0.0006292296,0.00090396695],"study_design_scores_gemma":[0.00025333182,0.00007126237,0.007862486,0.00005174593,0.000012211132,3.8159988e-7,0.00031071875,0.00014787473,0.9870217,0.000058844784,0.0041669137,0.000042549997],"about_ca_topic_score_codex":0.00003113804,"about_ca_topic_score_gemma":0.00005524299,"teacher_disagreement_score":0.009148454,"about_ca_system_score_codex":0.000008875524,"about_ca_system_score_gemma":0.00006552514,"threshold_uncertainty_score":0.1415007},"labels":[],"label_agreement":null},{"id":"W3028971888","doi":"10.1200/jco.2020.38.15_suppl.10023","title":"Time to central nervous system (CNS) metastases (mets) with atezolizumab (A) or placebo (P) combined with cobimetinib (C) + vemurafenib (V) in the phase III IMspire150 study.","year":2020,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada)","funders":"Roche","keywords":"Medicine; Vemurafenib; Internal medicine; Gastroenterology; Magnetic resonance imaging; Placebo; Nuclear medicine; Pathology; Metastatic melanoma; Cancer; Radiology","score_opus":0.06613375915990369,"score_gpt":0.37508031753054516,"score_spread":0.30894655837064144,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3028971888","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945909,0.00009291088,0.0002960927,0.0026897723,0.00019900389,0.0009468795,0.000025986536,0.000010480651,0.001147983],"genre_scores_gemma":[0.99553907,0.000019322111,0.00093413785,0.0025249736,0.00075276376,0.000026689813,0.000017107102,0.000029280814,0.00015667816],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9957251,0.0014181547,0.0016404723,0.0003934984,0.00040678086,0.00041602438],"domain_scores_gemma":[0.9972919,0.0005967243,0.001046261,0.00033500165,0.0002262995,0.0005038169],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021983187,0.00027283328,0.0013323177,0.00006428405,0.00007013124,0.00003043246,0.00064540136,0.00022189657,0.0000865854],"category_scores_gemma":[0.0008133791,0.00013571278,0.00021503819,0.0002807195,0.00015829652,0.000010317542,0.00011535339,0.0005528104,0.000034314253],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.80411345,0.015780346,0.008900712,0.00019428252,0.003742231,0.020221652,0.0031248236,0.0019085709,0.01842019,0.00016010205,0.04571931,0.077714354],"study_design_scores_gemma":[0.14747831,0.5704144,0.013238982,0.00021109593,0.0015186492,0.0025394687,0.008180088,0.00054812373,0.004050496,0.0000050481904,0.25093666,0.00087865285],"about_ca_topic_score_codex":0.000016782691,"about_ca_topic_score_gemma":0.00013676888,"teacher_disagreement_score":0.6566351,"about_ca_system_score_codex":0.00004288518,"about_ca_system_score_gemma":0.0011439666,"threshold_uncertainty_score":0.55342066},"labels":[],"label_agreement":null},{"id":"W3029372856","doi":"10.1200/jco.2020.38.15_suppl.e22102","title":"Management of pyrexia in metastatic melanoma patients: A real-world clinical experience survey study.","year":2020,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"Novartis","keywords":"Medicine; Dabrafenib; Trametinib; Adverse effect; Internal medicine; Melanoma; Metastatic melanoma; Vemurafenib; Oncology; Cancer","score_opus":0.20203369067340887,"score_gpt":0.4764066622415882,"score_spread":0.2743729715681793,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3029372856","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996659,0.00009347566,0.00014618743,0.00022289879,0.0007580584,0.0002917486,0.000010687645,0.0000023180835,0.0018156589],"genre_scores_gemma":[0.99657893,0.0005597964,0.0018724323,0.0005870038,0.00028650244,0.000007107465,0.000012160769,0.000014270288,0.00008181324],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9936985,0.0018551255,0.0035906096,0.0003385316,0.0003013328,0.00021591916],"domain_scores_gemma":[0.99674076,0.0005860843,0.0017977466,0.00026278975,0.0003031143,0.00030951892],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0045996583,0.00015335818,0.0012270854,0.0000667965,0.000017355795,0.0000058604173,0.0004695067,0.00017046185,0.00004316486],"category_scores_gemma":[0.0021628249,0.00012067737,0.00034422264,0.00022249605,0.0001707268,0.000009452559,0.00024189941,0.00042119974,0.0000071583686],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003121176,0.0033868859,0.9672778,0.000024602949,0.00034190208,0.00031436636,0.00018569054,0.000010576442,0.00012094785,0.00004555283,0.001260547,0.023909952],"study_design_scores_gemma":[0.00629395,0.020313004,0.96224695,0.000022901446,0.00009139289,0.0000033131594,0.0005064481,0.000018177114,0.0001629093,0.000029062867,0.010194192,0.00011768889],"about_ca_topic_score_codex":0.00007212721,"about_ca_topic_score_gemma":0.0005761447,"teacher_disagreement_score":0.023792263,"about_ca_system_score_codex":0.00001980569,"about_ca_system_score_gemma":0.00034868845,"threshold_uncertainty_score":0.49210802},"labels":[],"label_agreement":null},{"id":"W3029728451","doi":"10.1200/jco.2020.38.15_suppl.10013","title":"Long-term survival from pembrolizumab (pembro) completion and pembro retreatment: Phase III KEYNOTE-006 in advanced melanoma.","year":2020,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Family medicine","score_opus":0.08588612701183446,"score_gpt":0.40634895926037484,"score_spread":0.3204628322485404,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3029728451","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99422115,0.0013217799,0.0011466944,0.0012397505,0.0007896193,0.00018211917,0.000037599788,0.000006373024,0.0010548849],"genre_scores_gemma":[0.995317,0.0011394897,0.0011104121,0.0008750368,0.0013540016,0.00000409216,0.00012290917,0.000021348927,0.00005573613],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969439,0.0005380133,0.0016385963,0.00040185582,0.00021358901,0.00026405696],"domain_scores_gemma":[0.9978729,0.00033250471,0.0010246238,0.0002049239,0.00014766346,0.00041740978],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00074467895,0.00021510092,0.0011429277,0.00005210412,0.00004368248,0.000015638612,0.00024762747,0.0004782446,0.000093263996],"category_scores_gemma":[0.0008081959,0.00018010903,0.0002800521,0.00008066245,0.00014957857,0.000016086975,0.00013821133,0.0005082031,0.000008148986],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06873065,0.0040046,0.4229689,0.00006963026,0.0008954906,0.002363911,0.00040143493,0.00006897827,0.29885057,0.00022593055,0.0021213465,0.19929858],"study_design_scores_gemma":[0.1241998,0.04687355,0.7668882,0.00009399882,0.00038611118,0.00026471712,0.00018714066,0.00031144507,0.014196423,0.00035176138,0.04560596,0.00064088125],"about_ca_topic_score_codex":0.000030568783,"about_ca_topic_score_gemma":0.00018047504,"teacher_disagreement_score":0.3439193,"about_ca_system_score_codex":0.00004141597,"about_ca_system_score_gemma":0.0004124318,"threshold_uncertainty_score":0.7344633},"labels":[],"label_agreement":null},{"id":"W3031004830","doi":"10.1200/jco.2020.38.15_suppl.10022","title":"A phase II, multicenter study of encorafenib/binimetinib followed by a rational triple-combination after progression in patients with advanced BRAF V600-mutated melanoma (LOGIC2).","year":2020,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; McGill University; Jewish General Hospital","funders":"","keywords":"Medicine; Internal medicine; Oncology; Logistic regression","score_opus":0.03068166014931388,"score_gpt":0.37951458013537354,"score_spread":0.34883291998605964,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3031004830","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981852,0.00010650102,0.00016445322,0.00042199864,0.0003164397,0.0006816935,0.000019173423,0.0000037469417,0.000100753845],"genre_scores_gemma":[0.9980772,0.000018126606,0.0011580515,0.00047752447,0.00012830459,0.00002756148,0.00007501093,0.000015265608,0.000022946488],"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99685025,0.0005880314,0.0017391797,0.00029759514,0.0003438421,0.00018108229],"domain_scores_gemma":[0.9974885,0.00015731112,0.001572568,0.00013305162,0.00044537225,0.00020319723],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008077152,0.00016757373,0.00075399695,0.00006549756,0.000031733987,0.000006370857,0.00019797306,0.00026997243,0.00004412087],"category_scores_gemma":[0.001349654,0.00011775477,0.00016426356,0.00014158746,0.00007632352,0.000021906228,0.000093124705,0.00033936114,0.0000014713545],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.11178699,0.061653953,0.72948,0.000029024282,0.00037929806,0.00014969095,0.00078528264,0.000033423603,0.042469967,0.0000041457106,0.0018096556,0.051418517],"study_design_scores_gemma":[0.1999237,0.44302237,0.33498114,0.000081078564,0.00019962757,0.000007076543,0.00036247043,0.00017394233,0.012360811,0.00002042443,0.008538069,0.0003292986],"about_ca_topic_score_codex":0.000002001017,"about_ca_topic_score_gemma":0.000017144299,"teacher_disagreement_score":0.3944989,"about_ca_system_score_codex":0.000023449831,"about_ca_system_score_gemma":0.0003233916,"threshold_uncertainty_score":0.48019},"labels":[],"label_agreement":null},{"id":"W3031975191","doi":"10.1007/s00401-020-02167-1","title":"An optimized workflow to improve reliability of detection of KIAA1549:BRAF fusions from RNA sequencing data","year":2020,"lang":"en","type":"article","venue":"Acta Neuropathologica","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"Deutsches Krebsforschungszentrum; Fondation Charles-Bruneau; Nationales Centrum für Tumorerkrankungen Heidelberg; Brain Tumour Charity; Pediatric Brain Tumor Foundation","keywords":"Workflow; Reliability (semiconductor); Computational biology; RNA; Computer science; Biology; Medicine; Bioinformatics; Pathology; Genetics; Gene; Database","score_opus":0.03664230203625043,"score_gpt":0.25754302520665556,"score_spread":0.22090072317040513,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3031975191","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.989812,0.000039385377,0.008839136,0.0002025602,0.00015999096,0.00026844267,0.0004386208,0.000027603635,0.0002122671],"genre_scores_gemma":[0.98556393,0.000056983277,0.013448626,0.0004943686,0.00016212964,0.000010103952,0.00023961364,0.00001761642,0.000006650123],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984155,0.0002320823,0.00034159736,0.0007118872,0.00012295191,0.00017595157],"domain_scores_gemma":[0.9982753,0.000041966425,0.00017466278,0.0012583071,0.00008816555,0.00016159419],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023216085,0.0001540668,0.00026487838,0.000022255565,0.000050005307,0.000009905615,0.0006425261,0.00014121967,0.000027648599],"category_scores_gemma":[0.0011078649,0.00013175202,0.000067623885,0.00013441253,0.00006564352,0.000011652058,0.00054684596,0.00012703497,0.0000040398572],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000312884,0.00005770315,0.0003353303,0.000013011113,0.0000057563357,0.000015589127,0.00008300924,0.0001668404,0.9938169,0.0000014411252,0.00006651677,0.0051250225],"study_design_scores_gemma":[0.00036554236,0.0016127119,0.0041898405,0.0000075208773,0.000030673284,0.0000048477345,0.00004887283,0.0013742232,0.9912332,0.000038619197,0.0009472624,0.00014663274],"about_ca_topic_score_codex":0.000039138406,"about_ca_topic_score_gemma":0.0000062638715,"teacher_disagreement_score":0.0049783895,"about_ca_system_score_codex":0.000005962767,"about_ca_system_score_gemma":0.000053501033,"threshold_uncertainty_score":0.5372692},"labels":[],"label_agreement":null},{"id":"W3033214396","doi":"10.3390/ijms21114055","title":"The MNK1/2-eIF4E Axis as a Potential Therapeutic Target in Melanoma","year":2020,"lang":"en","type":"review","venue":"International Journal of Molecular Sciences","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; McGill University; Jewish General Hospital","funders":"Fonds de Recherche du Québec - Santé; Terry Fox Research Institute; Canadian Cancer Society; Canadian Institutes of Health Research; Réseau de cancérologie Rossy","keywords":"EIF4E; Melanoma; Cancer research; PI3K/AKT/mTOR pathway; Targeted therapy; Medicine; MAPK/ERK pathway; Translation (biology); Kinase; Signal transduction; Protein kinase A; Cancer; Biology; Bioinformatics; Messenger RNA; Internal medicine; Cell biology; Gene; Genetics","score_opus":0.02101689350704776,"score_gpt":0.31828228895370075,"score_spread":0.297265395446653,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3033214396","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00090028485,0.99509424,0.0009502469,0.0005111381,0.0013184367,0.00014775593,0.000012862259,0.0000023894365,0.0010626231],"genre_scores_gemma":[0.012742186,0.9858817,0.0004035575,0.00027533475,0.00055705215,0.000009434577,0.0000152458515,0.000018692059,0.000096825715],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99783534,0.00024804624,0.0006568163,0.0002935017,0.00074418564,0.00022212525],"domain_scores_gemma":[0.99888945,0.000043137185,0.0006279517,0.00015911426,0.00018727081,0.00009309306],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007183944,0.00023143667,0.00044370312,0.00016639903,0.00008531382,0.00018415162,0.001905246,0.00015853166,0.000022507065],"category_scores_gemma":[0.00018563207,0.00014372202,0.0005164753,0.00018806866,0.00021395755,0.000010513634,0.00022108563,0.00028305376,0.000020802781],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006687283,0.000067223875,0.000023538518,0.000093433744,0.0005719778,0.0012713124,0.00004752123,0.000056901223,0.00476616,0.0017171156,0.00038574357,0.9909322],"study_design_scores_gemma":[0.0002118661,0.00045164584,0.0000072536973,0.00039340297,0.00006369753,0.0011946319,0.000043559718,0.000017468466,0.0010878845,0.00077194866,0.99558645,0.00017018615],"about_ca_topic_score_codex":0.000008859222,"about_ca_topic_score_gemma":0.000005480337,"teacher_disagreement_score":0.9952007,"about_ca_system_score_codex":0.000039799736,"about_ca_system_score_gemma":0.0009720257,"threshold_uncertainty_score":0.5860814},"labels":[],"label_agreement":null},{"id":"W3034215768","doi":"10.1101/2020.06.11.145995","title":"Catalytic domain plasticity of MKK7 reveals structural mechanisms of allosteric activation and new targeting opportunities","year":2020,"lang":"en","type":"preprint","venue":"bioRxiv (Cold Spring Harbor Laboratory)","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Novartis Pharma; Ontario Ministry of Economic Development and Innovation; Deutschen Konsortium für Translationale Krebsforschung; European Federation of Pharmaceutical Industries and Associations; Merck KGaA; Ministero dello Sviluppo Economico; Fundação de Amparo à Pesquisa do Estado de São Paulo; Diamond Light Source; Genome Canada; Pfizer","keywords":"Allosteric regulation; Regulator; Transferase; Chemistry; Kinase; Structural biology; Helix (gastropod); Protein kinase domain; Structural plasticity; Cell biology; Computational biology; Enzyme; Biochemistry; Biology; Neuroscience; Gene; Ecology","score_opus":0.02937375849624991,"score_gpt":0.21955337550586998,"score_spread":0.19017961700962008,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3034215768","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98349625,0.0002799779,0.015260061,0.00008177166,0.00023093754,0.00034279207,0.00027144534,0.000026400068,0.000010375381],"genre_scores_gemma":[0.98962486,0.00009167179,0.009896682,0.00007631067,0.00023321781,0.000015871059,0.0000067664346,0.000050738676,0.0000039104166],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984188,0.00008517864,0.00050487067,0.0005494379,0.00020403857,0.00023766219],"domain_scores_gemma":[0.998553,0.00002473698,0.0006234343,0.00038701593,0.00020946837,0.0002023527],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00019362746,0.0003329912,0.00048574133,0.00008548966,0.000050517883,0.00002931523,0.00026309871,0.00036699418,0.000009908489],"category_scores_gemma":[0.00022014839,0.00035031483,0.00009398209,0.000083751525,0.00009371826,0.000010206419,0.0005201223,0.00020256081,8.87058e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006577652,0.000013378175,0.0005095343,0.00063283363,0.000112327,0.0000057828834,0.00001691111,0.00001315032,0.9971538,0.0013159324,0.00015739052,0.0000031778025],"study_design_scores_gemma":[0.00033949243,0.00017735503,0.009833011,0.00017129174,0.00006557002,3.6963495e-8,0.000017335251,0.000058192163,0.9887182,0.00009919218,0.00019209717,0.00032824086],"about_ca_topic_score_codex":0.00005233248,"about_ca_topic_score_gemma":9.955553e-7,"teacher_disagreement_score":0.009323477,"about_ca_system_score_codex":0.00002542115,"about_ca_system_score_gemma":0.00043812615,"threshold_uncertainty_score":0.99989486},"labels":[],"label_agreement":null},{"id":"W3034783173","doi":"10.1016/j.trecan.2020.05.009","title":"Clinical Development of BRAF plus MEK Inhibitor Combinations","year":2020,"lang":"en","type":"review","venue":"Trends in cancer","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":352,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Daiichi Sankyo Company; Bristol-Myers Squibb Canada; Genentech; European Society for Medical Oncology; Exelixis; Prometheus; Roche; Pfizer; Novartis Pharmaceuticals Corporation; Celgene; American Society of Clinical Oncology; AstraZeneca; Novartis; Spectrum Pharmaceuticals; Amgen; GlaxoSmithKline","keywords":"MEK inhibitor; Cancer research; Chemistry; Pharmacology; Medicine; MAPK/ERK pathway; Phosphorylation; Biochemistry","score_opus":0.13543415085614935,"score_gpt":0.44001653710992666,"score_spread":0.3045823862537773,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3034783173","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00021748793,0.99664897,0.00003739501,0.000025642892,0.00058746844,0.00013866322,0.00011065035,0.000006907127,0.0022268163],"genre_scores_gemma":[0.00040251197,0.99661505,0.0007502579,0.000038383045,0.0003662276,0.00015871577,0.0005951886,0.00003145873,0.001042201],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99845874,0.00009593155,0.0007795777,0.0003878278,0.000116544434,0.00016139536],"domain_scores_gemma":[0.9993481,0.000022379634,0.0002717726,0.00024528225,0.000034197834,0.00007828287],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000164028,0.00021961196,0.0008646386,0.00007391772,0.000022894099,0.000005333845,0.0002344593,0.00034202708,0.00009966312],"category_scores_gemma":[0.000032726504,0.00019162394,0.0002676852,0.00022400626,0.000054403314,0.0000012033282,0.00015218263,0.00020425269,0.000011877773],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000006810905,0.000083598476,0.000022004815,0.0009697064,0.00009557474,0.00000448799,0.000044077606,4.386228e-7,0.00001608187,0.00003463255,0.0036456943,0.9950769],"study_design_scores_gemma":[0.00045853775,0.00009965745,0.000043977252,0.0009974837,0.00008362276,0.0000023753269,0.000004857221,0.0000014740783,0.00019219094,0.000002868134,0.9979141,0.00019889756],"about_ca_topic_score_codex":0.000010891903,"about_ca_topic_score_gemma":0.00024311313,"teacher_disagreement_score":0.994878,"about_ca_system_score_codex":0.000067912195,"about_ca_system_score_gemma":0.0008235517,"threshold_uncertainty_score":0.78141975},"labels":[],"label_agreement":null},{"id":"W3036759197","doi":"10.1038/s41580-020-0255-7","title":"ERK signalling: a master regulator of cell behaviour, life and fate","year":2020,"lang":"en","type":"review","venue":"Nature Reviews Molecular Cell Biology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1202,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Institute for Research in Immunology and Cancer","funders":"Canadian Institutes of Health Research","keywords":"Cell biology; MAPK/ERK pathway; Kinase; Biology; Cell growth; Cell fate determination; Extracellular; Cell; Signal transduction; Intracellular; Protein kinase A; Cell signaling; Regulator; Cell metabolism; Biochemistry; Transcription factor","score_opus":0.024231471057119387,"score_gpt":0.28033844892549703,"score_spread":0.25610697786837766,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3036759197","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00022170761,0.99544334,0.0004956075,0.000022599572,0.0003000662,0.001535016,0.00017073435,0.000015019979,0.0017958919],"genre_scores_gemma":[0.00090352417,0.9944055,0.002098944,0.0004859003,0.00030661895,0.00012665297,0.0012753564,0.00011787958,0.00027963743],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99603647,0.0008258116,0.0012380133,0.0012713873,0.00014263883,0.00048568659],"domain_scores_gemma":[0.9975317,0.00003593718,0.0011110987,0.0008643043,0.00009764224,0.00035932355],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00041510523,0.00089069863,0.0029545957,0.00013521602,0.00004848852,0.000019978675,0.0006430559,0.0026515315,0.0000393802],"category_scores_gemma":[0.00016630502,0.00068571896,0.0011273876,0.00024102027,0.00016564807,0.0000028565617,0.00046438063,0.001031134,0.000047267862],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005316558,0.00018676672,0.000036383495,0.040649153,0.0003573079,0.00012142183,0.000025475583,3.1682876e-7,0.31022054,0.0002915961,0.0035080693,0.6445498],"study_design_scores_gemma":[0.0003037116,0.00049065804,5.262186e-7,0.0011392841,0.0008313317,0.000032193348,0.000002465999,9.1767635e-7,0.016382802,0.000016429818,0.98018765,0.00061205006],"about_ca_topic_score_codex":0.0000020898203,"about_ca_topic_score_gemma":0.0000011198816,"teacher_disagreement_score":0.97667956,"about_ca_system_score_codex":0.000017235408,"about_ca_system_score_gemma":0.00032856409,"threshold_uncertainty_score":0.9995594},"labels":[],"label_agreement":null},{"id":"W3038254578","doi":"10.1002/cpdd.822","title":"Effect of Itraconazole, a Potent CYP3A4 Inhibitor, on the Steady‐State Pharmacokinetics of Vemurafenib in Patients With <i>BRAF</i><sup>V600</sup> Mutation–Positive Malignancies","year":2020,"lang":"en","type":"article","venue":"Clinical Pharmacology in Drug Development","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada)","funders":"","keywords":"Vemurafenib; Itraconazole; Medicine; Pharmacokinetics; Dosing; Pharmacology; Crossover study; Confidence interval; Area under the curve; Internal medicine; Adverse effect; Urology; Gastroenterology; Cancer; Dermatology; Pathology; Metastatic melanoma","score_opus":0.012223719638403855,"score_gpt":0.2778418450221536,"score_spread":0.26561812538374974,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3038254578","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99757737,0.00009887745,0.00002305323,0.0006951075,0.00024919593,0.0010830229,0.000047589194,0.000007806079,0.00021800217],"genre_scores_gemma":[0.9967611,0.000064908876,0.00016876028,0.0026248016,0.00010056366,0.00011170984,0.00010507968,0.000024261237,0.000038855767],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9972196,0.00071359414,0.0010103362,0.00047272997,0.00026104096,0.0003226777],"domain_scores_gemma":[0.9987492,0.00048420083,0.0003379342,0.00015286908,0.00014635164,0.00012946525],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008611402,0.0002786057,0.00049259653,0.000070895265,0.000040376108,0.000005167812,0.00030980044,0.00013222921,0.000025902536],"category_scores_gemma":[0.00015497151,0.0001956392,0.00009695411,0.00021699148,0.0002751602,0.0000069783423,0.00018426696,0.0003592735,0.0000107971655],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.040037226,0.007356582,0.5949381,0.0011085559,0.0019868396,0.00046837638,0.016782988,0.022539135,0.25079492,0.00007469835,0.02202133,0.04189127],"study_design_scores_gemma":[0.010641102,0.0031187774,0.093493134,0.00009746533,0.00006664481,0.0000017287421,0.00008877293,0.00016754198,0.88927066,0.0000064549045,0.0027520934,0.00029564463],"about_ca_topic_score_codex":0.000005391706,"about_ca_topic_score_gemma":0.0000056669605,"teacher_disagreement_score":0.6384757,"about_ca_system_score_codex":0.0000329015,"about_ca_system_score_gemma":0.00022035766,"threshold_uncertainty_score":0.79779345},"labels":[],"label_agreement":null},{"id":"W3043280112","doi":"10.1016/j.jaad.2020.07.044","title":"Cutaneous reactions in children treated with MEK inhibitors, BRAF inhibitors, or combination therapy: A multicenter study","year":2020,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":42,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Institutes of Health","keywords":"Medicine; Multicenter study; Oncology; Dermatology; Internal medicine; Randomized controlled trial","score_opus":0.012379842251330356,"score_gpt":0.2599215950624793,"score_spread":0.24754175281114896,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3043280112","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99549776,0.00012446273,0.000018640781,0.003969455,0.000032304917,0.00032270132,0.000008161271,0.0000046997047,0.000021835634],"genre_scores_gemma":[0.99870443,0.00017137208,0.00010678169,0.0008670255,0.00010454814,0.000005136639,0.0000035143148,0.000017608594,0.000019595698],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986879,0.00030996578,0.0005235674,0.00014680927,0.00016974911,0.00016196599],"domain_scores_gemma":[0.9988121,0.00003286953,0.00091951975,0.0001023939,0.000053084525,0.000080049045],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007352519,0.00014650341,0.00038608903,0.00008683582,0.00004188356,0.0000068983654,0.00028658245,0.00007923825,0.0000050208305],"category_scores_gemma":[0.000077858516,0.00008668732,0.000097254364,0.00027371006,0.0001913356,0.000009878587,0.000066987486,0.00031361857,0.0000010513885],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020560801,0.0005669574,0.7663333,0.000008361157,0.00027784318,0.00004560644,0.00032327985,0.000041787152,0.22795056,0.000006022812,0.0013330567,0.0010571553],"study_design_scores_gemma":[0.009150858,0.006788281,0.329913,0.00008492724,0.0001757754,0.010290127,0.0017813047,0.000078787794,0.634431,0.000021199074,0.0068910276,0.00039375335],"about_ca_topic_score_codex":0.0000393495,"about_ca_topic_score_gemma":0.000006282103,"teacher_disagreement_score":0.43642032,"about_ca_system_score_codex":0.000014949106,"about_ca_system_score_gemma":0.000067299225,"threshold_uncertainty_score":0.35350066},"labels":[],"label_agreement":null},{"id":"W3044551578","doi":"10.1016/j.jdcr.2020.07.021","title":"Isotretinoin for the treatment of severe acneiform eruptions associated with the MEK inhibitor trametinib","year":2020,"lang":"en","type":"article","venue":"JAAD Case Reports","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; Université de Montréal","funders":"","keywords":"Trametinib; Medicine; MEK inhibitor; Selumetinib; Vemurafenib; Dabrafenib; Protein kinase A; Cancer research; Internal medicine; Oncology; Melanoma; MAPK/ERK pathway; Cancer; Kinase; Biology","score_opus":0.02314795344111546,"score_gpt":0.2455809543987585,"score_spread":0.22243300095764304,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3044551578","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99619305,0.00048439697,0.00039448598,0.0015266411,0.00008611167,0.0006794984,0.000110546316,0.000013123345,0.00051213807],"genre_scores_gemma":[0.9985541,0.000057659665,0.00013620722,0.00020333797,0.00023338434,0.00016063974,0.0001343961,0.00001775899,0.0005024837],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9992514,0.00003274248,0.00022536865,0.00023279469,0.000101606514,0.00015607169],"domain_scores_gemma":[0.9992224,0.00007487173,0.00022768666,0.00031764474,0.0000927951,0.00006460841],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013880432,0.0001310253,0.00015018373,0.000007786662,0.00014407838,0.000014211149,0.000042315078,0.000086309796,0.000013895183],"category_scores_gemma":[0.00012416283,0.00006478034,0.0001490418,0.00007396208,0.00006580364,0.0000020743178,0.000017780458,0.00003876072,7.5181526e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023313423,0.0030028485,0.011590807,0.00027035293,0.0046746177,0.022913879,0.012969234,0.0012376346,0.7883137,0.0004937975,0.090754114,0.06144771],"study_design_scores_gemma":[0.002267002,0.007083272,0.0018215354,0.000030916486,0.00069198146,0.013212757,0.0022984096,0.00024357045,0.46543193,0.00004662585,0.5064134,0.00045858396],"about_ca_topic_score_codex":0.000029331895,"about_ca_topic_score_gemma":0.00016435569,"teacher_disagreement_score":0.4156593,"about_ca_system_score_codex":0.000014606406,"about_ca_system_score_gemma":0.00009623383,"threshold_uncertainty_score":0.26416656},"labels":[],"label_agreement":null},{"id":"W3045758154","doi":"10.1016/j.ophtha.2020.05.043","title":"Re: Francis et al.: Immune checkpoint inhibitor associated optic neuritis (Ophthalmology. 2020;127:1585-1589)","year":2020,"lang":"en","type":"letter","venue":"Ophthalmology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Kensington Health; University of Toronto","funders":"","keywords":"Medicine; Optic neuritis; Ophthalmology; Immunology; Multiple sclerosis","score_opus":0.018155429263734313,"score_gpt":0.25912125608346587,"score_spread":0.24096582681973155,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3045758154","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.35623702,0.004656561,0.000031937285,0.6093411,0.006230653,0.0016131346,0.0011432752,0.00016197213,0.020584386],"genre_scores_gemma":[0.40802684,0.0003626489,0.0008093449,0.5542971,0.006064544,0.00065786217,0.016464597,0.0005703471,0.012746753],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99314773,0.0011758541,0.0013254661,0.0022921723,0.0005210077,0.0015377728],"domain_scores_gemma":[0.9967628,0.00018553308,0.0008585254,0.0016120417,0.00027976226,0.0003013259],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0005368696,0.0012570148,0.0016568748,0.00017834589,0.0002495833,0.00008511867,0.0012412723,0.0033894111,0.0015814168],"category_scores_gemma":[0.0009693447,0.001362587,0.0009098119,0.00035437822,0.00045898522,0.000013549002,0.0009985907,0.003289269,0.0006390876],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014197858,0.00015400499,0.0006731478,0.00014270407,0.0004766746,0.04873275,0.000050197534,0.000003921792,0.111525096,0.0000064556984,0.83801174,0.00008133891],"study_design_scores_gemma":[0.0021874625,0.003920324,0.0020069852,0.00013597184,0.0002385557,0.030473031,0.00004595843,0.000033149256,0.026598332,0.00036275425,0.93186635,0.0021311427],"about_ca_topic_score_codex":0.00015308254,"about_ca_topic_score_gemma":0.000005410386,"teacher_disagreement_score":0.093854606,"about_ca_system_score_codex":0.000095219424,"about_ca_system_score_gemma":0.00037719836,"threshold_uncertainty_score":0.9993313},"labels":[],"label_agreement":null},{"id":"W3048853605","doi":"10.1016/j.chembiol.2020.07.014","title":"Catalytic Domain Plasticity of MKK7 Reveals Structural Mechanisms of Allosteric Activation and Diverse Targeting Opportunities","year":2020,"lang":"en","type":"article","venue":"Cell chemical biology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Eshelman Institute for Innovation, University of North Carolina at Chapel Hill; Shenzhen Gas Corporation; Innovative Medicines Initiative; Deutsche Forschungsgemeinschaft; Ontario Ministry of Economic Development and Innovation; European Federation of Pharmaceutical Industries and Associations; Takeda Pharmaceutical Company; Boehringer Ingelheim; Janssen Pharmaceuticals; Merck KGaA; European Commission; Meso Scale Diagnostics; Sanofi; Wellcome Trust; Astellas Pharma US; Genome Canada; Novartis Pharma; Deutschen Konsortium für Translationale Krebsforschung; Canada Foundation for Innovation; Novartis; Pfizer","keywords":"Allosteric regulation; Regulator; Transferase; Chemistry; Protein kinase domain; Helix (gastropod); Kinase; Structural biology; Cell biology; Enzyme; Computational biology; Biochemistry; Biology; Gene","score_opus":0.0262139424188548,"score_gpt":0.22298158617900635,"score_spread":0.19676764376015154,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3048853605","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970175,0.000070631846,0.0022874277,0.00006280674,0.000032690343,0.00008120097,0.00006490698,0.000005019668,0.00037781862],"genre_scores_gemma":[0.9980224,0.00002101202,0.0014682817,0.00014590245,0.000063305284,0.0000026589232,0.0002600588,0.000006916156,0.000009459119],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993677,0.000036834623,0.00021266406,0.00021133099,0.000040777675,0.00013068471],"domain_scores_gemma":[0.9996279,0.000029656432,0.00014590981,0.00007445977,0.000043562635,0.000078526195],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00004828154,0.000104411665,0.00019857635,0.000014653563,0.000018503064,0.0000020096252,0.00010042376,0.00015304022,0.000018504155],"category_scores_gemma":[0.00009134943,0.000092158174,0.00004157122,0.000027261516,0.00014006428,0.0000028002746,0.0001677705,0.000054874785,7.589573e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009141767,0.000008784343,0.00043585835,0.000101692705,0.000015755368,8.9425896e-7,0.00008818199,8.3191463e-7,0.9982579,0.00067993934,0.00010821933,0.00021054302],"study_design_scores_gemma":[0.0003167249,0.0002765633,0.00010133778,0.0000053880153,0.000012940202,0.0000024840367,0.0002510929,0.000028340053,0.9975387,0.0012047722,0.00016797952,0.000093669965],"about_ca_topic_score_codex":0.000007350022,"about_ca_topic_score_gemma":2.0342416e-7,"teacher_disagreement_score":0.0010049084,"about_ca_system_score_codex":0.00000393499,"about_ca_system_score_gemma":0.000022722938,"threshold_uncertainty_score":0.37581012},"labels":[],"label_agreement":null},{"id":"W3049717158","doi":"10.1021/acsomega.0c02419","title":"Synthesis of a <sup>11</sup>C-Isotopologue of the B-Raf-Selective Inhibitor Encorafenib Using In-Loop [<sup>11</sup>C]CO<sub>2</sub> Fixation","year":2020,"lang":"en","type":"article","venue":"ACS Omega","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Centre Hospitalier de l’Université de Montréal","funders":"Dana-Farber Cancer Institute","keywords":"Chemistry","score_opus":0.015347437260393683,"score_gpt":0.2303034083146331,"score_spread":0.21495597105423944,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3049717158","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980781,0.0002282758,0.00025522048,0.00035402,0.00007582173,0.0005120346,0.00013712583,0.00001768003,0.00034171075],"genre_scores_gemma":[0.9989045,0.000058566122,0.00024043724,0.0002836142,0.00031508354,0.000052853233,0.00006702917,0.0000455003,0.000032398897],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978584,0.0002644723,0.00060395093,0.0005650278,0.00029992202,0.00040821062],"domain_scores_gemma":[0.9986876,0.00010879885,0.00036806433,0.0005231718,0.00019312298,0.00011919486],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000279289,0.00031354916,0.0004687725,0.00011527342,0.00010578753,0.000018107452,0.00044620724,0.00038227698,0.0000064923042],"category_scores_gemma":[0.00086527824,0.00026905036,0.00022562318,0.00051461,0.0002287344,0.000021270072,0.0002443057,0.00020433925,0.000007506301],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014997844,0.00013182434,0.016015911,0.000113477974,0.00007015446,0.0000062895265,0.0008025497,0.0019676345,0.9788413,0.000102094076,0.00084454974,0.0009542067],"study_design_scores_gemma":[0.00069714774,0.00026749473,0.0017628217,0.000082860104,0.00006953938,0.000013846587,0.0005769394,0.0019045053,0.9930458,0.00007623964,0.0012288301,0.0002739495],"about_ca_topic_score_codex":0.00014589123,"about_ca_topic_score_gemma":0.00009395049,"teacher_disagreement_score":0.014253089,"about_ca_system_score_codex":0.000048888505,"about_ca_system_score_gemma":0.000279769,"threshold_uncertainty_score":0.99997616},"labels":[],"label_agreement":null},{"id":"W3068892982","doi":"10.1016/j.ejmech.2020.112721","title":"Selective targeting of the αC and DFG-out pocket in p38 MAPK","year":2020,"lang":"en","type":"article","venue":"European Journal of Medicinal Chemistry","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Eshelman Institute for Innovation, University of North Carolina at Chapel Hill; Pfizer Canada; Merck Sharp and Dohme; AbbVie Deutschland; Innovative Medicines Initiative; Novartis Pharma; Canada Foundation for Innovation; Ontario Ministry of Economic Development and Innovation; Fundação de Amparo à Pesquisa do Estado de São Paulo; Genome Canada; Merck KGaA; Boehringer Ingelheim; Wellcome Trust; Bayer","keywords":"Chemistry; Allosteric regulation; MAPK/ERK pathway; p38 mitogen-activated protein kinases; Binding pocket; Drug discovery; Combinatorial chemistry; Binding site; Computational biology; Signal transduction; Biochemistry; Receptor; Biology","score_opus":0.01038204048651175,"score_gpt":0.2036884798109804,"score_spread":0.19330643932446864,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3068892982","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98950243,0.0018833786,0.00013763303,0.0006424154,0.00007905106,0.00003505161,0.0000041843036,0.0000015479592,0.007714323],"genre_scores_gemma":[0.99857104,0.0000958959,0.0001700492,0.00041322003,0.0006425196,1.9482081e-7,0.0000030342953,0.000013325326,0.000090734495],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991076,0.00012607906,0.00034854782,0.00012864951,0.00016767601,0.000121463905],"domain_scores_gemma":[0.99940705,0.000013959908,0.00028452178,0.000094051895,0.00008374417,0.00011667954],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00049457676,0.00009970757,0.00016668274,0.000010179772,0.000024840732,0.000004909238,0.00023115546,0.000035116187,0.00002427267],"category_scores_gemma":[0.00047476694,0.000069337824,0.0000668634,0.00006129676,0.00008553213,0.0000028856657,0.0001035805,0.0002711151,9.4852174e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012507365,0.000016288583,0.0035334418,0.00007720068,0.000024756788,0.000064007116,0.0004581041,0.000006142241,0.99140614,0.0000011301557,0.0035782375,0.00070947275],"study_design_scores_gemma":[0.0009669767,0.00032141013,0.006263909,0.00012418143,0.000021788988,0.00015100765,0.00055616203,0.000010578199,0.98179334,0.000008321701,0.009696457,0.00008588758],"about_ca_topic_score_codex":7.89738e-7,"about_ca_topic_score_gemma":3.1896172e-7,"teacher_disagreement_score":0.009612825,"about_ca_system_score_codex":0.0000070963533,"about_ca_system_score_gemma":0.000076092096,"threshold_uncertainty_score":0.28275144},"labels":[],"label_agreement":null},{"id":"W3082347199","doi":"10.1097/cad.0000000000000951","title":"The positive correlation between drug addiction and drug dosage in vemurafenib-resistant melanoma cells is underpinned by activation of ERK1/2-FRA-1 pathway","year":2020,"lang":"en","type":"article","venue":"Anti-Cancer Drugs","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Aging","funders":"","keywords":"Vemurafenib; Melanoma; Cancer research; Downregulation and upregulation; Medicine; Drug resistance; Pharmacology; clone (Java method); Drug; Addiction; Biology; Metastatic melanoma; Psychiatry; Genetics; Gene","score_opus":0.006785868286619531,"score_gpt":0.21391821300337346,"score_spread":0.20713234471675393,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3082347199","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99482656,0.0011394765,0.00047556244,0.0020986514,0.00010648122,0.00031669563,0.0003778718,0.000011956976,0.0006467346],"genre_scores_gemma":[0.99814,0.00050706445,0.00003361278,0.00057330524,0.00015359253,0.000024106515,0.00027809403,0.00002198474,0.00026825312],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987882,0.00011496584,0.00031626798,0.00037165143,0.00017535042,0.00023355747],"domain_scores_gemma":[0.99936944,0.000068147005,0.0002247239,0.00018847956,0.00006420085,0.00008500814],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017208568,0.00017678547,0.00020698196,0.000031964657,0.00013099753,0.00002872201,0.00012051341,0.000118996686,0.000012962165],"category_scores_gemma":[0.000018556093,0.0001497107,0.000073128416,0.0001462181,0.00008683655,0.000018637083,0.00007301059,0.0001380623,0.0000038349776],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022269713,0.00003124243,0.009487733,0.000027968721,0.000101260186,9.0272397e-7,0.0012924079,0.00001935452,0.9743584,0.00012801848,0.008275157,0.0060548577],"study_design_scores_gemma":[0.00087557244,0.00011996321,0.015679829,0.000050995914,0.00003260249,2.438395e-7,0.0005760863,0.00016775803,0.9701827,0.000042996962,0.012086177,0.00018506004],"about_ca_topic_score_codex":0.0005168372,"about_ca_topic_score_gemma":0.00005883619,"teacher_disagreement_score":0.006192095,"about_ca_system_score_codex":0.000032626536,"about_ca_system_score_gemma":0.000078047124,"threshold_uncertainty_score":0.61050254},"labels":[],"label_agreement":null},{"id":"W3083445513","doi":"10.1158/1538-7445.am2020-3491","title":"Abstract 3491: COX-2 inhibitor use and risk of skin cancer: three prospective cohort studies","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Proportional hazards model; Hazard ratio; Skin cancer; Internal medicine; Prospective cohort study; Cancer; Confidence interval; Oncology; Melanoma; Relative risk; Cohort; Basal cell carcinoma; Incidence (geometry); Basal cell; Cancer research","score_opus":0.08770271116284245,"score_gpt":0.37661962489656703,"score_spread":0.2889169137337246,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3083445513","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9867074,0.012013065,0.000014442955,0.000220455,0.000088760906,0.000495429,0.00024213128,0.0000073422184,0.00021099692],"genre_scores_gemma":[0.9820142,0.01700692,0.000060233375,0.000053719923,0.00049742975,0.00023379081,0.00001013015,0.000019370536,0.00010423721],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99880207,0.00006793365,0.00016753783,0.00041236394,0.00027486586,0.00027524607],"domain_scores_gemma":[0.99908614,0.00005269176,0.00006811879,0.0002074792,0.00045041073,0.00013515048],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003285809,0.000117389725,0.00020998449,0.000033750086,0.00011159393,0.00002421983,0.00013821351,0.00009457063,0.000034126333],"category_scores_gemma":[0.00037415477,0.000099155695,0.000045707195,0.00014139223,0.00031531067,0.000007671342,0.00023456351,0.00023945508,0.0000038842168],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002975097,0.00002532822,0.53364766,0.00014299055,0.00042787616,0.0000066900834,0.00037991808,0.000014747496,0.45512024,0.000052463118,0.007091369,0.002793219],"study_design_scores_gemma":[0.0006362605,0.00043020997,0.28039572,0.000056343666,0.0000382894,9.876454e-7,0.0002824136,0.00001582939,0.7072768,0.00009279761,0.010626124,0.00014822758],"about_ca_topic_score_codex":0.0014324064,"about_ca_topic_score_gemma":0.0017675381,"teacher_disagreement_score":0.25325194,"about_ca_system_score_codex":0.00004051867,"about_ca_system_score_gemma":0.00022461372,"threshold_uncertainty_score":0.40434518},"labels":[],"label_agreement":null},{"id":"W3085796913","doi":"10.1016/j.jaad.2020.09.027","title":"Stevens-Johnson syndrome and toxic epidermal necrolysis reactions to BRAF and MEK inhibitors in patients with melanoma: A systematic review","year":2020,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Psoriasis Association","keywords":"Vemurafenib; Medicine; Toxic epidermal necrolysis; Adverse effect; Melanoma; MEK inhibitor; Dermatology; Internal medicine; MEDLINE; Oncology; Pediatrics; Metastatic melanoma; Cancer research","score_opus":0.010522160189657064,"score_gpt":0.2689324435796214,"score_spread":0.25841028338996436,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3085796913","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.05581537,0.9417246,0.000010208123,0.0014375641,0.000047832113,0.0009203719,0.000033915738,0.0000021952071,0.000007956155],"genre_scores_gemma":[0.034138177,0.96475965,0.00020403026,0.0007873546,0.000031623513,0.00003071319,0.0000056695344,0.000032775115,0.000009991932],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.9971079,0.00077026314,0.001401088,0.0002815174,0.00021377385,0.00022540682],"domain_scores_gemma":[0.99665934,0.00011372028,0.0027927412,0.00020379732,0.00004909762,0.00018131848],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024615283,0.00032523775,0.0031808554,0.00021239911,0.00004030206,0.000008756074,0.0003762573,0.00018067843,0.0000012256716],"category_scores_gemma":[0.00034604163,0.00019513845,0.00030002304,0.00041327308,0.00020547687,0.000010291237,0.00021704704,0.00048289876,0.000001303243],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031487359,0.00033218332,0.0060458747,0.92421067,0.00346576,0.00037173368,0.00016879913,0.000003109419,0.0004605938,0.00004293434,0.0041501904,0.060433254],"study_design_scores_gemma":[0.0019170766,0.0028112524,0.0052258014,0.4418381,0.009734274,0.058859758,0.00011423849,0.0000025006445,0.0003236695,0.000023851893,0.47789332,0.0012561529],"about_ca_topic_score_codex":0.0000062973436,"about_ca_topic_score_gemma":0.0000017439123,"teacher_disagreement_score":0.4823726,"about_ca_system_score_codex":0.000029800578,"about_ca_system_score_gemma":0.0001292119,"threshold_uncertainty_score":0.7957515},"labels":[],"label_agreement":null},{"id":"W3086268953","doi":"10.1007/s10875-020-00860-0","title":"Correction to: A Nonsense N –Terminus NFKB2 Mutation Leading to Haploinsufficiency in a Patient with a Predominantly Antibody Deficiency","year":2020,"lang":"en","type":"erratum","venue":"Journal of Clinical Immunology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"National Institute of Allergy and Infectious Diseases","keywords":"Haploinsufficiency; Nonsense; Nonsense mutation; Medicine; Medical microbiology; Genetics; Mutation; Biology; Immunology; Missense mutation; Gene; Phenotype","score_opus":0.0214848113097823,"score_gpt":0.33713476711934814,"score_spread":0.31564995580956584,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3086268953","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9476776,0.0013399423,0.005302262,0.000575412,0.041156325,0.0005489207,0.000016828932,0.00000974842,0.0033729353],"genre_scores_gemma":[0.9871216,0.0008564255,0.0017801755,0.001199825,0.0022940652,0.000025796564,0.000121020166,0.00008125846,0.0065198294],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9964659,0.00040549564,0.0018468731,0.00056925195,0.0002954898,0.00041695448],"domain_scores_gemma":[0.9975729,0.0001614995,0.001265974,0.0003524864,0.00041912356,0.00022801188],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007002351,0.00033195253,0.0010291269,0.0003510679,0.00006214362,0.000034433568,0.00040928583,0.0006949626,0.000009600268],"category_scores_gemma":[0.0038287796,0.00027029056,0.0003085896,0.00036581114,0.000113239024,0.000009594308,0.00018711523,0.0013656464,0.000041260464],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014743431,0.002473985,0.0020293181,0.00014382377,0.00051816367,0.00878434,0.0023756889,0.00079425203,0.23073794,0.000021420105,0.6540339,0.083343714],"study_design_scores_gemma":[0.0073953946,0.1665807,0.023818921,0.003211832,0.00055442663,0.018294258,0.0015026556,0.0005824015,0.014696202,0.00005417364,0.7613297,0.0019792856],"about_ca_topic_score_codex":0.000032085634,"about_ca_topic_score_gemma":0.00016629139,"teacher_disagreement_score":0.21604174,"about_ca_system_score_codex":0.000057518457,"about_ca_system_score_gemma":0.0011606866,"threshold_uncertainty_score":0.9999749},"labels":[],"label_agreement":null},{"id":"W3088566771","doi":"10.1016/j.annonc.2020.08.1260","title":"1137P Incidence and time course of adverse events (AEs) with atezolizumab (A) in combination with vemurafenib (V) and cobimetinib (C) in the phase III IMspire150 study","year":2020,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada)","funders":"F. Hoffmann-La Roche","keywords":"Medicine; Rash; Internal medicine; Gastroenterology; Adverse effect; Diarrhea; Incidence (geometry); Population; Asymptomatic; Placebo; Pathology","score_opus":0.03152753028955441,"score_gpt":0.331205111221538,"score_spread":0.2996775809319836,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3088566771","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981812,0.00022102201,0.000016654605,0.00072668196,0.0000084325,0.00048675106,0.000013660976,0.0000020803354,0.00034349694],"genre_scores_gemma":[0.999471,0.00008822659,0.00005983023,0.00030719265,0.000012284033,0.000022414562,0.000023511697,0.0000070731458,0.000008472231],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991226,0.00019011655,0.0002311234,0.00022388696,0.000100521655,0.00013175499],"domain_scores_gemma":[0.9995166,0.00004494669,0.0001706499,0.0001398845,0.00008155378,0.000046355493],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003225907,0.000108552704,0.0002700818,0.00003839224,0.000019603453,0.0000013834003,0.00012387615,0.00007625513,0.000004102193],"category_scores_gemma":[0.00004111369,0.00007402182,0.000015148677,0.00012722294,0.00013804552,0.0000071128293,0.0000638045,0.00007989068,6.3701503e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.026248472,0.010389786,0.5330948,0.00025967852,0.0004486896,0.0005185359,0.020525577,0.00012933352,0.36074704,0.00052793615,0.0009049911,0.046205163],"study_design_scores_gemma":[0.07452522,0.18639335,0.55839485,0.0002398248,0.00021217245,0.00023716823,0.018255368,0.0009967547,0.15612157,0.00032986823,0.0034591104,0.00083476264],"about_ca_topic_score_codex":0.00006138532,"about_ca_topic_score_gemma":0.00018462804,"teacher_disagreement_score":0.20462546,"about_ca_system_score_codex":0.0000032738337,"about_ca_system_score_gemma":0.00010655482,"threshold_uncertainty_score":0.30185223},"labels":[],"label_agreement":null},{"id":"W3088872436","doi":"10.1016/j.annonc.2020.08.1225","title":"1102P Clinical benefit in BRAFV600 mutation-positive melanoma defined by programmed death ligand 1 (PD-L1) and/or lactate dehydrogenase (LDH) status: Exploratory analyses from the IMspire150 study","year":2020,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada)","funders":"F. Hoffmann-La Roche","keywords":"Medicine; Hazard ratio; Internal medicine; Vemurafenib; Lactate dehydrogenase; Gastroenterology; Oncology; Melanoma; Cancer; Confidence interval; Metastatic melanoma; Cancer research","score_opus":0.16536285663747388,"score_gpt":0.4136882348580487,"score_spread":0.2483253782205748,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3088872436","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947356,0.0024410402,0.000087090644,0.0015782645,0.00007193046,0.00062614866,0.00028848764,0.000014068465,0.00015737793],"genre_scores_gemma":[0.9950161,0.0008420902,0.00031032684,0.0030996448,0.00016059277,0.00009858101,0.00042416283,0.000025427578,0.000023087294],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99771553,0.00049119646,0.0006932193,0.00057675183,0.00014950651,0.0003738154],"domain_scores_gemma":[0.9985977,0.00039778915,0.0003089449,0.00028389596,0.00016329544,0.0002483653],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004623785,0.00024015104,0.000539951,0.00003838059,0.00007558897,0.000022915441,0.00024213093,0.00023673924,0.000016245442],"category_scores_gemma":[0.0005501013,0.00017249808,0.00012871517,0.00017476162,0.00019613268,0.000013401892,0.00018190334,0.00019009589,0.0000057383527],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010159012,0.00590241,0.5735891,0.000058642865,0.0023509618,0.00082488084,0.009850987,0.000076140146,0.3041378,0.000119792065,0.012043594,0.08088666],"study_design_scores_gemma":[0.013604342,0.05955533,0.24216363,0.00006293285,0.00054306485,0.00003325868,0.011593924,0.00044488136,0.6296859,0.00050296495,0.040711746,0.0010980446],"about_ca_topic_score_codex":0.000405491,"about_ca_topic_score_gemma":0.0016877642,"teacher_disagreement_score":0.3314255,"about_ca_system_score_codex":0.000009508219,"about_ca_system_score_gemma":0.00027948673,"threshold_uncertainty_score":0.7034268},"labels":[],"label_agreement":null},{"id":"W3090469545","doi":"10.1200/jco.20.00995","title":"Five-Year Outcomes With Nivolumab in Patients With Wild-Type <i>BRAF</i> Advanced Melanoma","year":2020,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":227,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Victoria Hospital; McGill University; University of British Columbia; BC Cancer Agency","funders":"Ono Pharmaceutical; Bristol-Myers Squibb","keywords":"Medicine; Nivolumab; Melanoma; Oncology; Internal medicine; Metastatic melanoma; Ipilimumab; Cancer research; Cancer; Immunotherapy","score_opus":0.029349432258848444,"score_gpt":0.3323646425640745,"score_spread":0.30301521030522605,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3090469545","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99661756,0.000082151884,0.00010552452,0.0013785813,0.0003158374,0.0001427555,0.000005271531,0.0000039673405,0.0013483325],"genre_scores_gemma":[0.9930516,0.00006376246,0.0034514286,0.0029507817,0.00032575193,0.0000017560031,0.000013589097,0.000020585909,0.000120783196],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99813807,0.00020730791,0.00095839816,0.0002508349,0.0002290319,0.00021635697],"domain_scores_gemma":[0.99831975,0.00013662773,0.0008011399,0.0001742759,0.00029298244,0.0002752184],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004175025,0.00015583073,0.00080108683,0.0000354453,0.000022845135,0.00000690355,0.00025657794,0.00027046434,0.000026441174],"category_scores_gemma":[0.0008369702,0.00009853877,0.000142632,0.00011500934,0.00011083969,0.000012616293,0.00007018324,0.00043098885,0.000011422409],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010034859,0.00059888675,0.97602886,0.000010272061,0.00017681491,0.0001294032,0.000045646782,0.00009188448,0.0005786257,0.00002378343,0.0018709421,0.010410012],"study_design_scores_gemma":[0.018591339,0.060705174,0.85153806,0.000028559753,0.00007131189,0.00001609894,0.00009100756,0.0000067718647,0.0006033509,0.000020643134,0.06812043,0.0002072691],"about_ca_topic_score_codex":0.0000047600897,"about_ca_topic_score_gemma":0.000060939135,"teacher_disagreement_score":0.12449082,"about_ca_system_score_codex":0.000019200119,"about_ca_system_score_gemma":0.0006083183,"threshold_uncertainty_score":0.40182942},"labels":[],"label_agreement":null},{"id":"W3097226470","doi":"10.1186/s12915-020-00895-0","title":"TRIM25 promotes Capicua degradation independently of ERK in the absence of ATXN1L","year":2020,"lang":"en","type":"article","venue":"BMC Biology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; Canada's Michael Smith Genome Sciences Centre; Simon Fraser University; University of British Columbia; BC Cancer Agency","funders":"Canadian Institutes of Health Research; BC Cancer Foundation","keywords":"Biology; MAPK/ERK pathway; Ubiquitin ligase; Transcription factor; Cell biology; Ubiquitin; Protein kinase A; Protein degradation; Proteasome; Cancer research; Downregulation and upregulation; Signal transduction; Kinase; Genetics; Gene","score_opus":0.03512778592242114,"score_gpt":0.26047648144950186,"score_spread":0.22534869552708073,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3097226470","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972511,0.00040909334,0.001337064,0.00014181682,0.00004752249,0.00017529503,0.000022097533,0.0000026427117,0.00061336433],"genre_scores_gemma":[0.9991102,0.000036373032,0.00051041954,0.00014929552,0.00006454668,0.000010780695,0.00008934017,0.000004073364,0.000024960873],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99934405,0.00012705837,0.00020816285,0.0001694678,0.000047198588,0.000104058076],"domain_scores_gemma":[0.9996431,0.00002780796,0.00010801123,0.00016640757,0.000033850156,0.00002081332],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016471873,0.00006990004,0.0001293218,0.000020513455,0.000011616064,0.0000015831203,0.00021360844,0.00013036597,0.000010705858],"category_scores_gemma":[0.00016711093,0.00004870459,0.000045610133,0.00008294407,0.00007484698,0.000001433003,0.00005245903,0.00005525498,0.0000029233843],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000659476,0.00003586219,0.08382363,0.000036006022,0.000007873681,6.582961e-7,0.00017437382,0.0000037678728,0.91388744,0.001116234,0.00012260687,0.0007256201],"study_design_scores_gemma":[0.00067839,0.0009795901,0.057371587,0.00000898873,0.000008023316,0.000008275159,0.00027954936,0.00006085211,0.93690985,0.00037978927,0.003207651,0.00010742521],"about_ca_topic_score_codex":0.000057851037,"about_ca_topic_score_gemma":0.00012586566,"teacher_disagreement_score":0.026452044,"about_ca_system_score_codex":0.000001974315,"about_ca_system_score_gemma":0.00007217038,"threshold_uncertainty_score":0.19861156},"labels":[],"label_agreement":null},{"id":"W3103606205","doi":"10.1136/jitc-2020-sitc2020.0307","title":"307 Atezolizumab plus vemurafenib and cobimetinib provides favorable survival outcomes in patients with high tumor mutation burden and proinflammatory gene signature in the phase 3 IMspire150 study","year":2020,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada)","funders":"Pritzker School of Medicine; American Society of Hematology","keywords":"Vemurafenib; Internal medicine; Medicine; Atezolizumab; Hazard ratio; Oncology; Progression-free survival; Melanoma; Pembrolizumab; Immunotherapy; Cancer research; Cancer; Overall survival; Metastatic melanoma; Confidence interval","score_opus":0.00991258563327047,"score_gpt":0.21943228970482428,"score_spread":0.20951970407155382,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3103606205","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979126,0.00036019264,0.0000033636177,0.00041951126,0.00005130564,0.0011741841,0.00003619383,0.000014441783,0.000028198137],"genre_scores_gemma":[0.99933594,0.000013851328,0.00014397566,0.00019528411,0.000089656554,0.00005668606,0.00011798094,0.000025871122,0.000020759433],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99852204,0.00015859463,0.00032217745,0.00049017166,0.00024949524,0.00025754224],"domain_scores_gemma":[0.9993579,0.000024864341,0.00014146495,0.0001974537,0.000053177777,0.00022516206],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032047954,0.00026300692,0.0003215451,0.000050068902,0.00009292835,0.0000882907,0.00012150406,0.00011432534,9.033142e-7],"category_scores_gemma":[0.00016935907,0.00018568683,0.000023065633,0.00010359764,0.000156756,0.000028865503,0.00007049189,0.00019484796,6.943601e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012657648,0.00044688283,0.83115125,0.00035053355,0.00016386088,0.00046394783,0.006628434,0.00026023446,0.15779656,0.0000936368,0.00012324257,0.0012556468],"study_design_scores_gemma":[0.010765829,0.0026445668,0.94720066,0.000056568755,0.00007808321,0.000034046552,0.001953762,0.000116896816,0.035946965,0.00008115986,0.0006322903,0.00048918085],"about_ca_topic_score_codex":0.00019146754,"about_ca_topic_score_gemma":0.0001731319,"teacher_disagreement_score":0.1218496,"about_ca_system_score_codex":0.000014731836,"about_ca_system_score_gemma":0.00018280798,"threshold_uncertainty_score":0.75720894},"labels":[],"label_agreement":null},{"id":"W3107364439","doi":"10.1097/der.0000000000000670","title":"Treatment of Checkpoint Inhibitor–Induced Vitiligo in a Patient with Metastatic Renal Cell Cancer","year":2020,"lang":"en","type":"article","venue":"Dermatitis","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Vitiligo; Dermatology; Skin cancer; Medical school; Cancer; Family medicine; Internal medicine; Medical education","score_opus":0.01574324815981502,"score_gpt":0.22528239601845876,"score_spread":0.20953914785864375,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3107364439","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99768496,0.00050466356,0.00018006386,0.0004525531,0.00003305747,0.00021060187,0.00007109231,0.0000049104015,0.0008581097],"genre_scores_gemma":[0.9985488,0.00009993826,0.0007118232,0.00042472928,0.00004506746,0.00007935536,0.00006189957,0.0000117998525,0.000016608501],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999378,0.00003219531,0.00020323097,0.0001783669,0.00007934587,0.00012884081],"domain_scores_gemma":[0.9996908,0.0000038004641,0.00008517935,0.00012214888,0.000025668625,0.00007244088],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00001177373,0.00011147464,0.00016954083,0.00002120546,0.000013399249,0.0000053338667,0.000045135435,0.000035235968,0.00003027689],"category_scores_gemma":[0.0000056764006,0.00008925656,0.000046041194,0.000067679975,0.000018284618,0.0000027824522,0.000019956537,0.000025742946,0.000004858059],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000044223023,0.00017828934,0.0017005511,0.000087756256,0.000045328965,0.00014285352,0.0019251066,0.00006383161,0.9903151,0.000014504706,0.0006675184,0.0048149503],"study_design_scores_gemma":[0.0010974209,0.0016525895,0.0016385216,0.000021432725,0.000016383803,0.000020811114,0.00021671591,0.000095271105,0.9881887,0.0000058617165,0.006937944,0.00010837266],"about_ca_topic_score_codex":0.0002991897,"about_ca_topic_score_gemma":0.00025636752,"teacher_disagreement_score":0.0062704254,"about_ca_system_score_codex":0.000016992712,"about_ca_system_score_gemma":0.00006970839,"threshold_uncertainty_score":0.3639777},"labels":[],"label_agreement":null},{"id":"W3112196266","doi":"10.1093/neuonc/noaa222.624","title":"NURS-04. COMBINATION OF NEURO-ONCOLOGY AND DERMATOLOGY CLINICS IMPROVE THE MANAGEMENT AND KNOWLEDGE OF SKIN-RELATED TOXICITIES WITH MEK AND BRAF TARGETED THERAPY","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Dermatology; Oncology nursing; Oncology; Internal medicine; Nursing; Nurse education","score_opus":0.012253833091315423,"score_gpt":0.2562277906902607,"score_spread":0.24397395759894527,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112196266","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9924767,0.002629631,0.00013947886,0.0020274064,0.00022972684,0.000586828,0.000020330246,0.000014032062,0.0018758613],"genre_scores_gemma":[0.99477696,0.0033153968,0.00024349184,0.0015026353,0.00004783714,0.00003550972,0.000029489795,0.000025474785,0.000023228491],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984495,0.00039487923,0.00042395064,0.00043392618,0.000071553324,0.00022616315],"domain_scores_gemma":[0.99900585,0.000254595,0.0003149624,0.00021687233,0.000107361346,0.00010035336],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016305476,0.00020930792,0.00045368093,0.000058041096,0.00007731674,0.000008111208,0.00016168524,0.00030438814,0.0000066058383],"category_scores_gemma":[0.00006847736,0.0001558867,0.000044194465,0.00011172165,0.00064152014,0.0000078054145,0.0002159915,0.0002014094,7.482792e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008928448,0.00022618881,0.0032368342,0.00013416086,0.0001976689,0.000035731675,0.0020014253,0.0000037092864,0.9391699,0.0023465608,0.0006453668,0.051109653],"study_design_scores_gemma":[0.01290115,0.025219094,0.013002836,0.000019991769,0.00029294295,0.0007566826,0.0026006715,0.0009727214,0.7636066,0.001033471,0.1791149,0.00047896538],"about_ca_topic_score_codex":0.0000068954223,"about_ca_topic_score_gemma":0.000023538361,"teacher_disagreement_score":0.17846952,"about_ca_system_score_codex":0.000008599096,"about_ca_system_score_gemma":0.00011880223,"threshold_uncertainty_score":0.6356875},"labels":[],"label_agreement":null},{"id":"W3113132520","doi":"10.1016/j.annonc.2020.12.004","title":"Cobimetinib plus atezolizumab in BRAFV600 wild-type melanoma: primary results from the randomized phase III IMspire170 study","year":2020,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":99,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada)","funders":"Genentech; F. Hoffmann-La Roche","keywords":"Atezolizumab; Medicine; Internal medicine; Oncology; Cancer; Pembrolizumab; Immunotherapy","score_opus":0.06816358705992281,"score_gpt":0.3451095596220558,"score_spread":0.276945972562133,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3113132520","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9850333,0.0014208166,0.000051396048,0.0046054386,0.00024902882,0.001115144,0.00013974398,0.000015342732,0.007369834],"genre_scores_gemma":[0.9939355,0.0004728301,0.00012551459,0.0043831016,0.00039733143,0.000050572304,0.00048997364,0.000022552642,0.00012260748],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99719244,0.0009054325,0.0008582078,0.0005423919,0.00017551373,0.00032601983],"domain_scores_gemma":[0.99841774,0.00042792925,0.00039057646,0.00048323796,0.00015268668,0.00012782103],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010881553,0.00023443424,0.00094646483,0.000038878716,0.00005975464,0.0000115108805,0.00047737535,0.0002511246,0.000041152372],"category_scores_gemma":[0.0010090258,0.00016966049,0.0001906933,0.00019206369,0.0002166057,0.0000061187657,0.00027514863,0.00021048305,0.00002228383],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.66780555,0.0027958378,0.0010699756,0.000029620549,0.0010392648,0.0003254377,0.0070078024,0.00010630277,0.23524792,0.00016965647,0.059768103,0.024634542],"study_design_scores_gemma":[0.7094726,0.018654961,0.0027386767,0.000029672465,0.0002239812,0.000018119968,0.0014350913,0.0002189094,0.07215981,0.00021642665,0.19426516,0.0005665947],"about_ca_topic_score_codex":0.0006123176,"about_ca_topic_score_gemma":0.00024465375,"teacher_disagreement_score":0.16308811,"about_ca_system_score_codex":0.000015169515,"about_ca_system_score_gemma":0.00043840878,"threshold_uncertainty_score":0.69185543},"labels":[],"label_agreement":null},{"id":"W3114062763","doi":"10.3390/curroncol28010021","title":"A Rare p.T599dup BRAF Mutant NSCLC in a Non-Smoker","year":2020,"lang":"en","type":"article","venue":"Current Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Kinase; Cancer research; Mutation; Lung cancer; Targeted therapy; Fibrosarcoma; MAPK/ERK pathway; Mutant; non-small cell lung cancer (NSCLC); Cancer; Oncogene; MEK inhibitor; Oncology; Biology; Internal medicine; Genetics; Gene; Pathology; Cell cycle; A549 cell","score_opus":0.058268392822122296,"score_gpt":0.3323510831691569,"score_spread":0.2740826903470346,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3114062763","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9904988,0.0014976987,0.0008478291,0.0010647093,0.0007852131,0.00029182347,0.000028521072,0.000018219967,0.0049672313],"genre_scores_gemma":[0.9978831,0.00022228906,0.0001316839,0.0008781222,0.0006102137,0.000057466645,0.0001418159,0.000018973084,0.000056326055],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99883354,0.0000853629,0.00025103852,0.0004253086,0.000085099615,0.00031964388],"domain_scores_gemma":[0.9994919,0.000011657606,0.000072628696,0.00021188548,0.000041958112,0.00016999537],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000104324354,0.00016434732,0.0002451563,0.000039830597,0.00003179175,0.000009118023,0.00022077918,0.00020058257,0.00009589114],"category_scores_gemma":[0.00011219025,0.00015596437,0.00008929625,0.00012546913,0.000058616188,0.0000028959485,0.00018249075,0.0002051502,0.00010508396],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035176257,0.0005053488,0.026560368,0.00012329094,0.000038519906,0.0001904356,0.000918763,0.000017301563,0.84734964,0.0002860856,0.02958829,0.09407021],"study_design_scores_gemma":[0.0029162527,0.0015819775,0.009652468,0.00003485982,0.000021051219,0.00004892041,0.00017482998,0.0003835201,0.057647374,0.00006385333,0.9271,0.00037486377],"about_ca_topic_score_codex":0.0000064242845,"about_ca_topic_score_gemma":0.000050066956,"teacher_disagreement_score":0.8975117,"about_ca_system_score_codex":0.000029956775,"about_ca_system_score_gemma":0.0001761478,"threshold_uncertainty_score":0.6360042},"labels":[],"label_agreement":null},{"id":"W3115651269","doi":"10.1158/1078-0432.ccr-20-2563","title":"LXH254, a Potent and Selective ARAF-Sparing Inhibitor of BRAF and CRAF for the Treatment of MAPK-Driven Tumors","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":88,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mood Disorders Association of British Columbia; Aegera Therapeutics (Canada)","funders":"","keywords":"Neuroblastoma RAS viral oncogene homolog; KRAS; In vivo; Biology; Cancer research; Mutant; MAPK/ERK pathway; Kinase; Cell culture; Mutation; Cell biology; Genetics; Gene","score_opus":0.19876116464915,"score_gpt":0.45473027212063105,"score_spread":0.25596910747148105,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3115651269","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948496,0.0031954201,0.00015334603,0.001034017,0.00004591045,0.0005473553,0.00005753742,0.0000023772996,0.00011443379],"genre_scores_gemma":[0.99569684,0.0034784,0.00015067929,0.000071975504,0.0003734085,0.000115168856,0.0000068058894,0.000010749976,0.000095965595],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99901557,0.00010441731,0.00026005998,0.0003023954,0.0001328926,0.0001846731],"domain_scores_gemma":[0.9992103,0.00028125278,0.000065032975,0.00015123501,0.0001710447,0.00012116609],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034108304,0.00007862941,0.00021711533,0.000017771052,0.000067327106,0.000008846512,0.00009983652,0.00008681327,0.000004364355],"category_scores_gemma":[0.00027727173,0.000052330837,0.000080229715,0.000073000454,0.00031515816,0.0000019040883,0.00010658658,0.00009842481,3.721844e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0060009332,0.0006879275,0.1519182,0.0005550864,0.00071418314,0.000015271049,0.0016204244,0.000084620144,0.6517745,0.0003580395,0.005454129,0.18081664],"study_design_scores_gemma":[0.005562606,0.022214323,0.08129831,0.00010310603,0.00010307866,0.0000063924317,0.00061452616,0.0018028724,0.8334768,0.00026570895,0.05429011,0.00026218133],"about_ca_topic_score_codex":0.000112187416,"about_ca_topic_score_gemma":0.00009150099,"teacher_disagreement_score":0.18170224,"about_ca_system_score_codex":0.000011865695,"about_ca_system_score_gemma":0.0001566646,"threshold_uncertainty_score":0.21339896},"labels":[],"label_agreement":null},{"id":"W3117376274","doi":"10.2147/jir.s284471","title":"Repurposing FDA Approved Drugs as JNK3 Inhibitor for Prevention of Neuroinflammation Induced by MCAO in Rats","year":2020,"lang":"en","type":"article","venue":"Journal of Inflammation Research","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":31,"is_retracted":true,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Riphah International University","keywords":"Medicine; Pharmacology; Neuroprotection; Drug repositioning; Neuroinflammation; Dabigatran; Pitavastatin; Brain ischemia; Ischemia; Anesthesia; Drug; Internal medicine; Inflammation; Atorvastatin; Warfarin","score_opus":0.05871791790637751,"score_gpt":0.35316671300971425,"score_spread":0.29444879510333677,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3117376274","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964026,0.00015876968,0.001264974,0.0011481461,0.00008175421,0.0005224185,0.000003408498,0.0000027421283,0.00041515994],"genre_scores_gemma":[0.9986019,0.000094470044,0.00061439927,0.000023243849,0.00047586366,0.000019960968,0.000045563025,0.000014725337,0.00010987069],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982347,0.00027153618,0.00072360755,0.00016278107,0.00042542492,0.00018196896],"domain_scores_gemma":[0.9985521,0.00006341228,0.0004597276,0.00013020256,0.0006958692,0.00009873269],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014878955,0.00008714068,0.00018009434,0.00016877685,0.00005403659,0.000035277797,0.00017401774,0.00013692015,0.000008776997],"category_scores_gemma":[0.0014252781,0.00008295353,0.00010007776,0.00022204973,0.0000300286,0.00003324662,0.0000577817,0.00022786259,0.0000028578231],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006448607,0.000034285917,0.00010641962,0.00011798452,0.00001712182,0.000002236812,0.0004417099,0.00006704848,0.9823679,0.00011236841,0.0016646602,0.014423412],"study_design_scores_gemma":[0.0011682713,0.0014878015,0.00021644564,0.00007435208,0.000005979319,0.0000053560366,0.00031725064,0.0007286556,0.9878675,0.00033948544,0.0077165132,0.00007243933],"about_ca_topic_score_codex":0.0000062271138,"about_ca_topic_score_gemma":0.000005782747,"teacher_disagreement_score":0.014350973,"about_ca_system_score_codex":0.000029356559,"about_ca_system_score_gemma":0.00023363333,"threshold_uncertainty_score":0.3382747},"labels":[],"label_agreement":null},{"id":"W3126538193","doi":"10.1007/s00432-021-03545-2","title":"Personalized oncology and BRAFK601N melanoma: model development, drug discovery, and clinical correlation","year":2021,"lang":"en","type":"article","venue":"Journal of Cancer Research and Clinical Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; Ottawa Regional Cancer Foundation; University of Ottawa","funders":"Natural Sciences and Engineering Research Council of Canada; Institute of Cancer Research; Terry Fox Research Institute","keywords":"Melanoma; Medicine; Cancer research; Trametinib; Oncology; Internal medicine; MEK inhibitor; Hematology; Drug development; Drug; Pharmacology; Biology; MAPK/ERK pathway; Genetics","score_opus":0.13277753751436236,"score_gpt":0.49654022204450077,"score_spread":0.3637626845301384,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3126538193","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98427916,0.00978805,0.0010629662,0.003084712,0.00043512724,0.00012250664,0.000010531373,0.0000021870399,0.0012147734],"genre_scores_gemma":[0.93989843,0.05122736,0.0032737446,0.00069451844,0.00095657026,0.000010312622,0.000017998715,0.000018108616,0.003902975],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9970595,0.00090882013,0.0010243228,0.00040596805,0.00027233182,0.00032900748],"domain_scores_gemma":[0.9976723,0.000822289,0.0003723201,0.0001403703,0.0005496399,0.0004430839],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0038512317,0.00013274464,0.0006052062,0.00006858589,0.00015408269,0.000048340036,0.00013748083,0.00044914088,0.00002713558],"category_scores_gemma":[0.0010822252,0.000106561565,0.00012164479,0.000078866884,0.000786244,0.000024224932,0.00033132176,0.0008520662,0.0000015565126],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00902791,0.0020219034,0.4563664,0.000116145755,0.001364946,0.00070075475,0.0005437757,0.00001850412,0.025418919,0.0022836619,0.024103492,0.4780336],"study_design_scores_gemma":[0.018809097,0.015356638,0.13768886,0.00015048624,0.00028015324,0.0011038833,0.0013029854,0.0014232938,0.004688848,0.0036554765,0.8150082,0.0005320332],"about_ca_topic_score_codex":0.000021525257,"about_ca_topic_score_gemma":0.0008587965,"teacher_disagreement_score":0.79090476,"about_ca_system_score_codex":0.000068413836,"about_ca_system_score_gemma":0.0034154162,"threshold_uncertainty_score":0.60588014},"labels":[],"label_agreement":null},{"id":"W3126869189","doi":"10.1016/j.hoc.2020.09.005","title":"Advanced Melanoma","year":2020,"lang":"en","type":"review","venue":"Hematology/Oncology Clinics of North America","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Bristol-Myers Squibb Canada; National Heart, Lung, and Blood Institute; National Cancer Institute; National Institutes of Health; Merck; Bristol-Myers Squibb","keywords":"Melanoma; Acquired resistance; Medicine; Innate immune system; Metastatic melanoma; Cancer research; Immunology; Cancer; Immune system; Internal medicine","score_opus":0.031864286746907264,"score_gpt":0.3485917963956079,"score_spread":0.3167275096487006,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3126869189","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00049640506,0.9944607,0.00031328,0.000077779645,0.000864277,0.0008530865,0.0002998278,0.00004690291,0.002587753],"genre_scores_gemma":[0.00020413347,0.9927041,0.0039936714,0.00050976005,0.00033321057,0.00022433451,0.0017289651,0.000112854075,0.00018899114],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99571383,0.00053019606,0.0018182456,0.0011568677,0.00017458049,0.0006062684],"domain_scores_gemma":[0.99601376,0.00037964463,0.0020531823,0.0010733088,0.00016204815,0.0003180301],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001897165,0.00073070684,0.004253479,0.0001503513,0.00008052639,0.0000057185493,0.0010034599,0.0012373595,0.000059135105],"category_scores_gemma":[0.000715248,0.0006624423,0.0011381991,0.00037135737,0.000620116,0.000004102958,0.00059066765,0.0007056041,0.00032201514],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009855869,0.00019589221,0.0003737774,0.0029703742,0.0005231291,0.00019570526,0.0000179889,0.000001275686,0.000006993627,0.00009142225,0.0047042277,0.99082065],"study_design_scores_gemma":[0.0005264173,0.002629565,0.000016267288,0.00040894098,0.0006266745,0.00044297276,0.000019966395,0.0000028997138,0.000024364286,0.000018689363,0.99473166,0.00055159745],"about_ca_topic_score_codex":0.0000037855184,"about_ca_topic_score_gemma":0.000036808702,"teacher_disagreement_score":0.99026906,"about_ca_system_score_codex":0.000037328024,"about_ca_system_score_gemma":0.0016267574,"threshold_uncertainty_score":0.9995827},"labels":[],"label_agreement":null},{"id":"W3127097750","doi":"10.1158/2159-8290.cd-20-1050","title":"Mutations in the RAS/MAPK Pathway Drive Replication Repair–Deficient Hypermutated Tumors and Confer Sensitivity to MEK Inhibition","year":2021,"lang":"en","type":"article","venue":"Cancer Discovery","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; Mount Sinai Hospital; University Health Network; University of Toronto; Alberta Cancer Foundation; Princess Margaret Cancer Centre; Hospital for Sick Children","funders":"Stand Up To Cancer; Ontario Genomics Institute; Government of Canada; Canadian Institutes of Health Research; Ontario Genomics; Genome Canada; National Cancer Institute; Entertainment Industry Foundation; Garron Family Cancer Centre; American Association for Cancer Research; Bristol-Myers Squibb; Government of Ontario","keywords":"Mutation; MAPK/ERK pathway; Genetics; Cancer research; Biology; Replication (statistics); Cell biology; Signal transduction; Gene; Virology","score_opus":0.013850318711776386,"score_gpt":0.25563188791150726,"score_spread":0.24178156919973087,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3127097750","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99626404,0.00037324964,0.0015032786,0.00068921695,0.0000979868,0.0002526276,0.00015387514,0.000011928667,0.00065381883],"genre_scores_gemma":[0.99761313,0.000080221085,0.00007684156,0.0012347252,0.00009135536,0.00012710544,0.0004934673,0.000010346273,0.00027277812],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990347,0.00013888246,0.00015412865,0.00042549145,0.00009925416,0.00014752152],"domain_scores_gemma":[0.999417,0.000027496619,0.000046701258,0.00037807773,0.00008806411,0.00004267036],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022287792,0.00010120446,0.0001045111,0.000028904053,0.00007619334,0.000045024193,0.00003336624,0.00005805968,0.0000053083654],"category_scores_gemma":[0.0001360444,0.00008435228,0.00004932911,0.00015059311,0.000048756126,0.000011850168,0.000056945242,0.00006661009,0.0000034348004],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003330479,0.00005916425,0.0031473048,0.000019324896,0.000014212892,0.000058286187,0.0005954967,0.00031069826,0.99300283,0.0010841533,0.0008107705,0.00086446694],"study_design_scores_gemma":[0.00046633268,0.00010860062,0.07824297,0.00006907082,0.000023981042,0.00008902783,0.0015273364,0.00018334403,0.9121796,0.00018386019,0.006708171,0.0002176922],"about_ca_topic_score_codex":0.00010242003,"about_ca_topic_score_gemma":0.0006877427,"teacher_disagreement_score":0.080823205,"about_ca_system_score_codex":0.00003083823,"about_ca_system_score_gemma":0.00019381667,"threshold_uncertainty_score":0.3439786},"labels":[],"label_agreement":null},{"id":"W3128792891","doi":"10.1016/j.annonc.2021.01.065","title":"A phase II randomized trial of cobimetinib plus chemotherapy, with or without atezolizumab, as first-line treatment for patients with locally advanced or metastatic triple-negative breast cancer (COLET): primary analysis","year":2021,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":88,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada)","funders":"Exelixis; Genentech; F. Hoffmann-La Roche","keywords":"Atezolizumab; Medicine; Triple-negative breast cancer; Internal medicine; Tolerability; Oncology; Taxane; Cohort; Breast cancer; Cancer; Adverse effect; Immunotherapy; Pembrolizumab","score_opus":0.035305087332164566,"score_gpt":0.3644163185437791,"score_spread":0.3291112312116145,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3128792891","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9913441,0.00023264944,0.0032450168,0.00057696993,0.00007679681,0.0034341724,0.0008627647,0.000010955436,0.00021657496],"genre_scores_gemma":[0.98832756,0.0013876647,0.0058926316,0.000621265,0.00008992747,0.0014508974,0.00074812793,0.00005238006,0.0014295488],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9980174,0.00027103518,0.000671901,0.00051469146,0.00020576868,0.00031922082],"domain_scores_gemma":[0.99746543,0.00029121852,0.0007943686,0.00037036525,0.0009535929,0.00012501907],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027241057,0.00032784024,0.0019026734,0.00010977528,0.000071697534,0.000006518456,0.00014064142,0.00014027598,0.00014415805],"category_scores_gemma":[0.00019669192,0.00018697219,0.0003801842,0.00037472084,0.00027292938,0.000009934307,0.000046551217,0.000053150092,3.09101e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9484727,0.006659109,0.00009135653,0.00008903557,0.007262538,0.000022359975,0.00029539785,0.00028264394,0.0028474284,0.000009860552,0.00012393003,0.03384368],"study_design_scores_gemma":[0.81621903,0.10414594,0.00005738833,0.000051398038,0.0019538947,0.00001522354,0.00008666005,0.00017870452,0.07279265,0.000018305778,0.0042416337,0.00023917247],"about_ca_topic_score_codex":0.00020822625,"about_ca_topic_score_gemma":0.0020796903,"teacher_disagreement_score":0.13225362,"about_ca_system_score_codex":0.000057822355,"about_ca_system_score_gemma":0.0020225008,"threshold_uncertainty_score":0.76245046},"labels":[],"label_agreement":null},{"id":"W3134877629","doi":"10.1177/1534735421990078","title":"Current Advancements and Novel Strategies in the Treatment of Metastatic Melanoma","year":2021,"lang":"en","type":"review","venue":"Integrative Cancer Therapies","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":53,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Windsor","funders":"","keywords":"Medicine; Melanoma; Ipilimumab; Vemurafenib; Cancer; Oncology; Radiation therapy; Targeted therapy; Clinical trial; Skin cancer; Internal medicine; Intensive care medicine; Metastatic melanoma; Immunotherapy; Cancer research","score_opus":0.07854031110835175,"score_gpt":0.3955977993313937,"score_spread":0.31705748822304197,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3134877629","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0014673525,0.9968488,0.0003907745,0.000013934334,0.00019018483,0.00054751185,0.00041979607,0.0000019892705,0.00011960689],"genre_scores_gemma":[0.00067346025,0.9979618,0.00014305545,0.000014485759,0.00009388745,0.00071898656,0.00029484156,0.000018442413,0.0000810252],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989051,0.0001956131,0.00032342886,0.0003244531,0.00010053595,0.00015085987],"domain_scores_gemma":[0.99938273,0.00005821225,0.0002116213,0.0002551968,0.00007068724,0.000021545457],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000078433404,0.0003471008,0.0008281949,0.000056151894,0.000030006893,0.000030475252,0.00016515517,0.000071249466,0.00002167219],"category_scores_gemma":[0.000010117151,0.00017668778,0.00020941663,0.000111890746,0.00012259198,0.000004829939,0.000022313392,0.00009342725,5.0287395e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00001448997,0.0002561705,0.000021872127,0.00095977704,0.00055361394,0.0000039722513,0.0018224134,6.5233576e-7,0.0005327398,0.0017102631,0.00006025282,0.9940638],"study_design_scores_gemma":[0.00035015467,0.00060505216,0.000011973884,0.0022350359,0.00020871627,0.000008199062,0.002563351,4.40531e-7,0.0005751094,0.00008969596,0.99317795,0.0001743375],"about_ca_topic_score_codex":0.00007046146,"about_ca_topic_score_gemma":0.00047639356,"teacher_disagreement_score":0.99388945,"about_ca_system_score_codex":0.00004108578,"about_ca_system_score_gemma":0.00033985806,"threshold_uncertainty_score":0.72051185},"labels":[],"label_agreement":null},{"id":"W3156993746","doi":"10.1097/md9.0000000000000080","title":"Acute liver failure caused by metastatic malignant melanoma of liver","year":2021,"lang":"en","type":"article","venue":"Medicine Case Reports and Study Protocols","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CAE (Canada)","funders":"","keywords":"Medicine; Liver transplantation; Malignancy; Melanoma; Liver biopsy; Jaundice; Transplantation; Contraindication; Biopsy; Radiology; Surgery; Pathology","score_opus":0.024654315077299746,"score_gpt":0.29679260924580775,"score_spread":0.272138294168508,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3156993746","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.977323,0.00095797225,0.00030502735,0.00008773544,0.000049218106,0.020856436,0.000033576995,0.000010166885,0.00037689635],"genre_scores_gemma":[0.9871368,0.00004789656,0.00019269514,0.00010373219,0.000105064115,0.0109499805,0.00008426899,0.000021975471,0.0013575796],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99838626,0.00013251352,0.0005330079,0.0005039302,0.00023673728,0.00020754446],"domain_scores_gemma":[0.9988321,0.00001777336,0.00026514835,0.000530714,0.0002079204,0.00014632771],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042745852,0.00021286578,0.00044137795,0.00003588574,0.00008669136,0.000013522266,0.000043832442,0.00007261513,0.00012522028],"category_scores_gemma":[0.000116358606,0.00015201981,0.00006122033,0.00009431794,0.000103082486,0.000004985825,0.00012699804,0.000082350416,7.3492095e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009464275,0.0007409594,0.011023889,0.0003234743,0.00062358245,0.31666142,0.0010181603,5.3547626e-7,0.6508147,0.000032393113,0.0162486,0.0024176482],"study_design_scores_gemma":[0.006852289,0.012115571,0.0049065673,0.00039871957,0.0011582344,0.17389946,0.0046579153,0.00004524178,0.58970374,0.000051257866,0.20535031,0.00086069654],"about_ca_topic_score_codex":0.00013238391,"about_ca_topic_score_gemma":0.00017280472,"teacher_disagreement_score":0.18910171,"about_ca_system_score_codex":0.0000063866833,"about_ca_system_score_gemma":0.0001055789,"threshold_uncertainty_score":0.61991876},"labels":[],"label_agreement":null},{"id":"W3160335069","doi":"10.3390/cancers13092282","title":"Defining the Criteria for Reflex Testing for BRAF Mutations in Cutaneous Melanoma Patients","year":2021,"lang":"en","type":"review","venue":"Cancers","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Health Sciences Centre; Sunnybrook Health Science Centre; University of Toronto; Princess Margaret Cancer Centre; University of Alberta; Université Laval; McGill University","funders":"Canadian Institutes of Health Research; Cancer Research Society; Canadian Dermatology Foundation","keywords":"Melanoma; Medicine; Pathogenesis; Mutation; Cancer research; Oncology; Bioinformatics; Dermatology; Internal medicine; Biology; Genetics; Gene","score_opus":0.05549257327763334,"score_gpt":0.35491248685543847,"score_spread":0.2994199135778051,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3160335069","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00050488807,0.99592054,0.00021846051,0.000008407417,0.00059371634,0.0011662826,0.00075897697,0.000007917625,0.00082078774],"genre_scores_gemma":[0.0017298827,0.97616965,0.006950978,0.0002972056,0.00084808195,0.0037609453,0.009333087,0.00015964225,0.00075051],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99888366,0.00006120155,0.00033800502,0.00039251323,0.00005684518,0.0002677808],"domain_scores_gemma":[0.99914545,0.00021453887,0.00019490818,0.00027662746,0.00012580973,0.000042656135],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001197732,0.00021790792,0.00046586082,0.00003837531,0.00011779518,0.000033762808,0.00020586471,0.00021134669,0.000005966514],"category_scores_gemma":[0.0006801163,0.00017173604,0.00023275997,0.00011622201,0.000035123965,0.0000017299157,0.000057066718,0.00008993632,0.000001758556],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000014549952,0.000010671028,0.000028605356,0.0029667357,0.000092730916,0.000006219022,0.00005273119,0.00001958187,0.00010316937,0.0002690149,0.0037447375,0.9926913],"study_design_scores_gemma":[0.00027263697,0.00027193542,0.0000027947913,0.0014453043,0.00016270862,0.000025570886,0.000036467372,0.000027035081,0.00011055536,0.000035158857,0.99738747,0.00022238809],"about_ca_topic_score_codex":0.0000245531,"about_ca_topic_score_gemma":0.00008948937,"teacher_disagreement_score":0.9936427,"about_ca_system_score_codex":0.00018144379,"about_ca_system_score_gemma":0.0010622483,"threshold_uncertainty_score":0.70031923},"labels":[],"label_agreement":null},{"id":"W3163104866","doi":"10.1503/cmaj.78702","title":"To act or not to act","year":2021,"lang":"en","type":"letter","venue":"Canadian Medical Association Journal","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; University of Toronto","funders":"","keywords":"Sorafenib; Psoriasis; Angiogenesis; Medicine; Vascular endothelial growth factor; Cancer research; Hepatocellular carcinoma; Platelet-derived growth factor receptor; Growth factor; Immunology; Receptor; Internal medicine; VEGF receptors","score_opus":0.01196275540531416,"score_gpt":0.24371330590064616,"score_spread":0.231750550495332,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3163104866","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.018131414,0.00008050861,0.00015358215,0.9747241,0.002914769,0.00018430599,0.00024168075,0.0000075999824,0.003562043],"genre_scores_gemma":[0.003395513,0.000072606636,0.00022334896,0.94633585,0.027148768,0.000013418659,0.00042301524,0.00004739789,0.022340056],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99707997,0.00022892808,0.00040503655,0.00037802092,0.0011439216,0.00076410116],"domain_scores_gemma":[0.99694645,0.00005698294,0.00017379246,0.0002615981,0.00039939117,0.002161807],"candidate_categories":["research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00077293656,0.00024427593,0.0003352823,0.00018048772,0.00017967283,0.00015790193,0.00049673603,0.0019367894,0.0042711105],"category_scores_gemma":[0.0035910637,0.00021618146,0.00019556063,0.00017556627,0.000011823356,0.000003308202,0.00007032701,0.0017969036,0.0004001489],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00001432966,0.0000052895084,0.00034964303,0.000009720836,0.00012451052,0.0025839983,0.00004584125,8.545433e-7,0.0008394135,0.000001421695,0.98838246,0.0076425187],"study_design_scores_gemma":[0.00025442854,0.00017822388,0.0009070065,0.00007245053,0.000023938097,0.0004446768,0.000028793358,0.0000010529685,0.0009146961,0.0000026765342,0.9968819,0.0002901638],"about_ca_topic_score_codex":0.00068301277,"about_ca_topic_score_gemma":0.026497595,"teacher_disagreement_score":0.02838822,"about_ca_system_score_codex":0.00055620936,"about_ca_system_score_gemma":0.00813928,"threshold_uncertainty_score":0.9993589},"labels":[],"label_agreement":null},{"id":"W3163843574","doi":"10.1002/cam4.3938","title":"Cardiovascular adverse events associated with BRAF versus BRAF/MEK inhibitor: Cross‐sectional and longitudinal analysis using two large national registries","year":2021,"lang":"en","type":"article","venue":"Cancer Medicine","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Metropolitan University","funders":"","keywords":"Vemurafenib; Medicine; Dabrafenib; Adverse effect; Trametinib; Internal medicine; Odds ratio; Oncology; Cancer; MAPK/ERK pathway; Metastatic melanoma","score_opus":0.037405770399443636,"score_gpt":0.32047314155232587,"score_spread":0.2830673711528822,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3163843574","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9922516,0.0048856377,0.0016606452,0.00006456203,0.00045133388,0.00007375596,0.00016121214,0.000011026179,0.00044024756],"genre_scores_gemma":[0.9974649,0.00018600171,0.000092277776,0.00010060076,0.00086320343,0.000014289879,0.0008558858,0.000014828185,0.00040799848],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99859613,0.000067975336,0.00019522384,0.00045057555,0.00046825796,0.00022181205],"domain_scores_gemma":[0.9990926,0.00002571666,0.0001022367,0.00021135117,0.00046023043,0.00010787018],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031469858,0.00015885095,0.00028367797,0.00007027866,0.00016583005,0.0000091012735,0.00006452851,0.00010396326,0.00010615181],"category_scores_gemma":[0.000256194,0.00013822642,0.00014765616,0.00035461792,0.00015233521,0.000009687351,0.000065611894,0.00009948486,6.978197e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047081185,0.00007225859,0.9642059,0.000034037497,0.007299931,0.00010979615,0.000086785185,0.003623759,0.023143556,0.000115707866,0.00067949743,0.00015792386],"study_design_scores_gemma":[0.01643916,0.0005143763,0.94040054,0.0001495134,0.002599146,0.00012037343,0.00025532686,0.00082326104,0.01927678,0.00004310167,0.01881796,0.0005604567],"about_ca_topic_score_codex":0.00012561622,"about_ca_topic_score_gemma":0.0007394098,"teacher_disagreement_score":0.02380539,"about_ca_system_score_codex":0.00010024245,"about_ca_system_score_gemma":0.00036948346,"threshold_uncertainty_score":0.56367093},"labels":[],"label_agreement":null},{"id":"W3167698157","doi":"10.1200/jco.2021.39.15_suppl.tps10056","title":"FIREFLY-1: A phase 2 study of the pan-RAF inhibitor DAY101 in pediatric patients with low-grade glioma.","year":2021,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; MAPK/ERK pathway; Cancer; MEK inhibitor; Glioma; Oncology; Internal medicine; Kinase; Adverse effect; Cancer research; Biology; Genetics","score_opus":0.039711479461763115,"score_gpt":0.3844723848679845,"score_spread":0.3447609054062214,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3167698157","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981991,0.00023682257,0.000010349687,0.00022120283,0.00092108326,0.00019127503,0.000007635343,0.0000011896896,0.00021130756],"genre_scores_gemma":[0.9986315,0.000081180784,0.00016529423,0.00021571688,0.0008407686,0.0000039482247,0.0000053988624,0.0000118630915,0.000044364842],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99718714,0.0006669996,0.0014621716,0.00021839587,0.00028791864,0.00017738355],"domain_scores_gemma":[0.997763,0.00023492376,0.0012111992,0.0002993874,0.00036984583,0.00012169433],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009457762,0.00012191626,0.00063589535,0.000057377605,0.000028903409,0.000005765168,0.0002724246,0.00026936075,0.0000130709395],"category_scores_gemma":[0.0014791212,0.00007278496,0.00022293846,0.00023678657,0.00007641191,0.0000064073215,0.00015608108,0.0004247736,0.0000013767992],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003199104,0.024536537,0.9490259,0.000032604483,0.00018648469,0.00053399376,0.00017857118,0.000021455997,0.011367837,0.0000061941273,0.0015798513,0.009331452],"study_design_scores_gemma":[0.03054237,0.035240274,0.9191407,0.0000330634,0.00021851284,0.00006249538,0.00028461745,0.0000059611593,0.008951676,0.000035445104,0.0053282063,0.00015670709],"about_ca_topic_score_codex":0.000006600965,"about_ca_topic_score_gemma":0.00016688906,"teacher_disagreement_score":0.029885244,"about_ca_system_score_codex":0.000019754247,"about_ca_system_score_gemma":0.0010238938,"threshold_uncertainty_score":0.29680845},"labels":[],"label_agreement":null},{"id":"W3168328251","doi":"10.1200/jco.2021.39.15_suppl.e21575","title":"BRAF testing timelines and impact on the starting of systemic treatment.","year":2021,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Vemurafenib; Melanoma; Stage (stratigraphy); Internal medicine; Oncology; Turnaround time; Cancer; Timeline; Retrospective cohort study; Disease; Log-rank test; Metastatic melanoma; Survival analysis; Cancer research","score_opus":0.15285928230950835,"score_gpt":0.4414122225085154,"score_spread":0.28855294019900707,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3168328251","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99670935,0.0011891827,0.000045184668,0.00054429955,0.00025724497,0.000046426983,0.0000053886174,0.0000011862229,0.0012017669],"genre_scores_gemma":[0.9975825,0.00039378405,0.00076275435,0.00033773493,0.00078095536,8.5793215e-7,0.0000020589046,0.000006694612,0.0001326907],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983829,0.00038243283,0.0009277107,0.000112630645,0.000085252905,0.00010906088],"domain_scores_gemma":[0.9972526,0.0013181437,0.000907493,0.00014283582,0.00028768895,0.00009128455],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012703829,0.000083867526,0.00047718463,0.000017746614,0.000031399224,0.000006145684,0.00008277465,0.00016348691,0.000016622951],"category_scores_gemma":[0.0046556895,0.00004317066,0.00022111493,0.00004747457,0.00007299157,0.0000024192445,0.000042616728,0.00015153058,0.0000016629986],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010074466,0.00071390433,0.10934329,0.000030900184,0.00057109055,0.0002760003,0.000118524185,0.00016334422,0.7427471,0.00013184136,0.0022894086,0.14260714],"study_design_scores_gemma":[0.019162772,0.17045243,0.2360462,0.0011057726,0.0011912473,0.0074212668,0.0034376464,0.001323361,0.5153191,0.0019435501,0.041774835,0.0008217927],"about_ca_topic_score_codex":0.000007547066,"about_ca_topic_score_gemma":0.000008018233,"teacher_disagreement_score":0.22742796,"about_ca_system_score_codex":0.000015041251,"about_ca_system_score_gemma":0.0007724406,"threshold_uncertainty_score":0.5573631},"labels":[],"label_agreement":null},{"id":"W3170480273","doi":"10.1200/jco.2021.39.15_suppl.tps9596","title":"Multicenter phase I/II trial of encorafenib with and without binimetinib in combination with nivolumab and low-dose ipilimumab in metastatic BRAF-mutant melanoma.","year":2021,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Bristol-Myers Squibb Canada","keywords":"Medicine; Ipilimumab; Nivolumab; Melanoma; Oncology; Internal medicine; Regimen; Immunotherapy; Targeted therapy; Vemurafenib; Cancer research; Metastatic melanoma; Cancer","score_opus":0.046277413154985965,"score_gpt":0.3880112685749552,"score_spread":0.34173385541996926,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3170480273","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99846137,0.0003746435,0.00012157919,0.00034479742,0.00019340632,0.00027187527,0.0000070373453,0.0000012566016,0.00022401687],"genre_scores_gemma":[0.99604285,0.00046612116,0.003150568,0.00016006433,0.000099781966,0.0000062845634,0.000011025384,0.000013325786,0.00004999201],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9975317,0.00050498353,0.0013424032,0.00026579795,0.00018018384,0.00017491549],"domain_scores_gemma":[0.9982546,0.00025307917,0.00095790747,0.00015455486,0.00023450024,0.00014533204],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016278897,0.00014463729,0.00092474703,0.000108663444,0.000022614682,0.0000090212225,0.00009374584,0.00019487664,0.000009627072],"category_scores_gemma":[0.00089334906,0.000101611775,0.00007992419,0.00012104045,0.00022399086,0.000016611795,0.00008041734,0.0003420292,2.6130104e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.49490798,0.02626962,0.12247586,0.00021469967,0.00079136377,0.0016648722,0.00064134155,0.000029230481,0.2134286,0.00018927835,0.00012180953,0.13926533],"study_design_scores_gemma":[0.698932,0.20332295,0.044097636,0.00033513186,0.00035202084,0.00091795827,0.00072961126,0.00037912413,0.04702865,0.00017882022,0.0033684555,0.0003576627],"about_ca_topic_score_codex":0.000015762382,"about_ca_topic_score_gemma":0.00053842005,"teacher_disagreement_score":0.20402399,"about_ca_system_score_codex":0.000018862487,"about_ca_system_score_gemma":0.0008657229,"threshold_uncertainty_score":0.4143608},"labels":[],"label_agreement":null},{"id":"W3172501354","doi":"10.1007/978-3-030-71155-9_17","title":"Dual Therapy BRAF Inhibitor Chemotherapy (Dabrafenib + Trametinib Chemotherapy) Induced Peripheral Edema","year":2021,"lang":"en","type":"book-chapter","venue":"Clinical cases in cardiology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"NOSM University","funders":"","keywords":"Dabrafenib; Trametinib; Medicine; Chemotherapy; Edema; Peripheral edema; Melanoma; Peripheral; Surgery; Internal medicine; Adverse effect; Cancer research; Vemurafenib; Metastatic melanoma; MAPK/ERK pathway","score_opus":0.0670888251642819,"score_gpt":0.3355022469181752,"score_spread":0.2684134217538933,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3172501354","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8699058,0.010172965,0.0001010249,0.0007148715,0.004666906,0.0012008502,0.00023815362,0.00008419681,0.11291522],"genre_scores_gemma":[0.8122053,0.029927913,0.00078313,0.011708063,0.022644872,0.00020541644,0.001911348,0.00061914726,0.119994804],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9949815,0.0005046249,0.0016048074,0.0018695301,0.0002939667,0.00074552814],"domain_scores_gemma":[0.99710965,0.00043642853,0.0004814573,0.0014545958,0.00021858925,0.00029927053],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.001019814,0.0009328355,0.0021109108,0.00013398912,0.0000927219,0.000046001358,0.0004964707,0.0035946153,0.00071659544],"category_scores_gemma":[0.00045922946,0.0008922438,0.0015332471,0.00007142929,0.0006098979,0.0000067221554,0.0002472817,0.0012916955,0.000044438446],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013228351,0.0018045877,0.02191182,0.00037672193,0.007080335,0.017264063,0.00036543948,0.00006020305,0.19221528,0.011205327,0.12088524,0.61360264],"study_design_scores_gemma":[0.0072764754,0.0044179955,0.0030378143,0.00011711465,0.00007144366,0.0015439645,0.0000463125,0.0000041621515,0.0070557576,0.00079439406,0.9741766,0.0014580047],"about_ca_topic_score_codex":0.000013893754,"about_ca_topic_score_gemma":0.0000633738,"teacher_disagreement_score":0.85329133,"about_ca_system_score_codex":0.00007002597,"about_ca_system_score_gemma":0.0006420605,"threshold_uncertainty_score":0.9993528},"labels":[],"label_agreement":null},{"id":"W3173018072","doi":"10.1200/jco.2021.39.15_suppl.9523","title":"Effects of baseline lactate dehydrogenase (LDH), interferon gamma (IFN-g) expression, and tumor mutational burden (TMB) on treatment response to first-line atezolizumab (A) + vemurafenib (V) and cobimetinib (C) in <i>BRAF</i><sup>V600</sup> mutation–positive advanced melanoma.","year":2021,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada)","funders":"F. Hoffmann-La Roche","keywords":"Medicine; Hazard ratio; Internal medicine; Lactate dehydrogenase; Atezolizumab; Vemurafenib; Oncology; Cancer; Metastatic melanoma; Pembrolizumab; Immunotherapy; Confidence interval; Enzyme; Biology","score_opus":0.021735436523024704,"score_gpt":0.3452379577453137,"score_spread":0.32350252122228895,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3173018072","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99625605,0.0010156619,0.00038193143,0.0016989072,0.00017931437,0.0003355738,0.00005409595,0.0000034898549,0.0000749906],"genre_scores_gemma":[0.9952568,0.0005271235,0.00299537,0.00067161245,0.00031054017,0.000026522752,0.00005254728,0.000022342521,0.00013715602],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.996499,0.0012434202,0.0014096592,0.00041576175,0.00019863498,0.00023350629],"domain_scores_gemma":[0.9954272,0.0029625965,0.00073787075,0.00018045718,0.00035254247,0.00033932173],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001272556,0.00023972765,0.00089549477,0.0001355467,0.000049965136,0.000011724199,0.00011752036,0.00024453155,0.000019194333],"category_scores_gemma":[0.0044257883,0.00018886414,0.00018728225,0.00011180674,0.0001283575,0.000015759593,0.00010975851,0.00025212576,0.0000030046904],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.09503812,0.002783965,0.0018277427,0.00012678368,0.00045531156,0.006549996,0.0013656061,0.0060415976,0.80701876,0.000032549102,0.00038830983,0.07837124],"study_design_scores_gemma":[0.024286412,0.05764819,0.023045205,0.0004756413,0.00019871448,0.0011361255,0.00037907486,0.0007254999,0.87734383,0.00016060246,0.014253506,0.00034722412],"about_ca_topic_score_codex":0.000012714122,"about_ca_topic_score_gemma":0.00007869634,"teacher_disagreement_score":0.078024015,"about_ca_system_score_codex":0.00007527892,"about_ca_system_score_gemma":0.00066329684,"threshold_uncertainty_score":0.7701656},"labels":[],"label_agreement":null},{"id":"W3173362811","doi":"10.1016/j.celrep.2021.109291","title":"Targeting p130Cas- and microtubule-dependent MYC regulation sensitizes pancreatic cancer to ERK MAPK inhibition","year":2021,"lang":"en","type":"article","venue":"Cell Reports","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Institute of General Medical Sciences; National Cancer Institute; University of North Carolina; Merck; Deutsche Forschungsgemeinschaft; American Association for Cancer Research; Eli Lilly and Company; American Cancer Society; Doris Duke Charitable Foundation; Pancreatic Cancer Action Network; Lustgarten Foundation; U.S. Department of Defense","keywords":"Pancreatic cancer; KRAS; Synthetic lethality; MAPK/ERK pathway; Cancer research; Biology; Small interfering RNA; Cancer cell; Cell biology; Kinase; Cancer; Mutant; Transfection; Cell culture; Biochemistry; Genetics","score_opus":0.006662341930106495,"score_gpt":0.21556977388780185,"score_spread":0.20890743195769534,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3173362811","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946971,0.0017446438,0.0010178318,0.000099946745,0.00027187713,0.0001759985,0.000008219058,0.000015226914,0.0019691822],"genre_scores_gemma":[0.9941007,0.00020104482,0.00090741913,0.0002765186,0.00028916897,0.000025757046,0.00026314103,0.000020141655,0.003916124],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990073,0.000041481,0.00024578712,0.00041799157,0.00010923413,0.00017824223],"domain_scores_gemma":[0.99941605,0.0000065185227,0.00011298171,0.00024784912,0.00011777917,0.000098790275],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015003276,0.000121127516,0.00013115528,0.000024379728,0.000080596335,0.0000327211,0.000016289878,0.00010549607,0.000049841183],"category_scores_gemma":[0.000065978296,0.0001253282,0.000038871793,0.000052699907,0.000016378728,0.0000036661722,0.00008507338,0.000047563884,0.0000055941846],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000138961495,0.000018345507,0.003086783,0.00005313826,0.000011858127,0.0004253277,0.00007201977,0.00008601494,0.99259335,0.0000050067933,0.002952914,0.0006813279],"study_design_scores_gemma":[0.00013896487,0.000044944045,0.0031989682,0.000039421808,0.000025600068,0.00037967117,0.00007287928,0.000014804907,0.9844632,0.0000989675,0.011361447,0.00016109475],"about_ca_topic_score_codex":0.00004982554,"about_ca_topic_score_gemma":0.00004281935,"teacher_disagreement_score":0.008408533,"about_ca_system_score_codex":0.000018056304,"about_ca_system_score_gemma":0.00008338083,"threshold_uncertainty_score":0.5110736},"labels":[],"label_agreement":null},{"id":"W3173401695","doi":"10.1158/1078-0432.ccr-21-0809","title":"5-Year Outcomes with Cobimetinib plus Vemurafenib in <i>BRAF</i> V600 Mutation–Positive Advanced Melanoma: Extended Follow-up of the coBRIM Study","year":2021,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":182,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada)","funders":"F. Hoffmann-La Roche; Roche","keywords":"Vemurafenib; Medicine; Placebo; Internal medicine; Melanoma; Gastroenterology; Surgery; Metastatic melanoma; Pathology; Cancer research; Cancer","score_opus":0.0778736949624746,"score_gpt":0.4348568937526744,"score_spread":0.3569831987901998,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3173401695","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965411,0.0006368361,0.000032440315,0.00034880466,0.00031778766,0.0008168751,0.00007059364,0.000006155453,0.0012294003],"genre_scores_gemma":[0.99584323,0.0001362072,0.00017135797,0.0001626468,0.00010027079,0.00019394257,0.00003989774,0.000028143162,0.0033242747],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99685264,0.0010508079,0.0005422798,0.0006223972,0.0005375666,0.00039433065],"domain_scores_gemma":[0.99811363,0.00033662986,0.00012992439,0.0006841945,0.00061429787,0.000121313096],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012648999,0.00016132797,0.00041516442,0.00004879119,0.00011490483,0.000023169472,0.00041758924,0.00015492173,0.000065490174],"category_scores_gemma":[0.00082978274,0.00011045699,0.00016169653,0.0004530596,0.00035854246,0.0000067928445,0.000381615,0.00049086567,0.0000085272395],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034106942,0.0018380508,0.9442267,0.00007029144,0.00040222198,0.00022919757,0.0008137942,0.00007468402,0.040604122,0.00022690845,0.0006065638,0.0074967803],"study_design_scores_gemma":[0.013450773,0.0021713453,0.88079786,0.000084795945,0.00004193392,0.000007860197,0.0022063062,0.000010522348,0.09946365,0.000050416882,0.001491461,0.0002231029],"about_ca_topic_score_codex":0.00015351725,"about_ca_topic_score_gemma":0.0039200094,"teacher_disagreement_score":0.06342886,"about_ca_system_score_codex":0.000042701515,"about_ca_system_score_gemma":0.0011813078,"threshold_uncertainty_score":0.4504305},"labels":[],"label_agreement":null},{"id":"W3175668895","doi":"10.1096/fasebj.2018.32.1_supplement.662.21","title":"MK5 and ERK3 play overlapping but distinct roles in regulating cardiac fibroblast function","year":2018,"lang":"en","type":"article","venue":"The FASEB Journal","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Montreal Heart Institute","funders":"Heart and Stroke Foundation of Canada","keywords":"Fibroblast; Kinase; Protein kinase A; Cell biology; Chemistry; Molecular biology; Biology; Biochemistry; In vitro","score_opus":0.008919299021695706,"score_gpt":0.2123710715336645,"score_spread":0.20345177251196878,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3175668895","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99705625,0.00039680957,0.00084444863,0.000059798527,0.00022622437,0.00005595048,0.000011737252,0.0000045545225,0.0013442382],"genre_scores_gemma":[0.9981882,0.000031642365,0.000113982846,0.000056655612,0.0012825791,0.0000021212081,0.0000126207415,0.0000102321055,0.00030194593],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99935204,0.00008648206,0.0001539396,0.0001354077,0.000088648885,0.00018345751],"domain_scores_gemma":[0.99966294,0.000016316366,0.00008737579,0.00013870705,0.000035996418,0.00005866272],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032576677,0.00009431164,0.00009637472,0.00002757724,0.00022265372,0.000049767208,0.0000835527,0.00006590425,0.000017516555],"category_scores_gemma":[0.000050588387,0.00006667052,0.00004869914,0.00004141343,0.000082763945,0.000005866226,0.000055958448,0.00012947478,0.0000044808758],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000093083945,0.0000063369093,0.013335614,0.0000043980294,0.000024326682,0.000002580258,0.00013407474,0.000014500782,0.9826389,0.000047670906,0.0005722717,0.0031262368],"study_design_scores_gemma":[0.0011219914,0.0009654199,0.2852977,0.00018749299,0.000050785668,0.0003029341,0.001055784,0.00036742768,0.6979562,0.00063035765,0.011710824,0.00035310804],"about_ca_topic_score_codex":0.000015258495,"about_ca_topic_score_gemma":0.00006895193,"teacher_disagreement_score":0.28468272,"about_ca_system_score_codex":0.000010989785,"about_ca_system_score_gemma":0.000032273754,"threshold_uncertainty_score":0.2718745},"labels":[],"label_agreement":null},{"id":"W3177280881","doi":"10.1096/fasebj.2019.33.1_supplement.478.9","title":"ERK3‐MK5 Signaling in Murine Ventricular Fibroblasts and its Role in Fibroblast Migration","year":2019,"lang":"en","type":"article","venue":"The FASEB Journal","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"Heart and Stroke Foundation of Canada","keywords":"Cell biology; Actin; Fibroblast; Protein kinase A; Kinase; Cytoplasm; Cytoskeleton; Chemistry; Molecular biology; Medicine; Biology; Cell; Biochemistry; In vitro","score_opus":0.00548516689490861,"score_gpt":0.19870412606958124,"score_spread":0.19321895917467263,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3177280881","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9982531,0.0012004054,0.000053062708,0.00012017969,0.00006282177,0.00012463858,0.0000034820391,0.0000022570832,0.00018004267],"genre_scores_gemma":[0.9993921,0.000098829645,0.000065147324,0.000053965283,0.00015833427,0.0000031039144,0.00001373136,0.000009175228,0.00020560976],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99930394,0.00008624888,0.0001848168,0.00013814354,0.00009663764,0.00019023722],"domain_scores_gemma":[0.9997287,0.000012969395,0.000074059295,0.00010799551,0.000024519877,0.000051805775],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028524167,0.000094578594,0.000100932244,0.00006379987,0.000042527397,0.000031167765,0.000109916764,0.00006975518,0.00003843259],"category_scores_gemma":[0.000026240956,0.0000695994,0.000040054565,0.00007736409,0.000011204714,0.0000081934495,0.000055107383,0.0001634289,0.000016741038],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006775051,0.000021938355,0.014211755,0.000012029415,0.000008725992,0.00002605569,0.00010436858,0.0013737848,0.9838493,0.00002904617,0.00004561727,0.00024964745],"study_design_scores_gemma":[0.0010543227,0.00031297212,0.013143724,0.000101042286,0.000006086868,0.00033553698,0.00019728797,0.0013662814,0.98241144,0.0001375038,0.0008009242,0.00013286852],"about_ca_topic_score_codex":0.0000118330845,"about_ca_topic_score_gemma":0.00007198199,"teacher_disagreement_score":0.0014378309,"about_ca_system_score_codex":0.000014007693,"about_ca_system_score_gemma":0.000035966073,"threshold_uncertainty_score":0.28381813},"labels":[],"label_agreement":null},{"id":"W3177660183","doi":"10.1038/s41388-021-01917-z","title":"The newly identified MEK1 tyrosine phosphorylation target MACC1 is druggable by approved MEK1 inhibitors to restrict colorectal cancer metastasis","year":2021,"lang":"en","type":"article","venue":"Oncogene","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; Partenariat Canadien Contre Le Cancer; Deutschen Konsortium für Translationale Krebsforschung","keywords":"Metastasis; Phosphorylation; Cancer research; Biology; Colorectal cancer; Tyrosine phosphorylation; Cancer; Cell biology; Genetics","score_opus":0.008646537518098555,"score_gpt":0.24667389127483258,"score_spread":0.23802735375673403,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3177660183","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9791972,0.013159603,0.0010864617,0.0018641099,0.0010105864,0.0003947466,0.0003782704,0.000022617603,0.0028863745],"genre_scores_gemma":[0.9696467,0.0017550344,0.0022842411,0.0012025455,0.0006859186,0.00021666563,0.0009174298,0.00006996367,0.02322153],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984004,0.00009864983,0.00031699674,0.0005426064,0.00026196957,0.00037940673],"domain_scores_gemma":[0.99905616,0.000024661025,0.00012508297,0.00041178026,0.00021178887,0.00017052119],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002559426,0.00022023717,0.00021005928,0.000028127433,0.00025681994,0.00010285218,0.00022790901,0.00015732137,0.00018093272],"category_scores_gemma":[0.0001212435,0.00018331653,0.00013820158,0.0003134843,0.000042093438,0.000007769398,0.00018470809,0.0000895195,0.00005332469],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010288989,0.00004716767,0.00027979494,0.0000071858426,0.00009665885,0.000005968706,0.000060143222,0.000037447386,0.78803664,0.000022943359,0.2065494,0.0047537605],"study_design_scores_gemma":[0.00033895177,0.00008380012,0.00009080298,0.00000581095,0.000035623554,0.0000045611787,0.00007606285,0.000035475696,0.63720953,0.000030340914,0.36193547,0.0001535817],"about_ca_topic_score_codex":0.00026527204,"about_ca_topic_score_gemma":0.00035944587,"teacher_disagreement_score":0.15538606,"about_ca_system_score_codex":0.000057066714,"about_ca_system_score_gemma":0.000272671,"threshold_uncertainty_score":0.74754316},"labels":[],"label_agreement":null},{"id":"W3180572238","doi":"10.1158/1538-7445.am2021-1218","title":"Abstract 1218: Targeting B-RAF and checkpoint inhibitor resistant melanoma with RSK inhibitor PMD-026 in pre-clinical models","year":2021,"lang":"en","type":"article","venue":"Cancer Research","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Institute of Public Health Inspectors","funders":"","keywords":"Melanoma; Cancer research; Cancer; Kinase; Medicine; MEK inhibitor; Metastasis; Targeted therapy; MAPK/ERK pathway; Mucosal melanoma; Vemurafenib; Immunotherapy; Biology; Internal medicine; Metastatic melanoma","score_opus":0.06307485076322,"score_gpt":0.3681155071778808,"score_spread":0.30504065641466077,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3180572238","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99024045,0.007134362,0.000051147363,0.00044867297,0.00014862677,0.0003167589,0.000048230388,0.000011457381,0.0016002943],"genre_scores_gemma":[0.9956578,0.0015891483,0.00056261435,0.00007802102,0.0008069672,0.00013415854,0.00007775073,0.00004296629,0.0010505858],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9974371,0.00025708333,0.00046295355,0.0008026871,0.00042902847,0.00061111705],"domain_scores_gemma":[0.9988284,0.000078798126,0.00007563865,0.00043965149,0.0003251202,0.00025238632],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013980793,0.00019214512,0.00028412443,0.00008436697,0.00013175208,0.000079611294,0.00019114946,0.00026997778,0.00008001034],"category_scores_gemma":[0.00027361544,0.00016529948,0.00008183583,0.00023316378,0.00024140184,0.000014902613,0.00033377056,0.00057895255,0.000007823463],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011203736,0.00015537055,0.007560151,0.00017361263,0.00006223249,0.00025413436,0.00027018946,0.00006479388,0.98439276,0.00011658097,0.0039000758,0.0019296964],"study_design_scores_gemma":[0.0027936115,0.0009719905,0.030327283,0.00040067453,0.000015032509,0.000026327207,0.0007075449,0.00017129075,0.941606,0.00044232406,0.022045633,0.00049232796],"about_ca_topic_score_codex":0.00040131292,"about_ca_topic_score_gemma":0.0015489683,"teacher_disagreement_score":0.042786825,"about_ca_system_score_codex":0.000065549924,"about_ca_system_score_gemma":0.0008231093,"threshold_uncertainty_score":0.6740717},"labels":[],"label_agreement":null},{"id":"W3183659755","doi":"10.1101/2021.07.26.453858","title":"Crosstalk with keratinocytes causes GNAQ oncogene specificity in melanoma","year":2021,"lang":"en","type":"preprint","venue":"bioRxiv (Cold Spring Harbor Laboratory)","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"GNAQ; Melanoma; Cancer research; Melanocyte; Oncogene; Biology; Crosstalk; Signal transduction; Epidermis (zoology); Cell cycle; Cell biology; Cell; Genetics; Mutation; Gene","score_opus":0.012932976784231023,"score_gpt":0.21420643201746833,"score_spread":0.2012734552332373,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3183659755","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99420637,0.0034415966,0.00075544964,0.000048071484,0.000589318,0.00053887075,0.00026247246,0.00008044626,0.00007742657],"genre_scores_gemma":[0.99368626,0.00052711676,0.004541765,0.00016728976,0.00071513234,0.00018465372,0.000009188234,0.00014024737,0.000028331702],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99685556,0.00017227481,0.00053850515,0.0014571028,0.0003277565,0.0006488319],"domain_scores_gemma":[0.99745655,0.000021064223,0.000309683,0.0015571251,0.00040216223,0.0002534233],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00032373273,0.0006812399,0.0006497866,0.00015202202,0.00012870814,0.00029943767,0.0005107235,0.0007607644,0.00006299454],"category_scores_gemma":[0.00010471159,0.0006784685,0.00016331855,0.00029389927,0.0001650178,0.000012787608,0.00067479745,0.0005651701,0.00001783087],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010190647,0.00020085307,0.037188698,0.0001895071,0.0001515796,0.00043342984,0.000011767103,0.00011199489,0.9613616,0.00007665822,0.00016965704,0.0000023854536],"study_design_scores_gemma":[0.00072137924,0.00020730813,0.079743646,0.00023918907,0.00004963578,2.1412302e-7,0.000013439721,0.000026750353,0.9120237,4.2088274e-7,0.0061399466,0.00083432614],"about_ca_topic_score_codex":0.00014730312,"about_ca_topic_score_gemma":0.00023447526,"teacher_disagreement_score":0.049337823,"about_ca_system_score_codex":0.00012313228,"about_ca_system_score_gemma":0.0011381072,"threshold_uncertainty_score":0.9995667},"labels":[],"label_agreement":null},{"id":"W3183839551","doi":"10.1038/s41388-021-01911-5","title":"Targeting mTOR signaling overcomes acquired resistance to combined BRAF and MEK inhibition in BRAF-mutant melanoma","year":2021,"lang":"en","type":"article","venue":"Oncogene","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":59,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital","funders":"National Institute of General Medical Sciences; DOD Peer Reviewed Cancer Research Program; U.S. Department of Health and Human Services; National Cancer Institute; National Institutes of Health; Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; U.S. Department of Defense","keywords":"mTORC1; PI3K/AKT/mTOR pathway; Melanoma; Cancer research; PTEN; MAPK/ERK pathway; MEK inhibitor; Biology; Protein kinase B; Signal transduction; Targeted therapy; Cell growth; Cancer; Cell biology; Biochemistry; Genetics","score_opus":0.009287203089561663,"score_gpt":0.2286472552873164,"score_spread":0.21936005219775473,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3183839551","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99605894,0.0018701488,0.00058822014,0.00045800325,0.00013435615,0.00015196197,0.000038184156,0.00001364508,0.00068653794],"genre_scores_gemma":[0.9950943,0.00012577491,0.0031771092,0.0005483218,0.00017527194,0.000021777543,0.00022555295,0.000023685394,0.0006082048],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99884784,0.00008695803,0.0002580012,0.0004283703,0.00011984565,0.00025899705],"domain_scores_gemma":[0.99949384,0.000018233102,0.00006250775,0.00024110709,0.000071278024,0.0001130258],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020286607,0.0001529764,0.00020000184,0.00004565929,0.00007336024,0.000034326626,0.00007016199,0.00012325321,0.000034516383],"category_scores_gemma":[0.00018576476,0.00016338812,0.000045918874,0.0001499867,0.000024769077,0.000006442523,0.00018514862,0.000045780176,0.000007839723],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014825493,0.000051067207,0.0013210947,0.000033726737,0.000017986684,0.00016915171,0.000098994366,0.00002505591,0.9967802,0.00013800952,0.000741122,0.00047533517],"study_design_scores_gemma":[0.0009993811,0.00016309401,0.001154064,0.00006423662,0.000009681192,0.00002414663,0.00013575864,0.000024206409,0.9889839,0.00019106598,0.008030037,0.00022038021],"about_ca_topic_score_codex":0.000011361861,"about_ca_topic_score_gemma":0.00024736387,"teacher_disagreement_score":0.0077962535,"about_ca_system_score_codex":0.000028050446,"about_ca_system_score_gemma":0.00009865195,"threshold_uncertainty_score":0.6662774},"labels":[],"label_agreement":null},{"id":"W3185536495","doi":"10.1111/cas.15075","title":"Tumor suppressor miR‐193a‐3p enhances efficacy of BRAF/MEK inhibitors in <i>BRAF</i>‐mutated colorectal cancer","year":2021,"lang":"en","type":"article","venue":"Cancer Science","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Aging","funders":"","keywords":"Cancer research; Trametinib; MCL1; Dabrafenib; MAPK/ERK pathway; MEK inhibitor; Cetuximab; Colorectal cancer; EGFR inhibitors; Epidermal growth factor receptor; Cancer; microRNA; KRAS; Cyclin-dependent kinase 6; Biology; Cell cycle; Medicine; Kinase; Vemurafenib; Downregulation and upregulation; Internal medicine; Melanoma; Cell biology; Cyclin-dependent kinase; Gene","score_opus":0.00941443090138921,"score_gpt":0.273504839717919,"score_spread":0.2640904088165298,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3185536495","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940363,0.0033269278,0.000026979204,0.00014660216,0.0009217332,0.00017343197,0.000095044095,0.0000112244425,0.0012617608],"genre_scores_gemma":[0.99882907,0.00026396237,0.00017440853,0.00021301613,0.00018567988,0.00008386779,0.00002066929,0.000013336934,0.00021598063],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998295,0.0000497044,0.00029192213,0.0006369172,0.00029274452,0.00043370912],"domain_scores_gemma":[0.9991942,0.000024452072,0.00013449528,0.0002833947,0.0002281802,0.0001352583],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022036843,0.00016626496,0.00022800962,0.000076079916,0.00009336435,0.000036313362,0.00042240907,0.0000744825,0.00012094384],"category_scores_gemma":[0.00019224806,0.0001565434,0.00007070758,0.000745403,0.0005443317,0.000019669516,0.0002086975,0.00010541965,0.0000035053924],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006844516,0.00007827697,0.0047590337,0.000030975483,0.0000100519455,0.000026163863,0.00020646302,0.00015925549,0.99190766,0.0000391381,0.0005643337,0.0021501773],"study_design_scores_gemma":[0.0006644975,0.00012805802,0.021996683,0.000076893695,0.000009698531,0.000010805174,0.00009564288,0.000081514336,0.9735591,0.000018951216,0.0031591046,0.00019905886],"about_ca_topic_score_codex":0.00031974178,"about_ca_topic_score_gemma":0.0010291293,"teacher_disagreement_score":0.018348593,"about_ca_system_score_codex":0.000056548583,"about_ca_system_score_gemma":0.0014289708,"threshold_uncertainty_score":0.6383655},"labels":[],"label_agreement":null},{"id":"W3196331378","doi":"10.3390/cancers13174362","title":"Skin Cancers and the Contribution of Rho GTPase Signaling Networks to Their Progression","year":2021,"lang":"en","type":"review","venue":"Cancers","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"Cancer Research Society","keywords":"Skin cancer; Basal cell carcinoma; Cancer research; Cancer; GTPase; Melanoma; Biology; Signal transduction; Carcinogenesis; Tumor progression; Medicine; Basal cell; Bioinformatics; Pathology; Cell biology; Genetics","score_opus":0.016520006515555127,"score_gpt":0.2967562630684083,"score_spread":0.28023625655285317,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3196331378","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005665998,0.99746335,0.0006545927,0.00001583102,0.00035266127,0.00072283315,0.000057970294,0.000004668132,0.00016150513],"genre_scores_gemma":[0.009560705,0.9891051,0.000055741486,0.000104897365,0.00045470035,0.0002443941,0.00038795118,0.000024721036,0.000061785926],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99886346,0.00018470467,0.00029735698,0.0003484469,0.00008624308,0.00021977596],"domain_scores_gemma":[0.99920934,0.00004370102,0.00024687362,0.00031102955,0.00009749602,0.00009154635],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002960126,0.00023404628,0.00072293833,0.000026680575,0.00007425761,0.000019243025,0.0001680111,0.00025429725,0.000008267623],"category_scores_gemma":[0.00007370728,0.00014318628,0.0002395216,0.0001351439,0.00012643663,0.000001378931,0.00012323522,0.00014235168,5.0076494e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008921509,0.000003712074,0.000003872117,0.0009270814,0.0002406012,0.0000045057473,0.000058931448,0.00042773027,0.00046268036,0.0002215681,0.0018027695,0.99575734],"study_design_scores_gemma":[0.00045674722,0.00010414411,4.7281603e-7,0.0040580905,0.00020462566,0.000011975049,0.00004660811,0.000060263043,0.0027067866,0.0000058056635,0.99214447,0.00020003718],"about_ca_topic_score_codex":0.00007446439,"about_ca_topic_score_gemma":0.00006576309,"teacher_disagreement_score":0.9955573,"about_ca_system_score_codex":0.00019241103,"about_ca_system_score_gemma":0.001010652,"threshold_uncertainty_score":0.5838967},"labels":[],"label_agreement":null},{"id":"W3197946942","doi":"10.1177/12034754211045380","title":"Reflex Molecular Testing in Melanoma Diagnosis: When Should <i>BRAF</i> Mutation Testing Be Ordered and Who Should Order It?","year":2021,"lang":"en","type":"letter","venue":"Journal of Cutaneous Medicine and Surgery","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Université Laval; McGill University","funders":"","keywords":"Medicine; Melanoma; Mutation; Reflex; Melanoma diagnosis; Diagnostic test; Dermatology; Cancer research; Internal medicine; Genetics; Pediatrics; Gene","score_opus":0.08945554226016338,"score_gpt":0.29274899018997197,"score_spread":0.20329344792980858,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3197946942","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6328211,0.027333649,0.00022208966,0.336357,0.0008588486,0.000332209,0.000027965394,0.000017825385,0.0020293188],"genre_scores_gemma":[0.16476423,0.008208723,0.0048094695,0.8099502,0.010257635,0.000052159463,0.0006496226,0.00028308417,0.0010249111],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9969583,0.000300752,0.0011951578,0.0005152807,0.0005645632,0.00046592482],"domain_scores_gemma":[0.99667937,0.0013857941,0.000828252,0.00029134686,0.00063702906,0.00017823055],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008437901,0.00046956734,0.0011510866,0.00037478624,0.000088735615,0.00006328599,0.00016281407,0.00083852734,0.000033983164],"category_scores_gemma":[0.005468439,0.00039082105,0.00012955994,0.00029858522,0.00015783751,0.000014998083,0.000104989515,0.0012213022,3.4713136e-7],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011269689,0.00006201432,0.012945565,0.00070162653,0.00027982803,0.062280484,0.00039293926,0.00002709342,0.048420873,0.0000022729846,0.8500439,0.024730735],"study_design_scores_gemma":[0.001702293,0.0023967063,0.00043986388,0.0063500726,0.00066611555,0.06803546,0.0008384042,0.00015542324,0.008006786,0.00041958824,0.9097051,0.0012841999],"about_ca_topic_score_codex":0.000107765336,"about_ca_topic_score_gemma":0.000048258506,"teacher_disagreement_score":0.47359318,"about_ca_system_score_codex":0.000028736767,"about_ca_system_score_gemma":0.00046150657,"threshold_uncertainty_score":0.9998544},"labels":[],"label_agreement":null},{"id":"W3199125645","doi":"10.2139/ssrn.3188455","title":"The Dynamics of ERK Signaling in Melanoma, and the Response to BRAF or MEK Inhibition, Are Cell Cycle Dependent","year":2018,"lang":"en","type":"article","venue":"SSRN Electronic Journal","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"","keywords":"MAPK/ERK pathway; Melanoma; Dynamics (music); Cell cycle; Cell cycle progression; Cancer research; Cell biology; Chemistry; Signal transduction; Cell; Biology; Psychology; Biochemistry","score_opus":0.003852610130388821,"score_gpt":0.2135390917261883,"score_spread":0.20968648159579947,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3199125645","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994551,0.0014465856,0.002376965,0.0012097878,0.00007297817,0.000151444,0.0000061494875,0.0000022925526,0.00018279617],"genre_scores_gemma":[0.9979862,0.0007974363,0.000051999195,0.00013691984,0.00016636688,0.000007523666,0.0000031583372,0.0000131506395,0.0008372599],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985291,0.00027089,0.0002490936,0.00015401932,0.0001320802,0.0006648293],"domain_scores_gemma":[0.99944395,0.000083434,0.00014562861,0.00018306663,0.00009172668,0.00005221407],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024697713,0.000102890954,0.000120570796,0.000041416824,0.0002220667,0.00003191609,0.00018204731,0.00007189716,0.0000048354837],"category_scores_gemma":[0.00018670115,0.000057182035,0.00004951766,0.000089658715,0.00012720817,0.0000040300756,0.00008147906,0.00034286236,0.0000029553564],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.021471081,0.00013142762,0.0035914653,0.000019018102,0.00017378648,0.000023651077,0.0009767952,0.00014963617,0.9439747,0.022176897,0.00024880827,0.0070627797],"study_design_scores_gemma":[0.013518101,0.0081042405,0.005296587,0.00015958893,0.00012787792,0.0021128296,0.01932121,0.0009464916,0.85386246,0.0915348,0.004208937,0.0008068451],"about_ca_topic_score_codex":0.000037614143,"about_ca_topic_score_gemma":0.0084946565,"teacher_disagreement_score":0.090112165,"about_ca_system_score_codex":0.00009288409,"about_ca_system_score_gemma":0.00060381275,"threshold_uncertainty_score":0.4740218},"labels":[],"label_agreement":null},{"id":"W3200475404","doi":"10.3389/fonc.2021.756001","title":"Melanoma Plasticity: Promoter of Metastasis and Resistance to Therapy","year":2021,"lang":"en","type":"review","venue":"Frontiers in Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":61,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Melanoma; Phenotype; Metastasis; Targeted therapy; Medicine; Cancer research; Immunotherapy; Cancer; Acquired resistance; Metastatic melanoma; Phenotypic plasticity; Immunology; Biology; Gene; Internal medicine; Genetics","score_opus":0.03250405160715081,"score_gpt":0.3179603603004406,"score_spread":0.2854563086932898,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3200475404","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0006379933,0.99526215,0.00137249,0.000039774037,0.0005904851,0.0005640628,0.00010542199,0.000003931716,0.001423716],"genre_scores_gemma":[0.000048189795,0.9785031,0.020219605,0.00009313369,0.0001383551,0.0001466996,0.00013455116,0.000035971338,0.0006804106],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9982519,0.00035241854,0.00048287088,0.00055529986,0.00008938251,0.0002681301],"domain_scores_gemma":[0.9992781,0.00004228944,0.00021668908,0.00031506087,0.00005268874,0.000095154544],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00023632638,0.00028513267,0.0015753013,0.0001763862,0.000022904851,0.000008211456,0.00024225484,0.00053311576,0.000015244355],"category_scores_gemma":[0.00013862413,0.00024693145,0.00018450098,0.00018526678,0.00009351494,0.0000017181145,0.00017111984,0.00017264568,0.0000018692054],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008875294,0.00011133651,0.00010541983,0.0016005571,0.0003377518,0.00007174387,0.00006991289,2.1331019e-7,0.0003441928,0.00010230432,0.025700504,0.9714673],"study_design_scores_gemma":[0.00033826637,0.00058258773,0.000010298834,0.00073070783,0.000111500834,0.000028917184,0.000031675827,2.9524807e-7,0.0006759651,0.000040465795,0.9972218,0.00022747536],"about_ca_topic_score_codex":0.000004479206,"about_ca_topic_score_gemma":0.00005868092,"teacher_disagreement_score":0.9715213,"about_ca_system_score_codex":0.000053983153,"about_ca_system_score_gemma":0.00044030417,"threshold_uncertainty_score":0.9999983},"labels":[],"label_agreement":null},{"id":"W3200916137","doi":"10.2196/30270","title":"From the Cochrane Library: Systemic Treatments for Metastatic Cutaneous Melanoma","year":2021,"lang":"en","type":"article","venue":"JMIR Dermatology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Cochrane Library; Melanoma; Systemic therapy; Dermatology; Oncology; Internal medicine; Cancer; Meta-analysis; Cancer research","score_opus":0.012197214202803654,"score_gpt":0.2632564708871007,"score_spread":0.251059256684297,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3200916137","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98910886,0.0062556774,0.00087337085,0.0014099024,0.00039331632,0.00053517456,0.00037842974,0.000033189845,0.0010120632],"genre_scores_gemma":[0.99325734,0.0002785989,0.0010784501,0.0010930173,0.00025662055,0.00035051233,0.0018712502,0.00003639922,0.0017777986],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989082,0.00015646536,0.00023473556,0.0003588944,0.00007238627,0.00026929766],"domain_scores_gemma":[0.99917495,0.00013132553,0.00008750003,0.0004957855,0.00004232863,0.00006810671],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000021264064,0.00017377782,0.00028084355,0.000015446243,0.000099930156,0.000030978874,0.00021694922,0.00013924991,0.00008639223],"category_scores_gemma":[0.00004425046,0.00012678099,0.00013872863,0.000057422134,0.000055408647,0.000004285023,0.00009835013,0.000057212685,0.00005429878],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045326215,0.0003564736,0.012887289,0.00026053266,0.0015810245,0.0021634845,0.0005742135,0.000008928174,0.8544982,0.002748878,0.12070234,0.0037653933],"study_design_scores_gemma":[0.0029937122,0.00037686928,0.000982843,0.00008115343,0.0003517784,0.017626967,0.00067847443,0.00016246765,0.7625283,0.0017657055,0.21200842,0.00044330713],"about_ca_topic_score_codex":0.000007899394,"about_ca_topic_score_gemma":0.00001443003,"teacher_disagreement_score":0.09196988,"about_ca_system_score_codex":0.000006095872,"about_ca_system_score_gemma":0.00013051133,"threshold_uncertainty_score":0.5169978},"labels":[],"label_agreement":null},{"id":"W3201018429","doi":"10.3390/curroncol28050304","title":"Management of Pyrexia Associated with the Combination of Dabrafenib and Trametinib: Canadian Consensus Statements","year":2021,"lang":"en","type":"article","venue":"Current Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"University of Toronto; University of Ottawa; University of British Columbia; Health Sciences Centre; Credit Valley Hospital; Université Laval; Ottawa Hospital; Princess Margaret Cancer Centre; McGill University; Sunnybrook Health Science Centre","funders":"Novartis Pharmaceuticals Canada","keywords":"Dabrafenib; Trametinib; Medicine; Discontinuation; Melanoma; Delphi method; Intensive care medicine; Oncology; Internal medicine; Vemurafenib; Metastatic melanoma; Cancer research","score_opus":0.048106139953511845,"score_gpt":0.3433593410423441,"score_spread":0.29525320108883224,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3201018429","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99559784,0.0007792643,0.000061461935,0.000358184,0.00016278382,0.00016011467,0.00006173293,0.0000019535787,0.0028166915],"genre_scores_gemma":[0.99930197,0.00017922142,0.000086156426,0.00003259088,0.000009661115,0.000011501188,0.00021579825,0.000005636915,0.00015746884],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9993984,0.000111166526,0.00014827048,0.00014326748,0.00007075232,0.0001281296],"domain_scores_gemma":[0.99952847,0.000023544033,0.00012175135,0.0001352326,0.00013819423,0.000052788015],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001674754,0.00006721368,0.00012608597,0.000023694596,0.000034999317,0.0000031466773,0.00006426249,0.00005868947,0.000013581721],"category_scores_gemma":[0.000028202017,0.000051065843,0.000021652459,0.00006942047,0.00011794583,9.787618e-7,0.000041424246,0.000047623827,4.3333836e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00093852385,0.004995237,0.18227783,0.0013394941,0.0038794798,0.00041110325,0.0027305612,0.00009010691,0.343303,0.043003183,0.03739595,0.3796355],"study_design_scores_gemma":[0.011700198,0.004085587,0.29100665,0.00028874679,0.0005537334,0.0000601635,0.0042269793,0.00018686625,0.22509152,0.0007654013,0.46145567,0.0005785025],"about_ca_topic_score_codex":0.00019702692,"about_ca_topic_score_gemma":0.0065873824,"teacher_disagreement_score":0.42405972,"about_ca_system_score_codex":0.000023056504,"about_ca_system_score_gemma":0.0001952918,"threshold_uncertainty_score":0.36759138},"labels":[],"label_agreement":null},{"id":"W3201749259","doi":"10.51731/cjht.2021.150","title":"Encorafenib in Combination With Binimetinib (Braftovi and Mektovi)","year":2021,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Metastatic melanoma; Medicine; Business; Test (biology); Marketing; Melanoma; Economic growth; Economics; Cancer research; Health care","score_opus":0.012647135161659275,"score_gpt":0.23328943117980475,"score_spread":0.22064229601814547,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3201749259","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9605218,0.032843094,0.0003156943,0.005866774,0.000094076895,0.000076499186,0.000007049596,0.000008269149,0.00026674586],"genre_scores_gemma":[0.99784666,0.00071421923,0.0011607835,0.00020506339,0.0000064748765,0.0000024562398,0.000008518933,0.0000070724027,0.00004873704],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9993246,0.000050336334,0.0002342403,0.00012068107,0.000057095116,0.00021302639],"domain_scores_gemma":[0.99954325,0.000010258797,0.00014583366,0.00013511913,0.000108548484,0.000056992754],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027465294,0.00007435134,0.00016205641,0.0001889446,0.0000653588,0.000017583445,0.00010640528,0.000112747904,0.0000041784415],"category_scores_gemma":[0.00024470553,0.000063412605,0.000018557543,0.00015994474,0.00009847004,0.000005262299,0.000018876935,0.00015052437,5.348352e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009716744,0.00010341164,0.17266273,0.00023472597,0.000085036685,0.0009302536,0.00045671308,0.000029308929,0.040688686,0.0058532814,0.0039669727,0.7748917],"study_design_scores_gemma":[0.004395593,0.0049052327,0.1079776,0.0005067329,0.000021368489,0.003096818,0.009454341,0.000017120714,0.26149037,0.0060435934,0.6014981,0.0005931095],"about_ca_topic_score_codex":0.00045910513,"about_ca_topic_score_gemma":0.009639872,"teacher_disagreement_score":0.7742986,"about_ca_system_score_codex":0.000037018926,"about_ca_system_score_gemma":0.0016702035,"threshold_uncertainty_score":0.5379275},"labels":[],"label_agreement":null},{"id":"W3201926698","doi":"10.1016/j.annonc.2021.08.1428","title":"1043P NF1 mutations and immune checkpoint inhibitor outcomes in patients with BRAF wildtype melanoma","year":2021,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network; McGill University; Princess Margaret Cancer Centre","funders":"GlaxoSmithKline","keywords":"Medicine; Melanoma; Oncology; Immune checkpoint; Cancer research; Wild type; Mutation; Internal medicine; Immunotherapy; Genetics; Cancer; Mutant; Gene","score_opus":0.018644000686201933,"score_gpt":0.28473757577301784,"score_spread":0.2660935750868159,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3201926698","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960282,0.00041722434,0.000018589577,0.00082265236,0.00009602936,0.00011830327,0.00002722753,0.0000038600097,0.002467948],"genre_scores_gemma":[0.99857175,0.00007127306,0.00050315616,0.00035082936,0.000034356293,0.000012831288,0.0001808461,0.000011277978,0.00026367814],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991944,0.00007175285,0.0002590411,0.0002251695,0.00007427636,0.0001753893],"domain_scores_gemma":[0.99943626,0.000025828584,0.000109710556,0.00019757374,0.00017643807,0.000054189946],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011199616,0.000106598025,0.00025505477,0.000046882724,0.000028154904,0.0000055048267,0.00006554042,0.00014225664,0.00002257128],"category_scores_gemma":[0.00011641419,0.00009131886,0.000048022484,0.00007681319,0.00008735296,0.0000050971225,0.00009009964,0.00006877673,0.0000035848886],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043310985,0.0011381581,0.7953548,0.00005277595,0.0001932457,0.00006178993,0.00028401415,0.0000131945735,0.18678205,0.0005026011,0.0005514458,0.014632819],"study_design_scores_gemma":[0.0020891598,0.0028975937,0.70777035,0.000016798484,0.000014090707,0.000012025711,0.00009913057,0.0000023956559,0.27684453,0.00016995518,0.009938931,0.00014502677],"about_ca_topic_score_codex":0.000030515836,"about_ca_topic_score_gemma":0.00021026745,"teacher_disagreement_score":0.09006248,"about_ca_system_score_codex":0.000005765765,"about_ca_system_score_gemma":0.00015870579,"threshold_uncertainty_score":0.3723875},"labels":[],"label_agreement":null},{"id":"W3203575639","doi":"10.1016/j.annonc.2021.08.1053","title":"531P Binimetinib and encorafenib for the treatment of advanced solid tumors with non-V600E BRAF mutations (mts): Preliminary results of the investigator initiated phase II BEAVER trial","year":2021,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre; University of Toronto; Jewish General Hospital","funders":"Servier; Pfizer; American Association for Cancer Research","keywords":"Medicine; Clinical trial; Oncology; Internal medicine; Cancer research","score_opus":0.0708436817400616,"score_gpt":0.3694569890258601,"score_spread":0.2986133072857985,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3203575639","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964401,0.00052573957,0.00005868951,0.0012504963,0.00013238852,0.0007665366,0.00041720722,0.0000026050466,0.00040622626],"genre_scores_gemma":[0.9980045,0.0003678008,0.00070658186,0.00024801353,0.00008453162,0.00012964956,0.0001964201,0.000012126408,0.00025037397],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989761,0.00013181301,0.00042136628,0.00023341009,0.0000813851,0.00015589737],"domain_scores_gemma":[0.99862534,0.00025339157,0.00040984937,0.0003329358,0.00031119463,0.000067310255],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018823518,0.00012816617,0.00032886554,0.000029136712,0.000093686096,0.0000025272063,0.00012131854,0.00011937075,0.0000039724277],"category_scores_gemma":[0.0004530644,0.00007615801,0.00012049794,0.00011466552,0.0003653051,0.0000045098764,0.000062691906,0.00004071099,1.4422976e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07802293,0.0037024384,0.0001499423,0.00007483899,0.0005602684,0.00001651354,0.0019948028,0.00022522973,0.88712615,0.00013468534,0.0029833894,0.025008839],"study_design_scores_gemma":[0.033649035,0.06854084,0.0005439163,0.000029253255,0.000118057775,0.00001964959,0.00038350516,0.000057106452,0.87449807,0.000099738696,0.021977974,0.00008284976],"about_ca_topic_score_codex":0.000020492109,"about_ca_topic_score_gemma":0.00004263314,"teacher_disagreement_score":0.0648384,"about_ca_system_score_codex":0.0000049986875,"about_ca_system_score_gemma":0.00070253375,"threshold_uncertainty_score":0.31056333},"labels":[],"label_agreement":null},{"id":"W3204422403","doi":"10.30683/1929-2279.2020.09.03","title":"The Role of BRAF Gene in Cancer: Literature Review and Future Directions","year":2020,"lang":"en","type":"article","venue":"Journal of cancer research updates","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Vemurafenib; Cancer research; Cancer; Melanoma; Targeted therapy; Thyroid cancer; Dabrafenib; Colorectal cancer; Medicine; Kinase; Lung cancer; Mutation; Metastasis; Biology; Oncology; Internal medicine; Gene; Genetics","score_opus":0.018332240925627668,"score_gpt":0.34667016034944154,"score_spread":0.32833791942381385,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3204422403","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.20193818,0.78461474,7.722225e-7,0.013108277,0.00006397523,0.000095565774,0.000036116362,7.2995095e-7,0.00014161738],"genre_scores_gemma":[0.16795719,0.83078986,0.000041100222,0.0003045865,0.0008334596,0.000014406598,0.0000044870644,0.000006619615,0.000048286973],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9992137,0.00012971535,0.0002159561,0.00010106215,0.00018898146,0.0001505824],"domain_scores_gemma":[0.99934226,0.000020747833,0.0001050572,0.00009995035,0.00033580474,0.000096192685],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044202196,0.00006105323,0.00015485402,0.000036549198,0.00006599713,0.000025911648,0.00018726038,0.000054906664,0.000022048964],"category_scores_gemma":[0.00009400948,0.000037581176,0.000050444334,0.00024525422,0.000065841414,0.000007331427,0.000070645154,0.00029103545,2.8653875e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002981909,0.000038074963,0.0072718575,0.00049470906,0.00014772278,0.000019613648,0.00034866168,0.0000054744637,0.8286254,0.00015731926,0.025509657,0.13708334],"study_design_scores_gemma":[0.00019137225,0.00022542951,0.0012384503,0.00027404513,0.000015527856,0.0000196592,0.000111145004,0.000003901234,0.15676819,0.0000891056,0.84102184,0.000041365885],"about_ca_topic_score_codex":0.000046289297,"about_ca_topic_score_gemma":0.00022470318,"teacher_disagreement_score":0.8155121,"about_ca_system_score_codex":0.000013293603,"about_ca_system_score_gemma":0.0002016727,"threshold_uncertainty_score":0.15325159},"labels":[],"label_agreement":null},{"id":"W3207342838","doi":"10.1016/j.jid.2021.08.292","title":"286 HORMAD1 Contributes to the Development of Squamous Cell Carcinomas in Melanoma Patients","year":2021,"lang":"en","type":"article","venue":"Journal of Investigative Dermatology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Trametinib; Vemurafenib; HaCaT; Cancer research; Melanoma; MAPK/ERK pathway; Cell growth; Medicine; MEK inhibitor; Cell culture; Biology; Signal transduction; Cell biology; Metastatic melanoma","score_opus":0.01307378266497812,"score_gpt":0.22431127542538232,"score_spread":0.2112374927604042,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3207342838","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968467,0.0010301766,0.00044438464,0.00088257535,0.00019665509,0.00011436428,0.00001086586,0.0000010378266,0.00047325014],"genre_scores_gemma":[0.9969771,0.000009431715,0.0021987068,0.0006973746,0.00003591792,0.0000068068393,0.00002539795,0.000008849857,0.00004043187],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99861073,0.00023454394,0.0006814574,0.00013978474,0.00013257297,0.00020092416],"domain_scores_gemma":[0.9988271,0.000059596383,0.0003473919,0.00016318528,0.0004997318,0.000102967046],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019952313,0.00012563841,0.00031145662,0.00009379429,0.00004783635,0.0000075398043,0.00022834935,0.000116127005,0.0000063408334],"category_scores_gemma":[0.00047107605,0.00009209121,0.00007516686,0.00016155087,0.000120092016,0.000005144236,0.00013093784,0.00014751256,0.0000049768014],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009770931,0.00018321055,0.12820292,0.000047223588,0.00006152418,0.00008687669,0.0016349377,0.00003746595,0.86405134,0.00024368454,0.0049833525,0.00036977726],"study_design_scores_gemma":[0.0009822936,0.000174723,0.1154389,0.00001821521,0.000013255518,0.000079613405,0.00040577826,0.000003284235,0.8707745,0.00015603153,0.011870567,0.00008282328],"about_ca_topic_score_codex":0.0000032577063,"about_ca_topic_score_gemma":0.0001309083,"teacher_disagreement_score":0.012764015,"about_ca_system_score_codex":0.00002617283,"about_ca_system_score_gemma":0.0005838383,"threshold_uncertainty_score":0.37553707},"labels":[],"label_agreement":null},{"id":"W3207422538","doi":"10.3390/curroncol28050338","title":"Real World Outcomes in Patients with Advanced Melanoma Treated in Alberta, Canada: A Time-Era Based Analysis","year":2021,"lang":"en","type":"article","venue":"Current Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Occupational Cancer Research Centre; Cambridge Memorial Hospital; University of Calgary; Alberta Health Services","funders":"","keywords":"Medicine; Ipilimumab; Nivolumab; Melanoma; Oncology; Internal medicine; Proportional hazards model; Immunotherapy; Targeted therapy; Metastatic melanoma; Survival analysis; Cancer; Cancer research","score_opus":0.012003939860057506,"score_gpt":0.2725845505070179,"score_spread":0.2605806106469604,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3207422538","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973525,0.000093638206,0.000014512547,0.0001672067,0.00015182908,0.00017924997,0.000050993847,0.0000043225764,0.0019857944],"genre_scores_gemma":[0.9971948,0.000014433075,0.00016866521,0.00010841478,0.000022026197,0.00005264722,0.0016728536,0.000013464864,0.0007526569],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99866575,0.00016622416,0.00029129384,0.00043784993,0.00012235108,0.00031651254],"domain_scores_gemma":[0.9993489,0.000057006047,0.00009825794,0.00030793317,0.0000949492,0.00009298032],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000064140586,0.00018418001,0.00045308654,0.00017893889,0.000023892355,0.0000058013175,0.00011757841,0.00009598401,0.00010448272],"category_scores_gemma":[0.00006146326,0.00015952105,0.00007378186,0.0005785154,0.000029333183,0.0000032454961,0.000051866456,0.0001319925,0.0000041062367],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023727365,0.00052734575,0.99319124,0.0000090267085,0.00011568036,0.00004313881,0.000015917149,0.00020471624,0.0007362488,0.000012097451,0.00029484145,0.0046124943],"study_design_scores_gemma":[0.003428912,0.00036773126,0.9749966,0.000012277202,0.000092976734,4.9064937e-7,0.000010685203,0.00022860346,0.00324817,0.0000022822944,0.017399933,0.00021128629],"about_ca_topic_score_codex":0.06332719,"about_ca_topic_score_gemma":0.96496755,"teacher_disagreement_score":0.90164036,"about_ca_system_score_codex":0.00021783281,"about_ca_system_score_gemma":0.00089818006,"threshold_uncertainty_score":0.9429102},"labels":[],"label_agreement":null},{"id":"W3212667942","doi":"10.21203/rs.3.rs-1041332/v1","title":"Phase I Pharmacokinetic Study of Single Agent Trametinib in Patients With Advanced Cancer and Hepatic Dysfunction","year":2021,"lang":"en","type":"preprint","venue":"Research Square","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Cancer Centre; University of Toronto; BC Cancer Agency; Princess Margaret Cancer Centre","funders":"National Cancer Institute; Genentech; Ipsen; Eisai; Bristol-Myers Squibb; Eli Lilly and Company; Symphogen; Exelixis; Iterion Therapeutics; Karyopharm Therapeutics; Celgene; Servier; Amgen","keywords":"Pharmacokinetics; Trametinib; Medicine; Cancer; Oncology; Hepatic dysfunction; Internal medicine; Pharmacology; Chemistry","score_opus":0.040257514435766105,"score_gpt":0.37023546769469734,"score_spread":0.32997795325893126,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3212667942","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966982,0.0013560348,0.000038303406,0.000014541954,0.0001231167,0.0016031159,0.00007559771,0.0000049511436,0.00008613062],"genre_scores_gemma":[0.9985957,0.0003900751,0.00007768155,0.0000075322255,0.000057904417,0.00038103043,0.00040077075,0.00002879137,0.00006047906],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99800545,0.0003364621,0.0002695645,0.0006045251,0.00048826844,0.00029575537],"domain_scores_gemma":[0.99893403,0.00002636701,0.000102956714,0.00041220832,0.00042278404,0.00010162471],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030856658,0.00018808497,0.00028719156,0.00015730169,0.000044866378,0.000031321313,0.00014017586,0.00014045564,0.00003442564],"category_scores_gemma":[0.00009834627,0.00016566616,0.000039271566,0.00018249569,0.00006842255,0.0000037243608,0.00040260714,0.00035548475,4.1684524e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004636427,0.02519252,0.37854668,0.0030768528,0.0004287973,0.00008013251,0.0026021271,0.0020482817,0.46188012,0.0000018150439,0.0001588951,0.12134736],"study_design_scores_gemma":[0.06217043,0.06415617,0.520926,0.00276707,0.00024513103,0.000003370846,0.007381807,0.00066055154,0.33851498,0.000027340406,0.0017808377,0.0013662991],"about_ca_topic_score_codex":0.0002659371,"about_ca_topic_score_gemma":0.00052477326,"teacher_disagreement_score":0.14237933,"about_ca_system_score_codex":0.000056028108,"about_ca_system_score_gemma":0.00018482072,"threshold_uncertainty_score":0.67556703},"labels":[],"label_agreement":null},{"id":"W3215111763","doi":"10.1016/j.ejca.2021.09.024","title":"KEYNOTE-022: Pembrolizumab with trametinib in patients with BRAF wild-type melanoma or advanced solid tumours irrespective of BRAF mutation","year":2021,"lang":"en","type":"article","venue":"European Journal of Cancer","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; McGill University; University of Toronto; Jewish General Hospital; McMaster University; Juravinski Cancer Centre","funders":"","keywords":"Trametinib; Pembrolizumab; Dosing; Medicine; Adverse effect; Internal medicine; Melanoma; Oncology; Immunotherapy; MAPK/ERK pathway; Cancer; Cancer research; Biology; Kinase","score_opus":0.00713408438545517,"score_gpt":0.24500162893397942,"score_spread":0.23786754454852424,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3215111763","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99704796,0.00072763534,0.0003569797,0.000068695656,0.0001705547,0.00011005432,0.000018741042,0.0000029165492,0.0014964343],"genre_scores_gemma":[0.998213,0.00011529211,0.0010886192,0.00009923812,0.0001463742,0.0000016221667,0.000022615894,0.000039794308,0.00027347333],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99871534,0.00023719211,0.0003751221,0.00021819123,0.0002691101,0.00018502137],"domain_scores_gemma":[0.99861264,0.000017270551,0.00045938508,0.00018221671,0.0006388084,0.00008969272],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018106551,0.00015866973,0.00026943345,0.0000736254,0.000029089804,0.000015737305,0.00015101366,0.000031783075,0.000058521186],"category_scores_gemma":[0.000109712324,0.00011068992,0.000058332203,0.00020063063,0.00006245159,0.000016918846,0.000033316006,0.0001609172,0.0000016997184],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.088814884,0.0017633785,0.38942814,0.00023253277,0.0012449251,0.0046261773,0.0034473948,0.015775008,0.38260326,0.000074708434,0.0013396649,0.11064994],"study_design_scores_gemma":[0.013357325,0.009827985,0.70784605,0.00037900647,0.00010598767,0.00022774548,0.00043208798,0.000010447813,0.2631801,0.000010784281,0.0042878417,0.000334649],"about_ca_topic_score_codex":0.000005513683,"about_ca_topic_score_gemma":0.00012882553,"teacher_disagreement_score":0.3184179,"about_ca_system_score_codex":0.000034456654,"about_ca_system_score_gemma":0.00041848436,"threshold_uncertainty_score":0.4513804},"labels":[],"label_agreement":null},{"id":"W3215169578","doi":"10.1101/2021.11.30.470372","title":"Replication Study: RAF inhibitors prime wild-type RAF to activate the MAPK pathway and enhance growth","year":2021,"lang":"en","type":"preprint","venue":"bioRxiv (Cold Spring Harbor Laboratory)","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Kinexus Bioinformatics Corporation (Canada); University of British Columbia","funders":"Medical Research Council; Genentech; University of Dundee","keywords":"MAPK/ERK pathway; Mutant; Gene knockdown; Replication (statistics); Biology; Wild type; V600E; Cancer research; Kinase; Molecular biology; Cell culture; Cell biology; Genetics; Gene; Virology","score_opus":0.010002097264704315,"score_gpt":0.2253415694101344,"score_spread":0.2153394721454301,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3215169578","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99528015,0.0011785865,0.0007115131,0.0003270897,0.0009218193,0.0014230182,0.000054465727,0.00008737795,0.000015997824],"genre_scores_gemma":[0.9971141,0.00030308732,0.0009016161,0.00040325502,0.00078596186,0.00034635921,0.0000038805465,0.00010770162,0.00003402109],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9967435,0.0002714391,0.0004693823,0.0017554901,0.00031129055,0.00044889533],"domain_scores_gemma":[0.99612266,0.000028882234,0.00033408336,0.0026738225,0.0005828639,0.00025768083],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00080991804,0.0005289407,0.00043833422,0.000097139615,0.00023013534,0.00023605402,0.0006007164,0.00048406585,0.00000868005],"category_scores_gemma":[0.00060065975,0.00047043583,0.00011251294,0.00036370932,0.00008608678,0.000013671134,0.001232654,0.000483872,0.000016705502],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007637066,0.00016675316,0.007277756,0.000086853106,0.00012978337,0.000018573988,0.000046374782,0.0000048954303,0.99172235,0.000042991363,0.00040789816,0.000019400717],"study_design_scores_gemma":[0.00028856305,0.00025588096,0.05855809,0.000108625085,0.000061192324,6.4503695e-8,0.00002239325,0.000006722895,0.9307868,9.616945e-7,0.009375585,0.0005351196],"about_ca_topic_score_codex":0.000058861955,"about_ca_topic_score_gemma":0.000011687548,"teacher_disagreement_score":0.06093555,"about_ca_system_score_codex":0.000068034555,"about_ca_system_score_gemma":0.0005294738,"threshold_uncertainty_score":0.99977475},"labels":[],"label_agreement":null},{"id":"W4200029899","doi":"10.3390/cancers13246388","title":"Insights of RKIP-Derived Suppression of Prostate Cancer","year":2021,"lang":"en","type":"review","venue":"Cancers","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Joseph’s Healthcare Hamilton; McMaster University; St. Joseph's Hospital","funders":"Canadian Institutes of Health Research","keywords":"Prostate cancer; Cancer research; Metastasis; MAPK/ERK pathway; Medicine; Metastasis suppressor; Cancer; Androgen deprivation therapy; Androgen receptor; Tumor progression; Signal transduction; Biology; Internal medicine; Cell biology","score_opus":0.028794948096742407,"score_gpt":0.30850954569623346,"score_spread":0.279714597599491,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200029899","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0034264007,0.99473274,0.000008622253,0.0000017666334,0.00051059655,0.00031172315,0.00024310955,0.000003276491,0.0007617449],"genre_scores_gemma":[0.0020563712,0.9964426,0.00005567084,0.00001296962,0.0001631779,0.00011913371,0.0005389013,0.00003317535,0.0005780117],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989468,0.00008215118,0.00037930388,0.00033508896,0.0001114849,0.00014521368],"domain_scores_gemma":[0.9990287,0.000009629613,0.00040113318,0.00037997952,0.00011965489,0.000060893686],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00003326402,0.00022143981,0.00087873207,0.000043948723,0.000020897574,0.0000036706335,0.00019116086,0.00027543312,0.000050477043],"category_scores_gemma":[0.000025409066,0.00017575656,0.00030579636,0.00011090031,0.000091208305,0.0000014517427,0.00011331437,0.00009632441,0.000001039204],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000045112698,0.000029112667,0.000015223184,0.029210128,0.00064670737,0.000017214226,0.00019088232,0.000050599494,0.13060577,0.0001143283,0.009039339,0.83003557],"study_design_scores_gemma":[0.00015380821,0.00008543835,0.0000015275969,0.0059544425,0.00018169825,0.0000027293552,0.000021696229,9.782858e-7,0.078458585,0.0000025009172,0.91496366,0.00017294475],"about_ca_topic_score_codex":0.0000828795,"about_ca_topic_score_gemma":0.00003939199,"teacher_disagreement_score":0.9059243,"about_ca_system_score_codex":0.000084994215,"about_ca_system_score_gemma":0.0020803837,"threshold_uncertainty_score":0.71671444},"labels":[],"label_agreement":null},{"id":"W4200303884","doi":"10.51731/cjht.2021.152","title":"Encorafenib (Braftovi)","year":2021,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Medicine; Cetuximab; Drug class; Drug; Family medicine; Business; Pharmacology; Economic growth; Internal medicine; Economics; Cancer; Health care","score_opus":0.01682635852450084,"score_gpt":0.24471893124743535,"score_spread":0.2278925727229345,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200303884","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.79715186,0.1771728,0.002177455,0.019531054,0.0011820329,0.00012784179,0.000040990493,0.000042198084,0.0025737556],"genre_scores_gemma":[0.9972534,0.00067780184,0.0011647472,0.00059316156,0.00003170672,0.0000016525,0.000010768117,0.000009428894,0.00025732533],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99916863,0.0000445492,0.00029510562,0.00012259305,0.00006720194,0.00030192846],"domain_scores_gemma":[0.9993083,0.0000065421264,0.00017661626,0.00025027507,0.00017318933,0.00008510401],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002398306,0.000083180086,0.00017367529,0.00012557129,0.00012004238,0.00002003737,0.00023544283,0.00014928171,0.000023003993],"category_scores_gemma":[0.00044709974,0.00007665499,0.00007040405,0.00012990918,0.00009042642,0.0000034685092,0.000028775523,0.00016805239,0.00000595892],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000022189146,0.000044117034,0.0130200805,0.0001302421,0.00011459841,0.0011467816,0.00017392576,0.000026847812,0.1201329,0.0046262015,0.07118103,0.7893811],"study_design_scores_gemma":[0.00023750812,0.000344821,0.0022435666,0.000042554395,0.000004299894,0.0007961147,0.0011144775,8.979077e-7,0.110140964,0.0013849573,0.8835803,0.000109522574],"about_ca_topic_score_codex":0.0002774116,"about_ca_topic_score_gemma":0.0029404312,"teacher_disagreement_score":0.81239927,"about_ca_system_score_codex":0.000045829176,"about_ca_system_score_gemma":0.0036975872,"threshold_uncertainty_score":0.65593606},"labels":[],"label_agreement":null},{"id":"W4205235372","doi":"10.1007/978-1-4419-0461-4_382","title":"RSK (p90 Ribosomal S6 Kinase)","year":2012,"lang":"en","type":"book-chapter","venue":"","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Institute for Research in Immunology and Cancer","funders":"","keywords":"Ribosomal s6 kinase; Biology; Cell biology; P70-S6 Kinase 1; Phosphorylation","score_opus":0.014844498128020349,"score_gpt":0.2108818129668865,"score_spread":0.19603731483886613,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205235372","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0015804459,0.0038281973,0.00034210787,0.00006756959,0.0005578122,0.00019636237,0.00008997361,0.00003418188,0.99330336],"genre_scores_gemma":[0.03011821,0.00057397305,0.0004913105,0.00060271827,0.0021598884,0.00001268483,0.0009034523,0.000088915134,0.96504885],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.9988495,0.0000106753005,0.00022723725,0.0004286621,0.00015449557,0.00032942405],"domain_scores_gemma":[0.9990519,0.000005732878,0.000102543854,0.00059629447,0.0000602437,0.00018328213],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00007927669,0.0003572778,0.00025461995,0.000045443845,0.000054966924,0.000016525582,0.00023085246,0.00071882806,0.0021783628],"category_scores_gemma":[0.00001027398,0.00031955758,0.00022910819,0.000006871801,0.00006979105,0.0000023748473,0.00020457729,0.00017227509,0.00090227067],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011791059,0.00009074372,0.00023920652,0.0001378541,0.00041148483,0.00008324522,0.000023531522,7.4379614e-7,0.37648338,0.41571358,0.17296647,0.03373184],"study_design_scores_gemma":[0.00021091186,0.00017603255,0.000039516875,0.000019104396,0.000049825045,0.000043628046,0.0000026798684,5.5064794e-7,0.039075255,0.00071137457,0.9592444,0.000426729],"about_ca_topic_score_codex":0.000006204278,"about_ca_topic_score_gemma":0.000021551656,"teacher_disagreement_score":0.7862779,"about_ca_system_score_codex":0.0000125955885,"about_ca_system_score_gemma":0.00007508993,"threshold_uncertainty_score":0.9999257},"labels":[],"label_agreement":null},{"id":"W4205496667","doi":"10.1200/po.21.00303","title":"Sustained Response to the Mitogen-Activated Extracellular Kinase Inhibitor Trametinib in a Spindle Cell Sarcoma Harboring a QKI-RAF1 Gene Fusion","year":2022,"lang":"en","type":"article","venue":"JCO Precision Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Trametinib; Fusion gene; Kinase; Extracellular; Fusion protein; Sarcoma; Cell culture; Gene","score_opus":0.014707803517898384,"score_gpt":0.26693388961498593,"score_spread":0.2522260860970875,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205496667","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99422324,0.0008959098,0.0007061746,0.0015068582,0.0010727132,0.0010684199,0.000049250288,0.000027427477,0.00045000185],"genre_scores_gemma":[0.9945373,0.00004168645,0.0012602533,0.00052518374,0.00025589156,0.00043225416,0.00009242726,0.000047152316,0.002807833],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9964053,0.0014616138,0.0005336353,0.00072615733,0.00032697464,0.0005463209],"domain_scores_gemma":[0.998565,0.00022532609,0.00017768712,0.00075099355,0.0000929134,0.00018805703],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019393753,0.00026459433,0.0003251995,0.00024318247,0.0003336458,0.000028061062,0.00056211685,0.00026054282,0.00023255669],"category_scores_gemma":[0.0005489,0.00022708689,0.00014637531,0.00046425566,0.000048422393,0.0000065665495,0.0012012412,0.00042051513,0.000034710316],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008406561,0.00048195792,0.00016271757,0.000008092329,0.000011520253,0.00023056888,0.0006742311,0.00049315963,0.96934456,0.000011733308,0.004161244,0.016013663],"study_design_scores_gemma":[0.0018691053,0.002648375,0.00090162276,0.0000064436263,0.000008925722,0.000048445454,0.0007930647,0.000110667956,0.56366134,0.000025253563,0.42972568,0.00020111936],"about_ca_topic_score_codex":0.000054791468,"about_ca_topic_score_gemma":0.00006139142,"teacher_disagreement_score":0.4255644,"about_ca_system_score_codex":0.00025345964,"about_ca_system_score_gemma":0.00045746355,"threshold_uncertainty_score":0.92603344},"labels":[],"label_agreement":null},{"id":"W4206568596","doi":"10.1038/s12276-021-00721-9","title":"FBXW7-mediated ERK3 degradation regulates the proliferation of lung cancer cells","year":2022,"lang":"en","type":"article","venue":"Experimental & Molecular Medicine","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Korea Basic Science Institute; Sidney Kimmel Comprehensive Cancer Center; Ministry of Education; Ministry of Science, ICT and Future Planning; School of Medicine, New York University; Catholic University of Korea; York University; Johns Hopkins University","keywords":"Ubiquitin ligase; Ubiquitin; Cell biology; Cullin; F-box protein; Protein kinase A; MAPK/ERK pathway; Kinase; Cancer research; Cell cycle; Biology; Chemistry; Cell; Biochemistry","score_opus":0.007396185953717162,"score_gpt":0.26628059258692216,"score_spread":0.258884406633205,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4206568596","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9876569,0.009957416,0.00037085946,0.0005621117,0.00039918703,0.00043784277,0.000024847492,0.000011379703,0.0005794839],"genre_scores_gemma":[0.9978246,0.000058479232,0.00008178608,0.0007176865,0.00016190493,0.00024661777,0.0005151429,0.000021522574,0.00037225118],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99891794,0.00013405655,0.00023412488,0.0002448713,0.00031333996,0.00015564174],"domain_scores_gemma":[0.9994762,0.0000091153515,0.00012917242,0.00029104666,0.00004312539,0.000051361345],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018456733,0.00013403282,0.0001408393,0.000039012702,0.00014705781,0.0000046688983,0.00018383893,0.000044377255,0.00031316144],"category_scores_gemma":[0.000021776239,0.00010017811,0.00005582693,0.00012488708,0.00010469145,0.0000032879914,0.00013017804,0.000086875545,0.0000011793478],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007551119,0.00006798899,0.00026939032,0.000010688169,0.000049586804,0.00000577758,0.00042659236,0.00012576659,0.99438536,0.00019002458,0.0042360746,0.00015722796],"study_design_scores_gemma":[0.0007404877,0.0005652083,0.0002770373,0.000011671919,0.000028142289,0.000011800321,0.0006329084,0.0003912601,0.99003464,0.000009137296,0.007192873,0.00010485441],"about_ca_topic_score_codex":0.000086517,"about_ca_topic_score_gemma":0.0000045850074,"teacher_disagreement_score":0.010167737,"about_ca_system_score_codex":0.00003681521,"about_ca_system_score_gemma":0.000063023144,"threshold_uncertainty_score":0.4085145},"labels":[],"label_agreement":null},{"id":"W4206618846","doi":"10.1016/j.celrep.2021.110223","title":"Fine-tuning of MEK signaling is pivotal for limiting B and T cell activation","year":2022,"lang":"en","type":"article","venue":"Cell Reports","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Hôtel-Dieu de Québec","funders":"Canadian Institutes of Health Research; Agence Nationale de la Recherche","keywords":"MAPK/ERK pathway; Cell biology; Biology; T cell; Cell growth; Immune system; Mutant; Signal transduction; Cancer research; Genetics; Gene","score_opus":0.013544772937852494,"score_gpt":0.21663507103853014,"score_spread":0.20309029810067764,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4206618846","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99491453,0.00023239339,0.0016220673,0.000019882338,0.0000996306,0.00014010334,0.000010281064,0.0000049787786,0.0029561264],"genre_scores_gemma":[0.99788177,0.000004536904,0.00092793006,0.000055790515,0.00007755395,0.000026896652,0.0000923521,0.00001324402,0.0009199335],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99938965,0.000016237262,0.00019191806,0.000212306,0.00008140325,0.00010849958],"domain_scores_gemma":[0.99956137,0.000017954619,0.00021467524,0.00013781313,0.00003785013,0.000030358797],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019765778,0.00006767935,0.000085326064,0.000023749615,0.000115095194,0.000006504245,0.000032316748,0.000037017602,0.000026207686],"category_scores_gemma":[0.000036031834,0.000074318436,0.00004856736,0.000030954565,0.00001242862,0.0000022142297,0.00008678887,0.00004445433,8.136145e-8],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000018552659,0.000024573423,0.0013618203,0.000058846337,0.000005843666,0.00001028627,0.00014931968,0.00011480535,0.9969133,0.000006138071,0.0004944469,0.0008420765],"study_design_scores_gemma":[0.00016468266,0.00021577605,0.0001135726,0.000005030628,0.000011489324,0.000033242406,0.00019167658,0.00013351161,0.9845529,0.000051912102,0.01444186,0.00008430409],"about_ca_topic_score_codex":0.000006518311,"about_ca_topic_score_gemma":6.008106e-7,"teacher_disagreement_score":0.013947413,"about_ca_system_score_codex":0.0000057231646,"about_ca_system_score_gemma":0.000045035773,"threshold_uncertainty_score":0.3030618},"labels":[],"label_agreement":null},{"id":"W4210357560","doi":"10.5742/mewfm.2021.94167","title":"Malignant Melanoma","year":2021,"lang":"en","type":"article","venue":"World Family Medicine Journal /Middle East Journal of Family Medicine","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Grand Challenges Canada; King Saud University","keywords":"Melanoma; Medicine; Dermatology; Cancer research","score_opus":0.07280346032310021,"score_gpt":0.2858853146514904,"score_spread":0.21308185432839022,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4210357560","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7908541,0.12410496,0.008705278,0.008893059,0.011784849,0.0002576988,0.000018162133,0.000024523228,0.055357356],"genre_scores_gemma":[0.9341504,0.010586482,0.0022787969,0.008421414,0.023711411,0.000005772371,0.00007531438,0.00014383392,0.020626599],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9941645,0.0005247039,0.002348625,0.000504308,0.0016306753,0.0008271435],"domain_scores_gemma":[0.99449927,0.00012972638,0.0016394834,0.0007035256,0.0018562134,0.0011717775],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002870832,0.0006231142,0.0014104359,0.00073926523,0.00029009665,0.000040943276,0.00084654207,0.00024246912,0.0006031572],"category_scores_gemma":[0.0012925261,0.00042556843,0.00044845304,0.00085474155,0.00054606324,0.00003807698,0.00018023979,0.0012761024,0.000028321509],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005676361,0.00019480256,0.003894046,0.000083122075,0.0004850391,0.0028420503,0.00054050254,0.000039604707,0.77971923,0.00031598206,0.20357706,0.0077409474],"study_design_scores_gemma":[0.013752,0.0074358275,0.034375876,0.0044957576,0.0008360929,0.029182872,0.012097149,0.000030826483,0.015161577,0.00092576415,0.8808465,0.0008597522],"about_ca_topic_score_codex":0.000019845213,"about_ca_topic_score_gemma":0.00003336998,"teacher_disagreement_score":0.76455766,"about_ca_system_score_codex":0.00010964826,"about_ca_system_score_gemma":0.0009138845,"threshold_uncertainty_score":0.99981964},"labels":[],"label_agreement":null},{"id":"W4210750855","doi":"10.1016/j.annonc.2022.01.076","title":"Biomarkers of treatment benefit with atezolizumab plus vemurafenib plus cobimetinib in BRAFV600 mutation–positive melanoma","year":2022,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada)","funders":"Roche","keywords":"Atezolizumab; Medicine; Vemurafenib; Internal medicine; Hazard ratio; Oncology; Confidence interval; Cancer; Pembrolizumab; Immunotherapy; Metastatic melanoma","score_opus":0.03356083637505654,"score_gpt":0.30657651588933427,"score_spread":0.27301567951427774,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4210750855","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9892612,0.0007600511,0.000043041815,0.0003830972,0.000096864154,0.00037282513,0.00023245906,0.000005751712,0.00884472],"genre_scores_gemma":[0.99832386,0.00014970308,0.00031593317,0.00020705647,0.000035667177,0.00011975741,0.000406395,0.00001933088,0.0004222887],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987359,0.00017162829,0.0003677133,0.00032684044,0.0001305328,0.00026739817],"domain_scores_gemma":[0.9992034,0.00006151409,0.0002885934,0.0002582224,0.00012196148,0.000066350774],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020140517,0.00017114157,0.00040818148,0.00014145015,0.00006290662,0.000002832984,0.00018111976,0.00011602033,0.00008973111],"category_scores_gemma":[0.000021889431,0.00015455749,0.00010692673,0.00018933101,0.00013820153,0.0000035312735,0.00011599857,0.000069318514,0.0000024081842],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03783767,0.0034021405,0.017199855,0.00021587005,0.0036454264,0.0013452718,0.007791847,0.021618754,0.6869654,0.0066035255,0.0057474826,0.20762676],"study_design_scores_gemma":[0.014255329,0.07471192,0.027312618,0.000043280197,0.00012848561,0.00046904283,0.0023429685,0.00036763243,0.8221746,0.0004319502,0.0571553,0.0006068733],"about_ca_topic_score_codex":0.0005148377,"about_ca_topic_score_gemma":0.0004495404,"teacher_disagreement_score":0.2070199,"about_ca_system_score_codex":0.000104843915,"about_ca_system_score_gemma":0.0006288007,"threshold_uncertainty_score":0.63026714},"labels":[],"label_agreement":null},{"id":"W4211049750","doi":"10.1007/978-3-319-48066-4_4","title":"Melanoma—Treatment","year":2016,"lang":"en","type":"book-chapter","venue":"","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Melanoma; Dabrafenib; Vemurafenib; Trametinib; Sentinel lymph node; Adjuvant therapy; Oncology; Radiation therapy; Immunotherapy; Sentinel node; Internal medicine; Adjuvant; Stage (stratigraphy); Ipilimumab; Cancer; Dermatology; Surgery; Metastatic melanoma; Breast cancer; Cancer research","score_opus":0.015611525560762991,"score_gpt":0.21833499398967784,"score_spread":0.20272346842891487,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4211049750","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00026285718,0.0009629177,0.00027147896,0.00008104297,0.00027303546,0.00017445355,0.00010122963,0.00002314689,0.9978498],"genre_scores_gemma":[0.004975019,0.0008983208,0.00017962995,0.00016077179,0.000906443,0.000014579576,0.00022945866,0.000057044686,0.99257874],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.9991591,0.0000057205884,0.00015847053,0.00040875602,0.000087149034,0.00018080836],"domain_scores_gemma":[0.99926096,0.000005391964,0.000072445306,0.00052491867,0.000038139933,0.00009814054],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0000290182,0.000296596,0.00020648002,0.000033857163,0.000034852914,0.000009581351,0.00013005262,0.00041688696,0.0015964223],"category_scores_gemma":[0.000003986383,0.00019306305,0.00019347908,0.0000026680893,0.00004652144,5.7355106e-7,0.000078015335,0.000038091275,0.0010519513],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012658913,0.00005744654,0.00008154978,0.000033479486,0.0007799335,0.000104211074,0.00001523379,2.0653545e-7,0.17917089,0.6188894,0.08123459,0.119506486],"study_design_scores_gemma":[0.0003087715,0.00061077095,0.000005340207,0.000018922528,0.00003176199,0.000023348795,7.430724e-7,1.1448433e-7,0.03649639,0.0024207563,0.95980394,0.00027916164],"about_ca_topic_score_codex":0.0000030426272,"about_ca_topic_score_gemma":0.00002960843,"teacher_disagreement_score":0.8785693,"about_ca_system_score_codex":0.000026801192,"about_ca_system_score_gemma":0.00009281145,"threshold_uncertainty_score":0.9997258},"labels":[],"label_agreement":null},{"id":"W4211123988","doi":"10.1016/s0140-6736(13)60802-8","title":"Cutaneous melanoma","year":2013,"lang":"en","type":"review","venue":"The Lancet","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":532,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Melanoma; Medicine; Immunotherapy; Oncology; Targeted therapy; Lymph node; Sentinel lymph node; Immunology; Cancer research; Internal medicine; Cancer","score_opus":0.053280273530099134,"score_gpt":0.30253506249533585,"score_spread":0.24925478896523673,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4211123988","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007283627,0.9829134,0.000018712211,0.00005717116,0.000319566,0.00041531617,0.000082588995,0.000020550067,0.016099887],"genre_scores_gemma":[0.00003038306,0.98783493,0.00010350681,0.00019490389,0.0035374246,0.000119508535,0.000342411,0.000044414763,0.0077925157],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990307,0.00012684756,0.0002164859,0.00023918152,0.00008770804,0.00029903962],"domain_scores_gemma":[0.9987064,0.000023780503,0.00014211122,0.0010536644,0.00002140173,0.00005262374],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00011044818,0.00026647176,0.00086870196,0.000018079381,0.0000631552,0.0000391221,0.0007363395,0.00027561325,0.000116168194],"category_scores_gemma":[0.00003966643,0.00014709626,0.00025334232,0.000050281407,0.000052820084,6.94393e-7,0.00018807128,0.00019532628,0.00082895014],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000005401413,0.000010918486,0.0000025696406,0.001674095,0.00014289808,0.000013397157,0.000014925805,1.2477854e-7,0.00012945241,0.0002790211,0.12494849,0.8727787],"study_design_scores_gemma":[0.00008087237,0.00007735732,5.3605646e-7,0.00036637264,0.0001294923,0.00046937447,0.0000033890376,3.5179553e-7,0.00006462286,0.00005145637,0.9985573,0.00019886903],"about_ca_topic_score_codex":0.000008301818,"about_ca_topic_score_gemma":0.0000046884898,"teacher_disagreement_score":0.8736088,"about_ca_system_score_codex":0.00001223646,"about_ca_system_score_gemma":0.00014099595,"threshold_uncertainty_score":0.99994904},"labels":[],"label_agreement":null},{"id":"W4211260689","doi":"10.3390/molecules27041172","title":"3, 3′- (3, 5-DCPBC) Down-Regulates Multiple Phosphokinase Dependent Signal Transduction Pathways in Malignant Melanoma Cells through Specific Diminution of EGFRY1086 Phosphorylation","year":2022,"lang":"en","type":"article","venue":"Molecules","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Universität Ulm; International Union of Biochemistry and Molecular Biology; University of Karachi","keywords":"Phosphorylation; Cancer research; Melanoma; Signal transduction; Proto-oncogene tyrosine-protein kinase Src; Kinase; Tyrosine kinase; Receptor tyrosine kinase; Tyrosine phosphorylation; Cell growth; Epidermal growth factor receptor; Cell biology; Biology; Chemistry; Receptor; Biochemistry","score_opus":0.013840483644331568,"score_gpt":0.2007239063609254,"score_spread":0.18688342271659383,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4211260689","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9898726,0.002106531,0.0066850707,0.000036219553,0.00035710406,0.00043454583,0.00017066469,0.000021778958,0.00031553296],"genre_scores_gemma":[0.9977214,0.0002238849,0.0010140871,0.000043569282,0.00008263918,0.00011708976,0.0006422839,0.000036876063,0.00011821468],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998113,0.000177252,0.00047298498,0.0005616816,0.00034146992,0.00033365423],"domain_scores_gemma":[0.9992876,0.0000191527,0.00019869997,0.00037536892,0.00005926775,0.00005990826],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00026451994,0.00025411084,0.00025314765,0.00009279246,0.00015907154,0.000017234608,0.0002364229,0.00013657434,0.0002720464],"category_scores_gemma":[0.000010890568,0.00026959917,0.00015881064,0.00019432639,0.00007392656,0.000013253451,0.0001286176,0.00015571002,0.0000075746075],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000422082,0.00031940342,0.0014775943,0.000028354885,0.000027479286,0.00003850841,0.0005701628,0.0055156923,0.9884897,0.0004333403,0.00030239127,0.0023752798],"study_design_scores_gemma":[0.0012420939,0.00062257954,0.0027866785,0.000016304159,0.000018872639,0.000027916998,0.00058832014,0.0005779859,0.9875388,0.00037858597,0.0058991746,0.00030268388],"about_ca_topic_score_codex":0.00021072947,"about_ca_topic_score_gemma":0.0000925407,"teacher_disagreement_score":0.007848803,"about_ca_system_score_codex":0.00007639589,"about_ca_system_score_gemma":0.00007344994,"threshold_uncertainty_score":0.9999756},"labels":[],"label_agreement":null},{"id":"W4214507203","doi":"10.3390/curroncol29030126","title":"Real-World Evidence of Systemic Therapy Sequencing on Overall Survival for Patients with Metastatic BRAF-Mutated Cutaneous Melanoma","year":2022,"lang":"en","type":"article","venue":"Current Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Western University; Queen's University","funders":"","keywords":"Metastatic melanoma; Medicine; Systemic therapy; Melanoma; Overall survival; Oncology; Targeted therapy; Vemurafenib; Cancer research; Internal medicine; Bioinformatics; Cancer; Biology","score_opus":0.08902090121553219,"score_gpt":0.3500544874061776,"score_spread":0.26103358619064543,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4214507203","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965646,0.000875939,0.00029188328,0.000033577955,0.0009238972,0.00088564923,0.00013492924,0.000015753527,0.00027371733],"genre_scores_gemma":[0.99863803,0.00030343447,0.00019406743,0.000054738557,0.00008814388,0.00025439725,0.00032151185,0.000029749572,0.00011593847],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998402,0.000328572,0.00034428565,0.00041056436,0.00022573034,0.00028886882],"domain_scores_gemma":[0.99894226,0.0001826874,0.00031694767,0.00031794448,0.00016996247,0.00007020367],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026499515,0.00019399694,0.00036281292,0.00009198401,0.00011871815,0.0000066060743,0.00025305065,0.0000442594,0.0000366085],"category_scores_gemma":[0.00006993877,0.00016298548,0.000097642136,0.00011426858,0.000047817928,0.0000043716564,0.00009581752,0.00013738732,0.0000020869682],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017824544,0.003550852,0.09265401,0.0010170395,0.0008702094,0.00012274222,0.0013869174,0.0037158718,0.8267767,0.0023944646,0.0037587257,0.045927912],"study_design_scores_gemma":[0.056577004,0.27742618,0.025858006,0.0020299875,0.0011540699,0.001107375,0.0027065545,0.002771945,0.39557153,0.0014796075,0.22842935,0.004888382],"about_ca_topic_score_codex":0.000045231867,"about_ca_topic_score_gemma":0.0000653316,"teacher_disagreement_score":0.43120515,"about_ca_system_score_codex":0.00020978958,"about_ca_system_score_gemma":0.00046218737,"threshold_uncertainty_score":0.66463554},"labels":[],"label_agreement":null},{"id":"W4214602468","doi":"10.1002/hep.26804","title":"NASH: Diagnosis and Treatment","year":2013,"lang":"en","type":"article","venue":"Hepatology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Assistance publique-Hôpitaux de Paris; Universitat de Barcelona; National Institute for Health and Care Research; Università degli Studi di Milano; University of Alberta; University of Texas Southwestern Medical Center; Università degli Studi di Padova; Arizona State University","keywords":"Medicine; Intensive care medicine; Computer science","score_opus":0.015932113447580297,"score_gpt":0.22817976251818992,"score_spread":0.2122476490706096,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4214602468","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99522614,0.0009003936,0.000044681627,0.0003917378,0.00010681494,0.00014374462,0.000004723518,0.000010110473,0.003171634],"genre_scores_gemma":[0.99732167,0.00091699226,0.00028262564,0.00038461725,0.00008856152,0.0002190425,0.000031615808,0.000008446682,0.00074645865],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99951905,0.0000297596,0.000078306,0.0001960778,0.000022122917,0.00015470579],"domain_scores_gemma":[0.9997207,0.000010240597,0.000020762385,0.00016310526,0.000018914925,0.00006629442],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000017249104,0.000086765394,0.000102342616,0.000017481114,0.00003666093,0.000008144799,0.00004268591,0.000103061044,0.00014860881],"category_scores_gemma":[0.000015836746,0.00007036041,0.000029301276,0.000016673572,0.000050064198,0.0000013458184,0.000040029397,0.000018863597,0.00011005656],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000014223289,0.00009381169,0.8165027,0.0000076155875,0.000057098816,0.000014320195,0.00005928542,1.8070513e-7,0.11773323,0.00093614415,0.016271459,0.04830997],"study_design_scores_gemma":[0.0009308221,0.0014408892,0.03987562,0.0000035434755,0.000025160323,0.00017639433,0.000052778923,0.0001013072,0.25858903,0.000512617,0.69801366,0.00027819624],"about_ca_topic_score_codex":0.00018332258,"about_ca_topic_score_gemma":0.00011059329,"teacher_disagreement_score":0.77662706,"about_ca_system_score_codex":0.000005648627,"about_ca_system_score_gemma":0.000019239891,"threshold_uncertainty_score":0.2869214},"labels":[],"label_agreement":null},{"id":"W4220865860","doi":"10.1200/op.21.00810","title":"Turnaround Times in Melanoma BRAF Testing and the Impact on the Initiation of Systemic Therapy at a Single Tertiary Care Cancer Center","year":2022,"lang":"en","type":"article","venue":"JCO Oncology Practice","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Melanoma; Internal medicine; Cancer; Oncology; Biopsy; Retrospective cohort study; Disease; Cancer research","score_opus":0.025367693740765477,"score_gpt":0.3065768639556606,"score_spread":0.2812091702148951,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220865860","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9892628,0.0028883533,0.0000027813,0.0017180323,0.00013923453,0.00039806726,0.000035317746,0.0000043933874,0.0055509843],"genre_scores_gemma":[0.99773645,0.00024469523,0.000034435132,0.0016202199,0.000099186254,0.0001525446,0.000024145307,0.000011890909,0.00007644458],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984167,0.0009610477,0.00019176237,0.00018651804,0.000101617334,0.00014235242],"domain_scores_gemma":[0.9983329,0.0010664924,0.0002947585,0.0002157679,0.00006925626,0.00002081321],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00058489724,0.000105851796,0.0001466693,0.000030482577,0.00018378285,0.0000125247125,0.0001509925,0.00007479422,0.00004366183],"category_scores_gemma":[0.0005122458,0.00005979677,0.000045869852,0.00007889503,0.00008592567,0.000009148395,0.00016799994,0.00019426773,0.0000012912458],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0051566926,0.00057550246,0.13547072,0.000045387907,0.00028462044,0.00006483613,0.0075062662,0.00077016227,0.8322445,0.0002203424,0.002438406,0.015222573],"study_design_scores_gemma":[0.0461976,0.027394619,0.27325457,0.00042525493,0.00055175513,0.008614168,0.061217245,0.0026071444,0.34852886,0.0006414096,0.22866623,0.0019011328],"about_ca_topic_score_codex":0.0004309632,"about_ca_topic_score_gemma":0.00007579568,"teacher_disagreement_score":0.48371562,"about_ca_system_score_codex":0.00015835502,"about_ca_system_score_gemma":0.0001542308,"threshold_uncertainty_score":0.24384415},"labels":[],"label_agreement":null},{"id":"W4221120669","doi":"10.1111/jcmm.17260","title":"Novel chloroquine derivative suppresses melanoma cell growth by DNA damage through increasing ROS levels","year":2022,"lang":"en","type":"article","venue":"Journal of Cellular and Molecular Medicine","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health","funders":"Project 211; National Natural Science Foundation of China","keywords":"Melanoma; Apoptosis; Cancer research; Chloroquine; DNA damage; Flow cytometry; Cell growth; Mutant; Chemistry; Biology; Molecular biology; Immunology; DNA; Biochemistry; Gene","score_opus":0.011514993698753037,"score_gpt":0.2278742348919947,"score_spread":0.21635924119324168,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4221120669","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9426102,0.009941186,0.04481973,0.00069597026,0.00029414473,0.00015851953,0.00006240095,0.000005875811,0.0014119713],"genre_scores_gemma":[0.9966706,0.00024131888,0.001217037,0.0011582763,0.00032193647,0.0000074420986,0.00014774768,0.000042920037,0.00019270713],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982031,0.00020651927,0.0005156145,0.0002991194,0.00047983893,0.0002957847],"domain_scores_gemma":[0.9988975,0.000041282852,0.00042681766,0.0002552362,0.00019119335,0.0001879815],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00065127556,0.00026347445,0.00042676006,0.00009139124,0.00019448291,0.000014246431,0.00031563998,0.00009716586,0.00012107786],"category_scores_gemma":[0.00019784641,0.00022283566,0.00012544701,0.00014485305,0.00016001506,0.000016605147,0.00025769506,0.00030960585,5.053494e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022605107,0.0001513434,0.00030529036,0.000051931787,0.000108591674,0.00023143388,0.00035051527,0.000011632682,0.9959279,0.00023207277,0.0023147347,0.00008855584],"study_design_scores_gemma":[0.0027942674,0.0023956976,0.0005263397,0.000036060803,0.00013164773,0.0007038247,0.0005656913,0.000013284596,0.95971286,0.00019175306,0.032687735,0.0002408069],"about_ca_topic_score_codex":0.00007034648,"about_ca_topic_score_gemma":0.0000012511791,"teacher_disagreement_score":0.054060414,"about_ca_system_score_codex":0.00002427762,"about_ca_system_score_gemma":0.000109868764,"threshold_uncertainty_score":0.9086974},"labels":[],"label_agreement":null},{"id":"W4223492952","doi":"10.1016/j.celrep.2022.110634","title":"Melanomas with concurrent BRAF non-p.V600 and NF1 loss-of-function mutations are targetable by BRAF/MEK inhibitor combination therapy","year":2022,"lang":"en","type":"article","venue":"Cell Reports","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; McGill University Health Centre; Sunnybrook Health Science Centre; Health Sciences Centre; University of British Columbia; McGill University","funders":"Canadian Institutes of Health Research","keywords":"Neuroblastoma RAS viral oncogene homolog; Melanoma; Mutant; Cancer research; MEK inhibitor; Mutation; Combination therapy; Trametinib; Context (archaeology); In vivo; Targeted therapy; Medicine; MAPK/ERK pathway; Biology; Kinase; Cancer; KRAS; Pharmacology; Genetics; Internal medicine; Gene","score_opus":0.006085928717589404,"score_gpt":0.20014177039258874,"score_spread":0.19405584167499934,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4223492952","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99507135,0.0016982392,0.0009757598,0.00003579982,0.00042044892,0.00032002898,0.00003855978,0.00001214966,0.0014276557],"genre_scores_gemma":[0.9970754,0.000082593506,0.00005847457,0.000067856905,0.00005286341,0.000087066874,0.0009941838,0.000020809135,0.001560799],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990353,0.00004505237,0.0002501645,0.00033880278,0.00018408486,0.00014661367],"domain_scores_gemma":[0.9992722,0.000009488283,0.0003300232,0.00023195968,0.00009085508,0.00006546494],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015193695,0.00013206044,0.00014820392,0.000039414408,0.00018286158,0.00001707057,0.000047677677,0.00005935376,0.000072574854],"category_scores_gemma":[0.000011361236,0.00012262959,0.00004247222,0.000088247485,0.000059836475,0.000008012449,0.000059669797,0.000087052715,8.64095e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000104575825,0.00045946226,0.040170994,0.000051126957,0.00006054551,0.000093767405,0.00017013025,0.00012791136,0.9488653,0.000049951163,0.008148682,0.0016975622],"study_design_scores_gemma":[0.0013988042,0.0017415972,0.0063497405,0.000011035433,0.000037035832,0.00023367557,0.00032354935,0.00005782412,0.8761578,0.00014426665,0.11327151,0.00027314774],"about_ca_topic_score_codex":0.000033640532,"about_ca_topic_score_gemma":0.0000077977365,"teacher_disagreement_score":0.10512283,"about_ca_system_score_codex":0.00001580375,"about_ca_system_score_gemma":0.00009473021,"threshold_uncertainty_score":0.50006896},"labels":[],"label_agreement":null},{"id":"W4225272646","doi":"10.1101/2022.04.29.490009","title":"MEK inhibitor resistance in lung cancer cells associated with addiction to sustained ERK suppression","year":2022,"lang":"en","type":"preprint","venue":"bioRxiv (Cold Spring Harbor Laboratory)","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Canadian Institutes of Health Research; BC Cancer Foundation; Loxo Oncology; Japanese Respiratory Society; Michael Smith Health Research BC; Memorial Sloan-Kettering Cancer Center; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Trametinib; KRAS; MAPK/ERK pathway; MEK inhibitor; Cancer research; Mutant; Drug resistance; Mutation; Biology; Medicine; Kinase; Gene; Cell biology; Genetics","score_opus":0.0060579338931166056,"score_gpt":0.21419827142526218,"score_spread":0.2081403375321456,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4225272646","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9935952,0.0025554178,0.00034303244,0.00015810718,0.001210324,0.0010905233,0.00091097254,0.00009783986,0.000038598773],"genre_scores_gemma":[0.9969693,0.00021212896,0.000948032,0.0001757607,0.0004189052,0.00096751074,0.00001289027,0.00013245172,0.00016304254],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9971863,0.00024537984,0.00042987915,0.0011563931,0.00039464294,0.0005874132],"domain_scores_gemma":[0.9981487,0.000023189137,0.0003377294,0.000930147,0.00032187585,0.00023840566],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00046271997,0.00048196092,0.00043567276,0.00022014309,0.0001686113,0.0000795469,0.0004360391,0.0005091648,0.00009530191],"category_scores_gemma":[0.000174497,0.00050215895,0.00009791745,0.00047976166,0.00004642885,0.000009810411,0.0006425945,0.0005778882,0.000003222432],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035739795,0.00013262584,0.006867773,0.00017230718,0.00013242224,0.000073282186,0.000019501442,0.00050924,0.98332614,0.000039426053,0.008369311,5.9133055e-7],"study_design_scores_gemma":[0.0011139436,0.00018870315,0.04600415,0.000675922,0.000102613,5.801525e-9,0.000011842881,0.000084070474,0.92420405,4.821216e-7,0.026718784,0.0008954236],"about_ca_topic_score_codex":0.000081132916,"about_ca_topic_score_gemma":0.00021336197,"teacher_disagreement_score":0.05912206,"about_ca_system_score_codex":0.00049576466,"about_ca_system_score_gemma":0.0008712728,"threshold_uncertainty_score":0.999743},"labels":[],"label_agreement":null},{"id":"W4225315024","doi":"10.2217/mmt-2021-0005","title":"Improved Overall Survival in Dual Compared to Single Immune Checkpoint Inhibitors in <i>BRAF</i> V600-Negative Advanced Melanoma","year":2022,"lang":"en","type":"article","venue":"Melanoma Management","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Kingston Health Sciences Centre; Queen's University","funders":"","keywords":"Melanoma; Medicine; Hazard ratio; Retrospective cohort study; Adverse effect; Internal medicine; Oncology; Immune system; Immune checkpoint; Gastroenterology; Immunotherapy; Cancer; Cancer research; Immunology; Confidence interval","score_opus":0.010721805563873874,"score_gpt":0.22081334006982017,"score_spread":0.2100915345059463,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4225315024","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98517704,0.00025923862,0.00017607106,0.00033053698,0.00087679725,0.0012710766,0.000059510716,0.000032322518,0.011817378],"genre_scores_gemma":[0.9955576,0.000017314776,0.0011859477,0.00032264023,0.00012368275,0.0006081778,0.00026071793,0.000052421754,0.0018714685],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.997233,0.0002457496,0.0007037952,0.0008332241,0.00033900517,0.00064523454],"domain_scores_gemma":[0.9990215,0.000022217326,0.00016810234,0.0006232439,0.000033456137,0.00013149528],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00057025754,0.0003595214,0.00042815914,0.00028874967,0.00012775404,0.000040457297,0.00036518727,0.00008261473,0.00009901414],"category_scores_gemma":[0.000038633847,0.00040537096,0.00014464419,0.00040209453,0.000039969425,0.000013644692,0.0012711739,0.00023734821,0.000020285419],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014837742,0.0012204421,0.0065393727,0.00009028962,0.00014221635,0.00054192304,0.0008996504,0.0033610186,0.9771079,0.0006485683,0.0008746769,0.0070902146],"study_design_scores_gemma":[0.018690325,0.0051499675,0.12103426,0.0001248468,0.0000618557,0.000061318395,0.0065492103,0.0007555689,0.689988,0.0005593698,0.15471238,0.0023128903],"about_ca_topic_score_codex":0.00036261627,"about_ca_topic_score_gemma":0.0008534822,"teacher_disagreement_score":0.28711984,"about_ca_system_score_codex":0.0002559405,"about_ca_system_score_gemma":0.000043269818,"threshold_uncertainty_score":0.99983984},"labels":[],"label_agreement":null},{"id":"W4225533145","doi":"10.1186/s13046-021-02236-7","title":"Phase I pharmacokinetic study of single agent trametinib in patients with advanced cancer and hepatic dysfunction","year":2022,"lang":"en","type":"article","venue":"Journal of Experimental & Clinical Cancer Research","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Cancer Centre; Princess Margaret Cancer Centre; University of Toronto","funders":"National Cancer Institute","keywords":"Pharmacokinetics; Medicine; Trametinib; Oncology; Internal medicine; Cancer; Pharmacology; Chemistry; MAPK/ERK pathway; Signal transduction","score_opus":0.10032305673022786,"score_gpt":0.47567527607257537,"score_spread":0.3753522193423475,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4225533145","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99640316,0.0027091398,0.0000033100357,0.000037751677,0.00029761204,0.000484352,0.000019864032,0.0000010607148,0.000043761494],"genre_scores_gemma":[0.999371,0.00024137009,0.00004078756,0.000048774767,0.0001223411,0.00011373431,0.0000061502915,0.000015952708,0.000039918275],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978891,0.0004518426,0.00059781456,0.00024035423,0.00061838346,0.00020251122],"domain_scores_gemma":[0.9992358,0.000057671095,0.00026330602,0.00013592801,0.00018341071,0.00012387444],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00091406703,0.000098112134,0.00026831785,0.000110956025,0.00007870343,0.000009727447,0.00016615441,0.000034187797,0.0001619239],"category_scores_gemma":[0.000060531638,0.00007943931,0.000056942026,0.00017849046,0.00010365436,0.000009489007,0.00017140264,0.00036285893,1.7310701e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015479471,0.020736447,0.22930977,0.000023680603,0.00015463184,0.000028107597,0.0006254303,0.00029879913,0.705534,0.0000010950981,0.00033283516,0.027475758],"study_design_scores_gemma":[0.09405482,0.2456563,0.13564324,0.00013745208,0.00009960054,0.000013599433,0.008695111,0.000094913376,0.50825715,0.000009829849,0.006925115,0.00041285064],"about_ca_topic_score_codex":0.00011120968,"about_ca_topic_score_gemma":0.0000474235,"teacher_disagreement_score":0.22491986,"about_ca_system_score_codex":0.00010753891,"about_ca_system_score_gemma":0.00015379503,"threshold_uncertainty_score":0.32394412},"labels":[],"label_agreement":null},{"id":"W4225994592","doi":"10.1016/j.jtocrr.2022.100324","title":"Clinical Outcomes With Dabrafenib Plus Trametinib in a Clinical Trial Versus Real-World Standard of Care in Patients With BRAF-Mutated Advanced NSCLC","year":2022,"lang":"en","type":"article","venue":"JTO Clinical and Research Reports","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Merck Sharp and Dohme; Roche; Novartis; Amgen; Pfizer; Les Laboratories Pierre Fabre; Novartis Pharmaceuticals Corporation; AstraZeneca; Takeda Pharmaceutical Company; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Dabrafenib; Hazard ratio; Medicine; Trametinib; Internal medicine; Oncology; Confidence interval; Proportional hazards model; Vemurafenib; Cancer","score_opus":0.07276526832441786,"score_gpt":0.4439244341244604,"score_spread":0.37115916580004255,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4225994592","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959848,0.00012512863,0.00000427241,0.00014386338,0.00064392673,0.0016007582,0.00006332901,0.000012367962,0.0014215317],"genre_scores_gemma":[0.99838716,0.00023010664,0.00046315242,0.00005431738,0.0001573742,0.00014494985,0.00023471894,0.000036422418,0.00029179815],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99252796,0.0019661577,0.002544488,0.0011606567,0.0012300753,0.00057067233],"domain_scores_gemma":[0.996719,0.0010906153,0.00054795167,0.0008009945,0.000498845,0.00034258465],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008616886,0.00024306032,0.0011213626,0.00020475943,0.00012972664,0.000023430672,0.00025922217,0.000277541,0.000034656132],"category_scores_gemma":[0.0035126,0.00016985279,0.00026251454,0.00051723357,0.00081920915,0.000011931814,0.0005255151,0.0013650707,6.812807e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.25438172,0.0010069167,0.7291397,0.000032844124,0.00009501312,0.00048599677,0.000052001837,0.00002824847,0.00000928672,0.00001786754,0.00018733156,0.014563078],"study_design_scores_gemma":[0.12106628,0.054445207,0.8094368,0.00007311909,0.000034147146,0.0000070775613,0.00045371405,0.0000076004258,0.00008166847,0.00004487597,0.014036227,0.00031326362],"about_ca_topic_score_codex":0.00020488653,"about_ca_topic_score_gemma":0.004069986,"teacher_disagreement_score":0.13331543,"about_ca_system_score_codex":0.00006764654,"about_ca_system_score_gemma":0.0014844054,"threshold_uncertainty_score":0.6926396},"labels":[],"label_agreement":null},{"id":"W4231437775","doi":"10.3410/f.1123822.580910","title":"Faculty Opinions recommendation of The human ERG1 channel polymorphism, K897T, creates a phosphorylation site that inhibits channel activity.","year":2008,"lang":"en","type":"dataset","venue":"Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Channel (broadcasting); Phosphorylation; Psychology; Chemistry; Computer science; Telecommunications; Biochemistry","score_opus":0.03479540733954763,"score_gpt":0.3132672033714569,"score_spread":0.2784717960319093,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4231437775","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00013408491,0.0016534231,0.000036489375,0.04690662,0.0009397337,0.0014409333,0.9487835,0.000022734179,0.00008245383],"genre_scores_gemma":[0.0013588116,0.0008338248,0.000053423224,0.0023307705,0.0005237267,0.00025888687,0.9927456,0.00004068729,0.0018542876],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99622244,0.0004899664,0.0009969849,0.0008194498,0.0010629852,0.0004081684],"domain_scores_gemma":[0.99396634,0.000043664804,0.0016932352,0.0017364476,0.0023247872,0.00023554129],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00073016324,0.00062266603,0.00076459843,0.00021151907,0.0005091472,0.00008215855,0.0013864656,0.001017956,0.00009810777],"category_scores_gemma":[0.0017401496,0.000387358,0.0007986246,0.00104093,0.0003986501,0.000055585464,0.00079198816,0.00078044715,0.00002053338],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000021239326,0.00033112703,0.000013784043,0.0016885422,0.0001348183,2.1495919e-7,0.00011851182,3.0386494e-7,0.0006139859,0.000034163866,0.99666494,0.00037835754],"study_design_scores_gemma":[0.0006597971,0.00019324488,0.002819402,0.0035622313,0.00013855746,0.000057567348,0.000016693612,0.0000063362686,0.0064591654,0.000014158889,0.98567766,0.00039517964],"about_ca_topic_score_codex":0.00014026114,"about_ca_topic_score_gemma":0.000025888132,"teacher_disagreement_score":0.04457585,"about_ca_system_score_codex":0.00006903841,"about_ca_system_score_gemma":0.0004123271,"threshold_uncertainty_score":0.99985784},"labels":[],"label_agreement":null},{"id":"W4232359937","doi":"10.1515/iupac.88.1490","title":"Vimentin","year":2017,"lang":"it","type":"dataset","venue":"IUPAC Standards Online","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada Research Chairs; University of Toronto","funders":"","keywords":"Glossary; Terminology; Relation (database); Computer science; Linguistics; Data mining; Philosophy","score_opus":0.014453146301263787,"score_gpt":0.3957062548108621,"score_spread":0.3812531085095983,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4232359937","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0078069777,0.004029755,0.00021081758,0.0003153834,0.0023523276,0.0005110162,0.98371416,0.000022903467,0.0010366635],"genre_scores_gemma":[0.0031216524,0.0036252968,0.00013932202,0.00038407737,0.0038822729,0.0000269936,0.98103535,0.00010172366,0.0076832976],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9958505,0.00016669172,0.0007325473,0.0013414866,0.0009812308,0.00092753564],"domain_scores_gemma":[0.9950373,0.000019386616,0.0007922022,0.003115363,0.00060606725,0.00042963566],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000795713,0.00092288,0.00094566226,0.00013312792,0.0005529531,0.00027212952,0.0014763522,0.001320416,0.0023296939],"category_scores_gemma":[0.0007466123,0.00090227916,0.0005065118,0.00006530881,0.00036932147,0.0000083341365,0.0009837613,0.000665594,0.000036057194],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005385441,0.00050841074,0.00007879866,0.0002822339,0.00043763718,0.0002075024,0.000011686401,0.0000010901867,0.009055756,0.000014178378,0.98504394,0.0038202226],"study_design_scores_gemma":[0.001741498,0.0016546207,0.00010644481,0.00029616847,0.0003324264,0.000068987,0.000034610774,0.0000078484545,0.006435674,0.0000352571,0.98830014,0.0009863373],"about_ca_topic_score_codex":0.000107071915,"about_ca_topic_score_gemma":0.0005890713,"teacher_disagreement_score":0.006646634,"about_ca_system_score_codex":0.0001322543,"about_ca_system_score_gemma":0.0017023253,"threshold_uncertainty_score":0.9999761},"labels":[],"label_agreement":null},{"id":"W4232840593","doi":"10.1515/iupac.88.1255","title":"Protein Kinase","year":2017,"lang":"en","type":"dataset","venue":"IUPAC Standards Online","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada Research Chairs; University of Toronto","funders":"","keywords":"Glossary; Terminology; Relation (database); Computer science; Linguistics; Data mining; Philosophy","score_opus":0.013921763962676383,"score_gpt":0.3801489457770687,"score_spread":0.36622718181439234,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4232840593","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0043810857,0.0011583884,0.000062216975,0.000112561574,0.0005461167,0.0004404851,0.9931019,0.000016880513,0.00018037617],"genre_scores_gemma":[0.00030455404,0.00029961424,0.000095608666,0.00015333082,0.0018750649,0.00004780438,0.9947559,0.00004240303,0.0024257037],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99815017,0.00006446698,0.00028838112,0.00062749384,0.00048062348,0.0003888608],"domain_scores_gemma":[0.9974726,0.0000041251433,0.00029550606,0.0017697098,0.00027619413,0.00018185396],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00032810678,0.00041535712,0.00040653552,0.00006901336,0.00019563663,0.000085640226,0.00072672777,0.0006361616,0.00039343865],"category_scores_gemma":[0.00057730527,0.0003767655,0.00019910611,0.000029860952,0.00014314135,0.000002848963,0.00036630876,0.00032809895,0.0000058417854],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015803019,0.00014008641,0.000004110617,0.0001341806,0.00007674045,0.00010767416,0.0000014676,3.7478347e-7,0.011501434,0.000003843074,0.98650324,0.0013688232],"study_design_scores_gemma":[0.0006618473,0.0005913575,0.00001738769,0.00013904323,0.00005664648,0.00002053779,0.00000479694,7.9064773e-7,0.0077537703,0.000032764117,0.99027336,0.00044770568],"about_ca_topic_score_codex":0.000102455684,"about_ca_topic_score_gemma":0.00085235585,"teacher_disagreement_score":0.0040765316,"about_ca_system_score_codex":0.000047134527,"about_ca_system_score_gemma":0.0008530912,"threshold_uncertainty_score":0.99986845},"labels":[],"label_agreement":null},{"id":"W4234030450","doi":"10.2113/gscanmin.43.2.847","title":"ERRATA","year":2005,"lang":"en","type":"article","venue":"The Canadian Mineralogist","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Geology","score_opus":0.014865137677562241,"score_gpt":0.22357956046888375,"score_spread":0.20871442279132152,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4234030450","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.73712987,0.0011208131,0.00008449296,0.014881591,0.00032372665,0.00020924267,0.000098237615,0.000017046601,0.24613498],"genre_scores_gemma":[0.97927773,0.000014416225,0.00021104956,0.0039817696,0.00079522945,0.000009751637,0.00012521475,0.000010340172,0.015574512],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9994669,0.00002416176,0.00007670892,0.00014315057,0.000048873597,0.00024018603],"domain_scores_gemma":[0.9994208,0.0000029799428,0.000017987843,0.00036293204,0.000024162846,0.00017110167],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010698133,0.000080006204,0.000051658586,0.000022777154,0.00016268807,0.000027759708,0.0002420462,0.00007129738,0.00010166284],"category_scores_gemma":[0.000036216647,0.000057234887,0.000036835238,0.000041342897,0.0000952588,0.0000013858472,0.000025062622,0.0000597376,0.00016499935],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000012939938,0.000012313287,0.001258688,0.0000032400744,0.000028523962,0.000014540114,0.00007486327,0.00010978166,0.19209543,0.0075033833,0.79006416,0.00882217],"study_design_scores_gemma":[0.00011728245,0.00003993716,0.001991398,0.0000011633972,0.0000048517045,0.000029135857,0.000012719109,0.00003449946,0.009017122,0.00006175919,0.98858845,0.000101666585],"about_ca_topic_score_codex":0.044568256,"about_ca_topic_score_gemma":0.8685838,"teacher_disagreement_score":0.82401556,"about_ca_system_score_codex":0.0000292399,"about_ca_system_score_gemma":0.0002159721,"threshold_uncertainty_score":0.961794},"labels":[],"label_agreement":null},{"id":"W4234696818","doi":"10.3410/f.732647410.793546173","title":"Faculty Opinions recommendation of MEK drives BRAF activation through allosteric control of KSR proteins.","year":2018,"lang":"en","type":"dataset","venue":"Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Institutes of Health Research; National Institutes of Health; Canada Research Chairs","keywords":"Allosteric regulation; Kinase; Gene isoform; GTP'; Chemistry; Enzyme; Cell biology; Enzyme activator; Protein kinase domain; Domain (mathematical analysis); Computational biology; Biochemistry; Biology; Gene","score_opus":0.024391906352065805,"score_gpt":0.32756743757347645,"score_spread":0.30317553122141067,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4234696818","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00001321404,0.0006296807,0.00064697897,0.03532417,0.00056881696,0.0017758375,0.96095127,0.000012903549,0.000077143915],"genre_scores_gemma":[0.00019677615,0.00033305353,0.001184839,0.0021022381,0.00045145795,0.00026067364,0.9950558,0.000026554106,0.00038862063],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9964007,0.00045672138,0.001389697,0.0006291438,0.000843833,0.000279863],"domain_scores_gemma":[0.99192494,0.000052759082,0.0020140104,0.0013586822,0.004505245,0.0001443552],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007729526,0.00045202934,0.0008145622,0.00015374251,0.00013422935,0.00004505905,0.0011642398,0.00080370595,0.0001696048],"category_scores_gemma":[0.0039119744,0.00030498012,0.0005342394,0.0007747022,0.00042165877,0.000053891577,0.0003747357,0.0004150435,0.000010934261],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000048692535,0.00032806728,0.0000053788026,0.004524199,0.00021705491,7.172666e-8,0.00007160184,7.924766e-8,0.0014875903,0.00012265662,0.9923074,0.00088717346],"study_design_scores_gemma":[0.00093109574,0.0005396629,0.0005034138,0.004424837,0.00013961887,0.000015050536,0.00001842027,0.0000029651826,0.004932121,0.000028734803,0.9881846,0.00027951508],"about_ca_topic_score_codex":0.00004351688,"about_ca_topic_score_gemma":0.0000051419847,"teacher_disagreement_score":0.034104533,"about_ca_system_score_codex":0.000035143185,"about_ca_system_score_gemma":0.0004664976,"threshold_uncertainty_score":0.9999402},"labels":[],"label_agreement":null},{"id":"W4236592345","doi":"10.3410/f.7127958.7358060","title":"Faculty Opinions recommendation of ERK1/2 MAP kinases promote cell cycle entry by rapid, kinase-independent disruption of retinoblastoma-lamin A complexes.","year":2010,"lang":"en","type":"dataset","venue":"Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Kinase; Retinoblastoma; Lamin; Mitogen-activated protein kinase; Cell biology; Chemistry; Cancer research; Biochemistry; Biology; Nucleus; Gene","score_opus":0.013630118544551971,"score_gpt":0.30005259364004166,"score_spread":0.2864224750954897,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4236592345","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001019297,0.0018109035,0.00006701315,0.020410657,0.0007824503,0.001464305,0.9752689,0.00001705283,0.00007676147],"genre_scores_gemma":[0.00033207235,0.0005865533,0.00056229514,0.00076891365,0.00030358607,0.00017862658,0.99635947,0.000034862154,0.00087360095],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99577826,0.0004376458,0.0015464519,0.00080253644,0.0010648223,0.00037025913],"domain_scores_gemma":[0.9932918,0.000048182093,0.001995308,0.0016125967,0.0027822836,0.00026985107],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009807496,0.00055454805,0.00085643516,0.00019813806,0.00015877026,0.000060846625,0.0013681639,0.0011052963,0.00035111466],"category_scores_gemma":[0.001723994,0.0003999502,0.0006208225,0.00061120593,0.00037871892,0.00003530247,0.00059923314,0.00084564695,0.000021607691],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000413434,0.00077632733,0.0000057553634,0.0068690875,0.00009446295,2.9726039e-7,0.000043227465,7.314431e-8,0.0070773885,0.000035085952,0.9831722,0.0018847492],"study_design_scores_gemma":[0.00087136065,0.00045085658,0.0003540992,0.0032772725,0.00015775206,0.000024718463,0.000023916327,0.0000051791308,0.015317001,0.000010926451,0.97914267,0.00036427836],"about_ca_topic_score_codex":0.000080134945,"about_ca_topic_score_gemma":0.000018688454,"teacher_disagreement_score":0.021090562,"about_ca_system_score_codex":0.00004379364,"about_ca_system_score_gemma":0.00037991125,"threshold_uncertainty_score":0.99984527},"labels":[],"label_agreement":null},{"id":"W4237501644","doi":"10.1016/s1701-2163(15)30225-5","title":"ERRATA","year":2015,"lang":"en","type":"article","venue":"Journal of Obstetrics and Gynaecology Canada","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Gynecology","score_opus":0.016453142509333683,"score_gpt":0.21714037484115087,"score_spread":0.20068723233181718,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4237501644","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97916293,0.007315155,0.00012281016,0.00016473167,0.008895504,0.000035653633,0.000009429003,8.972937e-7,0.0042928886],"genre_scores_gemma":[0.99870366,0.00007516247,0.00035637052,0.0003724954,0.00007341485,5.27073e-7,0.0000053022727,0.000006116785,0.00040694184],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9994113,0.000032457225,0.00020314215,0.000085517015,0.00013315077,0.000134424],"domain_scores_gemma":[0.999217,0.00007730636,0.00015372333,0.000100434816,0.00022871478,0.00022282639],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018164466,0.000070730865,0.0001365525,0.00005050162,0.000029577997,0.000009536381,0.00012208655,0.000087792214,0.000018588253],"category_scores_gemma":[0.0018962666,0.000059113692,0.000026365024,0.000074398886,0.000028197277,0.0000029070566,0.0000511994,0.000095904565,4.3752627e-7],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000453648,0.00020073373,0.30834022,0.00005060875,0.00044003403,0.004503959,0.0001934514,0.00022597342,0.010875246,0.0013083549,0.51820815,0.1556079],"study_design_scores_gemma":[0.0023208624,0.0013614254,0.06294433,0.0000016297208,0.00003997242,0.00027074048,0.0003561688,0.00002323902,0.004113824,0.00028019628,0.9280813,0.00020633596],"about_ca_topic_score_codex":0.0019212988,"about_ca_topic_score_gemma":0.011253188,"teacher_disagreement_score":0.40987313,"about_ca_system_score_codex":0.00008394033,"about_ca_system_score_gemma":0.0015929459,"threshold_uncertainty_score":0.62795436},"labels":[],"label_agreement":null},{"id":"W4238150434","doi":"10.3410/f.718281745.793492031","title":"Faculty Opinions recommendation of Mapping the molecular determinants of BRAF oncogene dependence in human lung cancer.","year":2014,"lang":"en","type":"dataset","venue":"Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Oncogene; Lung cancer; Computational biology; Cancer; Human lung; Cancer research; Oncology; Biology; Internal medicine; Medicine; Lung","score_opus":0.03207066754461356,"score_gpt":0.36094466241952294,"score_spread":0.32887399487490937,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4238150434","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00017418341,0.0031288732,0.00009632769,0.015781913,0.0004525894,0.0010575129,0.97926784,0.000005908332,0.000034856796],"genre_scores_gemma":[0.00091082224,0.0005085132,0.0002091765,0.0014593062,0.0001862489,0.00022687012,0.9962746,0.000020920465,0.00020355216],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9965122,0.00050194806,0.0013873822,0.0005631553,0.00074336457,0.00029198875],"domain_scores_gemma":[0.9949303,0.00004714924,0.0015302927,0.0013647337,0.0019976147,0.00012990879],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012900811,0.00038121358,0.0007284531,0.0001882337,0.00013377897,0.000036383903,0.0016165489,0.0006162933,0.00007634726],"category_scores_gemma":[0.0021906728,0.00023950798,0.0004261515,0.0008339395,0.00027159663,0.000020666383,0.0005585445,0.0005148577,0.0000024000713],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000008796584,0.00014748484,0.00010987591,0.0048700646,0.00008180351,3.6130402e-7,0.000048749727,6.151863e-7,0.0013135368,0.000072149895,0.99150544,0.0018411169],"study_design_scores_gemma":[0.00046208312,0.00012013305,0.0019160053,0.0068264073,0.00009310077,0.000020844429,0.000016200254,0.000015966909,0.00395221,0.000009252884,0.9863286,0.0002391731],"about_ca_topic_score_codex":0.00018927542,"about_ca_topic_score_gemma":0.000091316746,"teacher_disagreement_score":0.017006755,"about_ca_system_score_codex":0.000046335008,"about_ca_system_score_gemma":0.0004339153,"threshold_uncertainty_score":0.97668517},"labels":[],"label_agreement":null},{"id":"W4238605545","doi":"10.1161/res.121.suppl_1.111","title":"Abstract 111: Reduced MK5 Expression Alters Migration, Proliferation, and Collagen Biosynthesis in Murine Ventricular Fibroblasts","year":2017,"lang":"en","type":"article","venue":"Circulation Research","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Heart Institute","funders":"","keywords":"Cytoplasm; Fibroblast; Cell biology; Kinase; Protein kinase A; Biology; Molecular biology; Chemistry; Endocrinology; Internal medicine; Medicine; Biochemistry; In vitro","score_opus":0.0480049123205058,"score_gpt":0.3347805609489195,"score_spread":0.2867756486284137,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4238605545","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99793756,0.00020103763,0.00011819777,0.0005834988,0.000056256984,0.00044432943,0.000007977655,0.0000073913493,0.00064377533],"genre_scores_gemma":[0.99922174,0.00008590582,0.00014432865,0.000015387572,0.00018342932,0.000065373286,0.000105999046,0.000014718352,0.00016310267],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99874526,0.00012348783,0.00021564559,0.000383542,0.00028140238,0.00025066914],"domain_scores_gemma":[0.99906653,0.000028562574,0.000092533985,0.0005090693,0.00020245287,0.00010086853],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006863631,0.00010389113,0.00010777751,0.00014369051,0.00043836588,0.00017615086,0.00018479013,0.0001442018,0.000035418834],"category_scores_gemma":[0.0005961561,0.00010062852,0.000032966,0.00008082689,0.000097645076,0.000024216744,0.00011616509,0.00008011858,0.000014289397],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006342747,0.000044219418,0.06613363,0.0000415619,0.000008283017,0.000014530669,0.00007732515,0.00019943957,0.9314044,0.00003400858,0.0010057291,0.0009734194],"study_design_scores_gemma":[0.0004050948,0.00005539826,0.5179482,0.00005383751,0.0000021111146,0.000007217027,0.000042222327,0.00052380504,0.47946584,0.000111454385,0.0012778887,0.00010690446],"about_ca_topic_score_codex":0.00008890573,"about_ca_topic_score_gemma":0.00016205643,"teacher_disagreement_score":0.45193857,"about_ca_system_score_codex":0.000026912876,"about_ca_system_score_gemma":0.00009814722,"threshold_uncertainty_score":0.4103512},"labels":[],"label_agreement":null},{"id":"W4239344658","doi":"10.1002/9780471420194.tnmm52","title":"Melanoma","year":2017,"lang":"en","type":"other","venue":"TNM Online","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Melanoma; Immunotherapy; Targeted therapy; Metastatic melanoma; Disease; Oncology; Chemotherapy; Internal medicine; Dermatology; Surgery; Cancer; Cancer research","score_opus":0.01503629735674408,"score_gpt":0.27086701819224546,"score_spread":0.2558307208355014,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4239344658","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000540735,0.002197023,0.0000843706,0.000053036154,0.0005383841,0.00014519916,0.003421248,0.00005296579,0.992967],"genre_scores_gemma":[0.00056519115,0.000509458,0.0010831545,0.00015668836,0.0028995706,0.000011248277,0.008708396,0.00026671268,0.98579955],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9993165,0.000016422846,0.00008471512,0.00031696007,0.000081672675,0.00018370365],"domain_scores_gemma":[0.9989326,0.000002017368,0.00015018684,0.000825797,0.00001590287,0.00007350774],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00003208815,0.00020373745,0.0001972678,0.000045047276,0.000036065336,0.000013724687,0.00034022066,0.00040905608,0.0031871838],"category_scores_gemma":[0.000047849382,0.00018366381,0.00009144276,0.000010675511,0.000054289874,3.939342e-7,0.00012908896,0.00009060957,0.00028504452],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000007786148,0.000039452134,0.000039417668,0.000024401263,0.00005322509,0.000017374987,0.0000015823377,2.8997084e-8,0.00910617,0.000026638092,0.9844388,0.0062451344],"study_design_scores_gemma":[0.00023038233,0.00011820441,0.00009048191,0.00006391465,0.000018675231,0.00001204163,0.0000016794377,0.0000013712103,0.0020777718,0.000010858705,0.9971497,0.00022490179],"about_ca_topic_score_codex":0.00005365209,"about_ca_topic_score_gemma":0.00051579345,"teacher_disagreement_score":0.012710928,"about_ca_system_score_codex":0.0000036891117,"about_ca_system_score_gemma":0.000073632815,"threshold_uncertainty_score":0.99772406},"labels":[],"label_agreement":null},{"id":"W4240418344","doi":"10.3410/f.737102223.793579864","title":"Faculty Opinions recommendation of Metabolic heterogeneity confers differences in melanoma metastatic potential.","year":2020,"lang":"en","type":"dataset","venue":"Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Metastatic melanoma; Melanoma; Computational biology; Medicine; Internal medicine; Oncology; Cancer research; Biology","score_opus":0.03795361420794748,"score_gpt":0.3287469055302956,"score_spread":0.29079329132234816,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4240418344","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000040012485,0.0022198288,0.0000817579,0.03924169,0.0005940083,0.0010374389,0.95674676,0.000010363154,0.000028117312],"genre_scores_gemma":[0.0005631004,0.0010062155,0.0004269587,0.0025034538,0.00021276851,0.00019025651,0.994899,0.00002089877,0.00017737845],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9961126,0.00067488325,0.0013651352,0.0007221342,0.0008051652,0.00032011175],"domain_scores_gemma":[0.99572164,0.000036503876,0.0011486368,0.0010320796,0.0018014212,0.00025970323],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00076940557,0.0004918153,0.0010390722,0.00021751161,0.00010501805,0.00007144886,0.0013101813,0.00051479775,0.00014075576],"category_scores_gemma":[0.0029572689,0.00033071035,0.0006034461,0.00090982503,0.00026423144,0.00002824857,0.0005172087,0.00057707634,0.000029154817],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000022599937,0.00025683764,0.000036036843,0.0030030287,0.00023110893,6.3564977e-7,0.000033021617,1.1793442e-7,0.00012680308,0.00013144607,0.9954071,0.0007512884],"study_design_scores_gemma":[0.0006823977,0.00020768282,0.0037597506,0.0015473097,0.00021147713,0.0000280858,0.000025212055,0.0000071108207,0.00067996746,0.000012772711,0.9925299,0.0003083256],"about_ca_topic_score_codex":0.000060607286,"about_ca_topic_score_gemma":0.00002416693,"teacher_disagreement_score":0.038152188,"about_ca_system_score_codex":0.000020813772,"about_ca_system_score_gemma":0.00046666092,"threshold_uncertainty_score":0.99991447},"labels":[],"label_agreement":null},{"id":"W4241605155","doi":"10.1016/j.ejca.2012.06.013","title":"Diagnosis and treatment of melanoma. European consensus-based interdisciplinary guideline – Update 2012","year":2012,"lang":"en","type":"article","venue":"European Journal of Cancer","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":229,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Cancer Research UK","keywords":"Medicine; Ipilimumab; Melanoma; Guideline; Oncology; Vemurafenib; Internal medicine; Stage (stratigraphy); Systemic therapy; Adjuvant therapy; Skin cancer; Cancer; Surgery; Dermatology; Breast cancer; Immunotherapy; Pathology; Cancer research; Metastatic melanoma","score_opus":0.02186877716028896,"score_gpt":0.2939923508756755,"score_spread":0.27212357371538654,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4241605155","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96697736,0.026782144,0.00042907856,0.00072232774,0.0004452781,0.000075124255,0.000048893715,0.000003562952,0.00451622],"genre_scores_gemma":[0.9952442,0.0018420957,0.0013137354,0.00019663497,0.0010628677,0.0000016725509,0.000016079282,0.00003401763,0.00028868252],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9988063,0.00032890672,0.00046847278,0.00011380429,0.00010283652,0.00017969185],"domain_scores_gemma":[0.99912083,0.000014015307,0.0003724738,0.0001804918,0.00013960285,0.00017260134],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00053730706,0.00014429304,0.00020000251,0.00005488621,0.00003939696,0.000008828515,0.00011623657,0.000019573812,0.00010077805],"category_scores_gemma":[0.000022778737,0.00010728588,0.00011723048,0.000033638025,0.000078972866,0.0000064399565,0.00009010505,0.000048434547,0.000009547345],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011285095,0.0007785621,0.09784544,0.000058771016,0.00063943205,0.00030206214,0.0007492624,0.00019535983,0.35840854,0.00003640344,0.11517896,0.4246787],"study_design_scores_gemma":[0.0021500783,0.0019718194,0.045305755,0.00008286115,0.00015270896,0.000115074996,0.000083345505,0.000009666508,0.14421336,0.0000036354736,0.80570626,0.0002054331],"about_ca_topic_score_codex":0.0000025270037,"about_ca_topic_score_gemma":0.000006563845,"teacher_disagreement_score":0.6905273,"about_ca_system_score_codex":0.000015985108,"about_ca_system_score_gemma":0.000045493645,"threshold_uncertainty_score":0.43749914},"labels":[],"label_agreement":null},{"id":"W4242515395","doi":"10.1007/978-1-4419-0461-4_193","title":"Mitogen-Activated Protein Kinases","year":2012,"lang":"en","type":"book-chapter","venue":"","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Institute for Research in Immunology and Cancer","funders":"","keywords":"Mitogen-activated protein kinase; Kinase; Cell biology; Biology","score_opus":0.018690065625357133,"score_gpt":0.2155802233983124,"score_spread":0.19689015777295527,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4242515395","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.008293923,0.0029534153,0.0001194645,0.000032321997,0.00038291974,0.00047192047,0.00008820137,0.000043484793,0.98761433],"genre_scores_gemma":[0.06846696,0.00015258513,0.0002254232,0.0001318482,0.0009807027,0.000030449783,0.00079035637,0.00007660974,0.92914504],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99907136,0.000010914755,0.00018457431,0.0003572543,0.00012423942,0.0002516857],"domain_scores_gemma":[0.99921656,0.0000031863192,0.00010845172,0.00047790425,0.00006505159,0.00012887562],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000051647952,0.0003110159,0.0002123442,0.00004115032,0.00004514859,0.00001347618,0.0001662204,0.00056016695,0.0013981264],"category_scores_gemma":[0.000014551405,0.00027223845,0.00015751776,0.000007723047,0.000053754822,0.0000015311717,0.00012845246,0.00013202708,0.0003576342],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004413205,0.000015486885,0.000006533327,0.00003202569,0.00009234293,0.0000060133634,0.000005571186,5.9064774e-8,0.96303654,0.015805429,0.015836226,0.005119665],"study_design_scores_gemma":[0.00010638465,0.000100454425,0.000004341,0.00001937096,0.000015871656,0.000008601518,0.0000013887197,6.864485e-8,0.4568045,0.00024393738,0.5424763,0.00021875452],"about_ca_topic_score_codex":0.000013578345,"about_ca_topic_score_gemma":0.000014766837,"teacher_disagreement_score":0.52664006,"about_ca_system_score_codex":0.000010737175,"about_ca_system_score_gemma":0.00007387374,"threshold_uncertainty_score":0.999973},"labels":[],"label_agreement":null},{"id":"W4242647017","doi":"10.3410/f.725372069.793506833","title":"Faculty Opinions recommendation of Structural assembly of the signaling competent ERK2-RSK1 heterodimeric protein kinase complex.","year":2015,"lang":"en","type":"dataset","venue":"Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Protein kinase A; Cell biology; Kinase; Chemistry; Computational biology; Biology","score_opus":0.044033456622931774,"score_gpt":0.3392537000004153,"score_spread":0.29522024337748354,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4242647017","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001240449,0.0010536739,0.000034534805,0.024852553,0.0007234039,0.0016275843,0.9715304,0.000010463922,0.00004335641],"genre_scores_gemma":[0.00077921944,0.00004616459,0.0007493027,0.0012489485,0.0002821026,0.00013753046,0.99635315,0.000024479707,0.00037907303],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9959201,0.0006879348,0.0013930809,0.0005851436,0.0011062315,0.00030750094],"domain_scores_gemma":[0.99203885,0.000033254324,0.0018805057,0.0016024618,0.004227842,0.00021708371],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010050124,0.00047260625,0.00079495774,0.00013037282,0.00018249241,0.00005542458,0.0017441318,0.0005697677,0.00010694283],"category_scores_gemma":[0.002713021,0.00027277417,0.000637778,0.0008379768,0.0003883682,0.00002654421,0.00079451245,0.0005881805,0.000006972236],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000232366,0.00015541138,0.000007932699,0.0034224868,0.00013858672,1.1919253e-7,0.00003711594,6.9212507e-7,0.0031330131,0.0000932427,0.9923816,0.0006065751],"study_design_scores_gemma":[0.0005931799,0.0002682042,0.0008563101,0.0035991755,0.0001271889,0.000026159047,0.000022070379,0.000011040294,0.0031853588,0.000014552404,0.991017,0.00027977547],"about_ca_topic_score_codex":0.000053515407,"about_ca_topic_score_gemma":0.000009781815,"teacher_disagreement_score":0.024822796,"about_ca_system_score_codex":0.000051023722,"about_ca_system_score_gemma":0.0005872569,"threshold_uncertainty_score":0.99997246},"labels":[],"label_agreement":null},{"id":"W4243158089","doi":"10.5858/2007-131-1361-bmimla","title":"BRAF Mutations in Melanocytic Lesions and Papillary Thyroid Carcinoma Samples Identified Using Melting Curve Analysis of Polymerase Chain Reaction Products","year":2007,"lang":"en","type":"article","venue":"Archives of Pathology & Laboratory Medicine","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Calgary Laboratory Services; University of Calgary","funders":"","keywords":"Polymerase chain reaction; Thyroid carcinoma; V600E; Mutation; Pathology; Context (archaeology); Molecular biology; Melanoma; Concordance; Digital polymerase chain reaction; Melting curve analysis; Carcinoma; Biology; Cancer research; Medicine; Gene; Thyroid; Genetics","score_opus":0.02144916971540927,"score_gpt":0.2794666409867749,"score_spread":0.2580174712713656,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4243158089","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99423003,0.0038436428,0.0013755134,0.0000798327,0.00009871332,0.00016184452,0.00007737051,0.0000063293232,0.00012674415],"genre_scores_gemma":[0.99801517,0.00019917743,0.0012958412,0.000061344675,0.000097961456,0.000004235355,0.00029948333,0.000013470925,0.000013332195],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99855256,0.00023919794,0.0005113385,0.00036745067,0.00011202997,0.00021739735],"domain_scores_gemma":[0.9990166,0.00018610393,0.00029492087,0.00033329742,0.00009337366,0.0000756919],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00069732673,0.00014615316,0.00040125306,0.0006169328,0.00006505862,0.0000017028472,0.00009787696,0.000098391785,0.000003408917],"category_scores_gemma":[0.00064337644,0.00013416761,0.00004829619,0.00061319664,0.00051134976,0.000007949205,0.00006938955,0.000107287546,1.2936344e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008582639,0.000049918934,0.09634576,0.000053383308,0.000113971415,0.00007700959,0.001357718,0.000023353437,0.9008319,0.0001905372,0.0000047177723,0.0008658972],"study_design_scores_gemma":[0.0007386104,0.00031671915,0.4910963,0.000051420167,0.0003795248,0.000033919285,0.0016484614,0.00015984899,0.50535184,0.00007017502,0.000034457833,0.00011870959],"about_ca_topic_score_codex":0.00023509214,"about_ca_topic_score_gemma":0.0005441351,"teacher_disagreement_score":0.39548004,"about_ca_system_score_codex":0.000009014829,"about_ca_system_score_gemma":0.00013059161,"threshold_uncertainty_score":0.5471196},"labels":[],"label_agreement":null},{"id":"W4244027507","doi":"10.1128/.20.10.3442-3448.2000","title":"Deficient Gene Expression in Protein Kinase Inhibitor α Null Mutant Mice","year":2000,"lang":"en","type":"article","venue":"Molecular and Cellular Biology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Nutrition, Metabolism and Diabetes","funders":"","keywords":"Biology; Mutant; Gene; Molecular biology; Gene expression; Protein kinase A; Kinase; Genetics; Cell biology","score_opus":0.0048735671419802085,"score_gpt":0.19712885734831215,"score_spread":0.19225529020633195,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4244027507","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99212587,0.003718808,0.002335483,0.000062127125,0.00007566296,0.00035382205,0.000022594142,0.000013958832,0.0012916491],"genre_scores_gemma":[0.9978771,0.00010237678,0.0009908383,0.00023091288,0.000092472634,0.00006552484,0.00026244947,0.000025178402,0.00035312993],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99853003,0.00017265379,0.0002564016,0.0005824224,0.00007591287,0.00038258068],"domain_scores_gemma":[0.9994717,0.0000040394953,0.00004601216,0.00033478532,0.000025144509,0.00011828713],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001728151,0.00022338858,0.0002019174,0.00006419268,0.00006537234,0.000015715357,0.000151085,0.00029509378,0.00009616168],"category_scores_gemma":[0.000021119458,0.0002017005,0.00007907625,0.000088988636,0.00010234689,0.0000026846776,0.00010136606,0.00012155506,0.000028004471],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011982359,0.000104241786,0.00037560466,0.000015829639,0.000008922613,0.00011278758,0.00003562909,0.000014448446,0.99526346,0.00014999192,0.000034002034,0.0037652417],"study_design_scores_gemma":[0.00077410165,0.00040914773,0.000081782215,0.000020298672,0.0000075893463,0.00003422716,0.000021554933,0.00003041167,0.9745192,0.00018869898,0.023658304,0.00025466594],"about_ca_topic_score_codex":0.000032732434,"about_ca_topic_score_gemma":0.000012185447,"teacher_disagreement_score":0.023624301,"about_ca_system_score_codex":0.000010691454,"about_ca_system_score_gemma":0.00003979126,"threshold_uncertainty_score":0.8225108},"labels":[],"label_agreement":null},{"id":"W4245477498","doi":"10.1007/978-1-4614-6438-9_382-1","title":"RSK (p90 Ribosomal S6 Kinase)","year":2016,"lang":"en","type":"book-chapter","venue":"","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Institute for Research in Immunology and Cancer","funders":"","keywords":"Ribosomal s6 kinase; Chemistry; Biochemistry; P70-S6 Kinase 1; Phosphorylation; Protein kinase B","score_opus":0.011135923531443534,"score_gpt":0.20667481781722633,"score_spread":0.1955388942857828,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4245477498","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0007738026,0.0008668826,0.00072453707,0.0001655529,0.0004739489,0.00017955223,0.00014673038,0.00003433006,0.99663466],"genre_scores_gemma":[0.010759759,0.00036480575,0.0002653005,0.0005825553,0.0015153558,0.000011618302,0.00029830955,0.00007806489,0.9861242],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987927,0.000010076003,0.0002305979,0.00054049114,0.00015219796,0.00027394106],"domain_scores_gemma":[0.9990488,0.000007867705,0.00010307463,0.00062745874,0.00007234439,0.00014043417],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00006248792,0.0003501686,0.00025058078,0.000047424113,0.00005198703,0.000016159713,0.00025616906,0.00066803,0.001962219],"category_scores_gemma":[0.000014167567,0.00026131957,0.0002320507,0.000005395537,0.00008549285,0.0000018346736,0.00019958601,0.00011635862,0.0010053754],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009298597,0.000027639078,0.000049866394,0.000056659304,0.0002292347,0.00010490499,0.00000559228,1.3914286e-7,0.38591105,0.47794634,0.114924125,0.020651465],"study_design_scores_gemma":[0.00031283047,0.00024928653,0.000013204708,0.00004340825,0.000028291704,0.000035237867,0.0000012924052,2.8404867e-7,0.04851392,0.002827131,0.9475619,0.0004131753],"about_ca_topic_score_codex":0.0000023216212,"about_ca_topic_score_gemma":0.000018701625,"teacher_disagreement_score":0.8326378,"about_ca_system_score_codex":0.000013911755,"about_ca_system_score_gemma":0.00010307453,"threshold_uncertainty_score":0.9999839},"labels":[],"label_agreement":null},{"id":"W4246100262","doi":"10.1007/978-1-4419-0461-4_542","title":"Erk3 and Erk4","year":2012,"lang":"en","type":"book-chapter","venue":"","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Institute for Research in Immunology and Cancer","funders":"","keywords":"History","score_opus":0.012906163130893879,"score_gpt":0.2016056041995225,"score_spread":0.18869944106862863,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4246100262","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0011238543,0.0059340997,0.000119176475,0.00003040863,0.00014071063,0.00009562221,0.00002599228,0.0000117599775,0.99251837],"genre_scores_gemma":[0.016433693,0.0013074833,0.00030248196,0.0002930676,0.0007212323,0.0000037271043,0.00019981625,0.00003805676,0.98070043],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.9994498,0.000003865099,0.00010454227,0.0002364188,0.00006127884,0.00014408187],"domain_scores_gemma":[0.99956435,0.000003048356,0.0000452061,0.00026284403,0.000023330595,0.000101203805],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00004966561,0.0001787646,0.00013561705,0.00002215055,0.000028503715,0.000009337905,0.00007132084,0.00037048524,0.00056863873],"category_scores_gemma":[0.00000464805,0.00015459124,0.00006141976,0.0000023066184,0.000047983896,7.025901e-7,0.00012091511,0.000080007136,0.00018672051],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007900072,0.000037589427,0.00038420453,0.00016450009,0.00038738776,0.000025153136,0.000043193737,1.4800378e-7,0.20317154,0.5451433,0.1408362,0.10972778],"study_design_scores_gemma":[0.0001141284,0.000090724134,0.000056677964,0.000009263566,0.000028833374,0.000034118657,0.0000016412048,3.3065427e-7,0.009276627,0.0010596904,0.98910874,0.0002192304],"about_ca_topic_score_codex":0.0000030733481,"about_ca_topic_score_gemma":0.000012982316,"teacher_disagreement_score":0.84827256,"about_ca_system_score_codex":0.000003019478,"about_ca_system_score_gemma":0.000023133996,"threshold_uncertainty_score":0.63040483},"labels":[],"label_agreement":null},{"id":"W4246498996","doi":"10.1128/mmbr.00013-12","title":"Activation and Function of the MAPKs and Their Substrates, the MAPK-Activated Protein Kinases","year":2012,"lang":"en","type":"article","venue":"Microbiology and Molecular Biology Reviews","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":182,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Institute for Research in Immunology and Cancer","funders":"","keywords":"Biology; Kinase; MAPK/ERK pathway; Function (biology); Cell biology; Mitogen-activated protein kinase; Protein-Serine-Threonine Kinases; p38 mitogen-activated protein kinases; Protein kinase A; Computational biology","score_opus":0.013875150653033878,"score_gpt":0.22869412866250177,"score_spread":0.2148189780094679,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4246498996","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94890404,0.04947567,0.0005700487,0.0002361962,0.00009342808,0.0006022297,0.000028718607,0.000004562012,0.00008512802],"genre_scores_gemma":[0.99702656,0.002060529,0.0000853586,0.00051830057,0.000055706423,0.00006126226,0.00012938134,0.000009701271,0.000053218635],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987997,0.00049325556,0.00022383583,0.00025458337,0.000011219527,0.00021740468],"domain_scores_gemma":[0.99946123,0.000020576203,0.00017572951,0.00027183173,0.000029888093,0.000040747134],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004133857,0.00018946663,0.00023955226,0.00001798495,0.00013720679,0.000006091193,0.00010435952,0.0002603269,0.0000058963506],"category_scores_gemma":[0.00007815804,0.00009505179,0.000062080544,0.000060929884,0.00044554388,0.0000055475357,0.00015350062,0.00012538495,9.2358965e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004710258,0.000021269794,0.0033703856,0.000040238683,0.000045429082,7.132518e-8,0.0000405314,3.9816893e-8,0.98886687,0.0012829254,0.00013560806,0.0061495057],"study_design_scores_gemma":[0.00020126985,0.00017942632,0.004848282,0.000029232831,0.000025778803,0.000051594183,0.000027621554,2.7110906e-7,0.87322235,0.00016724746,0.121142104,0.00010482596],"about_ca_topic_score_codex":0.00001129628,"about_ca_topic_score_gemma":0.000008106992,"teacher_disagreement_score":0.121006496,"about_ca_system_score_codex":0.0000030493352,"about_ca_system_score_gemma":0.000018069904,"threshold_uncertainty_score":0.38761},"labels":[],"label_agreement":null},{"id":"W4247001916","doi":"10.1007/978-3-662-48986-4_310576","title":"BÄK","year":2019,"lang":"de","type":"book-chapter","venue":"Springer Reference Medizin","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Mathematics","score_opus":0.030438737332141114,"score_gpt":0.24122985714062195,"score_spread":0.21079111980848084,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4247001916","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.037769925,0.013857561,0.0003392056,0.00029366446,0.0049494677,0.0009982743,0.00042471214,0.00006939151,0.94129777],"genre_scores_gemma":[0.46566793,0.012295982,0.0007368693,0.00071655866,0.0035077522,0.0000389619,0.0019973677,0.0002794698,0.5147591],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9964818,0.00005786525,0.00068440696,0.0014418754,0.00055248174,0.0007816204],"domain_scores_gemma":[0.9972371,0.000031708158,0.00042213383,0.0017129871,0.00021443104,0.0003816443],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00034450158,0.00090137264,0.00080374646,0.00015883528,0.000119472315,0.00007123893,0.0008826756,0.0016058203,0.0025667467],"category_scores_gemma":[0.000088608256,0.0008636794,0.00035861923,0.00003718859,0.00024204788,0.000006019025,0.0006761436,0.0008756154,0.011847226],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006744518,0.0002112108,0.0018343402,0.0012299366,0.0015402552,0.0003150601,0.00023852197,0.000009873505,0.65720904,0.2575785,0.016487248,0.06267159],"study_design_scores_gemma":[0.000606838,0.000755282,0.00026248995,0.0003470145,0.00016933594,0.00002208068,0.000021339347,0.0000073454526,0.033780057,0.00046828252,0.9625253,0.0010346271],"about_ca_topic_score_codex":0.000029639603,"about_ca_topic_score_gemma":0.00006266072,"teacher_disagreement_score":0.94603807,"about_ca_system_score_codex":0.000055204415,"about_ca_system_score_gemma":0.00052504503,"threshold_uncertainty_score":0.9996903},"labels":[],"label_agreement":null},{"id":"W4249533637","doi":"10.15562/bdv.v3i2.38","title":"Focus on the dabrafenib, vemurafenib, and trametinib in clinical outcome of melanoma: a systematic review and meta-analysis","year":2020,"lang":"en","type":"review","venue":"Bali Dermatology and Venereology Journal","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Trametinib; Dabrafenib; Vemurafenib; Medicine; Oncology; Internal medicine; Melanoma; MEK inhibitor; Targeted therapy; Randomized controlled trial; Meta-analysis; Cancer; Cancer research; Metastatic melanoma; MAPK/ERK pathway","score_opus":0.10863957499082004,"score_gpt":0.3745808384374596,"score_spread":0.26594126344663954,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4249533637","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0008248382,0.9960191,0.000049207778,0.0021034821,0.00006881612,0.0007847296,0.000054975033,0.0000037517605,0.00009106998],"genre_scores_gemma":[0.015600628,0.9828642,0.00008311088,0.0012089618,0.000047544956,0.000103192826,0.00002936394,0.000023631103,0.000039393573],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99335235,0.0034011102,0.0022652356,0.00056706596,0.000114428425,0.00029981765],"domain_scores_gemma":[0.9970783,0.0008264202,0.0013731541,0.00048101466,0.000057458812,0.00018366592],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0016495475,0.0004775234,0.0071792803,0.00020672378,0.000106387386,0.00001982702,0.0003601239,0.00077360234,0.00003330333],"category_scores_gemma":[0.00092442747,0.000271467,0.0013351203,0.00023911965,0.00048951124,0.000004899316,0.00021587056,0.0008311436,0.0000034647778],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017821105,0.00047332203,0.010051498,0.63940895,0.31560004,0.0020373242,0.00015003416,6.9240014e-7,0.000008581857,0.012514054,0.0016300305,0.01794727],"study_design_scores_gemma":[0.0008930283,0.00049764,0.00020883435,0.004962767,0.87671185,0.02788445,0.00005106099,0.000007640178,0.00001525531,0.00045815454,0.08754662,0.00076271006],"about_ca_topic_score_codex":0.000004459233,"about_ca_topic_score_gemma":0.000030313642,"teacher_disagreement_score":0.6344462,"about_ca_system_score_codex":0.0000065360077,"about_ca_system_score_gemma":0.00012176396,"threshold_uncertainty_score":0.9999738},"labels":[],"label_agreement":null},{"id":"W4252336504","doi":"10.3410/f.725693254.793509614","title":"Faculty Opinions recommendation of Functional Redundancy of ERK1 and ERK2 MAP Kinases during Development.","year":2015,"lang":"en","type":"dataset","venue":"Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Redundancy (engineering); Kinase; Mitogen-activated protein kinase; Computer science; Information retrieval; Biology; Cell biology","score_opus":0.032858658023750875,"score_gpt":0.31604434362280376,"score_spread":0.2831856855990529,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4252336504","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000050626262,0.0026584,0.000027804203,0.014027903,0.00065718935,0.00061502936,0.9818998,0.000009142741,0.00005409108],"genre_scores_gemma":[0.00007712383,0.00031006837,0.0006697113,0.00046922316,0.00026930068,0.000100882346,0.9969702,0.00001807381,0.0011154461],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.997183,0.00021375416,0.0011084907,0.0005196728,0.0007522752,0.0002228012],"domain_scores_gemma":[0.99437726,0.00002782543,0.0010828631,0.0008076687,0.003495349,0.00020902714],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00076052645,0.00035345822,0.0005829843,0.0001814165,0.000139406,0.000035397352,0.0006136671,0.0005475138,0.00012316818],"category_scores_gemma":[0.0024065601,0.00024880067,0.00024980135,0.00047439587,0.0002618544,0.000027708986,0.000520803,0.00035101868,0.000007631714],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003097001,0.00019433092,0.00002176506,0.006199881,0.00013407331,1.417834e-7,0.000040903076,8.2633775e-8,0.00024879168,0.000057330206,0.9922998,0.00077194674],"study_design_scores_gemma":[0.00063931174,0.00013682328,0.0032549547,0.0037135761,0.00008182219,0.000036600894,0.000021126696,6.064939e-7,0.0012377021,0.000010770224,0.9906297,0.00023700774],"about_ca_topic_score_codex":0.000014612914,"about_ca_topic_score_gemma":0.000006330105,"teacher_disagreement_score":0.015070356,"about_ca_system_score_codex":0.000037370715,"about_ca_system_score_gemma":0.0006927373,"threshold_uncertainty_score":0.9999964},"labels":[],"label_agreement":null},{"id":"W4253022805","doi":"10.21203/rs.3.rs-59611/v1","title":"Conformation and Dynamics of the Kinase Domain Drive Subcellular Location and Activation of LRRK2.","year":2020,"lang":"en","type":"preprint","venue":"Research Square","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Novartis Pharma; National Cancer Institute; National Institutes of Health; Ministero dello Sviluppo Economico; Fundação de Amparo à Pesquisa do Estado de São Paulo; Deutsche Forschungsgemeinschaft; Merck KGaA; Ontario Ministry of Economic Development and Innovation; Genome Canada","keywords":"Dynamics (music); Domain (mathematical analysis); LRRK2; Subcellular localization; Cell biology; Kinase; Computer science; Chemistry; Physics; Biochemistry; Biology; Mathematics; Cytoplasm; Gene","score_opus":0.02588846582245569,"score_gpt":0.3045738191004528,"score_spread":0.2786853532779971,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4253022805","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9933343,0.00038176426,0.0049202936,0.00037180271,0.000036167887,0.00051706535,0.00010801762,0.0000027017304,0.00032786548],"genre_scores_gemma":[0.9986259,0.00036930208,0.00017607558,0.000008790865,0.000049505965,0.000020881678,0.00071734074,0.0000092242435,0.00002302592],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99903935,0.00018399203,0.00019301548,0.00020806285,0.00026516145,0.00011042709],"domain_scores_gemma":[0.99903876,0.000035226196,0.0001873046,0.00030645623,0.00038389282,0.000048369173],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039635992,0.000091635906,0.00013231079,0.0000589673,0.000058351972,0.000013292099,0.0001374586,0.00021626074,0.000003061384],"category_scores_gemma":[0.0003002049,0.000074285934,0.000037054804,0.000088529116,0.00018192407,0.000003913802,0.0005567463,0.00023152542,4.4613952e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001894507,0.00005184864,0.00516533,0.0032034554,0.000055851342,9.502622e-7,0.001356569,0.000106980726,0.9737673,0.011937749,0.00024401145,0.00392051],"study_design_scores_gemma":[0.00067020743,0.0004371977,0.047212355,0.0005384094,0.000020430267,0.0000035163268,0.0021376873,0.005937092,0.93339866,0.008680092,0.0007630582,0.00020127518],"about_ca_topic_score_codex":0.00008216244,"about_ca_topic_score_gemma":0.000039484134,"teacher_disagreement_score":0.042047024,"about_ca_system_score_codex":0.00002309199,"about_ca_system_score_gemma":0.00017700347,"threshold_uncertainty_score":0.30292925},"labels":[],"label_agreement":null},{"id":"W4254037848","doi":"10.1007/978-3-319-67199-4_193","title":"Mitogen-Activated Protein Kinases","year":2017,"lang":"en","type":"book-chapter","venue":"","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Institute for Research in Immunology and Cancer","funders":"","keywords":"Mitogen-activated protein kinase; Kinase; Cell biology; Chemistry; Biology","score_opus":0.021580523433992176,"score_gpt":0.23458300397695808,"score_spread":0.21300248054296592,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4254037848","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0040518926,0.00065636984,0.00006702282,0.000045294455,0.00035120422,0.00040308337,0.00009462512,0.000030604257,0.9942999],"genre_scores_gemma":[0.03925039,0.00010501148,0.00015118287,0.00008624468,0.00066865364,0.00002623093,0.0006331694,0.00006593063,0.95901316],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990455,0.000008114014,0.00016731907,0.00045942,0.00012293545,0.00019674306],"domain_scores_gemma":[0.9987564,0.0000025327038,0.00017996346,0.0008834542,0.00008061407,0.00009700363],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00004700179,0.00031043316,0.00023462354,0.000036259513,0.0001119971,0.00003830607,0.00031593154,0.00056291086,0.0006070908],"category_scores_gemma":[0.000035310306,0.00027305543,0.00017201906,0.0000021858457,0.00008790773,0.0000015235661,0.00017307872,0.00013417928,0.00022344606],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005770057,0.000010289678,0.000003696109,0.000033897482,0.000107654574,0.000026348229,0.000003883718,7.1313e-8,0.95832664,0.01139044,0.025781734,0.004257674],"study_design_scores_gemma":[0.00014190892,0.00013937951,0.0000042776687,0.000036925907,0.000012939877,0.000008352542,8.0718894e-7,1.4586992e-7,0.43374637,0.0006498515,0.56503296,0.00022610823],"about_ca_topic_score_codex":0.000026416537,"about_ca_topic_score_gemma":0.000048383048,"teacher_disagreement_score":0.5392512,"about_ca_system_score_codex":0.000008773507,"about_ca_system_score_gemma":0.00011974601,"threshold_uncertainty_score":0.99997216},"labels":[],"label_agreement":null},{"id":"W4255458617","doi":"10.3390/books978-3-03842-413-0","title":"An Updated View on an Emerging Target: Selected Papers from the 8th International Conference on Protein Kinase CK2","year":2017,"lang":"en","type":"book","venue":"","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institute of General Medical Sciences; Natural Sciences and Engineering Research Council of Canada; Schulich School of Medicine and Dentistry, Western University; Schulich School of Medicine and Dentistry; Universität des Saarlandes; City University of New York; School of Medicine, Boston University; Collegio Ghislieri di Pavia; Deutsche Forschungsgemeinschaft; Associazione Italiana per la Ricerca sul Cancro; Canadian Institutes of Health Research; Universität Ulm","keywords":"Computer science; Political science","score_opus":0.020602863577209682,"score_gpt":0.2671349620025971,"score_spread":0.24653209842538742,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4255458617","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.052858036,0.00018422626,0.00025443736,0.00069958344,0.00071334996,0.0011094692,0.00092762586,0.00008727167,0.943166],"genre_scores_gemma":[0.3999608,0.00024129362,0.00089798216,0.002152067,0.0024453446,0.00013635097,0.056865662,0.00014040251,0.5371601],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984517,0.00012123556,0.00022356318,0.0007101064,0.00025581033,0.00023755594],"domain_scores_gemma":[0.99839675,0.000006165135,0.0002318311,0.0010504945,0.00018602128,0.00012876252],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00013096113,0.0003716287,0.00024075591,0.00003550347,0.00019740692,0.00012581337,0.0009682971,0.00040591555,0.0018762406],"category_scores_gemma":[0.000038875914,0.00026060906,0.00008761218,0.000017491962,0.0000799112,0.0000061192773,0.00009357588,0.00031487603,0.000070895105],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003554099,0.00019879441,0.00004463853,0.000013476946,0.00030386497,0.0000390196,0.00007271031,0.0000086207665,0.9299362,0.010425575,0.04772795,0.010873751],"study_design_scores_gemma":[0.0005821325,0.0011212545,0.0002725302,0.0001578428,0.00003601372,0.0000031002953,0.000030747957,0.00020034976,0.1344268,0.00090547046,0.86168545,0.000578322],"about_ca_topic_score_codex":0.00008492399,"about_ca_topic_score_gemma":0.00028615113,"teacher_disagreement_score":0.8139575,"about_ca_system_score_codex":0.000033925,"about_ca_system_score_gemma":0.00042981518,"threshold_uncertainty_score":0.9999846},"labels":[],"label_agreement":null},{"id":"W4256429561","doi":"10.3109/9781420020588-14","title":"Apoptosis Modulators: p53 Targeting","year":2007,"lang":"en","type":"book-chapter","venue":"","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Apoptosis; Chemistry; Biochemistry","score_opus":0.019979597610203296,"score_gpt":0.23497497308322624,"score_spread":0.21499537547302294,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4256429561","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.003175468,0.00091695256,0.0021102256,0.000021881904,0.00041767137,0.00017304567,0.000030936815,0.000039617225,0.9931142],"genre_scores_gemma":[0.04126949,0.00030400968,0.002550719,0.0005163112,0.0017289786,0.0000063423463,0.0008144997,0.00011307668,0.95269656],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99872,0.0000066915736,0.00029736248,0.0005101717,0.00017467287,0.0002910944],"domain_scores_gemma":[0.99920505,0.0000069093194,0.00012641755,0.0004455998,0.000084183535,0.0001318229],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00016506822,0.0003364854,0.00024693005,0.00007271268,0.00006251876,0.000018550007,0.00020272675,0.00072816305,0.0006882481],"category_scores_gemma":[0.00002139987,0.00031425257,0.00022601523,0.000011137902,0.00005108906,0.0000011925187,0.00016081393,0.00017641536,0.00023596374],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009760429,0.000049830585,0.00013149175,0.00015220772,0.0004885546,0.00002828739,0.000033046577,0.000011722647,0.6685264,0.12290818,0.18479484,0.022777809],"study_design_scores_gemma":[0.00013745131,0.00012009602,0.000004567722,0.000022324115,0.000027151067,0.000006227334,0.0000050695,0.000004473446,0.18858846,0.00078333507,0.8099079,0.0003929596],"about_ca_topic_score_codex":0.0000121398525,"about_ca_topic_score_gemma":0.00001060531,"teacher_disagreement_score":0.62511307,"about_ca_system_score_codex":0.000017032822,"about_ca_system_score_gemma":0.00006046484,"threshold_uncertainty_score":0.999931},"labels":[],"label_agreement":null},{"id":"W4256628608","doi":"10.3410/f.725773107.793511270","title":"Faculty Opinions recommendation of BRAF Mutants Evade ERK-Dependent Feedback by Different Mechanisms that Determine Their Sensitivity to Pharmacologic Inhibition.","year":2015,"lang":"en","type":"dataset","venue":"Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Sensitivity (control systems); MAPK/ERK pathway; Mutant; Process (computing); Pharmacology; Computational biology; Biology; Computer science; Cell biology; Genetics; Kinase; Gene; Engineering","score_opus":0.03932157064087754,"score_gpt":0.3301473169275142,"score_spread":0.29082574628663665,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4256628608","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000095439886,0.00074377545,0.00040626797,0.043180767,0.0010399637,0.0016883971,0.9528012,0.00002086817,0.000023265611],"genre_scores_gemma":[0.00094117847,0.0003402354,0.00026684903,0.005517113,0.00030131114,0.00025412723,0.99171865,0.0000327069,0.0006278017],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99581265,0.0007466316,0.0010686199,0.00087138586,0.001084,0.0004166847],"domain_scores_gemma":[0.9942768,0.00006223034,0.0010995935,0.0011900924,0.0028909007,0.00048037907],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0013267561,0.00064495986,0.00089445204,0.00018361019,0.00017179806,0.00008496556,0.00085858203,0.0008326831,0.00017673193],"category_scores_gemma":[0.002066019,0.0004076538,0.0004805234,0.00057746645,0.00016958409,0.000034892066,0.00088339584,0.00061784434,0.000032386633],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000042097585,0.0004918985,0.0000024907383,0.0018056959,0.00013974923,8.5391116e-7,0.000039120663,1.6115368e-7,0.00876343,0.000015237997,0.98759943,0.0010998421],"study_design_scores_gemma":[0.00089265464,0.0004147171,0.00018626176,0.002382594,0.0001410804,0.00007930991,0.000029139406,0.0000046097443,0.028395668,0.000024644865,0.9670328,0.00041650792],"about_ca_topic_score_codex":0.000025046433,"about_ca_topic_score_gemma":0.000017792492,"teacher_disagreement_score":0.038917422,"about_ca_system_score_codex":0.0001038325,"about_ca_system_score_gemma":0.00032933053,"threshold_uncertainty_score":0.9998375},"labels":[],"label_agreement":null},{"id":"W4281393985","doi":"10.1021/acs.jmedchem.2c00173","title":"Illuminating the Dark: Highly Selective Inhibition of Serine/Threonine Kinase 17A with Pyrazolo[1,5- <i>a</i> ]pyrimidine-Based Macrocycles","year":2022,"lang":"en","type":"article","venue":"Journal of Medicinal Chemistry","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Structural Genomics Consortium; Deutsche Forschungsgemeinschaft","keywords":"Kinome; Chemistry; Serine; Pyrimidine; Kinase; Programmed cell death; Protein kinase A; Threonine; Biochemistry; Cell growth; In vitro; Drug discovery; Apoptosis; Cell biology; Cancer research; Phosphorylation; Biology","score_opus":0.0054145322059472485,"score_gpt":0.2062778087777506,"score_spread":0.20086327657180333,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281393985","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965201,0.0008051046,0.00036317224,0.0007548118,0.000091652495,0.000086103726,0.000025766138,0.000004834146,0.0013484367],"genre_scores_gemma":[0.99874276,0.000030817726,0.0003403646,0.00025807496,0.00043033052,0.000012457486,0.000051278505,0.00002061453,0.00011331711],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986183,0.00006275985,0.00042185627,0.00017991218,0.0005150823,0.00020208782],"domain_scores_gemma":[0.9987143,0.00004429895,0.00065370096,0.00020889712,0.00028055743,0.00009821165],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005762218,0.0001688568,0.00025575643,0.00003556469,0.00016903183,0.00000760873,0.0002458745,0.00006742058,0.000050540122],"category_scores_gemma":[0.00012084044,0.00011498119,0.00011663058,0.0001635171,0.00015589368,0.000005854277,0.00009369377,0.00041287998,1.834171e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008362225,0.00012490335,0.00070481043,0.00011308121,0.00007223295,0.00012959121,0.00010251613,0.00068934803,0.9946407,0.000007709564,0.0018818572,0.0006970491],"study_design_scores_gemma":[0.0017150337,0.0013213413,0.0003575991,0.00009035431,0.000088136556,0.00096975226,0.0011282107,0.000060238108,0.9900419,0.00003239602,0.0040614507,0.0001335746],"about_ca_topic_score_codex":0.000009878989,"about_ca_topic_score_gemma":0.0000043336763,"teacher_disagreement_score":0.0045987656,"about_ca_system_score_codex":0.000053699932,"about_ca_system_score_gemma":0.00034993343,"threshold_uncertainty_score":0.46887967},"labels":[],"label_agreement":null},{"id":"W4281786110","doi":"10.1200/jco.2022.40.16_suppl.9547","title":"Overall survival (OS) with first-line atezolizumab (A) or placebo (P) in combination with vemurafenib (V) and cobimetinib (C) in <i>BRAF</i><sup>V600</sup> mutation-positive advanced melanoma: Second interim OS analysis of the phase 3 IMspire150 study.","year":2022,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada)","funders":"","keywords":"Medicine; Hazard ratio; Vemurafenib; Interim analysis; Internal medicine; Melanoma; Gastroenterology; Oncology; Metastatic melanoma; Cancer; Confidence interval; Randomized controlled trial; Cancer research","score_opus":0.037436212219799016,"score_gpt":0.37055697196171805,"score_spread":0.333120759741919,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281786110","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99826235,0.00010032218,0.00015436941,0.0004346273,0.00015099766,0.00053879747,0.000059096576,0.0000020243194,0.00029739845],"genre_scores_gemma":[0.9991737,0.000051874034,0.0002700372,0.0002473026,0.000060461414,0.000035404188,0.000044171076,0.000016189259,0.00010086067],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99661505,0.0011348278,0.0014259886,0.00032527608,0.0003016129,0.00019723458],"domain_scores_gemma":[0.997159,0.000903555,0.0013838777,0.00022957397,0.0002231507,0.000100851445],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018605326,0.00018287811,0.0010455288,0.00022039961,0.00007540208,0.000010278415,0.00028321758,0.00014284432,0.00010686819],"category_scores_gemma":[0.00057754735,0.00011559802,0.00017157807,0.00046143914,0.00017161675,0.000020421408,0.00018364066,0.0005421657,2.21494e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.24854638,0.029454902,0.6035096,0.00011579346,0.006729046,0.002612977,0.0056398367,0.056795143,0.011493206,0.00020539374,0.00030933737,0.034588415],"study_design_scores_gemma":[0.15018348,0.196848,0.62750316,0.00011889994,0.0018224532,0.0005435675,0.0064014276,0.0044526705,0.0045481203,0.0001103933,0.0068432577,0.00062456523],"about_ca_topic_score_codex":0.000059041307,"about_ca_topic_score_gemma":0.006568695,"teacher_disagreement_score":0.1673931,"about_ca_system_score_codex":0.00009013563,"about_ca_system_score_gemma":0.0007305463,"threshold_uncertainty_score":0.47139505},"labels":[],"label_agreement":null},{"id":"W4281861539","doi":"10.1200/jco.2022.40.16_suppl.9516","title":"Pembrolizumab (pembro) plus dabrafenib (dab) and trametinib (tram) in <i>BRAF</i><sup>V600E/K</sup>-mutant melanoma: Long-term follow-up of KEYNOTE-022 parts 1, 2, and 3.","year":2022,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Dabrafenib; Medicine; Tolerability; Trametinib; Pembrolizumab; Melanoma; Placebo; Internal medicine; Adverse effect; Metastatic melanoma; Oncology; Dermatology; Vemurafenib; Cancer; Cancer research; Pathology; Immunotherapy; MAPK/ERK pathway; Chemistry","score_opus":0.05212084778346847,"score_gpt":0.35385471353698156,"score_spread":0.3017338657535131,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281861539","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946299,0.002488807,0.00013878781,0.0007403522,0.0008238873,0.00028776645,0.00004643835,0.000005317102,0.0008387308],"genre_scores_gemma":[0.9967233,0.0012789832,0.00048850686,0.0006720642,0.0005119008,0.000018096174,0.000028823166,0.00003364873,0.0002447067],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9952243,0.0010717191,0.0023877292,0.0005010471,0.0003825773,0.00043265804],"domain_scores_gemma":[0.9969838,0.00068419403,0.0014433516,0.00035070608,0.00015440947,0.0003835024],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030814887,0.00028124533,0.0014896499,0.00016875526,0.000107456835,0.00001838822,0.00041500828,0.00049598893,0.00012191724],"category_scores_gemma":[0.0011981974,0.00024492678,0.00040504176,0.00015173519,0.00036666656,0.000018365574,0.00045656261,0.0009775112,0.0000014231326],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06178533,0.00817017,0.52228254,0.00057348533,0.0019248774,0.005708859,0.0025906865,0.0018917597,0.12627271,0.0013392615,0.0071372553,0.26032305],"study_design_scores_gemma":[0.1590518,0.10392458,0.4717102,0.00025615108,0.001220921,0.011769081,0.0021757418,0.0016033956,0.02227527,0.0019985628,0.22195747,0.0020568194],"about_ca_topic_score_codex":0.00002485225,"about_ca_topic_score_gemma":0.00011078368,"teacher_disagreement_score":0.25826624,"about_ca_system_score_codex":0.000064061685,"about_ca_system_score_gemma":0.0011116521,"threshold_uncertainty_score":0.99878246},"labels":[],"label_agreement":null},{"id":"W4282022545","doi":"10.1200/jco.2022.40.16_suppl.9522","title":"Long-term survival in advanced melanoma for patients treated with nivolumab plus ipilimumab in CheckMate 067.","year":2022,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":86,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Ipilimumab; Nivolumab; Internal medicine; Placebo; Oncology; Gastroenterology; Cancer; Immunotherapy; Pathology","score_opus":0.043367404318560704,"score_gpt":0.3662485159631802,"score_spread":0.3228811116446195,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282022545","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99782944,0.00017148016,0.000067736204,0.00015125333,0.00073298253,0.00034363067,0.000025173971,0.0000028948646,0.0006754087],"genre_scores_gemma":[0.9985451,0.00011912382,0.0004702896,0.0002126719,0.00023782332,0.00004516714,0.0000698046,0.000023183338,0.00027682644],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973206,0.0004788087,0.0014021234,0.00028465255,0.00021018894,0.0003036458],"domain_scores_gemma":[0.99831307,0.0002540231,0.00093654526,0.000189464,0.00016934313,0.00013753131],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014552771,0.00015309258,0.00083922525,0.00011313756,0.000047938418,0.000005341499,0.0003007204,0.00022804538,0.000032943048],"category_scores_gemma":[0.00052985817,0.00012519016,0.00021641552,0.00012527591,0.000071796465,0.0000094454745,0.00013093943,0.00045984113,0.000001312949],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.021589026,0.0020720125,0.94355804,0.000024215607,0.00011455263,0.0002972059,0.000051127277,0.00032763596,0.0029603483,0.000027362943,0.0002097789,0.028768698],"study_design_scores_gemma":[0.04289931,0.047902893,0.8921627,0.000031326166,0.000056404173,0.00007953693,0.000112790454,0.000061784034,0.0013569916,0.000050375747,0.015028735,0.0002571672],"about_ca_topic_score_codex":0.000016129408,"about_ca_topic_score_gemma":0.0005502817,"teacher_disagreement_score":0.051395353,"about_ca_system_score_codex":0.00015866816,"about_ca_system_score_gemma":0.0008146453,"threshold_uncertainty_score":0.5105107},"labels":[],"label_agreement":null},{"id":"W4282946667","doi":"10.1158/1538-7445.am2022-98","title":"Abstract 98: The role of HORMAD1 in transformation of keratinocytes following vemurafenib treatment","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Business Development Bank of Canada; McGill University Health Centre","funders":"","keywords":"Vemurafenib; Trametinib; HaCaT; Cancer research; MAPK/ERK pathway; MEK inhibitor; Medicine; Melanoma; Cell growth; Kinase; Cell culture; Pharmacology; Biology; Metastatic melanoma; Cell biology","score_opus":0.04021768466794612,"score_gpt":0.3462389301832301,"score_spread":0.306021245515284,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282946667","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99326426,0.003011169,0.0000032051223,0.000093649425,0.00004136591,0.00024183065,0.000041057014,0.0000013344376,0.0033021097],"genre_scores_gemma":[0.9993043,0.00027824522,0.000008659654,0.0000070025003,0.000034183606,0.00022974965,0.000041080013,0.0000059135623,0.000090851776],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992848,0.00009398413,0.00015354545,0.000102385005,0.00021435008,0.00015090183],"domain_scores_gemma":[0.99972916,0.000022363625,0.00003148935,0.00016173799,0.000035519108,0.000019749374],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041496285,0.000048724378,0.00008633977,0.000052821655,0.00008937925,0.000004788061,0.00014640512,0.000026391821,0.00007592359],"category_scores_gemma":[0.000012475193,0.00003627891,0.00006279576,0.0001233252,0.00003690995,0.0000031241343,0.00004478539,0.000092293805,7.165872e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000115977964,0.000067349974,0.001831778,0.0000146291995,0.00002561401,0.0000013039518,0.0009279153,0.00031534352,0.982894,0.0001587384,0.00006109655,0.013586253],"study_design_scores_gemma":[0.0004313665,0.00038505654,0.0050607687,0.000007287019,0.0000035057,6.993167e-7,0.0016390777,0.000040949264,0.97743744,0.000092354676,0.014862695,0.000038801183],"about_ca_topic_score_codex":0.0008239983,"about_ca_topic_score_gemma":0.0002322982,"teacher_disagreement_score":0.014801598,"about_ca_system_score_codex":0.00005273319,"about_ca_system_score_gemma":0.00017620246,"threshold_uncertainty_score":0.1479411},"labels":[],"label_agreement":null},{"id":"W4282959988","doi":"10.1158/1538-7445.am2022-404","title":"Abstract 404: Identification of combination partners to combat acquired resistance to ulixertinib (ERK1/2 inhibitor) using transcriptomics","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Phenomenome Discoveries (Canada)","funders":"","keywords":"MAPK/ERK pathway; Transcriptome; PI3K/AKT/mTOR pathway; Cancer research; Drug resistance; Melanoma; Signal transduction; Biology; Phenotype; Gene; Protein kinase B; Acquired resistance; Gene expression; Cell biology; Genetics","score_opus":0.08828580308583767,"score_gpt":0.39857790460185183,"score_spread":0.31029210151601416,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282959988","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99717313,0.00042629224,0.0004108982,0.0006010917,0.00030750068,0.0005495656,0.00014243048,0.0000079350575,0.00038117575],"genre_scores_gemma":[0.9982434,0.000041122217,0.00011578162,0.00012399683,0.00010729738,0.00026135158,0.00009624824,0.000023686944,0.0009871039],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99835014,0.00014868026,0.00031196355,0.00037805887,0.0005012508,0.00030989767],"domain_scores_gemma":[0.999108,0.000018621236,0.00007400365,0.0003836333,0.0002830638,0.0001326365],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009925817,0.00009332294,0.00013008591,0.00015440257,0.0002542641,0.000028121865,0.0003288416,0.00005836772,0.000068693924],"category_scores_gemma":[0.00010468305,0.00010897573,0.000052578816,0.00043030118,0.000060145696,0.000006663587,0.00015190999,0.000116787916,0.00000636788],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043473218,0.00007687105,0.0003762962,0.00004893889,0.00001568242,0.0000019299098,0.00042080745,0.0006004475,0.98885804,0.00025243594,0.008016986,0.00089682493],"study_design_scores_gemma":[0.00041142886,0.0001902824,0.0039605517,0.000022924538,0.0000043033806,8.5380714e-7,0.00037150845,0.000033477936,0.94642115,0.00009005256,0.048368238,0.00012523872],"about_ca_topic_score_codex":0.000104740946,"about_ca_topic_score_gemma":0.00012315073,"teacher_disagreement_score":0.04243691,"about_ca_system_score_codex":0.00016198479,"about_ca_system_score_gemma":0.00025903233,"threshold_uncertainty_score":0.44439012},"labels":[],"label_agreement":null},{"id":"W4283016030","doi":"10.1200/po.21.00561","title":"Locoregionally Advanced, BRAF V600L–Positive, Mucosal Melanoma of the Hypopharynx Treated With a Combination of <i>BRAF</i> and <i>MEK</i> Inhibitors","year":2022,"lang":"en","type":"article","venue":"JCO Precision Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University; Université de Montréal; Hôpital Maisonneuve-Rosemont; Université de Sherbrooke","funders":"","keywords":"Mucosal melanoma; Medicine; Melanoma; Cancer research; MEK inhibitor; Trametinib; Dermatology; Oncology; Internal medicine; Biology; Genetics; MAPK/ERK pathway","score_opus":0.005415797021471048,"score_gpt":0.21854370826433173,"score_spread":0.21312791124286068,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283016030","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99565417,0.00044997767,0.00013863802,0.00030273607,0.00018473556,0.00047858982,0.00013426287,0.000007799819,0.0026490772],"genre_scores_gemma":[0.9985128,0.0000720382,0.00045854232,0.00027972483,0.00003991623,0.00007594706,0.00012323476,0.000019489276,0.00041828153],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986186,0.00029087788,0.00033164112,0.00033839833,0.00025586595,0.00016460249],"domain_scores_gemma":[0.9990396,0.00010818455,0.00034619603,0.00030655158,0.00014268249,0.000056775894],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024044325,0.00015383384,0.00027762388,0.00006588749,0.00013490432,0.0000041589733,0.00024105376,0.00012494922,0.000031429932],"category_scores_gemma":[0.000050133014,0.00011203499,0.000083763305,0.00016971648,0.0002111334,0.000007514435,0.0003854569,0.00014171172,7.5148046e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020958264,0.0006109289,0.01740189,0.000024559806,0.00006665793,0.000017655777,0.00014216371,0.00015001197,0.9436401,0.0005987172,0.0031902425,0.03206126],"study_design_scores_gemma":[0.007153764,0.013125567,0.045338143,0.000046399215,0.00009153878,0.00046525456,0.0003036583,0.00008878102,0.84168035,0.0005185712,0.0908541,0.0003338692],"about_ca_topic_score_codex":0.000027314398,"about_ca_topic_score_gemma":0.000042176052,"teacher_disagreement_score":0.10195973,"about_ca_system_score_codex":0.00003659974,"about_ca_system_score_gemma":0.00019545827,"threshold_uncertainty_score":0.45686543},"labels":[],"label_agreement":null},{"id":"W4283026383","doi":"10.1007/s11523-022-00888-9","title":"Cobimetinib in Pediatric and Young Adult Patients with Relapsed or Refractory Solid Tumors (iMATRIX-cobi): A Multicenter, Phase I/II Study","year":2022,"lang":"en","type":"article","venue":"Targeted Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada)","funders":"National Cancer Institute; Genentech; F. Hoffmann-La Roche","keywords":"Medicine; Refractory (planetary science); Multicenter study; Phases of clinical research; Internal medicine; Oncology; Clinical trial; Randomized controlled trial","score_opus":0.008484783094617332,"score_gpt":0.27110953133376103,"score_spread":0.2626247482391437,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283026383","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99775237,0.00024334222,0.0000122252195,0.00003180919,0.000389837,0.0010783643,0.000108437765,0.000025563815,0.00035805805],"genre_scores_gemma":[0.9981713,0.000056784775,0.00033573745,0.00021669397,0.000119367294,0.0003037534,0.00039205275,0.000039831197,0.000364428],"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9979176,0.00041372722,0.00044034747,0.000595669,0.00021038693,0.00042227333],"domain_scores_gemma":[0.99914473,0.000038719456,0.00025774885,0.00031638608,0.00010972588,0.00013270695],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030413043,0.00024668433,0.0003832438,0.00018022559,0.00025583926,0.000009195833,0.00022301353,0.0001282495,0.00011678686],"category_scores_gemma":[0.00016642216,0.00020925846,0.000042317184,0.000253646,0.00006013284,0.000007883665,0.00040001023,0.00033502944,0.000004257279],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.033551306,0.026477167,0.86671895,0.00009512214,0.00021628378,0.0009448751,0.00394666,0.00005321165,0.055481773,0.000017760269,0.0055099917,0.006986885],"study_design_scores_gemma":[0.1872081,0.41630644,0.33352226,0.000026745349,0.00057692366,0.00022688929,0.011497902,0.00061301177,0.0076054484,0.000025331046,0.04003537,0.0023555642],"about_ca_topic_score_codex":0.00010113702,"about_ca_topic_score_gemma":0.0005519096,"teacher_disagreement_score":0.5331967,"about_ca_system_score_codex":0.000090858375,"about_ca_system_score_gemma":0.0002767717,"threshold_uncertainty_score":0.85333127},"labels":[],"label_agreement":null},{"id":"W4283373229","doi":"10.1101/2022.02.17.22271120","title":"Clinical activity of MAPK targeted therapies in patients with non-V600 BRAF mutant tumors","year":2022,"lang":"en","type":"preprint","venue":"medRxiv","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; McGill University; University of Toronto; University Health Network; McGill University Health Centre; Jewish General Hospital","funders":"Daiichi Sankyo Europe; National Cancer Institute; Fonds de Recherche du Québec - Santé; Foundation Medicine; Bayer Yakuhin; Chugai Pharmaceutical; EMD Serono; PharmaMar; Eisai; University of Texas MD Anderson Cancer Center; Insmed; BeiGene; Helsinn; Les Laboratories Pierre Fabre; AstraZeneca; Novocure; Array BioPharma; Jazz Pharmaceuticals; Conquer Cancer Foundation; Merck KGaA; Taiho Pharmaceutical; Karyopharm Therapeutics; Exelixis; Sanofi; National Institutes of Health; Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; GlaxoSmithKline; Yakult Honsha; American Society of Clinical Oncology; Ono Pharmaceutical; Eli Lilly and Company; Bristol-Myers Squibb; Symphogen; Moderna; Incyte; Pfizer; Genentech; Aeglea BioTherapeutics; Helsinn Therapeutics; Amgen; Clovis Oncology; Melanoma Research Alliance; AIM at Melanoma; Daiichi Sankyo Company; American Cancer Society","keywords":"Medicine; Targeted therapy; MAPK/ERK pathway; Oncology; Lung cancer; Cancer; Melanoma; Internal medicine; Cancer research; Kinase; Biology; Genetics","score_opus":0.013277811220506495,"score_gpt":0.2615942006891303,"score_spread":0.2483163894686238,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283373229","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99820113,0.00013623066,0.00010330678,0.000027477512,0.00043083602,0.00047969125,0.00016879753,0.000010294069,0.000442236],"genre_scores_gemma":[0.9989087,0.00007152302,0.00028024512,0.000055126424,0.000099878314,0.000071668364,0.0003573819,0.00003985111,0.00011564524],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981246,0.00026016805,0.0004446078,0.0006522383,0.0002651222,0.00025326092],"domain_scores_gemma":[0.9986988,0.000021329763,0.00036032207,0.0007650299,0.000076677636,0.00007787164],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046347317,0.00027617117,0.0005063582,0.000079801845,0.000036436628,0.00000935707,0.00041816852,0.0002852609,0.00010475573],"category_scores_gemma":[0.00007655794,0.00023033157,0.0001731542,0.000091570735,0.00011802247,0.0000022643876,0.0007054353,0.00051987456,0.0000023238485],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005184537,0.0005718175,0.9447988,0.000102177655,0.00013322012,0.000018454253,0.00010478537,0.00005902632,0.05208978,0.000005778494,0.00006387981,0.0015337836],"study_design_scores_gemma":[0.0012163117,0.0009090228,0.94227344,0.000049583527,0.000020585503,8.169509e-7,0.000026373531,0.00001877541,0.053747848,0.000036048103,0.0014167632,0.00028444678],"about_ca_topic_score_codex":0.00007178785,"about_ca_topic_score_gemma":0.000058013942,"teacher_disagreement_score":0.0025254171,"about_ca_system_score_codex":0.000018943982,"about_ca_system_score_gemma":0.00024237898,"threshold_uncertainty_score":0.9392649},"labels":[],"label_agreement":null},{"id":"W4283459037","doi":"10.1186/s12575-022-00170-2","title":"A novel 7 RNA-based signature for prediction of prognosis and therapeutic responses of wild-type BRAF cutaneous melanoma","year":2022,"lang":"en","type":"article","venue":"Biological Procedures Online","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health","funders":"","keywords":"Melanoma; Signature (topology); Computational biology; RNA; Cancer research; Biology; Bioinformatics; Medicine; Gene; Genetics; Mathematics","score_opus":0.03382879992296209,"score_gpt":0.26695094034701516,"score_spread":0.23312214042405308,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283459037","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936249,0.0028126135,0.00040962306,0.00018977968,0.0000703821,0.0005010254,0.0023603283,0.000015423422,0.000015877557],"genre_scores_gemma":[0.9966488,0.00007168229,0.00174404,0.00029187722,0.00008358869,0.00007643647,0.0009894092,0.00001222094,0.00008197826],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999139,0.00006295079,0.00024376107,0.00030448716,0.00010162339,0.00014817397],"domain_scores_gemma":[0.9994768,0.00007741638,0.00015174533,0.00013781695,0.000114456234,0.00004177547],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014126992,0.00013068948,0.00020076113,0.000043430708,0.00007557916,0.000003050054,0.00013914853,0.00016384118,0.000018774555],"category_scores_gemma":[0.00035988964,0.00009785888,0.00008126635,0.00009666149,0.00011792752,0.0000011767418,0.00007075004,0.000087902794,6.375867e-8],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028475414,0.00053108425,0.0064692963,0.00010111792,0.000053440614,0.0000014731634,0.000013550592,0.000104510036,0.98797876,0.000070025155,0.00020714583,0.001622085],"study_design_scores_gemma":[0.0023508086,0.023521084,0.026393013,0.000040262872,0.00009869314,0.00015925137,0.00016896518,0.0009624127,0.9312058,0.00033384634,0.01444847,0.00031737552],"about_ca_topic_score_codex":0.0000043417604,"about_ca_topic_score_gemma":0.000008347575,"teacher_disagreement_score":0.056772914,"about_ca_system_score_codex":0.0000069307707,"about_ca_system_score_gemma":0.00014629739,"threshold_uncertainty_score":0.39905694},"labels":[],"label_agreement":null},{"id":"W4283727421","doi":"10.1051/medsci/2022083","title":"La résistance aux inhibiteurs de BRAF","year":2022,"lang":"fr","type":"review","venue":"médecine/sciences","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"Ligue Contre le Cancer; Agence Nationale de la Recherche","keywords":"Molecular biology; Biology","score_opus":0.06437820404074798,"score_gpt":0.33454828691499844,"score_spread":0.2701700828742505,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283727421","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.013418682,0.9144828,0.00030384513,0.0003469388,0.0011183416,0.0004024336,0.0001764048,0.00002704062,0.06972353],"genre_scores_gemma":[0.009490421,0.97976303,0.0012709051,0.00069202186,0.0008311135,0.00015810432,0.00020143329,0.000059321126,0.00753362],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9958027,0.00083762076,0.00066222873,0.001269371,0.00053021027,0.00089784164],"domain_scores_gemma":[0.9984557,0.00027806888,0.0004154104,0.00056687836,0.000044627097,0.00023929361],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0019831385,0.00061029056,0.0008648479,0.00016217121,0.00097531045,0.0001639583,0.001372913,0.0005205159,0.0013037287],"category_scores_gemma":[0.00047079168,0.0005467921,0.0005450021,0.0007676693,0.0013006874,0.000011872299,0.0006342539,0.00053606974,0.00012866664],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000041967523,0.0007434243,0.003339751,0.0064751944,0.0002649419,0.00038371468,0.00026832856,0.00012827912,0.0089663435,0.047342204,0.03225457,0.8997913],"study_design_scores_gemma":[0.0003226047,0.00079115824,0.000103741346,0.00076408207,0.00015204556,0.00047900106,0.00019799847,0.000021034084,0.00080055906,0.0005715447,0.9951629,0.00063334726],"about_ca_topic_score_codex":0.0000857168,"about_ca_topic_score_gemma":0.000072323506,"teacher_disagreement_score":0.9629083,"about_ca_system_score_codex":0.00010476096,"about_ca_system_score_gemma":0.0023065838,"threshold_uncertainty_score":0.99969834},"labels":[],"label_agreement":null},{"id":"W4283740577","doi":"10.1111/pcmr.13053","title":"The <scp>MITF</scp> regulatory network in melanoma","year":2022,"lang":"en","type":"article","venue":"Pigment Cell & Melanoma Research","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Centre hospitalier universitaire de Québec","funders":"Deutsche Krebshilfe; Cancer Research UK; Ludwig Institute for Cancer Research","keywords":"Microphthalmia-associated transcription factor; Biology; Melanoma; Transcription factor; Phenotype; Immune system; IRF4; Cancer research; Cell biology; Gene; Genetics","score_opus":0.025625129441628976,"score_gpt":0.27978217988864623,"score_spread":0.25415705044701725,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283740577","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9370301,0.008122964,0.000022530516,0.00022916529,0.0005833815,0.00073649164,0.000022391707,0.000021218642,0.053231794],"genre_scores_gemma":[0.97547656,0.0005806758,0.0000913308,0.0001337066,0.0007091013,0.0006511226,0.00014880733,0.000059507638,0.022149181],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99516904,0.0012154812,0.00043469292,0.0007400604,0.0010740083,0.0013666861],"domain_scores_gemma":[0.99812555,0.00034185985,0.00010769955,0.0010953541,0.000109213186,0.00022033216],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0040548234,0.00025399806,0.00023046207,0.00014445,0.0012792676,0.00009725411,0.0010944774,0.00015104156,0.00012391536],"category_scores_gemma":[0.00014787013,0.0002168984,0.00014438153,0.0005290485,0.00021487389,0.000006195308,0.0012060229,0.00078940747,0.00010968998],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037357572,0.0007997903,0.09839681,0.000100154284,0.00015301986,0.00034870073,0.0007844686,0.0018536533,0.50664026,0.0058266246,0.37637964,0.008343337],"study_design_scores_gemma":[0.0011214173,0.001553133,0.01863336,0.0000100641,0.000009493037,0.00003229424,0.0014236943,0.00017427122,0.067971036,0.00089327584,0.9080326,0.00014536036],"about_ca_topic_score_codex":0.00008304751,"about_ca_topic_score_gemma":0.00014323242,"teacher_disagreement_score":0.531653,"about_ca_system_score_codex":0.00017074824,"about_ca_system_score_gemma":0.00033042688,"threshold_uncertainty_score":0.9839221},"labels":[],"label_agreement":null},{"id":"W4285392780","doi":"10.1038/s41467-022-31690-w","title":"Qualitative differences in disease-associated MEK mutants reveal molecular signatures and aberrant signaling-crosstalk in cancer","year":2022,"lang":"en","type":"article","venue":"Nature Communications","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Core Research for Evolutional Science and Technology; University of Tokyo; Mitsubishi Foundation; Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science and Technology; Princess Takamatsu Cancer Research Fund; Université Laval","keywords":"Crosstalk; Mutant; Disease; Biology; Signal transduction; Genetics; Cancer research; Computational biology; Cell biology; Gene; Medicine; Internal medicine; Physics","score_opus":0.03331426079489453,"score_gpt":0.3463030226673061,"score_spread":0.3129887618724116,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4285392780","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9635924,0.0344072,0.0000073362635,0.0011020935,0.000067865665,0.00024118999,0.00040539308,0.000009134725,0.00016737019],"genre_scores_gemma":[0.99792737,0.00060967,0.00018403723,0.00043759774,0.000010635346,0.0002607624,0.0004619562,0.000014292172,0.000093653296],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9985053,0.0006672443,0.00021112693,0.00026605136,0.00015745054,0.0001928114],"domain_scores_gemma":[0.9991616,0.00010338746,0.000096962445,0.00051985617,0.000053205997,0.00006500923],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035417374,0.00013024344,0.00016530033,0.000086018175,0.00020175031,0.000018430008,0.0005094097,0.00015062414,0.000015232797],"category_scores_gemma":[0.00023184846,0.00013191959,0.000044222175,0.00025731517,0.00011483035,0.000004784731,0.00046339925,0.0006797302,2.7611196e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027924095,0.0008818523,0.1041882,0.000035305333,0.00014189725,0.00005170678,0.010549806,0.0003121736,0.87748057,0.004198847,0.0010458129,0.0008345763],"study_design_scores_gemma":[0.0063209767,0.0008987247,0.9079559,0.00031034628,0.00016163943,0.000014273918,0.01649161,0.0021362447,0.03220126,0.009680663,0.021759702,0.0020687038],"about_ca_topic_score_codex":0.00016551152,"about_ca_topic_score_gemma":0.002674505,"teacher_disagreement_score":0.84527934,"about_ca_system_score_codex":0.00005370055,"about_ca_system_score_gemma":0.00013301894,"threshold_uncertainty_score":0.5379524},"labels":[],"label_agreement":null},{"id":"W4288855843","doi":"10.5281/zenodo.6941499","title":"Antibody Characterization Report for Mitogenactivated protein kinase 1 (MAPK1)","year":2022,"lang":"en","type":"article","venue":"Zenodo (CERN European Organization for Nuclear Research)","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Neurological Institute and Hospital","funders":"","keywords":"Antibody; Characterization (materials science); Protein kinase A; Chemistry; Kinase; Medicine; Immunology; Biochemistry; Materials science; Nanotechnology","score_opus":0.0215495625673884,"score_gpt":0.2462846470707449,"score_spread":0.2247350845033565,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4288855843","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88648695,0.00004656005,0.09597906,0.00047656376,0.00024365536,0.0016665135,0.0011528698,0.00031050207,0.013637308],"genre_scores_gemma":[0.81700623,0.00001095874,0.00026624405,0.00012683697,0.00027398457,0.0000013432375,0.17827195,0.00077855116,0.003263898],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9986773,0.00020500009,0.00021414833,0.00043079798,0.00021077962,0.0002619753],"domain_scores_gemma":[0.999038,0.00000325424,0.0001424896,0.00041649383,0.00030418942,0.00009558048],"candidate_categories":["sts","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004725604,0.000116238596,0.00010090452,0.000093906005,0.0018109059,0.0001462247,0.00044809948,0.00005200817,0.0018708889],"category_scores_gemma":[0.0003433773,0.00013274304,0.00006155701,0.00021443535,0.000044708482,0.000012665752,0.00076627487,0.000118010634,0.00014535744],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017240859,0.0001208593,0.000006538414,0.000030819498,0.000029437013,0.000023892922,0.00008956935,0.000011253016,0.9888414,0.00037916543,0.004738906,0.005555759],"study_design_scores_gemma":[0.00043135913,0.0005401509,0.00023708215,0.0000047596686,0.0000071711524,0.00020897656,0.00007821224,0.00007635769,0.1406781,0.000027482185,0.8575671,0.00014324952],"about_ca_topic_score_codex":0.0000044663752,"about_ca_topic_score_gemma":7.073998e-8,"teacher_disagreement_score":0.8528282,"about_ca_system_score_codex":0.00005116859,"about_ca_system_score_gemma":0.000009463966,"threshold_uncertainty_score":0.9994886},"labels":[],"label_agreement":null},{"id":"W4291782573","doi":"10.3899/jrheum.220367","title":"A Retrospective Analysis of Outcome in Melanoma Differentiation–Associated Gene 5–Related Interstitial Lung Disease Treated with Tofacitinib or Tacrolimus","year":2022,"lang":"en","type":"article","venue":"The Journal of Rheumatology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Internal medicine; Tacrolimus; Interstitial lung disease; Hazard ratio; Gastroenterology; Tocilizumab; Mortality rate; Proportional hazards model; Retrospective cohort study; Surgery; Lung; Disease; Transplantation; Confidence interval","score_opus":0.00900281164908297,"score_gpt":0.23844536508486508,"score_spread":0.2294425534357821,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4291782573","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99898,0.00016099006,0.00032857465,0.0000937007,0.000100934114,0.0001191091,0.00017010621,0.000004153467,0.00004242666],"genre_scores_gemma":[0.99963945,0.000062111445,0.0000116283845,0.00003441417,0.0000038531302,0.000008076187,0.0001531734,0.000013203205,0.00007407332],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99836415,0.0004633238,0.0006363801,0.0001425292,0.00020207258,0.00019154351],"domain_scores_gemma":[0.9987801,0.00004356999,0.00076533767,0.00020943416,0.00013271635,0.00006888087],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039696484,0.00013798918,0.0005413363,0.00029451674,0.00008712674,0.0000050889907,0.00027135885,0.0000684165,0.00024845797],"category_scores_gemma":[0.00016716025,0.000087522036,0.00017557248,0.00054326653,0.000090083784,0.0000050671874,0.00008996869,0.00022090049,3.296375e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028770417,0.00017923127,0.98671067,0.000008034297,0.0020580762,0.000054071414,0.00044740725,0.0019582282,0.0055646203,0.00007209564,0.000050555223,0.000019981137],"study_design_scores_gemma":[0.0044855406,0.0018269636,0.9829859,0.000027382295,0.0020733564,0.0007607434,0.00078928826,0.0040536774,0.0026506924,0.00007939443,0.00003118674,0.00023585928],"about_ca_topic_score_codex":0.00011955266,"about_ca_topic_score_gemma":0.00028470374,"teacher_disagreement_score":0.003724742,"about_ca_system_score_codex":0.000074126605,"about_ca_system_score_gemma":0.000109376204,"threshold_uncertainty_score":0.3569045},"labels":[],"label_agreement":null},{"id":"W4292182315","doi":"10.1101/2022.08.16.504086","title":"Kinase Suppressor of RAS 1 (KSR1) maintains the transformed phenotype of BRAFV600E mutant human melanoma cells","year":2022,"lang":"en","type":"preprint","venue":"bioRxiv (Cold Spring Harbor Laboratory)","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Children's Health Foundation; Science Foundation Ireland","keywords":"MAPK/ERK pathway; Biology; Kinase; Phenotype; Cell biology; Mutant; Cell growth; Cell cycle; Melanoma; Protein kinase A; Cancer research; Apoptosis; Genetics; Gene","score_opus":0.01124051392551464,"score_gpt":0.2180414584811038,"score_spread":0.20680094455558914,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4292182315","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99518037,0.0009622204,0.00047707066,0.000077172794,0.00074351416,0.0009568555,0.0014679076,0.000042429045,0.00009245277],"genre_scores_gemma":[0.9986602,0.00020514584,0.00045307374,0.000096380325,0.00029632324,0.00013970156,0.000007704842,0.00012010538,0.000021342788],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99714136,0.0002804011,0.0007903668,0.0008391472,0.0004294682,0.00051925454],"domain_scores_gemma":[0.9970355,0.00004026371,0.0006260311,0.0018321062,0.00029522227,0.00017089526],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00068264775,0.0005310183,0.0006642279,0.0001415979,0.00019816746,0.00003550048,0.001143272,0.0004905233,0.00025058756],"category_scores_gemma":[0.000081088794,0.0004678138,0.00038381925,0.00023892608,0.00029396417,0.000006554479,0.00071351364,0.000548362,0.0000051936286],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001331848,0.00024040267,0.00084435457,0.00048045936,0.00027996488,0.000026953885,0.000038700327,0.000086361484,0.996338,0.0012266289,0.0003029969,0.0000019865906],"study_design_scores_gemma":[0.00072030834,0.00040151222,0.0064224047,0.00007964273,0.00017546296,3.7873086e-8,0.000025105857,0.00002100388,0.9809333,0.0000060984603,0.010719992,0.0004951281],"about_ca_topic_score_codex":0.00011336961,"about_ca_topic_score_gemma":0.000014955021,"teacher_disagreement_score":0.015404703,"about_ca_system_score_codex":0.00006505865,"about_ca_system_score_gemma":0.00060717337,"threshold_uncertainty_score":0.9997774},"labels":[],"label_agreement":null},{"id":"W4292265616","doi":"10.1200/po.22.00107","title":"Clinical Activity of Mitogen-Activated Protein Kinase–Targeted Therapies in Patients With Non–V600 BRAF-Mutant Tumors","year":2022,"lang":"en","type":"review","venue":"JCO Precision Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; McGill University Health Centre; University of Toronto; University Health Network; McGill University; Jewish General Hospital","funders":"National Cancer Institute; Fonds de Recherche du Québec - Santé; Association Neurofibromatoses et Recklinghause; American Society of Clinical Oncology; Conquer Cancer Foundation","keywords":"Medicine; MAPK/ERK pathway; Lung cancer; Melanoma; Targeted therapy; Oncology; Cancer; Cancer research; Internal medicine; Protein kinase A; Mutant; Kinase; Biology; Gene; Genetics","score_opus":0.038454183383332424,"score_gpt":0.34254752105524694,"score_spread":0.3040933376719145,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4292265616","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.67962366,0.31567425,0.000049192306,0.0000116184965,0.0007015339,0.003209567,0.00024509034,0.000019283883,0.00046577284],"genre_scores_gemma":[0.096340865,0.8994677,0.00078307337,0.000064584005,0.00027085884,0.0010167208,0.0014227997,0.00017272696,0.00046068346],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99553883,0.0015410918,0.0011660989,0.0009875544,0.00034676638,0.00041963693],"domain_scores_gemma":[0.99750924,0.00021708925,0.0011725374,0.00085040805,0.00011745125,0.00013330094],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008307621,0.0005256865,0.0021502587,0.00023266369,0.00007508348,0.000010071057,0.0005910437,0.0009348075,0.0002540661],"category_scores_gemma":[0.00036269752,0.00038914825,0.00045593534,0.00036957848,0.00017350898,0.000007704073,0.0004979449,0.0007544455,0.0000099851995],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012866524,0.0014020551,0.00073263946,0.0007729828,0.00026099518,0.000040133324,0.000042739262,0.0000011817921,0.00984612,0.000003960543,0.00021423445,0.9853963],"study_design_scores_gemma":[0.0024019629,0.0072242087,0.0025021525,0.0009413943,0.00011246096,0.000011409898,0.0000141242745,0.0000011608203,0.005741089,0.000009401582,0.9805688,0.00047182266],"about_ca_topic_score_codex":0.000036752164,"about_ca_topic_score_gemma":0.00004922195,"teacher_disagreement_score":0.9849245,"about_ca_system_score_codex":0.00015365168,"about_ca_system_score_gemma":0.001235788,"threshold_uncertainty_score":0.99985605},"labels":[],"label_agreement":null},{"id":"W4293199696","doi":"10.1101/2022.08.24.505130","title":"On the therapeutic potential of MAPK4 in triple-negative breast cancer","year":2022,"lang":"en","type":"preprint","venue":"bioRxiv (Cold Spring Harbor Laboratory)","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Institute for Research in Immunology and Cancer","funders":"Helse Nord RHF; Deutsche Forschungsgemeinschaft; Cancer Research Society; Kreftforeningen","keywords":"Triple-negative breast cancer; PI3K/AKT/mTOR pathway; Cancer research; Protein kinase B; Kinase; Subfamily; Cell growth; Biology; Cancer; Breast cancer; Signal transduction; Cell biology; Gene; Genetics","score_opus":0.011440819637779218,"score_gpt":0.22296386856018097,"score_spread":0.21152304892240176,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4293199696","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956859,0.0010096035,0.00014736791,0.000346539,0.0010009179,0.000702043,0.0010483731,0.000022885115,0.000036407924],"genre_scores_gemma":[0.9983111,0.00042342293,0.00008886369,0.0003761035,0.0002824674,0.00042951928,0.0000012886027,0.00006832055,0.000018902952],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99804664,0.00027817528,0.00037017878,0.0006754365,0.00028884463,0.00034070807],"domain_scores_gemma":[0.99841785,0.0000342817,0.00032916458,0.0009849827,0.0001567801,0.00007693917],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004321603,0.00035776,0.00035173167,0.00012232283,0.0000981836,0.00003281063,0.00061707094,0.00031758155,0.00029934285],"category_scores_gemma":[0.00006762997,0.0002994118,0.00017787638,0.00023109672,0.000116024465,0.0000033989468,0.00051541475,0.00056423433,0.0000057564926],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023294905,0.0001678467,0.002530294,0.000092294555,0.00018116094,0.000018493549,0.000009863063,0.00031739578,0.99481064,0.0012062371,0.0004277499,0.0000050815534],"study_design_scores_gemma":[0.0010891377,0.00022595873,0.19051766,0.00016988444,0.00009365144,5.3265694e-8,0.00001861251,0.00015022226,0.8049779,0.000027017695,0.00206418,0.0006657233],"about_ca_topic_score_codex":0.00019056957,"about_ca_topic_score_gemma":0.000014553252,"teacher_disagreement_score":0.18983275,"about_ca_system_score_codex":0.00009474366,"about_ca_system_score_gemma":0.0005607968,"threshold_uncertainty_score":0.9999458},"labels":[],"label_agreement":null},{"id":"W4295817741","doi":"10.1016/j.annonc.2022.07.925","title":"799P A pilot study of the neo-adjuvant use of vemurafenib plus cobimetinib in patients with BRAF mutant melanoma with palpable lymph node metastases","year":2022,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital; Sunnybrook Health Science Centre; McGill University Health Centre; Ottawa Hospital; Health Sciences Centre","funders":"","keywords":"Medicine; Vemurafenib; Melanoma; Internal medicine; Surgery; Oncology; Metastatic melanoma; Cancer; Cancer research","score_opus":0.0520053171506117,"score_gpt":0.27798662691980586,"score_spread":0.22598130976919417,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4295817741","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99847984,0.00012723047,0.000012122152,0.00008307952,0.00007712522,0.00066005724,0.0002644786,0.0000033854246,0.0002926511],"genre_scores_gemma":[0.9993624,0.000013994447,0.0001485135,0.00022474877,0.000011867679,0.00007761182,0.00007248461,0.000021683509,0.00006670549],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99818975,0.00045679943,0.00046668897,0.000318945,0.00030085945,0.0002669387],"domain_scores_gemma":[0.99861735,0.000064474945,0.0005183632,0.00052977,0.00021935166,0.000050681978],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003288473,0.0001789776,0.00053213397,0.00008863369,0.00006713839,0.0000035878315,0.0003364225,0.00004864953,0.000037276102],"category_scores_gemma":[0.000071289585,0.000118537086,0.000058839287,0.00026127006,0.00016231414,0.0000070370647,0.00033736203,0.00010698604,3.6448952e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01624595,0.014072799,0.8296011,0.000105887055,0.0008070684,0.00007682723,0.0011488657,0.005506421,0.129212,0.00015681724,0.00089661166,0.0021696305],"study_design_scores_gemma":[0.018154303,0.12621194,0.6944018,0.00005540691,0.00022649685,0.00004333151,0.002121687,0.000046528832,0.14857253,0.00002362492,0.009704835,0.00043751765],"about_ca_topic_score_codex":0.0009646094,"about_ca_topic_score_gemma":0.0007748719,"teacher_disagreement_score":0.13519931,"about_ca_system_score_codex":0.000021280948,"about_ca_system_score_gemma":0.00038334433,"threshold_uncertainty_score":0.4833802},"labels":[],"label_agreement":null},{"id":"W4295820891","doi":"10.1016/j.annonc.2022.07.939","title":"813P Time to development of central nervous system (CNS) metastases (mets) with atezolizumab (A) or placebo (P) combined with vemurafenib (V) + cobimetinib (C): Updated results from the phase III IMspire150 study","year":2022,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada)","funders":"","keywords":"Medicine; Atezolizumab; Vemurafenib; Placebo; Internal medicine; Oncology; Pembrolizumab; Pathology; Cancer; Immunotherapy; Metastatic melanoma","score_opus":0.03804869258544963,"score_gpt":0.3045034102998207,"score_spread":0.26645471771437107,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4295820891","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99559265,0.00009767574,0.00011501113,0.00040603656,0.00009506784,0.0014474574,0.0011668407,0.000023319533,0.0010559524],"genre_scores_gemma":[0.996517,0.000004983455,0.000985548,0.0003157165,0.000053550222,0.00019584082,0.0013923319,0.000033379496,0.0005016764],"study_design_codex":"randomized_trial","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.997277,0.000634898,0.00074581656,0.000546279,0.0003560824,0.0004399133],"domain_scores_gemma":[0.9982668,0.00014689832,0.00055256503,0.0006340556,0.00024156022,0.00015809997],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007729673,0.000284733,0.0006751197,0.00007500812,0.00022782065,0.000011096277,0.0005588421,0.00008351766,0.00018188167],"category_scores_gemma":[0.00007139434,0.00017720218,0.00007204228,0.00029910734,0.0001129137,0.0000049063906,0.0003792825,0.00014113256,0.000011231989],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5134033,0.0104668895,0.0007459639,0.000095834606,0.006012492,0.0009166075,0.008096732,0.0029244486,0.3213405,0.00009204002,0.08274317,0.05316202],"study_design_scores_gemma":[0.060462974,0.112056166,0.003026899,0.00008758236,0.00053728925,0.00018217658,0.010981713,0.0001444357,0.50995755,0.0000044943654,0.3017099,0.00084879185],"about_ca_topic_score_codex":0.00022524598,"about_ca_topic_score_gemma":0.00036016284,"teacher_disagreement_score":0.45294032,"about_ca_system_score_codex":0.00004272794,"about_ca_system_score_gemma":0.000862788,"threshold_uncertainty_score":0.7226095},"labels":[],"label_agreement":null},{"id":"W4295837169","doi":"10.1016/j.annonc.2022.07.1765","title":"1686P Evaluating the relationship between BRAF mutation class and patient demographics in an international cancer cohort","year":2022,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital; McGill University Health Centre","funders":"","keywords":"Medicine; Demographics; Cohort; Oncology; Cancer; Mutation; Internal medicine; Family medicine; Demography; Genetics; Gene","score_opus":0.15137463734243106,"score_gpt":0.4302997214824439,"score_spread":0.2789250841400128,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4295837169","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99713516,0.00028464608,0.000035691213,0.0015161622,0.0001559597,0.00017249702,0.000048417976,0.0000027024353,0.00064877066],"genre_scores_gemma":[0.9987876,0.00006899471,0.00009973895,0.00066335074,0.00007412285,0.00010495249,0.00017689752,0.000006198281,0.000018151066],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99907815,0.00030691657,0.00021060847,0.00016938406,0.0001331408,0.00010177647],"domain_scores_gemma":[0.9994994,0.00012325263,0.00014414998,0.00012102191,0.00008445489,0.000027759006],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005749372,0.00005613233,0.000091732785,0.00006081182,0.00009853668,0.000005160971,0.00012259815,0.00006748182,0.000020075446],"category_scores_gemma":[0.00018073841,0.00005045895,0.000028114095,0.00008571634,0.00006129096,0.00000596404,0.00011175157,0.00012431193,2.3117893e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007192285,0.00005223836,0.9646033,0.0000033616109,0.000028898086,0.0000023423747,0.00030813404,0.0007298064,0.00554772,0.0007357701,0.0002581942,0.02765833],"study_design_scores_gemma":[0.00036089122,0.0027006092,0.9848619,0.0000035633907,0.000013995662,0.000010374746,0.00034855888,0.00050548185,0.0014579156,0.0009175888,0.008745524,0.00007356211],"about_ca_topic_score_codex":0.00006475799,"about_ca_topic_score_gemma":0.0002369963,"teacher_disagreement_score":0.027584769,"about_ca_system_score_codex":0.000013736434,"about_ca_system_score_gemma":0.00011363547,"threshold_uncertainty_score":0.20576563},"labels":[],"label_agreement":null},{"id":"W4296929566","doi":"10.1016/j.ejca.2022.09.002","title":"Corrigendum to ‘p53 Reactivation by PRIMA-1Met (APR-246) sensitises V600E/KBRAF melanoma to vemurafenib’[Eur J of Cancer 55 (2016) 98–110]","year":2022,"lang":"en","type":"erratum","venue":"European Journal of Cancer","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Vemurafenib; Melanoma; Medicine; Cancer research; Protein kinase B; PI3K/AKT/mTOR pathway; MAPK/ERK pathway; Metastatic melanoma; Phosphorylation; Chemistry; Signal transduction","score_opus":0.015286994784977513,"score_gpt":0.2587760244581139,"score_spread":0.24348902967313635,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296929566","genre_codex":"empirical","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5170059,0.1117972,0.0033245392,0.0060548414,0.19157326,0.0025947536,0.007887383,0.00009335049,0.15966874],"genre_scores_gemma":[0.18313183,0.020470703,0.0015233725,0.006665242,0.022825392,0.00010242989,0.0017345716,0.0007869956,0.76275945],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9964208,0.00055124366,0.0010871928,0.0006315181,0.00078995427,0.0005193114],"domain_scores_gemma":[0.9967121,0.000018346193,0.0014604157,0.0006317388,0.0007300834,0.00044730978],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007396342,0.000538935,0.0008204907,0.00029379938,0.00013997118,0.00005541726,0.0007942398,0.00019646401,0.0009588105],"category_scores_gemma":[0.00022024121,0.0005076895,0.00036592188,0.00028928285,0.00006377285,0.00001795524,0.00038121827,0.0008132593,0.000037457456],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038974686,0.00005352741,0.00014151973,0.00006640832,0.00028674075,0.00012932684,0.00017070184,0.00006567586,0.31583282,0.000003816144,0.67177504,0.011084678],"study_design_scores_gemma":[0.00065525546,0.0011950745,0.0025851608,0.00034249967,0.00017864037,0.00007146529,0.0000896151,0.0000021174353,0.09218858,0.000002440914,0.90217596,0.00051320245],"about_ca_topic_score_codex":0.00027952372,"about_ca_topic_score_gemma":0.00014186888,"teacher_disagreement_score":0.6030907,"about_ca_system_score_codex":0.00023199196,"about_ca_system_score_gemma":0.0011335182,"threshold_uncertainty_score":0.99995446},"labels":[],"label_agreement":null},{"id":"W4297752154","doi":"","title":"Cutaneous mosaic syndromes associated with early postzygotic activating BRAF mutations","year":2017,"lang":"en","type":"preprint","venue":"HAL (Le Centre pour la Communication Scientifique Directe)","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Mosaic; Genetics; Mutation; Biology; Medicine; Gene","score_opus":0.014294349959851276,"score_gpt":0.2264035959307994,"score_spread":0.21210924597094813,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4297752154","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96845853,0.0003867637,0.009783554,0.0010370731,0.00014960136,0.0004030901,0.00020071391,0.00009617812,0.019484475],"genre_scores_gemma":[0.9822081,0.000107874104,0.0043386538,0.000040315284,0.00003140434,0.00006223555,0.0030192272,0.000063239146,0.010128996],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9968244,0.001548601,0.00032363398,0.0006547777,0.00029421868,0.00035437773],"domain_scores_gemma":[0.9956383,0.00032146196,0.00066755136,0.001956494,0.0012583116,0.00015789326],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011269836,0.00033733476,0.00032323008,0.00008824224,0.0005524855,0.00038325682,0.0009770092,0.0004122767,0.000033160468],"category_scores_gemma":[0.0023237392,0.0003391199,0.00015736633,0.00009469143,0.00023288613,0.000012724844,0.00084856345,0.00045581764,0.000016804312],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031227953,0.004487045,0.09500152,0.0011405607,0.0042582066,0.0005367749,0.030494278,0.0014284619,0.72387815,0.023666931,0.0057427483,0.10905305],"study_design_scores_gemma":[0.0034526528,0.000029896066,0.06288721,0.008668375,0.00052084774,0.00075759745,0.0005653511,0.0059431638,0.8932485,0.0052143647,0.015132392,0.0035796624],"about_ca_topic_score_codex":0.00062210124,"about_ca_topic_score_gemma":0.0012868315,"teacher_disagreement_score":0.16937035,"about_ca_system_score_codex":0.000056348727,"about_ca_system_score_gemma":0.00041573757,"threshold_uncertainty_score":0.99990606},"labels":[],"label_agreement":null},{"id":"W4307492590","doi":"10.15252/emmm.202215677","title":"The AhR‐SRC axis as a therapeutic vulnerability in BRAFi‐resistant melanoma","year":2022,"lang":"en","type":"article","venue":"EMBO Molecular Medicine","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"College of Natural Resources and Sciences, Humboldt State University; Centre Hospitalier Universitaire de Rennes; Université de Rennes 1; Institut National Du Cancer; Ligue Contre le Cancer; Institut National de la Santé et de la Recherche Médicale; CNIB; Centre National de la Recherche Scientifique; Stichting Tegen Kanker; Alliance Nationale pour les Sciences de la Vie et de la Santé","keywords":"Melanoma; Cancer research; Downregulation and upregulation; Proto-oncogene tyrosine-protein kinase Src; Dasatinib; Aryl hydrocarbon receptor; Biology; Medicine; Transcription factor; Immunology; Signal transduction; Cell biology; Gene; Genetics","score_opus":0.010478176335757492,"score_gpt":0.2579483852212526,"score_spread":0.2474702088854951,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4307492590","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9695682,0.013364741,0.0004896382,0.0039892476,0.00048499124,0.0004911801,0.000013048155,0.000022915325,0.011576036],"genre_scores_gemma":[0.99566627,0.00013348248,0.000035561225,0.002596315,0.00016315494,0.00020018227,0.00010272751,0.00003502775,0.0010672954],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9976852,0.0005268076,0.0003848104,0.00051923963,0.00045672225,0.00042721312],"domain_scores_gemma":[0.99880207,0.00006204076,0.0001038091,0.0008599506,0.000051590847,0.0001205162],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011188715,0.00023095553,0.0002553885,0.00006653685,0.00034937647,0.0000110339115,0.0005022943,0.0000852091,0.0002499231],"category_scores_gemma":[0.00027091286,0.0001671516,0.00013165269,0.0002639002,0.00020553959,0.0000024063154,0.00028729002,0.0003217014,0.0000123512045],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044632715,0.00012135442,0.0014134697,0.000018334076,0.00009969321,0.00020236195,0.0002780686,0.000061348626,0.9833148,0.004382046,0.0022630931,0.0073991194],"study_design_scores_gemma":[0.0041321395,0.0052577876,0.01661244,0.000033476124,0.00009354524,0.00024987594,0.0018410775,0.00016888723,0.1274734,0.008026211,0.83542985,0.0006813171],"about_ca_topic_score_codex":0.0002253067,"about_ca_topic_score_gemma":0.000105285195,"teacher_disagreement_score":0.8558414,"about_ca_system_score_codex":0.000058983525,"about_ca_system_score_gemma":0.00016011823,"threshold_uncertainty_score":0.6816244},"labels":[],"label_agreement":null},{"id":"W4307642528","doi":"10.1007/s40264-022-01248-2","title":"Characterization of Serous Retinopathy Associated with Cobimetinib: Integrated Safety Analysis of Four Studies","year":2022,"lang":"en","type":"article","venue":"Drug Safety","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada)","funders":"Genentech; F. Hoffmann-La Roche; Roche","keywords":"Medicine; Serous fluid; Retinopathy; Ophthalmology; Internal medicine; Endocrinology","score_opus":0.013423989524145823,"score_gpt":0.22816094373591547,"score_spread":0.21473695421176964,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4307642528","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969976,0.00010662712,0.0005702756,0.00006517427,0.000097773,0.00017632832,0.0015978966,0.000013654025,0.00037469264],"genre_scores_gemma":[0.9936745,0.000119865486,0.00008605251,0.000063291925,0.000017961256,0.000019625795,0.005319018,0.000016552092,0.0006831011],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986438,0.00030870995,0.00041419367,0.00026569024,0.00021625192,0.00015135799],"domain_scores_gemma":[0.99891806,0.0000405388,0.0004283719,0.00029289073,0.00028653804,0.00003361254],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00057766587,0.000141802,0.00043060328,0.00012278689,0.00011424173,0.0000027512328,0.00016082362,0.000051634535,0.00007643315],"category_scores_gemma":[0.00014659736,0.00012218553,0.00013231246,0.0007759319,0.000074346586,0.000003089322,0.00014856941,0.00009359521,3.968524e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010263665,0.00018278154,0.026479607,0.000029100276,0.00282523,0.000005429082,0.0009862033,0.0007142087,0.96679264,0.000103872706,0.00012007269,0.00073450943],"study_design_scores_gemma":[0.0025636354,0.0014930192,0.2935734,0.0000691116,0.0022844847,0.000011600362,0.0039879344,0.00088834716,0.676257,0.000016997488,0.018222697,0.0006317591],"about_ca_topic_score_codex":0.000034228644,"about_ca_topic_score_gemma":0.00010512287,"teacher_disagreement_score":0.29053563,"about_ca_system_score_codex":0.000039773546,"about_ca_system_score_gemma":0.00008627484,"threshold_uncertainty_score":0.49825814},"labels":[],"label_agreement":null},{"id":"W4307844453","doi":"10.1038/s41467-022-34179-8","title":"CDK12 is hyperactivated and a synthetic-lethal target in BRAF-mutated melanoma","year":2022,"lang":"en","type":"article","venue":"Nature Communications","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Université du Québec à Montréal; Université de Montréal; Institute for Research in Immunology and Cancer","funders":"CIHR Skin Research Training Centre; University of Colorado School of Medicine, Anschutz Medical Campus; University of Toronto; Cancer Research Society; Natural Sciences and Engineering Research Council of Canada; Government of Canada; McGill University","keywords":"Melanoma; Cancer research; Mutation; Medicine; Biology; Computational biology; Genetics; Gene","score_opus":0.011272290712120582,"score_gpt":0.26318901355589375,"score_spread":0.25191672284377314,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4307844453","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9833501,0.007110782,0.00001671791,0.0031912536,0.00009568372,0.00021057572,0.00014846817,0.000019767325,0.005856666],"genre_scores_gemma":[0.99630874,0.00022402039,0.0016014215,0.0008556939,0.000021817474,0.000097255455,0.0005691676,0.000017674458,0.00030418584],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.999141,0.00022326062,0.00015161859,0.00023200765,0.00009624176,0.00015589347],"domain_scores_gemma":[0.9988226,0.000050618786,0.000058978432,0.00097429997,0.0000432888,0.000050210554],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018324019,0.00010765443,0.00011368032,0.000072887684,0.0002656883,0.000014757318,0.0005300284,0.00016495111,0.000083509294],"category_scores_gemma":[0.00009351544,0.0001143164,0.00003847494,0.00019520125,0.0000707114,0.000004270365,0.0007298077,0.0006343318,0.0000041519525],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010995045,0.00042008248,0.019022644,0.000010568246,0.00007911507,0.00001595934,0.0006529959,0.000028160865,0.9649527,0.0030684918,0.009977529,0.0016618021],"study_design_scores_gemma":[0.0012077715,0.00032024193,0.020471998,0.000012237446,0.000026838192,0.00026877568,0.0006678545,0.00078744115,0.116886124,0.0004613585,0.8584487,0.00044066124],"about_ca_topic_score_codex":0.00003999905,"about_ca_topic_score_gemma":0.00008735388,"teacher_disagreement_score":0.84847116,"about_ca_system_score_codex":0.000022030965,"about_ca_system_score_gemma":0.000067627036,"threshold_uncertainty_score":0.46616873},"labels":[],"label_agreement":null},{"id":"W4307911011","doi":"10.1016/s0959-8049(22)00972-8","title":"Characterizing mechanisms of resistance to BRAF and MEK inhibitors in cancers with Class 2 BRAF mutations: uncovering novel therapeutic opportunities","year":2022,"lang":"en","type":"article","venue":"European Journal of Cancer","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; McGill University Health Centre; University of Toronto; University Health Network; McGill University; Jewish General Hospital","funders":"","keywords":"Melanoma; Cancer research; Vemurafenib; Medicine; Mutant; Targeted therapy; Cancer; MEK inhibitor; Biology; MAPK/ERK pathway; Gene; Internal medicine; Signal transduction; Genetics; Metastatic melanoma","score_opus":0.02404520859833804,"score_gpt":0.23654860479195203,"score_spread":0.212503396193614,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4307911011","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99454993,0.0018859705,0.0017311627,0.0004558716,0.00021650532,0.00008535422,0.000052133648,0.0000021407425,0.0010209032],"genre_scores_gemma":[0.9981677,0.00021816666,0.00052486104,0.00061407447,0.000097086355,0.0000070362626,0.000004491374,0.000023550205,0.000343029],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99920297,0.00010578792,0.00027484415,0.000121417936,0.00017555535,0.000119418655],"domain_scores_gemma":[0.9994945,0.000009220622,0.00026491893,0.00009059589,0.00007674138,0.00006400742],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003807009,0.000091029375,0.00014018765,0.000089471374,0.000057271096,0.000013470111,0.00012162689,0.000010380754,0.000016124899],"category_scores_gemma":[0.000012494751,0.000082067876,0.00003080864,0.000089636036,0.000032692587,0.000010429069,0.00006661823,0.00010883534,8.751698e-8],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040670368,0.000019390334,0.00054554915,0.00002851694,0.00005807191,0.00007172529,0.0007997651,0.0018448904,0.99012756,0.00016786864,0.00012114472,0.005808805],"study_design_scores_gemma":[0.004147246,0.0033663567,0.02067581,0.0006386904,0.00009786415,0.00024776085,0.009688226,0.000035885547,0.7272537,0.00013840581,0.23307836,0.0006317114],"about_ca_topic_score_codex":0.000019875937,"about_ca_topic_score_gemma":0.00014133407,"teacher_disagreement_score":0.2628739,"about_ca_system_score_codex":0.00005555861,"about_ca_system_score_gemma":0.00021549201,"threshold_uncertainty_score":0.3346631},"labels":[],"label_agreement":null},{"id":"W4309889913","doi":"10.1038/s41698-022-00328-x","title":"MEK inhibitor resistance in lung adenocarcinoma is associated with addiction to sustained ERK suppression","year":2022,"lang":"en","type":"article","venue":"npj Precision Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"Canadian Institutes of Health Research; Japanese Respiratory Society; National Cancer Institute; BC Cancer Foundation; Government of Canada; Michael Smith Health Research BC; Memorial Sloan-Kettering Cancer Center; Eli Lilly and Company","keywords":"Trametinib; KRAS; MEK inhibitor; MAPK/ERK pathway; Cancer research; Drug resistance; Mutant; Adenocarcinoma; Medicine; Cancer; Biology; Kinase; Internal medicine; Gene; Genetics; Colorectal cancer","score_opus":0.00917306857849693,"score_gpt":0.2587210472632028,"score_spread":0.24954797868470585,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309889913","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9927973,0.0009809225,0.00050367706,0.0008340079,0.0005279618,0.00058881624,0.00011040169,0.000026786929,0.0036301385],"genre_scores_gemma":[0.9927229,0.000021473574,0.0008076302,0.0006820851,0.00013544098,0.0002673998,0.0003015401,0.000031022635,0.0050304644],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979682,0.00043665315,0.00032910847,0.0005888453,0.0003083507,0.00036882493],"domain_scores_gemma":[0.9991363,0.000087770706,0.00015066151,0.0003786122,0.0001187197,0.00012790808],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00053784996,0.00017753697,0.00026702773,0.00016588715,0.00021076141,0.000013582796,0.00026157903,0.00022089614,0.00034453985],"category_scores_gemma":[0.00028631996,0.00016555162,0.000058090507,0.00034962775,0.000033716577,0.000006837403,0.00038639674,0.00025475898,0.0000082720435],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007904796,0.0007577402,0.023040919,0.000021673446,0.00009886586,0.00035327638,0.0017091321,0.00038505296,0.52755004,0.00022354421,0.43184385,0.006111094],"study_design_scores_gemma":[0.007039877,0.008463627,0.08292345,0.0001100812,0.00006731786,0.00006931643,0.0012773798,0.00031536358,0.11619968,0.00031283573,0.78244233,0.0007787492],"about_ca_topic_score_codex":0.000018495806,"about_ca_topic_score_gemma":0.00046383325,"teacher_disagreement_score":0.41135037,"about_ca_system_score_codex":0.00034536197,"about_ca_system_score_gemma":0.0002876705,"threshold_uncertainty_score":0.67509997},"labels":[],"label_agreement":null},{"id":"W4310554573","doi":"10.1016/s1470-2045(22)00687-8","title":"Overall survival with first-line atezolizumab in combination with vemurafenib and cobimetinib in BRAFV600 mutation-positive advanced melanoma (IMspire150): second interim analysis of a multicentre, randomised, phase 3 study","year":2022,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":104,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada)","funders":"F. Hoffmann-La Roche; Roche","keywords":"Medicine; Vemurafenib; Atezolizumab; Interim analysis; Placebo; Internal medicine; Tolerability; Oncology; Adverse effect; Surgery; Randomized controlled trial; Metastatic melanoma; Pembrolizumab; Cancer; Immunotherapy; Pathology","score_opus":0.017250538822363423,"score_gpt":0.2996574736859282,"score_spread":0.2824069348635648,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310554573","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997758,0.00016737058,0.00019004356,0.00019752675,0.000050743147,0.0010291198,0.00010345579,0.0000057341817,0.00049802347],"genre_scores_gemma":[0.9990169,0.000039339553,0.00015142786,0.0001253802,0.000024109973,0.00025325688,0.00031543474,0.000013334728,0.000060831335],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9983956,0.00061554485,0.00031939504,0.00032496464,0.00013036348,0.00021408082],"domain_scores_gemma":[0.99918646,0.00022679153,0.00024642245,0.00024415023,0.00006213279,0.000034066827],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00057454914,0.00015379858,0.0005968349,0.00015992012,0.00007426586,0.000007849265,0.00017165621,0.00004918581,0.000061974206],"category_scores_gemma":[0.0000493604,0.00011188105,0.000040416282,0.00035235088,0.00009217251,0.0000078636585,0.00011860543,0.00016064478,2.92465e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.4932207,0.016725782,0.27987722,0.0002258166,0.0058530886,0.0011698763,0.028418144,0.035359927,0.11864242,0.0007811613,0.00015126637,0.019574631],"study_design_scores_gemma":[0.53581834,0.05845401,0.3573609,0.000056330828,0.0013187308,0.00014047469,0.010319115,0.009718267,0.021966653,0.00011421905,0.0038783366,0.00085462356],"about_ca_topic_score_codex":0.00020067526,"about_ca_topic_score_gemma":0.0170622,"teacher_disagreement_score":0.09667577,"about_ca_system_score_codex":0.00006679714,"about_ca_system_score_gemma":0.000096819094,"threshold_uncertainty_score":0.95211077},"labels":[],"label_agreement":null},{"id":"W4312060640","doi":"10.1101/2022.12.09.519777","title":"p38γ and p38δ modulate innate immune response by regulating MEF2D activation","year":2022,"lang":"en","type":"preprint","venue":"bioRxiv (Cold Spring Harbor Laboratory)","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University; Institute for Research in Immunology and Cancer","funders":"Medical Research Council; Agencia Estatal de Investigación; Ministerio de Educación y Formación Profesional; Universidad Autónoma de Madrid; Cancer Research UK; Wellcome Trust; Francis Crick Institute; Centro Nacional de Biotecnología; University of Dundee","keywords":"p38 mitogen-activated protein kinases; Innate immune system; Cell biology; Biology; MEF2C; Inflammation; Transcription factor; Immune system; Kinase; Protein kinase A; Immunology; Gene; Biochemistry","score_opus":0.009305685861567265,"score_gpt":0.21207144322676835,"score_spread":0.20276575736520108,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4312060640","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99571216,0.0017798918,0.0008027725,0.00025546245,0.00052014185,0.0005233859,0.00028245593,0.00010471341,0.000019036548],"genre_scores_gemma":[0.99744934,0.00026915877,0.0014270324,0.00020218542,0.00022512184,0.00020040975,0.00001081993,0.00013318853,0.00008275294],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9972741,0.0003868511,0.00049280206,0.0011019468,0.00029060768,0.00045370884],"domain_scores_gemma":[0.99792296,0.000037234233,0.00045605926,0.0012148777,0.00018860906,0.0001802416],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010210004,0.00049493107,0.0004106246,0.00015039189,0.00029335945,0.00012696981,0.00039880018,0.0005466004,0.00004435111],"category_scores_gemma":[0.00034813772,0.00057383894,0.00012073764,0.00020330465,0.00009624113,0.0000137664765,0.0012044534,0.00055339705,0.0000051414468],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037600662,0.000054112086,0.000850525,0.000107721426,0.000117531454,0.00000974609,0.000010294223,0.00008483194,0.9975903,0.00007530556,0.0007163234,0.0000072935863],"study_design_scores_gemma":[0.000595206,0.00017378794,0.033248797,0.00008937391,0.00004179887,5.4655672e-8,0.000005958594,0.00026589056,0.93106234,0.0000031429681,0.033837005,0.0006766143],"about_ca_topic_score_codex":0.00004886058,"about_ca_topic_score_gemma":5.378274e-7,"teacher_disagreement_score":0.06652794,"about_ca_system_score_codex":0.00010672591,"about_ca_system_score_gemma":0.00031710113,"threshold_uncertainty_score":0.9996713},"labels":[],"label_agreement":null},{"id":"W4312224396","doi":"10.1186/s13046-022-02559-z","title":"The traditional chinese medicine monomer Ailanthone improves the therapeutic efficacy of anti-PD-L1 in melanoma cells by targeting c-Jun","year":2022,"lang":"en","type":"article","venue":"Journal of Experimental & Clinical Cancer Research","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health","funders":"Science and Technology Innovative Research Team in Higher Educational Institutions of Hunan Province; Project 211; Higher Education Discipline Innovation Project; National Natural Science Foundation of China","keywords":"Melanoma; Cancer research; Flow cytometry; Medicine; In vitro; Apoptosis; Combination therapy; Tumor microenvironment; Pharmacology; Immunology; Chemistry; Tumor cells","score_opus":0.09284339632606865,"score_gpt":0.4406179071527125,"score_spread":0.34777451082664385,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4312224396","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96941143,0.027663693,0.0000063131947,0.0016899178,0.00068241206,0.00023504166,0.000031725485,0.0000012092197,0.00027828265],"genre_scores_gemma":[0.9965298,0.0019681181,0.000021303813,0.00023832546,0.00097237236,0.00004634142,0.000016586057,0.000018027871,0.00018912174],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9968731,0.00091905775,0.00089286856,0.00022444713,0.00078062434,0.00030993365],"domain_scores_gemma":[0.9983538,0.00082074606,0.00034776586,0.00023913826,0.00013041787,0.00010813325],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0044594123,0.00012612827,0.00030627544,0.00006150616,0.00031873875,0.00001768444,0.0006749621,0.000073106865,0.00025050162],"category_scores_gemma":[0.00024856252,0.00006730627,0.00019631963,0.0002142716,0.00056234765,0.000007930157,0.0002445636,0.0008361682,0.0000011503934],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012144282,0.0004952606,0.0045417445,0.0000051518573,0.00009904689,0.0000106951475,0.0002456235,0.000025527079,0.9787574,0.00004352747,0.012836285,0.0017253029],"study_design_scores_gemma":[0.0066292454,0.009360295,0.046756815,0.000051186846,0.00002802998,0.00005823606,0.0052235033,0.00014277555,0.8467375,0.00027859156,0.084468186,0.00026562478],"about_ca_topic_score_codex":0.00013005733,"about_ca_topic_score_gemma":0.00000979402,"teacher_disagreement_score":0.13201989,"about_ca_system_score_codex":0.000062576226,"about_ca_system_score_gemma":0.00026561512,"threshold_uncertainty_score":0.36327812},"labels":[],"label_agreement":null},{"id":"W4313126052","doi":"10.22374/cjgim.v17i2.578","title":"Small-Cell Lung Cancer Presenting with Ocular and Scalp Metastases","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of General Internal Medicine","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; University of Toronto","funders":"","keywords":"Medicine; Lung cancer; Dermatology; Scalp; Malignancy; Gynecology; Presentation (obstetrics); Cancer; Pathology; Internal medicine; Surgery","score_opus":0.013736591902029891,"score_gpt":0.23865913792013949,"score_spread":0.2249225460181096,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4313126052","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98202515,0.0151529815,0.0005459189,0.0007160796,0.00046172176,0.00007119518,0.000031452466,0.000001090988,0.0009943871],"genre_scores_gemma":[0.99500877,0.00012853237,0.0004136506,0.000736822,0.00089995965,0.0000073088586,0.000018065917,0.00001717611,0.0027697396],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99919343,0.00007609834,0.00022658988,0.00014068407,0.00014575529,0.00021743527],"domain_scores_gemma":[0.999181,0.0000073346646,0.00017257559,0.00010658234,0.000105038205,0.00042750718],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002525117,0.00011321439,0.00018109631,0.00012551034,0.00013096147,0.000015235398,0.00019838358,0.000025829977,0.0002552473],"category_scores_gemma":[0.000034734356,0.00008412591,0.000044123648,0.00006229991,0.00008909993,0.0000041489884,0.00004644237,0.00018764964,1.9191494e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035011914,0.000041347288,0.24329923,0.00012921663,0.00074695534,0.002975242,0.00088207965,0.0017493828,0.6372165,0.0001827078,0.10867542,0.003751764],"study_design_scores_gemma":[0.0075033037,0.0073617185,0.016851973,0.00039419095,0.00089697767,0.009636922,0.0018656154,0.0013972993,0.2260874,0.00011548558,0.7269976,0.0008914928],"about_ca_topic_score_codex":0.008166099,"about_ca_topic_score_gemma":0.008497319,"teacher_disagreement_score":0.6183222,"about_ca_system_score_codex":0.000040004717,"about_ca_system_score_gemma":0.00042442555,"threshold_uncertainty_score":0.9984386},"labels":[],"label_agreement":null},{"id":"W4313503211","doi":"10.3390/cancers15010025","title":"On the Therapeutic Potential of ERK4 in Triple-Negative Breast Cancer","year":2022,"lang":"en","type":"article","venue":"Cancers","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Institute for Research in Immunology and Cancer","funders":"Helse Nord RHF; Deutsche Forschungsgemeinschaft; Canadian Institutes of Health Research; Cancer Research Society; Kreftforeningen","keywords":"Triple-negative breast cancer; Cancer research; PI3K/AKT/mTOR pathway; Kinase; Breast cancer; Cell growth; Protein kinase B; Cancer; Mitogen-activated protein kinase; Medicine; Biology; Signal transduction; Cell biology; Internal medicine; Biochemistry","score_opus":0.010923095163950874,"score_gpt":0.23875614717970448,"score_spread":0.2278330520157536,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4313503211","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965544,0.00045652507,0.000033282893,0.0003718556,0.00031719697,0.00017766566,0.00020170858,0.0000025855236,0.0018848182],"genre_scores_gemma":[0.9985276,0.00008217371,0.0000036631316,0.0007220035,0.000070382855,0.00013296495,0.000011805003,0.000008549352,0.00044087096],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9994707,0.00007680561,0.000089451,0.0001455263,0.000098950106,0.00011857219],"domain_scores_gemma":[0.9997398,0.00001106347,0.000054196382,0.00015825474,0.000018045057,0.000018639998],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009366437,0.00006616175,0.00007505435,0.000022442035,0.00006308799,0.0000027161138,0.00014904792,0.000025374891,0.00039042463],"category_scores_gemma":[0.0000075673775,0.000049953895,0.000048320166,0.00008988248,0.00005081218,8.562302e-7,0.00005186111,0.000089406545,9.864625e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013134612,0.000058225123,0.0015958948,0.000019216803,0.00015390397,0.000010448197,0.0005289656,0.018985616,0.9516661,0.0035849197,0.012105161,0.009978049],"study_design_scores_gemma":[0.007645459,0.0025704233,0.06876745,0.00007528766,0.00011552939,0.00007279814,0.005875945,0.003229282,0.8631239,0.004892406,0.042573307,0.001058235],"about_ca_topic_score_codex":0.0005275477,"about_ca_topic_score_gemma":0.00015618395,"teacher_disagreement_score":0.08854226,"about_ca_system_score_codex":0.00013006676,"about_ca_system_score_gemma":0.00028558407,"threshold_uncertainty_score":0.42748758},"labels":[],"label_agreement":null},{"id":"W4313556534","doi":"10.18433/jpps33020","title":"Post-Marketing Safety of Vemurafenib: A Real-World Pharmacovigilance Study of the FDA Adverse Event Reporting System","year":2022,"lang":"en","type":"article","venue":"Journal of Pharmacy & Pharmaceutical Sciences","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Vemurafenib; Adverse Event Reporting System; Medicine; Pharmacovigilance; Adverse effect; Internal medicine; Pharmacology; Metastatic melanoma; Cancer","score_opus":0.0480715049185764,"score_gpt":0.37734010287839204,"score_spread":0.3292685979598156,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4313556534","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962091,0.0005501479,0.000020826921,0.0002738473,0.0010677277,0.0003986938,0.000023648174,0.0000065527006,0.0014494542],"genre_scores_gemma":[0.9992297,0.00009954586,0.00009930672,0.00018709943,0.00025981487,0.000011130411,0.0000012651648,0.000012454466,0.0000996567],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9953529,0.0009686682,0.001949171,0.0003078739,0.0010771162,0.00034424092],"domain_scores_gemma":[0.99594885,0.00014740996,0.003215629,0.00021786129,0.00029774776,0.00017250492],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006964921,0.00018040463,0.0003993375,0.0001249043,0.00045426417,0.000011967507,0.0009419652,0.000019070507,0.000135263],"category_scores_gemma":[0.0004392237,0.00012516606,0.00033080552,0.0006134465,0.00022520979,0.000018531826,0.0005655858,0.0003957442,5.663934e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011959823,0.00051509513,0.13496707,0.00012207705,0.00013088883,0.00005994882,0.00030824626,0.003676018,0.8539575,0.000037450707,0.00017617745,0.0048535746],"study_design_scores_gemma":[0.0058148783,0.0016092764,0.027710523,0.00016414688,0.00048707737,0.00068282016,0.008502283,0.004047976,0.8948699,0.0000058881087,0.055708278,0.00039694348],"about_ca_topic_score_codex":0.000078448815,"about_ca_topic_score_gemma":0.000013146,"teacher_disagreement_score":0.10725655,"about_ca_system_score_codex":0.000082501334,"about_ca_system_score_gemma":0.00046448433,"threshold_uncertainty_score":0.51041234},"labels":[],"label_agreement":null},{"id":"W4313856340","doi":"10.1016/j.jtocrr.2022.100460","title":"Real-World Treatment Patterns and Effectiveness of Targeted and Immune Checkpoint Inhibitor-Based Systemic Therapy in BRAF Mutation-Positive NSCLC","year":2023,"lang":"en","type":"article","venue":"JTO Clinical and Research Reports","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Health Services; University of Calgary","funders":"AstraZeneca; Pfizer; Bristol-Myers Squibb","keywords":"Systemic therapy; Targeted therapy; Medicine; Oncology; Immune checkpoint; Mutation; Immune system; Cancer research; Internal medicine; Immunotherapy; Immunology; Biology; Cancer; Genetics; Gene","score_opus":0.050758505383652536,"score_gpt":0.391417087290026,"score_spread":0.34065858190637344,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4313856340","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983583,0.00068003836,0.000011518357,0.00007341822,0.000084689615,0.0006314796,0.000019301395,0.000009241761,0.00013198503],"genre_scores_gemma":[0.9970278,0.0025153786,0.000017332108,0.000006416979,0.00007613729,0.00009588905,0.00012846218,0.000013355232,0.000119238735],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99789876,0.00067083695,0.0005384329,0.00045650333,0.00021234878,0.0002231192],"domain_scores_gemma":[0.99892926,0.0004410563,0.00011555484,0.00022570614,0.00016917137,0.00011922256],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003255425,0.00012006076,0.00031730114,0.00013641118,0.00006666778,0.000019308232,0.000034164237,0.00014425456,0.0000024285523],"category_scores_gemma":[0.00035229517,0.00008703609,0.00006767119,0.0001779392,0.0002310046,0.000004359153,0.00008584491,0.00013255235,5.6922795e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00076562504,0.00022136081,0.60078615,0.00025923137,0.00008045183,0.0006922451,0.000089103996,0.0000057918346,0.38806018,0.000021533193,0.000015747335,0.009002562],"study_design_scores_gemma":[0.0013392394,0.0017625284,0.74081224,0.00023496091,0.000005174799,0.00004187636,0.00006639505,0.000056852026,0.2553997,0.00014428193,0.000053120413,0.00008364192],"about_ca_topic_score_codex":0.0013654385,"about_ca_topic_score_gemma":0.0002756971,"teacher_disagreement_score":0.14002606,"about_ca_system_score_codex":0.000018216559,"about_ca_system_score_gemma":0.00015901777,"threshold_uncertainty_score":0.35492286},"labels":[],"label_agreement":null},{"id":"W4317437925","doi":"10.1073/pnas.2218373120","title":"HER2-driven breast cancer suppression by the JNK signaling pathway","year":2023,"lang":"en","type":"article","venue":"Proceedings of the National Academy of Sciences","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; Canadian Institutes of Health Research; National Institutes of Health; Government of Canada","keywords":"Cancer research; Biology; Signal transduction; Breast cancer; Kinase; Cancer; MAPK/ERK pathway; Cell biology; Genetics","score_opus":0.027348133353117636,"score_gpt":0.2895597089851433,"score_spread":0.2622115756320257,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4317437925","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99399394,0.00015745971,7.8833955e-7,0.00400112,0.000034527344,0.00010292315,0.00010655075,0.0000067226483,0.0015959479],"genre_scores_gemma":[0.99896836,0.00006485746,0.000055134205,0.00024216787,0.00014520342,0.00001663744,0.0000013773927,0.0000039584193,0.0005023126],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99899954,0.000007230877,0.00015456807,0.00018880062,0.00051624415,0.00013362573],"domain_scores_gemma":[0.99962705,0.000025322757,0.00018141931,0.0000094442275,0.00013302616,0.000023739844],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000587896,0.000068760084,0.0000715952,0.000035196663,0.00020102841,0.000014886266,0.0006149651,0.00007540156,0.000014149605],"category_scores_gemma":[0.000093665345,0.000036833906,0.000058144735,0.0003313291,0.00034766842,0.000013427302,0.00018440894,0.00007721512,0.0000015375933],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000009030387,0.000010007643,0.0036561436,0.00001649827,0.000008120494,2.5726774e-9,0.000051915482,0.00009751627,0.98181397,0.0010462657,0.0128608495,0.00042971256],"study_design_scores_gemma":[0.00008854566,0.000026443528,0.01253313,0.000043614415,0.000004495173,0.0000054625243,0.00012284135,0.0002969702,0.981916,0.0016460869,0.0032607818,0.000055597942],"about_ca_topic_score_codex":0.000009087086,"about_ca_topic_score_gemma":1.1867579e-7,"teacher_disagreement_score":0.0096000675,"about_ca_system_score_codex":0.0000066074786,"about_ca_system_score_gemma":0.00003534303,"threshold_uncertainty_score":0.15461683},"labels":[],"label_agreement":null},{"id":"W4319071946","doi":"10.1007/s11684-022-0935-0","title":"NETO2 promotes melanoma progression via activation of the Ca2+/CaMKII signaling pathway","year":2023,"lang":"en","type":"article","venue":"Frontiers of Medicine","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health","funders":"","keywords":"Melanoma; Cancer research; CREB; Carcinogenesis; Signal transduction; Metastasis; Cancer; Biology; Chemistry; Medicine; Cell biology; Internal medicine; Gene; Transcription factor; Genetics","score_opus":0.011193098576051934,"score_gpt":0.23978654342470793,"score_spread":0.22859344484865599,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4319071946","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98820376,0.00085202896,0.007976989,0.0012046162,0.0006926675,0.00037140737,0.000010995975,0.000019540534,0.00066801626],"genre_scores_gemma":[0.9981016,0.00003821737,0.0009853572,0.000057019617,0.00028564414,0.00001517788,0.000111354595,0.000015618878,0.00039002375],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990925,0.00006521105,0.00025595824,0.00018501723,0.0002433474,0.00015793345],"domain_scores_gemma":[0.9993309,0.000012599614,0.00022143002,0.0003007658,0.00008889063,0.000045415658],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031385964,0.000110164634,0.0001978939,0.000061900864,0.000052612904,0.0000016002873,0.0002011994,0.00011505874,0.000011357063],"category_scores_gemma":[0.00019703757,0.00006835463,0.00006360159,0.00020248063,0.00017853267,0.0000034946986,0.000081280516,0.000065769826,9.473509e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000068627196,0.000024606852,0.0051399814,0.000057720135,0.000039386778,0.0000012303183,0.00019318165,0.00007992571,0.9687208,0.000028602934,0.01774915,0.007896817],"study_design_scores_gemma":[0.00066732557,0.00062889815,0.0024465604,0.00014522548,0.00002210451,0.0000030353085,0.00026684435,0.0005237339,0.9875164,0.00014092455,0.007559585,0.00007935715],"about_ca_topic_score_codex":0.000020897813,"about_ca_topic_score_gemma":0.0000022963009,"teacher_disagreement_score":0.018795636,"about_ca_system_score_codex":0.0000072305684,"about_ca_system_score_gemma":0.000058490827,"threshold_uncertainty_score":0.2787421},"labels":[],"label_agreement":null},{"id":"W4321480727","doi":"10.1139/bcb-2022-0371","title":"Mitogen- and stress-activated protein kinase (MSK1/2) regulated gene expression in normal and disease states","year":2023,"lang":"en","type":"review","venue":"Biochemistry and Cell Biology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"Canadian Institutes of Health Research; University of Manitoba; Natural Sciences and Engineering Research Council of Canada; CancerCare Manitoba Foundation","keywords":"Signal transduction; Biology; Regulation of gene expression; Gene expression; Cell biology; Kinase; Transcription factor; Epigenetics; Histone; Mitogen-activated protein kinase; Gene; Cancer research; Genetics","score_opus":0.01611058602091132,"score_gpt":0.255082661481922,"score_spread":0.23897207546101068,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4321480727","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.2868238,0.7118128,0.0000042695974,0.000009943435,0.000062340274,0.00042383268,0.0007934797,0.000020403573,0.000049152724],"genre_scores_gemma":[0.015705794,0.9757771,0.0000821494,0.000017472494,0.00019534053,0.00018627956,0.0064849895,0.00005497983,0.0014958776],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979458,0.00015992028,0.00043658493,0.0009863545,0.00006128319,0.00041005647],"domain_scores_gemma":[0.9989557,0.000031673328,0.0002243727,0.00039629082,0.000031921467,0.00036004058],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00014104859,0.00051043683,0.00070502516,0.00007716345,0.000091826754,0.000031086038,0.00016199566,0.0008374607,0.00001144113],"category_scores_gemma":[0.000084270745,0.0004317569,0.000094807496,0.00011527071,0.00024695453,0.000004331806,0.00041594592,0.00023726885,0.0000026837085],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013410454,0.000057625606,0.00016338132,0.008243489,0.000050668143,0.000053783664,0.0000147996125,2.2622724e-7,0.95484656,0.0000034243496,0.00016020877,0.036271717],"study_design_scores_gemma":[0.0006359906,0.00015643315,0.0000272821,0.001719604,0.0001029557,0.000022243012,0.000029805185,0.0000038491035,0.7744536,0.000043623917,0.2222083,0.00059630134],"about_ca_topic_score_codex":0.000015524243,"about_ca_topic_score_gemma":0.0000036693232,"teacher_disagreement_score":0.27111802,"about_ca_system_score_codex":0.000013457528,"about_ca_system_score_gemma":0.00018041489,"threshold_uncertainty_score":0.99981344},"labels":[],"label_agreement":null},{"id":"W4321601768","doi":"10.3389/fnmol.2023.1022364","title":"The clinicopathological features of ganglioglioma with CD34 expression and BRAF mutation in patients with epilepsy","year":2023,"lang":"en","type":"article","venue":"Frontiers in Molecular Neuroscience","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Capital Health","keywords":"Ganglioglioma; Epilepsy; Medicine; Mutation; Pathology; Biology; Genetics; Gene; Psychiatry","score_opus":0.004740434434397551,"score_gpt":0.2154295113190737,"score_spread":0.21068907688467614,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4321601768","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973331,0.00013342765,0.0020268997,0.00003213819,0.00015497471,0.00021841777,0.0000071305576,0.0000073682063,0.00008655454],"genre_scores_gemma":[0.9986533,0.000051155646,0.0011156867,0.00009737798,0.0000059811723,0.00001808465,0.000020309197,0.000009716082,0.00002841764],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99898034,0.00010820548,0.00014656289,0.00035109252,0.00020346949,0.00021033405],"domain_scores_gemma":[0.9996185,0.000013745817,0.000077443474,0.00022133395,0.000028373037,0.000040606858],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021807829,0.00010198179,0.00011187004,0.00010153261,0.00006255438,0.000020160729,0.0001858389,0.0000655119,2.4904185e-7],"category_scores_gemma":[0.00014455833,0.00006271006,0.000014950871,0.00041217217,0.0002820018,0.0000075235657,0.0000884354,0.00009027237,2.2427953e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039663515,0.000065896806,0.5880691,0.000011822962,0.0000012634782,0.00017426276,0.000057116213,0.00027425395,0.4077451,0.000037322097,0.0004866948,0.0026805687],"study_design_scores_gemma":[0.0009192567,0.0010661507,0.8952993,0.000023950459,0.000003063953,0.00001079073,0.00009162767,0.00010506502,0.102074705,0.000069725604,0.0002263638,0.00010999367],"about_ca_topic_score_codex":0.0000030723816,"about_ca_topic_score_gemma":0.0000079911215,"teacher_disagreement_score":0.30723026,"about_ca_system_score_codex":0.0000046650707,"about_ca_system_score_gemma":0.000029059182,"threshold_uncertainty_score":0.2557242},"labels":[],"label_agreement":null},{"id":"W4322011930","doi":"10.1016/j.ejmech.2023.115231","title":"Design, synthesis and characterisation of a novel type II B-RAF paradox breaker inhibitor","year":2023,"lang":"en","type":"article","venue":"European Journal of Medicinal Chemistry","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Genentech; Vlaamse regering; Innovative Medicines Initiative; Ontario Genomics Institute; European Federation of Pharmaceutical Industries and Associations; Merck KGaA; McGill University; Innovative Health Initiative; Ontario Genomics; Genome Canada; Fundação de Amparo à Pesquisa do Estado de São Paulo; Bayer; Pfizer","keywords":"Chemistry; Kinase; Vemurafenib; Protein kinase domain; MAPK/ERK pathway; Protein kinase A; V600E; Moiety; Allosteric regulation; Mutant; Stereochemistry; Cell biology; Biochemistry; Enzyme; Cancer research; Biology","score_opus":0.02658339831722194,"score_gpt":0.23327497006591655,"score_spread":0.2066915717486946,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4322011930","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99712265,0.00034972408,0.0011863809,0.00018055024,0.0001504057,0.00003657372,0.0000068220306,0.0000056494487,0.00096125924],"genre_scores_gemma":[0.9980719,0.00025597372,0.0005544587,0.00004890979,0.000733747,6.447609e-7,0.000013608424,0.00002017289,0.0003005729],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991324,0.00006979421,0.0003515895,0.00013096424,0.00018888921,0.00012636611],"domain_scores_gemma":[0.9992705,0.000032666987,0.0003069406,0.0001386494,0.000138808,0.00011244302],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008629126,0.000110579174,0.00018090235,0.000034362452,0.000042514577,0.0000064323804,0.00013510806,0.00004805539,0.000032161945],"category_scores_gemma":[0.00038881783,0.000091475595,0.000052426563,0.00008837988,0.00007444598,0.000004894219,0.00007640216,0.00011522461,0.0000035637156],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024483167,0.000042536514,0.00017154173,0.000066665874,0.00004491503,0.000066838285,0.0001312632,0.0000074353275,0.99333537,6.669575e-7,0.0021778222,0.003710105],"study_design_scores_gemma":[0.0007892767,0.0005357457,0.004938571,0.00018761506,0.000052879674,0.0005327896,0.00014297865,0.000036778336,0.9863141,0.0000025505478,0.0063586333,0.0001080815],"about_ca_topic_score_codex":4.5774271e-7,"about_ca_topic_score_gemma":3.8608142e-8,"teacher_disagreement_score":0.0070212777,"about_ca_system_score_codex":0.0000059473873,"about_ca_system_score_gemma":0.00006878899,"threshold_uncertainty_score":0.37302664},"labels":[],"label_agreement":null},{"id":"W4328050936","doi":"10.1101/2023.03.17.533211","title":"Multiple cancer types rapidly escape from multiple MAPK inhibitors to generate mutagenesis-prone subpopulations","year":2023,"lang":"en","type":"preprint","venue":"bioRxiv (Cold Spring Harbor Laboratory)","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institutes of Health; Université Laval; Damon Runyon Cancer Research Foundation","keywords":"MAPK/ERK pathway; KRAS; Cancer research; Biology; Cancer; Melanoma; Cell cycle; Neuroblastoma RAS viral oncogene homolog; DNA damage; Kinase; Mutation; Genetics; DNA; Gene","score_opus":0.02282854965967724,"score_gpt":0.2334979828291233,"score_spread":0.21066943316944606,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4328050936","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9883225,0.0020964989,0.0017305656,0.00028153116,0.003510627,0.0010598275,0.002701866,0.0002917513,0.000004849954],"genre_scores_gemma":[0.990052,0.00045322732,0.005115335,0.000289169,0.0027881449,0.000888402,0.00004570632,0.0002776022,0.00009041541],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9965212,0.00016035233,0.0006344737,0.0016360602,0.00034404395,0.000703869],"domain_scores_gemma":[0.99716663,0.000045510802,0.00032788242,0.0015906503,0.00041570753,0.00045364042],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00030916656,0.00070928456,0.0005846998,0.00023855142,0.0002458735,0.00016407933,0.00063934975,0.0008430255,0.000054879252],"category_scores_gemma":[0.00037993558,0.0007821991,0.00025067202,0.00038567922,0.000070061935,0.0000119718425,0.0007759948,0.0003866528,0.00024979436],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007197778,0.00008196124,0.052782603,0.00009493955,0.00026014927,0.000026376087,0.000012376882,0.0017689229,0.94113415,0.000009667891,0.0037481582,0.000008741711],"study_design_scores_gemma":[0.000570733,0.000062995765,0.12805416,0.0001451058,0.00011106408,8.383603e-9,0.0000040917676,0.0005411565,0.85361344,0.000001288429,0.016019285,0.00087669207],"about_ca_topic_score_codex":0.0015328428,"about_ca_topic_score_gemma":0.00059694314,"teacher_disagreement_score":0.0875207,"about_ca_system_score_codex":0.00012384295,"about_ca_system_score_gemma":0.000531574,"threshold_uncertainty_score":0.9994629},"labels":[],"label_agreement":null},{"id":"W4361246377","doi":"10.1158/0008-5472.c.6497147.v1","title":"Data from Modeling Genomic Diversity and Tumor Dependency in Malignant Melanoma","year":2023,"lang":"en","type":"preprint","venue":"","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pediatric Oncology Group","funders":"National Cancer Institute; Genentech; Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung; National Science Foundation","keywords":"PTEN; Tensin; Cancer research; Biology; Melanoma; MAPK/ERK pathway; Kinase; Comparative genomic hybridization; Cancer; Effector; Gene; Computational biology; Genetics; PI3K/AKT/mTOR pathway; Signal transduction; Chromosome; Cell biology","score_opus":0.0985299461382925,"score_gpt":0.269137022450537,"score_spread":0.1706070763122445,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4361246377","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9920582,0.0010361752,0.004594914,0.000043976164,0.00036990564,0.00024110134,0.0011330543,0.00002811775,0.0004945265],"genre_scores_gemma":[0.9932701,0.0006714635,0.0015013978,0.00008113833,0.00022286353,0.0000104808205,0.0038098206,0.000029881543,0.00040286584],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99823606,0.000054564338,0.00025831538,0.0010840577,0.00011957357,0.00024743396],"domain_scores_gemma":[0.99859303,0.00001173955,0.0000757831,0.0012041786,0.000023997327,0.00009127244],"candidate_categories":["open_science"],"consensus_categories":[],"category_scores_codex":[0.00025031756,0.00024002194,0.00026866078,0.0000660929,0.00011802604,0.000030948922,0.0008512821,0.00029250124,0.00003240022],"category_scores_gemma":[0.000043091684,0.00023544705,0.000049180224,0.00002584463,0.000024858697,0.0000034423263,0.022919806,0.00023105185,0.000029535953],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043721587,0.0002633076,0.5182634,0.00041798927,0.0006968665,0.0010651402,0.00077789684,0.0060968003,0.4651473,0.00031268812,0.0044396305,0.0020817737],"study_design_scores_gemma":[0.0062028673,0.0005972171,0.20209998,0.0007972021,0.0006646275,0.0001182062,0.0019127696,0.69258773,0.04714832,0.03766182,0.0043232255,0.0058860052],"about_ca_topic_score_codex":0.005369017,"about_ca_topic_score_gemma":0.006161009,"teacher_disagreement_score":0.68649095,"about_ca_system_score_codex":0.000018008399,"about_ca_system_score_gemma":0.0001093913,"threshold_uncertainty_score":0.9849826},"labels":[],"label_agreement":null},{"id":"W4361247448","doi":"10.1158/0008-5472.c.6497147","title":"Data from Modeling Genomic Diversity and Tumor Dependency in Malignant Melanoma","year":2023,"lang":"en","type":"preprint","venue":"","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pediatric Oncology Group","funders":"National Cancer Institute; Genentech; Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung; National Science Foundation","keywords":"PTEN; Tensin; Cancer research; Biology; Melanoma; MAPK/ERK pathway; Kinase; Effector; Cancer; Comparative genomic hybridization; Gene; Computational biology; Genetics; PI3K/AKT/mTOR pathway; Signal transduction; Chromosome; Cell biology","score_opus":0.0985299461382925,"score_gpt":0.269137022450537,"score_spread":0.1706070763122445,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4361247448","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9920582,0.0010361752,0.004594914,0.000043976164,0.00036990564,0.00024110134,0.0011330543,0.00002811775,0.0004945265],"genre_scores_gemma":[0.9932701,0.0006714635,0.0015013978,0.00008113833,0.00022286353,0.0000104808205,0.0038098206,0.000029881543,0.00040286584],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99823606,0.000054564338,0.00025831538,0.0010840577,0.00011957357,0.00024743396],"domain_scores_gemma":[0.99859303,0.00001173955,0.0000757831,0.0012041786,0.000023997327,0.00009127244],"candidate_categories":["open_science"],"consensus_categories":[],"category_scores_codex":[0.00025031756,0.00024002194,0.00026866078,0.0000660929,0.00011802604,0.000030948922,0.0008512821,0.00029250124,0.00003240022],"category_scores_gemma":[0.000043091684,0.00023544705,0.000049180224,0.00002584463,0.000024858697,0.0000034423263,0.022919806,0.00023105185,0.000029535953],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043721587,0.0002633076,0.5182634,0.00041798927,0.0006968665,0.0010651402,0.00077789684,0.0060968003,0.4651473,0.00031268812,0.0044396305,0.0020817737],"study_design_scores_gemma":[0.0062028673,0.0005972171,0.20209998,0.0007972021,0.0006646275,0.0001182062,0.0019127696,0.69258773,0.04714832,0.03766182,0.0043232255,0.0058860052],"about_ca_topic_score_codex":0.005369017,"about_ca_topic_score_gemma":0.006161009,"teacher_disagreement_score":0.68649095,"about_ca_system_score_codex":0.000018008399,"about_ca_system_score_gemma":0.0001093913,"threshold_uncertainty_score":0.9849826},"labels":[],"label_agreement":null},{"id":"W4361816124","doi":"10.1158/1078-0432.c.6529128.v1","title":"Data from ERK Mutations and Amplification Confer Resistance to ERK-Inhibitor Therapy","year":2023,"lang":"en","type":"preprint","venue":"","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Discovery Centre","funders":"Genentech","keywords":"MAPK/ERK pathway; Cancer research; Mutant; MEK inhibitor; Acquired resistance; Kinase; Biology; Chemistry; Cancer; Cell biology; Genetics; Gene","score_opus":0.11274219032447373,"score_gpt":0.32470702541379165,"score_spread":0.2119648350893179,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4361816124","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9271574,0.0022682399,0.05011792,0.0030449291,0.0013581722,0.0013080804,0.009521414,0.00014091487,0.005082924],"genre_scores_gemma":[0.9230137,0.0013863771,0.013612846,0.0008127126,0.0012648877,0.00022652009,0.04313791,0.0000799856,0.016465085],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99852467,0.000052087402,0.0002329031,0.00091535196,0.00011872063,0.00015629793],"domain_scores_gemma":[0.9981581,0.000029345572,0.000085387794,0.0015274538,0.00009310251,0.00010659766],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015079355,0.00019570114,0.00017293329,0.000041800897,0.00007104427,0.00008848327,0.00044955176,0.0002745636,0.00004967436],"category_scores_gemma":[0.00010011931,0.00018440587,0.00003692596,0.00004440525,0.000040864852,0.0000026260907,0.00084900047,0.00012314074,0.000086388805],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001504935,0.00006126413,0.001117924,0.000045788187,0.00017798517,0.0000048105508,0.00014144357,0.000019983196,0.8185821,0.0008672359,0.1769993,0.001831644],"study_design_scores_gemma":[0.0008091661,0.00012046681,0.025090981,0.000107656655,0.000059412312,0.0000015164613,0.00025627608,0.00013769294,0.2226354,0.0056754686,0.744257,0.0008490169],"about_ca_topic_score_codex":0.00015894356,"about_ca_topic_score_gemma":0.0011981464,"teacher_disagreement_score":0.5959467,"about_ca_system_score_codex":0.000008091466,"about_ca_system_score_gemma":0.00014135709,"threshold_uncertainty_score":0.7519853},"labels":[],"label_agreement":null},{"id":"W4361819285","doi":"10.1158/1078-0432.c.6529128","title":"Data from ERK Mutations and Amplification Confer Resistance to ERK-Inhibitor Therapy","year":2023,"lang":"en","type":"preprint","venue":"","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Discovery Centre","funders":"Genentech","keywords":"MAPK/ERK pathway; Cancer research; Mutant; MEK inhibitor; Acquired resistance; Kinase; Biology; Chemistry; Cancer; Cell biology; Genetics; Gene","score_opus":0.11274219032447373,"score_gpt":0.32470702541379165,"score_spread":0.2119648350893179,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4361819285","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9271574,0.0022682399,0.05011792,0.0030449291,0.0013581722,0.0013080804,0.009521414,0.00014091487,0.005082924],"genre_scores_gemma":[0.9230137,0.0013863771,0.013612846,0.0008127126,0.0012648877,0.00022652009,0.04313791,0.0000799856,0.016465085],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99852467,0.000052087402,0.0002329031,0.00091535196,0.00011872063,0.00015629793],"domain_scores_gemma":[0.9981581,0.000029345572,0.000085387794,0.0015274538,0.00009310251,0.00010659766],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015079355,0.00019570114,0.00017293329,0.000041800897,0.00007104427,0.00008848327,0.00044955176,0.0002745636,0.00004967436],"category_scores_gemma":[0.00010011931,0.00018440587,0.00003692596,0.00004440525,0.000040864852,0.0000026260907,0.00084900047,0.00012314074,0.000086388805],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001504935,0.00006126413,0.001117924,0.000045788187,0.00017798517,0.0000048105508,0.00014144357,0.000019983196,0.8185821,0.0008672359,0.1769993,0.001831644],"study_design_scores_gemma":[0.0008091661,0.00012046681,0.025090981,0.000107656655,0.000059412312,0.0000015164613,0.00025627608,0.00013769294,0.2226354,0.0056754686,0.744257,0.0008490169],"about_ca_topic_score_codex":0.00015894356,"about_ca_topic_score_gemma":0.0011981464,"teacher_disagreement_score":0.5959467,"about_ca_system_score_codex":0.000008091466,"about_ca_system_score_gemma":0.00014135709,"threshold_uncertainty_score":0.7519853},"labels":[],"label_agreement":null},{"id":"W4361943399","doi":"10.1158/1078-0432.c.6517965","title":"Data from Phosphorylated 4E-BP1 Is Associated with Poor Survival in Melanoma","year":2023,"lang":"en","type":"preprint","venue":"","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institutes of Health; York University; American Skin Association","keywords":"PTEN; Melanoma; Cancer research; Protein kinase B; Phosphorylation; Protein kinase A; PI3K/AKT/mTOR pathway; Kinase; Biology; Signal transduction; Medicine; Internal medicine; Molecular biology; Cell biology","score_opus":0.06088095513259808,"score_gpt":0.27480969225632385,"score_spread":0.21392873712372576,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4361943399","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98559856,0.0004792767,0.00047152195,0.00034478895,0.0008432003,0.00044554644,0.0070889145,0.00010878277,0.004619421],"genre_scores_gemma":[0.9311619,0.0002795348,0.00046571775,0.0003745991,0.00028981565,0.00004809498,0.058558557,0.00011552346,0.008706254],"study_design_codex":"not_applicable","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9971999,0.00014638524,0.00044114472,0.0014607405,0.0003051114,0.00044672922],"domain_scores_gemma":[0.9975871,0.00005643896,0.0002137794,0.0019095715,0.000100642734,0.0001324609],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004272604,0.0004442054,0.00054972654,0.00007870477,0.000043821776,0.00006929467,0.0012182021,0.0009463809,0.00031384264],"category_scores_gemma":[0.00022186727,0.0003837523,0.0000911373,0.00015620746,0.0000629524,0.000003754283,0.002700839,0.0004899965,0.00013896512],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021088612,0.0015117319,0.24750684,0.0002476557,0.006358393,0.001616322,0.00054156664,0.00034844474,0.32814556,0.00020477793,0.40860814,0.002801691],"study_design_scores_gemma":[0.012899798,0.0018786907,0.3514991,0.0014737785,0.00089468615,0.000022101587,0.0009119571,0.010310939,0.5087759,0.0033150471,0.101024464,0.006993511],"about_ca_topic_score_codex":0.0034239036,"about_ca_topic_score_gemma":0.012923146,"teacher_disagreement_score":0.30758366,"about_ca_system_score_codex":0.000039148752,"about_ca_system_score_gemma":0.0003683425,"threshold_uncertainty_score":0.9998614},"labels":[],"label_agreement":null},{"id":"W4361949475","doi":"10.1158/1078-0432.c.6517965.v1","title":"Data from Phosphorylated 4E-BP1 Is Associated with Poor Survival in Melanoma","year":2023,"lang":"en","type":"preprint","venue":"","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institutes of Health; York University; American Skin Association","keywords":"PTEN; Melanoma; Cancer research; Protein kinase B; Phosphorylation; Protein kinase A; Kinase; Biology; PI3K/AKT/mTOR pathway; Signal transduction; Medicine; Internal medicine; Molecular biology; Cell biology","score_opus":0.06088095513259808,"score_gpt":0.27480969225632385,"score_spread":0.21392873712372576,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4361949475","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98559856,0.0004792767,0.00047152195,0.00034478895,0.0008432003,0.00044554644,0.0070889145,0.00010878277,0.004619421],"genre_scores_gemma":[0.9311619,0.0002795348,0.00046571775,0.0003745991,0.00028981565,0.00004809498,0.058558557,0.00011552346,0.008706254],"study_design_codex":"not_applicable","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9971999,0.00014638524,0.00044114472,0.0014607405,0.0003051114,0.00044672922],"domain_scores_gemma":[0.9975871,0.00005643896,0.0002137794,0.0019095715,0.000100642734,0.0001324609],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004272604,0.0004442054,0.00054972654,0.00007870477,0.000043821776,0.00006929467,0.0012182021,0.0009463809,0.00031384264],"category_scores_gemma":[0.00022186727,0.0003837523,0.0000911373,0.00015620746,0.0000629524,0.000003754283,0.002700839,0.0004899965,0.00013896512],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021088612,0.0015117319,0.24750684,0.0002476557,0.006358393,0.001616322,0.00054156664,0.00034844474,0.32814556,0.00020477793,0.40860814,0.002801691],"study_design_scores_gemma":[0.012899798,0.0018786907,0.3514991,0.0014737785,0.00089468615,0.000022101587,0.0009119571,0.010310939,0.5087759,0.0033150471,0.101024464,0.006993511],"about_ca_topic_score_codex":0.0034239036,"about_ca_topic_score_gemma":0.012923146,"teacher_disagreement_score":0.30758366,"about_ca_system_score_codex":0.000039148752,"about_ca_system_score_gemma":0.0003683425,"threshold_uncertainty_score":0.9998614},"labels":[],"label_agreement":null},{"id":"W4364353540","doi":"10.1007/s10637-022-01326-3","title":"Results of an open-label phase 1b study of the ERK inhibitor MK-8353 plus the MEK inhibitor selumetinib in patients with advanced or metastatic solid tumors","year":2023,"lang":"en","type":"article","venue":"Investigational New Drugs","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Tolerability; Adverse effect; Selumetinib; Nausea; Discontinuation; Vomiting; MEK inhibitor; Internal medicine; Response Evaluation Criteria in Solid Tumors; Gastroenterology; Population; Cancer; Phases of clinical research; Surgery; Oncology; Chemotherapy; MAPK/ERK pathway; Kinase; Colorectal cancer","score_opus":0.034795656958310404,"score_gpt":0.3114770306345717,"score_spread":0.27668137367626133,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4364353540","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99784964,0.00001549836,0.0000041974404,0.00028559254,0.00013722588,0.0013404074,0.00025479318,0.000009410813,0.00010321464],"genre_scores_gemma":[0.997847,0.0000020725129,0.0008768906,0.00021053446,0.00008691421,0.00008713097,0.00039780466,0.000025892678,0.00046572226],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980991,0.00025066623,0.00059004076,0.00038122997,0.00047010777,0.000208847],"domain_scores_gemma":[0.9987298,0.000079286685,0.00039117225,0.00049752963,0.00018470899,0.00011747147],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045616098,0.00018932958,0.0002719948,0.00006823256,0.00009886398,0.000023605617,0.00055997644,0.000048909475,0.0000047350673],"category_scores_gemma":[0.00046710184,0.00010788122,0.000027449403,0.00055727497,0.0001904914,0.000024773211,0.0002936637,0.000116732204,0.0000032680693],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019759865,0.018060602,0.009852589,0.000286603,0.0007556628,0.00004744045,0.024670076,0.008747662,0.88303554,0.00076410896,0.021080732,0.012939091],"study_design_scores_gemma":[0.12751395,0.019329034,0.05420246,0.00043657387,0.00017820958,0.000008406724,0.0070068548,0.0011087714,0.78574735,0.00135837,0.0022972564,0.0008127438],"about_ca_topic_score_codex":0.00016285201,"about_ca_topic_score_gemma":0.0003220102,"teacher_disagreement_score":0.107754074,"about_ca_system_score_codex":0.000018531438,"about_ca_system_score_gemma":0.00073682296,"threshold_uncertainty_score":0.43992683},"labels":[],"label_agreement":null},{"id":"W4367059606","doi":"10.1126/sciadv.ade0631","title":"Abrogation of MAP4K4 protein function causes congenital anomalies in humans and zebrafish","year":2023,"lang":"en","type":"article","venue":"Science Advances","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre; McMaster University; Trillium Health Centre","funders":"Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Institute of Child Health and Human Development; National Institute of Mental Health; National Institute of General Medical Sciences; National Center for Advancing Translational Sciences; National Institute of Arthritis and Musculoskeletal and Skin Diseases; National Human Genome Research Institute","keywords":"Zebrafish; Biology; Kinase; Protein kinase A; Genetics; Signal transduction; Cell biology; Gene","score_opus":0.010896861559003938,"score_gpt":0.25496915998211905,"score_spread":0.24407229842311512,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4367059606","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9987764,0.00037707688,0.00007987064,0.000025138543,0.00009792577,0.000118783144,0.0000055508026,0.000013583313,0.0005056833],"genre_scores_gemma":[0.99949485,0.000032608816,0.00015998384,0.000014255188,0.000029879266,0.000019120587,0.000008572454,0.0000036749213,0.00023704949],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9994577,0.000011703182,0.00009530567,0.00020015097,0.00010698438,0.00012815735],"domain_scores_gemma":[0.99979424,0.0000045220136,0.000041739422,0.000094460236,0.00004095255,0.000024054025],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019191272,0.000050210005,0.00005619074,0.00008503675,0.000065168424,0.000013323206,0.00007883346,0.000025331223,0.000003652757],"category_scores_gemma":[0.00006973607,0.000045636032,0.000010879189,0.0002697928,0.0002976372,0.000027420114,0.00004913952,0.000020310412,0.0000037561897],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000014256487,0.0000072495054,0.016051123,0.000014446785,0.0000013081432,8.4485345e-7,0.00006642136,0.00001666963,0.98068136,0.00036782853,0.000010834761,0.0027676788],"study_design_scores_gemma":[0.00019150486,0.00029057928,0.10571967,0.000013923762,0.0000022272516,0.0000013116859,0.00059341436,0.00001951218,0.8897047,0.0010791968,0.002303016,0.00008092088],"about_ca_topic_score_codex":0.000011481629,"about_ca_topic_score_gemma":0.00023933403,"teacher_disagreement_score":0.09097662,"about_ca_system_score_codex":0.0000039679653,"about_ca_system_score_gemma":0.000044195636,"threshold_uncertainty_score":0.18609834},"labels":[],"label_agreement":null},{"id":"W4376604468","doi":"10.1021/acschemneuro.3c00205","title":"Synthesis and Preclinical Positron Emission Tomography Imaging of the p38 MAPK Inhibitor [<sup>11</sup>C]Talmapimod: Effects of Drug Efflux and Sex Differences","year":2023,"lang":"en","type":"article","venue":"ACS Chemical Neuroscience","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"Canadian Institutes of Health Research; Azrieli Foundation; Canada Research Chairs; Canada Foundation for Innovation; Ontario Research Foundation","keywords":"Radiosynthesis; Positron emission tomography; Chemistry; In vivo; Blood–brain barrier; Pharmacology; Ex vivo; p38 mitogen-activated protein kinases; Nuclear medicine; Kinase; MAPK/ERK pathway; In vitro; Medicine; Biochemistry; Biology; Internal medicine; Central nervous system","score_opus":0.007631859850970237,"score_gpt":0.22907015645282564,"score_spread":0.2214382966018554,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4376604468","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9993178,0.00018639043,0.000010306482,0.00015251942,0.000099998644,0.00015931914,0.000013561537,0.00001371046,0.000046393387],"genre_scores_gemma":[0.9995769,0.00012705119,0.000041050716,0.00009419449,0.000052937237,0.000012972174,0.0000027750232,0.00000968055,0.00008238382],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988023,0.00008522918,0.00022567112,0.0004530386,0.00021162117,0.00022212433],"domain_scores_gemma":[0.9992233,0.00026639953,0.00009529277,0.00028723516,0.000024323794,0.00010348271],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001800683,0.00014304701,0.00020115201,0.000039874947,0.00007639206,0.000018176392,0.00029793964,0.00007850205,5.74044e-7],"category_scores_gemma":[0.0007854708,0.00009833137,0.00007434035,0.0002274619,0.0005709515,0.000009016287,0.0004972689,0.000094918105,2.0394096e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000012844698,0.000036300327,0.10416237,0.000108233624,0.0000023823252,0.0000013558138,0.000061028615,6.7497825e-7,0.89457977,0.000008326036,0.00019026818,0.0008364584],"study_design_scores_gemma":[0.00018264011,0.000063301115,0.058133684,0.00008487223,0.000017416483,0.00000946786,0.000023055443,0.00039251414,0.94081426,0.00006330107,0.00011692615,0.00009859234],"about_ca_topic_score_codex":0.000009094466,"about_ca_topic_score_gemma":3.305266e-7,"teacher_disagreement_score":0.046234477,"about_ca_system_score_codex":0.0000022682252,"about_ca_system_score_gemma":0.000023199007,"threshold_uncertainty_score":0.4009837},"labels":[],"label_agreement":null},{"id":"W4376641322","doi":"10.1158/2159-8290.c.6649132.v1","title":"Data from Late-Stage Metastatic Melanoma Emerges through a Diversity of Evolutionary Pathways","year":2023,"lang":"en","type":"preprint","venue":"","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"Medical Research Council; Genentech; Ipsen; Ono Pharmaceutical; Cancer Research UK; Gordon and Rose McAlpine Foundation for Neuroscience Research; Francis Crick Institute; Wellcome Trust; National Institute for Health and Care Research; Melanoma Research Alliance; Invitae; Bristol-Myers Squibb; AstraZeneca; Pfizer; Rosetrees Trust; U.S. Department of Defense","keywords":"Biology; Melanoma; Cancer research; Loss of heterozygosity; Amplicon; Genetics; Gene; Allele; Polymerase chain reaction","score_opus":0.1500584193282261,"score_gpt":0.3023461955995019,"score_spread":0.15228777627127577,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4376641322","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9478618,0.002115921,0.008062114,0.00011781104,0.001164065,0.00046426093,0.03662422,0.00008892946,0.0035008895],"genre_scores_gemma":[0.9309924,0.0015788261,0.012721042,0.00011718331,0.0003294838,0.000027308748,0.048272934,0.00006313597,0.00589768],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99773717,0.00013608558,0.00044252895,0.00107816,0.00031611187,0.0002899353],"domain_scores_gemma":[0.997179,0.000046625606,0.0003042383,0.0022728648,0.00011032985,0.00008696352],"candidate_categories":["metaepi_narrow","open_science"],"consensus_categories":[],"category_scores_codex":[0.00021070198,0.0003491488,0.0004788692,0.000053674215,0.0001263227,0.000015564297,0.0014700984,0.0003560115,0.00040306099],"category_scores_gemma":[0.00013557737,0.00033005732,0.00020323564,0.00007546074,0.00011258779,0.000008508752,0.014874271,0.00024366878,0.00008307217],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008238644,0.0012705359,0.04454221,0.0019802544,0.0070366394,0.00047223535,0.0015469618,0.0036367164,0.48826602,0.0037538067,0.44535407,0.0013166816],"study_design_scores_gemma":[0.007671116,0.0024863917,0.14035003,0.0009935579,0.003843333,0.000020084035,0.0061624916,0.021377549,0.43191344,0.079819344,0.29751801,0.007844646],"about_ca_topic_score_codex":0.0034317346,"about_ca_topic_score_gemma":0.0010450454,"teacher_disagreement_score":0.14783604,"about_ca_system_score_codex":0.00001682514,"about_ca_system_score_gemma":0.00023545645,"threshold_uncertainty_score":0.9999151},"labels":[],"label_agreement":null},{"id":"W4377691942","doi":"10.1016/j.jcjo.2023.04.013","title":"Utility of systemic brigatinib therapy in tumour recurrence of choroid metastasis from non-small cell lung carcinoma","year":2023,"lang":"en","type":"letter","venue":"Canadian Journal of Ophthalmology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Metastasis; Carcinoma; Lung; Oncology; Choroid; Systemic therapy; Internal medicine; Cancer; Psychology; Retina; Neuroscience","score_opus":0.03329928215595812,"score_gpt":0.24880242088775223,"score_spread":0.2155031387317941,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4377691942","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9888343,0.006261209,0.000019558687,0.0011913822,0.0011435822,0.00027780054,0.0011238502,9.83244e-7,0.0011473193],"genre_scores_gemma":[0.99749917,0.00011575358,0.00019454901,0.0007828322,0.0007640772,0.000008470715,0.00032080957,0.000052428484,0.00026188462],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9973842,0.00043532037,0.001098439,0.00041223614,0.00016952939,0.00050030433],"domain_scores_gemma":[0.99762815,0.00010198026,0.0011518748,0.00052889745,0.00034617772,0.0002429135],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00051498564,0.00033638816,0.00101139,0.00041577,0.00003070759,0.000010217108,0.0008299455,0.0008809,0.0001996416],"category_scores_gemma":[0.00013624462,0.0003280613,0.00035283822,0.00019646247,0.00018945234,0.0000047650788,0.000048588787,0.00090505276,0.0000037162276],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031107783,0.00010185953,0.45799693,0.0015676836,0.0007447063,0.054770228,0.0010347225,0.000044839508,0.23672976,0.0000036778301,0.24587253,0.0008219859],"study_design_scores_gemma":[0.0061397124,0.005945675,0.3038865,0.0025267834,0.00054132036,0.05937296,0.00092032057,0.000087510474,0.60019124,0.00044224778,0.01778891,0.002156843],"about_ca_topic_score_codex":0.015878545,"about_ca_topic_score_gemma":0.00079008006,"teacher_disagreement_score":0.36346146,"about_ca_system_score_codex":0.000045745695,"about_ca_system_score_gemma":0.0027165725,"threshold_uncertainty_score":0.99991715},"labels":[],"label_agreement":null},{"id":"W4378078276","doi":"10.3389/fcell.2023.1192221","title":"ERK3 and DGKζ interact to modulate cell motility in lung cancer cells","year":2023,"lang":"en","type":"article","venue":"Frontiers in Cell and Developmental Biology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"National Cancer Institute; National Institutes of Health","keywords":"Extracellular; Kinase; Cell biology; Cancer cell; Biology; Cell migration; Cancer research; Cell; Chemistry; Biochemistry; Cancer","score_opus":0.006770923796486746,"score_gpt":0.23272096913110638,"score_spread":0.22595004533461963,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4378078276","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996098,0.001215984,0.00029552565,0.000058096237,0.00065787137,0.00021974317,0.000041701463,0.000010030644,0.0014030397],"genre_scores_gemma":[0.9943963,0.0011846506,0.0030092965,0.0002483558,0.000034313034,0.000044890647,0.000104666586,0.0000116948795,0.0009657929],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99892116,0.000052561663,0.00021136556,0.00045721728,0.000035022516,0.00032264908],"domain_scores_gemma":[0.9997556,0.000010536366,0.000031376865,0.00009415636,0.000010727711,0.00009760533],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015978128,0.00015861575,0.0001999344,0.0001460961,0.000037592064,0.000010252756,0.000099662386,0.00016549986,0.000014755419],"category_scores_gemma":[0.000009791595,0.00015038846,0.000020688354,0.000148877,0.0000570208,0.000004345513,0.00024823027,0.00009304633,0.000008193598],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007460565,0.000028935772,0.39900404,0.000054495908,0.000009123044,0.000011861245,0.0003892712,0.000019465679,0.5873786,0.0000017061249,0.008581512,0.0044463845],"study_design_scores_gemma":[0.0014438982,0.00020292572,0.19641727,0.000034611756,0.000007085068,0.0000058278433,0.000830501,0.0008229658,0.7747311,0.00019224986,0.024850758,0.00046079388],"about_ca_topic_score_codex":0.00012809955,"about_ca_topic_score_gemma":0.00015759043,"teacher_disagreement_score":0.20258676,"about_ca_system_score_codex":0.000036524856,"about_ca_system_score_gemma":0.000053132466,"threshold_uncertainty_score":0.61326635},"labels":[],"label_agreement":null},{"id":"W4378528003","doi":"10.3390/cancers15112938","title":"Mutation in the Common Docking Domain Affects MAP Kinase ERK2 Catalysis and Stability","year":2023,"lang":"en","type":"article","venue":"Cancers","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Ontario Genomics Institute; European Federation of Pharmaceutical Industries and Associations; Merck KGaA; Ministero dell’Istruzione, dell’Università e della Ricerca; Ontario Genomics; Genome Canada; McGill University; Genentech; Bayer; Pfizer; Bristol-Myers Squibb","keywords":"MAPK/ERK pathway; Phosphorylation; Signal transduction; Kinase; Cell biology; Mutant; Effector; Docking (animal); Chemistry; Protein kinase A; Biology; Missense mutation; Mutation; Biochemistry; Gene; Medicine","score_opus":0.014041745965945833,"score_gpt":0.25502261268155413,"score_spread":0.24098086671560828,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4378528003","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99869454,0.00034076665,0.000037847476,0.0001674868,0.00008976709,0.00014043857,0.000012510173,0.000008776754,0.00050787994],"genre_scores_gemma":[0.99950796,0.000044505654,0.000022437143,0.00013785658,0.0000598602,0.000042934567,0.00016211894,0.000005603164,0.000016697692],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99948657,0.00007966273,0.000067796354,0.0001733155,0.00006290946,0.00012973393],"domain_scores_gemma":[0.9997256,0.000023579381,0.00002690713,0.00018907916,0.000008876072,0.000025967818],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002823603,0.000063464366,0.00006932708,0.000026195732,0.000054468946,0.000014354831,0.0000757625,0.000047356676,0.000004211498],"category_scores_gemma":[0.0000244953,0.000050216866,0.000025211119,0.0001244483,0.00004566704,0.0000023737703,0.00003530146,0.00004615862,0.0000036467627],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014213692,0.000023710869,0.04968604,0.00022588606,0.000055754546,0.00013528309,0.0046434114,0.0009913397,0.92092323,0.0004451355,0.0056406274,0.017087447],"study_design_scores_gemma":[0.002761899,0.0007771004,0.13367622,0.000088308116,0.000078969555,0.000034544068,0.012688114,0.001758269,0.7893526,0.0028320872,0.055159517,0.0007923904],"about_ca_topic_score_codex":0.00023990519,"about_ca_topic_score_gemma":0.0014793632,"teacher_disagreement_score":0.13157064,"about_ca_system_score_codex":0.000052205392,"about_ca_system_score_gemma":0.000057588186,"threshold_uncertainty_score":0.20477843},"labels":[],"label_agreement":null},{"id":"W4379280787","doi":"10.1200/jco.2023.41.16_suppl.9579","title":"A pilot study of the neoadjuvant use of vemurafenib plus cobimetinib in patients with BRAF-mutant melanoma with palpable lymph node metastases: Survival results.","year":2023,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; McGill University; Ottawa Hospital; Jewish General Hospital; University of Ottawa; Royal Victoria Hospital; Health Sciences Centre; Sunnybrook Hospital","funders":"","keywords":"Medicine; Vemurafenib; Melanoma; Internal medicine; Neoadjuvant therapy; Lymph node; Surgery; Oncology; Cancer; Metastatic melanoma; Breast cancer; Cancer research","score_opus":0.09954392322007363,"score_gpt":0.35462500954589155,"score_spread":0.25508108632581794,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379280787","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99854445,0.00003505259,0.00003213646,0.00016240476,0.0005242964,0.00040576645,0.00009586832,0.000003378561,0.00019664248],"genre_scores_gemma":[0.9991519,0.000048617952,0.0004295956,0.00011078186,0.00012418233,0.0000063386096,0.000023025375,0.00002316616,0.000082387705],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99565125,0.0010960645,0.002173128,0.00030067202,0.0004956669,0.00028323062],"domain_scores_gemma":[0.9958142,0.0007478464,0.002294294,0.00048682225,0.0005126326,0.00014420725],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026709943,0.00019495143,0.0012089083,0.00011120609,0.000038068625,0.000008340604,0.00042489625,0.00014413515,0.0000064115034],"category_scores_gemma":[0.0019684513,0.00010517908,0.00017346327,0.00036749005,0.00023377743,0.000013792316,0.00020831599,0.0003497897,0.0000017364415],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.049007483,0.007902771,0.9274249,0.000038788305,0.00089815084,0.000246709,0.00021103908,0.0023200635,0.00867138,0.00003130086,0.0007655929,0.002481802],"study_design_scores_gemma":[0.029493634,0.07247621,0.89223224,0.000097509386,0.00022855376,0.000023722874,0.00039663527,0.000034287135,0.0021829605,0.000010672141,0.002670974,0.00015262402],"about_ca_topic_score_codex":0.0002289292,"about_ca_topic_score_gemma":0.0010842802,"teacher_disagreement_score":0.06457344,"about_ca_system_score_codex":0.000034944638,"about_ca_system_score_gemma":0.0011657329,"threshold_uncertainty_score":0.42890784},"labels":[],"label_agreement":null},{"id":"W4379282676","doi":"10.1200/jco.2023.41.16_suppl.e21535","title":"Efficacy and safety of BRAF/MEK inhibitor rechallenge in patients with advanced melanoma: Systematic review and meta-analysis.","year":2023,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Internal medicine; Oncology; Meta-analysis; Melanoma; Adverse effect; Cochrane Library; Confidence interval; Targeted therapy; Randomized controlled trial; Cancer; Cancer research","score_opus":0.08060896918441193,"score_gpt":0.3887397324274803,"score_spread":0.3081307632430683,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379282676","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.975729,0.02272255,0.0000384553,0.00075440854,0.00007676029,0.0005300008,0.000015757852,0.0000024998176,0.00013060267],"genre_scores_gemma":[0.987652,0.011091552,0.0007078141,0.0004128522,0.00004415957,0.000010674022,0.000014917396,0.000010431502,0.00005560863],"study_design_codex":"meta_analysis","study_design_gemma":"observational","domain_scores_codex":[0.996918,0.00065615214,0.0019066047,0.00021331642,0.00017082297,0.00013507658],"domain_scores_gemma":[0.99741715,0.000553606,0.0014788342,0.00021488655,0.00020101467,0.00013448395],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028349187,0.00012983632,0.0028351494,0.000111112495,0.000016595137,0.0000030988158,0.00012231263,0.00018778234,0.000010711589],"category_scores_gemma":[0.0018676651,0.00007766072,0.00038055397,0.00022082795,0.00009537616,0.000007800297,0.00008375035,0.00021349927,0.0000011971505],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.036678072,0.012525012,0.20053616,0.17965549,0.53409547,0.0010657291,0.00087863783,0.00053979864,0.007735288,0.00089701265,0.0051841317,0.020209182],"study_design_scores_gemma":[0.02780868,0.042515654,0.5196608,0.0024831418,0.40265357,0.0000883373,0.00015953099,0.000017420918,0.00056208996,0.000115646835,0.0032229146,0.00071225595],"about_ca_topic_score_codex":0.000001401902,"about_ca_topic_score_gemma":0.000036058605,"teacher_disagreement_score":0.31912458,"about_ca_system_score_codex":0.0000089198,"about_ca_system_score_gemma":0.00012066576,"threshold_uncertainty_score":0.31669122},"labels":[],"label_agreement":null},{"id":"W4379283236","doi":"10.1200/jco.2023.41.16_suppl.3125","title":"Clinical activity of mitogen-activated protein kinase (MAPK) inhibitors in patients with MAP2K1 (MEK1)-mutated metastatic cancers: A systematic review and meta-analysis.","year":2023,"lang":"en","type":"review","venue":"Journal of Clinical Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"KRAS; Neuroblastoma RAS viral oncogene homolog; Medicine; HRAS; MAPK/ERK pathway; Cancer research; Cancer; Colorectal cancer; Mutation; Mutant; Melanoma; Lung cancer; Kinase; Oncology; Internal medicine; Biology; Gene; Genetics","score_opus":0.2124749365452833,"score_gpt":0.4693900631818412,"score_spread":0.2569151266365579,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379283236","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0135696605,0.9825427,0.000031105323,0.000087613924,0.00029067337,0.0032996018,0.00014819718,0.000005703951,0.00002476075],"genre_scores_gemma":[0.0055838837,0.9930438,0.00042627114,0.00021206516,0.00014109575,0.00021055814,0.00010192077,0.000068338784,0.0002121131],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.98426956,0.006401647,0.007801414,0.00067414116,0.0005061636,0.0003470879],"domain_scores_gemma":[0.98484063,0.0014028936,0.012045202,0.00066771585,0.0006675183,0.00037602842],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.008438638,0.0005842683,0.019525083,0.00038712856,0.000028648767,0.000013520925,0.00048644113,0.0008928924,0.000028561622],"category_scores_gemma":[0.006187402,0.00033572433,0.0042611626,0.00092301535,0.00029663017,0.00001747993,0.00020378514,0.0012780258,0.000004714721],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013710982,0.0024660141,0.00034980185,0.57502615,0.3942736,0.00037568496,0.000018011908,0.0000063062867,0.000033452736,0.0000074622526,0.0008883244,0.02518406],"study_design_scores_gemma":[0.0037735535,0.012501173,0.00025929004,0.029193904,0.92548025,0.00004323909,0.0000131153765,0.0000021818018,0.00007249871,0.00001781836,0.028000502,0.00064246915],"about_ca_topic_score_codex":0.000041854022,"about_ca_topic_score_gemma":0.00015978154,"teacher_disagreement_score":0.5458323,"about_ca_system_score_codex":0.00010531546,"about_ca_system_score_gemma":0.002787685,"threshold_uncertainty_score":0.99990946},"labels":[],"label_agreement":null},{"id":"W4379339637","doi":"10.1200/jco.2023.41.16_suppl.e21506","title":"Patient characteristics and treatment patterns in BRAF-mutated unresectable or metastatic melanoma in the United States: A snapshot from real-world data.","year":2023,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pfizer (Canada)","funders":"Pfizer","keywords":"Medicine; Ipilimumab; Melanoma; Dabrafenib; Trametinib; Internal medicine; Nivolumab; Oncology; Metastatic melanoma; Targeted therapy; Retrospective cohort study; Gastroenterology; Vemurafenib; Cancer; Cancer research; Immunotherapy; Kinase","score_opus":0.2015642610219666,"score_gpt":0.44122866727246157,"score_spread":0.23966440625049498,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379339637","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99802184,0.000050759565,0.000026263568,0.0009827729,0.00029945272,0.00020470422,0.00032328806,0.0000029442172,0.000088003195],"genre_scores_gemma":[0.9915407,0.0046044337,0.00030293394,0.00092256715,0.00023856314,0.000011729385,0.002307395,0.000013952161,0.000057764548],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967815,0.0010615117,0.0014612201,0.00027574095,0.00015990529,0.0002600983],"domain_scores_gemma":[0.9971713,0.001495128,0.00076397444,0.00036460045,0.00007576078,0.00012922469],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017841898,0.0001537373,0.0007320356,0.00020149467,0.000027548187,0.000021544214,0.00031097388,0.00012208881,0.0000413694],"category_scores_gemma":[0.00096484134,0.00008796065,0.000077991805,0.0003482217,0.00009185699,0.000010077007,0.00016039105,0.00030714495,0.000004220796],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009608265,0.0031351466,0.8518017,0.000040467563,0.00076628185,0.00856648,0.0018356199,0.00016394757,0.002493651,0.00004053383,0.0074255983,0.11412233],"study_design_scores_gemma":[0.006480422,0.017390935,0.8644727,0.00007363332,0.0001531894,0.00007597453,0.0017085173,0.0018626993,0.00044323565,0.0001756944,0.10695814,0.00020484213],"about_ca_topic_score_codex":0.0023006424,"about_ca_topic_score_gemma":0.024009952,"teacher_disagreement_score":0.11391749,"about_ca_system_score_codex":0.000043483058,"about_ca_system_score_gemma":0.0004524822,"threshold_uncertainty_score":0.9937993},"labels":[],"label_agreement":null},{"id":"W4379341627","doi":"10.1200/jco.2023.41.16_suppl.9542","title":"Durable clinical outcomes in patients (pts) with advanced melanoma and progression-free survival (PFS) ≥3y on nivolumab (NIVO) ± ipilimumab (IPI) or IPI in checkmate 067.","year":2023,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Nivolumab; Ipilimumab; Internal medicine; Oncology; Progression-free survival; Placebo; Melanoma; Overall survival; Cancer; Immunotherapy; Pathology; Cancer research","score_opus":0.06243232627494016,"score_gpt":0.41519514953864695,"score_spread":0.3527628232637068,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379341627","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959283,0.00008029093,0.000009373086,0.0010968928,0.0014471522,0.00035094674,0.000016723996,0.000011833372,0.0010584698],"genre_scores_gemma":[0.9966334,0.0008968294,0.0009876894,0.0005142997,0.00039851273,0.000017708207,0.000022167571,0.00003668525,0.0004927105],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99518126,0.0008512681,0.002529475,0.0005200875,0.00042821612,0.0004897043],"domain_scores_gemma":[0.9965547,0.0011860337,0.0012534517,0.00045806498,0.00021894307,0.0003288223],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0038829735,0.00027576863,0.0015134835,0.00018810369,0.00005272294,0.000016441134,0.00047070315,0.0007061672,0.00002937834],"category_scores_gemma":[0.005121899,0.00017597036,0.0002672055,0.00024409506,0.00024341857,0.000023856961,0.00029032628,0.0008872699,0.000018032537],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018833168,0.0021448086,0.91183436,0.00002933258,0.00014205484,0.0004903893,0.000037228787,0.000042307896,0.00023705095,0.000036585578,0.0013199046,0.06485282],"study_design_scores_gemma":[0.029642168,0.03458882,0.92469215,0.00014060213,0.000036247977,0.000027897817,0.00012178981,0.00004100853,0.00027200117,0.00016018281,0.010028362,0.00024877785],"about_ca_topic_score_codex":0.000013480802,"about_ca_topic_score_gemma":0.00073701347,"teacher_disagreement_score":0.064604044,"about_ca_system_score_codex":0.000056144003,"about_ca_system_score_gemma":0.0007878597,"threshold_uncertainty_score":0.7175863},"labels":[],"label_agreement":null},{"id":"W4380362186","doi":"10.1016/b978-0-12-817134-9.00015-5","title":"Integrated pharmacokinetic/pharmacodynamic/efficacy analysis in oncology: importance of pharmacodynamic/efficacy relationships","year":2023,"lang":"en","type":"book-chapter","venue":"Elsevier eBooks","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Pharmacodynamics; Pharmacokinetics; Context (archaeology); Pharmacology; Medicine; Biomarker; Oncology; Drug; Clinical efficacy; Efficacy; Computational biology; Internal medicine; Biology","score_opus":0.03322566239138656,"score_gpt":0.30059597343123423,"score_spread":0.26737031103984765,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380362186","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.10276018,0.0015283199,0.00007040971,0.000088991714,0.00074965,0.0014513604,0.00076077145,0.00011492747,0.89247537],"genre_scores_gemma":[0.21139711,0.0014178975,0.00042784502,0.00021130237,0.00040337228,0.00010455855,0.0035439138,0.00024515286,0.78224885],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9961468,0.00024247149,0.0014771941,0.001153256,0.00040031777,0.00057998014],"domain_scores_gemma":[0.9975011,0.000188424,0.0009019372,0.0008967275,0.0002526595,0.00025918725],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008722029,0.0007826527,0.0012541496,0.0009129308,0.00010530244,0.00002096269,0.0007100156,0.00089714327,0.00028154248],"category_scores_gemma":[0.00013527277,0.0008012286,0.0008196619,0.00028545933,0.00028571297,0.000006605788,0.00031849087,0.0012076037,0.0001026097],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008128494,0.00033213024,0.002637219,0.00025827982,0.005481128,0.00040939765,0.00036841398,0.0008501826,0.16983137,0.001622634,0.0011509574,0.81624544],"study_design_scores_gemma":[0.0049962075,0.00045941028,0.0035704714,0.00032141324,0.0040694955,0.00003072371,0.000053512424,0.0019379295,0.008148245,0.0006986458,0.9740102,0.0017037112],"about_ca_topic_score_codex":0.00000489922,"about_ca_topic_score_gemma":0.0004488746,"teacher_disagreement_score":0.97285926,"about_ca_system_score_codex":0.00016005315,"about_ca_system_score_gemma":0.00047989353,"threshold_uncertainty_score":0.9994439},"labels":[],"label_agreement":null},{"id":"W4384029604","doi":"10.1093/noajnl/vdad071.016","title":"ACQUIRED PTEN LOSS MAY MEDIATE DABRAFENIB AND TRAMETINIB RESISTANCE IN BRAF V600E–MUTATED EPITHELIOID GLIOBLASTOMA: A CASE REPORT","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology Advances","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Trametinib; Dabrafenib; PTEN; Temozolomide; Medicine; Cancer research; Vemurafenib; Melanoma; MEK inhibitor; Oncology; PI3K/AKT/mTOR pathway; Glioma; Internal medicine; Biology; MAPK/ERK pathway; Metastatic melanoma; Signal transduction","score_opus":0.010870951514336478,"score_gpt":0.2837415345649626,"score_spread":0.2728705830506261,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4384029604","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941305,0.0020209705,0.000050288345,0.0009900057,0.0006536498,0.00038140477,0.00007622746,0.00010130674,0.0015956607],"genre_scores_gemma":[0.9963662,0.001277008,0.0005361713,0.00049251266,0.00023973246,0.00014491112,0.00011603174,0.000048340156,0.0007790642],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9975236,0.00028810304,0.0005511007,0.0009045572,0.0001602422,0.0005724179],"domain_scores_gemma":[0.9987699,0.00024842986,0.0002618869,0.000474803,0.00006871881,0.00017627566],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005182598,0.00029800762,0.00042475772,0.00019227486,0.00014088397,0.000020383985,0.0002178741,0.00031407413,0.00001817829],"category_scores_gemma":[0.000723746,0.00028604554,0.000079195524,0.00047199134,0.0003740641,0.000022852666,0.00019102155,0.00018372598,0.000025338182],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001438836,0.00018769255,0.008230603,0.00013125528,0.000056423512,0.22477062,0.00048112764,0.000095891344,0.75177324,0.00013250414,0.0032824683,0.009419334],"study_design_scores_gemma":[0.00578916,0.0020780074,0.0063812844,0.000059705348,0.00007326709,0.048253734,0.000678819,0.00012506955,0.34566423,0.0015180039,0.5884658,0.0009129275],"about_ca_topic_score_codex":0.000013820021,"about_ca_topic_score_gemma":0.0018442641,"teacher_disagreement_score":0.5851833,"about_ca_system_score_codex":0.000022915567,"about_ca_system_score_gemma":0.0001520859,"threshold_uncertainty_score":0.9999592},"labels":[],"label_agreement":null},{"id":"W4385241321","doi":"10.3390/cancers15153754","title":"Efficacy and Safety of Rechallenge with BRAF/MEK Inhibitors in Advanced Melanoma Patients: A Systematic Review and Meta-Analysis","year":2023,"lang":"en","type":"review","venue":"Cancers","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Melanoma; Oncology; Internal medicine; Overall survival; Meta-analysis; Refractory (planetary science); Immunotherapy; Disease; Clinical Practice; Cancer research; Cancer; Physical therapy","score_opus":0.045585849554262654,"score_gpt":0.30551939764361535,"score_spread":0.2599335480893527,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385241321","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001809496,0.99709386,0.0000074144664,0.0000100684565,0.000024995366,0.0022984017,0.0002670452,0.0000073279343,0.000109939654],"genre_scores_gemma":[0.0002909863,0.99851,0.0000641489,0.000046056623,0.000012826986,0.00056276016,0.000310845,0.00004169301,0.00016066876],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99799144,0.00026592752,0.00083258376,0.0005728019,0.00014396089,0.00019330854],"domain_scores_gemma":[0.99861634,0.00007523235,0.0006396031,0.00050936727,0.00007087069,0.00008861825],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003430733,0.00037842148,0.004076816,0.00016584848,0.000025204661,0.0000077606865,0.00015347762,0.00019949762,0.0000082889765],"category_scores_gemma":[0.00014536468,0.00024703713,0.00048876344,0.0005024802,0.00007027006,0.000004057403,0.000096925294,0.00012623312,0.0000012169705],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000035026045,0.00001761219,0.000006736954,0.94383234,0.0489739,0.000008134641,0.00003911011,0.000007664686,0.0000023517232,0.000015961808,0.00007772021,0.006983469],"study_design_scores_gemma":[0.001197516,0.0008396135,0.00001437904,0.08773658,0.83965594,0.00001369577,0.00006363847,0.0000012739837,0.000019840867,0.0000037832156,0.069575764,0.00087801187],"about_ca_topic_score_codex":0.000028157721,"about_ca_topic_score_gemma":0.00021510311,"teacher_disagreement_score":0.85609573,"about_ca_system_score_codex":0.00009275163,"about_ca_system_score_gemma":0.00022859653,"threshold_uncertainty_score":0.9999982},"labels":[],"label_agreement":null},{"id":"W4385450961","doi":"10.1126/scisignal.ade8744","title":"Multiple cancers escape from multiple MAPK pathway inhibitors and use DNA replication stress signaling to tolerate aberrant cell cycles","year":2023,"lang":"en","type":"article","venue":"Science Signaling","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Anschutz Medical Campus, University of Colorado; National Cancer Institute; National Institutes of Health; National Institute of Standards and Technology; Université Laval; Damon Runyon Cancer Research Foundation","keywords":"MAPK/ERK pathway; Biology; Cancer research; Cell growth; DNA damage; DNA replication; KRAS; DNA repair; Kinase; Cancer cell; Cancer; Cell biology; Mutation; DNA; Genetics; Gene","score_opus":0.021194317219238996,"score_gpt":0.2445866611679958,"score_spread":0.2233923439487568,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385450961","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99780345,0.00013887782,0.0010183769,0.000069830385,0.0003524085,0.00032043335,0.00017154559,0.00006411024,0.00006097332],"genre_scores_gemma":[0.99737483,0.00003053666,0.0018209959,0.00015609448,0.0002556306,0.00004775832,0.00016578462,0.00002601178,0.00012233558],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.997828,0.00005031904,0.00029313384,0.001005843,0.00032263863,0.00050007174],"domain_scores_gemma":[0.9988573,0.000082130486,0.00011829229,0.00053924706,0.00013363286,0.0002693687],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005842585,0.00020620818,0.00016865107,0.00015026555,0.0004155153,0.00019896039,0.00032404624,0.00010300598,0.000008671851],"category_scores_gemma":[0.0003417028,0.00019970046,0.000055492605,0.00052175537,0.00015918347,0.00003861247,0.00024373714,0.00009345492,0.000020023388],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000033232824,0.000014282998,0.010607578,0.000013102615,0.0000061668597,0.0000067680758,0.0005529024,0.0052189254,0.9816762,0.0000041149437,0.00011772112,0.0017490129],"study_design_scores_gemma":[0.00034475018,0.00009213092,0.0035568418,0.00006520036,0.0000074855398,0.0000013669171,0.0007656766,0.006210445,0.9874141,0.00003150301,0.0012292257,0.0002812745],"about_ca_topic_score_codex":0.0007286795,"about_ca_topic_score_gemma":0.00024146494,"teacher_disagreement_score":0.0070507363,"about_ca_system_score_codex":0.000045660883,"about_ca_system_score_gemma":0.00020866931,"threshold_uncertainty_score":0.8143548},"labels":[],"label_agreement":null},{"id":"W4385481458","doi":"10.3390/biom13081212","title":"A Combination of Conformation-Specific RAF Inhibitors Overcome Drug Resistance Brought about by RAF Overexpression","year":2023,"lang":"en","type":"article","venue":"Biomolecules","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Core Research for Evolutional Science and Technology; National Cancer Institute; National Institutes of Health; Queen's University; European Commission; Irish Research Council; Albert-Ludwigs-Universität Freiburg; Japan Society for the Promotion of Science; Queen's University Belfast; Uehara Memorial Foundation","keywords":"Downregulation and upregulation; Gene isoform; MAPK/ERK pathway; Chemistry; Phenotype; Cell biology; Signal transduction; Cancer research; Biology; Biochemistry; Gene","score_opus":0.006780478765837725,"score_gpt":0.22388524567376852,"score_spread":0.2171047669079308,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385481458","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9912991,0.0028830506,0.0010038613,0.00024810014,0.00027890058,0.00026159178,0.00017976423,0.000056231096,0.003789398],"genre_scores_gemma":[0.9935386,0.00075689337,0.00021135759,0.00007295522,0.00008463153,0.000026587863,0.0012852032,0.00002326552,0.004000501],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988703,0.000064850705,0.00033236935,0.00026980756,0.00024311115,0.0002195285],"domain_scores_gemma":[0.9992957,0.000020249694,0.00018654768,0.0003303239,0.00010033501,0.000066819484],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017546203,0.00016048575,0.00015815126,0.00008802312,0.00008919687,0.000020690497,0.00018533278,0.00013566692,0.00001973939],"category_scores_gemma":[0.00004144618,0.000152578,0.0000924299,0.00023381205,0.00011119786,0.000012507852,0.000102263955,0.00005335506,0.000044680804],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000066039036,0.000040813877,0.00011945951,0.000051779236,0.00001236687,0.0000016383862,0.00009681727,0.0000015157267,0.78460026,0.0014175816,0.21317135,0.0004204187],"study_design_scores_gemma":[0.0006857745,0.000045026984,0.00089281145,0.00007705896,0.0000037840923,0.0000013504622,0.000092474125,0.000019458488,0.76765263,0.00015641727,0.23021881,0.00015438044],"about_ca_topic_score_codex":0.000013981046,"about_ca_topic_score_gemma":0.000009524711,"teacher_disagreement_score":0.017047474,"about_ca_system_score_codex":0.000014558309,"about_ca_system_score_gemma":0.000036429865,"threshold_uncertainty_score":0.622195},"labels":[],"label_agreement":null},{"id":"W4385515906","doi":"10.1016/j.jcjo.2023.07.008","title":"BRAF and MEK inhibitor-associated optic neuropathy in stage IIIC BRAF+ melanoma","year":2023,"lang":"en","type":"letter","venue":"Canadian Journal of Ophthalmology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"MEK inhibitor; Melanoma; Medicine; Stage (stratigraphy); Cancer research; Melanoma diagnosis; Optic neuropathy; Oncology; Internal medicine; Optic nerve; Biology; MAPK/ERK pathway; Ophthalmology; Genetics; Signal transduction","score_opus":0.020235514592606675,"score_gpt":0.23465095754453869,"score_spread":0.21441544295193202,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385515906","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.978626,0.0014933486,0.000001933905,0.015049723,0.0019386568,0.00018032317,0.00024445448,0.0000042062584,0.0024613484],"genre_scores_gemma":[0.9756818,0.00005277717,0.00005414221,0.01280245,0.0023156332,0.00000994272,0.00039968232,0.00014259353,0.008541007],"study_design_codex":"case_report","study_design_gemma":"not_applicable","domain_scores_codex":[0.99749494,0.00040517785,0.00068428577,0.00045997344,0.00017241738,0.00078319595],"domain_scores_gemma":[0.9984871,0.00008513853,0.0004923751,0.0003364137,0.0001629896,0.00043599188],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00047808312,0.00038479856,0.00066695997,0.0006527271,0.00008845179,0.000055655866,0.00046850144,0.0012972074,0.00015123852],"category_scores_gemma":[0.0005180338,0.00039735925,0.00018324943,0.00021267073,0.0002091758,0.000008399058,0.00008061022,0.0013817482,0.000021272994],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000058039433,0.000030644784,0.026539793,0.0001584437,0.00026839325,0.5776564,0.00017254414,0.000029154682,0.006617786,0.000022348468,0.38826692,0.00017951103],"study_design_scores_gemma":[0.0053492985,0.009142285,0.068082795,0.0006244982,0.00028102376,0.4125453,0.00025514362,0.00003815291,0.0033365784,0.0006100605,0.49724808,0.0024867866],"about_ca_topic_score_codex":0.0018926712,"about_ca_topic_score_gemma":0.001363544,"teacher_disagreement_score":0.16511112,"about_ca_system_score_codex":0.000109284534,"about_ca_system_score_gemma":0.0016126964,"threshold_uncertainty_score":0.99999934},"labels":[],"label_agreement":null},{"id":"W4385635813","doi":"10.33590/emjoncol/10305035","title":"Acquired PTEN Loss May Mediate Dabrafenib and Trametinib Resistance in BRAF V600E-Mutated Epithelioid Glioblastoma: A Case Report and Literature Review","year":2023,"lang":"en","type":"article","venue":"EMJ Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Hospital for Sick Children; SickKids Foundation; Western University","funders":"","keywords":"Trametinib; Dabrafenib; Temozolomide; PTEN; Medicine; Cancer research; MEK inhibitor; Vemurafenib; Melanoma; Oncology; Glioma; MAPK/ERK pathway; Internal medicine; Kinase; PI3K/AKT/mTOR pathway; Biology; Signal transduction; Metastatic melanoma","score_opus":0.010798618170922066,"score_gpt":0.2937090708532966,"score_spread":0.2829104526823745,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385635813","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9560967,0.03966961,0.000009515879,0.0023417145,0.00023055311,0.0004740026,0.00008256015,0.00004506577,0.0010502405],"genre_scores_gemma":[0.9767808,0.017219346,0.0005517149,0.0012979901,0.00027437945,0.00017392387,0.00044173116,0.000048696515,0.0032114403],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99807584,0.00027568868,0.00048349772,0.0006626393,0.000105655905,0.0003967038],"domain_scores_gemma":[0.9990789,0.00008466904,0.00019164007,0.00040297874,0.00007524681,0.00016653506],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008349022,0.0002383058,0.0004615333,0.00013193808,0.00007606077,0.00002408697,0.000120751065,0.0003731669,0.000016596123],"category_scores_gemma":[0.0004629571,0.000213673,0.000060937185,0.0004563061,0.00018353714,0.000009111248,0.00017613498,0.00016194452,0.00001132669],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005595878,0.00011959869,0.00071365223,0.0012969027,0.00008685947,0.92431724,0.000948862,0.0000011732077,0.04221612,0.0001400494,0.023269344,0.006330604],"study_design_scores_gemma":[0.005410559,0.0018119266,0.0052747466,0.0017300372,0.00015546901,0.58026624,0.00030265262,0.00004393318,0.029440807,0.0007398404,0.3738436,0.0009801962],"about_ca_topic_score_codex":0.000013099442,"about_ca_topic_score_gemma":0.00091832934,"teacher_disagreement_score":0.35057425,"about_ca_system_score_codex":0.000021395948,"about_ca_system_score_gemma":0.00012815339,"threshold_uncertainty_score":0.8713332},"labels":[],"label_agreement":null},{"id":"W4385807698","doi":"10.7717/peerj.15873","title":"Prognostic and clinicopathological role of RACK1 for cancer patients: a systematic review and meta-analysis","year":2023,"lang":"en","type":"review","venue":"PeerJ","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"West China Hospital, Sichuan University; Sichuan University; China Postdoctoral Science Foundation; National Natural Science Foundation of China","keywords":"Internal medicine; Medicine; Meta-analysis; Hazard ratio; Cochrane Library; Confidence interval; Oncology; Lymphovascular invasion; Odds ratio; Cancer; Metastasis","score_opus":0.10998793342270693,"score_gpt":0.38418002799342343,"score_spread":0.27419209457071647,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385807698","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00004908914,0.9959975,0.000025181289,0.000015170612,0.000022646063,0.0028785672,0.0009869328,0.000007795182,0.000017137103],"genre_scores_gemma":[0.00007142169,0.9959314,0.00011041441,0.00007887864,0.000029043456,0.0026207909,0.00062767323,0.000027025033,0.0005033757],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99823374,0.00022131472,0.0008053705,0.00047312104,0.000107473665,0.00015898005],"domain_scores_gemma":[0.9986668,0.00016314237,0.00060278527,0.0003465296,0.00015212165,0.00006861239],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005792597,0.00027843573,0.004384787,0.00006775639,0.000029783017,0.000012610994,0.00014693604,0.00022766039,0.0000140701395],"category_scores_gemma":[0.0010070578,0.00016906664,0.0012712369,0.00017023113,0.000047607646,0.0000014608346,0.0001358564,0.00007055901,0.000002771465],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000024661097,0.000043876094,0.000049911505,0.97191954,0.025279889,9.5289033e-7,0.0000067501132,6.362734e-8,0.0000035005653,0.00002544846,0.00019123145,0.0024763597],"study_design_scores_gemma":[0.00009079114,0.00024457206,0.00001589261,0.008202259,0.93185,0.000004890052,0.000004406132,0.000002023165,0.000004383747,0.000023878536,0.05932024,0.00023666082],"about_ca_topic_score_codex":0.000004830548,"about_ca_topic_score_gemma":0.000013176558,"teacher_disagreement_score":0.9637173,"about_ca_system_score_codex":0.0000046665714,"about_ca_system_score_gemma":0.000052126994,"threshold_uncertainty_score":0.68943375},"labels":[],"label_agreement":null},{"id":"W4386012742","doi":"10.1016/j.pediatrneurol.2023.08.019","title":"Treatment of Refractory Epilepsy With MEK Inhibitor in Patients With RASopathy","year":2023,"lang":"en","type":"article","venue":"Pediatric Neurology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Trametinib; Discontinuation; Medicine; Epilepsy; Levetiracetam; Pediatrics; Refractory (planetary science); Internal medicine; Oncology; MAPK/ERK pathway; Biology; Psychiatry","score_opus":0.005595701158758129,"score_gpt":0.19526764394857712,"score_spread":0.189671942789819,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386012742","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99917245,0.000107481865,0.000007779107,0.000056604087,0.00014546675,0.00023346783,0.000027376766,0.000016485483,0.00023288118],"genre_scores_gemma":[0.9991134,0.00023253921,0.00004057515,0.000064614505,0.0002497495,0.00004273233,0.00014745202,0.00002353738,0.000085440486],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990604,0.000070975104,0.0001776105,0.00033372035,0.00010622413,0.00025108043],"domain_scores_gemma":[0.9995066,0.000028547542,0.00010143173,0.00026145237,0.00004453667,0.000057422596],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000039068615,0.00014583734,0.00019719478,0.00014084218,0.000020753703,0.0000024219828,0.00008273657,0.00011137316,0.0000070652236],"category_scores_gemma":[0.00001919104,0.00010488368,0.00003264334,0.0002444294,0.00004436139,0.000002702192,0.00003513383,0.00005658985,0.000015036102],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011386969,0.00030233138,0.99484044,0.0000154147,0.000013154392,0.00005848697,0.000052497442,0.000035116624,0.0023467652,0.000008188594,0.0003763046,0.00081257307],"study_design_scores_gemma":[0.0042519644,0.019382237,0.96466905,0.0000011897118,0.00003983543,0.000008723102,0.000008044634,0.0000067941223,0.0041015213,0.0000103707425,0.0073461165,0.0001741572],"about_ca_topic_score_codex":0.000021069176,"about_ca_topic_score_gemma":0.00004078194,"teacher_disagreement_score":0.030171424,"about_ca_system_score_codex":0.0000061331043,"about_ca_system_score_gemma":0.00008394661,"threshold_uncertainty_score":0.42770323},"labels":[],"label_agreement":null},{"id":"W4386281917","doi":"10.1016/j.ygyno.2023.08.007","title":"The spectrum of MAPK-ERK pathway genomic alterations in gynecologic malignancies: Opportunities for novel therapeutic approaches","year":2023,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"","keywords":"KRAS; Neuroblastoma RAS viral oncogene homolog; HRAS; Medicine; MAPK/ERK pathway; Cancer research; Serous fluid; Gynecologic oncology; Ovarian cancer; Oncology; Cervix; Cancer; Internal medicine; Biology; Signal transduction; Colorectal cancer; Genetics","score_opus":0.14032292412891686,"score_gpt":0.28610429681241273,"score_spread":0.14578137268349586,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386281917","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98628664,0.00068130135,0.0012687305,0.0027684772,0.00088348123,0.0012195756,0.0001535305,0.00005126913,0.006687018],"genre_scores_gemma":[0.9939276,0.0005692588,0.0006555875,0.0005457199,0.00017242946,0.00093725725,0.00026976882,0.00002670683,0.0028956502],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981106,0.00019618477,0.0005341607,0.00044130386,0.00009229781,0.00062546425],"domain_scores_gemma":[0.9984079,0.00078121806,0.0002531712,0.00042808917,0.000062423795,0.000067170826],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011233025,0.00023053028,0.00037888167,0.00012534576,0.00026212606,0.000022009253,0.00046528928,0.0003871914,0.000032641685],"category_scores_gemma":[0.0003968917,0.00016939135,0.0001636763,0.00019134898,0.0003168569,0.0000060176612,0.00020879813,0.00013534886,0.00001634459],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047146875,0.0008419011,0.004364346,0.00013260535,0.0002731178,0.000059417736,0.0006654429,0.0013554256,0.8681508,0.081174366,0.0057459604,0.036765203],"study_design_scores_gemma":[0.0053572785,0.012575689,0.08811308,0.000022501408,0.000117434356,0.0000961504,0.013307511,0.0028824292,0.12194403,0.022804925,0.73163086,0.0011480981],"about_ca_topic_score_codex":0.000011872315,"about_ca_topic_score_gemma":0.0009033187,"teacher_disagreement_score":0.7462067,"about_ca_system_score_codex":0.00009140587,"about_ca_system_score_gemma":0.0005569476,"threshold_uncertainty_score":0.6907579},"labels":[],"label_agreement":null},{"id":"W4386356684","doi":"10.1126/sciadv.ade7486","title":"BRAF <sup>Δβ3-αC</sup> in-frame deletion mutants differ in their dimerization propensity, HSP90 dependence, and druggability","year":2023,"lang":"en","type":"article","venue":"Science Advances","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; Ontario Institute for Cancer Research","funders":"Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung; Deutsche Forschungsgemeinschaft","keywords":"Druggability; Mutant; Linker; Amino acid; Mutation; Exon; Dabrafenib; Alanine; Cancer research; Chemistry; Biology; Molecular biology; Genetics; Gene; Vemurafenib; Melanoma","score_opus":0.01324951791092464,"score_gpt":0.25451904860327607,"score_spread":0.24126953069235144,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386356684","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998729,0.00024012323,0.000244611,0.00009917758,0.000100007484,0.00025279383,0.00000962056,0.000018205985,0.0003064444],"genre_scores_gemma":[0.9993621,0.0002264856,0.00016266335,0.00007261397,0.000035301466,0.000024785802,0.000025369056,0.000006290249,0.000084354295],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99873465,0.00005409414,0.00017419702,0.00052495074,0.00019825409,0.00031383254],"domain_scores_gemma":[0.99958426,0.000019524881,0.000048803107,0.0002302245,0.000052692933,0.00006449344],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005706604,0.00011546181,0.00012776365,0.00012665956,0.00011266229,0.000041846317,0.00022554903,0.00006867847,0.0000051252805],"category_scores_gemma":[0.00021717242,0.00009324931,0.000018203269,0.0007105993,0.0003696883,0.00005617598,0.00019714824,0.00007833552,0.000009862252],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002471298,0.00003356539,0.22149985,0.000019971656,0.0000010899599,0.000005317036,0.00026630075,0.00055863295,0.7606963,0.00006682025,0.0000061273417,0.016821332],"study_design_scores_gemma":[0.0004205112,0.00018955285,0.56083477,0.0000442951,0.0000022438064,0.000012984452,0.0004973533,0.0028361322,0.43151918,0.0022503624,0.0011345196,0.00025807586],"about_ca_topic_score_codex":0.000025308376,"about_ca_topic_score_gemma":0.00024278453,"teacher_disagreement_score":0.33933493,"about_ca_system_score_codex":0.000018426772,"about_ca_system_score_gemma":0.000093966395,"threshold_uncertainty_score":0.38025966},"labels":[],"label_agreement":null},{"id":"W4386863242","doi":"10.1101/2023.09.15.557847","title":"The clinical, genomic, and transcriptomic landscape of BRAF mutant cancers","year":2023,"lang":"en","type":"preprint","venue":"bioRxiv (Cold Spring Harbor Laboratory)","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; McGill University Health Centre; McGill University; Jewish General Hospital","funders":"Fonds de Recherche du Québec - Santé; EMD Serono; Fondation de l'Hôpital général juif; Jewish General Hospital; Advanced Accelerator Applications; Canadian Institutes of Health Research; Genome Canada; AstraZeneca Canada; AstraZeneca; American Society of Clinical Oncology; Pfizer; Conquer Cancer Foundation","keywords":"Wnt signaling pathway; Transcriptome; Cancer; Melanoma; Cancer research; Biology; Mutant; Mutation; Medicine; Gene; Genetics; Oncology; Internal medicine; Gene expression","score_opus":0.02277451477685394,"score_gpt":0.24925717703166586,"score_spread":0.22648266225481192,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386863242","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99277043,0.0044217524,0.00019533955,0.00014121467,0.0015986031,0.0004366757,0.0003660321,0.00005641728,0.000013536777],"genre_scores_gemma":[0.9903568,0.008421722,0.00035277315,0.000099028905,0.0005745081,0.000079942554,0.0000013441571,0.00009375614,0.000020127965],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979349,0.000143718,0.0006162715,0.00076707645,0.00016014093,0.00037793693],"domain_scores_gemma":[0.9981844,0.000047163037,0.0003525649,0.0010687911,0.00016880909,0.00017831218],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00083519367,0.00033716473,0.00043526475,0.00006228917,0.00014527989,0.000073919415,0.00050786295,0.0005285819,0.0000068581962],"category_scores_gemma":[0.00015072999,0.0002841396,0.0001994278,0.00010404751,0.00026189766,0.0000031097536,0.00040636762,0.00037570993,0.000011363936],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006716525,0.000024748424,0.009943955,0.0001468316,0.00024070454,0.00001080209,0.000005160172,0.00001879041,0.9882949,0.00011139984,0.0011260627,0.000009457784],"study_design_scores_gemma":[0.0011655027,0.00032518848,0.25624457,0.00018067418,0.00020498496,6.1393806e-8,0.000014803569,0.00020894122,0.6983368,0.0000060077223,0.04252656,0.00078594347],"about_ca_topic_score_codex":0.00007795604,"about_ca_topic_score_gemma":0.000054826738,"teacher_disagreement_score":0.28995815,"about_ca_system_score_codex":0.000031619238,"about_ca_system_score_gemma":0.000779278,"threshold_uncertainty_score":0.9999611},"labels":[],"label_agreement":null},{"id":"W4386863695","doi":"10.1007/s12265-023-10431-4","title":"The Role of p90 Ribosomal S6 Kinase (RSK) in Tyrosine Kinase Inhibitor (TKI)-Induced Cardiotoxicity","year":2023,"lang":"en","type":"review","venue":"Journal of Cardiovascular Translational Research","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Cardiotoxicity; Ribosomal s6 kinase; Tyrosine kinase; Kinase; Tyrosine-kinase inhibitor; Biology; Protein kinase A; Effector; Cancer research; Cell biology; Pharmacology; Cancer; Phosphorylation; Signal transduction; P70-S6 Kinase 1; Protein kinase B; Genetics; Chemotherapy","score_opus":0.09482116411547385,"score_gpt":0.3732754609136442,"score_spread":0.27845429679817035,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386863695","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0059427912,0.99223757,0.00008720684,0.000045678255,0.0003094782,0.00075250684,0.00012655844,0.0000041870117,0.00049402734],"genre_scores_gemma":[0.023287654,0.97465557,0.000100227546,0.0000028487946,0.0016128332,0.000062310646,0.00011454565,0.000083175546,0.00008081679],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9933783,0.0018199808,0.001380891,0.00044296443,0.002394427,0.0005834384],"domain_scores_gemma":[0.99718916,0.00043415313,0.00034646745,0.00078552164,0.0010281024,0.00021660251],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0078001916,0.00036502743,0.0016545254,0.00055920583,0.00018943298,0.00006027824,0.0008153157,0.0005912858,0.000006055775],"category_scores_gemma":[0.00082409836,0.0002610267,0.0035827903,0.00083969155,0.0002174496,0.000018600289,0.00015271439,0.0012507071,0.000012838026],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003690477,0.00021445577,0.0000650973,0.0039884015,0.006456969,0.0004766891,0.000060496448,0.00041424241,0.01675129,0.000785834,0.00036937438,0.9700481],"study_design_scores_gemma":[0.0008898583,0.00035652777,0.0000945394,0.0022149812,0.00048212108,0.0002070371,0.000049075225,0.000011552612,0.0068208366,0.00030514138,0.988306,0.00026236605],"about_ca_topic_score_codex":0.00003825577,"about_ca_topic_score_gemma":0.000032924112,"teacher_disagreement_score":0.9879366,"about_ca_system_score_codex":0.000093425035,"about_ca_system_score_gemma":0.0019477064,"threshold_uncertainty_score":0.9999842},"labels":[],"label_agreement":null},{"id":"W4387158006","doi":"10.1097/pas.0000000000002131","title":"Clinical, Morphologic, and Molecular Features of Benign and Intermediate-grade Melanocytic Tumors With Activating Mutations in MAP2K1","year":2023,"lang":"en","type":"article","venue":"The American Journal of Surgical Pathology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; William Osler Health System","funders":"","keywords":"HRAS; Pathology; Missense mutation; Pleomorphism (cytology); V600E; Biology; Spitz nevus; Nevus; Medicine; Dermatology; Melanoma; Mutation; KRAS; Cancer research; Genetics; Immunohistochemistry; Gene","score_opus":0.015221080423406915,"score_gpt":0.28988806644840565,"score_spread":0.2746669860249987,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387158006","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9987809,0.00037490972,0.00008752639,0.0005437666,0.000036454054,0.000068028814,0.000006044428,0.0000035356904,0.000098811055],"genre_scores_gemma":[0.99847496,0.0007347043,0.00055783737,0.00014187607,0.000053765838,0.00000352668,0.000006606794,0.00001045887,0.000016267588],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99879646,0.00038191015,0.00038272096,0.00016997659,0.00009437186,0.00017457477],"domain_scores_gemma":[0.9990672,0.00023866861,0.00042901497,0.00013934355,0.000050992658,0.00007479647],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006975354,0.00010657178,0.00038412467,0.000099101395,0.000032414115,0.000006704083,0.0001407261,0.000054881,0.0000020206148],"category_scores_gemma":[0.00014766297,0.000064059364,0.000061591454,0.00019438157,0.0009308964,0.000004242234,0.00009750265,0.00024161795,4.52179e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002698024,0.00026403033,0.1715524,0.000056816094,0.00027941458,0.009276151,0.0013074247,0.00044064262,0.73436487,0.0007430787,0.00031249507,0.07870465],"study_design_scores_gemma":[0.004530422,0.012804912,0.9148239,0.00014824474,0.000112427406,0.01386602,0.0045063966,0.00008132285,0.045600064,0.002218906,0.00087341276,0.00043399323],"about_ca_topic_score_codex":0.000008886182,"about_ca_topic_score_gemma":0.000004314735,"teacher_disagreement_score":0.74327147,"about_ca_system_score_codex":0.0000041650624,"about_ca_system_score_gemma":0.000047014888,"threshold_uncertainty_score":0.34299266},"labels":[],"label_agreement":null},{"id":"W4388656122","doi":"10.1101/2023.11.13.566904","title":"Impaired migration and metastatic spread of human melanoma by a novel small molecule targeting the transmembrane domain of death receptor p75 <sup>NTR</sup>","year":2023,"lang":"en","type":"preprint","venue":"bioRxiv (Cold Spring Harbor Laboratory)","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital; University of Calgary","funders":"National Medical Research Council; Medical Research Council; Vetenskapsrådet; Cancerfonden","keywords":"Small molecule; Intracellular; Melanoma; Receptor; Cancer research; Cell biology; Extracellular; Transmembrane protein; Biology; Low-affinity nerve growth factor receptor; Nerve growth factor; Ligand (biochemistry); Pharmacology; Biochemistry","score_opus":0.018221027005160092,"score_gpt":0.22024053574720714,"score_spread":0.20201950874204705,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388656122","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99200433,0.0018376783,0.0038437413,0.00013642438,0.00013925305,0.0008364908,0.0011415766,0.000055274777,0.0000051999546],"genre_scores_gemma":[0.9944276,0.00032581663,0.004716206,0.000047944464,0.00015017312,0.00016521306,0.00003214725,0.00012014026,0.000014753858],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9975143,0.00018646372,0.00077647506,0.00082968053,0.00027275147,0.00042033315],"domain_scores_gemma":[0.99801385,0.00005683033,0.0005916765,0.00089512795,0.00028677002,0.00015574887],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00086465984,0.00050222984,0.00063760125,0.00012496099,0.00013749218,0.000054044896,0.0005023517,0.00041020918,0.000010787119],"category_scores_gemma":[0.00016806617,0.0004424053,0.0002248697,0.00021265744,0.00018528017,0.000008640501,0.0003019871,0.00030790124,0.000002872797],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006749824,0.00014504838,0.0022525976,0.00064754393,0.00032951243,0.0000049952614,0.00007086178,0.00006623756,0.99583197,0.00023181489,0.00035051358,0.0000014159817],"study_design_scores_gemma":[0.0008366818,0.00031969856,0.0031632744,0.00020492089,0.00018479035,7.558334e-8,0.000035950015,0.00030688103,0.99366915,0.000004864873,0.0008272976,0.00044640873],"about_ca_topic_score_codex":0.00035868777,"about_ca_topic_score_gemma":0.000030551884,"teacher_disagreement_score":0.0024232445,"about_ca_system_score_codex":0.000030917447,"about_ca_system_score_gemma":0.00025623842,"threshold_uncertainty_score":0.99980277},"labels":[],"label_agreement":null},{"id":"W4388781591","doi":"10.1016/j.fander.2023.09.267","title":"Recherche de la mutation BRAF sur les mélanomes au CHU de Québec : sept ans de données","year":2023,"lang":"fr","type":"article","venue":"Annales de Dermatologie et de Vénéréologie - FMC","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University; Hôtel-Dieu de Québec","funders":"","keywords":"Molecular biology; Biology; Mutation; Philosophy; Genetics; Gene","score_opus":0.14152347085577557,"score_gpt":0.3602038730258062,"score_spread":0.21868040217003062,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388781591","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9519054,0.015241148,0.007845673,0.0190682,0.0003502224,0.00031024843,0.0001694144,0.00037938624,0.004730272],"genre_scores_gemma":[0.96371216,0.020860739,0.0076114726,0.0031287072,0.0003574757,0.00016843637,0.00048726256,0.000100455465,0.0035732833],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99258316,0.0038059785,0.0005937802,0.000802754,0.00019179973,0.0020225055],"domain_scores_gemma":[0.99619013,0.0022417242,0.00028433674,0.0006934886,0.00017412224,0.00041620186],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0034495164,0.00060365384,0.00058993994,0.00022555867,0.00033028045,0.00016113446,0.00087149866,0.002403455,0.00006750181],"category_scores_gemma":[0.0063629663,0.0006366463,0.0004192022,0.00044904722,0.00075634895,0.00004272316,0.00040942276,0.0010021353,0.00015254357],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029554754,0.0004835408,0.5986111,0.0012902922,0.0006290049,0.0067443694,0.0069126384,0.002217901,0.22402504,0.0026382965,0.1150341,0.041118134],"study_design_scores_gemma":[0.0018547564,0.0008122221,0.23303336,0.00037679178,0.0003644447,0.010038152,0.0077947383,0.003773476,0.45305452,0.011873984,0.27529612,0.0017274206],"about_ca_topic_score_codex":0.0081075495,"about_ca_topic_score_gemma":0.0140020065,"teacher_disagreement_score":0.36557776,"about_ca_system_score_codex":0.00085755624,"about_ca_system_score_gemma":0.007658537,"threshold_uncertainty_score":0.99960846},"labels":[],"label_agreement":null},{"id":"W4388848431","doi":"10.1016/j.ejca.2023.113458","title":"First-in-human study of naporafenib (LXH254) with or without spartalizumab in adult patients with advanced solid tumors harboring MAPK signaling pathway alterations","year":2023,"lang":"en","type":"article","venue":"European Journal of Cancer","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"National Cancer Institute; Novartis Pharmaceuticals UK Limited; Chugai Pharmaceutical; Italfarmaco; Bristol-Myers Squibb; AstraZeneca; Symphogen; Sun Pharma; Eisai; Sanofi; Genentech; Pfizer; Novartis Pharmaceuticals Corporation; Daiichi-Sankyo","keywords":"Medicine; Rash; Nausea; KRAS; Adverse effect; Internal medicine; Gastroenterology; Dysgeusia; Pharmacology; Oncology; Cancer; Colorectal cancer","score_opus":0.013822229583305158,"score_gpt":0.26503973175402923,"score_spread":0.2512175021707241,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388848431","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9992032,0.00006885923,0.00009249082,0.000016380453,0.00010765375,0.00026784526,0.000011658051,0.0000059538716,0.00022598275],"genre_scores_gemma":[0.9993877,0.00002814916,0.00021291603,0.000023992288,0.00014959661,0.000012854176,0.000012399502,0.000045371416,0.00012701818],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985841,0.00014338946,0.0005469326,0.00022095325,0.0002763902,0.0002282367],"domain_scores_gemma":[0.9989804,0.000009319995,0.00043241834,0.000192287,0.00030430336,0.000081265025],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027070084,0.00016978492,0.00029826834,0.00016391109,0.00006208179,0.00001962141,0.00018715455,0.000019090967,0.00001524576],"category_scores_gemma":[0.00003836903,0.0001183972,0.00003697995,0.00025343834,0.000032983313,0.000019800567,0.000046787092,0.00014986839,0.0000013559198],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003942447,0.0009984439,0.782536,0.00014924775,0.0002460527,0.0013860863,0.004928544,0.06887817,0.13373749,0.000014747208,0.00013421642,0.00304857],"study_design_scores_gemma":[0.040601123,0.03042758,0.67184436,0.0036173344,0.00014832827,0.000059543236,0.0055719726,0.00034238218,0.24310865,0.000008565727,0.0030670771,0.0012030998],"about_ca_topic_score_codex":0.000028024844,"about_ca_topic_score_gemma":0.0016307954,"teacher_disagreement_score":0.11069164,"about_ca_system_score_codex":0.000028667848,"about_ca_system_score_gemma":0.00011130178,"threshold_uncertainty_score":0.48280975},"labels":[],"label_agreement":null},{"id":"W4388879933","doi":"10.1101/2023.11.21.568071","title":"Tumorigenesis driven by the BRAF <sup>V600E</sup> oncoprotein requires secondary mutations that overcome its feedback inhibition of migration and invasion","year":2023,"lang":"en","type":"preprint","venue":"bioRxiv (Cold Spring Harbor Laboratory)","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Fonds de Recherche du Québec - Santé; Emerson Collective; Geoffrey Beene Cancer Research Center; Memorial Sloan-Kettering Cancer Center; National Institutes of Health; Yale University; Canadian Institutes of Health Research; Melanoma Research Alliance","keywords":"Carcinogenesis; Cancer research; Mutation; V600E; Biology; Genetics; Cancer; Gene","score_opus":0.019692991710014804,"score_gpt":0.2185973495610697,"score_spread":0.19890435785105487,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388879933","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99520266,0.0017520369,0.00042065053,0.0003595474,0.0002689014,0.00091217883,0.0009957233,0.000078048084,0.000010248543],"genre_scores_gemma":[0.99767524,0.0010172335,0.00044341153,0.00011455968,0.00030121257,0.0002645118,0.00004336276,0.00009398231,0.00004650267],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978859,0.00020457906,0.00047878767,0.0008114981,0.0003023108,0.00031694685],"domain_scores_gemma":[0.9982687,0.000048590187,0.0004471773,0.00081278605,0.00028526,0.00013747993],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004423846,0.00040533618,0.00037038032,0.00013345116,0.00021261681,0.00010777971,0.0002897065,0.0005425324,0.000019748488],"category_scores_gemma":[0.00019381478,0.0003702335,0.00014068272,0.00022026594,0.00016135567,0.00002637627,0.0004975873,0.00033783665,0.000019485531],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003452469,0.000057994905,0.0038362015,0.00034570662,0.000091393034,0.000009195939,0.000030734416,0.000105478335,0.99400765,0.00008004033,0.0013914093,0.000009693091],"study_design_scores_gemma":[0.00044595104,0.00014712683,0.03858954,0.00026560822,0.00007777282,1.0716259e-7,0.00002482185,0.000285615,0.9574932,0.000007916012,0.00226275,0.00039961174],"about_ca_topic_score_codex":0.00016232555,"about_ca_topic_score_gemma":0.000054231128,"teacher_disagreement_score":0.03651445,"about_ca_system_score_codex":0.000058960395,"about_ca_system_score_gemma":0.0004123828,"threshold_uncertainty_score":0.99987495},"labels":[],"label_agreement":null},{"id":"W4389007994","doi":"10.1096/fasebj.30.1_supplement.1115.1","title":"Differential Expression and Subcellular Localization of MK5, ERK3 and ERK4 in Cardiac Fibroblasts and Myocytes","year":2016,"lang":"en","type":"article","venue":"The FASEB Journal","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"","keywords":"Myocyte; Cell biology; Protein kinase A; Kinase; Biology; Medicine; Chemistry","score_opus":0.0059942445050817595,"score_gpt":0.19539153467754367,"score_spread":0.1893972901724619,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389007994","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.993492,0.0016878707,0.0046182983,0.000045714263,0.000053876618,0.000051264233,0.000009114415,0.0000012231982,0.000040634124],"genre_scores_gemma":[0.99828583,0.001462985,0.000046746267,0.000010399773,0.00010308629,0.000001145246,0.0000040499585,0.0000058524674,0.00007991198],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99954224,0.00008431081,0.00011871274,0.00009937179,0.00006209225,0.00009328477],"domain_scores_gemma":[0.99976724,0.000017377028,0.000061355364,0.000082010665,0.000020253809,0.000051785188],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012185725,0.000068573834,0.00009740945,0.000025323998,0.00005594554,0.000014380195,0.000041909392,0.000057897036,0.000007699599],"category_scores_gemma":[0.00002517541,0.000036878464,0.00002084389,0.000016160988,0.00008445038,0.0000050016242,0.00006917709,0.000041715557,2.2200658e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007188129,0.00000774447,0.031038828,0.000012341297,0.000009852172,0.0000017974872,0.000079593316,0.000002028051,0.96642494,0.000022786555,0.00007001544,0.002258168],"study_design_scores_gemma":[0.0005999455,0.00014616385,0.0135832215,0.00007936856,0.000011675817,0.00004167854,0.000050350955,0.000056514906,0.9849302,0.00016785358,0.0002736639,0.000059325434],"about_ca_topic_score_codex":0.0000039488905,"about_ca_topic_score_gemma":0.000003900879,"teacher_disagreement_score":0.018505273,"about_ca_system_score_codex":0.0000029910032,"about_ca_system_score_gemma":0.000012907421,"threshold_uncertainty_score":0.15038602},"labels":[],"label_agreement":null},{"id":"W4389149792","doi":"10.20944/preprints202311.1711.v1","title":"Extracellular Signal-Regulated Kinases: One Pathway, Multiple Fates","year":2023,"lang":"en","type":"preprint","venue":"Preprints.org","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; Université de Montréal; Montreal Clinical Research Institute","funders":"Canadian Institutes of Health Research","keywords":"MAPK/ERK pathway; Cell biology; Cell fate determination; Kinase; Cell growth; Signal transduction; Context (archaeology); Biology; Extracellular; Transcription factor; Genetics","score_opus":0.12530728223178414,"score_gpt":0.30264643438751676,"score_spread":0.17733915215573262,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389149792","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99340105,0.0014852115,0.0010468076,0.00016503084,0.00088695454,0.0010277348,0.0002482123,0.00031232924,0.0014266886],"genre_scores_gemma":[0.9810446,0.00039678437,0.0003545602,0.000059351394,0.00071039365,0.00036075138,0.0024540233,0.00017511935,0.014444455],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9959631,0.00024215801,0.0007526363,0.0019115107,0.0004190401,0.00071155006],"domain_scores_gemma":[0.9967042,0.000057720506,0.00041567173,0.002285738,0.0002439248,0.00029270365],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007033923,0.0006742306,0.00063072966,0.00016125951,0.00015967787,0.000044423537,0.0010418863,0.0011251221,0.00053970766],"category_scores_gemma":[0.00042917443,0.0007459306,0.0004762161,0.00014912857,0.00015939772,0.000005810682,0.0034866398,0.0007229461,0.0021685727],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011651867,0.00025792446,0.091766454,0.00026362925,0.0003391077,0.00007027521,0.00013293687,0.0008745787,0.90529376,0.00009627639,0.0003122604,0.0004762505],"study_design_scores_gemma":[0.00066820544,0.00009664713,0.05012098,0.00020642977,0.00008530271,0.000010684157,0.000065328895,0.00033961068,0.92501414,0.00091189396,0.02162863,0.0008521363],"about_ca_topic_score_codex":0.00032645912,"about_ca_topic_score_gemma":0.0000937177,"teacher_disagreement_score":0.041645475,"about_ca_system_score_codex":0.000055884066,"about_ca_system_score_gemma":0.0002979825,"threshold_uncertainty_score":0.99949914},"labels":[],"label_agreement":null},{"id":"W4389992286","doi":"10.3390/cells13010019","title":"Promising and Minimally Invasive Biomarkers: Targeting Melanoma","year":2023,"lang":"en","type":"article","venue":"Cells","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Melanoma; Tumour heterogeneity; Biomarker; Medicine; Targeted therapy; Liquid biopsy; Immunotherapy; Cancer; Bioinformatics; Computational biology; Biology; Cancer research; Internal medicine","score_opus":0.011481993520989749,"score_gpt":0.2214415800887308,"score_spread":0.20995958656774105,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389992286","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953822,0.0004514046,0.000031260395,0.00007183393,0.00017328862,0.0001311291,0.000011752629,0.000029122508,0.003717998],"genre_scores_gemma":[0.9971025,0.00020068166,0.0009804884,0.000106029365,0.00019653353,0.000011183304,0.00011655982,0.000020338264,0.0012656781],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992998,0.00003125951,0.00011996681,0.00027245947,0.00006112065,0.00021536062],"domain_scores_gemma":[0.99968654,0.000021516382,0.000043549106,0.0001460812,0.000027132566,0.00007520902],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016289455,0.00010338324,0.000089890666,0.000040543255,0.00007217051,0.000027621176,0.00008562759,0.00009275746,0.0000159146],"category_scores_gemma":[0.00007360062,0.00009849543,0.000037528964,0.00008408813,0.000044762004,0.0000025955087,0.00012699694,0.000035704,0.000075569325],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000019306528,0.0000073129477,0.0012243576,0.00003505858,0.000026744581,0.00002204156,0.00008689501,0.0000014149576,0.9850348,0.000012187813,0.012279177,0.0012506957],"study_design_scores_gemma":[0.00027263767,0.00013868973,0.0014788954,0.000015696407,0.000008734575,0.000007194099,0.00020439766,0.000034760596,0.97161293,0.000052320374,0.02602936,0.00014437552],"about_ca_topic_score_codex":0.000005713609,"about_ca_topic_score_gemma":0.0000057550214,"teacher_disagreement_score":0.013750182,"about_ca_system_score_codex":0.0000038767116,"about_ca_system_score_gemma":0.000045979883,"threshold_uncertainty_score":0.40165272},"labels":[],"label_agreement":null},{"id":"W4390174857","doi":"10.3390/cancers16010095","title":"Extracellular Signal-Regulated Kinases: One Pathway, Multiple Fates","year":2023,"lang":"en","type":"article","venue":"Cancers","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Clinical Research Institute; Université de Montréal","funders":"Canadian Institutes of Health Research","keywords":"MAPK/ERK pathway; Cell biology; Cell fate determination; Cell growth; Kinase; Signal transduction; Context (archaeology); Extracellular; Biology; Transcription factor; Genetics","score_opus":0.021110256261635228,"score_gpt":0.22854535866931927,"score_spread":0.20743510240768404,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390174857","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99570614,0.001973996,0.00046910645,0.000060876766,0.00027914447,0.00019710088,0.00007039885,0.000094305644,0.0011489489],"genre_scores_gemma":[0.9930845,0.00019101416,0.00012661007,0.00008264914,0.00028765216,0.000056894543,0.00053002115,0.000033498618,0.0056071733],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989928,0.0000342348,0.00015926601,0.00035550527,0.00012363103,0.00033457478],"domain_scores_gemma":[0.9994389,0.000015568736,0.000056424815,0.0003209555,0.000052638807,0.00011553936],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011419331,0.00015046794,0.00013885916,0.00005131236,0.0000891896,0.000018752558,0.00017092723,0.00014265145,0.00011229118],"category_scores_gemma":[0.00004797312,0.00015419508,0.000088930916,0.00019213466,0.00006808574,0.0000030906956,0.00007609826,0.00006613139,0.00014726487],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000045251643,0.000009494116,0.00069639005,0.000024504809,0.000045879722,0.00002347514,0.000052687345,0.0010813309,0.9878281,0.00009778007,0.006685725,0.003409402],"study_design_scores_gemma":[0.00057523267,0.00019086976,0.0008579198,0.000023363498,0.000012966653,0.0000036200086,0.00013331164,0.0013292064,0.8657075,0.00008567561,0.13083711,0.00024319961],"about_ca_topic_score_codex":0.00011713228,"about_ca_topic_score_gemma":0.00007329395,"teacher_disagreement_score":0.12415138,"about_ca_system_score_codex":0.000068255424,"about_ca_system_score_gemma":0.00022842712,"threshold_uncertainty_score":0.6287893},"labels":[],"label_agreement":null},{"id":"W4390512567","doi":"10.1126/scisignal.adg4422","title":"The induction of SHP-1 degradation by TAOK3 ensures the responsiveness of T cells to TCR stimulation","year":2024,"lang":"en","type":"article","venue":"Science Signaling","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; University of Toronto; Mount Sinai Hospital; McGill University","funders":"","keywords":"T-cell receptor; Cell biology; Protein tyrosine phosphatase; Phosphorylation; Biology; Phosphatase; Signal transduction; T cell; Kinase; Tyrosine kinase; Cytotoxic T cell; Molecular biology; Chemistry; Biochemistry; Immunology; Immune system","score_opus":0.0135716060954329,"score_gpt":0.26972808616762917,"score_spread":0.25615648007219627,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390512567","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99244934,0.00051148597,0.006328415,0.00014584353,0.00033145363,0.00012484094,0.000008627911,0.000003949381,0.00009604738],"genre_scores_gemma":[0.999521,0.000016120635,0.00021520868,0.00002037934,0.000056017147,0.000005317191,0.0000066616567,0.0000037993648,0.00015546173],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993389,0.00005281693,0.00013708882,0.00016503461,0.00020293792,0.00010322614],"domain_scores_gemma":[0.99957275,0.00005857711,0.000049469985,0.00016601948,0.00012994478,0.000023215467],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010068098,0.000047971145,0.000043998076,0.000042112286,0.0001649625,0.000036762343,0.00019106026,0.000031372376,0.000002845098],"category_scores_gemma":[0.00015359919,0.000028439348,0.000027099753,0.000313332,0.00017332016,0.000007983146,0.000045337496,0.00003584417,0.0000015420504],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000024273504,0.0000040075797,0.000044880035,0.00000792765,0.0000035959488,1.0085042e-7,0.00014194172,0.0018948757,0.99151766,0.0003754078,0.00022182983,0.0057634893],"study_design_scores_gemma":[0.000028376557,0.000103050246,0.0003374129,0.00002092595,0.0000055826736,9.955597e-7,0.00020648583,0.0006470446,0.9951183,0.00015019221,0.0033444506,0.00003715736],"about_ca_topic_score_codex":0.000020737838,"about_ca_topic_score_gemma":0.0000042388165,"teacher_disagreement_score":0.007071698,"about_ca_system_score_codex":0.000008551381,"about_ca_system_score_gemma":0.00013752587,"threshold_uncertainty_score":0.12687749},"labels":[],"label_agreement":null},{"id":"W4390706303","doi":"10.1038/s41568-023-00650-x","title":"The role of CRAF in cancer progression: from molecular mechanisms to precision therapies","year":2024,"lang":"en","type":"review","venue":"Nature reviews. Cancer","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":35,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; McGill University; Jewish General Hospital","funders":"","keywords":"Kinase; Cancer research; Biology; Cancer; Melanoma; Protein kinase A; Bioinformatics; Genetics","score_opus":0.01771481328387154,"score_gpt":0.37752539805915375,"score_spread":0.3598105847752822,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390706303","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000028845694,0.99617684,0.000035561767,0.00011384624,0.0010640724,0.0020024823,0.0003089135,0.000010054472,0.00025935954],"genre_scores_gemma":[0.00006832315,0.99574196,0.0004757668,0.00018564581,0.00050848955,0.0024101534,0.00014895927,0.000080890335,0.00037978802],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9975737,0.0003091836,0.00073953817,0.00075203425,0.00030681456,0.00031877006],"domain_scores_gemma":[0.99859875,0.000041647865,0.00036579816,0.00080998393,0.000089110246,0.00009467876],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004602126,0.0005169224,0.0013390081,0.00008416044,0.000050033497,0.000041610154,0.0006978834,0.00097433326,0.00005829816],"category_scores_gemma":[0.000113762646,0.0002719315,0.0006146592,0.0003935623,0.00003823416,0.0000030916099,0.00029883755,0.00073952,0.0000250336],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000015562342,0.000021912747,0.0000012303234,0.0029806248,0.0001559887,0.000005116992,0.00003212793,3.7097413e-7,0.0048498474,0.00031685203,0.003125054,0.9884953],"study_design_scores_gemma":[0.00006936389,0.00008053698,9.964082e-7,0.026413335,0.0003627639,0.0000026200862,0.0000079835145,6.8349766e-7,0.0049520163,0.00058303296,0.9672265,0.00030014748],"about_ca_topic_score_codex":0.00005892701,"about_ca_topic_score_gemma":0.00035588825,"teacher_disagreement_score":0.9881952,"about_ca_system_score_codex":0.0000782952,"about_ca_system_score_gemma":0.00041670603,"threshold_uncertainty_score":0.9999733},"labels":[],"label_agreement":null},{"id":"W4391023398","doi":"10.3390/cancers16020445","title":"The Clinical, Genomic, and Transcriptomic Landscape of BRAF Mutant Cancers","year":2024,"lang":"en","type":"article","venue":"Cancers","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; McGill University Health Centre; McGill University; Jewish General Hospital","funders":"Fonds de Recherche du Québec - Santé; Institut TransMedTech; Association Neurofibromatoses et Recklinghause; American Society of Clinical Oncology; Conquer Cancer Foundation","keywords":"Transcriptome; Mutant; Biology; Computational biology; Cancer research; Medicine; Genetics; Gene; Gene expression","score_opus":0.016992680293118866,"score_gpt":0.278747568436457,"score_spread":0.26175488814333814,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391023398","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97324824,0.023212876,0.00009088813,0.00012326706,0.0008908844,0.00010303828,0.00005112431,0.000009496303,0.0022701542],"genre_scores_gemma":[0.9901324,0.008946017,0.000032614003,0.00013594083,0.00027304082,0.000013079452,0.000012162664,0.000013846206,0.00044088732],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9993802,0.000028271503,0.00018257288,0.00021841713,0.000048570942,0.00014201569],"domain_scores_gemma":[0.99969065,0.00002027155,0.00003147508,0.00018168846,0.000017283573,0.00005864528],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018202704,0.00008134774,0.00010623859,0.000013659271,0.000053642827,0.0000221557,0.000111555186,0.00007483217,0.000019103913],"category_scores_gemma":[0.000014460522,0.000057157213,0.00007668495,0.000039464743,0.00015565648,0.0000016854369,0.00002428572,0.00007174018,0.0000029803168],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011303869,0.000002934658,0.0013632366,0.000077602315,0.0001787021,0.0000076787965,0.00016845386,0.000079462036,0.94755226,0.00053277134,0.0154669,0.03445698],"study_design_scores_gemma":[0.00071565964,0.0005137892,0.004093912,0.000058986614,0.00007805492,0.000024066932,0.00039264443,0.0010479314,0.12523171,0.00015036404,0.8674486,0.0002442335],"about_ca_topic_score_codex":0.000106094216,"about_ca_topic_score_gemma":0.00036208463,"teacher_disagreement_score":0.85198176,"about_ca_system_score_codex":0.00004478755,"about_ca_system_score_gemma":0.000609612,"threshold_uncertainty_score":0.23308036},"labels":[],"label_agreement":null},{"id":"W4391792274","doi":"10.1016/j.jbc.2024.105739","title":"Identification of RSK substrates using an analog-sensitive kinase approach","year":2024,"lang":"en","type":"article","venue":"Journal of Biological Chemistry","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Institute for Research in Immunology and Cancer","funders":"Fonds pour la Formation à la Recherche dans l’Industrie et dans l’Agriculture; Fonds Wetenschappelijk Onderzoek; Vlaamse regering; Fonds De La Recherche Scientifique - FNRS; Canadian Institutes of Health Research; Cancer Research Society","keywords":"Gene isoform; Kinase; Biology; Ribosomal s6 kinase; Cell biology; Molecular biology; Biochemistry; Phosphorylation; Gene; P70-S6 Kinase 1; Protein kinase B","score_opus":0.038998189072817935,"score_gpt":0.2783685005082478,"score_spread":0.23937031143542986,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391792274","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99429214,0.0012802705,0.0038477806,0.000013786143,0.000094272415,0.000037425878,0.00003111137,0.0000058469236,0.00039738123],"genre_scores_gemma":[0.99855024,0.000117388096,0.0007431868,0.000014120095,0.00044421828,8.7766216e-7,0.00007048059,0.000007868942,0.000051606305],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990754,0.00005062252,0.00043081693,0.00020634632,0.000107589316,0.0001292241],"domain_scores_gemma":[0.99935156,0.000016647358,0.00022608918,0.00015002843,0.00016372198,0.00009192809],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003776914,0.00011668178,0.00019048524,0.00002625164,0.000027869164,0.000026748305,0.00015741211,0.00022454909,0.000014255298],"category_scores_gemma":[0.00009957139,0.000083727595,0.00015577771,0.000089746594,0.00011546746,0.0000080717555,0.000034810993,0.00014783013,8.142865e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006699462,0.000116882315,0.00042909523,0.000069706,0.000056933117,0.000033456054,0.000023313067,0.00008418838,0.99857587,0.000028720544,0.000052527197,0.0004622946],"study_design_scores_gemma":[0.00012256816,0.00022162052,0.0008376946,0.000026668313,0.000031082007,0.00033103573,0.00021285644,0.00060186454,0.99714434,0.00012922684,0.0002389197,0.0001021463],"about_ca_topic_score_codex":0.0000018029889,"about_ca_topic_score_gemma":1.4657326e-7,"teacher_disagreement_score":0.0042581283,"about_ca_system_score_codex":0.000014512466,"about_ca_system_score_gemma":0.00008539757,"threshold_uncertainty_score":0.34143123},"labels":[],"label_agreement":null},{"id":"W4392058118","doi":"10.1038/s41594-024-01233-6","title":"The CNK–HYP scaffolding complex promotes RAF activation by enhancing KSR–MEK interaction","year":2024,"lang":"en","type":"article","venue":"Nature Structural & Molecular Biology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada Research Chairs; University of Toronto; Sinai Health System; Institute for Research in Immunology and Cancer; Université de Montréal; Lunenfeld-Tanenbaum Research Institute","funders":"Argonne National Laboratory; National Institute of General Medical Sciences; Office of Research Infrastructure Programs, National Institutes of Health; Canadian Institutes of Health Research; Canada Research Chairs; Office of Science; National Institutes of Health; Fondation pour la Recherche Médicale; U.S. Department of Energy","keywords":"MAPK/ERK pathway; Scaffold protein; Cell biology; Allosteric regulation; Kinase; MEK inhibitor; Small GTPase; Chemistry; Phosphorylation; Biology; Signal transduction; Biochemistry; Receptor","score_opus":0.005813699272387353,"score_gpt":0.30016669159552783,"score_spread":0.2943529923231405,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392058118","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9823347,0.006500295,0.0073661236,0.0011065305,0.0014829963,0.00035205754,0.000044435325,0.00007537133,0.0007375437],"genre_scores_gemma":[0.99697685,0.000084379724,0.0005214207,0.0005539849,0.0004606533,0.00002791041,0.0010722731,0.00003651952,0.0002660253],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99846405,0.00016720603,0.00026584408,0.00057943974,0.00012452905,0.00039894835],"domain_scores_gemma":[0.99936444,0.000050435185,0.00009566398,0.00032106828,0.00009702066,0.0000713484],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018433316,0.00027602608,0.00017570278,0.000061722894,0.00027468282,0.000121761674,0.00028538782,0.0005631468,0.000028695838],"category_scores_gemma":[0.00018896558,0.00019043329,0.00015160255,0.00015641066,0.0001160421,0.000012869835,0.00013915804,0.0005001698,0.000009487519],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000056876488,0.0000038176536,0.00003429268,0.000023737517,0.00010508694,0.000005773473,0.000033325945,0.0000052462287,0.97678995,0.0042054937,0.0023805904,0.016355824],"study_design_scores_gemma":[0.00017191237,0.00020747838,0.00016757005,0.000027534548,0.000020422347,0.000076179145,0.000052052266,0.0003479115,0.87123305,0.0015169594,0.12595609,0.00022284836],"about_ca_topic_score_codex":0.000020176287,"about_ca_topic_score_gemma":0.000022836944,"teacher_disagreement_score":0.1235755,"about_ca_system_score_codex":0.000044327848,"about_ca_system_score_gemma":0.000063351195,"threshold_uncertainty_score":0.7765644},"labels":[],"label_agreement":null},{"id":"W4392805481","doi":"10.1007/s10637-024-01428-0","title":"A phase 1 trial of the MEK inhibitor selumetinib in combination with pembrolizumab for advanced or metastatic solid tumors","year":2024,"lang":"en","type":"article","venue":"Investigational New Drugs","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Université Laval","funders":"","keywords":"Selumetinib; Medicine; Pembrolizumab; Adverse effect; Internal medicine; MEK inhibitor; Gastroenterology; Pharmacology; Urology; Oncology; Cancer; Colorectal cancer; MAPK/ERK pathway; Immunotherapy; Chemistry; Kinase","score_opus":0.02116369759197948,"score_gpt":0.29944718956827593,"score_spread":0.2782834919762964,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392805481","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99654764,0.00012049956,0.0010252318,0.000876195,0.0002565289,0.0009080905,0.00008178551,0.000010673045,0.00017335753],"genre_scores_gemma":[0.99459904,0.0000048249744,0.0034663065,0.00018187225,0.00018603592,0.00017369937,0.00021699216,0.000019579704,0.0011516553],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99909914,0.000057582463,0.00028609607,0.0002331821,0.00019443825,0.00012956966],"domain_scores_gemma":[0.9995423,0.00008113537,0.00009710593,0.00014323591,0.0000721686,0.00006403722],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018898002,0.0001171427,0.0001480902,0.000057882604,0.00003761091,0.000019344621,0.000117944866,0.00004345272,0.0000099659355],"category_scores_gemma":[0.00024740177,0.000075911696,0.00006967024,0.00019383254,0.00009685269,0.000010435936,0.000028159517,0.00006372026,0.0000016741342],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.035392728,0.0008951553,0.000061624705,0.00044474698,0.00019180213,0.000012438992,0.001358224,0.0007503036,0.9209279,0.019679928,0.008557369,0.011727783],"study_design_scores_gemma":[0.10288482,0.0051197927,0.00009195527,0.00032759176,0.00008042823,0.00003314646,0.00019834617,0.0022369428,0.8596213,0.011137917,0.017979164,0.0002886105],"about_ca_topic_score_codex":0.00001336786,"about_ca_topic_score_gemma":0.000038405902,"teacher_disagreement_score":0.0674921,"about_ca_system_score_codex":0.000017307058,"about_ca_system_score_gemma":0.0009590286,"threshold_uncertainty_score":0.30955893},"labels":[],"label_agreement":null},{"id":"W4393071322","doi":"10.1158/1538-7445.am2024-3484","title":"Abstract 3484: Mechanism of BRAF V600E resistance revealed by cell panel screening and bioinformatics","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Micropharma (Canada)","funders":"","keywords":"Mechanism (biology); Medicine; Computational biology; Bioinformatics; Biology; Physics","score_opus":0.05578470948236121,"score_gpt":0.33464701982419764,"score_spread":0.27886231034183645,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393071322","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96517825,0.021567238,0.002257611,0.00028976428,0.0001431376,0.00030199694,0.0002893367,0.00001972316,0.009952968],"genre_scores_gemma":[0.9895095,0.0029250132,0.001093747,0.000038499555,0.00012822126,0.000038394188,0.00005770097,0.000022508604,0.006186409],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99893945,0.000040342868,0.00020375353,0.0002493124,0.00026746895,0.00029967297],"domain_scores_gemma":[0.99945664,0.00004203874,0.000035964,0.0002539772,0.00010868174,0.00010268782],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00057345163,0.00010037306,0.000121864425,0.00007346745,0.00007980038,0.00004889116,0.00017283595,0.00012488822,0.000053027405],"category_scores_gemma":[0.000042784548,0.00009080626,0.000041740972,0.00014469694,0.000109079534,0.000007754138,0.00012698268,0.00020414084,0.0000087837525],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000054365883,0.000012080668,0.000051377836,0.00075333146,0.000023834382,0.000008191717,0.00012641311,0.000001100216,0.9634504,0.00044808327,0.030875275,0.0041955635],"study_design_scores_gemma":[0.00030657434,0.00013242131,0.00019538074,0.00022513124,0.000007887867,0.0000035124942,0.00021030876,0.00011718365,0.9266888,0.000326339,0.071640946,0.00014554117],"about_ca_topic_score_codex":0.00007088805,"about_ca_topic_score_gemma":0.00004086194,"teacher_disagreement_score":0.04076567,"about_ca_system_score_codex":0.000016317917,"about_ca_system_score_gemma":0.00015250278,"threshold_uncertainty_score":0.37029716},"labels":[],"label_agreement":null},{"id":"W4393092741","doi":"10.1158/1538-7445.am2024-5661","title":"Abstract 5661: Identifying and intervening rare resistant subclones to BRAF/MEK inhibitors in metastatic melanoma","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mediprobe Research (Canada)","funders":"","keywords":"Metastatic melanoma; Melanoma; Cancer research; Medicine; Oncology; Internal medicine; Biology","score_opus":0.08646921128498422,"score_gpt":0.4047472445627559,"score_spread":0.3182780332777717,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393092741","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98244333,0.015878659,0.00007638423,0.00043488416,0.00025632154,0.0002686134,0.000054779342,0.0000148166355,0.0005721967],"genre_scores_gemma":[0.99815583,0.00042508374,0.00017533738,0.000038135837,0.00022598558,0.00015232571,0.000028940887,0.000031655083,0.00076672324],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99849397,0.00011132293,0.00023659674,0.00048605504,0.0002607643,0.00041127173],"domain_scores_gemma":[0.99948525,0.00005790421,0.000018043482,0.0002170204,0.00007356114,0.00014822667],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008894211,0.00012612944,0.00014834387,0.0002785634,0.00008583079,0.00017038577,0.00017505027,0.000069924645,0.000069006484],"category_scores_gemma":[0.00014021064,0.00011574025,0.000052791303,0.0003310986,0.00007186885,0.000011838624,0.000249989,0.00026685148,0.000021950776],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014446597,0.000016810312,0.0012113324,0.00046265285,0.000040205163,0.00028556542,0.0005366927,0.0000082317765,0.9754361,0.00016762537,0.0039962647,0.017694037],"study_design_scores_gemma":[0.00060028996,0.0005398119,0.016194837,0.0015109,0.000016054288,0.00003482259,0.0016991684,0.00003583653,0.8889078,0.00052782375,0.08952205,0.00041062702],"about_ca_topic_score_codex":0.0006839877,"about_ca_topic_score_gemma":0.0016709816,"teacher_disagreement_score":0.08652834,"about_ca_system_score_codex":0.000064050466,"about_ca_system_score_gemma":0.000185241,"threshold_uncertainty_score":0.47197506},"labels":[],"label_agreement":null},{"id":"W4393095547","doi":"10.1158/1538-7445.am2024-5063","title":"Abstract 5063: Exploring the mutational landscape of <i>KRAS</i> and <i>NRAS</i> in tumors with non-V600 <i>BRAF</i> mutations","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Neuroblastoma RAS viral oncogene homolog; KRAS; Biology; Cancer research; Cancer; Computational biology; Genetics; Colorectal cancer","score_opus":0.049181328696039195,"score_gpt":0.33532084791382694,"score_spread":0.28613951921778774,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393095547","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938821,0.0024135483,0.000044224416,0.0003961143,0.00007467276,0.00020615695,0.000055746415,0.000006418613,0.0029210134],"genre_scores_gemma":[0.9987152,0.00042760753,0.00004542056,0.000045548117,0.00017323198,0.0002938934,0.00004947148,0.000018773537,0.00023081401],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99905074,0.000043032327,0.00014667754,0.0002693291,0.0002535975,0.0002366542],"domain_scores_gemma":[0.999566,0.000090823065,0.00001955615,0.00017066467,0.00009542821,0.000057527348],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004191223,0.00008744154,0.00009268896,0.00009625032,0.00008215764,0.00004664619,0.00013830222,0.000040628347,0.000034083918],"category_scores_gemma":[0.000029506922,0.000059523798,0.000026514197,0.00029645584,0.00017960013,0.000012010503,0.000067267254,0.00021739923,0.00000513052],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017666194,0.000057827736,0.009634511,0.00035383238,0.0000718758,0.00010092392,0.0011778651,0.0006696933,0.9748289,0.00064682,0.004232187,0.00804891],"study_design_scores_gemma":[0.0013510922,0.00060037273,0.08173615,0.00066082535,0.000023399947,0.00008715654,0.0023427417,0.00023030827,0.87784374,0.0005763311,0.034176763,0.0003711118],"about_ca_topic_score_codex":0.0001944302,"about_ca_topic_score_gemma":0.0003881541,"teacher_disagreement_score":0.09698514,"about_ca_system_score_codex":0.000014480115,"about_ca_system_score_gemma":0.00035164107,"threshold_uncertainty_score":0.242731},"labels":[],"label_agreement":null},{"id":"W4393155298","doi":"10.1101/2024.03.23.24304779","title":"Clinical activity of Mitogen-Activated Protein Kinase (MAPK) inhibitors in patients with MAP2K1 (MEK1)-mutated metastatic cancers","year":2024,"lang":"en","type":"preprint","venue":"medRxiv","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Intégré Universitaire de Santé et de Services Sociaux du Saguenay–Lac-Saint-Jean; Jewish General Hospital; Institute for Research in Immunology and Cancer; McGill University; McGill University Health Centre","funders":"Fonds de Recherche du Québec - Santé","keywords":"MAPK/ERK pathway; Protein kinase A; Mitogen-activated protein kinase; Cancer research; Mitogen-activated protein kinase kinase; Kinase; Medicine; Internal medicine; Biology; Cell biology","score_opus":0.018004168532599327,"score_gpt":0.27794224844238125,"score_spread":0.2599380799097819,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393155298","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99674976,0.00039691298,0.000043118776,0.000045981375,0.0009350564,0.0013197915,0.0002648391,0.000027695238,0.00021683668],"genre_scores_gemma":[0.9985263,0.00003761863,0.00029926174,0.000025176592,0.00013331528,0.00020307266,0.00042825012,0.00007476228,0.0002722548],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99728775,0.00036967057,0.00067279325,0.0009689225,0.0003340701,0.00036678967],"domain_scores_gemma":[0.998484,0.00002418389,0.00042414636,0.0007380962,0.00017258828,0.00015696792],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00045742773,0.0004458659,0.00067392294,0.00016467075,0.000026660215,0.00002316695,0.00031648847,0.00042920525,0.000020674222],"category_scores_gemma":[0.00017030009,0.00036866558,0.00022328846,0.00023857848,0.00018025393,0.000004070256,0.0006477745,0.00076122757,0.000008820679],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023215462,0.0007158344,0.14990927,0.0013882176,0.0007960979,0.000098759025,0.00014589888,0.00020653893,0.83591694,0.0000135353,0.0006178215,0.007869526],"study_design_scores_gemma":[0.0019865208,0.0010262507,0.045823365,0.0005661842,0.0001284039,0.000001232679,0.000017133118,0.00005447052,0.9485447,0.00016864945,0.0011390446,0.00054405973],"about_ca_topic_score_codex":0.00034394776,"about_ca_topic_score_gemma":0.0002329164,"teacher_disagreement_score":0.11262772,"about_ca_system_score_codex":0.0000766623,"about_ca_system_score_gemma":0.00075363426,"threshold_uncertainty_score":0.99987656},"labels":[],"label_agreement":null},{"id":"W4393227360","doi":"10.51559/myphje28","title":"Focus on the dabrafenib, vemurafenib, and trametinib in the clinical outcome of melanoma: A systematic review and meta-analysis","year":2020,"lang":"en","type":"review","venue":"Bali Dermatology Venereology and Aesthetic Journal","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Dabrafenib; Vemurafenib; Trametinib; Meta-analysis; Medicine; Melanoma; Oncology; Internal medicine; Metastatic melanoma; Cancer research; Biology; MAPK/ERK pathway; Genetics","score_opus":0.11116023517452486,"score_gpt":0.3703861669011715,"score_spread":0.25922593172664665,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393227360","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0011889797,0.9904128,0.00003593604,0.00720471,0.00005208183,0.0009693888,0.000032151234,0.0000032225103,0.00010073881],"genre_scores_gemma":[0.024848446,0.97247905,0.00006637783,0.0023660923,0.000031046962,0.00014163443,0.000020052039,0.000022019485,0.000025266152],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99186873,0.0051860004,0.001962084,0.00052034156,0.00015190839,0.0003109507],"domain_scores_gemma":[0.99722886,0.00075202825,0.0012276075,0.000609965,0.000050211445,0.00013133435],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023419592,0.00048017985,0.0056365794,0.00015297113,0.00014685949,0.00002915992,0.00055859773,0.0006106482,0.000020206964],"category_scores_gemma":[0.00054324867,0.00022818998,0.0013112454,0.0002539887,0.0006858012,0.000004255883,0.0001681296,0.00090535794,0.0000037808722],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026199318,0.0012857459,0.0048787966,0.6057344,0.24788879,0.0048441384,0.0009197714,0.0000018511967,0.0000074286436,0.052726258,0.0040506455,0.077400185],"study_design_scores_gemma":[0.0008298538,0.0007921006,0.00007412036,0.0041669803,0.7662599,0.08798251,0.00015969858,0.0000067672977,0.000005389784,0.0011948395,0.1378074,0.0007204439],"about_ca_topic_score_codex":0.000004026581,"about_ca_topic_score_gemma":0.000020332222,"teacher_disagreement_score":0.6015674,"about_ca_system_score_codex":0.0000049663604,"about_ca_system_score_gemma":0.00011598818,"threshold_uncertainty_score":0.93053174},"labels":[],"label_agreement":null},{"id":"W4393987697","doi":"10.1158/1538-7445.am2024-ct178","title":"Abstract CT178: Phase 1 trial of PF-07799933 (ARRY-440), a next-generation BRAF inhibitor, for BRAF-mutant cancers","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Mutant; Medicine; Cancer research; Internal medicine; Cancer; Oncology; Biology; Genetics; Gene","score_opus":0.16352622464378694,"score_gpt":0.43476064472679554,"score_spread":0.2712344200830086,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393987697","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9905968,0.0050146133,0.0004354832,0.00040178365,0.0013785796,0.0011190793,0.0004162615,0.000019223487,0.0006181895],"genre_scores_gemma":[0.99303895,0.0010353158,0.00008309434,0.000052310254,0.0038242145,0.00069009745,0.00029227865,0.000045039626,0.00093868474],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981822,0.000079861115,0.00034553133,0.00053842005,0.00038805668,0.00046592494],"domain_scores_gemma":[0.99911577,0.000050579154,0.00005531306,0.00035755456,0.0002721849,0.00014858773],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008554228,0.00016139644,0.00020518679,0.00014165022,0.00013102985,0.00010372769,0.00023739497,0.00020891563,0.00015706634],"category_scores_gemma":[0.00016421686,0.00014674415,0.00016063238,0.00023207636,0.00014341914,0.000015605814,0.00008107047,0.00022862088,0.000011765503],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00402257,0.0000913668,0.0000030523702,0.00023138885,0.00007953572,0.000012396159,0.000108043714,0.0000359135,0.9362293,0.0002788955,0.02951313,0.029394398],"study_design_scores_gemma":[0.008942493,0.0014658662,0.000004209315,0.00008107703,0.000015717864,0.0000027784226,0.000061007606,0.00043319174,0.8365291,0.000091168826,0.1522224,0.00015100157],"about_ca_topic_score_codex":0.00040236177,"about_ca_topic_score_gemma":0.0004711399,"teacher_disagreement_score":0.12270927,"about_ca_system_score_codex":0.00014962758,"about_ca_system_score_gemma":0.0015746219,"threshold_uncertainty_score":0.59840524},"labels":[],"label_agreement":null},{"id":"W4394099245","doi":"10.6084/m9.figshare.15015807","title":"Human-BB-EALH-10080","year":2022,"lang":"en","type":"dataset","venue":"Figshare","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"","keywords":"Geography","score_opus":0.03156695583384264,"score_gpt":0.2753141566316339,"score_spread":0.24374720079779125,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394099245","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000020303432,0.0007983834,3.5679697e-8,0.000009657024,0.00020857749,0.00021957194,0.99712294,0.000018157561,0.0016023755],"genre_scores_gemma":[0.000025136882,0.000022831504,0.0000037465754,0.00047925612,0.0008203873,0.00044992947,0.9955577,0.00003685661,0.0026041446],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9986792,0.00006160848,0.00020368285,0.0005379107,0.00021587354,0.00030173297],"domain_scores_gemma":[0.99875915,0.000008323774,0.0001621055,0.00091601734,0.00004777709,0.00010663813],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000040238137,0.00029081624,0.00022197848,0.00005895296,0.00018798978,0.000037261358,0.000691389,0.00039859768,0.8309446],"category_scores_gemma":[0.00021222359,0.00030714253,0.00018018766,0.00006466299,0.00000696406,0.0000013610193,0.0007746537,0.00033808104,0.001646059],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000005081531,0.00003674818,3.9990326e-7,0.00019966353,0.000038669114,0.000059083763,0.0000016593805,0.0000016792837,0.001140231,7.027916e-7,0.99842477,0.000091324415],"study_design_scores_gemma":[0.0001760203,0.00023939574,0.000020609123,0.000099428304,0.000018206587,0.0000256255,0.0000053648782,1.471453e-7,0.0014657363,0.0000037054417,0.9975773,0.00036846515],"about_ca_topic_score_codex":0.000024042476,"about_ca_topic_score_gemma":0.00006055013,"teacher_disagreement_score":0.82929856,"about_ca_system_score_codex":0.000021185688,"about_ca_system_score_gemma":0.00014926953,"threshold_uncertainty_score":0.9999381},"labels":[],"label_agreement":null},{"id":"W4394223942","doi":"10.6084/m9.figshare.15015813","title":"Human-BB-EALH-10120","year":2022,"lang":"en","type":"dataset","venue":"Figshare","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"","keywords":"Computer science","score_opus":0.03179092619975781,"score_gpt":0.2752377814709838,"score_spread":0.243446855271226,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394223942","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000018347022,0.0007919554,3.809725e-8,0.000009974522,0.00020411171,0.00021898864,0.99712753,0.000018033985,0.0016110438],"genre_scores_gemma":[0.00002426785,0.00002103718,0.0000040580358,0.0004865102,0.0008444006,0.00044455586,0.99556655,0.000036692447,0.002571937],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99868876,0.000062050305,0.00020240815,0.0005315531,0.0002135327,0.00030167276],"domain_scores_gemma":[0.99877584,0.000008192562,0.00016150817,0.00089989055,0.00004636253,0.0001081929],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00003980619,0.0002897742,0.00022099346,0.00005765352,0.0001837832,0.000037126305,0.00068356225,0.00039605112,0.8385941],"category_scores_gemma":[0.00021490233,0.00030623368,0.00017651083,0.000064345295,0.0000067881842,0.0000013813722,0.0007687031,0.00033813337,0.0016776567],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000005153582,0.00003676787,4.1187747e-7,0.00020403381,0.000038303806,0.000055413442,0.0000016645561,0.0000015932216,0.0010883657,6.490522e-7,0.9984736,0.000094049945],"study_design_scores_gemma":[0.00017472082,0.00023599625,0.000021952148,0.00009781672,0.00001841485,0.00002386524,0.0000053934014,1.5261617e-7,0.0014140237,0.0000036700164,0.9976367,0.00036729418],"about_ca_topic_score_codex":0.000023560044,"about_ca_topic_score_gemma":0.00006241089,"teacher_disagreement_score":0.83691645,"about_ca_system_score_codex":0.000020529937,"about_ca_system_score_gemma":0.0001436045,"threshold_uncertainty_score":0.99993896},"labels":[],"label_agreement":null},{"id":"W4394298753","doi":"10.6084/m9.figshare.15015831","title":"Human-BB-EALH-11323","year":2022,"lang":"en","type":"dataset","venue":"Figshare","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"","keywords":"Business; Computer science","score_opus":0.03252014426929625,"score_gpt":0.2765554766786453,"score_spread":0.24403533240934902,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394298753","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000018158282,0.0007281774,3.6935102e-8,0.000009652316,0.00021136442,0.00021984706,0.99701333,0.00001833916,0.0017810836],"genre_scores_gemma":[0.000022106451,0.000021361691,0.00000378952,0.00046099775,0.0008227349,0.00045367936,0.9951758,0.00003708282,0.0030024454],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99867934,0.00006225136,0.00020346486,0.0005368268,0.00021510606,0.00030301113],"domain_scores_gemma":[0.99876326,0.000008404694,0.00016162726,0.0009127233,0.000047761132,0.00010624374],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00004118602,0.00029009074,0.00022127062,0.000059051534,0.00018616392,0.00003769079,0.0006887397,0.00039840073,0.8304421],"category_scores_gemma":[0.00022566158,0.00030641822,0.00017701206,0.0000651998,0.000006845813,0.0000013529675,0.0007734601,0.00033276738,0.0017364845],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000050550366,0.00003622123,3.520321e-7,0.00020234458,0.000038489638,0.000058027577,0.0000015548004,0.0000019600925,0.0011088244,6.5057753e-7,0.9984492,0.00009731854],"study_design_scores_gemma":[0.00017588351,0.00023385648,0.000020561665,0.00010138617,0.000017984963,0.000024189247,0.000005519684,1.6947669e-7,0.0013377722,0.000003953362,0.9977109,0.0003678384],"about_ca_topic_score_codex":0.000024443227,"about_ca_topic_score_gemma":0.00006603725,"teacher_disagreement_score":0.8287056,"about_ca_system_score_codex":0.000020469137,"about_ca_system_score_gemma":0.00013885964,"threshold_uncertainty_score":0.9999388},"labels":[],"label_agreement":null},{"id":"W4394440783","doi":"10.6084/m9.figshare.15015801","title":"Human-BB-EALH-2702","year":2022,"lang":"en","type":"dataset","venue":"Figshare","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"","keywords":"Computer science","score_opus":0.03238490869043247,"score_gpt":0.2752502536298163,"score_spread":0.24286534493938383,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394440783","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000019959696,0.00076946866,3.4338086e-8,0.000010041569,0.00020909848,0.00021579904,0.9971549,0.000017697848,0.0016030297],"genre_scores_gemma":[0.00002468371,0.000021631637,0.0000036872736,0.00048464807,0.00080159114,0.00044313993,0.99556243,0.00003599523,0.0026221855],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9986998,0.00006201692,0.00020009048,0.0005307224,0.00021027168,0.0002970915],"domain_scores_gemma":[0.9987769,0.000008151894,0.00015922161,0.0009042395,0.000046904883,0.000104578205],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000039688686,0.00028600683,0.00021773162,0.000057537694,0.0001829656,0.000037148104,0.0006815361,0.0003908624,0.8432477],"category_scores_gemma":[0.0002198553,0.00030209124,0.00017425214,0.00006306678,0.0000067011206,0.0000013262601,0.00076168304,0.00033522167,0.0017025751],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000004884364,0.000036397396,3.96798e-7,0.00019908501,0.000036886086,0.000056984118,0.0000015549031,0.0000016551596,0.0011018243,6.257559e-7,0.998467,0.00009267714],"study_design_scores_gemma":[0.00017258842,0.00023721039,0.000022411268,0.00009625551,0.000017894514,0.000023724726,0.000005100895,1.6580975e-7,0.0012648464,0.0000036098943,0.9977954,0.0003607974],"about_ca_topic_score_codex":0.000023025654,"about_ca_topic_score_gemma":0.000059333488,"teacher_disagreement_score":0.84154516,"about_ca_system_score_codex":0.000019860436,"about_ca_system_score_gemma":0.00013792324,"threshold_uncertainty_score":0.99994314},"labels":[],"label_agreement":null},{"id":"W4395001749","doi":"10.21037/tlcr-24-117","title":"The evolving treatment landscape for BRAF-mutated non-small cell lung cancer","year":2024,"lang":"en","type":"editorial","venue":"Translational Lung Cancer Research","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Fonds de Recherche du Québec - Santé","keywords":"Medicine; Lung cancer; Computational biology; Bioinformatics; Cancer research; Oncology; Biology","score_opus":0.023759278697591632,"score_gpt":0.3710229324003498,"score_spread":0.34726365370275813,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4395001749","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.013289344,0.4065334,0.0011986294,0.0023364532,0.55069023,0.0058435746,0.012536208,0.00007792709,0.0074942713],"genre_scores_gemma":[0.029634384,0.029199228,0.00024143937,0.000026807986,0.86508137,0.007875689,0.007954613,0.0003081929,0.059678275],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9971422,0.00013118968,0.00034723117,0.00081776985,0.00081450003,0.00074713636],"domain_scores_gemma":[0.9980043,0.00059935445,0.00007576593,0.00040195909,0.00077206705,0.0001465222],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00070344517,0.00036432585,0.00028925433,0.00012547654,0.00053362054,0.00021576269,0.0004750363,0.00066059566,0.00012420159],"category_scores_gemma":[0.00005972476,0.00026527164,0.00028382696,0.00020245512,0.00010010202,0.0000057481466,0.00006779497,0.0005915083,0.000009817516],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005050419,0.00004437421,0.00024792075,0.000912445,0.0005004597,0.000007221876,0.00021578876,0.00030455136,0.019756075,0.000029853787,0.97573954,0.0017367222],"study_design_scores_gemma":[0.0013859847,0.00030694014,0.000050890343,0.00025855837,0.0002095248,7.0060275e-7,0.00002421134,0.004666925,0.011767363,0.0000599437,0.980935,0.00033398494],"about_ca_topic_score_codex":0.00073036796,"about_ca_topic_score_gemma":0.003398032,"teacher_disagreement_score":0.37733415,"about_ca_system_score_codex":0.00023681349,"about_ca_system_score_gemma":0.004069525,"threshold_uncertainty_score":0.99998},"labels":[],"label_agreement":null},{"id":"W4395039339","doi":"10.1161/circ.128.suppl_22.a19146","title":"Abstract 19146: Disruption of TRAF2-TAK1-IKKB Signaling Triggers Mitochondrial Perturbations and Necrotic Cell Death in Doxorubicin Cardiotoxicity","year":2013,"lang":"en","type":"article","venue":"Circulation","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Cardiotoxicity; Medicine; TRAF2; Doxorubicin; Programmed cell death; Apoptosis; Cancer research; Pharmacology; Cell biology; Tumor necrosis factor alpha; Internal medicine; Chemotherapy; Tumor necrosis factor receptor; Biology; Biochemistry","score_opus":0.014022354746231614,"score_gpt":0.22579377784202032,"score_spread":0.2117714230957887,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4395039339","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996836,0.00018675798,0.0016111349,0.000023812514,0.00011866033,0.00042724493,0.000008848781,0.0000075072508,0.00078002765],"genre_scores_gemma":[0.99917126,0.000023956954,0.00041543168,0.000018636532,0.00015679844,0.000031256364,0.00014781448,0.000011813427,0.000023021314],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9992075,0.000046631983,0.0002585948,0.00024358547,0.000101500766,0.00014219058],"domain_scores_gemma":[0.9995338,0.000022428138,0.00017138156,0.00016385772,0.000053612435,0.000054944165],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001004661,0.00010938255,0.00014591216,0.00006946763,0.000047572918,0.000020968524,0.000053810592,0.00015242236,0.000025113659],"category_scores_gemma":[0.00007273837,0.000110026296,0.00006873602,0.000071862065,0.000029538498,0.000013005346,0.00001497843,0.000067791225,0.000004870661],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000016210844,0.00003806867,0.039837655,0.000041250558,0.000008719686,6.1463743e-7,0.00012515344,0.0013519508,0.9577067,0.000035442223,0.00002533929,0.0008129024],"study_design_scores_gemma":[0.000818941,0.00005969902,0.6719987,0.000024669085,0.000021214184,0.000003951828,0.000089160196,0.0021945608,0.32436016,0.00018827575,0.00008180839,0.00015888347],"about_ca_topic_score_codex":0.00023594325,"about_ca_topic_score_gemma":0.000026711363,"teacher_disagreement_score":0.63334656,"about_ca_system_score_codex":0.000021458492,"about_ca_system_score_gemma":0.00003949103,"threshold_uncertainty_score":0.4486742},"labels":[],"label_agreement":null},{"id":"W4396229481","doi":"10.4103/joco.joco_21_23","title":"Hypotony and Anterior Uveitis following Dual Therapy with Nivolumab and Ipilimumab for Metastatic Melanoma: A Case Report","year":2023,"lang":"en","type":"article","venue":"Journal of Current Ophthalmology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Ipilimumab; Nivolumab; Metastatic melanoma; Melanoma; Uveitis; Dermatology; Oncology; Internal medicine; Ophthalmology; Immunotherapy; Cancer research; Cancer","score_opus":0.04593346516438089,"score_gpt":0.32841571685621895,"score_spread":0.28248225169183805,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396229481","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99182683,0.0067716744,0.00036599432,0.00008053931,0.000635573,0.00024817316,0.000023797138,0.0000053741232,0.00004202837],"genre_scores_gemma":[0.9983761,0.00038900512,0.0008257451,0.000014634712,0.00021199293,0.000024642799,0.000022494829,0.000023603552,0.00011178782],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9989003,0.00007886003,0.00040601898,0.00025267247,0.000113180125,0.0002489749],"domain_scores_gemma":[0.99923927,0.00006138532,0.0003174228,0.00015376434,0.00010683396,0.000121352896],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047205965,0.00016947475,0.00036851893,0.00012186762,0.000098168566,0.000026251522,0.00006655392,0.00007137717,0.0000061012393],"category_scores_gemma":[0.00010543647,0.00012797506,0.0001250697,0.000078986,0.000079347396,0.000011700958,0.00005861271,0.00010894202,5.5503324e-7],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0050284206,0.00069536327,0.04579659,0.00051124726,0.0022006156,0.5666345,0.0009636208,0.000018114952,0.3091881,0.00012947978,0.003008222,0.065825745],"study_design_scores_gemma":[0.005297401,0.0060544605,0.004312869,0.00007239757,0.00013696328,0.9690395,0.00028915316,0.000045345405,0.0078019663,0.00024930685,0.0064537325,0.00024687932],"about_ca_topic_score_codex":0.0000044888193,"about_ca_topic_score_gemma":0.00000300655,"teacher_disagreement_score":0.40240502,"about_ca_system_score_codex":0.000007556154,"about_ca_system_score_gemma":0.00011575182,"threshold_uncertainty_score":0.52186716},"labels":[],"label_agreement":null},{"id":"W4396541840","doi":"10.1158/2159-8290.cd-24-0024","title":"A Next-Generation BRAF Inhibitor Overcomes Resistance to BRAF Inhibition in Patients with <i>BRAF</i> -Mutant Cancers Using Pharmacokinetics-Informed Dose Escalation","year":2024,"lang":"en","type":"article","venue":"Cancer Discovery","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"National Cancer Institute","keywords":"Pharmacokinetics; Mutant; Cancer research; Vemurafenib; Medicine; Pharmacology; Oncology; Internal medicine; Biology; Melanoma; Genetics; Metastatic melanoma; Gene","score_opus":0.020333717682602878,"score_gpt":0.2673368469978584,"score_spread":0.24700312931525553,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396541840","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955704,0.0010254929,0.0013715911,0.00015829565,0.000829743,0.00055203895,0.00024004484,0.000024260818,0.00022813183],"genre_scores_gemma":[0.9973509,0.00020382924,0.00020960053,0.00057733373,0.0007374664,0.00010733262,0.00048703284,0.000042671756,0.00028386142],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986033,0.000035975852,0.0003009213,0.0004993294,0.00025330015,0.00030719177],"domain_scores_gemma":[0.999528,0.000008601522,0.00007757841,0.00021475335,0.000072201365,0.00009885974],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007901851,0.00023412207,0.00017346359,0.00012474114,0.000071608185,0.00019278939,0.000068935995,0.000112480855,0.000015411482],"category_scores_gemma":[0.000019288509,0.00021104522,0.000059593283,0.00032486985,0.000050553714,0.00011562831,0.00005943432,0.000110074594,0.0000041086905],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005689514,0.0000553329,0.007462939,0.00021351766,0.000050403407,0.000015332853,0.00023564236,0.0053981417,0.980737,0.00009379981,0.0031573607,0.002011611],"study_design_scores_gemma":[0.0032358135,0.0004730328,0.021233857,0.0010558354,0.00008696423,0.000004422682,0.00008239084,0.0022885627,0.9557177,0.000041819076,0.014964978,0.00081461493],"about_ca_topic_score_codex":0.0001403946,"about_ca_topic_score_gemma":0.0022901557,"teacher_disagreement_score":0.025019258,"about_ca_system_score_codex":0.0004532524,"about_ca_system_score_gemma":0.00060568313,"threshold_uncertainty_score":0.8606174},"labels":[],"label_agreement":null},{"id":"W4396705239","doi":"10.3390/curroncol31050199","title":"Incidence of Ophthalmological Complications in NF-1 Patients Treated with MEK Inhibitors","year":2024,"lang":"en","type":"article","venue":"Current Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"University of Texas MD Anderson Cancer Center","keywords":"Medicine; Incidence (geometry); Pediatrics; Internal medicine","score_opus":0.05485758313077425,"score_gpt":0.353153969199409,"score_spread":0.29829638606863473,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396705239","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99605745,0.0008678236,0.0001065695,0.00005568677,0.00024016807,0.00019548749,0.00003596223,0.000011725176,0.00242915],"genre_scores_gemma":[0.99940276,0.00006752801,0.000121743265,0.0000140364855,0.00005809302,0.00006117412,0.00023639956,0.000008203225,0.000030039922],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992179,0.00007500689,0.00021109883,0.0002746035,0.000071622024,0.00014973557],"domain_scores_gemma":[0.9996412,0.000030502228,0.000050560437,0.0001579831,0.000070246206,0.000049508053],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000084501575,0.00009996843,0.00014977455,0.000069640286,0.00001892593,0.000005041743,0.0001166707,0.00011048876,0.000016700102],"category_scores_gemma":[0.00004458187,0.00007586076,0.000038113296,0.0001557671,0.00011502633,0.00000302825,0.00007054719,0.000106548265,0.0000101603355],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013785138,0.0008964713,0.90512514,0.00009931387,0.000029021146,0.000038856888,0.00009522076,0.000014475204,0.06506849,0.00083017774,0.0018777702,0.02578724],"study_design_scores_gemma":[0.0020546017,0.006533567,0.77646554,0.00029184023,0.000059746075,0.00014747819,0.00008465411,0.00026377238,0.08211371,0.0003322539,0.13117006,0.00048275042],"about_ca_topic_score_codex":0.00001268906,"about_ca_topic_score_gemma":0.000024927569,"teacher_disagreement_score":0.1292923,"about_ca_system_score_codex":0.000033015964,"about_ca_system_score_gemma":0.00010579841,"threshold_uncertainty_score":0.3093512},"labels":[],"label_agreement":null},{"id":"W4397026662","doi":"10.52768/2993-1142/1096","title":"Regulation of Stem Cell Proliferation by p38 MAPK Signaling","year":2023,"lang":"en","type":"article","venue":"Med Discoveries","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Trois-Rivières; Innovation and Economic Development Trois Rivières","funders":"Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research","keywords":"Cell biology; Cell growth; p38 mitogen-activated protein kinases; Effector; Biology; MAPK/ERK pathway; Stem cell; Protein kinase A; Proinflammatory cytokine; Signal transduction; Kinase; Secretion; Immunology; Inflammation; Genetics; Biochemistry","score_opus":0.009281786729640935,"score_gpt":0.2109968121283673,"score_spread":0.20171502539872635,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4397026662","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996288,0.00018077296,0.0019238486,0.000056508197,0.00011097538,0.00012244435,0.000054606146,0.00001751782,0.0012453106],"genre_scores_gemma":[0.992219,0.000033606488,0.00007506336,0.000025028356,0.0000808173,0.00002041099,0.00067382446,0.000011246833,0.006861027],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9994557,0.000030393601,0.00014368306,0.00015104019,0.000108257474,0.0001109302],"domain_scores_gemma":[0.99971765,0.0000064419523,0.000068547364,0.00015049533,0.000031667714,0.000025215879],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009886772,0.00007451277,0.00008408781,0.000025776451,0.00004431235,0.000015665006,0.00005949273,0.00006589799,0.000017319355],"category_scores_gemma":[0.000009504872,0.00006787397,0.000037064867,0.00008214446,0.00003216556,0.0000067083606,0.000037834077,0.000021892418,0.000011682951],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000041977328,0.000014249362,0.0013638613,0.00004371702,0.000007895497,3.8628224e-7,0.0001714104,0.00010598285,0.99003685,0.00017789392,0.007370042,0.00066573836],"study_design_scores_gemma":[0.00018870222,0.00011915109,0.001083625,0.0000075914672,0.000006966408,5.9435683e-7,0.00025493177,0.000076005716,0.9862194,0.00011201596,0.011851513,0.000079473066],"about_ca_topic_score_codex":0.0000063379607,"about_ca_topic_score_gemma":0.000006437,"teacher_disagreement_score":0.005615716,"about_ca_system_score_codex":0.000004249951,"about_ca_system_score_gemma":0.00003348528,"threshold_uncertainty_score":0.276782},"labels":[],"label_agreement":null},{"id":"W4397041612","doi":"10.1681/asn.20233411s1482a","title":"A Case of Acute Interstitial Nephritis Associated with Belvarafenib, a Novel pan-RAF Kinase Inhibitor for Metastatic NRAS Mutant Melanoma","year":2023,"lang":"en","type":"article","venue":"Journal of the American Society of Nephrology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Neuroblastoma RAS viral oncogene homolog; Cancer research; Mutant; Medicine; Melanoma; Metastatic melanoma; Kinase; Interstitial nephritis; Internal medicine; Cancer; Biology; Colorectal cancer; Kidney; Cell biology; Gene; Genetics","score_opus":0.018594787320048496,"score_gpt":0.26523894046757,"score_spread":0.24664415314752153,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4397041612","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953098,0.00006891283,0.0028582977,0.0009991995,0.00013640126,0.00022467048,0.00038780947,0.0000058581454,0.000009011215],"genre_scores_gemma":[0.9941997,0.00009662316,0.0042080027,0.0011716862,0.00020703765,0.000012718725,0.000024327353,0.000027622911,0.000052308184],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99867475,0.00011999141,0.00054328056,0.00018495988,0.00017825476,0.00029877058],"domain_scores_gemma":[0.99782246,0.00014133251,0.0013902915,0.00024579812,0.0003214863,0.00007863502],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043634928,0.00017866107,0.00059525704,0.000056080917,0.00008241809,0.000006853777,0.0003012335,0.00008899267,0.0000045625297],"category_scores_gemma":[0.00010673427,0.00012467253,0.000610897,0.000290404,0.0006802235,0.000007988185,0.0001396568,0.00017263019,4.6037837e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009709341,0.00017322956,0.0002213215,0.000030271143,0.0020287887,0.00016259897,0.00042308454,0.00003522541,0.9850453,0.00002387676,0.009962575,0.00092279864],"study_design_scores_gemma":[0.021626804,0.046754017,0.018874537,0.00034913575,0.004499558,0.027425596,0.008846316,0.0020374511,0.8392095,0.00053609995,0.028704435,0.001136565],"about_ca_topic_score_codex":0.00006971045,"about_ca_topic_score_gemma":0.000064952896,"teacher_disagreement_score":0.14583582,"about_ca_system_score_codex":0.00002854509,"about_ca_system_score_gemma":0.00023972808,"threshold_uncertainty_score":0.5083998},"labels":[],"label_agreement":null},{"id":"W4398160457","doi":"10.1038/s41388-024-03060-x","title":"Recent insights into the therapeutic strategies targeting the pseudokinase PTK7 in cancer","year":2024,"lang":"en","type":"article","venue":"Oncogene","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"FPInnovations","funders":"Institut National Du Cancer; Institut Universitaire de France; Ministère de l'Education Nationale, de l'Enseignement Supérieur et de la Recherche; Ligue Contre le Cancer; Fondation ARC pour la Recherche sur le Cancer","keywords":"Kinome; Biology; Kinase; Receptor tyrosine kinase; Cancer research; Cancer; Tyrosine kinase; Cancer cell; Trastuzumab; Signal transduction; Cell biology; Breast cancer","score_opus":0.018334259795092487,"score_gpt":0.2875386479947466,"score_spread":0.2692043881996541,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4398160457","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.86019504,0.13365923,0.00014414589,0.0018199655,0.0005350927,0.00016966082,0.000003309728,0.000015246105,0.0034582727],"genre_scores_gemma":[0.98215604,0.016181795,0.000034138844,0.0005563944,0.00050103123,0.00008899658,0.000026074176,0.000018395776,0.00043711244],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9992329,0.00009654142,0.00014521039,0.00024494695,0.00009958415,0.00018082872],"domain_scores_gemma":[0.9996565,0.000023382176,0.000025759577,0.0002358386,0.000030458154,0.000028085398],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020181038,0.00012217091,0.00007837012,0.000022547145,0.000108632485,0.00007720762,0.00021746213,0.000078675665,0.000052355084],"category_scores_gemma":[0.000013911879,0.0000629284,0.000051827923,0.000153124,0.00006501953,0.0000044558524,0.00007535777,0.00012638993,0.000017061859],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000019838963,0.00002200273,0.00008053307,0.000016094906,0.0000436046,0.000017324057,0.0013183036,0.00015609553,0.912188,0.0015860223,0.0017003489,0.08285186],"study_design_scores_gemma":[0.000108696855,0.00007587641,0.00013127927,0.000021364554,0.000015212409,0.000004802458,0.00082843116,0.00027343558,0.28848454,0.0009988551,0.7089501,0.00010737224],"about_ca_topic_score_codex":0.00018622346,"about_ca_topic_score_gemma":0.0011578631,"teacher_disagreement_score":0.70724976,"about_ca_system_score_codex":0.000026805255,"about_ca_system_score_gemma":0.00024077453,"threshold_uncertainty_score":0.25661457},"labels":[],"label_agreement":null},{"id":"W4399323608","doi":"10.3390/cells13110973","title":"Multiple Endocrine Neoplasia Type 1 Regulates TGFβ-Mediated Suppression of Tumor Formation and Metastasis in Melanoma","year":2024,"lang":"en","type":"article","venue":"Cells","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"Canadian Institutes of Health Research","keywords":"Cancer research; MEN1; Melanoma; Carcinogenesis; Metastasis; Medicine; Cancer; Multiple endocrine neoplasia; Biology; Internal medicine; Gene","score_opus":0.008493583349461173,"score_gpt":0.22069814101719062,"score_spread":0.21220455766772944,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399323608","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997021,0.0021404927,0.000062219275,0.00002624589,0.00019209087,0.000117491414,0.000045921483,0.00001008357,0.00038446125],"genre_scores_gemma":[0.9988842,0.00021669507,0.0003738659,0.00001763709,0.00003825977,0.000005966546,0.00022860251,0.0000104181345,0.00022434845],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99947643,0.000031299194,0.00016138756,0.0001593664,0.000054929274,0.00011656632],"domain_scores_gemma":[0.9997529,0.000027662092,0.000032599786,0.000125244,0.000024763165,0.000036877598],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007578467,0.000083583465,0.00010766244,0.000060185077,0.00001331727,0.0000116950205,0.0000511903,0.00004588398,0.000028224309],"category_scores_gemma":[0.00004157864,0.000070000504,0.000027344144,0.00008603678,0.000024412999,0.0000069554717,0.000053989028,0.00004251351,0.000012053045],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000050022816,0.000017318102,0.0008578706,0.00012101862,0.000011886742,0.000015886224,0.000076842996,0.000010420573,0.99556273,0.000021710244,0.0016140138,0.0016402906],"study_design_scores_gemma":[0.00029424232,0.0001491091,0.001271744,0.000039961575,0.000011213944,0.00002220629,0.000047817986,0.0012266339,0.97221,0.00003013507,0.0246225,0.000074422336],"about_ca_topic_score_codex":0.000018193197,"about_ca_topic_score_gemma":0.000026964142,"teacher_disagreement_score":0.023352705,"about_ca_system_score_codex":0.0000047958506,"about_ca_system_score_gemma":0.00002260836,"threshold_uncertainty_score":0.28545377},"labels":[],"label_agreement":null},{"id":"W4399667123","doi":"10.1200/jco.2024.42.16_suppl.3104","title":"Binimetinib and encorafenib for the treatment of advanced solid tumors with non-V600E BRAF mutations (mts): Final results of the investigator-initiated phase II BEAVER trial.","year":2024,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; Princess Margaret Cancer Centre; University of Toronto; University Health Network; McGill University; Jewish General Hospital","funders":"Jewish General Hospital; Pfizer; Conquer Cancer Foundation","keywords":"Medicine; Internal medicine; Oncology; Mutation; Clinical trial; Solid tumor; Cancer research; Cancer; Genetics; Gene","score_opus":0.12547345969595325,"score_gpt":0.44443399536287137,"score_spread":0.3189605356669181,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399667123","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955815,0.00071204914,0.00028336194,0.0018128227,0.00073798996,0.0005273625,0.000121337456,0.0000022917923,0.00022127593],"genre_scores_gemma":[0.9968648,0.00058538787,0.0014496853,0.00021738614,0.0005307478,0.000025527923,0.000018359446,0.000013169385,0.0002949519],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99786496,0.00023736348,0.0014273925,0.00019184854,0.0001390291,0.00013942891],"domain_scores_gemma":[0.9968045,0.0014864387,0.0010939062,0.00021529336,0.00026021965,0.0001396901],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011401916,0.00013071978,0.0006135533,0.00004423691,0.00007991043,0.000007228814,0.00017657402,0.00018915541,0.0000046606374],"category_scores_gemma":[0.0019922233,0.00006235533,0.00034408632,0.00010914697,0.00046201525,0.000007648063,0.000039035538,0.00017242889,3.2121622e-7],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.35246304,0.012876735,0.0013443762,0.00021958235,0.004015544,0.00020630643,0.002150819,0.000913082,0.2898245,0.0006066756,0.01618106,0.3191983],"study_design_scores_gemma":[0.1854769,0.3133271,0.0036868968,0.0002637638,0.001320983,0.00024130297,0.00047537655,0.00075436983,0.19894578,0.0007080847,0.29454458,0.00025489123],"about_ca_topic_score_codex":0.0000074931822,"about_ca_topic_score_gemma":0.0000262485,"teacher_disagreement_score":0.31894344,"about_ca_system_score_codex":0.000015013878,"about_ca_system_score_gemma":0.0017384428,"threshold_uncertainty_score":0.3083923},"labels":[],"label_agreement":null},{"id":"W4399724959","doi":"10.1101/2024.06.14.599035","title":"Mitochondrial Signatures Shape Phenotype Switching and Apoptosis in Response to PLK1 and RSK Inhibitors in Melanoma","year":2024,"lang":"en","type":"preprint","venue":"bioRxiv (Cold Spring Harbor Laboratory)","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Phenotype; Apoptosis; Melanoma; Cancer research; Mitochondrion; Biology; Cell biology; Genetics; Gene","score_opus":0.007209653173887765,"score_gpt":0.21342225151442834,"score_spread":0.20621259834054056,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399724959","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9927042,0.0049007353,0.000041796986,0.00031509442,0.0011507169,0.0007225269,0.0001033473,0.00005207978,0.000009500005],"genre_scores_gemma":[0.99686366,0.00022684954,0.001771644,0.00020753371,0.0006490864,0.00017047633,9.542648e-7,0.000103178136,0.000006598509],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9973139,0.00022720157,0.00047866936,0.0013001056,0.00020041001,0.00047968363],"domain_scores_gemma":[0.99886864,0.00005484407,0.000119301956,0.0006175963,0.000080721045,0.00025889542],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006142882,0.00051325926,0.00047748224,0.00048306087,0.000060564384,0.0001835455,0.00027619937,0.0008367209,0.000005940723],"category_scores_gemma":[0.0004145921,0.0005448527,0.00007594652,0.00031920572,0.000056327546,0.000008491337,0.0012270224,0.0007582807,0.000009701599],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006776344,0.000048728958,0.0043749423,0.00025616467,0.000048105107,0.000057117315,0.000057640635,0.000026304906,0.99410963,0.00008210894,0.00023937461,0.000022224565],"study_design_scores_gemma":[0.0013144984,0.0004111982,0.07810662,0.0010152911,0.0000683726,1.1778221e-7,0.000020641874,0.00024742188,0.9118852,0.000020444908,0.005670161,0.0012400168],"about_ca_topic_score_codex":0.00009803551,"about_ca_topic_score_gemma":0.00006139241,"teacher_disagreement_score":0.082224436,"about_ca_system_score_codex":0.00008350939,"about_ca_system_score_gemma":0.00035889185,"threshold_uncertainty_score":0.9997003},"labels":[],"label_agreement":null},{"id":"W4399737375","doi":"10.1200/jco.2024.42.16_suppl.tps3180","title":"A phase 1, open-label, dose escalation and dose expansion study to evaluate the safety, tolerability, pharmacokinetics, and antitumor activity of PF-07799544 (ARRY-134) as a single agent and in combination with PF-07799933 BRAF dimer inhibitor, in participants 16 years and older with advanced solid tumors.","year":2024,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier universitaire de Québec; Ottawa Hospital; McGill University; Health Sciences Centre; McGill University Health Centre; Sunnybrook Health Science Centre","funders":"Pfizer","keywords":"Medicine; Tolerability; Pharmacokinetics; Maximum tolerated dose; Pharmacology; Open label; Oncology; Adverse effect","score_opus":0.09363379947207903,"score_gpt":0.45930803875461584,"score_spread":0.36567423928253684,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399737375","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997326,0.0006386333,0.00008146814,0.00091043604,0.00014587659,0.0008640088,0.0000052749247,0.0000022184993,0.000026052045],"genre_scores_gemma":[0.99894404,0.00047266655,0.00030685752,0.00016311946,0.000065898115,0.000015960988,0.0000026685568,0.000013745406,0.000015039884],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9978119,0.0006051739,0.00084957073,0.00035171592,0.00020133247,0.00018026764],"domain_scores_gemma":[0.9989776,0.0002786482,0.00031442003,0.0001359941,0.00012334171,0.00016997023],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025399856,0.00014911829,0.00062844827,0.000088906956,0.000035977973,0.00004254815,0.000093671784,0.000100228106,0.0000044250532],"category_scores_gemma":[0.0003819312,0.00009630907,0.00002188409,0.0001317985,0.0002046869,0.000047700163,0.00022357918,0.0002941049,2.3260243e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.036916517,0.018797886,0.10894487,0.00015186005,0.00027744443,0.00047455035,0.0028767711,0.00017833276,0.4580703,0.000026586687,0.00010112128,0.37318376],"study_design_scores_gemma":[0.062067676,0.10082635,0.7972531,0.0005867993,0.000331751,0.00024892547,0.00090011593,0.0015704388,0.03495415,0.0002483476,0.0006696793,0.00034267607],"about_ca_topic_score_codex":0.00005730047,"about_ca_topic_score_gemma":0.00069281243,"teacher_disagreement_score":0.68830824,"about_ca_system_score_codex":0.00003304579,"about_ca_system_score_gemma":0.00030373884,"threshold_uncertainty_score":0.392737},"labels":[],"label_agreement":null},{"id":"W4400272226","doi":"10.1200/jco.2024.42.16_suppl.e21533","title":"Prospective real-world evidence for the use of immune-checkpoint inhibitors and BRAF-targeted therapy in advanced melanoma from a large Canadian cohort.","year":2024,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Credit Valley Hospital; Niagara Health System; University of Alberta; Princess Margaret Cancer Centre; University of Calgary; Health Sciences Centre; Ottawa Hospital; Dalhousie University; University of Toronto; Sunnybrook Health Science Centre; Queen's University; Cancer Care Ontario","funders":"","keywords":"Medicine; Melanoma; Oncology; Targeted therapy; Immune checkpoint; Cohort; Ipilimumab; Prospective cohort study; Internal medicine; Immunotherapy; Cancer; Cancer research","score_opus":0.10461052156559818,"score_gpt":0.4095387828409206,"score_spread":0.3049282612753224,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400272226","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98799163,0.008782653,0.00017972574,0.0014116255,0.0010035885,0.00048032732,0.000056041114,0.0000025739657,0.00009181811],"genre_scores_gemma":[0.9911353,0.0064763064,0.0013027865,0.0003394039,0.00057049847,0.000024405097,0.000009748414,0.000015991243,0.00012556193],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978132,0.00024868007,0.0013655103,0.0002460024,0.00010881582,0.00021774274],"domain_scores_gemma":[0.9969027,0.0019938932,0.0005460667,0.00019464675,0.00020356088,0.00015914727],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00208098,0.00012308267,0.0005761362,0.00009960544,0.0000393449,0.000018732639,0.00017328461,0.00026053394,0.000018075452],"category_scores_gemma":[0.0024727855,0.00007918152,0.00030558335,0.000116071205,0.00012822491,0.00002017606,0.00004978771,0.00036666478,7.0563084e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005061288,0.00031947828,0.80516195,0.000035712157,0.00084264396,0.00017004514,0.00035709143,0.000040827992,0.10810994,0.00043648158,0.0028012567,0.07666326],"study_design_scores_gemma":[0.0026463477,0.00569961,0.8526084,0.00017767459,0.00008649732,0.00002073959,0.00008538968,0.00024706096,0.01983367,0.00053004525,0.11793476,0.00012980911],"about_ca_topic_score_codex":0.012381201,"about_ca_topic_score_gemma":0.11627762,"teacher_disagreement_score":0.1151335,"about_ca_system_score_codex":0.000068039975,"about_ca_system_score_gemma":0.0015160766,"threshold_uncertainty_score":0.99419546},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"observational","genre":"empirical","about_ca_system":false,"about_ca_topic":true,"confidence":"low"},{"model":"gpt","categories":[],"domain":null,"study_design":"observational","genre":"empirical","about_ca_system":false,"about_ca_topic":true,"confidence":"high"}],"label_agreement":"agree"},{"id":"W4401159118","doi":"10.1101/2024.07.28.24311101","title":"CDK4/6 and SHP2 mediate BRAF/MEK inhibitor resistance in Class 2 and 3 BRAF mutant cancers","year":2024,"lang":"en","type":"preprint","venue":"medRxiv","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; McGill University Health Centre; Princess Margaret Cancer Centre; Jewish General Hospital; McGill University; University of Toronto; University Health Network","funders":"","keywords":"Neuroblastoma RAS viral oncogene homolog; Cancer research; MEK inhibitor; MAPK/ERK pathway; Mutant; Cancer; Mutation; Medicine; Biology; Kinase; Gene; KRAS; Internal medicine; Genetics","score_opus":0.009096468143398267,"score_gpt":0.23354354613141465,"score_spread":0.22444707798801639,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401159118","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9714905,0.02377782,0.000013752977,0.00055978785,0.0010308855,0.0003106348,0.00020282842,0.00002578242,0.0025880348],"genre_scores_gemma":[0.992948,0.0045694527,0.00023920737,0.00020950212,0.00057011604,0.00009076376,0.00011568139,0.000053295724,0.0012039914],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981012,0.000086888016,0.0003504548,0.00094811746,0.00017087521,0.00034247953],"domain_scores_gemma":[0.9992058,0.000020033815,0.00010832605,0.00045858827,0.00003994347,0.00016729084],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000326448,0.00034413047,0.00036306874,0.00010729915,0.00004318881,0.00007037895,0.0001983359,0.0004715079,0.000011347205],"category_scores_gemma":[0.00010002829,0.00032421158,0.00007092143,0.000085299645,0.00017092138,0.0000025277461,0.0009231317,0.00049700344,0.000007544516],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027860174,0.000057290952,0.020153763,0.002444467,0.0002200357,0.00069520425,0.0010769914,0.000029797808,0.96338993,0.00086335023,0.0064588026,0.00433176],"study_design_scores_gemma":[0.003659738,0.0006592201,0.05959742,0.0027254713,0.00030868026,0.00014224299,0.0003985186,0.0005870279,0.55377406,0.016312338,0.35855353,0.0032817514],"about_ca_topic_score_codex":0.000116549534,"about_ca_topic_score_gemma":0.003910783,"teacher_disagreement_score":0.40961587,"about_ca_system_score_codex":0.00004566692,"about_ca_system_score_gemma":0.00029683122,"threshold_uncertainty_score":0.999921},"labels":[],"label_agreement":null},{"id":"W4401475093","doi":"10.1101/2024.08.08.607128","title":"The “DDVF” motif used by viral and bacterial proteins to hijack RSK kinases evolved as a mimic of a short linear motif (SLiM) found in proteins related to the RAS-ERK MAP kinase pathway","year":2024,"lang":"en","type":"preprint","venue":"bioRxiv (Cold Spring Harbor Laboratory)","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institut National de la Recherche Scientifique","funders":"","keywords":"Biology; Kinase; MAPK/ERK pathway; Cell biology; Phosphorylation; Structural motif; Sequence motif; Genetics; Computational biology; Biochemistry; Gene","score_opus":0.008859051855275125,"score_gpt":0.2194177831227795,"score_spread":0.21055873126750435,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401475093","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99082893,0.0018835121,0.00012669041,0.0007142475,0.0010541513,0.004562128,0.0007402183,0.00008014209,0.000009997287],"genre_scores_gemma":[0.99668676,0.000095518066,0.0009801434,0.00011627122,0.00045741448,0.0013999934,0.000010317398,0.00016671747,0.00008688944],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.996254,0.00033990413,0.0008587946,0.0014107875,0.00041270643,0.0007237796],"domain_scores_gemma":[0.9973141,0.000049014205,0.0002452418,0.0017267978,0.00031930726,0.00034555732],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009602256,0.0007318147,0.00063056406,0.00018276127,0.000203857,0.00025756378,0.0008780147,0.0007455039,0.000015091011],"category_scores_gemma":[0.0005550171,0.00055563496,0.00019792857,0.00046610748,0.00019542137,0.000011452775,0.0015378646,0.0007329681,0.000050875886],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033441457,0.00016088891,0.0006037691,0.0003787779,0.00018369248,0.000047748683,0.00007600294,0.000046586698,0.99733144,0.00016087817,0.00066070707,0.000015101229],"study_design_scores_gemma":[0.00069656345,0.00080742344,0.005478908,0.0006539395,0.00009500054,1.6240594e-7,0.000023265653,0.00014733526,0.96648055,0.0000135357695,0.02483154,0.00077176926],"about_ca_topic_score_codex":0.0002954674,"about_ca_topic_score_gemma":0.00014750152,"teacher_disagreement_score":0.030850876,"about_ca_system_score_codex":0.000127656,"about_ca_system_score_gemma":0.0008727865,"threshold_uncertainty_score":0.9996895},"labels":[],"label_agreement":null},{"id":"W4401805242","doi":"10.1007/s00520-024-08810-x","title":"Mucocutaneous toxicities from MEK inhibitors: a scoping review of the literature","year":2024,"lang":"en","type":"review","venue":"Supportive Care in Cancer","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medicine; Mucocutaneous zone; Nursing research; Dermatology; Pain medicine; Intensive care medicine; Internal medicine; Pathology; Disease","score_opus":0.021352138554916397,"score_gpt":0.34933402696338633,"score_spread":0.3279818884084699,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401805242","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001233792,0.99340796,4.6140852e-7,0.00003119663,0.0012841736,0.001139268,0.0032891673,0.000007209195,0.00071720325],"genre_scores_gemma":[0.00010697879,0.99707276,0.00001331409,0.00026322555,0.0007131651,0.0004171932,0.0010286191,0.00005251705,0.00033224822],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99822545,0.00016995116,0.0006730244,0.0005261812,0.0001843489,0.00022106436],"domain_scores_gemma":[0.9989183,0.000027919268,0.00034534096,0.00049744314,0.0001670177,0.000043965323],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009542041,0.0003715008,0.0010234177,0.00005899327,0.00002304642,0.000022234932,0.00032127154,0.0003745911,0.00010078794],"category_scores_gemma":[0.000118367236,0.0002306955,0.0006341733,0.00027638953,0.00008372778,0.0000032931473,0.0002558715,0.00034852946,0.000005053099],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000009503766,0.000014407908,0.000014635816,0.7002277,0.00021923715,0.00013069523,0.00062352826,2.0362359e-7,0.0001928355,0.00001309595,0.011140578,0.2874136],"study_design_scores_gemma":[0.000031286756,0.00004413513,2.6217313e-7,0.55118585,0.0002893035,0.00001598787,0.00006980029,1.4783261e-8,0.00103109,0.000007630076,0.44715878,0.000165844],"about_ca_topic_score_codex":0.00006673667,"about_ca_topic_score_gemma":0.0004350824,"teacher_disagreement_score":0.4360182,"about_ca_system_score_codex":0.00010446901,"about_ca_system_score_gemma":0.0015460075,"threshold_uncertainty_score":0.940749},"labels":[],"label_agreement":null},{"id":"W4402560067","doi":"10.1016/j.annonc.2024.08.681","title":"614MO Type II RAF inhibitor tovorafenib in recurrent/refractory (R/R) melanoma or other solid tumors with RAF fusions and/or RAF1 amplification","year":2024,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Refractory (planetary science); Cancer research; Melanoma; Solid tumor; Oncology; Internal medicine; Cancer","score_opus":0.06356548457946962,"score_gpt":0.3571273992258349,"score_spread":0.2935619146463653,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402560067","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99315023,0.0021057276,0.0000847381,0.0010801441,0.00037738922,0.00029551738,0.00004836061,0.000022666269,0.002835239],"genre_scores_gemma":[0.9956193,0.0010333576,0.0003511514,0.0004881834,0.00029315785,0.0000448261,0.000089241505,0.000030687017,0.0020501013],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987633,0.0001124425,0.00034997604,0.0004026871,0.0000991692,0.0002724129],"domain_scores_gemma":[0.9993299,0.00006501529,0.00011914628,0.0002680241,0.00011809769,0.000099770645],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028738283,0.0001795931,0.00030542625,0.00013519349,0.000059770762,0.000013182771,0.0001390652,0.00025287535,0.00017121267],"category_scores_gemma":[0.00012898096,0.00012472057,0.000049750757,0.00021031672,0.00013420546,0.0000108635895,0.0001165634,0.00015588917,0.000016787306],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0064484044,0.00095337105,0.0012367518,0.00025365915,0.00018521922,0.00020687564,0.0012281904,0.000013005076,0.8448162,0.0010392598,0.032586876,0.11103218],"study_design_scores_gemma":[0.0013784743,0.01596828,0.0024700442,0.00021284053,0.000035938447,0.00015067501,0.00032617577,0.00007679564,0.1637474,0.00016399739,0.81511235,0.00035705103],"about_ca_topic_score_codex":0.000037137925,"about_ca_topic_score_gemma":0.00049172767,"teacher_disagreement_score":0.7825255,"about_ca_system_score_codex":0.000015831994,"about_ca_system_score_gemma":0.00047918278,"threshold_uncertainty_score":0.5085957},"labels":[],"label_agreement":null},{"id":"W4402560083","doi":"10.1016/j.annonc.2024.08.691","title":"624P Belvarafenib in patients (pts) with BRAF class II or III alteration-positive tumours: TAPISTRY study","year":2024,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada)","funders":"","keywords":"Medicine; Internal medicine; Oncology","score_opus":0.026726967471272407,"score_gpt":0.32412004431273234,"score_spread":0.29739307684145994,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402560083","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99541056,0.00021342772,0.00007473683,0.0005019798,0.00022245824,0.00043832508,0.00005501755,0.000012025198,0.0030714427],"genre_scores_gemma":[0.9980726,0.000043765758,0.000085837775,0.00047408222,0.0001562027,0.00005683409,0.00018606927,0.000020001951,0.00090456393],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99875224,0.00013253333,0.00031815114,0.00040130244,0.00013744114,0.0002583443],"domain_scores_gemma":[0.99940085,0.000039104347,0.000092897346,0.00023221233,0.00016391685,0.00007098963],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002222566,0.00016826589,0.00027552558,0.000091068956,0.00005986185,0.000015363295,0.00015943254,0.0001697651,0.000043940403],"category_scores_gemma":[0.00004465169,0.00012912563,0.000055113018,0.00014947468,0.00008032778,0.000010133026,0.0001241512,0.0001380604,0.000009227472],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.020782394,0.030218843,0.41771838,0.0006171746,0.002765752,0.0029236642,0.015651157,0.00061980967,0.24503636,0.004162175,0.11135878,0.14814553],"study_design_scores_gemma":[0.016481983,0.19728711,0.30069798,0.00041201914,0.00021260566,0.00014958036,0.0025617662,0.00024932556,0.35086313,0.0002718926,0.1293694,0.0014432031],"about_ca_topic_score_codex":0.00006598122,"about_ca_topic_score_gemma":0.00053946034,"teacher_disagreement_score":0.16706826,"about_ca_system_score_codex":0.00001984571,"about_ca_system_score_gemma":0.00032081432,"threshold_uncertainty_score":0.52655905},"labels":[],"label_agreement":null},{"id":"W4402775563","doi":"10.1007/s11912-024-01599-2","title":"Risk Stratification, Screening and Treatment of BRAF/MEK Inhibitors-Associated Cardiotoxicity","year":2024,"lang":"en","type":"review","venue":"Current Oncology Reports","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier universitaire de Québec","funders":"","keywords":"Medicine; Cardiotoxicity; Risk stratification; Oncology; Internal medicine; Stratification (seeds); Chemotherapy","score_opus":0.07883167995989944,"score_gpt":0.38152584444017396,"score_spread":0.30269416448027453,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402775563","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.007981588,0.9889313,0.000058010013,0.00000505124,0.0015344948,0.00080924545,0.00027097994,0.000025109826,0.0003842287],"genre_scores_gemma":[0.004883742,0.9923054,0.000081173945,0.000001755818,0.00052747194,0.00013117514,0.0018310349,0.000042019325,0.0001962235],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9975654,0.00031518773,0.000987643,0.00075781596,0.0001341103,0.0002398426],"domain_scores_gemma":[0.99805063,0.00004285538,0.0011546693,0.00052312505,0.0001068411,0.00012190778],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00040007484,0.00041505272,0.0013440844,0.000107600776,0.0000782856,0.00001950467,0.000081024365,0.0006361879,0.0000050843364],"category_scores_gemma":[0.00016152479,0.00032211054,0.00053155114,0.00013339613,0.00013641088,0.0000027011022,0.000102685044,0.00022124816,0.0000029611049],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000004356316,0.0002734932,0.00054834195,0.0015435489,0.00068935886,0.00011768009,0.000054538756,4.508368e-7,0.00016713928,0.000009625225,0.0026673323,0.99392414],"study_design_scores_gemma":[0.0001581275,0.00075359206,0.000092999624,0.0011957047,0.00221618,0.00041791116,0.000013425312,0.0000016897454,0.00035290563,0.000030111953,0.99453276,0.00023456932],"about_ca_topic_score_codex":0.000023547846,"about_ca_topic_score_gemma":0.000041286417,"teacher_disagreement_score":0.99368954,"about_ca_system_score_codex":0.00010955015,"about_ca_system_score_gemma":0.0007113698,"threshold_uncertainty_score":0.9999231},"labels":[],"label_agreement":null},{"id":"W4403215038","doi":"10.1093/toxsci/kfae129","title":"Development and safety of investigational and approved drugs targeting the RAS function regulation in RAS mutant cancers","year":2024,"lang":"en","type":"review","venue":"Toxicological Sciences","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Artificial Intelligence in Medicine (Canada)","funders":"National Natural Science Foundation of China","keywords":"Adverse effect; Medicine; Dosing; Investigational Drugs; Cancer; Food and drug administration; Pharmacology; Drug development; Drug; Adverse Outcome Pathway; Bioinformatics; Intensive care medicine; Clinical trial; Biology; Internal medicine; Computational biology","score_opus":0.049508986519040475,"score_gpt":0.29634851079449914,"score_spread":0.24683952427545866,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403215038","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.07052913,0.9279996,0.000063051004,0.00008882595,0.00015074476,0.00043143367,0.000008523529,0.0000062612057,0.00072239095],"genre_scores_gemma":[0.059137657,0.93885416,0.0014452497,0.00009962023,0.00013906766,0.00010045825,0.00008737783,0.0000073446513,0.00012908292],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989739,0.000105302366,0.00031082134,0.00034357107,0.00013645423,0.00012993025],"domain_scores_gemma":[0.9997026,0.00005277883,0.00013478154,0.000055471533,0.000014518153,0.00003989137],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008974189,0.00013029344,0.00025489414,0.000038660226,0.00012021071,0.000026452013,0.00010901048,0.00016438063,0.000009614781],"category_scores_gemma":[0.00011539543,0.00006759679,0.000036827587,0.00018544262,0.0004219288,0.0000038262697,0.00013165697,0.00009623689,8.936687e-7],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003364028,0.000026526553,0.00013554737,0.0017842448,0.000055593267,0.0000018429022,0.00033510078,0.000033039494,0.016037133,0.006036526,0.00032048544,0.9752003],"study_design_scores_gemma":[0.00012101896,0.00021346564,0.0006473949,0.0006775411,0.00007045301,0.0000093337485,0.00021062419,0.000108895394,0.0014165952,0.0007255438,0.99559367,0.00020544036],"about_ca_topic_score_codex":0.0000085067995,"about_ca_topic_score_gemma":0.000035400433,"teacher_disagreement_score":0.99527323,"about_ca_system_score_codex":0.00003353021,"about_ca_system_score_gemma":0.00036320533,"threshold_uncertainty_score":0.2756517},"labels":[],"label_agreement":null},{"id":"W4403663525","doi":"","title":"Post Proceedings of the STAF 2023 Workshops","year":2024,"lang":"en","type":"other","venue":"HAL (Le Centre pour la Communication Scientifique Directe)","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Environmental science","score_opus":0.006748592815243814,"score_gpt":0.20456993393816728,"score_spread":0.19782134112292346,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403663525","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00995071,0.0035513572,0.0004115062,0.0016633689,0.00028240526,0.00030725638,0.00018325866,0.000057315752,0.9835928],"genre_scores_gemma":[0.040344898,0.00040821667,0.001630138,0.00006909456,0.000073675845,0.000024767225,0.00017525406,0.00017595847,0.957098],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987736,0.0002514967,0.00020465492,0.00040454627,0.00018799248,0.00017771982],"domain_scores_gemma":[0.9984077,0.000034849483,0.00023454634,0.00073725113,0.0005230627,0.00006257727],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00082312396,0.00019082862,0.00017187194,0.00007262798,0.00005364103,0.00006617698,0.0006910925,0.0002835866,0.00026564865],"category_scores_gemma":[0.00035318432,0.000151983,0.00016173346,0.00019709712,0.0001584192,0.0000024536207,0.0004952122,0.00018712485,0.00007283674],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000009356484,0.0001583786,0.00029756993,0.00033629063,0.0001349172,0.0000011005566,0.0006020552,1.7846638e-7,0.24202777,0.026064603,0.72426146,0.0061062938],"study_design_scores_gemma":[0.00014022466,6.61606e-7,0.00018286041,0.0010967231,0.000035341844,0.000006394779,0.000075843964,0.000014043255,0.17845425,0.0002022398,0.8196071,0.00018435136],"about_ca_topic_score_codex":0.00022980302,"about_ca_topic_score_gemma":0.0008767727,"teacher_disagreement_score":0.09534559,"about_ca_system_score_codex":0.000011165694,"about_ca_system_score_gemma":0.000101665646,"threshold_uncertainty_score":0.6197687},"labels":[],"label_agreement":null},{"id":"W4403823250","doi":"10.2139/ssrn.4999742","title":"Extracellular Matrix Signals Promote Actin-Dependent Mitochondrial Elongation and Activity","year":2024,"lang":"en","type":"preprint","venue":"SSRN Electronic Journal","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Montréal; Université du Québec à Trois-Rivières","funders":"","keywords":"Extracellular matrix; Elongation; Actin; Cell biology; Extracellular; Chemistry; Mitochondrion; Matrix (chemical analysis); Biophysics; Biology; Materials science; Ultimate tensile strength","score_opus":0.008248094821110146,"score_gpt":0.25511395611132226,"score_spread":0.24686586129021212,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403823250","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9462007,0.038348153,0.0128307715,0.00040996794,0.0014683473,0.00048313645,0.000033720928,0.00002889977,0.00019625196],"genre_scores_gemma":[0.97909766,0.0065607163,0.0002658184,0.000008620624,0.002729678,0.000033787026,0.000084361876,0.000072722934,0.011146602],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9970137,0.00018749565,0.00035228138,0.0007115767,0.00032607402,0.0014088972],"domain_scores_gemma":[0.9990401,0.000012351993,0.0003229612,0.00037855166,0.00009871376,0.00014727763],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0010869727,0.00040365534,0.00032915804,0.00011897125,0.00016170254,0.00021441228,0.00030979858,0.0006440076,0.000019069515],"category_scores_gemma":[0.000071158,0.00037472858,0.00025091745,0.0000504791,0.000048583795,0.000007022689,0.00060980837,0.003542277,0.000022987166],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024819627,0.000070715505,0.000036216956,0.00011554678,0.0004632604,0.000028602497,0.00006517272,0.00008251093,0.9774283,0.0026835445,0.00019270042,0.018585218],"study_design_scores_gemma":[0.0024766147,0.0026600428,0.00017809636,0.00037052995,0.00083939056,0.0041400567,0.00042580697,0.00079048664,0.62600976,0.34163806,0.018542133,0.0019290218],"about_ca_topic_score_codex":0.00004513052,"about_ca_topic_score_gemma":0.00023303617,"teacher_disagreement_score":0.35141855,"about_ca_system_score_codex":0.0002765336,"about_ca_system_score_gemma":0.0028308877,"threshold_uncertainty_score":0.9998705},"labels":[],"label_agreement":null},{"id":"W4405070410","doi":"10.3390/curroncol31120568","title":"Braf-Mutant Melanomas: Biology and Therapy","year":2024,"lang":"en","type":"review","venue":"Current Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Melanoma; Medicine; Adjuvant; Targeted therapy; Cancer research; Mutant; Adjuvant therapy; Disease; Mutation; Oncology; Cancer; Internal medicine; Gene; Immunology; Biology; Genetics","score_opus":0.14769301815361696,"score_gpt":0.44821491817125264,"score_spread":0.3005219000176357,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405070410","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00030517732,0.9936466,0.000046295685,0.00003368105,0.0034902222,0.00060787366,0.00019704492,0.000037950613,0.001635118],"genre_scores_gemma":[0.00006915196,0.996579,0.000054461478,0.000051766525,0.001573663,0.0002309878,0.0010873068,0.00007413301,0.0002795375],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99775076,0.0003251612,0.0005216243,0.0009090598,0.00006448832,0.00042891572],"domain_scores_gemma":[0.9990725,0.000038720784,0.00021359883,0.00047457157,0.000043719247,0.00015689342],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002584757,0.0005456234,0.0012894683,0.00015989189,0.00006146028,0.000028788696,0.0003423515,0.00092142087,0.00004505289],"category_scores_gemma":[0.000049205537,0.00038675911,0.0003886135,0.00012486409,0.00020480936,0.0000017595992,0.00037755416,0.00047091293,0.00016756509],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000009140999,0.000086880485,0.000011222384,0.0024057077,0.00021754115,0.000021613465,0.000018230536,5.570729e-9,0.00041504137,0.00075068534,0.0061518988,0.98991203],"study_design_scores_gemma":[0.0003010197,0.0009421379,0.0000013169686,0.0007320272,0.00036715157,0.00034644624,0.000006161043,9.28078e-7,0.0000613114,0.00022376783,0.9966088,0.0004089287],"about_ca_topic_score_codex":0.0000028431552,"about_ca_topic_score_gemma":0.0000075414105,"teacher_disagreement_score":0.9904569,"about_ca_system_score_codex":0.000045926037,"about_ca_system_score_gemma":0.0005622329,"threshold_uncertainty_score":0.99985844},"labels":[],"label_agreement":null},{"id":"W4405181476","doi":"10.1158/1538-8514.cancerchem24-ia020","title":"Abstract IA020: Discovery of brain-penetrant inhibitors for the treatment of BRAF mutant tumors","year":2024,"lang":"en","type":"article","venue":"Molecular Cancer Therapeutics","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Penetrant (biochemical); Cancer research; Mutant; Cancer; Kinase; Neuroblastoma RAS viral oncogene homolog; Medicine; Pharmacology; Biology; Gene; Genetics; Internal medicine","score_opus":0.020412385785389217,"score_gpt":0.28341883247375693,"score_spread":0.2630064466883677,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405181476","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9553143,0.03540132,0.007321075,0.00054518087,0.000443918,0.00053061306,0.00030630175,0.000010910319,0.00012637473],"genre_scores_gemma":[0.9966494,0.0024270378,0.00009936038,0.00024987568,0.00019018483,0.000105347564,0.000050495626,0.000043465792,0.00018484035],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990495,0.000023108578,0.0002918594,0.0002759285,0.00014982747,0.00020981082],"domain_scores_gemma":[0.9994082,0.000049655486,0.00008938858,0.00036504678,0.000055567623,0.000032181586],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009789804,0.00019285968,0.0002041647,0.000038236045,0.00003937809,0.00002603023,0.00016832688,0.00009499924,0.000009991339],"category_scores_gemma":[0.000005752707,0.00012748696,0.0003126795,0.00009546967,0.00011209881,0.000004206321,0.000019466472,0.000044960667,7.492696e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000107965716,0.00011165964,0.0000852297,0.00012461554,0.0005203118,0.000011583008,0.00022408899,0.00023666471,0.968996,0.00058588275,0.00009074886,0.028905263],"study_design_scores_gemma":[0.00045377715,0.0008191154,0.000467475,0.000063050895,0.00014755694,0.0000059076397,0.000073919604,0.00019782202,0.92958874,0.00014936978,0.067891054,0.00014219011],"about_ca_topic_score_codex":0.000087037515,"about_ca_topic_score_gemma":0.000051589508,"teacher_disagreement_score":0.067800306,"about_ca_system_score_codex":0.000029895295,"about_ca_system_score_gemma":0.00020694618,"threshold_uncertainty_score":0.5198767},"labels":[],"label_agreement":null},{"id":"W4405181970","doi":"10.1158/1538-8514.cancerchem24-ia018","title":"Abstract IA018: Pan-RAF-MEK molecular glue NST-628 is a potent and brain-penetrant inhibitor of the RAS-MAPK pathway","year":2024,"lang":"en","type":"article","venue":"Molecular Cancer Therapeutics","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"MAPK/ERK pathway; Cancer research; MEK inhibitor; Tolerability; Phosphorylation; Medicine; Kinase; Cancer; Chemistry; Pharmacology; Internal medicine; Biochemistry; Adverse effect","score_opus":0.012600471978043988,"score_gpt":0.2521511944222847,"score_spread":0.2395507224442407,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405181970","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9525502,0.04017178,0.0026831029,0.0022462318,0.00079090864,0.0005250596,0.00022690624,0.000034922185,0.0007708955],"genre_scores_gemma":[0.9935346,0.0010606381,0.00019912087,0.004520199,0.00017868698,0.000066080494,0.000034189394,0.0000916178,0.00031487193],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99799395,0.00009980087,0.00041401433,0.0006597024,0.00039058886,0.00044192307],"domain_scores_gemma":[0.99888617,0.000026403548,0.0001234024,0.0007331789,0.00011235913,0.00011847933],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00021551049,0.00039235165,0.00029833603,0.00006960738,0.00009813076,0.000083187384,0.00038324486,0.00028602642,0.00003503491],"category_scores_gemma":[0.000017582031,0.00030168088,0.00033708112,0.0002252557,0.00021099877,0.000008326458,0.00019441856,0.000273467,0.000007154067],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000061755665,0.000061725266,0.0001774327,0.00019061085,0.0004011415,0.00007353142,0.0002953182,0.000046814534,0.97265506,0.0007092805,0.000518777,0.024808573],"study_design_scores_gemma":[0.000526691,0.00019881473,0.001206879,0.00016403846,0.000121341065,0.00003602271,0.00006568212,0.00013356464,0.8968619,0.0004248778,0.09990467,0.00035549828],"about_ca_topic_score_codex":0.00008671653,"about_ca_topic_score_gemma":0.00003347755,"teacher_disagreement_score":0.09938589,"about_ca_system_score_codex":0.000039758266,"about_ca_system_score_gemma":0.00034749188,"threshold_uncertainty_score":0.99994355},"labels":[],"label_agreement":null},{"id":"W4405289324","doi":"10.14740/wjon1945","title":"Loss of MK2 Enhances Radiation-Mediated Apoptosis in Bladder Cancer","year":2024,"lang":"en","type":"article","venue":"World Journal of Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"National Institute of General Medical Sciences; National Cancer Institute; National Institutes of Health","keywords":"Medicine; Apoptosis; Bladder cancer; Cancer research; Cancer; Radiation therapy; Oncology; Internal medicine; Genetics","score_opus":0.010965381108806129,"score_gpt":0.2963152185490005,"score_spread":0.2853498374401944,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405289324","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9837924,0.010742888,0.00015009179,0.0010588573,0.001218496,0.000059483213,0.000015130412,0.0000026143175,0.0029600256],"genre_scores_gemma":[0.9954407,0.0029899613,0.0002227813,0.00017364911,0.0005241852,0.000006269109,0.0000093170875,0.000009902705,0.0006232418],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9991663,0.00007861954,0.0003980732,0.00011789545,0.000095409465,0.00014368181],"domain_scores_gemma":[0.99952525,0.00006843644,0.00018752921,0.0000801619,0.00008286324,0.000055782624],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028188273,0.00008277183,0.00022816441,0.00021545564,0.000012514913,0.0000066373127,0.00013310905,0.000100599646,0.00015931392],"category_scores_gemma":[0.000064569336,0.000068783316,0.000092230846,0.00021435945,0.00006467075,0.0000060866314,0.000026996744,0.0001508165,0.000006617124],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019783019,0.00013896855,0.009031677,0.000057233014,0.00022452915,0.00007385505,0.00027529124,0.00012870377,0.9264442,0.00023878842,0.015789742,0.047399234],"study_design_scores_gemma":[0.0007723905,0.0008182856,0.004692916,0.000083405845,0.00004615738,0.0000560755,0.00007193455,0.00003909894,0.43405664,0.00015204729,0.55909634,0.00011472918],"about_ca_topic_score_codex":0.000028161181,"about_ca_topic_score_gemma":0.00046623248,"teacher_disagreement_score":0.5433066,"about_ca_system_score_codex":0.000047083566,"about_ca_system_score_gemma":0.00045852148,"threshold_uncertainty_score":0.28049022},"labels":[],"label_agreement":null},{"id":"W4405437295","doi":"10.1021/acs.jmedchem.4c02552","title":"Design, Synthesis, and Biochemical Evaluation of Novel MLK3 Inhibitors: A Target Hopping Example","year":2024,"lang":"en","type":"article","venue":"Journal of Medicinal Chemistry","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Structural Genomics Consortium; Deutsche Forschungsgemeinschaft","keywords":"Kinome; Druggability; Chemistry; Kinase; Computational biology; Focal adhesion; Lineage (genetic); MAP kinase kinase kinase; Protein kinase A; Cell biology; Signal transduction; Biochemistry; Biology","score_opus":0.043370069545414947,"score_gpt":0.2840475989558541,"score_spread":0.24067752941043913,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405437295","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96892595,0.016417606,0.013556556,0.00016788939,0.00020310367,0.00007693218,0.000007722983,0.00000446608,0.00063975237],"genre_scores_gemma":[0.9961285,0.00019127697,0.0025718047,0.000019426709,0.0010102072,0.000005219968,0.000009858953,0.0000141788,0.00004951117],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987711,0.000043629243,0.00040256034,0.00018031598,0.0004684929,0.00013394732],"domain_scores_gemma":[0.99923205,0.00007942278,0.00018725362,0.00012982805,0.0002519331,0.000119508666],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016003447,0.00012578288,0.00021353696,0.000042477044,0.000022157832,0.0000145046815,0.0001176594,0.00016196394,0.00008629578],"category_scores_gemma":[0.00064735685,0.00010170362,0.00008396346,0.000072769726,0.000091146016,0.000006935219,0.000043841927,0.00017162002,3.7583564e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000079165824,0.000051105235,0.00005296016,0.00024791146,0.0000906723,0.0000088212655,0.00007057485,0.000021584357,0.99233556,0.0000031573938,0.00503231,0.002006205],"study_design_scores_gemma":[0.00055250473,0.00015645343,0.000048714377,0.0005301782,0.00017594812,0.00065358815,0.00015564694,0.0014056294,0.99388194,0.000056646328,0.002282499,0.00010026705],"about_ca_topic_score_codex":0.000003929739,"about_ca_topic_score_gemma":1.1499213e-7,"teacher_disagreement_score":0.027202545,"about_ca_system_score_codex":0.00002860247,"about_ca_system_score_gemma":0.00037194026,"threshold_uncertainty_score":0.41473532},"labels":[],"label_agreement":null},{"id":"W4405516329","doi":"10.21203/rs.3.rs-5632942/v1","title":"FRAME: A phase I trial of defactinib (FAK inhibitor) in combination with avutometinib (RAF-MEK clamp) in patients with solid tumours including low grade serous ovarian cancer","year":2024,"lang":"en","type":"preprint","venue":"Research Square","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Ottawa Mental Health Centre; Institute of Cancer Research","funders":"Royal Marsden NHS Foundation Trust","keywords":"Medicine; Tolerability; Pharmacokinetics; MEK inhibitor; Pharmacodynamics; Ovarian cancer; Internal medicine; Clinical endpoint; Oncology; Serous fluid; Confidence interval; Dosing; Clinical trial; Cancer; MAPK/ERK pathway; Pharmacology; Adverse effect; Kinase; Chemistry","score_opus":0.04171688311191956,"score_gpt":0.3854444483205771,"score_spread":0.34372756520865755,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405516329","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956613,0.0003706362,0.000050963718,0.00017149479,0.00033495825,0.0027687335,0.00034176378,0.000019485984,0.00028066747],"genre_scores_gemma":[0.9973678,0.00014485973,0.00019029644,0.000013784232,0.00026816493,0.0007705197,0.001075941,0.00008530837,0.00008329829],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9961071,0.0005514722,0.00059493893,0.0009679806,0.0010796606,0.00069883425],"domain_scores_gemma":[0.9983608,0.00008549433,0.00024799735,0.00061399565,0.0005224841,0.00016919893],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0012314093,0.0003857401,0.000580476,0.00079630583,0.000079136946,0.00009275842,0.0003948888,0.0005931326,0.000020147407],"category_scores_gemma":[0.00029467425,0.00032466385,0.00010519608,0.00071040523,0.00018226966,0.0000100478155,0.00092786615,0.0016976531,0.0000041746703],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.32817927,0.028648442,0.459457,0.018205846,0.0014269155,0.0010261589,0.009162833,0.0050199735,0.11692619,0.00090847956,0.0026397088,0.028399179],"study_design_scores_gemma":[0.42691687,0.04872619,0.12291435,0.020967843,0.00023534027,0.00001866131,0.0025134895,0.0016655661,0.36743507,0.003037495,0.0020387692,0.003530339],"about_ca_topic_score_codex":0.0009949864,"about_ca_topic_score_gemma":0.00167394,"teacher_disagreement_score":0.33654267,"about_ca_system_score_codex":0.00025954898,"about_ca_system_score_gemma":0.001467504,"threshold_uncertainty_score":0.99992055},"labels":[],"label_agreement":null},{"id":"W4406463200","doi":"10.1007/s11060-024-04930-w","title":"It’s all downstream from here: RTK/Raf/MEK/ERK pathway resistance mechanisms in glioblastoma","year":2025,"lang":"en","type":"review","venue":"Journal of Neuro-Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"Canadian Institutes of Health Research","keywords":"Glioblastoma; MAPK/ERK pathway; Downstream (manufacturing); Resistance (ecology); Cancer research; Cell biology; Biology; Signal transduction; Business; Ecology","score_opus":0.024110785795744393,"score_gpt":0.30871339111734475,"score_spread":0.28460260532160037,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406463200","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00048411975,0.98949516,0.00033795316,0.0006134795,0.0029172136,0.0005617688,0.0002845978,0.000013038265,0.005292673],"genre_scores_gemma":[0.00023116177,0.9943624,0.001708936,0.0015940855,0.0009051004,0.00004939912,0.00010737556,0.00007628039,0.0009652378],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99546653,0.0010333994,0.001848603,0.0007373316,0.00033790365,0.0005762328],"domain_scores_gemma":[0.9965449,0.0004710662,0.0018004434,0.00071516266,0.00019937432,0.00026908345],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0006309514,0.0006671622,0.0025017455,0.00041961766,0.000059529993,0.00003968742,0.0010808756,0.0013863993,0.000069350215],"category_scores_gemma":[0.00061442726,0.0005619597,0.00093501905,0.00031595523,0.00009192253,0.000010932124,0.00036303556,0.0011913003,0.00003162041],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014165379,0.001113803,0.0000094973875,0.0050946027,0.0010297085,0.009319516,0.00016704184,0.000010617833,0.07733131,0.00049876334,0.10403658,0.799972],"study_design_scores_gemma":[0.0011436911,0.002243559,0.0000024243673,0.0028268117,0.0004006406,0.0006818981,0.000046217876,7.4009847e-7,0.0033033444,0.00035051155,0.9885818,0.00041837842],"about_ca_topic_score_codex":0.000010053299,"about_ca_topic_score_gemma":0.0005371353,"teacher_disagreement_score":0.8845452,"about_ca_system_score_codex":0.00024677056,"about_ca_system_score_gemma":0.0026031174,"threshold_uncertainty_score":0.99991},"labels":[],"label_agreement":null},{"id":"W4406638397","doi":"10.1016/b978-0-7506-3993-4.50292-2","title":"10.1016/b978-0-7506-3993-4.50292-2","year":2000,"lang":"en","type":"book-chapter","venue":"Time to knit","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Geology","score_opus":0.006951697914268973,"score_gpt":0.1687909199803848,"score_spread":0.16183922206611584,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406638397","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000142232675,0.0007428489,0.0000028965687,0.000048751048,0.000009677159,0.00032883184,0.000247675,0.00005129019,0.9985538],"genre_scores_gemma":[0.00001090248,0.0000011652215,0.000086640866,0.00010666793,0.0010212045,0.000024398689,0.0010640599,0.00013028388,0.99755466],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984029,0.000019778721,0.00031267304,0.0006818379,0.00021336476,0.00036946748],"domain_scores_gemma":[0.9987335,0.000010466076,0.000106939595,0.00082177937,0.00007626967,0.00025104245],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00010117041,0.00047027637,0.00038110194,0.00010147599,0.00007578679,0.00003510075,0.0004043621,0.0006469244,0.98090804],"category_scores_gemma":[0.0000196003,0.0004842716,0.0002503277,0.000021812099,0.000065617874,0.0000022235733,0.00019385936,0.00021824929,0.9783806],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000215899,0.00003292101,1.7740925e-8,0.000024774912,0.00016026293,0.00004574136,0.000004595189,0.0000067821675,0.0068774465,0.00014054566,0.1527187,0.83977234],"study_design_scores_gemma":[0.00024597882,0.0005345015,6.123379e-7,0.00004930585,0.00006316985,0.00003983693,1.6900559e-7,0.0000016266221,0.002569524,0.00010628846,0.9957975,0.0005914691],"about_ca_topic_score_codex":0.0000075583303,"about_ca_topic_score_gemma":8.673365e-7,"teacher_disagreement_score":0.8430788,"about_ca_system_score_codex":0.00002310154,"about_ca_system_score_gemma":0.0001166709,"threshold_uncertainty_score":0.99976087},"labels":[],"label_agreement":null},{"id":"W4406649743","doi":"10.1016/b978-2-294-73068-9.00508-9","title":"10.1016/b978-2-294-73068-9.00508-9","year":2000,"lang":"en","type":"book-chapter","venue":"Time to knit","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Geology","score_opus":0.00683809002744843,"score_gpt":0.16842494315321083,"score_spread":0.1615868531257624,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406649743","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000017286906,0.00067307096,0.0000029139067,0.000055215576,0.000009580218,0.00032945286,0.00024115617,0.00005121225,0.9986201],"genre_scores_gemma":[0.000009509366,0.000005248084,0.00009401857,0.00010730543,0.001133448,0.000023290426,0.0010535937,0.00013141999,0.9974422],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99841356,0.0000194731,0.00030886082,0.0006736449,0.00021145088,0.00037298494],"domain_scores_gemma":[0.9987524,0.0000104019855,0.00010637553,0.0008020156,0.00007298246,0.00025580998],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00009690149,0.0004719499,0.0003844412,0.00010324644,0.000074605494,0.00003430165,0.00040926778,0.0006574725,0.9787517],"category_scores_gemma":[0.000018067756,0.00048669276,0.00025061247,0.000022025506,0.00006376946,0.000002279101,0.00019053501,0.00021450726,0.9759585],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019773953,0.000030196286,1.5567267e-8,0.000025431573,0.00015009128,0.00004043825,0.0000040570117,0.0000063742523,0.0071489117,0.00008391858,0.60692966,0.38538316],"study_design_scores_gemma":[0.0002537431,0.0005345675,5.508671e-7,0.000050239563,0.00006329922,0.000039411425,1.6706595e-7,0.0000020417092,0.0032166594,0.00010640713,0.9951393,0.00059364125],"about_ca_topic_score_codex":0.0000051640386,"about_ca_topic_score_gemma":7.8041836e-7,"teacher_disagreement_score":0.3882096,"about_ca_system_score_codex":0.000024065934,"about_ca_system_score_gemma":0.00012047036,"threshold_uncertainty_score":0.9997585},"labels":[],"label_agreement":null},{"id":"W4406854679","doi":"10.1200/po.24.00199","title":"Clinical Activity of Mitogen-Activated Protein Kinase Inhibitors in Patients With MAP2K1 (MEK1)-Mutated Metastatic Cancers","year":2025,"lang":"en","type":"review","venue":"JCO Precision Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; McGill University; Jewish General Hospital","funders":"National Cancer Institute; Conquer Cancer Foundation","keywords":"MAPK/ERK pathway; Mutant; Cancer; Mutation; Cancer research; Medicine; Kinase; Protein kinase A; Internal medicine; Oncology; Biology; Gene; Genetics","score_opus":0.033493044826011814,"score_gpt":0.3678672657524481,"score_spread":0.3343742209264363,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406854679","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.26931787,0.72039473,0.00020384166,0.000024134115,0.0018529139,0.006471658,0.00047986858,0.000031634696,0.0012233449],"genre_scores_gemma":[0.027060008,0.9671591,0.0013688578,0.00006740914,0.00021789943,0.00095707574,0.0015536384,0.00011733037,0.0014986936],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99562156,0.0014848973,0.0012677616,0.0009508161,0.00027350365,0.00040147902],"domain_scores_gemma":[0.9975103,0.00031002003,0.0010831428,0.00071839406,0.00022749329,0.00015061726],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00067899283,0.00052256015,0.0022659611,0.00032203307,0.000042588086,0.00000985093,0.0004180703,0.0009574561,0.00003735101],"category_scores_gemma":[0.000688265,0.0003924854,0.0004143895,0.00051403913,0.00018154785,0.000007809184,0.00032690808,0.0005736972,0.000008621019],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012419802,0.000703468,0.00032864534,0.002724211,0.0003161376,0.00002775789,0.000013839041,0.0000042172373,0.0015197459,0.000004121956,0.0014136337,0.99170226],"study_design_scores_gemma":[0.003722354,0.004800444,0.0003797838,0.005283796,0.00042066813,0.0000048521088,0.000008514233,0.0000022297647,0.0094936155,0.00001899948,0.9753093,0.0005554479],"about_ca_topic_score_codex":0.00009126815,"about_ca_topic_score_gemma":0.00017189786,"teacher_disagreement_score":0.9911468,"about_ca_system_score_codex":0.00028078372,"about_ca_system_score_gemma":0.0029886535,"threshold_uncertainty_score":0.9998527},"labels":[],"label_agreement":null},{"id":"W4408592042","doi":"10.1158/1078-0432.ccr-24-0254","title":"Longitudinal Genomic Analysis to Fine-tune Targeted Therapy: Results of the Phase II LOGIC 2 Trial in Patients with <i>BRAF</i> V600-Mutant Metastatic Melanoma","year":2025,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; McGill University; University of Toronto; Jewish General Hospital","funders":"Memorial Sloan-Kettering Cancer Center; Pfizer; National Cancer Institute; Foundation for the National Institutes of Health","keywords":"Medicine; Metastatic melanoma; Melanoma; Adverse effect; MEK inhibitor; Clinical endpoint; Internal medicine; Oncology; Phases of clinical research; Clinical trial; Cancer research; MAPK/ERK pathway; Kinase","score_opus":0.10792660299837883,"score_gpt":0.4474522176663169,"score_spread":0.33952561466793807,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408592042","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99658126,0.00048171706,0.000076237724,0.00092284323,0.00020634131,0.0011728774,0.00028336613,0.0000040875584,0.00027126024],"genre_scores_gemma":[0.99859464,0.00012662844,0.00010989776,0.0002803521,0.0001134419,0.0001528938,0.000113889764,0.000012771801,0.0004955015],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99697477,0.0007344635,0.0007944626,0.00064699724,0.00043476332,0.00041454483],"domain_scores_gemma":[0.99836713,0.0002030752,0.0001550258,0.0007938901,0.0003575865,0.00012328551],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020159665,0.00016422468,0.00048850756,0.0002203794,0.00013128045,0.000018919349,0.00057954073,0.00012777772,0.000049063317],"category_scores_gemma":[0.0008228408,0.00010075028,0.00024120983,0.001448224,0.0002520519,0.0000037783648,0.00039926587,0.00035166703,0.0000029412759],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.53196144,0.008884479,0.3131259,0.00007563589,0.0042969,0.00003127053,0.00023587968,0.00084741745,0.09551558,0.00021285216,0.00826382,0.036548816],"study_design_scores_gemma":[0.2637554,0.03553871,0.5654288,0.00011651476,0.00052800844,5.268182e-7,0.00007810251,0.00013016282,0.10248558,0.00033731427,0.031013435,0.00058742653],"about_ca_topic_score_codex":0.00033430776,"about_ca_topic_score_gemma":0.0014231688,"teacher_disagreement_score":0.26820603,"about_ca_system_score_codex":0.000048450966,"about_ca_system_score_gemma":0.00060515833,"threshold_uncertainty_score":0.4108477},"labels":[],"label_agreement":null},{"id":"W4408853818","doi":"10.1038/s44276-025-00133-6","title":"A phase Ia study of the MEK1/2 inhibitor PD-0325901 with the c-MET inhibitor crizotinib in patients with advanced solid cancers","year":2025,"lang":"en","type":"article","venue":"BJC Reports","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"FP7 Health; RECETOX Přírodovědecké Fakulty Masarykovy Univerzity; Takeda Oncology; Chugai Pharmaceutical; Bristol-Myers Squibb; Samsung; University of Oxford; Genentech; Cancer Research UK; Aptitude Health; Daiichi Sankyo Europe; Gilead Sciences; Servier; Queen's University; Merck KGaA; Ministerstvo Školství, Mládeže a Tělovýchovy; National Institute for Health and Care Research; Queen's University Belfast; Seagen; European Commission; Sanofi; GlaxoSmithKline; Amgen; Pfizer; Eli Lilly and Company; Associazione Italiana per la Ricerca sul Cancro; Les Laboratories Pierre Fabre; AstraZeneca","keywords":"Crizotinib; Tolerability; Medicine; Adverse effect; Internal medicine; Pharmacokinetics; Toxicity; Clinical trial; Oncology; Pharmacology; Colorectal cancer; ALK inhibitor; MEK inhibitor; Cancer; Lung cancer; Kinase; MAPK/ERK pathway; Chemistry","score_opus":0.004268398584754407,"score_gpt":0.2552967227798368,"score_spread":0.25102832419508236,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408853818","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99727416,0.00009625275,0.000019571175,0.00006327293,0.0003317562,0.0011704316,0.000013218358,0.000007958626,0.0010233743],"genre_scores_gemma":[0.9991345,0.0000035790704,0.000044508848,0.00012593897,0.000065663946,0.0001383752,0.000026085603,0.000018284201,0.00044308096],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986348,0.00008014626,0.00037379414,0.0004161458,0.00026908302,0.00022598692],"domain_scores_gemma":[0.9987105,0.000011513587,0.0003242142,0.000760694,0.0001508225,0.000042262192],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018529745,0.00019053304,0.0002327863,0.00004389632,0.0000948325,0.00001497592,0.00016245783,0.00007203032,0.0000050713224],"category_scores_gemma":[0.000066941335,0.00009886539,0.00005069181,0.0002601979,0.00009275235,0.0000062574168,0.0001307977,0.00012118393,2.6597368e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0041206116,0.005046597,0.7506798,0.00012691409,0.0004748094,0.00021266885,0.0017018719,0.0007019038,0.22054216,0.000028672594,0.0076329904,0.008731028],"study_design_scores_gemma":[0.02021434,0.014818662,0.2505359,0.00041612174,0.00025787583,0.000044360153,0.0032842972,0.000010815629,0.6840114,0.00003611436,0.025658038,0.0007120984],"about_ca_topic_score_codex":0.0001119446,"about_ca_topic_score_gemma":0.000895103,"teacher_disagreement_score":0.5001439,"about_ca_system_score_codex":0.000033274373,"about_ca_system_score_gemma":0.0003266071,"threshold_uncertainty_score":0.40316138},"labels":[],"label_agreement":null},{"id":"W4409039258","doi":"10.1016/j.jcjo.2025.03.003","title":"Disproportionality analysis of BRAF and MEK inhibitors demonstrate risk of retinal detachment: an analysis of the FDA Adverse Event Reporting System","year":2025,"lang":"en","type":"letter","venue":"Canadian Journal of Ophthalmology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"University of British Columbia Hospital; University of British Columbia","funders":"","keywords":"Adverse effect; Medicine; Event (particle physics); Adverse Event Reporting System; Oncology; Pharmacology","score_opus":0.013670933649898555,"score_gpt":0.26224896115549584,"score_spread":0.2485780275055973,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409039258","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965779,0.00056021556,0.00007682356,0.0009648747,0.00032432607,0.00013311689,0.00079765584,7.0516205e-7,0.00056438736],"genre_scores_gemma":[0.9989453,0.000011336415,0.00013130333,0.00025128716,0.0001814798,0.0000029537387,0.0003201765,0.000011983576,0.00014416392],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9960069,0.00065714185,0.0024154645,0.00035804982,0.00027772263,0.00028470444],"domain_scores_gemma":[0.9910809,0.00006007776,0.007446197,0.0006050015,0.0006001973,0.00020761677],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015314437,0.00024628986,0.0012779098,0.0009302659,0.00009094781,0.0000073128767,0.00039382433,0.0005673491,0.0000752872],"category_scores_gemma":[0.0005555932,0.00019391692,0.001109975,0.0008083401,0.00038050866,0.0000068658383,0.00006043665,0.00050058577,5.1856826e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000060450977,0.00002992663,0.9768751,0.00034234137,0.014181091,0.003122056,0.000078334335,0.0013645065,0.0026429521,0.00003667694,0.0011617984,0.00010475574],"study_design_scores_gemma":[0.0005245011,0.00087881344,0.922737,0.00037729423,0.048015106,0.010031099,0.0006710751,0.00045523938,0.01458266,0.00007121629,0.0011878596,0.00046815013],"about_ca_topic_score_codex":0.006470372,"about_ca_topic_score_gemma":0.0015977654,"teacher_disagreement_score":0.054138124,"about_ca_system_score_codex":0.00007527592,"about_ca_system_score_gemma":0.0015902995,"threshold_uncertainty_score":0.97813106},"labels":[],"label_agreement":null},{"id":"W4409283259","doi":"10.1016/j.molcel.2025.03.015","title":"MLKL activity requires a splicing-regulated, druggable intramolecular interaction","year":2025,"lang":"en","type":"article","venue":"Molecular Cell","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"European Research Council; Medical Research Council; Natural Sciences and Engineering Research Council of Canada; Bundesministerium für Bildung und Forschung; Max-Planck-Gesellschaft; Deutsche Forschungsgemeinschaft; Canada Research Chairs; Wellcome Trust; Alexander von Humboldt-Stiftung","keywords":"Biology; Druggability; Intramolecular force; RNA splicing; Alternative splicing; Computational biology; Cell biology; Genetics; Gene; Gene isoform; Stereochemistry; RNA","score_opus":0.00469308000108386,"score_gpt":0.23257445785790754,"score_spread":0.22788137785682366,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409283259","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9138655,0.0006619886,0.031730488,0.00020519755,0.00041427874,0.00029516983,0.000006969577,0.000049085927,0.052771334],"genre_scores_gemma":[0.9939572,0.00004875821,0.0006509848,0.00068731536,0.00007868805,0.000041963594,0.000090907815,0.00003536474,0.0044087693],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99851435,0.00012092866,0.00022818113,0.0005942624,0.00015869009,0.00038356977],"domain_scores_gemma":[0.9990049,0.000010208208,0.00009788068,0.0007035458,0.00008542685,0.000098063254],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00016275934,0.00026763862,0.00021481191,0.00012103235,0.000113861766,0.00006159593,0.0002699993,0.0002528501,0.000040286766],"category_scores_gemma":[0.000051896746,0.00028164167,0.00018526091,0.00022175619,0.00006388436,0.000008569425,0.00021393293,0.00018394295,0.000047812206],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012319049,0.0001309206,0.00013174121,0.000061261286,0.000066166176,0.00004711787,0.000025194766,0.00023638515,0.991217,0.00040373675,0.0033268526,0.004230434],"study_design_scores_gemma":[0.00059046363,0.00016828644,0.00018046096,0.000033174136,0.000046987145,0.000010038046,0.000034790188,0.00035754536,0.9220979,0.00021942402,0.076006964,0.00025394023],"about_ca_topic_score_codex":0.00009603338,"about_ca_topic_score_gemma":0.000020167416,"teacher_disagreement_score":0.08009176,"about_ca_system_score_codex":0.000039451876,"about_ca_system_score_gemma":0.00011159319,"threshold_uncertainty_score":0.9999636},"labels":[],"label_agreement":null},{"id":"W4409403709","doi":"10.1093/mtomcs/mfag019","title":"The PBAF chromatin remodeling complex contributes to metal homeostasis through MTF1 regulation","year":2025,"lang":"en","type":"preprint","venue":"Metallomics","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institute of Arthritis and Musculoskeletal and Skin Diseases; Center for Research Computing, University of Pittsburgh; National Institutes of Health; University of Pittsburgh; Canadian Institute for Advanced Research","keywords":"Chromatin remodeling; Chromatin; Cell biology; Homeostasis; Biology; Genetics; DNA","score_opus":0.03456263041632805,"score_gpt":0.2897207606766446,"score_spread":0.25515813026031653,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409403709","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.77524257,0.013101518,0.17785025,0.0034128998,0.0035631359,0.0027282846,0.0012014018,0.00013878959,0.022761138],"genre_scores_gemma":[0.966501,0.001585239,0.022490175,0.0012150496,0.00055868865,0.00019871345,0.0027911288,0.0000579247,0.0046021105],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99799585,0.0001719562,0.0005622065,0.0006846331,0.00020703202,0.00037832494],"domain_scores_gemma":[0.99829596,0.0000620936,0.00024177732,0.0011117137,0.00021916075,0.000069307134],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005754784,0.00038008983,0.00048506958,0.000063738386,0.00030816218,0.00014939546,0.00065372733,0.00043493087,0.000014640566],"category_scores_gemma":[0.00033896993,0.00030914138,0.00034173275,0.0001258811,0.0000827452,0.0000033478777,0.0012925889,0.00026662243,0.000014656158],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024433873,0.000070426206,0.000043243046,0.00019292497,0.0010692654,0.000002422982,0.00016284463,0.008580376,0.95180976,0.010987749,0.010715171,0.016121464],"study_design_scores_gemma":[0.000660657,0.00013112377,0.0007484662,0.00011892633,0.0003902165,0.000007043192,0.00012413834,0.0050899726,0.30203137,0.01088024,0.67916673,0.0006511101],"about_ca_topic_score_codex":0.00006836702,"about_ca_topic_score_gemma":0.00016019611,"teacher_disagreement_score":0.66845155,"about_ca_system_score_codex":0.000062455714,"about_ca_system_score_gemma":0.00023563713,"threshold_uncertainty_score":0.99993604},"labels":[],"label_agreement":null},{"id":"W4410347733","doi":"10.21203/rs.3.rs-6635662/v1","title":"Adenosine kinase role in melanoma progression and resistance","year":2025,"lang":"en","type":"preprint","venue":"Research Square","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"Conselho Nacional de Desenvolvimento Científico e Tecnológico; Coordenação de Aperfeiçoamento de Pessoal de Nível Superior; Fundação de Amparo à Pesquisa do Estado de São Paulo","keywords":"Cancer research; Biology; Melanoma; Epigenetics; Neuroblastoma RAS viral oncogene homolog; Cell growth; Tumor microenvironment; Tumor progression; Cancer; Gene; Mutation; Genetics","score_opus":0.02505236830304632,"score_gpt":0.3624558500968223,"score_spread":0.337403481793776,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410347733","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93133736,0.03997654,0.000047625155,0.0006629207,0.00015480968,0.001264632,0.00024164902,0.000022769287,0.02629167],"genre_scores_gemma":[0.9892996,0.0021861068,0.0009013709,0.000027412858,0.000257534,0.00036434204,0.00052072573,0.000023119639,0.006419797],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99772394,0.00038098678,0.00024120425,0.00078646396,0.00038999788,0.0004774123],"domain_scores_gemma":[0.99883777,0.000042213756,0.000058187135,0.0007102919,0.00021587973,0.00013564012],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00081082573,0.00021382244,0.0002465195,0.00025554257,0.00010837376,0.000070803646,0.0003485748,0.0005239265,0.000020906715],"category_scores_gemma":[0.00033813438,0.0002009449,0.00006506779,0.00018692607,0.00013413299,0.0000024467117,0.0016847647,0.00072435645,0.000005962204],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004093388,0.0015438226,0.14830644,0.01546237,0.00026885982,0.0009992853,0.0014430928,0.00006573,0.67104775,0.011152283,0.06813491,0.07748209],"study_design_scores_gemma":[0.0033458637,0.0016577992,0.10458819,0.00912486,0.000035677716,0.000016894446,0.00090286613,0.00025623487,0.39005294,0.014043301,0.47441986,0.0015554889],"about_ca_topic_score_codex":0.000091388436,"about_ca_topic_score_gemma":0.000615554,"teacher_disagreement_score":0.40628496,"about_ca_system_score_codex":0.000050591254,"about_ca_system_score_gemma":0.0004332664,"threshold_uncertainty_score":0.8194295},"labels":[],"label_agreement":null},{"id":"W4410804792","doi":"10.1200/jco.2025.43.16_suppl.10037","title":"Post hoc analysis of rashes reported in patients (pts) with <i>BRAF</i> -altered relapsed/refractory (r/r) pediatric low-grade glioma (pLGG) treated with the type II RAF inhibitor tovorafenib in FIREFLY-1.","year":2025,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Medicine; Post-hoc analysis; Refractory (planetary science); Post hoc; Glioma; Internal medicine; Oncology; Cancer research","score_opus":0.023774918182884755,"score_gpt":0.3318645945096321,"score_spread":0.3080896763267474,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410804792","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980214,0.00045025238,0.000013223601,0.0005473554,0.0003370489,0.00023051607,0.0000131076295,0.0000037153825,0.00038338252],"genre_scores_gemma":[0.99858266,0.00031231222,0.00019584347,0.00042464782,0.00025742454,0.000005624699,0.000053758107,0.000015057378,0.00015266474],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9964968,0.00058472925,0.002040915,0.00034210694,0.00027652134,0.0002589125],"domain_scores_gemma":[0.99647206,0.0004348923,0.0019853287,0.00040139805,0.0005829175,0.00012341922],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014502616,0.00021184242,0.0011948306,0.00047164314,0.000046838013,0.000008636448,0.00031328664,0.000483358,0.000016204038],"category_scores_gemma":[0.0010734878,0.00012309117,0.00030182605,0.001333393,0.00017546244,0.000015218727,0.000107559004,0.0005742992,7.8602096e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.020171115,0.0036917008,0.9548792,0.00003367244,0.0013587055,0.00031589327,0.00009679523,0.00021647247,0.013122611,0.0000077698205,0.0017370303,0.004369024],"study_design_scores_gemma":[0.014342241,0.033485312,0.94042057,0.00006887497,0.0014335845,0.00002296673,0.000107919135,0.00003130395,0.00400085,0.000009884077,0.0058637634,0.00021270683],"about_ca_topic_score_codex":0.000053965596,"about_ca_topic_score_gemma":0.0008912179,"teacher_disagreement_score":0.02979361,"about_ca_system_score_codex":0.00006283154,"about_ca_system_score_gemma":0.0011116046,"threshold_uncertainty_score":0.5019512},"labels":[],"label_agreement":null},{"id":"W4410822612","doi":"10.1200/jco.2025.43.16_suppl.3117","title":"Exploring the efficacy and mechanism of action of combined pan-Raf and MEK inhibition in halting the growth of non-V600 BRAF mutated tumors.","year":2025,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; McGill University; University of Toronto; Jewish General Hospital","funders":"Conquer Cancer Foundation","keywords":"Medicine; Mechanism of action; Cancer research; Mechanism (biology); Trametinib; Pharmacology; MAPK/ERK pathway; Phosphorylation; In vitro; Cell biology; Biology; Genetics","score_opus":0.11044413258769474,"score_gpt":0.38591487342573005,"score_spread":0.2754707408380353,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410822612","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99809533,0.00012297853,0.00044269493,0.00072868774,0.00026995092,0.00012638718,0.0000019043067,8.2756605e-7,0.00021121689],"genre_scores_gemma":[0.99888474,0.0006786753,0.00021665038,0.00011592299,0.00008425633,0.0000029695,0.0000018633827,0.00000442469,0.000010525163],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982189,0.00033316936,0.0011623745,0.00010677609,0.00009021648,0.00008859186],"domain_scores_gemma":[0.9978961,0.00077715504,0.0010137302,0.000101772246,0.00017746606,0.0000338155],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002043959,0.000071848415,0.00048203784,0.00006421844,0.000028432181,0.000002975361,0.00008384678,0.0001327677,0.0000012175718],"category_scores_gemma":[0.0015116445,0.000043345703,0.000093564995,0.00009767441,0.00018324291,0.0000093188155,0.00008830771,0.00026111837,5.634482e-8],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001986533,0.00042942772,0.0072972486,0.000108062864,0.00013830549,0.000016625263,0.0002703073,0.00001668988,0.9644217,0.0015759337,0.000056223747,0.023682958],"study_design_scores_gemma":[0.0057070027,0.005660974,0.22700948,0.00022695355,0.00011085922,0.00005432326,0.0006531214,0.00017635747,0.75808525,0.0021207903,0.0001277928,0.00006711868],"about_ca_topic_score_codex":0.000039478375,"about_ca_topic_score_gemma":0.000045995035,"teacher_disagreement_score":0.21971221,"about_ca_system_score_codex":0.000007609709,"about_ca_system_score_gemma":0.00021093896,"threshold_uncertainty_score":0.18096888},"labels":[],"label_agreement":null},{"id":"W4410850949","doi":"10.1126/science.adp2742","title":"BRAF oncogenic mutants evade autoinhibition through a common mechanism","year":2025,"lang":"en","type":"article","venue":"Science","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; University of Calgary; Institute for Research in Immunology and Cancer","funders":"National Cancer Institute","keywords":"Mutant; Kinase; Protein kinase domain; Mutation; Cell biology; Helix (gastropod); MAPK/ERK pathway; V600E; HEK 293 cells; Extracellular; Biology; Protein kinase A; Signal transduction; Point mutation; Chemistry; Biochemistry; Receptor; Gene","score_opus":0.009250420946475735,"score_gpt":0.2858589757979586,"score_spread":0.2766085548514829,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410850949","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97605646,0.0002466109,0.006042276,0.00022408346,0.00048436673,0.00013600368,0.0000106517755,0.00002376761,0.016775776],"genre_scores_gemma":[0.99706894,0.000032535023,0.0009158292,0.00080658996,0.00005238091,0.000010866446,0.000012310554,0.000004271381,0.0010962955],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99911094,0.000022612716,0.0001160259,0.00034869695,0.00016153128,0.0002402239],"domain_scores_gemma":[0.99954337,0.0000051582088,0.00003680954,0.00031845586,0.000051754632,0.000044430773],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002568835,0.00008429644,0.00007831514,0.000042835727,0.00020618015,0.00003505257,0.00029253567,0.00006860684,0.000016947735],"category_scores_gemma":[0.00006658829,0.000077850986,0.000041592255,0.00029865772,0.00018925212,0.000009201002,0.00017251675,0.000053619846,0.000030319557],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000008062896,0.000021540412,0.00009765876,0.000005748085,0.000003180391,0.00000298137,0.000035921235,0.0000025270047,0.9877881,0.009557307,0.0003279477,0.002149024],"study_design_scores_gemma":[0.00021201909,0.00011827594,0.0010182963,0.000018592453,0.000005959001,0.000014112996,0.0000406075,0.00011633721,0.97658044,0.010638726,0.011142153,0.0000944956],"about_ca_topic_score_codex":0.00001451116,"about_ca_topic_score_gemma":0.000024262574,"teacher_disagreement_score":0.021012457,"about_ca_system_score_codex":0.000023056133,"about_ca_system_score_gemma":0.0002820146,"threshold_uncertainty_score":0.3174671},"labels":[],"label_agreement":null},{"id":"W4410923604","doi":"10.14738/bjhr.1202.18696","title":"Case Report: Malignant Melanoma Treated with Ipilimumab and Nivolumab in Patient with Multiple Sclerosis","year":2025,"lang":"en","type":"article","venue":"British journal of healthcare and medical research","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Saskatchewan Cancer Agency","funders":"","keywords":"Nivolumab; Ipilimumab; Melanoma; Medicine; Multiple sclerosis; Dermatology; Oncology; Metastatic melanoma; Internal medicine; Immunotherapy; Cancer research; Cancer; Immunology","score_opus":0.035081720030283293,"score_gpt":0.313850099638557,"score_spread":0.27876837960827366,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410923604","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9877236,0.01061161,0.000056208784,0.0011824681,0.00002901259,0.00021350531,0.000012354258,0.0000021861288,0.00016905028],"genre_scores_gemma":[0.9944961,0.0049701342,0.00018602176,0.0001488839,0.00004728745,0.000014720654,0.000011827703,0.000010305123,0.00011471645],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9981367,0.00029224672,0.000395715,0.0002725879,0.0005239929,0.00037875547],"domain_scores_gemma":[0.99881524,0.000092931,0.000089435605,0.00013412516,0.0004208905,0.00044740658],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013032273,0.00009313467,0.0002458243,0.00014432134,0.00015867084,0.000042261614,0.000083569445,0.00016546235,0.0000084090825],"category_scores_gemma":[0.00068468734,0.00007283356,0.000024219264,0.00019659186,0.00023317378,0.000007535504,0.000091606395,0.0004645641,1.4927515e-7],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017099277,0.0002416968,0.058962215,0.00028994228,0.000080594895,0.47273943,0.00013997844,6.0251745e-7,0.0028062603,0.000031973028,0.0012303042,0.46176708],"study_design_scores_gemma":[0.007584652,0.009458533,0.049985524,0.004622996,0.000025129273,0.9077537,0.0021796238,0.000052158837,0.008972355,0.000054753316,0.009060558,0.0002499864],"about_ca_topic_score_codex":0.0049331305,"about_ca_topic_score_gemma":0.014641848,"teacher_disagreement_score":0.4615171,"about_ca_system_score_codex":0.000034404336,"about_ca_system_score_gemma":0.0009048422,"threshold_uncertainty_score":0.8170495},"labels":[],"label_agreement":null},{"id":"W4411027220","doi":"10.1200/jco.2025.43.17_suppl.lba9500","title":"Nivolumab plus relatlimab vs nivolumab alone for the adjuvant treatment of completely resected stage III–IV melanoma: Primary results from RELATIVITY-098.","year":2025,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Nivolumab; Adjuvant; Stage (stratigraphy); Oncology; Internal medicine; Immunotherapy; Cancer","score_opus":0.09703807293845568,"score_gpt":0.39292538388310383,"score_spread":0.29588731094464815,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411027220","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9770696,0.0051240753,0.004946839,0.0038006091,0.0020608217,0.0007663893,0.0004953061,0.000010781025,0.005725555],"genre_scores_gemma":[0.98624706,0.0020304814,0.0044269143,0.000555067,0.0010013615,0.00002392571,0.00020882202,0.00002737091,0.005479017],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99522346,0.00076822797,0.0029199203,0.0004595592,0.00027864228,0.0003502143],"domain_scores_gemma":[0.9920317,0.004216688,0.002377432,0.00069696706,0.0005023734,0.0001748389],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022050822,0.00026774092,0.0017636935,0.00009763498,0.00015249813,0.000014595766,0.00051434606,0.0007485835,0.000023049352],"category_scores_gemma":[0.002927549,0.00017782442,0.00084225665,0.00014224477,0.0003725727,0.000012934524,0.0001757643,0.0004940651,0.0000037463985],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.32040933,0.010178112,0.0137411,0.00019147746,0.009446218,0.0007112582,0.001044057,0.00072567083,0.17213634,0.0019815925,0.12656619,0.34286866],"study_design_scores_gemma":[0.07369911,0.051177382,0.098477736,0.00013612029,0.0010747666,0.00006116694,0.0002814532,0.0008595002,0.012551186,0.0008999397,0.7604248,0.00035686867],"about_ca_topic_score_codex":0.00033386296,"about_ca_topic_score_gemma":0.00063441816,"teacher_disagreement_score":0.63385856,"about_ca_system_score_codex":0.00021814017,"about_ca_system_score_gemma":0.0023262273,"threshold_uncertainty_score":0.72514695},"labels":[],"label_agreement":null},{"id":"W4411253612","doi":"10.1016/j.xcrm.2025.102183","title":"BRAF/MEK inhibition induces cell state transitions boosting immune checkpoint sensitivity in BRAFV600E-mutant glioma","year":2025,"lang":"en","type":"article","venue":"Cell Reports Medicine","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"Stanford Cancer Institute; Baton Rouge Area Foundation; National Institutes of Health; National Cancer Institute; National Institute of Neurological Disorders and Stroke; University of California, San Francisco","keywords":"Boosting (machine learning); Mutant; Glioma; Cancer research; Immune checkpoint; Sensitivity (control systems); Immune system; Melanoma; Chemistry; Biology; Immunotherapy; Immunology; Computer science; Genetics; Gene; Artificial intelligence","score_opus":0.008069683595600147,"score_gpt":0.23174627332294867,"score_spread":0.22367658972734852,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411253612","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9805079,0.0010893377,0.002165711,0.00060733274,0.0005055439,0.00035154467,0.000010940005,0.000032148408,0.014729538],"genre_scores_gemma":[0.9980178,0.00009542037,0.00011975918,0.00025867607,0.00016505051,0.000022642678,0.0003515222,0.000021373318,0.0009477495],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99805295,0.00010200899,0.0007712538,0.0005375244,0.00019140108,0.0003448435],"domain_scores_gemma":[0.99903435,0.00003110012,0.0002709982,0.00044593334,0.00011076271,0.00010684158],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00090399594,0.0002386022,0.00034409147,0.00019665972,0.00010760854,0.000013723589,0.00004998209,0.0001692985,0.00003117964],"category_scores_gemma":[0.00016868339,0.00021706741,0.00009288292,0.00031413534,0.00013420558,0.000008912357,0.00007115365,0.00022410155,0.0000034991713],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000045665427,0.00014158389,0.0007155611,0.00012840955,0.000013350229,0.0022519052,0.00036214222,0.00005493825,0.9947951,0.0000075669736,0.00029469683,0.0011891105],"study_design_scores_gemma":[0.0009855545,0.00020070895,0.004388381,0.0002518025,0.000037189846,0.00038533725,0.0004123554,0.000055034678,0.99044216,0.0002379094,0.002395761,0.00020778476],"about_ca_topic_score_codex":0.00026664615,"about_ca_topic_score_gemma":0.00017136014,"teacher_disagreement_score":0.017509902,"about_ca_system_score_codex":0.000038671355,"about_ca_system_score_gemma":0.00019492158,"threshold_uncertainty_score":0.8851752},"labels":[],"label_agreement":null},{"id":"W4412073469","doi":"10.1038/s41698-025-01025-1","title":"Exceptional response to the ATR inhibitor, camonsertib, in a patient with ALT+ metastatic melanoma","year":2025,"lang":"en","type":"article","venue":"npj Precision Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Telesta Therapeutics (Canada)","funders":"National Cancer Institute; University of Texas MD Anderson Cancer Center; National Institutes of Health; U.S. Department of Defense","keywords":"Metastatic melanoma; Melanoma; Medicine; Dermatology; Internal medicine; Oncology; Cancer research","score_opus":0.01024201955165141,"score_gpt":0.28245354135337647,"score_spread":0.27221152180172503,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412073469","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99036944,0.00028799445,0.0023712704,0.0034214023,0.00035977588,0.0005870196,0.000021977821,0.000009847064,0.0025712638],"genre_scores_gemma":[0.9931349,0.000020752765,0.0024726002,0.00218473,0.00007310774,0.00024198991,0.000034151817,0.000013313581,0.0018244107],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981903,0.00061049295,0.00032809295,0.00042360649,0.00017622001,0.00027132014],"domain_scores_gemma":[0.9990527,0.00024545143,0.00007496861,0.00044058793,0.00009994506,0.00008632949],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006757319,0.00016301507,0.00021737021,0.0001524346,0.000094195726,0.000016378477,0.00024766588,0.00014417266,0.000065864806],"category_scores_gemma":[0.00041157723,0.000107155036,0.000060108076,0.0002674753,0.0000654943,0.0000038055314,0.00023013049,0.0001467458,0.000057965786],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.026593149,0.00079657894,0.0058000446,0.000023300468,0.00014127154,0.000322707,0.0011543053,0.0011544325,0.7210507,0.00048002411,0.092766985,0.14971653],"study_design_scores_gemma":[0.0021707541,0.0060684183,0.025558617,0.000076193006,0.000029755955,0.00015425106,0.00044634438,0.00009126612,0.05914408,0.00029084354,0.90571886,0.00025059763],"about_ca_topic_score_codex":0.000043131407,"about_ca_topic_score_gemma":0.0012390702,"teacher_disagreement_score":0.8129519,"about_ca_system_score_codex":0.000087803855,"about_ca_system_score_gemma":0.0004934642,"threshold_uncertainty_score":0.43696555},"labels":[],"label_agreement":null},{"id":"W4412516480","doi":"10.3390/ijms26146957","title":"Hydroxytyrosol Reprograms the Tumor Microenvironment in 3D Melanoma Models by Suppressing ERBB Family and Kinase Pathways","year":2025,"lang":"en","type":"article","venue":"International Journal of Molecular Sciences","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institut National de la Recherche Scientifique","funders":"Malta Council for Science and Technology","keywords":"Hydroxytyrosol; ErbB; Melanoma; Cancer research; MAPK/ERK pathway; Cell cycle; Protein kinase B; PI3K/AKT/mTOR pathway; Oncogene; Biology; Signal transduction; Apoptosis; Cell; Kinase; Chemistry; Cell biology; Biochemistry","score_opus":0.01090314123258337,"score_gpt":0.2428423201403975,"score_spread":0.23193917890781413,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412516480","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9848976,0.0066516474,0.0062869163,0.00066855404,0.00027420514,0.00008157487,0.000009107832,0.0000017852597,0.0011285868],"genre_scores_gemma":[0.9971929,0.0002887086,0.001547272,0.0008772749,0.000043094493,0.000003777639,0.0000048251827,0.000004599943,0.000037550733],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99892706,0.00007789389,0.00029496974,0.00022556615,0.00032310234,0.00015143192],"domain_scores_gemma":[0.9995917,0.000017747072,0.00016231416,0.00012619421,0.000058982823,0.000043043012],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00051470724,0.00010286849,0.00010745044,0.00008556554,0.000071851406,0.00011202558,0.00055502134,0.000042143165,0.0000028060774],"category_scores_gemma":[0.00004564208,0.000072757175,0.00006647754,0.00007639172,0.00024743026,0.000018460918,0.00017873237,0.000102777136,4.5770403e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000039693532,0.00006544461,0.0013905568,0.0000029999867,0.000037090795,0.000092149916,0.00008123544,0.00078706874,0.9872494,0.00037292694,0.0002954884,0.009585991],"study_design_scores_gemma":[0.0011667189,0.00048881356,0.002414848,0.00015562333,0.000024968811,0.00029368326,0.00060119387,0.0036014554,0.97841567,0.0032112019,0.00940887,0.00021697949],"about_ca_topic_score_codex":0.000020717547,"about_ca_topic_score_gemma":0.00000519599,"teacher_disagreement_score":0.012295274,"about_ca_system_score_codex":0.000020925938,"about_ca_system_score_gemma":0.0000987916,"threshold_uncertainty_score":0.29669517},"labels":[],"label_agreement":null},{"id":"W4412975036","doi":"10.3390/ph18081161","title":"Design, Synthesis, and Bioactivity Assessment of Modified Vemurafenib Analog","year":2025,"lang":"en","type":"article","venue":"Pharmaceuticals","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine","funders":"Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro; Conselho Nacional de Desenvolvimento Científico e Tecnológico","keywords":"Vemurafenib; Medicine; Melanoma; Cancer research; Metastasis; Matrix metalloproteinase; Drug resistance; Malignancy; V600E; Pharmacology; Oncology; Internal medicine; Metastatic melanoma; Cancer; Mutation; Chemistry; Biology; Biochemistry","score_opus":0.04929140372200529,"score_gpt":0.37330805511450804,"score_spread":0.32401665139250274,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412975036","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.84796846,0.0013891837,0.13859029,0.00040489677,0.00016241541,0.00036971687,0.000032007094,0.000017496986,0.01106554],"genre_scores_gemma":[0.9970949,0.00040453573,0.002072491,0.00021961052,0.00003010408,0.000036226455,0.00000732721,0.000006697529,0.00012808027],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992031,0.00014607853,0.00016730334,0.00024201696,0.00007785714,0.00016363042],"domain_scores_gemma":[0.9995345,0.00010512253,0.000046584035,0.00020005347,0.000042808762,0.00007091626],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034736216,0.00010934507,0.0001759076,0.00004895628,0.000043178596,0.0000105142,0.00010271719,0.00008562705,0.000019789572],"category_scores_gemma":[0.00009343954,0.00009866085,0.000044771623,0.00007658114,0.00009806965,0.000002668844,0.000098991826,0.00006833489,0.0000010207108],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006766499,0.00009910617,0.0026082573,0.00006068648,0.00010010588,0.0000018956883,0.0000058644737,0.000030433333,0.9855671,0.0015446028,0.00033449425,0.009579805],"study_design_scores_gemma":[0.00037993284,0.000061207655,0.0052809236,0.000016225486,0.00007331837,0.000002687609,0.000008447548,0.0019412434,0.9866917,0.00031487856,0.0051268702,0.00010253543],"about_ca_topic_score_codex":0.000005326314,"about_ca_topic_score_gemma":9.3632286e-7,"teacher_disagreement_score":0.14912648,"about_ca_system_score_codex":0.000007918433,"about_ca_system_score_gemma":0.00007420255,"threshold_uncertainty_score":0.40232727},"labels":[],"label_agreement":null},{"id":"W4413057852","doi":"10.21203/rs.3.rs-6857127/v1","title":"mTOR inhibition enhances the antitumor efficacy of RAF dimer-MEK blockade by inhibiting the ATF4-MTHFD2 pathway","year":2025,"lang":"en","type":"preprint","venue":"Research Square","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; McGill University","funders":"","keywords":"Cancer research; MEK inhibitor; Vemurafenib; Mutant; Melanoma; Neuroblastoma RAS viral oncogene homolog; Biology; Mutation; MAPK/ERK pathway; Gene; KRAS; Kinase; Genetics; Metastatic melanoma","score_opus":0.028942815259880534,"score_gpt":0.3385003813407827,"score_spread":0.3095575660809022,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413057852","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9858772,0.005807361,0.00028375039,0.0012719879,0.00031672162,0.0014442852,0.00073586055,0.000024575758,0.004238249],"genre_scores_gemma":[0.99439543,0.0010880859,0.00007292807,0.00006552679,0.0007037873,0.00027513655,0.0008788712,0.000030955864,0.0024892634],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99647886,0.000835587,0.00050391146,0.0007603424,0.00079636346,0.0006249257],"domain_scores_gemma":[0.99774885,0.00035495375,0.00024640374,0.0010453495,0.00050216756,0.0001022991],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017255652,0.00032175382,0.00034396222,0.000118011354,0.00047398816,0.00011463906,0.00078817643,0.00043060587,0.00004405803],"category_scores_gemma":[0.0009912661,0.00020200267,0.00030306264,0.0002969127,0.0005071225,0.0000046783684,0.0019068331,0.0011616234,0.000018761657],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012683502,0.00015987114,0.00017292037,0.00064746285,0.00009960256,0.0000100469915,0.00033394908,0.000036359925,0.9819855,0.0003598427,0.0131841395,0.0028834739],"study_design_scores_gemma":[0.00043935626,0.00027047578,0.00044452873,0.0006971564,0.000022062019,0.000005782237,0.0005278151,0.000046752375,0.964295,0.0002629052,0.032764975,0.00022315903],"about_ca_topic_score_codex":0.00022401674,"about_ca_topic_score_gemma":0.00007010686,"teacher_disagreement_score":0.019580834,"about_ca_system_score_codex":0.00004096053,"about_ca_system_score_gemma":0.00069068756,"threshold_uncertainty_score":0.823743},"labels":[],"label_agreement":null},{"id":"W4413094252","doi":"10.1080/07391102.2025.2543358","title":"Mutation-specific structural changes in BRAF: understanding dimerization and drug binding for targeted therapy","year":2025,"lang":"en","type":"article","venue":"Journal of Biomolecular Structure and Dynamics","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pancreas Centre (Canada)","funders":"","keywords":"Allosteric regulation; Sorafenib; Mutation; Mutant; MAPK/ERK pathway; Cancer research; Kinase; Carcinogenesis; HEK 293 cells; V600E; Plasma protein binding; Protein structure; Biology; Chemistry; Cell biology; Biochemistry; Enzyme; Gene","score_opus":0.008845506066400517,"score_gpt":0.24243876862815797,"score_spread":0.23359326256175744,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413094252","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9292466,0.0027845046,0.06724493,0.00026291102,0.0002540747,0.00015076868,0.000037036687,0.000002247308,0.000016939057],"genre_scores_gemma":[0.9970678,0.00072994037,0.0018714173,0.000112535214,0.00006730508,0.0000014343957,0.000116927724,0.00001076803,0.000021850927],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99941206,0.00003576411,0.00020102634,0.00015307026,0.0000723457,0.0001257255],"domain_scores_gemma":[0.9996641,0.000017389999,0.0001465561,0.00007366664,0.000058620615,0.000039619128],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010508037,0.00011984843,0.00015692996,0.0001915744,0.00008207581,0.000047515037,0.00006582825,0.000106167485,0.0000016646297],"category_scores_gemma":[0.000022261203,0.000101346326,0.000040142968,0.00013260673,0.000048657836,0.000008779888,0.000024461053,0.000073382194,1.2710796e-8],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001957537,0.000006328296,0.0042094006,0.000038840233,0.000071808594,0.000012240052,0.00018712798,0.000045664874,0.9827834,0.0040904726,0.000052710184,0.008306291],"study_design_scores_gemma":[0.008922885,0.0014037193,0.022194397,0.0002311037,0.00010541175,0.000508936,0.0028698281,0.008756331,0.9226722,0.02869351,0.0028373126,0.0008043692],"about_ca_topic_score_codex":0.0000032606454,"about_ca_topic_score_gemma":0.00008813866,"teacher_disagreement_score":0.067821234,"about_ca_system_score_codex":0.000032702836,"about_ca_system_score_gemma":0.000040193743,"threshold_uncertainty_score":0.4132783},"labels":[],"label_agreement":null},{"id":"W4413306536","doi":"10.4204/eptcs.426.12","title":"Dagger-Drazin Inverses","year":2025,"lang":"en","type":"article","venue":"Electronic Proceedings in Theoretical Computer Science","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Natural Sciences and Engineering Research Council of Canada; Eesti Teadusagentuur","keywords":"Dagger; Mathematics; Computer science; Algebra over a field; Pure mathematics; Philosophy; Theology","score_opus":0.0031368408452571005,"score_gpt":0.23388263556294983,"score_spread":0.23074579471769274,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413306536","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9286265,0.0002447241,0.030720355,0.0004824753,0.00039176978,0.00019459968,7.199976e-7,0.000035169764,0.0393037],"genre_scores_gemma":[0.9972365,0.000034328226,0.001713701,0.0007438733,0.0001483113,0.00001530131,0.0000017556558,0.0000060948328,0.0001001406],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984561,0.000010859105,0.00016960007,0.0005525701,0.00018310692,0.000627772],"domain_scores_gemma":[0.99960935,0.000013524136,0.00003111849,0.0001709507,0.000100162884,0.00007491159],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007085245,0.0001327158,0.00012208086,0.00015650199,0.00013165032,0.00008224288,0.0007007773,0.00008411179,0.000012275425],"category_scores_gemma":[0.00015720398,0.000119391174,0.000039257684,0.00067090744,0.001011735,0.000012892081,0.00041540133,0.00018507084,0.000008675403],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002663402,0.000034375385,0.0009746853,0.000010424251,0.0000040576406,9.318189e-7,0.00003591089,0.0000035403264,0.1171819,0.87729234,0.0005476704,0.0038875411],"study_design_scores_gemma":[0.00082693074,0.00089114887,0.0019705615,0.00008149936,0.000010505696,0.000034936922,0.00004419048,0.009743443,0.79908407,0.16570383,0.02118361,0.0004252709],"about_ca_topic_score_codex":0.0000016287428,"about_ca_topic_score_gemma":0.0000026359194,"teacher_disagreement_score":0.7115885,"about_ca_system_score_codex":0.000069585505,"about_ca_system_score_gemma":0.00035903417,"threshold_uncertainty_score":0.48686308},"labels":[],"label_agreement":null},{"id":"W4413450173","doi":"10.1101/2025.08.18.670743","title":"O-mannosylation and protein maturation check-points represent therapeutic opportunities in BRAF fusion protein oncogenesis","year":2025,"lang":"en","type":"preprint","venue":"bioRxiv (Cold Spring Harbor Laboratory)","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Carcinogenesis; Fusion protein; Fusion; Cancer research; Computational biology; Biology; Genetics; Cancer; Philosophy; Gene; Recombinant DNA","score_opus":0.024032494674530586,"score_gpt":0.2322331060019839,"score_spread":0.20820061132745332,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413450173","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99430096,0.0018655505,0.0010235133,0.0003950479,0.00027698072,0.0018775257,0.00012023322,0.000071359944,0.00006883355],"genre_scores_gemma":[0.9968886,0.00039835018,0.0014124321,0.00012859728,0.00026889227,0.00069622265,0.000008847812,0.000051385257,0.00014671244],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99770963,0.0002582557,0.00050511106,0.0009470151,0.00023855457,0.0003414181],"domain_scores_gemma":[0.9983935,0.000011055071,0.00031635258,0.0009070736,0.00025015263,0.00012188013],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005450052,0.00043629605,0.00036879242,0.0002454943,0.00011346767,0.000121452555,0.00026869794,0.00069247314,0.000011867744],"category_scores_gemma":[0.00012746557,0.00046248868,0.00009068213,0.0001746655,0.00007875593,0.000016689612,0.0005360509,0.0003268725,0.0000042026013],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013863042,0.000090466216,0.0016120833,0.00047070955,0.000058634192,0.000021041984,0.000011196526,0.000014668328,0.996981,0.000488755,0.00006380124,0.00004896348],"study_design_scores_gemma":[0.0005228278,0.00011726665,0.034901787,0.00058689865,0.00003986543,3.9766107e-8,0.000010948113,0.00026434028,0.95751023,0.000016936165,0.0054899035,0.0005389465],"about_ca_topic_score_codex":0.00008175745,"about_ca_topic_score_gemma":0.000021997337,"teacher_disagreement_score":0.03947081,"about_ca_system_score_codex":0.00008488773,"about_ca_system_score_gemma":0.00056190824,"threshold_uncertainty_score":0.9997827},"labels":[],"label_agreement":null},{"id":"W4413843120","doi":"10.1101/2025.08.26.672105","title":"Metabolic rewiring of cancer cells induces metastasis via ERK5 but triggers recognition by NK cells","year":2025,"lang":"en","type":"preprint","venue":"bioRxiv (Cold Spring Harbor Laboratory)","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Nautical Research Society","funders":"Direction Générale de l’offre de Soins; Région Occitanie Pyrénées-Méditerranée; Université de Montpellier; Institut National Du Cancer; Centre Hospitalier Régional Universitaire de Montpellier; Agence Nationale de la Recherche","keywords":"Cancer cell; Metastasis; Cancer; Cancer research; Cancer metastasis; Cell biology; Chemistry; Biology; Genetics","score_opus":0.014844090479305462,"score_gpt":0.22857418518903128,"score_spread":0.21373009470972582,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413843120","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9782746,0.0137139745,0.0012596293,0.00003847294,0.0018510367,0.00069718156,0.004043197,0.00007401778,0.000047934576],"genre_scores_gemma":[0.98888475,0.007381808,0.002553762,0.00019453088,0.00047215004,0.00033509414,0.000010376838,0.000096414165,0.000071088434],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.996966,0.0002291525,0.00074228086,0.0011878884,0.00032056213,0.0005540987],"domain_scores_gemma":[0.99738705,0.000031398806,0.0006993921,0.0011331964,0.00052111514,0.00022785095],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005133879,0.00064478745,0.0008304944,0.00025970713,0.00011167941,0.000072554234,0.00062423444,0.0008568186,0.00007643317],"category_scores_gemma":[0.000076636556,0.00069883413,0.0003412235,0.0003565327,0.00012396248,0.000013653642,0.00052808266,0.0004981606,0.000022300806],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000611324,0.00012752121,0.00016304755,0.0005803167,0.0006021109,0.00000689447,0.000004531783,0.00003488525,0.9965368,0.00000920708,0.0017901318,0.00008342799],"study_design_scores_gemma":[0.000508488,0.000067826404,0.00034758658,0.00027399842,0.0004996769,9.0555385e-9,0.0000041838475,0.000024083845,0.9803323,0.0000015854049,0.017257405,0.00068286835],"about_ca_topic_score_codex":0.0004654028,"about_ca_topic_score_gemma":0.0000116986375,"teacher_disagreement_score":0.016204504,"about_ca_system_score_codex":0.00006703599,"about_ca_system_score_gemma":0.0007072131,"threshold_uncertainty_score":0.9995463},"labels":[],"label_agreement":null},{"id":"W4414292789","doi":"10.1038/s44321-025-00297-1","title":"Impaired migration and lung invasion of human melanoma by a novel small molecule targeting the transmembrane domain of death receptor p75NTR","year":2025,"lang":"en","type":"article","venue":"EMBO Molecular Medicine","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital; University of Calgary","funders":"Peking University; Vetenskapsrådet; National Natural Science Foundation of China; Cancerfonden; Canadian Cancer Society","keywords":"Fascin; Melanoma; Small molecule; Filopodia; Transmembrane protein; Receptor; Extracellular; Intracellular; Low-affinity nerve growth factor receptor","score_opus":0.008880508441601851,"score_gpt":0.23456900386811294,"score_spread":0.2256884954265111,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414292789","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97353035,0.0062378505,0.017871475,0.0009875713,0.000080380676,0.0003848023,0.00002438379,0.0000087816725,0.0008743906],"genre_scores_gemma":[0.99811727,0.00016683555,0.00073924026,0.0003539265,0.000052405554,0.000023801324,0.0003722737,0.000019229108,0.00015499117],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998774,0.00009537371,0.00044160936,0.00032088143,0.00017379741,0.00019436542],"domain_scores_gemma":[0.9992886,0.00002848451,0.00017644449,0.00034021944,0.00010208711,0.000064152904],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045782333,0.00019432625,0.00031354386,0.00007390202,0.00008520485,0.0000053749422,0.00020248165,0.0001519299,0.000016093836],"category_scores_gemma":[0.00012865699,0.00014062713,0.00007924947,0.00015752012,0.0001763055,0.0000031415652,0.00006898537,0.00009998765,2.0057126e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008140892,0.00006859039,0.00083782955,0.0001732587,0.00010424283,0.000002621858,0.00030901632,0.0000038423013,0.9953468,0.0012478527,0.0015651158,0.0002594528],"study_design_scores_gemma":[0.0016427241,0.0006135932,0.0006523993,0.00017061841,0.000093918374,0.00000582691,0.0002556933,0.00008300411,0.99467987,0.00012165083,0.0015556851,0.00012502489],"about_ca_topic_score_codex":0.00022479668,"about_ca_topic_score_gemma":0.000048617072,"teacher_disagreement_score":0.024586933,"about_ca_system_score_codex":0.000010009571,"about_ca_system_score_gemma":0.000058428937,"threshold_uncertainty_score":0.57346076},"labels":[],"label_agreement":null},{"id":"W4414565348","doi":"10.51731/cjht.2025.1232","title":"Mirikizumab (Omvoh)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Drug; Public health; Disease; Pharmacotherapy","score_opus":0.010457072088659793,"score_gpt":0.2574572150895341,"score_spread":0.24700014300087433,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414565348","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7263254,0.21424712,0.0049952054,0.04363326,0.0019586158,0.00032523708,0.000037716916,0.000068422494,0.00840905],"genre_scores_gemma":[0.9978394,0.00041335123,0.0005463101,0.0007324093,0.000013608332,0.0000025935435,0.0000042896277,0.0000058104897,0.00044226286],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9992312,0.000030896677,0.00029878636,0.00010597315,0.00004740337,0.000285705],"domain_scores_gemma":[0.9994616,0.000006612962,0.00015246471,0.00023122985,0.000098394885,0.00004972567],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027968566,0.00008265047,0.00016887262,0.00028634488,0.0001369211,0.000016671045,0.00032919078,0.00015538721,0.0000068187996],"category_scores_gemma":[0.0003081524,0.00007309176,0.00006186049,0.000145386,0.00011280687,0.0000026739642,0.000026564772,0.00016018812,0.0000033672527],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004820863,0.000021204123,0.004960842,0.000121689285,0.000096455435,0.0000837066,0.000067461195,0.000011420316,0.008599854,0.0090608625,0.13404904,0.84287924],"study_design_scores_gemma":[0.0002609115,0.0003229702,0.004110535,0.00007230993,0.0000049402906,0.000090338996,0.00059246615,0.0000012121377,0.025048941,0.0024424312,0.9669723,0.000080635764],"about_ca_topic_score_codex":0.00059113605,"about_ca_topic_score_gemma":0.002330655,"teacher_disagreement_score":0.8427986,"about_ca_system_score_codex":0.000064926375,"about_ca_system_score_gemma":0.0026762043,"threshold_uncertainty_score":0.47474718},"labels":[],"label_agreement":null},{"id":"W4415067350","doi":"10.1038/s41416-025-03216-w","title":"Modeling response to the KRAS-G12C inhibitor AZD4625 in KRASG12C NSCLC patient-derived xenografts reveals insights into primary resistance mechanisms","year":2025,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; Princess Margaret Cancer Centre; Public Health Ontario; University of Toronto; University Health Network","funders":"Canadian Institutes of Health Research; Genome British Columbia; Genome Canada; Scheme for Promotion of Academic and Research Collaboration; AstraZeneca","keywords":"Acquired resistance; Drug resistance; Primary (astronomy); Cancer; Resistance (ecology)","score_opus":0.005566039474640553,"score_gpt":0.23504852688843866,"score_spread":0.22948248741379812,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415067350","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.963947,0.025874961,0.0077111293,0.0009714896,0.0008324362,0.00028826605,0.000016126283,0.0000054817906,0.0003531136],"genre_scores_gemma":[0.99332684,0.0019861818,0.0017119731,0.0021580453,0.00029637304,0.00004828283,0.0000060524867,0.000021907032,0.0004443535],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982807,0.00028648687,0.0006094791,0.00027818294,0.00027636957,0.0002687669],"domain_scores_gemma":[0.9991137,0.000031220097,0.0001823848,0.00024813396,0.00030926717,0.00011531735],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00056204986,0.00016355175,0.00029216902,0.00013416598,0.00014313223,0.0000726508,0.00034672243,0.00014758426,0.000008946974],"category_scores_gemma":[0.00026565342,0.0001503436,0.00013270882,0.0002577702,0.000035674682,0.00001656668,0.00014811865,0.00024972853,0.0000016302181],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019490777,0.000055235545,0.00005797699,0.000041505245,0.00005743142,0.00013289702,0.00036254464,0.0009500395,0.9692653,0.000048842023,0.004968382,0.022110762],"study_design_scores_gemma":[0.004362353,0.0010140283,0.006394949,0.0046228236,0.000105433726,0.00019752716,0.0008231978,0.00018228787,0.77320516,0.0041085505,0.2041586,0.0008250886],"about_ca_topic_score_codex":0.00013496478,"about_ca_topic_score_gemma":0.0024302779,"teacher_disagreement_score":0.19919021,"about_ca_system_score_codex":0.00011988327,"about_ca_system_score_gemma":0.00045984966,"threshold_uncertainty_score":0.6130834},"labels":[],"label_agreement":null},{"id":"W4415762739","doi":"10.1016/j.celrep.2025.116495","title":"CDK12 inhibition reveals melanoma dependence on the RUNX1/CBFβ complex for genomic stability","year":2025,"lang":"en","type":"article","venue":"Cell Reports","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Université de Montréal; Institute for Research in Immunology and Cancer","funders":"Fonds de Recherche du Québec - Santé; Canadian Institutes of Health Research; Cancer Research Society","keywords":"Melanoma; Effector; Transcription factor; Kinase; DNA damage; Proto-Oncogene Proteins c-myc; MAPK/ERK pathway; Transcription (linguistics)","score_opus":0.025471571092833125,"score_gpt":0.248679615308324,"score_spread":0.22320804421549087,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415762739","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.972402,0.00020026698,0.0017932226,0.00023356316,0.0002927156,0.0006634014,0.00002407167,0.000015258584,0.024375511],"genre_scores_gemma":[0.99636847,0.000019107789,0.0002708019,0.0006386009,0.0001159265,0.00011626152,0.00018726994,0.000012332255,0.0022712387],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99887335,0.000061264705,0.0003198751,0.0004358833,0.00009462672,0.00021498116],"domain_scores_gemma":[0.9989823,0.000051801642,0.00015910828,0.00067389425,0.00008455715,0.000048319547],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005165088,0.000138871,0.00014087364,0.000024085806,0.00015861845,0.000025060031,0.00010063591,0.00012216477,0.000054219836],"category_scores_gemma":[0.00016796557,0.00010665345,0.00011618546,0.00005139752,0.00005720682,0.0000022239276,0.00009066247,0.00007143352,0.0000068365507],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000051419687,0.000059418595,0.003908204,0.000051258325,0.00001359765,0.000019626794,0.000018906427,0.000005694819,0.9852864,0.00047389147,0.009659346,0.00045220667],"study_design_scores_gemma":[0.00019213872,0.00018170344,0.012462114,0.0000167888,0.000019680268,0.00002876016,0.000046494974,0.00001495679,0.93016106,0.00217853,0.054562036,0.00013573369],"about_ca_topic_score_codex":0.000012274759,"about_ca_topic_score_gemma":0.000022387743,"teacher_disagreement_score":0.055125367,"about_ca_system_score_codex":0.000028476228,"about_ca_system_score_gemma":0.00011451977,"threshold_uncertainty_score":0.43492016},"labels":[],"label_agreement":null},{"id":"W4415940943","doi":"10.1016/j.annonc.2025.08.1239","title":"664MO Long-term efficacy and safety of larotrectinib in TRK fusion primary central nervous system tumours: An updated analysis","year":2025,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Trk receptor; Central nervous system; Nervous system; Fusion; Neurotrophin","score_opus":0.020674499688767927,"score_gpt":0.31606979547465125,"score_spread":0.2953952957858833,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415940943","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99615514,0.000665994,0.0002676113,0.00015558403,0.000117565636,0.00023008583,0.000035308884,0.000012689332,0.0023599928],"genre_scores_gemma":[0.9988545,0.00027643013,0.000119879776,0.00016475984,0.000044209202,0.000006829889,0.00044069297,0.00000951266,0.00008316375],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9986042,0.00029902463,0.0004507966,0.00031983972,0.000073129166,0.0002530257],"domain_scores_gemma":[0.9992769,0.000035551682,0.00020183783,0.00029961785,0.00010944335,0.00007665276],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041168847,0.00013268167,0.0005057661,0.00021497325,0.00002732326,0.0000045271127,0.00016412279,0.00025038296,0.0000094156085],"category_scores_gemma":[0.000039478567,0.00012562425,0.00010738457,0.00033064946,0.000089956106,0.0000051146467,0.00012025394,0.00008498181,3.5191573e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030760267,0.0011041334,0.3612319,0.00030530678,0.0007651115,0.000072480034,0.00026356595,0.0002469976,0.5478304,0.00043442313,0.00076372316,0.08390595],"study_design_scores_gemma":[0.0014880048,0.0014291193,0.8992057,0.00004825829,0.00017952266,0.0000117918635,0.00009735412,0.00006317653,0.09581314,0.000007833228,0.0015367244,0.000119374214],"about_ca_topic_score_codex":0.00011898802,"about_ca_topic_score_gemma":0.00045789755,"teacher_disagreement_score":0.5379738,"about_ca_system_score_codex":0.000018469838,"about_ca_system_score_gemma":0.00017502041,"threshold_uncertainty_score":0.5122808},"labels":[],"label_agreement":null},{"id":"W4415941719","doi":"10.1016/j.annonc.2025.08.933","title":"510P Clinical and molecular characteristics of cancers that switch phenotype from ER+ primary to triple negative in metastatic disease","year":2025,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"","keywords":"Phenotype; Disease; Breast cancer; Clinical phenotype; Cancer; Metastasis","score_opus":0.053523999403280266,"score_gpt":0.3713198270787527,"score_spread":0.31779582767547243,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415941719","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956583,0.0010262156,0.0005848155,0.00090827653,0.00020707081,0.0002510718,0.00019972706,0.0000023645794,0.001162187],"genre_scores_gemma":[0.99519956,0.0006562096,0.001036673,0.002862154,0.000033871453,0.000023125882,0.00010050658,0.000007859575,0.000080054786],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99891275,0.00018134741,0.00039651853,0.00028010612,0.00006985772,0.0001594269],"domain_scores_gemma":[0.99928963,0.000105205516,0.00015838761,0.0002352769,0.00010096674,0.000110507615],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027011515,0.00011040272,0.0004334346,0.000067871326,0.000012919118,0.0000030312206,0.00013475372,0.00009104658,0.000011319485],"category_scores_gemma":[0.000411722,0.0001070443,0.00007626161,0.000095246665,0.00013671868,0.00000305291,0.00013697793,0.00007981022,0.0000011182203],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0077804183,0.0010539067,0.24508002,0.00036269764,0.00082284614,0.00018482636,0.00045818128,0.000032777152,0.5567911,0.0016007096,0.00938433,0.17644818],"study_design_scores_gemma":[0.00300227,0.0027289365,0.76858944,0.000118343,0.00016100818,0.0000011396809,0.000181009,0.00005467311,0.18879816,0.0035296015,0.03254601,0.00028942234],"about_ca_topic_score_codex":0.0002337209,"about_ca_topic_score_gemma":0.0001400133,"teacher_disagreement_score":0.5235094,"about_ca_system_score_codex":0.000011251922,"about_ca_system_score_gemma":0.0005373882,"threshold_uncertainty_score":0.436514},"labels":[],"label_agreement":null},{"id":"W4415942559","doi":"10.1016/j.annonc.2025.08.607","title":"173TiP DyNAMIc trial: Circulating tumour DNA guided adaptive BRAF and MEK inhibitor therapy - A phase II randomised proof of concept study","year":2025,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research; St. Thomas Hospital","funders":"","keywords":"MEK inhibitor; Population; Mutation; Acquired resistance; Mutant; Phases of clinical research","score_opus":0.06634267648748954,"score_gpt":0.38295494382005774,"score_spread":0.3166122673325682,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415942559","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940539,0.0016513473,0.00041225387,0.000279415,0.00020515894,0.0018240253,0.000032291548,0.000008006853,0.0015336204],"genre_scores_gemma":[0.9990084,0.000098642886,0.0001487446,0.00028622293,0.00008119409,0.000116884265,0.000035071967,0.000013723927,0.00021108033],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99833554,0.00036229118,0.0006236278,0.0003558214,0.00010531066,0.00021738012],"domain_scores_gemma":[0.9989406,0.00010587206,0.00038512136,0.00025411465,0.00025519167,0.000059138674],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006359467,0.00018007908,0.0006079751,0.000091386195,0.000077520766,0.0000049877544,0.00015600758,0.00018783739,0.00001250085],"category_scores_gemma":[0.00030509068,0.00015889914,0.00014105186,0.000114725844,0.00017785943,0.0000052051837,0.00013266935,0.00008488125,1.5796476e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.048751596,0.0025847366,0.00007612447,0.000026463022,0.0004372593,0.000015189535,0.0008513233,0.000016753385,0.8869218,0.0000990091,0.0014722878,0.058747455],"study_design_scores_gemma":[0.21855915,0.036227252,0.00018652136,0.000033158725,0.000060385417,0.000008608985,0.00081266527,0.00017584252,0.74076194,0.00027167896,0.0027323863,0.00017042198],"about_ca_topic_score_codex":0.000033586944,"about_ca_topic_score_gemma":0.000032167885,"teacher_disagreement_score":0.16980754,"about_ca_system_score_codex":0.000008669665,"about_ca_system_score_gemma":0.0003265251,"threshold_uncertainty_score":0.64797187},"labels":[],"label_agreement":null},{"id":"W4416140904","doi":"10.1093/neuonc/noaf201.0359","title":"CSIG-25. EXPLORING THE ROLE OF THE CIC/YY1 COMPLEX IN MODULATING SENSITIVITY OF MEK INHIBITORS IN GLIOBLASTOMA","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto","funders":"","keywords":"MAPK/ERK pathway; Effector; Transcription factor; Suppressor; Kinase; Transcription (linguistics); Downregulation and upregulation; Cell growth; Signal transduction","score_opus":0.019920383563121712,"score_gpt":0.25587932083091514,"score_spread":0.23595893726779343,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416140904","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961415,0.000102748876,0.000046963913,0.00032846947,0.00034262193,0.00024301044,0.000009200714,0.0000047230983,0.002780786],"genre_scores_gemma":[0.9995485,0.000020717574,0.00007757472,0.00023159944,0.000069963484,0.000029409759,0.0000028317236,0.000009871938,0.000009508105],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99853057,0.0005557841,0.00036287907,0.0002473489,0.000091442314,0.00021199632],"domain_scores_gemma":[0.9992157,0.0002267269,0.0001472887,0.00034261338,0.000046371744,0.000021304588],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044453438,0.00011887672,0.00025495797,0.00008150428,0.000044227396,0.0000033824256,0.00018863489,0.00012294829,0.000002752696],"category_scores_gemma":[0.00034664874,0.00008683893,0.000085458494,0.00026940284,0.00014248295,0.000004118234,0.00032685537,0.00020018667,5.358647e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000879786,0.00007951699,0.026308365,0.000018144514,0.000009309523,0.000008545873,0.0002657461,0.0005913794,0.9553563,0.000421531,0.000076954304,0.016776208],"study_design_scores_gemma":[0.0005245651,0.00025606705,0.033080436,0.00003136329,0.000008718015,0.000012844197,0.00052487437,0.0010680602,0.9490621,0.0002332346,0.015124814,0.0000729393],"about_ca_topic_score_codex":0.00018618896,"about_ca_topic_score_gemma":0.0015904421,"teacher_disagreement_score":0.016703269,"about_ca_system_score_codex":0.000028894434,"about_ca_system_score_gemma":0.00013604517,"threshold_uncertainty_score":0.35411888},"labels":[],"label_agreement":null},{"id":"W4416140972","doi":"10.1093/neuonc/noaf201.0589","title":"CTP-17. Clinical stability following tovorafenib treatment in relapsed/refractory pediatric low-grade glioma: updated results from the phase 2 FIREFLY-1 trial","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Clinical trial; Radiography; Drug; Retrospective cohort study; Phases of clinical research; Drug holiday","score_opus":0.041871743802711574,"score_gpt":0.35258401359150787,"score_spread":0.3107122697887963,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416140972","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9912273,0.00055223395,0.000024758847,0.0012149086,0.003525315,0.0011374035,0.00026349755,0.00004150945,0.0020130598],"genre_scores_gemma":[0.99633473,0.00024903243,0.00010382184,0.00094107364,0.0013528009,0.00013462258,0.00074477005,0.000025129042,0.00011401405],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9957239,0.0014345596,0.001154209,0.0010450833,0.00016419803,0.00047801726],"domain_scores_gemma":[0.99727523,0.0012258919,0.0002925803,0.0010085327,0.00005183097,0.00014594792],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00096478156,0.00033366997,0.00061252376,0.000089752466,0.00014529467,0.000025231231,0.00044619647,0.0006901506,0.000029637375],"category_scores_gemma":[0.0015347628,0.0002515287,0.00041547988,0.00033918355,0.00012690446,0.0000069655985,0.00022525205,0.00045001862,0.0000195321],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.08443938,0.008940071,0.012085029,0.000014366155,0.00026080976,0.0009663,0.0003753812,0.000022647066,0.8424478,0.00003415287,0.03260132,0.017812734],"study_design_scores_gemma":[0.24304365,0.014396757,0.0037264414,0.000010840193,0.00042051263,0.000011468517,0.00018952979,0.000105133724,0.13542517,0.00016375007,0.60200036,0.0005063738],"about_ca_topic_score_codex":0.0002229301,"about_ca_topic_score_gemma":0.0006508855,"teacher_disagreement_score":0.70702267,"about_ca_system_score_codex":0.00016147629,"about_ca_system_score_gemma":0.0010229354,"threshold_uncertainty_score":0.9999937},"labels":[],"label_agreement":null},{"id":"W4417465128","doi":"10.1080/17576180.2025.2601855","title":"Accelerating the discovery of MET inhibitors powered by high-throughput hit identification","year":2025,"lang":"en","type":"editorial","venue":"Bioanalysis","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Onex (Canada)","funders":"","keywords":"Identification (biology); Drug discovery; Key (lock); Drug industry","score_opus":0.005987982221905168,"score_gpt":0.2411850595054003,"score_spread":0.23519707728349515,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417465128","genre_codex":"editorial","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.04591178,0.023204692,0.003812135,0.00043287073,0.91673386,0.0008432504,0.006749697,0.000048953963,0.002262738],"genre_scores_gemma":[0.5302243,0.0030512884,0.00036201338,0.0000728244,0.4092453,0.00012914432,0.025761662,0.00007665907,0.031076748],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99773645,0.00018137759,0.0007039209,0.0006557226,0.00049428904,0.00022825359],"domain_scores_gemma":[0.99788696,0.00011860997,0.0006821649,0.0009929567,0.00028194638,0.000037337126],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004664302,0.0003130273,0.0004917345,0.000113761314,0.00014401929,0.0001352825,0.0006072991,0.00071956456,0.000019042945],"category_scores_gemma":[0.00074151985,0.00023470871,0.0004434627,0.000350198,0.00011382263,0.000009533189,0.00026092716,0.00023514907,0.0000052208734],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000023859815,0.000045716202,0.000049209313,0.00006575286,0.0007353082,6.867326e-7,0.000019996642,0.0000044055937,0.18491147,0.000046706373,0.81277615,0.0013207088],"study_design_scores_gemma":[0.00025213108,0.00008781366,0.00002383384,0.000040980693,0.0008029185,1.6246933e-7,0.00009461508,0.000007771654,0.24710473,0.000042223703,0.7512751,0.00026766316],"about_ca_topic_score_codex":0.00049687707,"about_ca_topic_score_gemma":0.00011612076,"teacher_disagreement_score":0.50748855,"about_ca_system_score_codex":0.00004010567,"about_ca_system_score_gemma":0.00029748146,"threshold_uncertainty_score":0.95711434},"labels":[],"label_agreement":null},{"id":"W571830263","doi":"10.71781/29189","title":"Étude du rôle de la MAP Kinase non-conventionnelle ERK3 dans le développement thymique et l'activation des lymphocytes T","year":2009,"lang":"fr","type":"dissertation","venue":"Open MIND","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Institutes of Health Research","keywords":"Molecular biology; Humanities; Philosophy; Biology","score_opus":0.016164046712867496,"score_gpt":0.2809208107904095,"score_spread":0.264756764077542,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W571830263","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96924967,0.00052095664,0.007961253,0.0003648635,0.0002494995,0.0007067533,0.00005574341,0.0000021066937,0.020889182],"genre_scores_gemma":[0.9712211,0.0006452802,0.01314137,0.00012759099,0.00021845054,0.00012854027,0.0060383286,0.00005022221,0.008429144],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980789,0.00033139848,0.00041346037,0.000648531,0.00014799762,0.0003797278],"domain_scores_gemma":[0.99896646,0.000038919596,0.00030872037,0.00037605458,0.00015384374,0.00015600467],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00067975564,0.00039934414,0.00031334805,0.00006717581,0.0003720113,0.0002528492,0.0005220686,0.0006255808,0.00037332764],"category_scores_gemma":[0.00008665295,0.00044183646,0.00017375802,0.000095676536,0.000108854154,0.0000303359,0.00015230167,0.000173636,0.00011119212],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029141278,0.00065371586,0.0032451535,0.00013469778,0.00015425253,0.000039861632,0.0037845082,0.00020064812,0.9599087,0.00043768418,0.0010253892,0.030123964],"study_design_scores_gemma":[0.0015772976,0.00039267854,0.040961716,0.000355698,0.00008220435,0.000026287255,0.0034431354,0.00015837295,0.9320102,0.00047713998,0.020028729,0.00048657198],"about_ca_topic_score_codex":0.0011366709,"about_ca_topic_score_gemma":0.003115998,"teacher_disagreement_score":0.037716564,"about_ca_system_score_codex":0.0001956537,"about_ca_system_score_gemma":0.0011523535,"threshold_uncertainty_score":0.99980336},"labels":[],"label_agreement":null},{"id":"W6885990720","doi":"10.14288/1.0402940","title":"Management of Pyrexia Associated with the Combination of Dabrafenib and Trametinib: Canadian Consensus Statements","year":2021,"lang":"en","type":"article","venue":"Open Collections","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Dabrafenib; Discontinuation; Delphi method; Trametinib; Quality of life (healthcare); Adverse effect","score_opus":0.015268687383697018,"score_gpt":0.26159927816296846,"score_spread":0.24633059077927144,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6885990720","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8193894,0.00010128985,0.00011222805,0.00042840926,0.000070898466,0.0005396796,0.00021482212,0.0000025038128,0.17914076],"genre_scores_gemma":[0.96137536,0.000041871343,0.00024209033,0.00003899728,0.0000030504605,0.000027306365,0.00010542696,0.000005607695,0.038160298],"study_design_codex":"not_applicable","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999592,0.00005759842,0.00010001424,0.00011300751,0.000056715202,0.00008067526],"domain_scores_gemma":[0.9996248,0.000013103626,0.00006582614,0.00013217032,0.00012646418,0.000037644986],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011617816,0.000047376594,0.00007647459,0.000015518914,0.00027553877,0.00004624551,0.000076074844,0.000031849457,0.000041782998],"category_scores_gemma":[0.000018946057,0.00003788868,0.000014608784,0.00022419616,0.000050927363,0.0000018619713,0.00005254335,0.000025375666,1.4739271e-7],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008026469,0.0026473813,0.010821355,0.00039057963,0.006869302,0.00019548752,0.0014787407,0.0004501862,0.25082573,0.013750066,0.7029533,0.008815251],"study_design_scores_gemma":[0.014096143,0.0030018534,0.0702025,0.00037780203,0.00073614914,0.000090872214,0.011623856,0.00034007122,0.65355206,0.0017013003,0.24345449,0.00082290446],"about_ca_topic_score_codex":0.013484457,"about_ca_topic_score_gemma":0.1236895,"teacher_disagreement_score":0.4594988,"about_ca_system_score_codex":0.000013318773,"about_ca_system_score_gemma":0.00018825715,"threshold_uncertainty_score":0.99308485},"labels":[],"label_agreement":null},{"id":"W6888975055","doi":"10.25345/c5s46hj34","title":"MassIVE MSV000096432 - MEF2A, MEF2C, and MEF2D Interactomes in Mouse MA-10 Leydig Cells","year":2024,"lang":"en","type":"dataset","venue":"California Digital Library","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Cell culture; HEK 293 cells; Mutation; Reprogramming; Saccharomyces cerevisiae","score_opus":0.005095941209822667,"score_gpt":0.19742357420841986,"score_spread":0.19232763299859718,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6888975055","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0131602,0.0024744417,0.0000026045939,0.00013352669,0.00034349997,0.00035358215,0.9808591,0.000050583018,0.0026224414],"genre_scores_gemma":[0.0028278804,0.0009690089,0.00004441326,0.0004549741,0.0005114248,0.00006526531,0.98633224,0.000105149054,0.008689646],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99786377,0.000050568982,0.00050245074,0.0009143373,0.00019599433,0.00047289013],"domain_scores_gemma":[0.9988706,0.000042625205,0.0001453464,0.00065193855,0.000019374751,0.0002701214],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00005510722,0.0005898192,0.0004944629,0.00024174305,0.000038767364,0.00058592873,0.00049176684,0.00064924156,0.0005521884],"category_scores_gemma":[0.00005499243,0.0005200117,0.00019118757,0.00014382726,0.00014823844,0.00005317569,0.0010703666,0.00043793692,0.004313005],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001441075,0.000088948094,0.000083440806,0.00040111825,0.00009370293,0.00030643336,0.000006789371,0.0000011832823,0.0038685163,0.0000064642404,0.9943429,0.0006563447],"study_design_scores_gemma":[0.00032040593,0.00021170221,0.0000056413655,0.00014796508,0.000035911824,0.000039188388,0.000031429037,0.0000066723605,0.03283121,0.00015559148,0.96562904,0.0005852469],"about_ca_topic_score_codex":0.000005794822,"about_ca_topic_score_gemma":0.000008652757,"teacher_disagreement_score":0.028962696,"about_ca_system_score_codex":0.000018101025,"about_ca_system_score_gemma":0.00021039892,"threshold_uncertainty_score":0.99972516},"labels":[],"label_agreement":null},{"id":"W6920955846","doi":"10.6084/m9.figshare.13161576.v1","title":"Additional file 7 of TRIM25 promotes Capicua degradation independently of ERK in the absence of ATXN1L","year":2020,"lang":"en","type":"article","venue":"Figshare","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; Canada's Michael Smith Genome Sciences Centre; Simon Fraser University; University of British Columbia; BC Cancer Agency","funders":"","keywords":"Gene knockdown; Western blot; Cell culture; Blot; Northern blot; Messenger RNA; Small interfering RNA; Cell","score_opus":0.029590144715436018,"score_gpt":0.2229487473642402,"score_spread":0.19335860264880417,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6920955846","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.012858508,0.00005499575,0.0000010823891,0.000023361104,0.0000040663335,0.00011610192,0.9855973,0.000001515231,0.0013430276],"genre_scores_gemma":[0.39177763,8.79485e-7,0.000118347474,0.000046879766,0.000035989855,0.00007665738,0.6078838,0.0000032585763,0.000056556804],"study_design_codex":"not_applicable","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99955046,0.000028624714,0.00015070202,0.00010121282,0.00011169222,0.000057293182],"domain_scores_gemma":[0.99958694,0.00008696378,0.0001306405,0.00010850982,0.00006985017,0.000017099777],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000018246341,0.000050495593,0.000080961785,0.000013819958,0.000008499161,0.0000019670422,0.00015482638,0.00006112179,0.5129383],"category_scores_gemma":[0.0011480236,0.00003983364,0.000043401793,0.00007627544,0.000008819289,0.000002624644,0.00004213032,0.000041333533,0.000025444697],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000013853007,0.000029497478,0.000030945113,0.00010459952,0.000006362903,0.0000011813902,0.00007421082,0.000002804072,0.039674602,0.0000053424774,0.95966697,0.00038960986],"study_design_scores_gemma":[0.00041092327,0.00056790304,0.019006776,0.00071969064,0.0000047961153,0.000006790599,0.00022043232,0.000098361794,0.58917516,0.00004090213,0.38960478,0.00014344385],"about_ca_topic_score_codex":0.000004335697,"about_ca_topic_score_gemma":0.000013589355,"teacher_disagreement_score":0.5700622,"about_ca_system_score_codex":0.0000016193572,"about_ca_system_score_gemma":0.00008092593,"threshold_uncertainty_score":0.48750696},"labels":[],"label_agreement":null},{"id":"W6928684693","doi":"10.4224/40001876","title":"Canadair CT-133 aircraft low speed large sideslip angle flight characteristics","year":2002,"lang":"en","type":"report","venue":"NPARC","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Angle of attack; Control system; Stability (learning theory); Noise (video); Work (physics); Acceleration","score_opus":0.016574321116959726,"score_gpt":0.2370394712802922,"score_spread":0.22046515016333249,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6928684693","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.202804,0.0019434416,0.00016686902,0.0003272025,0.0055106836,0.0008200143,0.003441615,0.00010544317,0.78488076],"genre_scores_gemma":[0.759844,0.0034841248,0.00038808494,0.00073135324,0.006289431,0.00003864298,0.007638545,0.00023749153,0.2213483],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99715257,0.00006711525,0.0005626864,0.0008132258,0.000645287,0.0007591254],"domain_scores_gemma":[0.9979428,0.000014909395,0.00035331596,0.001023736,0.00034940237,0.00031582435],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00032420555,0.00054280873,0.00063786283,0.00009892169,0.00014622763,0.00005062497,0.0004330653,0.0005509911,0.0020773518],"category_scores_gemma":[0.00026955173,0.0005366464,0.00030460267,0.00009972616,0.00006699586,0.000003269826,0.0002367267,0.00039747814,0.00027047127],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00001944422,0.00015626477,0.0012588724,0.00028500517,0.00017873709,0.00063697516,0.000019860434,2.8792604e-7,0.22694892,0.000037755508,0.76724756,0.0032103446],"study_design_scores_gemma":[0.00037554742,0.00016133087,0.00094814895,0.00009469086,0.000087996246,0.00031329214,0.000008654316,0.000024820305,0.040234335,0.000025011743,0.9570867,0.0006394808],"about_ca_topic_score_codex":0.0002470055,"about_ca_topic_score_gemma":0.00070907205,"teacher_disagreement_score":0.5635324,"about_ca_system_score_codex":0.00013327386,"about_ca_system_score_gemma":0.0011611424,"threshold_uncertainty_score":0.99970853},"labels":[],"label_agreement":null},{"id":"W6928997765","doi":"10.4224/crm.2023.bfly-1","title":"BFLY-1: Black Soldier Fly Meal Certified Reference Material","year":2023,"lang":"en","type":"other","venue":"NRC Digital Repository","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"National Research Council Canada","funders":"","keywords":"Meal; Certification; Certified reference materials; Larva; Research council; Fly ash","score_opus":0.015285640654572892,"score_gpt":0.22101571234159725,"score_spread":0.20573007168702437,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6928997765","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.009280991,0.0001975573,0.00003000757,0.0000085370075,0.0025415735,0.0002275468,0.00038223492,0.00029333902,0.9870382],"genre_scores_gemma":[0.08987356,0.00007106974,0.000035176814,0.000041514184,0.002386911,0.00003387573,0.00048158993,0.0006836662,0.90639263],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.998348,0.000029266908,0.00027881897,0.0006524224,0.0003341332,0.00035733444],"domain_scores_gemma":[0.99892974,0.0000074216723,0.0001772855,0.00067459303,0.00006711412,0.00014382691],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000055946817,0.00035590594,0.00029239745,0.00007236491,0.00004655122,0.00017114257,0.00033144714,0.00067384884,0.000104164596],"category_scores_gemma":[0.00006895985,0.00033468023,0.00014631318,0.000048397673,0.0001349916,0.0000061528112,0.000233546,0.0001298705,0.0005234397],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009314707,0.00004952075,0.0001051074,0.00007967251,0.00014495736,0.00009067235,0.000012360373,4.9124236e-7,0.12656556,0.00007570387,0.86931634,0.0034664755],"study_design_scores_gemma":[0.00021633426,0.00020255319,0.00012515226,0.00008345735,0.000027252316,0.000028680299,0.000013929819,0.0000011785577,0.059762698,0.000028644927,0.9390894,0.00042070777],"about_ca_topic_score_codex":0.000106959495,"about_ca_topic_score_gemma":0.00012723825,"teacher_disagreement_score":0.080645576,"about_ca_system_score_codex":0.0000345959,"about_ca_system_score_gemma":0.00016561359,"threshold_uncertainty_score":0.99991053},"labels":[],"label_agreement":null},{"id":"W6929228637","doi":"10.48550/arxiv.1711.03093","title":"Milky Way Globular Cluster Metallicity and Low-Mass X-ray Binaries: The Red Giant Influence","year":2017,"lang":"en","type":"preprint","venue":"arXiv (Cornell University)","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Globular cluster; Metallicity; Milky Way; Galaxy; Red-giant branch; Star cluster; Stellar density; Stars","score_opus":0.02981949781744656,"score_gpt":0.18291808655779443,"score_spread":0.15309858874034787,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6929228637","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9887483,0.00062546524,0.0072907866,0.00022271049,0.00029867527,0.0004167596,0.00006924659,0.00002574906,0.0023022972],"genre_scores_gemma":[0.99472386,0.0013043388,0.00013689592,0.00023281488,0.00014242399,0.0000030158242,0.000069347116,0.000024952593,0.0033623516],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99828863,0.00015543314,0.00018610166,0.0009503605,0.00007905583,0.00034042983],"domain_scores_gemma":[0.99775404,0.000028232911,0.00028860907,0.0016185583,0.00015215843,0.00015838856],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00030934153,0.00036222834,0.00032979672,0.000053852644,0.0003812367,0.00011293532,0.0010213228,0.00051290035,0.00001585495],"category_scores_gemma":[0.00014366988,0.00030475858,0.000206782,0.00006076654,0.0004364766,0.000013296876,0.0014966612,0.00037743011,0.000018280496],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018076769,0.00043366285,0.022985501,0.0013337106,0.0026815042,0.0014031912,0.0007796245,0.1259712,0.8167863,0.017871462,0.0066534244,0.0012927897],"study_design_scores_gemma":[0.01528347,0.0027928287,0.14810212,0.0021953657,0.0046221777,0.0001885403,0.0015806914,0.10990044,0.24774274,0.07715241,0.37920463,0.01123457],"about_ca_topic_score_codex":0.000187707,"about_ca_topic_score_gemma":0.000091506845,"teacher_disagreement_score":0.5690435,"about_ca_system_score_codex":0.000033872668,"about_ca_system_score_gemma":0.00014871248,"threshold_uncertainty_score":0.99994045},"labels":[],"label_agreement":null},{"id":"W6929437301","doi":"10.5061/dryad.hh76j","title":"Data from: Taxonomic and functional diversity in Mediterranean pastures: Insights on the biodiversity-productivity trade-off","year":2016,"lang":"en","type":"dataset","venue":"Data Archiving and Networked Services (DANS)","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec en Outaouais","funders":"","keywords":"Species richness; Biodiversity; Vegetation (pathology); Woody plant; Biomass (ecology); Productivity; Species diversity; Herbaceous plant","score_opus":0.05747742101261689,"score_gpt":0.23448804519597377,"score_spread":0.1770106241833569,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6929437301","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.22746359,0.0009275471,0.000030665302,0.0002520398,0.00044077044,0.00020286127,0.7706294,0.000008581412,0.00004451598],"genre_scores_gemma":[0.05194829,0.0035382954,0.000020529615,0.000491233,0.0013484076,0.0000052993146,0.9426208,0.000010641347,0.000016461676],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9974928,0.00033839754,0.00021666709,0.0014277494,0.00021491184,0.00030945672],"domain_scores_gemma":[0.9967421,0.00022627423,0.00018230197,0.0027109652,0.000008845303,0.0001295018],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004527699,0.00038379786,0.0003224608,0.00007826944,0.00052794593,0.0000743824,0.0021582455,0.00023704469,0.00002626409],"category_scores_gemma":[0.00003224704,0.0002580231,0.00003279071,0.000062958476,0.00023053955,0.000038624996,0.007772838,0.00038900884,0.000013274412],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003426942,0.0000734348,0.0029129037,0.00009061112,0.00017546932,0.00002060889,0.00015481561,0.000003719649,0.00084403343,0.0000027709184,0.9936592,0.0017197548],"study_design_scores_gemma":[0.00057335425,0.00010455764,0.025129832,0.00021040847,0.00012484108,0.000010016155,0.00014553261,0.00041135398,0.000044145363,0.000071863964,0.9727726,0.00040148245],"about_ca_topic_score_codex":0.0011732955,"about_ca_topic_score_gemma":0.015871337,"teacher_disagreement_score":0.1755153,"about_ca_system_score_codex":0.000012033281,"about_ca_system_score_gemma":0.000044935237,"threshold_uncertainty_score":0.9999872},"labels":[],"label_agreement":null},{"id":"W6929727411","doi":"10.5064/f6z31wj1/pstv7q","title":"0_README_Johnson.txt","year":2018,"lang":"el","type":"dataset","venue":"Syracuse University Qualitative Data Repository","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University","funders":"","keywords":"Process (computing); Identification (biology); Product (mathematics)","score_opus":0.051447091421987556,"score_gpt":0.3217349744076935,"score_spread":0.27028788298570594,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6929727411","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.013018522,0.0006455568,0.00037123062,0.000078536694,0.0020142996,0.0005845747,0.9793509,0.00004568685,0.0038906664],"genre_scores_gemma":[0.0018680444,0.0016315228,0.0010962259,0.00019289817,0.0019879087,0.0000024709936,0.9826421,0.000072380026,0.010506459],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99273986,0.0025002656,0.0006885898,0.0025743034,0.0006651342,0.00083187793],"domain_scores_gemma":[0.99219126,0.00026420673,0.0006780006,0.0057081576,0.000622405,0.0005359677],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0012557751,0.00095224555,0.0008844712,0.0003222467,0.0008797441,0.00013725243,0.0040623173,0.0013691174,0.00027559203],"category_scores_gemma":[0.0005260016,0.0010588092,0.0003191654,0.0003272965,0.0012358103,0.00007588318,0.004339908,0.0007376916,0.001253799],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006480785,0.0004268499,0.000017755112,0.0003422292,0.0010387226,0.0006430567,0.0013235469,4.2528936e-7,0.019142436,0.000088677654,0.97621936,0.00010884791],"study_design_scores_gemma":[0.0011817387,0.0010742325,0.000054970104,0.0002108118,0.00067776185,0.00011486826,0.008137721,0.000013236481,0.005968747,0.0000112065445,0.98133135,0.0012233743],"about_ca_topic_score_codex":0.0013451796,"about_ca_topic_score_gemma":0.00047525484,"teacher_disagreement_score":0.013173688,"about_ca_system_score_codex":0.00022514297,"about_ca_system_score_gemma":0.0011476453,"threshold_uncertainty_score":0.99992734},"labels":[],"label_agreement":null},{"id":"W6930093850","doi":"10.5281/zenodo.11955896","title":"cervical dystonia pdf","year":2024,"lang":"en","type":"other","venue":"Zenodo (CERN European Organization for Nuclear Research)","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Spasmodic Torticollis; Brachial Plexopathy; Hyporeflexia; Dystonia; Paralysis","score_opus":0.017384316441048913,"score_gpt":0.23234698456982494,"score_spread":0.21496266812877604,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6930093850","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00014977984,0.00091233704,0.0006932317,0.00014906241,0.0002882889,0.0002643557,0.00037679268,0.00039700978,0.99676913],"genre_scores_gemma":[0.0056819315,0.000283105,0.00018428752,0.00015848056,0.0011741275,6.4570905e-8,0.006316548,0.008470062,0.9777314],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9986732,0.00013158862,0.00015334743,0.0005484731,0.00020548476,0.0002879275],"domain_scores_gemma":[0.9991366,0.0000016974591,0.000067369205,0.00054585,0.00009838964,0.00015009174],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00019096254,0.0001970293,0.00015025042,0.00016305716,0.0002774083,0.0002867844,0.00068983773,0.0002689412,0.07387679],"category_scores_gemma":[0.000105887906,0.00019886359,0.00008338943,0.0001528638,0.00010319488,0.000002475453,0.0010602035,0.00022508054,0.12700282],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00001623327,0.000036423226,2.2746312e-7,0.0001450471,0.00007481539,0.000022543501,0.000035192308,4.174263e-7,0.013910671,0.00093171006,0.97755635,0.0072703557],"study_design_scores_gemma":[0.00018884776,0.00021432519,0.000008160358,0.00006177549,0.000024056344,0.0001097563,0.000024602408,0.0000065761064,0.0011904733,0.00006250657,0.9978868,0.00022215438],"about_ca_topic_score_codex":0.000012726843,"about_ca_topic_score_gemma":0.0000012177779,"teacher_disagreement_score":0.053126022,"about_ca_system_score_codex":0.000028493096,"about_ca_system_score_gemma":0.0000051237525,"threshold_uncertainty_score":0.9269698},"labels":[],"label_agreement":null},{"id":"W6930130010","doi":"10.5281/zenodo.11796480","title":"Thomas international gia test pdf","year":2024,"lang":"en","type":"other","venue":"Zenodo (CERN European Organization for Nuclear Research)","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Test (biology); Sample (material); Multiple choice; Cognition; International comparisons; Test score; Work (physics); Section (typography)","score_opus":0.017326469146929327,"score_gpt":0.23630322072275942,"score_spread":0.21897675157583008,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6930130010","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000054248056,0.0005098899,0.0006031558,0.00020685652,0.00048596726,0.00021506104,0.00067720114,0.0003201169,0.9969275],"genre_scores_gemma":[0.0038087866,0.00034437634,0.00020234208,0.00012202276,0.0013769204,6.768135e-8,0.008391102,0.0054141716,0.9803402],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99884033,0.00007320187,0.00014978688,0.00049225305,0.0002198053,0.00022461981],"domain_scores_gemma":[0.9992455,0.0000033108458,0.000080059726,0.0004325459,0.00012989373,0.00010867491],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00018211166,0.00017832265,0.0001177312,0.00018376968,0.00021715541,0.00034880164,0.00081651576,0.00020027535,0.05773303],"category_scores_gemma":[0.00029304085,0.00018305657,0.0000742664,0.00012079267,0.000090620095,0.0000036915199,0.0010747745,0.00019365066,0.07201159],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000010962023,0.000050704333,0.0000010144901,0.00006444087,0.00008169042,0.000019919582,0.000032702912,4.20949e-7,0.023999706,0.000611916,0.96821827,0.006908251],"study_design_scores_gemma":[0.00019421866,0.00017574974,0.000011591479,0.00006215167,0.000017260634,0.00010049952,0.000029197065,0.000010057814,0.001477109,0.000051530184,0.99767256,0.0001980758],"about_ca_topic_score_codex":0.000007893464,"about_ca_topic_score_gemma":9.575685e-7,"teacher_disagreement_score":0.029454287,"about_ca_system_score_codex":0.000031398715,"about_ca_system_score_gemma":0.0000050782664,"threshold_uncertainty_score":0.94312835},"labels":[],"label_agreement":null},{"id":"W6930155680","doi":"10.5281/zenodo.11884942","title":"the war of art book pdf free download","year":2024,"lang":"en","type":"other","venue":"Zenodo (CERN European Organization for Nuclear Research)","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Spanish Civil War; Download; World War II; Face (sociological concept); Period (music); First world war; Event (particle physics); Decolonization","score_opus":0.012511240167585088,"score_gpt":0.21679373379586447,"score_spread":0.20428249362827938,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6930155680","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00003222726,0.005123912,0.00023262104,0.00024675642,0.00022268448,0.00029189888,0.000711377,0.00016681457,0.9929717],"genre_scores_gemma":[0.0006422958,0.0027453927,0.000055649452,0.000113389644,0.0004799747,8.7433264e-8,0.003433344,0.0034193776,0.98911047],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9988819,0.00013276252,0.00018109119,0.00035727466,0.0002130906,0.0002338902],"domain_scores_gemma":[0.9988469,0.0000046311297,0.00011018953,0.0008277146,0.00012771472,0.00008284198],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00027357702,0.00015695867,0.0001321765,0.00009534457,0.00032401466,0.00012543521,0.0010298915,0.00016708147,0.020956637],"category_scores_gemma":[0.00023640966,0.00012614782,0.00008625165,0.00011783785,0.00018421738,0.0000026849705,0.0012451616,0.00017605472,0.037961364],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000022097114,0.000023068173,1.024007e-7,0.00009713828,0.00009065326,0.000005469907,0.000035405727,3.6467117e-7,0.016549945,0.0005168178,0.9778455,0.004813465],"study_design_scores_gemma":[0.00018669633,0.00021234341,0.0000022388022,0.000052736916,0.000021650365,0.00003256689,0.000036524125,0.000002228475,0.003801342,0.00006361842,0.9954513,0.00013680305],"about_ca_topic_score_codex":0.000006557823,"about_ca_topic_score_gemma":0.0000014236653,"teacher_disagreement_score":0.017605778,"about_ca_system_score_codex":0.000015882191,"about_ca_system_score_gemma":0.0000061344417,"threshold_uncertainty_score":0.9799383},"labels":[],"label_agreement":null},{"id":"W6930294228","doi":"10.5281/zenodo.11351238","title":"+27723039124, I NEED POWERFUL REVENGE INSTANT DEATH SPELL CASTER IN LIECHTENSTEIN, LITHUANIA, LUXEMBOURG, BAHRAIN, ALASKA, USA, UK, CANADA, AUSTRALIA.","year":2024,"lang":"en","type":"other","venue":"Zenodo (CERN European Organization for Nuclear Research)","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Spell; Psychic; Face (sociological concept); Anger; Instant; Wish; Notice; Need to know; Mistake; Recklessness","score_opus":0.029806894418486593,"score_gpt":0.24350503531932452,"score_spread":0.21369814090083794,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6930294228","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.011865492,0.0010282248,0.00009116121,0.00025044585,0.00044437233,0.0006721843,0.0014351922,0.000082125276,0.9841308],"genre_scores_gemma":[0.10999912,0.00026783152,0.00012404028,0.00026900062,0.00055566407,4.6364317e-8,0.0024956367,0.0044530733,0.8818356],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9973845,0.00026423755,0.00040423792,0.00088850065,0.00041408988,0.0006444465],"domain_scores_gemma":[0.9985271,0.0000060677094,0.0001663532,0.0008253934,0.00018837176,0.00028670195],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00039741842,0.00041258777,0.00035276075,0.00032954355,0.00013052323,0.00031063,0.00090750324,0.0003846617,0.05210504],"category_scores_gemma":[0.00018709472,0.00042949533,0.00009922017,0.00032444252,0.00010228841,0.000006616465,0.0010254922,0.00049110077,0.04148452],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000049851165,0.00004852398,0.000021702484,0.00019496516,0.00009865802,0.00031651207,0.00011017751,0.0000033339281,0.009263684,0.00048810148,0.98854905,0.00085540756],"study_design_scores_gemma":[0.0004828591,0.0002863105,0.00015930358,0.00022050909,0.00003132275,0.00019914529,0.00012934142,0.00000664214,0.0015210636,0.000032426393,0.99646604,0.00046503806],"about_ca_topic_score_codex":0.0134457275,"about_ca_topic_score_gemma":0.011079438,"teacher_disagreement_score":0.10229521,"about_ca_system_score_codex":0.00020456527,"about_ca_system_score_gemma":0.00005118661,"threshold_uncertainty_score":0.9998157},"labels":[],"label_agreement":null},{"id":"W6930398408","doi":"10.5281/zenodo.11200905","title":"HeuDiConv: flexible DICOM conversion into structured directory layouts","year":2024,"lang":"en","type":"other","venue":"Zenodo (CERN European Organization for Nuclear Research)","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill Genome Centre","funders":"","keywords":"Documentation; Directory; Container (type theory); DICOM","score_opus":0.0178797308174471,"score_gpt":0.2419833400854723,"score_spread":0.2241036092680252,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6930398408","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0018913603,0.0023599456,0.0006917056,0.0001565882,0.0009327854,0.00049721694,0.0006950064,0.0010264062,0.991749],"genre_scores_gemma":[0.09005295,0.0010193133,0.000590292,0.00036482656,0.0023217364,2.0231954e-7,0.020804906,0.017548231,0.86729753],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9985669,0.0001419816,0.00016665467,0.00061167293,0.00023440953,0.00027836012],"domain_scores_gemma":[0.9990213,0.0000028164625,0.0000989957,0.0005901477,0.00011636376,0.00017038718],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0001888524,0.00023770248,0.00018322488,0.00022267143,0.00037901642,0.00025545395,0.0006827954,0.00035168132,0.019958591],"category_scores_gemma":[0.00012835502,0.00023980589,0.00008976923,0.00016714203,0.00015693647,0.000004705798,0.001104289,0.0003450297,0.009234052],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000029866478,0.000025803307,0.0000011190576,0.0001895552,0.00008009242,0.0000141029395,0.00009141707,5.058194e-7,0.124711625,0.00037917803,0.8651841,0.009292609],"study_design_scores_gemma":[0.00028489277,0.00017551272,0.000015750718,0.000068425186,0.000027803437,0.000045568548,0.000044257034,0.0000065692107,0.014490601,0.00008414356,0.9844971,0.00025942063],"about_ca_topic_score_codex":0.000039216757,"about_ca_topic_score_gemma":0.000003085826,"teacher_disagreement_score":0.12445144,"about_ca_system_score_codex":0.000035903144,"about_ca_system_score_gemma":0.000008689734,"threshold_uncertainty_score":0.9915374},"labels":[],"label_agreement":null},{"id":"W6930477615","doi":"10.5281/zenodo.11679523","title":"Medecine interne pdf","year":2024,"lang":"fr","type":"other","venue":"Zenodo (CERN European Organization for Nuclear Research)","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Publishing; Reading (process); Open university; Face (sociological concept); Healthcare system","score_opus":0.019600414817425964,"score_gpt":0.23411785632846605,"score_spread":0.21451744151104007,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6930477615","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0016240183,0.0037974473,0.0023936513,0.0007982647,0.0008006301,0.00045924995,0.00047866727,0.00022912439,0.9894189],"genre_scores_gemma":[0.03285695,0.0010183966,0.0002523285,0.00025075083,0.0018358933,8.1672695e-8,0.006446243,0.0066039227,0.95073545],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99768734,0.00030657143,0.00034167015,0.0008768216,0.00028270826,0.0005048666],"domain_scores_gemma":[0.9985184,0.000006507124,0.00013583018,0.0007613597,0.0002962668,0.0002816128],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00042278098,0.00035647897,0.00027736928,0.00024255777,0.0005098912,0.000608004,0.0011533101,0.00038878954,0.30188546],"category_scores_gemma":[0.0004097044,0.00037117634,0.00016060335,0.0002790477,0.00025695888,0.000008428728,0.002156217,0.0004299329,0.31342718],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000056585366,0.00012254772,9.727553e-7,0.00036284226,0.00023494207,0.00006884647,0.00021964575,0.000002483422,0.046957307,0.006163547,0.8644368,0.0813735],"study_design_scores_gemma":[0.00042404985,0.00065652723,0.000029598663,0.0002254149,0.00007192062,0.0003207369,0.00010138197,0.000055126635,0.0050522424,0.00018932532,0.9924957,0.00037797476],"about_ca_topic_score_codex":0.000016058095,"about_ca_topic_score_gemma":0.000002323002,"teacher_disagreement_score":0.12805891,"about_ca_system_score_codex":0.00010614842,"about_ca_system_score_gemma":0.000009392865,"threshold_uncertainty_score":0.999874},"labels":[],"label_agreement":null},{"id":"W6930544418","doi":"10.5281/zenodo.12217428","title":"Sae j300 pdf","year":2024,"lang":"en","type":"other","venue":"Zenodo (CERN European Organization for Nuclear Research)","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Lubricant; Viscosity; Viscosity index; Diesel fuel; Motor oil; Oil viscosity","score_opus":0.01881929531598979,"score_gpt":0.23166779270642812,"score_spread":0.21284849739043832,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6930544418","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00014995327,0.0011629012,0.00042358093,0.00011061251,0.00029707662,0.0002690512,0.00041141905,0.0003919156,0.9967835],"genre_scores_gemma":[0.0039860266,0.00041043945,0.00014202736,0.00014135097,0.0010939618,5.5044236e-8,0.006246639,0.008172471,0.979807],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987236,0.00012076413,0.0001478256,0.00053267466,0.00019294568,0.00028216268],"domain_scores_gemma":[0.9991395,0.0000016458197,0.00007418564,0.00055336417,0.00009848953,0.00013284931],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00020013502,0.00019509283,0.00014419488,0.00017518086,0.00027528312,0.000295407,0.0006672021,0.0002382106,0.07131103],"category_scores_gemma":[0.0001280853,0.00019992972,0.00008277891,0.0001536352,0.000094586605,0.0000026318114,0.0009791933,0.00020626387,0.12953556],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00001193573,0.000031415835,2.002176e-7,0.000120226,0.00007689626,0.00001782964,0.000036976515,4.3614892e-7,0.024190778,0.00062678853,0.9651558,0.009730738],"study_design_scores_gemma":[0.00017917411,0.00020478218,0.000008025836,0.00006272978,0.00002203227,0.00008126315,0.000029809335,0.0000027011279,0.001248257,0.00006066157,0.9978946,0.0002059601],"about_ca_topic_score_codex":0.00001179287,"about_ca_topic_score_gemma":0.0000015193528,"teacher_disagreement_score":0.05822453,"about_ca_system_score_codex":0.000026364303,"about_ca_system_score_gemma":0.000004938177,"threshold_uncertainty_score":0.9295379},"labels":[],"label_agreement":null},{"id":"W6930673055","doi":"10.5281/zenodo.15577723","title":"The Role of Upskilling and Reskilling Initiatives in Downsizing: A Strategic HR Approach","year":2025,"lang":"en","type":"article","venue":"Zenodo (CERN European Organization for Nuclear Research)","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Seneca Polytechnic","funders":"","keywords":"Strategic planning; Government (linguistics); Work (physics); Context (archaeology)","score_opus":0.02091440354431256,"score_gpt":0.23744462089682714,"score_spread":0.21653021735251457,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6930673055","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6951566,0.0018927566,0.0021425902,0.00010946447,0.000040485804,0.0003250926,0.000035281384,0.00004983004,0.30024794],"genre_scores_gemma":[0.99889934,0.00040933915,0.0002075499,0.000020752526,0.000031183074,5.5845007e-8,0.00018989269,0.000112385474,0.00012951905],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99924856,0.00015968492,0.00015320827,0.00020572163,0.000078300676,0.00015451998],"domain_scores_gemma":[0.9995795,0.000014907276,0.00005035062,0.00019555242,0.00012647452,0.00003325237],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041356168,0.00006756812,0.000074452284,0.00007460325,0.00053587096,0.0001227385,0.0002755352,0.000049177506,0.00003017072],"category_scores_gemma":[0.00021920672,0.000057401172,0.000020162852,0.00018531404,0.000116720665,0.000007245645,0.00038292995,0.000104873594,0.0000120320965],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030313944,0.00022202292,0.00027950702,0.00016064968,0.000114266855,0.0000041888375,0.0018674164,0.00036820606,0.83113885,0.10680998,0.0016923379,0.05703941],"study_design_scores_gemma":[0.0013584746,0.00054826547,0.003463885,0.0001189172,0.000022073697,0.00004355869,0.009133123,0.0027809297,0.12774841,0.0059310147,0.848521,0.00033036945],"about_ca_topic_score_codex":0.000006774931,"about_ca_topic_score_gemma":6.448677e-7,"teacher_disagreement_score":0.84682864,"about_ca_system_score_codex":0.000010669618,"about_ca_system_score_gemma":0.0000056804106,"threshold_uncertainty_score":0.41215402},"labels":[],"label_agreement":null},{"id":"W6930882358","doi":"10.5281/zenodo.227088","title":"Irrigation System In Thanjavur District Under The Cholas","year":2017,"lang":"en","type":"article","venue":"Zenodo (CERN European Organization for Nuclear Research)","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Bay; Irrigation; Quarter (Canadian coin); Population; BENGAL; West bengal; Delta","score_opus":0.03173363134769063,"score_gpt":0.2453925231150591,"score_spread":0.21365889176736846,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6930882358","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.74034053,0.00009234451,0.0031450086,0.0006106842,0.0002023146,0.00041973148,0.000101286954,0.000121944846,0.25496614],"genre_scores_gemma":[0.9982296,0.000022792723,0.000022915972,0.0000465804,0.00017161491,6.5804606e-8,0.00061087153,0.00026869428,0.00062682945],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99912,0.00015646363,0.0001317426,0.0002516941,0.00014608838,0.00019399394],"domain_scores_gemma":[0.9990424,0.000004592443,0.00009746823,0.0006656455,0.0001291773,0.000060715665],"candidate_categories":["sts","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004622894,0.000084390194,0.00006909618,0.000041202606,0.001850904,0.0005180319,0.00087171077,0.00006350237,0.0002343683],"category_scores_gemma":[0.00022619725,0.000068816305,0.000034544915,0.00006885121,0.000106749576,0.000015271115,0.0006751649,0.000116369,0.00082600873],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004186604,0.00039567176,0.0007031099,0.00030180882,0.00018401205,0.00005157522,0.0013341461,0.0003459509,0.5840891,0.123265795,0.15355673,0.13535342],"study_design_scores_gemma":[0.0007229999,0.00020584546,0.042578064,0.000034272725,0.000009912265,0.00009380237,0.00062782486,0.00024971386,0.013150717,0.00015727553,0.94198567,0.00018393362],"about_ca_topic_score_codex":0.000026983698,"about_ca_topic_score_gemma":0.000003114404,"teacher_disagreement_score":0.7884289,"about_ca_system_score_codex":0.000044120003,"about_ca_system_score_gemma":0.000003635685,"threshold_uncertainty_score":0.99995196},"labels":[],"label_agreement":null},{"id":"W6930959661","doi":"10.5281/zenodo.14968371","title":"Plagiothecium denticulatum var. denticulatum Schimp.","year":2025,"lang":"en","type":"article","venue":"Zenodo (CERN European Organization for Nuclear Research)","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Apex (geometry); Phytogeography; Taxonomy (biology); Subject (documents)","score_opus":0.014171856971355264,"score_gpt":0.23882063954793,"score_spread":0.22464878257657475,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6930959661","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.64789873,0.00067676144,0.028425198,0.00080018176,0.0008600106,0.0007673615,0.00016250966,0.00052657846,0.31988266],"genre_scores_gemma":[0.9893808,0.00007608549,0.00028243155,0.00032332618,0.00019815774,7.38089e-8,0.0015519218,0.0005106615,0.0076765767],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99868083,0.00016724518,0.00020211852,0.00042899826,0.00018588504,0.000334897],"domain_scores_gemma":[0.9990022,0.0000053472663,0.00006008246,0.0005294321,0.00028499996,0.000117922464],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00031095682,0.00014351508,0.000118380995,0.00014156563,0.0010604397,0.00036631385,0.00068141794,0.000118146454,0.0014686474],"category_scores_gemma":[0.00031735023,0.00015033055,0.000082126644,0.00028336036,0.00010740739,0.000012077985,0.0010163711,0.00015519942,0.0016669867],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000119808545,0.00019553315,0.00006608406,0.00009650396,0.0001505081,0.00002198607,0.00012673171,0.00004049556,0.5205949,0.011177199,0.4395581,0.027852189],"study_design_scores_gemma":[0.00053107465,0.00014491852,0.0023031998,0.000026291998,0.000022560005,0.00006773254,0.000055272238,0.00010646681,0.033420227,0.00018117893,0.962974,0.00016707869],"about_ca_topic_score_codex":0.000006283193,"about_ca_topic_score_gemma":5.631656e-7,"teacher_disagreement_score":0.5234159,"about_ca_system_score_codex":0.000038369915,"about_ca_system_score_gemma":0.0000081574135,"threshold_uncertainty_score":0.9994441},"labels":[],"label_agreement":null},{"id":"W6931438848","doi":"10.5281/zenodo.6941498","title":"Antibody Characterization Report for Mitogenactivated protein kinase 1 (MAPK1)","year":2022,"lang":"en","type":"article","venue":"Zenodo (CERN European Organization for Nuclear Research)","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Neurological Institute and Hospital","funders":"","keywords":"Immunoprecipitation; Antibody; Protein kinase A; Mitogen-activated protein kinase kinase; Kinase; MAP2K7; Cyclin-dependent kinase 9; c-Raf","score_opus":0.0215495625673884,"score_gpt":0.2462846470707449,"score_spread":0.2247350845033565,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6931438848","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88648695,0.00004656005,0.09597906,0.00047656376,0.00024365536,0.0016665135,0.0011528698,0.00031050207,0.013637308],"genre_scores_gemma":[0.81700623,0.00001095874,0.00026624405,0.00012683697,0.00027398457,0.0000013432375,0.17827195,0.00077855116,0.003263898],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9986773,0.00020500009,0.00021414833,0.00043079798,0.00021077962,0.0002619753],"domain_scores_gemma":[0.999038,0.00000325424,0.0001424896,0.00041649383,0.00030418942,0.00009558048],"candidate_categories":["sts","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004725604,0.000116238596,0.00010090452,0.000093906005,0.0018109059,0.0001462247,0.00044809948,0.00005200817,0.0018708889],"category_scores_gemma":[0.0003433773,0.00013274304,0.00006155701,0.00021443535,0.000044708482,0.000012665752,0.00076627487,0.000118010634,0.00014535744],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017240859,0.0001208593,0.000006538414,0.000030819498,0.000029437013,0.000023892922,0.00008956935,0.000011253016,0.9888414,0.00037916543,0.004738906,0.005555759],"study_design_scores_gemma":[0.00043135913,0.0005401509,0.00023708215,0.0000047596686,0.0000071711524,0.00020897656,0.00007821224,0.00007635769,0.1406781,0.000027482185,0.8575671,0.00014324952],"about_ca_topic_score_codex":0.0000044663752,"about_ca_topic_score_gemma":7.073998e-8,"teacher_disagreement_score":0.8528282,"about_ca_system_score_codex":0.00005116859,"about_ca_system_score_gemma":0.000009463966,"threshold_uncertainty_score":0.9994886},"labels":[],"label_agreement":null},{"id":"W6931550473","doi":"10.5479/si.097884601x.10\"&gt;10.5479/si.097884601x.10&lt;/a&gt","title":"From Tent to Trading Post and Back Again - Smithsonian Anthropology in Nunavut, Nunavik, Nitassinan, and Nunatsiavut: The Changing IPY Agenda, 1882 2007","year":2009,"lang":"en","type":"other","venue":"DSpace Repository (Smithsonian)","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Field (mathematics); Ethnography; Term (time); History of anthropology","score_opus":0.007453054626166857,"score_gpt":0.23620933734459656,"score_spread":0.2287562827184297,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6931550473","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8227511,0.047696806,0.0006888976,0.0040504513,0.0030466786,0.0026705074,0.0006252174,0.00018246938,0.11828784],"genre_scores_gemma":[0.60370326,0.0037074743,0.004460496,0.003970341,0.0067557776,0.00021698755,0.00010134469,0.0013512197,0.37573314],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.996668,0.0002969011,0.0004636979,0.0013459529,0.0002821975,0.00094327447],"domain_scores_gemma":[0.99829936,0.00004972946,0.00033362483,0.00092835736,0.00005293753,0.00033601193],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00032097407,0.0007759577,0.0007352736,0.00039173506,0.00030026564,0.00016144328,0.00043341663,0.0009075349,0.00019466395],"category_scores_gemma":[0.00006000904,0.0006553199,0.00015513528,0.00023534287,0.00037014054,0.000011984075,0.00028272966,0.00048786483,0.000049160095],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00078074296,0.00075804134,0.14706874,0.00063412415,0.0012413192,0.0025457956,0.012273606,0.000018676585,0.095456846,0.00024243658,0.6752978,0.063681886],"study_design_scores_gemma":[0.003990457,0.002501236,0.19107205,0.0023527953,0.00045080073,0.001247199,0.007142289,0.0003173804,0.03206047,0.00012228909,0.75484604,0.0038970152],"about_ca_topic_score_codex":0.0027482186,"about_ca_topic_score_gemma":0.0026300522,"teacher_disagreement_score":0.25744528,"about_ca_system_score_codex":0.00011514869,"about_ca_system_score_gemma":0.00018901705,"threshold_uncertainty_score":0.9995898},"labels":[],"label_agreement":null},{"id":"W6931590913","doi":"10.5281/zenodo.8320154","title":"Lasioglossum (Dialictus) helianthi","year":2023,"lang":"en","type":"article","venue":"Zenodo (CERN European Organization for Nuclear Research)","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Manitoba","funders":"","keywords":"Margin (machine learning); Dorsum; Thermokarst","score_opus":0.03132129813550377,"score_gpt":0.2464983750202048,"score_spread":0.21517707688470103,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6931590913","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.73663837,0.00023759923,0.0030033702,0.0018135889,0.00052437006,0.00061567605,0.00059558445,0.0014025462,0.25516888],"genre_scores_gemma":[0.99019796,0.00025674194,0.000091249414,0.00022156979,0.00039374598,5.98735e-8,0.004251057,0.0008241185,0.0037635288],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99889374,0.00014164322,0.00013560137,0.00032626415,0.00017902063,0.0003237126],"domain_scores_gemma":[0.9992258,0.0000045911515,0.000040978623,0.00039063563,0.00019382068,0.00014415303],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00037087826,0.00010043648,0.00008038875,0.0001145568,0.0009838245,0.00020250946,0.0005243382,0.00007893875,0.0020277728],"category_scores_gemma":[0.00035372018,0.00010354441,0.00005134558,0.00033912456,0.000084592495,0.000006980038,0.0008413928,0.000091534464,0.013212174],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000040622457,0.000052998195,0.00001468808,0.000031285905,0.00003513269,0.000021122738,0.0001831669,0.000017042621,0.46210542,0.0021072337,0.49899346,0.036397815],"study_design_scores_gemma":[0.0002687316,0.00022115458,0.00056129845,0.0000065256586,0.000004219799,0.000044869925,0.000107081745,0.000060831906,0.023117332,0.00006713747,0.9754157,0.00012512108],"about_ca_topic_score_codex":0.0000041871444,"about_ca_topic_score_gemma":3.5090926e-7,"teacher_disagreement_score":0.47642222,"about_ca_system_score_codex":0.000017590182,"about_ca_system_score_gemma":0.000003892835,"threshold_uncertainty_score":0.9988845},"labels":[],"label_agreement":null},{"id":"W6939113131","doi":"10.60692/necx6-1sh61","title":"MK3 Modulation Affects BMI1-Dependent and Independent Cell Cycle Check-Points","year":2015,"lang":"en","type":"article","venue":"Greater South Information System","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Cell cycle; Fibroblast; Cell growth; Cell; Carcinogenesis; Senescence; Epigenetics","score_opus":0.02042482514501518,"score_gpt":0.19746634159446497,"score_spread":0.1770415164494498,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6939113131","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98088247,0.00001283926,0.010000322,0.000015246426,0.00035509432,0.0003117289,0.000038578964,0.00004438557,0.008339331],"genre_scores_gemma":[0.99918306,3.7737493e-7,0.00019046996,0.00008152633,0.0001276125,0.000034642046,0.00009176209,0.000010878177,0.0002796546],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99906546,0.000057635796,0.0002709628,0.00017656547,0.00024195477,0.0001874149],"domain_scores_gemma":[0.99926096,0.0000012719003,0.00017741365,0.00028771276,0.00010824456,0.00016439322],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003410596,0.00015466206,0.00013629261,0.00008347337,0.000063253734,0.00008994681,0.00009719082,0.00016863043,0.000003863521],"category_scores_gemma":[0.000015935544,0.000136404,0.000038236965,0.000048574115,0.000015913865,0.000036946647,0.00010590106,0.000055245964,0.00020632512],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013301902,0.00006430968,0.83051115,0.0027995245,0.0003374939,0.00004716297,0.11578638,0.0051488187,0.03162134,0.0010216807,0.0049950015,0.0063369274],"study_design_scores_gemma":[0.01743903,0.0017265088,0.33036217,0.00027523446,0.00015294855,0.0006660994,0.038888168,0.02525536,0.57516086,0.000034612935,0.007760848,0.0022781463],"about_ca_topic_score_codex":0.00000705085,"about_ca_topic_score_gemma":6.9728816e-7,"teacher_disagreement_score":0.5435395,"about_ca_system_score_codex":0.000039152113,"about_ca_system_score_gemma":0.00004456214,"threshold_uncertainty_score":0.55623937},"labels":[],"label_agreement":null},{"id":"W6939236861","doi":"10.60692/p6tn8-w0m15","title":"MK3 Modulation Affects BMI1-Dependent and Independent Cell Cycle Check-Points","year":2015,"lang":"en","type":"article","venue":"Greater South Information System","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Cell cycle; Fibroblast; Cell growth; Cell; Carcinogenesis; Senescence; Epigenetics","score_opus":0.02042482514501518,"score_gpt":0.19746634159446497,"score_spread":0.1770415164494498,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6939236861","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98088247,0.00001283926,0.010000322,0.000015246426,0.00035509432,0.0003117289,0.000038578964,0.00004438557,0.008339331],"genre_scores_gemma":[0.99918306,3.7737493e-7,0.00019046996,0.00008152633,0.0001276125,0.000034642046,0.00009176209,0.000010878177,0.0002796546],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99906546,0.000057635796,0.0002709628,0.00017656547,0.00024195477,0.0001874149],"domain_scores_gemma":[0.99926096,0.0000012719003,0.00017741365,0.00028771276,0.00010824456,0.00016439322],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003410596,0.00015466206,0.00013629261,0.00008347337,0.000063253734,0.00008994681,0.00009719082,0.00016863043,0.000003863521],"category_scores_gemma":[0.000015935544,0.000136404,0.000038236965,0.000048574115,0.000015913865,0.000036946647,0.00010590106,0.000055245964,0.00020632512],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013301902,0.00006430968,0.83051115,0.0027995245,0.0003374939,0.00004716297,0.11578638,0.0051488187,0.03162134,0.0010216807,0.0049950015,0.0063369274],"study_design_scores_gemma":[0.01743903,0.0017265088,0.33036217,0.00027523446,0.00015294855,0.0006660994,0.038888168,0.02525536,0.57516086,0.000034612935,0.007760848,0.0022781463],"about_ca_topic_score_codex":0.00000705085,"about_ca_topic_score_gemma":6.9728816e-7,"teacher_disagreement_score":0.5435395,"about_ca_system_score_codex":0.000039152113,"about_ca_system_score_gemma":0.00004456214,"threshold_uncertainty_score":0.55623937},"labels":[],"label_agreement":null},{"id":"W6957908865","doi":"10.6084/m9.figshare.12873323.v1","title":"Additional file 8 of Genome-wide gene expression analysis supports a developmental model of low temperature tolerance gene regulation in wheat (Triticum aestivum L.)","year":2020,"lang":"en","type":"article","venue":"Figshare","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"","keywords":"Gene expression; Gene; Regulation of gene expression; Expression (computer science); Gene expression profiling; Regulator gene","score_opus":0.013896541151029323,"score_gpt":0.19941329271452685,"score_spread":0.18551675156349753,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6957908865","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.07057685,0.00007084023,0.000050718987,0.00001516649,0.000004663344,0.0001268238,0.92893934,0.000005381984,0.00021019249],"genre_scores_gemma":[0.39899912,0.0000013988297,0.0031377727,0.000082398066,0.000048123922,0.000098193486,0.5975161,0.000007959418,0.00010889002],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99913067,0.000024180941,0.00026632435,0.00029081263,0.00015232498,0.00013568717],"domain_scores_gemma":[0.9995045,0.000033786237,0.00012681093,0.00013879528,0.000120621786,0.00007545391],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00001454551,0.00012428578,0.00020442728,0.00006219106,0.00002382363,0.0000048410457,0.000116455296,0.00014798445,0.4899367],"category_scores_gemma":[0.00038037274,0.00012692198,0.00010443495,0.00022052866,0.0000089054665,0.0000084616895,0.00008777713,0.000060336224,0.000023765944],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002812163,0.00002612088,0.000071715585,0.00006282853,0.000020464036,0.0000037513812,0.00003253526,0.0048137982,0.53026384,7.096849e-8,0.46465948,0.000017259576],"study_design_scores_gemma":[0.0002679872,0.000068097586,0.011563934,0.0003252794,0.000013363258,0.000003269255,0.000016514878,0.004572464,0.97077,0.000003867798,0.012209695,0.0001855328],"about_ca_topic_score_codex":7.531068e-7,"about_ca_topic_score_gemma":0.000007231728,"teacher_disagreement_score":0.48991293,"about_ca_system_score_codex":0.000013315039,"about_ca_system_score_gemma":0.00018268185,"threshold_uncertainty_score":0.5175728},"labels":[],"label_agreement":null},{"id":"W6967290733","doi":"10.5281/zenodo.10581731","title":"ATR: SCAF1 immunoprecipitation","year":2023,"lang":"en","type":"article","venue":"Zenodo (CERN European Organization for Nuclear Research)","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Immunoprecipitation; Spectral line; Antibody; Monoclonal antibody","score_opus":0.02756479338311642,"score_gpt":0.24374128268047318,"score_spread":0.21617648929735675,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6967290733","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7856724,0.0003696953,0.003986044,0.00069380837,0.0003875965,0.00053336134,0.00026192935,0.0010383588,0.20705679],"genre_scores_gemma":[0.98753095,0.00027006504,0.0001368077,0.00010630357,0.00027112587,6.902776e-8,0.0070707076,0.0007331182,0.0038808677],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99905604,0.0001342135,0.00013262063,0.00027563886,0.00015873667,0.0002427378],"domain_scores_gemma":[0.999318,0.0000048541046,0.00004571103,0.00033546687,0.00021264353,0.000083326246],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00037219614,0.00008652737,0.000066196284,0.00010723405,0.00087256375,0.00017955631,0.0004269055,0.0000660468,0.0014193535],"category_scores_gemma":[0.00027665278,0.00009342083,0.000044750315,0.00029973063,0.000059993978,0.000011762343,0.0005831897,0.0000783642,0.009516537],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005857404,0.000038858838,0.000011423348,0.000031214426,0.00002974029,0.000006733332,0.0002862266,0.00004968424,0.54139656,0.0011051925,0.375596,0.081389785],"study_design_scores_gemma":[0.00028361214,0.00023379632,0.0013309222,0.000006716773,0.0000048693887,0.000035490993,0.00014129934,0.00007925243,0.01645545,0.000103317434,0.9812116,0.00011364764],"about_ca_topic_score_codex":0.0000030885685,"about_ca_topic_score_gemma":1.8849622e-7,"teacher_disagreement_score":0.6056156,"about_ca_system_score_codex":0.00002000356,"about_ca_system_score_gemma":0.00000275735,"threshold_uncertainty_score":0.9994935},"labels":[],"label_agreement":null},{"id":"W6969086089","doi":"10.5281/zenodo.7308668","title":"atmos-cloud-sim-uj/PySDM-examples: PySDM-examples v2.14","year":2022,"lang":"en","type":"other","venue":"Zenodo (CERN European Organization for Nuclear Research)","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Semtech (Canada)","funders":"","keywords":"Breakup; Product (mathematics); Plot (graphics); Current (fluid); Event (particle physics)","score_opus":0.028208722359177034,"score_gpt":0.23248044913913116,"score_spread":0.20427172677995412,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6969086089","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0021049522,0.0012751307,0.0014266243,0.00018585728,0.0006279416,0.0009034567,0.0020514908,0.0010370918,0.99038744],"genre_scores_gemma":[0.02262377,0.0028124272,0.0011992333,0.0010319815,0.0044277585,0.0000016190899,0.067509644,0.028534966,0.8718586],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9969046,0.00050420675,0.0003628301,0.0010512198,0.0005254084,0.0006516947],"domain_scores_gemma":[0.9979351,0.000013900353,0.00027709026,0.0012646707,0.00022666127,0.0002825893],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00052911614,0.00043426413,0.00035544002,0.00022958113,0.0011983323,0.0003660169,0.0016796434,0.00035080576,0.11056656],"category_scores_gemma":[0.00044918605,0.0004726893,0.00017497981,0.00035107735,0.00023030242,0.000009298452,0.0026955337,0.00045669655,0.0055234865],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005547001,0.00012757856,0.000008251308,0.00012790355,0.00016078445,0.00002538043,0.00014932483,0.000007345067,0.015852148,0.0013265429,0.9723053,0.009853967],"study_design_scores_gemma":[0.0006320026,0.00052454293,0.000058371294,0.000037379566,0.000041297284,0.00009951636,0.00020579831,0.000008247766,0.0009063548,0.00004440597,0.9969192,0.0005228536],"about_ca_topic_score_codex":0.00008987499,"about_ca_topic_score_gemma":0.000008649293,"teacher_disagreement_score":0.11852885,"about_ca_system_score_codex":0.00010480691,"about_ca_system_score_gemma":0.000022643992,"threshold_uncertainty_score":0.9997725},"labels":[],"label_agreement":null},{"id":"W6976900606","doi":"10.6084/m9.figshare.13161576","title":"Additional file 7 of TRIM25 promotes Capicua degradation independently of ERK in the absence of ATXN1L","year":2020,"lang":"en","type":"article","venue":"Figshare","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; Canada's Michael Smith Genome Sciences Centre; Simon Fraser University; University of British Columbia; BC Cancer Agency","funders":"","keywords":"Gene knockdown; Western blot; Cell culture; Blot; Northern blot; Messenger RNA; Small interfering RNA; Cell","score_opus":0.029590144715436018,"score_gpt":0.2229487473642402,"score_spread":0.19335860264880417,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6976900606","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.012858508,0.00005499575,0.0000010823891,0.000023361104,0.0000040663335,0.00011610192,0.9855973,0.000001515231,0.0013430276],"genre_scores_gemma":[0.39177763,8.79485e-7,0.000118347474,0.000046879766,0.000035989855,0.00007665738,0.6078838,0.0000032585763,0.000056556804],"study_design_codex":"not_applicable","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99955046,0.000028624714,0.00015070202,0.00010121282,0.00011169222,0.000057293182],"domain_scores_gemma":[0.99958694,0.00008696378,0.0001306405,0.00010850982,0.00006985017,0.000017099777],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000018246341,0.000050495593,0.000080961785,0.000013819958,0.000008499161,0.0000019670422,0.00015482638,0.00006112179,0.5129383],"category_scores_gemma":[0.0011480236,0.00003983364,0.000043401793,0.00007627544,0.000008819289,0.000002624644,0.00004213032,0.000041333533,0.000025444697],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000013853007,0.000029497478,0.000030945113,0.00010459952,0.000006362903,0.0000011813902,0.00007421082,0.000002804072,0.039674602,0.0000053424774,0.95966697,0.00038960986],"study_design_scores_gemma":[0.00041092327,0.00056790304,0.019006776,0.00071969064,0.0000047961153,0.000006790599,0.00022043232,0.000098361794,0.58917516,0.00004090213,0.38960478,0.00014344385],"about_ca_topic_score_codex":0.000004335697,"about_ca_topic_score_gemma":0.000013589355,"teacher_disagreement_score":0.5700622,"about_ca_system_score_codex":0.0000016193572,"about_ca_system_score_gemma":0.00008092593,"threshold_uncertainty_score":0.48750696},"labels":[],"label_agreement":null},{"id":"W6977622042","doi":"10.6084/m9.figshare.3578379","title":"Trends in Relative Abundance and Early Life Survival of Atlantic Menhaden during 1977–2013 from Long-Term Ichthyoplankton Programs","year":2016,"lang":"en","type":"article","venue":"Figshare","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Ichthyoplankton; Larva; Abundance (ecology); Juvenile; Chesapeake bay; Relative species abundance; North Atlantic oscillation","score_opus":0.02358459435305714,"score_gpt":0.24027648955098554,"score_spread":0.21669189519792842,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6977622042","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9901977,0.0008542124,0.0000024577782,0.000047019887,0.000032901255,0.00011115525,0.00842324,0.00001045091,0.0003208367],"genre_scores_gemma":[0.9883506,0.0000349146,0.000028559536,0.0000060726707,0.00011866909,0.00004472808,0.010861102,0.000016302649,0.0005390656],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99917,0.000043321827,0.00018679105,0.00030476917,0.00009816651,0.00019693938],"domain_scores_gemma":[0.99953634,0.000023925264,0.000104742794,0.00021621975,0.000034649063,0.00008415078],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000031034262,0.0001354351,0.00017875872,0.000049345857,0.00002463494,0.000014513663,0.00012985148,0.00014456475,0.0021441418],"category_scores_gemma":[0.00009938644,0.0001032747,0.000049876544,0.00006605708,0.000018382289,0.000011091797,0.00012023959,0.0000583162,0.0000447458],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021832828,0.000093308896,0.57298034,0.00016176546,0.00011356605,0.000056269393,0.00035027406,5.358486e-7,0.41209173,0.000006304971,0.0037264887,0.010201095],"study_design_scores_gemma":[0.000917315,0.00020751309,0.93871725,0.0008188763,0.000008450496,0.000004400772,0.000007940324,0.0000012788022,0.0575152,0.000010865024,0.0016108366,0.00018008634],"about_ca_topic_score_codex":0.00009417613,"about_ca_topic_score_gemma":0.0004200278,"teacher_disagreement_score":0.3657369,"about_ca_system_score_codex":0.00000777665,"about_ca_system_score_gemma":0.000024656534,"threshold_uncertainty_score":0.99876803},"labels":[],"label_agreement":null},{"id":"W6981700026","doi":"","title":"Extracción de características morfológicas y análisis estadístico de imágenes digitales de microscopía de biomateriales con aplicaciones en ingeniería tisular","year":2016,"lang":"es","type":"dissertation","venue":"RiuNet (Politechnical University of Valencia)","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Head and neck; 3d printer; Glottis; Mallinckrodt","score_opus":0.007197873256983863,"score_gpt":0.24443650812399917,"score_spread":0.2372386348670153,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6981700026","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9871119,0.0016194748,0.0077337585,0.00012496636,0.00015991443,0.00043289777,0.0021973897,0.000089841094,0.0005298131],"genre_scores_gemma":[0.9876954,0.0050376127,0.004458976,0.000053461266,0.00034261242,0.0000063693774,0.0015241666,0.000077861885,0.0008035229],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9967833,0.00040260557,0.00053726684,0.000910355,0.0002848011,0.001081652],"domain_scores_gemma":[0.9976509,0.00022366674,0.0005440266,0.00076338917,0.00027247475,0.0005455152],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0005080132,0.000635328,0.0007999851,0.00025991804,0.00039090074,0.000066359804,0.0010135933,0.0018371212,0.00007418373],"category_scores_gemma":[0.00041418773,0.00070503354,0.0005206759,0.0001711096,0.0005208481,0.00003504883,0.00041742052,0.0002754745,0.000020583157],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006444077,0.00029912876,0.01798306,0.0007271457,0.0002725136,0.00022336296,0.0007493608,0.000006041117,0.9756284,0.0008145727,0.00015882564,0.0024932215],"study_design_scores_gemma":[0.0010783386,0.00066867535,0.099184,0.0007188591,0.00079225644,0.00023539468,0.00094579585,0.000057105226,0.88418716,0.00060093263,0.010553243,0.0009782588],"about_ca_topic_score_codex":0.00071829534,"about_ca_topic_score_gemma":0.00016086975,"teacher_disagreement_score":0.091441214,"about_ca_system_score_codex":0.00037282196,"about_ca_system_score_gemma":0.0011263188,"threshold_uncertainty_score":0.9995401},"labels":[],"label_agreement":null},{"id":"W6983739028","doi":"","title":"The Novel Roles of MAP Kinase-Interacting Serine/Threonine- Protein Kinase 1 (MNK1) in Melanoma Progression","year":2020,"lang":"en","type":"dissertation","venue":"eScholarship@McGill (McGill)","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"McGill University","keywords":"EIF4E; MAPK/ERK pathway; Melanoma; PI3K/AKT/mTOR pathway; Kinase; Downregulation and upregulation; Translation (biology); Phosphorylation; Protein kinase A; EIF4EBP1","score_opus":0.012412843075706321,"score_gpt":0.2516364096251161,"score_spread":0.23922356654940977,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6983739028","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98490673,0.0012036326,7.7092795e-7,0.00005693526,0.0007672961,0.0013030231,0.00055657804,0.000051960793,0.011153057],"genre_scores_gemma":[0.9932162,0.00014123833,0.00088966923,0.00005530663,0.00013919619,0.0004116841,0.002395037,0.00017731184,0.002574349],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9963141,0.0002753716,0.001069099,0.0011134259,0.0005492656,0.00067873596],"domain_scores_gemma":[0.99760306,0.00008054293,0.00093110494,0.00083694956,0.000306824,0.00024151082],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006479549,0.0007388221,0.0006583847,0.00016128134,0.0005259624,0.00007144485,0.00085957756,0.0007911628,0.00002928441],"category_scores_gemma":[0.0009740464,0.0006262059,0.00036129152,0.00029263238,0.00007187584,0.0000357674,0.00032552154,0.0010690981,0.000036477733],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000978162,0.00021396493,0.00008498292,0.0005161479,0.00011554396,0.00006843245,0.000011949183,0.000008327626,0.9422986,0.0046807732,0.000007871298,0.05101524],"study_design_scores_gemma":[0.0010144719,0.00064897665,0.0004915796,0.000975877,0.000056113367,0.00001757062,0.00037731483,0.00003157795,0.8904523,0.00036042457,0.104931675,0.00064211694],"about_ca_topic_score_codex":0.00009667739,"about_ca_topic_score_gemma":0.002427361,"teacher_disagreement_score":0.1049238,"about_ca_system_score_codex":0.00011515158,"about_ca_system_score_gemma":0.00013793062,"threshold_uncertainty_score":0.99961895},"labels":[],"label_agreement":null},{"id":"W6990619212","doi":"","title":"Effectiveness of dabrafenib in the treatment of patients with &lt;i&gt;BRAF &lt;/i&gt;V600-mutated metastatic melanoma in a Named Patient Program","year":2019,"lang":"en","type":"article","venue":"UWA Profiles and Research Repository (UWA)","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Metastatic melanoma; Dabrafenib; Melanoma; Radiation therapy; Chemotherapy","score_opus":0.01135371363391633,"score_gpt":0.2704309587925473,"score_spread":0.25907724515863095,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6990619212","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99463207,0.0012079196,0.0000034030927,0.000011786156,0.00006727611,0.0031969037,0.000041110183,0.0000063280704,0.0008332287],"genre_scores_gemma":[0.9986932,0.00012021576,0.00017112603,0.0000029917437,0.00001912776,0.00065558194,0.0001769887,0.00002305861,0.00013769136],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99709344,0.0010977348,0.00038728604,0.0004936946,0.0005177789,0.00041004087],"domain_scores_gemma":[0.9988323,0.00017693994,0.00015191648,0.00050640374,0.000247367,0.000085079206],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006590346,0.00021418848,0.0003890186,0.00018069024,0.00007576562,0.000027919852,0.00021017305,0.00012060918,0.0000040956206],"category_scores_gemma":[0.000048794613,0.00012705156,0.000079682664,0.00030859426,0.00025095366,0.000011407421,0.00008334316,0.00012364314,0.0000015158598],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002075261,0.003135623,0.10718925,0.0007650608,0.00017655175,0.00006994513,0.0011258237,0.00002785244,0.8785281,0.000238323,0.00002226798,0.006645897],"study_design_scores_gemma":[0.0030226267,0.0119854165,0.2244832,0.00019065791,0.00002180882,0.000010473401,0.00024480504,0.00007607618,0.7584283,0.000026754247,0.0013609894,0.00014890051],"about_ca_topic_score_codex":0.00008697822,"about_ca_topic_score_gemma":0.000009741636,"teacher_disagreement_score":0.12009986,"about_ca_system_score_codex":0.000048988833,"about_ca_system_score_gemma":0.00017412764,"threshold_uncertainty_score":0.5181013},"labels":[],"label_agreement":null},{"id":"W6997474366","doi":"","title":"The αNAC transcriptional coregulator is a substrate of p38α MAP kinase","year":2016,"lang":"en","type":"dissertation","venue":"eScholarship@McGill (McGill)","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Kinase; Substrate (aquarium); Enzyme; MAP kinase kinase kinase; Protein kinase A; Substrate specificity; Signal transduction; Drosophila melanogaster","score_opus":0.011456803248181296,"score_gpt":0.2240894065185231,"score_spread":0.2126326032703418,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6997474366","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9702881,0.001928472,5.6239213e-7,0.00003905877,0.0015694959,0.00049548823,0.0037868218,0.00003317879,0.021858813],"genre_scores_gemma":[0.9672431,0.000693042,0.00009872751,0.00015848702,0.00017174114,0.00012754615,0.0019679125,0.00013424811,0.029405205],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9969745,0.000196358,0.0007766896,0.00088163646,0.00057238585,0.000598374],"domain_scores_gemma":[0.9977543,0.00005961342,0.0005336895,0.00093710003,0.00046531693,0.0002499937],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005122498,0.00061017124,0.00047986288,0.000105150255,0.00074823253,0.000040874493,0.0007362167,0.00090293685,0.00020819016],"category_scores_gemma":[0.00014143178,0.00046079836,0.00056380057,0.00013095548,0.0001492806,0.000020776028,0.00006630663,0.00045102488,0.00012637707],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00058471435,0.000093102164,0.000024708264,0.00018968787,0.00025167433,0.0000130263315,0.000004636255,5.3505755e-7,0.9392348,0.03482935,0.00010213887,0.024671614],"study_design_scores_gemma":[0.0007306314,0.0002461774,0.0012507681,0.00015524356,0.00010374772,0.000012403779,0.00007325056,8.7817034e-7,0.7345701,0.0051509193,0.2572198,0.00048607172],"about_ca_topic_score_codex":0.000046981426,"about_ca_topic_score_gemma":0.00046126344,"teacher_disagreement_score":0.25711766,"about_ca_system_score_codex":0.00007667751,"about_ca_system_score_gemma":0.00014148775,"threshold_uncertainty_score":0.99978435},"labels":[],"label_agreement":null},{"id":"W7000280021","doi":"","title":"Étude de l'hétérogénéité de la réponse immunitaires aux inhibiteurs des kinases RSK et PLK dans le mélanome","year":2024,"lang":"fr","type":"dissertation","venue":"Papyrus : Institutional Repository (Université de Montréal)","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Université de Montréal; Cancer Research Society","keywords":"Kinase; SAMHD1; Gain of function; Human immunodeficiency virus (HIV)","score_opus":0.005445796602505507,"score_gpt":0.19738224149766478,"score_spread":0.19193644489515926,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7000280021","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92236173,0.048332643,0.0006184384,0.00024104888,0.00060149474,0.0002809116,0.00020997328,0.00008873984,0.027265012],"genre_scores_gemma":[0.9644879,0.0030284256,0.00091758714,0.00017689775,0.00025964144,0.00005385725,0.0016812064,0.00008227837,0.029312195],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99707156,0.00066791783,0.0004182478,0.0007719789,0.00035705106,0.00071324286],"domain_scores_gemma":[0.9984246,0.00014224356,0.0002480055,0.00052040233,0.00022319623,0.0004415845],"candidate_categories":["metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.000481007,0.0006285869,0.00041538192,0.00026883988,0.004586833,0.00015367068,0.00056574127,0.0009773407,0.000018340781],"category_scores_gemma":[0.00019058006,0.0007482335,0.0005055269,0.00025967578,0.000813404,0.00005242991,0.00035596214,0.00064092386,0.00003958614],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009921965,0.0004529324,0.01257683,0.00051676127,0.0006596362,0.004885609,0.024795752,0.0023235413,0.90519744,0.045277175,0.00072856195,0.0015935895],"study_design_scores_gemma":[0.0016786355,0.000690879,0.09451132,0.0009433268,0.00081964314,0.00537118,0.08998564,0.0007407326,0.7507357,0.0019778565,0.05117017,0.0013748873],"about_ca_topic_score_codex":0.058965243,"about_ca_topic_score_gemma":0.027067011,"teacher_disagreement_score":0.15446168,"about_ca_system_score_codex":0.0022724585,"about_ca_system_score_gemma":0.006816357,"threshold_uncertainty_score":0.9994969},"labels":[],"label_agreement":null},{"id":"W70018851","doi":"10.1016/b978-012124546-7/50444-7","title":"MAP Kinases","year":2003,"lang":"en","type":"book-chapter","venue":"Elsevier eBooks","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"p38 mitogen-activated protein kinases; Kinase; MAPK/ERK pathway; Mitogen-activated protein kinase; Tyrosine kinase; Small molecule; Protein-Serine-Threonine Kinases; Biology; Computational biology; Protein kinase A; Signal transduction; Medicine; Bioinformatics; Cell biology; Biochemistry","score_opus":0.012202823450679006,"score_gpt":0.21848790712278376,"score_spread":0.20628508367210477,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W70018851","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00021887338,0.0038278727,0.000007805873,0.00003268921,0.0006266796,0.00027908478,0.00006404654,0.000020425232,0.9949225],"genre_scores_gemma":[0.0006299034,0.00018458585,0.00023285297,0.0010356806,0.0006942778,0.000026150738,0.0002414086,0.0000986053,0.9968565],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99877244,0.000021712436,0.00026161564,0.0005146769,0.00016045451,0.00026907478],"domain_scores_gemma":[0.99897784,0.0000061936216,0.00013963236,0.0006813209,0.00006654625,0.00012844321],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00009772764,0.00038394774,0.00030760496,0.000051665833,0.000070675975,0.00002283156,0.00022681717,0.00052197534,0.00030515756],"category_scores_gemma":[0.0000115191315,0.0003696341,0.00025696505,0.000002736225,0.00009737811,7.0869675e-7,0.00011421114,0.00019485415,0.0004146439],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003533422,0.000015250236,0.000010142357,0.0001380765,0.0002030356,0.00008798339,0.000020848925,2.8990578e-7,0.021546565,0.008655131,0.025316725,0.9439706],"study_design_scores_gemma":[0.00019927828,0.00017550366,0.0000024841872,0.00006718842,0.00005697247,0.000035660316,0.0000018798141,1.02987784e-7,0.012837468,0.0024568052,0.98373806,0.00042861322],"about_ca_topic_score_codex":1.5771366e-7,"about_ca_topic_score_gemma":0.000010541479,"teacher_disagreement_score":0.9584213,"about_ca_system_score_codex":0.000015212997,"about_ca_system_score_gemma":0.00009397541,"threshold_uncertainty_score":0.99987555},"labels":[],"label_agreement":null},{"id":"W7006065617","doi":"","title":"Synthèse et optimisation d'inhibiteurs spécifiques de ERK3 pour le développement d'une thérapie ciblée au cancer du sein triple-négatif","year":2022,"lang":"fr","type":"dissertation","venue":"Papyrus : Institutional Repository (Université de Montréal)","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cancer; Breast cancer; Immunosurveillance; Wilms' tumor","score_opus":0.01067306005750071,"score_gpt":0.2114415922600376,"score_spread":0.20076853220253688,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7006065617","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94875365,0.022764271,0.0047629783,0.0033579604,0.0019864386,0.00074316707,0.0003634007,0.00006891696,0.01719919],"genre_scores_gemma":[0.9475337,0.0055006775,0.0028894218,0.0005173962,0.0005616164,0.00024073443,0.004502794,0.00008013185,0.038173486],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9968107,0.00044635858,0.0005459047,0.00096828584,0.0005735053,0.000655286],"domain_scores_gemma":[0.99814373,0.0000612623,0.0005961693,0.00048138582,0.0003232627,0.00039418403],"candidate_categories":["metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.00044718685,0.0006244796,0.000462605,0.00025595992,0.0049910382,0.00007340965,0.00048312522,0.0006200859,0.00013748632],"category_scores_gemma":[0.000103531514,0.000784687,0.00044543477,0.00029841968,0.00020467918,0.000054280874,0.0002928359,0.00048566476,0.000014415208],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.002306554,0.0009832967,0.025472663,0.00051274546,0.0012369535,0.002045204,0.03870042,0.034702346,0.85355294,0.025159469,0.0076242182,0.0077031706],"study_design_scores_gemma":[0.0047844118,0.00068648235,0.05824611,0.0005564667,0.0008972025,0.0012174587,0.050805215,0.005942787,0.651678,0.00064536097,0.22249147,0.0020490065],"about_ca_topic_score_codex":0.10763022,"about_ca_topic_score_gemma":0.034013625,"teacher_disagreement_score":0.21486725,"about_ca_system_score_codex":0.0054936693,"about_ca_system_score_gemma":0.009411072,"threshold_uncertainty_score":0.9994604},"labels":[],"label_agreement":null},{"id":"W7011524568","doi":"","title":"New insights into MKK7 regulation in mammalian cells","year":2005,"lang":"en","type":"dissertation","venue":"eScholarship@McGill (McGill)","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Phosphorylation; Kinase; p38 mitogen-activated protein kinases; MAPK/ERK pathway; Protein kinase A; Mitogen-activated protein kinase; Mutant; Signal transduction","score_opus":0.008784869998845559,"score_gpt":0.2236614782020792,"score_spread":0.21487660820323365,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7011524568","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9185603,0.0010088995,0.0000014724528,0.000012404057,0.0013027077,0.00057552196,0.00009782961,0.00005658999,0.078384236],"genre_scores_gemma":[0.95499855,0.00044075534,0.0017169777,0.00019907788,0.00038880322,0.00007030722,0.0045594457,0.00018243032,0.03744368],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9966233,0.00023199488,0.00083469495,0.0012474474,0.00046839344,0.0005941714],"domain_scores_gemma":[0.9980791,0.000024101608,0.0004317008,0.0009074607,0.00018582755,0.0003717903],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0003043755,0.0007221712,0.0005516345,0.00037405858,0.0003423244,0.00005818316,0.0005887333,0.0015013168,0.00024818067],"category_scores_gemma":[0.00014490171,0.0007978303,0.00029666082,0.000339577,0.000028328835,0.000042814645,0.00012678257,0.00074138836,0.0003253959],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023547921,0.00009151702,0.000020398575,0.00012781456,0.000055210567,0.0000299288,0.00001571011,0.000046248137,0.8901188,0.0081964005,0.00010129078,0.1009612],"study_design_scores_gemma":[0.00080283143,0.00019313252,0.0017044148,0.00012940289,0.00004911672,0.000007462301,0.00008005248,0.000005529021,0.6975911,0.004414176,0.29429471,0.00072803],"about_ca_topic_score_codex":0.0005248353,"about_ca_topic_score_gemma":0.015438627,"teacher_disagreement_score":0.29419342,"about_ca_system_score_codex":0.00026069375,"about_ca_system_score_gemma":0.00015340214,"threshold_uncertainty_score":0.99979496},"labels":[],"label_agreement":null},{"id":"W7024313345","doi":"","title":"Rhamm-/- mice are defective in skin wound repair due to aberrant ERK1,2 signaling in \\nfibroblast migration","year":2006,"lang":"en","type":"article","venue":"eScholarship (California Digital Library)","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Congressionally Directed Medical Research Programs; Biological and Environmental Research; Canadian Institutes of Health Research; Breast Cancer Society of Canada; U.S. Department of Energy; U.S. Department of Defense","keywords":"Wound healing; Signal transduction; Immune system; Fibroblast; Tissue repair; Disease; Inflammation; Cell migration","score_opus":0.006880987525309037,"score_gpt":0.19331985505314986,"score_spread":0.18643886752784083,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7024313345","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9933538,0.0002612184,0.00023552292,0.00017605898,0.00007362516,0.00045079488,0.00060941157,0.000079389036,0.0047602234],"genre_scores_gemma":[0.9968241,0.0000048244056,0.0008045477,0.00035973618,0.0002416657,0.000066538836,0.0011729354,0.00006489526,0.00046078837],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99799335,0.00011644337,0.0005134542,0.0006862462,0.000198264,0.00049222267],"domain_scores_gemma":[0.9993047,0.000044864268,0.00012338073,0.00033112353,0.00003528476,0.00016062739],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00019331292,0.0003175294,0.0002911372,0.00023112564,0.00006269821,0.00030286823,0.0002477428,0.00027301704,0.00003457576],"category_scores_gemma":[0.00015554552,0.00032502468,0.00017464964,0.00045863574,0.000040682575,0.00013706584,0.00017515873,0.00027882593,0.00024758303],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00080111565,0.0006439148,0.6926402,0.00012344234,0.000043678567,0.00034583345,0.0000888392,0.0012789703,0.29808325,0.0004001949,0.004354497,0.001196042],"study_design_scores_gemma":[0.0021530136,0.0005972354,0.2833254,0.00043808934,0.00001786289,0.00008462132,0.00023785695,0.00017982243,0.5879165,0.0036750177,0.120007016,0.0013675577],"about_ca_topic_score_codex":0.000077069024,"about_ca_topic_score_gemma":0.0007795274,"teacher_disagreement_score":0.4093148,"about_ca_system_score_codex":0.00004484113,"about_ca_system_score_gemma":0.00009224862,"threshold_uncertainty_score":0.9999202},"labels":[],"label_agreement":null},{"id":"W7028458492","doi":"","title":"ERK4, a new tumor suppressor gene candidate implicated in prostate cancer progression","year":2005,"lang":"en","type":"dissertation","venue":"eScholarship@McGill (McGill)","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Prostate cancer; Tumor suppressor gene; Candidate gene; Locus (genetics); Metastasis; Allele; Cancer; Microarray analysis techniques; Gene; Genotyping","score_opus":0.010162663386806702,"score_gpt":0.26521674450347604,"score_spread":0.25505408111666933,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7028458492","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9813012,0.002473585,8.215546e-8,0.000034341738,0.0006943202,0.0014456616,0.002260379,0.00009004108,0.011700394],"genre_scores_gemma":[0.97084314,0.0012565823,0.0005191477,0.00030773322,0.00029201587,0.0008225925,0.009023926,0.0002794189,0.016655423],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99578243,0.00021495752,0.00090636074,0.0015736949,0.00048972946,0.0010328336],"domain_scores_gemma":[0.9976883,0.000018273813,0.00060693704,0.00092833134,0.00025432825,0.0005038455],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00035761125,0.0008838845,0.0007175483,0.00027830055,0.00037627676,0.00007502663,0.00069536414,0.0007828927,0.00019417531],"category_scores_gemma":[0.00018454969,0.00087216543,0.0002772811,0.00037289728,0.000044683635,0.000038222774,0.00020645355,0.00091658765,0.000088554545],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00095349445,0.00017655073,0.0002371227,0.00019162668,0.00012421943,0.00011144134,0.000009381303,0.000025709882,0.9318676,0.0003580268,0.00013520301,0.0658096],"study_design_scores_gemma":[0.0017669247,0.000286074,0.0028828986,0.00034827666,0.00009845601,0.000049648395,0.000043036485,0.000008970422,0.8516765,0.00038615058,0.14147753,0.0009755265],"about_ca_topic_score_codex":0.001130704,"about_ca_topic_score_gemma":0.011832669,"teacher_disagreement_score":0.14134233,"about_ca_system_score_codex":0.00028077082,"about_ca_system_score_gemma":0.00036126736,"threshold_uncertainty_score":0.9993729},"labels":[],"label_agreement":null},{"id":"W7034750744","doi":"","title":"Transplant Glomerulopathy, Late Antibody-Mediated Rejection and the ABCD Tetrad in Kidney Allograft Biopses for Cause","year":2007,"lang":"en","type":"article","venue":"NPARC","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Kidney; Tetrad; Kidney transplant; Kidney transplantation; Transplantation","score_opus":0.008621300434230967,"score_gpt":0.24756249071980677,"score_spread":0.2389411902855758,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7034750744","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938148,0.0003466922,0.0029986738,0.00045211744,0.00020434734,0.0003729739,0.00008776732,0.000014652984,0.0017079592],"genre_scores_gemma":[0.9976127,0.0007719336,0.00052207103,0.00046930456,0.00012738205,0.000019047875,0.00026800294,0.000014135029,0.00019538405],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99922407,0.000038060945,0.0001853151,0.00023438329,0.000069014015,0.00024914733],"domain_scores_gemma":[0.9996327,0.000048873477,0.000044527973,0.00015841342,0.000027833401,0.000087645],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004886186,0.000117541436,0.00012989451,0.000052706215,0.00006115583,0.000014060605,0.00008252225,0.00013312332,0.000006954042],"category_scores_gemma":[0.00010696269,0.00008370031,0.000054368706,0.00008787411,0.000107686385,0.000003148145,0.000018296103,0.00007173918,0.000002161573],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00054430775,0.000033955115,0.0077970414,0.00003413534,0.000022815899,0.00001248793,0.00015203842,7.4993693e-7,0.9895871,0.0003395396,0.00037546502,0.0011003083],"study_design_scores_gemma":[0.009295636,0.0007277761,0.046381496,0.00011167796,0.000093727904,0.00011967226,0.00015061475,0.0003743035,0.8700161,0.001686108,0.070521444,0.0005214736],"about_ca_topic_score_codex":0.000038558563,"about_ca_topic_score_gemma":0.00017334176,"teacher_disagreement_score":0.11957108,"about_ca_system_score_codex":0.0000059546524,"about_ca_system_score_gemma":0.000037306396,"threshold_uncertainty_score":0.34131995},"labels":[],"label_agreement":null},{"id":"W7039633588","doi":"","title":"Mountains to climb – healthcare challenges in rural British Columbia","year":2023,"lang":"en","type":"article","venue":"Figshare","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Health care; Rural area; Population; Referral; Rural health; Service (business); Relocation; Quality (philosophy)","score_opus":0.05599379876591076,"score_gpt":0.27625425906694784,"score_spread":0.22026046030103708,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7039633588","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.87969,0.0024914746,1.3002662e-7,0.0011214622,0.00015050809,0.00050114584,0.11256379,0.00009505798,0.0033864593],"genre_scores_gemma":[0.9122465,0.00025949744,0.000016113441,0.0005001246,0.00027034376,0.00032205632,0.08440585,0.00002731773,0.0019521927],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99917877,0.00003261627,0.00012366519,0.00026387558,0.00008986813,0.00031120665],"domain_scores_gemma":[0.9995785,0.000008692121,0.000023893637,0.00022281881,0.000048316913,0.000117827556],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00004781195,0.0000730101,0.000107201435,0.000028831086,0.000052951284,0.00005935806,0.00016362961,0.00013497907,0.0043800324],"category_scores_gemma":[0.00022083722,0.000118276854,0.000045043984,0.00013733919,0.000002858677,0.0000024216147,0.00017262195,0.00006898058,0.0009805607],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000010920992,0.000027615406,0.0025019096,0.00020639728,0.000008921181,0.000118287426,0.000111880465,0.000007603747,0.004998999,0.0000066071543,0.9556298,0.036371037],"study_design_scores_gemma":[0.0003626163,0.00034354292,0.1955111,0.0006690583,0.00000131609,0.000033891134,0.00047607612,0.000015523916,0.0013858665,0.000039520677,0.8008722,0.00028928198],"about_ca_topic_score_codex":0.0008887472,"about_ca_topic_score_gemma":0.08660147,"teacher_disagreement_score":0.1930092,"about_ca_system_score_codex":0.000015587862,"about_ca_system_score_gemma":0.000054945358,"threshold_uncertainty_score":0.9997973},"labels":[],"label_agreement":null},{"id":"W7043179990","doi":"","title":"Rôle de la signalisation par ERK et de la sénescence cellulaire dans la progression du cancer pancréatique","year":2022,"lang":"fr","type":"dissertation","venue":"Papyrus : Institutional Repository (Université de Montréal)","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"MAPK/ERK pathway; Extracellular signal-regulated kinases; Kinase; Cancer","score_opus":0.0030215408433268967,"score_gpt":0.20196235655652456,"score_spread":0.19894081571319766,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7043179990","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9487832,0.01270893,0.0021144592,0.00017926544,0.0005637118,0.00037557053,0.00016336616,0.000050356633,0.03506114],"genre_scores_gemma":[0.9847165,0.002908304,0.0008038749,0.00010307734,0.00028805935,0.000134375,0.0017173543,0.000049150854,0.009279314],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9966357,0.0015301886,0.00032101755,0.00066237844,0.00042125685,0.0004295123],"domain_scores_gemma":[0.99864835,0.00017314148,0.00041463427,0.00032578106,0.00015774381,0.0002803773],"candidate_categories":["metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.00069063564,0.00043384972,0.0002984995,0.00011478699,0.0035888487,0.000080228434,0.00041257415,0.0008924893,0.00007569327],"category_scores_gemma":[0.00011281725,0.0005106566,0.0002746197,0.00017994718,0.0004545484,0.00004059452,0.00020830189,0.0005847207,0.0000047462186],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006706701,0.00034125504,0.07591923,0.00026297866,0.00020968232,0.0019410105,0.026590126,0.0045662206,0.86109,0.025746016,0.0006653033,0.001997482],"study_design_scores_gemma":[0.001535275,0.00034854186,0.11710255,0.00057005504,0.0004742248,0.0019289482,0.025259461,0.0019270323,0.63028526,0.00032987943,0.2192398,0.0009989531],"about_ca_topic_score_codex":0.016937925,"about_ca_topic_score_gemma":0.0032374097,"teacher_disagreement_score":0.23080473,"about_ca_system_score_codex":0.0028140442,"about_ca_system_score_gemma":0.0055214185,"threshold_uncertainty_score":0.9997345},"labels":[],"label_agreement":null},{"id":"W7066542686","doi":"","title":"Interaction of combined administration of multi-targeted kinase inhibitors with ionizing radiation","year":2014,"lang":"en","type":"dissertation","venue":"eScholarship@McGill (McGill)","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Institutes of Health Research; McGill University","keywords":"Ionizing radiation; Radiation therapy; Cancer; Sorafenib; In vivo; Breast cancer; Radiation sensitivity; Cancer cell; Kinase","score_opus":0.01181685063901404,"score_gpt":0.23916196535394693,"score_spread":0.2273451147149329,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7066542686","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945468,0.00025467057,0.0000064585865,0.0000032136809,0.0007854522,0.00052597,0.00032877413,0.000029843137,0.0035188643],"genre_scores_gemma":[0.991178,0.00010417951,0.00067136216,0.000021046451,0.000068304806,0.000062128696,0.0070744106,0.00009104238,0.0007295308],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9977178,0.00022856882,0.0008083172,0.00061562756,0.00036210983,0.00026756607],"domain_scores_gemma":[0.9976129,0.000039718845,0.0012090363,0.00050254585,0.0005018901,0.00013389994],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00036955092,0.000435006,0.0005004168,0.00023270803,0.0001988781,0.00001815934,0.00023041623,0.00066071533,0.000024828398],"category_scores_gemma":[0.00037508356,0.0004386266,0.00021143444,0.0002112491,0.000047202848,0.00003541329,0.00003883003,0.00037906892,0.000008619527],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014364222,0.0002646241,0.00012689203,0.00039535773,0.00015576136,0.000005660697,0.000007421588,0.000048229034,0.96019614,0.0012168912,0.000004716562,0.036141887],"study_design_scores_gemma":[0.0014996808,0.001696464,0.0019598794,0.0003100099,0.0001443834,0.000010435163,0.0001703453,0.000049638253,0.98851085,0.00010123766,0.005107439,0.00043963466],"about_ca_topic_score_codex":0.00010931721,"about_ca_topic_score_gemma":0.0008376211,"teacher_disagreement_score":0.03570225,"about_ca_system_score_codex":0.000080759346,"about_ca_system_score_gemma":0.000099156634,"threshold_uncertainty_score":0.9998065},"labels":[],"label_agreement":null},{"id":"W7071460085","doi":"","title":"An shRNA expression system to interrogate the role of PTEN proximal genes in BRAFV600E-driven melanoma in vitro","year":2015,"lang":"en","type":"dissertation","venue":"eScholarship@McGill (McGill)","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"PTEN; Melanoma; Gene silencing; Neuroblastoma RAS viral oncogene homolog; Gene knockdown; Cancer; MAPK/ERK pathway; Small hairpin RNA; Suppressor","score_opus":0.009787350508491537,"score_gpt":0.24070911103934592,"score_spread":0.2309217605308544,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7071460085","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98671645,0.00072668155,2.3117522e-7,0.000004536597,0.00045957006,0.0010003616,0.00064340414,0.000034971243,0.010413802],"genre_scores_gemma":[0.9969415,0.000039408922,0.00040752764,0.00004098722,0.00009085012,0.00030337888,0.0016973121,0.00011920847,0.00035979363],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99659127,0.0005547514,0.0008611683,0.00097189436,0.00046550634,0.00055541494],"domain_scores_gemma":[0.9980448,0.00002582048,0.0004341184,0.0009748355,0.00024706102,0.0002733711],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00079560163,0.00056001154,0.0006606367,0.0003249758,0.00016187273,0.00003780342,0.0010268292,0.00079584395,0.000010169781],"category_scores_gemma":[0.00016795738,0.0004673719,0.00019313316,0.00028869367,0.000037445854,0.000037215097,0.00025066448,0.0005670843,0.000025932783],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011482436,0.0001609798,0.00029586226,0.00018314863,0.000040513827,0.00003119251,0.000053869648,0.000086963744,0.96468014,0.0006177719,0.0000021622193,0.032699134],"study_design_scores_gemma":[0.0008158887,0.00047000154,0.0009119449,0.0004628022,0.00003825308,0.000020990994,0.0022107898,0.00011790299,0.986369,0.0003136924,0.007739529,0.00052919734],"about_ca_topic_score_codex":0.00041288056,"about_ca_topic_score_gemma":0.0031649307,"teacher_disagreement_score":0.032169938,"about_ca_system_score_codex":0.00021312785,"about_ca_system_score_gemma":0.00010492842,"threshold_uncertainty_score":0.9997778},"labels":[],"label_agreement":null},{"id":"W7071734702","doi":"","title":"Uncovering the role of mutant RAC1 in cutaneous melanoma","year":2018,"lang":"en","type":"dissertation","venue":"eScholarship@McGill (McGill)","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Université de Montréal; McGill University","keywords":"Transcriptome; Melanoma; Mutant; RAC1; Signal transduction; Proteomics; Microphthalmia-associated transcription factor; Carcinogenesis","score_opus":0.006690504937081659,"score_gpt":0.21545414854402964,"score_spread":0.208763643606948,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7071734702","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9139274,0.00081958243,9.36234e-8,0.0000028267934,0.000734898,0.0004536166,0.0005638151,0.000024380646,0.08347339],"genre_scores_gemma":[0.99531233,0.0003349416,0.00016948654,0.000072465526,0.00013322567,0.00007653336,0.0010267751,0.00012572609,0.0027484905],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99724627,0.00021194917,0.00074841344,0.0008256621,0.0004176062,0.0005500892],"domain_scores_gemma":[0.99812657,0.00005488421,0.00050283584,0.0009472929,0.00023108604,0.00013734798],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00046628443,0.0005449934,0.00053692906,0.00016138637,0.00030635597,0.000028973815,0.00077701884,0.000827724,0.00010128505],"category_scores_gemma":[0.00040249465,0.00046885942,0.00029797183,0.0002485419,0.00008041859,0.000014856803,0.00019280447,0.0006066956,0.00007186973],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039759517,0.00010296234,0.00013195335,0.000114013805,0.0001286737,0.000062477,0.000014032633,0.00001822648,0.9499383,0.003145312,0.000003940142,0.04594253],"study_design_scores_gemma":[0.00043104202,0.00043459187,0.0003627649,0.00016481528,0.00007097049,0.0001049978,0.00038155154,0.0000076166725,0.86447257,0.0052932007,0.12777928,0.00049660506],"about_ca_topic_score_codex":0.00032221625,"about_ca_topic_score_gemma":0.0033302912,"teacher_disagreement_score":0.12777533,"about_ca_system_score_codex":0.00010640687,"about_ca_system_score_gemma":0.000095807976,"threshold_uncertainty_score":0.9997763},"labels":[],"label_agreement":null},{"id":"W7084141838","doi":"10.5194/wes-2025-152-rc1","title":"Comment on wes-2025-152","year":2025,"lang":"en","type":"peer-review","venue":"","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"North Island College","funders":"","keywords":"Mesoscale meteorology; Wake; Turbine; Wind power; Offshore wind power; Wind speed","score_opus":0.02559297736461563,"score_gpt":0.3016156857295934,"score_spread":0.2760227083649778,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7084141838","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000025014147,0.04164032,0.0003767038,0.17177615,0.004241069,0.0008148411,0.000632627,0.000039968618,0.7804533],"genre_scores_gemma":[0.000083727784,0.018217511,0.0002090668,0.1397414,0.00069689745,0.00010388349,0.0072206226,0.000026663618,0.83370024],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99855965,0.00007968067,0.000300704,0.0005735989,0.00021288135,0.00027349123],"domain_scores_gemma":[0.99878436,0.000019760717,0.000102285165,0.0009004766,0.000101303274,0.0000918212],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00020443305,0.00035419193,0.00043567526,0.000055048007,0.00005660296,0.000017923372,0.0003993419,0.00041905622,0.0009268611],"category_scores_gemma":[0.00009495853,0.0002898774,0.00028205293,0.0000645981,0.000027214584,4.153342e-7,0.00027077258,0.00024121674,0.00024408325],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000012479268,0.000062966035,0.0000028939635,0.0010537779,0.00009212382,0.0000060521547,9.229586e-7,3.1185087e-7,0.0005903341,0.000732188,0.99200934,0.00543663],"study_design_scores_gemma":[0.00021523544,0.00030786687,0.0000038121484,0.0011434915,0.000082961364,0.0000030472352,0.0000021502742,9.0506785e-7,0.009391174,0.000032176005,0.98851323,0.0003039678],"about_ca_topic_score_codex":0.00005046038,"about_ca_topic_score_gemma":0.000045297766,"teacher_disagreement_score":0.05324692,"about_ca_system_score_codex":0.000024288485,"about_ca_system_score_gemma":0.00023257452,"threshold_uncertainty_score":0.9999864},"labels":[],"label_agreement":null},{"id":"W7105162640","doi":"10.71781/30271","title":"Rôle de la signalisation par ERK et de la sénescence cellulaire dans la progression du cancer pancréatique","year":2022,"lang":"fr","type":"dissertation","venue":"Papyrus : Institutional Repository (Université de Montréal)","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"MAPK/ERK pathway; Extracellular signal-regulated kinases; Kinase; Cancer","score_opus":0.0030215408433268967,"score_gpt":0.20196235655652456,"score_spread":0.19894081571319766,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7105162640","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9487832,0.01270893,0.0021144592,0.00017926544,0.0005637118,0.00037557053,0.00016336616,0.000050356633,0.03506114],"genre_scores_gemma":[0.9847165,0.002908304,0.0008038749,0.00010307734,0.00028805935,0.000134375,0.0017173543,0.000049150854,0.009279314],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9966357,0.0015301886,0.00032101755,0.00066237844,0.00042125685,0.0004295123],"domain_scores_gemma":[0.99864835,0.00017314148,0.00041463427,0.00032578106,0.00015774381,0.0002803773],"candidate_categories":["metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.00069063564,0.00043384972,0.0002984995,0.00011478699,0.0035888487,0.000080228434,0.00041257415,0.0008924893,0.00007569327],"category_scores_gemma":[0.00011281725,0.0005106566,0.0002746197,0.00017994718,0.0004545484,0.00004059452,0.00020830189,0.0005847207,0.0000047462186],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006706701,0.00034125504,0.07591923,0.00026297866,0.00020968232,0.0019410105,0.026590126,0.0045662206,0.86109,0.025746016,0.0006653033,0.001997482],"study_design_scores_gemma":[0.001535275,0.00034854186,0.11710255,0.00057005504,0.0004742248,0.0019289482,0.025259461,0.0019270323,0.63028526,0.00032987943,0.2192398,0.0009989531],"about_ca_topic_score_codex":0.016937925,"about_ca_topic_score_gemma":0.0032374097,"teacher_disagreement_score":0.23080473,"about_ca_system_score_codex":0.0028140442,"about_ca_system_score_gemma":0.0055214185,"threshold_uncertainty_score":0.9997345},"labels":[],"label_agreement":null},{"id":"W7105234012","doi":"10.71781/29577","title":"Synthèse et optimisation d'inhibiteurs spécifiques de ERK3 pour le développement d'une thérapie ciblée au cancer du sein triple-négatif","year":2022,"lang":"fr","type":"dissertation","venue":"Papyrus : Institutional Repository (Université de Montréal)","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cancer; Breast cancer; Immunosurveillance; Childhood cancer","score_opus":0.01067306005750071,"score_gpt":0.2114415922600376,"score_spread":0.20076853220253688,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7105234012","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94875365,0.022764271,0.0047629783,0.0033579604,0.0019864386,0.00074316707,0.0003634007,0.00006891696,0.01719919],"genre_scores_gemma":[0.9475337,0.0055006775,0.0028894218,0.0005173962,0.0005616164,0.00024073443,0.004502794,0.00008013185,0.038173486],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9968107,0.00044635858,0.0005459047,0.00096828584,0.0005735053,0.000655286],"domain_scores_gemma":[0.99814373,0.0000612623,0.0005961693,0.00048138582,0.0003232627,0.00039418403],"candidate_categories":["metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.00044718685,0.0006244796,0.000462605,0.00025595992,0.0049910382,0.00007340965,0.00048312522,0.0006200859,0.00013748632],"category_scores_gemma":[0.000103531514,0.000784687,0.00044543477,0.00029841968,0.00020467918,0.000054280874,0.0002928359,0.00048566476,0.000014415208],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.002306554,0.0009832967,0.025472663,0.00051274546,0.0012369535,0.002045204,0.03870042,0.034702346,0.85355294,0.025159469,0.0076242182,0.0077031706],"study_design_scores_gemma":[0.0047844118,0.00068648235,0.05824611,0.0005564667,0.0008972025,0.0012174587,0.050805215,0.005942787,0.651678,0.00064536097,0.22249147,0.0020490065],"about_ca_topic_score_codex":0.10763022,"about_ca_topic_score_gemma":0.034013625,"teacher_disagreement_score":0.21486725,"about_ca_system_score_codex":0.0054936693,"about_ca_system_score_gemma":0.009411072,"threshold_uncertainty_score":0.9994604},"labels":[],"label_agreement":null},{"id":"W7112163010","doi":"","title":"Outcomes with Postrecurrence Systemic Therapy Following Adjuvant Checkpoint Inhibitor Treatment for Resected Melanoma in CheckMate 238","year":2024,"lang":"en","type":"article","venue":"UWA Profiles and Research Repository (University of Western Australia)","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Systemic therapy; Melanoma; Adjuvant; Adjuvant therapy; Nivolumab; Ipilimumab; Programmed cell death 1","score_opus":0.06648043261754608,"score_gpt":0.32505338550426205,"score_spread":0.258572952886716,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7112163010","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969944,0.0017805352,0.000044140565,0.00011726932,0.00014060277,0.00077639206,0.000054949513,0.00001775646,0.00007397044],"genre_scores_gemma":[0.9933351,0.00043079766,0.0002182899,0.0000016817597,0.00006951325,0.000015383574,0.000059284986,0.000016362312,0.0058535454],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986903,0.00013095039,0.00016352802,0.0004590706,0.00022482725,0.00033131705],"domain_scores_gemma":[0.99944836,0.000043239394,0.000055123528,0.00024355734,0.0001014282,0.00010830578],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030091446,0.0001654049,0.00026293236,0.00013884237,0.00015538947,0.000055418765,0.00017074318,0.0001495246,0.0000029693722],"category_scores_gemma":[0.000010276478,0.00013136471,0.00012171399,0.00013118993,0.00014780693,0.00002136481,0.000080382335,0.00012600081,0.000002410671],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00066146196,0.000108502194,0.10249891,0.00041515476,0.0002220442,0.00030574907,0.0008894295,0.000003701663,0.8918445,0.000047327867,0.0001147414,0.0028884413],"study_design_scores_gemma":[0.0029742816,0.004633057,0.11457052,0.0011083401,0.00004517416,0.00011402339,0.0031388004,0.00011541992,0.8698323,0.00001888235,0.0030951172,0.0003541177],"about_ca_topic_score_codex":0.00063057995,"about_ca_topic_score_gemma":0.00009950014,"teacher_disagreement_score":0.02201227,"about_ca_system_score_codex":0.000058083064,"about_ca_system_score_gemma":0.00015461247,"threshold_uncertainty_score":0.5356897},"labels":[],"label_agreement":null},{"id":"W7113146127","doi":"","title":"Updated overall survival (OS) data from the phase 1b study of tebentafusp (tebe) as monotherapy or combination therapy with durvalumab (durva) and/or tremelimumab (treme) in metastatic cutaneous melanoma (mCM).","year":2022,"lang":"en","type":"article","venue":"Research Explorer (The University of Manchester)","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Particle Physics","funders":"","keywords":"Tremelimumab; Durvalumab; Combination therapy; Overall survival; Immunotherapy; Melanoma; Ipilimumab; Metastatic melanoma","score_opus":0.14737765955495585,"score_gpt":0.33922039090865874,"score_spread":0.1918427313537029,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7113146127","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979253,0.00021607101,0.00006753351,0.00043050252,0.000034995457,0.001094905,0.00017868687,0.000008322597,0.000043696717],"genre_scores_gemma":[0.9984519,0.00070155837,0.000076042605,0.00004945319,0.000022205253,0.000010624845,0.00049768493,0.000024577395,0.00016596376],"study_design_codex":"bench_or_experimental","study_design_gemma":"qualitative","domain_scores_codex":[0.99682355,0.0014354971,0.00022710838,0.0005232857,0.00070277625,0.00028775746],"domain_scores_gemma":[0.99826723,0.00027640714,0.00015479632,0.0011103007,0.00012580231,0.000065453154],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010338537,0.000179633,0.0002996311,0.000115804854,0.00035620737,0.000024576355,0.0012142678,0.000044302975,0.0004190534],"category_scores_gemma":[0.00004829423,0.00011601819,0.00004182147,0.0002974841,0.00026174655,0.000030311256,0.00077702175,0.00028382565,0.000003861424],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.23679382,0.05070852,0.057655018,0.0002218908,0.005830838,0.0030706371,0.21520811,0.00068811135,0.35680443,0.00052662764,0.011390895,0.061101098],"study_design_scores_gemma":[0.15936437,0.08002916,0.05175479,0.00015486838,0.0004200728,0.0002591252,0.5810657,0.0069740308,0.031025015,0.0007883866,0.0866596,0.0015048428],"about_ca_topic_score_codex":0.0007958077,"about_ca_topic_score_gemma":0.00093374326,"teacher_disagreement_score":0.36585763,"about_ca_system_score_codex":0.00005338635,"about_ca_system_score_gemma":0.00023797249,"threshold_uncertainty_score":0.47310844},"labels":[],"label_agreement":null},{"id":"W7118075936","doi":"10.47743/jpd.2025.32.1.976","title":"PREDICTION OF 3D STRUCTURE OF MITOGEN-ACTIVATED PROTEIN KINASE KINASE 2 USING ALPHAFOLD 2 AND SIMULATION OF ITS INTERACTION WITH MITOGEN-ACTIVATED PROTEIN KINASE 6 IN ARABIDOPSIS THALIANA","year":2025,"lang":"","type":"article","venue":"Journal of Plant Development","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Carleton University","funders":"","keywords":"Mitogen-activated protein kinase kinase; MAP kinase kinase kinase; MAP2K7; Cyclin-dependent kinase 9; Protein kinase A; c-Raf; Docking (animal); Cyclin-dependent kinase 2; ASK1","score_opus":0.01961443145398404,"score_gpt":0.24467038891252194,"score_spread":0.2250559574585379,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7118075936","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99532723,0.001088045,0.0015602491,0.000022198741,0.0004341692,0.001183171,0.00036303143,0.0000032662372,0.00001862745],"genre_scores_gemma":[0.99684435,0.00008801077,0.0027433136,0.0000077848445,0.000060765007,0.000009787697,0.00015902516,0.000025350095,0.00006158262],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9968925,0.00025151644,0.0016985926,0.00039759555,0.0004599614,0.00029979815],"domain_scores_gemma":[0.99660915,0.000043115997,0.0022377209,0.00023432472,0.00074775703,0.00012793847],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00036213594,0.0004147556,0.00075751095,0.0006264969,0.00007841916,0.00002155657,0.00017875896,0.00040074074,0.000025843736],"category_scores_gemma":[0.00021637151,0.00036162278,0.000100897756,0.00048796,0.000087422726,0.000067607965,0.000097552314,0.0003511529,9.7515795e-8],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0070055393,0.00037688416,0.002310821,0.0013953013,0.00067723595,0.00005467714,0.0007738401,0.008581673,0.97502524,0.0000086311165,0.000014963645,0.0037751785],"study_design_scores_gemma":[0.0034445948,0.0011852873,0.0033748536,0.004528511,0.00015744267,0.00007000301,0.0003714589,0.0023030373,0.9836855,0.000017264016,0.0005891837,0.00027287027],"about_ca_topic_score_codex":0.00006489438,"about_ca_topic_score_gemma":0.000057233967,"teacher_disagreement_score":0.008660238,"about_ca_system_score_codex":0.0002170238,"about_ca_system_score_gemma":0.0011247689,"threshold_uncertainty_score":0.9998836},"labels":[],"label_agreement":null},{"id":"W7125212277","doi":"10.1098/rsbm.2025.0021","title":"Christopher John Marshall","year":2025,"lang":"en","type":"article","venue":"Biographical Memoirs of Fellows of the Royal Society","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"Francis Crick Institute","keywords":"Rigour; Passion; Biography; Rest (music); Bench to bedside; Cancer; Identification (biology)","score_opus":0.00519449700143627,"score_gpt":0.217008585054037,"score_spread":0.21181408805260074,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7125212277","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98433846,0.0018442532,0.00047029584,0.0004991787,0.00035660624,0.00021229885,0.000037537113,0.000010525632,0.012230857],"genre_scores_gemma":[0.9965287,0.00016176075,0.0009947905,0.000322461,0.00007585164,0.000008680615,0.000011470425,0.000010209389,0.0018861076],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990532,0.00005469096,0.00027949663,0.000250953,0.00016779793,0.0001938871],"domain_scores_gemma":[0.9991749,0.00002226046,0.00012669782,0.00053530873,0.00009047329,0.000050376944],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021040186,0.00014346163,0.00021615691,0.00002488417,0.00007584903,0.0000053096783,0.0004966309,0.00028030068,0.000021698896],"category_scores_gemma":[0.000060249604,0.00010172911,0.0009097873,0.00028280503,0.00041866075,0.0000012328005,0.00028704022,0.00012070199,9.1635246e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016065744,0.0003959535,0.049899172,0.0002569385,0.00059121015,5.624653e-7,0.00006667806,0.000079700294,0.83828324,0.0024317298,0.106096335,0.0017377913],"study_design_scores_gemma":[0.0013770738,0.00032839648,0.08709668,0.00013746164,0.00019351611,0.0000012023497,0.00021737792,0.00029546887,0.78219587,0.001445256,0.12634346,0.0003682503],"about_ca_topic_score_codex":0.0000847755,"about_ca_topic_score_gemma":0.000011855993,"teacher_disagreement_score":0.056087416,"about_ca_system_score_codex":0.0000056641416,"about_ca_system_score_gemma":0.000059485174,"threshold_uncertainty_score":0.41483927},"labels":[],"label_agreement":null},{"id":"W7133073096","doi":"","title":"Genetic variants of the MAPK pathways: In silico characterization to breast cancer association","year":2007,"lang":"","type":"dissertation","venue":"TSpace","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Heritage; Library and Archives Canada","funders":"","keywords":"Breast cancer; In silico; Single-nucleotide polymorphism; Heterozygote advantage; Cancer; Genotype; MAPK/ERK pathway","score_opus":0.010039658556636213,"score_gpt":0.2819842480923982,"score_spread":0.271944589535762,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7133073096","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99478567,0.0003283476,0.00031756435,0.00029230202,0.0017306419,0.0009673776,0.0004199092,0.0000061101364,0.0011520715],"genre_scores_gemma":[0.98688173,0.00063584174,0.000078350015,0.00029350142,0.00052976655,0.00009962015,0.00089144596,0.00006034906,0.0105294045],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9974187,0.0002073541,0.00070463715,0.0006712167,0.00046375493,0.00053433806],"domain_scores_gemma":[0.99789685,0.000024114037,0.00092593994,0.00060616614,0.0004118999,0.00013503054],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00041146466,0.00042480443,0.00045584314,0.00016960877,0.0001033935,0.000035123954,0.00043663583,0.00096087327,0.00020625169],"category_scores_gemma":[0.00015866586,0.0003937464,0.00019437075,0.00053563126,0.000024396517,0.0000065800123,0.000115694085,0.0002853273,0.000027189068],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002678067,0.00015294422,0.045761853,0.00018885371,0.00008209126,0.0000031082104,0.002889386,0.00008225802,0.9435102,0.000027292179,0.00013526327,0.006898995],"study_design_scores_gemma":[0.0004541535,0.000105683204,0.70410454,0.00027768343,0.00007035249,0.000004630008,0.0005768524,0.0000688552,0.29259244,0.000006146983,0.001417117,0.00032155632],"about_ca_topic_score_codex":0.00062661816,"about_ca_topic_score_gemma":0.0017354281,"teacher_disagreement_score":0.65834266,"about_ca_system_score_codex":0.00025005144,"about_ca_system_score_gemma":0.0004979352,"threshold_uncertainty_score":0.99985147},"labels":[],"label_agreement":null},{"id":"W7161803099","doi":"10.82308/18628","title":"ERK4, a new tumor suppressor gene candidate implicated in prostate cancer progression","year":2005,"lang":"en","type":"dissertation","venue":"","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Prostate cancer; Tumor suppressor gene; Candidate gene; Locus (genetics); Metastasis; Allele; Cancer; Microarray analysis techniques; Gene; Genotyping","score_opus":0.007563608998492463,"score_gpt":0.2876354614230219,"score_spread":0.2800718524245294,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7161803099","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9870138,0.003533812,0.000006598578,0.00012276016,0.0003212103,0.0009045786,0.00014998653,0.00003294089,0.007914273],"genre_scores_gemma":[0.86886185,0.0015654233,0.00091551425,0.00034593628,0.0009895746,0.000799837,0.018144324,0.00014728405,0.10823023],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99830496,0.000037105237,0.0003784416,0.0006737871,0.00016749282,0.0004382157],"domain_scores_gemma":[0.9991362,0.00000313404,0.00020440147,0.00039847475,0.00008412016,0.00017364084],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00007556559,0.00036105013,0.0003092502,0.00010009128,0.000048816943,0.000037531296,0.00024843603,0.00030245693,0.00024830294],"category_scores_gemma":[0.000020312275,0.0003064922,0.00009592674,0.00011853269,0.00001598845,0.0000042222273,0.00005418013,0.00019737503,0.000024864632],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005727639,0.000072113595,0.001254891,0.000090612346,0.00004519847,0.000026723752,0.00013494151,0.000010972106,0.96965563,0.000015647176,0.016296636,0.01182386],"study_design_scores_gemma":[0.0010118592,0.00016892754,0.0073777917,0.000118058095,0.000032982043,0.000014203927,0.00006774873,0.000023920345,0.9321237,0.00002173032,0.05859781,0.00044122763],"about_ca_topic_score_codex":0.0010453023,"about_ca_topic_score_gemma":0.013024419,"teacher_disagreement_score":0.11815197,"about_ca_system_score_codex":0.000037881946,"about_ca_system_score_gemma":0.000642947,"threshold_uncertainty_score":0.9999387},"labels":[],"label_agreement":null},{"id":"W7161992983","doi":"10.82308/27573","title":"Investigation of the co-operativity of mutations in the mitogen-activated protein kinase (MAPK) pathway in cutaneous melanomas","year":2022,"lang":"en","type":"dissertation","venue":"","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Kinase; MAPK/ERK pathway; Protein kinase A; Mutation; Neuroblastoma RAS viral oncogene homolog; Mutant","score_opus":0.014331388421173112,"score_gpt":0.24753158482972867,"score_spread":0.23320019640855555,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7161992983","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99441564,0.00021655925,0.000004725492,0.000047662692,0.00015127253,0.001120939,0.00015869323,0.0000039849515,0.003880533],"genre_scores_gemma":[0.99456346,0.000013560111,0.000048141806,0.000044380464,0.000025352749,0.00029736306,0.003049313,0.000020356874,0.0019380512],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998331,0.00050258636,0.00045661727,0.00029599827,0.00026382646,0.00014994762],"domain_scores_gemma":[0.9990939,0.000039187507,0.0003208445,0.0004451452,0.000077242905,0.000023694527],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027678433,0.0001991805,0.00024103429,0.00010026248,0.000074809825,0.000009791449,0.0003569763,0.00023385228,0.00009253102],"category_scores_gemma":[0.0001634777,0.00013439695,0.000109666886,0.00030009533,0.00007401567,0.000004317029,0.000040121675,0.0002731417,8.723738e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010961533,0.00007065938,0.0014172309,0.0001086176,0.000021007198,0.000007601155,0.002047736,0.000048013455,0.9952006,0.0005335069,0.000085379754,0.00035007426],"study_design_scores_gemma":[0.00034072998,0.00021872969,0.004666893,0.00005115899,0.000010799755,0.0000083921,0.0022768532,0.000014657264,0.99090666,0.00021064178,0.0011460363,0.00014847127],"about_ca_topic_score_codex":0.00067864015,"about_ca_topic_score_gemma":0.0049479627,"teacher_disagreement_score":0.0042939214,"about_ca_system_score_codex":0.000027666269,"about_ca_system_score_gemma":0.0004626044,"threshold_uncertainty_score":0.5480548},"labels":[],"label_agreement":null},{"id":"W761145466","doi":"","title":"Activation of mammalian target of rapamycin complex 1 (mTORC1) and 2 (mTORC2) is required for retinal ganglion cell dendrite regeneration after axonal injury.","year":2015,"lang":"en","type":"article","venue":"Investigative Ophthalmology & Visual Science","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"mTORC1; mTORC2; Regeneration (biology); Retinal ganglion cell; Neuroscience; Dendrite (mathematics); Cell biology; PI3K/AKT/mTOR pathway; Retina; Biology; Signal transduction","score_opus":0.04691283773313831,"score_gpt":0.3125197278770259,"score_spread":0.2656068901438876,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W761145466","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984993,0.00006847569,0.00041217412,0.00010897267,0.0001256946,0.00029291195,0.000083945844,0.000003938166,0.00040464208],"genre_scores_gemma":[0.9882442,0.0000019852364,0.011226423,0.00011107386,0.00011744422,0.000042762927,0.00010026728,0.00001068744,0.00014517721],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986392,0.00012215436,0.0003074505,0.00045157786,0.00023837987,0.0002412092],"domain_scores_gemma":[0.99889016,0.000021660211,0.0002491857,0.00018304664,0.00047432416,0.00018163254],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00062311074,0.00015393538,0.00020523064,0.00010858343,0.000088016975,0.0000129891105,0.00018007812,0.00014510202,0.000020264111],"category_scores_gemma":[0.00024224145,0.00014666554,0.00004490198,0.00023015673,0.0015605756,0.000033567307,0.00012165963,0.00005720976,0.0000010830108],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003502923,0.00004669836,0.012076131,0.000033660133,0.0000070338733,0.0000026770365,0.00043600012,0.00001269221,0.9865542,0.00010178971,0.0003126907,0.00006611567],"study_design_scores_gemma":[0.00047185455,0.0022813159,0.010702995,0.000019615276,0.000010289846,0.000028253091,0.00013412425,0.00034341664,0.98425984,0.0011741136,0.00042398507,0.00015019103],"about_ca_topic_score_codex":0.00003293146,"about_ca_topic_score_gemma":0.0000016231745,"teacher_disagreement_score":0.0108142495,"about_ca_system_score_codex":0.000025500967,"about_ca_system_score_gemma":0.00032095675,"threshold_uncertainty_score":0.5980847},"labels":[],"label_agreement":null},{"id":"W84962494","doi":"10.1096/fasebj.21.5.a258-a","title":"Involvement of ERK in the Regulation of Apoptosis of Breast Cancer Cells","year":2007,"lang":"en","type":"article","venue":"The FASEB Journal","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"NOSM University; Laurentian University","funders":"","keywords":"Apoptosis; MAPK/ERK pathway; Annexin; Kinase; Cell cycle; Cancer research; Cell growth; Cell biology; Signal transduction; Programmed cell death; Breast cancer; Biology; Cancer; Chemistry; Biochemistry","score_opus":0.013321051210858924,"score_gpt":0.2402353329071722,"score_spread":0.22691428169631328,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W84962494","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99869716,0.0002362722,0.00041122158,0.000099340774,0.000082197635,0.000064609056,0.000019859917,3.2500716e-7,0.00038902232],"genre_scores_gemma":[0.99957335,0.00013527059,0.00008809099,0.00005049174,0.000110358924,0.0000010480975,0.0000039056495,0.0000033110923,0.000034190063],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99943763,0.000056547964,0.00023897663,0.000046826444,0.00013299767,0.00008700142],"domain_scores_gemma":[0.99953985,0.00001428494,0.00021450261,0.00014460864,0.00006985076,0.000016929436],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007466107,0.000046094472,0.00007873978,0.00002916035,0.000023107394,0.0000023434638,0.00015965005,0.000037151272,0.00002764972],"category_scores_gemma":[0.0000059975946,0.000025665415,0.000056608893,0.00006512673,0.000053869855,0.0000016675692,0.0000224112,0.00005936447,2.1437103e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009041938,0.000045544282,0.0046294066,0.000013806546,0.000021124513,2.1918103e-7,0.00031003964,0.00011743951,0.9930317,0.00008272937,0.00026348358,0.0013941152],"study_design_scores_gemma":[0.00024819575,0.0000906681,0.047561146,0.000026432228,0.000015080887,0.00001200168,0.00042025946,0.0000082782635,0.9513884,0.000085912856,0.0001167912,0.000026818414],"about_ca_topic_score_codex":0.00007610899,"about_ca_topic_score_gemma":0.00006309614,"teacher_disagreement_score":0.04293174,"about_ca_system_score_codex":0.0000068992263,"about_ca_system_score_gemma":0.000041969754,"threshold_uncertainty_score":0.104660526},"labels":[],"label_agreement":null},{"id":"W937127559","doi":"10.1016/j.bmcl.2015.07.093","title":"Recent progress on MAP kinase pathway inhibitors","year":2015,"lang":"en","type":"review","venue":"Bioorganic & Medicinal Chemistry Letters","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":60,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"MAPK/ERK pathway; Signal transduction; Kinase; Anti-apoptotic Ras signalling cascade; Chemistry; Mitogen-activated protein kinase; Intracellular; Cancer research; Cell biology; Computational biology; Biology; Biochemistry","score_opus":0.03257826275852975,"score_gpt":0.2847047729781015,"score_spread":0.2521265102195717,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W937127559","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0014646117,0.9947011,0.0000066193347,0.0007401445,0.001246687,0.00066251005,0.00014896142,0.0000698773,0.0009595052],"genre_scores_gemma":[0.00018503636,0.9894255,0.00006185666,0.0008105037,0.005394145,0.00016692828,0.0028912239,0.000190728,0.0008741121],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9963886,0.0001472392,0.00079947273,0.001230372,0.0006997016,0.0007345954],"domain_scores_gemma":[0.9975525,0.000023952292,0.0005278022,0.0011883106,0.00012657372,0.0005808746],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000494875,0.0009713997,0.0013207243,0.00007284744,0.00009716588,0.000043687545,0.0007882167,0.0009011003,0.00019073304],"category_scores_gemma":[0.00016123046,0.0007861641,0.00043610288,0.00024678843,0.0002986719,0.0000037167172,0.00027261712,0.0006994427,0.00028501105],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005913162,0.00017821636,0.0000040590035,0.007689127,0.0002625324,0.0004857933,0.000023584702,7.9040134e-8,0.096617855,0.0000027752476,0.14296222,0.75171465],"study_design_scores_gemma":[0.00050441275,0.00019053597,4.2866068e-7,0.0033405777,0.00029713695,0.0002552703,0.000022101724,1.3691414e-7,0.05041207,0.0000017028942,0.94421417,0.0007614844],"about_ca_topic_score_codex":0.0000022087788,"about_ca_topic_score_gemma":6.8537537e-7,"teacher_disagreement_score":0.80125195,"about_ca_system_score_codex":0.0002479168,"about_ca_system_score_gemma":0.0008829389,"threshold_uncertainty_score":0.9994589},"labels":[],"label_agreement":null}]}